Citrus Sinensis ID: 017452

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-
Protein Sequence
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS
Secondary Structure (PSIPRED)
ccccccccccccccccccccccccccHHccccccccccccccEEEccccccEEEEEEEEEccccccccEEEEEEEEEEEEcccEEEEEEEEEcccccEEEEEcccccccHHHHHHHHHHHcccccEEEEcEEEccccccccEEEEEEEEcccccHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccccccccccEEcccccccEEEEccccccccccccccEEEEEEccccccHHccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHcccccHHHHHHHccccccccccccccccccccccccccHHHHHHHHHHccccccccccHHHHcccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
ccccccccccccccccccccccccccHHHccccccccccccccEEccccccccEEEEEEEEcccccccEEEEEEEEEEEEEcccEEEEEEEEcccccEEEEEEEEEccccccHHHHHHcccccccEccEEEEEEEccccccEEEEEEEEcccEEHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEccccccEEEccccccEEcccccccccccccHHHccHHHHccccccccHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHccccccccccccHHHHccccccHHHHHHHHccccccHHHcccHHHHcHHHHHcccccccccccccc
Coil and Loop (DISEMBL)
masvgvaptscvressghtvgvdklpeemndmkirddkemeatvvdgngteTGHIIVTTiggrngqpkqTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQtmrlldhpnvvslkhcffsttdkDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSigvchrdikpqnllvnphthqvklcdfgsakvlvkgepnisyicsryyrapelifgateyttaIDIWSAGCVVAELmlgkplfpgdsgvDQLVEIIKVLGtptreeikcmnpnytefkfpqikahpwhkifpkrmppeAVDLVSRLLqyspnlrctavskrilfsncpsllvlhhfcfrs
Flexible Loop (DISEMBL)
masvgvaptscvressghtvgvdklpeemNDMKIRDDKEMeatvvdgngteTGHIIvttiggrngqpKQTISYMAERIVGQGSFGVVFQAKCLETGETvaikkvlqdkrykNRELQtmrlldhpnvvSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHfnklnqrmpMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS
Low Complexity Region (SEG)
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS
Disordered region (IsUnstruct)
***********************************************NGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCF**
Disordered Region (DISOPRED)
**********************************************************T**********TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHF*F**
Disordered Region (DISEMBL)
*****************HTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS
Disordered Region (DISPRO)
******************************************TVVD**GTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHF****
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	371	2.2.26 [Sep-21-2011]
Q40518	409	Shaggy-related protein ki	N/A	no	0.940	0.853	0.914	0.0
P43288	405	Shaggy-related protein ki	yes	no	0.932	0.854	0.914	0.0
P43289	409	Shaggy-related protein ki	no	no	0.951	0.863	0.886	0.0
P51137	411	Glycogen synthase kinase-	N/A	no	0.943	0.851	0.909	0.0
P51139	411	Glycogen synthase kinase-	N/A	no	0.940	0.849	0.894	0.0
Q8VZD5	410	Shaggy-related protein ki	no	no	0.940	0.851	0.868	0.0
P51138	411	Glycogen synthase kinase-	N/A	no	0.940	0.849	0.845	1e-180
Q96287	472	Shaggy-related protein ki	no	no	0.938	0.737	0.778	1e-167
O04160	468	Shaggy-related protein ki	N/A	no	0.881	0.698	0.792	1e-164
Q39010	412	Shaggy-related protein ki	no	no	0.932	0.839	0.749	1e-159

>sp|Q40518|MSK1_TOBAC Shaggy-related protein kinase NtK-1 OS=Nicotiana tabacum GN=NTK-1 PE=2 SV=1

 Score =  679 bits (1751), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/349 (91%), Positives = 338/349 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           M SVG+AP S +RESS H+VGVD+LPEEMNDM+IRDDKE+EA +VDGNGTETGHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGR+GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVV LKHCFFSTT+KDE+YLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIH +IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 349

May mediate extracellular signals to regulate transcription in differentiating cells.
Nicotiana tabacum (taxid: 4097)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P43288|KSG1_ARATH Shaggy-related protein kinase alpha OS=Arabidopsis thaliana GN=ASK1 PE=2 SV=3

 Score =  671 bits (1731), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/350 (91%), Positives = 335/350 (95%), Gaps = 4/350 (1%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+AP    R+S+G    VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPNPGARDSTG----VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 56

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 57  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 116

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 117 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 176

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 177 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 236

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 237 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 296

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  A+ 
Sbjct: 297 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALD 346

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43289|KSG3_ARATH Shaggy-related protein kinase gamma OS=Arabidopsis thaliana GN=ASK3 PE=2 SV=1

 Score =  670 bits (1729), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/353 (88%), Positives = 337/353 (95%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+ P++ VRES+G+    D+LPEEM DMKI+DDKEMEAT+V+GN TETGHIIVTTI
Sbjct: 1   MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP++YVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFR+LSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI 353
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC A+   +
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLV 353

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51137|MSK1_MEDSA Glycogen synthase kinase-3 homolog MsK-1 OS=Medicago sativa GN=MSK-1 PE=2 SV=1

 Score =  662 bits (1709), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 320/352 (90%), Positives = 334/352 (94%), Gaps = 2/352 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDK-LPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVT 58
           MASVGVAPTS  RE  G   +GVD  LPEEM+DMKIRDD+EMEATVVDGNGTETGHIIVT
Sbjct: 1   MASVGVAPTSGFREVLGDGEIGVDDILPEEMSDMKIRDDREMEATVVDGNGTETGHIIVT 60

Query: 59  TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
           TIGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM
Sbjct: 61  TIGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 120

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           RLLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH++KLNQRMPMIYVKLY 
Sbjct: 121 RLLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQRMPMIYVKLYT 180

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           YQIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY
Sbjct: 181 YQIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 240

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           YRAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+ GVDQLVEIIKVLGTPTREEI
Sbjct: 241 YRAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGERGVDQLVEIIKVLGTPTREEI 300

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           KCMNPNYTEFKFPQIKAHPWHKIF KRMP EAVDLVSRLLQYSPNLRC A+ 
Sbjct: 301 KCMNPNYTEFKFPQIKAHPWHKIFHKRMPAEAVDLVSRLLQYSPNLRCQALD 352

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51139|MSK3_MEDSA Glycogen synthase kinase-3 homolog MsK-3 OS=Medicago sativa GN=MSK-3 PE=2 SV=2

 Score =  659 bits (1700), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 313/350 (89%), Positives = 334/350 (95%), Gaps = 1/350 (0%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEA-TVVDGNGTETGHIIVTT 59
           MAS GVAP S   + +  +VGV+KLPEEMNDMKIRDDKEMEA T+VDGNGTETGHIIVTT
Sbjct: 1   MASGGVAPASGFIDKNASSVGVEKLPEEMNDMKIRDDKEMEAATIVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV RV++H+NK+NQRMPMIYVKLY+Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVSRVIRHYNKMNQRMPMIYVKLYSY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI RAL+YIH SIGVCHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHNSIGVCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAIDIWSAGCV+ EL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDIWSAGCVLGELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSTAL 350

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8VZD5|KSG5_ARATH Shaggy-related protein kinase epsilon OS=Arabidopsis thaliana GN=ASK5 PE=2 SV=1

 Score =  641 bits (1653), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 304/350 (86%), Positives = 327/350 (93%), Gaps = 1/350 (0%)

Query: 1   MASVGVAPTSCVR-ESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           MASVG  P S +  + S  ++  +KLPE +N+MKI+DDKEMEA VVDGNGTETGHIIVTT
Sbjct: 1   MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAERIVGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV+RV KH+++ NQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI RAL+YIH  +GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTT IDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLR TA+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P51138|MSK2_MEDSA Glycogen synthase kinase-3 homolog MsK-2 OS=Medicago sativa GN=MSK-2 PE=2 SV=1

 Score =  632 bits (1631), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 296/350 (84%), Positives = 327/350 (93%), Gaps = 1/350 (0%)

Query: 1   MASVGVAPTSCVRE-SSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           MA+ GVAP S + + ++   + VDKLP+E+  M+I+DDKEMEA VVDGN TE GH+IVTT
Sbjct: 1   MATAGVAPASGIVDVNASSAIAVDKLPDEILGMRIKDDKEMEAHVVDGNSTEAGHVIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGG+NGQPKQTISYMAER VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGKNGQPKQTISYMAERAVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV+LKHCFFSTT+KDELYLNLVLE+VPETVHRV++H++K+NQRMP+IYVKLY+Y
Sbjct: 121 LLDHPNVVTLKHCFFSTTEKDELYLNLVLEFVPETVHRVIRHYSKMNQRMPLIYVKLYSY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QI R+L+YIH  +GV HRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QICRSLAYIHNCVGVSHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYT+AIDIWSAGCV+ EL+LG+PLFPG SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTSAIDIWSAGCVLGELLLGQPLFPGASGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR TA+
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFRKRMPPEAVDLVSRLLQYSPNLRSTAL 350

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q96287|KSG8_ARATH Shaggy-related protein kinase theta OS=Arabidopsis thaliana GN=ASK8 PE=2 SV=3

 Score =  586 bits (1511), Expect = e-167,   Method: Compositional matrix adjust.
 Identities = 277/356 (77%), Positives = 313/356 (87%), Gaps = 8/356 (2%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETG 53
           ++   VA TS V   S   V  D+LP+ M +MKIRD       DK+ME TVV+G+GTETG
Sbjct: 60  LSQESVAGTSNVPAVSEKPVD-DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
            +I TT+GGR+G+PKQTISYMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNR
Sbjct: 119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
           ELQ MRL DHPNVV L+H FFSTTDKDELYLNLVLEYVPETV+R  KH+ K+NQ MP+I+
Sbjct: 179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           V+LY YQI RAL+Y+HR +GVCHRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISY
Sbjct: 239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           ICSRYYRAPELIFGATEYT AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTP
Sbjct: 299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           TREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+
Sbjct: 359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 414

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O04160|KSGT_BRANA Shaggy-related protein kinase theta OS=Brassica napus PE=2 SV=2

 Score =  578 bits (1489), Expect = e-164,   Method: Compositional matrix adjust.
 Identities = 267/337 (79%), Positives = 303/337 (89%), Gaps = 10/337 (2%)

Query: 23  DKLPEEMNDMKIRDD----------KEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS 72
           D+LPE MNDM++R+D          K+ME  +V+G GTETG +I TT+GGR+G+PKQTIS
Sbjct: 74  DQLPEVMNDMRLREDEPHANRGEEDKDMEPPIVNGCGTETGQVITTTVGGRDGKPKQTIS 133

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           YMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNRELQ MRL DHPNVV L+H 
Sbjct: 134 YMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNRELQIMRLQDHPNVVRLRHS 193

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           FFSTTDKDELYLNLVLE+VPETV+R +KH+ K+NQ MP+I V+LY YQI RAL+Y+HR +
Sbjct: 194 FFSTTDKDELYLNLVLEFVPETVYRALKHYTKMNQHMPIILVQLYTYQICRALNYLHRVV 253

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           GVCHRDIKPQNLLVN HTHQ+K+CDFGSAK+LV GEPNISYICSRYYRAPELIFGATEYT
Sbjct: 254 GVCHRDIKPQNLLVNTHTHQLKICDFGSAKMLVPGEPNISYICSRYYRAPELIFGATEYT 313

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
            AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTPTREEI+CMNPNYTEFKFPQ
Sbjct: 314 NAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTPTREEIRCMNPNYTEFKFPQ 373

Query: 313 IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           IKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+
Sbjct: 374 IKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 410

May mediate extracellular signals to regulate transcription in differentiating cells.

Brassica napus (taxid: 3708)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q39010|KSG6_ARATH Shaggy-related protein kinase zeta OS=Arabidopsis thaliana GN=ASK6 PE=2 SV=2

 Score =  561 bits (1445), Expect = e-159,   Method: Compositional matrix adjust.
 Identities = 263/351 (74%), Positives = 303/351 (86%), Gaps = 5/351 (1%)

Query: 1   MASVGVAPTS--CVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVT 58
           M S+ + P     +     H  G D L    +   I +DKEM A V++GN   TGHII T
Sbjct: 1   MTSIPLGPPQPPSLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIIST 57

Query: 59  TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
           TIGG+NG+PKQTISYMAER+VG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ M
Sbjct: 58  TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLM 117

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           RL+DHPNVVSLKHCFFSTT +DEL+LNLV+EYVPET++RV+KH+   NQRMP+ YVKLY 
Sbjct: 118 RLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYT 177

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           YQIFR L+YIH + GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRY
Sbjct: 178 YQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRY 237

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           YRAPELIFGATEYT++IDIWSAGCV+AEL+LG+PLFPG++ VDQLVEIIKVLGTPTREEI
Sbjct: 238 YRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEI 297

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LRCTA+
Sbjct: 298 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 348

May mediate extracellular signals to regulate transcription in differentiating cells.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
225450484	409	PREDICTED: shaggy-related protein kinase	0.943	0.855	0.94	0.0
82623409	409	NtK-1-like [Solanum tuberosum]	0.943	0.855	0.928	0.0
224124570	409	predicted protein [Populus trichocarpa]	0.943	0.855	0.922	0.0
255543002	383	Glycogen synthase kinase-3 beta, putativ	0.938	0.908	0.939	0.0
81075765	409	Ser/Thr protein kinase-like [Solanum tub	0.943	0.855	0.92	0.0
224124962	409	predicted protein [Populus trichocarpa]	0.943	0.855	0.917	0.0
118482349	409	unknown [Populus trichocarpa]	0.943	0.855	0.917	0.0
297812879	409	hypothetical protein ARALYDRAFT_489503 [	0.943	0.855	0.917	0.0
233142272	410	glycogen synthase kinase [Glycine max]	0.943	0.853	0.920	0.0
11133532	409	RecName: Full=Shaggy-related protein kin	0.940	0.853	0.914	0.0

>gi|225450484|ref|XP_002280673.1| PREDICTED: shaggy-related protein kinase alpha [Vitis vinifera]

 Score =  696 bits (1796), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 329/350 (94%), Positives = 342/350 (97%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RE SGH  GVD+LPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPTSGLREPSGHNAGVDRLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ+KLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQLKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AELMLG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELMLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+ 
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAMD 350

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|82623409|gb|ABB87119.1| NtK-1-like [Solanum tuberosum]

 Score =  691 bits (1783), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 325/350 (92%), Positives = 341/350 (97%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RESSGH  GVD+LPEEMNDM+IRDDKEMEAT+VDGNGTETGHIIVTTI
Sbjct: 1   MASVGLAPTSGLRESSGHNAGVDRLPEEMNDMRIRDDKEMEATIVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC A+ 
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCGALD 350

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124570|ref|XP_002330056.1| predicted protein [Populus trichocarpa] gi|222871481|gb|EEF08612.1| predicted protein [Populus trichocarpa]

 Score =  687 bits (1774), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/350 (92%), Positives = 340/350 (97%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           M SVGVAP+S +RE+S H  GVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MGSVGVAPSSGLREASAHNAGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH++KLNQ+MP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYSKLNQKMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+ 
Sbjct: 301 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALD 350

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255543002|ref|XP_002512564.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis] gi|223548525|gb|EEF50016.1| Glycogen synthase kinase-3 beta, putative [Ricinus communis]

 Score =  687 bits (1773), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/349 (93%), Positives = 342/349 (97%), Gaps = 1/349 (0%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVGVAPT  +RE+SGH VGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGVAPTG-LREASGHNVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 59

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 60  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 119

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLYAYQ
Sbjct: 120 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYAYQ 179

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIH +IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 180 IFRALSYIHCAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 239

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 240 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 299

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC A+
Sbjct: 300 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCNAL 348

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|81075765|gb|ABB55385.1| Ser/Thr protein kinase-like [Solanum tuberosum]

 Score =  682 bits (1760), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 322/350 (92%), Positives = 338/350 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+APTS +RESSGH  GVD+LPEEMNDM+IRDDKEMEA +V G GTETGHIIVTTI
Sbjct: 1   MASVGLAPTSGLRESSGHNAGVDRLPEEMNDMRIRDDKEMEAAMVAGIGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC A+ 
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCGALD 350

Source: Solanum tuberosum

Species: Solanum tuberosum

Genus: Solanum

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224124962|ref|XP_002319468.1| predicted protein [Populus trichocarpa] gi|222857844|gb|EEE95391.1| predicted protein [Populus trichocarpa]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/350 (91%), Positives = 337/350 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MAS GVAPTS +RE+  H  GVDKLPEEMNDMKIRDDK+MEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASAGVAPTSGLREAGVHNAGVDKLPEEMNDMKIRDDKDMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLET ETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGNGSFGVVFQAKCLETSETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCF STT+KDELYLNLVLEYVPETVHRV+KH+ KLNQ+MP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFLSTTEKDELYLNLVLEYVPETVHRVIKHYRKLNQKMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+ 
Sbjct: 301 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALD 350

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|118482349|gb|ABK93098.1| unknown [Populus trichocarpa]

 Score =  682 bits (1759), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/350 (91%), Positives = 337/350 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MAS GVAPTS +RE+  H  GVDKLPEEMNDMKIRDDK+MEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASAGVAPTSGLREAGVHNAGVDKLPEEMNDMKIRDDKDMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLET ETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGNGSFGVVFQAKCLETSETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCF STT+KDELYLNLVLEYVPETVHRV+KH+ KLNQ+MP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFLSTTEKDELYLNLVLEYVPETVHRVIKHYRKLNQKMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR+IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRAIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTE+KFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+ 
Sbjct: 301 MNPNYTEYKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALD 350

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297812879|ref|XP_002874323.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata] gi|297320160|gb|EFH50582.1| hypothetical protein ARALYDRAFT_489503 [Arabidopsis lyrata subsp. lyrata]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 321/350 (91%), Positives = 337/350 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           MASVG+AP    R+S+ H +GVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct: 1   MASVGIAPNPGARDSTTHAIGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct: 61  GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct: 121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  A+ 
Sbjct: 301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAALD 350

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|233142272|gb|ACQ91102.1| glycogen synthase kinase [Glycine max]

 Score =  679 bits (1753), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 323/351 (92%), Positives = 339/351 (96%), Gaps = 1/351 (0%)

Query: 1   MASVGVAPTSCVRESSGH-TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
           M SVGVAPTS +RE+SGH   GVD+LPEEMNDMKIRDD+EMEATVVDGNGTETGHIIVTT
Sbjct: 1   MTSVGVAPTSGLREASGHGAAGVDRLPEEMNDMKIRDDREMEATVVDGNGTETGHIIVTT 60

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
           IGGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct: 61  IGGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           LLDHPNVV LKHCFFSTT+KDELYLNLVLEYVPETV+RV+KH+NKLNQRMP+IYVKLY Y
Sbjct: 121 LLDHPNVVCLKHCFFSTTEKDELYLNLVLEYVPETVNRVIKHYNKLNQRMPLIYVKLYTY 180

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           QIFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct: 181 QIFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPELIFGATEYTTAID+WS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct: 241 RAPELIFGATEYTTAIDVWSVGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
           CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+ 
Sbjct: 301 CMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTALD 351

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|11133532|sp|Q40518.1|MSK1_TOBAC RecName: Full=Shaggy-related protein kinase NtK-1 gi|456356|emb|CAA54803.1| shaggy like protein kinase [Nicotiana tabacum] gi|1094395|prf||2106142A Ser/Thr protein kinase

 Score =  679 bits (1751), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 319/349 (91%), Positives = 338/349 (96%)

Query: 1   MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
           M SVG+AP S +RESS H+VGVD+LPEEMNDM+IRDDKE+EA +VDGNGTETGHIIVTTI
Sbjct: 1   MTSVGLAPVSGLRESSSHSVGVDRLPEEMNDMRIRDDKEIEAAIVDGNGTETGHIIVTTI 60

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
           GGR+GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL
Sbjct: 61  GGRHGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           LDHPNVV LKHCFFSTT+KDE+YLNLVLEYVPETVHRV+KH+NKLNQRMP+I VKLY YQ
Sbjct: 121 LDHPNVVCLKHCFFSTTEKDEVYLNLVLEYVPETVHRVIKHYNKLNQRMPLILVKLYTYQ 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           IFRALSYIH +IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct: 181 IFRALSYIHHTIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APELIFGATEYTTAIDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct: 241 APELIFGATEYTTAIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           MNPNY EFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+
Sbjct: 301 MNPNYNEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 349

Source: Nicotiana tabacum

Species: Nicotiana tabacum

Genus: Nicotiana

Family: Solanaceae

Order: Solanales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	371
TAIR|locus:2832141	405	SK 11 "AT5G26751" [Arabidopsis	0.929	0.851	0.916	5.3e-175
TAIR|locus:2074464	409	ATSK12 [Arabidopsis thaliana (	0.951	0.863	0.886	8.6e-175
TAIR|locus:2222642	410	SK13 "shaggy-like kinase 13" [	0.940	0.851	0.868	2.6e-166
TAIR|locus:2126993	472	SK32 "shaggy-like protein kina	0.938	0.737	0.778	1.2e-150
TAIR|locus:2052861	412	SKdZeta "SHAGGY-related protei	0.932	0.839	0.749	3.2e-145
TAIR|locus:2202255	407	GSK1 "GSK3/SHAGGY-like protein	0.854	0.778	0.801	1.4e-144
TAIR|locus:2124082	380	BIN2 "BRASSINOSTEROID-INSENSIT	0.846	0.826	0.808	7.5e-144
TAIR|locus:2024341	421	SK41 "shaggy-like protein kina	0.929	0.819	0.712	4.9e-140
TAIR|locus:2098896	438	AT3G61160 [Arabidopsis thalian	0.919	0.778	0.700	3e-133
ZFIN|ZDB-GENE-990714-4	421	gsk3b "glycogen synthase kinas	0.835	0.736	0.653	1.8e-112

TAIR|locus:2832141 SK 11 "AT5G26751" [Arabidopsis thaliana (taxid:3702)]

 Score = 1700 (603.5 bits), Expect = 5.3e-175, P = 5.3e-175
 Identities = 320/349 (91%), Positives = 335/349 (95%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
             MASVG+AP    R+S+G    VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI
Sbjct:     1 MASVGIAPNPGARDSTG----VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 56

Query:    61 GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
             GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct:    57 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 116

Query:   121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
             LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP+IYVKLY YQ
Sbjct:   117 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLIYVKLYTYQ 176

Query:   181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
             IFRALSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   177 IFRALSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 236

Query:   241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct:   237 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 296

Query:   301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLR  A+
Sbjct:   297 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRSAAL 345

GO:0004672 "protein kinase activity" evidence=ISS;IDA

GO:0005634 "nucleus" evidence=ISM

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0016310 "phosphorylation" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=ISS

TAIR|locus:2074464 ATSK12 [Arabidopsis thaliana (taxid:3702)]

 Score = 1698 (602.8 bits), Expect = 8.6e-175, P = 8.6e-175
 Identities = 313/353 (88%), Positives = 337/353 (95%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTI 60
             MASVG+ P++ VRES+G+    D+LPEEM DMKI+DDKEMEAT+V+GN TETGHIIVTTI
Sbjct:     1 MASVGIEPSAAVRESTGNVTDADRLPEEMKDMKIQDDKEMEATIVNGNVTETGHIIVTTI 60

Query:    61 GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL 120
             GGRNGQPKQTISYMAER+VG GSFGVVFQAKCLETGETVAIKKVLQD+RYKNRELQTMRL
Sbjct:    61 GGRNGQPKQTISYMAERVVGHGSFGVVFQAKCLETGETVAIKKVLQDRRYKNRELQTMRL 120

Query:   121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
             LDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETVHRV+KH+NKLNQRMP++YVKLY YQ
Sbjct:   121 LDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVHRVIKHYNKLNQRMPLVYVKLYTYQ 180

Query:   181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
             IFR+LSYIHR IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR
Sbjct:   181 IFRSLSYIHRCIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240

Query:   241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             APELIFGATEYTTAID+WSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIKC
Sbjct:   241 APELIFGATEYTTAIDVWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIKC 300

Query:   301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI 353
             MNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRC A+   +
Sbjct:   301 MNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCAALDSLV 353

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009933 "meristem structural organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

TAIR|locus:2222642 SK13 "shaggy-like kinase 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 1618 (574.6 bits), Expect = 2.6e-166, P = 2.6e-166
 Identities = 304/350 (86%), Positives = 327/350 (93%)

Query:     1 MASVGVAPTSCVR-ESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTT 59
             MASVG  P S +  + S  ++  +KLPE +N+MKI+DDKEMEA VVDGNGTETGHIIVTT
Sbjct:     1 MASVGTLPASSMATKQSNASICAEKLPEGINEMKIKDDKEMEAAVVDGNGTETGHIIVTT 60

Query:    60 IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 119
             IGG+NGQPKQTISYMAERIVGQGSFG+VFQAKCLETGETVAIKKVLQDKRYKNRELQTMR
Sbjct:    61 IGGKNGQPKQTISYMAERIVGQGSFGIVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR 120

Query:   120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             LLDHPNVVSLKHCFFSTT+KDELYLNLVLEYVPETV+RV KH+++ NQRMP+IYVKLY Y
Sbjct:   121 LLDHPNVVSLKHCFFSTTEKDELYLNLVLEYVPETVYRVSKHYSRANQRMPIIYVKLYTY 180

Query:   180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
             QI RAL+YIH  +GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY
Sbjct:   181 QICRALAYIHGGVGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 240

Query:   240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
             RAPELIFGATEYTT IDIWSAGCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEIK
Sbjct:   241 RAPELIFGATEYTTTIDIWSAGCVLAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEIK 300

Query:   300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             CMNPNYTEFKFPQIKAHPWHKIF KR PPEAVDLVSRLLQYSPNLR TA+
Sbjct:   301 CMNPNYTEFKFPQIKAHPWHKIFHKRTPPEAVDLVSRLLQYSPNLRSTAM 350

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006972 "hyperosmotic response" evidence=IEP

GO:0009651 "response to salt stress" evidence=IEP

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2126993 SK32 "shaggy-like protein kinase 32" [Arabidopsis thaliana (taxid:3702)]

 Score = 1470 (522.5 bits), Expect = 1.2e-150, P = 1.2e-150
 Identities = 277/356 (77%), Positives = 313/356 (87%)

Query:     1 MASVGVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD-------DKEMEATVVDGNGTETG 53
             ++   VA TS V   S   V  D+LP+ M +MKIRD       DK+ME TVV+G+GTETG
Sbjct:    60 LSQESVAGTSNVPAVSEKPVD-DQLPDVMIEMKIRDERNANREDKDMETTVVNGSGTETG 118

Query:    54 HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR 113
              +I TT+GGR+G+PKQTISYMA+R+VG GSFGVVFQAKCLETGE VAIKKVLQDKRYKNR
Sbjct:   119 QVITTTVGGRDGKPKQTISYMAQRVVGTGSFGVVFQAKCLETGEQVAIKKVLQDKRYKNR 178

Query:   114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             ELQ MRL DHPNVV L+H FFSTTDKDELYLNLVLEYVPETV+R  KH+ K+NQ MP+I+
Sbjct:   179 ELQIMRLQDHPNVVRLRHSFFSTTDKDELYLNLVLEYVPETVYRASKHYTKMNQHMPIIF 238

Query:   174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             V+LY YQI RAL+Y+HR +GVCHRDIKPQNLLVNP THQ+K+CDFGSAK+LV GEPNISY
Sbjct:   239 VQLYTYQICRALNYLHRVVGVCHRDIKPQNLLVNPQTHQLKICDFGSAKMLVPGEPNISY 298

Query:   234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
             ICSRYYRAPELIFGATEYT AID+WS GCV+AEL+LG+PLFPG+SG+DQLVEIIK+LGTP
Sbjct:   299 ICSRYYRAPELIFGATEYTNAIDMWSGGCVMAELLLGQPLFPGESGIDQLVEIIKILGTP 358

Query:   294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             TREEI+CMNPNYTEFKFPQIKAHPWHKIF KRMPPEAVDLVSRLLQYSPNLRCTA+
Sbjct:   359 TREEIRCMNPNYTEFKFPQIKAHPWHKIFHKRMPPEAVDLVSRLLQYSPNLRCTAL 414

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0009741 "response to brassinosteroid stimulus" evidence=IMP

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2052861 SKdZeta "SHAGGY-related protein kinase dZeta" [Arabidopsis thaliana (taxid:3702)]

 Score = 1419 (504.6 bits), Expect = 3.2e-145, P = 3.2e-145
 Identities = 263/351 (74%), Positives = 303/351 (86%)

Query:     1 MASVGVAPTS--CVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVT 58
             M S+ + P     +     H  G D L    +   I +DKEM A V++GN   TGHII T
Sbjct:     1 MTSIPLGPPQPPSLAPQPPHLHGGDSLKRRPD---IDNDKEMSAAVIEGNDAVTGHIIST 57

Query:    59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
             TIGG+NG+PKQTISYMAER+VG GSFG+VFQAKCLETGE+VAIKKVLQD+RYKNRELQ M
Sbjct:    58 TIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLETGESVAIKKVLQDRRYKNRELQLM 117

Query:   119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             RL+DHPNVVSLKHCFFSTT +DEL+LNLV+EYVPET++RV+KH+   NQRMP+ YVKLY 
Sbjct:   118 RLMDHPNVVSLKHCFFSTTTRDELFLNLVMEYVPETLYRVLKHYTSSNQRMPIFYVKLYT 177

Query:   179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             YQIFR L+YIH + GVCHRD+KPQNLLV+P THQ KLCDFGSAKVLVKGE NISYICSRY
Sbjct:   178 YQIFRGLAYIHTAPGVCHRDVKPQNLLVDPLTHQCKLCDFGSAKVLVKGEANISYICSRY 237

Query:   239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             YRAPELIFGATEYT++IDIWSAGCV+AEL+LG+PLFPG++ VDQLVEIIKVLGTPTREEI
Sbjct:   238 YRAPELIFGATEYTSSIDIWSAGCVLAELLLGQPLFPGENSVDQLVEIIKVLGTPTREEI 297

Query:   299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             +CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+DL SRLLQYSP+LRCTA+
Sbjct:   298 RCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAIDLASRLLQYSPSLRCTAL 348

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=RCA;IDA

TAIR|locus:2202255 GSK1 "GSK3/SHAGGY-like protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 1413 (502.5 bits), Expect = 1.4e-144, P = 1.4e-144
 Identities = 254/317 (80%), Positives = 291/317 (91%)

Query:    33 KIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKC 92
             ++  DKEM A V++GN   TGHII TTIGG+NG+PKQTISYMAER+VG GSFG+VFQAKC
Sbjct:    30 ELDSDKEMSAAVIEGNDAVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKC 89

Query:    93 LETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP 152
             LETGE+VAIKKVLQD+RYKNRELQ MR +DHPNV+SLKHCFFSTT +DEL+LNLV+EYVP
Sbjct:    90 LETGESVAIKKVLQDRRYKNRELQLMRPMDHPNVISLKHCFFSTTSRDELFLNLVMEYVP 149

Query:   153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ 212
             ET++RV++H+   NQRMP+ YVKLY YQIFR L+YIH   GVCHRD+KPQNLLV+P THQ
Sbjct:   150 ETLYRVLRHYTSSNQRMPIFYVKLYTYQIFRGLAYIHTVPGVCHRDVKPQNLLVDPLTHQ 209

Query:   213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
             VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT +IDIWSAGCV+AEL+LG+P
Sbjct:   210 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTASIDIWSAGCVLAELLLGQP 269

Query:   273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD 332
             LFPG++ VDQLVEIIKVLGTPTREEI+CMNPNYT+F+FPQIKAHPWHK+F KRMPPEA+D
Sbjct:   270 LFPGENSVDQLVEIIKVLGTPTREEIRCMNPNYTDFRFPQIKAHPWHKVFHKRMPPEAID 329

Query:   333 LVSRLLQYSPNLRCTAV 349
             L SRLLQYSP+LRCTA+
Sbjct:   330 LASRLLQYSPSLRCTAL 346

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IDA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0042538 "hyperosmotic salinity response" evidence=IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IPI

GO:0032880 "regulation of protein localization" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0051049 "regulation of transport" evidence=RCA

TAIR|locus:2124082 BIN2 "BRASSINOSTEROID-INSENSITIVE 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1406 (500.0 bits), Expect = 7.5e-144, P = 7.5e-144
 Identities = 254/314 (80%), Positives = 290/314 (92%)

Query:    36 DDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLET 95
             DDKEM A VVDG+   TGHII TTIGG+NG+PKQTISYMAER+VG GSFG+VFQAKCLET
Sbjct:     3 DDKEMPAAVVDGHDQVTGHIISTTIGGKNGEPKQTISYMAERVVGTGSFGIVFQAKCLET 62

Query:    96 GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETV 155
             GETVAIKKVLQD+RYKNRELQ MR++DHPNVV LKHCFFSTT KDEL+LNLV+EYVPE++
Sbjct:    63 GETVAIKKVLQDRRYKNRELQLMRVMDHPNVVCLKHCFFSTTSKDELFLNLVMEYVPESL 122

Query:   156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
             +RV+KH++  NQRMP++YVKLY YQIFR L+YIH   GVCHRD+KPQNLLV+P THQVK+
Sbjct:   123 YRVLKHYSSANQRMPLVYVKLYMYQIFRGLAYIHNVAGVCHRDLKPQNLLVDPLTHQVKI 182

Query:   216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
             CDFGSAK LVKGE NISYICSR+YRAPELIFGATEYTT+IDIWSAGCV+AEL+LG+PLFP
Sbjct:   183 CDFGSAKQLVKGEANISYICSRFYRAPELIFGATEYTTSIDIWSAGCVLAELLLGQPLFP 242

Query:   276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS 335
             G++ VDQLVEIIKVLGTPTREEI+CMNP+YT+F+FPQIKAHPWHKIF KRMPPEA+D  S
Sbjct:   243 GENAVDQLVEIIKVLGTPTREEIRCMNPHYTDFRFPQIKAHPWHKIFHKRMPPEAIDFAS 302

Query:   336 RLLQYSPNLRCTAV 349
             RLLQYSP+LRCTA+
Sbjct:   303 RLLQYSPSLRCTAL 316

GO:0004672 "protein kinase activity" evidence=IEA;TAS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;ISS;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;IPI

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009729 "detection of brassinosteroid stimulus" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0009825 "multidimensional cell growth" evidence=IMP

GO:0009965 "leaf morphogenesis" evidence=IMP

GO:0005515 "protein binding" evidence=IPI

GO:0005886 "plasma membrane" evidence=IDA

GO:0046827 "positive regulation of protein export from nucleus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0006096 "glycolysis" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006972 "hyperosmotic response" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009651 "response to salt stress" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2024341 SK41 "shaggy-like protein kinase 41" [Arabidopsis thaliana (taxid:3702)]

 Score = 1370 (487.3 bits), Expect = 4.9e-140, P = 4.9e-140
 Identities = 250/351 (71%), Positives = 296/351 (84%)

Query:     5 GVAPTSCVRESSGHTVGVDKLPEEMNDMKIRD------DKEMEATVVDGNGTETGHIIVT 58
             GV  +   +     +  VD L  ++ + +IRD      +++ E  ++DG G E GH+I T
Sbjct:     9 GVGTSRSAKGLKSSSSSVDWLTRDLAETRIRDKVETDDERDSEPDIIDGAGAEPGHVIRT 68

Query:    59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
             T+ GRNGQ +QT+SY++E +VG GSFG+VFQAKC ETGE VAIKKVLQDKRYKNRELQ M
Sbjct:    69 TLRGRNGQSRQTVSYISEHVVGTGSFGMVFQAKCRETGEVVAIKKVLQDKRYKNRELQIM 128

Query:   119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++LDHPN V+LKH FFS TD +E+YLNLVLE+VPETV+RV + +++ NQ MP+IYVKLY 
Sbjct:   129 QMLDHPNAVALKHSFFSRTDNEEVYLNLVLEFVPETVNRVARSYSRTNQLMPLIYVKLYT 188

Query:   179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             YQI RAL+YIH S G+CHRDIKPQNLLVNPHTHQ+K+CDFGSAKVLVKGEPN+SYICSRY
Sbjct:   189 YQICRALAYIHNSFGLCHRDIKPQNLLVNPHTHQLKICDFGSAKVLVKGEPNVSYICSRY 248

Query:   239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             YRAPELIFGA+EYTTAIDIWS GCV+AEL+LG+PLFPG+SGVDQLVEIIKVLGTPTREEI
Sbjct:   249 YRAPELIFGASEYTTAIDIWSTGCVMAELLLGQPLFPGESGVDQLVEIIKVLGTPTREEI 308

Query:   299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             KCMNPNYTEFKFPQIK HPWHK+F KR+PPEAVDL+ R  QYSPNLRCTA+
Sbjct:   309 KCMNPNYTEFKFPQIKPHPWHKVFQKRLPPEAVDLLCRFFQYSPNLRCTAL 359

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0010075 "regulation of meristem growth" evidence=RCA

GO:0019344 "cysteine biosynthetic process" evidence=RCA

TAIR|locus:2098896 AT3G61160 [Arabidopsis thaliana (taxid:3702)]

 Score = 1306 (464.8 bits), Expect = 3.0e-133, P = 3.0e-133
 Identities = 239/341 (70%), Positives = 286/341 (83%)

Query:     9 TSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPK 68
             TS  ++S   +   D LP+E+ ++ + DDK+M+  ++ GNGTE+G II T   G N Q  
Sbjct:    45 TSYEKDSVSSSENSDHLPKEIREVGLGDDKDMDCGIIKGNGTESGRIITTKKKGLNDQKD 104

Query:    69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 128
             +TISY AE ++G GSFGVVFQAKCLET E VAIKKVLQDKRYKNRELQ MR+LDHPNVV 
Sbjct:   105 KTISYRAEHVIGTGSFGVVFQAKCLETEEKVAIKKVLQDKRYKNRELQIMRMLDHPNVVE 164

Query:   129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             LKH FFSTT+KDELYLNLVLEYVPET++R  + + K+NQ MP+IY++LY YQI RA++Y+
Sbjct:   165 LKHSFFSTTEKDELYLNLVLEYVPETIYRASRSYTKMNQHMPLIYIQLYTYQICRAMNYL 224

Query:   189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
             H+ +GVCHRDIKPQNLLVN  TH+VK+CDFGSAK+L+ GEPNISYICSRYYRAPELIFGA
Sbjct:   225 HQVVGVCHRDIKPQNLLVNNVTHEVKICDFGSAKMLIPGEPNISYICSRYYRAPELIFGA 284

Query:   249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             TEYT+AID+WS GCV+AEL LG PLFPG++ VDQLVEIIK+LGTP REEIK MNP Y +F
Sbjct:   285 TEYTSAIDMWSVGCVMAELFLGHPLFPGETSVDQLVEIIKILGTPAREEIKNMNPRYNDF 344

Query:   309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             KFPQIKA PWHKIF +++ PEA+DL SRLLQYSPNLRCTA+
Sbjct:   345 KFPQIKAQPWHKIFRRQVSPEAMDLASRLLQYSPNLRCTAL 385

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005829 "cytosol" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

ZFIN|ZDB-GENE-990714-4 gsk3b "glycogen synthase kinase 3 beta" [Danio rerio (taxid:7955)]

 Score = 1110 (395.8 bits), Expect = 1.8e-112, P = 1.8e-112
 Identities = 211/323 (65%), Positives = 260/323 (80%)

Query:    26 PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
             P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct:    20 PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 68

Query:    86 VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
             VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ DK DE+YL
Sbjct:    69 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGDKKDEVYL 128

Query:   145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
             NLVL+YVPETV+RV +H+++  Q +PM+YVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct:   129 NLVLDYVPETVYRVARHYSRAKQTLPMVYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187

Query:   205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
             L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct:   188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247

Query:   265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
             AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct:   248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307

Query:   325 RMPPEAVDLVSRLLQYSPNLRCT 347
             R PPEA+ L SRLL+Y+P  R T
Sbjct:   308 RTPPEAIALCSRLLEYTPTARLT 330

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0001947 "heart looping" evidence=IMP

GO:0003146 "heart jogging" evidence=IMP

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
P43289	KSG3_ARATH	2, ., 7, ., 1, 1, ., 1	0.8866	0.9514	0.8630	no	no
P43288	KSG1_ARATH	2, ., 7, ., 1, 1, ., 1	0.9142	0.9326	0.8543	yes	no
Q10452	GSK3_SCHPO	2, ., 7, ., 1, 1, ., 1	0.6109	0.7816	0.7493	yes	no
Q39010	KSG6_ARATH	2, ., 7, ., 1, 1, ., 1	0.7492	0.9326	0.8398	no	no
Q39011	KSG7_ARATH	2, ., 7, ., 1, 1, ., 1	0.8089	0.8463	0.8263	no	no
Q39019	KSG10_ARATH	2, ., 7, ., 1, 1, ., 1	0.7122	0.9299	0.8194	no	no
P38615	RIM11_YEAST	2, ., 7, ., 1, 1, ., 1	0.5765	0.7439	0.7459	yes	no
Q9U2Q9	GSK3_CAEEL	2, ., 7, ., 1, 1, ., 2, 6	0.6632	0.7870	0.8066	yes	no
Q9FVS6	KSG4_ARATH	2, ., 7, ., 1, 1, ., 1	0.7179	0.9299	0.8214	no	no
Q40518	MSK1_TOBAC	2, ., 7, ., 1, 1, ., 1	0.9140	0.9407	0.8533	N/A	no
Q9WV60	GSK3B_MOUSE	2, ., 7, ., 1, 1, ., 1	0.6461	0.8409	0.7428	yes	no
P51137	MSK1_MEDSA	2, ., 7, ., 1, 1, ., 1	0.9090	0.9433	0.8515	N/A	no
P51138	MSK2_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8457	0.9407	0.8491	N/A	no
P51139	MSK3_MEDSA	2, ., 7, ., 1, 1, ., 1	0.8942	0.9407	0.8491	N/A	no
O04160	KSGT_BRANA	2, ., 7, ., 1, 1, ., 1	0.7922	0.8814	0.6987	N/A	no
P18266	GSK3B_RAT	2, ., 7, ., 1, 1, ., 1	0.6461	0.8409	0.7428	yes	no
Q8VZD5	KSG5_ARATH	2, ., 7, ., 1, 1, ., 1	0.8685	0.9407	0.8512	no	no
P49841	GSK3B_HUMAN	2, ., 7, ., 1, 1, ., 1	0.6461	0.8409	0.7428	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.979
3rd Layer	2.7.11	0.983

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00022544001 SubName- Full=Chromosome chr14 scaffold_27, whole genome shotgun sequence; (409 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	371
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	1e-121
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	5e-86
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-85
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-81
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	2e-81
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-77
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	6e-77
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-76
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-74
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	2e-74
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-73
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-69
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	2e-65
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-65
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-64
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-63
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-62
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-61
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-60
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-59
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-59
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	3e-58
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	7e-58
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	8e-58
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	3e-57
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	4e-57
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-56
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	7e-56
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-55
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-53
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	5e-53
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	6e-53
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	2e-52
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	4e-52
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	1e-51
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-51
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-49
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-49
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-48
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	5e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-47
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-47
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-47
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-47
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	7e-47
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	7e-47
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-46
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-46
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	8e-46
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-44
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	7e-44
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-43
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	6e-43
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	6e-42
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-40
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	8e-40
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-39
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-38
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	6e-38
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-37
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-37
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	2e-37
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-37
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-36
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-35
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	2e-34
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-33
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-32
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-32
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-31
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-31
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	9e-31
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-30
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	5e-30
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-29
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-29
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	5e-29
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-28
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-28
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-28
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-28
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	2e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-27
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-26
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	3e-26
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-25
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-25
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-24
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	8e-23
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-22
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-22
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-22
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-22
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	5e-22
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	9e-22
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	1e-21
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	1e-21
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-21
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-21
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-21
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-21
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	4e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	5e-21
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	1e-20
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-20
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-20
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	4e-20
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	7e-20
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	8e-20
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	2e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	3e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-19
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	7e-19
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	9e-19
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-19
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-18
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-18
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	2e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-18
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	5e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	5e-18
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-18
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	6e-18
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-18
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	8e-18
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-17
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	1e-17
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-17
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-17
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-17
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-17
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-17
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	4e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	5e-17
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	6e-17
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	2e-16
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-16
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-16
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	2e-16
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-16
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	3e-16
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	6e-16
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	7e-16
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	1e-15
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	1e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-15
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-15
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-15
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	1e-15
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-15
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-15
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-15
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	3e-15
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	3e-15
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	3e-15
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	4e-15
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	5e-15
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-15
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-14
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-14
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-14
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	6e-14
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	6e-14
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	9e-14
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	1e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-13
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-13
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-13
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	3e-13
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	6e-13
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	7e-13
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	8e-13
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-12
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	2e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-12
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-12
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-11
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-11
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	5e-11
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	6e-11
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	6e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-10
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-10
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	1e-10
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-10
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-10
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-10
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	4e-10
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	4e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-10
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	7e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	8e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	2e-09
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-09
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	5e-09
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-09
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	7e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-09
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	9e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-08
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-08
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	4e-08
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-08
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	5e-08
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-08
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	7e-08
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-07
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-07
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-07
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	3e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-07
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-07
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	4e-07
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	5e-07
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-06
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	1e-06
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-06
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-06
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	3e-06
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-06
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-05
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	1e-05
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-05
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-05
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-05
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	3e-05
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	4e-05
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	4e-05
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-05
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	1e-04
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-04
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	4e-04
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-04
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	9e-04
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	0.001
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.001
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	0.002
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	0.002

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  357 bits (918), Expect = e-121
 Identities = 149/281 (53%), Positives = 212/281 (75%), Gaps = 4/281 (1%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           SY    I+G GSFGVV++A C++T E VAIKKVLQD +YKNREL  M+ L+H N++ LK 
Sbjct: 67  SYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKD 126

Query: 132 CFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            +++     ++  ++LN+V+E++P+TVH+ +KH+ + N  +P+  VKLY+YQ+ RAL+YI
Sbjct: 127 YYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYI 186

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    +CHRD+KPQNLL++P+TH +KLCDFGSAK L+ G+ ++SYICSR+YRAPEL+ GA
Sbjct: 187 HSKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGA 245

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T YTT ID+WS GC++AE++LG P+F G S VDQLV II+VLGTPT +++K MNPNY + 
Sbjct: 246 TNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADI 305

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           KFP +K     K+FPK  P +A++ +S+ L+Y P  R   +
Sbjct: 306 KFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPI 346

Length = 440

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  261 bits (670), Expect = 5e-86
 Identities = 110/287 (38%), Positives = 167/287 (58%), Gaps = 35/287 (12%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVVSL 129
            +G+G++GVV++A+  +TGE VA+KK+  D   +         RE+  ++ L HPN+V L
Sbjct: 6   KLGEGTYGVVYKARDKKTGEIVALKKIRLD--NEEEGIPSTALREISLLKELKHPNIVKL 63

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                +   + +LYL  V EY    +    K+ +K    +    +K   YQ+ R L+Y H
Sbjct: 64  LDVIHT---ERKLYL--VFEYCDMDLK---KYLDKRPGPLSPNLIKSIMYQLLRGLAYCH 115

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
            S  + HRD+KPQN+L+N     +KL DFG A+    G P  +Y   + + +YRAPE++ 
Sbjct: 116 -SHRILHRDLKPQNILIN-RDGVLKLADFGLARAF--GIPLRTYTHEVVTLWYRAPEILL 171

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G+  Y+TA+DIWS GC+ AE++ GKPLFPGDS +DQL +I ++LGTPT E      P  T
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESW----PGVT 227

Query: 307 EFK-----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +       FP+       K+ P R+ PE +DL+S++LQY+P  R +A
Sbjct: 228 KLPDYKPTFPKFPPKDLEKVLP-RLDPEGIDLLSKMLQYNPAKRISA 273

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  262 bits (671), Expect = 1e-85
 Identities = 110/291 (37%), Positives = 165/291 (56%), Gaps = 24/291 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + +G G++GVV  A    TG  VAIKK+      L D +   RE++ +R L H N+
Sbjct: 2   YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENI 61

Query: 127 VSLKHCF--FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L       S  D +++Y+  V E +   +H+V+K      Q +   +++ + YQI R 
Sbjct: 62  IGLLDILRPPSPEDFNDVYI--VTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYR 240
           L Y+H S  V HRD+KP N+LVN     +K+CDFG A+ +   E        Y+ +R+YR
Sbjct: 116 LKYLH-SANVIHRDLKPSNILVN-SNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYR 173

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+  ++ YT AIDIWS GC+ AEL+  KPLFPG   +DQL  I++VLGTP+ E++K 
Sbjct: 174 APELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKF 233

Query: 301 M-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + +     +    P+    P  K+FP    PEA+DL+ ++L + P  R TA
Sbjct: 234 ITSEKARNYLKSLPKKPKKPLSKLFPG-ASPEAIDLLEKMLVFDPKKRITA 283

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  250 bits (640), Expect = 1e-81
 Identities = 107/285 (37%), Positives = 164/285 (57%), Gaps = 20/285 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKN---RELQTMRLLDHPNV 126
           Y     +G+G++GVV++A+   TGE VAIKK+              RE++ ++ L+HPN+
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L   F     K +LYL  V E++   +++++K   +    +P   +K Y YQ+ + L+
Sbjct: 61  IKLLDVFR---HKGDLYL--VFEFMDTDLYKLIKDRQRG---LPESLIKSYLYQLLQGLA 112

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H   G+ HRD+KP+NLL+N     +KL DFG A+       P   Y+ +R+YRAPEL+
Sbjct: 113 FCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELL 170

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN- 304
            G   Y+T +DIWS GC+ AEL+  +PLFPG S +DQL +I + LGTP  E         
Sbjct: 171 LGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA 230

Query: 305 -YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +F FP+    P  K+FP    P+A+DL+S++L Y P+ R TA
Sbjct: 231 RNYKFSFPKKAGMPLPKLFPN-ASPQALDLLSQMLHYDPHKRITA 274

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  249 bits (639), Expect = 2e-81
 Identities = 105/286 (36%), Positives = 167/286 (58%), Gaps = 24/286 (8%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           +  RI G+G+ G+VF+AK  ETGETVA+KKV   +          RE++ ++   HP VV
Sbjct: 4   ILGRI-GEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVV 62

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L   F   +        LV+EY+P  +  V++      + +P   VK Y   + + ++Y
Sbjct: 63  KLLDVFPHGSG-----FVLVMEYMPSDLSEVLRD---EERPLPEAQVKSYMRMLLKGVAY 114

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSRYYRAPELI 245
           +H + G+ HRD+KP NLL++     +K+ DFG A++  + EP +    + +R+YRAPEL+
Sbjct: 115 MH-ANGIMHRDLKPANLLISADGV-LKIADFGLARLFSEEEPRLYSHQVATRWYRAPELL 172

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMN 302
           +GA +Y   +D+W+ GC+ AEL+ G PLFPG++ ++QL  + + LGTP  E    +  + 
Sbjct: 173 YGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSL- 231

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           P+Y +  FP+ K  P  +IFP    PEA+DL+  LL Y P+ R +A
Sbjct: 232 PDYNKITFPESKPIPLEEIFPD-ASPEALDLLKGLLVYDPSKRLSA 276

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  239 bits (612), Expect = 4e-77
 Identities = 108/290 (37%), Positives = 159/290 (54%), Gaps = 29/290 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 123
           Y   + +G+G++ VV++A+  ETG  VAIKK+   +R +          RE++ ++ L H
Sbjct: 2   YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKH 61

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN++ L   F          +NLV E++   + +V+K  +K +  +    +K Y     R
Sbjct: 62  PNIIGLLDVF--GHKS---NINLVFEFMETDLEKVIK--DK-SIVLTPADIKSYMLMTLR 113

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SRYYR 240
            L Y+H +  + HRD+KP NLL+      +KL DFG A+    G PN        +R+YR
Sbjct: 114 GLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLARSF--GSPNRKMTHQVVTRWYR 169

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+FGA  Y   +D+WS GC+ AEL+L  P  PGDS +DQL +I + LGTPT E    
Sbjct: 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPG 229

Query: 301 MN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +   P+Y EFK       P  +IFP     +A+DL+ RLL  +PN R TA
Sbjct: 230 VTSLPDYVEFKP--FPPTPLKQIFPAA-SDDALDLLQRLLTLNPNKRITA 276

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  237 bits (607), Expect = 6e-77
 Identities = 101/282 (35%), Positives = 147/282 (52%), Gaps = 43/282 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 127
           Y     +G+GSFG V+ A+  +TG+ VAIK +      +D+    RE++ ++ L HPN+V
Sbjct: 1   YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L   F    D+D+LYL  V+EY     +  ++K       R+     + Y  QI  AL 
Sbjct: 61  RLYDVF---EDEDKLYL--VMEYCEGGDLFDLLKK----RGRLSEDEARFYLRQILSALE 111

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           Y+H S G+ HRD+KP+N+L++   H VKL DFG A+ L  GE   +++ +  Y APE++ 
Sbjct: 112 YLH-SKGIVHRDLKPENILLDEDGH-VKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLL 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y  A+DIWS G ++ EL+ GKP FPGD   DQL+E+ K +G P             
Sbjct: 170 G-KGYGKAVDIWSLGVILYELLTGKPPFPGD---DQLLELFKKIGKPK------------ 213

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     P        + PEA DL+ +LL   P  R TA
Sbjct: 214 ----------PPFPPPEWDISPEAKDLIRKLLVKDPEKRLTA 245

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  237 bits (607), Expect = 7e-76
 Identities = 110/295 (37%), Positives = 171/295 (57%), Gaps = 31/295 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRE---LQTMRLLDH 123
           Y   + +G+G++G+V++A    T E VA+KK+        D +   RE   LQ +   DH
Sbjct: 9   YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELG--DH 66

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L +   +  DKD +YL  V EY+   +H V++    + + +   Y+    YQ+ +
Sbjct: 67  PNIVKLLNVIKAENDKD-IYL--VFEYMETDLHAVIRA--NILEDVHKRYI---MYQLLK 118

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------YICSR 237
           AL YIH S  V HRD+KP N+L+N     VKL DFG A+ L + E N        Y+ +R
Sbjct: 119 ALKYIH-SGNVIHRDLKPSNILLNSDCR-VKLADFGLARSLSELEENPENPVLTDYVATR 176

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE++ G+T YT  +D+WS GC++ E++LGKPLFPG S ++QL +II+V+G P+ E+
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 298 IKCMNPNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           I+ +   +        P     P  ++ PK    +A+DL+ +LL ++PN R TA 
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPK-ASDDALDLLKKLLVFNPNKRLTAE 290

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  231 bits (592), Expect = 1e-74
 Identities = 92/280 (32%), Positives = 137/280 (48%), Gaps = 39/280 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            R +G GSFG V++AK   TG+ VA+K + +            RE++ +R L HPN+V L
Sbjct: 4   LRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRL 63

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F    DKD LYL  V+EY           +      +     K  A QI R L Y+H
Sbjct: 64  IDAF---EDKDHLYL--VMEYCEGGDL---FDYLSRGGPLSEDEAKKIALQILRGLEYLH 115

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGA 248
            S G+ HRD+KP+N+L++     VK+ DFG AK L+K      +++ + +Y APE++ G 
Sbjct: 116 -SNGIIHRDLKPENILLD-ENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGG 173

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y   +D+WS G ++ EL+ GKP F G++ +DQL  I ++LG P               
Sbjct: 174 NGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPL-------------- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    + +        EA DL+ + L   P+ R TA
Sbjct: 220 --------EFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTA 251

Length = 260

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  232 bits (593), Expect = 2e-74
 Identities = 106/281 (37%), Positives = 159/281 (56%), Gaps = 21/281 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV + +   TGE VAIKK  +   D+  K    RE++ +R L H N+V+LK  
Sbjct: 9   VGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEA 68

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     K  LYL  V EYV  T+  +++        +P   V+ Y +Q+ +A++Y H   
Sbjct: 69  FRR---KGRLYL--VFEYVERTLLELLEASPG---GLPPDAVRSYIWQLLQAIAYCHSH- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPELIFGATE 250
            + HRDIKP+N+LV+     +KLCDFG A+ L      P   Y+ +R+YRAPEL+ G T 
Sbjct: 120 NIIHRDIKPENILVSESG-VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTN 178

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG--TPTREEIKCMNPNYTEF 308
           Y   +D+W+ GC++AEL+ G+PLFPGDS +DQL  I K LG   P+ +E+   NP +   
Sbjct: 179 YGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGV 238

Query: 309 KFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FP+        + +P ++   A+D +   L+  P  R T 
Sbjct: 239 AFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTC 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  229 bits (587), Expect = 1e-73
 Identities = 107/282 (37%), Positives = 169/282 (59%), Gaps = 26/282 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLK 130
           +G G+FG V+ A+  ETGE VAIKK+ +  ++ +       RE++++R L +HPN+V LK
Sbjct: 7   LGDGTFGSVYLARNKETGELVAIKKMKK--KFYSWEECMNLREVKSLRKLNEHPNIVKLK 64

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    + DELY   V EY+   +++++K      +      ++   YQI + L++IH+
Sbjct: 65  EVF---RENDELYF--VFEYMEGNLYQLMKDRKG--KPFSESVIRSIIYQILQGLAHIHK 117

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
             G  HRD+KP+NLLV+     VK+ DFG A+ +    P   Y+ +R+YRAPE++  +T 
Sbjct: 118 -HGFFHRDLKPENLLVSGPE-VVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTS 175

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMNPNYT 306
           Y++ +DIW+ GC++AEL   +PLFPG S +DQL +I  VLGTPT+++     K  +    
Sbjct: 176 YSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK--L 233

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            F+FPQ      H++ P    PEA+DL+  +L++ P  R TA
Sbjct: 234 GFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTA 274

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  218 bits (558), Expect = 4e-69
 Identities = 94/287 (32%), Positives = 154/287 (53%), Gaps = 24/287 (8%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 126
           E+I  +G+G++G V++A+  +TGE VA+KK+  +   K        RE++ ++ L HPN+
Sbjct: 2   EKIAQIGEGTYGQVYKARNKKTGELVALKKIRME-NEKEGFPITAIREIKLLQKLRHPNI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V LK    S   K  +Y+  V EY+   +  ++        +     +K Y  Q+   L 
Sbjct: 61  VRLKEIVTSK-GKGSIYM--VFEYMDHDLTGLLDS---PEVKFTESQIKCYMKQLLEGLQ 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPEL 244
           Y+H + G+ HRDIK  N+L+N     +KL DFG A+   K       + + + +YR PEL
Sbjct: 115 YLHSN-GILHRDIKGSNILINNDGV-LKLADFGLARPYTKRNSADYTNRVITLWYRPPEL 172

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCM 301
           + GAT Y   +D+WS GC++AEL LGKP+F G + ++QL +I ++ G+PT E    +  +
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL 232

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            P +   K  +       + F   + P A+DL+ +LL   P  R +A
Sbjct: 233 -PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISA 278

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  210 bits (537), Expect = 2e-65
 Identities = 98/291 (33%), Positives = 167/291 (57%), Gaps = 26/291 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 127
           Y     +G+G++G+V  A    TG  VAIKK+   + + +  R L+ +++L    H N++
Sbjct: 7   YQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENII 66

Query: 128 SLKHCFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +       +    +++Y+  V E +   +++++K      Q +   +++ + YQI R L
Sbjct: 67  GILDIIRPPSFESFNDVYI--VQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGL 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRA 241
            YIH S  V HRD+KP NLL+N     +K+CDFG A++      +      Y+ +R+YRA
Sbjct: 120 KYIH-SANVLHRDLKPSNLLLN-TNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRA 177

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++  +  YT AIDIWS GC++AE++  +PLFPG   + QL  I+ VLGTP++E++ C+
Sbjct: 178 PEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI 237

Query: 302 -NP---NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +    NY +   P     PW+K+FP    P+A+DL+ ++L ++P+ R T 
Sbjct: 238 ISLRARNYIK-SLPFKPKVPWNKLFPN-ADPKALDLLDKMLTFNPHKRITV 286

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  209 bits (533), Expect = 8e-65
 Identities = 102/292 (34%), Positives = 158/292 (54%), Gaps = 24/292 (8%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPN 125
            Y     +G G++GVV  A    +G+ VAIKK      V    +   REL+ +R   H N
Sbjct: 6   RYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDN 65

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +++++         D   + +V++ +   +H ++      +Q +   +++ + YQ+ R L
Sbjct: 66  IIAIRD-ILRPPGADFKDVYVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGL 120

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYR 240
            YIH S  V HRD+KP NLLVN     +++ DFG A+ L             Y+ +R+YR
Sbjct: 121 KYIH-SANVIHRDLKPSNLLVNEDCE-LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYR 178

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APEL+    EYTTAID+WS GC+ AE++  + LFPG + V QL  I+ VLG+P+ E +  
Sbjct: 179 APELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNR 238

Query: 301 MNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +       Y +   P+ +  PW KIFPK   PEA+DL+S++LQ+ P  R T 
Sbjct: 239 IGSDRVRKYIQ-NLPRKQPVPWSKIFPKA-SPEALDLLSQMLQFDPEERITV 288

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  206 bits (526), Expect = 2e-64
 Identities = 116/281 (41%), Positives = 168/281 (59%), Gaps = 23/281 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---RELQTMRLLDHPNVVSLKH 131
           +VG+GS+G+V + K  ETG+ VAIKK L+   DK  K    RE++ ++ L H N+V+L  
Sbjct: 8   LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F     K  LYL  V E+V  TV   ++ + N L++      V+ Y +QI R + + H 
Sbjct: 68  VF---RRKKRLYL--VFEFVDHTVLDDLEKYPNGLDESR----VRKYLFQILRGIEFCHS 118

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGAT 249
              + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE    Y+ +R+YRAPEL+ G T
Sbjct: 119 H-NIIHRDIKPENILVSQ-SGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 307
           +Y  A+DIW+ GC+V E++ G+PLFPGDS +DQL  IIK LG   P  +EI   NP +  
Sbjct: 177 KYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG 236

Query: 308 FKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            + P++K   P  K FPK +    +DL  + L+  P+ R +
Sbjct: 237 MRLPEVKEIEPLEKRFPK-LSGLVLDLAKQCLRIDPDDRPS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  204 bits (521), Expect = 1e-63
 Identities = 99/283 (34%), Positives = 161/283 (56%), Gaps = 28/283 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  +   +       RE+  ++ L+HPN+V L   
Sbjct: 7   IGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDV 66

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRS 191
             S     +LYL  V E++      + K+ +      +    +K Y YQ+ + ++Y H S
Sbjct: 67  VHSEN---KLYL--VFEFLD---LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCH-S 117

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             V HRD+KPQNLL++     +KL DFG A+    G P  +Y   + + +YRAPE++ G+
Sbjct: 118 HRVLHRDLKPQNLLID-REGALKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLGS 174

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNY 305
            +Y+T +DIWS GC+ AE++  +PLFPGDS +DQL  I + LGTP  +    +  + P+Y
Sbjct: 175 RQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSL-PDY 233

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+       K+ P  +  + +DL+S++L Y P  R +A
Sbjct: 234 KP-TFPKWARQDLSKVVP-NLDEDGLDLLSKMLVYDPAKRISA 274

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  202 bits (517), Expect = 2e-62
 Identities = 104/288 (36%), Positives = 168/288 (58%), Gaps = 23/288 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y+  + +G+G++G+V  AK  ET E VAIKK+        D +   RE++ +R LDH NV
Sbjct: 7   YVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENV 66

Query: 127 VSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +++K        ++   ++Y+  V E +   +H++++     +Q +   + + + YQ+ R
Sbjct: 67  IAIKDIM-PPPHREAFNDVYI--VYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLR 119

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 242
            L YIH S  V HRD+KP NLL+N +   +K+CDFG A+    KG+    Y+ +R+YRAP
Sbjct: 120 GLKYIH-SANVLHRDLKPSNLLLNANC-DLKICDFGLARTTSEKGDFMTEYVVTRWYRAP 177

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           EL+   +EYTTAID+WS GC+ AEL+  KPLFPG   V QL  I ++LG+P+ E++  + 
Sbjct: 178 ELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIR 237

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           N     +    P      + ++FP    P A+DL+ ++L + P+ R T
Sbjct: 238 NEKARRYIRSLPYTPRQSFARLFPH-ANPLAIDLLEKMLVFDPSKRIT 284

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  200 bits (510), Expect = 2e-61
 Identities = 99/289 (34%), Positives = 157/289 (54%), Gaps = 26/289 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y     VG G++G V  A   +TG  VAIKK+ +        KR Y  REL+ ++ +DH 
Sbjct: 17  YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTY--RELRLLKHMDHE 74

Query: 125 NVVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+ L   F   +  ++   + LV   +   ++ +VK      Q++   +++   YQI R
Sbjct: 75  NVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-----QKLSDDHIQFLVYQILR 129

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L YIH S G+ HRD+KP N+ VN    ++K+ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIH-SAGIIHRDLKPSNIAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPE 185

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y   +DIWS GC++AEL+ GK LFPG   +DQL  I+ ++GTP  E ++ ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISS 245

Query: 304 ----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               NY +   PQ+    + ++F     P A+DL+ ++L   P+ R TA
Sbjct: 246 ESARNYIQ-SLPQMPKKDFKEVFS-GANPLAIDLLEKMLVLDPDKRITA 292

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  194 bits (495), Expect = 8e-60
 Identities = 99/280 (35%), Positives = 153/280 (54%), Gaps = 25/280 (8%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLL-DHPNVVSLKH 131
           G+G+F  V +A+  +TG+  AIK +   K +K+       RE+Q +R L  HPN++ L  
Sbjct: 8   GEGTFSEVLKAQSRKTGKYYAIKCM--KKHFKSLEQVNNLREIQALRRLSPHPNILRLIE 65

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM--IYVKLYAYQIFRALSYIH 189
             F   D+    L LV E +   ++ ++K      ++ P+    VK Y YQ+ ++L ++H
Sbjct: 66  VLF---DRKTGRLALVFELMDMNLYELIK-----GRKRPLPEKRVKSYMYQLLKSLDHMH 117

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           R+ G+ HRDIKP+N+L+      +KL DFGS + +    P   YI +R+YRAPE +    
Sbjct: 118 RN-GIFHRDIKPENILIKDDI--LKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG 174

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-NYTEF 308
            Y   +DIW+ GCV  E++   PLFPG + +DQ+ +I  VLGTP  E +K      +  +
Sbjct: 175 YYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNY 234

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FP  K     K+ P     E +DL+ +LL Y P+ R TA
Sbjct: 235 NFPSKKGTGLRKLLPN-ASAEGLDLLKKLLAYDPDERITA 273

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  193 bits (492), Expect = 6e-59
 Identities = 102/289 (35%), Positives = 167/289 (57%), Gaps = 25/289 (8%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDH 123
           T  Y+  + VG G+FG+V  A+   TG+ VAIKK+++        +   REL+ ++ L H
Sbjct: 9   TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N++SL   F S    +++Y   V E +   +HR++      ++ +   +++ + YQI R
Sbjct: 69  ENIISLSDIFISP--LEDIYF--VTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILR 119

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 242
            L Y+H S GV HRD+KP N+L+N +   +K+CDFG A++    +P ++ Y+ +RYYRAP
Sbjct: 120 GLKYVH-SAGVVHRDLKPSNILINENC-DLKICDFGLARI---QDPQMTGYVSTRYYRAP 174

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           E++    +Y   +DIWSAGC+ AE++ GKPLFPG   V+Q   I  +LGTP  + I  + 
Sbjct: 175 EIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + N   F    P+ +  P+ + F     P A+DL+ ++L + P  R +A
Sbjct: 235 SENTLRFVQSLPKREPVPFSEKFKN-ADPSAIDLLEKMLVFDPQKRISA 282

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  191 bits (488), Expect = 8e-59
 Identities = 99/285 (34%), Positives = 161/285 (56%), Gaps = 25/285 (8%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVV 127
           E++  +G+GS+GVVF+ +  ETG+ VAIKK ++       K+   RE++ ++ L HPN+V
Sbjct: 4   EKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLV 63

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETV-HRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   F     + +  L+LV EY   TV + + K+   + + +    +K   +Q  +A++
Sbjct: 64  NLIEVF-----RRKRKLHLVFEYCDHTVLNELEKNPRGVPEHL----IKKIIWQTLQAVN 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELI 245
           + H+     HRD+KP+N+L+     Q+KLCDFG A++L     + + Y+ +R+YRAPEL+
Sbjct: 115 FCHKH-NCIHRDVKPENILITKQ-GQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELL 172

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG--TPTREEIKCMNP 303
            G T+Y   +D+W+ GCV AEL+ G+PL+PG S VDQL  I K LG   P  ++I   N 
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 304 NYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +     P+ +   P    FP  +   A+  +   LQ  P  R +
Sbjct: 233 FFKGLSIPEPETREPLESKFPN-ISSPALSFLKGCLQMDPTERLS 276

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  190 bits (484), Expect = 3e-58
 Identities = 103/286 (36%), Positives = 163/286 (56%), Gaps = 34/286 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 8   IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL  V E++    H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 68  IHT---ENKLYL--VFEFL----HQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCH- 117

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 118 SHRVLHRDLKPQNLLINTEGA-IKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 174

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       + P  T 
Sbjct: 175 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEV----VWPGVTS 230

Query: 308 FK-----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  FP+     + K+ P  +  +  DL+S++L Y PN R +A
Sbjct: 231 LPDYKPSFPKWARQDFSKVVPP-LDEDGRDLLSQMLHYDPNKRISA 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  191 bits (486), Expect = 7e-58
 Identities = 110/291 (37%), Positives = 166/291 (57%), Gaps = 23/291 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y  + ++G+GS+GVV  A    TGE VAIKK+      + D     RE++ +RLL HP++
Sbjct: 2   YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V +KH     + ++   + +V E +   +H+V+K  + L       + + + YQ+ RAL 
Sbjct: 62  VEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE----HHQFFLYQLLRALK 117

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----ISYICSRYYRAP 242
           YIH +  V HRD+KP+N+L N    ++K+CDFG A+V     P       Y+ +R+YRAP
Sbjct: 118 YIH-TANVFHRDLKPKNILANADC-KLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP 175

Query: 243 ELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-K 299
           EL  G+  ++YT AIDIWS GC+ AE++ GKPLFPG + V QL  I  +LGTP+ E I +
Sbjct: 176 ELC-GSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR 234

Query: 300 CMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             N     +     + +  P+ + FP    P A+ L+ RLL + P  R TA
Sbjct: 235 VRNEKARRYLSSMRKKQPVPFSQKFPN-ADPLALRLLERLLAFDPKDRPTA 284

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  189 bits (482), Expect = 8e-58
 Identities = 102/288 (35%), Positives = 163/288 (56%), Gaps = 38/288 (13%)

Query: 81  QGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHCFF 134
           +G++GVV++A+  +TGE VA+KK+  +K  +       RE+  +  L HPN+V++K    
Sbjct: 15  EGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVV 74

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
            +   D++Y+  V+EYV   +  +++      Q      VK    Q+   ++++H +  +
Sbjct: 75  GSNL-DKIYM--VMEYVEHDLKSLMETMK---QPFLQSEVKCLMLQLLSGVAHLHDN-WI 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATEY 251
            HRD+K  NLL+N +   +K+CDFG A+    G P   Y   + + +YRAPEL+ GA EY
Sbjct: 128 LHRDLKTSNLLLN-NRGILKICDFGLAREY--GSPLKPYTQLVVTLWYRAPELLLGAKEY 184

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF-KF 310
           +TAID+WS GC+ AEL+  KPLFPG S +DQL +I K+LGTPT +        +  F + 
Sbjct: 185 STAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEK-------IWPGFSEL 237

Query: 311 PQIKA-----HPWHKIFPKRMPP-----EAVDLVSRLLQYSPNLRCTA 348
           P  K      +P++++  K+ P         DL++RLL Y P  R +A
Sbjct: 238 PGAKKKTFTKYPYNQL-RKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  187 bits (477), Expect = 3e-57
 Identities = 103/283 (36%), Positives = 158/283 (55%), Gaps = 28/283 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 8   IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDV 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     +  L LV EY  + +    K+F+  N  +    VK + +Q+ + L++ H S 
Sbjct: 68  LHS-----DKKLTLVFEYCDQDLK---KYFDSCNGDIDPEIVKSFMFQLLKGLAFCH-SH 118

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N +  ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 119 NVLHRDLKPQNLLINKNG-ELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 175

Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYT 306
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E    ++  P+Y 
Sbjct: 176 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYK 235

Query: 307 EF-KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +  +P   +     + PK +     DL+  LL  +P  R +A
Sbjct: 236 PYPMYPATTS--LVNVVPK-LNSTGRDLLQNLLVCNPVQRISA 275

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  186 bits (475), Expect = 4e-57
 Identities = 93/282 (32%), Positives = 135/282 (47%), Gaps = 46/282 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLK 130
            ++G+GSFG V+ A   +TGE +A+K V L     +      RE++ +  L HPN+V   
Sbjct: 6   ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIV--- 62

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             + S  D+++  LN+ LEYV   ++  ++K F KL + +    ++ Y  QI   L+Y+H
Sbjct: 63  RYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV----IRKYTRQILEGLAYLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPELIF 246
            + G+ HRDIK  N+LV+     VKL DFG AK L   E        R   Y+ APE+I 
Sbjct: 119 SN-GIVHRDIKGANILVDS-DGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIR 176

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G  EY  A DIWS GC V E+  GKP +         +  I   G P             
Sbjct: 177 G-EEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGEP------------- 222

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               P+I         P+ +  EA D + + L+  P  R TA
Sbjct: 223 ----PEI---------PEHLSEEAKDFLRKCLRRDPKKRPTA 251

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  186 bits (474), Expect = 4e-56
 Identities = 105/287 (36%), Positives = 152/287 (52%), Gaps = 27/287 (9%)

Query: 79  VGQGSFGVVFQAKCLET--GETVAIKK---VLQDKRYKNRELQTMRLL----DHPNVVSL 129
           +GQG++G+V  A+  ET   ETVAIKK   V   K    R L+ ++LL     H N+  L
Sbjct: 8   LGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCL 67

Query: 130 KHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
                      +ELYL    E +   +H++++      Q +   + + + YQI   L YI
Sbjct: 68  YDMDIVFPGNFNELYL--YEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYI 121

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNIS-YICSRYYRAPE 243
           H S  V HRD+KP NLLVN    ++K+CDFG A+       +    ++ Y+ +R+YRAPE
Sbjct: 122 H-SANVLHRDLKPGNLLVNADC-ELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE 179

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKC 300
           ++     YT AID+WS GC++AEL+  KP+F G   VDQL +I++VLGTP  E    I  
Sbjct: 180 IMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS 239

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                     P I   P+  IFP    P A+DL+ +LL + P  R +
Sbjct: 240 PKAQNYIRSLPNIPKKPFESIFPN-ANPLALDLLEKLLAFDPTKRIS 285

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  184 bits (469), Expect = 7e-56
 Identities = 106/287 (36%), Positives = 167/287 (58%), Gaps = 30/287 (10%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           E+I G+G++GVV++A+   T ET+A+KK+  ++  +       RE+  ++ + H N+V L
Sbjct: 8   EKI-GEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK---HFNKLNQRMPMIYVKLYAYQIFRALS 186
           +    S     E  L LV EY+   + + +     F K N R+    +K Y YQI R ++
Sbjct: 67  QDVVHS-----EKRLYLVFEYLDLDLKKHMDSSPDFAK-NPRL----IKTYLYQILRGIA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y H S  V HRD+KPQNLL++  T+ +KL DFG A+    G P  ++   + + +YRAPE
Sbjct: 117 YCH-SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAF--GIPVRTFTHEVVTLWYRAPE 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN- 302
           ++ G+  Y+T +DIWS GC+ AE++  KPLFPGDS +D+L +I ++LGTP  E    +  
Sbjct: 174 ILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS 233

Query: 303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            P+Y    FP+        + P  + P  VDL+S++L+  P+ R TA
Sbjct: 234 LPDYKS-AFPKWPPKDLATVVPT-LEPAGVDLLSKMLRLDPSKRITA 278

Length = 294

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  183 bits (465), Expect = 2e-55
 Identities = 97/280 (34%), Positives = 163/280 (58%), Gaps = 22/280 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G++  V++ +   TGE VA+K++  D          RE+  M+ L H N+V L H  
Sbjct: 8   LGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRL-HDV 66

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             T +K    L LV EY+ + + + +   + +   +    VK + YQ+ + +++ H +  
Sbjct: 67  IHTENK----LMLVFEYMDKDLKKYMD-THGVRGALDPNTVKSFTYQLLKGIAFCHEN-R 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 250
           V HRD+KPQNLL+N    ++KL DFG A+    G P  ++   + + +YRAP+++ G+  
Sbjct: 121 VLHRDLKPQNLLINKRG-ELKLADFGLARAF--GIPVNTFSNEVVTLWYRAPDVLLGSRT 177

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTEF 308
           Y+T+IDIWS GC++AE++ G+PLFPG +  DQL++I +++GTPT      ++  P Y + 
Sbjct: 178 YSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEY-KP 236

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FP+       ++FP    P  +DL+ RLLQ +P LR +A
Sbjct: 237 TFPRYPPQDLQQLFP-HADPLGIDLLHRLLQLNPELRISA 275

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  177 bits (452), Expect = 2e-53
 Identities = 98/291 (33%), Positives = 157/291 (53%), Gaps = 26/291 (8%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 126
           +Y     +G+GS+  V++ +   TG+ VA+K++ L+ +        RE   ++ L H N+
Sbjct: 6   TYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRAL 185
           V+L H    T       L LV EY+       +K + +     + M  V+L+ +Q+ R L
Sbjct: 66  VTL-HDIIHTKKT----LTLVFEYL----DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 242
           +Y H+   V HRD+KPQNLL++    ++KL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 AYCHQR-RVLHRDLKPQNLLIS-ERGELKLADFGLARA--KSVPSKTYSNEVVTLWYRPP 172

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIK-- 299
           +++ G+TEY+T++D+W  GC+  E+  G+PLFPG + V DQL +I +VLGTPT E     
Sbjct: 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGV 232

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTAV 349
             NP +  + FP     P     P+    P   +L  + LQY P  R +A 
Sbjct: 233 SSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  174 bits (443), Expect = 5e-53
 Identities = 70/247 (28%), Positives = 122/247 (49%), Gaps = 40/247 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G FG V+ A+  +TG+ VAIK + ++          RE++ ++ L+HPN+V L   F
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                +DE +L LV+EY    ++  ++K   +   ++    +     QI   L Y+H S 
Sbjct: 61  -----EDENHLYLVMEYCEGGSLKDLLK---ENEGKLSEDEILRILLQILEGLEYLH-SN 111

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEY 251
           G+ HRD+KP+N+L++    +VKL DFG +K+L   +  +  I  +  Y APE++ G   Y
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKF 310
           +   DIWS G ++ EL              +L ++I+          K +  +  +    
Sbjct: 172 SEKSDIWSLGVILYEL-------------PELKDLIR----------KMLQKDPEKRPSA 208

Query: 311 PQIKAHP 317
            +I  H 
Sbjct: 209 KEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  177 bits (450), Expect = 6e-53
 Identities = 98/286 (34%), Positives = 149/286 (52%), Gaps = 30/286 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+G++G+V++A+   +GE VA+KKV  D           RE+  +  L HPN+V LK 
Sbjct: 14  RIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKE 73

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
                  K    + LV+EY  + +  ++   + +        VK    Q+ R L Y+H +
Sbjct: 74  V---VVGKHLDSIFLVMEYCEQDLASLL---DNMPTPFSESQVKCLMLQLLRGLQYLHEN 127

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+K  NLL+      +K+ DFG A+    G P       + + +YRAPEL+ G 
Sbjct: 128 F-IIHRDLKVSNLLLTDKGC-LKIADFGLARTY--GLPAKPMTPKVVTLWYRAPELLLGC 183

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYT 306
           T YTTAID+W+ GC++AEL+  KPL PG S ++QL  II++LGTP        +  P   
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243

Query: 307 EFKFPQIKAHPW----HKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +F  P+    P+    HK FP  +    + L++ LL Y P  R TA
Sbjct: 244 KFTLPK---QPYNNLKHK-FPW-LSEAGLRLLNFLLMYDPKKRATA 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  175 bits (446), Expect = 2e-52
 Identities = 93/286 (32%), Positives = 154/286 (53%), Gaps = 23/286 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNVVSLK 130
            +G+G++G V++A+   TG+ VA+KK   +   +       RE+  +++L     +V L 
Sbjct: 8   KIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLL 67

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                     +  L LV EY+   + + +  +     + +P   +K + YQ+ + +++ H
Sbjct: 68  DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCH 127

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
              GV HRD+KPQNLLV+     +K+ D G  +      P  SY   I + +YRAPE++ 
Sbjct: 128 -KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI--PVKSYTHEIVTLWYRAPEVLL 184

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G+T Y+T +DIWS GC+ AE+   +PLFPGDS + QL+ I K+LGTPT +      P  +
Sbjct: 185 GSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVW----PGVS 240

Query: 307 EFK----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + +    FPQ K     +  P  + PE +DL+ ++L+Y P  R +A
Sbjct: 241 KLRDWHEFPQWKPQDLSRAVPD-LSPEGLDLLQKMLRYDPAKRISA 285

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  174 bits (444), Expect = 4e-52
 Identities = 93/284 (32%), Positives = 148/284 (52%), Gaps = 24/284 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HP 124
            +G+G++G V++A+ L TG  VA+KKV    R             RE+  ++ L+   HP
Sbjct: 6   EIGEGAYGTVYKARDLNTGRFVALKKV----RVPLSEEGIPLSTLREIALLKQLESFEHP 61

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           N+V L           EL L LV E+V + +   +    K    +P   +K    Q+ R 
Sbjct: 62  NIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPG--LPPETIKDLMRQLLRG 119

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + ++H S  + HRD+KPQN+LV     QVK+ DFG A++        S + + +YRAPE+
Sbjct: 120 VDFLH-SHRIVHRDLKPQNILVT-SDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV 177

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  ++ Y T +D+WS GC+ AEL   +PLF G S  DQL +I  V+G P+ EE    N +
Sbjct: 178 LLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWP-RNVS 235

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                FP      +    P+ +  E +DL+ ++L ++P+ R +A
Sbjct: 236 LPRSSFPSYTPRSFKSFVPE-ICEEGLDLLKKMLTFNPHKRISA 278

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  173 bits (440), Expect = 1e-51
 Identities = 97/285 (34%), Positives = 154/285 (54%), Gaps = 31/285 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLDHPNVVS 128
           +G+G++GVV++ +  +TG+ VA+KK+    R ++          RE+  ++ L HPN+V 
Sbjct: 8   IGEGTYGVVYKGRNKKTGQIVAMKKI----RLESEEEGVPSTAIREISLLKELQHPNIVC 63

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L+          E  L L+ E++   + + +    K  Q M    VK Y YQI + + + 
Sbjct: 64  LQDVLM-----QESRLYLIFEFLSMDLKKYLDSLPK-GQYMDAELVKSYLYQILQGILFC 117

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H    V HRD+KPQNLL++ +   +KL DFG A+    G P   Y   + + +YRAPE++
Sbjct: 118 HSR-RVLHRDLKPQNLLID-NKGVIKLADFGLARAF--GIPVRVYTHEVVTLWYRAPEVL 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--P 303
            G+  Y+T +DIWS G + AE+   KPLF GDS +DQL  I ++LGTPT +    +   P
Sbjct: 174 LGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLP 233

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +Y    FP+ K         K +  + +DL+ ++L Y P  R +A
Sbjct: 234 DYKN-TFPKWKKGSLRSAV-KNLDEDGLDLLEKMLIYDPAKRISA 276

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  172 bits (439), Expect = 3e-51
 Identities = 93/297 (31%), Positives = 144/297 (48%), Gaps = 35/297 (11%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKHC 132
           G+G+FG V++A+ ++TG  VA+KK+L     K+       RE++ ++ L HPNVV L   
Sbjct: 17  GEGTFGEVYKARQIKTGRVVALKKILM-HNEKDGFPITALREIKILKKLKHPNVVPLIDM 75

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                DK +     V    P   H +       + ++    +K Y  Q+   ++Y+H + 
Sbjct: 76  AVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHEN- 134

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------------ICSRYYR 240
            + HRDIK  N+L++ +   +K+ DFG A+      PN               + +R+YR
Sbjct: 135 HILHRDIKAANILID-NQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYR 193

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PEL+ G   YTTA+DIW  GCV AE+   +P+  G S +DQL  I K+ GTPT E    
Sbjct: 194 PPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETW-- 251

Query: 301 MNPNYTEFKFPQIKAHPWHKIFP-------KRMPPEAVDLVSRLLQYSPNLRCTAVS 350
             P +     P  +       +P        ++ PE +DL+S+LL   P  R TA  
Sbjct: 252 --PGWR--SLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASD 304

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  167 bits (424), Expect = 2e-49
 Identities = 107/282 (37%), Positives = 165/282 (58%), Gaps = 28/282 (9%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 131
           +VG+G++GVV + +  ET E VAIKK          K    REL+ +R L   N+V LK 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKE 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F     + +LYL  V EYV + +  +++   ++   +P   V+ Y YQ+ +A+ + H++
Sbjct: 68  AF---RRRGKLYL--VFEYVEKNMLELLE---EMPNGVPPEKVRSYIYQLIKAIHWCHKN 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNIS-YICSRYYRAPELIFGAT 249
             + HRDIKP+NLL++ H   +KLCDFG A+ L +G   N + Y+ +R+YR+PEL+ GA 
Sbjct: 120 -DIVHRDIKPENLLIS-HNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP 177

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM--NPNYTE 307
            Y  A+D+WS GC++ EL  G+PLFPG+S +DQL  I KVLG    E++K    NP +  
Sbjct: 178 -YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHG 236

Query: 308 FKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLR 345
            +FP +  HP  +   +R    +    +DL+  LL+ +P  R
Sbjct: 237 LRFPAV-NHP--QSLERRYLGILSGVLLDLMKNLLKLNPTDR 275

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  168 bits (428), Expect = 3e-49
 Identities = 91/299 (30%), Positives = 157/299 (52%), Gaps = 34/299 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKR---YKNRELQTMRLLDHPNVVS 128
           YM  R +G GS G+VF A   +  + VA+KK VL D +   +  RE++ +R LDH N+V 
Sbjct: 7   YMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 66

Query: 129 LKHCFFSTTDKDELYLN---------LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           +      +       +          +V EY+   +  V++        +   + +L+ Y
Sbjct: 67  VYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-----GPLSEEHARLFMY 121

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ 233
           Q+ R L YIH S  V HRD+KP N+ +N     +K+ DFG A+++   +P+ S+      
Sbjct: 122 QLLRGLKYIH-SANVLHRDLKPANVFINTEDLVLKIGDFGLARIV---DPHYSHKGYLSE 177

Query: 234 -ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL---VEIIKV 289
            + +++YR+P L+     YT AID+W+AGC+ AE++ GKPLF G   ++Q+   +E + V
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +    R E+  + P++      + +  P   + P  + PEA+D + ++L ++P  R TA
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPR-RPLRDLLPG-VNPEALDFLEQILTFNPMDRLTA 294

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  168 bits (426), Expect = 1e-48
 Identities = 89/300 (29%), Positives = 133/300 (44%), Gaps = 48/300 (16%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHP 124
           SY   R +G+GSFG V+ A+  +    VA+K + +    K+       RE+Q +  L+HP
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKL---VALKVLAKKLESKSKEVERFLREIQILASLNHP 57

Query: 125 -NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V L   F     +DE  L LV+EYV       +         +          QI  
Sbjct: 58  PNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS 112

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-------SYICS 236
           AL Y+H   G+ HRDIKP+N+L++     VKL DFG AK+L              + + +
Sbjct: 113 ALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGT 171

Query: 237 RYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLG 291
             Y APE++ G +    +++ DIWS G  + EL+ G P F G+       Q ++II  L 
Sbjct: 172 PGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP 231

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
           TP                     A P     P+ +   A DL+ +LL   P  R ++ S 
Sbjct: 232 TP-------------------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD 272

Length = 384

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  164 bits (418), Expect = 5e-48
 Identities = 107/308 (34%), Positives = 146/308 (47%), Gaps = 46/308 (14%)

Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +G+G++G V++AK      G+  AIKK   DK           RE+  +R L H NVVSL
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSL 67

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK-HFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F    DK  +YL  + +Y    + +++K H       +P   VK   +QI   + Y+
Sbjct: 68  VEVFLEHADK-SVYL--LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124

Query: 189 HRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA-------KVLVKGEPNISYICSRY 238
           H S  V HRD+KP N+LV    P    VK+ D G A       K L   +P +  I   +
Sbjct: 125 H-SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTI---W 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKV 289
           YRAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F G             DQL  I +V
Sbjct: 181 YRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEV 240

Query: 290 LGTPTREE---IKCMNPNYTEFKFPQIKAHPWHKIFPKRM------PPEAVDLVSRLLQY 340
           LGTPT ++   IK M P Y                  K M        +  DL+ +LL+Y
Sbjct: 241 LGTPTEKDWPDIKKM-PEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 341 SPNLRCTA 348
            P  R TA
Sbjct: 300 DPTKRITA 307

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  161 bits (409), Expect = 2e-47
 Identities = 78/275 (28%), Positives = 125/275 (45%), Gaps = 42/275 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHCFF 134
           +G+G FG V++A+   TG+ VAIK + L+ K  K     E+Q ++   HPN+V     + 
Sbjct: 8   IGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
               KDEL+  +V+E+    ++  ++K     NQ +    +     ++ + L Y+H S G
Sbjct: 68  ---KKDELW--IVMEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLH-SNG 118

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRDIK  N+L+     +VKL DFG +  L   +   + + + Y+ APE+I G   Y  
Sbjct: 119 IIHRDIKAANILLT-SDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVING-KPYDY 176

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
             DIWS G    EL  GKP +  +    + +  I   G P                    
Sbjct: 177 KADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPPGLRN---------------- 219

Query: 314 KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    P++   E  D + + LQ +P  R TA
Sbjct: 220 ---------PEKWSDEFKDFLKKCLQKNPEKRPTA 245

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  163 bits (414), Expect = 3e-47
 Identities = 96/307 (31%), Positives = 148/307 (48%), Gaps = 53/307 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------------------RELQTMR 119
           +G+G++G V +A    TG+ VAIKKV +     N                   REL+ M 
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKV-KIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN 75

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            + H N++ L   +         ++NLV++ +   + +VV        R+    VK    
Sbjct: 76  EIKHENIMGLVDVYVE-----GDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILL 126

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----VLVKGEPNISYI 234
           QI   L+ +H+   + HRD+ P N+ +N      K+ DFG A+                +
Sbjct: 127 QILNGLNVLHKWYFM-HRDLSPANIFINSKG-ICKIADFGLARRYGYPPYSDTLSKDETM 184

Query: 235 CSR----------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
             R          +YRAPEL+ GA +Y  A+D+WS GC+ AEL+ GKPLFPG++ +DQL 
Sbjct: 185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG 244

Query: 285 EIIKVLGTPTRE---EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            I ++LGTP  +   + K + P YTEF   + K      IFP     +A+DL+  LL+ +
Sbjct: 245 RIFELLGTPNEDNWPQAKKL-PLYTEFTPRKPKD--LKTIFPNA-SDDAIDLLQSLLKLN 300

Query: 342 PNLRCTA 348
           P  R +A
Sbjct: 301 PLERISA 307

Length = 335

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  163 bits (413), Expect = 3e-47
 Identities = 96/281 (34%), Positives = 153/281 (54%), Gaps = 22/281 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 132
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 23  VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDV 82

Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D  +   LV+ ++   + +++KH     +++    ++   YQ+ + L YIH +
Sbjct: 83  FTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-----EKLSEDRIQFLVYQMLKGLKYIH-A 136

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP NL VN    ++K+ DFG A+          Y+ +R+YRAPE+I     Y
Sbjct: 137 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--TDSEMTGYVVTRWYRAPEVILNWMHY 193

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 307
           T  +DIWS GC++AE++ GKPLF G   +DQL+EI+KV GTP++E ++ +      NY +
Sbjct: 194 TQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVK 253

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            K P+ +   +  + P    P AV+++ ++L      R TA
Sbjct: 254 -KLPRFRKKDFRSLLPN-ANPLAVNVLEKMLVLDAESRITA 292

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  160 bits (407), Expect = 7e-47
 Identities = 96/280 (34%), Positives = 155/280 (55%), Gaps = 23/280 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+V+L H  
Sbjct: 13  LGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTL-HDI 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             T    E  L LV EY+   + + + +   L   M M  VK++ +Q+ R LSY H+   
Sbjct: 72  IHT----ERCLTLVFEYLDSDLKQYLDNCGNL---MSMHNVKIFMFQLLRGLSYCHKR-K 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGATE 250
           + HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+++ G+TE
Sbjct: 124 ILHRDLKPQNLLIN-EKGELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPDVLLGSTE 180

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK--CMNPNYTEF 308
           Y+T ID+W  GC++ E+  G+P+FPG +  ++L  I ++LGTPT E       N  +  +
Sbjct: 181 YSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSY 240

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FPQ +A P     P R+  + +DL+S LL Y    R +A
Sbjct: 241 LFPQYRAQPLINHAP-RLDTDGIDLLSSLLLYETKSRISA 279

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  163 bits (414), Expect = 7e-47
 Identities = 106/308 (34%), Positives = 158/308 (51%), Gaps = 65/308 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK---VLQD----KRYKNRELQTMRLLDHPNVVS 128
           +R +G G+FGVV+       G+ VA+KK   V Q+    KR   REL+ +    H NV+S
Sbjct: 5   DRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVF-RELKMLCFFKHDNVLS 63

Query: 129 --------LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
                       F      +E+Y+  V E +   +H+++       Q +   +VK++ YQ
Sbjct: 64  ALDILQPPHIDPF------EEIYV--VTELMQSDLHKIIVS----PQPLSSDHVKVFLYQ 111

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-----IC 235
           I R L Y+H S G+ HRDIKP NLLVN +   +K+CDFG A+V    EP+ S      + 
Sbjct: 112 ILRGLKYLH-SAGILHRDIKPGNLLVNSNC-VLKICDFGLARV---EEPDESKHMTQEVV 166

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           ++YYRAPE++ G+  YT+A+DIWS GC+ AEL+  + LF   S + QL  I  +LGTP+ 
Sbjct: 167 TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSL 226

Query: 296 EEIK--CMNPNYTEFKFPQIKAHPWHKIFPKRMPP-------------EAVDLVSRLLQY 340
           E ++  C             +AH      P + P              EAV L+ R+L +
Sbjct: 227 EAMRSACEGA----------RAHILRG--PHKPPSLPVLYTLSSQATHEAVHLLCRMLVF 274

Query: 341 SPNLRCTA 348
            P+ R +A
Sbjct: 275 DPDKRISA 282

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  161 bits (408), Expect = 7e-47
 Identities = 91/300 (30%), Positives = 153/300 (51%), Gaps = 49/300 (16%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+G++G V++A+  +TGE VA+KKV  D   +       RE++ +R L+H N+V+LK 
Sbjct: 14  QIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKE 73

Query: 132 CFFSTTD-----KDELYLNLVLEYVPETVHRVVK----HFNKLNQRMPMIYVKLYAYQIF 182
                 D     KD+    LV EY+   +  +++    HF++ +       +K +  Q+ 
Sbjct: 74  IVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDH-------IKSFMKQLL 126

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYR 240
             L+Y H+     HRDIK  N+L+N +  Q+KL DFG A++    E  P  + + + +YR
Sbjct: 127 EGLNYCHKK-NFLHRDIKCSNILLN-NKGQIKLADFGLARLYNSEESRPYTNKVITLWYR 184

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PEL+ G   Y  AID+WS GC++ EL   KP+F  +  + QL  I ++ G+P       
Sbjct: 185 PPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPC----PA 240

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRM------------PPEAVDLVSRLLQYSPNLRCTA 348
           + P+  +  +       ++ + PK+             P  A+DL+  +L   P+ RCTA
Sbjct: 241 VWPDVIKLPY-------FNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTA 293

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  160 bits (406), Expect = 2e-46
 Identities = 98/287 (34%), Positives = 159/287 (55%), Gaps = 23/287 (8%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  VF+ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L       TDK    L LV EY+ + +    ++ +     M M  VK++ YQI R L+
Sbjct: 67  VTLHDIVH--TDKS---LTLVFEYLDKDLK---QYMDDCGNIMSMHNVKIFLYQILRGLA 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSVPTKTYSNEVVTLWYRPPD 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G++EY+T ID+W  GC+  E+  G+PLFPG +  D+L  I ++LGTPT E    ++ 
Sbjct: 175 VLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISS 234

Query: 304 N--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N  +  + FP+ K  P     P R+  E ++L+++ LQY    R +A
Sbjct: 235 NDEFKNYNFPKYKPQPLINHAP-RLDTEGIELLTKFLQYESKKRISA 280

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  160 bits (406), Expect = 4e-46
 Identities = 98/288 (34%), Positives = 155/288 (53%), Gaps = 25/288 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL---DHPNV 126
           Y + + VG G++G V  A    TGE VAIKK+    Q + +  R  + + LL    H NV
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L   F S    DE     LV+ Y+   + +++ H   L++      V+   YQ+   L
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGH--PLSEDK----VQYLVYQMLCGL 130

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 244
            YIH + G+ HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE+
Sbjct: 131 KYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPEV 185

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-- 302
           I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +   
Sbjct: 186 ILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK 245

Query: 303 --PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +Y +   P+     +  +FP +  P+AVDL+ ++L+   + R TA
Sbjct: 246 AAKSYIK-SLPKYPRKDFSTLFP-KASPQAVDLLEKMLELDVDKRLTA 291

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  158 bits (401), Expect = 8e-46
 Identities = 94/287 (32%), Positives = 159/287 (55%), Gaps = 23/287 (8%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  V++ +   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 7   TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 66

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L H    T    E  L LV EY+ + +    ++ +     + M  VKL+ +Q+ R L+
Sbjct: 67  VTL-HDIIHT----EKSLTLVFEYLDKDLK---QYLDDCGNSINMHNVKLFLFQLLRGLN 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 119 YCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYSNEVVTLWYRPPD 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 175 ILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 234

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N  +  + +P+ +A   H   P R+  +  +L+S+LLQ+    R +A
Sbjct: 235 NEEFKSYNYPKYRADCLHNHAP-RLDSDGAELLSKLLQFEGRKRISA 280

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  153 bits (389), Expect = 2e-44
 Identities = 85/277 (30%), Positives = 133/277 (48%), Gaps = 52/277 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSLKH 131
           +G+GSFG V   +  +TG+  A+K     K+++ K   +   E   +  ++HP +V L +
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHY 60

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F     + E  L LVLEY P  E    + K       R      + YA +I  AL Y+H
Sbjct: 61  AF-----QTEEKLYLVLEYAPGGELFSHLSKEG-----RFSEERARFYAAEIVLALEYLH 110

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S+G+ +RD+KP+N+L++   H +KL DFG AK L       +  C +  Y APE++ G 
Sbjct: 111 -SLGIIYRDLKPENILLDADGH-IKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK 168

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  A+D WS G ++ E++ GKP F  +    ++ E I       ++ ++         
Sbjct: 169 -GYGKAVDWWSLGVLLYEMLTGKPPFYAED-RKEIYEKIL------KDPLR--------- 211

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        FP+ + PEA DL+S LLQ  P  R
Sbjct: 212 -------------FPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  154 bits (392), Expect = 7e-44
 Identities = 99/303 (32%), Positives = 157/303 (51%), Gaps = 44/303 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKK-------VLQDKR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A    TG+ VAIKK       V   KR Y  REL  M+L++H 
Sbjct: 18  YQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAY--RELVLMKLVNHK 75

Query: 125 NVVSLKHCFFSTTDKD-----ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           N++ L + F  T  K      ++YL  V+E +   + +V+   +  ++RM  +      Y
Sbjct: 76  NIIGLLNVF--TPQKSLEEFQDVYL--VMELMDANLCQVI-QMDLDHERMSYLL-----Y 125

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           Q+   + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYY
Sbjct: 126 QMLCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYY 183

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  +II+ LGTP+ E + 
Sbjct: 184 RAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMS 242

Query: 300 CMNP---NYTEFKFPQIKAHPWHKIFP------------KRMPPEAVDLVSRLLQYSPNL 344
            + P   NY E + P+   + + ++FP            K    +A DL+S++L   P  
Sbjct: 243 RLQPTVRNYVENR-PKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEK 301

Query: 345 RCT 347
           R +
Sbjct: 302 RIS 304

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  153 bits (388), Expect = 2e-43
 Identities = 95/288 (32%), Positives = 153/288 (53%), Gaps = 24/288 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     VG G++G V  A      + VA+KK+      L   R   REL+ ++ + H NV
Sbjct: 17  YQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENV 76

Query: 127 VSLKHCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           + L   F   T   + +E+YL  V   +   ++ +VK      Q++   +V+   YQ+ R
Sbjct: 77  IGLLDVFTPATSIENFNEVYL--VTNLMGADLNNIVKC-----QKLSDEHVQFLIYQLLR 129

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L YIH S G+ HRD+KP N+ VN    ++++ DFG A+     +    Y+ +R+YRAPE
Sbjct: 130 GLKYIH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADDEMTGYVATRWYRAPE 185

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y   +DIWS GC++AEL+ GK LFPG+  +DQL  I++V+GTP+ E +K ++ 
Sbjct: 186 IMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS 245

Query: 304 NYTEFKF---PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +        P +      KIF +   P A+DL+ ++L    + R +A
Sbjct: 246 EHARKYIQSLPHMPQQDLKKIF-RGANPLAIDLLEKMLVLDSDKRISA 292

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  150 bits (381), Expect = 6e-43
 Identities = 100/292 (34%), Positives = 161/292 (55%), Gaps = 30/292 (10%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN 125
           SY+    +G+GS+  V++      G+ VA+K V+  K  +       RE   ++ L H N
Sbjct: 6   SYLNLEKLGEGSYATVYKGISRINGQLVALK-VISMKTEEGVPFTAIREASLLKGLKHAN 64

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +V L H    T +     L  V EY+  +    +++H   L+       V+L+ +Q+ R 
Sbjct: 65  IVLL-HDIIHTKET----LTFVFEYMHTDLAQYMIQHPGGLHPY----NVRLFMFQLLRG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRA 241
           L+YIH    + HRD+KPQNLL++ +  ++KL DFG A+   K  P+ +Y   + + +YR 
Sbjct: 116 LAYIHGQ-HILHRDLKPQNLLIS-YLGELKLADFGLARA--KSIPSQTYSSEVVTLWYRP 171

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKC 300
           P+++ GAT+Y++A+DIW AGC+  E++ G+P FPG S V +QL +I  VLG PT +    
Sbjct: 172 PDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPG 231

Query: 301 MN--PNYTEFKFPQIKAHPWHKIFPKRM--PPEAVDLVSRLLQYSPNLRCTA 348
           ++  PNY    F   K      ++ KR+  PP+A DL S++L   P  R +A
Sbjct: 232 VSKLPNYKPEWFLPCKPQQLRVVW-KRLSRPPKAEDLASQMLMMFPKDRISA 282

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  149 bits (377), Expect = 6e-42
 Identities = 96/282 (34%), Positives = 150/282 (53%), Gaps = 24/282 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 25  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 83

Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 84  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 137

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 138 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 194

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 195 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 254

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +    Q+    +  +F     P AVDL+ ++L    + R TA
Sbjct: 255 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 294

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  142 bits (361), Expect = 3e-40
 Identities = 79/289 (27%), Positives = 126/289 (43%), Gaps = 60/289 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + +G+GSFG V+  +    G+   +K++       +++     E++ ++ L+HPN+
Sbjct: 2   YEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +     F     +++  L +V+EY     + + +K   K  +  P   +  +  Q+  AL
Sbjct: 62  IKYYESF-----EEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLAL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYICS 236
            Y+H S  + HRDIKPQN+ +      VKL DFG +KVL         V G P       
Sbjct: 117 KYLH-SRKILHRDIKPQNIFLT-SNGLVKLGDFGISKVLSSTVDLAKTVVGTP------- 167

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            YY +PEL      Y    DIWS GCV+ EL   K  F G++ + +L    K+L    + 
Sbjct: 168 -YYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGEN-LLELAL--KIL----KG 218

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           +   +   Y                       E  +LVS LLQ  P  R
Sbjct: 219 QYPPIPSQY---------------------SSELRNLVSSLLQKDPEER 246

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  142 bits (361), Expect = 8e-40
 Identities = 89/290 (30%), Positives = 142/290 (48%), Gaps = 26/290 (8%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +GQG+FG VF+A+  +T + VA+KKVL +   +       RE++ ++LL H NVV+L  
Sbjct: 19  KIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIE 78

Query: 132 -CFFSTT----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            C    T     K   YL  V E+     H +    +  N +  +  +K     +   L 
Sbjct: 79  ICRTKATPYNRYKGSFYL--VFEFCE---HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRA 241
           YIHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR 
Sbjct: 134 YIHRN-KILHRDMKAANILITKDG-ILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-KC 300
           PEL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E     
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 301 MN-PNYTEFKFPQ-IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                + + + PQ  K     ++ P    P A+DL+ +LL   P  R  A
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDA 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  141 bits (357), Expect = 1e-39
 Identities = 70/203 (34%), Positives = 111/203 (54%), Gaps = 20/203 (9%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKH 131
           ++G+G+FGVV++   LETG+ VAIK++ L+  + +      +E+  ++ L HPN+V    
Sbjct: 7   LIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  +    L ++LEY    ++ +++K F    + +    V +Y YQ+ + L+Y+H 
Sbjct: 67  SI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESL----VAVYVYQVLQGLAYLHE 117

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 249
             GV HRDIK  N+L       VKL DFG A  L     +  S + + Y+ APE+I   +
Sbjct: 118 Q-GVIHRDIKAANILTTKDGV-VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEM-S 174

Query: 250 EYTTAIDIWSAGCVVAELMLGKP 272
             +TA DIWS GC V EL+ G P
Sbjct: 175 GASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  137 bits (348), Expect = 3e-38
 Identities = 83/309 (26%), Positives = 137/309 (44%), Gaps = 73/309 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTM-RLLDHP 124
           +   +I+G+GSF  V  AK  ET +  AIK     +++++K+  Y   E + + RL  HP
Sbjct: 3   FKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            ++ L + F    D++ LY   VLEY P   + + ++ +  L+++      + YA +I  
Sbjct: 63  GIIKLYYTF---QDEENLY--FVLEYAPNGELLQYIRKYGSLDEKC----TRFYAAEILL 113

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRY- 238
           AL Y+H S G+ HRD+KP+N+L++   H +K+ DFG+AKVL                   
Sbjct: 114 ALEYLH-SKGIIHRDLKPENILLDKDMH-IKITDFGTAKVLDPNSSPESNKGDATNIDSQ 171

Query: 239 ----------------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
                           Y +PEL+        + D+W+ GC++ +++ GKP F G      
Sbjct: 172 IEKNRRRFASFVGTAEYVSPELL-NEKPAGKSSDLWALGCIIYQMLTGKPPFRGS----- 225

Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
                                   E+  F +I    +   FP   PP+A DL+ +LL   
Sbjct: 226 -----------------------NEYLTFQKILKLEYS--FPPNFPPDAKDLIEKLLVLD 260

Query: 342 PNLRCTAVS 350
           P  R     
Sbjct: 261 PQDRLGVNE 269

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  136 bits (345), Expect = 6e-38
 Identities = 85/285 (29%), Positives = 136/285 (47%), Gaps = 50/285 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN-----RELQTMRLLDHPNVVSLKHC 132
           +G G+FG V+ A  L+TGE +A+K++ +QD   K       E++ + LL HPN+V     
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVK---Y 64

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           +     ++++Y+   +EY    T+  +++H     + +    +++Y  Q+   L+Y+H S
Sbjct: 65  YGVEVHREKVYI--FMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLH-S 117

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYRAPELIF 246
            G+ HRDIKP N+ ++ H   +KL DFG A  L       GE   S   +  Y APE+I 
Sbjct: 118 HGIVHRDIKPANIFLD-HNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT 176

Query: 247 GAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           G     +  A DIWS GCVV E+  GK  +   S +D   +I+  +G          +  
Sbjct: 177 GGKGKGHGRAADIWSLGCVVLEMATGKRPW---SELDNEFQIMFHVGA--------GHK- 224

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                 P I           ++ PE  D + R L+  P  R TA 
Sbjct: 225 ------PPIPDS-------LQLSPEGKDFLDRCLESDPKKRPTAS 256

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  135 bits (343), Expect = 1e-37
 Identities = 88/283 (31%), Positives = 132/283 (46%), Gaps = 54/283 (19%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL----QDKRYK-NRELQTMRLLDHPNVVSLKHCFF 134
           GQGS GVV++ +   TG+  A+KK+     ++ R +  REL+T+R  + P VV     F+
Sbjct: 10  GQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                 E  +++VLEY+   ++  ++K   K+ + +    +   A QI + L Y+H    
Sbjct: 70  K-----EGEISIVLEYMDGGSLADLLKKVGKIPEPV----LAYIARQILKGLDYLHTKRH 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGA 248
           + HRDIKP NLL+N    +VK+ DFG +KVL     N    C+ +     Y +PE I G 
Sbjct: 121 IIHRDIKPSNLLIN-SKGEVKIADFGISKVL----ENTLDQCNTFVGTVTYMSPERIQGE 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGK-P-LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           + Y+ A DIWS G  + E  LGK P L PG     +L++ I            C  P   
Sbjct: 176 S-YSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAI------------CDGPPP- 221

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                            +   PE  D +S  LQ  P  R +A 
Sbjct: 222 ---SLP----------AEEFSPEFRDFISACLQKDPKKRPSAA 251

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  135 bits (342), Expect = 1e-37
 Identities = 87/282 (30%), Positives = 130/282 (46%), Gaps = 48/282 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL---QDKRYK------NRELQTMRLLDHPNVV 127
            ++G GSFG V++   L+ G+  A+K+V      +  +       +E+  +  L HPN+V
Sbjct: 6   ELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                 +  T+++E  L + LE VP  ++ +++K +       P   ++LY  QI   L 
Sbjct: 66  Q-----YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSF----PEPVIRLYTRQILLGLE 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           Y+H      HRDIK  N+LV+     VKL DFG AK +V+     S+  S Y+ APE+I 
Sbjct: 117 YLH-DRNTVHRDIKGANILVDT-NGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIA 174

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y  A DIWS GC V E+  GKP +    GV  +                       
Sbjct: 175 QQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAV----------------------- 211

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FK  + K  P     P  +  EA D + + LQ  P+LR TA
Sbjct: 212 -FKIGRSKELP---PIPDHLSDEAKDFILKCLQRDPSLRPTA 249

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  136 bits (343), Expect = 2e-37
 Identities = 97/287 (33%), Positives = 151/287 (52%), Gaps = 31/287 (10%)

Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 9   IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 68

Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+    +P   +K   +Q+ R L 
Sbjct: 69  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 124

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 125 FLH-SHRVVHRDLKPQNILVTS-SGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 182

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+     P   
Sbjct: 183 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR-- 235

Query: 307 EFKFPQIK-----AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +   P+       A P  K     +     DL+ + L ++P  R +A
Sbjct: 236 DVALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISA 281

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  136 bits (343), Expect = 2e-37
 Identities = 104/309 (33%), Positives = 160/309 (51%), Gaps = 34/309 (11%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKR----YKNRELQTMRLLDHPNV 126
           SY     +G+GS+  V++ K    G+ VA+K + LQ++        RE   ++ L H N+
Sbjct: 6   SYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V L H    T +     L LV EYV  +    + KH   L+       VKL+ +Q+ R L
Sbjct: 66  VLL-HDIIHTKET----LTLVFEYVHTDLCQYMDKHPGGLHPE----NVKLFLFQLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAP 242
           SYIH+   + HRD+KPQNLL++  T ++KL DFG A+   K  P+ +Y   + + +YR P
Sbjct: 117 SYIHQRY-ILHRDLKPQNLLIS-DTGELKLADFGLARA--KSVPSHTYSNEVVTLWYRPP 172

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCM 301
           +++ G+TEY+T +D+W  GC+  E++ G   FPG   + DQL  I  VLGTP  +    +
Sbjct: 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGV 232

Query: 302 N--PNYTEFKFPQIKA----HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS--KRI 353
           +  P++   +F           W+K+        A DL S+LLQ  P  R +A +     
Sbjct: 233 HSLPHFKPERFTLYSPKNLRQAWNKL---SYVNHAEDLASKLLQCFPKNRLSAQAALSHE 289

Query: 354 LFSNCPSLL 362
            FS+ P  L
Sbjct: 290 YFSDLPPRL 298

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  133 bits (336), Expect = 2e-36
 Identities = 88/281 (31%), Positives = 143/281 (50%), Gaps = 20/281 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LL------DHPNVVSL 129
           +G G++G V++A+   +G  VA+K V          L T+R   LL      DHPN+V L
Sbjct: 8   IGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRL 67

Query: 130 KH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSY 187
              C  S TD+ E  + LV E+V + +     + +K+    +P   +K    Q  R L +
Sbjct: 68  MDVCATSRTDR-ETKVTLVFEHVDQDLR---TYLDKVPPPGLPAETIKDLMRQFLRGLDF 123

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +H +  + HRD+KP+N+LV     QVKL DFG A++          + + +YRAPE++  
Sbjct: 124 LHANC-IVHRDLKPENILVTSGG-QVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQ 181

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
           +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    +     
Sbjct: 182 ST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVTLPR 239

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             F      P   + P+ +      L+  +L ++P+ R +A
Sbjct: 240 GAFSPRGPRPVQSVVPE-IEESGAQLLLEMLTFNPHKRISA 279

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  131 bits (331), Expect = 4e-35
 Identities = 91/294 (30%), Positives = 153/294 (52%), Gaps = 31/294 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 82

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 83  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 136

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 137 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 195 LG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLR 345
            NY E + PQ     + ++FP  + P           +A DL+S++L   P+ R
Sbjct: 254 RNYVENR-PQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKR 306

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  127 bits (321), Expect = 2e-34
 Identities = 87/286 (30%), Positives = 139/286 (48%), Gaps = 60/286 (20%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNR------ELQTMRLLDHPNVVSLKH 131
           + +G++G VF AK   TG+  AIK +   D   KN+      E   +     P VV L  
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKL-- 58

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            ++S   K  LYL  V+EY+P   +  ++++   L++ +     ++Y  +I  AL Y+H 
Sbjct: 59  -YYSFQGKKNLYL--VMEYLPGGDLASLLENVGSLDEDV----ARIYIAEIVLALEYLH- 110

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISY--------ICSRYYRA 241
           S G+ HRD+KP N+L++ + H +KL DFG +KV LV+ + N++         + +  Y A
Sbjct: 111 SNGIIHRDLKPDNILIDSNGH-LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIA 169

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   ++  +D WS GC++ E ++G P F G+                T EEI   
Sbjct: 170 PEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGE----------------TPEEI--- 209

Query: 302 NPNYTEFKFPQIKAH--PWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                   F  I      W +     +  EA+DL+S+LL   P  R
Sbjct: 210 --------FQNILNGKIEWPEDV--EVSDEAIDLISKLLVPDPEKR 245

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  127 bits (319), Expect = 2e-33
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 132

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  123 bits (310), Expect = 2e-32
 Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 57/280 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           + +G GSFG V   +   +G+  A+K     K+++ K+ +    E + ++ + HP +V+L
Sbjct: 7   KTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F     +D+  L LV+EYVP  E       H  K + R P    + YA Q+  AL Y
Sbjct: 67  YGSF-----QDDSNLYLVMEYVPGGELFS----HLRK-SGRFPEPVARFYAAQVVLALEY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+NLL++   + +K+ DFG AK +   +     +C +  Y APE+I 
Sbjct: 117 LH-SLDIVYRDLKPENLLLDSDGY-IKITDFGFAKRV---KGRTYTLCGTPEYLAPEIIL 171

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y  A+D W+ G ++ E++ G P F  D    Q+ E I          ++       
Sbjct: 172 S-KGYGKAVDWWALGILIYEMLAGYPPF-FDDNPIQIYEKI----------LEG------ 213

Query: 307 EFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSPNLR 345
                        K+ FP    P+A DL+  LLQ     R
Sbjct: 214 -------------KVRFPSFFSPDAKDLIRNLLQVDLTKR 240

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  124 bits (311), Expect = 3e-32
 Identities = 88/287 (30%), Positives = 149/287 (51%), Gaps = 31/287 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85

Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256

Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  118 bits (299), Expect = 3e-31
 Identities = 75/310 (24%), Positives = 126/310 (40%), Gaps = 78/310 (25%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V++             VA+K + +D   +      RE + MR LDHPN+
Sbjct: 4   GKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRA 184
           V L       T+++ L +  V+EY+P      +  + + N+   + +  +  +A QI R 
Sbjct: 64  VKLLGV---CTEEEPLMI--VMEYMP---GGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N LV      VK+ DFG ++ L   +         YY+    
Sbjct: 116 MEYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYKVKGG 164

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
                  APE +    ++T+  D+WS G ++ E+  LG+  +PG S      E+++ L  
Sbjct: 165 KLPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS----NAEVLEYLKK 219

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR 352
             R                           P   PPE   L+ +     P  R T     
Sbjct: 220 GYRLPK------------------------PPNCPPELYKLMLQCWAEDPEDRPT----- 250

Query: 353 ILFSNCPSLL 362
             FS    +L
Sbjct: 251 --FSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  117 bits (296), Expect = 8e-31
 Identities = 78/305 (25%), Positives = 128/305 (41%), Gaps = 77/305 (25%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V++ K      +    VA+K + +D   +      RE + MR LDHPNV
Sbjct: 4   GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L       T+++ LY+  V+EY+       +  + + N+ ++ +  +  +A QI R +
Sbjct: 64  VKLLGV---CTEEEPLYI--VMEYME---GGDLLSYLRKNRPKLSLSDLLSFALQIARGM 115

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  S    HRD+  +N LV      VK+ DFG ++ L   +         YYR     
Sbjct: 116 EYLE-SKNFIHRDLAARNCLVG-ENLVVKISDFGLSRDLYDDD---------YYRKRGGK 164

Query: 241 ------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTP 293
                 APE +    ++T+  D+WS G ++ E+  LG+  +PG S      E+++ L   
Sbjct: 165 LPIRWMAPESLK-EGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNE----EVLEYLKNG 219

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI 353
            R                           P   PPE  DL+ +     P  R T      
Sbjct: 220 YRLPQ------------------------PPNCPPELYDLMLQCWAEDPEDRPT------ 249

Query: 354 LFSNC 358
            FS  
Sbjct: 250 -FSEL 253

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  117 bits (295), Expect = 9e-31
 Identities = 75/278 (26%), Positives = 119/278 (42%), Gaps = 51/278 (18%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G FG V   K      T A+K V          + +   E + +   +HP +V L +
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKL-Y 59

Query: 132 CFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F    KD+ Y+ +++EY       T+ R    F++   R        Y   +  A  Y
Sbjct: 60  RTF----KDKKYIYMLMEYCLGGELWTILRDRGLFDEYTAR-------FYIACVVLAFEY 108

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +H + G+ +RD+KP+NLL++     VKL DFG AK L  G+   ++  +  Y APE+I  
Sbjct: 109 LH-NRGIIYRDLKPENLLLD-SNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILN 166

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  ++D WS G ++ EL+ G+P F  D   D +             +I   N     
Sbjct: 167 KG-YDFSVDYWSLGILLYELLTGRPPFGEDDE-DPME---------IYNDILKGNGKLE- 214

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                         FP  +   A DL+ +LL+ +P  R
Sbjct: 215 --------------FPNYIDKAAKDLIKQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  118 bits (297), Expect = 1e-30
 Identities = 100/310 (32%), Positives = 151/310 (48%), Gaps = 50/310 (16%)

Query: 79  VGQGSFGVVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV+SL+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 68

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S  D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 69  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 125

Query: 190 RSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYY 239
            +  V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF---------PGDSGVDQLVEIIKVL 290
           RAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 291 GTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPWHKIFPKRMPPEAVDLVSRLL 338
           G P     E+IK M  + T  K F +        IK    HK+ P     +A  L+ +LL
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS---KAFHLLQKLL 298

Query: 339 QYSPNLRCTA 348
              P  R T+
Sbjct: 299 TMDPIKRITS 308

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  116 bits (292), Expect = 5e-30
 Identities = 77/282 (27%), Positives = 129/282 (45%), Gaps = 56/282 (19%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+ G V++A    TG+ VAIKK+ L+ +  +    E+  M+   HPN+V     +  
Sbjct: 27  IGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYL- 85

Query: 136 TTDKDELYLNLVLEY--------VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
               DEL+  +V+EY        +      + ++F ++N+   + YV     ++ + L Y
Sbjct: 86  --VGDELW--VVMEYMDGGSLTDI------ITQNFVRMNEPQ-IAYV---CREVLQGLEY 131

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIF 246
           +H S  V HRDIK  N+L++     VKL DFG A  L K +    S + + Y+ APE+I 
Sbjct: 132 LH-SQNVIHRDIKSDNILLS-KDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              +Y   +DIWS G +  E+  G+P +  +  +  L  I    G P  +          
Sbjct: 190 R-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITT-KGIPPLKN--------- 238

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                           P++  PE  D +++ L   P  R +A
Sbjct: 239 ----------------PEKWSPEFKDFLNKCLVKDPEKRPSA 264

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  115 bits (289), Expect = 2e-29
 Identities = 97/311 (31%), Positives = 149/311 (47%), Gaps = 52/311 (16%)

Query: 79  VGQGSFGVVFQAKCLETGET--VAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +  +    A+K++          RE+  +R L HPNV++L+  F 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFL 68

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S +D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 69  SHSDRK---VWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLH 125

Query: 190 RSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKV-------LVKGEPNISYICSRYY 239
            +  V HRD+KP N+LV    P   +VK+ D G A++       L   +P    + + +Y
Sbjct: 126 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP---VVVTFWY 181

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF---------PGDSGVDQLVEIIKVL 290
           RAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVM 241

Query: 291 GTPTR---EEIKCMNPNY----------TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
           G P     E+I+ M P Y          T      IK    HK+ P     +   L+ +L
Sbjct: 242 GFPADKDWEDIRKM-PEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDS---KVFLLLQKL 297

Query: 338 LQYSPNLRCTA 348
           L   P  R T+
Sbjct: 298 LTMDPTKRITS 308

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  113 bits (285), Expect = 3e-29
 Identities = 74/241 (30%), Positives = 119/241 (49%), Gaps = 42/241 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-------QDKRYKN------RELQTMR 119
           ++   ++G GSFG V+      +GE +A+K+V           R ++      RE+  ++
Sbjct: 2   WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK 61

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYA 178
            L H N+V            D  +LN+ LEYVP  +V  ++ ++    + +    V+ + 
Sbjct: 62  ELQHENIVQYLGS-----SLDADHLNIFLEYVPGGSVAALLNNYGAFEETL----VRNFV 112

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI------- 231
            QI + L+Y+H + G+ HRDIK  N+LV+ +   +K+ DFG +K   K E N        
Sbjct: 113 RQILKGLNYLH-NRGIIHRDIKGANILVD-NKGGIKISDFGISK---KLEANSLSTKTNG 167

Query: 232 ---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
              S   S ++ APE++   T YT   DIWS GC+V E++ GK  FP      QL  I K
Sbjct: 168 ARPSLQGSVFWMAPEVV-KQTSYTRKADIWSLGCLVVEMLTGKHPFP---DCTQLQAIFK 223

Query: 289 V 289
           +
Sbjct: 224 I 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  112 bits (283), Expect = 5e-29
 Identities = 72/214 (33%), Positives = 108/214 (50%), Gaps = 17/214 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNR---ELQTMRLLDHPN 125
           +  E+ +G+G F VV++A CL  G  VA+KKV    + D + +     E+  ++ LDHPN
Sbjct: 4   FKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPN 63

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+     F      +   LN+VLE      + R++KHF K  + +P   +  Y  Q+  A
Sbjct: 64  VIKYLASFI-----ENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSA 118

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYRAPE 243
           L ++H S  + HRDIKP N+ +   T  VKL D G  +    K     S + + YY +PE
Sbjct: 119 LEHMH-SKRIMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE 176

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
            I     Y    DIWS GC++ E+   +  F GD
Sbjct: 177 RIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  111 bits (280), Expect = 2e-28
 Identities = 58/225 (25%), Positives = 98/225 (43%), Gaps = 47/225 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           + +G+G+FG V++      GE     VA+K + +    +       E   M+ L HPN+V
Sbjct: 5   KKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF---NKLNQRMPMIYVKLYAYQIFRA 184
            L       T  + LY  +V EY+P      +  F   +     +  +     A QI + 
Sbjct: 65  RLLGVC---TQGEPLY--IVTEYMP---GGDLLDFLRKHGEKLTLKDLL--QMALQIAKG 114

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N LV      VK+ DFG ++ + + +         YYR    
Sbjct: 115 MEYLE-SKNFVHRDLAARNCLVT-ENLVVKISDFGLSRDIYEDD---------YYRKRGG 163

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   APE +    ++T+  D+WS G ++ E+  LG+  +PG
Sbjct: 164 GKLPIKWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGEQPYPG 207

Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  110 bits (277), Expect = 4e-28
 Identities = 74/276 (26%), Positives = 126/276 (45%), Gaps = 44/276 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           R++G+G+FG V   +  +T +  A+K     K ++    +N   E + ++ L+HP +V+L
Sbjct: 6   RVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNL 65

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F     +DE  + LV++ +     R   H ++   +     VK +  +I  AL Y+H
Sbjct: 66  WYSF-----QDEENMYLVVDLLLGGDLRY--HLSQ-KVKFSEEQVKFWICEIVLALEYLH 117

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S G+ HRDIKP N+L++   H V + DF  A  +       S   +  Y APE++    
Sbjct: 118 -SKGIIHRDIKPDNILLDEQGH-VHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQG 175

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+ A+D WS G    E + GK  + G S                R++I+          
Sbjct: 176 -YSVAVDWWSLGVTAYECLRGKRPYRGHS-------------RTIRDQIRAK-------- 213

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             Q  A     ++P     EA+D +++LL+  P  R
Sbjct: 214 --QETADV---LYPATWSTEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  110 bits (277), Expect = 4e-28
 Identities = 63/215 (29%), Positives = 104/215 (48%), Gaps = 23/215 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSL 129
           ++G+G++G V++ K + TG  VA+K +        + D + +   L  +R    PN+   
Sbjct: 8   LIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              +          L +++EY      R +     + ++    Y+ +   ++  AL YIH
Sbjct: 68  YGSYLKGPR-----LWIIMEYAEGGSVRTLMKAGPIAEK----YISVIIREVLVALKYIH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGA 248
           +  GV HRDIK  N+LV  +T  VKLCDFG A +L +      +++ + Y+ APE+I   
Sbjct: 119 KV-GVIHRDIKAANILVT-NTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
             Y T  DIWS G  + E+  G P +   S VD  
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPPY---SDVDAF 208

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  110 bits (276), Expect = 5e-28
 Identities = 81/279 (29%), Positives = 126/279 (45%), Gaps = 49/279 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLL---DHPNVVSLK 130
           + +G+FG V+ AK   TG+  AIK      ++   +  N + +   ++   + P V  L 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL- 62

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             ++S   KD  YL LV+EY+       ++K    L    P  + K Y  ++   +  +H
Sbjct: 63  --YYSFQSKD--YLYLVMEYLNGGDCASLIKTLGGL----PEDWAKQYIAEVVLGVEDLH 114

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  G+ HRDIKP+NLL++   H +KL DFG ++    G  N  ++ +  Y APE I G  
Sbjct: 115 QR-GIIHRDIKPENLLIDQTGH-LKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVG 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +     D WS GCV+ E + G P F  ++  D + + I          I     N+ E  
Sbjct: 170 D-DKMSDWWSLGCVIFEFLFGYPPFHAET-PDAVFDNI------LSRRI-----NWPEEV 216

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                             PEAVDL++RLL   P  R  A
Sbjct: 217 KEFCS-------------PEAVDLINRLLCMDPAKRLGA 242

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (273), Expect = 1e-27
 Identities = 80/277 (28%), Positives = 122/277 (44%), Gaps = 43/277 (15%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
            +G+GS+G V++A   ETG+ VAIK V  ++  +   +E+  ++  D P +V     +F 
Sbjct: 10  KLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK 69

Query: 136 TTDKDELYLNLVLEY-VPETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            TD     L +V+EY    +V  ++K  NK L +      +    YQ  + L Y+H +  
Sbjct: 70  NTD-----LWIVMEYCGAGSVSDIMKITNKTLTEEE----IAAILYQTLKGLEYLHSN-K 119

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYT 252
             HRDIK  N+L+N    Q KL DFG +  L        + I + ++ APE+I     Y 
Sbjct: 120 KIHRDIKAGNILLN-EEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYN 177

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
              DIWS G    E+  GKP                    P  +    ++P    F  P 
Sbjct: 178 NKADIWSLGITAIEMAEGKP--------------------PYSD----IHPMRAIFMIPN 213

Query: 313 IKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
            K  P     P++  PE  D V + L   P  R +A+
Sbjct: 214 -KPPPTLSD-PEKWSPEFNDFVKKCLVKDPEERPSAI 248

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (273), Expect = 2e-27
 Identities = 72/271 (26%), Positives = 122/271 (45%), Gaps = 37/271 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL--QDKRYKN---RELQTMRLLDHPNVVSLKHCFF 134
           G G+ GVV +     TG+ +A+K +    ++  +    REL  +   + P +V     F+
Sbjct: 10  GAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           +  D     +++ +EY+      + K   ++  R+P   +   A  + + L+Y+H    +
Sbjct: 70  NNGD-----ISICMEYMDGG--SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKI 122

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
            HRD+KP N+LVN    Q+KLCDFG +  LV      +++ +  Y APE I G  +Y+  
Sbjct: 123 IHRDVKPSNILVN-SRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQG-NDYSVK 179

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            DIWS G  + EL  G+  FP     D    I ++L     + I    P       P++ 
Sbjct: 180 SDIWSLGLSLIELATGR--FPYPPENDPPDGIFELL-----QYIVNEPP-------PRLP 225

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           +  +         P+  D V+  L   P  R
Sbjct: 226 SGKF--------SPDFQDFVNLCLIKDPRER 248

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (272), Expect = 2e-27
 Identities = 63/225 (28%), Positives = 105/225 (46%), Gaps = 22/225 (9%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
            +G+GSFG V + +    G+ +  K++       ++K+    E+  +R L HPN+V    
Sbjct: 7   TIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYD 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                 D+    L +V+EY     + ++++   K  + +   ++     Q+  AL   H 
Sbjct: 67  RII---DRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHN 123

Query: 191 SIG----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 243
                  V HRD+KP N+ ++   + VKL DFG AK+L  G  +    +Y+ + YY +PE
Sbjct: 124 RSDPGNTVLHRDLKPANIFLD-ANNNVKLGDFGLAKIL--GHDSSFAKTYVGTPYYMSPE 180

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
            +   + Y    DIWS GC++ EL    P F       QL   IK
Sbjct: 181 QLNHMS-YDEKSDIWSLGCLIYELCALSPPFTA-RNQLQLASKIK 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (271), Expect = 2e-27
 Identities = 61/208 (29%), Positives = 98/208 (47%), Gaps = 21/208 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G+  VV+ A CL   E VAIK++  +K   +     +E+Q M   +HPNVV   +  
Sbjct: 9   IGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YTS 67

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F     DEL+  LV+ Y+   ++  ++K  + +      +I   L   ++ + L Y+H +
Sbjct: 68  F--VVGDELW--LVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL--KEVLKGLEYLHSN 121

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YICSRYYRAPELIF 246
            G  HRDIK  N+L+      VK+ DFG +  L  G          ++ +  + APE++ 
Sbjct: 122 -GQIHRDIKAGNILLGEDG-SVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y    DIWS G    EL  G   +
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPY 207

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  108 bits (271), Expect = 8e-27
 Identities = 79/267 (29%), Positives = 122/267 (45%), Gaps = 39/267 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAI----KKVLQDKRYKNRELQTMRLL---DHPNVVSLKH 131
           VGQG +G VF AK  +TGE VA+    K +L         L    +L       +V L +
Sbjct: 9   VGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLY 68

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F    D + LY  L +EYVP    R ++ +   L++     + + Y  ++F A+  +H 
Sbjct: 69  AF---QDDEYLY--LAMEYVPGGDFRTLLNNLGVLSED----HARFYMAEMFEAVDALHE 119

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
            +G  HRD+KP+N L++   H +KL DFG +K +V      S + S  Y APE++ G   
Sbjct: 120 -LGYIHRDLKPENFLIDASGH-IKLTDFGLSKGIV--TYANSVVGSPDYMAPEVLRG-KG 174

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII---KVLGTPTREEI--------- 298
           Y   +D WS GC++ E + G P F G +  +    +    + L  P  ++          
Sbjct: 175 YDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW 234

Query: 299 ----KCMNPNYTEFK-FPQIKAHPWHK 320
               K +N     F     IK HP+ K
Sbjct: 235 DLITKLINDPSRRFGSLEDIKNHPFFK 261

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 2e-26
 Identities = 62/228 (27%), Positives = 102/228 (44%), Gaps = 46/228 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 128
           + +G+G+FG V++ K          VA+K + +D   + R     E + M+ L HPNVV 
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETV-------HRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L       T+++ LY  LVLEY+            R V    + +  + +  +  +A QI
Sbjct: 61  LLGV---CTEEEPLY--LVLEYMEGGDLLDYLRKSRPVFPSPEKS-TLSLKDLLSFAIQI 114

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 240
            + + Y+  S    HRD+  +N LV      VK+ DFG ++ +   +         YYR 
Sbjct: 115 AKGMEYLA-SKKFVHRDLAARNCLVG-EDLVVKISDFGLSRDVYDDD---------YYRK 163

Query: 241 -----------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                      APE +     +T+  D+WS G ++ E+  LG   +PG
Sbjct: 164 KTGGKLPIRWMAPESLKDGI-FTSKSDVWSFGVLLWEIFTLGATPYPG 210

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  105 bits (264), Expect = 3e-26
 Identities = 67/218 (30%), Positives = 118/218 (54%), Gaps = 30/218 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYK------NRELQTM 118
           ++   ++G+G++G V+ A  + TGE +A+K+V          D R K        E++T+
Sbjct: 3   WVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETL 62

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLY 177
           + LDH N+V          +  E YL++ LEYVP  ++   ++ + +  +++    V+ +
Sbjct: 63  KDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL----VRFF 113

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---LVKGEPNISYI 234
             Q+   L+Y+H S G+ HRD+K  NLLV+      K+ DFG +K    +   + N+S  
Sbjct: 114 TEQVLEGLAYLH-SKGILHRDLKADNLLVD-ADGICKISDFGISKKSDDIYDNDQNMSMQ 171

Query: 235 CSRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGK 271
            S ++ APE+I   ++ Y+  +DIWS GCVV E+  G+
Sbjct: 172 GSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGR 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  106 bits (266), Expect = 3e-26
 Identities = 70/210 (33%), Positives = 106/210 (50%), Gaps = 27/210 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEY 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA--YQIFRALSY 187
           K C+       E    LV+EY   +   +++   K     P+  V++ A  +   + L+Y
Sbjct: 81  KGCYLR-----EHTAWLVMEYCLGSASDILEVHKK-----PLQEVEIAAICHGALQGLAY 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +H S    HRDIK  N+L+      VKL DFGSA ++    P  S++ + Y+ APE+I  
Sbjct: 131 LH-SHERIHRDIKAGNILLTEPG-TVKLADFGSASLV---SPANSFVGTPYWMAPEVILA 185

Query: 248 ATE--YTTAIDIWSAGCVVAELMLGK-PLF 274
             E  Y   +D+WS G    EL   K PLF
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 1e-25
 Identities = 63/210 (30%), Positives = 105/210 (50%), Gaps = 26/210 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR------ELQTMRLLDHPNVV 127
           +++GQG+FG V+    ++TG  +A+K+V         K        E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C      +D+  L++ +EY+P  +V   +K +  L + +     + Y  QI   + 
Sbjct: 68  QYYGCL-----RDDETLSIFMEYMPGGSVKDQLKAYGALTETV----TRKYTRQILEGVE 118

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K L      G    S   + Y+ +P
Sbjct: 119 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSP 176

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           E+I G   Y    D+WS GC V E++  KP
Sbjct: 177 EVISGEG-YGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  102 bits (256), Expect = 4e-25
 Identities = 66/212 (31%), Positives = 107/212 (50%), Gaps = 25/212 (11%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLL-DHPNVVSLKH 131
           ++G+G++G V++A+  +TG+ VAIK  + D           E   +R   +HPN+ +   
Sbjct: 13  VIGEGTYGKVYKARHKKTGQLVAIK--IMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 132 CFF---STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            F       + D+L+  LV+E     +V  +VK   K  +R+   ++     +  R L+Y
Sbjct: 71  AFIKKNPPGNDDQLW--LVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAY 128

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 246
           +H +  V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I 
Sbjct: 129 LHEN-KVIHRDIKGQNILLT-KNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVI- 185

Query: 247 GATE------YTTAIDIWSAGCVVAELMLGKP 272
            A +      Y    D+WS G    EL  GKP
Sbjct: 186 -ACDEQPDASYDARSDVWSLGITAIELADGKP 216

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 98.7 bits (246), Expect = 7e-24
 Identities = 78/274 (28%), Positives = 121/274 (44%), Gaps = 46/274 (16%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRE--LQTMRLL---DHPNVVSLKHCF 133
           G+GS+G V++ K L   +  A+K+V L     K RE  +  +R+L   +HPN++S K  F
Sbjct: 9   GKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF 68

Query: 134 FSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               D ++L +  V+EY P   + + +    K  + +P   +     Q+ R L  +H   
Sbjct: 69  L---DGNKLCI--VMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALH-EQ 122

Query: 193 GVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            + HRD+K  N LLV      VK+ D G +KVL K     + I + +Y APE ++    Y
Sbjct: 123 KILHRDLKSANILLVAND--LVKIGDLGISKVLKKNMAK-TQIGTPHYMAPE-VWKGRPY 178

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           +   DIWS GC++ E+    P F   S  D      KV                   K+P
Sbjct: 179 SYKSDIWSLGCLLYEMATFAPPFEARSMQDLRY---KVQRG----------------KYP 219

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            I         P     +  + +  +LQ  P LR
Sbjct: 220 PI---------PPIYSQDLQNFIRSMLQVKPKLR 244

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 97.8 bits (244), Expect = 8e-23
 Identities = 77/303 (25%), Positives = 124/303 (40%), Gaps = 81/303 (26%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNVVSLK 130
           ++G+G+FG V+  +  +TG+  A+K + +    K  ++  +R         D P +V L 
Sbjct: 8   VIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKL- 66

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           +  F    +DE +L LV+EY+P  + ++ +++         P    + Y  ++  AL  +
Sbjct: 67  YYSF----QDEEHLYLVMEYMPGGDLMNLLIRK-----DVFPEETARFYIAELVLALDSV 117

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-----------------------VLV 225
           H+ +G  HRDIKP N+L++   H +KL DFG  K                       VLV
Sbjct: 118 HK-LGFIHRDIKPDNILIDADGH-IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175

Query: 226 KGEPNISYICSRY-------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           +   +               Y APE++ G T Y    D WS G ++ E++ G P F  D 
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRG-TPYGLECDWWSLGVILYEMLYGFPPFYSD- 233

Query: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFP--KRMPPEAVDLVSR 336
                                      T  K   I        FP    + PEA+DL+ R
Sbjct: 234 -----------------------TLQETYNK---IINWKESLRFPPDPPVSPEAIDLICR 267

Query: 337 LLQ 339
           LL 
Sbjct: 268 LLC 270

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 65/211 (30%), Positives = 106/211 (50%), Gaps = 16/211 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNV 126
           Y   R+VG+G+FG+V   +     + V IK++  ++  K+       E Q ++LL HPN+
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +     F    DK    L +V+EY P  T+   ++   + N  +    +  +  QI  AL
Sbjct: 62  IEYYENFLE--DKA---LMIVMEYAPGGTLAEYIQ--KRCNSLLDEDTILHFFVQILLAL 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H  + + HRD+K QN+L++ H   VK+ DFG +K+L       + + +  Y +PEL 
Sbjct: 115 HHVHTKL-ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELC 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
            G   Y    DIW+ GCV+ EL   K  F  
Sbjct: 174 EG-KPYNQKSDIWALGCVLYELASLKRAFEA 203

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 96.0 bits (239), Expect = 1e-22
 Identities = 73/279 (26%), Positives = 124/279 (44%), Gaps = 71/279 (25%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G+FG V   +   +    A+K +       L+ +++ + E + ++ + HP ++ L  
Sbjct: 9   VGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRL-- 66

Query: 132 CFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            F++  D+  LY+  ++EYVP     +  R    F+             YA +I  AL Y
Sbjct: 67  -FWTEHDQRFLYM--LMEYVPGGELFSYLRNSGRFSNSTGL-------FYASEIVCALEY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYYRA 241
           +H S  + +RD+KP+N+L++   H +KL DFG AK L        G P         Y A
Sbjct: 117 LH-SKEIVYRDLKPENILLDKEGH-IKLTDFGFAKKLRDRTWTLCGTPE--------YLA 166

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I  +  +  A+D W+ G ++ E+++G P F      D    I               
Sbjct: 167 PEVI-QSKGHNKAVDWWALGILIYEMLVGYPPFFD----DNPFGI--------------- 206

Query: 302 NPNYTEFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQ 339
                   + +I A    K+ FP+ +   A DL+ +LL 
Sbjct: 207 --------YEKILA---GKLEFPRHLDLYAKDLIKKLLV 234

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.5 bits (237), Expect = 1e-22
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 3   NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + R++KHF K  + +P   V  Y  Q+  
Sbjct: 63  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCS 117

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           AL ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 ALEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 95.3 bits (237), Expect = 1e-22
 Identities = 82/282 (29%), Positives = 127/282 (45%), Gaps = 43/282 (15%)

Query: 76  ERIV-GQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK---NRELQTMRLLDHPNVVSLK 130
           ER+V G+G++G+V+ A+ L T   +AIK++  +D RY    + E+     L H N+V   
Sbjct: 12  ERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQ-- 69

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              +  +D +  +  + +E VP       +   +  L      I    Y  QI   L Y+
Sbjct: 70  ---YLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--IFYTKQILEGLKYL 124

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELI-F 246
           H +  + HRDIK  N+LVN ++  VK+ DFG++K L    P   ++  +  Y APE+I  
Sbjct: 125 HDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDK 183

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    DIWS GC + E+  GKP F                       I+   P   
Sbjct: 184 GPRGYGAPADIWSLGCTIVEMATGKPPF-----------------------IELGEPQAA 220

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FK    K HP     P+ +  EA + + R  +  P+ R +A
Sbjct: 221 MFKVGMFKIHP---EIPESLSAEAKNFILRCFEPDPDKRASA 259

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 95.6 bits (238), Expect = 2e-22
 Identities = 70/208 (33%), Positives = 104/208 (50%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTM-------RLLDHPNVV 127
           +++G+GSFG V  AK    G+  A+ KVLQ K    K  +   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKHKADGKFYAV-KVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F T DK  LY   VL+YV      +  H  +  +  P    + YA +I  AL Y
Sbjct: 60  GL-HYSFQTADK--LY--FVLDYV--NGGELFFHLQR-ERSFPEPRARFYAAEIASALGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE++ 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGH-VVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLR 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 170 -KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 94.8 bits (236), Expect = 3e-22
 Identities = 74/263 (28%), Positives = 117/263 (44%), Gaps = 35/263 (13%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           G+G++GVV + + + TG  +A+K++       + KR       +MR +D P  V+     
Sbjct: 10  GRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL 69

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           F   D     + + +E +  ++ +  K        +P   +   A  I +AL Y+H  + 
Sbjct: 70  FREGD-----VWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS 124

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
           V HRD+KP N+L+N    QVKLCDFG +  LV           + Y APE I        
Sbjct: 125 VIHRDVKPSNVLIN-RNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKG 183

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVLGTPTR-------EEI-- 298
           Y    D+WS G  + EL  G+  FP DS      QL ++++      +        E   
Sbjct: 184 YDVKSDVWSLGITMIELATGR--FPYDSWKTPFQQLKQVVE--EPSPQLPAEKFSPEFQD 239

Query: 299 ---KCMNPNYTEF-KFPQIKAHP 317
              KC+  NY E   +P++  HP
Sbjct: 240 FVNKCLKKNYKERPNYPELLQHP 262

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 93.8 bits (233), Expect = 5e-22
 Identities = 60/236 (25%), Positives = 120/236 (50%), Gaps = 30/236 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV--------LQDKRYKN--RELQTMRLLDHPNV 126
           + +G G+F   +QA+ ++TG  +A+K+V         Q++  +   +E++ M  L+HP++
Sbjct: 6   QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +       +T +    + NL +E++   +V  ++  +    + + + Y +    Q+ R L
Sbjct: 66  I---RMLGATCEDS--HFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTE----QLLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-----GEPNISYICSRYYR 240
           SY+H +  + HRD+K  NLL++    ++++ DFG+A  L       GE     + +  + 
Sbjct: 117 SYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFM 175

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV---LGTP 293
           APE++ G  +Y  + D+WS GCV+ E+   KP +  +   + L  I K+      P
Sbjct: 176 APEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.2 bits (231), Expect = 9e-22
 Identities = 68/215 (31%), Positives = 109/215 (50%), Gaps = 17/215 (7%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL   + VA+KKV    + D + +    +E+  ++ L+HP
Sbjct: 3   NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + +++K+F K  + +P   V  Y  Q+  
Sbjct: 63  NVIKYLDSFIEDNE-----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCS 117

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           A+ ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 118 AVEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 175

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 176 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 93.3 bits (232), Expect = 1e-21
 Identities = 74/238 (31%), Positives = 121/238 (50%), Gaps = 24/238 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A    TG  VA+KK+  D R + R      E+  MR   HPN+V +   
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKM--DLRKQQRRELLFNEVVIMRDYQHPNIVEM--- 81

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           + S    DEL++  V+E++    +  +V H      RM    +      + +ALS++H +
Sbjct: 82  YSSYLVGDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLH-A 133

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATE 250
            GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I     
Sbjct: 134 QGVIHRDIKSDSILLT-SDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVI-SRLP 191

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           Y T +DIWS G +V E++ G+P +  +  + Q ++ I+    P  + +  ++P    F
Sbjct: 192 YGTEVDIWSLGIMVIEMVDGEPPYFNEPPL-QAMKRIRDNLPPKLKNLHKVSPRLRSF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 75/278 (26%), Positives = 125/278 (44%), Gaps = 49/278 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  A+K + +D   ++ +++ TM   R+L     HP +  
Sbjct: 1   KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L H  F T  KD L+   V+EYV      ++ H  +   R      + YA +I   L ++
Sbjct: 61  L-HSCFQT--KDRLFF--VMEYV--NGGDLMFHIQRS-GRFDEPRARFYAAEIVLGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +K+ DFG  K  + G    S  C +  Y APE++  
Sbjct: 113 H-ERGIIYRDLKLDNVLLDSEGH-IKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  A+D W+ G ++ E++ G+  F GD   D+L                        
Sbjct: 171 -QPYGPAVDWWALGVLLYEMLAGQSPFEGD-DEDEL------------------------ 204

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             F  I        +P+ +  EA  ++   L  +P  R
Sbjct: 205 --FQSILEDEVR--YPRWLSKEAKSILKSFLTKNPEKR 238

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 56/213 (26%), Positives = 91/213 (42%), Gaps = 32/213 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVV 127
           +     +G+GSFG V++A    T + VAIK +       +     +E+Q +     P + 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYIT 62

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                F   +      L +++EY    +   ++K       ++   Y+     ++   L 
Sbjct: 63  KYYGSFLKGSK-----LWIIMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLE 112

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-------YY 239
           Y+H   G  HRDIK  N+L++     VKL DFG     V G+   S +  R       ++
Sbjct: 113 YLHEE-GKIHRDIKAANILLSEEG-DVKLADFG-----VSGQLT-STMSKRNTFVGTPFW 164

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            APE+I   + Y    DIWS G    EL  G+P
Sbjct: 165 MAPEVIKQ-SGYDEKADIWSLGITAIELAKGEP 196

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 91.7 bits (228), Expect = 2e-21
 Identities = 73/242 (30%), Positives = 112/242 (46%), Gaps = 44/242 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNR-----ELQTMRLLDHPNV 126
           Y+  R++G+G+FG     +  E    V  K+V L     K R     E+  + LL HPN+
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV------PETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           ++  + F      D+  L + +EY        + V +  + F           V  Y +Q
Sbjct: 62  IAYYNHFM-----DDNTLLIEMEYANGGTLYDKIVRQKGQLF-------EEEMVLWYLFQ 109

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNI 231
           I  A+SYIH   G+ HRDIK  N+ +      +KL DFG +K+L         V G P  
Sbjct: 110 IVSAVSYIH-KAGILHRDIKTLNIFLT-KAGLIKLGDFGISKILGSEYSMAETVVGTP-- 165

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
                 YY +PEL  G  +Y    DIW+ GCV+ EL+  K  F   + ++ +V+I++   
Sbjct: 166 ------YYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNY 218

Query: 292 TP 293
           TP
Sbjct: 219 TP 220

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 132

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANXFVGTPYWMAPEVILAMD 187

Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 92.8 bits (230), Expect = 3e-21
 Identities = 68/205 (33%), Positives = 103/205 (50%), Gaps = 22/205 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ + T E VAIKK+    +  N       +E++ ++ + HPN +  
Sbjct: 31  REIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEY 90

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K C+       E    LV+EY   +   +++   K  Q + +  +   A Q    L+Y+H
Sbjct: 91  KGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLH 142

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRDIK  N+L+     QVKL DFGSA +     P  S++ + Y+ APE+I    
Sbjct: 143 -SHNMIHRDIKAGNILLT-EPGQVKLADFGSASIA---SPANSFVGTPYWMAPEVILAMD 197

Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 198 EGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 92.4 bits (229), Expect = 3e-21
 Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 22/203 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 131
           +G GSFG V+ A    T E VA+KK+    +  N       +E++ ++ L HPN +  K 
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKG 88

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           C+       E    LV+EY   +   +++   K  Q + +  +   A Q    L+Y+H S
Sbjct: 89  CYLK-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQ---GLAYLH-S 139

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
             + HRDIK  N+L+     QVKL DFGSA       P  S++ + Y+ APE+I    E 
Sbjct: 140 HNMIHRDIKAGNILLT-EPGQVKLADFGSASKS---SPANSFVGTPYWMAPEVILAMDEG 195

Query: 251 -YTTAIDIWSAGCVVAELMLGKP 272
            Y   +D+WS G    EL   KP
Sbjct: 196 QYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 91.0 bits (226), Expect = 4e-21
 Identities = 62/221 (28%), Positives = 108/221 (48%), Gaps = 24/221 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQ--DKRYKNRELQTMRLL---DHPNVVSLKHC 132
           +G+GSFGVVF+          A+K++ L   ++R +   +   R+L   D   ++     
Sbjct: 8   IGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYES 67

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D+  LN+V+EY     +H+++K      + +P   V  +  QI   L+++H S
Sbjct: 68  FL-----DKGKLNIVMEYAENGDLHKLLKMQRG--RPLPEDQVWRFFIQILLGLAHLH-S 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFG 247
             + HRDIK  NL ++ +   VK+ D G AK+L     N ++    + + YY +PEL   
Sbjct: 120 KKILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL---SDNTNFANTIVGTPYYLSPELC-E 174

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
              Y    D+W+ G V+ E   GK  F  ++    +++II+
Sbjct: 175 DKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR 215

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 90.7 bits (225), Expect = 5e-21
 Identities = 61/213 (28%), Positives = 104/213 (48%), Gaps = 31/213 (14%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYK--NRELQTMRLLDHPNVV 127
           ++G+G++G V+       G+ +A+K+V  D        K Y+    E+  ++ L H N+V
Sbjct: 7   VLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                 +  T  D+  +++ +E+VP  ++  ++  F  L    P      Y  QI   ++
Sbjct: 66  Q-----YLGTCLDDNTISIFMEFVPGGSISSILNRFGPL----PEPVFCKYTKQILDGVA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI-------CSRYY 239
           Y+H +  V HRDIK  N+++ P    +KL DFG A+ L     + ++         + Y+
Sbjct: 117 YLHNN-CVVHRDIKGNNVMLMP-NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYW 174

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            APE+I   + Y    DIWS GC V E+  GKP
Sbjct: 175 MAPEVI-NESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 89.7 bits (222), Expect = 1e-20
 Identities = 70/242 (28%), Positives = 119/242 (49%), Gaps = 27/242 (11%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLL 121
           I++   +++GQG+FG V+    ++TG  +A K+V  D               E+Q ++ L
Sbjct: 2   INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNL 61

Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            H  +V    C     D+ E  L + +EY+P  +V   +K +  L + +     + Y  Q
Sbjct: 62  QHERIVQYYGCL---RDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV----TRKYTRQ 114

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICS 236
           I   +SY+H ++ + HRDIK  N+L +     VKL DFG++K L    + G    S   +
Sbjct: 115 ILEGMSYLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRLQTICMSGTGIRSVTGT 172

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            Y+ +PE+I G   Y    D+WS GC V E++  KP +   +  + +  I K+   PT  
Sbjct: 173 PYWMSPEVISGEG-YGRKADVWSLGCTVVEMLTEKPPW---AEYEAMAAIFKIATQPTNP 228

Query: 297 EI 298
           ++
Sbjct: 229 QL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 76/282 (26%), Positives = 119/282 (42%), Gaps = 42/282 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKH 131
             +G+G+ G V + +   TG   A+K +  D     ++   REL+  +    P +V    
Sbjct: 7   SRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYG 66

Query: 132 CFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F    D+    + + +EY    ++  + K   K   R+    +   A  + + LSY+H 
Sbjct: 67  AF---LDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLH- 122

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 246
           S  + HRDIKP N+L+     QVKLCDFG     V GE   S    +  + +Y APE I 
Sbjct: 123 SRKIIHRDIKPSNILLTRKG-QVKLCDFG-----VSGELVNSLAGTFTGTSFYMAPERIQ 176

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDS----GVDQLVEIIKVLGTPT-------- 294
           G   Y+   D+WS G  + E+   +  FP +     G  +L+  I  +  P         
Sbjct: 177 GKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNG 235

Query: 295 ---REEIK-----CMNPNYTEFKFP-QIKAHPWHKIFPKRMP 327
               EE K     C+  + T    P  +  HPW K   K+  
Sbjct: 236 IKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKKKV 277

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 88.9 bits (220), Expect = 2e-20
 Identities = 68/236 (28%), Positives = 115/236 (48%), Gaps = 27/236 (11%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 127
           +++GQG+FG V+     +TG  +A+K+V  D               E+Q ++ L H  +V
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C     D  E  L++ +E++P  ++   +K +  L + +     + Y  QI   +S
Sbjct: 68  QYYGCL---RDPMERTLSIFMEHMPGGSIKDQLKSYGALTENV----TRKYTRQILEGVS 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL----VKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K L    + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-VGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           E+I G   Y    DIWS GC V E++  KP +   +  + +  I K+   PT   +
Sbjct: 179 EVISGEG-YGRKADIWSVGCTVVEMLTEKPPW---AEFEAMAAIFKIATQPTNPVL 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 88.7 bits (220), Expect = 4e-20
 Identities = 74/276 (26%), Positives = 120/276 (43%), Gaps = 45/276 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K R+ + M L +           +VSL 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKK-LDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIH 189
           + F +  D     L LV+  +     +   H   + +   P      YA QI   L ++H
Sbjct: 60  YAFETKDD-----LCLVMTLMNGGDLKY--HIYNVGEPGFPEARAIFYAAQIICGLEHLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
           +   + +RD+KP+N+L++ H + V++ D G A  L  G+       +  Y APE++ G  
Sbjct: 113 QR-RIVYRDLKPENVLLDDHGN-VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGE- 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  ++D ++ GC + E++ G+  F       Q  E ++      +EE+K          
Sbjct: 170 VYDFSVDWFALGCTLYEMIAGRSPF------RQRKEKVE------KEELKRR-------- 209

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                       +P +  PEA DL   LLQ  P  R
Sbjct: 210 ---TLEMAVE--YPDKFSPEAKDLCEALLQKDPEKR 240

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 88.3 bits (219), Expect = 7e-20
 Identities = 84/291 (28%), Positives = 132/291 (45%), Gaps = 64/291 (21%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRLLDH---------- 123
           R++G G++G VF  + +   + G+  A+K VL+    K   +Q  +  +H          
Sbjct: 6   RVLGTGAYGKVFLVRKVGGHDAGKLYAMK-VLK----KATIVQKAKTAEHTRTERQVLEA 60

Query: 124 ----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLY 177
               P +V+L H  F T  K    L+L+L+YV        + F  L QR       V++Y
Sbjct: 61  VRRCPFLVTL-HYAFQTDTK----LHLILDYV-----NGGELFTHLYQREHFTESEVRVY 110

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC 235
             +I  AL ++H+ +G+ +RDIK +N+L++   H V L DFG +K  +  E     S+  
Sbjct: 111 IAEIVLALDHLHQ-LGIIYRDIKLENILLDSEGH-VVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 236 SRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           +  Y APE+I G +  +  A+D WS G +  EL+ G   F  D   +   EI       +
Sbjct: 169 TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEI-------S 221

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           R  +K   P                  FPK M  EA D + +LL+  P  R
Sbjct: 222 RRILKSKPP------------------FPKTMSAEARDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 87.8 bits (217), Expect = 8e-20
 Identities = 65/236 (27%), Positives = 118/236 (50%), Gaps = 27/236 (11%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---------ELQTMRLLDHPNVV 127
           +++G+G+FG V+     +TG  +A+K+V  D   +           E+Q ++ L H  +V
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               C     D +E  L++ +EY+P  ++   +K +  L + +     + Y  QI + +S
Sbjct: 68  QYYGCL---RDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV----TRRYTRQILQGVS 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----VLVKGEPNISYICSRYYRAP 242
           Y+H ++ + HRDIK  N+L +     VKL DFG++K    + + G    S   + Y+ +P
Sbjct: 121 YLHSNM-IVHRDIKGANILRDS-AGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           E+I G   Y    D+WS  C V E++  KP +   +  + +  I K+   PT+  +
Sbjct: 179 EVISGEG-YGRKADVWSVACTVVEMLTEKPPW---AEYEAMAAIFKIATQPTKPML 230

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 87.1 bits (216), Expect = 2e-19
 Identities = 77/295 (26%), Positives = 136/295 (46%), Gaps = 66/295 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHPNVV 127
           +++  G++G V+  +  ET +  A+KK+ +          + +  R++ T    ++P VV
Sbjct: 7   KLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA--ENPFVV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           S+  C F T    + +L +V+EYV       ++K+   L    P+   ++Y  +   AL 
Sbjct: 65  SM-FCSFET----KRHLCMVMEYVEGGDCATLLKNIGAL----PVDMARMYFAETVLALE 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNI-------------- 231
           Y+H + G+ HRD+KP NLL+    H +KL DFG +K+ L+    N+              
Sbjct: 116 YLH-NYGIVHRDLKPDNLLITSMGH-IKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 232 SYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
             +C +  Y APE+I     Y   +D W+ G ++ E ++G   F GD+  +   ++I   
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVIS-- 230

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                ++I    P   E                  +P +A DL+SRLL+ +P  R
Sbjct: 231 -----DDI--EWPEGDE-----------------ALPADAQDLISRLLRQNPLER 261

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 87.4 bits (216), Expect = 3e-19
 Identities = 70/208 (33%), Positives = 105/208 (50%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 127
           +++G+GSFG V  AK    G+  A+K VLQ K   NR+ Q          ++ + HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVK-VLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F TT+K    L  VL++V      +  H  +  +  P    + YA +I  AL Y
Sbjct: 60  GL-HYSFQTTEK----LYFVLDFV--NGGELFFHLQR-ERSFPEPRARFYAAEIASALGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H SI + +RD+KP+N+L++   H V L DFG  K  +      +  C +  Y APE+I 
Sbjct: 112 LH-SINIVYRDLKPENILLDSQGHVV-LTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVI- 168

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 169 RKQPYDNTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 85.8 bits (213), Expect = 3e-19
 Identities = 73/290 (25%), Positives = 123/290 (42%), Gaps = 66/290 (22%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDK---RYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G++G V++A+ + TGE VAIK + L+         +E+  ++   HPN+V+    + 
Sbjct: 11  IGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYL 70

Query: 135 STTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAY---QIFRALS 186
               +D+L++  V+EY     + +         ++L            AY   +  + L+
Sbjct: 71  R---RDKLWI--VMEYCGGGSLQDIYQVTRGPLSEL----------QIAYVCRETLKGLA 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPEL 244
           Y+H   G  HRDIK  N+L+      VKL DFG +  L     +   S+I + Y+ APE+
Sbjct: 116 YLH-ETGKIHRDIKGANILLTEDGD-VKLADFGVSAQLTATIAKRK-SFIGTPYWMAPEV 172

Query: 245 IFGATE----YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIK 299
              A E    Y    DIW+ G    EL   + P+F         +  ++ L   ++    
Sbjct: 173 A--AVERKGGYDGKCDIWALGITAIELAELQPPMFD--------LHPMRALFLISKS--- 219

Query: 300 CMNPNYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                   F  P++K    W  +F         D + + L   P  R TA
Sbjct: 220 -------NFPPPKLKDKEKWSPVF--------HDFIKKCLTKDPKKRPTA 254

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 85.9 bits (213), Expect = 5e-19
 Identities = 63/218 (28%), Positives = 102/218 (46%), Gaps = 31/218 (14%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKK-----VLQDKRYKNRELQ 116
            K+ + ++  + +G+G FG V      +     TGE VA+K        Q +    RE++
Sbjct: 2   EKRHLKFI--KQLGEGHFGKVELC-RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIE 58

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL 176
            +R LDH N+V  K             L L++EY+P    R     ++    +  +   L
Sbjct: 59  ILRTLDHENIVKYKGV---CEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLL--L 113

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EP 229
           ++ QI + + Y+  S    HRD+  +N+LV      VK+ DFG AKVL +        EP
Sbjct: 114 FSSQICKGMDYLG-SQRYIHRDLAARNILVE-SEDLVKISDFGLAKVLPEDKDYYYVKEP 171

Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
             S I   +Y APE +  +  +++A D+WS G  + EL
Sbjct: 172 GESPI--FWY-APECLRTSK-FSSASDVWSFGVTLYEL 205

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 86.0 bits (213), Expect = 7e-19
 Identities = 68/209 (32%), Positives = 110/209 (52%), Gaps = 24/209 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSLKH 131
           +G GSFG V  AK   TGE  AIK     ++L+ K+ +   +E   +  L HP +V++  
Sbjct: 26  LGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC 85

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F    D++ +Y   +LE+V      +  H  K   R P    K Y  ++  A  Y+H S
Sbjct: 86  SF---QDENRVYF--LLEFV--VGGELFTHLRKAG-RFPNDVAKFYHAELVLAFEYLH-S 136

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELIFGAT 249
             + +RD+KP+NLL++   H VK+ DFG AK +    P+ ++ +C +  Y APE+I  + 
Sbjct: 137 KDIIYRDLKPENLLLDNKGH-VKVTDFGFAKKV----PDRTFTLCGTPEYLAPEVI-QSK 190

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            +  A+D W+ G ++ E + G P F  D+
Sbjct: 191 GHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219

Length = 329

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 85.6 bits (212), Expect = 8e-19
 Identities = 77/282 (27%), Positives = 135/282 (47%), Gaps = 57/282 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  AIK + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRV--VKHFNKLNQRMPMIYVKLYAYQIFRA 184
           L  C F T +    +L  V+EY+   + +  +     F++   R        YA +I   
Sbjct: 61  L-FCTFQTKE----HLFFVMEYLNGGDLMFHIQSSGRFDEARAR-------FYAAEIICG 108

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++H+  G+ +RD+K  N+L++   H +K+ DFG  K  + GE   S  C +  Y APE
Sbjct: 109 LQFLHKK-GIIYRDLKLDNVLLDKDGH-IKIADFGMCKENMNGEGKASTFCGTPDYIAPE 166

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G  +Y  ++D WS G ++ E+++G+  F G+   D+L + I         +      
Sbjct: 167 ILKG-QKYNESVDWWSFGVLLYEMLIGQSPFHGE-DEDELFDSI-------LNDR----- 212

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        P    FP+ +  EA D +S+L +  P  R
Sbjct: 213 -------------PH---FPRWISKEAKDCLSKLFERDPTKR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 68/222 (30%), Positives = 120/222 (54%), Gaps = 21/222 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+    GE  A+K + +D    + +++ TM   R+L    ++P +  
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T +    +L  V+E++      ++ H      R  +     YA +I   L ++
Sbjct: 61  L-YCTFQTKE----HLFFVMEFL--NGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H S G+ +RD+K  N++++   H +K+ DFG  K  V G+   S  C +  Y APE++ G
Sbjct: 113 H-SKGIIYRDLKLDNVMLDRDGH-IKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
             +YT ++D WS G ++ E+++G+  F GD   D+L E I+V
Sbjct: 171 -LKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE-DELFESIRV 210

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 85.8 bits (212), Expect = 9e-19
 Identities = 89/289 (30%), Positives = 140/289 (48%), Gaps = 55/289 (19%)

Query: 77  RIVGQGSFGVVF---QAKCLETGETVAIKKVLQD----KRYKNRE-LQTMR-LLDH---- 123
           +++G G++G VF   +    +TG+  A+K VLQ     ++ K  E  +T R +L+H    
Sbjct: 6   KVLGTGAYGKVFLVRKVTGHDTGKLYAMK-VLQKAALVQKAKTVEHTRTERNVLEHVRQS 64

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQI 181
           P +V+L H  F T  K    L+L+L+YV        + F  L QR       V+ Y+ +I
Sbjct: 65  PFLVTL-HYAFQTEAK----LHLILDYVSGG-----EMFTHLYQRDNFSEDEVRFYSGEI 114

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-Y 239
             AL ++H+ +G+ +RDIK +N+L++   H V L DFG +K  +  E   +Y  C    Y
Sbjct: 115 ILALEHLHK-LGIVYRDIKLENILLDSEGHVV-LTDFGLSKEFLSEEKERTYSFCGTIEY 172

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I G   +  A+D WS G ++ EL+ G   F  +   +   E+       +R  +K
Sbjct: 173 MAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV-------SRRILK 225

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           C  P                  FP  + PEA DL+ +LL+  P  R  A
Sbjct: 226 CDPP------------------FPSFIGPEAQDLLHKLLRKDPKKRLGA 256

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 85.0 bits (210), Expect = 1e-18
 Identities = 75/275 (27%), Positives = 121/275 (44%), Gaps = 48/275 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLKH 131
           +G+GSFG V Q +  +T    A+K + +       E+         +  ++ P +V LK 
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLK- 59

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             FS    ++LYL L      E  H    H  +   R  +   + Y  ++  AL  +H  
Sbjct: 60  --FSFQSPEKLYLVLAFINGGELFH----HLQR-EGRFDLSRARFYTAELLCALENLH-K 111

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATE 250
             V +RD+KP+N+L++ +   + LCDFG  K+ +K +   +  C +  Y APEL+ G   
Sbjct: 112 FNVIYRDLKPENILLD-YQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG- 169

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           YT A+D W+ G ++ E++ G P F  D  V+++    K+L  P R               
Sbjct: 170 YTKAVDWWTLGVLLYEMLTGLPPFY-DENVNEMYR--KILQEPLR--------------- 211

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                      FP     +A DL+  LL   P  R
Sbjct: 212 -----------FPDGFDRDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 84.3 bits (209), Expect = 2e-18
 Identities = 65/229 (28%), Positives = 107/229 (46%), Gaps = 22/229 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQ----TMRLLDHPNVVSLKHC 132
           +G+G+FG V +     +G  +A+K++    D++ + R L      MR  D P +V     
Sbjct: 12  IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71

Query: 133 FFSTTDK---DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F   D     EL +++ L+   + V+        L   +P   +   A    +AL+Y+ 
Sbjct: 72  LFREGDCWICMEL-MDISLDKFYKYVY------EVLKSVIPEEILGKIAVATVKALNYLK 124

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI--FG 247
             + + HRD+KP N+L++ + + +KLCDFG +  LV           R Y APE I    
Sbjct: 125 EELKIIHRDVKPSNILLDRNGN-IKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA 183

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTR 295
              Y    D+WS G  + E+  GK  +P  +S  DQL +++K  G P  
Sbjct: 184 RDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVK--GDPPI 230

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 84.1 bits (208), Expect = 2e-18
 Identities = 77/281 (27%), Positives = 121/281 (43%), Gaps = 46/281 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G+ G V + K + TG  +A K V    +        RELQ M     P +VS    F
Sbjct: 13  LGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAF 72

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +  +     + + +E++   ++ R+ K    +    P+  +   A  +   L+Y++   
Sbjct: 73  LNENN-----ICMCMEFMDCGSLDRIYKKGGPI----PVEILGKIAVAVVEGLTYLYNVH 123

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRDIKP N+LVN    Q+KLCDFG +  L+    + +++ +  Y +PE I G  +YT
Sbjct: 124 RIMHRDIKPSNILVNSRG-QIKLCDFGVSGELINSIAD-TFVGTSTYMSPERIQGG-KYT 180

Query: 253 TAIDIWSAGCVVAELMLGKPLFP------GDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              D+WS G  + EL LGK  FP       D G D  + I+ +L                
Sbjct: 181 VKSDVWSLGISIIELALGK--FPFAFSNIDDDGQDDPMGILDLL---------------- 222

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                QI   P  ++     P +  D V   L   P  R T
Sbjct: 223 ----QQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERPT 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 83.1 bits (205), Expect = 3e-18
 Identities = 70/220 (31%), Positives = 110/220 (50%), Gaps = 26/220 (11%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           + +G+GSFG ++ AK     E   IK++      +++K    +E+  +  + HPN+V+  
Sbjct: 6   KKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTF- 64

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI---YVKLYAYQIFRALSY 187
             F S  +   L++  V+EY       ++K  N+  QR  +     +  +  QI   L +
Sbjct: 65  --FASFQENGRLFI--VMEYCDGG--DLMKRINR--QRGVLFSEDQILSWFVQISLGLKH 116

Query: 188 IH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPEL 244
           IH R I   HRDIK QN+ ++ +    KL DFG A+ L      ++Y C  + YY +PE 
Sbjct: 117 IHDRKI--LHRDIKSQNIFLSKNGMVAKLGDFGIARQL-NDSMELAYTCVGTPYYLSPE- 172

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           I     Y    DIWS GCV+ EL   K  F G++ + QLV
Sbjct: 173 ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN-LHQLV 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 84.1 bits (208), Expect = 3e-18
 Identities = 82/286 (28%), Positives = 136/286 (47%), Gaps = 49/286 (17%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNRELQTMRL-------LDHPNV 126
           +++GQGSFG VF  + +   + G+  A+K VL+    K R+    ++       ++HP +
Sbjct: 2   KVLGQGSFGKVFLVRKITGPDAGQLYAMK-VLKKATLKVRDRVRTKMERDILAEVNHPFI 60

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRA 184
           V L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  A
Sbjct: 61  VKL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALA 110

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE
Sbjct: 111 LDHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPE 168

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTPT-------- 294
           ++     +T + D WS G ++ E++ G   F G    + +  I+K  LG P         
Sbjct: 169 VV-NRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMPQFLSPEAQS 227

Query: 295 --REEIKCMNPNYTEFKFPQ----IKAHP------WHKIFPKRMPP 328
             R   K  NP       P     IK HP      W+K++ + + P
Sbjct: 228 LLRALFK-RNPANRLGAGPDGVEEIKRHPFFSTIDWNKLYRREIKP 272

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 83.2 bits (205), Expect = 5e-18
 Identities = 71/216 (32%), Positives = 111/216 (51%), Gaps = 25/216 (11%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTM 118
           G P++ +    +  +G+GS G+V  A    TG+ VA+KK+  D R + R      E+  M
Sbjct: 18  GDPREYLDSFIK--IGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVIM 73

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLY 177
           R   H NVV + + +      DEL++  V+E++    +  +V H      RM    +   
Sbjct: 74  RDYHHENVVDMYNSYLV---GDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIATV 123

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICS 236
              + RALSY+H   GV HRDIK  ++L+     ++KL DFG    + K  P   S + +
Sbjct: 124 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKSLVGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE+I     Y T +DIWS G +V E++ G+P
Sbjct: 182 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 76/283 (26%), Positives = 126/283 (44%), Gaps = 60/283 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG+  A+K + ++             ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D     L  V+EY    E    + +       R      + Y  +I  A
Sbjct: 58  TALKYSF-QTHD----RLCFVMEYANGGELFFHLSRERVFSEDR-----ARFYGAEIVSA 107

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L Y+H    V +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LGYLHSC-DVVYRDLKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR--- 213

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 214 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 83.5 bits (206), Expect = 5e-18
 Identities = 70/262 (26%), Positives = 129/262 (49%), Gaps = 32/262 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 13  LGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 70

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K   ++ +++    +   +  + + L+Y+  
Sbjct: 71  AFYSDGE-----ISICMEHMDGGSLDQVLKKAGRIPEQI----LGKVSIAVIKGLTYLRE 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 122 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 178

Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           Y+   DIWS G  + E+ +G+ P+ P D+   +L+    V G P   E    +P      
Sbjct: 179 YSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESE---TSPR----- 230

Query: 310 FPQIKAHPWHKIFPKRMPPEAV 331
            P+    P     P   PP A+
Sbjct: 231 -PRPPGRPLSSYGPDSRPPMAI 251

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 82.7 bits (204), Expect = 6e-18
 Identities = 75/286 (26%), Positives = 135/286 (47%), Gaps = 54/286 (18%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 124
           +++G G++G VF  + +   ++G+  A+K      ++Q  +         ++L+H    P
Sbjct: 6   KVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 65

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIF 182
            +V+L + F + T      L+L+L+Y+        + F  L+QR       V++Y+ +I 
Sbjct: 66  FLVTLHYAFQTDTK-----LHLILDYINGG-----ELFTHLSQRERFKEQEVQIYSGEIV 115

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YR 240
            AL ++H+ +G+ +RDIK +N+L++ + H V L DFG +K   + E   +Y  C    Y 
Sbjct: 116 LALEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFHEDEVERAYSFCGTIEYM 173

Query: 241 APELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           AP+++ G    +  A+D WS G ++ EL+ G   F  D   +   EI       +R  +K
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILK 226

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
              P                  +P+ M   A D++ RLL   P  R
Sbjct: 227 SEPP------------------YPQEMSALAKDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 83.4 bits (206), Expect = 6e-18
 Identities = 75/225 (33%), Positives = 116/225 (51%), Gaps = 31/225 (13%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG V  A+   T E  AIK + +D   ++ ++  TM   R+L     HP + +
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           L HC F T D+    L  V+EYV        + R  K F++   R        YA ++  
Sbjct: 61  L-HCCFQTKDR----LFFVMEYVNGGDLMFQIQRSRK-FDEPRSR-------FYAAEVTL 107

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAP 242
           AL ++HR  GV +RD+K  N+L++   H  KL DFG  K  ++ G    ++  +  Y AP
Sbjct: 108 ALMFLHRH-GVIYRDLKLDNILLDAEGH-CKLADFGMCKEGILNGVTTTTFCGTPDYIAP 165

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           E I    EY  ++D W+ G ++ E+M G+P F  D+  D L E I
Sbjct: 166 E-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE-DDLFESI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 7e-18
 Identities = 84/329 (25%), Positives = 133/329 (40%), Gaps = 102/329 (31%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 129
           +++G+G+FG V   +  +TG   A+KK+ + +  +  ++  +R    +L   D+P VV L
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +DE YL L++EY+P  + +  ++K  +   +     Y+   A  I  A+  
Sbjct: 67  YYSF-----QDENYLYLIMEYLPGGDMMTLLMKK-DTFTEEETRFYI---AETIL-AIDS 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYIC 235
           IH  +G  HRDIKP NLL++   H +KL DFG              ++L    P+     
Sbjct: 117 IH-KLGYIHRDIKPDNLLLDAKGH-IKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDF 174

Query: 236 SR--------------------Y-------YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
                                 Y       Y APE +F  T Y    D WS G ++ E++
Sbjct: 175 ISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPE-VFLQTGYNKECDWWSLGVIMYEML 233

Query: 269 LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFPKRM 326
           +G P F  D               P     K +N               W +   FP  +
Sbjct: 234 VGYPPFCSD--------------NPQETYRKIIN---------------WKETLQFPDEV 264

Query: 327 P--PEAVDLVSRLLQYSPNLRCTAVSKRI 353
           P  PEA DL+ RL        C    +R+
Sbjct: 265 PLSPEAKDLIKRL--------CCEAERRL 285

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 82.7 bits (204), Expect = 8e-18
 Identities = 64/209 (30%), Positives = 114/209 (54%), Gaps = 20/209 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG VF A+   T +  AIK + +D    + +++ TM   R+L    +HP +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T  K+ L+   V+EY+      ++ H    + +  +     YA +I   L ++
Sbjct: 61  L-YCTFQT--KENLF--FVMEYL--NGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+      C +  Y APE++ G
Sbjct: 113 H-SKGIVYRDLKLDNILLDTDGH-IKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
             +Y T++D WS G ++ E+++G+  F G
Sbjct: 171 -QKYNTSVDWWSFGVLLYEMLIGQSPFHG 198

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 73/283 (25%), Positives = 126/283 (44%), Gaps = 45/283 (15%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----------LQTMRLLDHPNVVS 128
           +G+G+FG V+Q +  +T    A+K + + +    +E          L    L + P +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           LK  F + +D     L LV +Y+  +   +  H  K   R      K Y  ++  AL ++
Sbjct: 61  LKFSFQTDSD-----LYLVTDYM--SGGELFWHLQK-EGRFSEDRAKFYIAELVLALEHL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H+   + +RD+KP+N+L++   H + LCDFG +K  L   +   ++  +  Y APE++  
Sbjct: 113 HKY-DIVYRDLKPENILLDATGH-IALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLD 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEII---------KVLGTPTREE 297
              YT  +D WS G +V E+  G  P +  D    Q+   I          VL    R+ 
Sbjct: 171 EKGYTKHVDFWSLGVLVFEMCCGWSPFYAED--TQQMYRNIAFGKVRFPKNVLSDEGRQF 228

Query: 298 IKCM---NPNY---TEFKFPQIKAHP------WHKIFPKRMPP 328
           +K +   NP +         ++K HP      W  +  K++ P
Sbjct: 229 VKGLLNRNPQHRLGAHRDAVELKEHPFFADIDWDLLSKKQITP 271

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 82/277 (29%), Positives = 127/277 (45%), Gaps = 47/277 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHQNVVEM--- 83

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           + S    +EL++  ++E++       +    +LN+      +      + +AL Y+H S 
Sbjct: 84  YKSYLVGEELWV--LMEFLQGGALTDIVSQTRLNEEQ----IATVCESVLQALCYLH-SQ 136

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSRYYRAPELIFGATEY 251
           GV HRDIK  ++L+     +VKL DFG    + K  P   S + + Y+ APE+I   T Y
Sbjct: 137 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVI-SRTPY 194

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
            T +DIWS G +V E++ G+P +  DS V  +  +        R+              P
Sbjct: 195 GTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRL--------RDS-------------P 233

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             K    HKI      P   D + R+L   P  R TA
Sbjct: 234 PPKLKNAHKI-----SPVLRDFLERMLTREPQERATA 265

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 81.5 bits (201), Expect = 2e-17
 Identities = 74/250 (29%), Positives = 126/250 (50%), Gaps = 22/250 (8%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+  +   E+I GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKKKYTRF-EKI-GQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             HPN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  NKHPNIVNYLDSYLVG---DELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238

Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 239 EKLSAIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 79/281 (28%), Positives = 126/281 (44%), Gaps = 55/281 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 58  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 109

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE +
Sbjct: 110 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 167

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 168 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 214

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                            FP+ + PEA  L+S LL+  P  R
Sbjct: 215 -----------------FPRTLSPEAKSLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 81.6 bits (201), Expect = 2e-17
 Identities = 67/229 (29%), Positives = 119/229 (51%), Gaps = 30/229 (13%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 126
           ERI  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 8   ERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V     F+S  +     +++ +E++   ++ +V+K      +R+P   +   +  + R L
Sbjct: 66  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE +
Sbjct: 117 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 174

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP 293
            G T Y+   DIWS G  + EL +G+ P+ P D+      E+  + G P
Sbjct: 175 QG-THYSVQSDIWSMGLSLVELAIGRYPIPPPDAK-----ELEAIFGRP 217

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 81.0 bits (200), Expect = 2e-17
 Identities = 69/210 (32%), Positives = 105/210 (50%), Gaps = 38/210 (18%)

Query: 79  VGQGSFGVVFQAKCL------ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 128
           +G+G+FG V    C        TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 12  LGKGNFGSV--ELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            K   +S   ++   L LV+EY+P    R  + KH  +L+ R  +    LYA QI + + 
Sbjct: 70  YKGVCYSAGRRN---LRLVMEYLPYGSLRDYLQKHRERLDHRKLL----LYASQICKGME 122

Query: 187 YI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSR 237
           Y+   R +   HRD+  +N+LV      VK+ DFG  KVL          EP  S I   
Sbjct: 123 YLGSKRYV---HRDLATRNILVESENR-VKIGDFGLTKVLPQDKEYYKVREPGESPI--- 175

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           ++ APE +   ++++ A D+WS G V+ EL
Sbjct: 176 FWYAPESL-TESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 80.8 bits (199), Expect = 3e-17
 Identities = 72/217 (33%), Positives = 112/217 (51%), Gaps = 27/217 (12%)

Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   +Y+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---TYLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKL 176
           MR   H NVV + + +      DEL++  V+E++    +  +V H      RM    +  
Sbjct: 71  MRDYQHENVVEMYNSYLV---GDELWV--VMEFLEGGALTDIVTH-----TRMNEEQIAA 120

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYIC 235
               + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P   S + 
Sbjct: 121 VCLAVLKALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKSLVG 178

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + Y+ APELI     Y   +DIWS G +V E++ G+P
Sbjct: 179 TPYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 48/282 (17%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           +G+G++G V++     TG T+A+K++   L + ++     EL  +     P +V     F
Sbjct: 9   LGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAF 68

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           F      E  + + +EY+       +       + +P   ++   Y + + L ++     
Sbjct: 69  FI-----EGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI-----FGA 248
           + HRD+KP N+LVN +  QVKLCDFG +  LV      +  C  Y  APE I        
Sbjct: 124 IIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLVASLAKTNIGCQSYM-APERIKSGGPNQN 181

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVLGTPTREEIKCMNPNY 305
             YT   D+WS G  + E+ LG+  +P ++  +   QL  I+   G P            
Sbjct: 182 PTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVD--GDPPT---------- 229

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                            P     +A D V++ L   PN R T
Sbjct: 230 ----------------LPSGYSDDAQDFVAKCLNKIPNRRPT 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 80.0 bits (197), Expect = 4e-17
 Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 19/224 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y   R+VG+GSFG     + + + +  A+K++   K         +E   +  + HPN+V
Sbjct: 2   YNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIV 61

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + K  F     + + +L +V+EY    + + ++     KL    P   +  +  Q+   +
Sbjct: 62  AFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKL---FPEDTILQWFVQMCLGV 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPEL 244
            +IH    V HRDIK +N+ +     +VKL DFGSA++L   G    +Y+ + YY  PE 
Sbjct: 114 QHIHEK-RVLHRDIKSKNIFLT-QNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPE- 170

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           I+    Y    DIWS GC++ EL   K  F  +S  + ++++ +
Sbjct: 171 IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQ 214

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 80.3 bits (198), Expect = 4e-17
 Identities = 62/206 (30%), Positives = 102/206 (49%), Gaps = 18/206 (8%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL--------LDHPNVVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ + M L        ++   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L L    +    +   +N  N          YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YNMGNPGFDEERAVFYAAEITCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           HR   + +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-RIVYRDLKPENILLDDYGH-IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV-KN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLF 274
             YT + D W  GC++ E++ GK  F
Sbjct: 176 ERYTFSPDWWGLGCLIYEMIEGKSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 80.2 bits (198), Expect = 5e-17
 Identities = 77/288 (26%), Positives = 133/288 (46%), Gaps = 41/288 (14%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-LQDK-RYKN---RELQTMRLLDHPNVVSLKHCFF 134
           G G+ GVV +     +G  +A K + L+ K   +N   REL+ +   + P +V     F+
Sbjct: 10  GAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY 69

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           S  +     +++ +E++   ++ +V+K       R+P   +   +  + R L+Y+     
Sbjct: 70  SDGE-----ISICMEHMDGGSLDQVLKKAG----RIPENILGKISIAVLRGLTYLREKHK 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T YT 
Sbjct: 121 IMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-THYTV 177

Query: 254 AIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
             DIWS G  + E+ +G+ P+ P D+      E+  + G P  E     +        P 
Sbjct: 178 QSDIWSLGLSLVEMAIGRYPIPPPDA-----KELEAMFGRPVSEGEAKESHRPVSGHPPD 232

Query: 313 IKAHPWHKIF----------PKRMP-----PEAVDLVSRLLQYSPNLR 345
             +     IF          P ++P      E  D V + L+ +P  R
Sbjct: 233 --SPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKER 278

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 79.8 bits (196), Expect = 6e-17
 Identities = 73/250 (29%), Positives = 125/250 (50%), Gaps = 22/250 (8%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRL 120
           G PK+   Y     +GQG+ G VF A  + TG+ VAIK++   K+ K      E+  M+ 
Sbjct: 15  GDPKK--KYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L +PN+V+    F      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  LKNPNIVNFLDSFLV---GDELF--VVMEYLAGGSLTDVVTE-----TCMDEAQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H +  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238

Query: 299 KCMNPNYTEF 308
           + ++P + +F
Sbjct: 239 EKLSPIFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 78.5 bits (193), Expect = 1e-16
 Identities = 75/281 (26%), Positives = 121/281 (43%), Gaps = 43/281 (15%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y   R+VG+GS+G V   +    G+   IKK+       ++++   +E Q +  L HPN
Sbjct: 1   AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPN 60

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V+ +  +    +   LY+ +      +  H++ +   KL   +P   V  +  QI  AL
Sbjct: 61  IVAYRESW--EGEDGLLYIVMGFCEGGDLYHKLKEQKGKL---LPENQVVEWFVQIAMAL 115

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPEL 244
            Y+H    + HRD+K QN+ +   T+ +K+ D G A+VL       S  I + YY +PEL
Sbjct: 116 QYLHEK-HILHRDLKTQNVFLT-RTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPEL 173

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
            F    Y    D+W+ GC V E+   K  F        +  II                 
Sbjct: 174 -FSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII----------------- 215

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             E K P +         PK   PE  +L++ +L   P  R
Sbjct: 216 --EGKLPPM---------PKDYSPELGELIATMLSKRPEKR 245

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 78.4 bits (193), Expect = 2e-16
 Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 21/203 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHC 132
           I+G G+ G V++A  L T   +A+K +  D     ++    EL+ +   D P ++     
Sbjct: 8   ILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGA 67

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           FF      E  +++  E++      V +       ++P   +   A  + + L+Y+  S+
Sbjct: 68  FFV-----ENRISICTEFMDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLW-SL 114

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + HRD+KP N+LVN    QVKLCDFG +  LV      +Y+ +  Y APE I G  +Y 
Sbjct: 115 KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVNSIAK-TYVGTNAYMAPERISG-EQYG 171

Query: 253 TAIDIWSAGCVVAELMLGKPLFP 275
              D+WS G    EL LG+  +P
Sbjct: 172 IHSDVWSLGISFMELALGRFPYP 194

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 67/208 (32%), Positives = 102/208 (49%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT---------MRLLDHPNVV 127
           +++G+GSFG V  AK    G   A+K VLQ K    ++ Q          ++ L HP +V
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVK-VLQKKTILKKKEQNHIMAERNVLLKNLKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L H  F T +K    L  VL+YV      +  H  +  +       + YA ++  A+ Y
Sbjct: 60  GL-HYSFQTAEK----LYFVLDYV--NGGELFFHLQR-ERCFLEPRARFYAAEVASAIGY 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H S+ + +RD+KP+N+L++   H V L DFG  K  V+ E   S  C +  Y APE + 
Sbjct: 112 LH-SLNIIYRDLKPENILLDSQGHVV-LTDFGLCKEGVEPEETTSTFCGTPEYLAPE-VL 168

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
               Y   +D W  G V+ E++ G P F
Sbjct: 169 RKEPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 76/277 (27%), Positives = 128/277 (46%), Gaps = 49/277 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK      V+QD   +    E + + L D P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P      YA +I   L ++H
Sbjct: 67  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEPQ--AVFYAAEISVGLFFLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGA 248
           R  G+ +RD+K  N++++   H +K+ DFG  K  +V G    ++  +  Y APE+I   
Sbjct: 119 RR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEII-AY 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I             M  N +  
Sbjct: 176 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI-------------MEHNVS-- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        +PK +  EAV +   L+   P+ R
Sbjct: 220 -------------YPKSLSKEAVSICKGLMTKHPSKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 68/207 (32%), Positives = 104/207 (50%), Gaps = 23/207 (11%)

Query: 77  RIVGQGSFGVVFQAKCL-ETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPNVVS 128
           R +G GSFG V  A    E    VAIK+  + K  K +       E + +  ++HP  V+
Sbjct: 36  RTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVN 95

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F     KDE YL LVLE+V   +      F + N+R P      YA QI     Y+
Sbjct: 96  LYGSF-----KDESYLYLVLEFV---IGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL 147

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
            +S+ + +RD+KP+NLL++     +K+ DFG AKV+   +     +C +  Y APE++  
Sbjct: 148 -QSLNIVYRDLKPENLLLDKDGF-IKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLN 202

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
              +  A D W+ G  + E+++G P F
Sbjct: 203 VG-HGKAADWWTLGIFIYEILVGCPPF 228

Length = 340

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 78.1 bits (192), Expect = 3e-16
 Identities = 71/289 (24%), Positives = 123/289 (42%), Gaps = 54/289 (18%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----------LDHPNV 126
           I+G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 127 VSLKHCFFSTTDKDELYLNLV----LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           V + + F  T DK    L+L+    L Y       + +H       M     + YA +I 
Sbjct: 60  VCMSYAF-HTPDKLSFILDLMNGGDLHY------HLSQHGVFSEAEM-----RFYAAEII 107

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y AP
Sbjct: 108 LGLEHMHNR-FVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAP 164

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG----------------------KPLFPGDSGV 280
           E++     Y ++ D +S GC++ +L+ G                          P     
Sbjct: 165 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSP 224

Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           +    +  +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 225 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSLDWQMVFLQKYPP 273

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 78.5 bits (193), Expect = 3e-16
 Identities = 68/210 (32%), Positives = 102/210 (48%), Gaps = 26/210 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY--KNRELQTM-------RLLDHPNVV 127
           +++G+GSFG V  A+  +  E     KVLQ K    K  E   M       + + HP +V
Sbjct: 1   KVIGKGSFGKVLLAR-HKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L H  F T DK    L  VL+Y+   E  + + +    L  R      + YA +I  AL
Sbjct: 60  GL-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASAL 109

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 244
            Y+H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE+
Sbjct: 110 GYLH-SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNGTTSTFCGTPEYLAPEV 167

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           +     Y   +D W  G V+ E++ G P F
Sbjct: 168 LH-KQPYDRTVDWWCLGAVLYEMLYGLPPF 196

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 77.4 bits (190), Expect = 6e-16
 Identities = 62/228 (27%), Positives = 116/228 (50%), Gaps = 28/228 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 61  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF--------PGDSGVDQLVEII 287
             +Y  ++D W+ G ++ E+M G+  F        P  +  D L ++I
Sbjct: 171 -EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI 217

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 68/220 (30%), Positives = 113/220 (51%), Gaps = 21/220 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           R++G+GSFG V  A+  E+G   A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L +C F T D+    L  V+E+V      ++ H  K ++R      + YA +I  AL ++
Sbjct: 61  L-YCCFQTPDR----LFFVMEFV--NGGDLMFHIQK-SRRFDEARARFYAAEITSALMFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H   G+ +RD+K  N+L++ H    KL DFG  K  +      S  C +  Y APE I  
Sbjct: 113 H-DKGIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPE-ILQ 169

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
              Y  ++D W+ G ++ E++ G   F  ++  D L E I
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 208

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 62/221 (28%), Positives = 105/221 (47%), Gaps = 33/221 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   + +  A+K + + +  K         E   M   +   +V L
Sbjct: 49  KVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQL 108

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            H  F    +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++  AL  
Sbjct: 109 -HYAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDIPEKWARFYTAEVVLALDA 157

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 242
           IH S+G  HRD+KP N+L++   H +KL DFG+    +K + N    C        Y +P
Sbjct: 158 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTC---MKMDANGMVRCDTAVGTPDYISP 212

Query: 243 ELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           E++    G   Y    D WS G  + E+++G   F  DS V
Sbjct: 213 EVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 55/208 (26%), Positives = 111/208 (53%), Gaps = 22/208 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLL-----DHPNVV 127
           R++G+GS+  V   +  +T    A+K V++ +   + E    +QT + +     +HP +V
Sbjct: 1   RVIGRGSYAKVLLVELKKTRRIYAMK-VIKKELVNDDEDIDWVQTEKHVFETASNHPFLV 59

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L  CF + +      L  V+E+V      ++ H  +  +++P  + + Y+ +I  AL++
Sbjct: 60  GLHSCFQTESR-----LFFVIEFVSGG--DLMFHMQR-QRKLPEEHARFYSAEISLALNF 111

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIF 246
           +H   G+ +RD+K  N+L++   H +KL D+G  K  +  G+   ++  +  Y APE++ 
Sbjct: 112 LHER-GIIYRDLKLDNVLLDAEGH-IKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILR 169

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
           G  +Y  ++D W+ G ++ E+M G+  F
Sbjct: 170 G-EDYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 75.5 bits (185), Expect = 1e-15
 Identities = 64/206 (31%), Positives = 102/206 (49%), Gaps = 22/206 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G++G V++A+ + TGE  AIK +     +D     +E+  M+   H N+V+    F 
Sbjct: 17  IGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAY---FG 73

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           S   +D+L++   +E+      + + H         + YV   + +  + L Y+H S G 
Sbjct: 74  SYLRRDKLWIC--MEFCGGGSLQDIYHVTGPLSESQIAYV---SRETLQGLYYLH-SKGK 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
            HRDIK  N+L+  + H VKL DFG SA++        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNGH-VKLADFGVSAQITATIAKRKSFIGTPYWMAPEV--AAVERKG 184

Query: 251 -YTTAIDIWSAGCVVAELM-LGKPLF 274
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 75.5 bits (186), Expect = 1e-15
 Identities = 66/215 (30%), Positives = 97/215 (45%), Gaps = 30/215 (13%)

Query: 77  RIVGQGSFGVVFQAK-CLETGE--TVAIKKVLQDKRYKNREL-----QTMRLLDHPNVVS 128
           R +G+G FG V+Q        E   VA+K          RE        MR  DHP++V 
Sbjct: 12  RCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVK 71

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L         ++ +++  V+E  P    R   +       + +  + LY+YQ+  AL+Y+
Sbjct: 72  L----IGVITENPVWI--VMELAPLGELR--SYLQVNKYSLDLASLILYSYQLSTALAYL 123

Query: 189 HRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
             S    HRDI  +N+LV +P    VKL DFG ++ L   E    Y  S+      + AP
Sbjct: 124 E-SKRFVHRDIAARNVLVSSPDC--VKLGDFGLSRYL---EDESYYKASKGKLPIKWMAP 177

Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LMLG   F G
Sbjct: 178 ESI-NFRRFTSASDVWMFGVCMWEILMLGVKPFQG 211

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 79/311 (25%), Positives = 128/311 (41%), Gaps = 83/311 (26%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR----ELQTMRLLDHPNVVSL 129
           +++G+G  G VF  +   TG+  A+K   K    KR K +    E + +  LDHP + +L
Sbjct: 7   KLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY-----VKLYAYQIFRA 184
              F + T     YL LV++Y P           +L QR P         + YA ++  A
Sbjct: 67  YASFQTET-----YLCLVMDYCPG------GELFRLLQRQPGKCLSEEVARFYAAEVLLA 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF-------------------GSAKVLV 225
           L Y+H  +G+ +RD+KP+N+L++   H + L DF                   GS +  V
Sbjct: 116 LEYLH-LLGIVYRDLKPENILLHESGH-IMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173

Query: 226 KGEPNISYICS-----------RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
              P+ ++                Y APE+I G   + +A+D W+ G ++ E++ G   F
Sbjct: 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPF 232

Query: 275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLV 334
            G +  +    I+K                  E  FP     P        +   A DL+
Sbjct: 233 KGSNRDETFSNILK-----------------KEVTFPG---SP-------PVSSSARDLI 265

Query: 335 SRLLQYSPNLR 345
            +LL   P+ R
Sbjct: 266 RKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 78/283 (27%), Positives = 126/283 (44%), Gaps = 60/283 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG          E +  K  +     ++R LQ  R   HP +
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 57

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 58  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 107

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C +  Y APE
Sbjct: 108 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 165

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 166 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 213

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 214 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 76.4 bits (188), Expect = 2e-15
 Identities = 75/286 (26%), Positives = 124/286 (43%), Gaps = 70/286 (24%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKK----VLQDKR---YKNRELQTMRLLDHPNVVSLK 130
           +VG+G FG V   +   TG+  A+K     VL  +    +   E   + + + P +  L+
Sbjct: 8   LVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQ 67

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           + F    DKD LYL  V+EY P  + +  + ++ ++ ++ M     + Y  ++  A+  +
Sbjct: 68  YAF---QDKDNLYL--VMEYQPGGDLLSLLNRYEDQFDEDM----AQFYLAELVLAIHSV 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-------KVLVK---GEPNISYICSRY 238
           H  +G  HRDIKP+N+L++   H +KL DFGSA        V  K   G P+        
Sbjct: 119 H-QMGYVHRDIKPENVLIDRTGH-IKLADFGSAARLTANKMVNSKLPVGTPD-------- 168

Query: 239 YRAPELI-----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           Y APE++      G   Y    D WS G +  E++ G+  F   +       I+      
Sbjct: 169 YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIM------ 222

Query: 294 TREEIKCMNPNYTEF-KFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                     N+  F KFP     P       ++  + +DL+  LL
Sbjct: 223 ----------NFQRFLKFP---EDP-------KVSSDFLDLIQSLL 248

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 67/237 (28%), Positives = 112/237 (47%), Gaps = 43/237 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 125
           Y   +++G+G+FG V   +   + +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           VV L  C F    +D+ YL +V+EY+P  + V+ +       N  +P  + K Y  ++  
Sbjct: 105 VVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVVL 153

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 233
           AL  IH S+G+ HRD+KP N+L++ H H +KL DFG+   + +          G P+   
Sbjct: 154 ALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVRCDTAVGTPD--- 208

Query: 234 ICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 75.2 bits (185), Expect = 2e-15
 Identities = 72/282 (25%), Positives = 115/282 (40%), Gaps = 52/282 (18%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           G G+FG V++A+  ETG   A K +       L+D      E+  +    HPN+V L   
Sbjct: 14  GDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMV---EIDILSECKHPNIVGLYEA 70

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           +F         L +++E+     +  ++    +L + +    ++    Q+  AL+++H  
Sbjct: 71  YFYENK-----LWILIEFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFLHSH 122

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI----F 246
             V HRD+K  N+L+      VKL DFG SAK     +   ++I + Y+ APE++    F
Sbjct: 123 K-VIHRDLKAGNILLTLDG-DVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETF 180

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y    DIWS G  + EL   +P                    P  E    +NP   
Sbjct: 181 KDNPYDYKADIWSLGITLIELAQMEP--------------------PHHE----LNPMRV 216

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             K    K+ P     P +      D +   L   P+ R TA
Sbjct: 217 LLKIL--KSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRPTA 256

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 69/232 (29%), Positives = 108/232 (46%), Gaps = 39/232 (16%)

Query: 62  GRNGQPKQTISYMA-ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNR 113
                P    S    ER+  +G G+ G V++     TG   A+K +  +     +R   R
Sbjct: 62  ASGSAPSAAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICR 121

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRM 169
           E++ +R ++HPNVV   H  F    +    + ++LE++     E  H   + F       
Sbjct: 122 EIEILRDVNHPNVVKC-HDMFDHNGE----IQVLLEFMDGGSLEGTHIADEQF------- 169

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-E 228
               +   A QI   ++Y+HR   + HRDIKP NLL+N     VK+ DFG +++L +  +
Sbjct: 170 ----LADVARQILSGIAYLHRR-HIVHRDIKPSNLLINS-AKNVKIADFGVSRILAQTMD 223

Query: 229 PNISYICSRYYRAPELI-----FGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
           P  S + +  Y +PE I      GA +   A DIWS G  + E  LG+  FP
Sbjct: 224 PCNSSVGTIAYMSPERINTDLNHGAYD-GYAGDIWSLGVSILEFYLGR--FP 272

Length = 353

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 74.9 bits (184), Expect = 3e-15
 Identities = 64/214 (29%), Positives = 104/214 (48%), Gaps = 41/214 (19%)

Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           R++G+G FG V    +      TGE VA+K + ++   +N      E+  ++ L H N+V
Sbjct: 10  RVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIV 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K C    +++    L L++EYVP    R  + KH   L Q +      L+A QI   +
Sbjct: 70  KYKGC---CSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLL------LFAQQICEGM 120

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE-- 243
           +Y+H S    HRD+  +N+L++ +   VK+ DFG AK + +G          YYR  E  
Sbjct: 121 AYLH-SQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDG 170

Query: 244 ---LIFGATE------YTTAIDIWSAGCVVAELM 268
              + + A E      ++ A D+WS G  + EL+
Sbjct: 171 DSPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 74.3 bits (183), Expect = 3e-15
 Identities = 76/304 (25%), Positives = 116/304 (38%), Gaps = 73/304 (24%)

Query: 79  VGQGSFGVVFQAKCLETGE---TVAIK-----KVLQDKRYKNRELQTMRLLDHPNVVSLK 130
           +G G+FG V +   L        VA+K      +   K+   RE   M  LDHP +V L 
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRL- 61

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    + L   LV+E  P   + +    + K  + +P+  +K  A+Q+   ++Y+ 
Sbjct: 62  ---IGVCKGEPLM--LVMELAPLGPLLK----YLKKRREIPVSDLKELAHQVAMGMAYLE 112

Query: 190 RSIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------- 240
               V HRD+  +N LLVN   HQ K+ DFG ++ L  G        S YYR        
Sbjct: 113 SKHFV-HRDLAARNVLLVN--RHQAKISDFGMSRALGAG--------SDYYRATTAGRWP 161

Query: 241 ----APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTR 295
               APE I     +++  D+WS G  + E    G   +    G     E+I +L +  R
Sbjct: 162 LKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKG----AEVIAMLESGER 216

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF 355
                          P+          P+  P E   ++    +Y P  R T       F
Sbjct: 217 --------------LPR----------PEECPQEIYSIMLSCWKYRPEDRPTFSELESTF 252

Query: 356 SNCP 359
              P
Sbjct: 253 RRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 74.5 bits (183), Expect = 3e-15
 Identities = 65/228 (28%), Positives = 110/228 (48%), Gaps = 26/228 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPNV 126
           Y+  + +G+GSFG     K  E G+   IK++    +  K  +   +E+  +  + HPN+
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNI 61

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIF 182
           V  +  F    +   LY+  V++Y           + K+N +  +++    +  +  QI 
Sbjct: 62  VQYQESF---EENGNLYI--VMDYCEGG-----DLYKKINAQRGVLFPEDQILDWFVQIC 111

Query: 183 RALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYR 240
            AL ++H R I   HRDIK QN+ +      +KL DFG A+VL    E   + I + YY 
Sbjct: 112 LALKHVHDRKI--LHRDIKSQNIFLTKDG-TIKLGDFGIARVLNSTVELARTCIGTPYYL 168

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           +PE I     Y    DIW+ GCV+ E+   K  F   +  + +++II+
Sbjct: 169 SPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIR 215

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 75.2 bits (185), Expect = 3e-15
 Identities = 76/282 (26%), Positives = 125/282 (44%), Gaps = 54/282 (19%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQ---------DKRYKNRELQTMRLLDHP 124
           +++G+G +G VFQ + +   +TG+  A+K VL+         D  +   E   +  + HP
Sbjct: 2   KVLGKGGYGKVFQVRKVTGADTGKIFAMK-VLKKATIVRNQKDTAHTKAERNILEAVKHP 60

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +V L    F T  K    L L+LEY+      +  H  +    M       Y  +I  A
Sbjct: 61  FIVDL-IYAFQTGGK----LYLILEYLSGG--ELFMHLEREGIFMEDT-ACFYLSEISLA 112

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H   G+ +RD+KP+N+L++   H VKL DFG  K  +         C    Y APE
Sbjct: 113 LEHLH-QQGIIYRDLKPENILLDAQGH-VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPE 170

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            I   + +  A+D WS G ++ +++ G P F  ++    + +I+K          K   P
Sbjct: 171 -ILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKG---------KLNLP 220

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            Y                    + PEA DL+ +LL+ +P+ R
Sbjct: 221 PY--------------------LTPEARDLLKKLLKRNPSSR 242

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 57/207 (27%), Positives = 110/207 (53%), Gaps = 20/207 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVS 128
           R++G+GS+  V   +  +  +  A+K V ++  + + ++  ++   H        P +V 
Sbjct: 1   RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF +T+      L LV+EYV      ++ H  +  +++P  + + YA +I  AL+++
Sbjct: 61  LHSCFQTTSR-----LFLVIEYV--NGGDLMFHMQR-QRKLPEEHARFYAAEICIALNFL 112

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ G
Sbjct: 113 HER-GIIYRDLKLDNVLLDADGH-IKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG 170

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             EY  ++D W+ G ++ E+M G+  F
Sbjct: 171 -EEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 74.2 bits (182), Expect = 5e-15
 Identities = 61/208 (29%), Positives = 104/208 (50%), Gaps = 18/208 (8%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 128
           R++G+G FG V   +   TG+  A K+ L+ KR K R+ ++M L     L+  N   VV+
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKR-LEKKRIKKRKGESMALNEKQILEKVNSQFVVN 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L +    +    +   +N  N          YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFEEERALFYAAEILCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           HR     +RD+KP+N+L++ + H +++ D G A  + +GE     + +  Y APE++   
Sbjct: 119 HRE-NTVYRDLKPENILLDDYGH-IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVL-NN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPG 276
             YT + D W  GC++ E++ G+  F G
Sbjct: 176 QRYTLSPDYWGLGCLIYEMIEGQSPFRG 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 66/237 (27%), Positives = 110/237 (46%), Gaps = 43/237 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPN 125
           Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P 
Sbjct: 45  YEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPW 104

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++  
Sbjct: 105 VVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVVL 153

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISY 233
           AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+   
Sbjct: 154 ALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD--- 208

Query: 234 ICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 209 -----YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 260

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 76/297 (25%), Positives = 129/297 (43%), Gaps = 48/297 (16%)

Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 6   RDLDPNEVWEIIGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYMVEIEI 62

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   +HP +V L   F+      +  L +++E+ P      +    +L++ +    +++ 
Sbjct: 63  LATCNHPYIVKLLGAFYW-----DGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVI 115

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL Y+H S+ + HRD+K  N+L+      +KL DFG SAK +   +   S+I +
Sbjct: 116 CRQMLEALQYLH-SMKIIHRDLKAGNVLLT-LDGDIKLADFGVSAKNVKTLQRRDSFIGT 173

Query: 237 RYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            Y+ APE++   T     Y    DIWS G  + E+   +P                    
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP-------------------- 213

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           P  E    +NP     K    K+ P     P +   E  D +   L   P  R +A 
Sbjct: 214 PHHE----LNPMRVLLKIA--KSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAA 264

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 72/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAIK++ LQ +  K     E+  MR 
Sbjct: 15  GDPKK--KYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE 72

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 73  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 122

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 123 ECLQALDFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 181 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY-LIATNGTPELQNP 238

Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 239 ERLSAVFRDF 248

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 61/210 (29%), Positives = 106/210 (50%), Gaps = 27/210 (12%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-----------DHPNV 126
           I+G+G FG V+  +  +TG+  A+K  L  KR K ++ +T+ L            D P +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPFI 59

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYAYQIFRA 184
           V + + F +    D+L   L L    +  + + +H  F++   R        YA +I   
Sbjct: 60  VCMTYAFHT---PDKLCFILDLMNGGDLHYHLSQHGVFSEKEMR-------FYATEIILG 109

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  Y APE+
Sbjct: 110 LEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHGYMAPEV 166

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           +   T Y ++ D +S GC++ +L+ G   F
Sbjct: 167 LQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 73.1 bits (179), Expect = 1e-14
 Identities = 65/238 (27%), Positives = 112/238 (47%), Gaps = 23/238 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH--------PNVVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K +  + M LL+         P +V+L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKK-LDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIH 189
           + F S T     +L LV+  +      +  H   + +R + M  V  Y+ QI   + ++H
Sbjct: 60  YAFESKT-----HLCLVMSLM--NGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+ + +RD+KP+N+L++      +L D G A  L  G+       +  Y APE I    
Sbjct: 113 -SMDIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTITQRAGTNGYMAPE-ILKEE 169

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            Y+  +D ++ GC + E++ G+  F       + V   ++      +E+K  + N+TE
Sbjct: 170 PYSYPVDWFAMGCSIYEMVAGRTPF---KDHKEKVAKEELKRRTLEDEVKFEHQNFTE 224

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 73.6 bits (180), Expect = 1e-14
 Identities = 77/278 (27%), Positives = 128/278 (46%), Gaps = 50/278 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLD---HPNVVSL 129
           +++G+G+FG V   +   +G+  A+K    +V+  K      L   R+L    HP + SL
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSL 60

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K+ F  T D+    L  V+EYV      +  H ++  +       + Y  +I  AL Y+H
Sbjct: 61  KYSF-QTKDR----LCFVMEYV--NGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDYLH 112

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S  + +RD+K +NL+++   H +K+ DFG  K  +     +   C +  Y APE +   
Sbjct: 113 -SGKIVYRDLKLENLMLDKDGH-IKITDFGLCKEGITDAATMKTFCGTPEYLAPE-VLED 169

Query: 249 TEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      E+IK        
Sbjct: 170 NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EDIK-------- 213

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                         FP+ +  +A  L+S LL   PN R
Sbjct: 214 --------------FPRTLSADAKSLLSGLLIKDPNKR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 73.2 bits (180), Expect = 1e-14
 Identities = 72/279 (25%), Positives = 123/279 (44%), Gaps = 52/279 (18%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----RLLD------HPNVV 127
           ++G+G FG V  A+  +TGE  AIK + +       E++++    R+ +      HP +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L    F T  +D +    V+EY       ++ H +             YA  +   L Y
Sbjct: 66  NL-FACFQT--EDHVCF--VMEYAAGG--DLMMHIHT--DVFSEPRAVFYAACVVLGLQY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H +  + +RD+K  NLL++     VK+ DFG  K  +      S  C +  + APE++ 
Sbjct: 117 LHEN-KIVYRDLKLDNLLLDTEGF-VKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT 174

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
             T YT A+D W  G ++ E+++G+  FPGD                  EE+        
Sbjct: 175 E-TSYTRAVDWWGLGVLIYEMLVGESPFPGD----------------DEEEV-------- 209

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
              F  I        +P+ +  EA+ ++ RLL+ +P  R
Sbjct: 210 ---FDSIVND--EVRYPRFLSREAISIMRRLLRRNPERR 243

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 72.4 bits (178), Expect = 3e-14
 Identities = 65/270 (24%), Positives = 122/270 (45%), Gaps = 39/270 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD-------H--PNVVSL 129
           +G G+ G V++ +  +TG  +A+K++   +R  N+E     L+D       H  P +V  
Sbjct: 23  IGSGTCGQVYKMRFKKTGHVMAVKQM---RRTGNKEENKRILMDLDVVLKSHDCPYIVKC 79

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F + +D     + + +E +   + +++K   ++   +P   +      I +AL Y+ 
Sbjct: 80  YGYFITDSD-----VFICMELMSTCLDKLLK---RIQGPIPEDILGKMTVAIVKALHYLK 131

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 248
              GV HRD+KP N+L++  +  VKLCDFG +  LV  +    S  C+ Y  APE I   
Sbjct: 132 EKHGVIHRDVKPSNILLD-ASGNVKLCDFGISGRLVDSKAKTRSAGCAAYM-APERIDPP 189

Query: 249 T---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
               +Y    D+WS G  + EL  G+  +       +++  I     P+    +  +P++
Sbjct: 190 DPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDF 249

Query: 306 TEF-------------KFPQIKAHPWHKIF 322
             F             K+ ++  HP+ + +
Sbjct: 250 CSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 72.4 bits (177), Expect = 3e-14
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVV-TRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239

Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 71.3 bits (175), Expect = 6e-14
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 49/277 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM------RLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK + +D   ++ +++ TM       L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P  +   YA +I   L ++H
Sbjct: 67  HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVGKFKEP--HAVFYAAEIAIGLFFLH 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGA 248
            S G+ +RD+K  N++++   H +K+ DFG  K  + G       C +  Y APE+I   
Sbjct: 119 -SKGIIYRDLKLDNVMLDAEGH-IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEII-AY 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I             M  N +  
Sbjct: 176 QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE-DELFQSI-------------MEHNVS-- 219

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        +PK +  EAV +   LL   P  R
Sbjct: 220 -------------YPKSLSKEAVSICKGLLTKHPAKR 243

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 85/320 (26%), Positives = 133/320 (41%), Gaps = 99/320 (30%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           + +G G+FG V  A  ++T    A+K  L+ K   NR        E   +   D+  VV 
Sbjct: 7   KTLGIGAFGEVCLACKVDTHALYAMK-TLRKKDVLNRNQVAHVKAERDILAEADNEWVVK 65

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRAL 185
           L   ++S  DKD LY   V++Y+P            L  RM   P +  + Y  ++  A+
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRMEVFPEVLARFYIAELTLAI 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG---------SAKVLVKG--------E 228
             +H+ +G  HRDIKP N+L++   H +KL DFG         ++K   KG        E
Sbjct: 115 ESVHK-MGFIHRDIKPDNILIDLDGH-IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSME 172

Query: 229 PNI-------------------------------SYICSRYYRAPELIFGATEYTTAIDI 257
           P+                                S + +  Y APE++     YT   D 
Sbjct: 173 PSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL-RKGYTQLCDW 231

Query: 258 WSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP 317
           WS G ++ E+++G+P F              +  TPT  ++K +N   T    PQ+K   
Sbjct: 232 WSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENTLHIPPQVK--- 274

Query: 318 WHKIFPKRMPPEAVDLVSRL 337
                   + PEAVDL+++L
Sbjct: 275 --------LSPEAVDLITKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 70.2 bits (172), Expect = 9e-14
 Identities = 60/247 (24%), Positives = 111/247 (44%), Gaps = 30/247 (12%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVL-------QDKRYKNRELQTM----- 118
            Y     +G G+FG V++ +    G+  +A+K++        +DKR +++ +  +     
Sbjct: 1   EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60

Query: 119 ---RLLDHPNVVSLKHCFFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKL---NQRMPM 171
                L HPN+V     F    + D LY+ + L E  P     + +HFN L    QR   
Sbjct: 61  IIKEQLRHPNIVRYYKTF---LENDRLYIVMDLIEGAP-----LGEHFNSLKEKKQRFTE 112

Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +     Q+  AL Y+H+   + HRD+ P N+++     +V + DFG AK         
Sbjct: 113 ERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLG-EDDKVTITDFGLAKQKQPESKLT 171

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           S + +  Y  PE++     Y    D+W+ GC++ ++   +P F   + +    +I++ + 
Sbjct: 172 SVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVY 230

Query: 292 TPTREEI 298
            P  E +
Sbjct: 231 EPLPEGM 237

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 70.4 bits (172), Expect = 1e-13
 Identities = 60/206 (29%), Positives = 104/206 (50%), Gaps = 18/206 (8%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-----LDHPN---VVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ ++M L     L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGESMALNEKQILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L L    +    +   ++             YA +I   L  +
Sbjct: 65  LAYAYET---KDALCLVLTLMNGGDLKFHI---YHMGEAGFEEGRAVFYAAEICCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H+   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++   
Sbjct: 119 HQE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV-KN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLF 274
             YT + D W+ GC++ E++ G+  F
Sbjct: 176 ERYTFSPDWWALGCLLYEMIAGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 70.1 bits (171), Expect = 1e-13
 Identities = 63/206 (30%), Positives = 101/206 (49%), Gaps = 22/206 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           VG G++G V++A+ L TGE  A+K +      D     +E+  ++   H N+V+    F 
Sbjct: 17  VGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAY---FG 73

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
           S   +++L+  + +EY      + + H       + + YV     +  + L+Y+H S G 
Sbjct: 74  SYLSREKLW--ICMEYCGGGSLQDIYHVTGPLSELQIAYV---CRETLQGLAYLH-SKGK 127

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE--- 250
            HRDIK  N+L+  +   VKL DFG +AK+        S+I + Y+ APE+   A E   
Sbjct: 128 MHRDIKGANILLTDNG-DVKLADFGVAAKITATIAKRKSFIGTPYWMAPEV--AAVEKNG 184

Query: 251 -YTTAIDIWSAGCVVAELM-LGKPLF 274
            Y    DIW+ G    EL  L  P+F
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPMF 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 70.6 bits (173), Expect = 1e-13
 Identities = 74/280 (26%), Positives = 124/280 (44%), Gaps = 56/280 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LL--DHPNVVSL 129
           +++G+G+FG V   K   TG+  A+K + + +  K  E    R     L+  D   + +L
Sbjct: 7   KVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F     +DE  L LV++Y       ++   +K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF-----QDENNLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVH 119

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNISYICSRYY 239
           + +G  HRDIKP N+L++ + H ++L DFGS   L+           G P+  YI     
Sbjct: 120 Q-LGYVHRDIKPDNVLLDKNGH-IRLADFGSCLRLLADGTVQSNVAVGTPD--YISPEIL 175

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           +A E   G   Y    D WS G  + E++ G+  F  +S V+   +I+            
Sbjct: 176 QAME--DGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM------------ 221

Query: 300 CMNPNYTE-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
               N+ E F+FP              +  EA DL+ RL+
Sbjct: 222 ----NHKEHFQFPPDVTD---------VSEEAKDLIRRLI 248

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 70.3 bits (172), Expect = 2e-13
 Identities = 67/268 (25%), Positives = 119/268 (44%), Gaps = 70/268 (26%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LL---DHPNVVSL 129
           +++G+G+FG V   +  +TG+  A+K +L+ + +K  +L  ++    +L   D P VVSL
Sbjct: 7   KVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +D  YL L++E++P  + +  ++K+             + Y  +   A+  
Sbjct: 67  YYSF-----QDAQYLYLIMEFLPGGDLMTMLIKY-----DTFSEDVTRFYMAECVLAIEA 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------SAKVLVKGEPNISYIC 235
           +H+ +G  HRDIKP N+L++   H +KL DFG              + L++G+ N + I 
Sbjct: 117 VHK-LGFIHRDIKPDNILIDRGGH-IKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRID 174

Query: 236 SRY------------------------------------YRAPELIFGATEYTTAIDIWS 259
           +R                                     Y APE IF    Y    D WS
Sbjct: 175 NRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE-IFLQQGYGQECDWWS 233

Query: 260 AGCVVAELMLGKPLFPGDSGVDQLVEII 287
            G ++ E ++G P F  ++  +   +II
Sbjct: 234 LGAIMFECLIGWPPFCSENSHETYRKII 261

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 68.9 bits (168), Expect = 3e-13
 Identities = 61/206 (29%), Positives = 103/206 (50%), Gaps = 18/206 (8%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-----RLLDHPN---VVS 128
           R++G+G FG V   +   TG+  A KK L+ KR K R+ + M     R+L+  N   VVS
Sbjct: 6   RVLGKGGFGEVCACQVRATGKMYACKK-LEKKRIKKRKGEAMALNEKRILEKVNSRFVVS 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L + + +   KD L L L +    +    +   +N  N          YA ++   L  +
Sbjct: 65  LAYAYET---KDALCLVLTIMNGGDLKFHI---YNMGNPGFDEQRAIFYAAELCCGLEDL 118

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            R   + +RD+KP+N+L++   H +++ D G A  + +GE     + +  Y APE+I   
Sbjct: 119 QRE-RIVYRDLKPENILLDDRGH-IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVI-NN 175

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLF 274
            +YT + D W  GC++ E++ G+  F
Sbjct: 176 EKYTFSPDWWGLGCLIYEMIQGQSPF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 64/240 (26%), Positives = 112/240 (46%), Gaps = 21/240 (8%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLKHCF 133
           +G G+FG V++A+  ETG  +A  KV+  K  +       E+  +   DHPN+V L   F
Sbjct: 13  LGDGAFGKVYKAQNKETG-VLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +   +     L +++E+        V    +L + +    +++   Q   AL+Y+H +  
Sbjct: 72  YYENN-----LWILIEFCAGGAVDAV--MLELERPLTEPQIRVVCKQTLEALNYLHEN-K 123

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATE-- 250
           + HRD+K  N+L       +KL DFG SAK     +   S+I + Y+ APE++   T   
Sbjct: 124 IIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD 182

Query: 251 --YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WS G  + E+   +P     + +  L++I K    PT  +    +  + +F
Sbjct: 183 RPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS-EPPTLAQPSRWSSEFKDF 241

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 69.2 bits (169), Expect = 7e-13
 Identities = 66/249 (26%), Positives = 118/249 (47%), Gaps = 38/249 (15%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTM---RLLDHPNVVSLKH 131
           ++G+G+FG V +A   +  E  A+K V    +Y      E+Q M   R  D  +   L  
Sbjct: 136 LLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMK 195

Query: 132 C--FFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              +F     +  ++ +V+ +Y P  +  ++KH    + R    ++    +Q   AL Y 
Sbjct: 196 IQRYFQN---ETGHMCIVMPKYGPCLLDWIMKH-GPFSHR----HLAQIIFQTGVALDYF 247

Query: 189 HRSIGVCHRDIKPQNLL-------VNPHTHQ--------VKLCDFGSAKVLVKGEPNISY 233
           H  + + H D+KP+N+L       V+P T++        V++CD G      +     + 
Sbjct: 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGC--CDERHSRTAI 305

Query: 234 ICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           + +R+YR+PE++ G    Y+T  D+WS GC++ EL  GK L+     ++ L  + K LG 
Sbjct: 306 VSTRHYRSPEVVLGLGWMYST--DMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR 363

Query: 293 -PTREEIKC 300
            P+    +C
Sbjct: 364 LPSEWAGRC 372

Length = 467

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 69.8 bits (170), Expect = 8e-13
 Identities = 66/252 (26%), Positives = 114/252 (45%), Gaps = 45/252 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G FG VF  K   T E    K +      +R K++   E+  MR L H N+
Sbjct: 15  YEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNI 74

Query: 127 VSLKHCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           V     F +  ++ +LY+  ++E+     +   + +  K F K+ +   +   +    Q+
Sbjct: 75  VRYIDRFLNKANQ-KLYI--LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR----QL 127

Query: 182 FRALSYIHR------SIGVCHRDIKPQNLLVNPHTHQV----------------KLCDFG 219
             AL+Y H          V HRD+KPQN+ ++     +                K+ DFG
Sbjct: 128 LHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187

Query: 220 SAKVLVKGEPNISYIC--SRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPG 276
            +K +  G  ++++ C  + YY +PEL+   T+ Y    D+W+ GC++ EL  GK  F  
Sbjct: 188 LSKNI--GIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 277 DSGVDQLVEIIK 288
            +   QL+  +K
Sbjct: 246 ANNFSQLISELK 257

Length = 1021

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 67.0 bits (163), Expect = 1e-12
 Identities = 62/210 (29%), Positives = 104/210 (49%), Gaps = 21/210 (10%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHC 132
            +VG G++G V++ + ++TG+  AIK   V +D+  + +    M  +   H N+ +    
Sbjct: 22  EVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGA 81

Query: 133 FFSTT---DKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           F   +     D+L+  LV+E+    +V  +VK  N     +   ++     +I R L+++
Sbjct: 82  FIKKSPPGHDDQLW--LVMEFCGAGSVTDLVK--NTKGNALKEDWIAYICREILRGLAHL 137

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF 246
           H    V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I 
Sbjct: 138 HAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIA 194

Query: 247 ----GATEYTTAIDIWSAGCVVAELMLGKP 272
                   Y    DIWS G    E+  G P
Sbjct: 195 CDENPDATYDYRSDIWSLGITAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 67.0 bits (163), Expect = 2e-12
 Identities = 64/221 (28%), Positives = 109/221 (49%), Gaps = 16/221 (7%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  NV+    C + T
Sbjct: 7   KVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFR--EERNVLVNGDCQWIT 64

Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           T     +DE YL LV++Y       ++   +K   R+P    + Y  ++  A+  IH+  
Sbjct: 65  TLHYAFQDENYLYLVMDYY--VGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH 122

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF---- 246
            V HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 123 YV-HRDIKPDNVLLDMNGH-IRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 66.3 bits (161), Expect = 2e-12
 Identities = 61/209 (29%), Positives = 104/209 (49%), Gaps = 21/209 (10%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 133
           +VG G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 13  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 72

Query: 134 FSTTD---KDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    D+L+  LV+E+    +V  ++K  N     +   ++     +I R LS++H
Sbjct: 73  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLH 128

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 246
           +   V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 129 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 185

Query: 247 ---GATEYTTAIDIWSAGCVVAELMLGKP 272
                  Y    D+WS G    E+  G P
Sbjct: 186 DENPDATYDFKSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 73/276 (26%), Positives = 121/276 (43%), Gaps = 47/276 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNR--ELQTMRLLDHPNVVSLK 130
           ++G+GSFG V  A+   T E  AIK      V+QD   +    E + + L   P  ++  
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQL 66

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++    ++  R    +   YA +I   L ++H 
Sbjct: 67  HSCFQTMDR----LYFVMEYV--NGGDLMYQIQQVG-RFKEPHAVFYAAEIAIGLFFLH- 118

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +  G    ++  +  Y APE+I    
Sbjct: 119 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEII-AYQ 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  ++D W+ G ++ E++ G+  F G+   D+L                          
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDE-DEL-------------------------- 209

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           F  I  H  +  +PK M  EAV +   L+   P  R
Sbjct: 210 FQSIMEH--NVAYPKSMSKEAVAICKGLMTKHPGKR 243

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 66.3 bits (162), Expect = 2e-12
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 30/226 (13%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK + ++   K       E   M  +DHP+VV
Sbjct: 13  KVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVV 72

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     S+       + L+ + +P    +  V  H + +  +    Y+  +  QI + +
Sbjct: 73  RLLGICLSSQ------VQLITQLMPLGCLLDYVRNHKDNIGSQ----YLLNWCVQIAKGM 122

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           SY+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 123 SYLEEK-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLDVDEKEYHAEGGKVPIKWMAL 180

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
           E I     YT   D+WS G  V ELM  G   + G   V+   L+E
Sbjct: 181 ESIL-HRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLE 225

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.8 bits (160), Expect = 3e-12
 Identities = 59/205 (28%), Positives = 96/205 (46%), Gaps = 14/205 (6%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 133
           +G+G++G VF+    + G   A+K +L      + E++        L DHPNVV     +
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVK-ILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMY 84

Query: 134 FSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +    K+   L LVLE     +V  +VK F K  +RM    +    ++    L ++H + 
Sbjct: 85  YKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK 144

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA--- 248
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I      
Sbjct: 145 TI-HRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 249 -TEYTTAIDIWSAGCVVAELMLGKP 272
            + Y    D+WS G    EL  G P
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 65.5 bits (160), Expect = 5e-12
 Identities = 68/252 (26%), Positives = 114/252 (45%), Gaps = 63/252 (25%)

Query: 78  IVGQGSFGVVFQAK-----CLETGETVAIKKVLQDKRYKN-----RELQTMRLL-DHPNV 126
            +G+G+FG V +A+           TVA+K +  D   K+      E++ M+++  H N+
Sbjct: 19  PLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNI 78

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL---------- 176
           ++L       T +  LY+  V+EY     H  ++ F +   R P  Y             
Sbjct: 79  INLLGV---CTQEGPLYV--VVEYAA---HGNLRDFLRAR-RPPGEYASPDDPRPPEETL 129

Query: 177 -------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
                  +AYQ+ R + ++  S    HRD+  +N+LV    H +K+ DFG A+       
Sbjct: 130 TQKDLVSFAYQVARGMEFL-ASKKCIHRDLAARNVLVT-EDHVMKIADFGLAR------- 180

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           +I +I   YYR            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 181 DIHHI--DYYRKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 237

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 238 IP-VEELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 63.9 bits (155), Expect = 2e-11
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 18/200 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V      +
Sbjct: 12  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 72  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 122

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +   + ++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 179

Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 180 SKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 63.5 bits (154), Expect = 2e-11
 Identities = 58/203 (28%), Positives = 95/203 (46%), Gaps = 19/203 (9%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLK 130
           ERI G+GSFG VF+     T + VAIK + L++   +     +E+  +   D P V    
Sbjct: 10  ERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYY 68

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             +   T      L +++EY+       +      ++      +K    +I + L Y+H 
Sbjct: 69  GSYLKGTK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHS 119

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGAT 249
              + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   +
Sbjct: 120 EKKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQS 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKP 272
            Y +  DIWS G    EL  G+P
Sbjct: 177 AYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 63.4 bits (154), Expect = 4e-11
 Identities = 57/226 (25%), Positives = 95/226 (42%), Gaps = 25/226 (11%)

Query: 82  GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE 141
           GS G VF A      + V +K  +  K     E   ++ ++HP+V+ +K    S      
Sbjct: 77  GSEGRVFVATKPGQPDPVVLK--IGQKGTTLIEAMLLQNVNHPSVIRMKDTLVSGA---- 130

Query: 142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP 201
               +    +P     +  +  K ++ +P+    +   QI   L Y+H +  + HRD+K 
Sbjct: 131 ----ITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLH-AQRIIHRDVKT 185

Query: 202 QNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAG 261
           +N+ +N    QV + D G+A+  V     +    +    APE +    +Y +  DIWSAG
Sbjct: 186 ENIFIN-DVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPE-VLARDKYNSKADIWSAG 243

Query: 262 CVVAELMLGKP--LF---------PGDSGVDQLVEIIKVLGTPTRE 296
            V+ E ML  P  +F            S    L++II  L     E
Sbjct: 244 IVLFE-MLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE 288

Length = 357

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 62.6 bits (152), Expect = 4e-11
 Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 43/243 (17%)

Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 10  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             K      T+     + L++E++P     E + R     N L Q++       YA QI 
Sbjct: 70  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKIN-LKQQLK------YAVQIC 119

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----- 237
           + + Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   E +  Y   +     
Sbjct: 120 KGMDYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAI---ETDKEYYTVKDDLDS 174

Query: 238 --YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
             ++ APE +  +  Y  A D+WS G  + EL     L   DS    +   +K++G PT 
Sbjct: 175 PVFWYAPECLIQSKFY-IASDVWSFGVTLYEL-----LTYCDSESSPMTLFLKMIG-PTH 227

Query: 296 EEI 298
            ++
Sbjct: 228 GQM 230

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 63.1 bits (153), Expect = 5e-11
 Identities = 61/240 (25%), Positives = 108/240 (45%), Gaps = 52/240 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   +   +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKM 66

Query: 133 FFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           F+S  DK  LYL  ++E++P  + +  ++K  + L++     Y+     +   A+  IH+
Sbjct: 67  FYSFQDKRNLYL--IMEFLPGGDMMTLLMKK-DTLSEEATQFYIA----ETVLAIDAIHQ 119

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFG------------------------------- 219
            +G  HRDIKP NLL++   H VKL DFG                               
Sbjct: 120 -LGFIHRDIKPDNLLLDAKGH-VKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN 177

Query: 220 ---SAKVLVKGEPNISY--ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
               A+   K    ++Y  + +  Y APE +F  T Y    D WS G ++ E+++G P F
Sbjct: 178 SKRKAETWKKNRRQLAYSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 64.1 bits (156), Expect = 5e-11
 Identities = 66/251 (26%), Positives = 101/251 (40%), Gaps = 61/251 (24%)

Query: 94  ETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 145
            TG  VAIK +  D         R++ RE      L HPN+V+L      + +     L 
Sbjct: 1   MTGHEVAIKLLRTDAPEEEHQRARFR-RETALCARLYHPNIVAL----LDSGEAPPGLLF 55

Query: 146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
            V EYVP  T+  V+     L         +L   Q+  AL+  H   G+ HRD+KPQN+
Sbjct: 56  AVFEYVPGRTLREVLAADGALP---AGETGRLML-QVLDALACAHNQ-GIVHRDLKPQNI 110

Query: 205 LVN-----PHTHQVKLCDFG------------SAKVLVKGEPNISYICSRYYRAPELIFG 247
           +V+     PH    K+ DFG             A +    E     + +  Y APE + G
Sbjct: 111 MVSQTGVRPHA---KVLDFGIGTLLPGVRDADVATLTRTTE----VLGTPTYCAPEQLRG 163

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
               T   D+++ G +  E + G+ +  G S    + EI+           + ++P   +
Sbjct: 164 EPV-TPNSDLYAWGLIFLECLTGQRVVQGAS----VAEILY----------QQLSPV--D 206

Query: 308 FKFPQ-IKAHP 317
              P  I  HP
Sbjct: 207 VSLPPWIAGHP 217

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 62.3 bits (151), Expect = 6e-11
 Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 14/205 (6%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKHCF 133
           +G+G++G V++    + G   A+K +L      + E++        L +HPNVV     F
Sbjct: 30  IGKGTYGKVYKVTNKKDGSLAAVK-ILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMF 88

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +         L LVLE     +V  +VK      QR+    +    Y     L ++H + 
Sbjct: 89  YKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN- 147

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            + HRD+K  N+L+      VKL DFG SA++        + + + ++ APE+I    +Y
Sbjct: 148 RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 252 TTA----IDIWSAGCVVAELMLGKP 272
             +     D+WS G    EL  G P
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 72/219 (32%), Positives = 107/219 (48%), Gaps = 25/219 (11%)

Query: 73  YMAERIVGQGSFGVVFQA-KCLETGETVAIKKV-LQDKR---YKNRELQTMRLLDHPNVV 127
           Y+   +VG+      F A +  +  E V  K V L D+R   Y   EL  +   DH  +V
Sbjct: 69  YVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIV 128

Query: 128 SLKHCF-FSTTDKDELYLNLVLEY-VPETVHRVVKHFNKLNQRMPM--IYVKLYAYQIFR 183
             KH   F + DK    L L++EY     +++ +K   +L + +P     V L  YQI  
Sbjct: 129 --KHFDDFKSDDK----LLLIMEYGSGGDLNKQIKQ--RLKEHLPFQEYEVGLLFYQIVL 180

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYR 240
           AL  +H S  + HRD+K  N+ + P T  +KL DFG +K     V  +   S+  + YY 
Sbjct: 181 ALDEVH-SRKMMHRDLKSANIFLMP-TGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYL 238

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDS 278
           APEL +    Y+   D+WS G ++ EL+ L +P F G S
Sbjct: 239 APEL-WERKRYSKKADMWSLGVILYELLTLHRP-FKGPS 275

Length = 478

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.8 bits (151), Expect = 6e-11
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 63/260 (24%)

Query: 101 IKKVLQDKRYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----- 152
           ++K+++ K +   E    Q M+  D+PN + L +    TT K  +   L+++Y+      
Sbjct: 45  VQKIIKAKNFNAIEPMVHQLMK--DNPNFIKLYYSV--TTLKGHV---LIMDYIKDGDLF 97

Query: 153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ 212
           + + +          ++    VK    Q+  AL+ +H    + H DIK +N+L +    +
Sbjct: 98  DLLKK--------EGKLSEAEVKKIIRQLVEALNDLH-KHNIIHNDIKLENVLYDRAKDR 148

Query: 213 VKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           + LCD+G  K  + G P      S Y     Y +PE I G   Y  + D W+ G +  EL
Sbjct: 149 IYLCDYGLCK--IIGTP------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL 199

Query: 268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP 327
           + GK   P     D   E +         +++ +     + K P          F K + 
Sbjct: 200 LTGK--HPFKEDED---EEL---------DLESLLKRQ-QKKLP----------FIKNVS 234

Query: 328 PEAVDLVSRLLQYSPNLRCT 347
             A D V  +L+Y+ N R T
Sbjct: 235 KNANDFVQSMLKYNINYRLT 254

Length = 267

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 62.4 bits (151), Expect = 6e-11
 Identities = 59/224 (26%), Positives = 111/224 (49%), Gaps = 22/224 (9%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-----LLDHPN--VVSL 129
           +++G+G+FG V   K     +  A+K + + +  K  E    R     L++  N  + +L
Sbjct: 7   KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            + F    D++ LYL  V++Y       ++   +K   R+P    + Y  ++  A+  +H
Sbjct: 67  HYAF---QDENNLYL--VMDYY--VGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVH 119

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELIF- 246
           + +   HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++  
Sbjct: 120 Q-LHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQA 177

Query: 247 ---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
              G  +Y    D WS G  + E++ G+  F  +S V+   +I+
Sbjct: 178 MEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 221

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 62.3 bits (151), Expect = 1e-10
 Identities = 65/227 (28%), Positives = 101/227 (44%), Gaps = 39/227 (17%)

Query: 88  FQAKCLE--TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN 145
           F   C++  T E V IK     +     E   +R ++HP+++ LK  F  T +K   +  
Sbjct: 107 FAFACIDNKTCEHVVIKA--GQRGGTATEAHILRAINHPSIIQLKGTF--TYNK---FTC 159

Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           L+L      ++  +       + + +  +      + RA+ Y+H +  + HRDIK +N+ 
Sbjct: 160 LILPRYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIF 214

Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY--------RAPELIFGATEYTTAIDI 257
           +N H   V L DFG+A   V    N      +YY         APEL+     Y  A+DI
Sbjct: 215 IN-HPGDVCLGDFGAACFPVDINAN------KYYGWAGTIATNAPELL-ARDPYGPAVDI 266

Query: 258 WSAGCVVAELMLGK-PLFPGDSGVD-------QLVEIIKVLGTPTRE 296
           WSAG V+ E+      LF  D G+D       Q+  II+  GT   E
Sbjct: 267 WSAGIVLFEMATCHDSLFEKD-GLDGDCDSDRQIKLIIRRSGTHPNE 312

Length = 391

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 49/164 (29%), Positives = 85/164 (51%), Gaps = 19/164 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKN--RELQTMR----LLDHPNVVSLKH 131
           + +G+FG V+  +     +  A+K V + D   KN   ++Q  R    L   P +V L  
Sbjct: 12  ISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHL-- 69

Query: 132 CFFSTTDKDELYLNLVLEY-VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            ++S    + +YL  V+EY +   V  ++  +   ++ M + Y+     ++  AL Y+HR
Sbjct: 70  -YYSLQSANNVYL--VMEYLIGGDVKSLLHIYGYFDEEMAVKYIS----EVALALDYLHR 122

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             G+ HRD+KP N+L++   H +KL DFG +KV +  E N+  I
Sbjct: 123 H-GIIHRDLKPDNMLISNEGH-IKLTDFGLSKVTLNRELNMMDI 164

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 62.0 bits (150), Expect = 1e-10
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 50/239 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   +  +TG   A+K + +    +  ++  +R    +L   + + +   
Sbjct: 7   KVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKM 66

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F+S  DK  LYL  ++E++P   +  ++   + L +     Y+     +   A+  IH+ 
Sbjct: 67  FYSFQDKLNLYL--IMEFLPGGDMMTLLMKKDTLTEEETQFYIA----ETVLAIDSIHQ- 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------------PN--------- 230
           +G  HRDIKP NLL++   H VKL DFG    L K              P+         
Sbjct: 120 LGFIHRDIKPDNLLLDSKGH-VKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNS 178

Query: 231 ---------------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
                           S + +  Y APE +F  T Y    D WS G ++ E+++G P F
Sbjct: 179 KRKAETWKRNRRQLAFSTVGTPDYIAPE-VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 60.5 bits (147), Expect = 2e-10
 Identities = 62/249 (24%), Positives = 99/249 (39%), Gaps = 80/249 (32%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIK--------KVLQDKRYKNR 113
           P   + ++ E  +G+G+FG V++ +        +  +VAIK        KV Q+ R   +
Sbjct: 3   PLSAVRFLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFR---Q 57

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMP-- 170
           E + M  L HPN+V    C      K++    L  EY+    +H        L +  P  
Sbjct: 58  EAELMSDLQHPNIV----CLLGVCTKEQPTCML-FEYLAHGDLHEF------LVRNSPHS 106

Query: 171 -------------------MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH 211
                               +++   A QI   + Y+  S    HRD+  +N LV     
Sbjct: 107 DVGAESGDETVKSSLDCSDFLHI---AIQIAAGMEYL-SSHHFVHRDLAARNCLVGEG-L 161

Query: 212 QVKLCDFGSAKVLVKGEPNISYICSRYYR------------APELI-FGATEYTTAIDIW 258
            VK+ DFG ++ +   +         YYR             PE I +G  ++TT  DIW
Sbjct: 162 TVKISDFGLSRDIYSAD---------YYRVQSKSLLPVRWMPPEAILYG--KFTTESDIW 210

Query: 259 SAGCVVAEL 267
           S G V+ E+
Sbjct: 211 SFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 61.1 bits (148), Expect = 3e-10
 Identities = 38/97 (39%), Positives = 53/97 (54%), Gaps = 16/97 (16%)

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A Q+  A+ YIH   G+ HRDIK +N+LVN     + L DFG+A    +G    S+    
Sbjct: 266 ARQLLSAIDYIHGE-GIIHRDIKTENVLVNG-PEDICLGDFGAA-CFARG----SWSTPF 318

Query: 238 YY--------RAPELIFGATEYTTAIDIWSAGCVVAE 266
           +Y         APE++ G   YT ++DIWSAG V+ E
Sbjct: 319 HYGIAGTVDTNAPEVLAG-DPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 60.4 bits (147), Expect = 3e-10
 Identities = 49/209 (23%), Positives = 80/209 (38%), Gaps = 45/209 (21%)

Query: 85  GVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHCFFSTTD 138
            +V  AK   T   VA+KK+  D   K        E+ T R L HPN++     F     
Sbjct: 14  MIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSF---IV 70

Query: 139 KDELYL-----------NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             ELY+           +L+  + PE               +P + +      +  AL Y
Sbjct: 71  DSELYVVSPLMAYGSCEDLLKTHFPEG--------------LPELAIAFILKDVLNALDY 116

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--------EPNISYICSRYY 239
           IH S G  HR +K  ++L++     V L     +  ++K         +   S + +  +
Sbjct: 117 IH-SKGFIHRSVKASHILLSGDGK-VVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPW 174

Query: 240 RAPELIFGATE-YTTAIDIWSAGCVVAEL 267
            +PE++    + Y    DI+S G    EL
Sbjct: 175 LSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 59.3 bits (144), Expect = 4e-10
 Identities = 55/225 (24%), Positives = 105/225 (46%), Gaps = 36/225 (16%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDH 123
           P++++    ER +G G FG V+      T + VA+K +           +E Q M+ L H
Sbjct: 4   PRESLKL--ERKLGAGQFGEVWMGTWNGTTK-VAVKTLKPGTMSPEAFLQEAQIMKKLRH 60

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYA 178
             +V L   +   ++++ +Y+  V EY+      + +        +L Q + M      A
Sbjct: 61  DKLVQL---YAVCSEEEPIYI--VTEYMSKGSLLDFLKSGEGKKLRLPQLVDM------A 109

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICS 236
            QI   ++Y+       HRD+  +N+LV  +    K+ DFG A+++   E +   +   +
Sbjct: 110 AQIAEGMAYLESR-NYIHRDLAARNILVGEN-LVCKIADFGLARLI---EDDEYTAREGA 164

Query: 237 RY---YRAPELI-FGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           ++   + APE   +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 165 KFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 59.7 bits (144), Expect = 4e-10
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYK----NRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG V++     T E VAIK + L++   +     +E+  +   D P +      +
Sbjct: 12  IGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSY 71

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L +     Y+     +I + L Y+H    
Sbjct: 72  LKGTK-----LWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSERK 122

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 123 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 179

Query: 253 TAIDIWSAGCVVAELMLGKP 272
              DIWS G    EL  G+P
Sbjct: 180 FKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 60.0 bits (145), Expect = 4e-10
 Identities = 47/169 (27%), Positives = 80/169 (47%), Gaps = 17/169 (10%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 179 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGSA 236

Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YTT  D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 237 RLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQINEEFCQ 288

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             ++  +   P     +  +I    W    PK  P     V+++  LLQ
Sbjct: 289 RLKDGTRMRAPENATPEIYRIMLACWQGD-PKERPTFSALVEILGDLLQ 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 60.2 bits (146), Expect = 4e-10
 Identities = 77/339 (22%), Positives = 118/339 (34%), Gaps = 117/339 (34%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           + +G G+FG V   + ++T    A+K  L+      R        E   +   D+  VV 
Sbjct: 7   KTIGIGAFGEVCLVRKVDTNALYAMKT-LRKADVLMRNQAAHVKAERDILAEADNEWVVK 65

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRAL 185
           L   ++S  DKD LY   V++Y+P            L  R+        + Y  ++  A+
Sbjct: 66  L---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRLGIFEEDLARFYIAELTCAI 114

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPH----------------THQVKL-------------- 215
             +H+ +G  HRDIKP N+L++                  TH  K               
Sbjct: 115 ESVHK-MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173

Query: 216 ---------CDFGSAKVLVK------------GEPNISYICSRYYRAPELIFGATEYTTA 254
                    C     +   K            G PN        Y APE++   T YT  
Sbjct: 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPN--------YIAPEVLL-RTGYTQL 224

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            D WS G ++ E+++G+P F  D              TP   ++K +N   T     Q K
Sbjct: 225 CDWWSVGVILYEMLVGQPPFLAD--------------TPAETQLKVINWETTLHIPSQAK 270

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI 353
                      +  EA DL+ RL        C     R+
Sbjct: 271 -----------LSREASDLILRL--------CCGAEDRL 290

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 58.7 bits (142), Expect = 7e-10
 Identities = 58/206 (28%), Positives = 100/206 (48%), Gaps = 19/206 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE-----LQTMRLLDHPN---VVSLK 130
           +G+G FG V   +   TG+  A KK L  KR K R+     +   R+L   +   +VSL 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKK-LNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLA 59

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRV-VKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + F + TD     L LV+  +     R  + + ++ N   P      Y  QI   L ++H
Sbjct: 60  YAFQTKTD-----LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLH 114

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGA 248
           +   + +RD+KP+N+L++   + V++ D G A  L  G+     Y  +  + APEL+ G 
Sbjct: 115 QR-RIIYRDLKPENVLLDNDGN-VRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQG- 171

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLF 274
            EY  ++D ++ G  + E++  +  F
Sbjct: 172 EEYDFSVDYFALGVTLYEMIAARGPF 197

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 58.5 bits (142), Expect = 8e-10
 Identities = 53/210 (25%), Positives = 89/210 (42%), Gaps = 40/210 (19%)

Query: 79  VGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 130
           +G GSFGVV + +   +G     VA+K +  DK         +E   M  LDH N++ L 
Sbjct: 3   LGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLY 62

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
               +        L +V E  P     + + +             +  +  YA QI   +
Sbjct: 63  GVVLTHP------LMMVTELAPLGSLLDRLRKDALGH------FLISTLCDYAVQIANGM 110

Query: 186 SYIH--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+   R I   HRD+  +N+L+     +VK+ DFG  + L + E +  Y+   + +   
Sbjct: 111 RYLESKRFI---HRDLAARNILL-ASDDKVKIGDFGLMRALPQNEDH--YVMEEHLKVPF 164

Query: 241 ---APELIFGATEYTTAIDIWSAGCVVAEL 267
              APE +   T ++ A D+W  G  + E+
Sbjct: 165 AWCAPESLRTRT-FSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 59.5 bits (144), Expect = 1e-09
 Identities = 62/219 (28%), Positives = 102/219 (46%), Gaps = 16/219 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   R++G G+ G V  AK +  GE  A+K V        DK     E+  +   D  ++
Sbjct: 34  YWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI 93

Query: 127 VSLKHCFFSTTDKDE---LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           V     F     ++    L + LVL+Y     + + +K   K N+        L   Q+ 
Sbjct: 94  VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVL 153

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            A+ ++H S  + HRDIK  N+L+  +   VKL DFG +K+    V  +   ++  + YY
Sbjct: 154 LAVHHVH-SKHMIHRDIKSANILLCSNG-LVKLGDFGFSKMYAATVSDDVGRTFCGTPYY 211

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            APE I+    Y+   D++S G ++ EL+  K  F G++
Sbjct: 212 VAPE-IWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249

Length = 496

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 58.6 bits (142), Expect = 1e-09
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 44/217 (20%)

Query: 78  IVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
            +G+G FG VF AK      E GET+ + K LQ  + +N      REL   R L H NVV
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVV 71

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYA--YQI 181
            L        + +  Y  ++LEY      +   R  K  ++  +  P+   +  A   QI
Sbjct: 72  RL---LGLCREAEPHY--MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQI 126

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 240
              + ++  +  V HRD+  +N LV+    +VK+    S   L K   N     S YY+ 
Sbjct: 127 ALGMDHLSNARFV-HRDLAARNCLVSS-QREVKV----SLLSLSKDVYN-----SEYYKL 175

Query: 241 ----------APELIFGATEYTTAIDIWSAGCVVAEL 267
                     APE +    +++T  D+WS G ++ E+
Sbjct: 176 RNALIPLRWLAPEAVQ-EDDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 49/171 (28%), Positives = 83/171 (48%), Gaps = 17/171 (9%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 184 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKDPDYVRKGDA 241

Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 242 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 293

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQYS 341
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ +
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQAN 343

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 57.6 bits (139), Expect = 2e-09
 Identities = 54/180 (30%), Positives = 87/180 (48%), Gaps = 16/180 (8%)

Query: 95  TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET 154
           T +T  +K + +   Y +RE  T+     PN+V L     S   +D ++L  VL++    
Sbjct: 17  TQQTFILKGLRKSSEY-SRERLTIIPHCVPNMVCLHKYIVS---EDSVFL--VLQHAEGG 70

Query: 155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK 214
             ++  H +K    +P   VK +A ++  AL  +HR   VC RD+ P N+L++   H ++
Sbjct: 71  --KLWSHISKF-LNIPEECVKRWAAEMVVALDALHREGIVC-RDLNPNNILLDDRGH-IQ 125

Query: 215 LCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL 273
           L  F       + E +         Y APE + G +E T A D WS G ++ EL+ GK L
Sbjct: 126 LTYFSR---WSEVEDSCDGEAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 57.1 bits (138), Expect = 3e-09
 Identities = 63/237 (26%), Positives = 94/237 (39%), Gaps = 50/237 (21%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 116
           P+  I Y   R +GQG+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 3   PRNNIEY--VRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 60

Query: 117 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNK 164
            M   DHPN+V L          C    + +  D +E   +          H        
Sbjct: 61  LMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKC 120

Query: 165 LNQRMPMIYVKLY--AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 222
               +P+   +    A Q+   ++Y+     V HRD+  +N LV  +   VK+ DFG ++
Sbjct: 121 GLNPLPLSCTEQLCIAKQVAAGMAYLSERKFV-HRDLATRNCLVGENM-VVKIADFGLSR 178

Query: 223 VLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
                  NI    + YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 179 -------NI--YSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 57/226 (25%), Positives = 104/226 (46%), Gaps = 36/226 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           R +G G FG V++   L    T VA+K +            E Q M+ L HP ++ L   
Sbjct: 12  RKLGAGQFGEVWEG--LWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQL--- 66

Query: 133 FFSTTDKDELYL-------NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +   T ++ +Y+         +LEY+     R +    KL Q + M      A Q+   +
Sbjct: 67  YAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRAL----KLPQLIDM------AAQVASGM 116

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+  +    HRD+  +N+LV  + +  K+ DFG A+V+ +     +   +++   + AP
Sbjct: 117 AYL-EAQNYIHRDLAARNVLVGEN-NICKVADFGLARVIKEDIYE-AREGAKFPIKWTAP 173

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG--VDQLVE 285
           E       ++   D+WS G ++ E++  G+  +PG +   V Q V+
Sbjct: 174 EAAL-YNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVD 218

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 57.0 bits (137), Expect = 4e-09
 Identities = 58/215 (26%), Positives = 100/215 (46%), Gaps = 35/215 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 13  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 72

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            L     S T      + LV + +P     + VH   +H + +  ++ +     +  QI 
Sbjct: 73  RLLGVCLSPT------IQLVTQLMPHGCLLDYVH---EHKDNIGSQLLLN----WCVQIA 119

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---Y 239
           + + Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    +
Sbjct: 120 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 177

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML--GKP 272
            A E I    ++T   D+WS G  + ELM   GKP
Sbjct: 178 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 211

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 4e-09
 Identities = 57/214 (26%), Positives = 94/214 (43%), Gaps = 30/214 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKK-----VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
             +G+G+FG V++   L+    VA+K          KR   +E + ++  DHPN+V L  
Sbjct: 1   EKIGKGNFGDVYKGV-LKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKL-- 57

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
                  K  +Y  +V+E VP     ++    K   R+ +  +   +      + Y+  S
Sbjct: 58  -IGVCVQKQPIY--IVMELVPGG--SLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ES 111

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-------APE- 243
               HRD+  +N LV    + +K+ DFG    + + E    Y  S   +       APE 
Sbjct: 112 KNCIHRDLAARNCLVG-ENNVLKISDFG----MSREEEGGIYTVSDGLKQIPIKWTAPEA 166

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           L +G   YT+  D+WS G ++ E   LG   +PG
Sbjct: 167 LNYG--RYTSESDVWSYGILLWETFSLGDTPYPG 198

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 56.5 bits (136), Expect = 5e-09
 Identities = 62/210 (29%), Positives = 95/210 (45%), Gaps = 35/210 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYK-NREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK++ +    K N+E+      M  +D+P+V 
Sbjct: 13  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 72

Query: 128 SLKH-CFFSTTDKDELYLNL-----VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            L   C  ST    +L   L     +L+YV E    +              Y+  +  QI
Sbjct: 73  RLLGICLTSTV---QLITQLMPFGCLLDYVREHKDNIGSQ-----------YLLNWCVQI 118

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 238
            + ++Y+     V HRD+  +N+LV    H VK+ DFG AK+L   E        +    
Sbjct: 119 AKGMNYLEERRLV-HRDLAARNVLVKTPQH-VKITDFGLAKLLGADEKEYHAEGGKVPIK 176

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           + A E I     YT   D+WS G  V ELM
Sbjct: 177 WMALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 56.3 bits (136), Expect = 6e-09
 Identities = 57/220 (25%), Positives = 101/220 (45%), Gaps = 34/220 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLL-DHPN 125
           + +G G+FG V +A      ++     VA+K +        R     EL+ M  L +H N
Sbjct: 41  KTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHEN 100

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           +V+L     + T    + +  + EY     +   + R  + F  L   +       ++YQ
Sbjct: 101 IVNL---LGACTIGGPILV--ITEYCCYGDLLNFLRRKRESFLTLEDLLS------FSYQ 149

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-- 238
           + + ++++  S    HRD+  +N+L+  H   VK+CDFG A+ ++     +    +R   
Sbjct: 150 VAKGMAFL-ASKNCIHRDLAARNVLLT-HGKIVKICDFGLARDIMNDSNYVVKGNARLPV 207

Query: 239 -YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 208 KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPG 246

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 55.7 bits (134), Expect = 7e-09
 Identities = 57/206 (27%), Positives = 98/206 (47%), Gaps = 24/206 (11%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     +K+ ++   E   M   DHPN++
Sbjct: 9   EKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  +   +V EY+      +     K + +  +I +      I   + Y
Sbjct: 69  HLEGVV--TKSKPVM---IVTEYMENG--SLDAFLRKHDGQFTVIQLVGMLRGIASGMKY 121

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 122 L-SDMGYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 179 EAI-AYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 55.6 bits (134), Expect = 7e-09
 Identities = 55/211 (26%), Positives = 103/211 (48%), Gaps = 29/211 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL------ 129
           +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F+  T+    Y NL L+Y+ E         N+  Q +  + +   A QI  A+ Y+ 
Sbjct: 74  EPPFYIITEF-MTYGNL-LDYLREC--------NR--QEVNAVVLLYMATQISSAMEYLE 121

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 246
           +     HRD+  +N LV  + H VK+ DFG ++ L+ G+   ++  +++   + APE + 
Sbjct: 122 KK-NFIHRDLAARNCLVGEN-HLVKVADFGLSR-LMTGDTYTAHAGAKFPIKWTAPESL- 177

Query: 247 GATEYTTAIDIWSAGCVVAEL-MLGKPLFPG 276
              +++   D+W+ G ++ E+   G   +PG
Sbjct: 178 AYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 55.3 bits (133), Expect = 9e-09
 Identities = 61/288 (21%), Positives = 123/288 (42%), Gaps = 48/288 (16%)

Query: 73  YMAERIVGQGSFGVVF--QAKCLETGETVAIKKVL-------QDKRYKNRELQTMRLLDH 123
           Y+ ++ +G+GSFG V+  + K     E + + K +        +    N+E Q +  LDH
Sbjct: 2   YILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDH 61

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           P +V   H  F   D       ++ EY     +   ++      + +    V  +  Q+ 
Sbjct: 62  PAIVKF-HASFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLL 116

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 241
             + Y+H+   + HRD+K +N+ +    + +K+ DFG +++L+   +   ++  + YY +
Sbjct: 117 LGVHYMHQR-RILHRDLKAKNIFLK--NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMS 173

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y +  DIWS GC++ E+      F    G + L  +++++  PT       
Sbjct: 174 PEAL-KHQGYDSKSDIWSLGCILYEMCCLAHAF---EGQNFLSVVLRIVEGPT------- 222

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                    P +         P+    +   ++  +L   P+LR +A 
Sbjct: 223 ---------PSL---------PETYSRQLNSIMQSMLNKDPSLRPSAA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.2 bits (133), Expect = 1e-08
 Identities = 61/229 (26%), Positives = 107/229 (46%), Gaps = 32/229 (13%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVV 127
           +++M E  +G G FGVV   K       VAIK + +    +     E + M  L HP +V
Sbjct: 6   LTFMKE--LGSGQFGVVHLGK-WRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLV 62

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L   +   T +  LY+  V E++     ++ + +   KL++ M +   +     +   +
Sbjct: 63  QL---YGVCTQQKPLYI--VTEFMENGCLLNYLRQRQGKLSKDMLLSMCQ----DVCEGM 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YY 239
            Y+ R+    HRD+  +N LV+  T  VK+ DFG  + ++  E    Y  S        +
Sbjct: 114 EYLERN-SFIHRDLAARNCLVS-STGVVKVSDFGMTRYVLDDE----YTSSSGAKFPVKW 167

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
             PE +F  ++Y++  D+WS G ++ E+   GK  F   S   ++VE+I
Sbjct: 168 SPPE-VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY-EVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 52/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 128
           +++G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 13  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVC 72

Query: 129 --LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
             L  C  ST       + LV + +P     ++ +  +   R+    +  +  QI + +S
Sbjct: 73  RLLGICLTST-------VQLVTQLMPYGC--LLDYVRENKDRIGSQDLLNWCVQIAKGMS 123

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 124 YL-EEVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 181

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            I     +T   D+WS G  V ELM
Sbjct: 182 SIL-HRRFTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 54.1 bits (130), Expect = 3e-08
 Identities = 51/172 (29%), Positives = 82/172 (47%), Gaps = 23/172 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   +  Y+  
Sbjct: 178 YSFQVARGMEFL-ASRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYK---DPDYVRK 232

Query: 237 RYYR------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
              R      APE IF    YTT  D+WS G ++ E+  LG   +PG       V+I + 
Sbjct: 233 GDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPG-------VQIDEE 284

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
                +E  +   P Y   +   I    WH   P+  P   E V+++  LLQ
Sbjct: 285 FCRRLKEGTRMRAPEYATPEIYSIMLDCWHN-NPEDRPTFSELVEILGDLLQ 335

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 53.6 bits (129), Expect = 4e-08
 Identities = 71/282 (25%), Positives = 125/282 (44%), Gaps = 43/282 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTMRLLDHPNVVS 128
           R++G+G FG V+    +++       A+K +     L++     +E   M+   HPNV+S
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLS 60

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALSY 187
           L          +   L +VL Y+    H  +++F +     P +   + +  Q+ + + Y
Sbjct: 61  LLGICL---PSEGSPL-VVLPYM---KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY 113

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL--I 245
           +     V HRD+  +N +++  +  VK+ DFG A+ +   E    Y     +   +L   
Sbjct: 114 LASKKFV-HRDLAARNCMLD-ESFTVKVADFGLARDIYDKE----YYSVHNHTGAKLPVK 167

Query: 246 FGATE------YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + A E      +TT  D+WS G ++ ELM  G P +P     D  V +++  G    +  
Sbjct: 168 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQ--GRRLLQPE 225

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQ 339
            C +P Y      ++    WH   PK  M P   +LVSR+ Q
Sbjct: 226 YCPDPLY------EVMLSCWH---PKPEMRPTFSELVSRIEQ 258

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 59/244 (24%), Positives = 105/244 (43%), Gaps = 58/244 (23%)

Query: 77  RIVGQGSFGVVFQAKCLE-----TGET-VAIKK-----VLQDKRYKNRELQTMRLLDHPN 125
             +G G+FG V++    +     +G   VA+K        Q+K+   +E   M   +HPN
Sbjct: 1   NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPN 60

Query: 126 VVS-LKHCFFSTTDKDELYLNLVLEYVP--ETVH-----RVVKHFNKLNQRMPMIYVKLY 177
           +V  L  C       +  Y+  ++E +   + +      RV +    L     ++ + L 
Sbjct: 61  IVKLLGVCL----LNEPQYI--IMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICL- 113

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISY 233
              + +   Y+ +   + HRD+  +N LV+   +     VK+ DFG A+ + K       
Sbjct: 114 --DVAKGCVYLEQMHFI-HRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYK------- 163

Query: 234 ICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG 279
             S YYR            APE L+ G   +TT  D+WS G ++ E++ LG+  +P  + 
Sbjct: 164 --SDYYRKEGEGLLPVRWMAPESLLDGK--FTTQSDVWSFGVLMWEILTLGQQPYPALNN 219

Query: 280 VDQL 283
            + L
Sbjct: 220 QEVL 223

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 53.2 bits (128), Expect = 5e-08
 Identities = 58/238 (24%), Positives = 92/238 (38%), Gaps = 60/238 (25%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC--LETGET---VAIKKVLQD------KRYKNREL 115
            + TI     R +G+G+FG VF  +C  LE       VA+ K L++      ++   RE 
Sbjct: 3   QRDTIVLK--RELGEGAFGKVFLGECYHLEPENDKELVAV-KTLKETASNDARKDFEREA 59

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMP 170
           + +    H N+V         T+ D     +V EY+      + +         L     
Sbjct: 60  ELLTNFQHENIVKFYGV---CTEGDPPI--MVFEYMEHGDLNKFLRSHGPDAAFLKSPDS 114

Query: 171 ---------MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA 221
                    ++ +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG +
Sbjct: 115 PMGELTLSQLLQI---AVQIASGMVYL-ASQHFVHRDLATRNCLVG-YDLVVKIGDFGMS 169

Query: 222 KVLVKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL 267
           + +        Y    YYR             PE I     +TT  D+WS G V+ E+
Sbjct: 170 RDV--------YTTD-YYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 53.1 bits (128), Expect = 5e-08
 Identities = 71/305 (23%), Positives = 117/305 (38%), Gaps = 81/305 (26%)

Query: 76  ERIVGQGSFGVVFQ--AKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPN 125
            R +GQGSFG+V++  AK +  GE    VAIK V ++   + R     E   M+  +  +
Sbjct: 11  IRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH 70

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-------NKLNQRMP-------- 170
           VV L              L +V    P  V   V          + L  R P        
Sbjct: 71  VVRL--------------LGVVSTGQPTLV---VMELMAKGDLKSYLRSRRPEAENNPGL 113

Query: 171 ----MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 226
               +      A +I   ++Y+  +    HRD+  +N +V      VK+ DFG  +    
Sbjct: 114 GPPTLQKFIQMAAEIADGMAYLA-AKKFVHRDLAARNCMVA-EDLTVKIGDFGMTR---- 167

Query: 227 GEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPL 273
              +I    + YYR            APE +     +TT  D+WS G V+ E+  L +  
Sbjct: 168 ---DIYE--TDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQP 221

Query: 274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDL 333
           + G S  +++++ +   G     E  C +      +        W   +  +M P  +++
Sbjct: 222 YQGLSN-EEVLKFVIDGGHLDLPE-NCPDKLLELMR------MCWQ--YNPKMRPTFLEI 271

Query: 334 VSRLL 338
           VS L 
Sbjct: 272 VSSLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 53.3 bits (128), Expect = 7e-08
 Identities = 57/240 (23%), Positives = 103/240 (42%), Gaps = 36/240 (15%)

Query: 82  GSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           GS G VF   C + G+      I K +   +   RE+  ++ + H  +++L H +     
Sbjct: 103 GSEGEVFV--CTKHGDEQRKKVIVKAVTGGKTPGREIDILKTISHRAIINLIHAY----- 155

Query: 139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD 198
               + + V   +P+    +  + ++    +P+        ++  AL+Y+H   G+ HRD
Sbjct: 156 ---RWKSTVCMVMPKYKCDLFTYVDRSGP-LPLEQAITIQRRLLEALAYLHGR-GIIHRD 210

Query: 199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPELIFGATEYTT 253
           +K +N+ ++   + V L DFG+A  L       +  C  +       +PEL+     Y  
Sbjct: 211 VKTENIFLDEPENAV-LGDFGAACKL--DAHPDTPQCYGWSGTLETNSPELL-ALDPYCA 266

Query: 254 AIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
             DIWSAG V+ E+ +    LF            +K   +  R  I+CM  +    +FPQ
Sbjct: 267 KTDIWSAGLVLFEMSVKNVTLFGKQ---------VKSSSSQLRSIIRCMQVH--PLEFPQ 315

Length = 392

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 52.7 bits (126), Expect = 1e-07
 Identities = 47/153 (30%), Positives = 76/153 (49%), Gaps = 23/153 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNR------ELQTMRLLDHPNVVSL 129
           + +G G+FG V  A+ ++T    A+K + + D   +N+      E   +   D+  VV L
Sbjct: 7   KTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM---PMIYVKLYAYQIFRALS 186
              ++S  DKD LY   V++Y+P            L  RM   P    + Y  ++  A+ 
Sbjct: 67  ---YYSFQDKDNLYF--VMDYIPG------GDMMSLLIRMGIFPEDLARFYIAELTCAVE 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
            +H+ +G  HRDIKP N+L++   H +KL DFG
Sbjct: 116 SVHK-MGFIHRDIKPDNILIDRDGH-IKLTDFG 146

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 52.0 bits (125), Expect = 1e-07
 Identities = 55/209 (26%), Positives = 96/209 (45%), Gaps = 31/209 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V + +    G+    VAIK +     DK+  +   E   M   DHPN++
Sbjct: 9   EKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRAL 185
            L+     +       + ++ EY+    +  +  F + N  +      V +    I   +
Sbjct: 69  RLEGVVTKSRP-----VMIITEYM---ENGSLDKFLRENDGKFTVGQLVGM-LRGIASGM 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYY 239
            Y+   +   HRD+  +N+LVN +    K+ DFG ++ L   +   +Y      I  R+ 
Sbjct: 120 KYL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRRL--EDSEATYTTKGGKIPIRW- 174

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELM 268
            APE I    ++T+A D+WS G V+ E+M
Sbjct: 175 TAPEAI-AYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 51.8 bits (124), Expect = 1e-07
 Identities = 54/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E ++G G FG V + +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 9   EEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNII 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     T  +  + +   +E      +  +  F + N  +  +I +      I   + 
Sbjct: 69  HLEGVV--TKSRPVMIITEFME------NGALDSFLRQNDGQFTVIQLVGMLRGIAAGMK 120

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  S        + 
Sbjct: 121 YL-SEMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 179 APEAI-AYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 30/214 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR----ELQTMRLLDHPNVVSLKH 131
           ER +G G FG V++         VAIK +  D   K +    E+Q ++ L H +++SL  
Sbjct: 11  ERKLGSGYFGEVWEGLWKNRVR-VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL-- 67

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHR-VVKHF--NKLNQRMPMIYVKLYAYQIFRALSYI 188
            F   +  + +Y+      + E + +  +  F  +   Q +P+  +   A Q+   ++Y+
Sbjct: 68  -FAVCSVGEPVYI------ITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYL 120

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSRYYRAPE 243
                  HRD+  +N+LV       K+ DFG A+++     +  +  I Y     + APE
Sbjct: 121 E-EQNSIHRDLAARNILVGEDL-VCKVADFGLARLIKEDVYLSSDKKIPY----KWTAPE 174

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
                  ++T  D+WS G ++ E+   G+  +PG
Sbjct: 175 AA-SHGTFSTKSDVWSFGILLYEMFTYGQVPYPG 207

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 33/108 (30%), Positives = 54/108 (50%), Gaps = 15/108 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++ Q+ + + ++  S    HRD+  +N+L+       K+CDFG A+        +VKG  
Sbjct: 217 FSSQVAQGMDFL-ASKNCIHRDVAARNVLLT-DGRVAKICDFGLARDIMNDSNYVVKGNA 274

Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +       + APE IF    YT   D+WS G ++ E+  LGK  +PG
Sbjct: 275 RLPV----KWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 27/69 (39%), Positives = 38/69 (55%), Gaps = 9/69 (13%)

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 238
           QI  AL  +H S G+ HRD+KPQN++ +  +   K+ D G+A  L  G   I+YI   + 
Sbjct: 263 QILFALDGLH-STGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVG---INYIPKEFL 318

Query: 239 ----YRAPE 243
               Y APE
Sbjct: 319 LDPRYAAPE 327

Length = 566

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 7/104 (6%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---Y 233
           + YQ+ R + ++  S    HRD+  +N+L+      VK+CDFG A+ ++     +S    
Sbjct: 242 FTYQVARGMEFL-ASKNCVHRDLAARNVLLA-QGKIVKICDFGLARDIMHDSNYVSKGST 299

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                + APE IF    YTT  D+WS G ++ E+  LG   +PG
Sbjct: 300 FLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPG 342

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 49/201 (24%), Positives = 79/201 (39%), Gaps = 34/201 (16%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---ELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V        G+ VA+K +  D         E   M  L HPN+V L      
Sbjct: 14  IGKGEFGDVMLG--DYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVL- 70

Query: 136 TTDKDELYLNLVLEYVPETV------HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
               + LY  +V EY+ +         R         Q         +A  +   + Y+ 
Sbjct: 71  --QGNPLY--IVTEYMAKGSLVDYLRSRGRAVITLAQQ-------LGFALDVCEGMEYL- 118

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIF 246
                 HRD+  +N+LV+      K+ DFG AK     E +      +    + APE + 
Sbjct: 119 EEKNFVHRDLAARNVLVS-EDLVAKVSDFGLAK-----EASQGQDSGKLPVKWTAPEAL- 171

Query: 247 GATEYTTAIDIWSAGCVVAEL 267
              +++T  D+WS G ++ E+
Sbjct: 172 REKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 50.5 bits (121), Expect = 4e-07
 Identities = 56/222 (25%), Positives = 98/222 (44%), Gaps = 32/222 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FGVV   K     + VAIK + +    ++    E + M  L HPN+V L   +  
Sbjct: 12  LGSGQFGVVHLGKWRGKID-VAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQL---YGV 67

Query: 136 TTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            T +  ++  +V EY+         R  K        + M         +  A+ Y+  +
Sbjct: 68  CTKQRPIF--IVTEYMANGCLLNYLRERKGKLGTEWLLDM------CSDVCEAMEYLESN 119

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-----APELIF 246
            G  HRD+  +N LV    + VK+ DFG A+ ++  +    Y  S+  +     AP  +F
Sbjct: 120 -GFIHRDLAARNCLVG-EDNVVKVSDFGLARYVLDDQ----YTSSQGTKFPVKWAPPEVF 173

Query: 247 GATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEII 287
             + +++  D+WS G ++ E+   GK  +   S   ++VE +
Sbjct: 174 DYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN-SEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 50.4 bits (120), Expect = 5e-07
 Identities = 55/211 (26%), Positives = 96/211 (45%), Gaps = 34/211 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ++++G G FG VF+      G     VAIK +      K R     E   M    H N++
Sbjct: 10  QKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNII 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK----HFNKLNQRMPMIYVKLYAYQIF 182
            L+     T  K  +   ++ EY+    + + ++     F+   Q + M+       +  
Sbjct: 70  RLEGVV--TKFKPAM---IITEYMENGALDKYLRDHDGEFSSY-QLVGMLRGIAAGMKYL 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----- 237
             ++Y+HR       D+  +N+LVN    + K+ DFG ++VL + +P  +Y  S      
Sbjct: 124 SDMNYVHR-------DLAARNILVN-SNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPI 174

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
            + APE I    ++T+A D+WS G V+ E+M
Sbjct: 175 RWTAPEAI-AYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 50.3 bits (120), Expect = 6e-07
 Identities = 54/238 (22%), Positives = 107/238 (44%), Gaps = 49/238 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A            TVA+K + ++      R    E   ++ ++HP+V
Sbjct: 6   KTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHV 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL---------- 176
           + L    +    +D   L L++EY     +  ++ F + ++++   Y+            
Sbjct: 66  IKL----YGACSQDGPLL-LIVEYAK---YGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117

Query: 177 --------------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK 222
                         +A+QI R + Y+   + + HRD+  +N+LV     ++K+ DFG ++
Sbjct: 118 NPDERALTMGDLISFAWQISRGMQYL-AEMKLVHRDLAARNVLV-AEGRKMKISDFGLSR 175

Query: 223 VLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            + + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 232

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 48.8 bits (116), Expect = 1e-06
 Identities = 50/208 (24%), Positives = 91/208 (43%), Gaps = 31/208 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  G+++ I    K +QD+  +         +  M  LDH  +V
Sbjct: 13  KLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIV 72

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ++       L LV +  P    +  V +H + L+   P   +  +  QI + 
Sbjct: 73  RLLGICPGAS-------LQLVTQLSPLGSLLDHVRQHRDSLD---PQRLLN-WCVQIAKG 121

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYR 240
           + Y+     + HR++  +N+L+      V++ DFG A +L   +    Y       ++  
Sbjct: 122 MYYLEEH-RMVHRNLAARNILLKS-DSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMA 179

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
              ++FG   YT   D+WS G  V E+M
Sbjct: 180 LESILFG--RYTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.9 bits (117), Expect = 1e-06
 Identities = 51/222 (22%), Positives = 90/222 (40%), Gaps = 45/222 (20%)

Query: 78  IVGQGSFGVVFQAKCLETG----ETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVS 128
           ++ +G+FG +F    ++      E V +K V              E   +  L H N++ 
Sbjct: 13  LLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILP 72

Query: 129 LKHCFFSTTDKDELYL------NLVL-----EYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           + H      +   +        NL L             +       L+ +     +   
Sbjct: 73  ILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA------LSTQQ----LVHM 122

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-- 235
           A QI   +SY+H+  GV H+DI  +N +++    QVK+ D   ++ L   +    Y C  
Sbjct: 123 AIQIACGMSYLHK-RGVIHKDIAARNCVID-EELQVKITDNALSRDLFPMD----YHCLG 176

Query: 236 ---SRYYR--APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
              +R  +  A E +    EY++A D+WS G ++ ELM LG+
Sbjct: 177 DNENRPVKWMALESLVN-KEYSSASDVWSFGVLLWELMTLGQ 217

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 48.7 bits (116), Expect = 1e-06
 Identities = 61/224 (27%), Positives = 106/224 (47%), Gaps = 35/224 (15%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLD 122
           P++T+  + +++ G G FG V+       G T VAIK + Q          E   M+ L 
Sbjct: 4   PRETLK-LVKKL-GAGQFGEVWMG--YYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ 59

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQ 180
           HP +V L    ++   ++ +Y+  + EY+    +  +  F K  + + +   KL   A Q
Sbjct: 60  HPRLVRL----YAVVTQEPIYI--ITEYM---ENGSLVDFLKTPEGIKLTINKLIDMAAQ 110

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 237
           I   +++I R     HRD++  N+LV+  T   K+ DFG A+++   E    Y       
Sbjct: 111 IAEGMAFIERK-NYIHRDLRAANILVS-ETLCCKIADFGLARLIEDNE----YTAREGAK 164

Query: 238 ---YYRAPELI-FGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               + APE I +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 165 FPIKWTAPEAINYGT--FTIKSDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.1 bits (117), Expect = 2e-06
 Identities = 35/108 (32%), Positives = 56/108 (51%), Gaps = 15/108 (13%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + +S++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 219 FSYQVAKGMSFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIRNDSNYVVKGNA 276

Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +       + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 277 RLPV----KWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPG 319

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 2e-06
 Identities = 60/242 (24%), Positives = 96/242 (39%), Gaps = 74/242 (30%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRL---LDHPNVV-- 127
           R++G+G  G V+ A        VA+KK+ +D       K R L+  ++   L HP +V  
Sbjct: 8   RLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPV 67

Query: 128 --------------------SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ 167
                               +LK    S   K+ L   L  +    +V   +  F+K   
Sbjct: 68  YSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEK---TSVGAFLSIFHK--- 121

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV---- 223
                        I   + Y+H S GV HRD+KP N+L+      V L D+G+A      
Sbjct: 122 -------------ICATIEYVH-SKGVLHRDLKPDNILLGLFGEVVIL-DWGAAIFKKLE 166

Query: 224 ------LVKGEPNISY---------ICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAE 266
                 +   E NI Y         + +  Y APE + G  A+E T   DI++ G ++ +
Sbjct: 167 EEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASEST---DIYALGVILYQ 223

Query: 267 LM 268
           ++
Sbjct: 224 ML 225

Length = 932

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 37/211 (17%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFFS 135
           I+G+G FG V Q +   TG+ VA+K +  D   +    E   M  L H N+V L      
Sbjct: 13  IIGEGEFGAVLQGE--YTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRL------ 64

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNK------LNQR----MPMIYVKLYAYQIFRAL 185
                   L ++L      ++ V++  +K      L  R    + +I +  ++  +   +
Sbjct: 65  --------LGVILH---NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            Y+  S  + HRD+  +N+LV+      K+ DFG A+V   G  N        + APE +
Sbjct: 114 EYL-ESKKLVHRDLAARNILVS-EDGVAKVSDFGLARVGSMGVDNSKLPVK--WTAPEAL 169

Query: 246 FGATEYTTAIDIWSAGCVVAELM-LGKPLFP 275
               ++++  D+WS G ++ E+   G+  +P
Sbjct: 170 -KHKKFSSKSDVWSYGVLLWEVFSYGRAPYP 199

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 47.7 bits (113), Expect = 3e-06
 Identities = 59/212 (27%), Positives = 98/212 (46%), Gaps = 29/212 (13%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHC 132
           ++G+G+FG VF+   L+    VA+K   +D  +  K + L   R+L   DHPN+V L   
Sbjct: 2   LLGKGNFGEVFKGT-LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKL--- 57

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               T +  +Y  +V+E VP      +    K    +    +  +A      ++Y+  S 
Sbjct: 58  IGVCTQRQPIY--IVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYL-ESK 112

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPE-LI 245
              HRD+  +N LV    + +K+ DFG    + + E +  Y  S        + APE L 
Sbjct: 113 NCIHRDLAARNCLVG-ENNVLKISDFG----MSRQEDDGIYSSSGLKQIPIKWTAPEALN 167

Query: 246 FGATEYTTAIDIWSAGCVVAE-LMLGKPLFPG 276
           +G   Y++  D+WS G ++ E   LG   +PG
Sbjct: 168 YG--RYSSESDVWSYGILLWETFSLGVCPYPG 197

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 48.1 bits (115), Expect = 3e-06
 Identities = 45/190 (23%), Positives = 73/190 (38%), Gaps = 42/190 (22%)

Query: 100 AIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------KHCFFSTTDKDELYLNLVL-EYV 151
           A     +D     +E++ +  L  PN+  L                 +   LN  L ++V
Sbjct: 58  ASDNAREDFL---KEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHV 114

Query: 152 PETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT 210
            ET           N +       LY A QI   + Y+  S+   HRD+  +N LV    
Sbjct: 115 AETS------GLACNSKSLSFSTLLYMATQIASGMRYL-ESLNFVHRDLATRNCLVGK-N 166

Query: 211 HQVKLCDFGSAKVLVKGEPNISYICSRYY----RAP--------ELIFGATEYTTAIDIW 258
           + +K+ DFG ++ L        Y    YY    RAP        E +    ++TT  D+W
Sbjct: 167 YTIKIADFGMSRNL--------YSSD-YYRVQGRAPLPIRWMAWESVLL-GKFTTKSDVW 216

Query: 259 SAGCVVAELM 268
           + G  + E++
Sbjct: 217 AFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.7 bits (113), Expect = 5e-06
 Identities = 46/167 (27%), Positives = 74/167 (44%), Gaps = 15/167 (8%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 233
           ++YQ+   + ++  S    HRD+  +N+L+      VK+CDFG A+ +++    I   S 
Sbjct: 244 FSYQVANGMEFL-ASKNCVHRDLAARNVLIC-EGKLVKICDFGLARDIMRDSNYISKGST 301

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
                + APE IF    YTT  D+WS G ++ E+  LG   +P     +Q    IK    
Sbjct: 302 FLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK---- 356

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP-PEAVDLVSRLL 338
                 +   P +   +  +I    W + F  R    + V LV  LL
Sbjct: 357 ---RGYRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 47.2 bits (112), Expect = 5e-06
 Identities = 69/288 (23%), Positives = 120/288 (41%), Gaps = 50/288 (17%)

Query: 77  RIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           R++G+G FG V +A+      + + VA+K +  D    +      RE   M+  DHPNV+
Sbjct: 5   RMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVI 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ------RMPMIYVKLYAYQI 181
            L      +  K  L + +V+  +P   H  +  F  +++       +P+  +  +   I
Sbjct: 65  KLIGVSLRSRAKGRLPIPMVI--LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDI 122

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR- 240
              + Y+  S    HRD+  +N ++N +   V + DFG +K +  G+         YYR 
Sbjct: 123 ASGMEYL-SSKNFIHRDLAARNCMLNENM-TVCVADFGLSKKIYSGD---------YYRQ 171

Query: 241 --APELIFG--ATE------YTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
             A +L     A E      YTT  D+W+ G  + E+M  G+  + G    +    +IK 
Sbjct: 172 GCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIK- 230

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
            G   ++   C+   Y      ++    W    PK   P    L  +L
Sbjct: 231 -GNRLKQPPDCLEDVY------ELMCQCWSPE-PKCR-PSFQHLRDQL 269

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 46.1 bits (109), Expect = 1e-05
 Identities = 56/215 (26%), Positives = 103/215 (47%), Gaps = 25/215 (11%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVLQDKRYKN---RELQTMRLLDHPNVV 127
           S    + +G G FG V+       G T VA+K +            E Q M+ L H  +V
Sbjct: 7   SLQLIKKLGNGQFGEVWMG--TWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLV 64

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L    ++   ++ +Y+  V EY+ + ++   +K       ++P + V + A Q+   ++
Sbjct: 65  QL----YAVVSEEPIYI--VTEYMSKGSLLDFLKDGEGRALKLPNL-VDMAA-QVAAGMA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           YI R +   HRD++  N+LV       K+ DFG A+ L++     +   +++   + APE
Sbjct: 117 YIER-MNYIHRDLRSANILVG-DGLVCKIADFGLAR-LIEDNEYTARQGAKFPIKWTAPE 173

Query: 244 L-IFGATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
             ++G   +T   D+WS G ++ EL+  G+  +PG
Sbjct: 174 AALYG--RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 40/117 (34%), Positives = 57/117 (48%), Gaps = 10/117 (8%)

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--ICSR 237
           Q+  A+ YIH    + HRDIK +N+ +N     V L DFG+A    K      Y  + + 
Sbjct: 275 QLLCAVEYIHDKK-LIHRDIKLENIFLNCDGKIV-LGDFGTAMPFEKEREAFDYGWVGTV 332

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-GDSGVD---QLVEIIKVL 290
              +PE++ G   Y    DIWS G ++ + ML     P GD G     QL++II  L
Sbjct: 333 ATNSPEILAGDG-YCEITDIWSCGLILLD-MLSHDFCPIGDGGGKPGKQLLKIIDSL 387

Length = 501

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 30/75 (40%), Positives = 40/75 (53%), Gaps = 5/75 (6%)

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPN 230
           +K    Q+   L  +HR IG+ HRDIKP+NLLV     QVK+ DFG+A  +  G    P 
Sbjct: 311 IKGVMRQVLTGLRKLHR-IGIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPL 368

Query: 231 ISYICSRYYRAPELI 245
              +  RY    EL+
Sbjct: 369 YGMLDPRYSPPEELV 383

Length = 507

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 45.3 bits (107), Expect = 2e-05
 Identities = 50/198 (25%), Positives = 92/198 (46%), Gaps = 24/198 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G FG+V+    LE  + VAIK +    + ++ +   E Q M  L HP +V L     
Sbjct: 12  IGSGQFGLVWLGYWLEKRK-VAIKTIREGAMSEEDFI-EEAQVMMKLSHPKLVQLYGVCT 69

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALSYIHRSI 192
             +      + LV E++    H  +  + +  QR       L      +   ++Y+  S 
Sbjct: 70  ERSP-----ICLVFEFME---HGCLSDYLR-AQRGKFSQETLLGMCLDVCEGMAYLESS- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGAT 249
            V HRD+  +N LV      VK+ DFG  + ++  +   S   +++   + +PE +F  +
Sbjct: 120 NVIHRDLAARNCLVG-ENQVVKVSDFGMTRFVLDDQYTSST-GTKFPVKWSSPE-VFSFS 176

Query: 250 EYTTAIDIWSAGCVVAEL 267
           +Y++  D+WS G ++ E+
Sbjct: 177 KYSSKSDVWSFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 57/210 (27%), Positives = 103/210 (49%), Gaps = 29/210 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +GQG FG V+      T + VAIK +           +E Q M+ L H  +V L    ++
Sbjct: 14  LGQGCFGEVWMGTWNGTTK-VAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPL----YA 68

Query: 136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
              ++ +Y+  V E++ + ++   +K  +    ++P + V + A QI   ++YI R +  
Sbjct: 69  VVSEEPIYI--VTEFMGKGSLLDFLKEGDGKYLKLPQL-VDM-AAQIADGMAYIER-MNY 123

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYRAPEL-IFG 247
            HRD++  N+LV  +    K+ DFG A+++   E    Y   +       + APE  ++G
Sbjct: 124 IHRDLRAANILVGDNL-VCKIADFGLARLIEDNE----YTARQGAKFPIKWTAPEAALYG 178

Query: 248 ATEYTTAIDIWSAGCVVAELML-GKPLFPG 276
              +T   D+WS G ++ EL+  G+  +PG
Sbjct: 179 --RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 45.0 bits (106), Expect = 3e-05
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 37/218 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 12  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71

Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 72  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 125

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 126 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 181

Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 182 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 44.6 bits (105), Expect = 4e-05
 Identities = 54/222 (24%), Positives = 94/222 (42%), Gaps = 50/222 (22%)

Query: 79  VGQGSFGVVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL 129
           +G+G+FG VF A+C     E  + +   K L++     ++   RE + + +L H ++V  
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVR- 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK------HFNKLNQRMPMIYVKL-----Y 177
              F+    +    L +V EY+    ++R ++            + +    + L      
Sbjct: 72  ---FYGVCTEGRP-LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAI 127

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A QI   + Y+  S+   HRD+  +N LV      VK+ DFG ++ +   +         
Sbjct: 128 ASQIASGMVYL-ASLHFVHRDLATRNCLVGQGL-VVKIGDFGMSRDIYSTD--------- 176

Query: 238 YYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
           YYR             PE I    ++TT  DIWS G V+ E+
Sbjct: 177 YYRVGGRTMLPIRWMPPESIL-YRKFTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 44.1 bits (104), Expect = 4e-05
 Identities = 48/200 (24%), Positives = 93/200 (46%), Gaps = 19/200 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   +  
Sbjct: 12  LGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQL---YGV 67

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
            T +  +Y  +V EY+      ++ +  +  +R     +      +   ++Y+  S    
Sbjct: 68  CTKQRPIY--IVTEYMSNGC--LLNYLREHGKRFQPSQLLEMCKDVCEGMAYL-ESKQFI 122

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYT 252
           HRD+  +N LV+     VK+ DFG ++ ++  E   S + S++   +  PE +   ++++
Sbjct: 123 HRDLAARNCLVDDQG-CVKVSDFGLSRYVLDDE-YTSSVGSKFPVRWSPPE-VLLYSKFS 179

Query: 253 TAIDIWSAGCVVAELM-LGK 271
           +  D+W+ G ++ E+  LGK
Sbjct: 180 SKSDVWAFGVLMWEVYSLGK 199

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 44.0 bits (104), Expect = 5e-05
 Identities = 48/226 (21%), Positives = 97/226 (42%), Gaps = 38/226 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ-------TMRLLDHPNV 126
           +I+G+G FG V + + L   +   +K   K ++   +   E++        M+  DHPNV
Sbjct: 5   KILGEGEFGSVMEGQ-LSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNV 63

Query: 127 VSLKHCFFSTTDKDELYLNLV-LEYVPETVHRVVKHFNKLN---QRMPMIYVKLYAYQIF 182
           + L    F  +   ++   +V L ++          +++L    +++P+  +  +   I 
Sbjct: 64  MKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y+  +    HRD+  +N ++      V + DFG +K +  G+         YYR  
Sbjct: 124 LGMEYL-SNRNFIHRDLAARNCMLR-EDMTVCVADFGLSKKIYSGD---------YYRQG 172

Query: 243 ELI-----FGATE------YTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +      + A E      YT+  D+W+ G  + E+   G+  +PG
Sbjct: 173 RIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 43.0 bits (101), Expect = 1e-04
 Identities = 60/230 (26%), Positives = 98/230 (42%), Gaps = 59/230 (25%)

Query: 79  VGQGSFGVVFQ------AKCLETGET--------VAIKKVLQD--KRYKN---RELQTMR 119
           +G+G FG V        A+ L  G          VA+K +  D  K  +N   +E++ M 
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMI 172
            L +PN++ L      + D     L ++ EY+         +   +   F   N  +P +
Sbjct: 73  RLKNPNIIRLL-GVCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANN-IPSV 126

Query: 173 YVK--LY-AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            +   LY A QI   + Y+  S+   HRD+  +N LV  H + +K+ DFG ++ L  G+ 
Sbjct: 127 SIANLLYMAVQIASGMKYL-ASLNFVHRDLATRNCLVGNH-YTIKIADFGMSRNLYSGD- 183

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL 267
                   YYR            A E I    ++TTA D+W+ G  + E+
Sbjct: 184 --------YYRIQGRAVLPIRWMAWESIL-LGKFTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 56/221 (25%), Positives = 98/221 (44%), Gaps = 29/221 (13%)

Query: 77  RIVGQGSFGVVFQAKCLETGET--VAIK--KVLQDKRYKN----RELQTMRLLDHPNVVS 128
           + +G+G FG V + +  +      VA+K  K+    R +      E   M+  DHPNV+ 
Sbjct: 5   KTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMR 64

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF---NKLN---QRMPMIYVKLYAYQIF 182
           L      T + +     +V+  +P   H  +  F   ++L    Q +P   +  +   I 
Sbjct: 65  LIGVCLQTVESEGYPSPVVI--LPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y+  S    HRD+  +N ++N + + V + DFG +K +  G+    Y   R  + P
Sbjct: 123 SGMEYL-SSKSFIHRDLAARNCMLNENMN-VCVADFGLSKKIYNGD---YYRQGRIAKMP 177

Query: 243 ELIFGATE------YTTAIDIWSAGCVVAELML-GKPLFPG 276
            + + A E      YTT  D+WS G  + E+   G+  +PG
Sbjct: 178 -VKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 42.3 bits (99), Expect = 2e-04
 Identities = 64/255 (25%), Positives = 107/255 (41%), Gaps = 54/255 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 10  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIY 173
           V     +    D D L   +V EY+             P+ +  V     +    + +  
Sbjct: 70  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 124

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++ +         
Sbjct: 125 MLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANL-LVKIGDFGMSRDVYS------- 175

Query: 234 ICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAELM-LGK-PLFP-GDS 278
             + YYR             PE I    ++TT  D+WS G ++ E+   GK P F   ++
Sbjct: 176 --TDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232

Query: 279 GVDQLVEIIKVLGTP 293
            V + +   +VL  P
Sbjct: 233 EVIECITQGRVLERP 247

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 41.5 bits (97), Expect = 4e-04
 Identities = 42/224 (18%), Positives = 94/224 (41%), Gaps = 39/224 (17%)

Query: 64  NGQPKQTIS---YMAERIVGQGSFGVVFQAKCLE---------------TGETVAIKKVL 105
            G P   I+   +  ++++G G FG V++ +C                   ET+ ++ ++
Sbjct: 2   EGIPLIDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLV 61

Query: 106 QDKRY-KNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF 162
            +  Y  ++      +  +DH  +     C   +  +  +Y   +L      + ++V++ 
Sbjct: 62  YNNIYDIDKIALWKNIHNIDHLGIPKYYGC--GSFKRCRMYYRFIL------LEKLVENT 113

Query: 163 NKLNQRM---PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
            ++ +R+       +K     +   L YIH   G+ H DIKP+N++V+ + ++  + D+G
Sbjct: 114 KEIFKRIKCKNKKLIKNIMKDMLTTLEYIH-EHGISHGDIKPENIMVDGN-NRGYIIDYG 171

Query: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCV 263
            A   +    +I      Y +  + +   T Y   +D  +  CV
Sbjct: 172 IASHFIIHGKHI-----EYSKEQKDLHRGTLYYAGLDAHNGACV 210

Length = 294

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 41.0 bits (96), Expect = 6e-04
 Identities = 69/297 (23%), Positives = 112/297 (37%), Gaps = 65/297 (21%)

Query: 79  VGQGSFGVVFQAKCLETGETVA--IKKVLQDKRYKN------RELQTMRLLDHPNVVS-L 129
           +G G FG V   +    G + A  + K L+     +      +E+Q  R L+HPNV+  L
Sbjct: 3   IGNGWFGKVLLGE-AHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61

Query: 130 KHCFFSTTDKDELYLNLVLEYVP----------ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
             C  S       YL LVLE+ P                      + QRM        A 
Sbjct: 62  GQCIESIP-----YL-LVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRM--------AC 107

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY- 238
           ++   L ++H++  + H D+  +N  +      VK+ D+G A      +  I+  C    
Sbjct: 108 EVASGLLWLHQADFI-HSDLALRNCQLTADL-SVKIGDYGLALEQYPEDYYITKDCHAVP 165

Query: 239 --YRAPEL--IFGA----TEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKV 289
             + APEL  I G      + T   +IWS G  + EL       +P  S    L ++++ 
Sbjct: 166 LRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVR- 224

Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF------PKRMPPEAVDLVSRLLQY 340
                 ++IK   P           +  W+++       P+  P    + V  LL Y
Sbjct: 225 -----EQDIKLPKPQ-----LDLKYSDRWYEVMQFCWLDPETRP--TAEEVHELLTY 269

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 40.3 bits (94), Expect = 9e-04
 Identities = 56/204 (27%), Positives = 92/204 (45%), Gaps = 32/204 (15%)

Query: 79  VGQGSFGVVFQA--KCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           +G G+FG V +   K  +    VAIK VL+++  K+      RE + M  LD+P +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIK-VLKNENEKSVRDEMMREAEIMHQLDNPYIVRM- 60

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  + + L   LV+E        + K  +     + +  V    +Q+   + Y+  
Sbjct: 61  ---IGVCEAEALM--LVMEMASGG--PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG 113

Query: 191 SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-------YRAP 242
              V HRD+  +N LLVN   H  K+ DFG +K L   +   SY  +R        + AP
Sbjct: 114 KNFV-HRDLAARNVLLVN--QHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAP 167

Query: 243 ELIFGATEYTTAIDIWSAGCVVAE 266
           E I    ++++  D+WS G  + E
Sbjct: 168 ECI-NFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 40.0 bits (93), Expect = 0.001
 Identities = 57/222 (25%), Positives = 97/222 (43%), Gaps = 45/222 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           E ++G+G+FG V +A   + G     AIK + +     D R    EL+ + +L  HPN++
Sbjct: 7   EDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNII 66

Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVP--------------ETVHRVVKHFNKLNQRMPMI 172
           +L   C      ++  YL + +EY P              ET     K     +      
Sbjct: 67  NLLGAC------ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQ 120

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
            ++ +A  +   + Y+     + HRD+  +N+LV  +    K+ DFG    L +GE    
Sbjct: 121 LLQ-FASDVATGMQYLSEKQFI-HRDLAARNVLVGENL-ASKIADFG----LSRGEE--V 171

Query: 233 YICSRYYRAPELIFGATE------YTTAIDIWSAGCVVAELM 268
           Y+     R P + + A E      YTT  D+WS G ++ E++
Sbjct: 172 YVKKTMGRLP-VRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 39.6 bits (92), Expect = 0.001
 Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 63/303 (20%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMR 119
           T+ +M E  +G+  FG V++         E  + VAIK  L+DK     R + +    MR
Sbjct: 6   TVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIK-TLKDKAEGPLREEFKHEAMMR 62

Query: 120 L-LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VH------------------RVV 159
             L HPN+V    C      K++  L+++  Y   + +H                  + V
Sbjct: 63  SRLQHPNIV----CLLGVVTKEQP-LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTV 117

Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           K     +   P  +V +   QI   + ++  S  V H+D+  +N+LV    + VK+ D G
Sbjct: 118 K-----STLEPADFVHIVT-QIAAGMEFL-SSHHVVHKDLATRNVLVFDKLN-VKISDLG 169

Query: 220 SAKVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLF 274
             + +   +       S +  R+     +++G  +++   DIWS G V+ E+   G   +
Sbjct: 170 LFREVYAADYYKLMGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPY 227

Query: 275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLV 334
            G S  D ++E+I+      R+ + C  P+        +    W++ FP R  P   D+ 
Sbjct: 228 CGYSNQD-VIEMIR-----NRQVLPC--PDDCPAWVYTLMLECWNE-FPSRR-PRFKDIH 277

Query: 335 SRL 337
           SRL
Sbjct: 278 SRL 280

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 39.2 bits (91), Expect = 0.002
 Identities = 72/311 (23%), Positives = 130/311 (41%), Gaps = 77/311 (24%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQ--AKCLETGET---VAIKKVLQDKRYKNR-----ELQ 116
            ++ I+ + E  +GQGSFG+V++  A+ +  GE    VA+K V +    + R     E  
Sbjct: 4   SREKITLLRE--LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEAS 61

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMI 172
            M+     +VV L         K +  L +V+E +     ++  R ++   + N   P  
Sbjct: 62  VMKGFTCHHVVRL----LGVVSKGQPTL-VVMELMAHGDLKSYLRSLRPEAENNPGRPPP 116

Query: 173 YVK---LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            ++     A +I   ++Y++    V HRD+  +N +V  H   VK+ DFG  + + + + 
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFV-HRDLAARNCMV-AHDFTVKIGDFGMTRDIYETD- 173

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAEL-MLGKPLFPG 276
                   YYR            APE +     +TT+ D+WS G V+ E+  L +  + G
Sbjct: 174 --------YYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQG 224

Query: 277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSR 336
            S  +Q+++ +             M+  Y +               P   P    DL+  
Sbjct: 225 LSN-EQVLKFV-------------MDGGYLD--------------QPDNCPERVTDLMRM 256

Query: 337 LLQYSPNLRCT 347
             Q++P +R T
Sbjct: 257 CWQFNPKMRPT 267

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 39.1 bits (91), Expect = 0.002
 Identities = 30/104 (28%), Positives = 49/104 (47%), Gaps = 24/104 (23%)

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           A QI   + Y+  S+   HRD+  +N LV  +   +K+ DFG ++ L  G+         
Sbjct: 144 ALQIASGMKYL-SSLNFVHRDLATRNCLVGENLT-IKIADFGMSRNLYAGD--------- 192

Query: 238 YYR------------APELIFGATEYTTAIDIWSAGCVVAELML 269
           YYR            A E I    ++TTA D+W+ G  + E+++
Sbjct: 193 YYRIQGRAVLPIRWMAWECIL-MGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	371
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.98
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.96
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.93
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.93
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.92
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.89
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.89
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.88
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.88
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.87
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.87
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.84
PRK10345	210	hypothetical protein; Provisional	99.83
smart00090	237	RIO RIO-like kinase.	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.75
PRK14879	211	serine/threonine protein kinase; Provisional	99.75
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.73
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.71
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.69
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.69
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.67
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.64
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.63
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.59
KOG1243	690	consensus Protein kinase [General function predict	99.53
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.42
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.42
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.42
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.41
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.4
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.37
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.33
COG4248	637	Uncharacterized protein with protein kinase and he	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.29
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.2
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.15
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.13
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.06
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.98
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.83
PRK09902	216	hypothetical protein; Provisional	98.82
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.76
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.74
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.68
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.47
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.42
PF01636	239	APH: Phosphotransferase enzyme family This family	98.42
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.39
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.32
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.26
PLN02876	822	acyl-CoA dehydrogenase	98.11
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.06
KOG2270	520	consensus Serine/threonine protein kinase involved	98.01
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.01
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.92
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.88
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.87
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.73
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.72
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.68
PRK10593	297	hypothetical protein; Provisional	97.62
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.56
PRK05231	319	homoserine kinase; Provisional	97.47
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.46
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.3
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.24
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.23
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.1
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.04
PLN02236	344	choline kinase	97.0
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.96
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.89
PRK12396	409	5-methylribose kinase; Reviewed	96.85
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.83
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	96.75
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	96.71
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.63
PLN02756	418	S-methyl-5-thioribose kinase	96.37
PTZ00384	383	choline kinase; Provisional	95.98
COG2334	331	Putative homoserine kinase type II (protein kinase	95.82
PRK11768	325	serine/threonine protein kinase; Provisional	95.49
KOG1236	565	consensus Predicted unusual protein kinase [Genera	95.39
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.49
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.27
PRK10271	188	thiK thiamine kinase; Provisional	94.03
PF07914	414	DUF1679: Protein of unknown function (DUF1679); In	93.85

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.4e-62  Score=426.07  Aligned_cols=301  Identities=72%  Similarity=1.186  Sum_probs=283.7

Q ss_pred             cceEEeecCCCCCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeeccee
Q 017452           53 GHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC  132 (371)
Q Consensus        53 ~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~  132 (371)
                      ++.+.+...+.........+|...+.+|.|+||.||+|....+++.||||++..+.+...+|+.+|+.++|||||++..+
T Consensus         6 ~~~~~~~~~~~~~~~~~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~HpNIV~L~~~   85 (364)
T KOG0658|consen    6 GHVIQTVAEGRNDGKKVEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLDHPNIVRLLYF   85 (364)
T ss_pred             eeEEEEEeecCCCCcceEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcCCcCeeeEEEE
Confidence            34444555555556666778999999999999999999999999999999999999999999999999999999999999


Q ss_pred             EEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      |....+.+..+..+||||++.+|.+.+.++...+..++...++-+..||++||.|||.. ||+||||||.|+|+|.+.+.
T Consensus        86 f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~-~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   86 FSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH-GICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             EEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc-CcccCCCChheEEEcCCCCe
Confidence            98877666788999999999999999999888889999999999999999999999986 99999999999999999889


Q ss_pred             EEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      +||||||.|+....++...+..+|+.|+|||.+.+...|+.+.||||.||++.||+-|++.|.+.+..+++..|++.+|.
T Consensus       165 LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~  244 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGT  244 (364)
T ss_pred             EEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      |+++.+.++++++.+..++++...+|...+....++++.+|+.++|+++|.+|.++.+++.|
T Consensus       245 Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  245 PTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             CCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence            99999999999999999999999999998999999999999999999999999999999999

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.4e-56  Score=379.62  Aligned_cols=273  Identities=36%  Similarity=0.671  Sum_probs=241.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|....++|+|+||+||+|+++.||+.||||++....      ....||+++|++++|+|+|.++..|     +....+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF-----rrkrkl   76 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF-----RRKRKL   76 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH-----Hhccee
Confidence            46889999999999999999999999999999996542      3456899999999999999999999     666668


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|+|||+.++++.++.+   ...++.+.++.++.|++.|+.|+|++ ++|||||||+||||+.++ .+||||||+|+.+
T Consensus        77 hLVFE~~dhTvL~eLe~~---p~G~~~~~vk~~l~Q~l~ai~~cHk~-n~IHRDIKPENILit~~g-vvKLCDFGFAR~L  151 (396)
T KOG0593|consen   77 HLVFEYCDHTVLHELERY---PNGVPSELVKKYLYQLLKAIHFCHKN-NCIHRDIKPENILITQNG-VVKLCDFGFARTL  151 (396)
T ss_pred             EEEeeecchHHHHHHHhc---cCCCCHHHHHHHHHHHHHHhhhhhhc-CeecccCChhheEEecCC-cEEeccchhhHhh
Confidence            999999999887777754   57899999999999999999999987 999999999999999998 9999999999988


Q ss_pred             c-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh--hc
Q 017452          225 V-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK--CM  301 (371)
Q Consensus       225 ~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~  301 (371)
                      . ++...+.++.|++|.|||.+.+..+|+..+|||++||++.||++|.+.|.+.++.+++..|++.+|...+....  ..
T Consensus       152 ~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~  231 (396)
T KOG0593|consen  152 SAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSS  231 (396)
T ss_pred             cCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhcc
Confidence            7 66667788999999999999998999999999999999999999999999999999999999999998877665  44


Q ss_pred             CCCccccccCcccCCC-CcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHP-WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ++-|..+.+|+..... +...+| .++.-+.+|+.+||+.||.+|++..+++.|
T Consensus       232 N~~F~Gv~lP~~~~~epLe~k~p-~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  232 NPFFHGVRLPEPEHPEPLERKYP-KISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             CCceeeeecCCCCCccchhhhcc-cchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence            5667777888766533 333333 367889999999999999999999997776

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-57  Score=404.51  Aligned_cols=278  Identities=35%  Similarity=0.631  Sum_probs=249.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  142 (371)
                      ...+|.+.++||.|.||.||+|+...+|+.||||++++..     ....||+..|++|+ ||||+++...+.+.+    .
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~----~   83 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDND----R   83 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccC----c
Confidence            3468999999999999999999999999999999886543     23348999999998 999999999884322    1


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||||+.+|+.++..+   ++.|++..++.|+.||++||+|+|++ |+.||||||+|||+.... .+||+|||+|+
T Consensus        84 ~L~fVfE~Md~NLYqLmK~R---~r~fse~~irnim~QilqGL~hiHk~-GfFHRDlKPENiLi~~~~-~iKiaDFGLAR  158 (538)
T KOG0661|consen   84 ILYFVFEFMDCNLYQLMKDR---NRLFSESDIRNIMYQILQGLAHIHKH-GFFHRDLKPENILISGND-VIKIADFGLAR  158 (538)
T ss_pred             eEeeeHHhhhhhHHHHHhhc---CCcCCHHHHHHHHHHHHHHHHHHHhc-CcccccCChhheEecccc-eeEeccccccc
Confidence            68999999999999999875   68999999999999999999999987 999999999999999766 89999999999


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc-
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-  301 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-  301 (371)
                      ........+.++.|++|+|||++.....|+.+.|||++|||++|+.+-++.|.+.+..+++.+|...+|.|....|... 
T Consensus       159 ev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~  238 (538)
T KOG0661|consen  159 EVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGY  238 (538)
T ss_pred             ccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHH
Confidence            9888888888999999999999998888999999999999999999999999999999999999999999998887642 


Q ss_pred             -CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          302 -NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       302 -~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                       .-+...+++++...-++...++. .+.++.++|.+||.+||.+||||.++|+|.+
T Consensus       239 ~La~~mnf~~P~~~~~~l~~L~p~-~s~~~~~li~~ll~WDP~kRpTA~~al~~pf  293 (538)
T KOG0661|consen  239 NLASAMNFRFPQVKPSPLKDLLPN-ASSEAASLIERLLAWDPDKRPTASQALQHPF  293 (538)
T ss_pred             HHHHHhccCCCcCCCCChHHhCcc-cCHHHHHHHHHHhcCCCccCccHHHHhcCcc
Confidence             23445678888888888887888 9999999999999999999999999998833

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-55  Score=383.94  Aligned_cols=248  Identities=29%  Similarity=0.514  Sum_probs=209.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+.+.+..||+|..|+||+++++.+++.+|+|++...     ...+.+|+++++..+||+||++|++|+....    .++
T Consensus        79 ~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~----~is  154 (364)
T KOG0581|consen   79 SDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGE----EIS  154 (364)
T ss_pred             HHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCc----eEE
Confidence            3577888999999999999999999999999999432     3455689999999999999999999976442    378


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+||||+| +|..++..    .+++++.....++.+|++||.|||...+||||||||+|||++..| .|||||||.++.+
T Consensus       155 I~mEYMDgGSLd~~~k~----~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskG-eVKicDFGVS~~l  229 (364)
T KOG0581|consen  155 ICMEYMDGGSLDDILKR----VGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKG-EVKICDFGVSGIL  229 (364)
T ss_pred             eehhhcCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCC-CEEeccccccHHh
Confidence            99999995 66666654    378999999999999999999999745999999999999999998 9999999999988


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD--SGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .+. ...+..||..|||||.+.+.. |+.++||||||+.++|+++|+.||...  .....+..+......+++.      
T Consensus       230 vnS-~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~------  301 (364)
T KOG0581|consen  230 VNS-IANTFVGTSAYMSPERISGES-YSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR------  301 (364)
T ss_pred             hhh-hcccccccccccChhhhcCCc-CCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC------
Confidence            766 567889999999999998765 899999999999999999999999774  1222233333333222221      


Q ss_pred             CCccccccCcccCCCCcccCCCC-CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         +|.. +|+++++|+..||++||.+|||+.++++|
T Consensus       302 -------------------lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~H  335 (364)
T KOG0581|consen  302 -------------------LPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQH  335 (364)
T ss_pred             -------------------CCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                               4454 89999999999999999999999999888

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.7e-55  Score=405.28  Aligned_cols=243  Identities=31%  Similarity=0.499  Sum_probs=218.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+|..++.||+|||+.||.+++..+|+.||+|++.+.       .....+|+++.+.|+|||||+++++|     ++..+
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~F-----EDs~n   92 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFF-----EDSNN   92 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEe-----ecCCc
Confidence            5799999999999999999999999999999999652       45566899999999999999999999     77778


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|||+|+|. ++|.+++..    .+.++|.+++.+++||+.||.|||++ +|+|||||..|+|++.+. +|||+|||+|.
T Consensus        93 VYivLELC~~~sL~el~Kr----rk~ltEpEary~l~QIv~GlkYLH~~-~IiHRDLKLGNlfL~~~~-~VKIgDFGLAt  166 (592)
T KOG0575|consen   93 VYIVLELCHRGSLMELLKR----RKPLTEPEARYFLRQIVEGLKYLHSL-GIIHRDLKLGNLFLNENM-NVKIGDFGLAT  166 (592)
T ss_pred             eEEEEEecCCccHHHHHHh----cCCCCcHHHHHHHHHHHHHHHHHHhc-CceecccchhheeecCcC-cEEecccceee
Confidence            999999999 677776663    68899999999999999999999987 999999999999999988 89999999999


Q ss_pred             cccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .... ++...+.+|||.|.|||++.... .+..+||||+||+||.||+|++||...+-.+.+..|...            
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~------------  233 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN------------  233 (592)
T ss_pred             eecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc------------
Confidence            8764 47778899999999999997544 799999999999999999999999998888877777653            


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       +-.+|..+|.++.+||.+||+.||.+|||++++|.|
T Consensus       234 -----------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  234 -----------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             -----------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                             112567899999999999999999999999999998

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=6e-55  Score=363.55  Aligned_cols=275  Identities=37%  Similarity=0.696  Sum_probs=239.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|...++||+|.||+||+|++..+|+.||||+++..+      ....||++.|+.++|+||+.++++|     .....+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F-----~~~~~l   76 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF-----PHKSNL   76 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc-----cCCCce
Confidence            36899999999999999999999999999999996542      3346899999999999999999999     555558


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      .+|+||++.+|...+...   ...++...++.|+.++++||+|||.+ .|+||||||.|+||+++| .+||+|||+|+..
T Consensus        77 ~lVfEfm~tdLe~vIkd~---~i~l~pa~iK~y~~m~LkGl~y~H~~-~IlHRDlKPnNLLis~~g-~lKiADFGLAr~f  151 (318)
T KOG0659|consen   77 SLVFEFMPTDLEVVIKDK---NIILSPADIKSYMLMTLKGLAYCHSK-WILHRDLKPNNLLISSDG-QLKIADFGLARFF  151 (318)
T ss_pred             EEEEEeccccHHHHhccc---ccccCHHHHHHHHHHHHHHHHHHHhh-hhhcccCCccceEEcCCC-cEEeecccchhcc
Confidence            899999999988877753   56889999999999999999999987 999999999999999999 8999999999987


Q ss_pred             ccCCCc-ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC-
Q 017452          225 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (371)
Q Consensus       225 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (371)
                      ...... ...+.|++|.|||.+++...|+..+||||.|||+.||+.|.+.|.+.++.+++..|.+.+|.|.++.|+.+. 
T Consensus       152 ~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~  231 (318)
T KOG0659|consen  152 GSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTS  231 (318)
T ss_pred             CCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccc
Confidence            654433 334789999999999999999999999999999999999999999999999999999999999999998775 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh--hcCC
Q 017452          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL--FSNC  358 (371)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~--l~~~  358 (371)
                       +++.+++  +.+..+.+..++. .+.++.+|+.+||.+||.+|+|+.|+++|  |...
T Consensus       232 lpdY~~~~--~~P~~~~~~lf~a-as~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~  287 (318)
T KOG0659|consen  232 LPDYVKIQ--QFPKPPLNNLFPA-ASSDALDLLSKMLTYNPKKRITASQALKHPYFKSL  287 (318)
T ss_pred             cccHHHHh--cCCCCcccccccc-ccHHHHHHHHhhhccCchhcccHHHHhcchhhhcC
Confidence             4444444  4444444545555 67888999999999999999999999999  5543

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-55  Score=387.81  Aligned_cols=249  Identities=32%  Similarity=0.453  Sum_probs=206.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ..|.+.+.||+|+||.|-+|..+.+|+.||||++.+..           ...++|+++|++++|||||+++++|     .
T Consensus       172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f-----~  246 (475)
T KOG0615|consen  172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFF-----E  246 (475)
T ss_pred             ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeee-----e
Confidence            45899999999999999999999999999999985431           2346899999999999999999998     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC--CCcEEEE
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLC  216 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~--~~~~kl~  216 (371)
                      ...+.||||||++| .|.+.+-.    ++.+.+..-+.+++||+.|+.|||++ ||+||||||+|||+..+  ...+||+
T Consensus       247 ~~ds~YmVlE~v~GGeLfd~vv~----nk~l~ed~~K~~f~Qll~avkYLH~~-GI~HRDiKPeNILl~~~~e~~llKIt  321 (475)
T KOG0615|consen  247 VPDSSYMVLEYVEGGELFDKVVA----NKYLREDLGKLLFKQLLTAVKYLHSQ-GIIHRDIKPENILLSNDAEDCLLKIT  321 (475)
T ss_pred             cCCceEEEEEEecCccHHHHHHh----ccccccchhHHHHHHHHHHHHHHHHc-CcccccCCcceEEeccCCcceEEEec
Confidence            34447899999996 44444333    68899999999999999999999987 99999999999999765  2379999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCC
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGTP  293 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~  293 (371)
                      |||+|+....+....+.+|||.|.|||++.+.  ..+..++|+|||||+||-+++|.+||.+..... ...+|.++.-. 
T Consensus       322 DFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~-  400 (475)
T KOG0615|consen  322 DFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYA-  400 (475)
T ss_pred             ccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccc-
Confidence            99999999888778889999999999999643  234558999999999999999999998765544 44454442100 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                              +....+.++|.+.++||.+||..||++|||+.|+|+|
T Consensus       401 ------------------------f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~h  437 (475)
T KOG0615|consen  401 ------------------------FGPLQWDRISEEALDLINWMLVVDPENRPSADEALNH  437 (475)
T ss_pred             ------------------------ccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcC
Confidence                                    1111345689999999999999999999999998877

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.5e-53  Score=400.69  Aligned_cols=284  Identities=52%  Similarity=0.999  Sum_probs=252.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecC---CCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT---DKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~---~~~~~~~~l  146 (371)
                      ..+|++++.||+|+||.||+|.+..+++.||||++........+|+.+++.++||||++++++++...   .....++++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~l  144 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNV  144 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEE
Confidence            35799999999999999999999999999999999777667778999999999999999988775432   123456789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||+++++...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++....
T Consensus       145 vmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~-~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~  223 (440)
T PTZ00036        145 VMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK-FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLA  223 (440)
T ss_pred             EEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCcCHHHEEEcCCCCceeeeccccchhccC
Confidence            999999998888877666677899999999999999999999987 9999999999999997765799999999987765


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|.+||.+....+.+..+.+.++.++.+.+..+.+.+.
T Consensus       224 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~  303 (440)
T PTZ00036        224 GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYA  303 (440)
T ss_pred             CCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhh
Confidence            55555678899999999987766689999999999999999999999999988899999999999999999988888888


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.++......+...++...+.++.+||.+||++||.+|||+.++++|
T Consensus       304 ~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        304 DIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             cccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence            888888877788888888899999999999999999999999999998

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-53  Score=384.04  Aligned_cols=279  Identities=37%  Similarity=0.603  Sum_probs=235.8

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      +.....|...++||+|.||.||+|++..+|+.||+|++..+.      ....||+.+|++|+||||+++.+.....   .
T Consensus       113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~---~  189 (560)
T KOG0600|consen  113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSK---L  189 (560)
T ss_pred             ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEec---C
Confidence            344567999999999999999999999999999999986543      3345899999999999999999988653   3


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+|||+|||+.+|..++..   ..-.|++.+++.++.||+.||+|+|.+ ||+|||||.+|||||.+| .+||+|||+
T Consensus       190 ~~siYlVFeYMdhDL~GLl~~---p~vkft~~qIKc~mkQLl~Gl~~cH~~-gvlHRDIK~SNiLidn~G-~LKiaDFGL  264 (560)
T KOG0600|consen  190 SGSIYLVFEYMDHDLSGLLSS---PGVKFTEPQIKCYMKQLLEGLEYCHSR-GVLHRDIKGSNILIDNNG-VLKIADFGL  264 (560)
T ss_pred             CceEEEEEecccchhhhhhcC---CCcccChHHHHHHHHHHHHHHHHHhhc-CeeeccccccceEEcCCC-CEEeccccc
Confidence            456899999999998888773   245899999999999999999999987 999999999999999998 899999999


Q ss_pred             ccccccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          221 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       221 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      |+++....  ..+..+.|.+|.|||.+.+...|+.++|+||.||||.||++|++.|.+.+..+++..|.+..|.|..+.|
T Consensus       265 Ar~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W  344 (560)
T KOG0600|consen  265 ARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYW  344 (560)
T ss_pred             eeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhcc
Confidence            99765444  3566788999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             hhc-CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCM-NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ... .+.+..+.-.+-....+... -..++....+|+..||..||.+|.||.++|++
T Consensus       345 ~~~kLP~~~~~kp~~~y~r~l~E~-~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  345 PVSKLPHATIFKPQQPYKRRLRET-FKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             ccccCCcccccCCCCcccchHHHH-hccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence            721 12222222211111111111 24588999999999999999999999999998

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-52  Score=359.70  Aligned_cols=278  Identities=33%  Similarity=0.558  Sum_probs=240.9

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh------hhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ....|+.+..|++|.||.||+|+++.+++.||+|+++.+..      ...||+.+|.+++|||||.+-.+..... .+  
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~-~d--  150 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSN-MD--  150 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccc-cc--
Confidence            34579999999999999999999999999999999976532      2358999999999999999988765433 22  


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+|||||||+.+|..++...   .++|...+++.++.|+++||+|||.+ .|+||||||+|+|++..| .+||+|||+|+
T Consensus       151 ~iy~VMe~~EhDLksl~d~m---~q~F~~~evK~L~~QlL~glk~lH~~-wilHRDLK~SNLLm~~~G-~lKiaDFGLAR  225 (419)
T KOG0663|consen  151 KIYIVMEYVEHDLKSLMETM---KQPFLPGEVKTLMLQLLRGLKHLHDN-WILHRDLKTSNLLLSHKG-ILKIADFGLAR  225 (419)
T ss_pred             eeeeeHHHHHhhHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHhhc-eeEecccchhheeeccCC-cEEecccchhh
Confidence            27899999999999988865   47899999999999999999999987 999999999999999998 89999999999


Q ss_pred             ccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .+.... ..+..+.|.+|.|||.+.+...|+++.|+||+|||+.||+++++.|.+....+++..|++.+|.|....|+..
T Consensus       226 ~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~  305 (419)
T KOG0663|consen  226 EYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGY  305 (419)
T ss_pred             hhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCc
Confidence            876543 3456677999999999999999999999999999999999999999999999999999999999999998755


Q ss_pred             C--CCccccccCcccCCCCcccCCCC-CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 N--PNYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~--~~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  +....+.++...-..+...|+.. ++....+|+..+|.+||.+|.||.+.|+|
T Consensus       306 ~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  306 SELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             cccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence            3  33334555555544555555554 78999999999999999999999999999

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-52  Score=364.74  Aligned_cols=246  Identities=30%  Similarity=0.506  Sum_probs=210.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+|.+.+.||+|+||+||.++.+.+++.||+|++++.       .+....|..+|..++||+||+++-.|     .+.
T Consensus        23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-----Qt~   97 (357)
T KOG0598|consen   23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-----QTE   97 (357)
T ss_pred             ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-----ccC
Confidence            346799999999999999999999999999999988653       34445799999999999999998888     555


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+|+|+||+.| .|...+.+    ++.|++..++.++..|+.||.|||++ |||||||||+|||+|.+| .++|+|||+
T Consensus        98 ~kLylVld~~~GGeLf~hL~~----eg~F~E~~arfYlaEi~lAL~~LH~~-gIiyRDlKPENILLd~~G-Hi~LtDFgL  171 (357)
T KOG0598|consen   98 EKLYLVLDYLNGGELFYHLQR----EGRFSEDRARFYLAEIVLALGYLHSK-GIIYRDLKPENILLDEQG-HIKLTDFGL  171 (357)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCcchhHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHeeecCCC-cEEEecccc
Confidence            569999999997 55555554    78999999999999999999999987 999999999999999999 799999999


Q ss_pred             cccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.... +....+.+||+.|||||++.+.. ++.++|+||||+++|+|++|.+||.+.+.......|.+....       
T Consensus       172 ~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------  243 (357)
T KOG0598|consen  172 CKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------  243 (357)
T ss_pred             chhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-------
Confidence            986544 44555679999999999998775 899999999999999999999999999988888887764211       


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC----CHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC----TAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~----t~~~~l~~  354 (371)
                                           ..+..++.+.+++++++|+.||.+|+    ++.++.+|
T Consensus       244 ---------------------~~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  244 ---------------------LPPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             ---------------------CCCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcC
Confidence                                 13445899999999999999999996    46664444

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-52  Score=363.66  Aligned_cols=276  Identities=40%  Similarity=0.707  Sum_probs=241.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|...+.||.|+||.|..|.+..+|+.||||++...      .....||+++|+.++|+||+.+.+.+..+....-.-+|
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvY  102 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVY  102 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeE
Confidence            577789999999999999999999999999998632      34456899999999999999999988663334445589


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|+|+|+.+|...+..    ++.+++..++.++.||++||.|+|+. +|+||||||+|++++.+. .+||+|||+|+...
T Consensus       103 iV~elMetDL~~iik~----~~~L~d~H~q~f~YQiLrgLKyiHSA-nViHRDLKPsNll~n~~c-~lKI~DFGLAR~~~  176 (359)
T KOG0660|consen  103 LVFELMETDLHQIIKS----QQDLTDDHAQYFLYQILRGLKYIHSA-NVIHRDLKPSNLLLNADC-DLKICDFGLARYLD  176 (359)
T ss_pred             EehhHHhhHHHHHHHc----CccccHHHHHHHHHHHHHhcchhhcc-cccccccchhheeeccCC-CEEeccccceeecc
Confidence            9999999888888875    55699999999999999999999986 999999999999999998 89999999999875


Q ss_pred             c---CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 K---GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .   ....+..+.|.+|.|||++.....|+.+.||||+||||.||++|++.|.+.+..+++..|...+|.|..+.+....
T Consensus       177 ~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~  256 (359)
T KOG0660|consen  177 KFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIR  256 (359)
T ss_pred             ccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhc
Confidence            4   2333566779999999999888889999999999999999999999999999999999999999999998887554


Q ss_pred             CC-ccc--cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PN-YTE--FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~-~~~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .. ...  ..+++....+|...++ +.++.+.+|+.+||..||.+|+|++|+|+|
T Consensus       257 s~~ar~yi~slp~~p~~~f~~~fp-~a~p~AidLlekmL~fdP~kRita~eAL~h  310 (359)
T KOG0660|consen  257 SEKARPYIKSLPQIPKQPFSSIFP-NANPLAIDLLEKMLVFDPKKRITAEEALAH  310 (359)
T ss_pred             cHHHHHHHHhCCCCCCCCHHHHcC-CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            21 121  2577888888988888 689999999999999999999999999999

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-52  Score=366.27  Aligned_cols=249  Identities=29%  Similarity=0.503  Sum_probs=212.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|.+.+.||+|+||+||+|+++.++..||||.+.+.      ......|+.+|+.++|||||.++++.     ....
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~-----~~~~   82 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCI-----EDDD   82 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEE-----ecCC
Confidence            456799999999999999999999999999999998554      24456899999999999999999998     4555


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-C----CcEEEE
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-T----HQVKLC  216 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-~----~~~kl~  216 (371)
                      ++|+|||||+ |+|..++..    .+.+++..++.++.||+.||++||++ +||||||||+|||++.. +    ..+||+
T Consensus        83 ~i~lVMEyC~gGDLs~yi~~----~~~l~e~t~r~Fm~QLA~alq~L~~~-~IiHRDLKPQNiLLs~~~~~~~~~~LKIA  157 (429)
T KOG0595|consen   83 FIYLVMEYCNGGDLSDYIRR----RGRLPEATARHFMQQLASALQFLHEN-NIIHRDLKPQNILLSTTARNDTSPVLKIA  157 (429)
T ss_pred             eEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCcceEEeccCCCCCCCceEEec
Confidence            7999999999 688777775    56899999999999999999999997 99999999999999764 1    369999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |||+|+...++....+.+|+|.|||||++..+ +|+.|+|+||+|+++|+|++|+.||...+..+.+..+.+....    
T Consensus       158 DFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~-~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~----  232 (429)
T KOG0595|consen  158 DFGFARFLQPGSMAETLCGSPLYMAPEVIMSQ-QYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEI----  232 (429)
T ss_pred             ccchhhhCCchhHHHHhhCCccccCHHHHHhc-cccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccc----
Confidence            99999999988888899999999999999654 4899999999999999999999999998887777644432111    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            ...++..++..+.+++..+|+.+|..|.+..+-..|
T Consensus       233 ----------------------~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  233 ----------------------VPVLPAELSNPLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             ----------------------cCchhhhccCchhhhhhHHHhcCccccCchHHhhhh
Confidence                                  111344567778889999999999999888886665

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-51  Score=373.01  Aligned_cols=246  Identities=31%  Similarity=0.564  Sum_probs=216.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      +...+|..++.||+|+|++|++|+++.+++.||||++.+.       .....+|-++|.+| .||.|++++..|     .
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF-----Q  144 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF-----Q  144 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe-----e
Confidence            4456899999999999999999999999999999987543       34556788999999 899999999988     5


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      +...+|+|+||++ |.|++++..    .+.|++..++.++.||+.||+|||+. |||||||||+|||+|.|+ .++|+||
T Consensus       145 D~~sLYFvLe~A~nGdll~~i~K----~Gsfde~caR~YAAeIldAleylH~~-GIIHRDlKPENILLd~dm-hikITDF  218 (604)
T KOG0592|consen  145 DEESLYFVLEYAPNGDLLDLIKK----YGSFDETCARFYAAEILDALEYLHSN-GIIHRDLKPENILLDKDG-HIKITDF  218 (604)
T ss_pred             cccceEEEEEecCCCcHHHHHHH----hCcchHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeEcCCC-cEEEeec
Confidence            5566899999999 688888876    47899999999999999999999986 999999999999999999 8999999


Q ss_pred             CCccccccCCC--------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017452          219 GSAKVLVKGEP--------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (371)
Q Consensus       219 g~a~~~~~~~~--------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (371)
                      |.|+.+.+...              ..+++||..|.+||++.... .++.+|+|+||||+|+|+.|.+||.+.+....++
T Consensus       219 GsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFq  297 (604)
T KOG0592|consen  219 GSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQ  297 (604)
T ss_pred             cccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCcccchHHHHHHHHHHhcCCCCCccccHHHHHH
Confidence            99988743221              14588999999999996554 8999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +|+...                             -.++.++++.+.+||.++|..||.+|+|+.++.+|
T Consensus       298 kI~~l~-----------------------------y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  298 KIQALD-----------------------------YEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             HHHHhc-----------------------------ccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            988751                             12677899999999999999999999999998888

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-53  Score=357.74  Aligned_cols=251  Identities=31%  Similarity=0.494  Sum_probs=213.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|++.++||.|.||.||++.+..+|+.+|.|.+.-      .+...-.|+.+|++|+|||||++++.-+.   ++...+
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~---~~~evl   95 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFI---EDNEVL   95 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhh---ccchhh
Confidence            469999999999999999999999999999998852      24455579999999999999999883222   333347


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-C--cEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-G--VCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~--ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      +||||||+ |+|...+.++.+..+.+++..+|+++.|+|.||..+|.+. .  |+||||||.||+++.+| .+||+|||+
T Consensus        96 nivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~g-vvKLGDfGL  174 (375)
T KOG0591|consen   96 NIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANG-VVKLGDFGL  174 (375)
T ss_pred             HHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCC-ceeeccchh
Confidence            89999999 7999999999999999999999999999999999999721 3  99999999999999998 899999999


Q ss_pred             ccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.+..... ..+.+|||+||+||.+.+.. |+.+|||||+||++|||+.-++||.+.+-.+...+|.++.-.|      
T Consensus       175 ~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~------  247 (375)
T KOG0591|consen  175 GRFLSSKTTFAHSLVGTPYYMSPERIHESG-YNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPP------  247 (375)
T ss_pred             HhHhcchhHHHHhhcCCCcccCHHHHhcCC-CCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCC------
Confidence            998765443 34689999999999998766 8999999999999999999999999997767667766642111      


Q ss_pred             hcCCCccccccCcccCCCCcccCC-CCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFP-KRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            +| ..+|.++..+|..|+..||..||+.-.++..
T Consensus       248 ----------------------~p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~d  281 (375)
T KOG0591|consen  248 ----------------------LPDEHYSTDLRELINMCIAVDPEQRPDTVPYVQD  281 (375)
T ss_pred             ----------------------CcHHHhhhHHHHHHHHHccCCcccCCCcchHHHH
Confidence                                  23 4589999999999999999999996555444

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4e-50  Score=369.81  Aligned_cols=247  Identities=30%  Similarity=0.441  Sum_probs=212.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcC-CCCeeecceeEEecC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTT  137 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  137 (371)
                      ...++|.+++.||+|+||+|+.|.+..+|..||+|++...         .....+|+.+++.+. ||||++++.++.   
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~---   90 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFA---   90 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEe---
Confidence            3456799999999999999999999999999999976542         234458999999999 999999999883   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-CCcEEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKL  215 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-~~~~kl  215 (371)
                        ....+++||||+.| .|.+.+..    .+++.+..++.+++||+.|++|||++ ||+||||||+|||++.+ + ++||
T Consensus        91 --t~~~~~ivmEy~~gGdL~~~i~~----~g~l~E~~ar~~F~Qlisav~y~H~~-gi~HRDLK~ENilld~~~~-~~Kl  162 (370)
T KOG0583|consen   91 --TPTKIYIVMEYCSGGDLFDYIVN----KGRLKEDEARKYFRQLISAVAYCHSR-GIVHRDLKPENILLDGNEG-NLKL  162 (370)
T ss_pred             --cCCeEEEEEEecCCccHHHHHHH----cCCCChHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEecCCCC-CEEE
Confidence              33448999999996 66666654    68899999999999999999999987 99999999999999998 6 8999


Q ss_pred             EeeCCcccc-ccCCCcccccccccccCcccccCCc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          216 CDFGSAKVL-VKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       216 ~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      +|||++... .......+.+||+.|+|||++.+.. +.+.++||||+||+||.|++|+.||...+.......+.+.    
T Consensus       163 ~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~----  238 (370)
T KOG0583|consen  163 SDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKG----  238 (370)
T ss_pred             eccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcC----
Confidence            999999988 4666777899999999999998877 6678999999999999999999999987766666654432    


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCC-ChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM-PPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                               .-.+|..+ |+++.+|+.+||..||.+|+|+.++++|
T Consensus       239 -------------------------~~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  239 -------------------------EFKIPSYLLSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             -------------------------CccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence                                     01155667 9999999999999999999999998766

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.9e-51  Score=375.99  Aligned_cols=244  Identities=32%  Similarity=0.487  Sum_probs=221.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +-|++++.||.|+.|.|-+|++..||+..|||++.+.       ...+++|+-+|+.+.|||++++|+.+     ....+
T Consensus        12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVw-----e~~~~   86 (786)
T KOG0588|consen   12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVW-----ENKQH   86 (786)
T ss_pred             cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeee-----ccCce
Confidence            4599999999999999999999999999999999765       57788999999999999999999999     66667


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|+|.||++| .|.+++-.    .+++++.+++.+++||+.|+.|+|.. +|+||||||+|+|+|.++ ++||+|||+|.
T Consensus        87 lylvlEyv~gGELFdylv~----kG~l~e~eaa~ff~QIi~gv~yCH~~-~icHRDLKpENlLLd~~~-nIKIADFGMAs  160 (786)
T KOG0588|consen   87 LYLVLEYVPGGELFDYLVR----KGPLPEREAAHFFRQILDGVSYCHAF-NICHRDLKPENLLLDVKN-NIKIADFGMAS  160 (786)
T ss_pred             EEEEEEecCCchhHHHHHh----hCCCCCHHHHHHHHHHHHHHHHHhhh-cceeccCCchhhhhhccc-CEeeeccceee
Confidence            9999999995 66655554    68999999999999999999999975 999999999999999998 69999999999


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ...++....+.||+|.|.|||++.+.++.+.++||||.|||||.||||+.||++++....+.++.++.            
T Consensus       161 Le~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~------------  228 (786)
T KOG0588|consen  161 LEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV------------  228 (786)
T ss_pred             cccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc------------
Confidence            98888888899999999999999999999999999999999999999999999888777777766531            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       -.+|..+|.++++||.+||..||.+|+|.+++++|
T Consensus       229 -----------------f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  229 -----------------FEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             -----------------ccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence                             11567899999999999999999999999998888

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-50  Score=340.19  Aligned_cols=251  Identities=29%  Similarity=0.475  Sum_probs=214.9

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+|...+.||.|+||.|.+++.+.+|..||+|++.+..       +...+|..+|+.+.||+++++++.+     .+.
T Consensus        42 ~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~-----~d~  116 (355)
T KOG0616|consen   42 SLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTF-----KDN  116 (355)
T ss_pred             chhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEee-----ccC
Confidence            3457999999999999999999999999999999986542       3345789999999999999999988     677


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .++|+||||++| .|..++..    .++|++..++.++.||+.||+|||+. +|++|||||+|||+|.+| -+||+|||+
T Consensus       117 ~~lymvmeyv~GGElFS~Lrk----~~rF~e~~arFYAAeivlAleylH~~-~iiYRDLKPENiLlD~~G-~iKitDFGF  190 (355)
T KOG0616|consen  117 SNLYMVMEYVPGGELFSYLRK----SGRFSEPHARFYAAEIVLALEYLHSL-DIIYRDLKPENLLLDQNG-HIKITDFGF  190 (355)
T ss_pred             CeEEEEEeccCCccHHHHHHh----cCCCCchhHHHHHHHHHHHHHHHHhc-CeeeccCChHHeeeccCC-cEEEEeccc
Confidence            779999999996 44444443    68999999999999999999999986 999999999999999999 799999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      |+.....  ..+.+|||.|+|||++.... ++.++|.|+|||++|||+.|.+||...+......+|....          
T Consensus       191 AK~v~~r--T~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~----------  257 (355)
T KOG0616|consen  191 AKRVSGR--TWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK----------  257 (355)
T ss_pred             eEEecCc--EEEecCCccccChHHhhcCC-CCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc----------
Confidence            9987443  67889999999999997665 8999999999999999999999999999988888887641          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC--cchhhccccccC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP--SLLVLHHFCFRS  371 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~--~~~~~~~~~~~~  371 (371)
                                         -.+|..+++++++||.++|+.|-.+|..         .++  .-.+-+||||+.
T Consensus       258 -------------------v~fP~~fs~~~kdLl~~LL~vD~t~R~g---------nlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  258 -------------------VKFPSYFSSDAKDLLKKLLQVDLTKRFG---------NLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             -------------------ccCCcccCHHHHHHHHHHHhhhhHhhhc---------CcCCCccccccCccccc
Confidence                               1267889999999999999999999921         111  223567777763

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=8e-50  Score=348.22  Aligned_cols=286  Identities=35%  Similarity=0.681  Sum_probs=240.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCC-eeecceeEEecCC-CCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPN-VVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~-~~~~  142 (371)
                      ..|..+++||+|.||+||+|+...+|+.||+|++.-+.      ....+|+.+|+.++|+| |+.+++++..... ....
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            45888899999999999999999999999999986443      23468999999999999 9999998865442 3345


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|+||++-+|...+....+....++...++.+++||+.||+|||++ +|+||||||.||||+++| .+||+|||+|+
T Consensus        91 ~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~-~IlHRDLKPQNlLi~~~G-~lKlaDFGlAr  168 (323)
T KOG0594|consen   91 KLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH-GILHRDLKPQNLLISSSG-VLKLADFGLAR  168 (323)
T ss_pred             eEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCcceEEECCCC-cEeeeccchHH
Confidence            6889999999999998887654446788899999999999999999987 999999999999999988 89999999998


Q ss_pred             ccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ... +....+...+|.+|+|||++.+...|+...||||+|||++||++++..|.+....+.+..|.+.+|.|..+.|+..
T Consensus       169 a~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v  248 (323)
T KOG0594|consen  169 AFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGV  248 (323)
T ss_pred             HhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCc
Confidence            765 3344567788999999999999988999999999999999999999999999999999999999999999998754


Q ss_pred             C--CCccccccCccc-CCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh--hcCCCc
Q 017452          302 N--PNYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL--FSNCPS  360 (371)
Q Consensus       302 ~--~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~--l~~~~~  360 (371)
                      .  +++.. .++... ...+....+ ..+++..+++.+||+++|.+|.||..++.|  |..+..
T Consensus       249 ~~~~~~k~-~f~~~~~~~~l~~~~~-~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~  310 (323)
T KOG0594|consen  249 SSLPDYKA-PFPKWPGPKDLSSILP-KLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPE  310 (323)
T ss_pred             cccccccc-cCcCCCCccchHHhcc-ccCccHHHHHHHHhccCcccCcCHHHHhcChhhccccc
Confidence            3  22222 333333 223333222 345799999999999999999999999999  666643

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=6.9e-49  Score=365.34  Aligned_cols=272  Identities=35%  Similarity=0.586  Sum_probs=224.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhH---HHHHHHHHcC-C-----CCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLD-H-----PNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~---~e~~~l~~l~-h-----~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||+|.||.|.+|.+..|++.||||+++.......   .|+.+|..|+ |     -|+|+++++|     ....
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F-----~fr~  261 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYF-----YFRN  261 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecc-----cccc
Confidence            78999999999999999999999999999999988766554   4788888886 3     4899999999     5666


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee-CCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~-~~~~~~kl~Dfg~a  221 (371)
                      ++|||+|.+..+|.+++....  ..+++...++.++.||+.||.+||+. ||||+||||+|||+. .+...|||+|||.|
T Consensus       262 HlciVfELL~~NLYellK~n~--f~Glsl~~ir~~~~Qil~~L~~L~~l-~IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  262 HLCIVFELLSTNLYELLKNNK--FRGLSLPLVRKFAQQILTALLFLHEL-GIIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             ceeeeehhhhhhHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCChhheeeccCCcCceeEEecccc
Confidence            799999999999999998633  56799999999999999999999985 999999999999995 34458999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      +.....-  .+.+.++.|.|||++.+.+ |+.+.||||||||++||++|.+.|.+.+..+.+..|+..+|.|+...+...
T Consensus       339 c~~~q~v--ytYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~  415 (586)
T KOG0667|consen  339 CFESQRV--YTYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTA  415 (586)
T ss_pred             cccCCcc--eeeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhc
Confidence            8764433  3778899999999998877 899999999999999999999999999999999999999999998877533


Q ss_pred             CCCcccccc-C------cc---------------------------cCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC
Q 017452          302 NPNYTEFKF-P------QI---------------------------KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT  347 (371)
Q Consensus       302 ~~~~~~~~~-~------~~---------------------------~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t  347 (371)
                      ......+.- .      ..                           ....|...++..-...+.+||.+||.+||.+|+|
T Consensus       416 ~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~t  495 (586)
T KOG0667|consen  416 KKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERIT  495 (586)
T ss_pred             cccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCC
Confidence            222211111 0      00                           1111222222222356899999999999999999


Q ss_pred             HHHHhhh
Q 017452          348 AVSKRIL  354 (371)
Q Consensus       348 ~~~~l~~  354 (371)
                      +.++|+|
T Consensus       496 p~qal~H  502 (586)
T KOG0667|consen  496 PAQALNH  502 (586)
T ss_pred             HHHHhcC
Confidence            9999999

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=350.52  Aligned_cols=256  Identities=31%  Similarity=0.515  Sum_probs=207.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .+|..++.||+|+||.||++.+..+|..+|||.+...    ....++|+.+|.+++|||||++++.......   ..+++
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~---~~~~i   93 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSREN---DEYNI   93 (313)
T ss_pred             chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccC---eeeEe
Confidence            4699999999999999999999999999999998665    3446899999999999999999986432221   45789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC-CCCcEEEEeeCCcccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVL  224 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~-~~~~~kl~Dfg~a~~~  224 (371)
                      .|||+. |+|.+++....   ..+++..++.+.+||++||+|||++ ||||+||||+|||++. ++ .+||+|||+++..
T Consensus        94 ~mEy~~~GsL~~~~~~~g---~~l~E~~v~~ytr~iL~GL~ylHs~-g~vH~DiK~~NiLl~~~~~-~~KlaDFG~a~~~  168 (313)
T KOG0198|consen   94 FMEYAPGGSLSDLIKRYG---GKLPEPLVRRYTRQILEGLAYLHSK-GIVHCDIKPANILLDPSNG-DVKLADFGLAKKL  168 (313)
T ss_pred             eeeccCCCcHHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCcccceEEEeCCCC-eEEeccCcccccc
Confidence            999999 47777776532   2799999999999999999999987 9999999999999999 56 8999999999876


Q ss_pred             cc----CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VK----GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~----~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ..    ........||+.|||||++.......+++|||||||++.||+||..||... ...+.+..+...   .      
T Consensus       169 ~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~---~------  239 (313)
T KOG0198|consen  169 ESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRE---D------  239 (313)
T ss_pred             ccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhcc---C------
Confidence            53    222346789999999999975333446999999999999999999999773 333322222211   0      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                               ..|         .+|..+|.++++||.+||..||++||||.++|+|.+.....
T Consensus       240 ---------~~P---------~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  240 ---------SLP---------EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             ---------CCC---------CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhccc
Confidence                     011         26778999999999999999999999999999996654433

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-49  Score=368.36  Aligned_cols=256  Identities=28%  Similarity=0.469  Sum_probs=216.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||+|+++..+.+++.||||.++++.       .....|..++... +||.++.++.+|     .
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~f-----Q  439 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCF-----Q  439 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeeccccc-----c
Confidence            34568999999999999999999999999999999987753       3334577777766 499999999999     6


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...++|+||||+.|+-  +...  ...+.|++..++.++..|+.||+|||++ ||||||||.+|||+|.+| .+||+|||
T Consensus       440 T~~~l~fvmey~~Ggd--m~~~--~~~~~F~e~rarfyaAev~l~L~fLH~~-~IIYRDlKLdNiLLD~eG-h~kiADFG  513 (694)
T KOG0694|consen  440 TKEHLFFVMEYVAGGD--LMHH--IHTDVFSEPRARFYAAEVVLGLQFLHEN-GIIYRDLKLDNLLLDTEG-HVKIADFG  513 (694)
T ss_pred             cCCeEEEEEEecCCCc--EEEE--EecccccHHHHHHHHHHHHHHHHHHHhc-CceeeecchhheEEcccC-cEEecccc
Confidence            6677999999999873  2222  2257899999999999999999999997 999999999999999999 79999999


Q ss_pred             Cccccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++..- .+....+.+|||.|||||++.+.. |+.++|+|||||+||||+.|..||.+.+..+....|...         
T Consensus       514 lcKe~m~~g~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d---------  583 (694)
T KOG0694|consen  514 LCKEGMGQGDRTSTFCGTPEFLAPEVLTEQS-YTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVND---------  583 (694)
T ss_pred             cccccCCCCCccccccCChhhcChhhhccCc-ccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcC---------
Confidence            998754 566778899999999999997655 899999999999999999999999999999988888762         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                                          .-.+|..+|.+..++++++|+.||++|+.+.+       ...-.+-.|||||+
T Consensus       584 --------------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e-------~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  584 --------------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGE-------RDAEDIKKHPFFRS  629 (694)
T ss_pred             --------------------CCCCCCcccHHHHHHHHHHhccCcccccCCCC-------CCchhhhhCCcccc
Confidence                                11267889999999999999999999988621       11112566777764

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=4e-48  Score=350.13  Aligned_cols=274  Identities=32%  Similarity=0.622  Sum_probs=223.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ..+|++.+.||.|+||.||+|.+..++..||+|++...     .....+|+.+++.++||||+++++++     ......
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~   78 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII-----HTERCL   78 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE-----cCCCeE
Confidence            35799999999999999999999999999999988532     22445899999999999999999987     344568


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~DfG~~~~~  153 (288)
T cd07871          79 TLVFEYLDSDLKQYLDNC---GNLMSMHNVKIFMFQLLRGLSYCHKR-KILHRDLKPQNLLINEKG-ELKLADFGLARAK  153 (288)
T ss_pred             EEEEeCCCcCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEECcCcceeec
Confidence            899999999887776532   34678999999999999999999987 999999999999999888 8999999998764


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++.+.|.....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07871         154 SVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITS  233 (288)
T ss_pred             cCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhcccc
Confidence            3222 223456789999999987666689999999999999999999999999888888899999999998888765432


Q ss_pred             --CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 --NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        .+....++.....++.. ....++.++.+||.+||++||.+|||+.|+++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         234 NEEFRSYLFPQYRAQPLIN-HAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             chhhhccccCccCCCchHH-hCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence              22233333333333332 234578999999999999999999999995544

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.4e-48  Score=352.89  Aligned_cols=248  Identities=31%  Similarity=0.502  Sum_probs=206.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|.++..||+|+||.||+|+.+.||..||+|++++..       .....|-.+|...++|.||++|-.|     .+.
T Consensus       139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-----QD~  213 (550)
T KOG0605|consen  139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-----QDK  213 (550)
T ss_pred             CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-----cCC
Confidence            4468999999999999999999999999999999997653       3334577888888999999999988     677


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .++||||||++| ++.+++..    .+.+++.+++.++.+++.|++.||+. |+|||||||+|+|||..| .+||+|||+
T Consensus       214 ~~LYLiMEylPGGD~mTLL~~----~~~L~e~~arfYiaE~vlAI~~iH~~-gyIHRDIKPdNlLiD~~G-HiKLSDFGL  287 (550)
T KOG0605|consen  214 EYLYLIMEYLPGGDMMTLLMR----KDTLTEDWARFYIAETVLAIESIHQL-GYIHRDIKPDNLLIDAKG-HIKLSDFGL  287 (550)
T ss_pred             CeeEEEEEecCCccHHHHHHh----cCcCchHHHHHHHHHHHHHHHHHHHc-CcccccCChhheeecCCC-CEeeccccc
Confidence            779999999996 55555554    68999999999999999999999986 999999999999999999 799999999


Q ss_pred             cccccc------------------------CC-----C-------------------cccccccccccCcccccCCcCCC
Q 017452          221 AKVLVK------------------------GE-----P-------------------NISYICSRYYRAPELIFGATEYT  252 (371)
Q Consensus       221 a~~~~~------------------------~~-----~-------------------~~~~~~t~~y~aPE~~~~~~~~~  252 (371)
                      +.-...                        ..     .                   ..+.+|||.|||||++.+.. |+
T Consensus       288 s~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~  366 (550)
T KOG0605|consen  288 STGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YG  366 (550)
T ss_pred             cchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCC-CC
Confidence            853211                        00     0                   01457899999999998776 89


Q ss_pred             CcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHH
Q 017452          253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD  332 (371)
Q Consensus       253 ~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~  332 (371)
                      ...|+||||||+||||.|.+||.+.+..+...+|+++.-..               .+|          -...+++++.|
T Consensus       367 ~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l---------------~fP----------~~~~~s~eA~D  421 (550)
T KOG0605|consen  367 KECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL---------------KFP----------EEVDLSDEAKD  421 (550)
T ss_pred             ccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc---------------cCC----------CcCcccHHHHH
Confidence            99999999999999999999999999999999888763111               111          11347899999


Q ss_pred             HHHhccCcCCCCCCC---HHHHhhh
Q 017452          333 LVSRLLQYSPNLRCT---AVSKRIL  354 (371)
Q Consensus       333 li~~~l~~dP~~R~t---~~~~l~~  354 (371)
                      ||.+||. ||.+|+.   ++||.+|
T Consensus       422 LI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  422 LITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHHhc-CHHHhcCcccHHHHhcC
Confidence            9999999 9999986   6674433

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.1e-49  Score=358.04  Aligned_cols=243  Identities=30%  Similarity=0.494  Sum_probs=211.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|.+.+.||+|.||.||+|+.+.+.+.||+|.+.+..      ....+|+++++.++|||||.+++.|     +....+
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf-----Et~~~~   76 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF-----ETSAHL   76 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh-----cccceE
Confidence            46899999999999999999999999999999885432      3356899999999999999999999     566669


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|.||+.|+|..++..    .+.++++.++.++.|++.||.|||+. +|+|||+||.|||+...+ .+|+||||+|+.+
T Consensus        77 ~vVte~a~g~L~~il~~----d~~lpEe~v~~~a~~LVsaL~yLhs~-rilhrd~kPqniLl~~~~-~~KlcdFg~Ar~m  150 (808)
T KOG0597|consen   77 WVVTEYAVGDLFTILEQ----DGKLPEEQVRAIAYDLVSALYYLHSN-RILHRDMKPQNILLEKGG-TLKLCDFGLARAM  150 (808)
T ss_pred             EEEehhhhhhHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHhc-CcccccCCcceeeecCCC-ceeechhhhhhhc
Confidence            99999999999988876    78999999999999999999999986 999999999999999888 8999999999987


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..+.. ....-|||.|||||.+.+.. |+..+|+|||||++||+.+|++||......+....|.+....           
T Consensus       151 ~~~t~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~-----------  218 (808)
T KOG0597|consen  151 STNTSVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVK-----------  218 (808)
T ss_pred             ccCceeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCC-----------
Confidence            66543 34567999999999997655 899999999999999999999999876665555555442111           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        .|..+|..+..|+..+|.+||.+|+|-.+++.|
T Consensus       219 ------------------~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  219 ------------------PPSTASSSFVNFLQGLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             ------------------CcccccHHHHHHHHHHhhcChhhcccHHHHhcC
Confidence                              344689999999999999999999999997666

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-48  Score=356.17  Aligned_cols=245  Identities=29%  Similarity=0.489  Sum_probs=211.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec----chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..|....+||+|+.|.||.|....+++.||||.+..    .++.+.+|+.+|+...|+|||.+++.|+..++     +++
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~de-----LWV  347 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDE-----LWV  347 (550)
T ss_pred             hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccce-----eEE
Confidence            358888999999999999999999999999999853    35666789999999999999999999976543     899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++| +|.+.+.     ...++|..++.+++++++||+|||.+ ||+|||||.+|||++.+| .+||+|||++....
T Consensus       348 VMEym~ggsLTDvVt-----~~~~~E~qIA~Icre~l~aL~fLH~~-gIiHrDIKSDnILL~~~g-~vKltDFGFcaqi~  420 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVT-----KTRMTEGQIAAICREILQGLKFLHAR-GIIHRDIKSDNILLTMDG-SVKLTDFGFCAQIS  420 (550)
T ss_pred             EEeecCCCchhhhhh-----cccccHHHHHHHHHHHHHHHHHHHhc-ceeeeccccceeEeccCC-cEEEeeeeeeeccc
Confidence            9999996 6666665     45699999999999999999999987 999999999999999998 89999999887765


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ...+.+|||+|||||++... .|+++.||||||++.+||+-|.+||-..+....+..|... |.|..         
T Consensus       421 ~~~~KR~TmVGTPYWMAPEVvtrk-~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~n-g~P~l---------  489 (550)
T KOG0578|consen  421 EEQSKRSTMVGTPYWMAPEVVTRK-PYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTPKL---------  489 (550)
T ss_pred             cccCccccccCCCCccchhhhhhc-ccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhc-CCCCc---------
Confidence            544 55678999999999999554 4999999999999999999999999887777766666543 22221         


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ..++.+|+.+++||.+||..|+.+|++|.|+|+|
T Consensus       490 ----------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  490 ----------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             ----------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcC
Confidence                            1456799999999999999999999999999998

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-47  Score=338.86  Aligned_cols=270  Identities=26%  Similarity=0.432  Sum_probs=216.2

Q ss_pred             CCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           64 NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ...+.....|.+...||.|..++||+|++..+++.||||++.-+     ...+.+|+..++.++||||++++.+|.... 
T Consensus        19 ~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~-   97 (516)
T KOG0582|consen   19 KEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDS-   97 (516)
T ss_pred             ccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecc-
Confidence            34455567899999999999999999999999999999999543     356678999999999999999999985443 


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                          .+|+||+||. |++.+++....  ...++|..+..|++++++||.|||.+ |.||||||+.||||+.+| .|||+|
T Consensus        98 ----~LWvVmpfMa~GS~ldIik~~~--~~Gl~E~~Ia~iLre~LkaL~YLH~~-G~IHRdvKAgnILi~~dG-~VkLad  169 (516)
T KOG0582|consen   98 ----ELWVVMPFMAGGSLLDIIKTYY--PDGLEEASIATILREVLKALDYLHQN-GHIHRDVKAGNILIDSDG-TVKLAD  169 (516)
T ss_pred             ----eeEEeehhhcCCcHHHHHHHHc--cccccHHHHHHHHHHHHHHHHHHHhc-CceecccccccEEEcCCC-cEEEcC
Confidence                4899999999 68888888765  46699999999999999999999987 999999999999999999 899999


Q ss_pred             eCCccccccCC-Cc----ccccccccccCccccc-CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          218 FGSAKVLVKGE-PN----ISYICSRYYRAPELIF-GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       218 fg~a~~~~~~~-~~----~~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      ||.+..+.... ..    ....||++|||||++. ....|+.|+||||||++..||++|..||........+..-.+  +
T Consensus       170 Fgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLq--n  247 (516)
T KOG0582|consen  170 FGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQ--N  247 (516)
T ss_pred             ceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhc--C
Confidence            99765543332 21    3458899999999953 334589999999999999999999999988877665543333  3


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh--hcCCCcc
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL--FSNCPSL  361 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~--l~~~~~~  361 (371)
                      .|+......                 ....-.+.++..++.++..||.+||.+||||.++++|  |.+.+..
T Consensus       248 ~pp~~~t~~-----------------~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  248 DPPTLLTSG-----------------LDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             CCCCccccc-----------------CChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence            333111000                 0000123467899999999999999999999998888  4444433

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=4.4e-47  Score=345.85  Aligned_cols=275  Identities=31%  Similarity=0.519  Sum_probs=211.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++.     .....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~   78 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIH-----TKETL   78 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEe-----cCCeE
Confidence            357999999999999999999999999999999885432     23467999999999999999999883     34458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+.+++.+.+..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        79 ~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~  153 (303)
T cd07869          79 TLVFEYVHTDLCQYMDK---HPGGLHPENVKLFLFQLLRGLSYIHQR-YILHRDLKPQNLLISDTG-ELKLADFGLARAK  153 (303)
T ss_pred             EEEEECCCcCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECCCCcceec
Confidence            99999999988777653   245689999999999999999999987 999999999999999887 8999999998754


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... .......+++.|+|||++.+...++.++|+|||||++|+|++|..||.+... .+.+..+....+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (303)
T cd07869         154 SVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVH  233 (303)
T ss_pred             cCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchh
Confidence            322 2223456789999999987666678899999999999999999999987544 34556666666666655543322


Q ss_pred             C--CccccccCcccCCCCcccC-CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 P--NYTEFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~--~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  .+....+.......+...+ ....++++.+|+.+||+.||.+|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         234 SLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             hccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence            1  1100011111111111111 11356789999999999999999999997776

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-48  Score=346.76  Aligned_cols=256  Identities=29%  Similarity=0.431  Sum_probs=209.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------------------hhhhHHHHHHHHHcCCCCeeec
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------------KRYKNRELQTMRLLDHPNVVSL  129 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------~~~~~~e~~~l~~l~h~niv~~  129 (371)
                      ...+.|++.+.||+|.||.|-+|++..+++.||||++.+.                  .+...+|+.+|+++.|||||++
T Consensus        94 k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~L  173 (576)
T KOG0585|consen   94 KQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKL  173 (576)
T ss_pred             eehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEE
Confidence            4557899999999999999999999999999999998442                  1345689999999999999999


Q ss_pred             ceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCC-CCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      +.+.   ++.....+|||+|||..+  ... .. ...+. +++.++++++++++.||+|||.+ |||||||||+|+|++.
T Consensus       174 iEvL---DDP~s~~~YlVley~s~G--~v~-w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Q-giiHRDIKPsNLLl~~  245 (576)
T KOG0585|consen  174 IEVL---DDPESDKLYLVLEYCSKG--EVK-WC-PPDKPELSEQQARKYLRDVVLGLEYLHYQ-GIIHRDIKPSNLLLSS  245 (576)
T ss_pred             EEee---cCcccCceEEEEEeccCC--ccc-cC-CCCcccccHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEEcC
Confidence            9887   345566789999999954  111 11 22344 89999999999999999999997 9999999999999999


Q ss_pred             CCCcEEEEeeCCccccccC------CCcccccccccccCcccccC---CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc
Q 017452          209 HTHQVKLCDFGSAKVLVKG------EPNISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG  279 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~------~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~~~  279 (371)
                      +| .+||+|||.+.....+      .......|||.|+|||.+.+   ....+.+.||||+||+||.|+.|+.||.+...
T Consensus       246 ~g-~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~  324 (576)
T KOG0585|consen  246 DG-TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFE  324 (576)
T ss_pred             CC-cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchH
Confidence            98 9999999988765222      22335789999999999976   34467799999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      .+...+|++..                 ..++.          ...+...+++||.+||.+||++|++..++..|..-..
T Consensus       325 ~~l~~KIvn~p-----------------L~fP~----------~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~  377 (576)
T KOG0585|consen  325 LELFDKIVNDP-----------------LEFPE----------NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTR  377 (576)
T ss_pred             HHHHHHHhcCc-----------------ccCCC----------cccccHHHHHHHHHHhhcChhheeehhhheecceecc
Confidence            88887777631                 11111          1136889999999999999999999999888855443

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.3e-47  Score=341.50  Aligned_cols=276  Identities=34%  Similarity=0.559  Sum_probs=216.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECC-CCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceeEEecCCCCc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~  141 (371)
                      +|++.+.||+|+||.||+|.+.. ++..||+|.+....      ....+|+.+++.+   +||||+++++++........
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~   81 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE   81 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCC
Confidence            69999999999999999999854 46889999885321      2344677777665   69999999998765443445


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~-~iiH~dlkp~Nil~~~~~-~~kl~Dfg~~  157 (290)
T cd07862          82 TKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFGLA  157 (290)
T ss_pred             CcEEEEEccCCCCHHHHHHhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEcCCC-CEEEccccce
Confidence            5688999999998888776422  34689999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .............+++.|+|||.+.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+....+...
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~  236 (290)
T cd07862         158 RIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD  236 (290)
T ss_pred             EeccCCcccccccccccccChHHHhCCC-CCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhh
Confidence            8765444444567899999999986544 789999999999999999999999999888888888888877766655322


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .. .....+......++.. +...++..+.+|+.+||+.||++|||+.++++|
T Consensus       237 ~~-~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         237 VA-LPRQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hc-ccchhccCCCCCCHHH-HccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence            11 1111111111122222 223578899999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.1e-47  Score=350.67  Aligned_cols=276  Identities=38%  Similarity=0.674  Sum_probs=217.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||+|.+..+|..||||++...      .....+|+.+++.++||||+++++++..........++
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~   80 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY   80 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence            599999999999999999999999999999988532      22355799999999999999999988655444445688


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++...
T Consensus        81 lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kL~Dfg~~~~~~  154 (338)
T cd07859          81 VVFELMESDLHQVIKA----NDDLTPEHHQFFLYQLLRALKYIHTA-NVFHRDLKPKNILANADC-KLKICDFGLARVAF  154 (338)
T ss_pred             EEEecCCCCHHHHHHh----cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEccCccccccc
Confidence            9999999888777654    45789999999999999999999987 999999999999999888 89999999987643


Q ss_pred             cCCC----cccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGEP----NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~~----~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ....    .....+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+....+..+....+.++...+..
T Consensus       155 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (338)
T cd07859         155 NDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISR  234 (338)
T ss_pred             cccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            2211    1245689999999998542 3478899999999999999999999998887777777777778777665543


Q ss_pred             cCCCccc-c--ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTE-F--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....... +  ........++...+ ..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       235 i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         235 VRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhhHHHHHHhhcccCCCchHHhc-CCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            2211100 0  00000001111112 2467889999999999999999999998887

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.6e-46  Score=339.42  Aligned_cols=272  Identities=36%  Similarity=0.675  Sum_probs=215.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||+|+||.||+|++..+++.||+|++...      .....+|+.+++.++||||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~   76 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF-----RRRGKLY   76 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE-----ecCCEEE
Confidence            699999999999999999999999999999988643      23345799999999999999999988     3445689


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.+++...+..   ....+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  151 (287)
T cd07848          77 LVFEYVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKN-DIVHRDIKPENLLISHND-VLKLCDFGFARNLS  151 (287)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccCccccc
Confidence            9999999876665543   245789999999999999999999986 999999999999999888 89999999998754


Q ss_pred             cCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....+++.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+....+..+.+.+.....
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (287)
T cd07848         152 EGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYS  230 (287)
T ss_pred             ccccccccccccccccCCcHHHcCCC-CCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhc
Confidence            3221  22456899999999997655 78999999999999999999999998887777777777777776665543221


Q ss_pred             --CccccccCccc-CCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 --NYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 --~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        .......+... ...+.......+|.++.+||.+||++||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         231 NPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             cchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence              11111111111 1112222334578999999999999999999999995543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-47  Score=345.36  Aligned_cols=254  Identities=28%  Similarity=0.427  Sum_probs=209.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcE-EEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGET-VAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~-vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ...+.+.||.|+||+||+|.+  .|.. ||+|++...      ...+.+|+.+|.+++|||||++++++.....    .+
T Consensus        42 ~l~~~~~iG~G~~g~V~~~~~--~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~----~~  115 (362)
T KOG0192|consen   42 ELPIEEVLGSGSFGTVYKGKW--RGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG----SL  115 (362)
T ss_pred             HhhhhhhcccCCceeEEEEEe--CCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC----ce
Confidence            355566799999999999998  4556 999998653      2367789999999999999999999843321    47


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC-cEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|||||++ |+|..++...  ....++...+..|+.||++|++|||++ + ||||||||+|||++.++..+||+|||+++
T Consensus       116 ~iVtEy~~~GsL~~~l~~~--~~~~l~~~~~l~~aldiArGm~YLH~~-~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr  192 (362)
T KOG0192|consen  116 CIVTEYMPGGSLSVLLHKK--RKRKLPLKVRLRIALDIARGMEYLHSE-GPIIHRDLKSDNILVDLKGKTLKIADFGLSR  192 (362)
T ss_pred             EEEEEeCCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCeeecccChhhEEEcCCCCEEEECCCccce
Confidence            89999999 5777776643  367899999999999999999999987 8 99999999999999885589999999998


Q ss_pred             ccccC-CCcccccccccccCcccccC-CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          223 VLVKG-EPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       223 ~~~~~-~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ..... .......||+.|||||++.+ ...++.++||||||+++|||+||+.||......+....+.....+++      
T Consensus       193 ~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~------  266 (362)
T KOG0192|consen  193 EKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPP------  266 (362)
T ss_pred             eeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------
Confidence            76554 33344789999999999974 24589999999999999999999999998887555555544322221      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                           ++..+++.+..++..||..||.+||+..+++..|+.+...
T Consensus       267 ---------------------~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~  306 (362)
T KOG0192|consen  267 ---------------------IPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSH  306 (362)
T ss_pred             ---------------------CCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHh
Confidence                                 4555889999999999999999999999999998876554

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-49  Score=325.66  Aligned_cols=250  Identities=28%  Similarity=0.399  Sum_probs=213.1

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+.|.+.+.||+|.|+.|+++.+..+|+.+|+|++.-      +.+.+++|+.+-+.|+|||||++.+.+     ....
T Consensus         9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti-----~~~~   83 (355)
T KOG0033|consen    9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   83 (355)
T ss_pred             cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhh-----cccc
Confidence            44579999999999999999999999999999998732      346678999999999999999999988     6777


Q ss_pred             eEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC--CCCcEEEEeeC
Q 017452          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~--~~~~~kl~Dfg  219 (371)
                      +.|+|+|++.|+ |...+-.    ...+++..+..+++||+.+|.|+|.+ ||||||+||+|+++-+  ++.-+||+|||
T Consensus        84 ~~ylvFe~m~G~dl~~eIV~----R~~ySEa~aSH~~rQiLeal~yCH~n-~IvHRDvkP~nllLASK~~~A~vKL~~FG  158 (355)
T KOG0033|consen   84 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILEALAYCHSN-GIVHRDLKPENLLLASKAKGAAVKLADFG  158 (355)
T ss_pred             eeEEEEecccchHHHHHHHH----HHHHHHHHHHHHHHHHHHHHHHHHhc-CceeccCChhheeeeeccCCCceeecccc
Confidence            899999999974 3332222    25678999999999999999999998 9999999999999943  33469999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      +|..+..+.......|||.|||||++...+ ++..+|||+.||+||-|+.|.+||.+.+....+++|.+..-..+.    
T Consensus       159 vAi~l~~g~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~----  233 (355)
T KOG0033|consen  159 LAIEVNDGEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPS----  233 (355)
T ss_pred             eEEEeCCccccccccCCCcccCHHHhhcCC-CCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCC----
Confidence            999988777777889999999999997666 899999999999999999999999998888888888774221111    


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      .     .+..++++.++|+++||..||.+|+|+.|+|+|
T Consensus       234 ----------------~-----~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~H  267 (355)
T KOG0033|consen  234 ----------------P-----EWDTVTPEAKSLIRRMLTVNPKKRITADEALKH  267 (355)
T ss_pred             ----------------c-----ccCcCCHHHHHHHHHHhccChhhhccHHHHhCC
Confidence                            1     235689999999999999999999999997766

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=8.1e-46  Score=334.96  Aligned_cols=276  Identities=29%  Similarity=0.506  Sum_probs=216.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.+   +||||+++++++.........
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            5899999999999999999999999999999885421      2344677776655   799999999987655444456


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..+++|||+.+++...+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus        81 ~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~kl~dfg~~~  156 (288)
T cd07863          81 KVTLVFEHVDQDLRTYLDKVP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-QVKLADFGLAR  156 (288)
T ss_pred             eEEEEEcccccCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccCccc
Confidence            688999999998877766432  34589999999999999999999987 999999999999999888 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............++..|+|||++.+.. ++.++|||||||++|+|++|.+||......+.+..+....+.+....+....
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (288)
T cd07863         157 IYSCQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDV  235 (288)
T ss_pred             cccCcccCCCccccccccCchHhhCCC-CCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccc
Confidence            765444444567899999999986544 8999999999999999999999999888888888888887777665554211


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .. ....+......++.. ....++..+.++|.+||++||.+|||+.+++.|
T Consensus       236 ~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         236 TL-PRGAFSPRGPRPVQS-VVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cc-cccccCCCCCCchHH-hCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            10 001111111111111 223578899999999999999999999995543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=7e-46  Score=338.86  Aligned_cols=273  Identities=33%  Similarity=0.639  Sum_probs=221.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+....     ....+|+.+++.++||||+++++++..     ....+
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   80 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHT-----DKSLT   80 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEee-----CCeEE
Confidence            57999999999999999999999999999999885332     234579999999999999999998843     34578


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~  155 (309)
T cd07872          81 LVFEYLDKDLKQYMDDC---GNIMSMHNVKIFLYQILRGLAYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  155 (309)
T ss_pred             EEEeCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECccccceecC
Confidence            99999999877766532   35688999999999999999999987 999999999999999888 89999999987543


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.|......
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (309)
T cd07872         156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN  235 (309)
T ss_pred             CCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcch
Confidence            222 2234567889999999876666889999999999999999999999998888888899999898888777644322


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        +....++.....++.. ....+++++.+||.+||..||.+|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         236 DEFKNYNFPKYKPQPLIN-HAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhhhhhcCccCCCchhh-hccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence              1122222222222222 123578999999999999999999999998877

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-45  Score=344.63  Aligned_cols=276  Identities=29%  Similarity=0.527  Sum_probs=216.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~  141 (371)
                      ...+|++.+.||+|+||.||+|.+..+|..||+|++...      .....+|+.+++.++||||+++++++..... ...
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~   98 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF   98 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence            346899999999999999999999999999999998542      2334579999999999999999998754322 122


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ...|+||||+++++...+.      ..+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        99 ~~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~~L~~LH~~-~ivHrDlkp~NIl~~~~~-~~kl~Dfg~a  170 (359)
T cd07876          99 QDVYLVMELMDANLCQVIH------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLA  170 (359)
T ss_pred             ceeEEEEeCCCcCHHHHHh------ccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEecCCCc
Confidence            4578999999998766553      3578899999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .............+|+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.+..+....+.+..+.+..+.+...
T Consensus       171 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (359)
T cd07876         171 RTACTNFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRL  249 (359)
T ss_pred             cccccCccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHH
Confidence            7654444445567899999999996644 789999999999999999999999988888888888888777766543321


Q ss_pred             C----------CCccccccCcccCCCCc----ccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 N----------PNYTEFKFPQIKAHPWH----KIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~----------~~~~~~~~~~~~~~~~~----~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .          +......+... ...|.    .......+.++.+||.+||..||.+|||+.|+++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  315 (359)
T cd07876         250 QPTVRNYVENRPQYPGISFEEL-FPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH  315 (359)
T ss_pred             HHHHHHHHhhCCCCCCcchhhh-ccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence            1          11111111000 00010    01223357889999999999999999999998888

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.7e-46  Score=336.52  Aligned_cols=240  Identities=27%  Similarity=0.411  Sum_probs=201.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+++++.++||||+++++.+     .+..++
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~   76 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTE-----HDQRFL   76 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhh-----ccCCeE
Confidence            699999999999999999999999999999998542       23356799999999999999998877     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.+ +|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~NIli~~~~-~~kl~Dfg~~~~  150 (291)
T cd05612          77 YMLMEYVPGGELFSYLRN----SGRFSNSTGLFYASEIVCALEYLHSK-EIVYRDLKPENILLDKEG-HIKLTDFGFAKK  150 (291)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEEecCcchh
Confidence            999999985 66666654    46789999999999999999999987 999999999999999887 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....|++.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+....+....             
T Consensus       151 ~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-------------  214 (291)
T cd05612         151 LRDR--TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-------------  214 (291)
T ss_pred             ccCC--cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-------------
Confidence            5332  23456899999999986544 7899999999999999999999998877655555443310             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                      ..++..++..+.+||.+||+.||.+|++     +.++++|
T Consensus       215 ----------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         215 ----------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             ----------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence                            0144567899999999999999999995     9998887

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=9.9e-46  Score=333.98  Aligned_cols=247  Identities=23%  Similarity=0.364  Sum_probs=199.9

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      |++.+.||+|+||.||+|.+..+|+.||+|.+....       ....+|+.+++.++|+||+++++++     ....+.+
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~-----~~~~~~~   76 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE-----ccCCeEE
Confidence            889999999999999999999999999999885431       2345799999999999999998887     3444689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|...+...  ....+++..+..++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++...
T Consensus        77 lv~e~~~~g~L~~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nill~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05631          77 LVLTIMNGGDLKFHIYNM--GNPGFDEQRAIFYAAELCCGLEDLQRE-RIVYRDLKPENILLDDRG-HIRISDLGLAVQI  152 (285)
T ss_pred             EEEEecCCCcHHHHHHhh--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeCCCcEEc
Confidence            99999985 565554432  234689999999999999999999986 999999999999999887 8999999999876


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...........+.......           
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~-----------  220 (285)
T cd05631         153 PEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-----------  220 (285)
T ss_pred             CCCCeecCCCCCCCccCHhhhcCCC-CCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcc-----------
Confidence            5444444567899999999997554 8999999999999999999999998765433333332221110           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                    ...++..++.++.+|+.+||+.||.+||+     +.++++|
T Consensus       221 --------------~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         221 --------------QEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             --------------cccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcC
Confidence                          11145568999999999999999999997     8998877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=6.5e-46  Score=347.61  Aligned_cols=277  Identities=33%  Similarity=0.545  Sum_probs=219.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+++++.++|+||+++++++...........+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~   80 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY   80 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence            378899999999999999999999999999988542      23456799999999999999999988544322233688


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++....
T Consensus        81 lv~e~~~~~l~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~a~~~~  154 (372)
T cd07853          81 VVTELMQSDLHKIIVS----PQPLSSDHVKVFLYQILRGLKYLHSA-GILHRDIKPGNLLVNSNC-VLKICDFGLARVEE  154 (372)
T ss_pred             EEeeccccCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHHEEECCCC-CEEeccccceeecc
Confidence            9999999887776643    56799999999999999999999987 999999999999999888 89999999987653


Q ss_pred             cCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+.+.....
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~  234 (372)
T cd07853         155 PDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACE  234 (372)
T ss_pred             cCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhH
Confidence            322  122346788999999997766678999999999999999999999999988888888988888888776543221


Q ss_pred             CccccccCcccCCC-Cc--ccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHP-WH--KIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~-~~--~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .............+ +.  ..+....++++.+||.+||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         235 GARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence            11111000000000 00  01234568899999999999999999999999998

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=7.9e-46  Score=341.27  Aligned_cols=242  Identities=29%  Similarity=0.422  Sum_probs=201.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   91 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSF-----QDEN   91 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEE-----EcCC
Confidence            457999999999999999999999999999999986432       3356799999999999999999988     3445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        92 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  165 (329)
T PTZ00263         92 RVYFLLEFVVGGELFTHLRK----AGRFPNDVAKFYHAELVLAFEYLHSK-DIIYRDLKPENLLLDNKG-HVKVTDFGFA  165 (329)
T ss_pred             EEEEEEcCCCCChHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEECCCC-CEEEeeccCc
Confidence            58999999985 66666653    46789999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ......  .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+...  .         
T Consensus       166 ~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~--~---------  231 (329)
T PTZ00263        166 KKVPDR--TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAG--R---------  231 (329)
T ss_pred             eEcCCC--cceecCChhhcCHHHHcCCC-CCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcC--C---------
Confidence            765332  23467899999999996654 789999999999999999999999876655444443321  0         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                        ..++..++..+.+||.+||+.||.+|++     +.++++|
T Consensus       232 ------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        232 ------------------LKFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             ------------------cCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                              0134457899999999999999999997     7998877

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=4.6e-45  Score=351.36  Aligned_cols=274  Identities=23%  Similarity=0.357  Sum_probs=207.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCC------CeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHP------NVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~------niv~~~~~~~~~~~~~  140 (371)
                      .++|++.+.||+|+||+||+|.+..+++.||||++...   ......|+.+++.+.|.      +++++++++..    .
T Consensus       128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~----~  203 (467)
T PTZ00284        128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN----E  203 (467)
T ss_pred             CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc----C
Confidence            46899999999999999999999999999999998643   22345678888777554      47777776632    2


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---------
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---------  211 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---------  211 (371)
                      ..++|+||++++++|.+.+..    ...+++..++.++.||+.||+|||.+.|||||||||+|||++.++.         
T Consensus       204 ~~~~~iv~~~~g~~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~  279 (467)
T PTZ00284        204 TGHMCIVMPKYGPCLLDWIMK----HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRA  279 (467)
T ss_pred             CceEEEEEeccCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccc
Confidence            345789999999888877654    4679999999999999999999997459999999999999986542         


Q ss_pred             ------cEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 017452          212 ------QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE  285 (371)
Q Consensus       212 ------~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  285 (371)
                            .+||+|||.+....  .......||+.|+|||++.+.. ++.++|||||||++|||++|+.||.+.+..+.+..
T Consensus       280 ~~~~~~~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  356 (467)
T PTZ00284        280 LPPDPCRVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHL  356 (467)
T ss_pred             cCCCCceEEECCCCccccCc--cccccccCCccccCcHHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence                  49999999876432  2234567899999999997654 89999999999999999999999999888888888


Q ss_pred             HHHHhCCCCHhHHhhcCCC-cccc-----cc-CcccCCCCccc-----C-CCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          286 IIKVLGTPTREEIKCMNPN-YTEF-----KF-PQIKAHPWHKI-----F-PKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~-~~~~-----~~-~~~~~~~~~~~-----~-~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                      +.+.++.++..+....... ...+     .+ +......+...     . ....++.+.+||.+||++||.+|||+.|+|
T Consensus       357 i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L  436 (467)
T PTZ00284        357 MEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMT  436 (467)
T ss_pred             HHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHh
Confidence            8888888776543221100 0000     00 00000000000     0 001246788999999999999999999988


Q ss_pred             hh
Q 017452          353 IL  354 (371)
Q Consensus       353 ~~  354 (371)
                      +|
T Consensus       437 ~H  438 (467)
T PTZ00284        437 TH  438 (467)
T ss_pred             cC
Confidence            88

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7e-47  Score=332.04  Aligned_cols=246  Identities=24%  Similarity=0.403  Sum_probs=218.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ....+|.+.+.||+|.||+|-+|.+...|+.||||.+.++       ...+.+|++||..|+||||+.+|..|     +.
T Consensus        50 nlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVF-----EN  124 (668)
T KOG0611|consen   50 NLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVF-----EN  124 (668)
T ss_pred             chhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhh-----cC
Confidence            3446899999999999999999999999999999988654       23456899999999999999999998     44


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+.|||||.. |.|++++..    .+.+++.+++.+++||+.|+.|+|++ +++|||||.+|||+|.++ ++||+|||
T Consensus       125 kdKIvivMEYaS~GeLYDYiSe----r~~LsErEaRhfFRQIvSAVhYCHkn-rVvHRDLKLENILLD~N~-NiKIADFG  198 (668)
T KOG0611|consen  125 KDKIVIVMEYASGGELYDYISE----RGSLSEREARHFFRQIVSAVHYCHKN-RVVHRDLKLENILLDQNN-NIKIADFG  198 (668)
T ss_pred             CceEEEEEEecCCccHHHHHHH----hccccHHHHHHHHHHHHHHHHHHhhc-cceecccchhheeecCCC-Ceeeeccc
Confidence            444889999998 688888876    57899999999999999999999987 999999999999999998 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++..+.......+++|+|-|.+||++.+.++-++.+|.||||++||.|+.|..||++.+....+.+|.++.-        
T Consensus       199 LSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaY--------  270 (668)
T KOG0611|consen  199 LSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAY--------  270 (668)
T ss_pred             hhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccc--------
Confidence            999988888888999999999999999999889999999999999999999999999988777777765321        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            .....+.++.-||+.||..||.+|.|+.++..|
T Consensus       271 ----------------------rEP~~PSdA~gLIRwmLmVNP~RRATieDiAsH  303 (668)
T KOG0611|consen  271 ----------------------REPETPSDASGLIRWMLMVNPERRATIEDIASH  303 (668)
T ss_pred             ----------------------cCCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence                                  112346788999999999999999999999888

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=3.3e-45  Score=341.95  Aligned_cols=276  Identities=29%  Similarity=0.509  Sum_probs=218.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            46899999999999999999999999999999998542      2334578999999999999999987743321 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..|+||||+++++...+.      ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       103 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~  174 (364)
T cd07875         103 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  174 (364)
T ss_pred             eEEEEEeCCCCCHHHHHH------hcCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEECCCC-cEEEEeCCCcc
Confidence            578999999998776654      3478889999999999999999987 999999999999999888 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+....+.+..+.+....
T Consensus       175 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (364)
T cd07875         175 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  253 (364)
T ss_pred             ccCCCCcccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhh
Confidence            765444445567899999999996644 7899999999999999999999999998888888888888887766544332


Q ss_pred             CCc----------cccccCcc---cCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNY----------TEFKFPQI---KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~----------~~~~~~~~---~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ...          ..+.+...   ...++........+..+.+||.+||+.||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         254 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            211          11111000   00111122223356789999999999999999999998888

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=1.7e-45  Score=342.69  Aligned_cols=276  Identities=30%  Similarity=0.518  Sum_probs=218.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            46899999999999999999999999999999988543      1334578999999999999999998754322 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++||||+++++...+.      ..+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        96 ~~~lv~e~~~~~l~~~~~------~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDikp~Nill~~~~-~~kl~Dfg~~~  167 (355)
T cd07874          96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  167 (355)
T ss_pred             eeEEEhhhhcccHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEECCCC-CEEEeeCcccc
Confidence            578999999998766553      3578899999999999999999987 999999999999999888 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............+|+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+....+.+..+.+..+.
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (355)
T cd07874         168 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  246 (355)
T ss_pred             cCCCccccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhc
Confidence            765544445567899999999986554 7899999999999999999999999988888888888888877766554332


Q ss_pred             CCc----------cccccCcccC---CCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNY----------TEFKFPQIKA---HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~----------~~~~~~~~~~---~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +..          ....++....   .++....+...+.++.+||.+||..||.+|||+.++++|
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         247 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence            211          1111111100   011112233456789999999999999999999999988

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.4e-45  Score=325.02  Aligned_cols=250  Identities=27%  Similarity=0.457  Sum_probs=209.1

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .....|++.+.||.|.-|+||+|+.+.++..+|+|++.+..       ...+.|.+||+.++||.++++|+.|     ..
T Consensus        74 l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~f-----et  148 (459)
T KOG0610|consen   74 LGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASF-----ET  148 (459)
T ss_pred             cCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhhee-----ec
Confidence            33457999999999999999999999999999999996542       3345689999999999999999999     77


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ..+.|++||||+| +|..+.+.  +..+.|++..++.++..++-||+|||. +|||+|||||+||||..+| .|.|+||.
T Consensus       149 ~~~~cl~meyCpGGdL~~Lrqk--Qp~~~fse~~aRFYaAEvl~ALEYLHm-lGivYRDLKPENILvredG-HIMLsDFD  224 (459)
T KOG0610|consen  149 DKYSCLVMEYCPGGDLHSLRQK--QPGKRFSESAARFYAAEVLLALEYLHM-LGIVYRDLKPENILVREDG-HIMLSDFD  224 (459)
T ss_pred             cceeEEEEecCCCccHHHHHhh--CCCCccchhhHHHHHHHHHHHHHHHHh-hceeeccCCcceeEEecCC-cEEeeecc
Confidence            7789999999996 66555543  447889999999999999999999997 5999999999999999999 79999999


Q ss_pred             Ccccccc---------------------------------C-C-----------------------CcccccccccccCc
Q 017452          220 SAKVLVK---------------------------------G-E-----------------------PNISYICSRYYRAP  242 (371)
Q Consensus       220 ~a~~~~~---------------------------------~-~-----------------------~~~~~~~t~~y~aP  242 (371)
                      ++.....                                 . .                       ...+.+||-.|.||
T Consensus       225 LS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAP  304 (459)
T KOG0610|consen  225 LSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAP  304 (459)
T ss_pred             ccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccc
Confidence            8643200                                 0 0                       01245678899999


Q ss_pred             ccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccC
Q 017452          243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF  322 (371)
Q Consensus       243 E~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  322 (371)
                      |++.+.. .+.++|+|+|||++|||+.|..||.+.+..+.+..++...-                 .|+.          
T Consensus       305 EvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l-----------------~Fp~----------  356 (459)
T KOG0610|consen  305 EVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPL-----------------KFPE----------  356 (459)
T ss_pred             eeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCC-----------------cCCC----------
Confidence            9998766 79999999999999999999999999999998888775311                 1111          


Q ss_pred             CCCCChhHHHHHHhccCcCCCCCCC----HHHHhhh
Q 017452          323 PKRMPPEAVDLVSRLLQYSPNLRCT----AVSKRIL  354 (371)
Q Consensus       323 ~~~~s~~l~~li~~~l~~dP~~R~t----~~~~l~~  354 (371)
                      ...++..++|||+++|.+||++|+.    |.||.+|
T Consensus       357 ~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  357 EPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             CCcchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            1147889999999999999999999    9998887

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-47  Score=318.88  Aligned_cols=248  Identities=26%  Similarity=0.437  Sum_probs=213.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------------hhhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      +|.-.+.||.|..++|-++.++.+|..+|+|++...            .+...+|+.+|+++ .||+|+++.+.|     
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y-----   92 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY-----   92 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec-----
Confidence            577788999999999999999999999999988321            12334689999988 699999999999     


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      ....++++|+|.|+ |.|.+.+..    ...++++..+.|++|++.|++|||.+ +||||||||+|||++.+. +++|+|
T Consensus        93 es~sF~FlVFdl~prGELFDyLts----~VtlSEK~tR~iMrqlfegVeylHa~-~IVHRDLKpENILlddn~-~i~isD  166 (411)
T KOG0599|consen   93 ESDAFVFLVFDLMPRGELFDYLTS----KVTLSEKETRRIMRQLFEGVEYLHAR-NIVHRDLKPENILLDDNM-NIKISD  166 (411)
T ss_pred             cCcchhhhhhhhcccchHHHHhhh----heeecHHHHHHHHHHHHHHHHHHHHh-hhhhcccChhheeecccc-ceEEec
Confidence            66777999999999 777777765    57899999999999999999999987 999999999999999887 899999


Q ss_pred             eCCccccccCCCcccccccccccCcccccC-----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      ||+|+.+..++.....+|||+|.|||.+..     .+.|+..+|+|++|+|||.|+.|.+||....+.-.+..|+++.-+
T Consensus       167 FGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyq  246 (411)
T KOG0599|consen  167 FGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQ  246 (411)
T ss_pred             cceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccc
Confidence            999999999999999999999999999853     344788999999999999999999999887777777777664222


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                      .                    .+..|     .++|...++||.+||+.||.+|+|++|+|.|-
T Consensus       247 F--------------------~speW-----adis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  247 F--------------------RSPEW-----ADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             c--------------------CCcch-----hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            1                    11223     35799999999999999999999999999883

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-45  Score=339.01  Aligned_cols=248  Identities=31%  Similarity=0.472  Sum_probs=211.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  141 (371)
                      ...|.+.+.||.|.||.||+|+++.+|+.+|+|.+.+..       ....+|+.+|+.+. |||||.+++.|     ++.
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~-----e~~  108 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAF-----EDP  108 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEE-----EcC
Confidence            357999999999999999999999999999999996542       36779999999998 99999999999     445


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC---CcEEEEe
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCD  217 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~---~~~kl~D  217 (371)
                      ..+++|||++.| .|.+.+...     .+++..+..++.|++.++.|||+. ||+||||||+|+|+....   ..+|++|
T Consensus       109 ~~~~lvmEL~~GGeLfd~i~~~-----~~sE~da~~~~~~il~av~~lH~~-gvvHrDlKpEN~L~~~~~~~~~~ik~~D  182 (382)
T KOG0032|consen  109 DSVYLVMELCEGGELFDRIVKK-----HYSERDAAGIIRQILEAVKYLHSL-GVVHRDLKPENLLLASKDEGSGRIKLID  182 (382)
T ss_pred             CeEEEEEEecCCchHHHHHHHc-----cCCHHHHHHHHHHHHHHHHHHHhC-CceeccCCHHHeeeccccCCCCcEEEee
Confidence            568999999995 555555542     399999999999999999999985 999999999999996442   2799999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ||++.....+......+||+.|+|||++... .++..+||||+|+++|.|++|.+||.+.+.......+.......    
T Consensus       183 FGla~~~~~~~~~~~~~Gtp~y~APEvl~~~-~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f----  257 (382)
T KOG0032|consen  183 FGLAKFIKPGERLHTIVGTPEYVAPEVLGGR-PYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDF----  257 (382)
T ss_pred             CCCceEccCCceEeeecCCccccCchhhcCC-CCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCC----
Confidence            9999998776677789999999999999644 48999999999999999999999999988877777665532111    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...     .+..+|..+.+||++||..||.+|+|+.++|+|
T Consensus       258 ----------------~~~-----~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H  293 (382)
T KOG0032|consen  258 ----------------TSE-----PWDDISESAKDFIRKLLEFDPRKRLTAAQALQH  293 (382)
T ss_pred             ----------------CCC-----CccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence                            112     234579999999999999999999999998886

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.1e-45  Score=346.85  Aligned_cols=269  Identities=23%  Similarity=0.320  Sum_probs=205.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|...  .....+|+.+++.++||||+++++++..     ..+.++|+|
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~--~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~lv~e  163 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ--RGGTATEAHILRAINHPSIIQLKGTFTY-----NKFTCLILP  163 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh--hhhhHHHHHHHHhCCCCCCCCEeEEEEE-----CCeeEEEEe
Confidence            357999999999999999999999999999999764  3346789999999999999999998843     345789999


Q ss_pred             cccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC--
Q 017452          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--  227 (371)
Q Consensus       150 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~--  227 (371)
                      ++.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......  
T Consensus       164 ~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~ylH~~-~IvHrDiKP~NIll~~~~-~vkL~DFG~a~~~~~~~~  237 (391)
T PHA03212        164 RYKTDLYCYLAA----KRNIAICDILAIERSVLRAIQYLHEN-RIIHRDIKAENIFINHPG-DVCLGDFGAACFPVDINA  237 (391)
T ss_pred             cCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHhEEEcCCC-CEEEEeCCcccccccccc
Confidence            999887776654    45789999999999999999999987 999999999999999888 8999999998653222  


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHhHHhh
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-------GVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....       ....+..+....+.++.+....
T Consensus       238 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        238 NKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             cccccccCccCCCChhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            2233467899999999986654 8999999999999999999998775432       2345666666666554322100


Q ss_pred             cCCCcccc--------ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEF--------KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~--------~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ........        .........|...  ..++.++.+||.+||++||.+|||+.|+|+|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNL--YELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHH--hhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00000000        0000001111111  1356789999999999999999999998877

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1e-45  Score=339.77  Aligned_cols=237  Identities=27%  Similarity=0.425  Sum_probs=194.7

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ....++++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~e   75 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986432       2344688999999999999998887     34456899999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-C
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  227 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-~  227 (371)
                      |+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.... .
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALGYLHSC-DVVYRDLKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEeeCCCCcccccCC
Confidence            9985 55555543    56789999999999999999999987 999999999999999888 899999999875322 2


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...                  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~------------------  210 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  210 (323)
T ss_pred             CcccceecCccccChhhhcCCC-CCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcC------------------
Confidence            2334567899999999986544 799999999999999999999999876654443333221                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                 ...++..+++++.+||.+||..||.+||     ++.++++|
T Consensus       211 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         211 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcC
Confidence                       0014566899999999999999999999     89998887

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=8.9e-45  Score=330.35  Aligned_cols=274  Identities=32%  Similarity=0.598  Sum_probs=218.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ..+|.+.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.++||||+++++++.     ...+.
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~-----~~~~~   79 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH-----TEKSL   79 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe-----cCCeE
Confidence            45799999999999999999999999999999988533     224457999999999999999999883     34458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|...+...   ...+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .++|+|||++...
T Consensus        80 ~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  154 (301)
T cd07873          80 TLVFEYLDKDLKQYLDDC---GNSINMHNVKLFLFQLLRGLNYCHRR-KVLHRDLKPQNLLINERG-ELKLADFGLARAK  154 (301)
T ss_pred             EEEEeccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHHHEEECCCC-cEEECcCcchhcc
Confidence            899999999877766542   45688999999999999999999986 999999999999999887 8999999998764


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.+...++.++||||||+++|+|++|+.||...+..+....+...++.+....|.....
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (301)
T cd07873         155 SIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS  234 (301)
T ss_pred             CCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhc
Confidence            3222 222345688999999987666678899999999999999999999998888788888888888777766653321


Q ss_pred             C--ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 N--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  +.....+...... .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         235 NEEFKSYNYPKYRADC-LHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             cccccccccCcccccc-HHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            1  1111222111111 111334678999999999999999999999996655

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-46  Score=338.78  Aligned_cols=248  Identities=29%  Similarity=0.463  Sum_probs=219.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|..++.+|.|+||.++.++++.++..|++|.+.-.      +.....|+.+++++.|||||.+.+.|.    .+..++
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~----~~~~~l   79 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFE----EDGQLL   79 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchh----cCCceE
Confidence            5799999999999999999999999999999998533      345678999999999999999999984    344458


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|||+||+| ++...+...+  ...|+++.+..|+.|++.|++|||++ +|+|||||+.|||++.++ .|+|+|||+|+.
T Consensus        80 ~Ivm~Y~eGg~l~~~i~~~k--~~~f~E~~i~~~~~Q~~~av~ylH~~-~iLHRDlK~~Nifltk~~-~VkLgDfGlaK~  155 (426)
T KOG0589|consen   80 CIVMEYCEGGDLAQLIKEQK--GVLFPEERILKWFVQILLAVNYLHEN-RVLHRDLKCANIFLTKDK-KVKLGDFGLAKI  155 (426)
T ss_pred             EEEEeecCCCCHHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhh-hhhcccchhhhhhccccC-ceeecchhhhhh
Confidence            999999996 6666666543  57899999999999999999999976 999999999999999998 789999999999


Q ss_pred             cccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..+.. ...+..|||.||+||.+.+.+ |+.++|||||||++|||++-+++|.+.+-...+.++.+....|         
T Consensus       156 l~~~~~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~P---------  225 (426)
T KOG0589|consen  156 LNPEDSLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSP---------  225 (426)
T ss_pred             cCCchhhhheecCCCcccCHHHhCCCC-CCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCC---------
Confidence            87776 677889999999999997655 8999999999999999999999999999888888888764333         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                         ++...+.+++.+|..||+.+|..||++.++|.+.
T Consensus       226 -------------------lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P  259 (426)
T KOG0589|consen  226 -------------------LPSMYSSELRSLVKSMLRKNPEHRPSALELLRRP  259 (426)
T ss_pred             -------------------CCccccHHHHHHHHHHhhcCCccCCCHHHHhhCh
Confidence                               5667899999999999999999999999999983

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.7e-46  Score=306.04  Aligned_cols=247  Identities=29%  Similarity=0.419  Sum_probs=214.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|.+++.||.|-||.||.|+.+.++..||+|++.+.       .....+|+++-..|+||||+++|++|     -+
T Consensus        19 ~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~f-----hd   93 (281)
T KOG0580|consen   19 WTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYF-----HD   93 (281)
T ss_pred             cchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhhe-----ec
Confidence            3456899999999999999999999999999999998654       34456899999999999999999999     44


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+++||.. |.+...+..  ....++++..++.++.|++.||.|+|.+ +++||||||+|+|++..+ .+||+|||
T Consensus        94 ~~riyLilEya~~gel~k~L~~--~~~~~f~e~~~a~Yi~q~A~Al~y~h~k-~VIhRdiKpenlLlg~~~-~lkiAdfG  169 (281)
T KOG0580|consen   94 SKRIYLILEYAPRGELYKDLQE--GRMKRFDEQRAATYIKQLANALLYCHLK-RVIHRDIKPENLLLGSAG-ELKIADFG  169 (281)
T ss_pred             cceeEEEEEecCCchHHHHHHh--cccccccccchhHHHHHHHHHHHHhccC-CcccCCCCHHHhccCCCC-CeeccCCC
Confidence            555899999998 676666653  2357899999999999999999999987 999999999999999998 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      -+.... .....+.+||..|.|||...+.. .+..+|+|++|++.||++.|.+||......+.+..|.+..         
T Consensus       170 wsV~~p-~~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~---------  238 (281)
T KOG0580|consen  170 WSVHAP-SNKRKTLCGTLDYLPPEMVEGRG-HDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD---------  238 (281)
T ss_pred             ceeecC-CCCceeeecccccCCHhhcCCCC-ccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc---------
Confidence            987654 55566889999999999996655 7999999999999999999999999988777888777641         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          -.+|..++..+.++|.+||.++|.+|.+..++++|
T Consensus       239 --------------------~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  239 --------------------LKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             --------------------ccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence                                12567799999999999999999999999998777

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8e-45  Score=338.13  Aligned_cols=271  Identities=22%  Similarity=0.334  Sum_probs=199.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .+|++.+.||+|+||.||+|.+..++..||+|+...  .....|+.+++.++|+||+++++++..     ....++|||+
T Consensus        66 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~--~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~e~  138 (357)
T PHA03209         66 LGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQK--GTTLIEAMLLQNVNHPSVIRMKDTLVS-----GAITCMVLPH  138 (357)
T ss_pred             cCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCc--cccHHHHHHHHhCCCCCCcChhheEEe-----CCeeEEEEEc
Confidence            469999999999999999999999999999997543  334569999999999999999998843     3457899999


Q ss_pred             ccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       151 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      +.++|...+..   ....+++..++.|+.||+.||.|||.+ ||+||||||+|||++.++ .+||+|||++.........
T Consensus       139 ~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~~~~~~~  213 (357)
T PHA03209        139 YSSDLYTYLTK---RSRPLPIDQALIIEKQILEGLRYLHAQ-RIIHRDVKTENIFINDVD-QVCIGDLGAAQFPVVAPAF  213 (357)
T ss_pred             cCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEecCccccccccCccc
Confidence            99988777653   246789999999999999999999987 999999999999999888 8999999999765443344


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCc---------HHHHHHHHHHhCCCCHhHHhh
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSG---------VDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ....||+.|+|||++.+.. ++.++|||||||++|+|+++. .+|.....         ...+..+....+..+......
T Consensus       214 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  292 (357)
T PHA03209        214 LGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRD  292 (357)
T ss_pred             ccccccccccCCeecCCCC-CCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCC
Confidence            4567899999999986654 899999999999999999865 44443221         122334444444332221100


Q ss_pred             cCCCc-c-ccccCcccCCCC---cccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNY-T-EFKFPQIKAHPW---HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~-~-~~~~~~~~~~~~---~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..... . .+........++   ...-...++.++.+||.+||+.||.+|||+.|+++|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        293 PGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            00000 0 000000111111   111122567889999999999999999999994433

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5e-45  Score=336.86  Aligned_cols=243  Identities=29%  Similarity=0.431  Sum_probs=200.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCC-cEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|.+.+.||+|+||.||+|.+..++ ..||+|.+...       .....+|+.+++.++||||+++++++     ..
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~  102 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSF-----KD  102 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEE-----Ee
Confidence            3457999999999999999999876554 68999988543       22345799999999999999999988     34


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ..+.++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       103 ~~~~~lv~Ey~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~ikL~DFG  176 (340)
T PTZ00426        103 ESYLYLVLEFVIGGEFFTFLRR----NKRFPNDVGCFYAAQIVLIFEYLQSL-NIVYRDLKPENLLLDKDG-FIKMTDFG  176 (340)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEecCC
Confidence            4568999999974 67666654    46789999999999999999999987 999999999999999887 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.....  ......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+.......+....         
T Consensus       177 ~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~---------  244 (340)
T PTZ00426        177 FAKVVDT--RTYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGI---------  244 (340)
T ss_pred             CCeecCC--CcceecCChhhcCHHHHhCCC-CCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCC---------
Confidence            9976532  234567899999999996544 7899999999999999999999998876654444443210         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                          ..++..+++.+.++|++||+.||.+|+     ++.++++|
T Consensus       245 --------------------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        245 --------------------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             --------------------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence                                014556789999999999999999995     89998877

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8e-47  Score=335.22  Aligned_cols=244  Identities=27%  Similarity=0.428  Sum_probs=205.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..|+..+.||+|.||.||+|.+..+++.||+|++.-+     ...+++|+.+|..++++||.++|++|+....     ++
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~-----Lw   87 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTK-----LW   87 (467)
T ss_pred             cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeeccc-----HH
Confidence            4588889999999999999999999999999998543     3556789999999999999999999966554     89


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||.| ++.+++..    ...+.+..+..++++++.||.|||.+ +.+|||||+.|||+..+| .+||+|||.+...
T Consensus        88 iiMey~~gGsv~~lL~~----~~~~~E~~i~~ilre~l~~l~ylH~~-~kiHrDIKaanil~s~~g-~vkl~DfgVa~ql  161 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKS----GNILDEFEIAVILREVLKGLDYLHSE-KKIHRDIKAANILLSESG-DVKLADFGVAGQL  161 (467)
T ss_pred             HHHHHhcCcchhhhhcc----CCCCccceeeeehHHHHHHhhhhhhc-ceecccccccceeEeccC-cEEEEecceeeee
Confidence            99999995 66666654    44558999999999999999999987 999999999999999997 8999999988766


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ...+++|||.|||||++. ...|+.++||||||++.+||++|.+|+........+..|-+.   .          
T Consensus       162 ~~~~~rr~tfvGTPfwMAPEVI~-~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~---~----------  227 (467)
T KOG0201|consen  162 TNTVKRRKTFVGTPFWMAPEVIK-QSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKS---A----------  227 (467)
T ss_pred             echhhccccccccccccchhhhc-cccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCC---C----------
Confidence            4433 336789999999999997 445999999999999999999999999876654333322211   0          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   +  -.+...+|+.+++|+..||.+||+.||+|.++|+|
T Consensus       228 -------------P--P~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  228 -------------P--PRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             -------------C--CccccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence                         0  01334689999999999999999999999999999

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.7e-44  Score=330.86  Aligned_cols=275  Identities=30%  Similarity=0.496  Sum_probs=204.1

Q ss_pred             eEeeccCCceEEEEEEEC--CCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      +.+||+|+||.||+|.+.  .+++.||+|.+...  .....+|+.+++.++||||+++++.+...   .....+++|||+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVWLLFDYA   82 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecC---CCcEEEEEEecc
Confidence            468999999999999965  46789999988643  23456899999999999999999887542   334578999999


Q ss_pred             cchHHHHHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCccc
Q 017452          152 PETVHRVVKHFNK-----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKV  223 (371)
Q Consensus       152 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a~~  223 (371)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+|||++.   ..+.+||+|||++..
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~  161 (317)
T cd07868          83 EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARL  161 (317)
T ss_pred             CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEecCCCCcCcEEEeecCceec
Confidence            9988877654321     123589999999999999999999987 9999999999999942   223799999999976


Q ss_pred             cccCC----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHHh
Q 017452          224 LVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKVL  290 (371)
Q Consensus       224 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~~~~~~  290 (371)
                      .....    ......+|+.|+|||++.+...++.++||||+||++|+|++|++||.....         ...+..+.+..
T Consensus       162 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~  241 (317)
T cd07868         162 FNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM  241 (317)
T ss_pred             cCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhc
Confidence            54322    123457799999999997766689999999999999999999999965432         35566777777


Q ss_pred             CCCCHhHHhhcCCCccc------cccCcccCC---CCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          291 GTPTREEIKCMNPNYTE------FKFPQIKAH---PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~------~~~~~~~~~---~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+....|.....-...      +........   .+........+..+.+||.+||++||.+|||++|+++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             CCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            87777666533211000      000000000   00000112345679999999999999999999995544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1e-44  Score=335.97  Aligned_cols=274  Identities=32%  Similarity=0.569  Sum_probs=217.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|++.+.||.|+||.||+|.+..+++.||+|++....      ....+|+.+++.++||||+++++++..... .....
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   94 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNE   94 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCc
Confidence            47999999999999999999999999999999986432      234579999999999999999988743321 22244


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++++++++++|...+.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~~~~~~~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~  167 (343)
T cd07878          95 VYLVTNLMGADLNNIVK-----CQKLSDEHVQFLIYQLLRGLKYIHSA-GIIHRDLKPSNVAVNEDC-ELRILDFGLARQ  167 (343)
T ss_pred             EEEEeecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCChhhEEECCCC-CEEEcCCcccee
Confidence            68999999888876654     35799999999999999999999987 999999999999999888 899999999986


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+..+.+.....
T Consensus       168 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd07878         168 ADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISS  245 (343)
T ss_pred             cCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcch
Confidence            5432  33457899999999987656688999999999999999999999998888888888888777776655433221


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   .++......+.. .....++.+.+||.+||..||.+|||+.++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         246 EHARKYIQSLPHMPQQDLKK-IFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhHHHHhhccccccchhHHH-hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            11110   011111111111 112467889999999999999999999998888

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-44  Score=325.05  Aligned_cols=272  Identities=33%  Similarity=0.530  Sum_probs=212.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+...      .....+|+.+++.++|+||+++++.+     .+....+
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~-----~~~~~~~   75 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVL-----HSDKKLT   75 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHh-----ccCCceE
Confidence            589999999999999999999999999999988542      13346799999999999999999988     3444589


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +++||+++++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        76 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  150 (284)
T cd07839          76 LVFEYCDQDLKKYFDSC---NGDIDPEIVKSFMFQLLKGLAFCHSH-NVLHRDLKPQNLLINKNG-ELKLADFGLARAFG  150 (284)
T ss_pred             EEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEcCCC-cEEECccchhhccC
Confidence            99999999877765532   45689999999999999999999986 999999999999999887 89999999987653


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... .....+++.|+|||.+.+...++.++|+|||||++|+|++|..|| .+.+..+.+..+.+..+.++...+.....
T Consensus       151 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (284)
T cd07839         151 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSK  230 (284)
T ss_pred             CCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhh
Confidence            3222 223456888999999877666789999999999999999998875 55555566677777777776665543221


Q ss_pred             CccccccCcccC-CCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .......+.... ..|.. ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         231 LPDYKPYPMYPATTSLVN-VVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccccccCCCCCcchhhh-hcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence            111111111111 11221 234578999999999999999999999996554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.4e-44  Score=324.76  Aligned_cols=274  Identities=33%  Similarity=0.586  Sum_probs=213.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|++|.||+|.+..++..||+|++...      .....+|+.+++.++||||+++++.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   75 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQ-----ESRLY   75 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEee-----CCeEE
Confidence            489999999999999999999999999999988532      1345679999999999999999998843     44588


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.+++.+.+.... ....+++..++.++.||+.||+|||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  152 (285)
T cd07861          76 LIFEFLSMDLKKYLDSLP-KGQYMDAELVKSYLYQILQGILFCHSR-RVLHRDLKPQNLLIDNKG-VIKLADFGLARAFG  152 (285)
T ss_pred             EEEecCCCCHHHHHhcCC-CCCcCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEEcCCC-cEEECcccceeecC
Confidence            999999988877765432 236789999999999999999999987 999999999999999888 89999999987543


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.........+....+.+....|.....-
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (285)
T cd07861         153 IPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL  232 (285)
T ss_pred             CCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhh
Confidence            221 1223456888999999876665788999999999999999999999988877777777777776665555322110


Q ss_pred             cc-ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YT-EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .. ...++......+ ......+++++.++|.+||..||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         233 PDYKNTFPKWKKGSL-RSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHHHhhccccCcchh-HHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence            00 001111111111 11233578999999999999999999999995554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-45  Score=288.30  Aligned_cols=272  Identities=36%  Similarity=0.619  Sum_probs=230.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.-.++||+|.||+||+|+...+++.||+|.+..+      .....+|+.+++.++|.|||++++...+     ...+.
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhs-----dkklt   77 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKLT   77 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhcc-----CceeE
Confidence            477778999999999999999999999999998654      2445799999999999999999998743     33478


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|+|||...|..++..   .++.++.+.++.++.|+++||.++|++ ++.||||||.|.||+.+| .+|++|||+++...
T Consensus        78 lvfe~cdqdlkkyfds---lng~~d~~~~rsfmlqllrgl~fchsh-nvlhrdlkpqnllin~ng-elkladfglarafg  152 (292)
T KOG0662|consen   78 LVFEFCDQDLKKYFDS---LNGDLDPEIVRSFMLQLLRGLGFCHSH-NVLHRDLKPQNLLINRNG-ELKLADFGLARAFG  152 (292)
T ss_pred             EeHHHhhHHHHHHHHh---cCCcCCHHHHHHHHHHHHhhhhhhhhh-hhhhccCCcceEEeccCC-cEEecccchhhhcC
Confidence            9999999988777664   478899999999999999999999987 999999999999999999 89999999998764


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      -.- ..+....|.+|.+|.++++..-|++..|+||.|||+.|+. .|++.|.+.+..+++..|...+|.+..+.|+.+..
T Consensus       153 ipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~  232 (292)
T KOG0662|consen  153 IPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTK  232 (292)
T ss_pred             CceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCcccc
Confidence            332 2234566999999999999988999999999999999998 68899999999999999999999999999987653


Q ss_pred             CccccccCccc-CCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      -......+... .-.|.++.|. ++..-+++++++|.-+|.+|++|+++++|
T Consensus       233 lpdyk~yp~ypattswsqivp~-lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  233 LPDYKPYPIYPATTSWSQIVPK-LNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             CCCCcccCCccccchHHHHhhh-hcchhHHHHHHHhccCcccccCHHHHhcC
Confidence            22222233222 2345554444 67778999999999999999999999988

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-45  Score=330.75  Aligned_cols=249  Identities=30%  Similarity=0.440  Sum_probs=221.8

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +..+-|.+.+.||+|.|.+|-+|++.-+|+.||||++.+.      ...+.+|+..|+.++|||||++|...     ..+
T Consensus        15 kIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-----DTQ   89 (864)
T KOG4717|consen   15 KIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-----DTQ   89 (864)
T ss_pred             ceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-----ccc
Confidence            3445699999999999999999999999999999999654      34556899999999999999999987     555


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+|+|+|.-++ +|.+++...   ...+.+..+++++.||+.|+.|+|+ +.+|||||||+||.|-..-+-|||.|||+
T Consensus        90 TKlyLiLELGD~GDl~DyImKH---e~Gl~E~La~kYF~QI~~AI~YCHq-LHVVHRDLKPENVVFFEKlGlVKLTDFGF  165 (864)
T KOG4717|consen   90 TKLYLILELGDGGDLFDYIMKH---EEGLNEDLAKKYFAQIVHAISYCHQ-LHVVHRDLKPENVVFFEKLGLVKLTDFGF  165 (864)
T ss_pred             ceEEEEEEecCCchHHHHHHhh---hccccHHHHHHHHHHHHHHHHHHhh-hhhhcccCCcceeEEeeecCceEeeeccc
Confidence            669999999985 888777643   6789999999999999999999996 59999999999998876666899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +..+.++....+.+|+..|.|||++.+..+..+++||||||||||.|++|++||...++.+.+..|+.+.-         
T Consensus       166 SNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY---------  236 (864)
T KOG4717|consen  166 SNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY---------  236 (864)
T ss_pred             cccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc---------
Confidence            99999999999999999999999999999889999999999999999999999999999998888876521         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ..|..+|.+.++||..||..||.+|.+.+++..+
T Consensus       237 --------------------tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  237 --------------------TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             --------------------cCchhhhHHHHHHHHHHHhcCchhhccHHHHhcc
Confidence                                1567789999999999999999999999996655

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-44  Score=334.26  Aligned_cols=248  Identities=29%  Similarity=0.449  Sum_probs=202.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+++++.++||||+++++++     ....+.
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~-----~~~~~~   76 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAF-----QDDEYL   76 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEE-----EcCCEE
Confidence            6999999999999999999999999999999986431       2345789999999999999999887     344568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++| +|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kL~Dfg~a~~  150 (333)
T cd05600          77 YLAMEYVPGGDFRTLLNN----LGVLSEDHARFYMAEMFEAVDALHEL-GYIHRDLKPENFLIDASG-HIKLTDFGLSKG  150 (333)
T ss_pred             EEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEEEeCcCCcc
Confidence            999999975 77776653    46789999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......||+.|+|||.+.+. .++.++|||||||++|+|++|..||...+..+....+.......          
T Consensus       151 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~----------  217 (333)
T cd05600         151 IVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETL----------  217 (333)
T ss_pred             ccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccc----------
Confidence            533  33456789999999999765 48999999999999999999999998877666555444321100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                           ..+.     +. .....++.++.+||.+||..+|.+||++.++++|
T Consensus       218 -----~~~~-----~~-~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         218 -----QRPV-----YD-DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             -----cCCC-----CC-ccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence                 0000     00 0012468999999999999999999999999888

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=2.4e-44  Score=335.89  Aligned_cols=245  Identities=26%  Similarity=0.397  Sum_probs=196.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||+||+|.+..+++.||+|++.+..       ....+|+.+++.++|+||+++++.+     .+...+
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~-----~~~~~~   76 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSF-----QDKLNL   76 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCCeE
Confidence            6999999999999999999999999999999986432       2345789999999999999999888     444568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++| +|.+.+..    ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-givHrDlKp~NILi~~~~-~vkL~DFGla~~  150 (363)
T cd05628          77 YLIMEFLPGGDMMTLLMK----KDTLTEEETQFYIAETVLAIDSIHQL-GFIHRDIKPDNLLLDSKG-HVKLSDFGLCTG  150 (363)
T ss_pred             EEEEcCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-CEEEeeccCccc
Confidence            999999985 66666653    56799999999999999999999986 999999999999999888 899999999875


Q ss_pred             cccCC------------------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHH
Q 017452          224 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       224 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  267 (371)
                      .....                                    .....+||+.|+|||++.+.. ++.++|+|||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~el  229 (363)
T cd05628         151 LKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (363)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCC-CCCchhhhhhHHHHHHH
Confidence            42211                                    012357899999999996654 78999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCC---C
Q 017452          268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN---L  344 (371)
Q Consensus       268 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~---~  344 (371)
                      ++|+.||.+.+..+....+.......               .++.          ...+++++.++|.+|+. +|.   .
T Consensus       230 l~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p~----------~~~~s~~~~~li~~l~~-~~~~r~~  283 (363)
T cd05628         230 LIGYPPFCSETPQETYKKVMNWKETL---------------IFPP----------EVPISEKAKDLILRFCC-EWEHRIG  283 (363)
T ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCcc---------------cCCC----------cCCCCHHHHHHHHHHcC-ChhhcCC
Confidence            99999998877666655554321100               0110          12368899999999775 444   4


Q ss_pred             CCCHHHHhhh
Q 017452          345 RCTAVSKRIL  354 (371)
Q Consensus       345 R~t~~~~l~~  354 (371)
                      ||++.++++|
T Consensus       284 r~~~~ei~~h  293 (363)
T cd05628         284 APGVEEIKTN  293 (363)
T ss_pred             CCCHHHHhCC
Confidence            5899998877

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=330.05  Aligned_cols=235  Identities=28%  Similarity=0.490  Sum_probs=192.4

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~e~~   75 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSF-----QSPEKLYLVLAFI   75 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEE-----ecCCeEEEEEcCC
Confidence            699999999999999999999999986431       2334688999999999999998887     3345589999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC-CC
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  229 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~-~~  229 (371)
                      ++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||+++..... ..
T Consensus        76 ~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~HrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~~~~  149 (312)
T cd05585          76 NGGELFHHLQR----EGRFDLSRARFYTAELLCALENLHKF-NVIYRDLKPENILLDYQG-HIALCDFGLCKLNMKDDDK  149 (312)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHeEECCCC-cEEEEECcccccCccCCCc
Confidence            85 66665543    46789999999999999999999986 999999999999999888 8999999998754322 22


Q ss_pred             cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccc
Q 017452          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (371)
Q Consensus       230 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+....+...                    
T Consensus       150 ~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~--------------------  208 (312)
T cd05585         150 TNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQE--------------------  208 (312)
T ss_pred             cccccCCcccCCHHHHcCCC-CCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcC--------------------
Confidence            33457899999999996644 799999999999999999999999876655444433221                    


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC---CHHHHhhh
Q 017452          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC---TAVSKRIL  354 (371)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~---t~~~~l~~  354 (371)
                               ...++..+++++.+||.+||..||.+||   ++.+++.|
T Consensus       209 ---------~~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~h  247 (312)
T cd05585         209 ---------PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNH  247 (312)
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcC
Confidence                     0014556889999999999999999997   57888877

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-44  Score=337.17  Aligned_cols=245  Identities=30%  Similarity=0.485  Sum_probs=198.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|++..+|+.||||++....       ....+|+.+++.++||||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSF-----QDENYL   76 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCeE
Confidence            6999999999999999999999999999999986431       2345799999999999999999888     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  150 (364)
T cd05599          77 YLIMEYLPGGDMMTLLMK----KDTFTEEETRFYIAETILAIDSIHKL-GYIHRDIKPDNLLLDAKG-HIKLSDFGLCTG  150 (364)
T ss_pred             EEEECCCCCcHHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEeeccccee
Confidence            999999975 66666653    45799999999999999999999987 999999999999999988 899999999865


Q ss_pred             cccCC---------------------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHH
Q 017452          224 LVKGE---------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV  264 (371)
Q Consensus       224 ~~~~~---------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  264 (371)
                      .....                                       ......||+.|+|||++.... ++.++|||||||++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  229 (364)
T cd05599         151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIM  229 (364)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCC-CCCeeeeecchhHH
Confidence            42211                                       011246899999999986544 79999999999999


Q ss_pred             HHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC
Q 017452          265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL  344 (371)
Q Consensus       265 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~  344 (371)
                      |+|++|..||...+..+....+......               ..++          ....+++++.+||.+||. +|.+
T Consensus       230 ~el~~G~~Pf~~~~~~~~~~~i~~~~~~---------------~~~~----------~~~~~s~~~~~li~~ll~-~p~~  283 (364)
T cd05599         230 YEMLVGYPPFCSDNPQETYRKIINWKET---------------LQFP----------DEVPLSPEAKDLIKRLCC-EAER  283 (364)
T ss_pred             HHhhcCCCCCCCCCHHHHHHHHHcCCCc---------------cCCC----------CCCCCCHHHHHHHHHHcc-CHhh
Confidence            9999999999887765555444331100               0000          012468999999999997 9999


Q ss_pred             CCC---HHHHhhh
Q 017452          345 RCT---AVSKRIL  354 (371)
Q Consensus       345 R~t---~~~~l~~  354 (371)
                      |++   +.++++|
T Consensus       284 R~~~~~~~~ll~h  296 (364)
T cd05599         284 RLGNNGVNEIKSH  296 (364)
T ss_pred             cCCCCCHHHHhcC
Confidence            998   9998888

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=2.3e-44  Score=330.68  Aligned_cols=237  Identities=27%  Similarity=0.418  Sum_probs=194.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.||+|+||.||++.+..+|..||+|++....       ....+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-----~~~~~~~lv~E   75 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHDRLCFVME   75 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCEEEEEEe
Confidence            36899999999999999999999999986431       2234688999999999999999888     33446899999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC-
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  227 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~-  227 (371)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~Dfg~~~~~~~~~  149 (323)
T cd05595          76 YANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLCKEGISDG  149 (323)
T ss_pred             CCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEEcCCC-CEEecccHHhccccCCC
Confidence            9985 55544433    46789999999999999999999987 999999999999999888 8999999998753222 


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......||+.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+...                  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~------------------  210 (323)
T cd05595         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME------------------  210 (323)
T ss_pred             CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcC------------------
Confidence            2233457899999999986554 799999999999999999999999877655444433221                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                 ...++..+++++.++|.+||..||.+|+     ++.++++|
T Consensus       211 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         211 -----------EIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcC
Confidence                       0014556899999999999999999998     89999988

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-44  Score=335.78  Aligned_cols=245  Identities=30%  Similarity=0.502  Sum_probs=201.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++|+||+++++++     .+..+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSF-----QDEEHL   76 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhhe-----ecCCeE
Confidence            699999999999999999999999999999998643       23345789999999999999999887     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.+ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-giiH~Dlkp~NIll~~~~-~~kL~Dfg~~~~  150 (350)
T cd05573          77 YLVMEYMPGGDLMNLLIR----KDVFPEETARFYIAELVLALDSVHKL-GFIHRDIKPDNILIDADG-HIKLADFGLCKK  150 (350)
T ss_pred             EEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEeecCCCCcc
Confidence            999999974 77766654    36799999999999999999999986 999999999999999988 899999999876


Q ss_pred             cccCC------------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCC
Q 017452          224 LVKGE------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL  273 (371)
Q Consensus       224 ~~~~~------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  273 (371)
                      .....                              ......||+.|+|||.+.+. .++.++|||||||++|+|++|+.|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~P  229 (350)
T cd05573         151 MNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLECDWWSLGVILYEMLYGFPP  229 (350)
T ss_pred             CcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCceeeEecchhhhhhccCCCC
Confidence            54433                              22345689999999999765 489999999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-HHHHh
Q 017452          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-AVSKR  352 (371)
Q Consensus       274 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-~~~~l  352 (371)
                      |...+.......+......               ..++          ....+++++.+||.+||. ||.+|++ +.+++
T Consensus       230 f~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll  283 (350)
T cd05573         230 FYSDTLQETYNKIINWKES---------------LRFP----------PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIK  283 (350)
T ss_pred             CCCCCHHHHHHHHhccCCc---------------ccCC----------CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHh
Confidence            9887765555444431110               0011          112268999999999998 9999999 99988


Q ss_pred             hh
Q 017452          353 IL  354 (371)
Q Consensus       353 ~~  354 (371)
                      +|
T Consensus       284 ~h  285 (350)
T cd05573         284 SH  285 (350)
T ss_pred             cC
Confidence            87

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=2.7e-44  Score=335.93  Aligned_cols=248  Identities=25%  Similarity=0.411  Sum_probs=201.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~-----~~~~  116 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAF-----QDDK  116 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----ecCC
Confidence            45799999999999999999999999999999998542       12345789999999999999999887     4455


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++++||||++| +|.+++.     ...+++.++..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~-~~kL~DfG~~  189 (370)
T cd05596         117 YLYMVMEYMPGGDLVNLMS-----NYDIPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEcCCC-CEEEEeccce
Confidence            68999999975 6766654     34689999999999999999999987 999999999999999888 8999999998


Q ss_pred             cccccCC--CcccccccccccCcccccCCc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGE--PNISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .......  ......||+.|+|||++.+..   .++.++|+|||||++|+|++|+.||.+.+....+..+......    
T Consensus       190 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~----  265 (370)
T cd05596         190 MKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNS----  265 (370)
T ss_pred             eeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCc----
Confidence            7654322  123457899999999986432   3788999999999999999999999887765555554431100    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~  354 (371)
                                 ..++          ....+|.++.+||.+||+.+|.+  |+|+.++++|
T Consensus       266 -----------~~~~----------~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         266 -----------LTFP----------DDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             -----------CCCC----------CcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence                       0000          11247899999999999999988  9999998887

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.5e-44  Score=321.71  Aligned_cols=248  Identities=24%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|++.+.||+|+||.||++.+..+++.||+|++....       ....+|+.+++.++||||+++++++     ....++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~~   75 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ETKDAL   75 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee-----cCCCeE
Confidence            3889999999999999999999999999999885431       2345699999999999999998887     344568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.+ +|...+..  .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        76 ~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l~Dfg~~~~  151 (285)
T cd05605          76 CLVLTLMNGGDLKFHIYN--MGNPGFDEERAVFYAAEITCGLEDLHRE-RIVYRDLKPENILLDDYG-HIRISDLGLAVE  151 (285)
T ss_pred             EEEEeccCCCcHHHHHHh--cCcCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHEEECCCC-CEEEeeCCCcee
Confidence            999999985 66555543  2235689999999999999999999987 999999999999999887 899999999887


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........|++.|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.........+.......          
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------  220 (285)
T cd05605         152 IPEGETIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKED----------  220 (285)
T ss_pred             cCCCCccccccCCCCccCcHHhcCCC-CCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhc----------
Confidence            64444434557899999999986544 7899999999999999999999998765544333333221100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                     ...++..++..+.+|+.+||..||.+||     +++++++|
T Consensus       221 ---------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         221 ---------------QEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             ---------------ccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcC
Confidence                           0113455789999999999999999999     89998777

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=2.9e-44  Score=330.61  Aligned_cols=237  Identities=26%  Similarity=0.412  Sum_probs=193.3

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.||+|+||.||++.+..+|+.||+|++.+..       ....+|+.+++.++||||+++++.+     .....+++|||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~lv~E   75 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSF-----QTKDRLCFVME   75 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986431       2345688999999999999998887     34455899999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC-
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-  227 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~-  227 (371)
                      |+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++...... 
T Consensus        76 y~~~g~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~NIll~~~~-~~kL~DfG~~~~~~~~~  149 (328)
T cd05593          76 YVNGGELFFHLSR----ERVFSEDRTRFYGAEIVSALDYLHSG-KIVYRDLKLENLMLDKDG-HIKITDFGLCKEGITDA  149 (328)
T ss_pred             CCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeEECCCC-cEEEecCcCCccCCCcc
Confidence            9985 55544432    46789999999999999999999987 999999999999999888 8999999998753222 


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+....+...                  
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~------------------  210 (328)
T cd05593         150 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  210 (328)
T ss_pred             cccccccCCcCccChhhhcCCC-CCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccC------------------
Confidence            2223457899999999986544 799999999999999999999999876554433332210                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                 ...++..+++++.+||.+||..||.+|+     ++.++++|
T Consensus       211 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  251 (328)
T cd05593         211 -----------DIKFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             -----------CccCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence                       0014556899999999999999999997     89999988

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=1.3e-43  Score=329.66  Aligned_cols=248  Identities=27%  Similarity=0.369  Sum_probs=194.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ....+|.+.+.||+|+||.||+|.+..+|+.||||++...     ...+.+|+++++.++|+||+++++++     ....
T Consensus        71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~  145 (353)
T PLN00034         71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMF-----DHNG  145 (353)
T ss_pred             CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEe-----ccCC
Confidence            3446799999999999999999999999999999998543     23456899999999999999999987     4445


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++||||+.++.+.   .    .....+..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       146 ~~~lv~e~~~~~~L~---~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DfG~~~  216 (353)
T PLN00034        146 EIQVLLEFMDGGSLE---G----THIADEQFLADVARQILSGIAYLHRR-HIVHRDIKPSNLLINSAK-NVKIADFGVSR  216 (353)
T ss_pred             eEEEEEecCCCCccc---c----cccCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEcccccce
Confidence            588999999974221   1    23456788889999999999999987 999999999999999887 89999999987


Q ss_pred             ccccCC-CcccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...... ......||..|+|||.+...    ...+.++|||||||++|+|++|+.||......+....+.......    
T Consensus       217 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~----  292 (353)
T PLN00034        217 ILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQ----  292 (353)
T ss_pred             ecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccC----
Confidence            654322 22345789999999987432    234568999999999999999999997543322222111110000    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....+..++.++.+||.+||+.||++|||+.++++|
T Consensus       293 ---------------------~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        293 ---------------------PPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             ---------------------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                 001334578999999999999999999999999888

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.4e-44  Score=329.08  Aligned_cols=240  Identities=28%  Similarity=0.468  Sum_probs=194.1

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHH---HHcCCCCeeecceeEEecCCCCce
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM---RLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l---~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      |++.+.||+|+||.||+|.+..+|+.||||++.+..       ....+|..++   +.++||||+++++++     ....
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~-----~~~~   75 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACF-----QTED   75 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEE-----EcCC
Confidence            788999999999999999999999999999986432       2233454444   456899999999988     3444


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..|+||||+.+ +|...+.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        76 ~~~lv~E~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrdlkp~Nill~~~~-~~kL~Dfg~~  148 (324)
T cd05589          76 HVCFVMEYAAGGDLMMHIH-----TDVFSEPRAVFYAACVVLGLQYLHEN-KIVYRDLKLDNLLLDTEG-FVKIADFGLC  148 (324)
T ss_pred             EEEEEEcCCCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecCCCHHHeEECCCC-cEEeCcccCC
Confidence            58999999996 4444332     35799999999999999999999986 999999999999999988 8999999998


Q ss_pred             ccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ..... ........|++.|+|||.+.+. .++.++|+|||||++|+|++|+.||.+.+..+....+....          
T Consensus       149 ~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~----------  217 (324)
T cd05589         149 KEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDE----------  217 (324)
T ss_pred             ccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC----------
Confidence            75322 2223456789999999998654 47899999999999999999999998876655554443310          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                         ..++..++..+.++|.+||+.||.+||     ++.++++|
T Consensus       218 -------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         218 -------------------VRYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence                               014456899999999999999999999     68888887

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=3.3e-44  Score=337.28  Aligned_cols=245  Identities=26%  Similarity=0.430  Sum_probs=196.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+++.||+|+||.||+|++..+++.||+|++.+..       ....+|+.+++.++|+||+++++.+.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~-----~~~~~   76 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQ-----DKDNL   76 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEE-----eCCEE
Confidence            5999999999999999999999999999999986432       34557999999999999999999884     34458


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~al~~lH~~-~ivHrDlKp~NILl~~~g-~~kL~DFGla~~  150 (382)
T cd05625          77 YFVMDYIPGGDMMSLLIR----MGIFPEDLARFYIAELTCAVESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (382)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEeECCCCcc
Confidence            999999985 66666653    45789999999999999999999986 999999999999999888 899999998743


Q ss_pred             cccC------------------------------------------------CCcccccccccccCcccccCCcCCCCcc
Q 017452          224 LVKG------------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAI  255 (371)
Q Consensus       224 ~~~~------------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~  255 (371)
                      ....                                                .......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (382)
T cd05625         151 FRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC  229 (382)
T ss_pred             ccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCC-CCCee
Confidence            2100                                                0011346899999999986554 78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 017452          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (371)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (371)
                      |||||||++|+|++|+.||...+..+....+.......               .++          ....+++++.++|.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~p----------~~~~~s~~~~~li~  284 (382)
T cd05625         230 DWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSL---------------HIP----------PQAKLSPEASDLII  284 (382)
T ss_pred             eEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCc---------------CCC----------CcccCCHHHHHHHH
Confidence            99999999999999999998877655554444321110               000          11347899999999


Q ss_pred             hccCcCCCCCCC---HHHHhhh
Q 017452          336 RLLQYSPNLRCT---AVSKRIL  354 (371)
Q Consensus       336 ~~l~~dP~~R~t---~~~~l~~  354 (371)
                      +|+ .+|.+|++   +.++++|
T Consensus       285 ~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         285 KLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHc-cCHhHcCCCCCHHHHhcC
Confidence            987 49999997   9998888

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=6.3e-44  Score=335.10  Aligned_cols=246  Identities=26%  Similarity=0.424  Sum_probs=195.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|.+++.||+|+||+||+|.+..+++.||+|++.+..       ....+|+.+++.++|+||+++++++.     +..++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~-----~~~~~   76 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQ-----DKDNL   76 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEe-----cCCEE
Confidence            5899999999999999999999999999999986432       23457999999999999999999883     44568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++| +|.+++..    ...+++..++.++.||+.||+|||.+ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDlKp~Nili~~~~-~~kL~DFGl~~~  150 (381)
T cd05626          77 YFVMDYIPGGDMMSLLIR----MEVFPEVLARFYIAELTLAIESVHKM-GFIHRDIKPDNILIDLDG-HIKLTDFGLCTG  150 (381)
T ss_pred             EEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCcHHHEEECCCC-CEEEeeCcCCcc
Confidence            999999985 66666653    46789999999999999999999986 999999999999999887 899999998753


Q ss_pred             cccCC------------------------------------------------CcccccccccccCcccccCCcCCCCcc
Q 017452          224 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  255 (371)
Q Consensus       224 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  255 (371)
                      .....                                                ......||+.|+|||.+.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~  229 (381)
T cd05626         151 FRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLC  229 (381)
T ss_pred             cccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCC-CCCcc
Confidence            21000                                                012346899999999986544 78999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 017452          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (371)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (371)
                      |||||||++|+|++|..||...+..+....+.......               .++          ....+++++.+||.
T Consensus       230 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~----------~~~~~s~~~~dli~  284 (381)
T cd05626         230 DWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTL---------------HIP----------PQVKLSPEAVDLIT  284 (381)
T ss_pred             ceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccccc---------------CCC----------CCCCCCHHHHHHHH
Confidence            99999999999999999998876555444443211000               000          11247899999999


Q ss_pred             hcc--CcCCCCCCCHHHHhhh
Q 017452          336 RLL--QYSPNLRCTAVSKRIL  354 (371)
Q Consensus       336 ~~l--~~dP~~R~t~~~~l~~  354 (371)
                      +|+  ..+|..|+++.+++.|
T Consensus       285 ~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         285 KLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHccCcccccCCCCHHHHhcC
Confidence            955  5566669999999888

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-44  Score=337.10  Aligned_cols=245  Identities=28%  Similarity=0.458  Sum_probs=196.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+.+.||+|+||.||+|.+..+++.||||++.+..       ....+|+++++.++||||+++++++     .+..++
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~-----~~~~~~   76 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSF-----QDAQYL   76 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCee
Confidence            6999999999999999999999999999999885432       2345789999999999999999988     445568


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||||++ |+|.+.+..    ...+++..++.++.|++.||+|||+. ||+||||||+|||++.++ .+||+|||+++.
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-givHrDlkp~NIll~~~~-~~kl~DfGla~~  150 (377)
T cd05629          77 YLIMEFLPGGDLMTMLIK----YDTFSEDVTRFYMAECVLAIEAVHKL-GFIHRDIKPDNILIDRGG-HIKLSDFGLSTG  150 (377)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEEeecccccc
Confidence            99999997 477666653    46789999999999999999999986 999999999999999888 899999999863


Q ss_pred             cccCC------------------------------------------------CcccccccccccCcccccCCcCCCCcc
Q 017452          224 LVKGE------------------------------------------------PNISYICSRYYRAPELIFGATEYTTAI  255 (371)
Q Consensus       224 ~~~~~------------------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  255 (371)
                      .....                                                ......||+.|+|||++.+.. ++.++
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  229 (377)
T cd05629         151 FHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQEC  229 (377)
T ss_pred             cccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCC-CCCce
Confidence            21100                                                001246899999999986544 79999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHH
Q 017452          256 DIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS  335 (371)
Q Consensus       256 DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~  335 (371)
                      |||||||++|+|++|..||...+..+.+..+......               ..++          -...++.++.+||.
T Consensus       230 DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~dli~  284 (377)
T cd05629         230 DWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRET---------------LYFP----------DDIHLSVEAEDLIR  284 (377)
T ss_pred             eeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCc---------------cCCC----------CCCCCCHHHHHHHH
Confidence            9999999999999999999887765555544431100               0000          01247899999999


Q ss_pred             hccCcCCCCC---CCHHHHhhh
Q 017452          336 RLLQYSPNLR---CTAVSKRIL  354 (371)
Q Consensus       336 ~~l~~dP~~R---~t~~~~l~~  354 (371)
                      +||. +|.+|   +++.+++.|
T Consensus       285 ~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         285 RLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             HHhc-CHhhcCCCCCHHHHhcC
Confidence            9998 77775   599998888

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.1e-44  Score=329.86  Aligned_cols=247  Identities=28%  Similarity=0.455  Sum_probs=195.2

Q ss_pred             ceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecch--------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      +|++.+.||+|+||.||++++.   .+++.||+|++.+..        ....+|+.+++.+ .|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAF-----Q   75 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEE-----e
Confidence            4899999999999999999864   478999999986421        2345688999999 599999998887     4


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ....+++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        76 ~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Df  149 (332)
T cd05614          76 TEAKLHLILDYVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKL-GIVYRDIKLENILLDSEG-HVVLTDF  149 (332)
T ss_pred             cCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEecCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999985 66665543    46789999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          219 GSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       219 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |++.......  ......||+.|+|||.+.+...++.++|||||||++|+|++|..||...........+......    
T Consensus       150 G~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~----  225 (332)
T cd05614         150 GLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILK----  225 (332)
T ss_pred             cCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhc----
Confidence            9987643322  2234578999999999976555788999999999999999999999654322211111111000    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                           ....++..+++.+.+++.+||..||.+||     ++.++++|
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         226 ---------------------CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             ---------------------CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence                                 00114456889999999999999999999     88898888

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.4e-43  Score=326.68  Aligned_cols=269  Identities=26%  Similarity=0.428  Sum_probs=201.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||++.+..+|..+|+|.+...     ...+.+|+++++.++||||+++++++..     ....
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   78 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI   78 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----CCEE
Confidence            35799999999999999999999999999999988643     2345689999999999999999998843     3347


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+++..    ...+++..+..++.|++.||.|||++.+|+||||||+|||++.++ .++|+|||++..
T Consensus        79 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~  153 (331)
T cd06649          79 SICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  153 (331)
T ss_pred             EEEeecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCC-cEEEccCccccc
Confidence            899999985 77766654    456899999999999999999999754699999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh----HHh
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE----EIK  299 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~  299 (371)
                      .... ......|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+..+.. .+   ++.+...    ...
T Consensus       154 ~~~~-~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~-~~---~~~~~~~~~~~~~~  227 (331)
T cd06649         154 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVELAIGRYPIPPPDAKELE-AI---FGRPVVDGEEGEPH  227 (331)
T ss_pred             cccc-ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHH-HH---hcccccccccCCcc
Confidence            5332 223456899999999986554 899999999999999999999999766543322 22   1211100    000


Q ss_pred             hcCCCcc----c---ccc------------CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYT----E---FKF------------PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~----~---~~~------------~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ...+...    .   ...            ..+............+++++.+||.+||++||++|||+.++++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h  301 (331)
T cd06649         228 SISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH  301 (331)
T ss_pred             ccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000000    0   000            00000000000112478899999999999999999999998888

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.5e-43  Score=333.56  Aligned_cols=272  Identities=21%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC--CCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ..+|.+.+.||+|+||.||+|...  .++..||+|.+... ....+|+.+++.++||||+++++.+     ......+++
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~~lv  164 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTISHRAIINLIHAY-----RWKSTVCMV  164 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcCCCCccceeeeE-----eeCCEEEEE
Confidence            357999999999999999999754  45678999988643 3456899999999999999999887     334458899


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus       165 ~e~~~~~l~~~l~~----~~~l~~~~~~~i~~ql~~aL~~LH~~-givHrDlkp~Nill~~~~-~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        165 MPKYKCDLFTYVDR----SGPLPLEQAITIQRRLLEALAYLHGR-GIIHRDVKTENIFLDEPE-NAVLGDFGAACKLDAH  238 (392)
T ss_pred             ehhcCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEccCccccccCcc
Confidence            99999988777632    56799999999999999999999987 999999999999999888 8999999998765433


Q ss_pred             CC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC---cHHHHHHHHHHhCCCCHhHHhhc
Q 017452          228 EP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---GVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       228 ~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ..   .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+..   ....+..+.+.++..+.+.....
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~  317 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNG  317 (392)
T ss_pred             cccccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCcc
Confidence            22   22456899999999986554 7899999999999999999999997654   34556666666554433211100


Q ss_pred             CC----CccccccCcccCCCCccc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NP----NYTEFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~----~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..    .+..+.........+... ....++.++.++|.+||..||++|||+.+++.|
T Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        318 STNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             chhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            00    000000000000000000 112467889999999999999999999998777

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=330.42  Aligned_cols=249  Identities=25%  Similarity=0.366  Sum_probs=209.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .+++++.||+|.||.||.|.++. ...||+|.++..   ...+.+|+.+|++|+|+|||++++++....     -++|||
T Consensus       207 ~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-----piyIVt  280 (468)
T KOG0197|consen  207 ELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-----PIYIVT  280 (468)
T ss_pred             HHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-----ceEEEE
Confidence            46778899999999999999843 247999988653   355668999999999999999999984322     378999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      |||. |+|.+.+..  .....+.......++.|||+|++||.++ ++|||||-..|||++.+. .+||+|||+|+...++
T Consensus       281 E~m~~GsLl~yLr~--~~~~~l~~~~Ll~~a~qIaeGM~YLes~-~~IHRDLAARNiLV~~~~-~vKIsDFGLAr~~~d~  356 (468)
T KOG0197|consen  281 EYMPKGSLLDYLRT--REGGLLNLPQLLDFAAQIAEGMAYLESK-NYIHRDLAARNILVDEDL-VVKISDFGLARLIGDD  356 (468)
T ss_pred             EecccCcHHHHhhh--cCCCccchHHHHHHHHHHHHHHHHHHhC-CccchhhhhhheeeccCc-eEEEcccccccccCCC
Confidence            9999 789988886  3467889999999999999999999987 999999999999999888 9999999999965444


Q ss_pred             CCcccc--cccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          228 EPNISY--ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       228 ~~~~~~--~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ......  -....|.|||.+.... ++.+||||||||+|||++| |+.||.+.+..+.+..+.++.+-|           
T Consensus       357 ~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp-----------  424 (468)
T KOG0197|consen  357 EYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLP-----------  424 (468)
T ss_pred             ceeecCCCCCCceecCHHHHhhCC-cccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCC-----------
Confidence            332222  2255699999996555 8999999999999999996 999999999999988887754332           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                       -|..+|+++.+++..||..+|++|||++.+...++++.
T Consensus       425 -----------------~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~  462 (468)
T KOG0197|consen  425 -----------------RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFF  462 (468)
T ss_pred             -----------------CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhh
Confidence                             46679999999999999999999999998888877653

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=1e-43  Score=326.60  Aligned_cols=242  Identities=27%  Similarity=0.434  Sum_probs=195.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCC-CeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~  143 (371)
                      +|++.+.||+|+||.||+|.+..+++.||+|++.+..       .....|..++..+.|+ +|+++++++.     ....
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~-----~~~~   75 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQ-----TMDR   75 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEE-----cCCE
Confidence            4899999999999999999999999999999986431       2334678888888765 5777777773     3345


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|+||||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~~~  149 (324)
T cd05587          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDAEG-HIKIADFGMCK  149 (324)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEEcCCC-CEEEeecCcce
Confidence            8899999985 66555543    46789999999999999999999987 999999999999999888 89999999986


Q ss_pred             cccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .... ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+...            
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~------------  216 (324)
T cd05587         150 ENIFGGKTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEH------------  216 (324)
T ss_pred             ecCCCCCceeeecCCccccChhhhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcC------------
Confidence            5322 22233457899999999997654 789999999999999999999999887765555444321            


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                       ...++..++.++.+++.+||..||.+|+++     .++++|
T Consensus       217 -----------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         217 -----------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                             011445689999999999999999999986     787777

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=6.4e-44  Score=330.01  Aligned_cols=256  Identities=24%  Similarity=0.368  Sum_probs=198.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||+|.+     ..++..||+|++...     .....+|+.+++.+ +||||+++++++..   
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~---   82 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTK---   82 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecC---
Confidence            35799999999999999999975     244578999998643     23456799999999 89999999987743   


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh-----------------------------------------------------
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  164 (371)
                       ....++++|||++ |+|.+.+.....                                                     
T Consensus        83 -~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (338)
T cd05102          83 -PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ  161 (338)
T ss_pred             -CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence             2234789999998 577777654211                                                     


Q ss_pred             -----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC---ccccccc
Q 017452          165 -----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICS  236 (371)
Q Consensus       165 -----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t  236 (371)
                           ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.......   .....++
T Consensus       162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDiKp~Nil~~~~~-~~kl~DfG~a~~~~~~~~~~~~~~~~~~  239 (338)
T cd05102         162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGSARLP  239 (338)
T ss_pred             hccccccCCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCccceEEEcCCC-cEEEeecccccccccCcchhcccCCCCC
Confidence                 123578888999999999999999987 999999999999999887 899999999976533221   1123446


Q ss_pred             ccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccC
Q 017452          237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKA  315 (371)
Q Consensus       237 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  315 (371)
                      +.|+|||++.+.. ++.++|||||||++|+|++ |..||.+....+.+....... ..                      
T Consensus       240 ~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~-~~----------------------  295 (338)
T cd05102         240 LKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDG-TR----------------------  295 (338)
T ss_pred             ccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcC-CC----------------------
Confidence            7899999986554 7999999999999999997 999998765433333222210 00                      


Q ss_pred             CCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          316 HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       316 ~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                          ...+..+++++.+++.+||+.||.+|||+.++++.|+.+.
T Consensus       296 ----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~  335 (338)
T cd05102         296 ----MRAPENATPEIYRIMLACWQGDPKERPTFSALVEILGDLL  335 (338)
T ss_pred             ----CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                0024457889999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=6.4e-44  Score=327.32  Aligned_cols=237  Identities=27%  Similarity=0.479  Sum_probs=192.1

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|..++..+ +||||+++++++     .....+++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~-----~~~~~~~iv~   75 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCF-----QTPDRLFFVM   75 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEE-----EcCCEEEEEE
Confidence            36899999999999999999999999986432       2234577777766 699999999988     3445589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 Ey~~~g~L~~~i~~----~~~l~~~~~~~~~~ql~~~L~~lH~~-~ivH~dlkp~NIli~~~~-~~kL~DfG~~~~~~~~  149 (320)
T cd05590          76 EFVNGGDLMFHIQK----SRRFDEARARFYAAEITSALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFGMCKEGIFN  149 (320)
T ss_pred             cCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeeCCCCeecCcC
Confidence            99985 66555543    46799999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||.+.+. .++.++|+|||||++|+|++|+.||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~----------------  212 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQEM-LYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE----------------  212 (320)
T ss_pred             CCcccccccCccccCHHHHcCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC----------------
Confidence            2233446789999999998654 47899999999999999999999998877655554443210                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                                   ..++..++.++.++|.+||+.||.+|+++      .++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         213 -------------VVYPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcC
Confidence                         01345578999999999999999999998      777766

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-45  Score=299.63  Aligned_cols=262  Identities=26%  Similarity=0.358  Sum_probs=208.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .||++.+.||+|||+.||+++...++..||+|++.-.    .+...+|++..++++|||++++++........+....||
T Consensus        21 ~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yl  100 (302)
T KOG2345|consen   21 KRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYL  100 (302)
T ss_pred             ceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEE
Confidence            4799999999999999999999999999999998533    455568999999999999999998876665556777899


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|.. |+|.+.+.........+++..+..|+.+|++||++||.. .  ++||||||.|||+..++ .++|.|||.++.
T Consensus       101 l~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~-~~vl~D~GS~~~  178 (302)
T KOG2345|consen  101 LLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSG-LPVLMDLGSATQ  178 (302)
T ss_pred             EeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCC-ceEEEeccCccc
Confidence            999987 789999998887777999999999999999999999986 6  99999999999999877 899999998865


Q ss_pred             ccc---CCC-------cccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          224 LVK---GEP-------NISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       224 ~~~---~~~-------~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      ..-   +..       .....+|..|.|||.+.-.  ...+.++|||||||+||+|+.|..||...-         +..+
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~---------~~Gg  249 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIY---------QQGG  249 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHh---------hcCC
Confidence            421   111       1234568889999998432  235789999999999999999999995311         1000


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      +....      -....+.+|.          ..++|..+.++|+.||+.||.+||++.+++.++.++.
T Consensus       250 SlaLA------v~n~q~s~P~----------~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  250 SLALA------VQNAQISIPN----------SSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             eEEEe------eeccccccCC----------CCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence            00000      0000111111          1248999999999999999999999999999988763

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-44  Score=336.79  Aligned_cols=245  Identities=26%  Similarity=0.411  Sum_probs=196.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|+.+++.++|+||+++++.+     .....+
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~-----~~~~~~   76 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSF-----QDKDNL   76 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEE-----EcCCEE
Confidence            699999999999999999999999999999998542       23355799999999999999999888     344568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~ikL~DFG~a~~  150 (376)
T cd05598          77 YFVMDYIPGGDMMSLLIR----LGIFEEDLARFYIAELTCAIESVHKM-GFIHRDIKPDNILIDRDG-HIKLTDFGLCTG  150 (376)
T ss_pred             EEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHEEECCCC-CEEEEeCCCCcc
Confidence            999999984 77776654    46789999999999999999999987 999999999999999888 899999998743


Q ss_pred             cccC--------------------------------------------CCcccccccccccCcccccCCcCCCCcchHHH
Q 017452          224 LVKG--------------------------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWS  259 (371)
Q Consensus       224 ~~~~--------------------------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  259 (371)
                      ....                                            .......||+.|+|||++.+.. ++.++||||
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwS  229 (376)
T cd05598         151 FRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWS  229 (376)
T ss_pred             ccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC-CCcceeeee
Confidence            2100                                            0011346899999999996544 789999999


Q ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccC
Q 017452          260 AGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQ  339 (371)
Q Consensus       260 lG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~  339 (371)
                      |||++|+|++|+.||.+.+..+....+.......               .++          ....+++++.++|.+|+ 
T Consensus       230 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---------------~~~----------~~~~~s~~~~~li~~l~-  283 (376)
T cd05598         230 VGVILYEMLVGQPPFLADTPAETQLKVINWETTL---------------HIP----------SQAKLSREASDLILRLC-  283 (376)
T ss_pred             ccceeeehhhCCCCCCCCCHHHHHHHHhccCccc---------------cCC----------CCCCCCHHHHHHHHHHh-
Confidence            9999999999999998877655544433211000               000          12347899999999977 


Q ss_pred             cCCCCCC---CHHHHhhh
Q 017452          340 YSPNLRC---TAVSKRIL  354 (371)
Q Consensus       340 ~dP~~R~---t~~~~l~~  354 (371)
                      .+|.+|+   |+.++++|
T Consensus       284 ~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         284 CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             cCHhhcCCCCCHHHHhCC
Confidence            5999999   99998888

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2.7e-44  Score=330.64  Aligned_cols=238  Identities=28%  Similarity=0.425  Sum_probs=193.0

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.||+|+||.||++.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     .....+++|||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~-----~~~~~~~lv~E   75 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSF-----QTHDRLCFVME   75 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEE-----EcCCEEEEEEe
Confidence            36899999999999999999999999986531       2334688889999999999998887     34456899999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-C
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-G  227 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-~  227 (371)
                      |+++ +|...+..    ...+++..++.++.||+.||.|||+..||+||||||+|||++.++ .+||+|||++..... .
T Consensus        76 ~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~-~~kL~Dfg~~~~~~~~~  150 (325)
T cd05594          76 YANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDG-HIKITDFGLCKEGIKDG  150 (325)
T ss_pred             CCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCC-CEEEecCCCCeecCCCC
Confidence            9985 55544432    467899999999999999999999723999999999999999888 899999999875322 2


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+...                  
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~------------------  211 (325)
T cd05594         151 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILME------------------  211 (325)
T ss_pred             cccccccCCcccCCHHHHccCC-CCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcC------------------
Confidence            2233457899999999986554 799999999999999999999999876654443333211                  


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                 ...++..+++++.+||.+||+.||.+|+     ++.++++|
T Consensus       212 -----------~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         212 -----------EIRFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcC
Confidence                       0014556899999999999999999997     89999888

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.7e-44  Score=332.59  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=199.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||.||++.+..+++.||+|++.+.       .....+|+.+++.++||||+++++++     ....
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~~  116 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAF-----QDDK  116 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCC
Confidence            35799999999999999999999999999999998542       23355789999999999999999888     4455


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++++||||+++ +|.+++.     ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       117 ~~~lv~Ey~~gg~L~~~l~-----~~~~~~~~~~~~~~qil~aL~~LH~~-~IvHrDLKp~NILl~~~~-~~kL~DFG~a  189 (370)
T cd05621         117 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWAKFYTAEVVLALDAIHSM-GLIHRDVKPDNMLLDKHG-HLKLADFGTC  189 (370)
T ss_pred             EEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEEecccc
Confidence            68999999985 7776664     34689999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCC--cccccccccccCcccccCCc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ........  .....||+.|+|||++.+..   .++.++|+|||||++|+|++|+.||...+.......+.......   
T Consensus       190 ~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  266 (370)
T cd05621         190 MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSL---  266 (370)
T ss_pred             eecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCccc---
Confidence            86543222  23457899999999986532   36789999999999999999999998877666555554321100   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~  354 (371)
                                  .++          ....++..+.+++.+||..++.+  |+++.++++|
T Consensus       267 ------------~~p----------~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         267 ------------NFP----------EDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ------------CCC----------CcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence                        000          01246899999999999855543  8999998888

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.3e-43  Score=319.25  Aligned_cols=243  Identities=23%  Similarity=0.363  Sum_probs=192.9

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||+|+||+||++.+..+|+.||+|.+....       .....|+.+++.++|+||+++.+++     ......++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAF-----QTKTDLCLVMTIM   75 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEE-----cCCCeEEEEEeCC
Confidence            699999999999999999999999986432       2234689999999999999998877     3445588999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC-
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-  229 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~-  229 (371)
                      ++ +|...+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++........ 
T Consensus        76 ~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~~~~~~~~  153 (280)
T cd05608          76 NGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR-RIIYRDLKPENVLLDNDG-NVRISDLGLAVELKDGQSK  153 (280)
T ss_pred             CCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCccceecCCCCcc
Confidence            85 66655544334456799999999999999999999987 999999999999999887 899999999876544322 


Q ss_pred             cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccc
Q 017452          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (371)
Q Consensus       230 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....||+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+.......                
T Consensus       154 ~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~----------------  216 (280)
T cd05608         154 TKGYAGTPGFMAPELLQGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILND----------------  216 (280)
T ss_pred             ccccCCCcCccCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhccc----------------
Confidence            22356899999999997654 7899999999999999999999997654332222222111000                


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                               ...++..++..+.+++.+||+.||.+||     +++++++|
T Consensus       217 ---------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         217 ---------SVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             ---------CCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence                     0013456899999999999999999999     88998877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.4e-43  Score=318.15  Aligned_cols=281  Identities=32%  Similarity=0.564  Sum_probs=215.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.+. |+||+++++++...........
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~   81 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSL   81 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceE
Confidence            6999999999999999999999999999999875432      34567999999995 6999999988865544445567


Q ss_pred             EEeeccccchHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|||+++++.+.+...... ...+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.++|+|||.+..
T Consensus        82 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~  160 (295)
T cd07837          82 YLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH-GVMHRDLKPQNLLVDKQKGLLKIADLGLGRA  160 (295)
T ss_pred             EEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEecCCCeEEEeeccccee
Confidence            899999999888877654332 35689999999999999999999987 9999999999999998344899999999875


Q ss_pred             cccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .... .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+.++...+....
T Consensus       161 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (295)
T cd07837         161 FSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVS  240 (295)
T ss_pred             cCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchh
Confidence            4322 122234568889999998665557899999999999999999999999888888777777777666655443221


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ........++....... .....++.++.+||.+||.+||.+||++.+++.|
T Consensus       241 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         241 KLRDWHEFPQWKPQDLS-RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             hccchhhcCcccchhHH-HhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            11111111111100000 1123478999999999999999999999994433

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=4.3e-43  Score=320.48  Aligned_cols=276  Identities=33%  Similarity=0.538  Sum_probs=217.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+....      ....+|+.+++.++|+||+++++++...   ....
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~~~   82 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGK---HLDS   82 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecC---CCCe
Confidence            357999999999999999999999999999999885332      1235799999999999999999887432   2234


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++||||+.++|.+++...   ...+++..++.++.||+.||.|||+. |++||||||+||+++.++ .++|+|||.+..
T Consensus        83 ~~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~kL~dfg~~~~  157 (309)
T cd07845          83 IFLVMEYCEQDLASLLDNM---PTPFSESQVKCLMLQLLRGLQYLHEN-FIIHRDLKVSNLLLTDKG-CLKIADFGLART  157 (309)
T ss_pred             EEEEEecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECccceeee
Confidence            7899999998887777643   36789999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          224 LVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+..+....+.+....+....
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (309)
T cd07845         158 YGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFS  237 (309)
T ss_pred             cCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhh
Confidence            54332 22233457889999998766667899999999999999999999999988888888888888877666554322


Q ss_pred             C--CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 P--NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~--~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  ....+..+......+... ....++++.++|.+||.+||++|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         238 DLPLVGKFTLPKQPYNNLKHK-FPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             cccccccccccCCCCCchHHh-ccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            1  111111111111111111 12368899999999999999999999998887

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=4.7e-43  Score=316.42  Aligned_cols=272  Identities=38%  Similarity=0.723  Sum_probs=219.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|++|.||+|.+..+|..||+|++....      ....+|+.+++.++||||+++++.+.     ...+.+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP-----HGSGFV   75 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe-----cCCeeE
Confidence            4899999999999999999999999999999986432      34567999999999999999999883     345688


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||++++|.+.+...   ...+++..++.++.||+.||+|||+. |++|+||||+||+++.++ .++|+|||.+....
T Consensus        76 ~v~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~~~~~~-~~~l~dfg~~~~~~  150 (286)
T cd07832          76 LVMEYMPSDLSEVLRDE---ERPLPEAQVKSYMRMLLKGVAYMHAN-GIMHRDLKPANLLISADG-VLKIADFGLARLFS  150 (286)
T ss_pred             EEecccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCHHHEEEcCCC-cEEEeeeeeccccc
Confidence            99999977887776543   36789999999999999999999986 999999999999999887 89999999987764


Q ss_pred             cCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC-
Q 017452          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (371)
Q Consensus       226 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (371)
                      ....  .....++..|+|||.+.+...++.++||||||+++|+|++|.+||.+......+..+....+.+....+.... 
T Consensus       151 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07832         151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTS  230 (286)
T ss_pred             CCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccC
Confidence            4331  2345678899999998766667899999999999999999999998888888888888888887776655322 


Q ss_pred             -CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 -PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       .+.....++.....+|...+ ...+..+.++|.+||..||++|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         231 LPDYNKITFPESKPIPLEEIF-PDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cchhhcccCCCCCcchHHHhC-CCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence             12222233332222332222 3467899999999999999999999996655

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=3.8e-43  Score=321.89  Aligned_cols=274  Identities=30%  Similarity=0.502  Sum_probs=201.7

Q ss_pred             eEeeccCCceEEEEEEECC--CCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      +.+||+|+||.||+|.+..  ++..||+|.+....  ....+|+.+++.++||||+++++++...   .....+++|||+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~---~~~~~~lv~e~~   82 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSH---SDRKVWLLFDYA   82 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEecc---CCCeEEEEEeee
Confidence            4689999999999999653  66889999886542  3456899999999999999999987542   334578999999


Q ss_pred             cchHHHHHHHhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee----CCCCcEEEEeeCCcc
Q 017452          152 PETVHRVVKHFNK-----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK  222 (371)
Q Consensus       152 ~~~l~~~~~~~~~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~----~~~~~~kl~Dfg~a~  222 (371)
                      ++++...+.....     ....+++..++.++.||+.||.|||++ ||+||||||+||++.    .++ .+||+|||+++
T Consensus        83 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~-~~kl~DfG~a~  160 (317)
T cd07867          83 EHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIADMGFAR  160 (317)
T ss_pred             CCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC-CEEcCCCCHHHEEEccCCCCCC-cEEEeecccee
Confidence            9988777653221     123588999999999999999999987 999999999999993    334 89999999998


Q ss_pred             ccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHHHHHHHH
Q 017452          223 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQLVEIIKV  289 (371)
Q Consensus       223 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~~~~~~~  289 (371)
                      .......    .....+|+.|+|||.+.+...++.++|||||||++|+|+||++||.....         ...+..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~  240 (317)
T cd07867         161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSV  240 (317)
T ss_pred             ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHh
Confidence            6543321    22356789999999987666689999999999999999999999975432         2445666677


Q ss_pred             hCCCCHhHHhhcCCC--cccc----ccCcccCCCC---cccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          290 LGTPTREEIKCMNPN--YTEF----KFPQIKAHPW---HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~--~~~~----~~~~~~~~~~---~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ++.+..+.|......  +...    ..........   ........+..+.+||.+||+.||.+|||+.|+++|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         241 MGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             cCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            776666655432211  0000    0000000000   001122346779999999999999999999995543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.7e-43  Score=319.19  Aligned_cols=272  Identities=35%  Similarity=0.603  Sum_probs=213.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||.|++|.||+|.+..+|+.||+|.+....         .....|+++++.++|+||+++++++.     +..
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~   75 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFG-----HKS   75 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheee-----cCC
Confidence            4889999999999999999999999999999986432         12346899999999999999999883     345


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +.++||||+.++|...+...   ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++.
T Consensus        76 ~~~lv~e~~~~~L~~~i~~~---~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~  150 (298)
T cd07841          76 NINLVFEFMETDLEKVIKDK---SIVLTPADIKSYMLMTLRGLEYLHSN-WILHRDLKPNNLLIASDG-VLKLADFGLAR  150 (298)
T ss_pred             EEEEEEcccCCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCChhhEEEcCCC-CEEEccceeee
Confidence            68999999987887776531   13689999999999999999999987 999999999999999887 89999999997


Q ss_pred             ccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...... ......+++.|+|||.+.+...++.++|+|||||++|+|++|.+||...+..+.+..+....+.+....+...
T Consensus       151 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (298)
T cd07841         151 SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGV  230 (298)
T ss_pred             eccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhc
Confidence            764432 2223456788999999866556789999999999999999999889888877777777777777766655432


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ...............+... .....+..+.++|.+||++||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         231 TSLPDYVEFKPFPPTPLKQ-IFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             ccccccccccccCCcchhh-hcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence            2111111111111111111 224568899999999999999999999996655

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=6.3e-44  Score=298.79  Aligned_cols=262  Identities=24%  Similarity=0.386  Sum_probs=211.8

Q ss_pred             ecCCCCCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHH-HHcCCCCeeeccee
Q 017452           59 TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTM-RLLDHPNVVSLKHC  132 (371)
Q Consensus        59 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l-~~l~h~niv~~~~~  132 (371)
                      ++++...++...++...+..||+|..|+|++++.+.+|...|||.+....     ..+...+.++ +..++|+||+++++
T Consensus        80 ti~~g~r~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~Gy  159 (391)
T KOG0983|consen   80 TIGGGQRYQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGY  159 (391)
T ss_pred             EecCCcccccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeE
Confidence            34444445555567788889999999999999999999999999986532     1222233333 33368999999999


Q ss_pred             EEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      |....+     ++|.||.|...+..++...   .++++|..+-++...++.||.||-++.||+|||+||+|||+|..| +
T Consensus       160 Fi~n~d-----V~IcMelMs~C~ekLlkri---k~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~G-n  230 (391)
T KOG0983|consen  160 FITNTD-----VFICMELMSTCAEKLLKRI---KGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-N  230 (391)
T ss_pred             EeeCch-----HHHHHHHHHHHHHHHHHHh---cCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCC-C
Confidence            976555     7889999997777777654   577999999999999999999999888999999999999999988 8


Q ss_pred             EEEEeeCCccccccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKV  289 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~  289 (371)
                      +||||||++..+.+....+...|.+.|||||.+.-  ...|.-.+||||||+.++||+||+.||.+.+ +.+.+..+.+.
T Consensus       231 iKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~  310 (391)
T KOG0983|consen  231 IKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNE  310 (391)
T ss_pred             EEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhc
Confidence            99999999999998888888999999999999853  3457889999999999999999999998865 44555555542


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                        .|+.              ++          ....+|+.+++|+..||++|+.+||...++|+|-
T Consensus       311 --ePP~--------------L~----------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~  350 (391)
T KOG0983|consen  311 --EPPL--------------LP----------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHP  350 (391)
T ss_pred             --CCCC--------------CC----------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCc
Confidence              1110              00          1234899999999999999999999999999983

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.6e-43  Score=325.21  Aligned_cols=237  Identities=28%  Similarity=0.475  Sum_probs=193.0

Q ss_pred             EeeccCCceEEEEEEEC---CCCcEEEEEEeecch--------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           77 RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +.||+|+||.||++.+.   .+++.||+|++....        ....+|+.+++.++||||+++++.+.     ....++
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~-----~~~~~~   76 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQ-----TGGKLY   76 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEe-----cCCeEE
Confidence            67999999999999864   478899999986421        23357899999999999999998883     344588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+.+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (323)
T cd05584          77 LILEYLSGGELFMHLER----EGIFMEDTACFYLSEISLALEHLHQQ-GIIYRDLKPENILLDAQG-HVKLTDFGLCKES  150 (323)
T ss_pred             EEEeCCCCchHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEeeCcCCeec
Confidence            99999986 66555543    56788999999999999999999986 999999999999999888 8999999998753


Q ss_pred             cc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .. ........||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+....+..+....             
T Consensus       151 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~-------------  216 (323)
T cd05584         151 IHEGTVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGK-------------  216 (323)
T ss_pred             ccCCCcccccCCCccccChhhccCCC-CCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            22 22233457899999999986544 7899999999999999999999998877655544443210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                      ..++..+++++.+||.+||+.||++||     ++.++++|
T Consensus       217 ----------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         217 ----------------LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcC
Confidence                            014456789999999999999999999     89998887

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=1.8e-43  Score=324.92  Aligned_cols=242  Identities=26%  Similarity=0.419  Sum_probs=195.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +|.+.+.||+|+||.||+|.+..+++.||+|++.+..       .....|..++..+ .|++|+++++++     .....
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCF-----QTMDR   75 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEE-----ecCCE
Confidence            4899999999999999999999999999999986532       1223466667666 578899888887     33445


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +++||||+++ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~E~~~~g~L~~~~~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~-~~kL~DfG~~~  149 (323)
T cd05616          76 LYFVMEYVNGGDLMYQIQQ----VGRFKEPHAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEecCCCHHHeEECCCC-cEEEccCCCce
Confidence            8899999985 66555543    46789999999999999999999986 999999999999999988 89999999987


Q ss_pred             cccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .... ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05616         150 ENMWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ecCCCCCccccCCCChhhcCHHHhcCCC-CCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            5432 22333567899999999996654 7999999999999999999999998877655555443310           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                        ..++..++.++.+++.+||+.||.+|++.     .++++|
T Consensus       218 ------------------~~~p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         218 ------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcC
Confidence                              01455689999999999999999999984     777666

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.5e-43  Score=326.10  Aligned_cols=238  Identities=25%  Similarity=0.455  Sum_probs=188.8

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~-----~~~~~~~lv~   75 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCF-----QTESRLFFVI   75 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEE-----EcCCEEEEEE
Confidence            36899999999999999999999999986531       2345688888888 799999999988     3445589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc-cc
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VK  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~-~~  226 (371)
                      ||+++ +|...+..    .+.+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.. ..
T Consensus        76 e~~~~g~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~~~~  149 (329)
T cd05588          76 EFVSGGDLMFHMQR----QRKLPEEHARFYSAEISLALNFLHER-GIIYRDLKLDNVLLDAEG-HIKLTDYGMCKEGIRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEECcCccccccccC
Confidence            99985 55554433    46799999999999999999999987 999999999999999887 8999999998753 22


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHhHH
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  298 (371)
                      ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.....        .+...+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~---------  219 (329)
T cd05588         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc---------
Confidence            33334567899999999996644 78999999999999999999999963211        1111111110         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC------HHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT------AVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t------~~~~l~~  354 (371)
                                       .  ...+|..++..+.++|.+||..||.+|++      +.++++|
T Consensus       220 -----------------~--~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         220 -----------------K--QIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             -----------------C--CCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence                             0  00145668999999999999999999997      6787776

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.5e-43  Score=338.99  Aligned_cols=253  Identities=26%  Similarity=0.376  Sum_probs=206.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC---CCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~~  141 (371)
                      .+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.++..++|+||+++...+.....   ...
T Consensus        32 ~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~  111 (496)
T PTZ00283         32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENV  111 (496)
T ss_pred             CCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccc
Confidence            5899999999999999999999999999999998543      2334578889999999999998877644322   122


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++||||++ |+|.+.+.........+++..+..++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       112 ~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~-~IiHrDLKP~NILl~~~~-~vkL~DFGl  189 (496)
T PTZ00283        112 LMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK-HMIHRDIKSANILLCSNG-LVKLGDFGF  189 (496)
T ss_pred             eEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEeCCC-CEEEEeccc
Confidence            35789999998 588887776555567899999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccC---CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          221 AKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       221 a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ++.....   .......||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+.....      
T Consensus       190 s~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~------  262 (496)
T PTZ00283        190 SKMYAATVSDDVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRY------  262 (496)
T ss_pred             CeeccccccccccccccCCcceeCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCC------
Confidence            8765332   1223467899999999996644 89999999999999999999999987765544443332100      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            ..++..+++++.+++.+||..||.+||++.++++|
T Consensus       263 ----------------------~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        263 ----------------------DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence                                  01345688999999999999999999999999988

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=5.2e-44  Score=329.53  Aligned_cols=247  Identities=25%  Similarity=0.426  Sum_probs=200.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++|+||+++++++     ....+.
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~-----~~~~~~   76 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAF-----QDKDNL   76 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEE-----ecCCeE
Confidence            6999999999999999999999999999999986532       3355788999999999999998887     334558


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++ ++|.+++...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~lH~~-~i~H~Dlkp~NIll~~~~-~~kL~Dfg~a~~  151 (330)
T cd05601          77 YLVMEYQPGGDLLSLLNRY---EDQFDEDMAQFYLAELVLAIHSVHQM-GYVHRDIKPENVLIDRTG-HIKLADFGSAAR  151 (330)
T ss_pred             EEEECCCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEcccCchHheEECCCC-CEEeccCCCCeE
Confidence            99999997 4776666542   36799999999999999999999986 999999999999999888 899999999976


Q ss_pred             cccCCCc--ccccccccccCcccccC-----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          224 LVKGEPN--ISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       224 ~~~~~~~--~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      .......  ....||+.|+|||++..     ...++.++|||||||++|+|++|..||...+....+..+.....     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~-----  226 (330)
T cd05601         152 LTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQR-----  226 (330)
T ss_pred             CCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            5433322  23468999999999853     33467899999999999999999999988776665555443210     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                ...++          ....++.++.+||.+||+ ||.+|||+.++++|
T Consensus       227 ----------~~~~~----------~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         227 ----------FLKFP----------EDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             ----------ccCCC----------CCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence                      00000          112478999999999998 99999999998888

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=1.3e-43  Score=325.62  Aligned_cols=237  Identities=29%  Similarity=0.486  Sum_probs=193.3

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++....       .....|.++++.+ +||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCF-----QTKDRLFFVM   75 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCeEEEEE
Confidence            36899999999999999999999999986532       2234577777765 799999999988     3444589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 E~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDikp~Nill~~~~-~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          76 EYVNGGDLMFQIQR----SRKFDEPRSRFYAAEVTLALMFLHRH-GVIYRDLKLDNILLDAEG-HCKLADFGMCKEGILN  149 (321)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEeecccceecccC
Confidence            99985 65555543    46789999999999999999999987 999999999999999888 899999999875432 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~----------------  212 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD----------------  212 (321)
T ss_pred             CccccccccCccccCHHHHcCCC-CCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------------
Confidence            22233456899999999986544 7899999999999999999999998877666555443310                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-------CHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-------TAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-------t~~~~l~~  354 (371)
                                   ..++..++.++.++|.+||+.||.+|+       ++.++++|
T Consensus       213 -------------~~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         213 -------------VLYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcC
Confidence                         013445789999999999999999999       89998888

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.6e-43  Score=324.65  Aligned_cols=277  Identities=33%  Similarity=0.614  Sum_probs=217.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|.+...     .....+|+.+++.++|+||+++++.+...........
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   83 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV   83 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence            35799999999999999999999999999999988532     1234568999999999999999987755444444567


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++++||+.+++...+.     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~ql~~aL~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~  156 (336)
T cd07849          84 YIVQELMETDLYKLIK-----TQHLSNDHIQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTNC-DLKICDFGLARIA  156 (336)
T ss_pred             EEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEECCCC-CEEECcccceeec
Confidence            8999999998776654     46799999999999999999999987 999999999999999888 8999999998765


Q ss_pred             ccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          225 VKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       225 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .....    .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+....+.++.+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (336)
T cd07849         157 DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNC  236 (336)
T ss_pred             cccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHH
Confidence            33221    12346788999999876655578999999999999999999999988887777777777777777666543


Q ss_pred             cCCCccccc---cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFK---FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~---~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .........   .+.....+|... ....+.++.++|.+||+.||.+|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         237 IISLRARNYIKSLPFKPKVPWNKL-FPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hhchhhhhHHhhcCcCCcccHHHH-hcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            321111000   111111112111 12468899999999999999999999999988

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.4e-43  Score=318.71  Aligned_cols=276  Identities=35%  Similarity=0.593  Sum_probs=220.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|++.+.||.|++|.||+|.+..+++.+|+|.+....      ....+|+.+++.++||||+++++++....   ..+.
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~---~~~~   81 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSN---LDKI   81 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecC---CCcE
Confidence            46999999999999999999999999999999886432      12357999999999999999998875432   2458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|.+++...   ...+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .++|+|||.+...
T Consensus        82 ~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~~l~d~g~~~~~  156 (293)
T cd07843          82 YMVMEYVEHDLKSLMETM---KQPFLQSEVKCLMLQLLSGVAHLHDN-WILHRDLKTSNLLLNNRG-ILKICDFGLAREY  156 (293)
T ss_pred             EEEehhcCcCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-cEEEeecCceeec
Confidence            899999999887777642   24689999999999999999999987 999999999999999887 8999999998876


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ... .......+++.|+|||.+.+....+.++|+||||+++|+|++|..||......+.+..+....+.+....|.....
T Consensus       157 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (293)
T cd07843         157 GSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE  236 (293)
T ss_pred             cCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence            443 2223455688899999987655568899999999999999999999999888888888888888887776654321


Q ss_pred             --CccccccCcccCCCCcccCCCC-CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 --NYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 --~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        ..............+...++.. +++.+.++|.+||+.||.+|||+.|+++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         237 LPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             cchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence              1111111111222233334554 68999999999999999999999995444

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.2e-44  Score=308.13  Aligned_cols=278  Identities=33%  Similarity=0.549  Sum_probs=222.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC----cEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..|++...||+|.||.||+|....++    +.+|||.++..      ....-||+..++.+.|||++++..+|...    
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~----   99 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSH----   99 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc----
Confidence            46999999999999999999765544    37899998654      23445899999999999999999988653    


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC----CCcEEE
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH----THQVKL  215 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~----~~~~kl  215 (371)
                      ...+++++||.+.+|...+...+.. .+.++...++.|+.||+.|+.|||++ -|+||||||.|||+..+    | .|||
T Consensus       100 d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N-WvlHRDLKPaNIlvmgdgperG-~VKI  177 (438)
T KOG0666|consen  100 DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN-WVLHRDLKPANILVMGDGPERG-RVKI  177 (438)
T ss_pred             CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh-heeeccCCcceEEEeccCCccC-eeEe
Confidence            4458999999999999998775532 35688999999999999999999987 89999999999999877    5 8999


Q ss_pred             EeeCCccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC---------cHHH
Q 017452          216 CDFGSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---------GVDQ  282 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~---------~~~~  282 (371)
                      +|||+++...+....    ...+.|.+|.|||.+.+...|+.+.|+|++|||+.||+|-.+.|.+..         ..+.
T Consensus       178 aDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQ  257 (438)
T KOG0666|consen  178 ADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQ  257 (438)
T ss_pred             ecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHH
Confidence            999999987554332    235669999999999999999999999999999999999998886532         3467


Q ss_pred             HHHHHHHhCCCCHhHHhhcCCCccc-cccCcccCCCCccc-------CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          283 LVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHKI-------FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~-------~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +..|.+.+|.|+.+.|+.+..-... ..+.....+.|++.       ....-++...+|+.+||++||.+|+|+.++++|
T Consensus       258 l~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh  337 (438)
T KOG0666|consen  258 LDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH  337 (438)
T ss_pred             HHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence            8899999999999998765421111 11122222223221       112235669999999999999999999999999

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.6e-43  Score=324.49  Aligned_cols=237  Identities=27%  Similarity=0.465  Sum_probs=192.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..++..||+|++.+..       ....+|.++++.+ +||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~-----~~~~~~lv~   75 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQ-----TKDRLFFVM   75 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEE-----cCCEEEEEE
Confidence            36899999999999999999999999986532       2334677888877 6999999999883     344589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~~~~~  149 (318)
T cd05570          76 EYVNGGDLMFHIQR----SGRFDEPRARFYAAEIVLGLQFLHER-GIIYRDLKLDNVLLDSEG-HIKIADFGMCKEGILG  149 (318)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEccCCCHHHeEECCCC-cEEecccCCCeecCcC
Confidence            99985 55555443    45799999999999999999999987 999999999999999988 899999999865322 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........|++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+...                 
T Consensus       150 ~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (318)
T cd05570         150 GVTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILED-----------------  211 (318)
T ss_pred             CCcccceecCccccCHHHhcCCC-CCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence            22233456899999999996654 789999999999999999999999877655444433221                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                  ...++..++..+.+||.+||..||.+||++     .++++|
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         212 ------------EVRYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcC
Confidence                        011445688999999999999999999999     998777

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.4e-43  Score=337.95  Aligned_cols=248  Identities=27%  Similarity=0.355  Sum_probs=203.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC-CcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..|.+.+.||+|++|.||+|.+..+ +..||+|.+...    .....+|+.+++.++||||+++++.+.     .....+
T Consensus        67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~-----~~~~~~  141 (478)
T PTZ00267         67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFK-----SDDKLL  141 (478)
T ss_pred             eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE-----ECCEEE
Confidence            3599999999999999999998877 788999976432    234557999999999999999999884     334589


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||++ |+|.+.+.........+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       142 lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~~~~-~~kL~DFgla~~~  219 (478)
T PTZ00267        142 LIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR-KMMHRDLKSANIFLMPTG-IIKLGDFGFSKQY  219 (478)
T ss_pred             EEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCcCHHhEEECCCC-cEEEEeCcCceec
Confidence            9999997 577777765444456789999999999999999999987 999999999999999888 8999999999875


Q ss_pred             ccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....   .....||+.|+|||++.+. .++.++|||||||++|+|++|+.||...+..+.+..+......         
T Consensus       220 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~---------  289 (478)
T PTZ00267        220 SDSVSLDVASSFCGTPYYLAPELWERK-RYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD---------  289 (478)
T ss_pred             CCccccccccccCCCccccCHhHhCCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC---------
Confidence            43321   3345689999999998654 4899999999999999999999999877665554444331100         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         .++..++.++.++|.+||..||.+||++.+++.+
T Consensus       290 -------------------~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        290 -------------------PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             -------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence                               0344578999999999999999999999999877

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=2.5e-43  Score=322.84  Aligned_cols=237  Identities=27%  Similarity=0.470  Sum_probs=189.8

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+|+.||+|.+....       .....|..++.. ++||||+++++++     ....++++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEE-----EeCCEEEEEE
Confidence            46999999999999999999999999986532       223456666665 4899999999888     3445689999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+.+ +|...+..    ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++......
T Consensus        76 E~~~~g~L~~~i~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivHrDlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05620          76 EFLNGGDLMFHIQD----KGRFDLYRATFYAAEIVCGLQFLHSK-GIIYRDLKLDNVMLDRDG-HIKIADFGMCKENVFG  149 (316)
T ss_pred             CCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEeCccCCCeecccC
Confidence            99985 66555543    46789999999999999999999987 999999999999999888 8999999998753222


Q ss_pred             -CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...  .              
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~--~--------------  212 (316)
T cd05620         150 DNRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVD--T--------------  212 (316)
T ss_pred             CCceeccCCCcCccCHHHHcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--C--------------
Confidence             2234567899999999996554 789999999999999999999999877655444333221  0              


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-HHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-VSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-~~~l~~  354 (371)
                                   ..++..++.++.++|.+||..||.+|+++ .++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h  248 (316)
T cd05620         213 -------------PHYPRWITKESKDILEKLFERDPTRRLGVVGNIRGH  248 (316)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                         01344578999999999999999999998 466666

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-43  Score=322.48  Aligned_cols=237  Identities=28%  Similarity=0.489  Sum_probs=189.4

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++....       .....|..++.. .+||||+++++.+     ....++++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~-----~~~~~~~lv~   75 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTF-----QTKEHLFFVM   75 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEE-----EcCCEEEEEE
Confidence            36899999999999999999999999986532       122345556654 4899999999887     3344689999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++......
T Consensus        76 e~~~gg~L~~~~~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          76 EYLNGGDLMFHIQS----SGRFDEARARFYAAEIICGLQFLHKK-GIIYRDLKLDNVLLDKDG-HIKIADFGMCKENMNG  149 (316)
T ss_pred             cCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHeEECCCC-CEEEccCcCCeECCCC
Confidence            99985 66555543    46799999999999999999999987 999999999999999888 8999999998764322


Q ss_pred             -CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       .......||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.+.+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILND-----------------  211 (316)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-----------------
Confidence             2233457899999999986554 789999999999999999999999887665544443221                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH-HHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV-SKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~-~~l~~  354 (371)
                                  ...++..++.++.++|.+||..||.+||++. ++++|
T Consensus       212 ------------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05592         212 ------------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQH  248 (316)
T ss_pred             ------------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcC
Confidence                        0014456789999999999999999999864 66666

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.5e-43  Score=325.59  Aligned_cols=276  Identities=31%  Similarity=0.554  Sum_probs=216.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|.+...      .....+|+.+++.++|+||+++++++..... .+..
T Consensus        15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            45799999999999999999999999999999988542      1234479999999999999999988754322 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +.++||||+.+++...+..      .+++..+..++.|++.||+|||.+ ||+||||||+||+++.++ .+||+|||++.
T Consensus        95 ~~~lv~e~~~~~l~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nil~~~~~-~~kL~Dfg~~~  166 (353)
T cd07850          95 DVYLVMELMDANLCQVIQM------DLDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  166 (353)
T ss_pred             cEEEEEeccCCCHHHHHhh------cCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCccce
Confidence            5789999999987776642      288999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...+.......+...++.++.+.+....
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (353)
T cd07850         167 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQ  245 (353)
T ss_pred             eCCCCCCCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            765444444456788999999986644 7899999999999999999999999888888888888888888766544322


Q ss_pred             CCccccc--cCcccCCCCcccC------------CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFK--FPQIKAHPWHKIF------------PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~--~~~~~~~~~~~~~------------~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....+.  .+.....++...+            +...+..+.++|.+||+.||++|||+.++|+|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         246 PTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            1111110  0000011111111            22356779999999999999999999998877

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.7e-43  Score=325.03  Aligned_cols=237  Identities=27%  Similarity=0.439  Sum_probs=188.9

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHH-HHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+|+.||+|++....       ....+|.. +++.++||||+++++.+.     .....++||
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~-----~~~~~~lv~   75 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQ-----TADKLYFVL   75 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEE-----eCCEEEEEE
Confidence            36899999999999999999999999986432       11223333 467789999999988873     344578999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-givH~dikp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (323)
T cd05575          76 DYVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGIEH  149 (323)
T ss_pred             cCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCCHHHeEECCCC-cEEEeccCCCcccccC
Confidence            99985 56555543    56789999999999999999999987 999999999999999888 8999999998754322


Q ss_pred             -CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       .......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+....+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (323)
T cd05575         150 SKTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNK---P-------------  212 (323)
T ss_pred             CCccccccCChhhcChhhhcCCC-CCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence             2233457899999999986654 889999999999999999999999877655544444321   0             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH----HHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----VSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~----~~~l~~  354 (371)
                                   ..++..++..+.++|.+||+.||.+||++    .++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         213 -------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcC
Confidence                         00334578999999999999999999998    476666

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=9e-43  Score=314.40  Aligned_cols=273  Identities=34%  Similarity=0.605  Sum_probs=212.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||.|++|.||+|.+..+|..||||++....      ....+|++++++++||||+++++++.     +....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH-----TENKLY   75 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc-----cCCcEE
Confidence            4899999999999999999999999999999885431      34567999999999999999999873     344578


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.++|...+...  ....+++..++.++.|++.||+|||++ +++|+||+|+||+++.++ .++|+|||++....
T Consensus        76 ~v~e~~~~~l~~~~~~~--~~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~H~~l~p~nill~~~~-~~~l~dfg~~~~~~  151 (284)
T cd07860          76 LVFEFLHQDLKKFMDAS--PLSGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAFG  151 (284)
T ss_pred             EEeeccccCHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEeeccchhhcc
Confidence            99999998877766542  245689999999999999999999986 999999999999999888 89999999987653


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .... .....+++.|+|||.+.+...++.++|+||||+++|+|+||+.||...+..+...++.+..+.+....+.....-
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (284)
T cd07860         152 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSL  231 (284)
T ss_pred             cCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHH
Confidence            3222 223456788999999876555688999999999999999999999988888888888887777765443311100


Q ss_pred             c-cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 Y-TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      . ....++......... ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         232 PDYKPSFPKWARQDFSK-VVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HHHHhhcccccccCHHH-HcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence            0 000111111111111 123478899999999999999999999995544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=5.5e-43  Score=332.90  Aligned_cols=275  Identities=25%  Similarity=0.320  Sum_probs=202.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      ...|.+.+.||+|+||.||+|.+..+++.||||...  .....+|+.++++++|+|||++++++..     ....++||+
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~--~~~~~~E~~iL~~L~HpnIv~l~~~~~~-----~~~~~lv~e  240 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW--YASSVHEARLLRRLSHPAVLALLDVRVV-----GGLTCLVLP  240 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc--ccCHHHHHHHHHHCCCCCCCcEEEEEEE-----CCEEEEEEE
Confidence            347999999999999999999999999999999643  2345689999999999999999988743     334789999


Q ss_pred             cccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC
Q 017452          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (371)
Q Consensus       150 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~  229 (371)
                      ++.++|...+...   ...+++..++.|+.||+.||.|||++ ||+||||||+|||++.++ .++|+|||+++.......
T Consensus       241 ~~~~~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDLKP~NILl~~~~-~vkL~DFGla~~~~~~~~  315 (461)
T PHA03211        241 KYRSDLYTYLGAR---LRPLGLAQVTAVARQLLSAIDYIHGE-GIIHRDIKTENVLVNGPE-DICLGDFGAACFARGSWS  315 (461)
T ss_pred             ccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEECcCCHHHEEECCCC-CEEEcccCCceecccccc
Confidence            9998887776532   34799999999999999999999987 999999999999999887 899999999876533221


Q ss_pred             ---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------cHHHHHHHHHHhCCCCHhHH-
Q 017452          230 ---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-------GVDQLVEIIKVLGTPTREEI-  298 (371)
Q Consensus       230 ---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-------~~~~~~~~~~~~~~~~~~~~-  298 (371)
                         .....||+.|+|||++.+.. ++.++|||||||++|||++|..++....       ....+.++++..+....+.. 
T Consensus       316 ~~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~  394 (461)
T PHA03211        316 TPFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQ  394 (461)
T ss_pred             cccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCC
Confidence               12356899999999997654 7999999999999999999876543221       12334444443322211100 


Q ss_pred             -------hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          299 -------KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       299 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                             ............+......|...  ..++.++.+||.+||+.||.+|||+.|            ++.||||++
T Consensus       395 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dli~~mL~~DP~~RPsa~e------------lL~hp~f~~  460 (461)
T PHA03211        395 HAGSRLVSQYRHRAARNRRPAYTRPAWTRY--YKLDLDVEYLVCRALTFDGARRPSAAE------------LLRLPLFQS  460 (461)
T ss_pred             CcchHHHHHHHhhhhcccCCccCCcchhhh--ccccchHHHHHHHHcccChhhCcCHHH------------HhhCcccCC
Confidence                   00000000001111112223221  146778999999999999999999999            556666654

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=3.8e-43  Score=323.31  Aligned_cols=238  Identities=26%  Similarity=0.477  Sum_probs=186.4

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|..++..+ +||||+++++++.     .....++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQ-----TESRLFFVI   75 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEE-----eCCEEEEEE
Confidence            46999999999999999999999999986531       2244677777766 8999999999883     344589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+++.... 
T Consensus        76 E~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dikp~Nili~~~~-~~kL~DfG~~~~~~~~  149 (329)
T cd05618          76 EYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDYGMCKEGLRP  149 (329)
T ss_pred             eCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-CEEEeeCCccccccCC
Confidence            99985 55444432    56799999999999999999999987 999999999999999988 899999999875322 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHHhCCCCHhHH
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~~~~~~~~~~~~~~  298 (371)
                      ........||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.....        ...+.+....         
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~---------  219 (329)
T cd05618         150 GDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE---------  219 (329)
T ss_pred             CCccccccCCccccCHHHHcCCC-CCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc---------
Confidence            22334567899999999996654 78999999999999999999999953111        1111111100         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                                       .  ...+|..++..+.++|.+||..||.+|+++      .++++|
T Consensus       220 -----------------~--~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         220 -----------------K--QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             -----------------C--CCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence                             0  001456689999999999999999999984      676665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.4e-43  Score=327.75  Aligned_cols=250  Identities=26%  Similarity=0.434  Sum_probs=199.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+|++.+.||+|+||.||+|.+..+++.||+|++.+.       .....+|..+++.++||||+++++++     ...
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~-----~~~  115 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDD  115 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            346799999999999999999999999999999998542       22345788999999999999999888     344


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .++++||||+++ +|..++.     ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       116 ~~~~lv~Ey~~gg~L~~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDLkp~NIll~~~~-~ikL~DfG~  188 (371)
T cd05622         116 RYLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGT  188 (371)
T ss_pred             CEEEEEEcCCCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CEEeCCCCHHHEEECCCC-CEEEEeCCc
Confidence            568999999975 6666654     34689999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCCC--cccccccccccCcccccCCc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +........  .....||+.|+|||++....   .++.++|||||||++|+|++|..||...+.......+......   
T Consensus       189 a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~---  265 (371)
T cd05622         189 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNS---  265 (371)
T ss_pred             eeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCc---
Confidence            976543221  23467899999999986432   3688999999999999999999999887765555554432110   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRILF  355 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~l  355 (371)
                                  ..++          ....++..+.++|.+||..++.+  |+++.++++|.
T Consensus       266 ------------~~~~----------~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         266 ------------LTFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             ------------ccCC----------CcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence                        0010          12357999999999999844433  78999999883

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=1.5e-42  Score=312.59  Aligned_cols=272  Identities=35%  Similarity=0.601  Sum_probs=211.5

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++.+.||+|+||.||+|.+..++..||+|++....     ....+|+.+++++. |+|++++++++...   ...++++
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~---~~~~~~l   77 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDR---KTGRLAL   77 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecC---CCCcEEE
Confidence            778999999999999999999999999999886432     12236888888885 99999999987542   1245789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||+++++.+.+...   ...+++..++.++.|++.||.|||++ |++||||||+||+++. + .+||+|||.+.....
T Consensus        78 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~qi~~~L~~LH~~-~i~H~dl~p~ni~l~~-~-~~kl~dfg~~~~~~~  151 (282)
T cd07831          78 VFELMDMNLYELIKGR---KRPLPEKRVKSYMYQLLKSLDHMHRN-GIFHRDIKPENILIKD-D-ILKLADFGSCRGIYS  151 (282)
T ss_pred             EEecCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEcC-C-CeEEEeccccccccc
Confidence            9999999877766532   35789999999999999999999987 9999999999999998 5 899999999987654


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc-
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY-  305 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  305 (371)
                      ........+++.|+|||.+.....++.++|+|||||++|+|++|..||.+.+..+....+....+.+............ 
T Consensus       152 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         152 KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence            4444445678899999987555557889999999999999999999999888888888887777777665433222111 


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+.++........ .....++.++.++|.+||.+||.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTGLR-KLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCcccccccHH-HHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            11111111111111 1123578999999999999999999999996554

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1.6e-42  Score=314.42  Aligned_cols=275  Identities=34%  Similarity=0.575  Sum_probs=212.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||.|++|.||+|.+..+|+.||+|.+...      .....+|+++++.++|+||+++++++.     ...+.
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVH-----SEKRL   76 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEe-----cCCeE
Confidence            4699999999999999999999999999999988532      134567999999999999999999883     34468


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+++++...+...  ....+++..++.++.||+.||+|||++ +++|+||+|+||+++.++..+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~  153 (294)
T PLN00009         77 YLVFEYLDLDLKKHMDSS--PDFAKNPRLIKTYLYQILRGIAYCHSH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAF  153 (294)
T ss_pred             EEEEecccccHHHHHHhC--CCCCcCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCcceEEEECCCCEEEEccccccccc
Confidence            899999998877766532  233468888999999999999999987 99999999999999876558999999998764


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+..+.+.++....+.+....|.....
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (294)
T PLN00009        154 GIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTS  233 (294)
T ss_pred             CCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccc
Confidence            33221 22345688899999986655578899999999999999999999998888777777777777776655542211


Q ss_pred             Cccc-cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTE-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      -... ..++..... ........+++++.+++.+||+.||.+||++.++++|
T Consensus       234 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        234 LPDYKSAFPKWPPK-DLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             chhhhhhcccCCCC-CHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            0000 000000000 0011234578899999999999999999999997665

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=5.1e-43  Score=320.71  Aligned_cols=237  Identities=27%  Similarity=0.485  Sum_probs=190.0

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHH-cCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++....       .....|..++.. ++||||+++++++.     ....+++||
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~-----~~~~~~lv~   75 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQ-----TKENLFFVM   75 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEE-----eCCEEEEEE
Confidence            36899999999999999999999999986532       223356667765 48999999998873     334588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|...+..    ...+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++......
T Consensus        76 ey~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~LH~~-~ivHrdikp~Nil~~~~~-~~kl~Dfg~~~~~~~~  149 (316)
T cd05619          76 EYLNGGDLMFHIQS----CHKFDLPRATFYAAEIICGLQFLHSK-GIVYRDLKLDNILLDTDG-HIKIADFGMCKENMLG  149 (316)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeCCCCHHHEEECCCC-CEEEccCCcceECCCC
Confidence            99985 66666543    45789999999999999999999987 999999999999999888 8999999998753222


Q ss_pred             -CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||...+..+....+...                 
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-----------------  211 (316)
T cd05619         150 DAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMD-----------------  211 (316)
T ss_pred             CCceeeecCCccccCHHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------
Confidence             2233467899999999986554 799999999999999999999999877655444333211                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH-HHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV-SKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~-~~l~~  354 (371)
                                  ...++..++.++.++|.+||+.||.+||++. ++++|
T Consensus       212 ------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h  248 (316)
T cd05619         212 ------------NPCYPRWLTREAKDILVKLFVREPERRLGVKGDIRQH  248 (316)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcC
Confidence                        0013445789999999999999999999996 77666

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.9e-43  Score=328.29  Aligned_cols=245  Identities=26%  Similarity=0.409  Sum_probs=196.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.++..++|+||+++++.+     ....++
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~~~~~~   76 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSF-----QDKRNL   76 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            599999999999999999999999999999998642       23345688999999999999999887     444568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++| +|.+.+..    ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .++|+|||++..
T Consensus        77 ~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~~L~~lH~~-givHrDLkp~NIli~~~~-~vkL~DfG~~~~  150 (360)
T cd05627          77 YLIMEFLPGGDMMTLLMK----KDTLSEEATQFYIAETVLAIDAIHQL-GFIHRDIKPDNLLLDAKG-HVKLSDFGLCTG  150 (360)
T ss_pred             EEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEccCCCHHHEEECCCC-CEEEeeccCCcc
Confidence            999999985 66666653    46789999999999999999999986 999999999999999888 899999999865


Q ss_pred             cccCC------------------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHH
Q 017452          224 LVKGE------------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       224 ~~~~~------------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  267 (371)
                      .....                                    ......||+.|+|||++.+.. ++.++|+|||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel  229 (360)
T cd05627         151 LKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEM  229 (360)
T ss_pred             cccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCC-CCCcceeccccceeeec
Confidence            42110                                    012346899999999986654 78999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC
Q 017452          268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT  347 (371)
Q Consensus       268 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t  347 (371)
                      ++|..||.+.+.......+......               ..++          -...++.++.+||.+|+. ||.+|++
T Consensus       230 ~tG~~Pf~~~~~~~~~~~i~~~~~~---------------~~~p----------~~~~~s~~~~~li~~l~~-~p~~R~~  283 (360)
T cd05627         230 LIGYPPFCSETPQETYRKVMNWKET---------------LVFP----------PEVPISEKAKDLILRFCT-DSENRIG  283 (360)
T ss_pred             ccCCCCCCCCCHHHHHHHHHcCCCc---------------eecC----------CCCCCCHHHHHHHHHhcc-ChhhcCC
Confidence            9999999887766655554431100               0000          011368899999999875 9999985


Q ss_pred             ---HHHHhhh
Q 017452          348 ---AVSKRIL  354 (371)
Q Consensus       348 ---~~~~l~~  354 (371)
                         +.++++|
T Consensus       284 ~~~~~ei~~h  293 (360)
T cd05627         284 SNGVEEIKSH  293 (360)
T ss_pred             CCCHHHHhcC
Confidence               7887777

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=7.6e-43  Score=313.85  Aligned_cols=240  Identities=23%  Similarity=0.346  Sum_probs=188.1

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||+|+||.||++.+..+|+.||+|.+...       ......|+++++.++||||+++++.+     ....+.++||||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAF-----ESKTHLCLVMSLM   75 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999988532       12334689999999999999998887     3445689999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      +| +|...+...  ....+++..+..++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++.........
T Consensus        76 ~g~~L~~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dikp~Nili~~~~-~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          76 NGGDLKYHIYNV--GERGLEMERVIHYSAQITCGILHLHSM-DIVYRDMKPENVLLDDQG-NCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             CCCCHHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEEccCChHhEEEcCCC-CEEEeeceeeeecCCCcee
Confidence            85 665555432  234688999999999999999999986 999999999999999887 8999999998776544444


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccccc
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ....+++.|+|||++.+.. ++.++|+|||||++|+|++|..||...........+.......             .   
T Consensus       152 ~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~-------------~---  214 (277)
T cd05607         152 TQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLED-------------E---  214 (277)
T ss_pred             eccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcc-------------c---
Confidence            4567899999999987655 8999999999999999999999997654322222222111000             0   


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                             . ......++.++.+|+.+||+.||.+||++.+++
T Consensus       215 -------~-~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~  248 (277)
T cd05607         215 -------V-KFEHQNFTEESKDICRLFLAKKPEDRLGSREKN  248 (277)
T ss_pred             -------c-ccccccCCHHHHHHHHHHhccCHhhCCCCccch
Confidence                   0 001134789999999999999999999996654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.7e-43  Score=312.48  Aligned_cols=249  Identities=34%  Similarity=0.553  Sum_probs=199.5

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhh------hHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY------KNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~------~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++++.||+|+||+||++.+..+++.||+|++......      ..+|+.+++.++||||+++++.+..     ..+.++
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~   75 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD-----DNYLYI   75 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE-----SSEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc-----cccccc
Confidence            88999999999999999999999999999999654321      2348899999999999999998844     455789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc-
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-  224 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~-  224 (371)
                      +|||+.+ +|.+.+..    ...+++..+..++.||+.||.+||++ ||+|+||||+||+++.++ .++|+|||.+... 
T Consensus        76 v~~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~Lh~~-~i~H~dikp~NIl~~~~~-~~~l~Dfg~~~~~~  149 (260)
T PF00069_consen   76 VMEYCPGGSLQDYLQK----NKPLSEEEILKIAYQILEALAYLHSK-GIVHRDIKPENILLDENG-EVKLIDFGSSVKLS  149 (260)
T ss_dssp             EEEEETTEBHHHHHHH----HSSBBHHHHHHHHHHHHHHHHHHHHT-TEEESSBSGGGEEESTTS-EEEESSGTTTEEST
T ss_pred             cccccccccccccccc----cccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccccc
Confidence            9999997 88877772    57889999999999999999999987 999999999999999877 8999999998763 


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..........++..|+|||.+......+.++|+||||+++|+|++|..||......+....+.+...........     
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~-----  224 (260)
T PF00069_consen  150 ENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQ-----  224 (260)
T ss_dssp             STTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTT-----
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccccccccc-----
Confidence            223334456779999999998634558999999999999999999999998874444444443332221111110     


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       .....+..+.++|.+||+.||++||++.++++|
T Consensus       225 -----------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  225 -----------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             -----------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTS
T ss_pred             -----------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                             001123789999999999999999999994433

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=4.3e-42  Score=310.17  Aligned_cols=273  Identities=34%  Similarity=0.623  Sum_probs=208.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||+|++|.||+|.+..+|+.||+|++....      ....+|+.+++.++|+|++++++++.     .....
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~   75 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFR-----RKRKL   75 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEe-----eCCEE
Confidence            36999999999999999999999999999999885432      23457999999999999999999884     34457


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+++++...+..   ....+++..++.++.||+.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 ~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~  150 (286)
T cd07847          76 HLVFEYCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKH-NCIHRDVKPENILITKQG-QIKLCDFGFARIL  150 (286)
T ss_pred             EEEEeccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCChhhEEEcCCC-cEEECccccceec
Confidence            89999999865554432   245689999999999999999999986 999999999999999888 8999999998876


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+....+.+..+............
T Consensus       151 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (286)
T cd07847         151 TGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFST  230 (286)
T ss_pred             CCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccc
Confidence            4433 222345688899999987655578899999999999999999999998877777776666655443322211110


Q ss_pred             C--ccccccCcccC-CCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 N--YTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~--~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  +.....+.... .++.. ....++..+.+|+.+||..||.+|||+.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         231 NQFFKGLSIPEPETREPLES-KFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccccccccCCCcccccCHHH-HhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence            0  00111111000 01111 123468899999999999999999999995554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=1.8e-43  Score=324.27  Aligned_cols=237  Identities=27%  Similarity=0.441  Sum_probs=192.8

Q ss_pred             EeeccCCceEEEEEEEC---CCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           77 RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      +.||+|+||.||++.+.   .+|+.||+|++....      ....+|++++++++||||+++++++     .....+|+|
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~-----~~~~~~~lv   76 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAF-----QTEGKLYLI   76 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEE-----EcCCEEEEE
Confidence            57999999999999863   578999999986432      2345689999999999999999888     334568899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.....
T Consensus        77 ~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~~~  150 (318)
T cd05582          77 LDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGLSKESID  150 (318)
T ss_pred             EcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHeEECCCC-cEEEeeccCCcccCC
Confidence            99998 466655543    46789999999999999999999986 999999999999999888 899999999876543


Q ss_pred             C-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 G-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      . .......|++.|+|||.+.+.. ++.++|||||||++|+|++|+.||...+..+.+..+.+..               
T Consensus       151 ~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~---------------  214 (318)
T cd05582         151 HEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAK---------------  214 (318)
T ss_pred             CCCceecccCChhhcCHHHHcCCC-CCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCC---------------
Confidence            3 2233567899999999986544 7899999999999999999999998776655544443210               


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                    ..++..+++++.+||.+||+.||.+||+     +.++++|
T Consensus       215 --------------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~  254 (318)
T cd05582         215 --------------LGMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRH  254 (318)
T ss_pred             --------------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCC
Confidence                          0134567899999999999999999999     6667766

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-43  Score=339.71  Aligned_cols=256  Identities=23%  Similarity=0.375  Sum_probs=203.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcC-CCCeeeccee-EEecCCCC-cee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHC-FFSTTDKD-ELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~-~~~~~~~~-~~~  143 (371)
                      .+++|.+.|.+|||+.||+|.+...|..||+|++...    .....+|+++|++|. |+|||.+++. ........ .--
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            3689999999999999999999988899999987543    244568999999996 9999999993 33332222 344


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      +.|.||||. |+|.+++..+.  +.+|++.++++|+.|+|+|+.+||.. .  |||||||-+||||+.++ .+||||||.
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rl--q~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g-~~KLCDFGS  192 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRL--QTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADG-NYKLCDFGS  192 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHH--hccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCC-CEEeCcccc
Confidence            678999999 69999988755  45699999999999999999999963 5  99999999999999998 899999998


Q ss_pred             ccccccCCCc----------ccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017452          221 AKVLVKGEPN----------ISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       221 a~~~~~~~~~----------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  288 (371)
                      ++........          ....-|+.|+|||.+.  .+...+.|+|||+|||+||.|+....||........    ++
T Consensus       193 att~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI----ln  268 (738)
T KOG1989|consen  193 ATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI----LN  268 (738)
T ss_pred             cccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE----Ee
Confidence            8654322211          1234599999999973  344579999999999999999999999977533221    11


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                      .                 .+.+|.          ..+++..+.+||+.||+.||.+||++.+++.++..+...
T Consensus       269 g-----------------~Y~~P~----------~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~  314 (738)
T KOG1989|consen  269 G-----------------NYSFPP----------FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANK  314 (738)
T ss_pred             c-----------------cccCCC----------CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcC
Confidence            0                 112221          135899999999999999999999999999998776554

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-42  Score=317.50  Aligned_cols=278  Identities=35%  Similarity=0.589  Sum_probs=209.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECC--CCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||+|++|.||+|.+..  ++..||+|.+....       ....+|+.+++.++||||+++++++...   ...
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~~   77 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEH---ADK   77 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCC---CCc
Confidence            48999999999999999999988  89999999986532       3446799999999999999999988542   235


Q ss_pred             eEEEeeccccchHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC----CCCcEEEEe
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP----HTHQVKLCD  217 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~----~~~~~kl~D  217 (371)
                      .+++||||+++++.+.+....... ..+++..++.++.||+.||.|||++ +|+||||||+||+++.    ++ .+||+|
T Consensus        78 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~h~dlkp~Nil~~~~~~~~~-~~kl~D  155 (316)
T cd07842          78 SVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN-WVLHRDLKPANILVMGEGPERG-VVKIGD  155 (316)
T ss_pred             eEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC-CEeeCCCCHHHEEEcCCCCccc-eEEECC
Confidence            689999999988877776544333 3789999999999999999999986 9999999999999998    76 899999


Q ss_pred             eCCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---------HHHH
Q 017452          218 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---------DQLV  284 (371)
Q Consensus       218 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---------~~~~  284 (371)
                      ||++........    .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||......         ..+.
T Consensus       156 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (316)
T cd07842         156 LGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE  235 (316)
T ss_pred             CccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHH
Confidence            999876543222    123456888999999876666789999999999999999999999765432         3455


Q ss_pred             HHHHHhCCCCHhHHhhcC--CCccc----cccCcccCCCCcccCC--CCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          285 EIIKVLGTPTREEIKCMN--PNYTE----FKFPQIKAHPWHKIFP--KRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~~~~~~~~--~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+...++.+....+....  +.+..    ..............+.  ...+.++.+++.+||++||.+|||+.++++|
T Consensus       236 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         236 RIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            566666666555443211  11111    0000000000001111  2577899999999999999999999995444

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=2.5e-42  Score=311.79  Aligned_cols=247  Identities=24%  Similarity=0.373  Sum_probs=198.4

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      |+..+.||+|+||.||+|.+..+++.||+|.+....       ....+|+.+++.++|+|++.+.+++     ......+
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAY-----ETKDALC   76 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEE-----ecCCEEE
Confidence            788899999999999999999999999999885431       2345799999999999999998877     3345589


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+.+ +|...+..  .....+++..+..++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~ql~~~l~~lH~~-~iiH~dikp~Nili~~~~-~~kl~Dfg~~~~~  152 (285)
T cd05632          77 LVLTIMNGGDLKFHIYN--MGNPGFEEERALFYAAEILCGLEDLHRE-NTVYRDLKPENILLDDYG-HIRISDLGLAVKI  152 (285)
T ss_pred             EEEEeccCccHHHHHHH--hcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecCCCHHHEEECCCC-CEEEecCCcceec
Confidence            99999986 55555443  2235799999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+........          
T Consensus       153 ~~~~~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~----------  221 (285)
T cd05632         153 PEGESIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETE----------  221 (285)
T ss_pred             CCCCcccCCCCCcCccChHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccc----------
Confidence            4443334567899999999986554 78999999999999999999999987655443333332211110          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                     ..++..++.++.+|+.+||+.||.+||+     +.+++.|
T Consensus       222 ---------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         222 ---------------EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             ---------------cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcC
Confidence                           0134557889999999999999999999     7786666

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.4e-42  Score=312.97  Aligned_cols=247  Identities=17%  Similarity=0.197  Sum_probs=199.4

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      ..||+|++|.||+|.+  +|+.||||.+....       ..+.+|+.++++++||||+++++++.... ....++++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~-~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV-DDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc-cCCCceEEEEE
Confidence            5689999999999987  78999999986432       33458999999999999999999875422 22345789999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      |+++ +|.+.+..    ...+++.....++.|++.||.|||+..+++||||||+||+++.++ .+||+|||++...... 
T Consensus       103 y~~~g~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~-~~kl~dfg~~~~~~~~-  176 (283)
T PHA02988        103 YCTRGYLREVLDK----EKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENY-KLKIICHGLEKILSSP-  176 (283)
T ss_pred             eCCCCcHHHHHhh----CCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCC-cEEEcccchHhhhccc-
Confidence            9995 67666653    467889999999999999999999745899999999999999988 8999999998765322 


Q ss_pred             CcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          229 PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       229 ~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                       .....++..|+|||.+.+. ..++.++|||||||++|+|++|+.||...+..+....+......+              
T Consensus       177 -~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~--------------  241 (283)
T PHA02988        177 -PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSL--------------  241 (283)
T ss_pred             -cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCC--------------
Confidence             2345678899999998642 357999999999999999999999998776555544443321111              


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                   .++..+++++.+|+.+||+.||.+|||+.++++.|+.+++
T Consensus       242 -------------~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        242 -------------KLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -------------CCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence                         0334578999999999999999999999999999887654

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.5e-42  Score=320.69  Aligned_cols=277  Identities=35%  Similarity=0.630  Sum_probs=218.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|.+.+.||+|+||.||+|.+..+++.||||.+...      .....+|+.+++.++|+||+++++++...........
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~   84 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDV   84 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcE
Confidence            4799999999999999999999999999999987542      2234579999999999999999998755433333457


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++++||++++|...+..    ...+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||++...
T Consensus        85 ~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~i~H~dlkp~Nil~~~~~-~~kL~Dfg~~~~~  158 (337)
T cd07858          85 YIVYELMDTDLHQIIRS----SQTLSDDHCQYFLYQLLRGLKYIHSA-NVLHRDLKPSNLLLNANC-DLKICDFGLARTT  158 (337)
T ss_pred             EEEEeCCCCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcCcccccc
Confidence            89999999887776653    46799999999999999999999987 999999999999999887 8999999998765


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ... .......++..|+|||.+.....++.++|+||||+++|+|++|+.||.+.+.......+....+.+..+.+.....
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         159 SEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            433 2223446788899999986544588999999999999999999999988887777777888888777665532111


Q ss_pred             Cccccc---cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFK---FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~---~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ......   .+......+.. ....+++++.++|.+||+.||++|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFAR-LFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hhhhHHHHhcCcccccCHHH-HcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence            110000   01101111111 223588999999999999999999999999988

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2.2e-42  Score=344.68  Aligned_cols=257  Identities=27%  Similarity=0.368  Sum_probs=206.2

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      +....+|.+.+.||.|+||.||+|.+..++..||+|.+...      ...+..|+.+++.++|||||+++++|...   .
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de---~   85 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNK---A   85 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEec---C
Confidence            34456899999999999999999999999999999988532      23456799999999999999999988642   3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc------CCcEeeccCCCceeeeCCC---
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS------IGVCHRDIKPQNLLVNPHT---  210 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~------~~ivH~dlkp~NIli~~~~---  210 (371)
                      ...+||||||++ ++|...+.........+++..++.|+.||+.||.|||..      .+||||||||+||||+.+.   
T Consensus        86 ~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l  165 (1021)
T PTZ00266         86 NQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI  165 (1021)
T ss_pred             CCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence            345789999998 588888876555557899999999999999999999973      1499999999999996421   


Q ss_pred             -------------CcEEEEeeCCccccccCCCcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          211 -------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       211 -------------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                                   ..+||+|||++.............||+.|+|||++.+. ..++.++|||||||+||+|++|..||..
T Consensus       166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~  245 (1021)
T PTZ00266        166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK  245 (1021)
T ss_pred             ccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence                         24899999999876544444456789999999998543 3478899999999999999999999987


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+....+..........                            .....+.++.+||..||..+|.+||++.++|.|
T Consensus       246 ~~~~~qli~~lk~~p~l----------------------------pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        246 ANNFSQLISELKRGPDL----------------------------PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             CCcHHHHHHHHhcCCCC----------------------------CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            66554443333211000                            112368899999999999999999999999987

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.6e-42  Score=319.80  Aligned_cols=271  Identities=25%  Similarity=0.429  Sum_probs=199.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ++|++.+.||+|+||.||++.+..++..+|+|.+...     ...+.+|+++++.++|+||+++++++..     ....+
T Consensus         5 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   79 (333)
T cd06650           5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEIS   79 (333)
T ss_pred             hhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEE-----CCEEE
Confidence            5799999999999999999999999999999987543     1345689999999999999999998844     34588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+++..    ...+++..+..++.|++.||.|||.+.+|+|+||||+|||++.++ .+||+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~-~~kL~Dfg~~~~~  154 (333)
T cd06650          80 ICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQL  154 (333)
T ss_pred             EEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCC-CEEEeeCCcchhh
Confidence            99999975 77776654    456899999999999999999999754799999999999999888 8999999998755


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh--CCCCHhHHh---
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL--GTPTREEIK---  299 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~---  299 (371)
                      ... ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||......+.. .+....  +.+......   
T Consensus       155 ~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~  231 (333)
T cd06650         155 IDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELE-LMFGCPVEGDPAESETSPRP  231 (333)
T ss_pred             hhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHH-HHhcCcccCCccccccCccc
Confidence            332 22345688999999998654 4789999999999999999999999765543222 111100  000000000   


Q ss_pred             --------hcCCCccc-c---cc-CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 --------CMNPNYTE-F---KF-PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 --------~~~~~~~~-~---~~-~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              ...+.... .   .. ..+....-.......++.++.+||.+||++||++|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         232 RPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             CCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                    00000000 0   00 00000000000112367899999999999999999999998888

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-42  Score=311.25  Aligned_cols=274  Identities=32%  Similarity=0.611  Sum_probs=210.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|++|.||+|.+..+++.||+|.+....     ....+|+++++.++|+||+++++++     ....+.
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   78 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII-----HTKKTL   78 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE-----ecCCeE
Confidence            357999999999999999999999899999999885432     2345799999999999999999887     334568


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        79 ~lv~e~~~~~L~~~~~~~---~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~  153 (291)
T cd07844          79 TLVFEYLDTDLKQYMDDC---GGGLSMHNVRLFLFQLLRGLAYCHQR-RVLHRDLKPQNLLISERG-ELKLADFGLARAK  153 (291)
T ss_pred             EEEEecCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccCCHHHEEEcCCC-CEEECcccccccc
Confidence            899999999887766532   34789999999999999999999987 999999999999999988 8999999998654


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .... ......++..|+|||.+.+...++.++|+||+|+++|+|++|..||.... ..+.+..+.+..+.+....+....
T Consensus       154 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (291)
T cd07844         154 SVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVS  233 (291)
T ss_pred             CCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhh
Confidence            3211 11223467889999998765557889999999999999999999997665 455566666777776666554322


Q ss_pred             CC--ccccccCcccCCCCcccCCCCCC--hhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PN--YTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~--~~~~~~~~~~~~~~~~~~~~~~s--~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..  +...........+..... ..++  .++.+++.+||+.||.+|||+.++++|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         234 SNPEFKPYSFPFYPPRPLINHA-PRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             hccccccccccccCChhHHHhC-cCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence            11  111111111111111111 1234  889999999999999999999995544

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=3.1e-42  Score=310.83  Aligned_cols=273  Identities=33%  Similarity=0.626  Sum_probs=215.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||.|++|.||+|.+..+|..||+|.+...     .....+|+.+++.++|+||+++++.+..     ....++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   75 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT-----ENKLML   75 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee-----CCcEEE
Confidence            489999999999999999999999999999988543     2344579999999999999999998843     344789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||+++++.+.+..... ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~h~dl~p~ni~~~~~~-~~~l~d~g~~~~~~~  152 (284)
T cd07836          76 VFEYMDKDLKKYMDTHGV-RGALDPNTVKSFTYQLLKGIAFCHEN-RVLHRDLKPQNLLINKRG-ELKLADFGLARAFGI  152 (284)
T ss_pred             EEecCCccHHHHHHhcCC-CCCcCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEECCCC-cEEEeecchhhhhcC
Confidence            999999988877764322 35689999999999999999999986 999999999999999887 899999999875433


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+..+....+......+....+.... ..
T Consensus       153 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  231 (284)
T cd07836         153 PVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS-QL  231 (284)
T ss_pred             CccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHh-cC
Confidence            21 12234568889999998766657889999999999999999999999888888888888877777766654332 11


Q ss_pred             ccc--ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+  .++......+.. +...++..+.+++.+||+.||.+||++.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         232 PEYKPTFPRYPPQDLQQ-LFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             chhcccccCCChHHHHH-HhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            111  111111111111 223468899999999999999999999995544

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=1.9e-42  Score=318.03  Aligned_cols=242  Identities=27%  Similarity=0.435  Sum_probs=193.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +|+..+.||+|+||.||+|.+..+|+.||+|++.+..       .....|..+++.+. |++|+++++++     .....
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~-----~~~~~   75 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCF-----QTVDR   75 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEE-----ecCCE
Confidence            3788999999999999999999999999999986532       22345777888776 46677787777     33445


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +++||||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        76 ~~lv~Ey~~~g~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivHrDikp~Nill~~~~-~ikL~Dfg~~~  149 (323)
T cd05615          76 LYFVMEYVNGGDLMYHIQQ----VGKFKEPQAVFYAAEISVGLFFLHRR-GIIYRDLKLDNVMLDSEG-HIKIADFGMCK  149 (323)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEecccccc
Confidence            8899999985 66555543    46799999999999999999999987 999999999999999888 89999999987


Q ss_pred             ccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ..... .......||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+....           
T Consensus       150 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~-----------  217 (323)
T cd05615         150 EHMVDGVTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHN-----------  217 (323)
T ss_pred             ccCCCCccccCccCCccccCHHHHcCCC-CCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            54322 2233456899999999986544 7899999999999999999999998876655554443310           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                        ..++..++.++.+++.+||+.||.+|+++     .++++|
T Consensus       218 ------------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05615         218 ------------------VSYPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREH  257 (323)
T ss_pred             ------------------CCCCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcC
Confidence                              01445678999999999999999999984     566655

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.7e-42  Score=311.55  Aligned_cols=247  Identities=24%  Similarity=0.380  Sum_probs=196.9

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      |++.+.||+|+||.||++.+..+++.||+|.+....       ....+|+.+++.++|+|++.+++.+     ......+
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~-----~~~~~~~   76 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY-----ETKDALC   76 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE-----ecCCEEE
Confidence            788899999999999999999999999999885431       2244689999999999999998887     3344589


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~g~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~lH~~-~iiH~dikp~Nil~~~~~-~~~l~Dfg~~~~~  152 (285)
T cd05630          77 LVLTLMNGGDLKFHIYHM--GEAGFEEGRAVFYAAEICCGLEDLHQE-RIVYRDLKPENILLDDHG-HIRISDLGLAVHV  152 (285)
T ss_pred             EEEEecCCCcHHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHEEECCCC-CEEEeeccceeec
Confidence            99999985 676665432  235689999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..........|+..|+|||.+.+.. ++.++|+||+|+++|+|++|+.||..................            
T Consensus       153 ~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~------------  219 (285)
T cd05630         153 PEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE------------  219 (285)
T ss_pred             CCCccccCCCCCccccChHHHcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh------------
Confidence            4444334457899999999996654 899999999999999999999999765432111111111000            


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                   ....++..+++++.+|+.+||+.||.+|||     +.++++|
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         220 -------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             -------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcC
Confidence                         001134557899999999999999999999     8998877

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-42  Score=318.81  Aligned_cols=249  Identities=26%  Similarity=0.403  Sum_probs=196.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||++.+..+++.||+|++.+.       ...+.+|..+++.++|+||+++++++     ....++
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAF-----QDENNL   76 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEE-----ecCCeE
Confidence            699999999999999999999999999999998642       12345788899999999999999888     344568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.| +|.+++..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~Dfg~~~~  151 (331)
T cd05597          77 YLVMDYYVGGDLLTLLSK---FEDRLPEDMARFYLAEMVLAIDSVHQL-GYVHRDIKPDNVLLDKNG-HIRLADFGSCLR  151 (331)
T ss_pred             EEEEecCCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeEECCCCHHHEEECCCC-CEEEEECCceee
Confidence            999999974 77666643   245789999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccCCCc--ccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          224 LVKGEPN--ISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       224 ~~~~~~~--~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......  ....||+.|+|||++..    ...++.++|||||||++|+|++|+.||...+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05597         152 LLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEH-----  226 (331)
T ss_pred             cCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCc-----
Confidence            5433221  23468999999999853    234678999999999999999999999877665554444321100     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCC--CCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN--LRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~--~R~t~~~~l~~  354 (371)
                                ..++.         ....++..+.++|.+||..+++  .|+++.++++|
T Consensus       227 ----------~~~~~---------~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         227 ----------FQFPP---------DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             ----------ccCCC---------ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence                      00000         1124789999999998865443  37899998888

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.9e-42  Score=318.51  Aligned_cols=238  Identities=26%  Similarity=0.472  Sum_probs=188.1

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++.+..       ....+|..++..+ .||||+++++++     .....+++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~~lv~   75 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCF-----QTTSRLFLVI   75 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEE-----EeCCEEEEEE
Confidence            36999999999999999999999999997532       2244678888777 699999999988     3344589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc-c
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-K  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~-~  226 (371)
                      ||+++ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++... .
T Consensus        76 e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~~~~~~~~  149 (327)
T cd05617          76 EYVNGGDLMFHMQR----QRKLPEEHARFYAAEICIALNFLHER-GIIYRDLKLDNVLLDADG-HIKLTDYGMCKEGLGP  149 (327)
T ss_pred             eCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEeCCC-CEEEeccccceeccCC
Confidence            99985 66555543    46799999999999999999999987 999999999999999888 89999999987532 2


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc------HHHHHHHHHHhCCCCHhHHhh
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~------~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ........||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||.....      .+...+....  .        
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~--~--------  218 (327)
T cd05617         150 GDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILE--K--------  218 (327)
T ss_pred             CCceecccCCcccCCHHHHCCCC-CCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHh--C--------
Confidence            23334567899999999986544 78999999999999999999999964221      1122221110  0        


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                                      +  ..++..++..+.++|.+||..||.+|+++      .++++|
T Consensus       219 ----------------~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         219 ----------------P--IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             ----------------C--CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence                            0  01455688999999999999999999985      576666

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-43  Score=324.69  Aligned_cols=254  Identities=19%  Similarity=0.244  Sum_probs=200.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+...++..||+|.||+||+|++-.   .||||++..+      .+.+++|+..+++-+|.||+-+.+++     ....
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~-----~~p~  461 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGAC-----MNPP  461 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhh-----cCCc
Confidence            33457788999999999999999854   4999998654      35567899999999999999999988     3333


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      + .||+.+|.| +|+.+++..   ...|.....+.|++||++|+.|||.+ +|||||||..|||+.+++ +|||+|||++
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~---etkfdm~~~idIAqQiaqGM~YLHAK-~IIHrDLKSnNIFl~~~~-kVkIgDFGLa  535 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQ---ETKFDMNTTIDIAQQIAQGMDYLHAK-NIIHRDLKSNNIFLHEDL-KVKIGDFGLA  535 (678)
T ss_pred             e-eeeehhccCchhhhhccch---hhhhhHHHHHHHHHHHHHhhhhhhhh-hhhhhhccccceEEccCC-cEEEecccce
Confidence            3 799999998 777777654   36789999999999999999999997 999999999999999887 9999999998


Q ss_pred             cccc---cCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLV---KGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~---~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..-.   .........|...|||||++..  ...|++.+||||||+++|||++|..||...+..+.+..+-++...++..
T Consensus       536 tvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s  615 (678)
T KOG0193|consen  536 TVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLS  615 (678)
T ss_pred             eeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccch
Confidence            6532   1222334567788999999853  2348999999999999999999999998544433333222221122211


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      .                        ...+.++++++|+..||.+++++||+..++|..++.++.
T Consensus       616 ~------------------------~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~  655 (678)
T KOG0193|consen  616 K------------------------IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP  655 (678)
T ss_pred             h------------------------hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence            1                        223467799999999999999999999999997666654

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.2e-44  Score=324.25  Aligned_cols=243  Identities=24%  Similarity=0.403  Sum_probs=205.4

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecccc-ch
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ET  154 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~  154 (371)
                      .+-||+|+.|.||+|+.  .++.||||+++   ...+.+++-|++|+||||+.+.+++     .....+|||||||. |-
T Consensus       129 LeWlGSGaQGAVF~Grl--~netVAVKKV~---elkETdIKHLRkLkH~NII~FkGVC-----tqsPcyCIiMEfCa~Gq  198 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRL--HNETVAVKKVR---ELKETDIKHLRKLKHPNIITFKGVC-----TQSPCYCIIMEFCAQGQ  198 (904)
T ss_pred             hhhhccCcccceeeeec--cCceehhHHHh---hhhhhhHHHHHhccCcceeeEeeee-----cCCceeEEeeecccccc
Confidence            35589999999999986  67899999774   3445688899999999999999998     66777999999999 67


Q ss_pred             HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCccccc
Q 017452          155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI  234 (371)
Q Consensus       155 l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  234 (371)
                      |.+.+..    .+.++......|..+|+.|+.|||.+ .|||||||.-||||..+. .|||+|||-++...+......++
T Consensus       199 L~~VLka----~~~itp~llv~Wsk~IA~GM~YLH~h-KIIHRDLKSPNiLIs~~d-~VKIsDFGTS~e~~~~STkMSFa  272 (904)
T KOG4721|consen  199 LYEVLKA----GRPITPSLLVDWSKGIAGGMNYLHLH-KIIHRDLKSPNILISYDD-VVKISDFGTSKELSDKSTKMSFA  272 (904)
T ss_pred             HHHHHhc----cCccCHHHHHHHHHHhhhhhHHHHHh-hHhhhccCCCceEeeccc-eEEeccccchHhhhhhhhhhhhh
Confidence            7777765    67888999999999999999999987 999999999999999888 89999999999887777777899


Q ss_pred             ccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCccc
Q 017452          235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK  314 (371)
Q Consensus       235 ~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  314 (371)
                      ||..|||||++...+ ++.|+|||||||+|||||||..||..-+....+.    ..|                       
T Consensus       273 GTVaWMAPEvIrneP-csEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIw----GVG-----------------------  324 (904)
T KOG4721|consen  273 GTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIW----GVG-----------------------  324 (904)
T ss_pred             hhHhhhCHHHhhcCC-cccccceehhHHHHHHHHhcCCCccccchheeEE----ecc-----------------------
Confidence            999999999997655 8999999999999999999999997655432211    111                       


Q ss_pred             CCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcch
Q 017452          315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLL  362 (371)
Q Consensus       315 ~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~  362 (371)
                      ...++--.|..+++-+.=||++||+-.|..||++.+++.|++-...-+
T Consensus       325 sNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pel  372 (904)
T KOG4721|consen  325 SNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPEL  372 (904)
T ss_pred             CCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHH
Confidence            111222267788999999999999999999999999999987665443

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.3e-42  Score=309.72  Aligned_cols=250  Identities=26%  Similarity=0.396  Sum_probs=197.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHH-HHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||++.+..+|+.||+|++....     .....|+.+ ++.++||||+++++++..     ....+
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~-----~~~~~   76 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFR-----EGDVW   76 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEec-----CCcEE
Confidence            6999999999999999999999999999999886432     122334443 566789999999998843     33478


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ++|||++++|.+.+.........+++..++.++.||+.||+|||++.+++||||||+||+++.++ .+||+|||.+....
T Consensus        77 lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~-~~kl~dfg~~~~~~  155 (283)
T cd06617          77 ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNG-QVKLCDFGISGYLV  155 (283)
T ss_pred             EEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecccccccc
Confidence            99999999888887765444568999999999999999999999755999999999999999888 89999999987654


Q ss_pred             cCCCcccccccccccCcccccCC---cCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHhHHhhc
Q 017452          226 KGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .........++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||.... ..+.+.......  .        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~--~--------  225 (283)
T cd06617         156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEP--S--------  225 (283)
T ss_pred             cccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcC--C--------
Confidence            43333345678889999988542   236789999999999999999999996532 223333222210  0        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       .......+|.++.++|.+||..+|.+||++.++++|
T Consensus       226 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         226 -----------------PQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             -----------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                             000113478999999999999999999999998777

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=7.2e-42  Score=308.34  Aligned_cols=272  Identities=33%  Similarity=0.590  Sum_probs=211.9

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++.+.||.|++|.||+|.+..+|..||+|++....      ....+|+++++.++|||++++++++.     ...+.++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~-----~~~~~~i   75 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVH-----SENKLYL   75 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheec-----cCCeEEE
Confidence            678899999999999999999999999999885432      33567999999999999999999883     3456889


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +|||++++|.+.+....  ...+++..+..++.|++.||+|||++ +++||||+|+||+++.++ .++|+|||++.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~i~~~L~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df~~~~~~~~  151 (283)
T cd07835          76 VFEFLDLDLKKYMDSSP--LTGLDPPLIKSYLYQLLQGIAYCHSH-RVLHRDLKPQNLLIDREG-ALKLADFGLARAFGV  151 (283)
T ss_pred             EEeccCcCHHHHHhhCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-cEEEeecccccccCC
Confidence            99999988877765422  24689999999999999999999987 999999999999999877 899999999875432


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .. ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...+.......+.+..+.+....+.......
T Consensus       152 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07835         152 PVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLP  231 (283)
T ss_pred             CccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhch
Confidence            22 12233568889999988665557889999999999999999999999888877777777777777665543221100


Q ss_pred             c-ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 T-EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      . ...++........ .....++.++.++|.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         232 DYKPTFPKWARQDLS-KVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhhhhcccccccchh-hhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence            0 0011111111111 1234578999999999999999999999996654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.2e-42  Score=319.71  Aligned_cols=237  Identities=24%  Similarity=0.402  Sum_probs=188.7

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHH-HHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRE-LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e-~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+++.||+|++....       ....+| ..+++.++||||+++++++.     .....++||
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~-----~~~~~~lv~   75 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQ-----TADKLYFVL   75 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEE-----cCCeEEEEE
Confidence            36899999999999999999999999986432       111223 23467789999999988873     344588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+.+ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-giiHrDlkp~Nili~~~~-~~kl~DfG~a~~~~~~  149 (325)
T cd05602          76 DYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDFGLCKENIEH  149 (325)
T ss_pred             eCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHeEECCCC-CEEEccCCCCcccccC
Confidence            99986 56555543    56788999999999999999999986 999999999999999888 899999999875432 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..+.+..+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~----------------  212 (325)
T cd05602         150 NGTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP----------------  212 (325)
T ss_pred             CCCcccccCCccccCHHHHcCCC-CCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC----------------
Confidence            22234567899999999986644 7899999999999999999999998877655554443310                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH----HHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV----SKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~----~~l~~  354 (371)
                                   ..++..+++.+.++|.+||+.||.+|+++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~  251 (325)
T cd05602         213 -------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNH  251 (325)
T ss_pred             -------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcC
Confidence                         003345789999999999999999999976    55555

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7e-42  Score=304.97  Aligned_cols=244  Identities=28%  Similarity=0.475  Sum_probs=198.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .|.+.+.||+|++|.||+|.+..+++.||+|.+....         ....+|+++++.++||||+++++++.     ...
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~   77 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLR-----DDE   77 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEc-----cCC
Confidence            5999999999999999999999999999999875321         23567999999999999999999883     344


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++
T Consensus        78 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nilv~~~~-~~~l~dfg~~  151 (263)
T cd06625          78 TLSIFMEYMPGGSVKDQLKA----YGALTETVTRKYTRQILEGVEYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGAS  151 (263)
T ss_pred             eEEEEEEECCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccc
Confidence            68999999985 66666553    45689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .........    ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+....       
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-------  223 (263)
T cd06625         152 KRLQTICSSGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP-------  223 (263)
T ss_pred             eeccccccccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC-------
Confidence            765332111    2345678899999997655 8899999999999999999999997765544433322210       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ....++..++..+.++|.+||..+|.+|||+.++++|
T Consensus       224 --------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         224 --------------------TNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             --------------------CCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence                                0112455688999999999999999999999997666

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4.5e-42  Score=317.28  Aligned_cols=273  Identities=33%  Similarity=0.521  Sum_probs=212.3

Q ss_pred             ccceee-eEeeccCCceEEEEEEECCCCcEEEEEEeecchh------------------hhHHHHHHHHHcCCCCeeecc
Q 017452           70 TISYMA-ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------YKNRELQTMRLLDHPNVVSLK  130 (371)
Q Consensus        70 ~~~y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------~~~~e~~~l~~l~h~niv~~~  130 (371)
                      .++|.. .+.||+|+||.||+|.+..+++.||+|++.....                  ...+|+++++.++|+||++++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~   86 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV   86 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence            346764 5779999999999999999999999998854321                  245799999999999999999


Q ss_pred             eeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                      +++.     ...+.+++|||+.++|.+.+..    ...+++..+..++.|++.||.|||++ ||+|+||+|+||+++.++
T Consensus        87 ~~~~-----~~~~~~lv~e~~~~~l~~~l~~----~~~~~~~~~~~~~~ql~~aL~~LH~~-~i~H~dl~~~nill~~~~  156 (335)
T PTZ00024         87 DVYV-----EGDFINLVMDIMASDLKKVVDR----KIRLTESQVKCILLQILNGLNVLHKW-YFMHRDLSPANIFINSKG  156 (335)
T ss_pred             EEEe-----cCCcEEEEEeccccCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHeEECCCC
Confidence            9883     3446889999999988877754    45789999999999999999999986 999999999999999888


Q ss_pred             CcEEEEeeCCccccccC---------------CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCC
Q 017452          211 HQVKLCDFGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP  275 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~  275 (371)
                       .++|+|||.+......               .......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.
T Consensus       157 -~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~  235 (335)
T PTZ00024        157 -ICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP  235 (335)
T ss_pred             -CEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCC
Confidence             8999999998765411               111223457789999998766557899999999999999999999999


Q ss_pred             CCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+..+.+..+....+.+....|...........+.......... .....+.++.++|.+||+.+|.+|||+.+++.|
T Consensus       236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        236 GENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             CCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHH-hCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            988888888888887777665443221110000000000011111 123468899999999999999999999997666

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=1.2e-42  Score=319.19  Aligned_cols=237  Identities=27%  Similarity=0.423  Sum_probs=187.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHH-HHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL-QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~-~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|++..+|+.||+|++.+..       ....+|. .+++.++||||+++++.+     ......++||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~-----~~~~~~~lv~   75 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSF-----QTAEKLYFVL   75 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEE-----EcCCEEEEEE
Confidence            36899999999999999999999999986432       1122333 357888999999998887     3344588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+++ +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~~~  149 (321)
T cd05603          76 DYVNGGELFFHLQR----ERCFLEPRARFYAAEVASAIGYLHSL-NIIYRDLKPENILLDSQG-HVVLTDFGLCKEGVEP  149 (321)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEccCCCCccCCCC
Confidence            99986 55544432    56789999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+...   +             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~---~-------------  212 (321)
T cd05603         150 EETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHK---P-------------  212 (321)
T ss_pred             CCccccccCCcccCCHHHhcCCC-CCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcC---C-------------
Confidence            22233457899999999986544 789999999999999999999999877654443333221   0             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH----HHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV----SKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~----~~l~~  354 (371)
                                   ..++...+..+.++|.+||+.||.+|+++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  251 (321)
T cd05603         213 -------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH  251 (321)
T ss_pred             -------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCC
Confidence                         013455788999999999999999999764    66666

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=4.5e-42  Score=318.00  Aligned_cols=278  Identities=29%  Similarity=0.513  Sum_probs=209.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC------
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK------  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~------  139 (371)
                      .++|.+.+.||.|+||.||+|.+..+|+.||+|.+...    .....+|+++++.++||||+++++++......      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~   83 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG   83 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence            35799999999999999999999999999999988543    23456799999999999999998876432211      


Q ss_pred             ---CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          140 ---DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       140 ---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                         .....++||||++++|.+.+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++..++|+
T Consensus        84 ~~~~~~~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-givH~dikp~Nili~~~~~~~kl~  157 (342)
T cd07854          84 SLTELNSVYIVQEYMETDLANVLE-----QGPLSEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANVFINTEDLVLKIG  157 (342)
T ss_pred             cccccceEEEEeecccccHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCCceEEEC
Confidence               123578999999987766654     35689999999999999999999986 999999999999998666579999


Q ss_pred             eeCCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          217 DFGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       217 Dfg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |||.+........    .....++..|+|||.+.....++.++|+|||||++|+|++|+.||...+..+....+......
T Consensus       158 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  237 (342)
T cd07854         158 DFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV  237 (342)
T ss_pred             CcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCC
Confidence            9999876532211    122356888999998766556788999999999999999999999888777766666655444


Q ss_pred             CCHhHHhhcCCCcccccc--CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          293 PTREEIKCMNPNYTEFKF--PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..................  ......++.. +...++.++.+||.+||..||.+|||+.+++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         238 VREEDRNELLNVIPSFVRNDGGEPRRPLRD-LLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CChHHhhhhhhhhhhhhhhcccccCCCHHH-HccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence            333222221111100000  0001111111 223578899999999999999999999998888

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.1e-43  Score=320.47  Aligned_cols=237  Identities=26%  Similarity=0.431  Sum_probs=188.1

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHH-HHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..+|+.||+|++.+..       ....+|.. +++.++||||+++++.+     ......++||
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~-----~~~~~~~lv~   75 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSF-----QTTEKLYFVL   75 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEE-----ecCCEEEEEE
Confidence            36899999999999999999999999986431       11223333 46778999999998887     3344588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc-
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-  226 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-  226 (371)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..... 
T Consensus        76 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givH~Dlkp~NIll~~~~-~~kL~DfG~~~~~~~~  149 (325)
T cd05604          76 DFVNGGELFFHLQR----ERSFPEPRARFYAAEIASALGYLHSI-NIVYRDLKPENILLDSQG-HVVLTDFGLCKEGIAQ  149 (325)
T ss_pred             cCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEEeecCCcccCCCC
Confidence            99986 55544432    56799999999999999999999986 999999999999999888 899999999875322 


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||.+.+.. ++.++|||||||++|+|++|..||...+..+....+...   .             
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~---~-------------  212 (325)
T cd05604         150 SDTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHK---P-------------  212 (325)
T ss_pred             CCCcccccCChhhCCHHHHcCCC-CCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcC---C-------------
Confidence            22234567899999999986654 789999999999999999999999877655544443321   0             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH----HHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV----SKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~----~~l~~  354 (371)
                                   ..++...+..+.++|.+||+.||.+||++.    ++++|
T Consensus       213 -------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h  251 (325)
T cd05604         213 -------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEH  251 (325)
T ss_pred             -------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcC
Confidence                         002345789999999999999999999874    77666

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-43  Score=322.04  Aligned_cols=237  Identities=26%  Similarity=0.427  Sum_probs=188.1

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecchh-------hhHHHHHHHHHc---CCCCeeecceeEEecCCCCceeEEEee
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ||+|+||.||+|++..+|+.||+|++.+...       ....|..++...   +||||+++++.+     ......++||
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~-----~~~~~~~lv~   75 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSF-----QTDSDLYLVT   75 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEE-----ecCCeEEEEE
Confidence            6999999999999999999999999864321       122355566554   699999999888     3344589999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+.+ +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||++......
T Consensus        76 e~~~~g~L~~~l~~----~~~~~~~~~~~~~~qil~al~~LH~~-~ivHrDlkp~Nili~~~~-~~kl~Dfg~a~~~~~~  149 (330)
T cd05586          76 DYMSGGELFWHLQK----EGRFSEDRAKFYIAELVLALEHLHKY-DIVYRDLKPENILLDATG-HIALCDFGLSKANLTD  149 (330)
T ss_pred             cCCCCChHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeEECCCC-CEEEecCCcCcCCCCC
Confidence            99985 66555543    56799999999999999999999987 999999999999999888 8999999998754322


Q ss_pred             -CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 -EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 -~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                       .......||+.|+|||++.+...++.++|||||||++|+|++|..||...+..+....+....                
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~----------------  213 (330)
T cd05586         150 NKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGK----------------  213 (330)
T ss_pred             CCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCC----------------
Confidence             223356789999999998766567899999999999999999999998776555444332210                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC----CHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC----TAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~----t~~~~l~~  354 (371)
                       ..+           ....+++++.+||.+||..||.+||    ++.++++|
T Consensus       214 -~~~-----------~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         214 -VRF-----------PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             -CCC-----------CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcC
Confidence             000           1123689999999999999999998    68898887

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.9e-41  Score=306.98  Aligned_cols=274  Identities=32%  Similarity=0.563  Sum_probs=205.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|++.+.||+|+||.||+|.+..+|..||+|.+....     ....+|+.+++.++|+||+++++++.     .....+
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~-----~~~~~~   79 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIH-----TKETLT   79 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEe-----cCCeEE
Confidence            57999999999999999999999999999999885431     23467999999999999999999873     334578


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.+++...+..   ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||++....
T Consensus        80 lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~~~  154 (291)
T cd07870          80 FVFEYMHTDLAQYMIQ---HPGGLHPYNVRLFMFQLLRGLAYIHGQ-HILHRDLKPQNLLISYLG-ELKLADFGLARAKS  154 (291)
T ss_pred             EEEecccCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChHHEEEcCCC-cEEEeccccccccC
Confidence            9999999887766543   135678888999999999999999987 999999999999999887 89999999987543


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHhHHhhcC-
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCMN-  302 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~-  302 (371)
                      ... ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+. .+.+.++...++.+....+.... 
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (291)
T cd07870         155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSK  234 (291)
T ss_pred             CCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhh
Confidence            221 223345688899999987655578899999999999999999999976543 35556666666666555443221 


Q ss_pred             -CCccccccCcccCCCCcccCC-CCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 -PNYTEFKFPQIKAHPWHKIFP-KRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 -~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       +.+....+............. -..+..+.+++.+||..||.+|||+.+++.|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         235 LPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             cccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence             111111111111111100000 0236789999999999999999999995544

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=5.1e-42  Score=320.90  Aligned_cols=254  Identities=22%  Similarity=0.320  Sum_probs=197.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCC-----CcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      ..+|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.+ +|+||+++++++     
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~-----  111 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGAC-----  111 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEe-----
Confidence            45799999999999999999986543     3579999986432     3355799999999 899999999988     


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh-----------------------------------------------------
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  164 (371)
                      ......++||||+. |+|.+.+.....                                                     
T Consensus       112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (374)
T cd05106         112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS  191 (374)
T ss_pred             cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence            33445789999998 477776643211                                                     


Q ss_pred             -------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCcc
Q 017452          165 -------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI  231 (371)
Q Consensus       165 -------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~  231 (371)
                                   ...++++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++|+|||+++.........
T Consensus       192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~-giiHrDLkp~Nil~~~~~-~~kL~DfGla~~~~~~~~~~  269 (374)
T cd05106         192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK-NCIHRDVAARNVLLTDGR-VAKICDFGLARDIMNDSNYV  269 (374)
T ss_pred             cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CEEeccCchheEEEeCCC-eEEEeeceeeeeccCCccee
Confidence                         123578889999999999999999987 999999999999999877 89999999987654332211


Q ss_pred             ---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          232 ---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       232 ---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                         ...++..|+|||++.... ++.++|||||||++|+|++ |+.||........+........                
T Consensus       270 ~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~----------------  332 (374)
T cd05106         270 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGY----------------  332 (374)
T ss_pred             eccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHccc----------------
Confidence               123456799999986544 8999999999999999997 9999977554433333332110                


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                 ....+..+++++.+++.+||+.||.+|||+.++++.|+++
T Consensus       333 -----------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~  372 (374)
T cd05106         333 -----------QMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQ  372 (374)
T ss_pred             -----------CccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                       0012344689999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=6.8e-42  Score=320.30  Aligned_cols=253  Identities=23%  Similarity=0.330  Sum_probs=196.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      ..+|++++.||+|+||.||+|.+     ..++..||+|++...     .....+|+.+++.+ +||||+++++++     
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~-----  108 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGAC-----  108 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeee-----
Confidence            45799999999999999999974     346678999988543     23355799999999 899999999988     


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh-----------------------------------------------------
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  164 (371)
                      ......++||||++ |+|.+.+.....                                                     
T Consensus       109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  188 (375)
T cd05104         109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS  188 (375)
T ss_pred             ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence            33444789999998 477776653210                                                     


Q ss_pred             ------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          165 ------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       165 ------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                                        ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.....
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~DfG~a~~~~~  266 (375)
T cd05104         189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK-NCIHRDLAARNILLTHGR-ITKICDFGLARDIRN  266 (375)
T ss_pred             cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCchhhEEEECCC-cEEEecCccceeccC
Confidence                              012578888999999999999999987 999999999999999877 899999999876543


Q ss_pred             CCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          227 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       227 ~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....   ....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||........+.+......           
T Consensus       267 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------  334 (375)
T cd05104         267 DSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGY-----------  334 (375)
T ss_pred             cccccccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCc-----------
Confidence            2221   1223456799999996654 8999999999999999997 8899977654444333332100           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                      ....+...+.++.+|+.+||..||++|||+.++++.|++
T Consensus       335 ----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~  373 (375)
T cd05104         335 ----------------RMLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQ  373 (375)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHh
Confidence                            001233467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.3e-42  Score=317.24  Aligned_cols=276  Identities=34%  Similarity=0.638  Sum_probs=219.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|.+.+.||.|++|.||+|.+..+|..||+|++...      .....+|+.+++.++||||+++++++.... ....+.
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPG-ADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccC-CCCceE
Confidence            5799999999999999999999999999999988543      123457999999999999999998764433 344568


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+.++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~lv~e~~~~~l~~~~~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~~~~~  157 (334)
T cd07855          84 YVVMDLMESDLHHIIHS----DQPLTEEHIRYFLYQLLRGLKYIHSA-NVIHRDLKPSNLLVNEDC-ELRIGDFGMARGL  157 (334)
T ss_pred             EEEEehhhhhHHHHhcc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEecccccceee
Confidence            89999999877666543    45689999999999999999999987 999999999999999888 8999999998765


Q ss_pred             ccCCC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .....     .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+....+..+....+.++...+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~  237 (334)
T cd07855         158 SSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN  237 (334)
T ss_pred             cccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhh
Confidence            33221     1234678899999998665557899999999999999999999999888888888888888888776554


Q ss_pred             hcCCCcccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .........   .++.....+|.. +....+.++.++|.+||+.+|.+|||+.+++.|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  294 (334)
T cd07855         238 RIGSDRVRKYIQNLPRKQPVPWSK-IFPKASPEALDLLSQMLQFDPEERITVEQALQH  294 (334)
T ss_pred             hhchhhHHHHHhhcccCCCCCHHH-HcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            322111000   111112222222 223468999999999999999999999998888

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=7.6e-42  Score=311.52  Aligned_cols=257  Identities=19%  Similarity=0.269  Sum_probs=195.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECC----------------CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeec
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE----------------TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSL  129 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~  129 (371)
                      ++|++.+.||+|+||.||+|.+..                ++..||+|.+...     ...+.+|+.+++.++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            579999999999999999998532                3457999988643     2345679999999999999999


Q ss_pred             ceeEEecCCCCceeEEEeecccc-chHHHHHHHhhh---------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 017452          130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNK---------------LNQRMPMIYVKLYAYQIFRALSYIHRSIG  193 (371)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  193 (371)
                      ++++..     ....++||||+. ++|.+.+.....               ....+++..+..++.||+.||.|||++ |
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~  158 (304)
T cd05096          85 LGVCVD-----EDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL-N  158 (304)
T ss_pred             EEEEec-----CCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC-C
Confidence            998843     334789999997 477777654221               113467788999999999999999987 9


Q ss_pred             cEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-
Q 017452          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-  269 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-  269 (371)
                      |+||||||+|||++.++ .+||+|||++........   .....++..|+|||.+.... ++.++||||||+++|+|++ 
T Consensus       159 ivH~dlkp~Nill~~~~-~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~  236 (304)
T cd05096         159 FVHRDLATRNCLVGENL-TIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK-FTTASDVWAFGVTLWEILML  236 (304)
T ss_pred             ccccCcchhheEEcCCc-cEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC-CCchhhhHHHHHHHHHHHHc
Confidence            99999999999999887 899999999876533321   11234477899999986544 8999999999999999986 


Q ss_pred             -CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH
Q 017452          270 -GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       270 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~  348 (371)
                       +..||...+..+.+..+..........                     .....+..++..+.+|+.+||+.||.+|||+
T Consensus       237 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~  295 (304)
T cd05096         237 CKEQPYGELTDEQVIENAGEFFRDQGRQ---------------------VYLFRPPPCPQGLYELMLQCWSRDCRERPSF  295 (304)
T ss_pred             cCCCCCCcCCHHHHHHHHHHHhhhcccc---------------------ccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence             567887766555444333221100000                     0001234578899999999999999999999


Q ss_pred             HHHhhhhc
Q 017452          349 VSKRILFS  356 (371)
Q Consensus       349 ~~~l~~l~  356 (371)
                      .++.+.|+
T Consensus       296 ~~i~~~l~  303 (304)
T cd05096         296 SDIHAFLT  303 (304)
T ss_pred             HHHHHHHh
Confidence            99988775

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-41  Score=307.32  Aligned_cols=273  Identities=37%  Similarity=0.667  Sum_probs=214.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|++|.||+|.+..+++.||+|++...      .....+|+++++.++|+||+++++++..     ....+
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   76 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRR-----KGRLY   76 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEE-----CCEEE
Confidence            699999999999999999999999999999987532      2345689999999999999999999844     34588


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ++|||+++++...+..   ....+++..+..++.||+.||.|||.+ +++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 iv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~g~~~~~~  151 (288)
T cd07833          77 LVFEYVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSH-NIIHRDIKPENILVSESG-VLKLCDFGFARALR  151 (288)
T ss_pred             EEEecCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEEeeecccccC
Confidence            9999999876654432   245689999999999999999999987 999999999999999887 89999999987765


Q ss_pred             cCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC-
Q 017452          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN-  302 (371)
Q Consensus       226 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  302 (371)
                      ...  ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||......+.+..+....+..+......+. 
T Consensus       152 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (288)
T cd07833         152 ARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS  231 (288)
T ss_pred             CCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhccc
Confidence            443  23345678889999999776468899999999999999999999998887777777777777666554433221 


Q ss_pred             -CCccccccCccc-CCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 -PNYTEFKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 -~~~~~~~~~~~~-~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       .......++... ...+...++..++.++.+||++||..+|.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             CccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             111111111111 1112222445568999999999999999999999995543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-44  Score=328.29  Aligned_cols=249  Identities=23%  Similarity=0.351  Sum_probs=204.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +-|.|+..||.|+||.||+|..+.++..-|.|++.-.    .....-|++||..++||+||++++.|+..+.     ++|
T Consensus        32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enk-----Lwi  106 (1187)
T KOG0579|consen   32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENK-----LWI  106 (1187)
T ss_pred             HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCc-----eEE
Confidence            3589999999999999999999989888888987422    2333458999999999999999999965444     899


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc-
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-  225 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~-  225 (371)
                      +.|||+|+--+.+..  .....+.+..++.+++|++.||.|||++ +|||||||..|||++-+| .++|+|||.+.... 
T Consensus       107 liEFC~GGAVDaiml--EL~r~LtE~QIqvvc~q~ldALn~LHs~-~iIHRDLKAGNiL~TldG-dirLADFGVSAKn~~  182 (1187)
T KOG0579|consen  107 LIEFCGGGAVDAIML--ELGRVLTEDQIQVVCYQVLDALNWLHSQ-NIIHRDLKAGNILLTLDG-DIRLADFGVSAKNKS  182 (1187)
T ss_pred             EEeecCCchHhHHHH--HhccccchHHHHHHHHHHHHHHHHHhhc-chhhhhccccceEEEecC-cEeeecccccccchh
Confidence            999999865554433  3478999999999999999999999997 999999999999999999 89999999765432 


Q ss_pred             cCCCcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          226 KGEPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....-+++|||+|||||+...    ...|.+++||||||++|.+|+.+.+|-...+....+..+.+.   .|+..    
T Consensus       183 t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKS---ePPTL----  255 (1187)
T KOG0579|consen  183 TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPPTL----  255 (1187)
T ss_pred             HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhc---CCCcc----
Confidence            2223447899999999999843    345899999999999999999999998877776666665542   22111    


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         .-|...+..+.+|+.+||.+||..||++.++++|
T Consensus       256 -------------------lqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  256 -------------------LQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             -------------------cCcchhhhHHHHHHHHHHhcCCccCCCHHHHhhC
Confidence                               1355678999999999999999999999996666

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=2.7e-43  Score=288.05  Aligned_cols=301  Identities=29%  Similarity=0.535  Sum_probs=246.5

Q ss_pred             CCChhhhccccccchhcccceeeCCCCCcccceEEeecCCCCCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEE
Q 017452           23 DKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK  102 (371)
Q Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK  102 (371)
                      -++-.+.+..+.++.++.|..+.+...                    ..+|++.+++|+|-++.||.|....+++.++||
T Consensus        10 ARvya~vn~~rp~eYWdYE~~~i~wg~--------------------~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViK   69 (338)
T KOG0668|consen   10 ARVYADVNEERPREYWDYESLVIDWGN--------------------QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIK   69 (338)
T ss_pred             hhhhhhccccCchhhcchhheeeeccc--------------------cchHHHHHHHcCccHhhHhcccccCCCceEEEe
Confidence            345567777778888888876655442                    236999999999999999999999999999999


Q ss_pred             Eeecc-hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHH
Q 017452          103 KVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ  180 (371)
Q Consensus       103 ~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~q  180 (371)
                      +++.. ...+.+|+.+|+.|. ||||+++++....   ..+....+|+||++..  +.-    ..-..++...++.++.+
T Consensus        70 iLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~D---p~SktpaLiFE~v~n~--Dfk----~ly~tl~d~dIryY~~e  140 (338)
T KOG0668|consen   70 ILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKD---PESKTPSLIFEYVNNT--DFK----QLYPTLTDYDIRYYIYE  140 (338)
T ss_pred             eechHHHHHHHHHHHHHHhccCCCCeeehhhhhcC---ccccCchhHhhhhccc--cHH----HHhhhhchhhHHHHHHH
Confidence            98654 466789999999996 9999999998744   3334467899999974  111    22456888899999999


Q ss_pred             HHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHH
Q 017452          181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSA  260 (371)
Q Consensus       181 i~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  260 (371)
                      ++.||.|+|+. ||+|||+||.|++||.....++|+|||+|.+..++....-.+.+..|-.||.+.....+...-|+|||
T Consensus       141 lLkALdyCHS~-GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~  219 (338)
T KOG0668|consen  141 LLKALDYCHSM-GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  219 (338)
T ss_pred             HHHHHhHHHhc-CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHH
Confidence            99999999985 99999999999999988879999999999998888777777889999999999988889999999999


Q ss_pred             HHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHhHHh-----hcCCCccccccCcccCCCCcccCCC----CCChhH
Q 017452          261 GCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIK-----CMNPNYTEFKFPQIKAHPWHKIFPK----RMPPEA  330 (371)
Q Consensus       261 G~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~----~~s~~l  330 (371)
                      ||+|..|++.+.|| .+.+..+++..|.+.+|........     .+.+.+.++ +......+|..+++.    -.++++
T Consensus       220 GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i-~~~~~rk~w~~Fi~~~n~hl~~pea  298 (338)
T KOG0668|consen  220 GCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDI-LGRHSRKPWSRFINSENQHLVSPEA  298 (338)
T ss_pred             HHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhH-hhccccccHHHhCCccccccCChHH
Confidence            99999999988775 6778899999999999876554331     233333332 334455677766553    357999


Q ss_pred             HHHHHhccCcCCCCCCCHHHHhhh
Q 017452          331 VDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       331 ~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+|+.++|.+|.++|+||+|++.|
T Consensus       299 iDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  299 IDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             HHHHHHHHhhccccccchHHHhcC
Confidence            999999999999999999999988

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2e-41  Score=309.27  Aligned_cols=281  Identities=29%  Similarity=0.501  Sum_probs=211.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC---C
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  139 (371)
                      ..++|.+.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+.+++.++||||+++++.+.....   .
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   89 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNR   89 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccC
Confidence            3457999999999999999999999999999999885431      123569999999999999999987754332   2


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      .....++||||+.+++...+..   ....+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .+||+|||
T Consensus        90 ~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg  164 (310)
T cd07865          90 YKGSFYLVFEFCEHDLAGLLSN---KNVKFTLSEIKKVMKMLLNGLYYIHRN-KILHRDMKAANILITKDG-ILKLADFG  164 (310)
T ss_pred             CCceEEEEEcCCCcCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEECCCC-cEEECcCC
Confidence            2345689999999887776653   234689999999999999999999987 999999999999999887 89999999


Q ss_pred             CccccccCCCc-----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          220 SAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       220 ~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ++.........     ....++..|+|||.+.+...++.++|+||||+++|+|++|..||.+.+.......+....+..+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~  244 (310)
T cd07865         165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSIT  244 (310)
T ss_pred             CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            98765332211     2345678899999987655578899999999999999999999988877776666777666665


Q ss_pred             HhHHhhcCC--CccccccCcccCCCCcccC-CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNP--NYTEFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.+.....  .+....++..........+ +...+..+.+||.+||..||.+|||++++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         245 PEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             hhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            554432210  0011111111111111111 11246788999999999999999999995544

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-41  Score=305.41  Aligned_cols=300  Identities=27%  Similarity=0.418  Sum_probs=228.6

Q ss_pred             eCCCCCcccceEEeecCCCCCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhh---hHHHHHHHHHc
Q 017452           45 VDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY---KNRELQTMRLL  121 (371)
Q Consensus        45 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~---~~~e~~~l~~l  121 (371)
                      ++.+....|...++.+|.    +...++|.+.++||.|.|++||+|.|....+.||+|+++.....   ...|+++|+++
T Consensus        56 E~~~dY~kGGYHpV~IGD----~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v  131 (590)
T KOG1290|consen   56 EDPEDYRKGGYHPVRIGD----VFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQV  131 (590)
T ss_pred             cChhhhhcCCCceeeccc----cccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHH
Confidence            344444556666666654    44457999999999999999999999999999999999876533   34699999988


Q ss_pred             C--------CCCeeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 017452          122 D--------HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG  193 (371)
Q Consensus       122 ~--------h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~  193 (371)
                      +        ..+||++++.|-... ....++|||+|+++..|+.++....  .+.++...++.|++||+.||.|||+++|
T Consensus       132 ~~~Dp~~~~~~~VV~LlD~FkhsG-pNG~HVCMVfEvLGdnLLklI~~s~--YrGlpl~~VK~I~~qvL~GLdYLH~ecg  208 (590)
T KOG1290|consen  132 REGDPNDPGKKCVVQLLDHFKHSG-PNGQHVCMVFEVLGDNLLKLIKYSN--YRGLPLSCVKEICRQVLTGLDYLHRECG  208 (590)
T ss_pred             HhcCCCCCCCceeeeeeccceecC-CCCcEEEEEehhhhhHHHHHHHHhC--CCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence            3        246999999886544 5567899999999999999998754  6889999999999999999999999999


Q ss_pred             cEeeccCCCceeee------------------------------------------------------------------
Q 017452          194 VCHRDIKPQNLLVN------------------------------------------------------------------  207 (371)
Q Consensus       194 ivH~dlkp~NIli~------------------------------------------------------------------  207 (371)
                      |||.||||+|||+.                                                                  
T Consensus       209 IIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l  288 (590)
T KOG1290|consen  209 IIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASL  288 (590)
T ss_pred             ccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhh
Confidence            99999999999983                                                                  


Q ss_pred             ------------------------------------------------CC------------------------------
Q 017452          208 ------------------------------------------------PH------------------------------  209 (371)
Q Consensus       208 ------------------------------------------------~~------------------------------  209 (371)
                                                                      +.                              
T Consensus       289 ~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~  368 (590)
T KOG1290|consen  289 AGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSP  368 (590)
T ss_pred             cccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCc
Confidence                                                            00                              


Q ss_pred             ---------------------CCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHH
Q 017452          210 ---------------------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM  268 (371)
Q Consensus       210 ---------------------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  268 (371)
                                           ..++||+|||.|+...  ...+.-+.|+.|+|||++.+.. |++.+||||++|+.|||+
T Consensus       369 ~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~--khFT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELa  445 (590)
T KOG1290|consen  369 SSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH--KHFTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELA  445 (590)
T ss_pred             CCccccccccccCCCCCCCccceeEEEeeccchhhhh--hhhchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhh
Confidence                                 0036677777665532  2233445688999999998876 899999999999999999


Q ss_pred             hCCCCCCC------CCcHHHHHHHHHHhCCCCHhHHhhcCCCcccc----ccC-cccCCCC--ccc------CCCCCChh
Q 017452          269 LGKPLFPG------DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF----KFP-QIKAHPW--HKI------FPKRMPPE  329 (371)
Q Consensus       269 tg~~pf~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~-~~~~~~~--~~~------~~~~~s~~  329 (371)
                      ||...|..      ..+.+.++.|+..+|..|......-.-.-..|    .+. +-..++|  ..+      ++.....+
T Consensus       446 TGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~  525 (590)
T KOG1290|consen  446 TGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQ  525 (590)
T ss_pred             cCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHH
Confidence            99999954      33567899999999999887654211111111    111 1112223  111      22334567


Q ss_pred             HHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          330 AVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       330 l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+||.-||+.+|++||||.++|+|
T Consensus       526 fsdFL~PmLef~PeKR~tA~~cl~h  550 (590)
T KOG1290|consen  526 FSDFLSPMLEFDPEKRPTAAQCLKH  550 (590)
T ss_pred             HHHHHHHHHhcCccccccHHHHhcC
Confidence            9999999999999999999998877

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-43  Score=300.27  Aligned_cols=246  Identities=27%  Similarity=0.433  Sum_probs=206.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-------hhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      -.++|...+.||+|.||+|-+++.+.+++.||+|+++++.-       ....|-.+|+..+||.+..+--.|     ..+
T Consensus       166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsF-----Qt~  240 (516)
T KOG0690|consen  166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSF-----QTQ  240 (516)
T ss_pred             ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhh-----ccC
Confidence            34679999999999999999999999999999999876532       223577899999999998876666     444


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..+|+||||++|+  +++.+..+ .+.+++..++.+...|+.||.|||++ +||+||||.+|.|+|.+| .+||+|||++
T Consensus       241 drlCFVMeyanGG--eLf~HLsr-er~FsE~RtRFYGaEIvsAL~YLHs~-~ivYRDlKLENLlLDkDG-HIKitDFGLC  315 (516)
T KOG0690|consen  241 DRLCFVMEYANGG--ELFFHLSR-ERVFSEDRTRFYGAEIVSALGYLHSR-NIVYRDLKLENLLLDKDG-HIKITDFGLC  315 (516)
T ss_pred             ceEEEEEEEccCc--eEeeehhh-hhcccchhhhhhhHHHHHHhhhhhhC-CeeeeechhhhheeccCC-ceEeeecccc
Confidence            5589999999974  33333222 67899999999999999999999987 999999999999999999 7999999999


Q ss_pred             cccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.-. .+....+.+|||.|.|||++... .|+.++|+|.+||++|||++|+.||...+....+..|.-.           
T Consensus       316 KE~I~~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~e-----------  383 (516)
T KOG0690|consen  316 KEEIKYGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILME-----------  383 (516)
T ss_pred             hhcccccceeccccCChhhcCchhhccc-cccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhh-----------
Confidence            8643 34556678999999999999654 4899999999999999999999999988877766666542           


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                        .-.+|..+++++..|+..+|.+||.+|+     .|.|+.+|
T Consensus       384 ------------------d~kFPr~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  384 ------------------DLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             ------------------hccCCccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhh
Confidence                              1117788999999999999999999996     47888877

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=2.8e-41  Score=305.80  Aligned_cols=257  Identities=25%  Similarity=0.339  Sum_probs=203.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|.+.+.||+|+||.||++.+..+++.+|+|.+...   .....+|+.+++++ +|||++++++++...........+
T Consensus        21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~  100 (291)
T cd06639          21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLW  100 (291)
T ss_pred             CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeE
Confidence            56799999999999999999999999999999988543   24456788999988 899999999988765443445678


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+++.........+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus       101 lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~dlkp~nili~~~~-~~kl~dfg~~~~~  178 (291)
T cd06639         101 LVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN-RIIHRDVKGNNILLTTEG-GVKLVDFGVSAQL  178 (291)
T ss_pred             EEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEeecccchhc
Confidence            99999975 77777665444456789999999999999999999987 999999999999999887 8999999998765


Q ss_pred             ccCC-CcccccccccccCcccccCCc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .... ......++..|+|||.+....    .++.++|+|||||++|+|++|+.||........+..+.+.   ..     
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~-----  250 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PP-----  250 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CC-----
Confidence            4322 122346788899999875432    2578999999999999999999999876554444333221   00     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        .....+...+..+.++|.+||+.||.+||++.++++|
T Consensus       251 ------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         251 ------------------PTLLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             ------------------CCCCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                              0000233467889999999999999999999995444

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=1.5e-41  Score=306.67  Aligned_cols=273  Identities=36%  Similarity=0.640  Sum_probs=207.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||+|.+..+++.||+|.+....      ....+|+++++.++||||+++++++     ......+
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~   76 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-----RRKKRLY   76 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc-----ccCCeEE
Confidence            6999999999999999999999899999999875421      2345799999999999999999988     4455689


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+++++...+..   ....+++..++.++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        77 lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~h~~l~p~ni~~~~~~-~~~l~dfg~~~~~~  151 (286)
T cd07846          77 LVFEFVDHTVLDDLEK---YPNGLDESRVRKYLFQILRGIEFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGFARTLA  151 (286)
T ss_pred             EEEecCCccHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-cEEEEeeeeeeecc
Confidence            9999999754443332   234689999999999999999999987 999999999999999887 89999999987654


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .... .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||......+....+....+.............
T Consensus       152 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (286)
T cd07846         152 APGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKN  231 (286)
T ss_pred             CCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccc
Confidence            3322 223457888999999876555788999999999999999999999887777766777666555433221111100


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        ......+......-.......++..+.+|+.+||..+|.+||++.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         232 PLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             hHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence              00111111111100011234578999999999999999999999996554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-42  Score=314.76  Aligned_cols=276  Identities=37%  Similarity=0.652  Sum_probs=221.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+...      .....+|+.+++.++|+||+++++.+..........++
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~   80 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY   80 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence            589999999999999999999889999999988543      23456799999999999999999987554433334678


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ++|||++++|...+..    ...+++..++.++.||+.||.+||++ ||+||||||+||+++.++ .++|+|||++....
T Consensus        81 lv~e~~~~~l~~~l~~----~~~l~~~~~~~i~~~l~~~l~~LH~~-gi~H~dlkp~nili~~~~-~~~L~dfg~~~~~~  154 (330)
T cd07834          81 IVTELMETDLHKVIKS----PQPLTDDHIQYFLYQILRGLKYLHSA-NVIHRDLKPSNILVNSNC-DLKICDFGLARGVD  154 (330)
T ss_pred             EEecchhhhHHHHHhC----CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEcccCceEeec
Confidence            9999999877766653    34899999999999999999999987 999999999999999987 89999999998765


Q ss_pred             cCC----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          226 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       226 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...    ......+++.|+|||.+.+...++.++|+||||+++|+|++|..||.+.+..+.+..+....+.++...+...
T Consensus       155 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  234 (330)
T cd07834         155 PDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFI  234 (330)
T ss_pred             ccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhc
Confidence            543    2334567889999999977646899999999999999999999999999888888888888888776655421


Q ss_pred             CCC-cccc--ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPN-YTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~-~~~~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ... ...+  ..+.....+|... ...++.++.++|.+||++||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         235 TSEKARNYLKSLPKKPKKPLSKL-FPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             cccchhhHHhhcccCCcchhHHh-cccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence            111 1111  0111111222222 23478999999999999999999999998887

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-41  Score=306.86  Aligned_cols=274  Identities=32%  Similarity=0.587  Sum_probs=213.8

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |.+.+.||+|++|.||+|.+..+|+.+|+|.+....      ....+|+.+++.++|+|++++++.+...   .....++
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~---~~~~~~l   77 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSK---GKGSIYM   77 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecC---CCCcEEE
Confidence            678999999999999999999999999999986542      2355799999999999999999887432   1255889


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||++++|.+.+...   ...+++..++.++.||+.||+|||++ |++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 v~e~~~~~l~~~~~~~---~~~~~~~~~~~i~~~i~~al~~LH~~-~~~h~dl~p~nil~~~~~-~~~l~d~g~~~~~~~  152 (287)
T cd07840          78 VFEYMDHDLTGLLDSP---EVKFTESQIKCYMKQLLEGLQYLHSN-GILHRDIKGSNILINNDG-VLKLADFGLARPYTK  152 (287)
T ss_pred             EeccccccHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEEcCCC-CEEEccccceeeccC
Confidence            9999998877766532   25789999999999999999999986 999999999999999988 899999999887644


Q ss_pred             CC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          227 GE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       227 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..  ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+....+..+....+.++...+.....-
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (287)
T cd07840         153 RNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKL  232 (287)
T ss_pred             CCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccc
Confidence            33  1233456788999998866555789999999999999999999999988887878888887777766655432211


Q ss_pred             --ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 --YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 --~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        .................+...++..+.+++.+||..||.+||++.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence              00000000000001111223358999999999999999999999996554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=2.7e-41  Score=308.59  Aligned_cols=278  Identities=32%  Similarity=0.568  Sum_probs=213.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC---CC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  140 (371)
                      .++|++.+.||+|++|.||+|.+..+++.+|+|++...      .....+|+++++.++|+||+++++.+.....   ..
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   86 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK   86 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence            46899999999999999999999999999999988532      1234679999999999999999987754332   23


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+++||||+.+++...+..   ....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus        87 ~~~~~lv~~~~~~~l~~~~~~---~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  161 (311)
T cd07866          87 RGSVYMVTPYMDHDLSGLLEN---PSVKLTESQIKCYMLQLLEGINYLHEN-HILHRDIKAANILIDNQG-ILKIADFGL  161 (311)
T ss_pred             CceEEEEEecCCcCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEECcCcc
Confidence            446789999999877666543   245799999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCCC------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017452          221 AKVLVKGEP------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       221 a~~~~~~~~------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  288 (371)
                      +........            .....+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+.+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            876533221            11235678899999986655578999999999999999999999998888888888888


Q ss_pred             HhCCCCHhHHhhcC--CCccc-cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          289 VLGTPTREEIKCMN--PNYTE-FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       289 ~~~~~~~~~~~~~~--~~~~~-~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+.+....+....  +.... ...... ...+... -..+++.+.++|.+||..||.+|||+.+++.|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNY-PRTLEER-FGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCC-CccHHHH-cccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            77777665544221  11100 000000 0011111 12356789999999999999999999995544

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.4e-42  Score=315.30  Aligned_cols=249  Identities=24%  Similarity=0.398  Sum_probs=196.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|+||.||++.+..+++.||+|++.+.       .....+|+.++..++|+||+++++++     .....+
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAF-----QDENNL   76 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEE-----ecCCEE
Confidence            699999999999999999999999999999998542       12245688889999999999998887     344558


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||+. ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~ey~~~g~L~~~l~~~---~~~l~~~~~~~~~~qi~~al~~lH~~-~iiHrDlkp~Nili~~~~-~~kL~DfG~a~~  151 (332)
T cd05623          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSCLK  151 (332)
T ss_pred             EEEEeccCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCHHHEEECCCC-CEEEeecchhee
Confidence            99999997 5777666532   45789999999999999999999986 999999999999999887 899999999876


Q ss_pred             cccCCC--cccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          224 LVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       224 ~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ......  .....||+.|+|||++..    ...++.++|+|||||++|+|++|+.||...+..+.+..+.....      
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~------  225 (332)
T cd05623         152 LMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKE------  225 (332)
T ss_pred             cccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCc------
Confidence            433222  223568999999999852    33478899999999999999999999988776665555433110      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCC--CCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN--LRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~--~R~t~~~~l~~  354 (371)
                               .+.++.         ....+++++.+||.+||..++.  .|+++.++++|
T Consensus       226 ---------~~~~p~---------~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         226 ---------RFQFPA---------QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             ---------cccCCC---------ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence                     000110         1235789999999999965444  47899998888

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-43  Score=321.33  Aligned_cols=248  Identities=28%  Similarity=0.435  Sum_probs=211.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|.=.+.||.|+||.||-|++..+.+.||||++.-..       ..+.+|+..|++++|||++.+-+||....+     .
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~T-----a  101 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHT-----A  101 (948)
T ss_pred             HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccch-----H
Confidence            4777889999999999999999999999999985331       345579999999999999999999965443     7


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||||-|+-.+++...   .+++-+-.+..|+.+.+.||.|||+. +.||||||..|||++..| .|||+|||.|...
T Consensus       102 WLVMEYClGSAsDlleVh---kKplqEvEIAAi~~gaL~gLaYLHS~-~~IHRDiKAGNILLse~g-~VKLaDFGSAsi~  176 (948)
T KOG0577|consen  102 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NRIHRDIKAGNILLSEPG-LVKLADFGSASIM  176 (948)
T ss_pred             HHHHHHHhccHHHHHHHH---hccchHHHHHHHHHHHHHHHHHHHHh-hHHhhhccccceEecCCC-eeeeccccchhhc
Confidence            899999999888888875   47889999999999999999999986 999999999999999888 9999999999775


Q ss_pred             ccCCCcccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .   +..+++|||+|||||++.  ....|+-++||||||++-.||+-.++|+...+....+..|.+.-            
T Consensus       177 ~---PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNe------------  241 (948)
T KOG0577|consen  177 A---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNE------------  241 (948)
T ss_pred             C---chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcC------------
Confidence            3   445789999999999984  34458999999999999999999999998888888877776531            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                             -|.+...        ..|..+..|+..||++-|++|||+.++++|-+-+.
T Consensus       242 -------sPtLqs~--------eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R  283 (948)
T KOG0577|consen  242 -------SPTLQSN--------EWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLR  283 (948)
T ss_pred             -------CCCCCCc--------hhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhcc
Confidence                   1112222        34789999999999999999999999999955543

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=7.2e-42  Score=315.19  Aligned_cols=249  Identities=25%  Similarity=0.398  Sum_probs=196.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+.+.||+|+||.||++.+..+++.||+|++.+.       .....+|..++..++|+||+++++++     ....+.
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~-----~~~~~~   76 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAF-----QDENYL   76 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EcCCEE
Confidence            699999999999999999999999999999998642       12245678889999999999999888     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||||+.| +|..++...   ...+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        77 ~lv~Ey~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~~L~~lH~~-~iiHrDlkp~Nill~~~~-~~kl~DfG~a~~  151 (331)
T cd05624          77 YLVMDYYVGGDLLTLLSKF---EDRLPEDMARFYIAEMVLAIHSIHQL-HYVHRDIKPDNVLLDMNG-HIRLADFGSCLK  151 (331)
T ss_pred             EEEEeCCCCCcHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCchHHEEEcCCC-CEEEEeccceee
Confidence            999999974 676666532   45789999999999999999999986 999999999999999888 899999999876


Q ss_pred             cccCCCc--ccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          224 LVKGEPN--ISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       224 ~~~~~~~--~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......  ....||+.|+|||++.+.    ..++.++|+|||||++|+|++|+.||...+..+....+......     
T Consensus       152 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~-----  226 (331)
T cd05624         152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEER-----  226 (331)
T ss_pred             ccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCc-----
Confidence            5433222  235689999999998542    24688999999999999999999999877665555444331100     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~  354 (371)
                                +.++.         ....++.++.+++.+||..++.+  |++++++++|
T Consensus       227 ----------~~~p~---------~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         227 ----------FQFPS---------HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             ----------ccCCC---------ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence                      00000         11346899999999999876654  5689998877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.3e-41  Score=301.84  Aligned_cols=250  Identities=22%  Similarity=0.336  Sum_probs=200.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ..|.+.+.||+|++|.||+|.+..+++.||+|.+..+.   ....+|+++++.++|+||+++++++.     ....++++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   80 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYII   80 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEc-----CCCCcEEE
Confidence            46999999999999999999999999999999986543   23567999999999999999998873     34457899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||++ ++|.+.+...  ....+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+|||.+.....
T Consensus        81 ~e~~~~~~L~~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~df~~~~~~~~  156 (263)
T cd05052          81 TEFMTYGNLLDYLREC--NRQEVNAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMTG  156 (263)
T ss_pred             EEeCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-cEEeCCCcccccccc
Confidence            99997 5777766532  234689999999999999999999987 999999999999999887 899999999876543


Q ss_pred             CCCcc--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....  ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+....             
T Consensus       157 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-------------  222 (263)
T cd05052         157 DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGY-------------  222 (263)
T ss_pred             ceeeccCCCCCccccCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            32211  122356799999886544 7899999999999999998 999998765544433332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                     ....+..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       223 ---------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         223 ---------------RMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                           0113456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.8e-41  Score=305.75  Aligned_cols=240  Identities=30%  Similarity=0.482  Sum_probs=199.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|++|.||++.+..+++.||+|.+...       .....+|+++++.++||||+++++++.     .....
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~   76 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQ-----DDSNL   76 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEE-----cCCeE
Confidence            699999999999999999999999999999988542       233557999999999999999999883     34458


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||++ ++|.+.+..    ...+++..+..++.||+.||.|||++ ||+|+||+|.||+++.++ .+||+|||++..
T Consensus        77 ~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~qil~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~dfg~~~~  150 (290)
T cd05580          77 YLVMEYVPGGELFSHLRK----SGRFPEPVARFYAAQVVLALEYLHSL-DIVYRDLKPENLLLDSDG-YIKITDFGFAKR  150 (290)
T ss_pred             EEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEeeCCCccc
Confidence            89999995 677776654    46789999999999999999999986 999999999999999888 899999999887


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....+++.|+|||.+.+. ..+.++|+||||+++|+|++|..||...+.......+...  .           
T Consensus       151 ~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~-----------  214 (290)
T cd05580         151 VKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEG--K-----------  214 (290)
T ss_pred             cCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--C-----------
Confidence            6443  3345678999999998654 4788999999999999999999999876644333333211  0           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                      ..++..++..+.++|.+||..||.+|+     +++++++|
T Consensus       215 ----------------~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         215 ----------------VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             ----------------ccCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcC
Confidence                            013455789999999999999999999     89998777

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.8e-41  Score=304.92  Aligned_cols=260  Identities=26%  Similarity=0.354  Sum_probs=204.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCcee
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.+|+|++...   .....+|+.+++.+ +|+||+++++++.........+
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~   94 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQ   94 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCe
Confidence            4456899999999999999999999999999999987542   23456789999999 7999999999886554445567


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||+++ +|.+.+.........+++..++.++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++.
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~  172 (286)
T cd06638          95 LWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN-KTIHRDVKGNNILLTTEG-GVKLVDFGVSA  172 (286)
T ss_pred             EEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC-CccccCCCHHhEEECCCC-CEEEccCCcee
Confidence            8999999985 77776654444456789999999999999999999987 999999999999999888 79999999987


Q ss_pred             ccccCC-CcccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...... ......+++.|+|||.+...    ..++.++|+|||||++|+|++|+.||........+..+...   .    
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~----  245 (286)
T cd06638         173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN---P----  245 (286)
T ss_pred             ecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc---C----
Confidence            654322 22344688999999987432    23688999999999999999999999766543332221110   0    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                         ......+..++..+.+++.+||+.||.+|||+.++++|.
T Consensus       246 -------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         246 -------------------PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             -------------------CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence                               000012334678899999999999999999999987774

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-41  Score=305.54  Aligned_cols=271  Identities=38%  Similarity=0.687  Sum_probs=215.2

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |.+.+.||.|++|.||+|.+..+|+.+++|.+....      ....+|+.+++.++|+||+++++.+.     .....++
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~   75 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFR-----HKGDLYL   75 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhc-----cCCCEEE
Confidence            677889999999999999998899999999885432      23557899999999999999999873     3455889


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ++||+++++...+...   ...+++..+..++.||+.||.|||++ +|+|+||||+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~df~~~~~~~~  150 (283)
T cd05118          76 VFEFMDTDLYKLIKDR---QRGLPESLIKSYLYQLLQGLAFCHSH-GILHRDLKPENLLINTEG-VLKLADFGLARSFGS  150 (283)
T ss_pred             EEeccCCCHHHHHHhh---cccCCHHHHHHHHHHHHHHHHHHHHC-CeeecCcCHHHEEECCCC-cEEEeeeeeeEecCC
Confidence            9999999877766542   35789999999999999999999987 999999999999999887 899999999876644


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC--
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP--  303 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--  303 (371)
                      .. ......++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+....+.+....+.....  
T Consensus       151 ~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (283)
T cd05118         151 PVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLA  230 (283)
T ss_pred             CcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhh
Confidence            33 222345788899999987664589999999999999999999999998888888888888777777666554432  


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....+.++........ .....++.++.++|.+||..||.+||++.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         231 RNYKFSFPKKAGMPLP-KLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhhhhhccccccCHH-HhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            1111222211111111 1223578999999999999999999999995544

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.5e-41  Score=306.88  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=197.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||+|+||.||++.+..+|..||+|.+...     .....+|+.++++++|+||+++++++.     ...+.++
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~l   76 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF-----IEGAVYM   76 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee-----cCCeEEE
Confidence            589999999999999999999999999999988543     134557999999999999999999884     3455889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|..++... .....+++..+..++.||+.||.|||.+.+|+|+||||+||+++.++ .++|+|||.+....
T Consensus        77 v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  154 (286)
T cd06622          77 CMEYMDAGSLDKLYAGG-VATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNG-QVKLCDFGVSGNLV  154 (286)
T ss_pred             EEeecCCCCHHHHHHhc-cccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCC-CEEEeecCCccccc
Confidence            9999996 555554431 11347899999999999999999999645999999999999999877 89999999987653


Q ss_pred             cCCCcccccccccccCcccccCCc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ... .....+++.|+|||.+.+..     .++.++|+|||||++|+|++|+.||...........+.......+      
T Consensus       155 ~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------  227 (286)
T cd06622         155 ASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDP------  227 (286)
T ss_pred             CCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCC------
Confidence            322 22345788899999985432     257899999999999999999999976554433333222211110      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ..++..++.++.++|.+||..+|.+||++.++++|
T Consensus       228 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~  262 (286)
T cd06622         228 -------------------PTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH  262 (286)
T ss_pred             -------------------CCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence                               01344588999999999999999999999998776

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.4e-41  Score=303.84  Aligned_cols=249  Identities=21%  Similarity=0.241  Sum_probs=195.8

Q ss_pred             cceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||.||+|.+.   ..+..||+|.+....     ..+.+|+.+++.++||||+++++++.     ...
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~   79 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVIT-----RGN   79 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEe-----cCC
Confidence            46999999999999999999865   456789999886532     34557999999999999999999874     334


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+++ +|.+.+..   ....+++..++.++.||+.||+|||++ |++||||||+||+++.++ .++++|||.+
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~i~~al~~lH~~-~iiH~dikp~nili~~~~-~~~l~dfg~~  154 (266)
T cd05064          80 TMMIVTEYMSNGALDSFLRK---HEGQLVAGQLMGMLPGLASGMKYLSEM-GYVHKGLAAHKVLVNSDL-VCKISGFRRL  154 (266)
T ss_pred             CcEEEEEeCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeeccccHhhEEEcCCC-cEEECCCccc
Confidence            57899999986 55555543   135789999999999999999999987 999999999999999887 8999999987


Q ss_pred             cccccCCCcc--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          222 KVLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       222 ~~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ..........  ...++..|+|||.+.+. .++.++|||||||++|++++ |..||...+..+.+..+......      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~------  227 (266)
T cd05064         155 QEDKSEAIYTTMSGKSPVLWAAPEAIQYH-HFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRL------  227 (266)
T ss_pred             ccccccchhcccCCCCceeecCHHHHhhC-CccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCC------
Confidence            6542221111  22345689999998654 48999999999999999775 99999877655544433221000      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                            ..+..++..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 ----------------------~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         228 ----------------------PAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ----------------------CCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence                                  02345788999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.5e-41  Score=306.33  Aligned_cols=251  Identities=23%  Similarity=0.303  Sum_probs=200.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC-----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .+|++.+.||+|+||.||+|.+...+     ..||+|.+....     ..+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT-----K   79 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc-----C
Confidence            46999999999999999999876555     679999885432     33567999999999999999998873     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                      ....+++|||++ ++|.+.+.....            ....+++..+..++.||+.||.|||++ |++|+||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nil~~  158 (283)
T cd05048          80 EQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH-HFVHRDLAARNCLVG  158 (283)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccccceEEEc
Confidence            344789999998 577777764321            114688899999999999999999987 999999999999999


Q ss_pred             CCCCcEEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 017452          208 PHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (371)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (371)
                      .++ .++|+|||++.......   ......+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05048         159 EGL-TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEECCCcceeeccccccccccCCCcccccccCHHHhccCc-CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 89999999987653322   122345578899999986544 7899999999999999998 99999877665544


Q ss_pred             HHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ..+.+...                            ...+..+++++.+|+.+||+.||.+||++.+++++|..
T Consensus       237 ~~i~~~~~----------------------------~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         237 EMIRSRQL----------------------------LPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCCc----------------------------CCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            44332100                            00345689999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=2.4e-41  Score=302.25  Aligned_cols=255  Identities=28%  Similarity=0.438  Sum_probs=202.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|.+...       .....+|+++++.++||||+++++++..     ...
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIE-----DNE   76 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEE-----CCe
Confidence            4699999999999999999999999999999977431       1234579999999999999999998743     334


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++++||+++ +|.+++.........+++..+..++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~~~nil~~~~~-~~~l~d~g~~~  154 (267)
T cd08228          77 LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCCHHHEEEcCCC-CEEECccccce
Confidence            7899999995 77777765554456789999999999999999999987 999999999999999887 89999999987


Q ss_pred             ccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHhHHhh
Q 017452          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       223 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ....... .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||..... ...+.......+.++      
T Consensus       155 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~------  227 (267)
T cd08228         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP------  227 (267)
T ss_pred             eccchhHHHhcCCCCccccChhhhccCC-CCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC------
Confidence            6543222 12346788899999986544 78899999999999999999999965432 122222221111110      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                          ..+..++..+.+++.+||..+|.+||++.++++.|+.++
T Consensus       228 --------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~  266 (267)
T cd08228         228 --------------------LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH  266 (267)
T ss_pred             --------------------CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence                                012346788999999999999999999999999988764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.4e-42  Score=316.99  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=214.9

Q ss_pred             CCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           65 GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        65 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ......+.|.+.+.||+|.|+.|.++++..++..||||++.+.      .....+|+++|+.++|||||+++.+..    
T Consensus        50 ~~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~----  125 (596)
T KOG0586|consen   50 DDSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIE----  125 (596)
T ss_pred             cccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeee----
Confidence            4456667899999999999999999999999999999998654      233568999999999999999999884    


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                       ....+|+||||+.+ .+.+++..    +.+..+..++.++.|++.|++|||++ +|||||||.+|||++.+. ++||+|
T Consensus       126 -t~~~lylV~eya~~ge~~~yl~~----~gr~~e~~ar~~F~q~vsaveYcH~k-~ivHrdLk~eNilL~~~m-nikIaD  198 (596)
T KOG0586|consen  126 -TEATLYLVMEYASGGELFDYLVK----HGRMKEKEARAKFRQIVSAVEYCHSK-NIVHRDLKAENILLDENM-NIKIAD  198 (596)
T ss_pred             -ecceeEEEEEeccCchhHHHHHh----cccchhhhhhhhhHHHHHHHHHHhhc-ceeccccchhhccccccc-ceeeec
Confidence             34448999999985 55555554    67788899999999999999999997 999999999999999988 899999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ||++..+..+....+.+|++.|.|||++.+..+.++.+|+||+|+++|.|+.|..||.+.+-.+.-...+..        
T Consensus       199 fgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~g--------  270 (596)
T KOG0586|consen  199 FGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRG--------  270 (596)
T ss_pred             cccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheee--------
Confidence            999999988888889999999999999999888899999999999999999999999887644332221110        


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               .+            .++-.++.+..++|+++|..+|.+|++.+++++|
T Consensus       271 ---------k~------------rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~~  306 (596)
T KOG0586|consen  271 ---------KY------------RIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD  306 (596)
T ss_pred             ---------ee------------cccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence                     00            0455688999999999999999999999999998

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-41  Score=302.88  Aligned_cols=272  Identities=38%  Similarity=0.677  Sum_probs=214.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |.+.+.||.|++|.||+|.+..+++.|+||.+....     ....+|+..++.++ |+|++++++++..     ....++
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~-----~~~~~l   75 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE-----NDELYF   75 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc-----CCcEEE
Confidence            678899999999999999998899999999885432     23346888999998 9999999998843     445789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||+++++.+.+....  ...+++..+..++.|++.+|.|||++ |++|+||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~dl~~~ni~i~~~~-~~~l~d~~~~~~~~~  151 (283)
T cd07830          76 VFEYMEGNLYQLMKDRK--GKPFSESVIRSIIYQILQGLAHIHKH-GFFHRDLKPENLLVSGPE-VVKIADFGLAREIRS  151 (283)
T ss_pred             EEecCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-CEEEeecccceeccC
Confidence            99999888877766422  34789999999999999999999987 999999999999999887 899999999987655


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc-
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY-  305 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-  305 (371)
                      ........++..|+|||.+.....++.++|+||||+++++|++|..||......+....+...++.+....+....... 
T Consensus       152 ~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (283)
T cd07830         152 RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS  231 (283)
T ss_pred             CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhc
Confidence            4444456678899999998665667899999999999999999999999888888888888888887765543221111 


Q ss_pred             -cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 -TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 -~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       ....++..........++ ..+..+.+++++||+.||.+|||+.+++.|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         232 KLGFRFPQFAPTSLHQLIP-NASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             cccccccccccccHHHHcc-cCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence             111111111111111122 237889999999999999999999996554

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.7e-41  Score=311.31  Aligned_cols=275  Identities=33%  Similarity=0.592  Sum_probs=212.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC-Cce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+|..||+|++...      .....+|+.+++.++||||+++++++...... ...
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFH   93 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccc
Confidence            35799999999999999999999999999999988532      12345799999999999999999887543221 123


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++||+|++++|...+.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~i~~qi~~al~~LH~~-gi~H~dlkp~Nill~~~~-~~kl~dfg~~~  166 (343)
T cd07880          94 DFYLVMPFMGTDLGKLMK-----HEKLSEDRIQFLVYQMLKGLKYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             eEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeccccc
Confidence            468999999887776654     35789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  .....+++.|+|||.+.+...++.++|+||||+++|++++|..||...+.......+.+..+..+.+......
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07880         167 QTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQ  244 (343)
T ss_pred             ccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhc
Confidence            65332  2334668899999998664557889999999999999999999999887777777777766666555433322


Q ss_pred             CCcccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ......   .++......+ ......+++++.++|.+||..||.+|||+.+++.|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         245 SEDAKNYVKKLPRFRKKDF-RSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             chhHHHHHHhccccCcchH-HHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            111000   0011100011 11234678899999999999999999999997776

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.3e-41  Score=304.15  Aligned_cols=250  Identities=25%  Similarity=0.368  Sum_probs=196.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .+|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++.+..     ....++
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~-----~~~~~i   83 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLS-----REKLWI   83 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEe-----CCEEEE
Confidence            4699999999999999999999999999999988543    2345679999999999999999988843     345789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nill~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06646          84 CMEYCGGGSLQDIYHV----TGPLSELQIAYVCRETLQGLAYLHSK-GKMHRDIKGANILLTDNG-DVKLADFGVAAKIT  157 (267)
T ss_pred             EEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEECCCC-CEEECcCccceeec
Confidence            9999985 66666543    45789999999999999999999987 999999999999999887 89999999987653


Q ss_pred             cCC-CcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGE-PNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... ......+++.|+|||.+..  ...++.++|+||+||++|+|++|..||...........+...             
T Consensus       158 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~-------------  224 (267)
T cd06646         158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKS-------------  224 (267)
T ss_pred             ccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecC-------------
Confidence            322 2234567889999998742  233678999999999999999999998654432221111110             


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                          .+..+.     +.  ....++..+.+++.+||..||++|||+.++++|+
T Consensus       225 ----~~~~~~-----~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         225 ----NFQPPK-----LK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             ----CCCCCC-----Cc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence                000000     00  1234688999999999999999999999999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-42  Score=294.97  Aligned_cols=254  Identities=27%  Similarity=0.373  Sum_probs=202.7

Q ss_pred             ccceeee-EeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHH-HcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           70 TISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-LLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        70 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      +++|++. ++||-|-.|.|..+.++.+|+.+|+|++. +....++|++.-- .-.|||||.++++|...- .+...+.+|
T Consensus        60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~-Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~-~~rkcLLiV  137 (400)
T KOG0604|consen   60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLL-DSPKARREVELHWMASGHPHIVSIIDVYENSY-QGRKCLLIV  137 (400)
T ss_pred             hhhheehhhhhccccCCceEEEEeccchhhhHHHHHh-cCHHHHhHhhhhhhhcCCCceEEeehhhhhhc-cCceeeEee
Confidence            4467775 47999999999999999999999999774 4555678888744 447999999999875433 456778899


Q ss_pred             eccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCCcccc
Q 017452          148 LEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKVL  224 (371)
Q Consensus       148 ~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~a~~~  224 (371)
                      ||.+.|+ |...+..  +....|++.++..|++||+.|+.|||+. +|.||||||+|+|....+  ..+||+|||+|+..
T Consensus       138 mE~meGGeLfsriq~--~g~~afTErea~eI~~qI~~Av~~lH~~-nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t  214 (400)
T KOG0604|consen  138 MECMEGGELFSRIQD--RGDQAFTEREASEIMKQIGLAVRYLHSM-NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKET  214 (400)
T ss_pred             eecccchHHHHHHHH--cccccchHHHHHHHHHHHHHHHHHHHhc-chhhccCChhheeeecCCCCcceEeccccccccc
Confidence            9999974 4444443  3356799999999999999999999985 999999999999996433  27999999999987


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCCHhHHhh
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV----DQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .......+.+.||+|.|||++ +...|+...|+||+||++|-|++|.+||.+....    ..-..|....-..+.++|  
T Consensus       215 ~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEW--  291 (400)
T KOG0604|consen  215 QEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEW--  291 (400)
T ss_pred             CCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhH--
Confidence            766666778889999999998 5555899999999999999999999999875542    222333332222222222  


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             ..+|.+.+++|+++|+.+|.+|+|+.++++|
T Consensus       292 -----------------------s~VSe~aKdlIR~LLkt~PteRlTI~~~m~h  322 (400)
T KOG0604|consen  292 -----------------------SCVSEAAKDLIRKLLKTEPTERLTIEEVMDH  322 (400)
T ss_pred             -----------------------hHHHHHHHHHHHHHhcCCchhheeHHHhhcC
Confidence                                   2379999999999999999999999998888

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=310.62  Aligned_cols=248  Identities=26%  Similarity=0.390  Sum_probs=203.6

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      |...+.|+.-+.||+||||.||-++.+.||+.||+|.+.+.       ......|-.+|.+++.+.||.+--+|..    
T Consensus       181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeT----  256 (591)
T KOG0986|consen  181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFET----  256 (591)
T ss_pred             hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecC----
Confidence            34445689999999999999999999999999999977433       2333468899999999999998666633    


Q ss_pred             CceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                       ...+|+||..|+|+ |.-.+  ++-.+..|++..++.++.+|+.||++||+. +||+|||||+|||+|..| .++|+|+
T Consensus       257 -kd~LClVLtlMNGGDLkfHi--yn~g~~gF~e~ra~FYAAEi~cGLehlH~~-~iVYRDLKPeNILLDd~G-hvRISDL  331 (591)
T KOG0986|consen  257 -KDALCLVLTLMNGGDLKFHI--YNHGNPGFDEQRARFYAAEIICGLEHLHRR-RIVYRDLKPENILLDDHG-HVRISDL  331 (591)
T ss_pred             -CCceEEEEEeecCCceeEEe--eccCCCCCchHHHHHHHHHHHhhHHHHHhc-ceeeccCChhheeeccCC-CeEeecc
Confidence             33389999999974 33322  333356899999999999999999999987 999999999999999998 7999999


Q ss_pred             CCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       219 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      |+|..+..+......+||.+|||||++.+.. |+...|+|||||++|+|+.|+.||........-.++-+.....+    
T Consensus       332 GLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~----  406 (591)
T KOG0986|consen  332 GLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDP----  406 (591)
T ss_pred             ceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcch----
Confidence            9999998888888889999999999997766 99999999999999999999999976554444333333222211    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV  349 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~  349 (371)
                                           ..+++.+|+++++|++.+|++||.+|+..+
T Consensus       407 ---------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcr  436 (591)
T KOG0986|consen  407 ---------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCR  436 (591)
T ss_pred             ---------------------hhcccccCHHHHHHHHHHHccCHHHhccCC
Confidence                                 126788999999999999999999997543

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.5e-41  Score=312.54  Aligned_cols=275  Identities=36%  Similarity=0.678  Sum_probs=216.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|.+.+.||+|+||.||+|.+..+|+.+|+|++...      .....+|+.+++.+ +|+||+++++++..   ...
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~---~~~   81 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKA---END   81 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeecc---CCC
Confidence            345799999999999999999999989999999987432      23345799999999 99999999987743   233


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ...++||||++++|...+..     ..+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||.+
T Consensus        82 ~~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~i~H~dl~p~nill~~~~-~~kl~d~g~~  154 (337)
T cd07852          82 KDIYLVFEYMETDLHAVIRA-----NILEDVHKRYIMYQLLKALKYIHSG-NVIHRDLKPSNILLNSDC-RVKLADFGLA  154 (337)
T ss_pred             ceEEEEecccccCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-cEEEeeccch
Confidence            45789999999887766652     3778889999999999999999986 999999999999999988 8999999998


Q ss_pred             cccccCC------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          222 KVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       222 ~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .......      ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||.+....+....+....+.++.
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~  234 (337)
T cd07852         155 RSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSA  234 (337)
T ss_pred             hccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCH
Confidence            7654322      1223467889999999866566788999999999999999999999988888888888887777766


Q ss_pred             hHHhhcCCCccccccCcc---cCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQI---KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+..+........+...   ...+..... ..++.++.++|.+||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         235 EDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHHHHhhhHHHhhhhcccccccchhhhc-cCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            554433221111111111   111111112 2378999999999999999999999999988

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.8e-41  Score=301.85  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=198.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC-CceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~~  144 (371)
                      .+.|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.+ +|+||+++++.+...... ....+
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   84 (272)
T cd06637           5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQL   84 (272)
T ss_pred             hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEE
Confidence            35799999999999999999999999999999998543   33456788999988 699999999988654322 23467


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|||+++ +|.+++...  ....+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|+|||++..
T Consensus        85 ~iv~e~~~~~~L~~~l~~~--~~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivh~dl~~~nili~~~~-~~~l~Dfg~~~~  160 (272)
T cd06637          85 WLVMEFCGAGSVTDLIKNT--KGNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  160 (272)
T ss_pred             EEEEEcCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHEEECCCC-CEEEccCCCcee
Confidence            899999985 776666542  245689999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccC-CCcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          224 LVKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       224 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .... .......|++.|+|||++.+    ...++.++|+|||||++|+|++|..||...............   +     
T Consensus       161 ~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~-----  232 (272)
T cd06637         161 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---P-----  232 (272)
T ss_pred             cccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---C-----
Confidence            5332 22234567889999999853    224678999999999999999999999765433322221110   0     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         .....+..++.++.+|+.+||..||.+|||+.++++|
T Consensus       233 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         233 -------------------APRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             -------------------CCCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence                               0001223468899999999999999999999995443

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=307.17  Aligned_cols=248  Identities=27%  Similarity=0.375  Sum_probs=206.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec--chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      -|.++.+||+|+||.||+|.++.+|..+|||.+.-  +...+.+|+.++++++.+++|++|+.|+...+     ++||||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sD-----LWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSD-----LWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCCc-----eEeehh
Confidence            58999999999999999999999999999999854  35666789999999999999999999977665     899999


Q ss_pred             ccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          150 YVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       150 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      ||+ |++.+.+..+   ++++++.++..+++..+.||+|||.- .-+|||||..|||++.+| ..||+|||.|..+.+..
T Consensus       109 YCGAGSiSDI~R~R---~K~L~E~EIs~iL~~TLKGL~YLH~~-~KIHRDIKAGNILLNT~G-~AKLADFGVAGQLTDTM  183 (502)
T KOG0574|consen  109 YCGAGSISDIMRAR---RKPLSEQEISAVLRDTLKGLQYLHDL-KKIHRDIKAGNILLNTDG-IAKLADFGVAGQLTDTM  183 (502)
T ss_pred             hcCCCcHHHHHHHh---cCCccHHHHHHHHHHHHhHHHHHHHH-HHHHhhcccccEEEcccc-hhhhhhccccchhhhhH
Confidence            999 6777776644   68899999999999999999999974 889999999999999999 89999999987654432


Q ss_pred             -CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          229 -PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       229 -~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                       ...+..|||.|||||++..-. |+.++||||||++..||+-|++||.+-....   .|.-....|++..          
T Consensus       184 AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPMR---AIFMIPT~PPPTF----------  249 (502)
T KOG0574|consen  184 AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPMR---AIFMIPTKPPPTF----------  249 (502)
T ss_pred             HhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCcccccccc---eeEeccCCCCCCC----------
Confidence             234678999999999996544 8999999999999999999999997644322   2222211222110          


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                   ..|+..|.++.+|+++||-++|++|-||.++++|-+
T Consensus       250 -------------~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~F  285 (502)
T KOG0574|consen  250 -------------KKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTF  285 (502)
T ss_pred             -------------CChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhh
Confidence                         134557899999999999999999999999999843

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=8.2e-41  Score=304.31  Aligned_cols=279  Identities=31%  Similarity=0.499  Sum_probs=214.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC-----
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-----  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----  138 (371)
                      .++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+++++.++|||++++++.+....+     
T Consensus         6 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            457999999999999999999999999999999885432      234579999999999999999988754331     


Q ss_pred             CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .+..++++++||+++++...+..   ....+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .+||+||
T Consensus        86 ~~~~~~~lv~e~~~~~l~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~i~H~dl~p~nili~~~~-~~kl~df  160 (302)
T cd07864          86 KDKGAFYLVFEYMDHDLMGLLES---GLVHFSEDHIKSFMKQLLEGLNYCHKK-NFLHRDIKCSNILLNNKG-QIKLADF  160 (302)
T ss_pred             ccCCcEEEEEcccCccHHHHHhc---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-cEEeCcc
Confidence            12336889999999977666543   235789999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       219 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |.+........  .....++..|+|||.+.+...++.++|||||||++|+|++|+.||...+..+.+..+.+..+.+...
T Consensus       161 g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (302)
T cd07864         161 GLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPA  240 (302)
T ss_pred             cccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChh
Confidence            99876543321  1223457789999988665557889999999999999999999999888888888888877777665


Q ss_pred             HHhhcCCC--ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPN--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .++.....  +............+.. ....++..+.+++.+||..||.+||++.+++.|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         241 VWPDVIKLPYFNTMKPKKQYRRRLRE-EFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             hcccccccccccccccccccccchhh-hcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            54322111  0000000000111111 123478999999999999999999999996554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=4.4e-41  Score=300.65  Aligned_cols=252  Identities=26%  Similarity=0.506  Sum_probs=199.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +|+..+.||+|++|.||++.+..+++.||+|.+....          ..+.+|+.+++.++|+||+++++.+     ...
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~   75 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGAT-----CED   75 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhcee-----ccC
Confidence            4888999999999999999999999999999885422          3456799999999999999999988     344


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++|+||+.+ +|.+.+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++..++|+|||.
T Consensus        76 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~ql~~al~~LH~~-~i~H~~i~~~nil~~~~~~~~~l~dfg~  150 (268)
T cd06630          76 SHFNLFVEWMAGGSVSHLLSK----YGAFKEAVIINYTEQLLRGLSYLHEN-QIIHRDVKGANLLIDSTGQRLRIADFGA  150 (268)
T ss_pred             CeEEEEEeccCCCcHHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccccc
Confidence            457899999985 66666543    45789999999999999999999987 9999999999999988775799999999


Q ss_pred             ccccccCCC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +........     .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+......   
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---  226 (268)
T cd06630         151 AARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA---  226 (268)
T ss_pred             ccccccccccCCccccccccccceeCHhHhccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhcc---
Confidence            876543211     1234568889999998654 4789999999999999999999999765443332222221100   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhcccccc
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFR  370 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~  370 (371)
                                           .....++..+++++.+++.+||..+|.+|||+.+            +++|||||
T Consensus       227 ---------------------~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~------------ll~~~~~~  268 (268)
T cd06630         227 ---------------------TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRE------------LLKHPVFR  268 (268)
T ss_pred             ---------------------CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHH------------HhcCcccC
Confidence                                 0011144557899999999999999999999999            55666664

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-42  Score=300.88  Aligned_cols=274  Identities=26%  Similarity=0.476  Sum_probs=213.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCC--C----CeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDH--P----NVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h--~----niv~~~~~~~~~~~~~  140 (371)
                      ..+|.+...+|+|.||.|-.+.+..++..||||+++.-.   +...-|+++|+++.+  |    -+|++.++|     ..
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF-----dy  162 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF-----DY  162 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh-----hc
Confidence            568999999999999999999999999999999986543   333458999999942  1    256666667     67


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-----------
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-----------  209 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-----------  209 (371)
                      .+++|||+|.++.++.+.+..  ....+++...++.+++|+++++++||+. +++|.||||+|||+.+.           
T Consensus       163 rghiCivfellG~S~~dFlk~--N~y~~fpi~~ir~m~~QL~~sv~fLh~~-kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  163 RGHICIVFELLGLSTFDFLKE--NNYIPFPIDHIRHMGYQLLESVAFLHDL-KLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             cCceEEEEeccChhHHHHhcc--CCccccchHHHHHHHHHHHHHHHHHHhc-ceeecCCChheEEEeccceEEEeccCCc
Confidence            788999999999888888775  2356799999999999999999999986 99999999999998311           


Q ss_pred             --------CCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017452          210 --------THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (371)
Q Consensus       210 --------~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (371)
                              ...|+|+|||.|+......  ...+.|..|.|||++.+-. ++.+.||||+||||+|+.||...|...++.+
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~E  316 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLE  316 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHH
Confidence                    1259999999998764433  5678899999999998765 9999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHhHHhhcC-CCc-c--ccccCccc-----------CCCCcccCC--CCCChhHHHHHHhccCcCCCC
Q 017452          282 QLVEIIKVLGTPTREEIKCMN-PNY-T--EFKFPQIK-----------AHPWHKIFP--KRMPPEAVDLVSRLLQYSPNL  344 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~-~~~-~--~~~~~~~~-----------~~~~~~~~~--~~~s~~l~~li~~~l~~dP~~  344 (371)
                      .++.+..++|+.|...+.... ..+ .  ....+...           ..+++....  ...-.++.+||++||.+||.+
T Consensus       317 HLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~  396 (415)
T KOG0671|consen  317 HLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPAR  396 (415)
T ss_pred             HHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccc
Confidence            999999999977766554331 000 0  00000000           011111110  111246899999999999999


Q ss_pred             CCCHHHHhhh
Q 017452          345 RCTAVSKRIL  354 (371)
Q Consensus       345 R~t~~~~l~~  354 (371)
                      |+|+.|+|.|
T Consensus       397 RiTl~EAL~H  406 (415)
T KOG0671|consen  397 RITLREALSH  406 (415)
T ss_pred             cccHHHHhcC
Confidence            9999999888

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=5.5e-41  Score=304.05  Aligned_cols=248  Identities=27%  Similarity=0.393  Sum_probs=195.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +.|++.+.||.|+||.||+|.+..++..+++|.+....    ....+|+.+++.++|+|++++++++..     ....++
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~l   86 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW-----DGKLWI   86 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe-----CCeEEE
Confidence            46999999999999999999999999999999986432    234568899999999999999998843     345889


Q ss_pred             eeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++++ +...+.   .....+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||.+....
T Consensus        87 v~e~~~~~~l~~~~~---~~~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~~~~~  161 (292)
T cd06644          87 MIEFCPGGAVDAIML---ELDRGLTEPQIQVICRQMLEALQYLHSM-KIIHRDLKAGNVLLTLDG-DIKLADFGVSAKNV  161 (292)
T ss_pred             EEecCCCCcHHHHHH---hhcCCCCHHHHHHHHHHHHHHHHHHhcC-CeeecCCCcceEEEcCCC-CEEEccCccceecc
Confidence            99999975 433332   2245689999999999999999999986 999999999999999877 89999999886543


Q ss_pred             cCC-CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ... ......+++.|+|||.+.+    ...++.++|+|||||++|+|++|..||...+......++...   ...     
T Consensus       162 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~~-----  233 (292)
T cd06644         162 KTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS---EPP-----  233 (292)
T ss_pred             ccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcC---CCc-----
Confidence            221 2234567889999999852    233677899999999999999999999776544433333211   000     


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ....+..++.++.++|.+||..||.+||++.++++|
T Consensus       234 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         234 ------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             ------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence                              000234578899999999999999999999998877

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.4e-41  Score=308.73  Aligned_cols=275  Identities=35%  Similarity=0.598  Sum_probs=215.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCC--CcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLET--GETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||+|+||.||++.+..+  +..||+|.+...      .....+|+.+++.+ +||||+++++...... ....
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFP-GNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeecc-ccCC
Confidence            489999999999999999999888  899999987542      12345789999998 5999999988754432 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++++++|++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||.+.
T Consensus        80 ~~~~~~e~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givH~dlkp~Nili~~~~-~~kl~Dfg~a~  153 (332)
T cd07857          80 ELYLYEELMEADLHQIIRS----GQPLTDAHFQSFIYQILCGLKYIHSA-NVLHRDLKPGNLLVNADC-ELKICDFGLAR  153 (332)
T ss_pred             cEEEEEecccCCHHHHHhc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHeEEcCCC-CEEeCcCCCce
Confidence            4689999999888777653    56789999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......     .....+++.|+|||.+.+...++.++|+||||+++|+|++|..||...+....+..+...++.++.+.
T Consensus       154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  233 (332)
T cd07857         154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET  233 (332)
T ss_pred             ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            6533221     12346788999999886655578999999999999999999999999888888899999988887765


Q ss_pred             HhhcCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.........   ..+.......+.. .....+..+.+|+.+||+.||.+|||+.+++.|
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             HHhhhhhhHHHHHHhccccCCcchHh-hCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            5433211100   0111111111111 123368899999999999999999999998777

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1e-40  Score=297.37  Aligned_cols=249  Identities=27%  Similarity=0.444  Sum_probs=203.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||.|+||.||++.+..++..||+|.+...      .....+|+.+++.++|+||+++++.+..   ......+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~---~~~~~~~   77 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIID---RSNQTLY   77 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeec---CCCCEEE
Confidence            489999999999999999999999999999988532      2234568899999999999999887643   3345578


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH-----hcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-----RSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ++|||+++ +|.+.+.........+++..++.++.||+.||.|||     +. +++|+||||+||+++.++ .++|+|||
T Consensus        78 ~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~-~i~h~dl~p~nili~~~~-~~kl~d~g  155 (265)
T cd08217          78 IVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN-TVLHRDLKPANIFLDANN-NVKLGDFG  155 (265)
T ss_pred             EEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC-cceecCCCHHHEEEecCC-CEEEeccc
Confidence            99999984 788887765555678999999999999999999999     76 999999999999999887 89999999


Q ss_pred             CccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ++........ .....+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....        
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--------  226 (265)
T cd08217         156 LAKILGHDSSFAKTYVGTPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGK--------  226 (265)
T ss_pred             ccccccCCcccccccccCCCccChhhhcCCC-CCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCC--------
Confidence            9887654443 33456889999999986544 7889999999999999999999998766433322221110        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ...++..++..+.+++.+||..+|.+|||+.++++|
T Consensus       227 --------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         227 --------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             --------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                                001445678999999999999999999999998777

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=4.3e-41  Score=302.81  Aligned_cols=244  Identities=26%  Similarity=0.414  Sum_probs=191.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||+|+||.||+|.+..++..||+|.+..+     ...+.+|++++++++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFV-----ENRISI   76 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEE-----CCEEEE
Confidence            588999999999999999999999999999988543     1334579999999999999999998844     334789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||++++.....       ..+++..+..++.|++.||.|||+. ||+|+||||+||+++.++ .++|+|||++.....
T Consensus        77 v~e~~~~~~l~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nill~~~~-~~~l~dfg~~~~~~~  147 (279)
T cd06619          77 CTEFMDGGSLDVY-------RKIPEHVLGRIAVAVVKGLTYLWSL-KILHRDVKPSNMLVNTRG-QVKLCDFGVSTQLVN  147 (279)
T ss_pred             EEecCCCCChHHh-------hcCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCCHHHEEECCCC-CEEEeeCCcceeccc
Confidence            9999997533321       3578889999999999999999986 999999999999999988 899999999876533


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ---LVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      . ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........   ............         
T Consensus       148 ~-~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~---------  216 (279)
T cd06619         148 S-IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDED---------  216 (279)
T ss_pred             c-cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccC---------
Confidence            2 223457889999999986554 78999999999999999999999965322111   011111110000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    .........++++.+++.+||+.||.+||++.++++|
T Consensus       217 --------------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~  253 (279)
T cd06619         217 --------------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDH  253 (279)
T ss_pred             --------------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence                          0000123467899999999999999999999998777

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-40  Score=294.57  Aligned_cols=246  Identities=28%  Similarity=0.417  Sum_probs=196.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .|++.+.||+|++|.||++.+..+++.||+|.+...      .....+|+++++.++|+|++++++.+.    .....++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~----~~~~~~~   76 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE----GEDGLLY   76 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec----CCCCEEE
Confidence            489999999999999999999999999999988543      234567889999999999999887652    2334578


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+++ +|.+.+...  ....+++..++.++.|++.||.+||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        77 lv~e~~~~~~l~~~l~~~--~~~~l~~~~~~~~~~~l~~~l~~lH~~-~i~H~di~p~nil~~~~~-~~~l~df~~~~~~  152 (257)
T cd08223          77 IVMGFCEGGDLYHKLKEQ--KGKLLPENQVVEWFVQIAMALQYLHEK-HILHRDLKTQNVFLTRTN-IIKVGDLGIARVL  152 (257)
T ss_pred             EEecccCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCchhEEEecCC-cEEEecccceEEe
Confidence            99999985 666666532  245689999999999999999999987 999999999999999887 8999999998765


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++++|++|+.||...+.......+....  .          
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  219 (257)
T cd08223         153 ENQCDMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGK--L----------  219 (257)
T ss_pred             cccCCccccccCCcCccChhHhcCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcC--C----------
Confidence            3322 223456788999999986544 7889999999999999999999998765444333332210  0          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...+..+++++.+++.+||+.||.+|||+.++++|
T Consensus       220 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         220 ----------------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             ----------------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                            01334578999999999999999999999996655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-41  Score=309.36  Aligned_cols=278  Identities=33%  Similarity=0.588  Sum_probs=214.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++|+||+++++++..... .....
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   94 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD   94 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence            4799999999999999999999999999999988542      1234579999999999999999998754322 12234


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|+||+..++....      ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        95 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~~~~qi~~aL~~LH~~-~i~H~dlkp~NIll~~~~-~~kL~dfg~~~~  166 (342)
T cd07879          95 FYLVMPYMQTDLQKIM------GHPLSEDKVQYLVYQMLCGLKYIHSA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARH  166 (342)
T ss_pred             EEEEecccccCHHHHH------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCCCCcC
Confidence            6899999987654432      34689999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||.+.+....+..+....+.+.....+....
T Consensus       167 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (342)
T cd07879         167 ADA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLED  244 (342)
T ss_pred             CCC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            432  223456788899999986655578899999999999999999999998887777888888777776665543322


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh--hcCCC
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL--FSNCP  359 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~--l~~~~  359 (371)
                      .....   ..+......+...+ ...+..+.+||.+||+.||.+||++.+++.|  |+.++
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         245 KAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             cchHHHHhhcCCcccchHHHHh-cCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence            11100   11111111222112 2368889999999999999999999998887  44443

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-41  Score=305.93  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=196.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|...+.||+|+||.||++.+..+++.||+|.+...     .....+|+.++.++. |+||+++++++..     ....+
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~-----~~~~~   79 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFR-----EGDCW   79 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEec-----CCcEE
Confidence            577788999999999999999999999999988543     233457888888886 9999999998743     23367


Q ss_pred             EeeccccchHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPETVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+.+++.++..... .....+++..+..++.|++.||+|||++.+|+||||||+||+++.++ .++|+|||++...
T Consensus        80 ~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~~~~  158 (288)
T cd06616          80 ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNG-NIKLCDFGISGQL  158 (288)
T ss_pred             EEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCC-cEEEeecchhHHh
Confidence            899999876665544322 22467999999999999999999999745999999999999999887 8999999998765


Q ss_pred             ccCCCcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..........+++.|+|||.+.+.  ..++.++|+||||+++|+|++|+.||.....  ....+.+.....+        
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~--------  228 (288)
T cd06616         159 VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDP--------  228 (288)
T ss_pred             ccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCC--------
Confidence            544444445678899999998665  3578899999999999999999999976541  2222222111100        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              +.     .....+..++.++.+|+.+||..||.+|||+.++++|
T Consensus       229 --------~~-----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         229 --------PI-----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             --------Cc-----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00     0001223478999999999999999999999997766

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=9e-41  Score=300.83  Aligned_cols=271  Identities=38%  Similarity=0.666  Sum_probs=218.1

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++.+.||+|++|.||+|....+++.||+|++....      ....+|+.+++.++|+|++++++++.     ...+.++
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~~   75 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIH-----TERKLYL   75 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhh-----cCCceEE
Confidence            677889999999999999999999999999886531      23457899999999999999999884     3355889


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||||++++|.+.+...   ...+++..+..++.|++.||.+||++ ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 v~e~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~~l~~~ni~~~~~~-~~~l~d~g~~~~~~~  150 (282)
T cd07829          76 VFEYCDMDLKKYLDKR---PGPLSPNLIKSIMYQLLRGLAYCHSH-RILHRDLKPQNILINRDG-VLKLADFGLARAFGI  150 (282)
T ss_pred             EecCcCcCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChheEEEcCCC-CEEEecCCcccccCC
Confidence            9999999888887752   25789999999999999999999987 999999999999999887 899999999876543


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .. ......++..|+|||.+.+...++.++|+||||+++|++++|..||...+..+.+..+.+..+.+....|.......
T Consensus       151 ~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (282)
T cd07829         151 PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP  230 (282)
T ss_pred             CccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc
Confidence            32 22234557789999998766468899999999999999999999999988888888888888888887765443221


Q ss_pred             -cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 -TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 -~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       ....++......+...++. ++..+.++|.+||..||.+||++.+++.|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         231 DYKPTFPKFPPKDLEKVLPR-LDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccccccCccchHHhccc-ccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             2223333333333232333 48899999999999999999999994443

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-41  Score=311.48  Aligned_cols=275  Identities=34%  Similarity=0.606  Sum_probs=215.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      .++|.+.+.||+|++|.||+|.+..++..||+|++...      .....+|+.+++.++|+|++++.+++..... ....
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQ   93 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccc
Confidence            35799999999999999999999999999999987542      1234469999999999999999887743322 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++|+||++++|.+++.     ...+++..++.++.||+.||.|||+. ||+||||||+||+++.++ .++|+|||++.
T Consensus        94 ~~~lv~e~~~~~L~~~~~-----~~~l~~~~~~~~~~ql~~aL~~LH~~-gi~H~dlkp~Nill~~~~-~~kL~dfg~~~  166 (343)
T cd07851          94 DVYLVTHLMGADLNNIVK-----CQKLSDDHIQFLVYQILRGLKYIHSA-GIIHRDLKPSNIAVNEDC-ELKILDFGLAR  166 (343)
T ss_pred             cEEEEEecCCCCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-CEEEccccccc
Confidence            578999999988877776     35799999999999999999999986 999999999999999887 89999999987


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  .....++..|+|||.+.+...++.++|+||||+++|+|++|+.||...+..+.+..+....+.++...+....
T Consensus       167 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  244 (343)
T cd07851         167 HTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKIS  244 (343)
T ss_pred             ccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhcc
Confidence            65332  2344678889999998665557889999999999999999999999888877778887777776665544332


Q ss_pred             CCccc-c--ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTE-F--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~-~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..... +  ..+......+.. ....++..+.++|.+||..||.+|||+.++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         245 SESARNYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             chhHHHHHHhccccCCCCHHH-HhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence            11110 0  001111111111 112468999999999999999999999997776

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=3.8e-41  Score=309.98  Aligned_cols=270  Identities=21%  Similarity=0.309  Sum_probs=191.4

Q ss_pred             eeEeeccC--CceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           75 AERIVGQG--SFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        75 ~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +++.||+|  +|++||++.+..+|+.||+|++...      .....+|+.+++.++||||+++++++..     ....++
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~-----~~~~~l   76 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIA-----DNELWV   76 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEE-----CCEEEE
Confidence            46789999  7889999999999999999998643      1345679999999999999999998843     344789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++ +++.+++....  ...+++..++.++.|++.||+|||++ ||+||||||+||+++.++ .++++||+.+....
T Consensus        77 v~e~~~~~~l~~~~~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiH~dlkp~Nil~~~~~-~~~l~~~~~~~~~~  152 (327)
T cd08227          77 VTSFMAYGSAKDLICTHF--MDGMSELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGLRSNLSMI  152 (327)
T ss_pred             EEeccCCCcHHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCChhhEEEecCC-cEEEcccchhhccc
Confidence            999998 46766665322  34589999999999999999999986 999999999999999887 89999998654332


Q ss_pred             cCCC--------cccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC----
Q 017452          226 KGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT----  292 (371)
Q Consensus       226 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~----  292 (371)
                      ....        .....++..|+|||++.+. ..++.++|||||||++|+|++|..||..................    
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  232 (327)
T cd08227         153 NHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLD  232 (327)
T ss_pred             cccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCcccccc
Confidence            1111        1123456779999998653 34789999999999999999999999765544333222211000    


Q ss_pred             ---CCHhHHh-hcC-----CCcccc-c----cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          293 ---PTREEIK-CMN-----PNYTEF-K----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       293 ---~~~~~~~-~~~-----~~~~~~-~----~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                         .+.+.+. ...     ...... .    .+..... ........+++++.+|+.+||++||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         233 TTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGES-SSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             ccchhhhhcccCCcccCCcCCCCcccccCCcCccccCC-cccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence               0001000 000     000000 0    0000000 0001223467899999999999999999999998877

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-40  Score=295.15  Aligned_cols=245  Identities=25%  Similarity=0.387  Sum_probs=199.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||+|++|.||+|.+..+++.|++|.+...      .....+|+++++.++||||+++++++.     .....+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL-----DKGKLN   75 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec-----cCCEEE
Confidence            488999999999999999999999999999987532      334457899999999999999999883     345688


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. ++|.+.+...  ....+++..++.++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||++...
T Consensus        76 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~-~i~h~dl~~~nili~~~~-~~~l~df~~~~~~  151 (256)
T cd08529          76 IVMEYAENGDLHKLLKMQ--RGRPLPEDQVWRFFIQILLGLAHLHSK-KILHRDIKSLNLFLDAYD-NVKIGDLGVAKLL  151 (256)
T ss_pred             EEEEeCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEeCCC-CEEEcccccceec
Confidence            9999997 4777776642  246789999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....+++.|+|||.+.+.. ++.++|+||||+++++|++|+.||...+.......+....             
T Consensus       152 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  217 (256)
T cd08529         152 SDNTNFANTIVGTPYYLSPELCEDKP-YNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV-------------  217 (256)
T ss_pred             cCccchhhccccCccccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC-------------
Confidence            44322 22346788999999986654 7899999999999999999999998776544433332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                            +         ..++..++.++.+++.+||+.+|++||++.++++|
T Consensus       218 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         218 ------F---------PPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             ------C---------CCCccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence                  0         00233578899999999999999999999998776

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=6.4e-41  Score=299.51  Aligned_cols=243  Identities=30%  Similarity=0.509  Sum_probs=195.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------------hhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      +|.+...||.|++|.||+|.+..++..||+|.+....             ....+|+.+++.++||||+++++++..   
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---   77 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLD---   77 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEe---
Confidence            4888999999999999999998899999999885321             234578999999999999999988743   


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                        ..+.+++|||+++ +|.+.+..    ...+++..+..++.|++.||+|||+. |++||||+|+||+++.++ .++|+|
T Consensus        78 --~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lH~~-~ivH~di~p~nil~~~~~-~~~l~d  149 (267)
T cd06628          78 --ADHLNIFLEYVPGGSVAALLNN----YGAFEETLVRNFVRQILKGLNYLHNR-GIIHRDIKGANILVDNKG-GIKISD  149 (267)
T ss_pred             --CCccEEEEEecCCCCHHHHHHh----ccCccHHHHHHHHHHHHHHHHHHHhc-CcccccCCHHHEEEcCCC-CEEecc
Confidence              3457899999985 66666643    46788999999999999999999986 999999999999999887 899999


Q ss_pred             eCCccccccCCC-------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017452          218 FGSAKVLVKGEP-------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       218 fg~a~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  290 (371)
                      ||.++.......       .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+....+..+....
T Consensus       150 fg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  228 (267)
T cd06628         150 FGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENA  228 (267)
T ss_pred             cCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccC
Confidence            999876642211       11235788899999986544 7889999999999999999999998765544333222210


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                                  ...++..++..+.++|.+||+.||.+||++.++++|
T Consensus       229 ----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         229 ----------------------------SPEIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ----------------------------CCcCCcccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence                                        001345578999999999999999999999996654

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1e-40  Score=304.58  Aligned_cols=270  Identities=24%  Similarity=0.400  Sum_probs=197.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||+|+||.||++.+..++..+|+|.+...     .....+|+++++.++||||+++++++..     ..+.++
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~l   76 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYS-----DGEISI   76 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCEEEE
Confidence            599999999999999999999999999999988543     1235579999999999999999998843     445889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+++ +|.+.+..    ...+++..+..++.|++.||.|||++.+++|+||||+||+++.++ .++|+|||++....
T Consensus        77 v~ey~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~  151 (308)
T cd06615          77 CMEHMDGGSLDQVLKK----AGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLI  151 (308)
T ss_pred             EeeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCC-cEEEccCCCccccc
Confidence            9999985 77766654    467899999999999999999999745899999999999999887 89999999987653


Q ss_pred             cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH-hHH-hhcC-
Q 017452          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR-EEI-KCMN-  302 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~-~~~~-  302 (371)
                      ... .....+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...+... ............. ... .... 
T Consensus       152 ~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  228 (308)
T cd06615         152 DSM-ANSFVGTRSYMSPERLQGT-HYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE-LEAMFGRPVSEGEAKESHRPVSG  228 (308)
T ss_pred             ccc-cccCCCCcCccChhHhcCC-CCCccchHHHHHHHHHHHHhCCCCCCCcchhh-HHHhhcCccccccccCCcccccC
Confidence            322 2345678899999998654 47899999999999999999999997655332 2222211100000 000 0000 


Q ss_pred             ---CCccccc----cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 ---PNYTEFK----FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ---~~~~~~~----~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                         +......    ...+............++.++.+|+.+||..||.+|||+.++++|
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence               0000000    000000000001112368899999999999999999999997777

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=9e-41  Score=303.19  Aligned_cols=246  Identities=29%  Similarity=0.455  Sum_probs=199.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||.|++|.||+|.+..+|+.|++|.+...    .....+|+.+++.++|+|++++++.+.     .....+
T Consensus        18 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~   92 (296)
T cd06655          18 KKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFL-----VGDELF   92 (296)
T ss_pred             cceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEe-----cCceEE
Confidence            34699999999999999999999999999999988543    234457899999999999999999884     334588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+||+.+ +|...+.     ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~-~i~H~dL~p~Nili~~~~-~~kl~dfg~~~~~  165 (296)
T cd06655          93 VVMEYLAGGSLTDVVT-----ETCMDEAQIAAVCRECLQALEFLHAN-QVIHRDIKSDNVLLGMDG-SVKLTDFGFCAQI  165 (296)
T ss_pred             EEEEecCCCcHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccchhc
Confidence            99999986 5555443     34689999999999999999999987 999999999999999887 8999999988765


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|..||...+.......+... +.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~-~~~----------  233 (296)
T cd06655         166 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATN-GTP----------  233 (296)
T ss_pred             ccccccCCCcCCCccccCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCc----------
Confidence            43322 22346788999999986544 789999999999999999999999887665444333221 000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ....+..+++.+.++|.+||..||.+|||+.+++.|
T Consensus       234 ---------------~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         234 ---------------ELQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             ---------------ccCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence                           001234578899999999999999999999998888

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-41  Score=301.74  Aligned_cols=242  Identities=26%  Similarity=0.387  Sum_probs=198.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||.|++|.||+|.+..+++.||+|.+....     ....+|+.+++.++|+||+++.+++..     ..+.++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLK-----GSKLWI   76 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEE-----CCeEEE
Confidence            6899999999999999999999999999999885432     345679999999999999999998743     345899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      |+||+.+ +|.+.+..     ..+++..++.++.|++.||.|||++ +++|+||+|+||+++.++ .++|+|||+++...
T Consensus        77 v~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  149 (274)
T cd06609          77 IMEYCGGGSCLDLLKP-----GKLDETYIAFILREVLLGLEYLHEE-GKIHRDIKAANILLSEEG-DVKLADFGVSGQLT  149 (274)
T ss_pred             EEEeeCCCcHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEcccccceeec
Confidence            9999985 66666553     3789999999999999999999987 999999999999999988 89999999998765


Q ss_pred             cC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .. .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....              
T Consensus       150 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~--------------  214 (274)
T cd06609         150 STMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNN--------------  214 (274)
T ss_pred             ccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcC--------------
Confidence            43 2233456788899999997655 8999999999999999999999997765443333222210              


Q ss_pred             ccccccCcccCCCCcccCCCC-CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ....+.. ++.++.+++.+||..||.+|||+.++++|
T Consensus       215 --------------~~~~~~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         215 --------------PPSLEGNKFSKPFKDFVSLCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             --------------CCCCcccccCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                          0002222 78899999999999999999999998877

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-41  Score=299.75  Aligned_cols=255  Identities=22%  Similarity=0.304  Sum_probs=198.4

Q ss_pred             eeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           73 YMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      |.+++.||+|+||.||+|....+   +..||+|++..+.      ....+|+..++.++|+||+++++.+..... ....
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   80 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP   80 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence            57889999999999999987653   4789999886432      234578999999999999999987754332 2334


Q ss_pred             eEEEeecccc-chHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      +.+++|||+. ++|...+....  .....+++..+..++.|++.||.|||++ +++||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~dfg  158 (273)
T cd05035          81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR-NFIHRDLAARNCMLREDM-TVCVADFG  158 (273)
T ss_pred             ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC-CeeccccchheEEECCCC-eEEECCcc
Confidence            5789999998 47766665432  1234689999999999999999999987 999999999999999887 89999999


Q ss_pred             CccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +++........   ....++..|+|||.+.+. .++.++||||||+++|+|++ |..||.+....+....+....     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----  232 (273)
T cd05035         159 LSKKIYSGDYYRQGRIAKMPVKWIAIESLADR-VYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGN-----  232 (273)
T ss_pred             ceeeccccccccccccccCCccccCHhhcccC-CCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----
Confidence            98865433221   122346679999998544 47899999999999999999 889997766544433322210     


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                             ....+..++.++.+++.+||+.||.+|||+.+++++|..+
T Consensus       233 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         233 -----------------------RLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             -----------------------CCCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                                   0013445789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.5e-40  Score=295.13  Aligned_cols=246  Identities=28%  Similarity=0.446  Sum_probs=201.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|++|.||+|.+..++..+|+|.+...      .....+|+.+++.++|||++++++.+.     .....+
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----~~~~~~   75 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL-----EDKALM   75 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe-----cCCEEE
Confidence            589999999999999999999999999999988543      234567999999999999999998773     344578


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+.+....  ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (256)
T cd08220          76 IVMEYAPGGTLAEYIQKRC--NSLLDEDTILHFFVQILLALHHVHTK-LILHRDLKTQNILLDKHKMVVKIGDFGISKIL  152 (256)
T ss_pred             EEEecCCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCCCEEEEccCCCceec
Confidence            99999985 7777765422  34589999999999999999999987 99999999999999877657899999999876


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+.......+.....             
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~-------------  218 (256)
T cd08220         153 SSKSKAYTVVGTPCYISPELCEGKP-YNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF-------------  218 (256)
T ss_pred             CCCccccccccCCcccCchhccCCC-CCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCC-------------
Confidence            5554444567788999999986544 78899999999999999999999987665544433322100             


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ..++..++.++.+++.+||..||.+|||+.+++.|
T Consensus       219 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         219 ---------------APISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             ---------------CCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence                           00344578999999999999999999999997766

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-41  Score=299.54  Aligned_cols=259  Identities=28%  Similarity=0.408  Sum_probs=204.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCC-CCce
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      ...++|++.+.||.|++|.||+|.+..+++.+++|++...   .....+|+.+++++ +|+||+++++++..... ....
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~   82 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDD   82 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcce
Confidence            4457899999999999999999999989999999988653   24456799999998 79999999998866443 3355


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      +.++||||+++ +|.+++.........+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~-~i~H~~l~p~ni~~~~~~-~~~l~d~~~~  160 (275)
T cd06608          83 QLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN-KVIHRDIKGQNILLTKNA-EVKLVDFGVS  160 (275)
T ss_pred             EEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEEccCC-eEEECCCccc
Confidence            67899999995 77777665444457899999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCC-CcccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGE-PNISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....... ......++..|+|||.+...    ..++.++|+||||+++|+|++|..||..........++...   +.  
T Consensus       161 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~--  235 (275)
T cd06608         161 AQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PP--  235 (275)
T ss_pred             eecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CC--
Confidence            7653322 22345678899999987432    33677899999999999999999999765544443333221   00  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    +.       ...+..++..+.+||.+||..||++|||+.++++|
T Consensus       236 --------------~~-------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 --------------PT-------LKSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             --------------CC-------CCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence                          00       00122367899999999999999999999996654

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.3e-41  Score=297.58  Aligned_cols=245  Identities=27%  Similarity=0.436  Sum_probs=198.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||.|+||.||++.+..++..||+|.+...     .....+|+.+++.++|+||+++++.+     .+..++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   75 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESF-----EADGHLYI   75 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEE-----EECCEEEE
Confidence            489999999999999999999999999999988532     23445788999999999999999988     34456899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+++ ++.+.+...  ....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        76 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  151 (255)
T cd08219          76 VMEYCDGGDLMQKIKLQ--RGKLFPEDTILQWFVQMCLGVQHIHEK-RVLHRDIKSKNIFLTQNG-KVKLGDFGSARLLT  151 (255)
T ss_pred             EEeeCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEECCCC-cEEEcccCcceeec
Confidence            9999985 666655432  245689999999999999999999987 999999999999999887 89999999987654


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......+++.|+|||++.+.. ++.++|+||||+++|+|++|..||...+.......+....  .           
T Consensus       152 ~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~--~-----------  217 (255)
T cd08219         152 SPGAYACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS--Y-----------  217 (255)
T ss_pred             ccccccccccCCccccCHHHHccCC-cCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC--C-----------
Confidence            322 223456788899999986544 7899999999999999999999998765544433332210  0           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ...+..++..+.+++.+||..||.+|||+.+++..
T Consensus       218 ---------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         218 ---------------KPLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence                           01344578899999999999999999999999865

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=3.9e-41  Score=305.84  Aligned_cols=253  Identities=21%  Similarity=0.297  Sum_probs=196.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc--EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ++|++.+.||+|+||.||+|.+..++.  .+++|.+...     .....+|+.++.++ +||||+++++++     ....
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-----~~~~   76 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC-----ENRG   76 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE-----ccCC
Confidence            369999999999999999999877765  4688877532     13456799999999 799999999887     3344


Q ss_pred             eEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~  209 (371)
                      ..+++|||++ ++|.+.+.....            ....+++..++.++.|++.||+|||++ ||+||||||+||+++.+
T Consensus        77 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nill~~~  155 (297)
T cd05089          77 YLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK-QFIHRDLAARNVLVGEN  155 (297)
T ss_pred             cceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCcCCcceEEECCC
Confidence            5789999998 577777754211            123588999999999999999999987 99999999999999988


Q ss_pred             CCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          210 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      + .+||+|||++..............+..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+....+..
T Consensus       156 ~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~  233 (297)
T cd05089         156 L-ASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSV-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ  233 (297)
T ss_pred             C-eEEECCcCCCccccceeccCCCCcCccccCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence            7 89999999986432221112222355699999986544 7899999999999999997 9999987665554433322


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ..                            ....+..++..+.+|+.+||+.+|.+|||+.++++.|..+.
T Consensus       234 ~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~  276 (297)
T cd05089         234 GY----------------------------RMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRML  276 (297)
T ss_pred             CC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            10                            00133457899999999999999999999999999976653

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-40  Score=308.13  Aligned_cols=274  Identities=33%  Similarity=0.545  Sum_probs=214.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      ++|.+.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++|+||+++++++..... .....
T Consensus        17 ~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   96 (345)
T cd07877          17 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   96 (345)
T ss_pred             CceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeeccccccccc
Confidence            57999999999999999999999999999999886432      334579999999999999999987753321 22344


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++++++++++|.+.+.     ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .++|+|||++..
T Consensus        97 ~~lv~~~~~~~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIll~~~~-~~kl~dfg~~~~  169 (345)
T cd07877          97 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  169 (345)
T ss_pred             EEEEehhcccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChHHEEEcCCC-CEEEeccccccc
Confidence            68899999888776654     35689999999999999999999986 999999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+++.|+|||.+.+...++.++|+|||||++|+|++|+.||...+.......+....+.++.........
T Consensus       170 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (345)
T cd07877         170 TDD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  247 (345)
T ss_pred             ccc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhccc
Confidence            432  223456788999999986655578899999999999999999999988877777777877777776665543322


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   ..+......+.. .....++++.++|.+||..||.+||++.++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         248 ESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HhHHHHHHHhcccCCcchhh-hcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            21110   001111111111 112468899999999999999999999998888

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.3e-41  Score=302.17  Aligned_cols=250  Identities=23%  Similarity=0.324  Sum_probs=199.0

Q ss_pred             cceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .+|.+.+.||+|+||.||+|.+.     .++..||+|.+...     .....+|+++++.++|+||+++++++..     
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   79 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTE-----   79 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEec-----
Confidence            46999999999999999999864     34678999988643     2345679999999999999999998843     


Q ss_pred             ceeEEEeecccc-chHHHHHHHhh----------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFN----------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~----------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~  209 (371)
                      ....+++|||++ ++|.+.+....          .....+++..+..++.|++.||.|||++ |++||||||+||+++.+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~  158 (280)
T cd05049          80 GDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ-HFVHRDLATRNCLVGYD  158 (280)
T ss_pred             CCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeeccccccceEEEcCC
Confidence            345789999998 47777765431          1234578899999999999999999987 99999999999999988


Q ss_pred             CCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 017452          210 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVE  285 (371)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  285 (371)
                      + .++|+|||++........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....
T Consensus       159 ~-~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05049         159 L-VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIEC  236 (280)
T ss_pred             C-eEEECCcccceecccCcceecCCCCcccceecChhhhccCC-cchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            7 899999999876432221   12334567899999986554 8999999999999999998 9999987666554444


Q ss_pred             HHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      +.....                            ...+..++..+.+++.+||..||.+||++.++++.|.
T Consensus       237 ~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         237 ITQGRL----------------------------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HHcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            332100                            0123457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.9e-41  Score=309.62  Aligned_cols=254  Identities=24%  Similarity=0.360  Sum_probs=196.4

Q ss_pred             cceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      .+|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.+ +|+||+++++++...   
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~---   83 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKP---   83 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecC---
Confidence            47999999999999999999754     345789999885421     2345689999999 899999999877432   


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhh------------------------------------------------------
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNK------------------------------------------------------  164 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------------------------------------------  164 (371)
                       ...++++|||+++ +|.+.+.....                                                      
T Consensus        84 -~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (337)
T cd05054          84 -GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG  162 (337)
T ss_pred             -CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence             2347799999985 67666643211                                                      


Q ss_pred             ---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC---ccccccccc
Q 017452          165 ---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRY  238 (371)
Q Consensus       165 ---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~  238 (371)
                         ....+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .++|+|||++........   .....++..
T Consensus       163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-~ivHrDikp~Nill~~~~-~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd05054         163 DELYKEPLTLEDLISYSFQVARGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKGDARLPLK  240 (337)
T ss_pred             hHHhhcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEeCCC-cEEEeccccchhcccCcchhhccCCCCCcc
Confidence               123688999999999999999999987 999999999999999887 899999999986533221   112344677


Q ss_pred             ccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCC
Q 017452          239 YRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHP  317 (371)
Q Consensus       239 y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  317 (371)
                      |+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+.+........                          
T Consensus       241 y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~--------------------------  293 (337)
T cd05054         241 WMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGT--------------------------  293 (337)
T ss_pred             ccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccC--------------------------
Confidence            99999987654 8999999999999999997 9999976544333332222100                          


Q ss_pred             CcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          318 WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       318 ~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                       ....+...++++.+++.+||+.+|.+||++.+++++|..+
T Consensus       294 -~~~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~  333 (337)
T cd05054         294 -RMRAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDL  333 (337)
T ss_pred             -CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence             0012345688999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-41  Score=312.10  Aligned_cols=268  Identities=26%  Similarity=0.358  Sum_probs=200.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+++|.-...||+|+||.||+|.. .+|..||||++...    ...+.+|++++.+++|||+|++++++.....    ..
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l-~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~----~~  147 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVL-SDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGE----HR  147 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEE-CCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCc----eE
Confidence            345788889999999999999985 45589999988543    2457899999999999999999999954332    47


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      +||+||+. |+|.+.+......  .++|....+|+.++++||+|||....  ||||||||+|||+|.+. +.||+|||+|
T Consensus       148 ~LVYEym~nGsL~d~L~~~~~~--~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~-~aKlsDFGLa  224 (361)
T KOG1187|consen  148 LLVYEYMPNGSLEDHLHGKKGE--PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDF-NAKLSDFGLA  224 (361)
T ss_pred             EEEEEccCCCCHHHHhCCCCCC--CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCC-CEEccCccCc
Confidence            89999999 6888877653221  88999999999999999999998653  99999999999999998 8999999999


Q ss_pred             ccccc-CCCcccc-cccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHH-HhCCCCHh
Q 017452          222 KVLVK-GEPNISY-ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS--GVDQLVEIIK-VLGTPTRE  296 (371)
Q Consensus       222 ~~~~~-~~~~~~~-~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~~-~~~~~~~~  296 (371)
                      +.... ....... .||.+|+|||..... ..+.++||||||++|+|++||+.+.....  ....+..+.. .+...   
T Consensus       225 ~~~~~~~~~~~~~~~gt~gY~~PEy~~~g-~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~---  300 (361)
T KOG1187|consen  225 KLGPEGDTSVSTTVMGTFGYLAPEYASTG-KLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG---  300 (361)
T ss_pred             ccCCccccceeeecCCCCccCChhhhccC-CcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc---
Confidence            76544 3333333 899999999998654 47999999999999999999998886543  1222333221 11110   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCC-CCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                             ...++.-+.+..    ..++. ..-..+..+...|++.+|.+||+..++++.|..+.
T Consensus       301 -------~~~eiiD~~l~~----~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  301 -------KLREIVDPRLKE----GEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             -------chhheeCCCccC----CCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence                   111111111110    11111 11234678899999999999999999999885543

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.3e-40  Score=299.36  Aligned_cols=251  Identities=22%  Similarity=0.285  Sum_probs=195.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|.+....     ....+|+.+++.++|+||+++++++     .
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~-----~   79 (277)
T cd05062           5 REKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV-----S   79 (277)
T ss_pred             HHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEE-----c
Confidence            457999999999999999999864     245679999875422     2345789999999999999999887     3


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      .....++||||++ ++|.+.+......      ...++...+..++.|++.||.|||+. |++|+||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~vH~dlkp~Nil~~~~~-~  157 (277)
T cd05062          80 QGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  157 (277)
T ss_pred             CCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCcchheEEEcCCC-C
Confidence            3445789999998 4777776543211      23457788999999999999999986 999999999999999887 8


Q ss_pred             EEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      ++|+|||++.........   ....+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.........+..
T Consensus       158 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (277)
T cd05062         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVME  236 (277)
T ss_pred             EEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            999999998755332211   1234467899999986544 7999999999999999998 7899987665444333222


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      . +.                           ...+..++..+.+++.+||+.||.+|||+.+++++|.
T Consensus       237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         237 G-GL---------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             C-Cc---------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            1 00                           0134457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=9.1e-41  Score=302.06  Aligned_cols=254  Identities=24%  Similarity=0.342  Sum_probs=200.0

Q ss_pred             cceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|.+.+.||+|+||.||++.+.     .++..+|+|.+...    .....+|+++++.++||||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----EG   79 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cC
Confidence            46999999999999999999852     34567999988543    234567999999999999999999873     34


Q ss_pred             eeEEEeecccc-chHHHHHHHhhh---------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNK---------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~---------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~  211 (371)
                      .+.+++|||++ ++|.+++.....         ....+++..++.++.||+.||+|||++ |++||||||+||+++.++ 
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~-~i~H~dlkp~Nili~~~~-  157 (288)
T cd05093          80 DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL-  157 (288)
T ss_pred             CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEccCC-
Confidence            45789999998 577777654321         123589999999999999999999987 999999999999999888 


Q ss_pred             cEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017452          212 QVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (371)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  287 (371)
                      .++|+|||++........   .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~  236 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECIT  236 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            899999999876533221   1223346789999998654 47899999999999999998 899998776555444433


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ...  .                          ...+..++.++.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       237 ~~~--~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~  281 (288)
T cd05093         237 QGR--V--------------------------LQRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK  281 (288)
T ss_pred             cCC--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence            210  0                          00234578899999999999999999999999999877643

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3e-40  Score=303.94  Aligned_cols=271  Identities=37%  Similarity=0.696  Sum_probs=213.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||.|+||.||+|.+..+++.||+|++.+.      .....+|+++++.++||||+++.+++...    ...
T Consensus         9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~----~~~   84 (328)
T cd07856           9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISP----LED   84 (328)
T ss_pred             ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecC----CCc
Confidence            45799999999999999999999999999999987432      23456799999999999999999887432    224


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++++||++++|...+.     ...+++..+..++.||+.||.|||++ ||+||||+|+||+++.++ .++|+|||.+..
T Consensus        85 ~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~aL~~LH~~-~iiH~dl~p~Nili~~~~-~~~l~dfg~~~~  157 (328)
T cd07856          85 IYFVTELLGTDLHRLLT-----SRPLEKQFIQYFLYQILRGLKYVHSA-GVVHRDLKPSNILINENC-DLKICDFGLARI  157 (328)
T ss_pred             EEEEeehhccCHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEeECCCC-CEEeCccccccc
Confidence            78999999888776654     35688899999999999999999986 999999999999999887 899999999875


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+++.|+|||.+.+...++.++|+||||+++|+|++|+.||...........+.+..+.++.+.+.....
T Consensus       158 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (328)
T cd07856         158 QDP--QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICS  235 (328)
T ss_pred             cCC--CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            432  223446688899999886645588999999999999999999999988887777777778888877665543221


Q ss_pred             Ccc-cc--ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYT-EF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~-~~--~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ... .+  ..+.....++.. ....++..+.++|.+||+.+|++|||+.+++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         236 ENTLRFVQSLPKREPVPFSE-KFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hhhHHHHhhccccCCCcHHH-HcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            110 00  011101111111 123478899999999999999999999998887

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=1.7e-40  Score=301.47  Aligned_cols=246  Identities=27%  Similarity=0.426  Sum_probs=198.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||+|++|.||+|.+..++..|++|.+...    .....+|+.+++.++|+|++++++.+..     ....+
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~-----~~~~~   93 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELW   93 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEe-----CCEEE
Confidence            35799999999999999999999999999999988543    2345678999999999999999998743     34588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+.+.     ...+++..+..++.|++.||.|||+. ||+||||||+||+++.++ .++|+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~ql~~aL~~LH~~-gi~H~dLkp~Nill~~~~-~~kl~dfg~~~~~  166 (296)
T cd06654          94 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (296)
T ss_pred             EeecccCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEECccccchhc
Confidence            99999985 6766654     34688999999999999999999987 999999999999999887 8999999988765


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....+++.|+|||.+.+.. ++.++|+|||||++|+|++|+.||...........+... +.+          
T Consensus       167 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~-~~~----------  234 (296)
T cd06654         167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATN-GTP----------  234 (296)
T ss_pred             cccccccCcccCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcC-CCC----------
Confidence            33222 23356788999999986544 789999999999999999999999776543332222110 000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ....+..++..+.+++.+||..||.+|||+.++++|
T Consensus       235 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         235 ---------------ELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence                           001234578899999999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-40  Score=311.51  Aligned_cols=256  Identities=23%  Similarity=0.350  Sum_probs=198.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecc-----hhhhHHHHHHHHHcC-CCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  137 (371)
                      ..++|++++.||+|+||.||+|.+..     ++..||||++...     .....+|+++++.+. ||||+++++++    
T Consensus        35 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~----  110 (400)
T cd05105          35 PRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGAC----  110 (400)
T ss_pred             cccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE----
Confidence            34579999999999999999998643     2357999988543     234557999999996 99999999988    


Q ss_pred             CCCceeEEEeecccc-chHHHHHHHhhh----------------------------------------------------
Q 017452          138 DKDELYLNLVLEYVP-ETVHRVVKHFNK----------------------------------------------------  164 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~----------------------------------------------------  164 (371)
                       ......++||||++ |+|.+.+.....                                                    
T Consensus       111 -~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (400)
T cd05105         111 -TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYV  189 (400)
T ss_pred             -ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccc
Confidence             33445899999998 577766654210                                                    


Q ss_pred             ----------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCce
Q 017452          165 ----------------------------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL  204 (371)
Q Consensus       165 ----------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NI  204 (371)
                                                              ....+++..+..++.||+.||+|||++ +|+||||||+||
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivH~dikp~Ni  268 (400)
T cd05105         190 PMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK-NCVHRDLAARNV  268 (400)
T ss_pred             hhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChHhE
Confidence                                                    113478888999999999999999986 999999999999


Q ss_pred             eeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcH
Q 017452          205 LVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGV  280 (371)
Q Consensus       205 li~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~  280 (371)
                      |++.++ .+||+|||+++.......   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||......
T Consensus       269 ll~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~  346 (400)
T cd05105         269 LLAQGK-IVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNL-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVD  346 (400)
T ss_pred             EEeCCC-EEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCcccchh
Confidence            999887 899999999876533222   12334577899999986544 7899999999999999996 99999765443


Q ss_pred             HHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ..+........                 ..          ..+..++.++.+++.+||..||.+|||+.++.+.|+.+.
T Consensus       347 ~~~~~~~~~~~-----------------~~----------~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         347 STFYNKIKSGY-----------------RM----------AKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHHHHHhcCC-----------------CC----------CCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            33332222100                 00          023457889999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.9e-41  Score=308.21  Aligned_cols=251  Identities=24%  Similarity=0.380  Sum_probs=192.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..|++.++||+||.+.||++.. .+...||+|++...      ......|++.|.+|+ |.+||+++++-     -.+.+
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~-s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYE-----v~d~~  434 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLN-SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYE-----VTDGY  434 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeec-CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeee-----ccCce
Confidence            3599999999999999999984 45566777766332      234568999999994 89999999976     55778


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +||||||.+.+|...+...   ...++.-+++.+..||+.|+.++|.+ ||||.||||.|+|+-. | .+||+|||+|..
T Consensus       435 lYmvmE~Gd~DL~kiL~k~---~~~~~~~~lk~ywkqML~aV~~IH~~-gIVHSDLKPANFLlVk-G-~LKLIDFGIA~a  508 (677)
T KOG0596|consen  435 LYMVMECGDIDLNKILKKK---KSIDPDWFLKFYWKQMLLAVKTIHQH-GIVHSDLKPANFLLVK-G-RLKLIDFGIANA  508 (677)
T ss_pred             EEEEeecccccHHHHHHhc---cCCCchHHHHHHHHHHHHHHHHHHHh-ceeecCCCcccEEEEe-e-eEEeeeechhcc
Confidence            9999999999888887753   23344458899999999999999997 9999999999999974 4 799999999988


Q ss_pred             cccCCCc---ccccccccccCcccccCCc----------CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017452          224 LVKGEPN---ISYICSRYYRAPELIFGAT----------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       224 ~~~~~~~---~~~~~t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  290 (371)
                      +......   ...+||+.||+||.+....          ..+.++||||||||||+|+.|+.||+.-..  .+.++... 
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n--~~aKl~aI-  585 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIIN--QIAKLHAI-  585 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHH--HHHHHHhh-
Confidence            7655443   3678999999999995322          256799999999999999999999975321  12222221 


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..|.           .++.|+++.         .  ..++.++++.||.+||.+|||+.++|+|-+..
T Consensus       586 ~~P~-----------~~Iefp~~~---------~--~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~  631 (677)
T KOG0596|consen  586 TDPN-----------HEIEFPDIP---------E--NDELIDVMKCCLARDPKKRWSIPELLQHPFLQ  631 (677)
T ss_pred             cCCC-----------ccccccCCC---------C--chHHHHHHHHHHhcCcccCCCcHHHhcCcccc
Confidence            1110           122333321         1  23499999999999999999999999995443

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1.6e-40  Score=296.88  Aligned_cols=246  Identities=28%  Similarity=0.461  Sum_probs=193.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|.+.+.||+|+||.||+|.+..++..|++|.+...         .....+|+.+++.++||||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~   78 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRD---RAE   78 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEc---CCC
Confidence            3699999999999999999999999999999987532         1235679999999999999999887643   223


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.|++.||.|||+. +|+||||||+||+++.++ .++|+|||+
T Consensus        79 ~~~~l~~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~LH~~-~i~H~~l~p~nil~~~~~-~~~l~dfg~  152 (266)
T cd06651          79 KTLTIFMEYMPGGSVKDQLKA----YGALTESVTRKYTRQILEGMSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  152 (266)
T ss_pred             CEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEccCCC
Confidence            457899999985 67666653    35688999999999999999999986 999999999999999887 899999999


Q ss_pred             ccccccCC----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +.......    ......++..|+|||.+.+. .++.++|+|||||++|+|++|+.||........+..+...   +   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~---~---  225 (266)
T cd06651         153 SKRLQTICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ---P---  225 (266)
T ss_pred             ccccccccccCCccccCCccccccCHHHhCCC-CCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC---C---
Confidence            87543211    11234578889999998654 4789999999999999999999999876544433322211   0   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....++..+++.+.+++ +||..+|.+||+++++++|
T Consensus       226 ---------------------~~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         226 ---------------------TNPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             ---------------------CCCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcC
Confidence                                 01113445788899999 6777899999999995443

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1.8e-40  Score=295.64  Aligned_cols=250  Identities=23%  Similarity=0.314  Sum_probs=198.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.++||+|++|.||+|.+ .++..||+|.+...   .....+|+.+++.++|+||+++++++     ......++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~-~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~l   78 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYY-NNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVV-----TKEEPIYI   78 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEe-cCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEE-----cCCCCcEE
Confidence            35799999999999999999986 45677999987643   23456799999999999999998877     33445789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+. ++|.+.+...  ....+++..+..++.|++.||+|||+. +++||||||+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~~~~  154 (261)
T cd05072          79 ITEYMAKGSLLDFLKSD--EGGKVLLPKLIDFSAQIAEGMAYIERK-NYIHRDLRAANVLVSESL-MCKIADFGLARVIE  154 (261)
T ss_pred             EEecCCCCcHHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEecCCC-cEEECCCccceecC
Confidence            999997 5777766542  245688889999999999999999986 999999999999999887 89999999998754


Q ss_pred             cCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  ....++..|+|||.+.... ++.++|+||||+++|+|++ |..||...........+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05072         155 DNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRM----------  223 (261)
T ss_pred             CCceeccCCCccceecCCHHHhccCC-CChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            33211  1233466799999986544 7889999999999999998 99999876655544443221100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        .....++.++.+++.+||..+|++||+++++++.|+++
T Consensus       224 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         224 ------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence                              02234788999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-40  Score=304.25  Aligned_cols=246  Identities=28%  Similarity=0.489  Sum_probs=197.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||+|++|.||+|.+..+++.||+|.+....       ....+|+++++.++|+||+++++.+     ....+.
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~   76 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASF-----QTETYL   76 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeee-----ecCCEE
Confidence            6999999999999999999999999999999886532       2345789999999999999999887     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.+ +|.+++..  .....+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++..
T Consensus        77 ~lv~e~~~~~~L~~~~~~--~~~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~~~~  152 (316)
T cd05574          77 CLVMDYCPGGELFRLLQR--QPGKCLSEEVARFYAAEVLLALEYLHLL-GIVYRDLKPENILLHESG-HIMLSDFDLSKQ  152 (316)
T ss_pred             EEEEEecCCCCHHHHHHh--CCCCccCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChHHeEEcCCC-CEEEeecchhhc
Confidence            999999975 77666653  2246789999999999999999999986 999999999999999887 899999998865


Q ss_pred             cccCCC------------------------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCC
Q 017452          224 LVKGEP------------------------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL  273 (371)
Q Consensus       224 ~~~~~~------------------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p  273 (371)
                      ......                              .....|+..|+|||.+.+.. ++.++||||||+++|+|++|..|
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~p  231 (316)
T cd05574         153 SDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTP  231 (316)
T ss_pred             ccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCC
Confidence            432211                              11235788899999986554 78899999999999999999999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC----HH
Q 017452          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT----AV  349 (371)
Q Consensus       274 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t----~~  349 (371)
                      |...+....+..+.....                 .++          ....++..+.++|.+||..||.+|||    +.
T Consensus       232 f~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~  284 (316)
T cd05574         232 FKGSNRDETFSNILKKEV-----------------TFP----------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAA  284 (316)
T ss_pred             CCCCchHHHHHHHhcCCc-----------------cCC----------CccccCHHHHHHHHHHccCCHhHCCCchhhHH
Confidence            987766554444332100                 000          01126899999999999999999999    99


Q ss_pred             HHhhh
Q 017452          350 SKRIL  354 (371)
Q Consensus       350 ~~l~~  354 (371)
                      ++++|
T Consensus       285 ~ll~~  289 (316)
T cd05574         285 EIKQH  289 (316)
T ss_pred             HHHcC
Confidence            98877

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-40  Score=300.08  Aligned_cols=247  Identities=26%  Similarity=0.389  Sum_probs=196.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      -|++.+.||.|+||.||++.+..++..+++|.+....    ....+|+++++.++|+|++++++.+..     ....++|
T Consensus         6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~-----~~~~~~v   80 (282)
T cd06643           6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWIL   80 (282)
T ss_pred             HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEee-----CCEEEEE
Confidence            3788999999999999999999999999999885432    334578999999999999999998843     3457899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +||+++ ++...+..   ....+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++.....
T Consensus        81 ~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~qi~~~L~~LH~~-~i~H~dlkp~nili~~~~-~~kl~dfg~~~~~~~  155 (282)
T cd06643          81 IEFCAGGAVDAVMLE---LERPLTEPQIRVVCKQTLEALNYLHEN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTR  155 (282)
T ss_pred             EEecCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEccCC-CEEEccccccccccc
Confidence            999986 44443332   245789999999999999999999987 999999999999999887 899999999865432


Q ss_pred             CC-CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          227 GE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .. ......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...+..+....+.......        
T Consensus       156 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~--------  227 (282)
T cd06643         156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT--------  227 (282)
T ss_pred             cccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC--------
Confidence            21 2233567889999999742    2346789999999999999999999998766555444443321000        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ...+..++.++.+||.+||..||.+||++.++++|
T Consensus       228 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         228 ------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             ------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              00234578899999999999999999999998777

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-41  Score=302.24  Aligned_cols=248  Identities=26%  Similarity=0.369  Sum_probs=198.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ++|++.+.||.|++|.||++.+..++..+|+|.+....    ....+|+++++.++|+||+++++.+.     .....++
T Consensus         5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (280)
T cd06611           5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF-----YENKLWI   79 (280)
T ss_pred             hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe-----cCCeEEE
Confidence            46999999999999999999998899999999885432    23457999999999999999999884     3445789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+++..   ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        80 v~e~~~~~~L~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~nili~~~~-~~~l~d~g~~~~~~  154 (280)
T cd06611          80 LIEFCDGGALDSIMLE---LERGLTEPQIRYVCRQMLEALNFLHSH-KVIHRDLKAGNILLTLDG-DVKLADFGVSAKNK  154 (280)
T ss_pred             EeeccCCCcHHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEECCCC-CEEEccCccchhhc
Confidence            9999986 66665543   235799999999999999999999987 999999999999999887 89999999886543


Q ss_pred             cCC-CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ... ......+++.|+|||.+..    ...++.++|+||||+++|+|++|+.||...+....+..+....  ++      
T Consensus       155 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~------  226 (280)
T cd06611         155 STLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSE--PP------  226 (280)
T ss_pred             ccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCC--CC------
Confidence            322 2234567889999999742    2336778999999999999999999998766544443332210  00      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ....+..++.++.++|.+||..||.+||++.++++|
T Consensus       227 ------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         227 ------------------TLDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             ------------------CcCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence                              000234578899999999999999999999998777

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.8e-42  Score=316.62  Aligned_cols=246  Identities=24%  Similarity=0.375  Sum_probs=199.2

Q ss_pred             cce-eeeEeeccCCceEEEEEEECCCCcEEEEEEe------ecch--hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISY-MAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~------~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ++| +....||+|+|-+||+|.|..+|..||.-.+      +...  ..+..|+.+|+.|+||||+++|+++.....   
T Consensus        39 gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n---  115 (632)
T KOG0584|consen   39 GRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDN---  115 (632)
T ss_pred             CceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCC---
Confidence            345 5667899999999999999999999985322      2222  566789999999999999999999876443   


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      .++.+|+|.+. |+|..+...    .++.+.+.++.|++||++||.|||++ -.|||||||.+||||+.+.+.|||+|+|
T Consensus       116 ~~in~iTEL~TSGtLr~Y~kk----~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLG  191 (632)
T KOG0584|consen  116 KTINFITELFTSGTLREYRKK----HRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLG  191 (632)
T ss_pred             ceeeeeeecccCCcHHHHHHH----hccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchh
Confidence            56788999998 666665554    67888999999999999999999975 2599999999999999888899999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHhHH
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~  298 (371)
                      +|+........ ..+|||.|||||.+.  ..|+..+||||||++++||+|+..||........+ .++..+  .+|..  
T Consensus       192 LAtl~r~s~ak-svIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SG--iKP~s--  264 (632)
T KOG0584|consen  192 LATLLRKSHAK-SVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSG--IKPAA--  264 (632)
T ss_pred             HHHHhhccccc-eeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcC--CCHHH--
Confidence            99987554443 489999999999984  45899999999999999999999999877655443 333332  22221  


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             +..--.+++++||.+||.. ..+|+|+.|+|+|
T Consensus       265 -----------------------l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  265 -----------------------LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             -----------------------hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence                                   1111258999999999999 9999999998888

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.2e-40  Score=298.55  Aligned_cols=255  Identities=21%  Similarity=0.285  Sum_probs=195.2

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCc--EEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      |.+++.||+|+||.||+|.+..++.  .+|+|.+...      .....+|+.+++.++|+||+++++.++.... .....
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            3577899999999999999877765  6899987532      2334578899999999999999987654322 22234


Q ss_pred             EEEeecccc-chHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          144 LNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .+++|||+. ++|.+.+....  .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .++|+|||+
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~  158 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK-SFIHRDLAARNCMLNENM-NVCVADFGL  158 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhheEEcCCC-CEEECCCCc
Confidence            678999998 56666553221  1234589999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ++.......   .....+++.|+|||.+.+. .++.++|+||||+++|+|++ |..||......+....+.+. ..    
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~----  232 (272)
T cd05075         159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADR-VYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQG-NR----  232 (272)
T ss_pred             ccccCcccceecCCcccCCcccCCHHHccCC-CcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-CC----
Confidence            987543321   1123456789999998654 47999999999999999999 88999776554433322211 00    


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                             ...+..++..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       233 -----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         233 -----------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                   002345788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.2e-40  Score=295.81  Aligned_cols=244  Identities=27%  Similarity=0.449  Sum_probs=193.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +|++.+.||.|+||.||+|.+ .+|..+|+|.+....          ....+|+++++.++|+||+++++++     ...
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~   74 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTC-----LDD   74 (265)
T ss_pred             CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEe-----ecC
Confidence            488999999999999999985 578899999875321          2356799999999999999999988     344


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .+.++++||+++ +|.+.+..    ...+++..++.++.|++.||+|||+. +|+|+||+|+||+++.++ .++|+|||+
T Consensus        75 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  148 (265)
T cd06631          75 NTISIFMEFVPGGSISSILNR----FGPLPEPVFCKYTKQILDGVAYLHNN-CVVHRDIKGNNVMLMPNG-IIKLIDFGC  148 (265)
T ss_pred             CeEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHhEEECCCC-eEEeccchh
Confidence            568999999985 66666643    35689999999999999999999986 999999999999999887 899999998


Q ss_pred             ccccccC-------CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          221 AKVLVKG-------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       221 a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      +......       .......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....+. 
T Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~-  226 (265)
T cd06631         149 ARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-  226 (265)
T ss_pred             hHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCC-
Confidence            8754211       1112345788999999986544 789999999999999999999999776544433322221000 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                               ...++..++.++.++|.+||..+|.+||++.++++|
T Consensus       227 -------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         227 -------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             -------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                                     011345678999999999999999999999995544

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=1.7e-40  Score=299.36  Aligned_cols=254  Identities=25%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHc-CCCCeeecceeEEecCC-CCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD-KDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~-~~~~~~  144 (371)
                      .+.|++.+.||.|+||.||+|.+..+++.+|+|++....   .....|+.+++++ +|+||+++++++..... ....+.
T Consensus        15 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~   94 (282)
T cd06636          15 AGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQL   94 (282)
T ss_pred             hhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEE
Confidence            357999999999999999999999999999999885432   3455688888888 79999999998864322 234568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||++..
T Consensus        95 ~iv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~ivH~dl~~~nili~~~~-~~~l~dfg~~~~  170 (282)
T cd06636          95 WLVMEFCGAGSVTDLVKNTK--GNALKEDWIAYICREILRGLAHLHAH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQ  170 (282)
T ss_pred             EEEEEeCCCCcHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEeeCcchhh
Confidence            899999985 7777665422  35688999999999999999999987 999999999999999888 899999999875


Q ss_pred             cccC-CCcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          224 LVKG-EPNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       224 ~~~~-~~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .... .......+++.|+|||.+..    ...++.++|+|||||++|+|++|..||...........+...   ..    
T Consensus       171 ~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~---~~----  243 (282)
T cd06636         171 LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PP----  243 (282)
T ss_pred             hhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhC---CC----
Confidence            4322 12234567889999998753    234678999999999999999999999765543332221110   00    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          .......++.++.+||.+||..||.+|||+.++++|
T Consensus       244 --------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         244 --------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             --------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence                                000223578899999999999999999999995444

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=8.2e-41  Score=303.64  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=197.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||+|++|.||++.+..++..||+|.+...    .....+|+.+++.++|+||+++++.+.     ...+.+
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~-----~~~~~~   92 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL-----VGDELW   92 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe-----cCCEEE
Confidence            35799999999999999999999999999999988543    234557899999999999999999883     344588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+.+.     ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||.+...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~l~~~L~~LH~~-~i~H~dL~p~Nili~~~~-~~~l~Dfg~~~~~  165 (297)
T cd06656          93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALDFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (297)
T ss_pred             EeecccCCCCHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEECcCccceEc
Confidence            99999985 6666554     35688999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....+++.|+|||.+.+. .++.++|+||||+++|++++|..||...+.......+.. .+.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~-~~~~----------  233 (297)
T cd06656         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------  233 (297)
T ss_pred             cCCccCcCcccCCccccCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeecc-CCCC----------
Confidence            43322 2235678899999998654 478999999999999999999999976554322211110 0000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ....+..++..+.+|+.+||..||.+||++.++++|
T Consensus       234 ---------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         234 ---------------ELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           011234578899999999999999999999998887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=6.8e-41  Score=305.03  Aligned_cols=253  Identities=22%  Similarity=0.313  Sum_probs=195.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcE--EEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|++.+.||+|+||.||+|.+..++..  +++|.+...     ...+.+|++++.++ +|+||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~-----~~~   80 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHR   80 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEE-----CCC
Confidence            35799999999999999999998877754  577766432     23445799999999 899999999987     344


Q ss_pred             eeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      .+.++||||++ ++|.+++.....            ....+++..++.++.||+.||+|||++ ||+||||||+|||++.
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dlkp~Nili~~  159 (303)
T cd05088          81 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  159 (303)
T ss_pred             CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEecC
Confidence            55789999997 577777654321            123688999999999999999999986 9999999999999998


Q ss_pred             CCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHH
Q 017452          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII  287 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~  287 (371)
                      ++ .+||+|||++.............++..|+|||.+.+.. ++.++|||||||++|+|+| |..||...+..+....+.
T Consensus       160 ~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~  237 (303)
T cd05088         160 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  237 (303)
T ss_pred             CC-cEEeCccccCcccchhhhcccCCCcccccCHHHHhccC-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHh
Confidence            87 89999999986432211122223356799999885544 7899999999999999998 999997665544332221


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..                            +....+..++.++.+|+.+||+.+|.+||++.+++.++..+
T Consensus       238 ~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~  280 (303)
T cd05088         238 QG----------------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  280 (303)
T ss_pred             cC----------------------------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            10                            00002334688999999999999999999999999987654

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.9e-40  Score=296.22  Aligned_cols=252  Identities=26%  Similarity=0.387  Sum_probs=199.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||.|++|.||+|.+..++..+++|++...     .....+|+++++.++|+|++++++.+..     ....++
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~i   76 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVV-----GDELWL   76 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEee-----CCEEEE
Confidence            699999999999999999999889999999988543     2445679999999999999999887733     345789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||++.+ +|.+.+..... ...+++..++.++.|++.||.+||+. ||+|+||+|+||+++.++ .++|+|||++....
T Consensus        77 v~e~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~~ql~~al~~lh~~-~i~h~~l~p~ni~~~~~~-~~~l~df~~~~~~~  153 (267)
T cd06610          77 VMPYLSGGSLLDIMKSSYP-RGGLDEAIIATVLKEVLKGLEYLHSN-GQIHRDIKAGNILLGEDG-SVKIADFGVSASLA  153 (267)
T ss_pred             EEeccCCCcHHHHHHHhcc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEcccchHHHhc
Confidence            9999985 66666654221 35689999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCCc-----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGEPN-----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .....     ....++..|+|||.+.....++.++|+||||+++|+|++|+.||...+...........   .+.     
T Consensus       154 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-----  225 (267)
T cd06610         154 DGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQN---DPP-----  225 (267)
T ss_pred             cCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcC---CCC-----
Confidence            43222     23467889999999876645889999999999999999999999876654444333321   000     


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              .+..       ......++..+.+++.+||..||.+|||+.++++|
T Consensus       226 --------~~~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         226 --------SLET-------GADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             --------CcCC-------ccccccccHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                    0000       00123578999999999999999999999996554

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8.9e-41  Score=306.10  Aligned_cols=250  Identities=24%  Similarity=0.371  Sum_probs=195.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcE----EEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|.+..++..    ||+|.+...     .....+|+.+++.++||||+++++++...     
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-----   81 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   81 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-----
Confidence            4699999999999999999998766654    899988533     23445788999999999999999887432     


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                       ..+++++|+. |+|.+.+..   ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-~iiH~dlkp~Nill~~~~-~~kl~DfG~  155 (316)
T cd05108          82 -TVQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEER-RLVHRDLAARNVLVKTPQ-HVKITDFGL  155 (316)
T ss_pred             -CceeeeecCCCCCHHHHHHh---ccccCCHHHHHHHHHHHHHHHHHHHhc-CeeccccchhheEecCCC-cEEEccccc
Confidence             2468899988 566666553   234688999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCCcc---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ++.........   ...++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+. ..+.......   
T Consensus       156 a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (316)
T cd05108         156 AKLLGADEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEI-SSILEKGERL---  230 (316)
T ss_pred             cccccCCCcceeccCCccceeecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHhCCCCC---
Confidence            98764433222   122356799999986544 7899999999999999997 9999977554332 2222210000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                    +          .+..++.++.+++.+||..||.+||++.+++.+|..+..
T Consensus       231 --------------~----------~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~  270 (316)
T cd05108         231 --------------P----------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  270 (316)
T ss_pred             --------------C----------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence                          0          223467899999999999999999999999999776643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.2e-40  Score=294.30  Aligned_cols=245  Identities=34%  Similarity=0.525  Sum_probs=198.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|+..+.||+|++|.||+|.+..++..|++|.+....         ....+|+.+++.++|+||+++++.+     ....
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~   75 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTE-----REED   75 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeE-----ecCC
Confidence            4888899999999999999998899999999875432         3455799999999999999999877     3344


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++++||+++ +|.+.+..    ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .+||+|||.+
T Consensus        76 ~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~~~ni~~~~~~-~~kl~d~~~~  149 (258)
T cd06632          76 NLYIFLELVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHDR-NTVHRDIKGANILVDTNG-VVKLADFGMA  149 (258)
T ss_pred             eEEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccCccc
Confidence            57899999985 67666653    45688999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .............++..|+|||.+.....++.++|+||||+++|+|++|+.||...........+.....          
T Consensus       150 ~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~----------  219 (258)
T cd06632         150 KQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE----------  219 (258)
T ss_pred             eeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhccc----------
Confidence            7765444344566788999999985544478899999999999999999999977654333332221100          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       ...++..+++.+.+++.+||..+|.+||++.+++.|
T Consensus       220 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         220 -----------------LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             -----------------CCCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcC
Confidence                             001345678999999999999999999999996655

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.2e-40  Score=296.22  Aligned_cols=244  Identities=27%  Similarity=0.427  Sum_probs=197.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|++.+.||.|+||.||+|.+..++..||+|.+.+.       .....+|+++++.++||||+++++++     ....+.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~   75 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF-----QDEENM   75 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh-----cCCCeE
Confidence            489999999999999999999999999999988643       23456789999999999999999887     445568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|+||+.+ +|...+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||.+..
T Consensus        76 ~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lh~~-~i~h~dl~~~nil~~~~~-~~~l~d~~~~~~  149 (258)
T cd05578          76 YLVVDLLLGGDLRYHLSQ----KVKFSEEQVKFWICEIVLALEYLHSK-GIIHRDIKPDNILLDEQG-HVHITDFNIATK  149 (258)
T ss_pred             EEEEeCCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEEcCCC-CEEEeecccccc
Confidence            999999986 66655543    35789999999999999999999987 999999999999999888 899999999877


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........++..|+|||.+.... ++.++|+||||+++|+|++|..||...+.. ....+......           
T Consensus       150 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~~-----------  216 (258)
T cd05578         150 VTPDTLTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVTAYECLRGKRPYRGHSRT-IRDQIRAKQET-----------  216 (258)
T ss_pred             cCCCccccccCCChhhcCHHHHcccC-CCCcccchhhHHHHHHHHhCCCCCCCCCcc-HHHHHHHHhcc-----------
Confidence            65443344566788899999986544 799999999999999999999999876642 11111111110           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH--HHHhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA--VSKRI  353 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~--~~~l~  353 (371)
                                    ....++..++..+.++|.+||..||.+||++  .++++
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         217 --------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             --------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhc
Confidence                          0111455678999999999999999999999  77443

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-40  Score=296.31  Aligned_cols=275  Identities=33%  Similarity=0.570  Sum_probs=210.0

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHc---CCCCeeecceeEEecCCCCcee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLL---DHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      |++.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.+   +|+|++++++++..........
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            788999999999999999998889999999986321      2334577777665   6999999999987655444456


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .+++|||+++++.+.+....  ...+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+..
T Consensus        81 ~~l~~e~~~~~l~~~l~~~~--~~~l~~~~~~~~~~~i~~al~~LH~~-~i~h~~l~~~nili~~~~-~~~l~dfg~~~~  156 (287)
T cd07838          81 LTLVFEHVDQDLATYLSKCP--KPGLPPETIKDLMRQLLRGVDFLHSH-RIVHRDLKPQNILVTSDG-QVKIADFGLARI  156 (287)
T ss_pred             eEEEehhcccCHHHHHHHcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhEEEccCC-CEEEeccCccee
Confidence            88999999988877765422  23689999999999999999999986 999999999999999987 899999999877


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........++..|+|||.+.+.. ++.++|+||||+++|+|++|.+||......+.+..+......+....+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07838         157 YSFEMALTSVVVTLWYRAPEVLLQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVS  235 (287)
T ss_pred             ccCCcccccccccccccChHHhccCC-CCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcc
Confidence            65444444455788899999986654 78899999999999999999999998888777777776655544333221100


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       .....++......+. .....+++.+.++|.+||+.||.+||++.+++.|
T Consensus       236 -~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         236 -LPRSSFPSYTPRSFK-SFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             -cchhhcccccccchh-hhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence             000011111111111 1223467889999999999999999999996654

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.8e-43  Score=289.86  Aligned_cols=280  Identities=31%  Similarity=0.517  Sum_probs=225.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEe---cCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFS---TTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~---~~~~~  140 (371)
                      .+.|.-..++|+|.||.||+|+...+|+.||+|++..+      .....+|+.+|..++|+|++.++..+-.   +...+
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~   95 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRD   95 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccc
Confidence            34688889999999999999999999999999876432      1234589999999999999888776533   33355


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+|+||.+|..+|..++..   ...+++...++.++.++..||.|+|+. .|+|||+|+.|+||+.++ .+||+|||+
T Consensus        96 r~t~ylVf~~cehDLaGlLsn---~~vr~sls~Ikk~Mk~Lm~GL~~iHr~-kilHRDmKaaNvLIt~dg-ilklADFGl  170 (376)
T KOG0669|consen   96 RATFYLVFDFCEHDLAGLLSN---RKVRFSLSEIKKVMKGLMNGLYYIHRN-KILHRDMKAANVLITKDG-ILKLADFGL  170 (376)
T ss_pred             cceeeeeHHHhhhhHHHHhcC---ccccccHHHHHHHHHHHHHHHHHHHHh-hHHhhcccHhhEEEcCCc-eEEeecccc
Confidence            667899999999988888764   247899999999999999999999987 999999999999999998 899999999


Q ss_pred             ccccccCC-----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ++......     ..+..+.|.+|.+||.+.+...++++.|||..||++.+|+|+.+.|.+......+..|....|..+.
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tk  250 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITK  250 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCc
Confidence            97654322     2234566999999999999999999999999999999999999999999999999999999999998


Q ss_pred             hHHhhcC--CCccccccCcccCCCCc---cc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMN--PNYTEFKFPQIKAHPWH---KI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~--~~~~~~~~~~~~~~~~~---~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +-|+...  +-+..+.++.+......   +. .|-.-.++..+|+.+||..||.+|++++++++|
T Consensus       251 evWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  251 EVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             ccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence            8876433  11122222221111111   11 111225689999999999999999999999998

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=293.82  Aligned_cols=249  Identities=22%  Similarity=0.302  Sum_probs=197.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|++|.||+|.+. +++.||+|.+...   .....+|+.+++.++|+||+++++++.     .....+++
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   79 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWN-NTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCT-----LEEPIYIV   79 (261)
T ss_pred             hheeeEEEecccCCccEEEEEec-CCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEe-----cCCCeeee
Confidence            46999999999999999999864 4578999988653   244567999999999999999998773     33447899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+. ++|.+.+....  ...+++..+..++.|++.||.+||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        80 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~~~~~~~  155 (261)
T cd05068          80 TELMKYGSLLEYLQGGA--GRALKLPQLIDMAAQVASGMAYLEAQ-NYIHRDLAARNVLVGENN-ICKVADFGLARVIKE  155 (261)
T ss_pred             eecccCCcHHHHHhccC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCcceEEEcCCC-CEEECCcceEEEccC
Confidence            99995 67777765421  34689999999999999999999987 999999999999999888 899999999987643


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||.+.+.......+.+...            
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  222 (261)
T cd05068         156 DIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR------------  222 (261)
T ss_pred             CcccccCCCcCceeccCccccccCC-CCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  1112245799999886544 7899999999999999999 9999987665544443322100            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                      ...+...+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       223 ----------------~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         223 ----------------MPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence                            002345788999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.3e-40  Score=297.52  Aligned_cols=254  Identities=30%  Similarity=0.447  Sum_probs=201.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+|++.+.||.|++|.||+|.+..++..+|+|.+...       .....+|+.+++.++|+||+++++++..     ...
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~   76 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----DNE   76 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEe-----CCe
Confidence            4699999999999999999999999999999987532       2344578999999999999999998843     344


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||+++ +|.+++.........+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||++.
T Consensus        77 ~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dl~p~nili~~~~-~~~l~dfg~~~  154 (267)
T cd08229          77 LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEECcchhhh
Confidence            7899999985 77777765544456789999999999999999999987 999999999999999887 89999999887


Q ss_pred             ccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHhHHhh
Q 017452          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       223 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ....... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.+.... ..........          
T Consensus       155 ~~~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08229         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQC----------  223 (267)
T ss_pred             ccccCCcccccccCCcCccCHHHhcCCC-ccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcC----------
Confidence            6543322 22346788999999986544 788999999999999999999999654321 1111111100          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                      .+....+..++..+.+++.+||..||++|||+.++++.+.++
T Consensus       224 ----------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         224 ----------------DYPPLPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             ----------------CCCCCCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence                            000112234788999999999999999999999999988765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-42  Score=317.96  Aligned_cols=244  Identities=28%  Similarity=0.474  Sum_probs=198.9

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (371)
                      .||+|.||+||.|+|..+...+|||.+...    ..-...|+..-+.++|.|||++++++     ..++++-|.||-++|
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~-----senGf~kIFMEqVPG  656 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSV-----SENGFFKIFMEQVPG  656 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhcc-----CCCCeEEEEeecCCC
Confidence            699999999999999999999999998543    23456899999999999999999997     666788899999995


Q ss_pred             -hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC-cc
Q 017452          154 -TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NI  231 (371)
Q Consensus       154 -~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~-~~  231 (371)
                       +|..++.. ....-.-.+..+..+.+||++||.|||++ .|||||||-+||||+...+.+||+|||-++.+..-.+ ..
T Consensus       657 GSLSsLLrs-kWGPlKDNEstm~fYtkQILeGLkYLHen-~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TE  734 (1226)
T KOG4279|consen  657 GSLSSLLRS-KWGPLKDNESTMNFYTKQILEGLKYLHEN-KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTE  734 (1226)
T ss_pred             CcHHHHHHh-ccCCCccchhHHHHHHHHHHHHhhhhhhc-ceeeccccCCcEEEeeccceEEecccccchhhccCCcccc
Confidence             66666654 22222338899999999999999999997 9999999999999998888999999999987654333 34


Q ss_pred             cccccccccCccccc-CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccccc
Q 017452          232 SYICSRYYRAPELIF-GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (371)
Q Consensus       232 ~~~~t~~y~aPE~~~-~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ++.||..|||||++. +...|+.++|||||||++.||+||++||......+..  +.+. |.                  
T Consensus       735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAA--MFkV-Gm------------------  793 (1226)
T KOG4279|consen  735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAA--MFKV-GM------------------  793 (1226)
T ss_pred             ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHh--hhhh-cc------------------
Confidence            688999999999995 3446899999999999999999999999765443321  1111 00                  


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        .   +-+.-+|+.+|.+.+.||.+|+.+||.+||+|.++|+.
T Consensus       794 --y---KvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  794 --Y---KVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             --e---ecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccC
Confidence              0   01112677789999999999999999999999998887

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=4.8e-40  Score=293.70  Aligned_cols=254  Identities=31%  Similarity=0.468  Sum_probs=202.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|.+.+.||+|++|.||+|.+..+|+.||+|.+...       .....+|+++++.++|+|++++++.+..     ...
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~-----~~~   76 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIE-----NNE   76 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeec-----CCe
Confidence            4799999999999999999999989999999987521       2345679999999999999999998843     345


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||+++ +|..++.........+++..++.++.|++.||.|||+. ||+||||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~nil~~~~~-~~~l~d~~~~~  154 (267)
T cd08224          77 LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK-RIMHRDIKPANVFITATG-VVKLGDLGLGR  154 (267)
T ss_pred             EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecCCcChhhEEECCCC-cEEEeccceee
Confidence            7899999985 78777765544456789999999999999999999986 999999999999999888 89999999987


Q ss_pred             ccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--HHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV--DQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~  299 (371)
                      ...... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......  +....+...          
T Consensus       155 ~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (267)
T cd08224         155 FFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKC----------  223 (267)
T ss_pred             eccCCCcccceecCCccccCHHHhccCC-CCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcC----------
Confidence            653322 223456788899999986544 788999999999999999999999654321  111111110          


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                               .+        .......++..+.++|.+||..+|++|||+.++++.|+.+.
T Consensus       224 ---------~~--------~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         224 ---------DY--------PPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             ---------CC--------CCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence                     00        00011246789999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.3e-40  Score=294.15  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=194.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||.||++.+. ++..+|+|.+...   .....+|+.+++.++||||+++++++     ......+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~iv   77 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVC-----TQQKPLYIV   77 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec-cCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEE-----ccCCCEEEE
Confidence            35899999999999999999864 4567999987543   23556799999999999999999887     334457899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||++ ++|.+.+...   ...+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05114          78 TEFMENGCLLNYLRQR---QGKLSKDMLLSMCQDVCEGMEYLERN-SFIHRDLAARNCLVSSTG-VVKVSDFGMTRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhC---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcceEEEcCCC-eEEECCCCCccccCC
Confidence            99998 5666655431   34688999999999999999999987 999999999999999887 899999998876533


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  ....++..|+|||.+.+. .++.++|+||||+++|+|++ |+.||...+..+....+.+...            
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~------------  219 (256)
T cd05114         153 DEYTSSSGAKFPVKWSPPEVFNFS-KYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFR------------  219 (256)
T ss_pred             CceeccCCCCCchhhCChhhcccC-ccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC------------
Confidence            2221  122345679999998654 47899999999999999999 8999987766555554433110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                      ...+...+..+.+++.+||..||.+||++.++++.|
T Consensus       220 ----------------~~~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         220 ----------------LYRPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                            002334678899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=9.6e-41  Score=301.07  Aligned_cols=251  Identities=20%  Similarity=0.261  Sum_probs=196.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .+|++.+.||+|+||.||+|.+..     ++..||+|++....     ..+.+|+.++..++||||+++++.+     ..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~-----~~   79 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVV-----TK   79 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE-----cC
Confidence            368999999999999999998754     35789999986432     2345788899999999999999887     33


Q ss_pred             ceeEEEeecccc-chHHHHHHHhh------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                      ....++++||+. ++|.+.+....            .....+++..+..++.|++.||.|||++ ||+||||||+||+++
T Consensus        80 ~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~-gi~H~dlkp~Nil~~  158 (283)
T cd05091          80 EQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH-HVVHKDLATRNVLVF  158 (283)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc-CccccccchhheEec
Confidence            344789999988 46666654211            1124588889999999999999999987 999999999999999


Q ss_pred             CCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 017452          208 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (371)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (371)
                      .++ .+||+|||+++.......   .....+++.|+|||.+.... ++.++||||||+++|+|++ |..||.+....+..
T Consensus       159 ~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05091         159 DKL-NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVI  236 (283)
T ss_pred             CCC-ceEecccccccccccchheeeccCccCCccccCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 899999999876533221   12234467899999986554 7899999999999999998 88899876655544


Q ss_pred             HHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ..+.....                            ..++..++.++.+++.+||+.+|.+||++++++..|+.
T Consensus       237 ~~i~~~~~----------------------------~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         237 EMIRNRQV----------------------------LPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             HHHHcCCc----------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            44332110                            01345688999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.2e-40  Score=298.74  Aligned_cols=251  Identities=20%  Similarity=0.293  Sum_probs=196.4

Q ss_pred             cceeeeEeeccCCceEEEEEEEC----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|...    .++..+++|.+....     ..+.+|+++++.++||||+++++++..     .
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~-----~   79 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQ-----E   79 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEec-----C
Confidence            46999999999999999999853    456789999886421     345679999999999999999988733     3


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhh-------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNK-------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~-------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                      ...+++|||+++ +|.+.+.....             ....+++..+..++.|++.||.|||++ |++||||||+||+++
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~nili~  158 (283)
T cd05090          80 QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH-FFVHKDLAARNILIG  158 (283)
T ss_pred             CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc-CeehhccccceEEEc
Confidence            347899999984 77776643211             123578888999999999999999987 999999999999999


Q ss_pred             CCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHH
Q 017452          208 PHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQL  283 (371)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~  283 (371)
                      .++ .+||+|||+++.......   .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.......
T Consensus       159 ~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~  236 (283)
T cd05090         159 EQL-HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVI  236 (283)
T ss_pred             CCC-cEEeccccccccccCCcceecccCCCccceecChHHhccCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHH
Confidence            887 899999999976533221   22334567799999986544 7899999999999999998 99999776544333


Q ss_pred             HHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ..+.... .+                           ..+..++..+.+++.+||+.||.+||++.+++++|.+
T Consensus       237 ~~~~~~~-~~---------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         237 EMVRKRQ-LL---------------------------PCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             HHHHcCC-cC---------------------------CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            3332210 00                           0334578999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.9e-40  Score=293.98  Aligned_cols=241  Identities=21%  Similarity=0.305  Sum_probs=188.9

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      +.||+|+||.||+|.+..+++.||+|.+...     .....+|+++++.++||||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQPIYIVMELV   75 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-----CCCCeEEEEeec
Confidence            3689999999999999999999999987543     234567999999999999999999873     334578999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      .+ +|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||.+.........
T Consensus        76 ~~~~L~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~~~~~~~~  150 (252)
T cd05084          76 QGGDFLTFLRT---EGPRLKVKELIQMVENAAAGMEYLESK-HCIHRDLAARNCLVTEKN-VLKISDFGMSREEEDGVYA  150 (252)
T ss_pred             cCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchheEEEcCCC-cEEECccccCccccccccc
Confidence            85 66665542   234688999999999999999999987 999999999999999887 8999999998754332111


Q ss_pred             c---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          231 I---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       231 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .   ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+....                
T Consensus       151 ~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~----------------  213 (252)
T cd05084         151 STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGV----------------  213 (252)
T ss_pred             ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----------------
Confidence            1   112245699999986554 7889999999999999997 889997655433322222110                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                  ....+...+..+.+++.+||..||++|||+.++++.|.
T Consensus       214 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         214 ------------RLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ------------CCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                        00134457889999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=3.7e-40  Score=296.37  Aligned_cols=251  Identities=21%  Similarity=0.286  Sum_probs=196.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ++|.+.+.||+|++|.||+|.+..     ++..||+|.+...     ...+.+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----   80 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFE-----   80 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEcc-----
Confidence            569999999999999999999877     7788999987533     2335678999999999999999987743     


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEE
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVK  214 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~k  214 (371)
                      ....++||||+. ++|.+++......   ...+++..+..++.||+.||+|||++ +++||||||+||+++.++  ..+|
T Consensus        81 ~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~nil~~~~~~~~~~k  159 (277)
T cd05036          81 RLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN-HFIHRDIAARNCLLTCKGPGRVAK  159 (277)
T ss_pred             CCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchheEEEeccCCCcceE
Confidence            233689999997 5777777653211   13588999999999999999999987 999999999999998654  2599


Q ss_pred             EEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHh
Q 017452          215 LCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~  290 (371)
                      |+|||+++........   .....+..|+|||++.+.. ++.++|||||||++|+|++ |..||...+.......+... 
T Consensus       160 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~-  237 (277)
T cd05036         160 IADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGI-FTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG-  237 (277)
T ss_pred             eccCccccccCCccceecCCCCCccHhhCCHHHHhcCC-cCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC-
Confidence            9999998765322111   1222346799999986554 8999999999999999996 99999876654433322211 


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      ..                           ...+..++..+.+++.+||+.||.+|||+.++++||.
T Consensus       238 ~~---------------------------~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         238 GR---------------------------LDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             Cc---------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            00                           0134557899999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.2e-40  Score=296.80  Aligned_cols=250  Identities=22%  Similarity=0.322  Sum_probs=201.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||.|+||.||+|.+.. +..+++|.+....    ....+|+.+++.++|+||+++++.+.     .....+
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~   78 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCS-----VGEPVY   78 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEe-----cCCCeE
Confidence            3469999999999999999999877 8999999986443    34567899999999999999988773     334478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+.+...  ....+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||.+...
T Consensus        79 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~h~dl~~~nilv~~~~-~~kl~d~g~~~~~  154 (261)
T cd05148          79 IITELMEKGSLLAFLRSP--EGQVLPVASLIDMACQVAEGMAYLEEQ-NSIHRDLAARNILVGEDL-VCKVADFGLARLI  154 (261)
T ss_pred             EEEeecccCCHHHHHhcC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccCcceEEEcCCc-eEEEccccchhhc
Confidence            99999985 777777642  245689999999999999999999987 999999999999999888 8999999998765


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..... .....++..|+|||.+... .++.++|+||||+++|+|++ |+.||...+..+.+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05148         155 KEDVYLSSDKKIPYKWTAPEAASHG-TFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRM----------  223 (261)
T ss_pred             CCccccccCCCCceEecCHHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcC----------
Confidence            33221 1123346679999998654 47889999999999999998 89999876655554444321100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        ..+..++..+.+++.+||+.||.+|||+.++++.|+.+
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         224 ------------------PCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence                              02345789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.9e-40  Score=293.59  Aligned_cols=246  Identities=19%  Similarity=0.262  Sum_probs=194.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||.||++.+.. +..+|+|.+...   .....+|+.+++.++||||+++++++.     .....+++
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv   77 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCT-----KQRPIYIV   77 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEc-----cCCCcEEE
Confidence            469999999999999999998643 456999988643   234567999999999999999999873     33347899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .+||+|||.++....
T Consensus        78 ~e~~~~~~l~~~i~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~nili~~~~-~~kl~d~g~~~~~~~  152 (256)
T cd05113          78 TEYMSNGCLLNYLREH---GKRFQPSQLLEMCKDVCEGMAYLESK-QFIHRDLAARNCLVDDQG-CVKVSDFGLSRYVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-CEEECCCccceecCC
Confidence            999975 666665432   34689999999999999999999987 999999999999999887 899999999876543


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-----------  220 (256)
T cd05113         153 DEYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRL-----------  220 (256)
T ss_pred             CceeecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCC-----------
Confidence            3211  1223456799999986544 7889999999999999998 99999876655444443321100           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                       ..+...+..+.+++.+||..||.+|||+.+++++++
T Consensus       221 -----------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         221 -----------------YRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             -----------------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence                             023346889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=6.8e-40  Score=291.08  Aligned_cols=246  Identities=31%  Similarity=0.454  Sum_probs=201.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||.|+||.||.+.+..++..+++|.+...      .....+|+.++++++|+||+++++++..     ....+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMD-----DNTLL   75 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEec-----CCeEE
Confidence            599999999999999999999999999999987533      2335579999999999999999999843     44588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++|+||+|+||+++.++ .+||+|||.+...
T Consensus        76 ~~~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~ni~~~~~~-~~kl~d~~~~~~~  151 (256)
T cd08221          76 IEMEYANGGTLYDKIVRQK--GQLFEEEMVLWYLFQIVSAVSYIHKA-GILHRDIKTLNIFLTKAG-LIKLGDFGISKIL  151 (256)
T ss_pred             EEEEecCCCcHHHHHHhcc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChHhEEEeCCC-CEEECcCcceEEc
Confidence            99999984 7777665422  35689999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+...  ...         
T Consensus       152 ~~~~~~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~--~~~---------  219 (256)
T cd08221         152 GSEYSMAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQG--NYT---------  219 (256)
T ss_pred             ccccccccccCCCccccCHhhcCCCC-CCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC--CCC---------
Confidence            4333 223456789999999986544 788999999999999999999999877665555544321  000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                       ..+..++.++.+++.+||..+|.+||++.++++|+
T Consensus       220 -----------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         220 -----------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             -----------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCc
Confidence                             01244788999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.2e-40  Score=293.41  Aligned_cols=246  Identities=28%  Similarity=0.457  Sum_probs=193.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||++.+..+|..||+|.+...         .....+|+.+++.+.||||+++++++..   ...
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   78 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRD---PME   78 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEecc---CCC
Confidence            3699999999999999999999999999999987432         1234579999999999999999887633   223


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..++++|||+++ +|.+.+..    ...+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||.
T Consensus        79 ~~~~~v~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~Dfg~  152 (265)
T cd06652          79 RTLSIFMEHMPGGSIKDQLKS----YGALTENVTRKYTRQILEGVSYLHSN-MIVHRDIKGANILRDSVG-NVKLGDFGA  152 (265)
T ss_pred             ceEEEEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEecCCC-CEEECcCcc
Confidence            457899999985 67666553    35688999999999999999999987 999999999999999887 899999998


Q ss_pred             ccccccC----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +......    .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||..........++..   .+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~---~~---  225 (265)
T cd06652         153 SKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT---QP---  225 (265)
T ss_pred             ccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhc---CC---
Confidence            8754321    112234578899999998654 478999999999999999999999976644443332211   11   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           .....+..++..+.++|.+||. +|++||++.++++|
T Consensus       226 ---------------------~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         226 ---------------------TNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             ---------------------CCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcC
Confidence                                 0111345578889999999995 99999999996554

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.4e-40  Score=297.32  Aligned_cols=249  Identities=24%  Similarity=0.341  Sum_probs=195.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ++|.+.+.||+|+||.||+|.+..+++.||+|.+....    ....+|+.+++.++||||+++++.+..     ....++
T Consensus         9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~-----~~~~~l   83 (267)
T cd06645           9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLR-----RDKLWI   83 (267)
T ss_pred             HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEe-----CCEEEE
Confidence            47999999999999999999999999999999886432    234578999999999999999998743     345789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+++ +|.+++..    .+.+++..++.++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||.+....
T Consensus        84 v~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~~~~~  157 (267)
T cd06645          84 CMEFCGGGSLQDIYHV----TGPLSESQIAYVSRETLQGLYYLHSK-GKMHRDIKGANILLTDNG-HVKLADFGVSAQIT  157 (267)
T ss_pred             EEeccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEECcceeeeEcc
Confidence            9999985 77766643    46789999999999999999999987 999999999999999887 89999999986553


Q ss_pred             cCC-CcccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGE-PNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... ......|++.|+|||.+.  ....++.++|+|||||++|+|++|..||..................+         
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~---------  228 (267)
T cd06645         158 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQP---------  228 (267)
T ss_pred             CcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCC---------
Confidence            222 123456889999999874  22347889999999999999999999997655433322221110000         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              +     .+.  ....++..+.+++.+||..||++||++.++++|
T Consensus       229 --------~-----~~~--~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         229 --------P-----KLK--DKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             --------C-----ccc--ccCCCCHHHHHHHHHHccCCchhCcCHHHHhcC
Confidence                    0     000  012367889999999999999999999997766

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.3e-40  Score=292.36  Aligned_cols=245  Identities=27%  Similarity=0.406  Sum_probs=198.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||++.+..+|+.||+|.+...      .....+|+.+++.++|+||+++++++     ....+.+
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~   75 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESF-----EENGNLY   75 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeee-----cCCCeEE
Confidence            599999999999999999999999999999988532      23456799999999999999999987     4455689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+||+.+ +|.+.+...  ....+++..+..++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~l~~~nil~~~~~-~~~l~d~~~~~~~  151 (256)
T cd08218          76 IVMDYCEGGDLYKKINAQ--RGVLFPEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TIKLGDFGIARVL  151 (256)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEEeeccceeec
Confidence            99999975 666665531  234678999999999999999999986 999999999999999887 8999999998765


Q ss_pred             ccCCCc-ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...... ....+++.|+|||.+.+.. .+.++|+||||+++++|++|..||...+..+....+....  .          
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~--~----------  218 (256)
T cd08218         152 NSTVELARTCIGTPYYLSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS--Y----------  218 (256)
T ss_pred             CcchhhhhhccCCccccCHHHhCCCC-CCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC--C----------
Confidence            433221 2345788899999986654 7889999999999999999999998766555444443210  0          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...+..++.++.++|.+||+.+|.+||++.++++|
T Consensus       219 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         219 ----------------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             ----------------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhC
Confidence                            00334578999999999999999999999997665

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-40  Score=296.16  Aligned_cols=251  Identities=23%  Similarity=0.288  Sum_probs=198.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCC-----CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.+...     +..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~-----   79 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   79 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEc-----
Confidence            35799999999999999999987643     4789999875432     23457899999999999999999873     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      .....++||||+. ++|.+.+......      ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .
T Consensus        80 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~di~p~nill~~~~-~  157 (277)
T cd05032          80 TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK-KFVHRDLAARNCMVAEDL-T  157 (277)
T ss_pred             CCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccChheEEEcCCC-C
Confidence            3355789999997 5877777643321      23478889999999999999999986 999999999999999988 8


Q ss_pred             EEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      +||+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|++++ |..||...+..+....+..
T Consensus       158 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~  236 (277)
T cd05032         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID  236 (277)
T ss_pred             EEECCcccchhhccCcccccCCCCCccccccCHHHHhcCC-CCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc
Confidence            99999999876543321   12334577899999986544 7899999999999999998 9999987665444333321


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                        +..                          ..++...+.++.+++.+||+.+|.+|||+.++++.|+
T Consensus       237 --~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         237 --GGH--------------------------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             --CCC--------------------------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence              000                          0134456899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.1e-40  Score=295.38  Aligned_cols=257  Identities=26%  Similarity=0.418  Sum_probs=197.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|...+.||.|++|.||+|.+..+++.+|+|.+...     .....+|+++++.++||||+++++++...   ....+++
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~~~~l   78 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDE---SSSSIGI   78 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEcc---CCCeEEE
Confidence            689999999999999999999999999999988643     23456799999999999999999887542   2345789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+++.........+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++....
T Consensus        79 v~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~dfg~~~~~~  156 (287)
T cd06621          79 AMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR-KIIHRDIKPSNILLTRKG-QVKLCDFGVSGELV  156 (287)
T ss_pred             EEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecCC-eEEEeecccccccc
Confidence            9999985 77776665444456789999999999999999999986 999999999999999887 89999999987543


Q ss_pred             cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--HHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--VDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||.....  .... +............+     
T Consensus       157 ~~~~-~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~-~~~~~~~~~~~~~~-----  228 (287)
T cd06621         157 NSLA-GTFTGTSFYMAPERIQGKP-YSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPI-ELLSYIVNMPNPEL-----  228 (287)
T ss_pred             cccc-ccccCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChH-HHHHHHhcCCchhh-----
Confidence            3222 2345678899999986544 78899999999999999999999976522  1111 11111111000000     


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                             +.   ..   ......++.+.+|+.+||+.||.+|||+.++++|
T Consensus       229 -------~~---~~---~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~  266 (287)
T cd06621         229 -------KD---EP---GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEH  266 (287)
T ss_pred             -------cc---CC---CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence                   00   00   0012246789999999999999999999998887

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=2.7e-40  Score=299.67  Aligned_cols=253  Identities=22%  Similarity=0.325  Sum_probs=198.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCC-----CcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||++.+...     ...+|+|.+....     ....+|+.+++.+ +|+||+++++.+.    
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~----   86 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCT----   86 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEc----
Confidence            45799999999999999999987643     3789999886432     2345789999999 8999999998873    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhh------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCcee
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIl  205 (371)
                       .....+++|||+. ++|...+....            .....+++..+..++.|++.||.|||++ +|+||||||+||+
T Consensus        87 -~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~Nil  164 (293)
T cd05053          87 -QEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK-KCIHRDLAARNVL  164 (293)
T ss_pred             -CCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CccccccceeeEE
Confidence             3344789999987 57777765421            2245688999999999999999999987 9999999999999


Q ss_pred             eeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017452          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (371)
Q Consensus       206 i~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (371)
                      ++.++ .+||+|||++........   .....++..|+|||.+.+. .++.++|||||||++|++++ |..||......+
T Consensus       165 ~~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  242 (293)
T cd05053         165 VTEDH-VMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE  242 (293)
T ss_pred             EcCCC-eEEeCccccccccccccceeccCCCCCCccccCHHHhccC-CcCcccceeehhhHHHHHhcCCCCCCCCCCHHH
Confidence            99887 899999999976543221   1122345679999988554 47899999999999999997 999998766544


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ....+....                            ....+...+..+.+|+.+||..||++|||+.+++++|..+
T Consensus       243 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~  291 (293)
T cd05053         243 LFKLLKEGY----------------------------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRM  291 (293)
T ss_pred             HHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHh
Confidence            433322110                            0012345688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.4e-40  Score=293.85  Aligned_cols=247  Identities=29%  Similarity=0.435  Sum_probs=198.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ++|.+.+.||+|++|.||+|.+..++..+++|.+...  .....+|+++++.++|+||+++++.+..     ..+.++++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFK-----NTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeec-----CCcEEEEE
Confidence            4699999999999999999999888999999998654  3456689999999999999999998843     35588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|.+.+..   ....+++..++.++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~---~~~~l~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~ni~~~~~~-~~~l~dfg~~~~~~~~  152 (256)
T cd06612          78 EYCGAGSVSDIMKI---TNKTLTEEEIAAILYQTLKGLEYLHSN-KKIHRDIKAGNILLNEEG-QAKLADFGVSGQLTDT  152 (256)
T ss_pred             ecCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEECCCC-cEEEcccccchhcccC
Confidence            99995 66666543   246789999999999999999999986 999999999999999888 8999999998876443


Q ss_pred             C-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      . ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+...   ..            
T Consensus       153 ~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~------------  216 (256)
T cd06612         153 MAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNK---PP------------  216 (256)
T ss_pred             ccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccC---CC------------
Confidence            3 22334578889999998655 4789999999999999999999999765443322221110   00            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               .  ....+..++.++.+++.+||+.||.+|||+.++++|
T Consensus       217 ---------~--~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         217 ---------P--TLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             ---------C--CCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcC
Confidence                     0  000234567899999999999999999999996554

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.5e-40  Score=293.05  Aligned_cols=250  Identities=26%  Similarity=0.383  Sum_probs=198.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .+|.+.+.||.|++|.||+|.+..+++.+++|.+...    .....+|+.+++.++||||+++++.+..     ...+++
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~~~~~l   77 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR-----RDKLWI   77 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe-----CCEEEE
Confidence            4799999999999999999999989999999988643    2445689999999999999999988743     345889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+++ +|.+++..   ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.+....
T Consensus        78 ~~e~~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~  152 (262)
T cd06613          78 VMEYCGGGSLQDIYQV---TRGPLSELQIAYVCRETLKGLAYLHET-GKIHRDIKGANILLTEDG-DVKLADFGVSAQLT  152 (262)
T ss_pred             EEeCCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHhC-CceecCCChhhEEECCCC-CEEECccccchhhh
Confidence            9999996 65555543   136789999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCC-CcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... ......++..|+|||.+...  ..++.++|+||||+++|+|++|..||...+.......+....-.+.        
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~--------  224 (262)
T cd06613         153 ATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPP--------  224 (262)
T ss_pred             hhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCc--------
Confidence            322 22345678889999998654  2478899999999999999999999987665444333322100000        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               .       ...+...+.++.+++.+||..+|.+|||+.+++.|
T Consensus       225 ---------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         225 ---------K-------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             ---------c-------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                     0       00123457889999999999999999999997765

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=4.5e-40  Score=294.01  Aligned_cols=249  Identities=23%  Similarity=0.285  Sum_probs=196.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ++|++.+.||+|+||.||+|.+..+   ...||+|.+....     ....+|+.+++.++||||+++++.+.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVT-----KSR   78 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEe-----cCC
Confidence            4699999999999999999998644   4579999875432     23456899999999999999998773     334


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..+++|||+.+ +|.+.+...   ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~iv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~Lh~~-~i~H~di~p~nili~~~~-~~~l~dfg~~  153 (266)
T cd05033          79 PVMIITEYMENGSLDKFLREN---DGKFTVGQLVGMLRGIASGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (266)
T ss_pred             ceEEEEEcCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-CEEECccchh
Confidence            47899999985 776666432   34789999999999999999999986 999999999999999887 8999999999


Q ss_pred             cccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .........   ....++..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+.....      
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------  226 (266)
T cd05033         154 RRLEDSEATYTTKGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR------  226 (266)
T ss_pred             hcccccccceeccCCCCCccccChhhhccC-CCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC------
Confidence            876422111   122335679999998654 47899999999999999997 9999977655444333322100      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                            ...+...+..+.+++.+||+.+|.+||++.+++++|.++
T Consensus       227 ----------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         227 ----------------------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                  002345788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.6e-40  Score=326.84  Aligned_cols=252  Identities=23%  Similarity=0.336  Sum_probs=192.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++..+       .....+|+.+++.++||||+++++++.     ....
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~-----d~~~   76 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICS-----DGDP   76 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEe-----eCCE
Confidence            5799999999999999999999999999999998643       223457999999999999999998873     3445


Q ss_pred             EEEeeccccc-hHHHHHHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNK-------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      .+++|||++| +|.+.+.....       .....+...+..++.||+.||+|||++ ||+||||||+||+++.++ .++|
T Consensus        77 lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~-GIIHRDLKPeNILLd~dg-~vKL  154 (932)
T PRK13184         77 VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK-GVLHRDLKPDNILLGLFG-EVVI  154 (932)
T ss_pred             EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC-CccccCCchheEEEcCCC-CEEE
Confidence            7899999985 77777654321       123456677889999999999999987 999999999999999888 8999


Q ss_pred             EeeCCccccccCC-------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          216 CDFGSAKVLVKGE-------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       216 ~Dfg~a~~~~~~~-------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                      +|||++.......                   ......||+.|+|||.+.+.. ++.++|||||||++|+|++|..||..
T Consensus       155 iDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~  233 (932)
T PRK13184        155 LDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVP-ASESTDIYALGVILYQMLTLSFPYRR  233 (932)
T ss_pred             EecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence            9999987651110                   011246899999999986654 79999999999999999999999976


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHH-Hhhhh
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS-KRILF  355 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~-~l~~l  355 (371)
                      .........  .....+. .                  ..     ....+++.+.+++.+||..||.+|++..+ +++.+
T Consensus       234 ~~~~ki~~~--~~i~~P~-~------------------~~-----p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~L  287 (932)
T PRK13184        234 KKGRKISYR--DVILSPI-E------------------VA-----PYREIPPFLSQIAMKALAVDPAERYSSVQELKQDL  287 (932)
T ss_pred             cchhhhhhh--hhccChh-h------------------cc-----ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            443322111  1000000 0                  00     11347889999999999999999976544 44434


Q ss_pred             c
Q 017452          356 S  356 (371)
Q Consensus       356 ~  356 (371)
                      +
T Consensus       288 e  288 (932)
T PRK13184        288 E  288 (932)
T ss_pred             H
Confidence            4

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=7.7e-40  Score=290.85  Aligned_cols=247  Identities=21%  Similarity=0.310  Sum_probs=196.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch--hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .+|.+.+.||+|+||.||++..  .|..+|+|.+..+.  ....+|+.+++.++|+|+++++++++..    ....+++|
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~--~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~----~~~~~lv~   79 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYIVT   79 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEE--cCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcC----CCceEEEE
Confidence            4699999999999999999976  57889999886543  3456799999999999999998876432    23468999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|.+.+...  ....+++..+..++.||+.||+|||++ |++||||||+||+++.++ .+||+|||++......
T Consensus        80 e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~  155 (256)
T cd05082          80 EYMAKGSLVDYLRSR--GRSVLGGDCLLKFSLDVCEAMEYLEAN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEASST  155 (256)
T ss_pred             ECCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccccchheEEEcCCC-cEEecCCccceecccc
Confidence            99984 777766532  133588999999999999999999987 999999999999999888 8999999998764332


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .  ....++..|+|||.+.+. .++.++|+|||||++|+|++ |+.||...+..+....+.+.                 
T Consensus       156 ~--~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~-----------------  215 (256)
T cd05082         156 Q--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-----------------  215 (256)
T ss_pred             C--CCCccceeecCHHHHccC-CCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-----------------
Confidence            2  223345679999998654 47889999999999999997 99999765544433332211                 


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                 +....+..+++.+.+++.+||+.+|.+|||+.+++++|..+
T Consensus       216 -----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         216 -----------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             -----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence                       00113456789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.5e-40  Score=298.64  Aligned_cols=254  Identities=23%  Similarity=0.312  Sum_probs=200.3

Q ss_pred             cceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ....+|+++++.++|+||+++++++.     ..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   79 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG-----DG   79 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEc-----cC
Confidence            46999999999999999999854     345678999885442    34668999999999999999999873     34


Q ss_pred             eeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      ...++||||++ ++|.+.+.....            ....+++..++.++.||+.||+|||++ ||+||||||+||+++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~Nil~~~  158 (291)
T cd05094          80 DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ-HFVHRDLATRNCLVGA  158 (291)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccCcceEEEcc
Confidence            45789999997 577777654321            124588999999999999999999987 9999999999999998


Q ss_pred             CCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017452          209 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (371)
                      ++ .++|+|||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+...
T Consensus       159 ~~-~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  236 (291)
T cd05094         159 NL-LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIE  236 (291)
T ss_pred             CC-cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence            87 899999999876533221   12344577899999986544 7889999999999999998 999997766555433


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      .+....                           + ...+..++..+.+++.+||..||.+|||+.++++.|.++..
T Consensus       237 ~~~~~~---------------------------~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~  284 (291)
T cd05094         237 CITQGR---------------------------V-LERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK  284 (291)
T ss_pred             HHhCCC---------------------------C-CCCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence            322110                           0 00233468899999999999999999999999999988743

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=5.1e-40  Score=292.17  Aligned_cols=240  Identities=24%  Similarity=0.345  Sum_probs=189.3

Q ss_pred             eeccCCceEEEEEEE--CCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           78 IVGQGSFGVVFQAKC--LETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      .||+|+||.||+|.+  ..++..+|+|++....      ....+|+.+++.++||||+++++.+     .+. ..++|||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~-~~~lv~e   75 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGIC-----EAE-SWMLVME   75 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEE-----cCC-CcEEEEe
Confidence            589999999999964  4577899999885432      2345788999999999999998865     212 2578999


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      |+++ +|.+.+..    ...+++..+..++.|++.||+|||++ ||+||||||.||+++.++ .++|+|||++.......
T Consensus        76 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~nill~~~~-~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          76 LAELGPLNKFLQK----NKHVTEKNITELVHQVSMGMKYLEET-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALGADE  149 (257)
T ss_pred             cCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccchhhEEEcCCC-eEEECCCccccccCCCC
Confidence            9995 67666643    45789999999999999999999987 999999999999999887 89999999987654332


Q ss_pred             Cc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          229 PN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       229 ~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..    ....++..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+.+..             
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~-------------  215 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNYY-KFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGE-------------  215 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhccC-CcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCC-------------
Confidence            21    122335789999988544 47889999999999999997 999998765544433332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                     ....+..+++++.++|.+||+.||++||++.++.+.|+..
T Consensus       216 ---------------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ---------------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ---------------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                           0013456889999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=5.1e-40  Score=292.25  Aligned_cols=244  Identities=26%  Similarity=0.377  Sum_probs=197.8

Q ss_pred             EeeccCCceEEEEEEECCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+...   +..|++|.+....     ....+|++.++.++|+|++++++++..     ....+++|
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~lv~   75 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE-----EEPLYLVL   75 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecC-----CCceEEEE
Confidence            4689999999999998866   8999999886542     345679999999999999999988743     44578999


Q ss_pred             cccc-chHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          149 EYVP-ETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ||++ ++|.+.+......     ...+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~nili~~~~-~~~l~dfg~~~  153 (262)
T cd00192          76 EYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK-KFVHRDLAARNCLVGEDL-VVKISDFGLSR  153 (262)
T ss_pred             EeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC-CcccCccCcceEEECCCC-cEEEccccccc
Confidence            9995 6777777653221     36789999999999999999999986 999999999999999987 89999999998


Q ss_pred             ccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ......   ......++..|+|||.+... .++.++|+||||+++|+|++ |..||......+....+...         
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~---------  223 (262)
T cd00192         154 DVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKG---------  223 (262)
T ss_pred             ccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcC---------
Confidence            765432   23345568889999998665 47899999999999999998 69999887554444333321         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                         +....+..++.++.+++.+||..||.+|||+.+++++|+
T Consensus       224 -------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         224 -------------------YRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             -------------------CCCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence                               011134567899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.7e-41  Score=323.17  Aligned_cols=275  Identities=20%  Similarity=0.274  Sum_probs=189.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC-cEEEEE------------------Eeecc---hhhhHHHHHHHHHcCCCCee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG-ETVAIK------------------KVLQD---KRYKNRELQTMRLLDHPNVV  127 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK------------------~~~~~---~~~~~~e~~~l~~l~h~niv  127 (371)
                      ..+|++.+.||+|+||.||+|..+... ...+.|                  .+...   ...+.+|+.+++.++|+||+
T Consensus       147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv  226 (501)
T PHA03210        147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENIL  226 (501)
T ss_pred             hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcC
Confidence            467999999999999999998754322 112211                  11111   23346799999999999999


Q ss_pred             ecceeEEecCCCCceeEEEeeccccchHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                      ++++++..     ....+++++++.+++...+.... ..........++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       227 ~l~~~~~~-----~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~-gIiHrDLKP~NILl  300 (501)
T PHA03210        227 KIEEILRS-----EANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK-KLIHRDIKLENIFL  300 (501)
T ss_pred             cEeEEEEE-----CCeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEE
Confidence            99998843     34478999999987777654321 1123344667888999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCC-CCCCC--CcHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP-LFPGD--SGVD  281 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~-pf~~~--~~~~  281 (371)
                      +.++ .+||+|||++........  .....||+.|+|||++.+.. ++.++|||||||++|+|++|.. ||...  ....
T Consensus       301 ~~~~-~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~  378 (501)
T PHA03210        301 NCDG-KIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGK  378 (501)
T ss_pred             CCCC-CEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHH
Confidence            9888 899999999987644322  22457899999999997654 8999999999999999999875 44332  2334


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCC-cc---ccccCcccCCCCccc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPN-YT---EFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~-~~---~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.+++...+....+ +...... +.   ...+.... ...... ....++.++.++|.+||++||.+|||+.|+|.|
T Consensus       379 ~~~~~~~~~~~~~~~-~p~~~~~~~~~i~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        379 QLLKIIDSLSVCDEE-FPDPPCKLFDYIDSAEIDHAG-HSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHHHHHHhcccChhh-cCCcHHHHHHHhhhhhcccCc-cchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            445555444322211 1000000 00   00000000 000000 112467789999999999999999999998887

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=292.94  Aligned_cols=245  Identities=22%  Similarity=0.292  Sum_probs=194.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||.||++.+. ++..+|+|++...   .....+|+++++.++|+||+++++++     ....+.++|
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv   77 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVC-----TKQRPIFIV   77 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEE-----cCCCceEEE
Confidence            36899999999999999999875 5678999988643   23456799999999999999998877     334457899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||.++...+
T Consensus        78 ~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~kl~dfg~~~~~~~  152 (256)
T cd05059          78 TEYMANGCLLNYLRER---KGKLGTEWLLDMCSDVCEAMEYLESN-GFIHRDLAARNCLVGEDN-VVKVSDFGLARYVLD  152 (256)
T ss_pred             EecCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHhhEEECCCC-cEEECCcccceeccc
Confidence            999975 676665532   34689999999999999999999987 999999999999999887 899999999876543


Q ss_pred             CCCcc--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....  ...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.....            
T Consensus       153 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  219 (256)
T cd05059         153 DQYTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYR------------  219 (256)
T ss_pred             ccccccCCCCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCc------------
Confidence            22111  122345799999986544 7889999999999999998 8999977655444433322100            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                      ...+...+.++.+++.+||..+|++|||+.++++.|
T Consensus       220 ----------------~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         220 ----------------LYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             ----------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence                            012345789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.3e-40  Score=298.71  Aligned_cols=252  Identities=23%  Similarity=0.349  Sum_probs=195.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +|++.+.||+|+||.||+|.+..     ....+++|.+....     ....+|+.+++.++||||+++++.+.     ..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~   75 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACS-----QD   75 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEe-----cC
Confidence            48899999999999999998753     23568888875432     23557999999999999999998873     33


Q ss_pred             eeEEEeecccc-chHHHHHHHhhh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNK--------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlk  200 (371)
                      ...++++||+. ++|.+++.....                    ....+++..+..++.|++.||.|||+. +|+|||||
T Consensus        76 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~ivH~dik  154 (290)
T cd05045          76 GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM-KLVHRDLA  154 (290)
T ss_pred             CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC-Ceehhhhh
Confidence            44789999998 577776654221                    124578999999999999999999986 99999999


Q ss_pred             CCceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 017452          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG  276 (371)
Q Consensus       201 p~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  276 (371)
                      |+||+++.++ .++|+|||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+
T Consensus       155 p~nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~  232 (290)
T cd05045         155 ARNVLVAEGR-KMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG  232 (290)
T ss_pred             hheEEEcCCC-cEEeccccccccccCccchhcccCCCCCccccCHHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCC
Confidence            9999999887 899999999876433221   12233466799999886544 7899999999999999998 9999977


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      .........+...                            +....+..++.++.+++.+||+.||.+||++.++++.|+
T Consensus       233 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~  284 (290)
T cd05045         233 IAPERLFNLLKTG----------------------------YRMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELE  284 (290)
T ss_pred             CCHHHHHHHHhCC----------------------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHH
Confidence            6544332222110                            000134557899999999999999999999999999988


Q ss_pred             CCC
Q 017452          357 NCP  359 (371)
Q Consensus       357 ~~~  359 (371)
                      ++-
T Consensus       285 ~~~  287 (290)
T cd05045         285 KMM  287 (290)
T ss_pred             HHH
Confidence            753

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.2e-39  Score=297.08  Aligned_cols=245  Identities=28%  Similarity=0.463  Sum_probs=193.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +|.+.+.||+|+||.||++.+..+++.|++|.+....       ....+|+++++.++||||+++++.+     ....++
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~-----~~~~~~   76 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSF-----ETKRHL   76 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEE-----ecCCEE
Confidence            5999999999999999999999999999999886432       2344788999999999999999887     344568


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+.| +|.+.+..    ...+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||+++.
T Consensus        77 ~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~NIll~~~~-~~~l~dfg~~~~  150 (305)
T cd05609          77 CMVMEYVEGGDCATLLKN----IGALPVDMARMYFAETVLALEYLHNY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKI  150 (305)
T ss_pred             EEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHEEECCCC-CEEEeeCCCccc
Confidence            999999985 66666654    45789999999999999999999986 999999999999999887 899999998864


Q ss_pred             cccCC----------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017452          224 LVKGE----------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (371)
Q Consensus       224 ~~~~~----------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  287 (371)
                      .....                ......++..|+|||.+.... ++.++|+||||+++|+|++|..||.+.+..+....+.
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~  229 (305)
T cd05609         151 GLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVI  229 (305)
T ss_pred             cCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            21100                011235678899999986544 7899999999999999999999998766544444333


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC---HHHHhhh
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---AVSKRIL  354 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t---~~~~l~~  354 (371)
                      ......                 +.         ....++.++.++|.+||+.||.+||+   +.++++|
T Consensus       230 ~~~~~~-----------------~~---------~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         230 SDDIEW-----------------PE---------GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             hcccCC-----------------CC---------ccccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            210000                 00         11247889999999999999999998   6675555

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=3e-40  Score=294.79  Aligned_cols=246  Identities=28%  Similarity=0.516  Sum_probs=194.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|.+.+.||.|++|.||++.+..+++.+|+|.+....     ....+|+++++.++||||+++++.+..     ....++
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~~~~~l   76 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYN-----NGDISI   76 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeec-----CCEEEE
Confidence            5888999999999999999999999999999886442     334578999999999999999998843     355889


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||++ ++|.+++...   ...+++..+..++.|++.||+|||+ . |++|+||||+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~-~i~H~dl~~~ni~~~~~~-~~~l~d~g~~~~~  151 (265)
T cd06605          77 CMEYMDGGSLDKILKEV---QGRIPERILGKIAVAVLKGLTYLHEKH-KIIHRDVKPSNILVNSRG-QIKLCDFGVSGQL  151 (265)
T ss_pred             EEEecCCCcHHHHHHHc---cCCCCHHHHHHHHHHHHHHHHHHcCCC-CeecCCCCHHHEEECCCC-CEEEeecccchhh
Confidence            999999 5777766542   2678999999999999999999998 6 999999999999999887 8999999998765


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHH-HhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIK-VLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~-~~~~~~~~~~~~~~  302 (371)
                      ...... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||..... ........+ ......        
T Consensus       152 ~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------  221 (265)
T cd06605         152 VNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPP--------  221 (265)
T ss_pred             HHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCC--------
Confidence            332222 26678889999998665 488999999999999999999999976531 111111111 111000        


Q ss_pred             CCccccccCcccCCCCcccCCC-CCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~-~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              +         ..+. .++.++.++|.+||..||.+|||+.+++.|
T Consensus       222 --------~---------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         222 --------P---------RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             --------C---------CCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhC
Confidence                    0         0122 278899999999999999999999995544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=7.6e-40  Score=291.81  Aligned_cols=237  Identities=29%  Similarity=0.473  Sum_probs=190.9

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||.|++|.||+|.+..+++.||+|++....       ..+.+|+.+++.++||||+++++.+.     +....++++||+
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~lv~e~~   75 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFK-----DKKYIYMLMEYC   75 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEE-----cCCccEEEEecC
Confidence            699999999999999899999999985432       34567899999999999999999873     334578999998


Q ss_pred             c-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 P-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      + ++|.+.+..    ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++.........
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~~~h~dl~~~nilv~~~~-~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          76 LGGELWTILRD----RGLFDEYTARFYIACVVLAFEYLHNR-GIIYRDLKPENLLLDSNG-YVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             CCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEEcCCC-CEEEeeCCcccccCccccc
Confidence            7 477666654    35689999999999999999999986 999999999999999888 8999999999876554433


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHHHhCCCCHhHHhhcCCCcccc
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS--GVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||....  .......+....                  
T Consensus       150 ~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  210 (262)
T cd05572         150 WTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGN------------------  210 (262)
T ss_pred             ccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccC------------------
Confidence            445678899999998654 47899999999999999999999997765  322222222100                  


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                               ....++...+.++.++|.+||..||.+||+     +.++++|
T Consensus       211 ---------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         211 ---------GKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             ---------CCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcC
Confidence                     011134456889999999999999999999     8886554

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.7e-40  Score=299.58  Aligned_cols=255  Identities=21%  Similarity=0.307  Sum_probs=197.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC-------CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEec
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  136 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~  136 (371)
                      .++|.+.+.||+|+||.||+|.+..       ++..+|+|.+....     ....+|+++++.+ +|+||+++++++.  
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~--   94 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT--   94 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe--
Confidence            3579999999999999999998643       23569999886432     2345688999999 7999999999873  


Q ss_pred             CCCCceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                         .....++||||++ ++|.+.+.....            ....+++..+..++.|++.||+|||+. |++||||||+|
T Consensus        95 ---~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~N  170 (307)
T cd05098          95 ---QDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK-KCIHRDLAARN  170 (307)
T ss_pred             ---cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-CcccccccHHh
Confidence               3345789999998 478777765321            123588899999999999999999986 99999999999


Q ss_pred             eeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCc
Q 017452          204 LLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSG  279 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~  279 (371)
                      |+++.++ .++|+|||.+........   .....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||.....
T Consensus       171 ill~~~~-~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~  248 (307)
T cd05098         171 VLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPV  248 (307)
T ss_pred             eEEcCCC-cEEECCCcccccccccchhhccccCCCccceeChHHhccCC-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCH
Confidence            9999887 899999999876533221   11122356799999986544 7899999999999999998 8899976554


Q ss_pred             HHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      .+....+... .                           ....+..++.++.+|+.+||..+|.+|||+.+++++|..+.
T Consensus       249 ~~~~~~~~~~-~---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~  300 (307)
T cd05098         249 EELFKLLKEG-H---------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIL  300 (307)
T ss_pred             HHHHHHHHcC-C---------------------------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHH
Confidence            3332222110 0                           00134457899999999999999999999999999987754


Q ss_pred             c
Q 017452          360 S  360 (371)
Q Consensus       360 ~  360 (371)
                      .
T Consensus       301 ~  301 (307)
T cd05098         301 A  301 (307)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=8.4e-40  Score=296.78  Aligned_cols=258  Identities=18%  Similarity=0.239  Sum_probs=197.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC----------------cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG----------------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVS  128 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~----------------~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~  128 (371)
                      ..+|++++.||+|+||.||+|.+...+                ..||+|.+...     .....+|+.+++.++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            357999999999999999999876543                56899988643     234457999999999999999


Q ss_pred             cceeEEecCCCCceeEEEeecccc-chHHHHHHHhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccC
Q 017452          129 LKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNK-------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (371)
Q Consensus       129 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlk  200 (371)
                      +++++..     ....+++|||+. ++|..++.....       ....+++..++.++.|++.||.|||++ ||+|+|||
T Consensus        84 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~-~i~H~dlk  157 (296)
T cd05051          84 LLGVCTV-----DPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL-NFVHRDLA  157 (296)
T ss_pred             EEEEEec-----CCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc-Cccccccc
Confidence            9988733     345789999998 477776654321       122689999999999999999999986 99999999


Q ss_pred             CCceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh--CCCCCC
Q 017452          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFP  275 (371)
Q Consensus       201 p~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~  275 (371)
                      |+||+++.++ .++|+|||.+........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++  |..||.
T Consensus       158 p~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~  235 (296)
T cd05051         158 TRNCLVGKNY-TIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILTLCREQPYE  235 (296)
T ss_pred             hhceeecCCC-ceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCC-CCccchhhhhHHHHHHHHhcCCCCCCC
Confidence            9999999887 899999999876533221   12334567899999986544 7999999999999999998  678887


Q ss_pred             CCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                      .....+.+............                     ......+..++.++.+++.+||+.||.+|||+.++++.|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L  294 (296)
T cd05051         236 HLTDQQVIENAGHFFRDDGR---------------------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFL  294 (296)
T ss_pred             CcChHHHHHHHHhccccccc---------------------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHh
Confidence            76655544443332111000                     000012345678999999999999999999999999887


Q ss_pred             c
Q 017452          356 S  356 (371)
Q Consensus       356 ~  356 (371)
                      .
T Consensus       295 ~  295 (296)
T cd05051         295 Q  295 (296)
T ss_pred             c
Confidence            5

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=289.02  Aligned_cols=246  Identities=24%  Similarity=0.350  Sum_probs=197.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh---hhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||.|++|.||+|..  .|+.||+|.+.....   ...+|+.+++.++|+||+++++.+..     ....++|
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~--~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~~v   78 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDY--RGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQ-----GNPLYIV   78 (256)
T ss_pred             hhccceeeeecCCCceEEEEEe--cCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcC-----CCCeEEE
Confidence            4699999999999999999986  588999999876543   45679999999999999999998743     3447899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||++ ++|.+.+....  ...+++..+..++.|++.||.|||.+ |++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~Nili~~~~-~~~l~d~g~~~~~~~  154 (256)
T cd05039          79 TEYMAKGSLVDYLRSRG--RAVITLAQQLGFALDVCEGMEYLEEK-NFVHRDLAARNVLVSEDL-VAKVSDFGLAKEASQ  154 (256)
T ss_pred             EEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccchhcccceEEEeCCC-CEEEccccccccccc
Confidence            99998 47777665421  23689999999999999999999987 999999999999999887 899999999987633


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ...  ....+..|+|||.+... .++.++|+||||+++|++++ |..||......+....+...                
T Consensus       155 ~~~--~~~~~~~~~ape~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~----------------  215 (256)
T cd05039         155 GQD--SGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKG----------------  215 (256)
T ss_pred             ccc--cCCCcccccCchhhcCC-cCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcC----------------
Confidence            222  23345679999998654 47889999999999999997 99999776544333222210                


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                  +....+..+++.+.+++.+||..+|.+|||+.++++.|..+
T Consensus       216 ------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~  256 (256)
T cd05039         216 ------------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI  256 (256)
T ss_pred             ------------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence                        00113345789999999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-39  Score=297.76  Aligned_cols=244  Identities=27%  Similarity=0.433  Sum_probs=196.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|.+....       ..+.+|+++++.++||||+++.+++...     ..
T Consensus        15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-----~~   89 (307)
T cd06607          15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-----HT   89 (307)
T ss_pred             hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-----Ce
Confidence            35999999999999999999999899999999885321       2355789999999999999999988543     34


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++||||+.|++.+.+...   ...+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~~~~ql~~~L~~LH~~-~i~H~dl~p~nIl~~~~~-~~kL~dfg~~~~  164 (307)
T cd06607          90 AWLVMEYCLGSASDILEVH---KKPLQEVEIAAICHGALQGLAYLHSH-ERIHRDIKAGNILLTEPG-TVKLADFGSASL  164 (307)
T ss_pred             EEEEHHhhCCCHHHHHHHc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEECCCC-CEEEeecCccee
Confidence            7899999999877766532   35689999999999999999999986 999999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          224 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....   ....+++.|+|||.+.+  ...++.++||||||+++|+|++|..||...+.......+...  .+        
T Consensus       165 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~--~~--------  231 (307)
T cd06607         165 VSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN--DS--------  231 (307)
T ss_pred             cCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcC--CC--------
Confidence            4322   23467888999998742  344788999999999999999999999776554433322210  00        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               +.        ..+..++..+.++|.+||..||.+||++.+++.|
T Consensus       232 ---------~~--------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         232 ---------PT--------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             ---------CC--------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                     00        0122367889999999999999999999998887

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=9.2e-40  Score=291.41  Aligned_cols=249  Identities=25%  Similarity=0.339  Sum_probs=195.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.++||+|+||.||+|.+..+ ..||+|.+...   .....+|+.+++.++|+||+++++.+.    .  .+.++
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~l   77 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS----E--EPIYI   77 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEEC----C--CCcEE
Confidence            35799999999999999999987655 45999988653   234567999999999999999987651    1  22579


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+.+...  ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~Nill~~~~-~~~L~dfg~~~~~~  153 (262)
T cd05071          78 VTEYMSKGSLLDFLKGE--MGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  153 (262)
T ss_pred             EEEcCCCCcHHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccCcccEEEcCCC-cEEeccCCceeecc
Confidence            9999985 777776532  234678999999999999999999987 999999999999999887 89999999987654


Q ss_pred             cCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  ....++..|+|||...+.. ++.++|+||||+++|+|++ |..||......+....+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (262)
T cd05071         154 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-----------  221 (262)
T ss_pred             ccccccccCCcccceecCHhHhccCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-----------
Confidence            33221  1234566799999885544 7899999999999999999 8889977665444433322100           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                       ...+..++..+.+++.+||+.||.+||++.++++.|+..
T Consensus       222 -----------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~  260 (262)
T cd05071         222 -----------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY  260 (262)
T ss_pred             -----------------CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence                             002334788999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=6e-40  Score=295.02  Aligned_cols=241  Identities=27%  Similarity=0.398  Sum_probs=190.9

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||+|+||.||+|.+..+|+.||+|.+...       .....+|+++++.++|||++++++.+     ......|+||||+
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~lv~e~~   75 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAF-----ETKDDLCLVMTLM   75 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEE-----ecCCeEEEEEecC
Confidence            69999999999999999999999988542       12335689999999999999998887     3345588999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      ++ +|.+.+....  ...+++..+..++.|++.||.|||+. |++||||+|+||+++.++ .++|+|||.+.........
T Consensus        76 ~~~~L~~~l~~~~--~~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~Nil~~~~~-~~~l~dfg~~~~~~~~~~~  151 (277)
T cd05577          76 NGGDLKYHIYNVG--EPGFPEARAIFYAAQIICGLEHLHQR-RIVYRDLKPENVLLDDHG-NVRISDLGLAVELKGGKKI  151 (277)
T ss_pred             CCCcHHHHHHHcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEECCCC-CEEEccCcchhhhccCCcc
Confidence            85 6666665422  24789999999999999999999987 999999999999999888 8999999998765443333


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccccc
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ....++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||...........+......                  
T Consensus       152 ~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~------------------  212 (277)
T cd05577         152 KGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLE------------------  212 (277)
T ss_pred             ccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhcccc------------------
Confidence            4456788899999986655 789999999999999999999999765542222222111000                  


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                             ....++..+++.+.++|.+||+.||.+||     ++.++++|
T Consensus       213 -------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         213 -------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             -------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhC
Confidence                   01113455789999999999999999999     88887776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=8.3e-40  Score=294.39  Aligned_cols=239  Identities=26%  Similarity=0.394  Sum_probs=183.3

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHH---cCCCCeeecceeEEecCCCCceeEEEe
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRL---LDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~---l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .||+|+||.||++.+..+++.+|+|.+.+..       ....+|..+++.   ..||||+.+++.+..     ....++|
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~-----~~~~~lv   75 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHT-----PDKLCFI   75 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEec-----CCeEEEE
Confidence            4899999999999999999999999885431       112234433333   479999999888733     3357899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+++ +|...+..    ...+++..+..++.|++.||.|||++ +|+|+||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~~~~L~~~i~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~ivH~dikp~Nil~~~~~-~~~l~dfg~~~~~~~  149 (279)
T cd05633          76 LDLMNGGDLHYHLSQ----HGVFSEKEMRFYATEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (279)
T ss_pred             EecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCCCCCHHHEEECCCC-CEEEccCCcceeccc
Confidence            999985 55555443    46799999999999999999999987 999999999999999887 899999999865433


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .. .....++..|+|||.+.+...++.++|+||+||++|+|++|..||......... .+.....               
T Consensus       150 ~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~---------------  212 (279)
T cd05633         150 KK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTL---------------  212 (279)
T ss_pred             cC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhh---------------
Confidence            22 233568999999999865455789999999999999999999999764332211 1111000               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                .+...++..++.++.++|.+||..||.+|+     |+.++++|
T Consensus       213 ----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         213 ----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             ----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence                      001114556889999999999999999999     69998777

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.5e-39  Score=290.92  Aligned_cols=247  Identities=25%  Similarity=0.370  Sum_probs=190.4

Q ss_pred             ceeeeEee--ccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           72 SYMAERIV--GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        72 ~y~~~~~l--g~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +|.+.+.+  |+|+||.||++.+..++..+|+|.+..... ...|+.....+ +|+||+++++++..     ....++||
T Consensus        15 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~-----~~~~~iv~   88 (267)
T PHA03390         15 NCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTT-----LKGHVLIM   88 (267)
T ss_pred             hhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEec-----CCeeEEEE
Confidence            46666665  999999999999999999999998865321 12234333333 79999999998843     33589999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++ ++|.+++..    ...+++..++.++.||+.||.|||+. |++||||||+||+++.++..++|+|||++......
T Consensus        89 e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~  163 (267)
T PHA03390         89 DYIKDGDLFDLLKK----EGKLSEAEVKKIIRQLVEALNDLHKH-NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP  163 (267)
T ss_pred             EcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC
Confidence            9997 577777653    34889999999999999999999987 99999999999999987757999999998765322


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-LVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                         ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||........ ...+......+             
T Consensus       164 ---~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------  226 (267)
T PHA03390        164 ---SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKK-------------  226 (267)
T ss_pred             ---ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhhccc-------------
Confidence               2346788999999996544 78999999999999999999999975543221 12221111000             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-HHHHhhhhcCCCcchhhccccccC
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-AVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                                   ...+..+++.+.+||.+||+.||.+|++ .++            ++.||||.|
T Consensus       227 -------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~------------~l~h~~~~~  267 (267)
T PHA03390        227 -------------LPFIKNVSKNANDFVQSMLKYNINYRLTNYNE------------IIKHPFLKI  267 (267)
T ss_pred             -------------CCcccccCHHHHHHHHHHhccChhhCCchHHH------------HhcCCcccC
Confidence                         0023458999999999999999999997 488            667777765

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=7.3e-40  Score=294.73  Aligned_cols=250  Identities=23%  Similarity=0.298  Sum_probs=195.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|.+..++.    .||+|.+...     .....+|..+++.+.|+||+++++.+..      
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~------   80 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT------   80 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC------
Confidence            479999999999999999999877776    4899987543     2334578889999999999999887742      


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+++++|++ |+|.+.+..   ....+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~l~~~~~~~g~l~~~l~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~-~iiH~dlkp~Nil~~~~~-~~kL~dfG~  155 (279)
T cd05109          81 STVQLVTQLMPYGCLLDYVRE---NKDRIGSQDLLNWCVQIAKGMSYLEEV-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (279)
T ss_pred             CCcEEEEEcCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccccceEEEcCCC-cEEECCCCc
Confidence            12568999998 576666543   235689999999999999999999987 999999999999998877 899999999


Q ss_pred             ccccccCCCcc---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ++.........   ...+++.|+|||.+.+.. ++.++|||||||++|||++ |..||...........+... ..++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~--  231 (279)
T cd05109         156 ARLLDIDETEYHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKG-ERLP--  231 (279)
T ss_pred             eeecccccceeecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCC-CcCC--
Confidence            88664332211   123456799999986544 7899999999999999998 89999765544332222111 0000  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                               .+...+.++.+++.+||..||++||++.++++.|..+..
T Consensus       232 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         232 -------------------------QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             -------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                                     223468899999999999999999999999998877643

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.3e-39  Score=289.47  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=191.1

Q ss_pred             EeeccCCceEEEEEEECCCC---cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETG---ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..++   ..+|+|.+....     ....+|+.+++.++|+||+++++++.     .. ..+++|
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~-~~~~v~   74 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-----GE-PLMLVM   74 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----CC-ceEEEE
Confidence            46899999999999876554   789999886443     24457899999999999999988652     11 257999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++ ++|.+.+..    ...+++..+..++.|++.||.|||.+ +++|+||||+||+++.++ .+||+|||.+......
T Consensus        75 e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lh~~-~i~H~di~p~nili~~~~-~~kl~df~~~~~~~~~  148 (257)
T cd05060          75 ELAPLGPLLKYLKK----RREIPVSDLKELAHQVAMGMAYLESK-HFVHRDLAARNVLLVNRH-QAKISDFGMSRALGAG  148 (257)
T ss_pred             EeCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHhhc-CeeccCcccceEEEcCCC-cEEeccccccceeecC
Confidence            9998 477776654    34789999999999999999999987 999999999999999888 8999999998766443


Q ss_pred             CCcc----cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          228 EPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       228 ~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....    ...++..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+..+....+....            
T Consensus       149 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~------------  215 (257)
T cd05060         149 SDYYRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE------------  215 (257)
T ss_pred             CcccccccCccccccccCHHHhcCCC-CCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC------------
Confidence            3211    112245799999986544 8899999999999999997 999998766544333322210            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                      ....+..++..+.+++.+||..||.+||++.++++.|..++
T Consensus       216 ----------------~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~  256 (257)
T cd05060         216 ----------------RLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP  256 (257)
T ss_pred             ----------------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence                            00133457889999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-39  Score=290.09  Aligned_cols=246  Identities=33%  Similarity=0.507  Sum_probs=198.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +|++.+.||+|++|.||+|.+..+++.|++|++...     .....+|+..+..++|+|++++++++.     .....++
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~l   76 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY-----KEGEISI   76 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-----cCCeEEE
Confidence            589999999999999999999999999999988654     244567899999999999999999884     3355889


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|||++ ++|.+.+..    ...+++..++.++.|++.||.|||+ . +++|+||+|+||+++.++ .++|+|||.+...
T Consensus        77 v~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~~l~~~l~~lh~~~-~~~H~~l~~~ni~~~~~~-~~~l~df~~~~~~  150 (264)
T cd06623          77 VLEYMDGGSLADLLKK----VGKIPEPVLAYIARQILKGLDYLHTKR-HIIHRDIKPSNLLINSKG-EVKIADFGISKVL  150 (264)
T ss_pred             EEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHhccC-CCccCCCCHHHEEECCCC-CEEEccCccceec
Confidence            999999 577777654    3678999999999999999999998 7 999999999999999888 8999999998776


Q ss_pred             ccCCCcc-cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....... ...++..|+|||.+.+. .++.++|+||||+++|+|++|..||....................         
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~---------  220 (264)
T cd06623         151 ENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPP---------  220 (264)
T ss_pred             ccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCC---------
Confidence            4433332 45678889999998655 478899999999999999999999977652111111111100000         


Q ss_pred             CccccccCcccCCCCcccCCCC-CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKR-MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~-~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...+.. ++..+.++|.+||..+|.+||++.++++|
T Consensus       221 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         221 ----------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             ----------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                            002333 78899999999999999999999997665

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.7e-40  Score=297.38  Aligned_cols=244  Identities=29%  Similarity=0.421  Sum_probs=195.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .|.....||+|+||.||++.+..++..||||.+...    .....+|+.+++.++|+||+++++.+.     ...+.++|
T Consensus        23 ~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~-----~~~~~~lv   97 (292)
T cd06658          23 YLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYL-----VGDELWVV   97 (292)
T ss_pred             HHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHhee-----cCCeEEEE
Confidence            466678899999999999999999999999988543    234557899999999999999999884     33457999


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+++ +|.+.+.     ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++.....
T Consensus        98 ~e~~~~~~L~~~~~-----~~~l~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nill~~~~-~~kL~dfg~~~~~~~  170 (292)
T cd06658          98 MEFLEGGALTDIVT-----HTRMNEEQIATVCLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSK  170 (292)
T ss_pred             EeCCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCC-CEEEccCcchhhccc
Confidence            999986 5555443     35689999999999999999999987 999999999999999887 899999998865432


Q ss_pred             CCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      ... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+....+..+........           
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------  238 (292)
T cd06658         171 EVPKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRV-----------  238 (292)
T ss_pred             ccccCceeecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCcc-----------
Confidence            222 23456788999999986544 78999999999999999999999987665554443322111000           


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     .....++..+.+++.+||..||++|||+.++++|
T Consensus       239 ---------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         239 ---------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQH  272 (292)
T ss_pred             ---------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                           0122468899999999999999999999999988

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.4e-39  Score=289.11  Aligned_cols=246  Identities=27%  Similarity=0.406  Sum_probs=197.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||+|+||.||++.+..+|..+|+|.+...      .....+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~-----~~~~~~~   75 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASF-----QENGRLF   75 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhhee-----ccCCeEE
Confidence            589999999999999999999999999999988532      23456899999999999999999987     4445689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +++||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+. +++|+||||+||+++.++..++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~  152 (257)
T cd08225          76 IVMEYCDGGDLMKRINRQ--RGVLFSEDQILSWFVQISLGLKHIHDR-KILHRDIKSQNIFLSKNGMVAKLGDFGIARQL  152 (257)
T ss_pred             EEEecCCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEcCCCCeEEecccccchhc
Confidence            99999975 766666532  123578999999999999999999986 99999999999999988656899999998766


Q ss_pred             ccCCCc-ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...... ....+++.|+|||.+.... ++.++|+||||+++++|++|..||...+..+....+....             
T Consensus       153 ~~~~~~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  218 (257)
T cd08225         153 NDSMELAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY-------------  218 (257)
T ss_pred             cCCcccccccCCCccccCHHHHcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc-------------
Confidence            443322 2345788899999886544 7899999999999999999999997765444433322110             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                            +.         .....++.++.+++.+||..+|.+|||+.++++|
T Consensus       219 ------~~---------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         219 ------FA---------PISPNFSRDLRSLISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             ------CC---------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                  00         0223568899999999999999999999996655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.9e-41  Score=285.18  Aligned_cols=247  Identities=26%  Similarity=0.420  Sum_probs=193.3

Q ss_pred             eee-eEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMA-ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~-~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++ .+.||+|+++.|--+....+|..||||++.+.    +....+|++++... .|+||++++++|     ++...+|+
T Consensus        79 YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefF-----Edd~~FYL  153 (463)
T KOG0607|consen   79 YKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFF-----EDDTRFYL  153 (463)
T ss_pred             HHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHh-----cccceEEE
Confidence            555 35799999999999999999999999999654    45567899999998 599999999998     66666899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCCccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  223 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~a~~  223 (371)
                      |||-|.| .|+..+..    ...|++.++.++.++|+.||.|||.+ ||.||||||+|||-....  .-||||||.+..-
T Consensus       154 VfEKm~GGplLshI~~----~~~F~E~EAs~vvkdia~aLdFlH~k-gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg  228 (463)
T KOG0607|consen  154 VFEKMRGGPLLSHIQK----RKHFNEREASRVVKDIASALDFLHTK-GIAHRDLKPENILCESPNKVSPVKICDFDLGSG  228 (463)
T ss_pred             EEecccCchHHHHHHH----hhhccHHHHHHHHHHHHHHHHHHhhc-CcccccCCccceeecCCCCcCceeeeccccccc
Confidence            9999996 55555544    57899999999999999999999997 999999999999975332  1499999988643


Q ss_pred             cccC--------CCcccccccccccCccccc----CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-----------
Q 017452          224 LVKG--------EPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-----------  280 (371)
Q Consensus       224 ~~~~--------~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-----------  280 (371)
                      ....        ....+.+|+..|||||+..    ....|..+.|.||||||||-|+.|.+||.+....           
T Consensus       229 ~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr  308 (463)
T KOG0607|consen  229 IKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCR  308 (463)
T ss_pred             cccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccH
Confidence            3211        1123567888899999973    2235788999999999999999999999764432           


Q ss_pred             ----HHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          281 ----DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       281 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                          ..+..|..+.-..|+++                    |     ..+|.+..++++.+|..|+.+|.++.++++|
T Consensus       309 ~CQ~~LFesIQEGkYeFPdkd--------------------W-----ahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  309 VCQNKLFESIQEGKYEFPDKD--------------------W-----AHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHHHHHHHHHhccCCcCChhh--------------------h-----HHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence                11233333222222222                    2     3489999999999999999999999995554

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.8e-40  Score=294.53  Aligned_cols=263  Identities=25%  Similarity=0.353  Sum_probs=194.9

Q ss_pred             ce-eeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           72 SY-MAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y-~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +| ++.+.||+|+||+||++.    ...++..||+|.+...     .....+|+++++.++||||+++++++..   ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (283)
T cd05080           4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSE---QGG   80 (283)
T ss_pred             hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEec---CCC
Confidence            45 999999999999998765    3357889999988643     2344579999999999999999887643   233


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+++|||+++ +|.+.+.     ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||+
T Consensus        81 ~~~~lv~e~~~~~~l~~~~~-----~~~l~~~~~~~i~~~l~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~~l~dfg~  153 (283)
T cd05080          81 KGLQLIMEYVPLGSLRDYLP-----KHKLNLAQLLLFAQQICEGMAYLHSQ-HYIHRDLAARNVLLDNDR-LVKIGDFGL  153 (283)
T ss_pred             ceEEEEecCCCCCCHHHHHH-----HcCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccChheEEEcCCC-cEEEeeccc
Confidence            457899999985 6666654     24689999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCH
Q 017452          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-GTPTR  295 (371)
Q Consensus       221 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~  295 (371)
                      +........    .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......  +....... +....
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l~el~tg~~p~~~~~~~--~~~~~~~~~~~~~~  230 (283)
T cd05080         154 AKAVPEGHEYYRVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTLYELLTHCDSKQSPPKK--FEEMIGPKQGQMTV  230 (283)
T ss_pred             ccccCCcchhhccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHHHHHHhCCCCCCCCcch--hhhhhcccccccch
Confidence            876543322    11233466799999986544 789999999999999999999998654321  11111100 00000


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ..+..            ..........+..++.++.+++.+||+.||++|||+.++++.|+.+.
T Consensus       231 ~~~~~------------~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         231 VRLIE------------LLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             hhhhh------------hhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            00000            00000011134567899999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2e-39  Score=288.93  Aligned_cols=247  Identities=24%  Similarity=0.329  Sum_probs=195.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ++|++.+.||+|++|.||+|.+..+ ..+|+|.+....   ....+|+.+++.++|+|++++++++.     . ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~~v   78 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-----E-EPIYIV   78 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEEc-----C-CCcEEE
Confidence            4699999999999999999987554 469999876432   34567999999999999999987652     1 235799


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+.+ +|.+.+...  ....+++..+..++.|++.||.|||+. |++|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dl~~~Nill~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05069          79 TEFMGKGSLLDFLKEG--DGKYLKLPQLVDMAAQIADGMAYIERM-NYIHRDLRAANILVGDNL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEcCCCCCHHHHHhhC--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccCcceEEEcCCC-eEEECCCccceEccC
Confidence            999985 777777542  234578999999999999999999986 999999999999999887 899999999976533


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  ....++..|+|||...+.. ++.++|+||||+++|+|++ |..||.+....+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05069         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR------------  221 (260)
T ss_pred             CcccccCCCccchhhCCHHHhccCC-cChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  1233466799999886544 7899999999999999999 8999987665544433322100            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                      ...+..++..+.+++.+||..||.+||+++++++.|+.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         222 ----------------MPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             ----------------CCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                            01234578899999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.8e-39  Score=295.47  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=198.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEec
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFST  136 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~  136 (371)
                      ...++|.+.+.||+|+||.||++.+     ..++..||+|.+....     ....+|+.+++++ +|+||+++++++.. 
T Consensus        32 ~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~-  110 (302)
T cd05055          32 FPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTI-  110 (302)
T ss_pred             ccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEec-
Confidence            3345799999999999999999975     3355689999886432     2356799999999 79999999998733 


Q ss_pred             CCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                          ....+++|||+. ++|.+.+...  ....+++..+..++.|++.||+|||++ +|+|+||||+||+++.++ .++|
T Consensus       111 ----~~~~~lv~e~~~~~~L~~~i~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~~l  182 (302)
T cd05055         111 ----GGPILVITEYCCYGDLLNFLRRK--RESFLTLEDLLSFSYQVAKGMAFLASK-NCIHRDLAARNVLLTHGK-IVKI  182 (302)
T ss_pred             ----CCceEEEEEcCCCCcHHHHHHhC--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeehhhhccceEEEcCCC-eEEE
Confidence                344789999998 5777666531  123489999999999999999999987 999999999999999877 8999


Q ss_pred             EeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017452          216 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      +|||++........   .....++..|+|||.+.+.. ++.++|||||||++|+|++ |..||......+.+....... 
T Consensus       183 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~-  260 (302)
T cd05055         183 CDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEG-  260 (302)
T ss_pred             CCCcccccccCCCceeecCCCCcccccCCHhhhccCC-CCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcC-
Confidence            99999876533221   11234467899999986654 7899999999999999998 999998766544443332210 


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                +....+...+.++.+++.+||..+|++|||+.++++.|.++
T Consensus       261 --------------------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         261 --------------------------YRMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             --------------------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence                                      00012334688999999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=1.8e-39  Score=289.05  Aligned_cols=248  Identities=24%  Similarity=0.337  Sum_probs=197.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.++||+|+||.||+|.. .+++.||+|.+....   ....+|+.+++.++|+||+++++.+.      ....++
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~-~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~------~~~~~~   77 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYY-NGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVVT------QEPIYI   77 (260)
T ss_pred             hHHceeeeeeccCccceEEeeec-CCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEEc------cCCcEE
Confidence            34799999999999999999985 467889999886533   44567999999999999999987652      123689


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+. ++|.+.+...  ....+++..+..++.|++.||+|||+. |++||||||+||+++.++ .++|+|||++....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  153 (260)
T cd05067          78 ITEYMENGSLVDFLKTP--EGIKLTINKLIDMAAQIAEGMAFIERK-NYIHRDLRAANILVSETL-CCKIADFGLARLIE  153 (260)
T ss_pred             EEEcCCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHHhEEEcCCC-CEEEccCcceeecC
Confidence            999997 5777666432  235688999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....  .....++..|+|||.+.... ++.++|+||||+++|++++ |+.||.+.+..+....+......          
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~----------  222 (260)
T cd05067         154 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM----------  222 (260)
T ss_pred             CCCcccccCCcccccccCHHHhccCC-cCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCC----------
Confidence            2221  11234467899999986544 7889999999999999998 99999877655544433221100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                        ..+...+.++.+++.+||..+|++|||++++++.|++
T Consensus       223 ------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         223 ------------------PRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence                              0234568899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.7e-39  Score=291.17  Aligned_cols=249  Identities=29%  Similarity=0.506  Sum_probs=194.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--------------hhhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      +|.+.+.||.|++|.||+|.+..+|+.+|+|.+...              ...+.+|+.+++.++|+|++++++++    
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~----   77 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFE----   77 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEe----
Confidence            589999999999999999999889999999987431              12345689999999999999999877    


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                       ......++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ +++||||+|+||+++.++ .++|+
T Consensus        78 -~~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~~~nil~~~~~-~~~l~  150 (272)
T cd06629          78 -TTEEYLSIFLEYVPGGSIGSCLRT----YGRFEEQLVRFFTEQVLEGLAYLHSK-GILHRDLKADNLLVDADG-ICKIS  150 (272)
T ss_pred             -ccCCceEEEEecCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CeeecCCChhhEEEcCCC-eEEEe
Confidence             334457899999985 66666553    36789999999999999999999987 999999999999999887 89999


Q ss_pred             eeCCccccccCC---CcccccccccccCcccccCCc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          217 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       217 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |||++.......   ......++..|+|||.+.... .++.++|+||||+++|++++|..||...+....+..+......
T Consensus       151 d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  230 (272)
T cd06629         151 DFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSA  230 (272)
T ss_pred             eccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccC
Confidence            999987643221   122345788899999986543 3688999999999999999999999765544333222111000


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             ..+.......++.++.+++.+||..+|.+|||+.++++|
T Consensus       231 -----------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         231 -----------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             -----------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence                                   000111223468999999999999999999999997766

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=8.9e-40  Score=302.74  Aligned_cols=256  Identities=23%  Similarity=0.333  Sum_probs=194.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||+|.+     ..+++.||||++...     .....+|+.++..+ +|+||+++++++...  
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~--   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecC--
Confidence            35799999999999999999984     356789999998643     22355799999999 689999999877432  


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh-----------------------------------------------------
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-----------------------------------------------------  164 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-----------------------------------------------------  164 (371)
                        ...++++|||++ |+|.+++.....                                                     
T Consensus        84 --~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (343)
T cd05103          84 --GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV  161 (343)
T ss_pred             --CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence              234689999998 477776653210                                                     


Q ss_pred             ----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC---cc
Q 017452          165 ----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NI  231 (371)
Q Consensus       165 ----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~  231 (371)
                                ....+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++........   ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~dfg~~~~~~~~~~~~~~~  239 (343)
T cd05103         162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSENN-VVKICDFGLARDIYKDPDYVRKG  239 (343)
T ss_pred             hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCccCeEEEcCCC-cEEEEecccccccccCcchhhcC
Confidence                      013467888899999999999999987 999999999999999887 899999999876432211   11


Q ss_pred             cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccccc
Q 017452          232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (371)
Q Consensus       232 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ...++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||........+.........                  
T Consensus       240 ~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~------------------  300 (343)
T cd05103         240 DARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTR------------------  300 (343)
T ss_pred             CCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCC------------------
Confidence            223456799999986544 7899999999999999996 99999765433332222211000                  


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                               ...+...++++.+++..||+.||.+|||+.++++||+.+.
T Consensus       301 ---------~~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~  340 (343)
T cd05103         301 ---------MRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  340 (343)
T ss_pred             ---------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                     0022346789999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.2e-39  Score=293.02  Aligned_cols=254  Identities=22%  Similarity=0.285  Sum_probs=195.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.++.     .+..||+|.+....     ....+|+.+++.++|+||+++++++.     
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----   79 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVS-----   79 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEc-----
Confidence            4579999999999999999997542     35589999875332     23456888999999999999998873     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      .....++||||+. |+|.+.+......      ...++...+..++.||+.||.|||++ +|+||||||+||+++.++ .
T Consensus        80 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dikp~nili~~~~-~  157 (288)
T cd05061          80 KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK-KFVHRDLAARNCMVAHDF-T  157 (288)
T ss_pred             CCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCCChheEEEcCCC-c
Confidence            3334789999997 5887777653221      23456778899999999999999987 999999999999999887 8


Q ss_pred             EEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      ++|+|||+++.......   .....++..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+.+..+....+..
T Consensus       158 ~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~  236 (288)
T cd05061         158 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGV-FTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD  236 (288)
T ss_pred             EEECcCCccccccccccccccCCCcccccccCHHHhccCC-CChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            99999999875432221   11223466799999986544 7899999999999999998 7889977655443332221


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      . +.                           ...+...++.+.+++.+||+.||.+|||+.++++.|.+..
T Consensus       237 ~-~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         237 G-GY---------------------------LDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             C-CC---------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            0 00                           0023456789999999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2e-39  Score=304.80  Aligned_cols=255  Identities=22%  Similarity=0.337  Sum_probs=198.1

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcC-CCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLD-HPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~  137 (371)
                      ...+|.+++.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.++.++. ||||+++++++..  
T Consensus        35 ~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~--  112 (401)
T cd05107          35 PRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTK--  112 (401)
T ss_pred             cHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEcc--
Confidence            3457899999999999999999854     345789999986532     23557999999997 9999999998833  


Q ss_pred             CCCceeEEEeecccc-chHHHHHHHhhh----------------------------------------------------
Q 017452          138 DKDELYLNLVLEYVP-ETVHRVVKHFNK----------------------------------------------------  164 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~----------------------------------------------------  164 (371)
                         ....++||||+. |+|.+.+.....                                                    
T Consensus       113 ---~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  189 (401)
T cd05107         113 ---GGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADY  189 (401)
T ss_pred             ---CCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCc
Confidence               334789999998 577777754211                                                    


Q ss_pred             ------------------------------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          165 ------------------------------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       165 ------------------------------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                                                                ....+++..++.++.||+.||+|||+. +|+||||||+
T Consensus       190 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrdlkp~  268 (401)
T cd05107         190 VPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK-NCVHRDLAAR  268 (401)
T ss_pred             cchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC-CcCcccCCcc
Confidence                                                      112467778899999999999999986 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      |||++.++ .++|+|||+++.......   .....+++.|+|||.+.... ++.++|+||||+++|||++ |..||....
T Consensus       269 NiLl~~~~-~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~  346 (401)
T cd05107         269 NVLICEGK-LVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNL-YTTLSDVWSFGILLWEIFTLGGTPYPELP  346 (401)
T ss_pred             eEEEeCCC-EEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCC
Confidence            99999877 899999999976432211   12345678899999986544 7899999999999999998 889997765


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+.....+...                           +....+..++.++.+++.+||..+|.+||++.++++.|+.+
T Consensus       347 ~~~~~~~~~~~~---------------------------~~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~  399 (401)
T cd05107         347 MNEQFYNAIKRG---------------------------YRMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDL  399 (401)
T ss_pred             chHHHHHHHHcC---------------------------CCCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            544433332210                           00013445789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-39  Score=296.92  Aligned_cols=256  Identities=22%  Similarity=0.309  Sum_probs=198.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECC-------CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ..++|.+.+.||+|+||.||+|.+..       ....+|+|.+....     ....+|+.+++.+ +||||+++++++. 
T Consensus        10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (314)
T cd05099          10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCT-   88 (314)
T ss_pred             cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc-
Confidence            34689999999999999999998632       34579999876432     2345789999999 6999999999873 


Q ss_pred             cCCCCceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          136 TTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                          .....+++|||++ ++|.+++.....            ....+++..+..++.||+.||.|||++ ||+||||||+
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~-gi~H~dlkp~  163 (314)
T cd05099          89 ----QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR-RCIHRDLAAR  163 (314)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC-Ceeeccccce
Confidence                3445789999998 577777765321            124588899999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      ||+++.++ .+||+|||.++.......   .....++..|+|||.+.+. .++.++|+||||+++|+|++ |..||....
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~~g~~p~~~~~  241 (314)
T cd05099         164 NVLVTEDN-VMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDR-VYTHQSDVWSFGILMWEIFTLGGSPYPGIP  241 (314)
T ss_pred             eEEEcCCC-cEEEccccccccccccccccccccCCCCccccCHHHHccC-CcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence            99999887 899999999976533211   1122334679999998654 47899999999999999998 889997765


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+....+....                            ....+..++.++.+++.+||..||.+|||+.++++.|.++
T Consensus       242 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~  293 (314)
T cd05099         242 VEELFKLLREGH----------------------------RMDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKV  293 (314)
T ss_pred             HHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence            544433322110                            0013445788999999999999999999999999998876


Q ss_pred             Cc
Q 017452          359 PS  360 (371)
Q Consensus       359 ~~  360 (371)
                      ..
T Consensus       294 ~~  295 (314)
T cd05099         294 LA  295 (314)
T ss_pred             HH
Confidence            54

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.5e-39  Score=287.16  Aligned_cols=247  Identities=30%  Similarity=0.466  Sum_probs=201.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||.|++|.||++.+..++..|++|++...      .....+|+++++.++|+|++++.+.+..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~-----~~~~~   75 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEE-----KGKLC   75 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEec-----CCEEE
Confidence            589999999999999999999989999999998643      2345678999999999999999988843     35588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +++|++++ +|.+.+.........+++..+..++.|++.||.+||++ |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        76 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~-~~~H~dl~~~nil~~~~~-~~~l~d~~~~~~~  153 (258)
T cd08215          76 IVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR-KILHRDIKPQNIFLTSNG-LVKLGDFGISKVL  153 (258)
T ss_pred             EEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHHeEEcCCC-cEEECCccceeec
Confidence            99999985 77777765443357899999999999999999999987 999999999999999877 8999999998765


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.... ++.++|+||+|+++++|++|..||...+..+.........             
T Consensus       154 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~-------------  219 (258)
T cd08215         154 SSTVDLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ-------------  219 (258)
T ss_pred             ccCcceecceeeeecccChhHhccCC-CCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC-------------
Confidence            4433 223456788999999986554 7889999999999999999999997766444333332210             


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                            .         ..++..++..+.+++.+||..+|.+|||+.++++|
T Consensus       220 ------~---------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         220 ------Y---------PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             ------C---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                  0         01344578999999999999999999999996655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-39  Score=294.16  Aligned_cols=250  Identities=29%  Similarity=0.442  Sum_probs=195.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|++.+.||+|+||.||++.+..+|+.||+|++...     ...+.+|+++++.++||||+++++++.     .....+
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~~~   79 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL-----NENNIC   79 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe-----cCCEEE
Confidence            4699999999999999999999999999999987543     234567999999999999999999884     335689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|...+..    .+.+++..++.++.|++.||.|||+..+++||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~-~~~l~d~gl~~~~  154 (284)
T cd06620          80 MCMEFMDCGSLDRIYKK----GGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRG-QIKLCDFGVSGEL  154 (284)
T ss_pred             EEEecCCCCCHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCC-cEEEccCCcccch
Confidence            99999986 55555433    457899999999999999999999744899999999999999887 8999999988654


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-------HHHHHHHhCCCCHhH
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-------LVEIIKVLGTPTREE  297 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-------~~~~~~~~~~~~~~~  297 (371)
                      .... .....++..|+|||.+.+. .++.++|+|||||++|++++|..||........       +...........   
T Consensus       155 ~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T cd06620         155 INSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEP---  229 (284)
T ss_pred             hhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhcc---
Confidence            3222 2245678999999998654 478899999999999999999999976543211       011111000000   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCC-CCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFP-KRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                  .+         .++ ..++.++.+|+.+||..||.+|||+.++++|..
T Consensus       230 ------------~~---------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~  268 (284)
T cd06620         230 ------------PP---------RLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPP  268 (284)
T ss_pred             ------------CC---------CCCchhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcc
Confidence                        00         011 126788999999999999999999999999843

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2e-39  Score=288.83  Aligned_cols=247  Identities=23%  Similarity=0.324  Sum_probs=195.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ++|++.+.||+|++|.||+|.+. ++..+|+|.+...   .....+|+.+++.++|+|++++++.+.    .  ...+++
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~----~--~~~~lv   78 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVS----E--EPIYIV   78 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEEC----C--CCcEEE
Confidence            47999999999999999999865 5677999988643   334568999999999999999987652    1  125799


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+.+ +|.+.+...  ....+++..++.++.|++.||.|||++ ||+|+||||+||+++.++ .++|+|||.+.....
T Consensus        79 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~di~p~Nili~~~~-~~~l~dfg~~~~~~~  154 (260)
T cd05070          79 TEYMSKGSLLDFLKDG--EGRALKLPNLVDMAAQVAAGMAYIERM-NYIHRDLRSANILVGDGL-VCKIADFGLARLIED  154 (260)
T ss_pred             EEecCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEEeCCc-eEEeCCceeeeeccC
Confidence            999985 777766531  234689999999999999999999987 999999999999999887 899999999876533


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||.+.+..+....+.....            
T Consensus       155 ~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~------------  221 (260)
T cd05070         155 NEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYR------------  221 (260)
T ss_pred             cccccccCCCCCccccChHHHhcCC-CcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            2211  1223456799999886544 7899999999999999999 8999987665544443322100            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                      ...+...+..+.+|+.+||..||.+|||+.++.+.|+.
T Consensus       222 ----------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         222 ----------------MPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                            00234578899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3e-41  Score=305.15  Aligned_cols=246  Identities=29%  Similarity=0.524  Sum_probs=204.7

Q ss_pred             eee--eEeeccCCceEEEEEEECCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           73 YMA--ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        73 y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      |++  .+.||+|.||+||-|+++.+|+.||||++.+      .....+.|+.||+.+.||.||.+.-.|     +....+
T Consensus       564 YQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~-----ET~erv  638 (888)
T KOG4236|consen  564 YQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMF-----ETPERV  638 (888)
T ss_pred             HHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEee-----cCCceE
Confidence            555  3689999999999999999999999999854      245567899999999999999986655     333348


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC--CCCcEEEEeeCCcc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAK  222 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~--~~~~~kl~Dfg~a~  222 (371)
                      ++|||-+.|+.++.+....  .+++++...+.++.||+.||.|||.+ +|+|+||||+|||+.+  +...+||||||+|+
T Consensus       639 FVVMEKl~GDMLEMILSsE--kgRL~er~TkFlvtQIL~ALr~LH~k-nIvHCDLKPENVLLas~~~FPQvKlCDFGfAR  715 (888)
T KOG4236|consen  639 FVVMEKLHGDMLEMILSSE--KGRLPERITKFLVTQILVALRYLHFK-NIVHCDLKPENVLLASASPFPQVKLCDFGFAR  715 (888)
T ss_pred             EEEehhhcchHHHHHHHhh--cccchHHHHHHHHHHHHHHHHHhhhc-ceeeccCCchheeeccCCCCCceeecccccee
Confidence            8999999999888887643  68999999999999999999999987 9999999999999954  34589999999999


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      +..+.....+.+|||.|.|||++.... |+..-|+||.|||+|.-+.|..||..+.+...  +|.+.             
T Consensus       716 iIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA-------------  779 (888)
T KOG4236|consen  716 IIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA-------------  779 (888)
T ss_pred             ecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc-------------
Confidence            998877778899999999999997655 89999999999999999999999977654332  22221             


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                          .+-+   +..+|     ..+++.+.+||..+|+..-.+|.|.+..+.|
T Consensus       780 ----aFMy---Pp~PW-----~eis~~AidlIn~LLqVkm~kRysvdk~lsh  819 (888)
T KOG4236|consen  780 ----AFMY---PPNPW-----SEISPEAIDLINNLLQVKMRKRYSVDKSLSH  819 (888)
T ss_pred             ----cccc---CCCch-----hhcCHHHHHHHHHHHHHHHHHhcchHhhccc
Confidence                1111   12334     3479999999999999999999999996665

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.4e-39  Score=293.01  Aligned_cols=250  Identities=24%  Similarity=0.332  Sum_probs=195.4

Q ss_pred             cceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||++...     .++..+|+|.+...    ...+.+|+++++.++|+||+++++.+..     .
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~   79 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE-----G   79 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec-----C
Confidence            36889999999999999999743     35678999987543    2345679999999999999999887733     3


Q ss_pred             eeEEEeecccc-chHHHHHHHhhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNK-----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~  209 (371)
                      ...+++|||++ ++|.+++.....           ....+++..+..++.||+.||+|||+. |++||||||+||+++.+
T Consensus        80 ~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~nil~~~~  158 (280)
T cd05092          80 RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL-HFVHRDLATRNCLVGQG  158 (280)
T ss_pred             CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC-CeecccccHhhEEEcCC
Confidence            44789999998 477777654321           013578999999999999999999986 99999999999999987


Q ss_pred             CCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHH
Q 017452          210 THQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVE  285 (371)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~  285 (371)
                      + .++|+|||++........   .....+++.|+|||.+.+.. ++.++|+|||||++|+|++ |..||......+....
T Consensus       159 ~-~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~  236 (280)
T cd05092         159 L-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIEC  236 (280)
T ss_pred             C-CEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHH
Confidence            7 899999999875432221   12233467899999886544 7899999999999999998 9999977665554433


Q ss_pred             HHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      +....  +                          ...+..+++.+.+++.+||+.||++||++.++++.|+
T Consensus       237 ~~~~~--~--------------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         237 ITQGR--E--------------------------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHcCc--c--------------------------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            32210  0                          0133457899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3e-39  Score=287.77  Aligned_cols=249  Identities=24%  Similarity=0.333  Sum_probs=198.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.+.||+|+||.||+|.+. .+..+|+|.+...   .....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~~   78 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCS-----EEEPIYI   78 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeee-----cCCceEE
Confidence            457999999999999999999865 5578999988653   345668999999999999999988773     3344789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||+.+ +|.+.+...  ....+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.+....
T Consensus        79 v~e~~~~~~L~~~i~~~--~~~~~~~~~~~~~~~~i~~al~~lh~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~  154 (261)
T cd05034          79 VTEYMSKGSLLDFLKSG--EGKKLRLPQLVDMAAQIAEGMAYLESR-NYIHRDLAARNILVGENL-VCKIADFGLARLIE  154 (261)
T ss_pred             EEeccCCCCHHHHHhcc--ccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcchheEEEcCCC-CEEECccccceecc
Confidence            9999985 776666532  235689999999999999999999987 999999999999999887 89999999987654


Q ss_pred             cCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  ....++..|+|||.+.+.. ++.++|+||||+++|++++ |+.||.+.+....+..+......          
T Consensus       155 ~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~----------  223 (261)
T cd05034         155 DDEYTAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRM----------  223 (261)
T ss_pred             chhhhhhhccCCCccccCHHHhccCC-cCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC----------
Confidence            32111  1223456799999986544 7899999999999999998 99999876655555444321100          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                        ..+...+.++.+++.+||..+|.+||+++++++.|+.
T Consensus       224 ------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         224 ------------------PRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             ------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence                              0233467899999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.1e-39  Score=294.31  Aligned_cols=251  Identities=24%  Similarity=0.372  Sum_probs=194.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|.+.+.||+|++|.||+|.+..++..||||.+....     ....+|+.++... .|+||+++++++.     ...
T Consensus        13 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~   87 (296)
T cd06618          13 DLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFI-----TDS   87 (296)
T ss_pred             CcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeee-----cCC
Confidence            3457999999999999999999998889999999986432     2233466655555 5999999999884     344


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..+++|||+++.+..++...   ...+++..+..++.|++.||.|||+..||+||||+|+||+++.++ .++|+|||++.
T Consensus        88 ~~~~v~e~~~~~l~~l~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~-~~kL~dfg~~~  163 (296)
T cd06618          88 DVFICMELMSTCLDKLLKRI---QGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASG-NVKLCDFGISG  163 (296)
T ss_pred             eEEEEeeccCcCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCC-CEEECccccch
Confidence            58999999998777666542   357899999999999999999999744999999999999999887 89999999987


Q ss_pred             ccccCCCcccccccccccCcccccCC---cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHhHH
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGA---TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~---~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  298 (371)
                      ............++..|+|||.+.+.   ..++.++|+||||+++|+|++|+.||...... +.+..+...   ..    
T Consensus       164 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---~~----  236 (296)
T cd06618         164 RLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQE---EP----  236 (296)
T ss_pred             hccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcC---CC----
Confidence            66444333444577889999998543   23678999999999999999999999654322 222222110   00    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                  +..   +    ....++.++.+|+.+||..||.+||++.++++|
T Consensus       237 ------------~~~---~----~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         237 ------------PSL---P----PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             ------------CCC---C----CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                        000   0    112367899999999999999999999999888

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=4.5e-40  Score=292.88  Aligned_cols=244  Identities=26%  Similarity=0.388  Sum_probs=189.4

Q ss_pred             eeeEeeccCCceEEEEEEEC----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           74 MAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+.+.||.|.||.||+|...    ..+..|+||.+...     ...+.+|++.+++++||||+++++++.....     .
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-----~   76 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-----L   76 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-----E
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-----c
Confidence            46789999999999999987    44678999999542     2455679999999999999999999863222     7


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|+||++ |+|.+.+...  ....+++..+..|+.||+.||.|||++ +++|+||+++||+++.++ .+||+|||++..
T Consensus        77 ~lv~e~~~~g~L~~~L~~~--~~~~~~~~~~~~i~~~i~~~l~~Lh~~-~iiH~~l~~~nill~~~~-~~Kl~~f~~~~~  152 (259)
T PF07714_consen   77 FLVMEYCPGGSLDDYLKSK--NKEPLSEQQRLSIAIQIAEALSYLHSN-NIIHGNLSPSNILLDSNG-QVKLSDFGLSRP  152 (259)
T ss_dssp             EEEEE--TTEBHHHHHHHT--CTTTSBHHHHHHHHHHHHHHHHHHHHT-TEEEST-SGGGEEEETTT-EEEEESTTTGEE
T ss_pred             ccccccccccccccccccc--ccccccccccccccccccccccccccc-cccccccccccccccccc-cccccccccccc
Confidence            89999998 6888888763  236789999999999999999999987 999999999999999988 999999999977


Q ss_pred             cccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          224 LVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       224 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ......   .........|+|||.+.... ++.++||||||+++||+++ |+.||...+..+....+.+...        
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~--------  223 (259)
T PF07714_consen  153 ISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQR--------  223 (259)
T ss_dssp             TTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEE--------
T ss_pred             ccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccc--------
Confidence            622221   12234567799999986655 7999999999999999999 7899988766555554422110        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                          ...+..++..+.+++.+||..||.+|||+.++++.|
T Consensus       224 --------------------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  224 --------------------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             --------------------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             --------------------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence                                003456789999999999999999999999998764

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.9e-39  Score=295.63  Aligned_cols=256  Identities=21%  Similarity=0.314  Sum_probs=198.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-------CCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ...+|.+.+.||+|+||.||+|.+.       .++..||+|.+...     .....+|+.+++.+ +||||+++++.+. 
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~-   91 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   91 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEe-
Confidence            3457999999999999999999753       23457999987543     23456799999999 8999999999873 


Q ss_pred             cCCCCceeEEEeeccccc-hHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                          .....+++|||+.+ +|.+++.....            ....++...+..++.||+.||.|||++ ||+||||||+
T Consensus        92 ----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~  166 (304)
T cd05101          92 ----QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ-KCIHRDLAAR  166 (304)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC-Ceeecccccc
Confidence                33457899999984 77777765321            123578888999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      ||+++.++ .+||+|||.++.......   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+..
T Consensus       167 Nili~~~~-~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~  244 (304)
T cd05101         167 NVLVTENN-VMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  244 (304)
T ss_pred             eEEEcCCC-cEEECCCccceecccccccccccCCCCCceeeCchhhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999887 899999999876543221   12233467799999986644 7899999999999999998 788887665


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+....+....                            ....+..++.++.+|+.+||..+|.+|||+.++++.|..+
T Consensus       245 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~  296 (304)
T cd05101         245 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRI  296 (304)
T ss_pred             HHHHHHHHHcCC----------------------------cCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHH
Confidence            444333222110                            0012345789999999999999999999999999998775


Q ss_pred             Cc
Q 017452          359 PS  360 (371)
Q Consensus       359 ~~  360 (371)
                      ..
T Consensus       297 ~~  298 (304)
T cd05101         297 LT  298 (304)
T ss_pred             HH
Confidence            43

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-39  Score=292.83  Aligned_cols=244  Identities=29%  Similarity=0.492  Sum_probs=194.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcC---CCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...     .....+|+.+++.+.   |||++++++++.     ....
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~-----~~~~   76 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYL-----KGPR   76 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeee-----eCCE
Confidence            488899999999999999999999999999987542     234567889999986   999999999874     3345


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||+.+ +|.+.+.     ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||.+.
T Consensus        77 ~~lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~~~  149 (277)
T cd06917          77 LWIIMEYAEGGSVRTLMK-----AGPIAEKYISVIIREVLVALKYIHKV-GVIHRDIKAANILVTNTG-NVKLCDFGVAA  149 (277)
T ss_pred             EEEEEecCCCCcHHHHHH-----ccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCcCHHHEEEcCCC-CEEEccCCcee
Confidence            7899999975 6665554     24789999999999999999999986 999999999999999877 89999999987


Q ss_pred             ccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....... .....|+..|+|||.+.+...++.++|+||||+++|+|++|..||...........+...            
T Consensus       150 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~------------  217 (277)
T cd06917         150 LLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS------------  217 (277)
T ss_pred             ecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC------------
Confidence            7644332 234567889999999876555788999999999999999999999765433222111000            


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                             ..+.        .....++.++.+++.+||..||.+||++.++++|
T Consensus       218 -------~~~~--------~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         218 -------KPPR--------LEDNGYSKLLREFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             -------CCCC--------CCcccCCHHHHHHHHHHcCCCcccCcCHHHHhhC
Confidence                   0000        0112368899999999999999999999998877

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=5.8e-39  Score=287.16  Aligned_cols=247  Identities=27%  Similarity=0.444  Sum_probs=190.3

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ......||+|+||.||+|.+..++..|++|.+...    .....+|+.+++.++|+||+++++++     ....+.++++
T Consensus        10 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-----~~~~~~~lv~   84 (268)
T cd06624          10 NGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSD-----SENGFFKIFM   84 (268)
T ss_pred             CCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeee-----ccCCEEEEEE
Confidence            33446899999999999999999999999987543    23456899999999999999999987     3445688999


Q ss_pred             ccccc-hHHHHHHHhhhccCCC--CHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRM--PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~--~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||+.+ +|.+.+...   ...+  ++..+..++.||+.||.|||++ ||+||||||+||+++.+...++|+|||.+....
T Consensus        85 e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~  160 (268)
T cd06624          85 EQVPGGSLSALLRSK---WGPLKDNEQTIIFYTKQILEGLKYLHDN-QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA  160 (268)
T ss_pred             ecCCCCCHHHHHHHh---cccCCCcHHHHHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEcCCCCeEEEecchhheecc
Confidence            99984 777666532   2334  7888999999999999999986 999999999999998754589999999987653


Q ss_pred             cCCC-cccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... .....+++.|+|||.+.+. ..++.++|+||||+++|+|++|..||.................            
T Consensus       161 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~------------  228 (268)
T cd06624         161 GINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGMFK------------  228 (268)
T ss_pred             cCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhhhc------------
Confidence            3222 2234578899999998543 2368899999999999999999999975433221111000000            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ....++..+++++.+++.+||..+|.+|||+.++++|
T Consensus       229 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         229 --------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             --------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhC
Confidence                          0111455678999999999999999999999996655

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.4e-39  Score=289.79  Aligned_cols=249  Identities=23%  Similarity=0.326  Sum_probs=195.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..|++.+.||+|+||.||+|.+..+++   .||+|.+...     ...+..|+.+++.++||||+++++++     ....
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~-----~~~~   78 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVV-----TKSR   78 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEE-----CCCC
Confidence            469999999999999999999877665   5999988643     23455789999999999999998887     3334


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+++ +|.+.+...   ...+++..++.++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~~l~~al~~lH~~-g~~H~dl~p~nili~~~~-~~kl~dfg~~  153 (269)
T cd05065          79 PVMIITEFMENGALDSFLRQN---DGQFTVIQLVGMLRGIAAGMKYLSEM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (269)
T ss_pred             ceEEEEecCCCCcHHHHHhhC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccChheEEEcCCC-cEEECCCccc
Confidence            47899999985 666655432   35689999999999999999999987 999999999999999887 8999999998


Q ss_pred             cccccCCCccc---cc---ccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          222 KVLVKGEPNIS---YI---CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       222 ~~~~~~~~~~~---~~---~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ...........   ..   .+..|+|||.+.+.. ++.++|+||||+++|++++ |..||...+..+....+.....   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~---  229 (269)
T cd05065         154 RFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYR---  229 (269)
T ss_pred             cccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---
Confidence            76543222111   11   134699999986544 7899999999999999886 9999987665544443321100   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                     .          ..+..++..+.+++.+||..+|.+||++.+++..|+.+
T Consensus       230 ---------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         230 ---------------L----------PPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             ---------------C----------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                           0          02234688999999999999999999999999988754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-39  Score=291.29  Aligned_cols=245  Identities=22%  Similarity=0.333  Sum_probs=188.4

Q ss_pred             eeccCCceEEEEEEECCCCc--EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEeec
Q 017452           78 IVGQGSFGVVFQAKCLETGE--TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~--~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      .||+|+||.||+|.+..++.  .+++|.+...     .....+|+++++++ .||||+++++++     ......+++||
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~-----~~~~~~~lv~e   76 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC-----EHRGYLYLAIE   76 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEE-----ecCCCceEEEE
Confidence            58999999999999887775  4688877532     13445799999999 799999999988     33445789999


Q ss_pred             ccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          150 YVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       150 ~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                      |++ ++|.+++.....            ....+++..++.++.|++.||+|||++ |++||||||+||+++.++ .+||+
T Consensus        77 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nili~~~~-~~kl~  154 (270)
T cd05047          77 YAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGENY-VAKIA  154 (270)
T ss_pred             eCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccccceEEEcCCC-eEEEC
Confidence            997 577777754321            123578999999999999999999986 999999999999999888 89999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |||++..............+..|+|||.+... .++.++|+||||+++|+|++ |..||.+.+..+....+...      
T Consensus       155 dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~------  227 (270)
T cd05047         155 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG------  227 (270)
T ss_pred             CCCCccccchhhhccCCCCccccCChHHHccC-CCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCC------
Confidence            99998543221111222335679999988554 47899999999999999996 99999765544433322110      


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                            +....+..++.++.+++.+||..||.+|||+.+++..|..+
T Consensus       228 ----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~  268 (270)
T cd05047         228 ----------------------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  268 (270)
T ss_pred             ----------------------CCCCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHh
Confidence                                  00002334688999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=304.03  Aligned_cols=242  Identities=29%  Similarity=0.438  Sum_probs=197.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ....|.+...+|.|+|+.|-.+.+..+++.+++|++.+......+|+.++... +||||+++.+.+     .+....|+|
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~-----~~~~~~~~v  394 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVY-----EDGKEIYLV  394 (612)
T ss_pred             cchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeeccee-----cCCceeeee
Confidence            35679999999999999999999999999999999988767777888776655 799999999988     667779999


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee-CCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~-~~~~~~kl~Dfg~a~~~~~  226 (371)
                      ||.+.|..  ++.+..  ..+.....+..|+.+|+.|+.|||.+ |+|||||||+|||++ ..+ .++|+|||.++....
T Consensus       395 ~e~l~g~e--ll~ri~--~~~~~~~e~~~w~~~lv~Av~~LH~~-gvvhRDLkp~NIL~~~~~g-~lrltyFG~a~~~~~  468 (612)
T KOG0603|consen  395 MELLDGGE--LLRRIR--SKPEFCSEASQWAAELVSAVDYLHEQ-GVVHRDLKPGNILLDGSAG-HLRLTYFGFWSELER  468 (612)
T ss_pred             ehhccccH--HHHHHH--hcchhHHHHHHHHHHHHHHHHHHHhc-CeeecCCChhheeecCCCC-cEEEEEechhhhCch
Confidence            99999752  222221  22333377888999999999999997 999999999999995 665 899999999986544


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .  ..+.+-|..|.|||++. ...++.++|+||||++||+|++|+.||......   .++...++.+.            
T Consensus       469 ~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~ei~~~i~~~~------------  530 (612)
T KOG0603|consen  469 S--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IEIHTRIQMPK------------  530 (612)
T ss_pred             h--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HHHHHhhcCCc------------
Confidence            3  22345578899999996 555999999999999999999999999876554   33344333322            


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     +...+|.++++||.+||+.||.+|+++.+++.|
T Consensus       531 ---------------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h  563 (612)
T KOG0603|consen  531 ---------------FSECVSDEAKDLLQQLLQVDPALRLGADEIGAH  563 (612)
T ss_pred             ---------------cccccCHHHHHHHHHhccCChhhCcChhhhccC
Confidence                           224589999999999999999999999998887

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=333.46  Aligned_cols=246  Identities=30%  Similarity=0.507  Sum_probs=202.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .-+|.-+.+||.|.||.||.|.+..+|+..|+|.+.-      ......+|..++..|+|||+|++|++-.....     
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRek----- 1308 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREK----- 1308 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHH-----
Confidence            3478889999999999999999999999999997742      23445689999999999999999987744333     


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ++|.||||. |+|.+++.+    .+..++...+.+..|++.|+.|||++ |||||||||.||+++.+| .+|++|||.|.
T Consensus      1309 v~IFMEyC~~GsLa~ll~~----gri~dE~vt~vyt~qll~gla~LH~~-gIVHRDIK~aNI~Ld~~g-~iK~~DFGsa~ 1382 (1509)
T KOG4645|consen 1309 VYIFMEYCEGGSLASLLEH----GRIEDEMVTRVYTKQLLEGLAYLHEH-GIVHRDIKPANILLDFNG-LIKYGDFGSAV 1382 (1509)
T ss_pred             HHHHHHHhccCcHHHHHHh----cchhhhhHHHHHHHHHHHHHHHHHhc-CceecCCCccceeeecCC-cEEeeccccee
Confidence            789999999 577777765    45677888888999999999999998 999999999999999998 89999999998


Q ss_pred             ccccCCC-----cccccccccccCcccccCCc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCC
Q 017452          223 VLVKGEP-----NISYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGTPT  294 (371)
Q Consensus       223 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~  294 (371)
                      .+.+...     .....||+-|||||++.+..  .-..+.|||||||+..||+||+.||...+..- .+...-.  |   
T Consensus      1383 ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~--g--- 1457 (1509)
T KOG4645|consen 1383 KIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAA--G--- 1457 (1509)
T ss_pred             EecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhc--c---
Confidence            8755432     23568999999999996543  24568999999999999999999997655433 3322221  1   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    .-|+         +|+++|.+-++||..||..||..|+++.|+++|
T Consensus      1458 --------------h~Pq---------~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1458 --------------HKPQ---------IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             --------------CCCC---------CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence                          1111         677899999999999999999999999999999

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=327.01  Aligned_cols=248  Identities=28%  Similarity=0.473  Sum_probs=206.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec-------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|.+++.||+|+||.|.+++.+.+++.||+|++.+       +...+..|-.+|..-+.+=|+.+.-+|     .+..
T Consensus        74 ~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-----QD~~  148 (1317)
T KOG0612|consen   74 AEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-----QDER  148 (1317)
T ss_pred             HHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-----cCcc
Confidence            3579999999999999999999999999999998855       235556788888888889999998777     7788


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      |+|+||||++| +|..++..+   . ++++.+++.++..|+.||.-||+ +|+|||||||+|||+|..| .+||+|||.+
T Consensus       149 ~LYlVMdY~pGGDlltLlSk~---~-~~pE~~ArFY~aEiVlAldslH~-mgyVHRDiKPDNvLld~~G-HikLADFGsC  222 (1317)
T KOG0612|consen  149 YLYLVMDYMPGGDLLTLLSKF---D-RLPEDWARFYTAEIVLALDSLHS-MGYVHRDIKPDNVLLDKSG-HIKLADFGSC  222 (1317)
T ss_pred             ceEEEEecccCchHHHHHhhc---C-CChHHHHHHHHHHHHHHHHHHHh-ccceeccCCcceeEecccC-cEeeccchhH
Confidence            89999999995 666666542   3 89999999999999999999997 6999999999999999999 7999999988


Q ss_pred             cccccCCC--cccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      -.+.....  ....+|||.|.+||++..    ...|+...|+||+||++|||+.|..||+..+-.+.+.+|++..     
T Consensus       223 lkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk-----  297 (1317)
T KOG0612|consen  223 LKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHK-----  297 (1317)
T ss_pred             HhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchh-----
Confidence            77763332  345789999999999952    2458899999999999999999999999998888888887631     


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC---HHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---AVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t---~~~~l~~  354 (371)
                                ..+.||.          ...+|.++.+||++++. +|..|..   +.++..|
T Consensus       298 ----------~~l~FP~----------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  298 ----------ESLSFPD----------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNH  338 (1317)
T ss_pred             ----------hhcCCCc----------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhC
Confidence                      1122221          03489999999999887 5788888   9995544

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=3.3e-39  Score=287.04  Aligned_cols=241  Identities=22%  Similarity=0.270  Sum_probs=188.4

Q ss_pred             eeccCCceEEEEEEEC--CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecc
Q 017452           78 IVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .||+|+||.||+|.+.  .++..||+|++....     ....+|+.+++.++|+||+++++.+.     . ...++||||
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-----~-~~~~lv~e~   75 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-----A-EALMLVMEM   75 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-----C-CCeEEEEEe
Confidence            3899999999999765  445679999885432     33567999999999999999988762     1 236899999


Q ss_pred             ccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC
Q 017452          151 VPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (371)
Q Consensus       151 ~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~  229 (371)
                      +++ +|.+.+..   ....+++..++.++.|++.||.|||++ |++||||||+||+++.++ .+||+|||++........
T Consensus        76 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~nil~~~~~-~~kl~dfg~~~~~~~~~~  150 (257)
T cd05115          76 ASGGPLNKFLSG---KKDEITVSNVVELMHQVSMGMKYLEGK-NFVHRDLAARNVLLVNQH-YAKISDFGLSKALGADDS  150 (257)
T ss_pred             CCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhc-CeeecccchheEEEcCCC-cEEeccCCccccccCCcc
Confidence            985 66655542   245789999999999999999999987 999999999999999887 899999999875533221


Q ss_pred             c----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          230 N----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       230 ~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .    ....++..|+|||.+.... ++.++|+||||+++|++++ |..||......+....+.+..  +           
T Consensus       151 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~--~-----------  216 (257)
T cd05115         151 YYKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGK--R-----------  216 (257)
T ss_pred             ceeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCC--C-----------
Confidence            1    1122356799999986544 7889999999999999996 999998776555443332210  0           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                     ..++...++++.+++.+||..||++||++.++.+.|+..
T Consensus       217 ---------------~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         217 ---------------LDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                           013455789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.7e-39  Score=292.11  Aligned_cols=242  Identities=25%  Similarity=0.380  Sum_probs=196.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .|+..+.||.|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++.     +..+.++
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KGTKLWI   79 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-----ECCEEEE
Confidence            5889999999999999999999999999999886432     34557899999999999999999884     3445899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+.+.     ...+++..+..++.|++.||+|||+. +++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~i~-----~~~l~~~~~~~~~~~l~~~l~~lh~~-~ivH~dl~p~Nil~~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06640          80 IMEYLGGGSALDLLR-----AGPFDEFQIATMLKEILKGLDYLHSE-KKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCcCCChhhEEEcCCC-CEEEcccccceecc
Confidence            9999985 6666554     35688999999999999999999986 999999999999999887 89999999987654


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...........+...  .            
T Consensus       153 ~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~--~------------  217 (277)
T cd06640         153 DTQIKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKN--N------------  217 (277)
T ss_pred             CCccccccccCcccccCHhHhccCC-CccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcC--C------------
Confidence            3322 22345688899999986554 789999999999999999999999766543332221110  0            


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ...++..++..+.+++.+||..+|.+||++.+++.|
T Consensus       218 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         218 --------------PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             --------------CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                          001334567899999999999999999999999888

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=293.94  Aligned_cols=257  Identities=20%  Similarity=0.252  Sum_probs=194.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC--------------cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG--------------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKH  131 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~--------------~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~  131 (371)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.+...     ...+.+|+++++.++|+|++++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            47999999999999999999875432              35899988643     123567999999999999999999


Q ss_pred             eEEecCCCCceeEEEeeccccc-hHHHHHHHhhh--------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNK--------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       132 ~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                      ++.     .....++||||+.+ +|.+.+.....        ....+++..+..++.|++.||.|||++ |++|+||||+
T Consensus        85 ~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~-~i~H~dlkp~  158 (295)
T cd05097          85 VCV-----SDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL-NFVHRDLATR  158 (295)
T ss_pred             EEc-----CCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc-CeeccccChh
Confidence            883     33457899999985 77776643210        012468888999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh--CCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPGD  277 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~~  277 (371)
                      ||+++.++ .+||+|||++.........   ....++..|+|||.+.... ++.++|+||||+++|+|++  |..||...
T Consensus       159 Nill~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         159 NCLVGNHY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             hEEEcCCC-cEEecccccccccccCcceeccCcCcCceeecChhhhccCC-cCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            99999887 8999999998765332211   1223467899999986554 7999999999999999988  66888776


Q ss_pred             CcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      +..+.+..+..........                    . ....+...++.+.+|+.+||+.||.+|||+.++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~~--------------------~-~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         237 SDEQVIENTGEFFRNQGRQ--------------------I-YLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             ChHHHHHHHHHhhhhcccc--------------------c-cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            6555444433211100000                    0 00023346889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.9e-39  Score=291.00  Aligned_cols=255  Identities=19%  Similarity=0.248  Sum_probs=198.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC----CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|++.+.||+|+||.||+|.+..    ++..|++|++...     .....+|+.+++.++|+||+++++++...    
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~----   80 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIED----   80 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC----
Confidence            3579999999999999999999865    3578999987643     23345789999999999999999876432    


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhcc----CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLN----QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      ....+++++|++ ++|...+.......    ..+++..+..++.|++.||+|||++ +++|+||||+||+++.++ .+||
T Consensus        81 ~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kl  158 (280)
T cd05043          81 GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR-GVIHKDIAARNCVIDEEL-QVKI  158 (280)
T ss_pred             CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCHhhEEEcCCC-cEEE
Confidence            233678999987 57777765532211    5689999999999999999999986 999999999999999887 8999


Q ss_pred             EeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017452          216 CDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      +|||+++........   ....++..|+|||.+.+.. ++.++||||||+++|++++ |+.||...+..+....+.... 
T Consensus       159 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-  236 (280)
T cd05043         159 TDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKE-YSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY-  236 (280)
T ss_pred             CCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCC-CCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC-
Confidence            999999765332211   1233466799999986544 7899999999999999998 999998765544332222110 


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                       .        +  ..+..+++++.+++.+||..||++|||+.++++.|..+.
T Consensus       237 -----------------~--------~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~  277 (280)
T cd05043         237 -----------------R--------L--AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFH  277 (280)
T ss_pred             -----------------C--------C--CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence                             0        0  012346889999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.3e-39  Score=289.65  Aligned_cols=249  Identities=25%  Similarity=0.332  Sum_probs=195.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||.||+|.+..++   ..+|+|.+...     .....+|+.+++.++||||+++++++.     ...
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   78 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT-----KSK   78 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe-----cCC
Confidence            47999999999999999999976544   37999987543     234567899999999999999998873     334


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      +.++||||+++ +|.+.+..   ....+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        79 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~h~dlkp~nili~~~~-~~~l~dfg~~  153 (267)
T cd05066          79 PVMIVTEYMENGSLDAFLRK---HDGQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILVNSNL-VCKVSDFGLS  153 (267)
T ss_pred             ccEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeehhhchhcEEECCCC-eEEeCCCCcc
Confidence            57899999985 66666643   235689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCcc----cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..........    ...++..|+|||.+.+.. ++.++|+||||+++|++++ |..||......+....+.+...     
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-----  227 (267)
T cd05066         154 RVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-----  227 (267)
T ss_pred             cccccccceeeecCCCccceeecCHhHhccCc-cCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-----
Confidence            7654332211    122245799999986544 7999999999999999886 9999987665444433322100     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                   .          ..+..+++.+.+++.+||+.+|.+||++.++++.|.++
T Consensus       228 -------------~----------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         228 -------------L----------PAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             -------------C----------CCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                         0          01234688999999999999999999999999988763

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.1e-39  Score=292.03  Aligned_cols=254  Identities=19%  Similarity=0.235  Sum_probs=187.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecchhhhH---------------HHHHHHHHcCCCCeeeccee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDKRYKN---------------RELQTMRLLDHPNVVSLKHC  132 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~~~~~---------------~e~~~l~~l~h~niv~~~~~  132 (371)
                      .+|++.+.||+|+||.||+|.+..+   +..+|+|+.........               .+...+..++|+|+++++++
T Consensus        12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   91 (294)
T PHA02882         12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC   91 (294)
T ss_pred             CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence            4799999999999999999998877   66778876432222111               12233445689999999887


Q ss_pred             EEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      ..... ....+.+++++++..++.+.+..    ....++..++.++.|++.||+|||++ +|+||||||+|||++.++ .
T Consensus        92 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiHrDiKp~Nill~~~~-~  164 (294)
T PHA02882         92 GSFKR-CRMYYRFILLEKLVENTKEIFKR----IKCKNKKLIKNIMKDMLTTLEYIHEH-GISHGDIKPENIMVDGNN-R  164 (294)
T ss_pred             eeEec-CCceEEEEEEehhccCHHHHHHh----hccCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-c
Confidence            64433 22335578889887776665543    23467888999999999999999987 999999999999999887 8


Q ss_pred             EEEEeeCCccccccCC--------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017452          213 VKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (371)
                      ++|+|||+|+......        ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||..........
T Consensus       165 ~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~  243 (294)
T PHA02882        165 GYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLI  243 (294)
T ss_pred             EEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHhCCCCCCccccchHHH
Confidence            9999999987653221        112346899999999986554 8999999999999999999999998764333222


Q ss_pred             HHHHH--hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          285 EIIKV--LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       285 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                      ...+.  .......                       .......++.+.+++..|++.+|.+||+..++++.|
T Consensus       244 ~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        244 HAAKCDFIKRLHEG-----------------------KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             HHhHHHHHHHhhhh-----------------------hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            22111  0000000                       001234578999999999999999999999998865

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-39  Score=293.49  Aligned_cols=242  Identities=26%  Similarity=0.376  Sum_probs=194.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .|+..+.||+|+||.||+|.+..++..||+|.+....     ....+|+.+++.++|+||+++++++.     .....++
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   79 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYL-----KGTKLWI   79 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccc-----cCCceEE
Confidence            4888899999999999999999999999999875332     34567999999999999999999883     3445889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+.+.     ...+++..++.++.|++.||.|||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~-~ivH~dl~p~ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06642          80 IMEYLGGGSALDLLK-----PGPLEETYIATILREILKGLDYLHSE-RKIHRDIKAANVLLSEQG-DVKLADFGVAGQLT  152 (277)
T ss_pred             EEEccCCCcHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHhcC-CeeccCCChheEEEeCCC-CEEEcccccccccc
Confidence            9999985 5555543     35789999999999999999999987 999999999999999887 89999999987654


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .... .....++..|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...               
T Consensus       153 ~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~---------------  216 (277)
T cd06642         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKN---------------  216 (277)
T ss_pred             CcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcC---------------
Confidence            3221 1234578889999998655 4788999999999999999999999765433322211110               


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   ....++..++.++.+++.+||..+|.+||++.++++|
T Consensus       217 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         217 -------------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             -------------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence                         0001234578899999999999999999999999887

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.9e-39  Score=290.04  Aligned_cols=266  Identities=24%  Similarity=0.334  Sum_probs=194.5

Q ss_pred             cceeeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||.||++.    +..++..||+|.+....    ..+.+|+++++.++||||+++++++...   +..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~---~~~   80 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---GRR   80 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccC---CCC
Confidence            369999999999999999997    34578899999986432    3456799999999999999998876442   233


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||++ ++|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .++|+|||++
T Consensus        81 ~~~lv~e~~~~~~L~~~l~~~---~~~l~~~~~~~~~~~l~~aL~~LH~~-~i~H~dlkp~nili~~~~-~~~l~dfg~~  155 (284)
T cd05081          81 NLRLVMEYLPYGSLRDYLQKH---RERLDHRKLLLYASQICKGMEYLGSK-RYVHRDLATRNILVESEN-RVKIGDFGLT  155 (284)
T ss_pred             ceEEEEEecCCCCHHHHHHhc---CcCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHhhEEECCCC-eEEECCCccc
Confidence            4789999997 5777766532   34689999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC-CCCHh
Q 017452          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG-TPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~  296 (371)
                      .........    ....++..|+|||.+.+.. ++.++|+||||+++|+|++|..++...... ....+..... .....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  233 (284)
T cd05081         156 KVLPQDKEYYKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYSDKSCSPPAE-FMRMMGNDKQGQMIVY  233 (284)
T ss_pred             ccccCCCcceeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHHHHHhhcCCcCCCcchh-hhhhcccccccccchH
Confidence            875433221    1122344599999986544 789999999999999999998776443211 1110000000 00000


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .+....            ........+..++.++.+|+.+||..+|++|||+.++++.|+.+
T Consensus       234 ~~~~~~------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         234 HLIELL------------KNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHHHH------------hcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000000            00000012346788999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-40  Score=292.65  Aligned_cols=255  Identities=27%  Similarity=0.429  Sum_probs=207.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-------hhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|..+..||+|+||+|.+|..+.+.+.||||+++++.-       -...|-.+|... +-|.++++..||...+   
T Consensus       347 ~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmD---  423 (683)
T KOG0696|consen  347 KATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMD---  423 (683)
T ss_pred             eecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhh---
Confidence            44579999999999999999999999999999998876521       122466666655 4678888888884433   


Q ss_pred             ceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                        .+|+||||++|+ |--.+..    -+.+-+..+..++..|+-||-+||++ ||++||||.+|||++.+| .+||+|||
T Consensus       424 --RLyFVMEyvnGGDLMyhiQQ----~GkFKEp~AvFYAaEiaigLFFLh~k-gIiYRDLKLDNvmLd~eG-HiKi~DFG  495 (683)
T KOG0696|consen  424 --RLYFVMEYVNGGDLMYHIQQ----VGKFKEPVAVFYAAEIAIGLFFLHSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  495 (683)
T ss_pred             --heeeEEEEecCchhhhHHHH----hcccCCchhhhhhHHHHHHhhhhhcC-CeeeeeccccceEeccCC-ceEeeecc
Confidence              388999999974 4333333    46788999999999999999999987 999999999999999999 79999999


Q ss_pred             Ccccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++.... +....+.+|||.|+|||++.-+ .|+..+|+||+||+||||+.|++||.+.+..+.++.|...         
T Consensus       496 mcKEni~~~~TTkTFCGTPdYiAPEIi~Yq-PYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~eh---------  565 (683)
T KOG0696|consen  496 MCKENIFDGVTTKTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEH---------  565 (683)
T ss_pred             cccccccCCcceeeecCCCcccccceEEec-ccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHc---------
Confidence            9987544 3445578999999999998544 4899999999999999999999999999999988888763         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                                          +..+|..+|.++.+++..+|.+.|.+|+...--       -+..+..|||||.
T Consensus       566 --------------------nvsyPKslSkEAv~ickg~ltK~P~kRLGcg~~-------ge~di~~H~FFR~  611 (683)
T KOG0696|consen  566 --------------------NVSYPKSLSKEAVAICKGLLTKHPGKRLGCGPE-------GERDIREHPFFRR  611 (683)
T ss_pred             --------------------cCcCcccccHHHHHHHHHHhhcCCccccCCCCc-------cccchhhCcchhh
Confidence                                223788899999999999999999999764321       1134667788774

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=2.4e-39  Score=293.49  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=195.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|.+.+.||+|+||.||++.+..++..||+|.+...    .....+|+.+++.++|||++++++.+..     ....+
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~   92 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-----GDELW   92 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeee-----CCcEE
Confidence            46899999999999999999999889999999987532    2345678899999999999999998843     33478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+||+.+ +|.+.+.     ...+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||++...
T Consensus        93 lv~e~~~~~~L~~~~~-----~~~l~~~~~~~i~~~l~~al~~LH~~-gi~H~dL~p~Nili~~~~-~~kL~dfg~~~~~  165 (293)
T cd06647          93 VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  165 (293)
T ss_pred             EEEecCCCCcHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CEeeccCCHHHEEEcCCC-CEEEccCcceecc
Confidence            99999985 6666554     34678999999999999999999987 999999999999999887 8999999987654


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+... .++.++|+||||+++|++++|..||...+.......+.. .+.+          
T Consensus       166 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~-~~~~----------  233 (293)
T cd06647         166 TPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTP----------  233 (293)
T ss_pred             cccccccccccCChhhcCchhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhc-CCCC----------
Confidence            3322 22234678889999998654 478899999999999999999999976554332221111 0000          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ....+..++..+.+++.+||..+|++||++.+++.|
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         234 ---------------ELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---------------CCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                           000233468899999999999999999999998888

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=3.2e-39  Score=298.11  Aligned_cols=255  Identities=21%  Similarity=0.309  Sum_probs=197.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCC-------CcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLET-------GETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ...+|++++.||+|+||.||+|.+...       +..||+|.+...     .....+|+.+++++ +||||+++++.+. 
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~-   88 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACT-   88 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEc-
Confidence            345799999999999999999986432       236899987643     23455789999999 7999999999883 


Q ss_pred             cCCCCceeEEEeeccccc-hHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                          .....+++|||+++ +|.+.+.....            ....++...+..++.||+.||.|||++ ||+||||||+
T Consensus        89 ----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~-givH~dlkp~  163 (334)
T cd05100          89 ----QDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ-KCIHRDLAAR  163 (334)
T ss_pred             ----cCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC-Ceeccccccc
Confidence                34457899999984 77777764321            123577888999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      ||+++.++ .+||+|||+++.......   .....++..|+|||++.+.. ++.++||||||+++|+|++ |..||.+.+
T Consensus       164 Nill~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~  241 (334)
T cd05100         164 NVLVTEDN-VMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPGIP  241 (334)
T ss_pred             eEEEcCCC-cEEECCcccceecccccccccccCCCcCceEcCHHHhccCC-cCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence            99999887 899999999876543221   11223356799999986544 7889999999999999998 889997765


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+....+....                            ....+..++.++.+++.+||..+|.+|||+.+++++|..+
T Consensus       242 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~  293 (334)
T cd05100         242 VEELFKLLKEGH----------------------------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRV  293 (334)
T ss_pred             HHHHHHHHHcCC----------------------------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHH
Confidence            444333322110                            0012345788999999999999999999999999998876


Q ss_pred             C
Q 017452          359 P  359 (371)
Q Consensus       359 ~  359 (371)
                      .
T Consensus       294 ~  294 (334)
T cd05100         294 L  294 (334)
T ss_pred             h
Confidence            5

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=4.9e-39  Score=287.74  Aligned_cols=251  Identities=21%  Similarity=0.378  Sum_probs=199.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECC-CCcEEEEEEeecch--------------hhhHHHHHHHHH-cCCCCeeecceeEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK--------------RYKNRELQTMRL-LDHPNVVSLKHCFFS  135 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~--------------~~~~~e~~~l~~-l~h~niv~~~~~~~~  135 (371)
                      .|.+.+.||+|+||.||+|.+.. +++.+|+|.+....              ....+|+.++.. ++|+||+++++.+  
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~--   78 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTF--   78 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeE--
Confidence            38889999999999999999887 67899999874221              112356666654 7999999999988  


Q ss_pred             cCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEE
Q 017452          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~k  214 (371)
                         ....+.+++|||+.+ +|.+.+.........+++..++.++.|++.||.|||+..+++|+||+|+||+++.++ .++
T Consensus        79 ---~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~-~~~  154 (269)
T cd08528          79 ---LENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDD-KVT  154 (269)
T ss_pred             ---ccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCC-cEE
Confidence               334568999999985 777777655455667999999999999999999999633899999999999999888 899


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+|||.+.............++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+......+ 
T Consensus       155 l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-  232 (269)
T cd08528         155 ITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEP-  232 (269)
T ss_pred             EecccceeecccccccccccCcccCcChhhhcCCC-CchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCc-
Confidence            99999997765444344566788999999997644 7899999999999999999999997766554444333211100 


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                                .....+++.+.+++.+||+.||.+||++.++..++.
T Consensus       233 --------------------------~~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         233 --------------------------LPEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             --------------------------CCcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence                                      012246889999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.2e-39  Score=287.99  Aligned_cols=249  Identities=23%  Similarity=0.316  Sum_probs=195.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|...+.||+|+||.||+|.+..++.   .+|+|.+...     ......|+++++.++|+|++++.+++.     ...
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   79 (268)
T cd05063           5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVT-----KFK   79 (268)
T ss_pred             HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEc-----cCC
Confidence            468999999999999999999876654   6999987543     233457899999999999999988873     334


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+++ +|.+.+..   ....+++..+..++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~al~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~dfg~~  154 (268)
T cd05063          80 PAMIITEYMENGALDKYLRD---HDGEFSSYQLVGMLRGIAAGMKYLSDM-NYVHRDLAARNILVNSNL-ECKVSDFGLS  154 (268)
T ss_pred             CcEEEEEcCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccccchhhEEEcCCC-cEEECCCccc
Confidence            47899999985 66555542   235789999999999999999999987 999999999999999887 8999999998


Q ss_pred             cccccCCCcc----cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEPNI----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~~----~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..........    ....+..|+|||.+... .++.++|+||||+++|+|++ |..||...+..+....+......+   
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~---  230 (268)
T cd05063         155 RVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP---  230 (268)
T ss_pred             eecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCC---
Confidence            7654322111    11224569999998654 47899999999999999997 999997766554444433211000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                               .+..++.++.+++.+||+.+|++||++.++++.|.++
T Consensus       231 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         231 -------------------------APMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence                                     1234688999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=4.4e-39  Score=289.52  Aligned_cols=239  Identities=25%  Similarity=0.371  Sum_probs=184.2

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHH---HHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNREL---QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~---~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .||+|+||.||+|.+..+++.||+|.+.+..       .....|.   ..++...||||+++++.+     ......++|
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~v   75 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----HTPDKLSFI   75 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeee-----ecCCEEEEE
Confidence            3799999999999999999999999885431       1112233   334445799999998887     344458899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+.| +|...+..    ...+++..++.++.|++.||.|||++ +|+||||||+||+++.++ .++|+|||++.....
T Consensus        76 ~e~~~g~~L~~~l~~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~di~p~nili~~~~-~~kl~dfg~~~~~~~  149 (278)
T cd05606          76 LDLMNGGDLHYHLSQ----HGVFSEAEMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDLGLACDFSK  149 (278)
T ss_pred             EecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCCCCHHHEEECCCC-CEEEccCcCccccCc
Confidence            999986 55544432    46799999999999999999999987 999999999999999887 899999999875533


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      . ......|+..|+|||.+.+...++.++|+||+|+++|+|++|+.||.................               
T Consensus       150 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---------------  213 (278)
T cd05606         150 K-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT---------------  213 (278)
T ss_pred             c-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc---------------
Confidence            2 223456899999999987555578999999999999999999999976533221111111000               


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                 ....++..++.++.+++.+||..+|.+||     ++.++++|
T Consensus       214 -----------~~~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         214 -----------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             -----------cCCCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhC
Confidence                       00113455789999999999999999999     99998876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=5.2e-39  Score=285.13  Aligned_cols=247  Identities=28%  Similarity=0.442  Sum_probs=201.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|++|.||++.+..+++.+++|.+...      .....+|+.+++.++|+||+++.+++..     ....+
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLD-----GNKLC   75 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhcc-----CCEEE
Confidence            489999999999999999999999999999988542      2234568899999999999999988843     35578


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|...+.........+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||++...
T Consensus        76 ~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~-~i~h~~l~~~ni~~~~~~-~~kl~d~g~~~~~  153 (256)
T cd08530          76 IVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ-KILHRDLKSANILLVAND-LVKIGDLGISKVL  153 (256)
T ss_pred             EEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCcceEEEecCC-cEEEeeccchhhh
Confidence            99999975 77777766544456789999999999999999999986 999999999999999877 8999999999876


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||...+.......+...               
T Consensus       154 ~~~-~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~---------------  216 (256)
T cd08530         154 KKN-MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRG---------------  216 (256)
T ss_pred             ccC-CcccccCCccccCHHHHCCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC---------------
Confidence            554 333456788999999986544 788999999999999999999999876654332222211               


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                          .++         ..+..++.++.+++.+||..+|.+||++.++++|.
T Consensus       217 ----~~~---------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p  254 (256)
T cd08530         217 ----KYP---------PIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASP  254 (256)
T ss_pred             ----CCC---------CCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCC
Confidence                000         02335788999999999999999999999988873

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3.6e-39  Score=289.94  Aligned_cols=242  Identities=26%  Similarity=0.399  Sum_probs=194.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      -|++.+.||+|+||.||+|.+..++..||+|.+....     ..+.+|+.+++.++||||+++++.+.     ...+.++
T Consensus         5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~~l   79 (277)
T cd06641           5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-----KDTKLWI   79 (277)
T ss_pred             hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEE-----eCCeEEE
Confidence            3888999999999999999998899999999875322     34567899999999999999999884     3445789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|...+.     ...+++..+..++.|++.|+.+||++ |++|+||+|+||+++.++ .++|+|||++....
T Consensus        80 v~e~~~~~~l~~~i~-----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~dl~p~Ni~i~~~~-~~~l~dfg~~~~~~  152 (277)
T cd06641          80 IMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQLT  152 (277)
T ss_pred             EEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHccC-CeecCCCCHHhEEECCCC-CEEEeecccceecc
Confidence            9999986 5555554     35689999999999999999999987 999999999999999887 89999999987653


Q ss_pred             cCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .... .....++..|+|||.+.+. ..+.++|+|||||++|+|++|..||...........+...  .+           
T Consensus       153 ~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~~-----------  218 (277)
T cd06641         153 DTQIKRNTFVGTPFWMAPEVIKQS-AYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKN--NP-----------  218 (277)
T ss_pred             cchhhhccccCCccccChhhhccC-CCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcC--CC-----------
Confidence            3221 2234578889999998654 4788999999999999999999999765543333222110  00           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ..++..++.++.+++.+||..+|.+||++.++++|
T Consensus       219 ---------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         219 ---------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             ---------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                           01334578899999999999999999999999988

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3e-39  Score=290.79  Aligned_cols=248  Identities=21%  Similarity=0.306  Sum_probs=191.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|.+..++.    .+++|.+....     .....|+.+++.++||||+++++++.     + 
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-----~-   80 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----G-   80 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-----C-
Confidence            479999999999999999999887776    47777764321     23345666788899999999998762     1 


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++++||+. |+|.+.+..   ....+++..+..|+.||+.||.|||++ |++||||||+||+++.++ .+||+|||+
T Consensus        81 ~~~~~i~e~~~~gsL~~~l~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~-~~kl~Dfg~  155 (279)
T cd05111          81 ASLQLVTQLSPLGSLLDHVRQ---HRDSLDPQRLLNWCVQIAKGMYYLEEH-RMVHRNLAARNILLKSDS-IVQIADFGV  155 (279)
T ss_pred             CccEEEEEeCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEEcCCcc
Confidence            12567899988 577776653   235689999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ++.......   .....++..|+|||.+.+.. ++.++|+||||+++|++++ |..||.+...... .++......+   
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~-~~~~~~~~~~---  230 (279)
T cd05111         156 ADLLYPDDKKYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEV-PDLLEKGERL---  230 (279)
T ss_pred             ceeccCCCcccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHH-HHHHHCCCcC---
Confidence            976543322   12234567899999986544 7999999999999999998 9999977654332 2222210000   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                              ..+...+.++.+++.+||..||.+|||+.++++.|..+
T Consensus       231 ------------------------~~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~  268 (279)
T cd05111         231 ------------------------AQPQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRM  268 (279)
T ss_pred             ------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                                    01233567899999999999999999999999987664

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.1e-39  Score=292.70  Aligned_cols=243  Identities=28%  Similarity=0.441  Sum_probs=196.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|...+.||+|+||.||+|.+..+|..|++|++....       ....+|+++++.++|||++++++++..     ....
T Consensus        22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   96 (313)
T cd06633          22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK-----EHTA   96 (313)
T ss_pred             HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEE
Confidence            4777888999999999999999999999999885321       234578999999999999999998843     3457


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+.+++.+.+...   ...+++..+..++.||+.||.|||++ |++|+||+|+||+++.++ .++|+|||++...
T Consensus        97 ~lv~e~~~~~l~~~l~~~---~~~l~~~~~~~~~~qi~~al~~LH~~-gi~H~dl~p~nili~~~~-~~kL~dfg~~~~~  171 (313)
T cd06633          97 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASKS  171 (313)
T ss_pred             EEEEecCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChhhEEECCCC-CEEEeecCCCccc
Confidence            899999999877766532   45689999999999999999999987 999999999999999887 8999999988653


Q ss_pred             ccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .   ......++..|+|||.+..  ...++.++|+||||+++|+|++|..||...+.......+....  .         
T Consensus       172 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~--~---------  237 (313)
T cd06633         172 S---PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQND--S---------  237 (313)
T ss_pred             C---CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcC--C---------
Confidence            2   2234567889999999842  2347889999999999999999999998776555444433210  0         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              +.        .....++..+.+|+.+||+.+|.+||++.+++.|
T Consensus       238 --------~~--------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         238 --------PT--------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             --------CC--------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                    00        0123467789999999999999999999998877

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-39  Score=285.22  Aligned_cols=247  Identities=26%  Similarity=0.449  Sum_probs=197.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|.+..+++.||+|.+...         ...+.+|+++++.++|+||+++++++..   ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~---~~~   78 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRD---PEE   78 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEc---CCC
Confidence            3699999999999999999999999999999987421         1244579999999999999999987743   223


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++++||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ |++|+||||+||+++.++ .++|+|||.
T Consensus        79 ~~~~~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~al~~LH~~-~i~H~dl~p~ni~i~~~~-~~~l~dfg~  152 (264)
T cd06653          79 KKLSIFVEYMPGGSIKDQLKA----YGALTENVTRRYTRQILQGVSYLHSN-MIVHRDIKGANILRDSAG-NVKLGDFGA  152 (264)
T ss_pred             CEEEEEEEeCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCC-CEEECcccc
Confidence            456799999985 66666653    35688999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccC----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +......    .......++..|+|||.+.+.. ++.++|+|||||++|+|++|+.||........+.++.   ..+   
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~---~~~---  225 (264)
T cd06653         153 SKRIQTICMSGTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA---TQP---  225 (264)
T ss_pred             ccccccccccCccccccCCcccccCHhhhcCCC-CCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH---cCC---
Confidence            8764321    1112345788999999986544 7899999999999999999999998765544433322   111   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                           ....++..+++.+.+++.+||. +|..||++.+++.|.
T Consensus       226 ---------------------~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~  262 (264)
T cd06653         226 ---------------------TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHP  262 (264)
T ss_pred             ---------------------CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCC
Confidence                                 1112566789999999999999 579999999987763

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.8e-39  Score=291.44  Aligned_cols=252  Identities=25%  Similarity=0.318  Sum_probs=195.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.+.     .++..||+|.+...     ...+.+|+.+++.++||||+++++++.     
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~-----   78 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCA-----   78 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEc-----
Confidence            357999999999999999999874     36788999988643     234567999999999999999998773     


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhh------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccC
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNK------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK  200 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlk  200 (371)
                      .....+++|||+++ +|.+.+.....                  ....+++..++.++.|++.||+|||.+ +++|||||
T Consensus        79 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~-~i~H~dl~  157 (288)
T cd05050          79 VGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER-KFVHRDLA  157 (288)
T ss_pred             CCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-Ceeccccc
Confidence            33347899999984 77777754211                  113478888999999999999999987 99999999


Q ss_pred             CCceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q 017452          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPG  276 (371)
Q Consensus       201 p~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~  276 (371)
                      |+||+++.++ .++|+|||.+........   ......+..|+|||.+.+.. ++.++|+|||||++|+|++ |..||.+
T Consensus       158 p~nil~~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         158 TRNCLVGENM-VVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             HhheEecCCC-ceEECccccceecccCccccccCCCccChhhcCHHHHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999888 899999999875432211   11223456799999886544 8999999999999999997 8889977


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      ....+....+....  .                        +  ..+..++.++.+|+.+||+.||.+|||+.|+++.|+
T Consensus       236 ~~~~~~~~~~~~~~--~------------------------~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         236 MAHEEVIYYVRDGN--V------------------------L--SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCHHHHHHHHhcCC--C------------------------C--CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            66554433322110  0                        0  023457889999999999999999999999998876


Q ss_pred             C
Q 017452          357 N  357 (371)
Q Consensus       357 ~  357 (371)
                      +
T Consensus       288 ~  288 (288)
T cd05050         288 R  288 (288)
T ss_pred             C
Confidence            3

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-41  Score=283.73  Aligned_cols=257  Identities=23%  Similarity=0.337  Sum_probs=202.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHH-HHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ...+.+-...||.|+||+|++..++.+|+..|||++....     ..+..|.+. ++.-+.||||++|++.+...+    
T Consensus        62 ~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGd----  137 (361)
T KOG1006|consen   62 TSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGD----  137 (361)
T ss_pred             ccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCc----
Confidence            3345566678999999999999999999999999996532     223334443 344479999999999876555    


Q ss_pred             eEEEeeccccchHHHHHHHhh-hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPETVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~-~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                       .+|.||.|+-+++.+..... -.+..++|..+-.|....+.||+||-+.+.|||||+||+|||++..| .+||||||++
T Consensus       138 -cWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G-~vKLCDFGIc  215 (361)
T KOG1006|consen  138 -CWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHG-DVKLCDFGIC  215 (361)
T ss_pred             -eeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCC-CEeeecccch
Confidence             78999999988877765533 33568999999999999999999999888999999999999999998 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcC-CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-CCCCHhHHh
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-GTPTREEIK  299 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~-~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  299 (371)
                      ..+.+.-..+.-.|...|||||.+..... |.-+||+||||++|||++||..||...+.  .+.++.... |.|+.-.. 
T Consensus       216 GqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l~~-  292 (361)
T KOG1006|consen  216 GQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPILLF-  292 (361)
T ss_pred             HhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCeecC-
Confidence            88777666667788999999999965444 78899999999999999999999987654  333333322 22211000 


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                 +         .-.-.++..+..+|..||.+|-+.||...+++++
T Consensus       293 -----------~---------~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  293 -----------D---------KECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             -----------c---------ccccccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence                       0         0012378999999999999999999999997766

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=6.9e-39  Score=284.78  Aligned_cols=242  Identities=26%  Similarity=0.348  Sum_probs=191.7

Q ss_pred             EeeccCCceEEEEEEECC-CC--cEEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLE-TG--ETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-~~--~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|++|.||+|.+.. .+  ..||+|.+.....     .+.+|+.++++++||||+++++.+..      ...+++|
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~------~~~~~v~   74 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT------HPLMMVT   74 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC------CeEEEEE
Confidence            368999999999999865 33  3689998865433     45679999999999999999988743      4578999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++ ++|.+.+....  ...+++..++.++.|++.||+|||++ |++|+||||+||+++.++ .+||+|||++......
T Consensus        75 e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~-~i~H~di~p~nil~~~~~-~~kl~dfg~~~~~~~~  150 (257)
T cd05040          75 ELAPLGSLLDRLRKDA--LGHFLISTLCDYAVQIANGMRYLESK-RFIHRDLAARNILLASDD-KVKIGDFGLMRALPQN  150 (257)
T ss_pred             EecCCCcHHHHHHhcc--cccCcHHHHHHHHHHHHHHHHHHHhC-CccccccCcccEEEecCC-EEEecccccccccccc
Confidence            9997 57777666422  15689999999999999999999987 999999999999999987 8999999998776432


Q ss_pred             CC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          228 EP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       228 ~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..    .....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...+..+....+.....           
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------  218 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-----------  218 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----------
Confidence            21    11234567899999886544 7899999999999999998 9999987666554444332100           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                      ....+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       219 ----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 ----------------RLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             ----------------cCCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence                            00023456889999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=4.9e-39  Score=291.88  Aligned_cols=257  Identities=19%  Similarity=0.250  Sum_probs=193.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECC----------------CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeec
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE----------------TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSL  129 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~----------------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~  129 (371)
                      ++|++.+.||+|+||.||++.+..                ++..+|+|.+....     ....+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            469999999999999999986432                34568999886432     345679999999999999999


Q ss_pred             ceeEEecCCCCceeEEEeecccc-chHHHHHHHhhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCC
Q 017452          130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKL-------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (371)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp  201 (371)
                      ++++..     ....+++|||+. ++|.+++......       ...+++..+..++.||+.||+|||++ |++|+||||
T Consensus        85 ~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dlkp  158 (296)
T cd05095          85 LAVCIT-----SDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL-NFVHRDLAT  158 (296)
T ss_pred             EEEEec-----CCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCh
Confidence            998733     334789999998 5777777653211       13477888999999999999999986 999999999


Q ss_pred             CceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh--CCCCCCC
Q 017452          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML--GKPLFPG  276 (371)
Q Consensus       202 ~NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt--g~~pf~~  276 (371)
                      +||+++.++ .++|+|||++.........   ....++..|+|||...... ++.++|+|||||++|+|++  |..||..
T Consensus       159 ~Nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~DiwSlG~~l~el~~~~~~~p~~~  236 (296)
T cd05095         159 RNCLVGKNY-TIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGK-FTTASDVWAFGVTLWEILTLCKEQPYSQ  236 (296)
T ss_pred             heEEEcCCC-CEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCC-ccchhhhhHHHHHHHHHHHhCCCCCccc
Confidence            999999877 8999999998765332211   1223356799999876554 7999999999999999998  7789876


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      ....+.+...........           .....          ..+..++..+.+|+.+||+.||.+||++.++++.|.
T Consensus       237 ~~~~~~~~~~~~~~~~~~-----------~~~~~----------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         237 LSDEQVIENTGEFFRDQG-----------RQVYL----------PKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             cChHHHHHHHHHHHhhcc-----------ccccC----------CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            655444332221110000           00000          023346789999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.2e-38  Score=292.05  Aligned_cols=247  Identities=28%  Similarity=0.420  Sum_probs=199.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|...+.||+|+||.||++.+..++..+|+|.+....       ..+.+|+.+++.++|+|++++++++..     ....
T Consensus        26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~  100 (317)
T cd06635          26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLR-----EHTA  100 (317)
T ss_pred             hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----CCeE
Confidence            3889999999999999999999999999999885321       234578999999999999999998844     3347


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+.|++.+.+...   ...+++..+..++.|++.||.|||++ ||+||||+|+||+++.++ .++|+|||++...
T Consensus       101 ~lv~e~~~g~l~~~~~~~---~~~l~~~~~~~i~~~i~~~l~~lH~~-~i~H~dL~p~Nil~~~~~-~~kl~dfg~~~~~  175 (317)
T cd06635         101 WLVMEYCLGSASDLLEVH---KKPLQEVEIAAITHGALQGLAYLHSH-NMIHRDIKAGNILLTEPG-QVKLADFGSASIA  175 (317)
T ss_pred             EEEEeCCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcccEEECCCC-CEEEecCCCcccc
Confidence            899999999877766432   45689999999999999999999987 999999999999999887 8999999988654


Q ss_pred             ccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..   .....+++.|+|||.+..  ...++.++|+|||||++|+|++|..||...+.......+.......         
T Consensus       176 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~---------  243 (317)
T cd06635         176 SP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPT---------  243 (317)
T ss_pred             CC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCC---------
Confidence            32   234567889999999742  2347889999999999999999999998766555444443321000         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        .....+++.+.+++.+||+.+|.+||++.++++|....
T Consensus       244 ------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~  281 (317)
T cd06635         244 ------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVL  281 (317)
T ss_pred             ------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhh
Confidence                              01234678899999999999999999999999995443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.5e-39  Score=285.94  Aligned_cols=233  Identities=32%  Similarity=0.507  Sum_probs=182.3

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecchh-------hhHHHHHH-HHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||.|++|.||+|.+..+|+.||+|.+.+...       ....|..+ ....+|+|++++++++.     .....++|+
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~   76 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQ-----SKDYLYLVM   76 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEE-----cCCeEEEEE
Confidence            568999999999999999999999998864321       11223333 34458999999999883     344588999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|.+++..    ...+++..+..++.||+.||.|||+. +++||||+|+||+++.++ .++|+|||++..... 
T Consensus        77 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~~~~~~~-  149 (260)
T cd05611          77 EYLNGGDCASLIKT----LGGLPEDWAKQYIAEVVLGVEDLHQR-GIIHRDIKPENLLIDQTG-HLKLTDFGLSRNGLE-  149 (260)
T ss_pred             eccCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEECCCC-cEEEeecccceeccc-
Confidence            99985 67666653    45789999999999999999999986 999999999999999887 899999998876432 


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                        .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+....                 
T Consensus       150 --~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-----------------  209 (260)
T cd05611         150 --NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRR-----------------  209 (260)
T ss_pred             --cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcc-----------------
Confidence              22345788899999987655 7899999999999999999999998766554443332210                 


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV  349 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~  349 (371)
                              ..|.......+++++.+++.+||+.||.+||++.
T Consensus       210 --------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~  243 (260)
T cd05611         210 --------INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGAN  243 (260)
T ss_pred             --------cCCCCcccccCCHHHHHHHHHHccCCHHHccCCC
Confidence                    0011112345789999999999999999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=9e-39  Score=283.87  Aligned_cols=246  Identities=21%  Similarity=0.319  Sum_probs=194.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||.|+||.||++.+. .+..+|+|.+...   .....+|+++++.++|||++++++++     ......+++
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~-----~~~~~~~~v   77 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVC-----TERSPICLV   77 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEE-----ccCCceEEE
Confidence            36999999999999999999875 4678999988643   24566899999999999999998887     334457899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+.+ +|.+.+..   ....+++..++.++.|++.||++||+. +++|+||||+||+++.++ .++|+|||.+.....
T Consensus        78 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~dl~p~ni~i~~~~-~~~l~d~g~~~~~~~  152 (256)
T cd05112          78 FEFMEHGCLSDYLRA---QRGKFSQETLLGMCLDVCEGMAYLESS-NVIHRDLAARNCLVGENQ-VVKVSDFGMTRFVLD  152 (256)
T ss_pred             EEcCCCCcHHHHHHh---CccCCCHHHHHHHHHHHHHHHHHHHHC-CccccccccceEEEcCCC-eEEECCCcceeeccc
Confidence            999985 55555542   134688999999999999999999987 999999999999999877 899999999876533


Q ss_pred             CCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  ....++..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+...              
T Consensus       153 ~~~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~--------------  217 (256)
T cd05112         153 DQYTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAG--------------  217 (256)
T ss_pred             CcccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCC--------------
Confidence            2211  1223456799999986544 7889999999999999998 99999876654443333211              


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                    +....+...+..+.+|+.+||..+|.+|||+.++++++.
T Consensus       218 --------------~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l~  256 (256)
T cd05112         218 --------------FRLYKPRLASQSVYELMQHCWKERPEDRPSFSLLLHQLA  256 (256)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHhhC
Confidence                          000123446889999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.7e-38  Score=283.26  Aligned_cols=245  Identities=30%  Similarity=0.515  Sum_probs=193.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|++.+.||+|+||.||+|.+..++..|++|.+....      ..+.+|+.+++.++|+||+++++.+     ......+
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~-----~~~~~~~   75 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVE-----VHREKVY   75 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeE-----ecCCEEE
Confidence            5899999999999999999998899999999986442      3445799999999999999998876     3344578


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+. ||+|+||+|+||+++.++ .+||+|||.+...
T Consensus        76 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~-~~kl~d~g~~~~~  149 (264)
T cd06626          76 IFMEYCSGGTLEELLEH----GRILDEHVIRVYTLQLLEGLAYLHSH-GIVHRDIKPANIFLDHNG-VIKLGDFGCAVKL  149 (264)
T ss_pred             EEEecCCCCcHHHHHhh----cCCCChHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEccccccccc
Confidence            99999985 66665543    35688999999999999999999986 999999999999999877 8999999998775


Q ss_pred             ccCCCcc-----cccccccccCcccccCCc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          225 VKGEPNI-----SYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       225 ~~~~~~~-----~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......     ...+++.|+|||.+.+..  ..+.++|+||||+++|++++|..||...+........... +..+   
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  225 (264)
T cd06626         150 KNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGA-GHKP---  225 (264)
T ss_pred             CCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhc-CCCC---
Confidence            4332211     245688899999986543  2688999999999999999999999765433222211111 1000   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCC--CCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             .++.  .++..+.+++.+||+.+|.+|||+.+++.|
T Consensus       226 -----------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         226 -----------------------PIPDSLQLSPEGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             -----------------------CCCcccccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                                   0122  358899999999999999999999996655

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=3.1e-39  Score=293.28  Aligned_cols=244  Identities=28%  Similarity=0.433  Sum_probs=195.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .|.....||+|+||.||+|.+..++..||+|.+...    .....+|+.+++.++|||++++++.+..     ....+++
T Consensus        22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~-----~~~~~iv   96 (297)
T cd06659          22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-----GEELWVL   96 (297)
T ss_pred             hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheee-----CCeEEEE
Confidence            356667899999999999999989999999988532    2345578999999999999999998843     3457899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+++ +|...+.     ...+++..++.++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++.....
T Consensus        97 ~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dl~p~Nill~~~~-~~kL~dfg~~~~~~~  169 (297)
T cd06659          97 MEFLQGGALTDIVS-----QTRLNEEQIATVCESVLQALCYLHSQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISK  169 (297)
T ss_pred             EecCCCCCHHHHHh-----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHeEEccCC-cEEEeechhHhhccc
Confidence            999986 5554443     35689999999999999999999987 999999999999999888 899999999865433


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .. ......++..|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+.+..+...   +. .         
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~---~~-~---------  235 (297)
T cd06659         170 DVPKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDS---PP-P---------  235 (297)
T ss_pred             ccccccceecCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcc---CC-C---------
Confidence            22 223456789999999986544 789999999999999999999999876655444332211   00 0         


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                 .+  .....++..+.++|.+||+.+|.+||++.++++|
T Consensus       236 -----------~~--~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         236 -----------KL--KNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -----------Cc--cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                       00  0123468899999999999999999999999998

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.7e-38  Score=280.75  Aligned_cols=246  Identities=29%  Similarity=0.483  Sum_probs=199.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      +|.+.+.||+|++|.||++.+..+++.+++|++....    ....+|+++++.++|+|++++++++..     ....+++
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~l~   75 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLK-----KDELWIV   75 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEEEE
Confidence            4889999999999999999998899999999986543    456689999999999999999998743     3447899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +||++ ++|.+.+...   ...+++..+..++.|++.||.+||.. |++||||+|+||+++.++ .++|+|||.+.....
T Consensus        76 ~e~~~~~~L~~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~-~i~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~~~  150 (253)
T cd05122          76 MEFCSGGSLKDLLKST---NQTLTESQIAYVCKELLKGLEYLHSN-GIIHRDIKAANILLTSDG-EVKLIDFGLSAQLSD  150 (253)
T ss_pred             EecCCCCcHHHHHhhc---CCCCCHHHHHHHHHHHHHHHHHhhcC-CEecCCCCHHHEEEccCC-eEEEeeccccccccc
Confidence            99999 5766665532   25789999999999999999999986 999999999999999887 899999999887655


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........++..|+|||.+.+.. .+.++|+||||+++|+|++|..||...+........... ..+             
T Consensus       151 ~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~-------------  215 (253)
T cd05122         151 TKARNTMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATN-GPP-------------  215 (253)
T ss_pred             cccccceecCCcccCHHHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhc-CCC-------------
Confidence            43334566788999999986554 788999999999999999999999876544443332220 000             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                           ..       ..+..++..+.++|.+||+.||++|||+.++++|
T Consensus       216 -----~~-------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         216 -----GL-------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             -----Cc-------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                 00       0112247899999999999999999999998776

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=9.5e-39  Score=283.68  Aligned_cols=245  Identities=27%  Similarity=0.382  Sum_probs=194.8

Q ss_pred             eeeeEeeccCCceEEEEEEECCCC----cEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +++.+.||.|+||.||++.+...+    ..||+|.+....     .....|+.+++.++|+||+++++.+..     ...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~   75 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTE-----EEP   75 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcC-----CCe
Confidence            356789999999999999998766    889999986432     345679999999999999999998843     345


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||+++ +|.+.+....  ...+++..+..++.|++.||.+||++ |++|+||||+||+++.++ .++|+|||.+.
T Consensus        76 ~~~i~e~~~~~~l~~~~~~~~--~~~~~~~~~~~~~~ql~~~l~~lh~~-~~~h~dl~~~nil~~~~~-~~~l~dfg~~~  151 (258)
T smart00219       76 LMIVMEYMEGGDLLDYLRKNR--PKELSLSDLLSFALQIARGMEYLESK-NFIHRDLAARNCLVGENL-VVKISDFGLSR  151 (258)
T ss_pred             eEEEEeccCCCCHHHHHHhhh--hccCCHHHHHHHHHHHHHHHHHHhcC-CeeecccccceEEEccCC-eEEEcccCCce
Confidence            7899999985 7776665422  12289999999999999999999987 999999999999999888 89999999987


Q ss_pred             ccccCCCcc--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .........  ...+++.|+|||.+.+ ..++.++|+||||+++|+|++ |..||...+.......+.+...        
T Consensus       152 ~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~--------  222 (258)
T smart00219      152 DLYDDDYYKKKGGKLPIRWMAPESLKD-GKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYR--------  222 (258)
T ss_pred             ecccccccccccCCCcccccChHHhcc-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC--------
Confidence            765442221  1236788999999844 447999999999999999998 8899887655554444332100        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                          ...+..++.++.+++.+||..||.+|||+.++++.|
T Consensus       223 --------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      223 --------------------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence                                012344789999999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.2e-39  Score=298.38  Aligned_cols=269  Identities=20%  Similarity=0.286  Sum_probs=188.8

Q ss_pred             EeeccC--CceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ..||.|  +||+||++.+..+|+.||+|++....      ..+.+|+.+++.++||||+++++++.     ...+.++||
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-----~~~~~~~v~   78 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFT-----TGSWLWVIS   78 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEe-----cCCceEEEE
Confidence            345666  99999999999999999999885432      34567888899999999999999883     344578999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+.+ ++.+++....  ...+++..++.++.||+.||+|||+. ||+||||||+||+++.++ .++++||+.+......
T Consensus        79 e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivHrDlkp~Nill~~~~-~~~~~~~~~~~~~~~~  154 (328)
T cd08226          79 PFMAYGSANSLLKTYF--PEGMSEALIGNILFGALRGLNYLHQN-GYIHRNIKASHILISGDG-LVSLSGLSHLYSLVRN  154 (328)
T ss_pred             ecccCCCHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEeCCC-cEEEechHHHhhhhcc
Confidence            99985 7666665432  34689999999999999999999986 999999999999999887 8999999865332211


Q ss_pred             CCc--------ccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH-
Q 017452          228 EPN--------ISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE-  297 (371)
Q Consensus       228 ~~~--------~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~-  297 (371)
                      ...        ....++..|+|||++.+. ..++.++|+|||||++|+|++|..||...................+... 
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  234 (328)
T cd08226         155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDIT  234 (328)
T ss_pred             CccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCcccc
Confidence            110        012235569999998654 3368899999999999999999999987665544433332111111000 


Q ss_pred             --------HhhcCCCc----ccccc-----CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 --------IKCMNPNY----TEFKF-----PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 --------~~~~~~~~----~~~~~-----~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                              +.......    .+...     .......+....+..+++.+.+|+++||+.||.+|||+.++++|
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~  308 (328)
T cd08226         235 TFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSH  308 (328)
T ss_pred             ccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence                    00000000    00000     00000111111233467889999999999999999999997777

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=1.4e-38  Score=283.47  Aligned_cols=248  Identities=23%  Similarity=0.341  Sum_probs=195.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.+.||+|+||.||++.+. .+..+|+|.+....   ....+|+.+++.++|+||+++++.+..      ...++
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~------~~~~~   77 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK------EPIYI   77 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC------CCeEE
Confidence            357999999999999999999854 55679999886532   345679999999999999999887632      33689


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||++ ++|.+.+...  ....+++..+..++.|++.||.|||++ |++|+||||+||+++.++ .++|+|||.+....
T Consensus        78 v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  153 (260)
T cd05073          78 ITEFMAKGSLLDFLKSD--EGSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVIE  153 (260)
T ss_pred             EEEeCCCCcHHHHHHhC--CccccCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCCcceeecc
Confidence            999997 5777776542  234678888999999999999999986 999999999999999887 89999999987653


Q ss_pred             cCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  ....++..|+|||.+... .++.++|+||||+++|++++ |..||...+.......+.....           
T Consensus       154 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-----------  221 (260)
T cd05073         154 DNEYTAREGAKFPIKWTAPEAINFG-SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYR-----------  221 (260)
T ss_pred             CCCcccccCCcccccccCHhHhccC-CcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCC-----------
Confidence            32211  123345679999998654 47889999999999999998 9999987665444333322100           


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                       ...+...+.++.+++.+||..+|++||++.++++.|..
T Consensus       222 -----------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         222 -----------------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             -----------------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                             00234578899999999999999999999999988865

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.3e-38  Score=285.97  Aligned_cols=252  Identities=22%  Similarity=0.281  Sum_probs=196.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .+|++.+.||+|+||.||+|+...     +.+.+++|.+....     ....+|+.++++++|+||+++++.+     ..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   79 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLC-----RE   79 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEE-----CC
Confidence            469999999999999999999653     34679999875432     3456799999999999999999877     44


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEE
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~k  214 (371)
                      ..+.++||||++ ++|.+++......     ...+++..+..++.||+.||.|||++ +|+||||||+||+++.++ .++
T Consensus        80 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~  157 (275)
T cd05046          80 AEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA-RFVHRDLAARNCLVSSQR-EVK  157 (275)
T ss_pred             CCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc-CcccCcCccceEEEeCCC-cEE
Confidence            455789999998 5777777653211     12689999999999999999999987 999999999999999887 899


Q ss_pred             EEeeCCccccccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhC
Q 017452          215 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       215 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      |+|||++.......  ......++..|+|||.+.+.. .+.++|+||||+++|++++ |..||...........+...  
T Consensus       158 l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~--  234 (275)
T cd05046         158 VSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDD-FSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAG--  234 (275)
T ss_pred             EcccccccccCcccccccCCceeEEeecChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcC--
Confidence            99999986543221  112334567799999886544 7889999999999999998 78899765544433332210  


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                               .+....+..++..+.+++.+||+.||.+|||+.+++.+|.+
T Consensus       235 -------------------------~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~~  275 (275)
T cd05046         235 -------------------------KLELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALGE  275 (275)
T ss_pred             -------------------------CcCCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhcC
Confidence                                     00011234578899999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=9e-39  Score=283.01  Aligned_cols=240  Identities=23%  Similarity=0.352  Sum_probs=188.5

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      +.||.|++|.||++.+.. ++.||+|.+...     .....+|+++++.++|+||+++++++.     .....++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~-----~~~~~~~v~e~~   74 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCV-----QKQPIYIVMELV   74 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEe-----cCCCeEEEEEcC
Confidence            368999999999999877 999999987643     234567999999999999999998873     334478999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      .+ +|.+.+..   ....+++..+..++.|++.||.|||++ +++||||||+||+++.++ .++|+|||.+.........
T Consensus        75 ~~~~l~~~l~~---~~~~~~~~~~~~~~~~~~~~l~~lH~~-~i~h~di~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (251)
T cd05041          75 PGGSLLTFLRK---KKNRLTVKKLLQMSLDAAAGMEYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSREEEGGIYT  149 (251)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CEehhhcCcceEEEcCCC-cEEEeeccccccccCCcce
Confidence            75 66655543   234678999999999999999999987 999999999999999887 8999999998765322211


Q ss_pred             c---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          231 I---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       231 ~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .   ....+..|+|||.+.+.. ++.++|+||||+++|+|++ |..||...........+....                
T Consensus       150 ~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~----------------  212 (251)
T cd05041         150 VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY----------------  212 (251)
T ss_pred             eccccCcceeccCChHhhccCC-CCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC----------------
Confidence            1   122355699999986554 7899999999999999998 889997765443333222110                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                  ....+..++.++.+++.+||..+|.+|||+.++++.|.
T Consensus       213 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 ------------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ------------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                        00133457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=8.9e-39  Score=286.27  Aligned_cols=249  Identities=26%  Similarity=0.368  Sum_probs=195.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|.+.+.||+|+||.||+|.+...   ...|++|......     ....+|+.+++.++||||+++++.+..     . 
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-----~-   79 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-----N-   79 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-----C-
Confidence            3699999999999999999987544   3568999875432     245679999999999999999987632     1 


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||++ ++|.+.+...   ...+++..++.++.|++.||+|||+. |++|+||||+||+++.++ .++|+|||++
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~  154 (270)
T cd05056          80 PVWIVMELAPLGELRSYLQVN---KYSLDLASLILYSYQLSTALAYLESK-RFVHRDIAARNVLVSSPD-CVKLGDFGLS  154 (270)
T ss_pred             CcEEEEEcCCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccChheEEEecCC-CeEEccCcee
Confidence            2579999998 4777766532   34689999999999999999999986 999999999999999887 8999999998


Q ss_pred             cccccCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          222 KVLVKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       222 ~~~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .........  ....++..|+|||.+... .++.++|+||||+++|++++ |..||......+....+.+...       
T Consensus       155 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~-------  226 (270)
T cd05056         155 RYLEDESYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGER-------  226 (270)
T ss_pred             eecccccceecCCCCccccccChhhhccC-CCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCc-------
Confidence            765433211  122234679999988544 47899999999999999986 9999987766555443322100       


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                           ...+..++.++.+++.+||..+|.+|||+.++++.|..+.
T Consensus       227 ---------------------~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~  266 (270)
T cd05056         227 ---------------------LPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDIL  266 (270)
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                 0134567899999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.1e-38  Score=282.33  Aligned_cols=240  Identities=22%  Similarity=0.359  Sum_probs=187.6

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      +.||+|+||.||+|.. .++..+|+|.+....     ....+|+.+++.++||||+++++.+..     ....++||||+
T Consensus         1 ~~ig~g~~g~vy~~~~-~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~e~~   74 (250)
T cd05085           1 ELLGKGNFGEVFKGTL-KDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQ-----RQPIYIVMELV   74 (250)
T ss_pred             CccCCCCCceEEEEEe-cCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEec-----CCccEEEEECC
Confidence            3689999999999985 468899999875432     235579999999999999999998733     33478999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      ++ +|.+.+..   ....+++..+..++.|++.||.|||++ |++||||||+||+++.++ .++|+|||++.........
T Consensus        75 ~~~~L~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~~~H~dl~p~nili~~~~-~~~l~d~g~~~~~~~~~~~  149 (250)
T cd05085          75 PGGDFLSFLRK---KKDELKTKQLVKFALDAAAGMAYLESK-NCIHRDLAARNCLVGENN-VLKISDFGMSRQEDDGIYS  149 (250)
T ss_pred             CCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccChheEEEcCCC-eEEECCCccceeccccccc
Confidence            84 66655542   234678999999999999999999987 999999999999999887 8999999998654332211


Q ss_pred             c--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          231 I--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       231 ~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      .  ...++..|+|||.+.+. .++.++|+||||+++|++++ |..||...........+....                 
T Consensus       150 ~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~-----------------  211 (250)
T cd05085         150 SSGLKQIPIKWTAPEALNYG-RYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY-----------------  211 (250)
T ss_pred             cCCCCCCcccccCHHHhccC-CCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-----------------
Confidence            1  12335679999998654 47889999999999999998 999998765544333322110                 


Q ss_pred             cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                 ....+..++..+.+++.+||..+|++||++.++++.|.
T Consensus       212 -----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 -----------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                       00133457899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.9e-38  Score=281.48  Aligned_cols=247  Identities=34%  Similarity=0.500  Sum_probs=198.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||+|++|.||+|.+..++..|++|++....      ....+|+.++++++|+||+++++.+....   ....+
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~---~~~~~   77 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEE---KNTLN   77 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCC---CCeEE
Confidence            4889999999999999999999899999999885543      34567999999999999999988874321   25578


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +++||++ ++|.+.+..    ...+++..++.++.|++.||.|||+. |++|+||+|+||+++.++ .++|+|||.+...
T Consensus        78 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~h~dl~p~ni~i~~~~-~~~l~d~~~~~~~  151 (260)
T cd06606          78 IFLEYVSGGSLSSLLKK----FGKLPEPVIRKYTRQILEGLAYLHSN-GIVHRDIKGANILVDSDG-VVKLADFGCAKRL  151 (260)
T ss_pred             EEEEecCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEcCCC-CEEEcccccEEec
Confidence            9999996 577666654    33889999999999999999999986 999999999999999887 8999999998876


Q ss_pred             ccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....   .....++..|+|||.+.+.. .+.++|+||||+++|+|++|..||........  .......          
T Consensus       152 ~~~~~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~~----------  218 (260)
T cd06606         152 GDIETGEGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCTVIEMATGKPPWSELGNPMA--ALYKIGS----------  218 (260)
T ss_pred             ccccccccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHH--HHHhccc----------
Confidence            55543   34466788999999986554 78999999999999999999999977652211  1111100          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ......++..++..+.+++.+||..||.+||++.++++|
T Consensus       219 --------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         219 --------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             --------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhC
Confidence                          000111455678999999999999999999999996554

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8e-39  Score=287.96  Aligned_cols=249  Identities=26%  Similarity=0.339  Sum_probs=196.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|++.+.||+|+||.||+|.+..+|.    .+|+|......     ....+|+.+++.++|+||+++++++..     
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----   80 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-----   80 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-----
Confidence            3579999999999999999999876665    58999875442     344579999999999999999988743     


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                       ...+++|||+. ++|.+.+..   ....+++..+..++.||+.||+|||+. ||+|+||||+||+++.++ .+||+|||
T Consensus        81 -~~~~~v~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~di~p~nil~~~~~-~~kL~dfg  154 (279)
T cd05057          81 -SQVQLITQLMPLGCLLDYVRN---HKDNIGSQYLLNWCVQIAKGMSYLEEK-RLVHRDLAARNVLVKTPQ-HVKITDFG  154 (279)
T ss_pred             -CceEEEEecCCCCcHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecccCcceEEEcCCC-eEEECCCc
Confidence             23689999997 477666543   234689999999999999999999986 999999999999999887 89999999


Q ss_pred             CccccccCCCccc---ccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .+...........   ..++..|+|||.+... .++.++|+||||+++|++++ |..||.+....+....+.... ..  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--  230 (279)
T cd05057         155 LAKLLDVDEKEYHAEGGKVPIKWMALESILHR-IYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGE-RL--  230 (279)
T ss_pred             ccccccCcccceecCCCcccccccCHHHhhcC-CcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCC-CC--
Confidence            9976543322211   2225679999988544 47899999999999999998 999998766544333332210 00  


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                               ..+...+..+.+++.+||..||++|||+.++++.|..+
T Consensus       231 -------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~  268 (279)
T cd05057         231 -------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKM  268 (279)
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                                     02344678899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=7.9e-39  Score=287.76  Aligned_cols=242  Identities=32%  Similarity=0.586  Sum_probs=197.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +|.+.+.||.|++|.||+|.+..+|..||+|++...       .....+|.++++.+. |+||+++++.+     .....
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~-----~~~~~   76 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTF-----QDEEN   76 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHh-----cCCce
Confidence            699999999999999999999999999999988542       234557889999998 99999999887     44455


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++||++. ++|.+.+..    ...+++..++.++.|++.||.+||+. |++|+||+|+||+++.++ .++|+|||++.
T Consensus        77 ~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~i~~ql~~~l~~Lh~~-~~~H~dl~~~ni~i~~~~-~~~l~df~~~~  150 (280)
T cd05581          77 LYFVLEYAPNGELLQYIRK----YGSLDEKCTRFYAAEILLALEYLHSK-GIIHRDLKPENILLDKDM-HIKITDFGTAK  150 (280)
T ss_pred             EEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHeEECCCC-CEEecCCcccc
Confidence            889999995 677776654    35799999999999999999999986 999999999999999888 89999999987


Q ss_pred             ccccCCC---------------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017452          223 VLVKGEP---------------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (371)
Q Consensus       223 ~~~~~~~---------------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (371)
                      .......                     .....++..|+|||.+.... ++.++|+||||++++++++|..||...+...
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  229 (280)
T cd05581         151 VLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYL  229 (280)
T ss_pred             ccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            6533221                     12335678899999986544 7889999999999999999999998776544


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH----HHHhhh
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----VSKRIL  354 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~----~~~l~~  354 (371)
                      .+..+...                             ...++..+++.+.+||.+||+.||.+||++    .++++|
T Consensus       230 ~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         230 TFQKILKL-----------------------------EYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             HHHHHHhc-----------------------------CCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            44333321                             011445678999999999999999999999    885554

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-41  Score=301.40  Aligned_cols=245  Identities=26%  Similarity=0.417  Sum_probs=214.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+.+++..||-||||.|-++........+|+|++++.       .+....|-.+|.....|.||++|..|     .++.|
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTf-----rd~ky  494 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTF-----RDSKY  494 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHh-----ccchh
Confidence            3577888999999999999987666556899987543       34455788999999999999999999     88889


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|++||-|- |.++..+..    .+.|.+..++.++..+++|++|||++ |||+|||||+|.+++.+| -+||.|||+|+
T Consensus       495 vYmLmEaClGGElWTiLrd----Rg~Fdd~tarF~~acv~EAfeYLH~k-~iIYRDLKPENllLd~~G-y~KLVDFGFAK  568 (732)
T KOG0614|consen  495 VYMLMEACLGGELWTILRD----RGSFDDYTARFYVACVLEAFEYLHRK-GIIYRDLKPENLLLDNRG-YLKLVDFGFAK  568 (732)
T ss_pred             hhhhHHhhcCchhhhhhhh----cCCcccchhhhhHHHHHHHHHHHHhc-CceeccCChhheeeccCC-ceEEeehhhHH
Confidence            999999887 466666655    67899999999999999999999987 999999999999999998 89999999999


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....+....+++|||.|.|||++.... ...++|+||||+++|||++|.+||.+.++...+..|.+.+...         
T Consensus       569 ki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i---------  638 (732)
T KOG0614|consen  569 KIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKI---------  638 (732)
T ss_pred             HhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhh---------
Confidence            999999999999999999999997655 6889999999999999999999999999999998888864211         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                        .+|..++....+||+++.+.+|.+|+.     +.++.+|
T Consensus       639 ------------------~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH  677 (732)
T KOG0614|consen  639 ------------------EFPRRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKH  677 (732)
T ss_pred             ------------------hcccccchhHHHHHHHHHhcCcHhhhccccCChHHHHhh
Confidence                              167889999999999999999999986     7777666

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=1.9e-38  Score=286.48  Aligned_cols=244  Identities=30%  Similarity=0.448  Sum_probs=194.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .|...+.||+|++|.||++.+..+++.+++|++...    .....+|+.+++.++|+|++++++.+..     ..+.+++
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~-----~~~~~~v   94 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLV-----GDELWVV   94 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEc-----CCeEEEE
Confidence            356667999999999999999999999999987532    2335678999999999999999998743     3447899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +||+.+ +|.+.+..     ..+++..+..++.|++.||+|||++ ||+||||+|+||+++.++ .++|+|||.+.....
T Consensus        95 ~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~ql~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~d~g~~~~~~~  167 (285)
T cd06648          95 MEFLEGGALTDIVTH-----TRMNEEQIATVCLAVLKALSFLHAQ-GVIHRDIKSDSILLTSDG-RVKLSDFGFCAQVSK  167 (285)
T ss_pred             EeccCCCCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChhhEEEcCCC-cEEEcccccchhhcc
Confidence            999975 66665542     5689999999999999999999987 999999999999999887 899999998765433


Q ss_pred             CC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          227 GE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       227 ~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .. ......+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+.... .+            
T Consensus       168 ~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~-~~------------  233 (285)
T cd06648         168 EVPRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNL-PP------------  233 (285)
T ss_pred             CCcccccccCCccccCHHHhcCCC-CCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcC-CC------------
Confidence            22 122346788999999986554 7899999999999999999999997766544443332210 00            


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   ....+..++..+.+++.+||..+|++|||+.++++|
T Consensus       234 -------------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         234 -------------KLKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             -------------CCcccccCCHHHHHHHHHHcccChhhCcCHHHHccC
Confidence                         000122368899999999999999999999998887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.6e-38  Score=280.24  Aligned_cols=243  Identities=35%  Similarity=0.573  Sum_probs=197.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +|.+.+.||+|++|.||++.+..+++.|++|.+....      ....+|++++++++|+|++++++++..     ....+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-----~~~~~   75 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIET-----SDSLY   75 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEe-----CCEEE
Confidence            4889999999999999999999999999999986543      245679999999999999999888733     34588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+++ +|.+.+..    ...+++..++.++.|++.||.+||+. ||+||||+|+||+++.++ .++|+|||.+...
T Consensus        76 ~v~e~~~~~~L~~~~~~----~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~  149 (254)
T cd06627          76 IILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGLAYLHEQ-GVIHRDIKAANILTTKDG-VVKLADFGVATKL  149 (254)
T ss_pred             EEEecCCCCcHHHHHHh----ccCCCHHHHHHHHHHHHHHHHHHhhC-CcccCCCCHHHEEECCCC-CEEEeccccceec
Confidence            99999986 66666553    36789999999999999999999986 999999999999999877 8999999998876


Q ss_pred             ccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..... .....++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+...........              
T Consensus       150 ~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--------------  214 (254)
T cd06627         150 NDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQD--------------  214 (254)
T ss_pred             CCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc--------------
Confidence            54333 23456788899999986554 788999999999999999999999766543333322210              


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ....++..++..+.+++.+||..+|++|||+.+++.|
T Consensus       215 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         215 --------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             --------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcC
Confidence                          0011445678999999999999999999999996544

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=8.2e-40  Score=320.84  Aligned_cols=255  Identities=28%  Similarity=0.416  Sum_probs=191.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC----
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK----  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~----  139 (371)
                      ...+|...+.||+||||.||+++.+-+|..||||++...     ...+.+|+..|.+|+|||||+++..+.+....    
T Consensus       477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~  556 (1351)
T KOG1035|consen  477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL  556 (1351)
T ss_pred             HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence            345688899999999999999999999999999998544     34456899999999999999997655211100    


Q ss_pred             --------------------------------------------------------------------------------
Q 017452          140 --------------------------------------------------------------------------------  139 (371)
Q Consensus       140 --------------------------------------------------------------------------------  139 (371)
                                                                                                      
T Consensus       557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~  636 (1351)
T KOG1035|consen  557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS  636 (1351)
T ss_pred             cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence                                                                                            


Q ss_pred             ------------------------------CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH
Q 017452          140 ------------------------------DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH  189 (371)
Q Consensus       140 ------------------------------~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  189 (371)
                                                    ...++||-||||+.++...+-+.+....  ....+++++++|+.||.|+|
T Consensus       637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH  714 (1351)
T KOG1035|consen  637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH  714 (1351)
T ss_pred             CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence                                          0156899999999876666655332111  46779999999999999999


Q ss_pred             hcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc-------------------cCCCcccccccccccCcccccCCc-
Q 017452          190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-------------------KGEPNISYICSRYYRAPELIFGAT-  249 (371)
Q Consensus       190 ~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~-------------------~~~~~~~~~~t~~y~aPE~~~~~~-  249 (371)
                      ++ |||||||||.||++++++ .|||+|||+|+...                   +....+..+||.-|+|||++.+.. 
T Consensus       715 ~~-giIHRDLKP~NIFLd~~~-~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~  792 (1351)
T KOG1035|consen  715 DQ-GIIHRDLKPRNIFLDSRN-SVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSS  792 (1351)
T ss_pred             hC-ceeeccCCcceeEEcCCC-CeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccc
Confidence            87 999999999999999887 89999999998721                   011234678899999999997655 


Q ss_pred             -CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCCh
Q 017452          250 -EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP  328 (371)
Q Consensus       250 -~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  328 (371)
                       .|+.|+||||||++|+||+.   ||..  ..+....+ ..++..               .+|.-      .-+...--+
T Consensus       793 ~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~iL-~~LR~g---------------~iP~~------~~f~~~~~~  845 (1351)
T KOG1035|consen  793 NKYNSKIDMYSLGIVLFEMLY---PFGT--SMERASIL-TNLRKG---------------SIPEP------ADFFDPEHP  845 (1351)
T ss_pred             ccccchhhhHHHHHHHHHHhc---cCCc--hHHHHHHH-HhcccC---------------CCCCC------cccccccch
Confidence             58999999999999999995   4543  22222222 211111               11110      002222345


Q ss_pred             hHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          329 EAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       329 ~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .-..+|++||++||++||||.|+|++
T Consensus       846 ~e~slI~~Ll~hdP~kRPtA~eLL~s  871 (1351)
T KOG1035|consen  846 EEASLIRWLLSHDPSKRPTATELLNS  871 (1351)
T ss_pred             HHHHHHHHHhcCCCccCCCHHHHhhc
Confidence            66789999999999999999999988

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=279.58  Aligned_cols=247  Identities=26%  Similarity=0.474  Sum_probs=199.6

Q ss_pred             CCCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceeEE
Q 017452           63 RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFF  134 (371)
Q Consensus        63 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (371)
                      .........+|.+.+.||+|+|.+|..++.+.+.+.||+|+++++       ....+.|..+..+- +||.+|-+..|| 
T Consensus       242 ~~~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscf-  320 (593)
T KOG0695|consen  242 KISQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCF-  320 (593)
T ss_pred             ccccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhh-
Confidence            334445567899999999999999999999999999999998654       23334566666554 799999999998 


Q ss_pred             ecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEE
Q 017452          135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (371)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~k  214 (371)
                          .....+++|.||++|+  +++.+.++ ++.++++.++.+...|+.||.|||++ |||+||||.+|||+|.+| .+|
T Consensus       321 ----qtesrlffvieyv~gg--dlmfhmqr-qrklpeeharfys~ei~lal~flh~r-giiyrdlkldnvlldaeg-hik  391 (593)
T KOG0695|consen  321 ----QTESRLFFVIEYVNGG--DLMFHMQR-QRKLPEEHARFYSAEICLALNFLHER-GIIYRDLKLDNVLLDAEG-HIK  391 (593)
T ss_pred             ----cccceEEEEEEEecCc--ceeeehhh-hhcCcHHHhhhhhHHHHHHHHHHhhc-CeeeeeccccceEEccCC-cee
Confidence                5566689999999975  44444332 67899999999999999999999997 999999999999999999 799


Q ss_pred             EEeeCCcccc-ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCC-------CCCcHHHHHHH
Q 017452          215 LCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP-------GDSGVDQLVEI  286 (371)
Q Consensus       215 l~Dfg~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~-------~~~~~~~~~~~  286 (371)
                      |+|+|.++.. .++...++.+|||.|.|||++.+.. |+..+|+|+||++++||+.|+.||.       ..+..+.+.++
T Consensus       392 ltdygmcke~l~~gd~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqv  470 (593)
T KOG0695|consen  392 LTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQV  470 (593)
T ss_pred             ecccchhhcCCCCCcccccccCCCcccchhhhcccc-cCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHH
Confidence            9999998763 4566677899999999999997755 8999999999999999999999994       12233333333


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~  348 (371)
                      +-.                     .++       .+|..+|-.+..+++..|.+||.+|+.-
T Consensus       471 ile---------------------kqi-------riprslsvkas~vlkgflnkdp~erlgc  504 (593)
T KOG0695|consen  471 ILE---------------------KQI-------RIPRSLSVKASHVLKGFLNKDPKERLGC  504 (593)
T ss_pred             Hhh---------------------hcc-------cccceeehhhHHHHHHhhcCCcHHhcCC
Confidence            221                     011       1567788889999999999999999753

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2.5e-39  Score=287.98  Aligned_cols=238  Identities=20%  Similarity=0.255  Sum_probs=182.9

Q ss_pred             EeeccCCceEEEEEEECCCCc-------EEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           77 RIVGQGSFGVVFQAKCLETGE-------TVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~-------~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +.||.|+||.||+|.+...+.       .+++|.+....    ....+|..+++.++|||++++++.+...     ...+
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-----~~~~   75 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-----DESI   75 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-----CCcE
Confidence            368999999999999865544       38888775432    3345688899999999999999988543     2367


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc-------EEEEe
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-------VKLCD  217 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~-------~kl~D  217 (371)
                      +||||+++ +|...+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++..       ++++|
T Consensus        76 lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          76 MVQEYVKFGSLDTYLKKN---KNLINISWKLEVAKQLAWALHFLEDK-GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             EEEecCCCCcHHHHHhcC---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccceEEEecccccccCCCceEEecc
Confidence            99999985 666665532   34689999999999999999999986 99999999999999877632       79999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ||.+.....   .....++..|+|||.+.+...++.++|+||||+++|+|++|. .||...+...... ....       
T Consensus       152 ~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~-~~~~-------  220 (258)
T cd05078         152 PGISITVLP---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQ-FYED-------  220 (258)
T ss_pred             cccccccCC---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHH-HHHc-------
Confidence            998865432   223457888999999876555788999999999999999985 6665444332211 1110       


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                            ...++...+.++.+++.+||+.||.+|||++++++.|.
T Consensus       221 ----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         221 ----------------------RHQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             ----------------------cccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                                  00134446788999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=1.2e-38  Score=282.84  Aligned_cols=244  Identities=23%  Similarity=0.340  Sum_probs=193.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .+|++.+.||+|+||.||++..  +++.||+|.+..+  .....+|+.+++.++|||++++++++..     . ..+++|
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-----~-~~~~v~   77 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILH-----N-GLYIVM   77 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcC-----C-CcEEEE
Confidence            4699999999999999999864  7889999988643  3345679999999999999999887732     1 157999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+. ++|.+.+...  ....+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+|||++......
T Consensus        78 e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~-~~~H~dl~p~nili~~~~-~~kl~Dfg~~~~~~~~  153 (254)
T cd05083          78 ELMSKGNLVNFLRTR--GRALVSVIQLLQFSLDVAEGMEYLESK-KLVHRDLAARNILVSEDG-VAKVSDFGLARVGSMG  153 (254)
T ss_pred             ECCCCCCHHHHHHhc--CcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccccCcceEEEcCCC-cEEECCCccceecccc
Confidence            9998 4777776542  234688999999999999999999986 999999999999999887 8999999998754322


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      .  .....+..|+|||.+.+.. ++.++|+||||+++|+|++ |+.||...+..+....+.+..                
T Consensus       154 ~--~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----------------  214 (254)
T cd05083         154 V--DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGY----------------  214 (254)
T ss_pred             C--CCCCCCceecCHHHhccCC-cCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCC----------------
Confidence            1  2233456799999886544 7889999999999999997 999998766544333222110                


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                  ....+..++..+.+++.+||+.+|.+||++.++++.|++
T Consensus       215 ------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         215 ------------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             ------------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence                        000234578999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.2e-38  Score=287.48  Aligned_cols=264  Identities=23%  Similarity=0.334  Sum_probs=192.8

Q ss_pred             ceeeeEeeccCCceEEEEEEE----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      -|++.+.||+|+||.||+|..    ..++..||+|.+...     .....+|+.+++.++|||++++.+++..   .+..
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~   81 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE---DGGN   81 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEec---CCCC
Confidence            379999999999999999974    457889999988533     2345679999999999999999887743   2234


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ |++||||||+||+++.++ .++|+|||++
T Consensus        82 ~~~lv~e~~~g~~L~~~l~~~---~~~~~~~~~~~i~~~i~~aL~~lH~~-gi~H~dlkp~Nil~~~~~-~~~l~dfg~~  156 (284)
T cd05079          82 GIKLIMEFLPSGSLKEYLPRN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGLT  156 (284)
T ss_pred             ceEEEEEccCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccchheEEEcCCC-CEEECCCccc
Confidence            4789999997 4676665431   34689999999999999999999987 999999999999999887 8999999998


Q ss_pred             cccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCHh
Q 017452          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~~  296 (371)
                      .........    ....++..|+|||.+.+.. ++.++|+||||+++|+|+++..|+.....  ........ .+.....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il~ellt~~~~~~~~~~--~~~~~~~~~~~~~~~~  233 (284)
T cd05079         157 KAIETDKEYYTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTLYELLTYCDSESSPMT--LFLKMIGPTHGQMTVT  233 (284)
T ss_pred             cccccCccceeecCCCCCCccccCHHHhccCC-CCccccchhhhhhhhhhhcCCCCCccccc--hhhhhcccccccccHH
Confidence            765433221    1334566799999986544 78999999999999999998766533211  00000000 0000000


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .....           .....+ ...+..++..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       234 ~~~~~-----------~~~~~~-~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         234 RLVRV-----------LEEGKR-LPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHHH-----------HHcCcc-CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            00000           000000 012345789999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2.5e-38  Score=286.35  Aligned_cols=247  Identities=27%  Similarity=0.461  Sum_probs=192.7

Q ss_pred             ceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc--------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      +|++.+.||.|+||.||+|.+.   .+|..||+|++...        .....+|+.+++.+ +|+||+++++++     .
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~-----~   75 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF-----Q   75 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEe-----e
Confidence            4889999999999999999875   47899999988642        13345789999999 599999998887     4


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .....++||||+++ +|.+.+..    ...+++..+..++.|++.||.|||+. |++||||||+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~i~H~dl~p~nil~~~~~-~~kl~df  149 (290)
T cd05613          76 TDTKLHLILDYINGGELFTHLSQ----RERFKEQEVQIYSGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLTDF  149 (290)
T ss_pred             cCCeEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeEECCCC-CEEEeeC
Confidence            44568899999995 66666543    45788999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCC--CcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          219 GSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       219 g~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |++.......  ......++..|+|||.+... ..++.++|+||||+++|+|++|..||...........+.......  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~--  227 (290)
T cd05613         150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKS--  227 (290)
T ss_pred             ccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhcc--
Confidence            9987654322  12245678899999998643 236788999999999999999999997543322222222211000  


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                             ...++..+++.+.+++.+||..||.+||     ++.+++.|
T Consensus       228 -----------------------~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         228 -----------------------EPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             -----------------------CCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence                                   0003455788999999999999999997     78997777

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.3e-38  Score=285.11  Aligned_cols=248  Identities=21%  Similarity=0.271  Sum_probs=184.8

Q ss_pred             eeccCCceEEEEEEECC--CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecc
Q 017452           78 IVGQGSFGVVFQAKCLE--TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .||+|+||.||+|....  ....+++|.+....     ....+|+..++.++|+||+++++.+.     .....++||||
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~-----~~~~~~lv~e~   76 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCI-----ESIPYLLVLEF   76 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEEC-----CCCceEEEEEe
Confidence            58999999999996432  34578888764331     23457889999999999999999873     33447899999


Q ss_pred             cc-chHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          151 VP-ETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       151 ~~-~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      ++ |+|.+.+..... .....++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++.......
T Consensus        77 ~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~-~~kl~dfg~~~~~~~~~  154 (269)
T cd05042          77 CPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA-DFIHSDLALRNCQLTADL-SVKIGDYGLALEQYPED  154 (269)
T ss_pred             CCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc-CEecccccHhheEecCCC-cEEEeccccccccccch
Confidence            98 477777665322 123456788899999999999999987 999999999999999888 89999999986543221


Q ss_pred             C---cccccccccccCcccccC------CcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          229 P---NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       229 ~---~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .   .....++..|+|||++..      ...++.++|||||||++|+|++ |..||......+.+...........    
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~----  230 (269)
T cd05042         155 YYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKL----  230 (269)
T ss_pred             heeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccC----
Confidence            1   122344677999998742      2346789999999999999998 7889977665554444333211000    


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                         .....+..++..+.+++..|+ .||.+|||+.++++.+.
T Consensus       231 -------------------~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~  268 (269)
T cd05042         231 -------------------PKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT  268 (269)
T ss_pred             -------------------CCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence                               001134457889999999999 59999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=2.3e-38  Score=283.43  Aligned_cols=249  Identities=20%  Similarity=0.243  Sum_probs=185.1

Q ss_pred             EeeccCCceEEEEEEEC--CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCL--ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.||+|+||.||+|.+.  .++..+|+|.+....     ....+|+.+++.++||||+++++++.     +....++|||
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~~~~~lv~e   75 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCT-----EVTPYLLVME   75 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEc-----CCCCcEEEEE
Confidence            35899999999999854  355679999885432     24557999999999999999998873     3344789999


Q ss_pred             ccc-chHHHHHHHhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          150 YVP-ETVHRVVKHFNKL-NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       150 ~~~-~~l~~~~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      |++ ++|.+.+...... ....++..++.++.|++.||.|||+. +++|+||||+||+++.++ .++|+|||.+......
T Consensus        76 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dlkp~nil~~~~~-~~kL~dfg~~~~~~~~  153 (269)
T cd05087          76 FCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN-NFIHSDLALRNCLLTADL-TVKIGDYGLSHNKYKE  153 (269)
T ss_pred             CCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CEeccccCcceEEEcCCC-cEEECCccccccccCc
Confidence            998 5777776543221 23566778889999999999999987 999999999999999887 8999999998754332


Q ss_pred             CC---cccccccccccCcccccCC------cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          228 EP---NISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       228 ~~---~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ..   .....++..|+|||++...      ..++.++|+||||+++|+|++ |..||......+............    
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~----  229 (269)
T cd05087         154 DYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLK----  229 (269)
T ss_pred             ceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCC----
Confidence            21   1223467789999998532      125789999999999999996 999997765544333222110000    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                  .+       ........+..+.+++.+|+ .+|.+|||+++++..|+
T Consensus       230 ------------~~-------~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         230 ------------LP-------KPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             ------------CC-------CCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence                        00       00022346788999999999 68999999999998764

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.4e-38  Score=283.88  Aligned_cols=238  Identities=18%  Similarity=0.190  Sum_probs=178.2

Q ss_pred             EeeccCCceEEEEEEECC------------CCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           77 RIVGQGSFGVVFQAKCLE------------TGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~------------~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      +.||+|+||.||+|....            ....+++|.+....    ....+|+.+++.++||||+++++++..     
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~-----   75 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVR-----   75 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----
Confidence            368999999999998532            22358888775432    234567889999999999999998743     


Q ss_pred             ceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC------cE
Q 017452          141 ELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH------QV  213 (371)
Q Consensus       141 ~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~------~~  213 (371)
                      ....+++|||++++ |...+..   ....+++..++.++.||+.||+|||++ +|+||||||+|||++.++.      .+
T Consensus        76 ~~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          76 DVENIMVEEFVEFGPLDLFMHR---KSDVLTTPWKFKVAKQLASALSYLEDK-DLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             CCCCEEEEecccCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHhhhC-CeECCCCCcccEEEecCCccCCCCcee
Confidence            33467999999964 4433321   235689999999999999999999987 9999999999999986552      28


Q ss_pred             EEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          214 KLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      +++|||++.....   .....++..|+|||.+.....++.++|||||||++|+|+ +|..||......+.. .....   
T Consensus       152 ~l~d~g~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~-~~~~~---  224 (262)
T cd05077         152 KLSDPGIPITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKE-RFYEG---  224 (262)
T ss_pred             EeCCCCCCccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHH-HHHhc---
Confidence            9999998865422   123456788999998865556889999999999999998 588888764432211 11110   


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      .                .          ......+.++.+|+.+||+.||.+||++.++++++.
T Consensus       225 ~----------------~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~~  262 (262)
T cd05077         225 Q----------------C----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDIN  262 (262)
T ss_pred             C----------------c----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhcC
Confidence            0                0          011224678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-40  Score=309.17  Aligned_cols=283  Identities=24%  Similarity=0.350  Sum_probs=207.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec-----chhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~  144 (371)
                      .-|...+.||+|+||.||+++++.+|+.||||.+.+     +.+..-+|+++|++++|+|||+++++-..... .-...-
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccc
Confidence            347888999999999999999999999999998865     23444579999999999999998775421110 002224


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC--C-CcEEEEeeCC
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--T-HQVKLCDFGS  220 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~--~-~~~kl~Dfg~  220 (371)
                      .+|||||.| +|...+.... ...++++.++..++..++.||.|||++ |||||||||.||++-..  | ...||+|||.
T Consensus        93 vlvmEyC~gGsL~~~L~~PE-N~~GLpE~e~l~lL~d~~~al~~LrEn-~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~  170 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPE-NAYGLPESEFLDLLSDLVSALRHLREN-GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGA  170 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcc-cccCCCHHHHHHHHHHHHHHHHHHHHc-CceeccCCCCcEEEeecCCCceEEeeecccc
Confidence            689999995 7666665433 256899999999999999999999987 99999999999997422  2 3689999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH----HHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV----DQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~  296 (371)
                      |+...++....+.+||+.|.+||.+..+..|+..+|.|||||++|+++||..||-.....    +.+..+...   ++..
T Consensus       171 Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tk---kp~~  247 (732)
T KOG4250|consen  171 ARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITK---KPSG  247 (732)
T ss_pred             cccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhcc---CCCc
Confidence            999999998899999999999999965567999999999999999999999999554333    233333221   1111


Q ss_pred             HHhhcCCCccccccCcccCC--CCcccCCC--CCCh----hHHHHHHhccCcCCCCCC--CHHHHhhhhcCCCcchhhcc
Q 017452          297 EIKCMNPNYTEFKFPQIKAH--PWHKIFPK--RMPP----EAVDLVSRLLQYSPNLRC--TAVSKRILFSNCPSLLVLHH  366 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~s~----~l~~li~~~l~~dP~~R~--t~~~~l~~l~~~~~~~~~~~  366 (371)
                               -.+...+....  .|...+|.  .++.    .+-..+..+|..+|++|.  ...+.-....++.+..++|.
T Consensus       248 ---------v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~~vvhi  318 (732)
T KOG4250|consen  248 ---------VAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNLKVVHI  318 (732)
T ss_pred             ---------eeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhhheeEE
Confidence                     11111111111  23333332  3333    345678889999999999  66665555555555555554


Q ss_pred             c
Q 017452          367 F  367 (371)
Q Consensus       367 ~  367 (371)
                      +
T Consensus       319 F  319 (732)
T KOG4250|consen  319 F  319 (732)
T ss_pred             E
Confidence            4

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.1e-38  Score=284.07  Aligned_cols=246  Identities=23%  Similarity=0.434  Sum_probs=193.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||+|+||.||++.+..++..+++|.++..         .....+|+.+++.++||||+++++.+.     ...
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~   75 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFL-----ERD   75 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHh-----cCC
Confidence            589999999999999999999877777777665421         123446888999999999999998873     333


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++|+||+.+ +|.+.+.........+++..++.++.|++.||.|||+. |++|+||||+||+++. + .++|+|||.+
T Consensus        76 ~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~h~~l~~~nili~~-~-~~~l~d~g~~  152 (260)
T cd08222          76 AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR-RILHRDLKAKNIFLKN-N-LLKIGDFGVS  152 (260)
T ss_pred             ceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc-CccccCCChhheEeec-C-CEeecccCce
Confidence            47899999985 77777765545567899999999999999999999986 9999999999999975 3 6999999998


Q ss_pred             cccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ........ .....+++.|+|||.+.+. .++.++|+||||+++|+|++|..||...........+...   ..      
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~---~~------  222 (260)
T cd08222         153 RLLMGSCDLATTFTGTPYYMSPEALKHQ-GYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEG---PT------  222 (260)
T ss_pred             eecCCCcccccCCCCCcCccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcC---CC------
Confidence            76543322 2245578889999988544 3788999999999999999999999765544333332211   00      


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ...+..++.++.++|.+||..||.+||++.++++|
T Consensus       223 -------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         223 -------------------PSLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             -------------------CCCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhC
Confidence                               01344578899999999999999999999996655

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=286.28  Aligned_cols=237  Identities=19%  Similarity=0.223  Sum_probs=179.8

Q ss_pred             eeccCCceEEEEEEECCC------------------------CcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeec
Q 017452           78 IVGQGSFGVVFQAKCLET------------------------GETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSL  129 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~------------------------~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~  129 (371)
                      .||+|+||.||+|....+                        ...|++|++....    ....+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            689999999999974321                        2358888875432    234567888999999999999


Q ss_pred             ceeEEecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          130 KHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      ++++..     ....++||||++++ |...+.   .....+++..+..++.||+.||+|||++ ||+||||||+||+++.
T Consensus        82 ~~~~~~-----~~~~~lv~ey~~~g~L~~~l~---~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~iiH~dlkp~Nill~~  152 (274)
T cd05076          82 HGVCVR-----GSENIMVEEFVEHGPLDVCLR---KEKGRVPVAWKITVAQQLASALSYLEDK-NLVHGNVCAKNILLAR  152 (274)
T ss_pred             EEEEEe-----CCceEEEEecCCCCcHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHcC-CccCCCCCcccEEEec
Confidence            998843     33478999999964 444443   2245789999999999999999999987 9999999999999975


Q ss_pred             CC------CcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHH
Q 017452          209 HT------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD  281 (371)
Q Consensus       209 ~~------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~  281 (371)
                      ++      ..++++|||.+......   ....++..|+|||.+.+...++.++|+||||+++|+++ +|..||......+
T Consensus       153 ~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  229 (274)
T cd05076         153 LGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSE  229 (274)
T ss_pred             cCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHH
Confidence            43      13899999987643221   23356778999999866556799999999999999985 7999997655433


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      ... .....                             ..++...++.+.++|.+||+.+|.+|||+.+++++|.
T Consensus       230 ~~~-~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~  274 (274)
T cd05076         230 KER-FYEKK-----------------------------HRLPEPSCKELATLISQCLTYEPTQRPSFRTILRDLT  274 (274)
T ss_pred             HHH-HHHhc-----------------------------cCCCCCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence            221 11110                             0023335678999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=1.4e-38  Score=283.52  Aligned_cols=234  Identities=31%  Similarity=0.544  Sum_probs=188.0

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||.|+||.||++.+..+|+.+++|.+....       ....+|+.+++.++|+||+++++.+     ......++++||+
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~-----~~~~~~~lv~e~~   75 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSF-----QGKKNLYLVMEYL   75 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHhe-----ecCcEEEEEEecC
Confidence            689999999999999999999999885432       2455788999999999999998887     4455688999999


Q ss_pred             cc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC--
Q 017452          152 PE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE--  228 (371)
Q Consensus       152 ~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~--  228 (371)
                      .+ +|.+.+..    ...+++..+..++.||+.||.|||+. |++|+||+|+||+++.++ .++|+|||++.......  
T Consensus        76 ~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~di~~~nil~~~~~-~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          76 PGGDLASLLEN----VGSLDEDVARIYIAEIVLALEYLHSN-GIIHRDLKPDNILIDSNG-HLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             CCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCCCHHHeEEcCCC-CEEEEecccchhcccCccc
Confidence            75 77776654    34789999999999999999999987 999999999999999988 89999999887643321  


Q ss_pred             -------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          229 -------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       229 -------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                             ......++..|+|||.+.... .+.++|+||||+++|++++|..||......+....+...  ..        
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~--~~--------  218 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNG--KI--------  218 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcC--Cc--------
Confidence                   122345678899999986655 788999999999999999999999876655444333220  00        


Q ss_pred             CCCccccccCcccCCCCcccCCC--CCChhHHHHHHhccCcCCCCCCCH---HHHhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA---VSKRI  353 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~--~~s~~l~~li~~~l~~dP~~R~t~---~~~l~  353 (371)
                             .            .+.  .++..+.+++.+||+.+|.+|||+   .++++
T Consensus       219 -------~------------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         219 -------E------------WPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             -------C------------CCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence                   0            111  248899999999999999999999   77443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.2e-39  Score=311.59  Aligned_cols=251  Identities=24%  Similarity=0.325  Sum_probs=208.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      +-+..+.||+|.||+||+|+.-.     +...||||.++..     ...++||++++..|+|||||++++.+...+.   
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P---  563 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDP---  563 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCe---
Confidence            46677899999999999998532     3357999988654     4567899999999999999999999954443   


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKL----------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                        +++|+|||. |+|.+++......          ..+++..+...|+.||+.|++||-++ .+|||||-..|+||..+.
T Consensus       564 --~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~-~FVHRDLATRNCLVge~l  640 (774)
T KOG1026|consen  564 --LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH-HFVHRDLATRNCLVGENL  640 (774)
T ss_pred             --eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-cccccchhhhhceeccce
Confidence              789999999 8999988765432          22378899999999999999999986 999999999999999888


Q ss_pred             CcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017452          211 HQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  286 (371)
                       .|||+|||+++........   ....-...|||||.+.-+. ++++|||||+||+|||+++ |+.||.+....+.+.-+
T Consensus       641 -~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~k-FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i  718 (774)
T KOG1026|consen  641 -VVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGK-FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECI  718 (774)
T ss_pred             -EEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCc-ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHH
Confidence             8999999999876443221   1233367799999997655 9999999999999999994 99999999998888877


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .++.-                            -..|++++.++++|+..||..+|.+||++.||-..|.+.
T Consensus       719 ~~g~l----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~  762 (774)
T KOG1026|consen  719 RAGQL----------------------------LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAW  762 (774)
T ss_pred             HcCCc----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHH
Confidence            65310                            015788999999999999999999999999998877654

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.2e-38  Score=289.16  Aligned_cols=249  Identities=26%  Similarity=0.401  Sum_probs=198.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..|...+.||+|++|.||+|++..++..+|+|.+...       .....+|+++++.++|+|++++.+++..     ...
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~   89 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT   89 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEc-----CCe
Confidence            3588889999999999999999999999999988532       1234468999999999999999998854     334


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++||||+.+++.+.+...   ...+++..++.++.|++.||.|||++ +++||||||+||+++.++ .++|+|||++..
T Consensus        90 ~~lv~e~~~~~l~~~~~~~---~~~l~~~~~~~~~~~l~~~l~~LH~~-~i~H~dl~p~nil~~~~~-~~kl~dfg~~~~  164 (308)
T cd06634          90 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  164 (308)
T ss_pred             eEEEEEccCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHhEEECCCC-cEEECCccccee
Confidence            7899999998877666432   35689999999999999999999987 999999999999999887 899999999876


Q ss_pred             cccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          224 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...   .....+++.|+|||.+.+  ...++.++|||||||++|+|++|..||...+..+....+..... +        
T Consensus       165 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~-~--------  232 (308)
T cd06634         165 MAP---ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------  232 (308)
T ss_pred             ecC---cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCC-C--------
Confidence            432   224467889999999742  23468899999999999999999999977654444333322100 0        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                        ......++..+.+||.+||..+|.+||++.++++|.....
T Consensus       233 ------------------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~  272 (308)
T cd06634         233 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLR  272 (308)
T ss_pred             ------------------CcCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccc
Confidence                              0012347889999999999999999999999999955444

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.5e-38  Score=289.68  Aligned_cols=248  Identities=23%  Similarity=0.316  Sum_probs=192.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|+..+.||+|+||.||+|.+..+|.    .+|+|.+....     ....+|+.+++.++||||+++++.+...     
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-----   81 (303)
T cd05110           7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-----   81 (303)
T ss_pred             hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-----
Confidence            468999999999999999999887776    46888775432     2345788999999999999999877421     


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                       ..+++++|++ |+|.+.+..   ....+++..+..++.|++.||.|||++ ||+|+||||+||+++.++ .+||+|||+
T Consensus        82 -~~~~v~e~~~~g~l~~~~~~---~~~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~dikp~Nill~~~~-~~kL~Dfg~  155 (303)
T cd05110          82 -TIQLVTQLMPHGCLLDYVHE---HKDNIGSQLLLNWCVQIAKGMMYLEER-RLVHRDLAARNVLVKSPN-HVKITDFGL  155 (303)
T ss_pred             -CceeeehhcCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHhhc-CeeccccccceeeecCCC-ceEEccccc
Confidence             1458999998 566666543   234688999999999999999999987 999999999999999877 899999999


Q ss_pred             ccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ++........   ....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+. ..+......++  
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~-~~~~~~~~~~~--  231 (303)
T cd05110         156 ARLLEGDEKEYNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIWELMTFGGKPYDGIPTREI-PDLLEKGERLP--  231 (303)
T ss_pred             cccccCcccccccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH-HHHHHCCCCCC--
Confidence            9865433221   1233467899999986544 7899999999999999997 8999976543332 22222110000  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                               .+...+..+.+++.+||..+|++||++.++++.|..+
T Consensus       232 -------------------------~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~  268 (303)
T cd05110         232 -------------------------QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRM  268 (303)
T ss_pred             -------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                     1234678899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.8e-38  Score=283.39  Aligned_cols=255  Identities=22%  Similarity=0.316  Sum_probs=193.7

Q ss_pred             eeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc-e
Q 017452           73 YMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE-L  142 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~-~  142 (371)
                      |.+.+.||+|+||.||+|.+.   .++..||||++..+.      ....+|+.+++.++||||+++++.+......+. .
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~   80 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP   80 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence            677889999999999999865   357899999886432      234578999999999999999987755433222 2


Q ss_pred             eEEEeecccc-chHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ..+++++|+. +++...+....  .....++...++.++.|++.||+|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~nili~~~~-~~kl~dfg  158 (273)
T cd05074          81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK-NFIHRDLAARNCMLNENM-TVCVADFG  158 (273)
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeecccchhhEEEcCCC-CEEECccc
Confidence            3467889987 46655554321  1123578899999999999999999987 999999999999999887 89999999


Q ss_pred             CccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      .+........   .....+++.|++||.+.... ++.++||||||+++|+|++ |..||...+..+....+... ..   
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~-~~---  233 (273)
T cd05074         159 LSKKIYSGDYYRQGCASKLPVKWLALESLADNV-YTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKG-NR---  233 (273)
T ss_pred             ccccccCCcceecCCCccCchhhcCHhHHhcCc-cchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcC-Cc---
Confidence            9886533221   12233457799999986544 7889999999999999998 88999776554433332221 00   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                              ...+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       234 ------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         234 ------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence                                    001234678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=278.62  Aligned_cols=279  Identities=34%  Similarity=0.553  Sum_probs=224.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+.+-.+.||.|+||.||.+.|..+|+.||+|++..-      .+...+|+++|..++|.|++..+++..-..-..-..+
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            3455567899999999999999999999999988542      3556789999999999999998887633222222236


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+++|.+..+|...+-.    .+.++...++-+++||++||.|||+. +|.||||||.|.|++++. .+||||||+++..
T Consensus       133 YV~TELmQSDLHKIIVS----PQ~Ls~DHvKVFlYQILRGLKYLHsA-~ILHRDIKPGNLLVNSNC-vLKICDFGLARve  206 (449)
T KOG0664|consen  133 YVLTELMQSDLHKIIVS----PQALTPDHVKVFVYQILRGLKYLHTA-NILHRDIKPGNLLVNSNC-ILKICDFGLARTW  206 (449)
T ss_pred             HHHHHHHHhhhhheecc----CCCCCcchhhhhHHHHHhhhHHHhhc-chhhccCCCccEEeccCc-eEEeccccccccc
Confidence            78899998887777654    67899999999999999999999986 999999999999999998 8999999999875


Q ss_pred             ccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....  .+..+.|.+|.|||.+++...|+.+.||||.|||+.||+..+..|...+..+.+..|...+|.|..+.+....
T Consensus       207 e~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC  286 (449)
T KOG0664|consen  207 DQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC  286 (449)
T ss_pred             chhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence            44332  2334568899999999999999999999999999999999999999999999999999999999999887555


Q ss_pred             CCccccccCcccCCC----Cccc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          303 PNYTEFKFPQIKAHP----WHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~----~~~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                      .+.+.-.+..-...+    +..+ -+..-..+...+++++|..||.+|.+..+++.|+
T Consensus       287 EGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  287 EGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            444432222111111    1111 1223345788999999999999999999999994

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.9e-38  Score=282.74  Aligned_cols=244  Identities=22%  Similarity=0.324  Sum_probs=184.1

Q ss_pred             EeeccCCceEEEEEEECC---CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +.||+|+||.||+|.+..   .+..+|+|.+...     .....+|+.+++.++||||+++++.+...    ....+++|
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~----~~~~~lv~   76 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS----EGSPLVVL   76 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecC----CCCcEEEE
Confidence            368999999999998653   3467999987432     12445688899999999999998866432    23367899


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+. ++|.+.+...   ....++..+..++.|++.||.|||+. +++||||||+||+++.++ .+||+|||++......
T Consensus        77 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlk~~nili~~~~-~~kl~dfg~~~~~~~~  151 (262)
T cd05058          77 PYMKHGDLRNFIRSE---THNPTVKDLIGFGLQVAKGMEYLASK-KFVHRDLAARNCMLDESF-TVKVADFGLARDIYDK  151 (262)
T ss_pred             ecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccCcceEEEcCCC-cEEECCccccccccCC
Confidence            9998 4776666531   34467778889999999999999986 999999999999999888 8999999998754322


Q ss_pred             CC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          228 EP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       228 ~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ..     .....++..|+|||.+.+. .++.++||||||+++|+|++| .+||...+..+....+...  .+        
T Consensus       152 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~--~~--------  220 (262)
T cd05058         152 EYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQG--RR--------  220 (262)
T ss_pred             cceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcC--CC--------
Confidence            11     1123346789999998654 478999999999999999995 5667655544333222111  00        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        ...+..++..+.+++.+||..+|++||++.++++.|.++
T Consensus       221 ------------------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~  259 (262)
T cd05058         221 ------------------LLQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQI  259 (262)
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                              002344688999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=3.4e-38  Score=284.91  Aligned_cols=248  Identities=29%  Similarity=0.443  Sum_probs=200.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ...|.+.+.||+|++|.||++.+..++..|++|++....   ....+|+++++.++|+|++++++++...     ...++
T Consensus        18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-----~~~~l   92 (286)
T cd06614          18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-----DELWV   92 (286)
T ss_pred             cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-----CEEEE
Confidence            346999999999999999999998889999999986543   3456799999999999999999988543     45889


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ++||++ ++|.+.+....   ..+++..+..++.|++.||.|||+. ||+|+||+|+||+++.++ .++|+|||.+....
T Consensus        93 v~e~~~~~~L~~~l~~~~---~~l~~~~~~~i~~~i~~~L~~lH~~-gi~H~dl~p~ni~i~~~~-~~~l~d~~~~~~~~  167 (286)
T cd06614          93 VMEYMDGGSLTDIITQNF---VRMNEPQIAYVCREVLQGLEYLHSQ-NVIHRDIKSDNILLSKDG-SVKLADFGFAAQLT  167 (286)
T ss_pred             EEeccCCCcHHHHHHHhc---cCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCChhhEEEcCCC-CEEECccchhhhhc
Confidence            999999 58877776521   3789999999999999999999986 999999999999999887 89999999876543


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......++..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+.......+... +.+.          
T Consensus       168 ~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~----------  235 (286)
T cd06614         168 KEKSKRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK-GIPP----------  235 (286)
T ss_pred             cchhhhccccCCcccCCHhHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc-CCCC----------
Confidence            322 112345678899999986544 789999999999999999999999876655444333221 0000          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ...+..++..+.++|.+||+.+|.+|||+.++++|
T Consensus       236 ---------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         236 ---------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             ---------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhC
Confidence                           00122368899999999999999999999998887

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.2e-38  Score=283.38  Aligned_cols=245  Identities=21%  Similarity=0.323  Sum_probs=189.1

Q ss_pred             EeeccCCceEEEEEEECCCC------cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           77 RIVGQGSFGVVFQAKCLETG------ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~------~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +.||+|+||.||+|.+....      ..+|+|.+...     .....+|+.+++.++||||+++++++.     .....+
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   75 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCL-----LNEPQY   75 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeec-----CCCCeE
Confidence            36899999999999876443      67999987543     234557899999999999999998873     334478


Q ss_pred             Eeecccc-chHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC----CcEEEEe
Q 017452          146 LVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCD  217 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~----~~~kl~D  217 (371)
                      ++|||++ ++|.+.+.....   ....+++..+..++.|++.||.|||++ +++|+||||+||+++.++    ..++|+|
T Consensus        76 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~-~i~H~dl~p~nil~~~~~~~~~~~~~l~d  154 (269)
T cd05044          76 IIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM-HFIHRDLAARNCLVSEKGYDADRVVKIGD  154 (269)
T ss_pred             EEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC-CcccCCCChheEEEecCCCCCCcceEECC
Confidence            9999998 577777764322   124578899999999999999999986 999999999999998754    2699999


Q ss_pred             eCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          218 FGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       218 fg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      ||++........   .....++..|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+... .  
T Consensus       155 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~-~--  230 (269)
T cd05044         155 FGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGK-FTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAG-G--  230 (269)
T ss_pred             cccccccccccccccCcccCCCccccCHHHHccCC-cccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcC-C--
Confidence            999876533221   11234467899999986554 7999999999999999998 99999876654433322110 0  


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                               ....+..++..+.+++.+||..+|.+||++.++++.|.
T Consensus       231 -------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         231 -------------------------RLQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             -------------------------ccCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence                                     00123457889999999999999999999999998875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-38  Score=277.11  Aligned_cols=234  Identities=34%  Similarity=0.559  Sum_probs=189.9

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ||.|++|.||++.+..+++.+|+|.+....       ....+|+.+++.++|+||+++++.+     ......+++|||+
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~~~~~v~e~~   75 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAF-----QTEEKLYLVLEYA   75 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHe-----ecCCeeEEEEecC
Confidence            699999999999998889999999886432       2456789999999999999999887     4455689999999


Q ss_pred             c-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC-CC
Q 017452          152 P-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EP  229 (371)
Q Consensus       152 ~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~-~~  229 (371)
                      . ++|.+.+..    ...+++..+..++.|++.||.|||+. +++|+||+|+||+++.++ .++|+|||.+...... ..
T Consensus        76 ~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~~l~~lh~~-~~~H~~l~p~ni~~~~~~-~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          76 PGGELFSHLSK----EGRFSEERARFYAAEIVLALEYLHSL-GIIYRDLKPENILLDADG-HIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             CCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcceEEEcCCC-cEEEeecCcceecccCCCc
Confidence            5 677766654    34689999999999999999999986 999999999999999887 8999999998765443 22


Q ss_pred             cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccc
Q 017452          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (371)
Q Consensus       230 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....++..|+|||...+.. .+.++|+||||+++|++++|..||...+.......+..  ..                 
T Consensus       150 ~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~-----------------  209 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK--DP-----------------  209 (250)
T ss_pred             ccCCcCCccccChHHhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc--CC-----------------
Confidence            33456788899999986544 78899999999999999999999977665333333222  00                 


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH---HHHhh
Q 017452          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA---VSKRI  353 (371)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~---~~~l~  353 (371)
                                ..++..++..+.+++.+||..||.+||++   .++++
T Consensus       210 ----------~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~  246 (250)
T cd05123         210 ----------LRFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKA  246 (250)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHh
Confidence                      01445568999999999999999999999   67433

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.5e-38  Score=283.37  Aligned_cols=244  Identities=29%  Similarity=0.474  Sum_probs=187.0

Q ss_pred             ceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecch--------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      +|++.+.||+|++|.||++.+.   .+++.||+|.+.+..        ....+|+.++..+ +||||+++++++     .
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----~   75 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAF-----Q   75 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheee-----e
Confidence            4889999999999999999864   467889999886421        2345789999999 599999999887     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .....++||||+.+ +|.+.+..    ...+++..++.++.|++.||.|||+. +++||||||+||+++.++ .++|+||
T Consensus        76 ~~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~ql~~~l~~lH~~-~~~H~dl~p~nil~~~~~-~~~l~df  149 (288)
T cd05583          76 TDTKLHLILDYVNGGELFTHLYQ----REHFTESEVRVYIAEIVLALDHLHQL-GIIYRDIKLENILLDSEG-HVVLTDF  149 (288)
T ss_pred             cCCEEEEEEecCCCCcHHHHHhh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHeEECCCC-CEEEEEC
Confidence            34457899999985 66555543    45689999999999999999999986 999999999999999887 8999999


Q ss_pred             CCccccccCCC--cccccccccccCcccccCCc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       219 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |++........  .....++..|+|||.+.+.. ..+.++|+||||+++|+|++|..||...........+.+..-..  
T Consensus       150 g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--  227 (288)
T cd05583         150 GLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS--  227 (288)
T ss_pred             ccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHcc--
Confidence            99876533322  22345788999999985433 35789999999999999999999996543222212221110000  


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHH
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK  351 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~  351 (371)
                                             ....+..++..+.+++.+||+.||.+|||+.++
T Consensus       228 -----------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~  260 (288)
T cd05583         228 -----------------------KPPFPKTMSAEARDFIQKLLEKDPKKRLGANGA  260 (288)
T ss_pred             -----------------------CCCCCcccCHHHHHHHHHHhcCCHhhccCcchH
Confidence                                   001344578899999999999999999996654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-38  Score=285.76  Aligned_cols=243  Identities=29%  Similarity=0.412  Sum_probs=192.8

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      |.....||+|+||.||++....+|..||+|++...    .....+|+.+++.++|+|++++++.+..     ..+.+++|
T Consensus        22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   96 (292)
T cd06657          22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWVVM   96 (292)
T ss_pred             hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEe-----CCEEEEEE
Confidence            44446799999999999999999999999987432    2335578999999999999999998843     34578999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|.+.+.     ...+++..++.++.|++.||+|||++ |++||||+|+||+++.++ .++|+|||.+......
T Consensus        97 e~~~~~~L~~~~~-----~~~~~~~~~~~~~~ql~~~l~~lH~~-givH~dl~p~Nilv~~~~-~~~l~dfg~~~~~~~~  169 (292)
T cd06657          97 EFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLKALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVSKE  169 (292)
T ss_pred             ecCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-CEEEcccccceecccc
Confidence            99986 5554433     35689999999999999999999987 999999999999999887 8999999988655332


Q ss_pred             C-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      . ......+++.|+|||.+.+. .++.++|+||+|+++|+|++|..||......+....+.......             
T Consensus       170 ~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~-------------  235 (292)
T cd06657         170 VPRRKSLVGTPYWMAPELISRL-PYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK-------------  235 (292)
T ss_pred             cccccccccCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc-------------
Confidence            2 12235678899999988544 47889999999999999999999998766554443332211000             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   ......++..+.+++.+||..||.+||++.++++|
T Consensus       236 -------------~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~  270 (292)
T cd06657         236 -------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  270 (292)
T ss_pred             -------------cCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcC
Confidence                         00123468899999999999999999999999888

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=6.2e-38  Score=287.03  Aligned_cols=269  Identities=21%  Similarity=0.276  Sum_probs=187.5

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |.+++.+|.|+  .||.++...+++.||+|++...      ...+.+|+.+++.++|+||+++++++..     ....++
T Consensus         4 ~~i~~~~~~~~--~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~-----~~~~~~   76 (314)
T cd08216           4 TLIGKCFEDLM--IVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIV-----DSELYV   76 (314)
T ss_pred             hhhhHhhcCCc--eEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeec-----CCeEEE
Confidence            34445555554  4555555669999999998643      1345689999999999999999998843     344789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|||++ +++.+++....  ...+++..++.++.|++.||+|||++ +|+||||||+||+++.++ .++|+|||.+....
T Consensus        77 ~~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~~l~~~L~~LH~~-~ivH~dlk~~Nili~~~~-~~kl~d~~~~~~~~  152 (314)
T cd08216          77 VSPLMAYGSCEDLLKTHF--PEGLPELAIAFILKDVLNALDYIHSK-GFIHRSVKASHILLSGDG-KVVLSGLRYSVSMI  152 (314)
T ss_pred             EEeccCCCCHHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCcceEEEecCC-ceEEecCccceeec
Confidence            999998 46666665432  35689999999999999999999987 999999999999999887 89999999886543


Q ss_pred             cCCC--------cccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          226 KGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       226 ~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ....        .....++..|+|||.+... ..++.++|+||+||++|+|++|..||..........+...  +.....
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~--~~~~~~  230 (314)
T cd08216         153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVR--GTVPCL  230 (314)
T ss_pred             cccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--ccCccc
Confidence            2211        1233457789999998653 3478899999999999999999999987655443322221  111100


Q ss_pred             ----HHhhcCCCcccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 ----EIKCMNPNYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ----~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                          ............   .................++.++.+|+.+||..||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         231 LDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                000000000000   0000001111111233456789999999999999999999998888

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.6e-37  Score=277.94  Aligned_cols=248  Identities=19%  Similarity=0.263  Sum_probs=184.2

Q ss_pred             eeccCCceEEEEEEECCC--CcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecc
Q 017452           78 IVGQGSFGVVFQAKCLET--GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~--~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .||+|+||.||++.....  ...+++|.+...     .....+|+.+++.++||||+++++.+.     .....++||||
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~-----~~~~~~lv~e~   76 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCV-----EAIPYLLVFEY   76 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEec-----CCCccEEEEec
Confidence            589999999999975433  345667766432     234557888899999999999999883     34457899999


Q ss_pred             cc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC-
Q 017452          151 VP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-  228 (371)
Q Consensus       151 ~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~-  228 (371)
                      +. ++|.+.+..........++..++.++.||+.||+|||++ +++||||||+|||++.++ .++|+|||++....... 
T Consensus        77 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~-~i~H~dikp~nil~~~~~-~~~l~Dfg~~~~~~~~~~  154 (268)
T cd05086          77 CELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH-NFLHSDLALRNCFLTSDL-TVKVGDYGIGPSRYKEDY  154 (268)
T ss_pred             CCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC-CeeccCCccceEEEcCCc-cEEecccccccccCcchh
Confidence            99 477777765333334567788899999999999999986 999999999999999888 89999999876432211 


Q ss_pred             --CcccccccccccCcccccCC------cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          229 --PNISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       229 --~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                        ......++..|+|||++...      ..++.++||||||+++|+|++ |..||......+.+..+.+.....      
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~------  228 (268)
T cd05086         155 IETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVK------  228 (268)
T ss_pred             hhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccc------
Confidence              12234578889999987421      235778999999999999997 567887766655555443321100      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                       .+...++..+++.+.+++..|| .+|.+||++.++++.|.
T Consensus       229 -----------------~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         229 -----------------LFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             -----------------cCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence                             0111133447889999999999 68999999999998765

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-38  Score=312.54  Aligned_cols=255  Identities=20%  Similarity=0.328  Sum_probs=206.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..-.+.+.||+|.||.||.|.......     .||+|.+.+.     ...+.+|..+|+.++|||||+++++.+....  
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~--  769 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGP--  769 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCC--
Confidence            457788999999999999998764332     3899988653     3445679999999999999999999976333  


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                         .+|++|||. |+|..++...+..   ...++......++.||++|..||+++ ++|||||-..|+|++... .+||+
T Consensus       770 ---~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~-~fvHRDLAaRNCLL~~~r-~VKIa  844 (1025)
T KOG1095|consen  770 ---PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK-HFVHRDLAARNCLLDERR-VVKIA  844 (1025)
T ss_pred             ---cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC-CCcCcchhhhheeecccC-cEEEc
Confidence               579999999 5777777654221   45688999999999999999999987 999999999999999987 99999


Q ss_pred             eeCCccccccCCCccc---ccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 017452          217 DFGSAKVLVKGEPNIS---YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~---~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |||+|+..........   ..-...|||||.+.... ++.++|||||||++||++| |..||.+.++.+.+....+.- +
T Consensus       845 DFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i-FtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~gg-R  922 (1025)
T KOG1095|consen  845 DFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI-FTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGG-R  922 (1025)
T ss_pred             ccchhHhhhhchheeccCccccceecCCHHHHhhcc-cccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCC-c
Confidence            9999996543322211   12245699999997654 9999999999999999996 889999999888877665531 1


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                       ++          .|..++..+.+++.+||+.+|++||++..+++.+.++.+.
T Consensus       923 -----------------L~----------~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~  964 (1025)
T KOG1095|consen  923 -----------------LD----------PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNA  964 (1025)
T ss_pred             -----------------cC----------CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhh
Confidence                             11          4678999999999999999999999999999976665433

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.1e-37  Score=277.33  Aligned_cols=237  Identities=20%  Similarity=0.206  Sum_probs=182.4

Q ss_pred             EeeccCCceEEEEEEECCCC----------cEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           77 RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~----------~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +.||+|+||.||+|.+..++          ..+++|.+...   .....+|+.+++.++||||+++++++..      ..
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR------DE   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec------CC
Confidence            36899999999999987766          35788876543   2355678999999999999999998754      22


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC------cEEEE
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH------QVKLC  216 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~------~~kl~  216 (371)
                      .++||||+.+ +|.+.+...   ...+++..+..++.||+.||.|||++ ||+||||||+||+++.++.      .++|+
T Consensus        75 ~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~-~i~H~dlkp~Nill~~~~~~~~~~~~~kl~  150 (259)
T cd05037          75 NIMVEEYVKFGPLDVFLHRE---KNNVSLHWKLDVAKQLASALHYLEDK-KLVHGNVCGKNILVARYGLNEGYVPFIKLS  150 (259)
T ss_pred             cEEEEEcCCCCcHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHhhC-CeecccCccceEEEecCccccCCceeEEeC
Confidence            5799999985 666555532   23789999999999999999999986 9999999999999987652      49999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |||++.....   .....++..|+|||.+.+. ..++.++|+||||+++|+|++ |..||...+..........      
T Consensus       151 Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~------  221 (259)
T cd05037         151 DPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD------  221 (259)
T ss_pred             CCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc------
Confidence            9999876543   2234456779999998665 357899999999999999999 5788866543222111110      


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                                              ....+...+..+.+++.+||..+|.+|||+.++++.|+
T Consensus       222 ------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~  259 (259)
T cd05037         222 ------------------------QHRLPMPDCAELANLINQCWTYDPTKRPSFRAILRDLN  259 (259)
T ss_pred             ------------------------CCCCCCCCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence                                    00011222478999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=1.6e-37  Score=309.51  Aligned_cols=142  Identities=26%  Similarity=0.440  Sum_probs=123.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|.+.+.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.++|+||++++.++     ....
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   77 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSL-----QSAN   77 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEE-----EECC
Confidence            357999999999999999999999999999999986532       4456789999999999999998877     3344


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++|+||||+. ++|..++..    ...+++..++.++.||+.||.|||.+ +|+||||||+|||++.++ .+||+|||++
T Consensus        78 ~~~lVmEy~~g~~L~~li~~----~~~l~~~~~~~i~~qil~aL~yLH~~-gIiHrDLKP~NILl~~~g-~vkL~DFGls  151 (669)
T cd05610          78 NVYLVMEYLIGGDVKSLLHI----YGYFDEEMAVKYISEVALALDYLHRH-GIIHRDLKPDNMLISNEG-HIKLTDFGLS  151 (669)
T ss_pred             EEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCccHHHEEEcCCC-CEEEEeCCCC
Confidence            5899999997 477766654    45688999999999999999999987 999999999999999888 8999999987


Q ss_pred             c
Q 017452          222 K  222 (371)
Q Consensus       222 ~  222 (371)
                      +
T Consensus       152 ~  152 (669)
T cd05610         152 K  152 (669)
T ss_pred             c
Confidence            5

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-39  Score=287.07  Aligned_cols=260  Identities=25%  Similarity=0.386  Sum_probs=204.6

Q ss_pred             CCCCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeeccee
Q 017452           64 NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHC  132 (371)
Q Consensus        64 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~  132 (371)
                      .+.|....+|-+...||+|||+.||+|.|....+.||+|+-...+           ...-+|..|-+.|+||.||++|++
T Consensus       456 kDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDy  535 (775)
T KOG1151|consen  456 KDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDY  535 (775)
T ss_pred             ccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeee
Confidence            345666789999999999999999999999999999999753221           122368899999999999999999


Q ss_pred             EEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcEeeccCCCceeeeCC-
Q 017452          133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPH-  209 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~ivH~dlkp~NIli~~~-  209 (371)
                      |...++    .+|.|+|||+| +|+-++.    .++.+++.+++.|+.||+.||.||... -.|||-||||.|||+... 
T Consensus       536 fslDtd----sFCTVLEYceGNDLDFYLK----QhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~Gt  607 (775)
T KOG1151|consen  536 FSLDTD----SFCTVLEYCEGNDLDFYLK----QHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGT  607 (775)
T ss_pred             eeeccc----cceeeeeecCCCchhHHHH----hhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCc
Confidence            865433    37899999998 4444443    367899999999999999999999963 369999999999998532 


Q ss_pred             -CCcEEEEeeCCccccccCCC--------cccccccccccCcccccC---CcCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q 017452          210 -THQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGD  277 (371)
Q Consensus       210 -~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~  277 (371)
                       .+.+||+|||+++++.+...        .....||.+|++||.+.-   .+..+.++||||+|||+|.++.|+.||+..
T Consensus       608 acGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhn  687 (775)
T KOG1151|consen  608 ACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHN  687 (775)
T ss_pred             ccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCc
Confidence             13799999999998865432        235678999999999853   345788999999999999999999999887


Q ss_pred             CcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....+.+.-..+             ...+.+||.          ..-++.++.+||++||++--++|....++..+
T Consensus       688 qsQQdILqeNTIl-------------kAtEVqFP~----------KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  688 QSQQDILQENTIL-------------KATEVQFPP----------KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             hhHHHHHhhhchh-------------cceeccCCC----------CCccCHHHHHHHHHHHHhhhhhhhhHHHHccC
Confidence            6655544432221             112333332          12479999999999999999999999996665

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-39  Score=274.75  Aligned_cols=274  Identities=32%  Similarity=0.554  Sum_probs=224.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|.-...+|.|.. .|-.|.|.-.++.||+|++..+      -+...+|+..+..++|+||++++.+|.-... ..-..
T Consensus        17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e   95 (369)
T KOG0665|consen   17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE   95 (369)
T ss_pred             eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence            47999999999998 8888999999999999988544      3445689999999999999999998843322 11233


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .|+|||+|..++...+.      -.++-..+..++.|++.|+.|||+. ||+||||||+||+++.+. .+||.|||+|+.
T Consensus        96 ~y~v~e~m~~nl~~vi~------~elDH~tis~i~yq~~~~ik~lhs~-~IihRdLkPsnivv~~~~-~lKi~dfg~ar~  167 (369)
T KOG0665|consen   96 VYLVMELMDANLCQVIL------MELDHETISYILYQMLCGIKHLHSA-GIIHRDLKPSNIVVNSDC-TLKILDFGLART  167 (369)
T ss_pred             HHHHHHhhhhHHHHHHH------HhcchHHHHHHHHHHHHHHHHHHhc-ceeecccCcccceecchh-heeeccchhhcc
Confidence            68999999998887776      3466778999999999999999986 999999999999999998 899999999988


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....-..+..+.|+.|.|||++.+.. +...+||||+||++.||++|...|.+.+..+...++...+|.|++..+..+.+
T Consensus       168 e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  168 EDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             cCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            76665667788999999999998876 89999999999999999999999999999999999999999999998876654


Q ss_pred             Ccccccc--CcccCCCCcccCC-----------CCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKF--PQIKAHPWHKIFP-----------KRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~--~~~~~~~~~~~~~-----------~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....+..  ++.....+...+|           ..-+..+++++.+||..||++|.+++++|+|
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence            3332211  1111111111121           1234568999999999999999999999999

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.3e-37  Score=280.51  Aligned_cols=265  Identities=24%  Similarity=0.341  Sum_probs=194.7

Q ss_pred             cceeeeEeeccCCceEEEEEEEC----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..|++.+.||+|+||.||+|...    .+++.+|+|.+....     ..+.+|+++++.++|+||+++++++..   .+.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~---~~~   80 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK---PGG   80 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeec---CCC
Confidence            35888899999999999999864    347899999986543     345689999999999999999887633   224


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .+.+++|||++ ++|.+.+...   ...+++..+..++.||+.||+|||++ |++|+||||+||+++.++ .++|+|||.
T Consensus        81 ~~~~lv~e~~~~~~l~~~l~~~---~~~~~~~~~~~~~~~l~~aL~~lH~~-~i~H~dl~p~nil~~~~~-~~~l~dfg~  155 (284)
T cd05038          81 RSLRLIMEYLPSGSLRDYLQRH---RDQINLKRLLLFSSQICKGMDYLGSQ-RYIHRDLAARNILVESED-LVKISDFGL  155 (284)
T ss_pred             CceEEEEecCCCCCHHHHHHhC---ccccCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHhEEEcCCC-CEEEccccc
Confidence            45789999997 4777766532   23589999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hCCCCH
Q 017452          221 AKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTPTR  295 (371)
Q Consensus       221 a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~  295 (371)
                      +.........    ....++..|+|||.+.+. .++.++|+||||+++|+|++|..||........  .+... .+....
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~--~~~~~~~~~~~~  232 (284)
T cd05038         156 AKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAEFL--RMIGIAQGQMIV  232 (284)
T ss_pred             ccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccchhc--cccccccccccH
Confidence            9876532221    122345569999988655 478999999999999999999999865332110  00000 000000


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+......  ..          ....+..++.++.+++.+||..+|.+|||+.++++.|.++
T Consensus       233 ~~~~~~~~~--~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         233 TRLLELLKE--GE----------RLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHHHHHHHc--CC----------cCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            000000000  00          0002234678999999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=2.9e-37  Score=300.53  Aligned_cols=274  Identities=19%  Similarity=0.229  Sum_probs=175.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCC----CcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLET----GETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~----~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      ..++|.+.+.||+|+||.||+|.+..+    +..||+|++...........+.++...+.++..+...+..... .....
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~~~~~  209 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNERVRRACPNSCADFVYGFLEPVSSKKEDE  209 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHHHHHhhchhhHHHHHHhhhcccccccCCc
Confidence            446899999999999999999999888    9999999875432211111122222233334443333322111 33445


Q ss_pred             EEEeeccccc-hHHHHHHHhhh----------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNK----------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~----------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                      .++|+||+++ +|.+++.....                .........+..++.||+.||.|||++ +|+||||||+|||+
T Consensus       210 ~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~-gIiHRDLKP~NILl  288 (566)
T PLN03225        210 YWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST-GIVHRDVKPQNIIF  288 (566)
T ss_pred             eEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC-CEEeCcCCHHHEEE
Confidence            7899999985 66666653210                001122445778999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCC--CcccccccccccCcccccCCc---------------------CCCCcchHHHHHHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGAT---------------------EYTTAIDIWSAGCV  263 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~---------------------~~~~~~DiwslG~i  263 (371)
                      +.+...+||+|||+|+....+.  ......+++.|+|||.+....                     .++.++|||||||+
T Consensus       289 ~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGvi  368 (566)
T PLN03225        289 SEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI  368 (566)
T ss_pred             eCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHH
Confidence            9754489999999997653322  223567899999999763221                     13446699999999


Q ss_pred             HHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcc--cCCCCCChhHHHHHHhccCcC
Q 017452          264 VAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK--IFPKRMPPEAVDLVSRLLQYS  341 (371)
Q Consensus       264 l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~l~~li~~~l~~d  341 (371)
                      ||||+++..++.  +....+..+....+.. ...|.......        ....+..  ...........+||.+||+.|
T Consensus       369 L~el~~~~~~~~--~~~~~~~~~l~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        369 FLQMAFPNLRSD--SNLIQFNRQLKRNDYD-LVAWRKLVEPR--------ASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHhCcCCCc--hHHHHHHHHHHhcCCc-HHHHHHhhccc--------cchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999765543  3333333333332222 12221111000        0000000  011123456779999999999


Q ss_pred             CCCCCCHHHHhhh
Q 017452          342 PNLRCTAVSKRIL  354 (371)
Q Consensus       342 P~~R~t~~~~l~~  354 (371)
                      |.+|||+.++|+|
T Consensus       438 P~kR~ta~e~L~H  450 (566)
T PLN03225        438 GRQRISAKAALAH  450 (566)
T ss_pred             cccCCCHHHHhCC
Confidence            9999999998888

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.4e-37  Score=273.09  Aligned_cols=219  Identities=26%  Similarity=0.321  Sum_probs=172.6

Q ss_pred             CCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHH
Q 017452           82 GSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK  160 (371)
Q Consensus        82 G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  160 (371)
                      |.+|.||++.+..+++.||+|.+..... ..+|...+....||||+++++++.     .....+++|||+++ +|.+.+.
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~-~~~~~~~~~~~~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~   77 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSSE-YSRERLTIIPHCVPNMVCLHKYIV-----SEDSVFLVLQHAEGGKLWSHIS   77 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchhh-hhhHHHHHHhcCCCceeehhhhee-----cCCeEEEEEecCCCCCHHHHHH
Confidence            8899999999999999999999866432 344555556667999999999883     33457899999985 7766665


Q ss_pred             HhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCccccccccccc
Q 017452          161 HFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR  240 (371)
Q Consensus       161 ~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~  240 (371)
                      .    ...+++..+..++.|++.||+|||++ ||+||||||+||+++.++ .++++|||.+......  .....++..|+
T Consensus        78 ~----~~~l~~~~~~~~~~ql~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~df~~~~~~~~~--~~~~~~~~~y~  149 (237)
T cd05576          78 K----FLNIPEECVKRWAAEMVVALDALHRE-GIVCRDLNPNNILLDDRG-HIQLTYFSRWSEVEDS--CDGEAVENMYC  149 (237)
T ss_pred             H----hcCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHEEEcCCC-CEEEecccchhccccc--cccCCcCcccc
Confidence            4    34689999999999999999999986 999999999999999888 8999999987654332  22344567799


Q ss_pred             CcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcc
Q 017452          241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  320 (371)
Q Consensus       241 aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (371)
                      |||.+.... ++.++|+||+|+++|+|++|..||.......  .                   ...            ..
T Consensus       150 aPE~~~~~~-~~~~~DvwslG~il~el~~g~~~~~~~~~~~--~-------------------~~~------------~~  195 (237)
T cd05576         150 APEVGGISE-ETEACDWWSLGAILFELLTGKTLVECHPSGI--N-------------------THT------------TL  195 (237)
T ss_pred             CCcccCCCC-CCchhhHHHHHHHHHHHHHCcchhhcCchhc--c-------------------ccc------------cc
Confidence            999885443 7889999999999999999998874321100  0                   000            00


Q ss_pred             cCCCCCChhHHHHHHhccCcCCCCCCCH
Q 017452          321 IFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       321 ~~~~~~s~~l~~li~~~l~~dP~~R~t~  348 (371)
                      .++..+++.+.++|.+||+.||.+|+++
T Consensus       196 ~~~~~~~~~~~~li~~~l~~dp~~R~~~  223 (237)
T cd05576         196 NIPEWVSEEARSLLQQLLQFNPTERLGA  223 (237)
T ss_pred             CCcccCCHHHHHHHHHHccCCHHHhcCC
Confidence            1345578999999999999999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=4.2e-38  Score=289.71  Aligned_cols=249  Identities=29%  Similarity=0.455  Sum_probs=203.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC--C--cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET--G--ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~--~--~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ....+.++||+|-||.||+|.....  |  --||||.-+.+     .+.+..|..+++.++||||+++++++....    
T Consensus       389 e~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P----  464 (974)
T KOG4257|consen  389 ELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQP----  464 (974)
T ss_pred             hhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccc----
Confidence            3455667899999999999987533  3  34888977653     345567899999999999999999984322    


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                        ++||||.++ |.|..++..   ....++......++.||+.||.|||++ .+|||||-..|||+.+.. -|||+|||+
T Consensus       465 --~WivmEL~~~GELr~yLq~---nk~sL~l~tL~ly~~Qi~talaYLeSk-rfVHRDIAaRNiLVsSp~-CVKLaDFGL  537 (974)
T KOG4257|consen  465 --MWIVMELAPLGELREYLQQ---NKDSLPLRTLTLYCYQICTALAYLESK-RFVHRDIAARNILVSSPQ-CVKLADFGL  537 (974)
T ss_pred             --eeEEEecccchhHHHHHHh---ccccchHHHHHHHHHHHHHHHHHHHhh-chhhhhhhhhheeecCcc-eeeecccch
Confidence              589999999 677666664   256789999999999999999999987 999999999999999887 799999999


Q ss_pred             ccccccCCCcccccc--cccccCcccccCCcCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          221 AKVLVKGEPNISYIC--SRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       221 a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ++.+.+........|  ...|||||.+. ...++.++|||.|||++||++ .|..||.+-...+.+..+.++-+.|    
T Consensus       538 SR~~ed~~yYkaS~~kLPIKWmaPESIN-fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP----  612 (974)
T KOG4257|consen  538 SRYLEDDAYYKASRGKLPIKWMAPESIN-FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP----  612 (974)
T ss_pred             hhhccccchhhccccccceeecCccccc-hhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC----
Confidence            998766544333333  55699999984 445899999999999999998 6999999988777776665542222    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                              .|.++++.+..|+.+||.++|.+||...++...|.++.
T Consensus       613 ------------------------~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~  650 (974)
T KOG4257|consen  613 ------------------------CPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVL  650 (974)
T ss_pred             ------------------------CCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHH
Confidence                                    57789999999999999999999999999988876653

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=288.86  Aligned_cols=250  Identities=24%  Similarity=0.342  Sum_probs=198.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCc---E-EEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGE---T-VAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~---~-vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      -.+.++||+|+||.||+|.....+.   . ||+|....+       ...+.+|.++++.++|||||++|++......   
T Consensus       159 v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P---  235 (474)
T KOG0194|consen  159 IELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP---  235 (474)
T ss_pred             ccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc---
Confidence            3456899999999999998765432   3 899987642       2344579999999999999999998744332   


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                        +++|||+|+| +|.+++...   ...++..+...++.+.+.||+|||++ +++||||-..|+|++.++ .+||+|||+
T Consensus       236 --l~ivmEl~~gGsL~~~L~k~---~~~v~~~ek~~~~~~AA~Gl~YLh~k-~~IHRDIAARNcL~~~~~-~vKISDFGL  308 (474)
T KOG0194|consen  236 --LMLVMELCNGGSLDDYLKKN---KKSLPTLEKLRFCYDAARGLEYLHSK-NCIHRDIAARNCLYSKKG-VVKISDFGL  308 (474)
T ss_pred             --cEEEEEecCCCcHHHHHHhC---CCCCCHHHHHHHHHHHHhHHHHHHHC-CCcchhHhHHHheecCCC-eEEeCcccc
Confidence              7899999995 777777642   33699999999999999999999987 999999999999999887 789999999


Q ss_pred             ccccccCCCcc-cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          221 AKVLVKGEPNI-SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       221 a~~~~~~~~~~-~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ++......... ..--...|+|||.+... .++.++|||||||++||+++ |..||.+....+....+....-       
T Consensus       309 s~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~-------  380 (474)
T KOG0194|consen  309 SRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGY-------  380 (474)
T ss_pred             ccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCc-------
Confidence            87643111111 11235679999999766 58999999999999999997 8899999988877777744211       


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                          .-..+...+.++..++.+||..||+.|||+.++.+.++.+..
T Consensus       381 --------------------r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~  422 (474)
T KOG0194|consen  381 --------------------RMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK  422 (474)
T ss_pred             --------------------cCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence                                111445678899999999999999999999999998776533

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=1.3e-37  Score=281.10  Aligned_cols=278  Identities=31%  Similarity=0.529  Sum_probs=222.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcC------CCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD------HPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~------h~niv~~~~~~~~~~~~  139 (371)
                      +-.+|.+....|.|-|++|.+|.+...|..||||++....   ..-.+|+++|++|+      --|+++++..|     .
T Consensus       430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F-----~  504 (752)
T KOG0670|consen  430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHF-----K  504 (752)
T ss_pred             hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHh-----h
Confidence            3457999999999999999999999999999999997653   33357999999995      35789998888     6


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...++|||+|.+.-+|.+++..+.. +..+....++.++.|++-||..|-. +||+|.||||+|||++.....+||||||
T Consensus       505 hknHLClVFE~LslNLRevLKKyG~-nvGL~ikaVRsYaqQLflALklLK~-c~vlHaDIKPDNiLVNE~k~iLKLCDfG  582 (752)
T KOG0670|consen  505 HKNHLCLVFEPLSLNLREVLKKYGR-NVGLHIKAVRSYAQQLFLALKLLKK-CGVLHADIKPDNILVNESKNILKLCDFG  582 (752)
T ss_pred             hcceeEEEehhhhchHHHHHHHhCc-ccceeehHHHHHHHHHHHHHHHHHh-cCeeecccCccceEeccCcceeeeccCc
Confidence            7778999999999999999998765 5678999999999999999999985 7999999999999999888899999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .|........ +.+..+..|.|||++.+.+ |....|+||.||+||||.||+..|.+....+.+...+...|..+...+.
T Consensus       583 SA~~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlR  660 (752)
T KOG0670|consen  583 SASFASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLR  660 (752)
T ss_pred             cccccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhh
Confidence            9987654433 3455677899999998877 8999999999999999999999999999999999999888888876554


Q ss_pred             hcC---CCc------cccccCcccCC----CCcccCC-----------CCCC-------hhHHHHHHhccCcCCCCCCCH
Q 017452          300 CMN---PNY------TEFKFPQIKAH----PWHKIFP-----------KRMP-------PEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       300 ~~~---~~~------~~~~~~~~~~~----~~~~~~~-----------~~~s-------~~l~~li~~~l~~dP~~R~t~  348 (371)
                      .-.   ..|      .......+...    ....+.|           .+++       .++.+||.+||..||++|.|.
T Consensus       661 KgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~  740 (752)
T KOG0670|consen  661 KGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITV  740 (752)
T ss_pred             hcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCH
Confidence            211   111      11100000000    0011111           1122       468999999999999999999


Q ss_pred             HHHhhhh
Q 017452          349 VSKRILF  355 (371)
Q Consensus       349 ~~~l~~l  355 (371)
                      .++|.|.
T Consensus       741 nqAL~Hp  747 (752)
T KOG0670|consen  741 NQALKHP  747 (752)
T ss_pred             HHHhcCC
Confidence            9987773

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-37  Score=291.97  Aligned_cols=260  Identities=25%  Similarity=0.380  Sum_probs=214.4

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +...+.|.+.+.||.|.+|.||+++.+.+++..|+|+...+   ...++.|.++|+.. .|||++.+|++|+........
T Consensus        15 pdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D   94 (953)
T KOG0587|consen   15 PDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD   94 (953)
T ss_pred             CCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence            33445699999999999999999999999999999987543   45566788888887 699999999999877766677


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++|||||+ |+..+++....  ..++.|+++..|++.++.||.+||.+ .++|||||-.|||++.++ .|||+|||.+
T Consensus        95 qLWLVMEfC~gGSVTDLVKn~~--g~rl~E~~IaYI~re~lrgl~HLH~n-kviHRDikG~NiLLT~e~-~VKLvDFGvS  170 (953)
T KOG0587|consen   95 QLWLVMEFCGGGSVTDLVKNTK--GNRLKEEWIAYILREILRGLAHLHNN-KVIHRDIKGQNVLLTENA-EVKLVDFGVS  170 (953)
T ss_pred             eEEEEeeccCCccHHHHHhhhc--ccchhhHHHHHHHHHHHHHHHHHhhc-ceeeecccCceEEEeccC-cEEEeeeeee
Confidence            7999999999 58888887665  78899999999999999999999987 999999999999999998 8999999987


Q ss_pred             cccccC-CCcccccccccccCcccccCCc----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKG-EPNISYICSRYYRAPELIFGAT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ..+... ....+.+|||+|||||++....    .|+..+|+||||++..||.-|.+|+.+.-....+.   .+.+-|++.
T Consensus       171 aQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF---~IpRNPPPk  247 (953)
T KOG0587|consen  171 AQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALF---LIPRNPPPK  247 (953)
T ss_pred             eeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhc---cCCCCCCcc
Confidence            665433 3445778999999999996543    35668999999999999999999997665443333   222223222


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      .                       .-|+..+.++.+||..||.+|..+||+..++++|-+
T Consensus       248 L-----------------------krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpF  284 (953)
T KOG0587|consen  248 L-----------------------KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPF  284 (953)
T ss_pred             c-----------------------cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCc
Confidence            1                       124557899999999999999999999999998844

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-37  Score=246.74  Aligned_cols=215  Identities=24%  Similarity=0.420  Sum_probs=178.8

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHH-HcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMR-LLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+...-+..||+|++|.|-+.++..+|...|+|.+....     ....+|+.+.. ...+|.+|++|+.++...+   
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd---  119 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD---  119 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc---
Confidence            33445566778999999999999999999999999985432     22234555433 3479999999998865444   


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                        ++|.||.|..+|+.+.....+..+.++|..+=+|+..++.||.|||+++.++|||+||+||||+.+| ++|+||||++
T Consensus       120 --vwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~G-qVKiCDFGIs  196 (282)
T KOG0984|consen  120 --VWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDG-QVKICDFGIS  196 (282)
T ss_pred             --EEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCC-cEEEcccccc
Confidence              8899999999999999888888999999999999999999999999999999999999999999999 9999999999


Q ss_pred             cccccCCCcccccccccccCcccccC---CcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHH
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFG---ATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIK  288 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~---~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~  288 (371)
                      ..+.+.-..+...|...|||||.+..   +..|+-++||||||+.+.||++++.||.... ..+++.+++.
T Consensus       197 G~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  197 GYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             eeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            88877766666778888999999843   2357889999999999999999999997654 4455555544

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=279.09  Aligned_cols=253  Identities=22%  Similarity=0.344  Sum_probs=209.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+..+..+||.|.||.||.|.|+.....||||.++.+   ...+..|..+|+.+.|||+|++++.+     ....-+|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVC-----T~EpPFYIi  341 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----THEPPFYII  341 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhh-----ccCCCeEEE
Confidence            3456678999999999999999999999999999765   35566899999999999999999998     334448999


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +|||. |+|++++..+++  ..++.-.+..++.||..|++||..+ ++|||||-..|.|+..+. .||++|||+++.+..
T Consensus       342 TEfM~yGNLLdYLRecnr--~ev~avvLlyMAtQIsSaMeYLEkk-nFIHRDLAARNCLVgEnh-iVKvADFGLsRlMtg  417 (1157)
T KOG4278|consen  342 TEFMCYGNLLDYLRECNR--SEVPAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-IVKVADFGLSRLMTG  417 (1157)
T ss_pred             EecccCccHHHHHHHhch--hhcchhHHHHHHHHHHHHHHHHHHh-hhhhhhhhhhhccccccc-eEEeeccchhhhhcC
Confidence            99988 899999987653  4567777889999999999999987 999999999999999876 899999999998754


Q ss_pred             CCCcc--cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEPNI--SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~~~--~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....  ..-....|.|||.+.- ..++.++|||+|||+|||++| |-.||.+-+-.+.+..+.+..+            
T Consensus       418 DTYTAHAGAKFPIKWTAPEsLAy-NtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyR------------  484 (1157)
T KOG4278|consen  418 DTYTAHAGAKFPIKWTAPESLAY-NTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYR------------  484 (1157)
T ss_pred             CceecccCccCcccccCcccccc-cccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhcccc------------
Confidence            32211  1222556999999854 348999999999999999996 8899998877666665554321            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                            +.          -|+.+++.+.+|++.||+++|.+||++.|+-+.|+.+.+.
T Consensus       485 ------M~----------~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~  526 (1157)
T KOG4278|consen  485 ------MD----------GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSS  526 (1157)
T ss_pred             ------cc----------CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcc
Confidence                  11          4678999999999999999999999999999999887543

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-36  Score=275.31  Aligned_cols=255  Identities=20%  Similarity=0.289  Sum_probs=201.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+-.++++||+|-||.|.+|+- ..+..||+|+++.+     ...+.+|+++|.+++||||+.+++.+...+.     ++
T Consensus       538 s~L~~~ekiGeGqFGEVhLCev-eg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP-----ic  611 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEV-EGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDP-----LC  611 (807)
T ss_pred             hheehhhhhcCcccceeEEEEe-cCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc-----hH
Confidence            4568899999999999999984 44699999998654     3566789999999999999999999865443     78


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+||+. |+|...+.......  +.......++.||+.|++||.+ +++|||||.+.|+|++.++ ++||+|||+++.+
T Consensus       612 mI~EYmEnGDLnqFl~aheapt--~~t~~~vsi~tqiasgmaYLes-~nfVHrd~a~rNcLv~~e~-~iKiadfgmsR~l  687 (807)
T KOG1094|consen  612 MITEYMENGDLNQFLSAHELPT--AETAPGVSICTQIASGMAYLES-LNFVHRDLATRNCLVDGEF-TIKIADFGMSRNL  687 (807)
T ss_pred             HHHHHHhcCcHHHHHHhccCcc--cccchhHHHHHHHHHHHHHHHh-hchhhccccccceeecCcc-cEEecCccccccc
Confidence            9999998 67777776532221  3445566799999999999996 6999999999999999999 8999999999876


Q ss_pred             ccCCCcc---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHH--hCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM--LGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ..+....   ..+-...|||+|.+..+. ++.++|+|+||+++||++  +...||....+.+........+..+..... 
T Consensus       688 ysg~yy~vqgr~vlpiRwmawEsillgk-FttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~-  765 (807)
T KOG1094|consen  688 YSGDYYRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVV-  765 (807)
T ss_pred             ccCCceeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCccee-
Confidence            5544321   233467899999997665 899999999999999987  477899877776665554443332222110 


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                          -..|.-++..+.+++..||..|-.+||+.+++..+|..
T Consensus       766 --------------------l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~  803 (807)
T KOG1094|consen  766 --------------------LSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQE  803 (807)
T ss_pred             --------------------ccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHH
Confidence                                01345688999999999999999999999999888764

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=5.6e-37  Score=291.08  Aligned_cols=250  Identities=29%  Similarity=0.430  Sum_probs=190.7

Q ss_pred             eeeeEeeccCCce-EEEEEEECCCCcEEEEEEeecch-hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEeec
Q 017452           73 YMAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        73 y~~~~~lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      |.-.+.+|.|+.| .||+|..  .|+.||||++..+. ...++|+..|+.- +|||||+++..-     .+..+.||..|
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y--e~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-----~d~qF~YIalE  583 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY--EGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-----QDRQFLYIALE  583 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee--CCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-----cCCceEEEEeh
Confidence            4445678999988 5899987  78899999987664 4778999999988 599999976543     77888999999


Q ss_pred             cccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CC-CcEEEEeeCCccccc
Q 017452          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HT-HQVKLCDFGSAKVLV  225 (371)
Q Consensus       150 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~-~~~kl~Dfg~a~~~~  225 (371)
                      .|..+|.++++..............+.++.|++.||++||+ ++||||||||.||||+.   ++ .+++|+|||+++...
T Consensus       584 LC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs-l~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~  662 (903)
T KOG1027|consen  584 LCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS-LKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA  662 (903)
T ss_pred             HhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh-cccccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence            99999999998631101111114567788999999999997 69999999999999976   23 479999999999986


Q ss_pred             cCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .+...    ....||-+|+|||++.... -+.++|||||||++|+.++| .+||+..-..+  ..|.+.  ..       
T Consensus       663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~--~~-------  730 (903)
T KOG1027|consen  663 GGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTG--NY-------  730 (903)
T ss_pred             CCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcC--cc-------
Confidence            65433    3557899999999997665 47799999999999999986 89997643322  223221  00       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                              .+..         +...-..++.+||.+|+.++|..||+|.+            +++||+||+
T Consensus       731 --------~L~~---------L~~~~d~eA~dLI~~ml~~dP~~RPsa~~------------VL~HPlFW~  772 (903)
T KOG1027|consen  731 --------TLVH---------LEPLPDCEAKDLISRMLNPDPQLRPSATD------------VLNHPLFWD  772 (903)
T ss_pred             --------ceee---------eccCchHHHHHHHHHhcCCCcccCCCHHH------------HhCCCccCC
Confidence                    0000         11111128999999999999999999999            667777774

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=281.80  Aligned_cols=249  Identities=24%  Similarity=0.349  Sum_probs=204.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      +...+.++||+|.||+|++|.|...+   ..||||.+..+     ...+.+|+.+|.+|+|+|++++|+......     
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-----  184 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-----  184 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-----
Confidence            35677889999999999999987533   46899988654     355679999999999999999999885421     


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                       +.+|||.+. |+|++.+..  .....|.......++.||+.|+.||..+ ++|||||-..|+|+-... .|||+|||+.
T Consensus       185 -~mMV~ELaplGSLldrLrk--a~~~~llv~~Lcdya~QiA~aM~YLesk-rlvHRDLAARNlllaspr-tVKI~DFGLm  259 (1039)
T KOG0199|consen  185 -AMMVFELAPLGSLLDRLRK--AKKAILLVSRLCDYAMQIAKAMQYLESK-RLVHRDLAARNLLLASPR-TVKICDFGLM  259 (1039)
T ss_pred             -hhHHhhhcccchHHHHHhh--ccccceeHHHHHHHHHHHHHHHHHHhhh-hhhhhhhhhhhheecccc-eeeeecccce
Confidence             458999999 688887775  4467888999999999999999999987 999999999999998876 8999999999


Q ss_pred             cccccCCCccccc----ccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEPNISYI----CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~~~~~----~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +.+..++......    -...|+|||.+.... ++.++|+|++||++|||++ |..||.+....+.+..+-..-.     
T Consensus       260 RaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~er-----  333 (1039)
T KOG0199|consen  260 RALGENEDMYVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGER-----  333 (1039)
T ss_pred             eccCCCCcceEecCCCcCcccccCHhHhcccc-ccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhcccccc-----
Confidence            9887665543222    255699999996544 9999999999999999996 7899999988777766643211     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                   ++          -|+.++.++++++..||.++|++|||+..+.+.+...
T Consensus       334 -------------Lp----------RPk~csedIY~imk~cWah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  334 -------------LP----------RPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             -------------CC----------CCCCChHHHHHHHHHhccCCccccccHHHHHHhHHHH
Confidence                         00          3567899999999999999999999999998664433

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-36  Score=268.33  Aligned_cols=274  Identities=21%  Similarity=0.290  Sum_probs=203.5

Q ss_pred             EeecCCCCCCCCcc-----cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHH--cCCCCeee
Q 017452           57 VTTIGGRNGQPKQT-----ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVS  128 (371)
Q Consensus        57 ~~~~~~~~~~~~~~-----~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~--l~h~niv~  128 (371)
                      ..++|+..|.|...     ...++.+.||+|.||.||+|.+  .|+.||||++... .....+|.++.+.  |+|+||+.
T Consensus       192 ~~tSGSGSGlplLVQRTiarqI~L~e~IGkGRyGEVwrG~w--rGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILg  269 (513)
T KOG2052|consen  192 LETSGSGSGLPLLVQRTIARQIVLQEIIGKGRFGEVWRGRW--RGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILG  269 (513)
T ss_pred             hccCCCCCCchhHhHHhhhheeEEEEEecCccccceeeccc--cCCceEEEEecccchhhhhhHHHHHHHHHhccchhhh
Confidence            34566667777544     3578999999999999999998  7899999999654 4555677777765  69999999


Q ss_pred             cceeEEecCCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcEeeccC
Q 017452          129 LKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-------GVCHRDIK  200 (371)
Q Consensus       129 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------~ivH~dlk  200 (371)
                      +++.-.... .....+++|++|.+ |+|.+++..     ..++-+.+.+++..++.||++||..+       .|.|||||
T Consensus       270 FIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-----~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlK  343 (513)
T KOG2052|consen  270 FIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-----NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLK  343 (513)
T ss_pred             hhhccccCC-CceEEEEEeeecccCCcHHHHHhh-----ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccc
Confidence            987654333 44567899999998 899999884     67889999999999999999999532       59999999


Q ss_pred             CCceeeeCCCCcEEEEeeCCccccccCC-----CcccccccccccCcccccCCcCC-----CCcchHHHHHHHHHHHHhC
Q 017452          201 PQNLLVNPHTHQVKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGATEY-----TTAIDIWSAGCVVAELMLG  270 (371)
Q Consensus       201 p~NIli~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~lltg  270 (371)
                      +.|||+.+++ ...|+|+|+|.......     .....+||..|||||++......     =..+||||||.++||++-.
T Consensus       344 SKNILVKkn~-~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarR  422 (513)
T KOG2052|consen  344 SKNILVKKNG-TCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARR  422 (513)
T ss_pred             cccEEEccCC-cEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHH
Confidence            9999999998 89999999998765542     23467899999999999543321     1258999999999999852


Q ss_pred             ----------CCCCCCC----CcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHh
Q 017452          271 ----------KPLFPGD----SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSR  336 (371)
Q Consensus       271 ----------~~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~  336 (371)
                                +.||.+-    ...+.+.+++-...                  +.......|..   ...-..+..+++.
T Consensus       423 c~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~------------------~RP~ipnrW~s---~~~l~~m~klMke  481 (513)
T KOG2052|consen  423 CESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQK------------------LRPNIPNRWKS---DPALRVMAKLMKE  481 (513)
T ss_pred             hhcCCEehhhcCCcccCCCCCCCHHHHhcceeecc------------------cCCCCCccccc---CHHHHHHHHHHHH
Confidence                      4677542    22222322221100                  00001111211   1122457789999


Q ss_pred             ccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          337 LLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       337 ~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ||..||.-|.||--+.+.+.++.+
T Consensus       482 CW~~Np~aRltALriKKtl~~l~~  505 (513)
T KOG2052|consen  482 CWYANPAARLTALRIKKTLAKLSN  505 (513)
T ss_pred             hhcCCchhhhHHHHHHHHHHHHhc
Confidence            999999999999999999887753

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=286.15  Aligned_cols=249  Identities=25%  Similarity=0.358  Sum_probs=210.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeec-----chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .-.|.+.||.|.||.|++|+.+..|   ..||||.++.     .+..+..|..||-+++||||+++.+....     ..-
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTk-----s~P  704 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTK-----SKP  704 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEec-----Cce
Confidence            4678899999999999999988766   4699999864     35566789999999999999999998833     233


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +.||+|||. |+|+.++...   .+.|+..++..+++.|+.|+.||-+ +|+|||||-..|||++.+- .+|++|||+++
T Consensus       705 vMIiTEyMENGsLDsFLR~~---DGqftviQLVgMLrGIAsGMkYLsd-m~YVHRDLAARNILVNsnL-vCKVsDFGLSR  779 (996)
T KOG0196|consen  705 VMIITEYMENGSLDSFLRQN---DGQFTVIQLVGMLRGIASGMKYLSD-MNYVHRDLAARNILVNSNL-VCKVSDFGLSR  779 (996)
T ss_pred             eEEEhhhhhCCcHHHHHhhc---CCceEeehHHHHHHHHHHHhHHHhh-cCchhhhhhhhheeeccce-EEEecccccee
Confidence            679999998 6777766643   4679999999999999999999997 5999999999999999998 89999999999


Q ss_pred             ccccCCC-cccccc---cccccCcccccCCcCCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGEP-NISYIC---SRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~~-~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .+.++.. ..+..|   ...|.|||.+. ...++.++||||+|++|||.+ .|..||-...+.+.+..+.+..+-|+   
T Consensus       780 vledd~~~~ytt~GGKIPiRWTAPEAIa-~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp---  855 (996)
T KOG0196|consen  780 VLEDDPEAAYTTLGGKIPIRWTAPEAIA-YRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP---  855 (996)
T ss_pred             ecccCCCccccccCCccceeecChhHhh-hcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC---
Confidence            8755442 222222   46799999995 455999999999999999977 69999999999999999988665553   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                               |.+++..+.+|+..||++|.++||++.+++.+|.++-
T Consensus       856 -------------------------PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklI  892 (996)
T KOG0196|consen  856 -------------------------PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLI  892 (996)
T ss_pred             -------------------------CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHh
Confidence                                     4568999999999999999999999999999998873

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-34  Score=275.90  Aligned_cols=268  Identities=20%  Similarity=0.236  Sum_probs=177.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC----------------CCCcEEEEEEeecchh------------------hhHHH
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL----------------ETGETVAIKKVLQDKR------------------YKNRE  114 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~----------------~~~~~vaiK~~~~~~~------------------~~~~e  114 (371)
                      ..++|.+.++||+|+||.||+|.+.                ..++.||||++.....                  ....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4568999999999999999999752                2456799999854321                  11235


Q ss_pred             HHHHHHcCCCCe-----eecceeEEecCC---CCceeEEEeeccccc-hHHHHHHHhhh--------------------c
Q 017452          115 LQTMRLLDHPNV-----VSLKHCFFSTTD---KDELYLNLVLEYVPE-TVHRVVKHFNK--------------------L  165 (371)
Q Consensus       115 ~~~l~~l~h~ni-----v~~~~~~~~~~~---~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------------~  165 (371)
                      +.++.+++|.++     +++++++.....   ......++||||+.+ +|.+++.....                    .
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            666777766554     556665543211   112346899999984 77776653110                    1


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCccc--ccccccccCcc
Q 017452          166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPE  243 (371)
Q Consensus       166 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~~t~~y~aPE  243 (371)
                      ...+++..++.++.|++.+|.|||++ +|+||||||+|||++.++ .+||+|||++.....+.....  ..+++.|+|||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~-~ivHrDLKp~NILl~~~~-~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE  380 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRI-GIVHRDIKPENLLVTVDG-QVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPE  380 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCchHhEEECCCC-cEEEEeCcCccccccCCccCccccCCCcceeChh
Confidence            12346778899999999999999986 999999999999999887 899999999876543322222  23478999999


Q ss_pred             cccCCcC---------------------CCCcchHHHHHHHHHHHHhCCC-CCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          244 LIFGATE---------------------YTTAIDIWSAGCVVAELMLGKP-LFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       244 ~~~~~~~---------------------~~~~~DiwslG~il~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .+.....                     ...+.|+||+||++|+|++|.. ||.............    ......|.. 
T Consensus       381 ~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~----~~~~~~~r~-  455 (507)
T PLN03224        381 ELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQY----DNDLNRWRM-  455 (507)
T ss_pred             hhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhc----cchHHHHHh-
Confidence            9853221                     1234799999999999999885 775432211110000    000011110 


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCC---CCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP---NLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP---~~R~t~~~~l~~  354 (371)
                                 .....+.-......++...+|+.+||..+|   .+|+|+.|+|+|
T Consensus       456 -----------~~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        456 -----------YKGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             -----------hcccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence                       000111111234578999999999999876   689999995544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=3.1e-35  Score=307.03  Aligned_cols=258  Identities=20%  Similarity=0.289  Sum_probs=188.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      .|...+.||+|+||.||+|.+..++..||+|++........+|++++++++|||||++++++...     ...++||||+
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~HpnIv~~~~~~~~~-----~~~~lv~Ey~  765 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-----KGAYLIHEYI  765 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCCCCCcceEEEEEEcC-----CCCEEEEeCC
Confidence            46677899999999999999989999999999876655556789999999999999999988433     3368999999


Q ss_pred             c-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH---hcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          152 P-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH---RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       152 ~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      + |+|.+.+.       .+++..+..++.|++.||+|||   .. +|+||||||+||+++.++ ..++. ||....... 
T Consensus       766 ~~g~L~~~l~-------~l~~~~~~~i~~~ia~~L~yLH~~~~~-~iiH~dlkp~Nil~~~~~-~~~~~-~~~~~~~~~-  834 (968)
T PLN00113        766 EGKNLSEVLR-------NLSWERRRKIAIGIAKALRFLHCRCSP-AVVVGNLSPEKIIIDGKD-EPHLR-LSLPGLLCT-  834 (968)
T ss_pred             CCCcHHHHHh-------cCCHHHHHHHHHHHHHHHHHhccCCCC-CeecCCCCHHhEEECCCC-ceEEE-ecccccccc-
Confidence            8 56766653       3788899999999999999999   44 999999999999999877 66665 665543221 


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                        .....+++.|+|||++.+.. ++.++|||||||++|||+||+.||..... ...+.++.+.......         ..
T Consensus       835 --~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---------~~  902 (968)
T PLN00113        835 --DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCH---------LD  902 (968)
T ss_pred             --CCCccccccccCcccccCCC-CCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccc---------hh
Confidence              12336789999999986544 89999999999999999999999854221 1112222211100000         00


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      .+..+.+.. .+  ..+.....++.+++.+||+.||++|||+.++++.|+.+..
T Consensus       903 ~~~~~~~~~-~~--~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        903 MWIDPSIRG-DV--SVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             heeCccccC-CC--CccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            000000000 00  0111123467889999999999999999999999987744

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-35  Score=274.41  Aligned_cols=244  Identities=26%  Similarity=0.433  Sum_probs=189.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      |..++.||-|+||.|.++....|...||+|.+.+.+       .....|-.||..-+.+-||++|-.|     .+...+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-----QDkdnLY  705 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-----QDKDNLY  705 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-----ccCCceE
Confidence            788899999999999999999999999999886543       2334578899999999999998887     4444488


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||+|++| ++-.++-.    .+.|+|..++.++..+..|+++.|+ +|+|||||||+|||||.+| .|||+|||+++-+
T Consensus       706 FVMdYIPGGDmMSLLIr----mgIFeE~LARFYIAEltcAiesVHk-mGFIHRDiKPDNILIDrdG-HIKLTDFGLCTGf  779 (1034)
T KOG0608|consen  706 FVMDYIPGGDMMSLLIR----MGIFEEDLARFYIAELTCAIESVHK-MGFIHRDIKPDNILIDRDG-HIKLTDFGLCTGF  779 (1034)
T ss_pred             EEEeccCCccHHHHHHH----hccCHHHHHHHHHHHHHHHHHHHHh-ccceecccCccceEEccCC-ceeeeeccccccc
Confidence            99999996 44444433    5789999999999999999999996 6999999999999999999 7999999998532


Q ss_pred             ---------ccCC----------------------------------CcccccccccccCcccccCCcCCCCcchHHHHH
Q 017452          225 ---------VKGE----------------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAG  261 (371)
Q Consensus       225 ---------~~~~----------------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  261 (371)
                               ..+.                                  .....+||+.|+|||++.... ++-..|+||.|
T Consensus       780 RWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g-~~q~cdwws~g  858 (1034)
T KOG0608|consen  780 RWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTG-YTQLCDWWSVG  858 (1034)
T ss_pred             eeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccC-ccccchhhHhh
Confidence                     0000                                  011457899999999996544 78899999999


Q ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcC
Q 017452          262 CVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS  341 (371)
Q Consensus       262 ~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~d  341 (371)
                      ||||||+.|+.||......+....++++....                         +--+..++|++..++|.++.. +
T Consensus       859 vil~em~~g~~pf~~~tp~~tq~kv~nw~~~l-------------------------~~~~~~~ls~e~~~li~kLc~-s  912 (1034)
T KOG0608|consen  859 VILYEMLVGQPPFLADTPGETQYKVINWRNFL-------------------------HIPYQGNLSKEALDLIQKLCC-S  912 (1034)
T ss_pred             HHHHHHhhCCCCccCCCCCcceeeeeehhhcc-------------------------ccccccccCHHHHHHHHHHhc-C
Confidence            99999999999998877665544444331110                         111345789999999988654 4


Q ss_pred             CCCCCC---HHHHhhh
Q 017452          342 PNLRCT---AVSKRIL  354 (371)
Q Consensus       342 P~~R~t---~~~~l~~  354 (371)
                      +..|+.   ++++..|
T Consensus       913 ad~RLGkng~d~vKaH  928 (1034)
T KOG0608|consen  913 ADSRLGKNGADQVKAH  928 (1034)
T ss_pred             hhhhhcccchhhhhcC
Confidence            566654   5555554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=6e-36  Score=265.05  Aligned_cols=274  Identities=27%  Similarity=0.461  Sum_probs=209.9

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECC---CCcEEEEEEeec--chhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQ--DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~--~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (371)
                      .....|.++++||+|.|++||++.+..   ..+.||+|.+..  ....+..|+++|..+ .+.||+++.+++     ..+
T Consensus        33 ~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-----rnn  107 (418)
T KOG1167|consen   33 FISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-----RNN  107 (418)
T ss_pred             hhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-----ccC
Confidence            344569999999999999999999887   788999998843  356678899999998 589999999988     555


Q ss_pred             eeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ....+|+||++.. ..++.       ..++...++.+++.++.||.++|.+ |||||||||+|+|++.....-.|+|||+
T Consensus       108 d~v~ivlp~~~H~~f~~l~-------~~l~~~~i~~Yl~~ll~Al~~~h~~-GIvHRDiKpsNFL~n~~t~rg~LvDFgL  179 (418)
T KOG1167|consen  108 DQVAIVLPYFEHDRFRDLY-------RSLSLAEIRWYLRNLLKALAHLHKN-GIVHRDIKPSNFLYNRRTQRGVLVDFGL  179 (418)
T ss_pred             CeeEEEecccCccCHHHHH-------hcCCHHHHHHHHHHHHHHhhhhhcc-CccccCCCccccccccccCCceEEechh
Confidence            5588999999963 22222       4567888999999999999999987 9999999999999998888899999999


Q ss_pred             ccccc-----------------c--CC--------------------------CcccccccccccCcccccCCcCCCCcc
Q 017452          221 AKVLV-----------------K--GE--------------------------PNISYICSRYYRAPELIFGATEYTTAI  255 (371)
Q Consensus       221 a~~~~-----------------~--~~--------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~  255 (371)
                      |....                 .  +.                          ......||++|.|||++...+..++++
T Consensus       180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai  259 (418)
T KOG1167|consen  180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI  259 (418)
T ss_pred             HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence            87210                 0  00                          001346899999999999888889999


Q ss_pred             hHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHhHHhhcCCC------------------ccccccCcccC-
Q 017452          256 DIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMNPN------------------YTEFKFPQIKA-  315 (371)
Q Consensus       256 DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~-  315 (371)
                      ||||.|+|++-+++++.|| ...++.+.+.++...+|.........+...                  +.......+.. 
T Consensus       260 Diws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~  339 (418)
T KOG1167|consen  260 DIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKS  339 (418)
T ss_pred             ceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccc
Confidence            9999999999999999887 456777888888888877554443322222                  00000000000 


Q ss_pred             C---CCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          316 H---PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       316 ~---~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .   .+.....+-.+..+.+|+.+||+.||.+|+||+++|+|
T Consensus       340 ~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  340 RQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             cccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence            0   01111223456689999999999999999999999998

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=6.2e-34  Score=249.82  Aligned_cols=235  Identities=37%  Similarity=0.595  Sum_probs=187.7

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc-hHH
Q 017452           83 SFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVH  156 (371)
Q Consensus        83 ~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  156 (371)
                      +||.||+|.+..+|+.+++|++...     .....+|+..+++++|+|++++++.+..     ....++++|++++ +|.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~l~~e~~~~~~L~   75 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFED-----EDKLYLVMEYCDGGDLF   75 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheee-----CCEEEEEEeCCCCCCHH
Confidence            5899999999888999999998543     3456789999999999999999998843     3457899999997 777


Q ss_pred             HHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCccccccc
Q 017452          157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS  236 (371)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t  236 (371)
                      +.+..    ...++...++.++.+++.++.+||+. +++|+||+|+||+++.++ .++|+|||.+.............++
T Consensus        76 ~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~~i~~~ni~~~~~~-~~~l~d~~~~~~~~~~~~~~~~~~~  149 (244)
T smart00220       76 DLLKK----RGRLSEDEARFYARQILSALEYLHSN-GIIHRDLKPENILLDEDG-HVKLADFGLARQLDPGGLLTTFVGT  149 (244)
T ss_pred             HHHHh----ccCCCHHHHHHHHHHHHHHHHHHHHc-CeecCCcCHHHeEECCCC-cEEEccccceeeeccccccccccCC
Confidence            77654    23389999999999999999999987 999999999999999887 8999999999876554444556778


Q ss_pred             ccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCC
Q 017452          237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAH  316 (371)
Q Consensus       237 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  316 (371)
                      ..|+|||.+.... ++.++|+||||++++++++|..||..........+..........                     
T Consensus       150 ~~~~~pE~~~~~~-~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~---------------------  207 (244)
T smart00220      150 PEYMAPEVLLGKG-YGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFP---------------------  207 (244)
T ss_pred             cCCCCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCc---------------------
Confidence            8999999986444 788999999999999999999999774443333332221000000                     


Q ss_pred             CCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          317 PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       317 ~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                          .....++.++.+++.+||..+|.+||++.++++|
T Consensus       208 ----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~  241 (244)
T smart00220      208 ----PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQH  241 (244)
T ss_pred             ----cccccCCHHHHHHHHHHccCCchhccCHHHHhhC
Confidence                0011167899999999999999999999997664

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=263.35  Aligned_cols=272  Identities=23%  Similarity=0.304  Sum_probs=193.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHH--cCCCCeeecceeEEecCCCCceeEEEee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ..++.+.+|+|.||.||+|..  +++.||||++... .+....|-++...  ++|+||+++++.--..+.. ...++||+
T Consensus       211 pl~l~eli~~Grfg~V~KaqL--~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~-~~eywLVt  287 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQL--DNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTAD-RMEYWLVT  287 (534)
T ss_pred             chhhHHHhhcCccceeehhhc--cCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcc-ccceeEEe
Confidence            467788999999999999986  6699999999643 4556667666654  5899999988765433322 44578999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--------CCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS--------IGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      +|.+ |+|.+++.     ...+++....+++..+++||+|||+.        ..|+|||||+.|||+.+|. +..|+|||
T Consensus       288 ~fh~kGsL~dyL~-----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~Dl-TccIaDFG  361 (534)
T KOG3653|consen  288 EFHPKGSLCDYLK-----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDL-TCCIADFG  361 (534)
T ss_pred             eeccCCcHHHHHH-----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCC-cEEeeccc
Confidence            9988 89999988     47789999999999999999999963        2699999999999999998 99999999


Q ss_pred             CccccccCCCc---ccccccccccCcccccCCcCCC-----CcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          220 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYT-----TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       220 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      +|..+..+...   ...+||..|||||++.+...+.     .+.||||+|.+|||+++....+......+...-....+|
T Consensus       362 LAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG  441 (534)
T KOG3653|consen  362 LALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVG  441 (534)
T ss_pred             eeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhc
Confidence            99887665443   3478899999999997665554     368999999999999986543321111111111111111


Q ss_pred             -CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          292 -TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       292 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                       .|..+.++......  -..|.++ ..|.+   ..-...+.+.+..||.+||+-|+||.-+-+.+..+
T Consensus       442 ~hPt~e~mq~~VV~k--K~RP~~p-~~W~~---h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l  503 (534)
T KOG3653|consen  442 NHPTLEEMQELVVRK--KQRPKIP-DAWRK---HAGMAVLCETIEECWDHDAEARLTAGCVEERMAEL  503 (534)
T ss_pred             CCCCHHHHHHHHHhh--ccCCCCh-hhhhc---CccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHH
Confidence             12222222111000  0001100 01111   11245689999999999999999999998886655

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-34  Score=259.98  Aligned_cols=198  Identities=28%  Similarity=0.423  Sum_probs=172.3

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhh------------HHHHHHHHHcC---CCCeeecce
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK------------NRELQTMRLLD---HPNVVSLKH  131 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~------------~~e~~~l~~l~---h~niv~~~~  131 (371)
                      +....+|...+.+|+|+||.|+.|.++.+...|+||.+.+++-..            -.|+.||..++   |+||+++++
T Consensus       557 ~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLd  636 (772)
T KOG1152|consen  557 YKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLD  636 (772)
T ss_pred             ecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhh
Confidence            344557999999999999999999999999999999887653222            25999999997   999999999


Q ss_pred             eEEecCCCCceeEEEeeccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC
Q 017452          132 CFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH  209 (371)
Q Consensus       132 ~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~  209 (371)
                      +|     +++.++||+||..+.  +|.++++.    ...++|.++..|++|++.|+++||++ ||||||||-+||.++.+
T Consensus       637 fF-----Eddd~yyl~te~hg~gIDLFd~IE~----kp~m~E~eAk~IFkQV~agi~hlh~~-~ivhrdikdenvivd~~  706 (772)
T KOG1152|consen  637 FF-----EDDDYYYLETEVHGEGIDLFDFIEF----KPRMDEPEAKLIFKQVVAGIKHLHDQ-GIVHRDIKDENVIVDSN  706 (772)
T ss_pred             ee-----ecCCeeEEEecCCCCCcchhhhhhc----cCccchHHHHHHHHHHHhcccccccc-CceecccccccEEEecC
Confidence            99     778889999999885  55555554    78899999999999999999999997 99999999999999999


Q ss_pred             CCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          210 THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       210 ~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                      | -+||+|||.|.... ..+.-.+.||..|.|||++.+..+.+..-|||+||++||.++....||..
T Consensus       707 g-~~klidfgsaa~~k-sgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  707 G-FVKLIDFGSAAYTK-SGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             C-eEEEeeccchhhhc-CCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            9 89999999886543 33445688999999999998888889999999999999999999999863

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-32  Score=266.62  Aligned_cols=251  Identities=25%  Similarity=0.401  Sum_probs=195.7

Q ss_pred             eeeeEeeccCCceEEEEEEEC---C----CCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           73 YMAERIVGQGSFGVVFQAKCL---E----TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~---~----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      ..+.+.||+|.||.|++|.-.   .    ....||||..+..     ...+..|+++++.+ .|+||+.+++++..    
T Consensus       298 l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~----  373 (609)
T KOG0200|consen  298 LKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQ----  373 (609)
T ss_pred             ccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeecc----
Confidence            456779999999999999743   1    1456999987543     34556799999988 59999999998843    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhh---hc-------c--CCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFN---KL-------N--QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~---~~-------~--~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                       ...+++|+||+. |+|...+...+   ..       .  ..++......++.||+.|++||+++ ++|||||-..|||+
T Consensus       374 -~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~-~~vHRDLAaRNVLi  451 (609)
T KOG0200|consen  374 -DGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV-PCVHRDLAARNVLI  451 (609)
T ss_pred             -CCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC-CccchhhhhhhEEe
Confidence             445789999998 78888887644   11       1  1388999999999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCCCccc--cc--ccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGEPNIS--YI--CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~~~~~--~~--~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (371)
                      ..+. .+||+|||+|+..........  ..  -...|||||.+.. ..++.++||||+|++|||+++ |..||.+-....
T Consensus       452 ~~~~-~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~  529 (609)
T KOG0200|consen  452 TKNK-VIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTE  529 (609)
T ss_pred             cCCC-EEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHHHhhCCCCCCCCCCcHH
Confidence            9887 899999999986544332221  11  2345999999976 559999999999999999996 789998754233


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .+.+..+. |..                          -..|..++.++.++++.||..+|.+||+..++.+.|...
T Consensus       530 ~l~~~l~~-G~r--------------------------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~  579 (609)
T KOG0200|consen  530 ELLEFLKE-GNR--------------------------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH  579 (609)
T ss_pred             HHHHHHhc-CCC--------------------------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence            33332221 110                          014667899999999999999999999999999998873

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=5.8e-32  Score=256.16  Aligned_cols=247  Identities=26%  Similarity=0.359  Sum_probs=197.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+..++||+|+||+||+|.+...|+    +||+|++...     ...+.+|.-+|..++|||++++++......     
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-----  771 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-----  771 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-----
Confidence            35667899999999999999987665    5788877543     345567889999999999999999884432     


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                       +-||++|++ |.|.++++..   ...+-.+....|..||++|+.|||++ ++|||||-..|||+.+-. .+||.|||++
T Consensus       772 -~qlvtq~mP~G~LlDyvr~h---r~~igsq~lLnw~~QIAkgM~YLe~q-rlVHrdLaaRNVLVksP~-hvkitdfgla  845 (1177)
T KOG1025|consen  772 -LQLVTQLMPLGCLLDYVREH---RDNIGSQDLLNWCYQIAKGMKYLEEQ-RLVHRDLAARNVLVKSPN-HVKITDFGLA  845 (1177)
T ss_pred             -HHHHHHhcccchHHHHHHHh---hccccHHHHHHHHHHHHHHHHHHHhc-chhhhhhhhhheeecCCC-eEEEEecchh
Confidence             558999999 6777777653   46788899999999999999999997 999999999999999877 8999999999


Q ss_pred             cccccCCCcccccc---cccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGEPNISYIC---SRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~~~~~~~~---t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      +............+   .+.|||-|.+... .++.++||||+||+.||++| |..|+.+....+.-..+....       
T Consensus       846 ~ll~~d~~ey~~~~gK~pikwmale~i~~~-~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~ge-------  917 (1177)
T KOG1025|consen  846 KLLAPDEKEYSAPGGKVPIKWMALESIRIR-KYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGE-------  917 (1177)
T ss_pred             hccCcccccccccccccCcHHHHHHHhhcc-CCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccc-------
Confidence            98766554433332   4559999988654 48999999999999999995 899998876554433332211       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                 +++          .|...+-++.-++.+||..|+..||+++++...|...
T Consensus       918 -----------RLs----------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~  957 (1177)
T KOG1025|consen  918 -----------RLS----------QPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRM  957 (1177)
T ss_pred             -----------cCC----------CCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHH
Confidence                       011          3556889999999999999999999999998886554

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.5e-32  Score=230.34  Aligned_cols=249  Identities=22%  Similarity=0.314  Sum_probs=186.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ..+.|.|.+.||+|.||.+-+|+++.++..+++|.+..+   .+.+.+|+..--.| .|.||+.-|+.-+...    .+.
T Consensus        22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~----d~Y   97 (378)
T KOG1345|consen   22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTS----DAY   97 (378)
T ss_pred             hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcC----ceE
Confidence            345799999999999999999999999999999988654   35566777665555 5899999877654432    356


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee-eCCCCcEEEEeeCCcc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAK  222 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli-~~~~~~~kl~Dfg~a~  222 (371)
                      ++++||++ |+|.+.+.     ..++-+...+.++.|++.|+.|||++ ++||||||.+|||| +.|..+|||||||.++
T Consensus        98 vF~qE~aP~gdL~snv~-----~~GigE~~~K~v~~ql~SAi~fMHsk-nlVHRdlK~eNiLif~~df~rvKlcDFG~t~  171 (378)
T KOG1345|consen   98 VFVQEFAPRGDLRSNVE-----AAGIGEANTKKVFAQLLSAIEFMHSK-NLVHRDLKAENILIFDADFYRVKLCDFGLTR  171 (378)
T ss_pred             EEeeccCccchhhhhcC-----cccccHHHHHHHHHHHHHHHHHhhcc-chhhcccccceEEEecCCccEEEeeeccccc
Confidence            78999999 67666555     36788899999999999999999997 99999999999997 6666699999999987


Q ss_pred             ccccCCCcccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~  297 (371)
                      ..+.  .....--+-.|.+||.+...    -...+.+|+|.||+++|.++||..||...... ....++.++.++.... 
T Consensus       172 k~g~--tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~~-  248 (378)
T KOG1345|consen  172 KVGT--TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNPA-  248 (378)
T ss_pred             ccCc--eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCcc-
Confidence            6422  11112224458999987432    23567899999999999999999999753322 2344555544433221 


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHH
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK  351 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~  351 (371)
                                  .|.         .=..+|+.+..+.++-|.++|++|--..++
T Consensus       249 ------------~P~---------~F~~fs~~a~r~Fkk~lt~~~~drcki~~~  281 (378)
T KOG1345|consen  249 ------------LPK---------KFNPFSEKALRLFKKSLTPRFKDRCKIWTA  281 (378)
T ss_pred             ------------Cch---------hhcccCHHHHHHHHHhcCCcccccchhHHH
Confidence                        000         012478999999999999999999444443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=8.1e-33  Score=256.86  Aligned_cols=251  Identities=25%  Similarity=0.340  Sum_probs=201.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .+|.+...+|+|.+|.||++++..+++..|+|+++..    ....+.|+-+++..+|||||.+++.|...+.     +++
T Consensus        15 ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dk-----lwi   89 (829)
T KOG0576|consen   15 DDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDK-----LWI   89 (829)
T ss_pred             cchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcC-----cEE
Confidence            4799999999999999999999999999999998643    4556789999999999999999999965444     789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      .||||+| +|.+...    ..+++++.++...++..++||+|||+. |-+|||||-.||+++..+ .+|+.|||.+..+.
T Consensus        90 cMEycgggslQdiy~----~TgplselqiayvcRetl~gl~ylhs~-gk~hRdiKGanilltd~g-DvklaDfgvsaqit  163 (829)
T KOG0576|consen   90 CMEYCGGGSLQDIYH----VTGPLSELQIAYVCRETLQGLKYLHSQ-GKIHRDIKGANILLTDEG-DVKLADFGVSAQIT  163 (829)
T ss_pred             EEEecCCCcccceee----ecccchhHHHHHHHhhhhccchhhhcC-CcccccccccceeecccC-ceeecccCchhhhh
Confidence            9999996 5544433    368999999999999999999999986 999999999999999888 89999999875543


Q ss_pred             c-CCCcccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 K-GEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~-~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      . -....++.|||+|||||+..  ....|+...|+|++|+...|+.--++|....-....+..+.+-.-+++        
T Consensus       164 ati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp--------  235 (829)
T KOG0576|consen  164 ATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPP--------  235 (829)
T ss_pred             hhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCC--------
Confidence            2 22345789999999999972  222378899999999999999887877655544444443333211111        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                               ..+       -+.+.++.+.+|++.+|.++|.+|||++.+|.|-+
T Consensus       236 ---------~lk-------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~f  273 (829)
T KOG0576|consen  236 ---------TLK-------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPF  273 (829)
T ss_pred             ---------ccc-------CCccchHHHHHHHHHHhcCCCccCCChhhheecee
Confidence                     110       12345788999999999999999999999999833

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=5.5e-30  Score=219.46  Aligned_cols=207  Identities=34%  Similarity=0.581  Sum_probs=174.6

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecccc-
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-  152 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-  152 (371)
                      ||+|.+|.||++.+..+++.+++|++....     ....+|+..++.+.|++++++++++..     ....++++|+++ 
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~-----~~~~~~~~e~~~~   75 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFED-----ENHLYLVMEYCEG   75 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeec-----CCeEEEEEecCCC
Confidence            689999999999998889999999997654     457789999999999999999988743     345789999999 


Q ss_pred             chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC-CCCcEEEEeeCCccccccCC-Cc
Q 017452          153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKVLVKGE-PN  230 (371)
Q Consensus       153 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~-~~~~~kl~Dfg~a~~~~~~~-~~  230 (371)
                      ++|...+...   ...++...++.++.+++.+|.+||+. |++|+||+|.||+++. ++ .++|+|||.+....... ..
T Consensus        76 ~~l~~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lh~~-~~~H~dl~~~ni~~~~~~~-~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          76 GSLKDLLKEN---EGKLSEDEILRILLQILEGLEYLHSN-GIIHRDLKPENILLDSDNG-KVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             CcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHhhEEEeCCCC-cEEEecCCceEEccCCcchh
Confidence            6777766532   14689999999999999999999987 9999999999999998 66 89999999987654332 12


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccccc
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF  310 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  310 (371)
                      ....+...|++||.+......+.+.|+|++|++++++                                           
T Consensus       151 ~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-------------------------------------------  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------------------  187 (215)
T ss_pred             hcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-------------------------------------------
Confidence            3355678899999986543578899999999999998                                           


Q ss_pred             CcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       311 ~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                       ..+.+++.+|+..||.+||++.++++++
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                             1477899999999999999999998874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=2.9e-29  Score=217.89  Aligned_cols=200  Identities=34%  Similarity=0.565  Sum_probs=165.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      |.+.+.||.|++|.||++....+++.+++|.+...     .....+|++.++.++|+|++++++.+..     ....+++
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~-----~~~~~~v   75 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFED-----PEPLYLV   75 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeec-----CCceEEE
Confidence            67889999999999999999888999999998653     3456679999999999999999988733     3447899


Q ss_pred             eccccc-hHHHHHHHhhhccCC-CCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQR-MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +|++++ +|.+.+...    .. +++..+..++.+++.++.+||++ +++|+||+|+||+++.++ .++|+|||.+....
T Consensus        76 ~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~l~~~l~~lh~~-~i~h~di~~~ni~v~~~~-~~~l~d~g~~~~~~  149 (225)
T smart00221       76 MEYCEGGDLFDYLRKK----GGKLSEEEARFYLRQILEALEYLHSL-GIVHRDLKPENILLGMDG-LVKLADFGLARFIH  149 (225)
T ss_pred             EeccCCCCHHHHHHhc----ccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeeCceeeEec
Confidence            999997 777776642    33 88999999999999999999987 999999999999999887 89999999988765


Q ss_pred             cCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHH
Q 017452          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQL  283 (371)
Q Consensus       226 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~  283 (371)
                      ...  ......++..|++||.+.+...++.++|+|+||+++++|++|+.||.. .+....+
T Consensus       150 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~  210 (225)
T smart00221      150 RDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLL  210 (225)
T ss_pred             CcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHH
Confidence            443  233456778899999884334467799999999999999999999977 4444333

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.96  E-value=2.7e-29  Score=256.15  Aligned_cols=200  Identities=17%  Similarity=0.159  Sum_probs=138.8

Q ss_pred             HcCC-CCeeecceeEEecCC--CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 017452          120 LLDH-PNVVSLKHCFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (371)
Q Consensus       120 ~l~h-~niv~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (371)
                      .+.| +||+.+++.|-....  .....+++++|+++++|.+.+..   ....+++..++.++.||+.||.|||++ ||+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-gIvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDN---PDRSVDAFECFHVFRQIVEIVNAAHSQ-GIVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhc---ccccccHHHHHHHHHHHHHHHHHHHhC-Ceee
Confidence            3445 466666666522211  12234678899999998888753   245699999999999999999999986 9999


Q ss_pred             eccCCCceeeeCCC------------------CcEEEEeeCCccccccCC-----------------CcccccccccccC
Q 017452          197 RDIKPQNLLVNPHT------------------HQVKLCDFGSAKVLVKGE-----------------PNISYICSRYYRA  241 (371)
Q Consensus       197 ~dlkp~NIli~~~~------------------~~~kl~Dfg~a~~~~~~~-----------------~~~~~~~t~~y~a  241 (371)
                      |||||+||||+..+                  ..+|++|||+++......                 ......||+.|||
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            99999999996433                  245666666664321100                 0012357889999


Q ss_pred             cccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCccc
Q 017452          242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI  321 (371)
Q Consensus       242 PE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (371)
                      ||++.+.. ++.++|||||||+||||++|..|+....  ..+..+.... .+ ..                         
T Consensus       184 PE~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~-~~-~~-------------------------  233 (793)
T PLN00181        184 PEEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV-LP-PQ-------------------------  233 (793)
T ss_pred             hhhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh-cC-hh-------------------------
Confidence            99987655 7999999999999999999988865321  1122221110 00 00                         


Q ss_pred             CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          322 FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       322 ~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      . ....+...+++.+||.+||.+||++.++++|
T Consensus       234 ~-~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h  265 (793)
T PLN00181        234 I-LLNWPKEASFCLWLLHPEPSCRPSMSELLQS  265 (793)
T ss_pred             h-hhcCHHHHHHHHHhCCCChhhCcChHHHhhc
Confidence            0 0113557789999999999999999999988

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-27  Score=206.26  Aligned_cols=209  Identities=23%  Similarity=0.324  Sum_probs=172.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEee--cchhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL--QDKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ...|+++++||+|+||.+|.|...-++++||||.-.  .+...+..|....+.|. .+.|..+|-+.     ....+-.+
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFG-----qeG~~NiL  101 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFG-----QEGKYNIL  101 (449)
T ss_pred             cccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeec-----cccchhhh
Confidence            346999999999999999999999999999999653  33445667888888885 68888875433     44455678


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee----CCCCcEEEEeeCCcc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAK  222 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~----~~~~~~kl~Dfg~a~  222 (371)
                      |+|.++.+|.+++..+   .++|+.+.+..++.|++.-++++|++ .+|+|||||+|+||.    ++.+.|.|+|||+|+
T Consensus       102 VidLLGPSLEDLFD~C---gR~FSvKTV~miA~Qmi~rie~vH~k-~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK  177 (449)
T KOG1165|consen  102 VIDLLGPSLEDLFDLC---GRRFSVKTVAMIAKQMITRIEYVHEK-DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAK  177 (449)
T ss_pred             hhhhhCcCHHHHHHHh---cCcccHHhHHHHHHHHHHHHHHHHhc-ceeecccCccceeecCCCCCCCceEEEEeccchh
Confidence            9999999999998865   68899999999999999999999997 999999999999994    344579999999998


Q ss_pred             ccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017452          223 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       223 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  288 (371)
                      ...+...        ..+..||..||+-....+.. .+...|+-|||-+++.+|-|..||.+......-.++.+
T Consensus       178 ~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeK  250 (449)
T KOG1165|consen  178 EYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEK  250 (449)
T ss_pred             hhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHH
Confidence            8654432        34667899999999988766 68999999999999999999999988655444444443

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=1.6e-28  Score=215.64  Aligned_cols=255  Identities=21%  Similarity=0.260  Sum_probs=192.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCC-----cEEEEEEeecchhhh-----HHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETG-----ETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-----~~vaiK~~~~~~~~~-----~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ...++++...+-+|.||.||.|.++...     +.|.+|.++.....+     ..|-..+..+.|||+..+.+...... 
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~-  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDY-  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeecc-
Confidence            3456888889999999999999876433     345666665433222     35666777788999999988776533 


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhh----hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcE
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFN----KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV  213 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~  213 (371)
                         ...++++.+++ |+|...+...+    +..+.++-.+...++.|++.|++|||++ |+||.||-..|.+|+..- ++
T Consensus       361 ---~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~-~ViHkDiAaRNCvIdd~L-qV  435 (563)
T KOG1024|consen  361 ---ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH-GVIHKDIAARNCVIDDQL-QV  435 (563)
T ss_pred             ---CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc-Ccccchhhhhcceehhhe-eE
Confidence               23567888887 77777776443    1234567788889999999999999987 999999999999999776 89


Q ss_pred             EEEeeCCccccccCCCcc---cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHH
Q 017452          214 KLCDFGSAKVLVKGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       214 kl~Dfg~a~~~~~~~~~~---~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~  289 (371)
                      ||+|=.+++...+....-   .......||+||.+... .|+.++|+||||++||||+| |+.|+..-+..+...-+..+
T Consensus       436 kltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdG  514 (563)
T KOG1024|consen  436 KLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDG  514 (563)
T ss_pred             EeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhcc
Confidence            999999998765543221   12225569999999654 48999999999999999996 89999887766544333221


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        +++.          .|-++++++..++.-||..+|++||+..++..-|...
T Consensus       515 ------------------yRla----------QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF  555 (563)
T KOG1024|consen  515 ------------------YRLA----------QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEF  555 (563)
T ss_pred             ------------------ceec----------CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence                              1111          3557899999999999999999999999987766543

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=8e-28  Score=201.27  Aligned_cols=166  Identities=19%  Similarity=0.194  Sum_probs=123.8

Q ss_pred             chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCccc
Q 017452          153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS  232 (371)
Q Consensus       153 ~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~  232 (371)
                      |+|.+.+...   ...+++..++.++.||+.||.|||++ +      ||+|||++.++ .+++  ||.+......    .
T Consensus         1 GsL~~~l~~~---~~~l~~~~~~~i~~qi~~~L~~lH~~-~------kp~Nil~~~~~-~~~~--fG~~~~~~~~----~   63 (176)
T smart00750        1 VSLADILEVR---GRPLNEEEIWAVCLQCLRALRELHRQ-A------KSGNILLTWDG-LLKL--DGSVAFKTPE----Q   63 (176)
T ss_pred             CcHHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhc-C------CcccEeEcCcc-ceee--ccceEeeccc----c
Confidence            4566666542   45699999999999999999999986 6      99999999887 7888  9998765332    2


Q ss_pred             ccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHhHHhhcCCCccccccC
Q 017452          233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFP  311 (371)
Q Consensus       233 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ..||+.|+|||++.+.. ++.++|||||||++|+|++|+.||....... .+..+..........               
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------  127 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPR---------------  127 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCcc---------------
Confidence            36789999999997655 7899999999999999999999997654432 222222211110000               


Q ss_pred             cccCCCCcccCCCCCCh--hHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          312 QIKAHPWHKIFPKRMPP--EAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       312 ~~~~~~~~~~~~~~~s~--~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                             ....+..++.  ++.+++.+||..||.+||++.++++|+..+
T Consensus       128 -------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      128 -------DRSNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             -------ccccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                   0000112333  699999999999999999999999997654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=4.1e-27  Score=194.59  Aligned_cols=257  Identities=22%  Similarity=0.281  Sum_probs=196.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCC-CCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..++|+++++||+|+||.+|.|....+|+.||||+-.+.  ......|..+.+.+++ ..|..+..+.     ....+-.
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~-----~e~~ynv   87 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYG-----TEKDYNV   87 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhc-----cccccce
Confidence            345799999999999999999999999999999977543  3445678889888864 4566665555     4455567


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee--CCCCcEEEEeeCCccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~--~~~~~~kl~Dfg~a~~  223 (371)
                      +||+.++.+|.+++..+   .+.++...+..++-|++.-++|+|.+ ++|||||||+|+|..  ...+.+.|+|||+|+.
T Consensus        88 lVMdLLGPsLEdLfnfC---~R~ftmkTvLMLaDQml~RiEyvH~r-~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   88 LVMDLLGPSLEDLFNFC---SRRFTMKTVLMLADQMLSRIEYVHLR-NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             eeeeccCccHHHHHHHH---hhhhhHHhHHHHHHHHHHHHHHHHhh-ccccccCCccceeeccccccceEEEEeccchhh
Confidence            99999999999988765   57899999999999999999999987 999999999999973  3445799999999988


Q ss_pred             cccCC--------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          224 LVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       224 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ..+..        ......||..|.+-....+.. .+...|+-|+|.+|..+.-|..||.+-......++..+..-....
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s  242 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMS  242 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcC
Confidence            64432        234567899999988876554 688999999999999999999999887665554444433211100


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhc
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFS  356 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~  356 (371)
                      .                     ..+.+...++.++.-.+.-|=..--.+-|.-.-+.+.|.
T Consensus       243 ~---------------------~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFr  282 (341)
T KOG1163|consen  243 T---------------------PIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFR  282 (341)
T ss_pred             C---------------------CHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHH
Confidence            0                     011134567778887787777776677777666555543

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=7.3e-26  Score=207.31  Aligned_cols=255  Identities=20%  Similarity=0.208  Sum_probs=193.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCC-cEEEEEEeecch----hhhHHHHHHHHHcCC----CCeeecceeEEecCCCCce
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQDK----RYKNRELQTMRLLDH----PNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~~----~~~~~e~~~l~~l~h----~niv~~~~~~~~~~~~~~~  142 (371)
                      +|.+.+.||+|+||.||+|.+..++ ..+|+|......    .....|..++..+..    .++..+++...    ....
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~----~~~~   94 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGR----STED   94 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEecc----CCCc
Confidence            7999999999999999999987775 678998775431    156778999988863    57777766552    2455


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC----CcEEEEee
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCDF  218 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~----~~~kl~Df  218 (371)
                      +-++||+.++.+|.++.....  .+.++...+..++.|++.+|++||+. |++||||||+|+++....    ..+.|.||
T Consensus        95 ~~~iVM~l~G~sL~dl~~~~~--~~~fs~~T~l~ia~q~l~~l~~lH~~-G~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   95 FNFIVMSLLGPSLEDLRKRNP--PGRFSRKTVLRIAIQNLNALEDLHSK-GFIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eeEEEEeccCccHHHHHHhCC--CCCcCHhHHHHHHHHHHHHHHHHHhc-CcccCCcCHHHeeecCCCCcccceEEEEec
Confidence            678999999999998776543  68899999999999999999999986 999999999999997543    47999999


Q ss_pred             CCcc--ccccCC--------C-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017452          219 GSAK--VLVKGE--------P-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (371)
Q Consensus       219 g~a~--~~~~~~--------~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  287 (371)
                      |+++  ......        . .....||..|+++.+..+.. .+.+.|+||++.++.+++.|..||..........+..
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e-~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~  250 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE-QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFE  250 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc-cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHH
Confidence            9998  321111        1 12345899999999987655 7999999999999999999999997655433333332


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      +.......               ..         +....+.++.++...+-..+...+|....+...|..+
T Consensus       251 ~~~~~~~~---------------~~---------~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~  297 (322)
T KOG1164|consen  251 KDPRKLLT---------------DR---------FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDV  297 (322)
T ss_pred             HHhhhhcc---------------cc---------ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHH
Confidence            21110000               00         1123456788888888889999999999988886544

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=8.9e-26  Score=206.53  Aligned_cols=159  Identities=19%  Similarity=0.287  Sum_probs=120.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECC-CCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      ...++|.+.+.||+|+||+||+|.+.. ++..+|||++...         ...+.+|+++|+.++|+|++..+..+   .
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---~   91 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---G   91 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc---C
Confidence            345679999999999999999998876 6788899986422         23467899999999999998532211   1


Q ss_pred             CCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecc-CCCceeeeCCCCcEEEE
Q 017452          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDI-KPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dl-kp~NIli~~~~~~~kl~  216 (371)
                           ..++||||++|..+...   .    ...   ...++.|++.+|.|||++ ||+|||| ||+|||++.++ .++|+
T Consensus        92 -----~~~LVmE~~~G~~L~~~---~----~~~---~~~~~~~i~~aL~~lH~~-gIiHrDL~KP~NILv~~~~-~ikLi  154 (365)
T PRK09188         92 -----KDGLVRGWTEGVPLHLA---R----PHG---DPAWFRSAHRALRDLHRA-GITHNDLAKPQNWLMGPDG-EAAVI  154 (365)
T ss_pred             -----CcEEEEEccCCCCHHHh---C----ccc---hHHHHHHHHHHHHHHHHC-CCeeCCCCCcceEEEcCCC-CEEEE
Confidence                 25899999997533221   1    111   146788999999999987 9999999 99999998877 89999


Q ss_pred             eeCCccccccCCCc---------ccccccccccCccccc
Q 017452          217 DFGSAKVLVKGEPN---------ISYICSRYYRAPELIF  246 (371)
Q Consensus       217 Dfg~a~~~~~~~~~---------~~~~~t~~y~aPE~~~  246 (371)
                      |||+|+........         ....+++.|+|||.+.
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999866443211         2345678899999884

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=9.3e-27  Score=226.45  Aligned_cols=251  Identities=25%  Similarity=0.356  Sum_probs=183.4

Q ss_pred             ce-eeeEeeccCCceEEEEEEECCCCcEEEEEEeec----chh------hhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           72 SY-MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----DKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        72 ~y-~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .| .-...+|.|.+|.|+.+......+.++.|.+..    ...      ....|+.+-..+.|+|++.....++....  
T Consensus       318 ~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~--  395 (601)
T KOG0590|consen  318 KYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDG--  395 (601)
T ss_pred             ccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhccc--
Confidence            35 566789999999999998887777777775531    110      12235555566799999887766644332  


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                         ..-+||||+++|..++..    ...+....+..++.|++.||+|||.. ||.|||+||+|++++.++ .+||+|||.
T Consensus       396 ---~~~~mE~~~~Dlf~~~~~----~~~~~~~e~~c~fKqL~~Gv~y~h~~-GiahrdlK~enll~~~~g-~lki~Dfg~  466 (601)
T KOG0590|consen  396 ---ILQSMEYCPYDLFSLVMS----NGKLTPLEADCFFKQLLRGVKYLHSM-GLAHRDLKLENLLVTENG-ILKIIDFGA  466 (601)
T ss_pred             ---chhhhhcccHHHHHHHhc----ccccchhhhhHHHHHHHHHHHHHHhc-CceeccCccccEEEecCC-ceEEeecCc
Confidence               223499999977777764    35788999999999999999999986 999999999999999998 999999998


Q ss_pred             ccccccCC-----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +.......     .....+|+..|+|||++.+..+.....||||.|+++..|.+|+.||......+........      
T Consensus       467 ~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~------  540 (601)
T KOG0590|consen  467 ASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNY------  540 (601)
T ss_pred             ceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhcc------
Confidence            87653322     2345778999999999988777777899999999999999999999655433322100000      


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                               ...+.   +...++  .+...++...+.+|.+||++||.+|.|+.++++
T Consensus       541 ---------~~~~~---~~~~~~--~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  541 ---------SDQRN---IFEGPN--RLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             ---------ccccc---cccChH--HHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence                     00000   000000  022347788999999999999999999999544

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3e-25  Score=195.80  Aligned_cols=200  Identities=24%  Similarity=0.375  Sum_probs=148.3

Q ss_pred             CCCCeeecceeEEecCC----------------------CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHH
Q 017452          122 DHPNVVSLKHCFFSTTD----------------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY  179 (371)
Q Consensus       122 ~h~niv~~~~~~~~~~~----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~  179 (371)
                      +|||||++...|.+...                      .....+|+||...+.+|..++..     ...+....+.++.
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~-----~~~s~r~~~~~la  348 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWT-----RHRSYRTGRVILA  348 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhc-----CCCchHHHHHHHH
Confidence            69999999887743211                      23456899999999999988874     5667778888999


Q ss_pred             HHHHHHHHHHhcCCcEeeccCCCceeee--CCC-CcEEEEeeCCccccccC-------CCcccccccccccCcccccCCc
Q 017452          180 QIFRALSYIHRSIGVCHRDIKPQNLLVN--PHT-HQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPELIFGAT  249 (371)
Q Consensus       180 qi~~~l~~LH~~~~ivH~dlkp~NIli~--~~~-~~~kl~Dfg~a~~~~~~-------~~~~~~~~t~~y~aPE~~~~~~  249 (371)
                      |+++|+.|||++ ||.|||+|++|||+.  +|+ ..+.|+|||++-.....       .......|...-||||+....+
T Consensus       349 QlLEav~hL~~h-gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~P  427 (598)
T KOG4158|consen  349 QLLEAVTHLHKH-GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVP  427 (598)
T ss_pred             HHHHHHHHHHHc-cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCC
Confidence            999999999987 999999999999983  232 36889999987553321       1123456778899999985433


Q ss_pred             CC-----CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCC
Q 017452          250 EY-----TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK  324 (371)
Q Consensus       250 ~~-----~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  324 (371)
                      ..     -.++|.|+.|.+.||+++...||.+......  +.                ..+.+-++|.         +++
T Consensus       428 Gp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~~----------------r~Yqe~qLPa---------lp~  480 (598)
T KOG4158|consen  428 GPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--DT----------------RTYQESQLPA---------LPS  480 (598)
T ss_pred             CCceeeccchhhhhhhhhhHHHHhccCCcccccchhee--ch----------------hhhhhhhCCC---------Ccc
Confidence            21     1278999999999999999999987322111  00                0122223333         677


Q ss_pred             CCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          325 RMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       325 ~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+++.+++++..+|+.||++|+++.-+.+-
T Consensus       481 ~vpp~~rqlV~~lL~r~pskRvsp~iAANv  510 (598)
T KOG4158|consen  481 RVPPVARQLVFDLLKRDPSKRVSPNIAANV  510 (598)
T ss_pred             cCChHHHHHHHHHhcCCccccCCccHHHhH
Confidence            899999999999999999999997655443

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.92  E-value=2.8e-25  Score=194.93  Aligned_cols=237  Identities=24%  Similarity=0.315  Sum_probs=147.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHH-------HHcC----------CCCeeecceeEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLD----------HPNVVSLKHCFF  134 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-------~~l~----------h~niv~~~~~~~  134 (371)
                      ....++.||.|+++.||.+.+..+|+.+|+|++........++++.+       ..+.          |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            46788899999999999999999999999998854332222222211       1111          111111112111


Q ss_pred             --------ecCCCCce----eEEEeeccccchHHHHHHHhhhccCC---CCHHHHHHHHHHHHHHHHHHHhcCCcEeecc
Q 017452          135 --------STTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQR---MPMIYVKLYAYQIFRALSYIHRSIGVCHRDI  199 (371)
Q Consensus       135 --------~~~~~~~~----~~~lv~e~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dl  199 (371)
                              ........    ..+++|+-+.++|..++.........   +.......+..|+++.+++||.. |++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~-GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY-GLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc-ceEeccc
Confidence                    11111111    24678898888888887654443333   23333445668999999999987 9999999


Q ss_pred             CCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCC-------cCCCCcchHHHHHHHHHHHHhCCC
Q 017452          200 KPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSAGCVVAELMLGKP  272 (371)
Q Consensus       200 kp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~  272 (371)
                      +|+|++++.+| .++|+||+.....+....  ....+..|.|||.....       ..++.+.|.|+||+++|.|++|..
T Consensus       172 ~~~nfll~~~G-~v~Lg~F~~~~r~g~~~~--~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~l  248 (288)
T PF14531_consen  172 KPENFLLDQDG-GVFLGDFSSLVRAGTRYR--CSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRL  248 (288)
T ss_dssp             SGGGEEE-TTS--EEE--GGGEEETTEEEE--GGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-
T ss_pred             ceeeEEEcCCC-CEEEcChHHHeecCceee--ccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccC
Confidence            99999999998 899999997765433222  13445779999977332       236888999999999999999999


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCC
Q 017452          273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR  345 (371)
Q Consensus       273 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R  345 (371)
                      ||+..........                               .|.. .. +++..+++||.++|++||.+|
T Consensus       249 Pf~~~~~~~~~~~-------------------------------~f~~-C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  249 PFGLSSPEADPEW-------------------------------DFSR-CR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             STCCCGGGSTSGG-------------------------------GGTT-SS----HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCCccccccc-------------------------------cchh-cC-CcCHHHHHHHHHHccCCcccC
Confidence            9976543211000                               1111 22 689999999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=6.3e-23  Score=187.73  Aligned_cols=252  Identities=34%  Similarity=0.509  Sum_probs=188.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCC-CeeecceeEEecCCCCceeE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHP-NVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~-niv~~~~~~~~~~~~~~~~~  144 (371)
                      |.+...||.|+||.||++.+.   ..+++|.+...       .....+|..+++.+.|+ +++++.+.+     ......
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~-----~~~~~~   73 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF-----QDEGSL   73 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE-----ecCCEE
Confidence            788999999999999999986   78899987543       23456788899999988 799998888     222336


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++++++.+ .+...+...... ..++...+..++.|++.++.++|.. +++|||+||+||+++..+..++++|||.+..
T Consensus        74 ~~~~~~~~~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~H~~-~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~  151 (384)
T COG0515          74 YLVMEYVDGGSLEDLLKKIGRK-GPLSESEALFILAQILSALEYLHSK-GIIHRDIKPENILLDRDGRVVKLIDFGLAKL  151 (384)
T ss_pred             EEEEecCCCCcHHHHHHhcccc-cCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeecCCCCeEEEeccCccee
Confidence            899999996 444233221100 3789999999999999999999987 9999999999999998764699999999875


Q ss_pred             cccCC-------CcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 017452          224 LVKGE-------PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLG  291 (371)
Q Consensus       224 ~~~~~-------~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~  291 (371)
                      .....       ......++..|+|||.+.+.  .......|+|++|++++++++|..||.....   ............
T Consensus       152 ~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~  231 (384)
T COG0515         152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELP  231 (384)
T ss_pred             cCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcC
Confidence            54332       23567889999999999763  4578899999999999999999999877664   333333333222


Q ss_pred             CC-CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          292 TP-TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       292 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+ ....                    ............+.+++..++..+|..|.+..+...+
T Consensus       232 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         232 TPSLASP--------------------LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             Ccccccc--------------------cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            11 0000                    0000001123578999999999999999999988776

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.89  E-value=1.3e-23  Score=205.63  Aligned_cols=247  Identities=29%  Similarity=0.382  Sum_probs=173.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhH---HHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKN---RELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~---~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .|...+.||++.|=+|.+|++. .|. |+||++.+..     ....   +|++ ...+++||.+.+....     .....
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~-----~t~kA   95 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-EGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVL-----VTDKA   95 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-Cce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHH-----HhhHH
Confidence            5888999999999999999864 344 9999986543     1122   2333 5566899999876543     33334


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .|||-+|...+|++.+..    ...+...+.+.|+.||+.||..+|+. ||+|||||.+||||++=. -+.|+||..-+.
T Consensus        96 AylvRqyvkhnLyDRlST----RPFL~~iEKkWiaFQLL~al~qcH~~-gVcHGDIKsENILiTSWN-W~~LtDFAsFKP  169 (1431)
T KOG1240|consen   96 AYLVRQYVKHNLYDRLST----RPFLVLIEKKWIAFQLLKALSQCHKL-GVCHGDIKSENILITSWN-WLYLTDFASFKP  169 (1431)
T ss_pred             HHHHHHHHhhhhhhhhcc----chHHHHHHHHHHHHHHHHHHHHHHHc-CccccccccceEEEeeec-hhhhhcccccCC
Confidence            678999999999888775    34567777888999999999999986 999999999999998754 799999986554


Q ss_pred             cccCCC----cccccc----cccccCcccccCCc----------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017452          224 LVKGEP----NISYIC----SRYYRAPELIFGAT----------EYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (371)
Q Consensus       224 ~~~~~~----~~~~~~----t~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (371)
                      ..-.+.    ..-+..    -.+|.|||.+....          ..+++-||||+||+++||++ |++||.-    ..+.
T Consensus       170 tYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L----SQL~  245 (1431)
T KOG1240|consen  170 TYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL----SQLL  245 (1431)
T ss_pred             ccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH----HHHH
Confidence            311111    111111    23599999985411          14678899999999999986 6888842    2222


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      .+.+.- ....+.           .+.++            -+..++.+|..|++.||.+|.+|++.|+-..-+..
T Consensus       246 aYr~~~-~~~~e~-----------~Le~I------------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yrG~~F  297 (1431)
T KOG1240|consen  246 AYRSGN-ADDPEQ-----------LLEKI------------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYRGLVF  297 (1431)
T ss_pred             hHhccC-ccCHHH-----------HHHhC------------cCccHHHHHHHHHccCchhccCHHHHHHhhhcccc
Confidence            222210 111111           11111            24579999999999999999999999998655433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.89  E-value=8e-23  Score=172.28  Aligned_cols=135  Identities=15%  Similarity=0.221  Sum_probs=102.3

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecchh------------------------------hhHHHHHHHHHcCCCC
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  125 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n  125 (371)
                      ...||+|++|.||+|.+. +|+.||||++.....                              ...+|+..+..+.+++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAG   80 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCC
Confidence            467999999999999986 899999999864311                              1124889999998877


Q ss_pred             eeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH-HhcCCcEeeccCCCce
Q 017452          126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI-HRSIGVCHRDIKPQNL  204 (371)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~ivH~dlkp~NI  204 (371)
                      +.......  ..   .  .+|||||++|+......   .....++...+..++.|++.+|.+| |+. ||+||||||+||
T Consensus        81 v~~p~~~~--~~---~--~~iVmE~i~g~~l~~~~---~~~~~~~~~~~~~i~~qi~~~L~~l~H~~-giiHrDlkP~NI  149 (190)
T cd05147          81 IPCPEPIL--LK---S--HVLVMEFIGDDGWAAPR---LKDAPLSESKARELYLQVIQIMRILYQDC-RLVHADLSEYNL  149 (190)
T ss_pred             CCCCcEEE--ec---C--CEEEEEEeCCCCCcchh---hhcCCCCHHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHE
Confidence            64332211  11   1  26999999975222111   1145789999999999999999999 675 999999999999


Q ss_pred             eeeCCCCcEEEEeeCCcccc
Q 017452          205 LVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       205 li~~~~~~~kl~Dfg~a~~~  224 (371)
                      |++. + .++|+|||+|...
T Consensus       150 li~~-~-~v~LiDFG~a~~~  167 (190)
T cd05147         150 LYHD-G-KLYIIDVSQSVEH  167 (190)
T ss_pred             EEEC-C-cEEEEEccccccC
Confidence            9984 4 7999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.88  E-value=1.2e-22  Score=173.33  Aligned_cols=170  Identities=11%  Similarity=0.150  Sum_probs=124.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhh---------hHHHHHHHHHcCCCCeeecceeEEec
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRY---------KNRELQTMRLLDHPNVVSLKHCFFST  136 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~---------~~~e~~~l~~l~h~niv~~~~~~~~~  136 (371)
                      .++|++.+.+|.|+||.||++.+  ++..+|+|.+...    ...         .++|+..+.++.|++|..+.+.+...
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~  107 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA  107 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence            46899999999999999999765  5778999998532    111         46788899999999999998876543


Q ss_pred             CCC---CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          137 TDK---DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       137 ~~~---~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      ...   .....+++|||++| +|.+..        .+++    ....+++.+|..||.. |++|||+||+||++++++  
T Consensus       108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~--------~~~~----~~~~~i~~~l~~lH~~-gi~H~Dikp~Nili~~~g--  172 (232)
T PRK10359        108 ERKTLRYAHTYIMLIEYIEGVELNDMP--------EISE----DVKAKIKASIESLHQH-GMVSGDPHKGNFIVSKNG--  172 (232)
T ss_pred             ccccccccCCeEEEEEEECCccHHHhh--------hccH----HHHHHHHHHHHHHHHc-CCccCCCChHHEEEeCCC--
Confidence            211   12346899999998 443321        1233    2355999999999987 999999999999999876  


Q ss_pred             EEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM  268 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  268 (371)
                      ++|+|||........... ..          .+.. ..+..++|+|+||+++..+.
T Consensus       173 i~liDfg~~~~~~e~~a~-d~----------~vle-r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        173 LRIIDLSGKRCTAQRKAK-DR----------IDLE-RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EEEEECCCcccccchhhH-HH----------HHHH-hHhcccccccceeEeehHHH
Confidence            999999988654221111 00          1222 23567899999999987654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.88  E-value=8.2e-23  Score=199.78  Aligned_cols=217  Identities=25%  Similarity=0.442  Sum_probs=158.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ....+|..++.+-.|++|.||.++++.+.+.+|+| +.++....++            |..+         .+..  +.|
T Consensus        80 p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lilRn------------ilt~---------a~np--fvv  135 (1205)
T KOG0606|consen   80 PSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLILRN------------ILTF---------AGNP--FVV  135 (1205)
T ss_pred             CCccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhhhc------------cccc---------cCCc--cee
Confidence            34457999999999999999999999999999995 4433222221            2221         1111  122


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                           |+-..++..    -+.++..        ++.+++|||.- ||+|||+||+|.+|+.-| .+|++|||+++.....
T Consensus       136 -----gDc~tllk~----~g~lPvd--------mvla~Eylh~y-givhrdlkpdnllIT~mG-hiKlTDfgLsk~GLms  196 (1205)
T KOG0606|consen  136 -----GDCATLLKN----IGPLPVD--------MVLAVEYLHSY-GIVHRDLKPDNLLITSMG-HIKLTDFGLSKKGLMS  196 (1205)
T ss_pred             -----chhhhhccc----CCCCcch--------hhHHhHhhccC-CeecCCCCCCcceeeecc-cccccchhhhhhhhhh
Confidence                 221122221    2344433        37799999975 999999999999999988 8999999998764221


Q ss_pred             CC----------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          228 EP----------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       228 ~~----------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      ..                ....+|||.|.|||++..+. |+..+|+|++|+|+|+++.|..||.++...+.+.+.+....
T Consensus       197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i  275 (1205)
T KOG0606|consen  197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDI  275 (1205)
T ss_pred             ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhc
Confidence            11                12458899999999997655 89999999999999999999999999999888888776432


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC---HHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT---AVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t---~~~~l~~  354 (371)
                      .-+++                          ...++++++++|.++|+.+|..|.-   +-++.+|
T Consensus       276 ~wpE~--------------------------dea~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h  315 (1205)
T KOG0606|consen  276 EWPEE--------------------------DEALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQH  315 (1205)
T ss_pred             ccccc--------------------------CcCCCHHHHHHHHHHHHhChHhhcccchhhhhhhc
Confidence            21111                          2347899999999999999999954   5555555

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.88  E-value=7e-22  Score=167.13  Aligned_cols=134  Identities=16%  Similarity=0.237  Sum_probs=104.3

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecchh------------------------------hhHHHHHHHHHcCCCC
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------------------YKNRELQTMRLLDHPN  125 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------~~~~e~~~l~~l~h~n  125 (371)
                      .+.||+|++|.||+|.+. +|+.||||++.....                              ...+|...+.++.|++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   80 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAG   80 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCC
Confidence            468999999999999976 899999999864311                              1246788899999988


Q ss_pred             eeecceeEEecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCCc
Q 017452          126 VVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQN  203 (371)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~N  203 (371)
                      +........  .   .  .++||||++|. +......    ...++...+..++.|++.+|.+||. . ||+||||||+|
T Consensus        81 i~~p~~~~~--~---~--~~lVmE~~~g~~~~~~~l~----~~~~~~~~~~~i~~~l~~~l~~lH~~~-givHrDlkP~N  148 (190)
T cd05145          81 VPVPEPILL--K---K--NVLVMEFIGDDGSPAPRLK----DVPLEEEEAEELYEQVVEQMRRLYQEA-GLVHGDLSEYN  148 (190)
T ss_pred             CCCceEEEe--c---C--CEEEEEEecCCCchhhhhh----hccCCHHHHHHHHHHHHHHHHHHHHhC-CEecCCCChhh
Confidence            754333221  1   1  36999999975 2221111    3567888999999999999999998 6 99999999999


Q ss_pred             eeeeCCCCcEEEEeeCCcccc
Q 017452          204 LLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+++ ++ .++|+|||++...
T Consensus       149 Ill~-~~-~~~liDFG~a~~~  167 (190)
T cd05145         149 ILYH-DG-KPYIIDVSQAVEL  167 (190)
T ss_pred             EEEE-CC-CEEEEEcccceec
Confidence            9999 55 8999999999765

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.6e-23  Score=195.37  Aligned_cols=221  Identities=29%  Similarity=0.450  Sum_probs=174.2

Q ss_pred             eccCCceEEEEEEE---CCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEEee
Q 017452           79 VGQGSFGVVFQAKC---LETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        79 lg~G~~g~V~~~~~---~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      +|.|.||.|+++..   ...|..||+|+.++.      ......|-.++...+ ||.+|++.-++     ......++++
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyaf-----qt~~kl~l~l   76 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAF-----QTDGKLYLIL   76 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeee-----ccccchhHhh
Confidence            68999999998753   245677899877543      122334777788886 99999997777     3344478999


Q ss_pred             ccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      ++..|+  +++.+ ......+.+...+.+...++-+++++|+- +|+|||+|++||+++.+| .+++.|||+++.....+
T Consensus        77 d~~rgg--~lft~-l~~~~~f~~~~~~~~~aelaLald~lh~l-~iiyrd~k~enilld~~G-hi~~tdfglske~v~~~  151 (612)
T KOG0603|consen   77 DFLRGG--DLFTR-LSKEVMFDELDVAFYLAELALALDHLHKL-GIAYRDYKLENVLLLLEG-HIKLTDFGLSKEAVKEK  151 (612)
T ss_pred             hhcccc--hhhhc-cccCCchHHHHHHHHHHHHHHHHhhcchh-HHHHhcccccceeecccC-ccccCCchhhhHhHhhh
Confidence            999974  22222 23356788888899999999999999975 999999999999999999 79999999998875554


Q ss_pred             CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcccc
Q 017452          229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF  308 (371)
Q Consensus       229 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  308 (371)
                      ..   +||..|||||+..+   ...++|.||+|+++++|+||..||..    +.+..|.+..-                 
T Consensus       152 ~~---cgt~eymApEI~~g---h~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~-----------------  204 (612)
T KOG0603|consen  152 IA---CGTYEYRAPEIING---HLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAEL-----------------  204 (612)
T ss_pred             hc---ccchhhhhhHhhhc---cCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhcc-----------------
Confidence            43   89999999999862   57889999999999999999999987    44555544211                 


Q ss_pred             ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH
Q 017452          309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~  348 (371)
                                  .+|..++..+.+++..++..+|.+|.-+
T Consensus       205 ------------~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  205 ------------EMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ------------CCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                        0455678999999999999999999765

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.87  E-value=1.4e-22  Score=170.68  Aligned_cols=245  Identities=15%  Similarity=0.208  Sum_probs=185.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ....+..+|.+...|..|+|++  .|..+++|++.-.      .+.+..|+-.|+.+.||||+.+++.+     .....+
T Consensus       190 ~~lnl~tkl~e~hsgelwrgrw--qgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgac-----nsppnl  262 (448)
T KOG0195|consen  190 SSLNLITKLAESHSGELWRGRW--QGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGAC-----NSPPNL  262 (448)
T ss_pred             hhhhhhhhhccCCCcccccccc--cCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhc-----cCCCCc
Confidence            3456677899999999999998  5667788876322      35567789999999999999999988     444558


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe-eccCCCceeeeCCCCcEEEE--eeCC
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH-RDIKPQNLLVNPHTHQVKLC--DFGS  220 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH-~dlkp~NIli~~~~~~~kl~--Dfg~  220 (371)
                      .++..||+ |+|+..+...  .....+-.++.+++.++++|++|||+--.++- --|.+..++||.+- +.+|+  |--+
T Consensus       263 v~isq~mp~gslynvlhe~--t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedl-tarismad~kf  339 (448)
T KOG0195|consen  263 VIISQYMPFGSLYNVLHEQ--TSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDL-TARISMADTKF  339 (448)
T ss_pred             eEeeeeccchHHHHHHhcC--ccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchh-hhheeccccee
Confidence            89999999 7888887752  23456777899999999999999997324443 36888999999876 55543  3222


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCC--CCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEY--TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~--~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +.      ......-.|.||+||.+...+..  -.+.|+|||++++|||.|...||......+.-.++.-.         
T Consensus       340 sf------qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkiale---------  404 (448)
T KOG0195|consen  340 SF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALE---------  404 (448)
T ss_pred             ee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhc---------
Confidence            21      11223347889999999765533  23789999999999999999999988776654443210         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                        -+.-.+|..++..+..|+.-|+..||.+||..+.++--|+++
T Consensus       405 ------------------glrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm  446 (448)
T KOG0195|consen  405 ------------------GLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKM  446 (448)
T ss_pred             ------------------cccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHh
Confidence                              011226788999999999999999999999999988777765

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=3.3e-21  Score=160.99  Aligned_cols=183  Identities=19%  Similarity=0.143  Sum_probs=132.4

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh--------hhHHHHHHHHHcC-CCCeeecceeEEecCCCCcee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +.+...|++|+||+||.+..  .+.+++.+.+.....        .+.+|+++|+++. |++++++++..     .    
T Consensus         4 ~~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~~-----~----   72 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHWD-----G----   72 (218)
T ss_pred             cccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEEc-----C----
Confidence            34678899999999998764  778888777754432        3578999999995 47788886631     1    


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeecc-CCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDI-KPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dl-kp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|+|+.|..+..  . .      +.. ...++.|++.+|.++|++ ||+|||| ||+|||++.++ .++|+|||++.
T Consensus        73 ~~lvmeyI~G~~L~~--~-~------~~~-~~~~~~qi~~~L~~lH~~-GIvHrDL~kp~NILv~~~g-~i~LIDFG~A~  140 (218)
T PRK12274         73 RHLDRSYLAGAAMYQ--R-P------PRG-DLAYFRAARRLLQQLHRC-GVAHNDLAKEANWLVQEDG-SPAVIDFQLAV  140 (218)
T ss_pred             EEEEEeeecCccHHh--h-h------hhh-hHHHHHHHHHHHHHHHHC-cCccCCCCCcceEEEcCCC-CEEEEECCCce
Confidence            579999999853211  1 0      111 134678999999999987 9999999 79999999887 89999999998


Q ss_pred             ccccCCCcc--------------cccccccccCcccccCCcCCC-CcchHHHHHHHHHHHHhCCCCCCCCC
Q 017452          223 VLVKGEPNI--------------SYICSRYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDS  278 (371)
Q Consensus       223 ~~~~~~~~~--------------~~~~t~~y~aPE~~~~~~~~~-~~~DiwslG~il~~lltg~~pf~~~~  278 (371)
                      .........              -...++.|+.|+.-.--...+ ...+.++.|.-+|.++|+..|+.++.
T Consensus       141 ~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        141 RGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             ecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence            654333210              112377788887653222223 45688899999999999998875543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.84  E-value=1.1e-20  Score=188.10  Aligned_cols=194  Identities=25%  Similarity=0.391  Sum_probs=149.2

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhh-hHHHHHHHHHcC---CCCeeecceeEEecCCCCce
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY-KNRELQTMRLLD---HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~  142 (371)
                      +.....|-|.+.||+|+||+||+|.... |+.||||+-+..... +.--..++.+|+   -+.|..+..++...+.    
T Consensus       694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~----  768 (974)
T KOG1166|consen  694 EVGGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNA----  768 (974)
T ss_pred             eecceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCc----
Confidence            3455689999999999999999999776 999999976554322 111123334443   2445555555533332    


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee------CCCCcEEE
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN------PHTHQVKL  215 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~------~~~~~~kl  215 (371)
                       -++|++|.+ |+|++++.    ..+.+++..+..+..|++..++.||.. +||||||||+|+||.      .+...++|
T Consensus       769 -S~lv~ey~~~Gtlld~~N----~~~~m~e~lv~~~~~qml~ive~lH~~-~IIHgDiKPDNfll~~~~~~~~~~~~l~l  842 (974)
T KOG1166|consen  769 -SVLVSEYSPYGTLLDLIN----TNKVMDEYLVMFFSCQMLRIVEHLHAM-GIIHGDIKPDNFLLRREICADSDSKGLYL  842 (974)
T ss_pred             -ceeeeeccccccHHHhhc----cCCCCCchhhhHHHHHHHHHHHHHHhc-ceecccCCcceeEeecccCCCCcccceEE
Confidence             468999999 78888877    378899999999999999999999986 999999999999983      22236999


Q ss_pred             EeeCCcccc---ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCC
Q 017452          216 CDFGSAKVL---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP  272 (371)
Q Consensus       216 ~Dfg~a~~~---~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~  272 (371)
                      +|||.+..+   .++.......+|-.+-.+|...+.+ +++.+|.|.|+.+++.||+|+.
T Consensus       843 IDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  843 IDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             EecccceeeeEcCCCcEEeeeeccccchhHHHhcCCC-CchhhhhHHHHHHHHHHHHHHH
Confidence            999998654   3333444566788899999986655 9999999999999999999973

>PRK10345 hypothetical protein; Provisional

Probab=99.83  E-value=1.7e-19  Score=153.48  Aligned_cols=134  Identities=18%  Similarity=0.252  Sum_probs=100.8

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHc-----CCCCeeecceeEEecCCCCceeE-
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYL-  144 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-----~h~niv~~~~~~~~~~~~~~~~~-  144 (371)
                      -.+.||+|+||.||.  +..++.. +||++...    .....+|+.+++.+     +||||+++++++....  +..++ 
T Consensus         6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~--g~g~v~   80 (210)
T PRK10345          6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDC--GTGYVY   80 (210)
T ss_pred             CcceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCC--CCeEEE
Confidence            356899999999995  5666665 69987643    44567899999999     6799999999875432  22343 


Q ss_pred             EEeecccc---chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHH-HHHHhcCCcEeeccCCCceeeeCCC---CcEEEEe
Q 017452          145 NLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL-SYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCD  217 (371)
Q Consensus       145 ~lv~e~~~---~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~ivH~dlkp~NIli~~~~---~~~kl~D  217 (371)
                      .+|+||.+   ++|.+++..     ..+++.  ..++.|++.++ +|||++ +|+||||||+|||++..+   ..++|+|
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~-----~~~~e~--~~~~~~~L~~l~~yLh~~-~IvhrDlKp~NILl~~~~~~~~~~~LiD  152 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQ-----CRYEED--VAQLRQLLKKLKRYLLDN-RIVTMELKPQNILCQRISESEVIPVVCD  152 (210)
T ss_pred             EEEecCCCCcchhHHHHHHc-----ccccHh--HHHHHHHHHHHHHHHHHC-CEeecCCCHHHEEEeccCCCCCcEEEEE
Confidence            47899955   588888753     345555  35577888777 999987 999999999999997422   2799999


Q ss_pred             eCCc
Q 017452          218 FGSA  221 (371)
Q Consensus       218 fg~a  221 (371)
                      |+-+
T Consensus       153 g~G~  156 (210)
T PRK10345        153 NIGE  156 (210)
T ss_pred             CCCC
Confidence            5443

>smart00090 RIO RIO-like kinase

Probab=99.82  E-value=8.7e-20  Score=158.97  Aligned_cols=138  Identities=15%  Similarity=0.151  Sum_probs=104.6

Q ss_pred             ceeeeEeeccCCceEEEEEE-ECCCCcEEEEEEeecch----------------------------hhhHHHHHHHHHcC
Q 017452           72 SYMAERIVGQGSFGVVFQAK-CLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLD  122 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~-~~~~~~~vaiK~~~~~~----------------------------~~~~~e~~~l~~l~  122 (371)
                      -|.+.+.||+|++|.||+|. +..+|+.||+|++....                            ....+|+..++++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            48999999999999999998 66789999999886431                            11357899999997


Q ss_pred             CCCeeecceeEEecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC-cEeeccC
Q 017452          123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-VCHRDIK  200 (371)
Q Consensus       123 h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-ivH~dlk  200 (371)
                      +. .+.+...+.. . .    .++||||++|. +.....    ....+....+..++.||+.+|.+||.+ | |+|||||
T Consensus       109 ~~-~i~~p~~~~~-~-~----~~lV~E~~~g~~L~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-g~iiH~Dik  176 (237)
T smart00090      109 EA-GVPVPKPIAW-R-R----NVLVMEFIGGDGLPAPRL----KDVEPEEEEEFELYDDILEEMRKLYKE-GELVHGDLS  176 (237)
T ss_pred             hc-CCCCCeeeEe-c-C----ceEEEEEecCCccccccc----ccCCcchHHHHHHHHHHHHHHHHHHhc-CCEEeCCCC
Confidence            53 2333233311 1 1    36999999984 222211    134556667789999999999999987 9 9999999


Q ss_pred             CCceeeeCCCCcEEEEeeCCccc
Q 017452          201 PQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       201 p~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||+++ ++ .++|+|||.+..
T Consensus       177 p~NIli~-~~-~i~LiDFg~a~~  197 (237)
T smart00090      177 EYNILVH-DG-KVVIIDVSQSVE  197 (237)
T ss_pred             hhhEEEE-CC-CEEEEEChhhhc
Confidence            9999999 55 899999998864

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=3e-20  Score=170.45  Aligned_cols=174  Identities=27%  Similarity=0.450  Sum_probs=127.2

Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ...|+||.|+.|.. +|.+.+. ........+...+..++.|++.|++|   + +.+|+|+||.||++..+. .+||.||
T Consensus       327 ~~~~lyI~Mn~c~~~tledWl~-rr~~~e~~s~s~~~~~~~q~~~~~~y---k-~~ihrdlkp~nif~~~d~-q~kIgDF  400 (516)
T KOG1033|consen  327 KKVYLYIQMNLCEKETLEDWLR-RRRTGEERSLSLMLDIFKQIAPAVEY---K-GLIHRDLKPSNIFFSDDD-QLKIGDF  400 (516)
T ss_pred             cccchhhhhhhhhhhhHHHHhh-CCCcccccchhHHHHHHHhhccchhh---c-cchhhhccccccccccch-hhhhhhh
Confidence            34568999999995 5555554 33445567788899999999999999   5 999999999999998887 8999999


Q ss_pred             CCccccccCC-------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHh
Q 017452          219 GSAKVLVKGE-------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       219 g~a~~~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~  290 (371)
                      |+........       ..+...||..||+||.+.++. |+.++|||+||++|+|+++- ..+|..   ...+..+..  
T Consensus       401 gl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~f~T~~er---~~t~~d~r~--  474 (516)
T KOG1033|consen  401 GLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQFSTQFER---IATLTDIRD--  474 (516)
T ss_pred             hheeecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHHhccHHHH---HHhhhhhhc--
Confidence            9988776555       445678999999999997765 89999999999999999972 222211   111111111  


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHH
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK  351 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~  351 (371)
                      |..++..+                         .+ -+.-..|+.+||...|.+||++.+.
T Consensus       475 g~ip~~~~-------------------------~d-~p~e~~ll~~lls~~p~~RP~~~~~  509 (516)
T KOG1033|consen  475 GIIPPEFL-------------------------QD-YPEEYTLLQQLLSPSPEERPSAIEV  509 (516)
T ss_pred             CCCChHHh-------------------------hc-CcHHHHHHHHhcCCCcccCchHHHH
Confidence            11111111                         11 2456689999999999999966554

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=2.5e-18  Score=160.55  Aligned_cols=213  Identities=24%  Similarity=0.339  Sum_probs=154.0

Q ss_pred             HHHcCCCCeeecceeEEecCCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 017452          118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (371)
Q Consensus       118 l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (371)
                      |+.+.|.|+.++++..+..     ..+++|.+||. |+|.+.+..   ....++......++++|+.||+|||.+....|
T Consensus         1 l~~l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~---~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSN---EDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhc---cccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            3568999999999988665     34789999999 788887764   35678888888999999999999998733399


Q ss_pred             eccCCCceeeeCCCCcEEEEeeCCccccccC---CCcccccccccccCcccccCCcC------CCCcchHHHHHHHHHHH
Q 017452          197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATE------YTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       197 ~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~------~~~~~DiwslG~il~~l  267 (371)
                      +.+++.|.+++... .+||+|||+.......   .......-..-|.|||.+.....      .+.+.|+||+|++++|+
T Consensus        73 g~l~s~nClvd~~w-~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei  151 (484)
T KOG1023|consen   73 GALKSSNCLVDSRW-VLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEI  151 (484)
T ss_pred             eeeccccceeeeeE-EEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHH
Confidence            99999999999998 8999999998765320   11111222444999999865311      36679999999999999


Q ss_pred             HhCCCCCCCCCcHH---HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC
Q 017452          268 MLGKPLFPGDSGVD---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL  344 (371)
Q Consensus       268 ltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~  344 (371)
                      ++...||.......   .+...++..+..+              ..|.+..      . ..+.+++..++..||..+|.+
T Consensus       152 ~~r~~~~~~~~~~~~~~eii~~~~~~~~~~--------------~rP~i~~------~-~e~~~~l~~l~~~cw~e~P~~  210 (484)
T KOG1023|consen  152 LFRSGPFDLRNLVEDPDEIILRVKKGGSNP--------------FRPSIEL------L-NELPPELLLLVARCWEEIPEK  210 (484)
T ss_pred             HhccCccccccccCChHHHHHHHHhcCCCC--------------cCcchhh------h-hhcchHHHHHHHHhcccChhh
Confidence            99999997633222   1222222111110              0011000      0 134568999999999999999


Q ss_pred             CCCHHHHhhhhcCCCc
Q 017452          345 RCTAVSKRILFSNCPS  360 (371)
Q Consensus       345 R~t~~~~l~~l~~~~~  360 (371)
                      ||+++++-..+..+..
T Consensus       211 rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  211 RPSIEQIRSKLLTINK  226 (484)
T ss_pred             CccHHHHHhhhhhhcc
Confidence            9999999888766644

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.75  E-value=7.6e-18  Score=143.52  Aligned_cols=131  Identities=18%  Similarity=0.192  Sum_probs=99.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch--------------------------hhhHHHHHHHHHcCCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------------------RYKNRELQTMRLLDHPN  125 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------------~~~~~e~~~l~~l~h~n  125 (371)
                      .|.+.+.||+|+||.||++.. .+|+.||||++....                          ....+|+.++..+.|++
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~-~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~   94 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALD-PDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEG   94 (198)
T ss_pred             hhhcCCccccCcceEEEEEEc-CCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcC
Confidence            388899999999999999986 479999999865321                          11346788888887774


Q ss_pred             e--eecceeEEecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          126 V--VSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       126 i--v~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                      +  +..++.         ...+++|||++|. +.....          ......++.+++.++.++|.. ||+||||||+
T Consensus        95 i~v~~~~~~---------~~~~lv~e~~~g~~L~~~~~----------~~~~~~~~~~i~~~l~~lh~~-gi~H~Dl~p~  154 (198)
T cd05144          95 FPVPKPIDW---------NRHAVVMEYIDGVELYRVRV----------LEDPEEVLDEILEEIVKAYKH-GIIHGDLSEF  154 (198)
T ss_pred             CCCCceeec---------CCceEEEEEeCCcchhhccc----------cccHHHHHHHHHHHHHHHHHC-CCCcCCCCcc
Confidence            3  332221         1247899999974 322111          134567888999999999986 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCcccc
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ||+++.++ .++|+|||.+...
T Consensus       155 Nill~~~~-~~~liDfg~~~~~  175 (198)
T cd05144         155 NILVDDDE-KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEcCCC-cEEEEECCccccC
Confidence            99999877 8999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.75  E-value=2e-17  Score=142.45  Aligned_cols=129  Identities=19%  Similarity=0.332  Sum_probs=100.5

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +.||+|++|.||+|.+  .|..+++|+.....            ....+|+.++..+.|+++......+....     ..
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~-----~~   74 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPE-----NF   74 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCC-----CC
Confidence            5789999999999987  77889999764321            23456889999999988876555443322     25


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|||++| +|.+.+...    .   . ....++.+++.+|.+||.. |++|+|++|.||+++ ++ .++|+|||.+..
T Consensus        75 ~lv~e~~~G~~L~~~~~~~----~---~-~~~~i~~~i~~~l~~lH~~-~i~H~Dl~p~Nil~~-~~-~~~liDf~~a~~  143 (211)
T PRK14879         75 IIVMEYIEGEPLKDLINSN----G---M-EELELSREIGRLVGKLHSA-GIIHGDLTTSNMILS-GG-KIYLIDFGLAEF  143 (211)
T ss_pred             EEEEEEeCCcCHHHHHHhc----c---H-HHHHHHHHHHHHHHHHHhC-CcccCCCCcccEEEE-CC-CEEEEECCcccC
Confidence            789999986 666555421    1   1 6788999999999999987 999999999999999 55 799999999865

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.73  E-value=4.2e-17  Score=139.14  Aligned_cols=125  Identities=18%  Similarity=0.325  Sum_probs=93.7

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .||+|++|.||+|..  +|..+++|.....            .....+|+++++.+.|+++......+...     ...+
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-----~~~~   73 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-----DNKT   73 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-----CCCE
Confidence            379999999999984  6788999986432            12234689999999888755443333221     1247


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|||++| +|.+.+...    ..       .++.|++.+|.+||.. |++|||++|.||+++ ++ .++++|||++..
T Consensus        74 lv~e~~~g~~l~~~~~~~----~~-------~~~~~i~~~l~~lH~~-gi~H~Dl~~~Nil~~-~~-~~~liDfg~a~~  138 (199)
T TIGR03724        74 IVMEYIEGKPLKDVIEEG----ND-------ELLREIGRLVGKLHKA-GIVHGDLTTSNIIVR-DD-KLYLIDFGLGKY  138 (199)
T ss_pred             EEEEEECCccHHHHHhhc----HH-------HHHHHHHHHHHHHHHC-CeecCCCCcceEEEE-CC-cEEEEECCCCcC
Confidence            89999986 555444321    10       7788999999999986 999999999999999 55 899999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.71  E-value=8.3e-17  Score=157.33  Aligned_cols=130  Identities=18%  Similarity=0.307  Sum_probs=98.2

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .|...+.||+|+||.||++.+.  +..+++|+....            .....+|+++++.++|++++....+.....  
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~--~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~--  409 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYL--GRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPE--  409 (535)
T ss_pred             ccCccceeccCCcEEEEEEeec--CccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCC--
Confidence            4677899999999999999864  334454432111            123457999999999999887655443221  


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                         ..++||||++| +|.+.+.            ....++.|++.+|.+||+. |++||||||+||+++ ++ .++|+||
T Consensus       410 ---~~~lv~E~~~g~~L~~~l~------------~~~~~~~~i~~~L~~lH~~-giiHrDlkp~NILl~-~~-~~~liDF  471 (535)
T PRK09605        410 ---EKTIVMEYIGGKDLKDVLE------------GNPELVRKVGEIVAKLHKA-GIVHGDLTTSNFIVR-DD-RLYLIDF  471 (535)
T ss_pred             ---CCEEEEEecCCCcHHHHHH------------HHHHHHHHHHHHHHHHHhC-CCccCCCChHHEEEE-CC-cEEEEeC
Confidence               25799999986 5555443            2467889999999999986 999999999999994 44 7999999


Q ss_pred             CCccc
Q 017452          219 GSAKV  223 (371)
Q Consensus       219 g~a~~  223 (371)
                      |+++.
T Consensus       472 Gla~~  476 (535)
T PRK09605        472 GLGKY  476 (535)
T ss_pred             ccccc
Confidence            99875

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=2.1e-18  Score=168.30  Aligned_cols=251  Identities=24%  Similarity=0.293  Sum_probs=184.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECC-CCcEEEEEEeecch------hhhHHHHHHHHHcC-CCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK------RYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~------~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..|.+.+.||+|.|+.|-.+.... ....+|.|.+....      .....|..+-+.+. |.|++++++..     ....
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~-----~~~~   94 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS-----SSPR   94 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc-----CCCc
Confidence            358999999999999998887643 34456666653321      22234677777776 99999998877     5555


Q ss_pred             eEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          143 YLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       143 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      +.+++++|..|+ +.+.+.  .......+...+..++.|+..++.|+| .. ++.|+|+||+|.+++..+..+++.|||+
T Consensus        95 ~~~~~~~~s~g~~~f~~i~--~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~-~~~h~~ikP~n~~l~~s~~~l~~~df~~  171 (601)
T KOG0590|consen   95 SYLLSLSYSDGGSLFSKIS--HPDSTGTSSSSASRYLPQLNSGLSYLHPEN-GVTHRDIKPSNSLLDESGSALKIADFGL  171 (601)
T ss_pred             ccccccCcccccccccccc--cCCccCCCCcchhhhhhhhccCccccCccc-ccccCCCCCccchhccCCCcccCCCchh
Confidence            678999997764 222221  111226677888999999999999999 76 9999999999999987764799999999


Q ss_pred             cccccc-CCC---cccccc-cccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCC
Q 017452          221 AKVLVK-GEP---NISYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEIIKVLGTPT  294 (371)
Q Consensus       221 a~~~~~-~~~---~~~~~~-t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~  294 (371)
                      |..... ...   ....+| ++.|+|||...+..+..+..|+||.|+++..+++|..|+......... ..+.       
T Consensus       172 At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~-------  244 (601)
T KOG0590|consen  172 ATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWK-------  244 (601)
T ss_pred             hccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeec-------
Confidence            987655 222   234577 999999999987666789999999999999999999998765443310 0000       


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       ... .......+..++....+++.+++..+|..|.+..++..+
T Consensus       245 -----------------~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  245 -----------------SNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             -----------------ccc-cccccCccccCChhhhhcccccccCCchhcccccccccc
Confidence                             000 111122445688999999999999999999999997655

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.69  E-value=1.5e-16  Score=134.22  Aligned_cols=131  Identities=21%  Similarity=0.232  Sum_probs=90.6

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecchhhh----------------------------HHHHHHHHHcCCCC--
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK----------------------------NRELQTMRLLDHPN--  125 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~----------------------------~~e~~~l~~l~h~n--  125 (371)
                      .+.||+|+||.||+|.+. +|+.||||++.......                            ..|...+..+.+..  
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999976 89999999886432110                            23444444443332  


Q ss_pred             eeecceeEEecCCCCceeEEEeeccccchH-H-HHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          126 VVSLKHCFFSTTDKDELYLNLVLEYVPETV-H-RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l-~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                      +.+.+.+.         ..+++|||++++. . ..+....     . ...++.++.+++.++.++|...||+|+||||+|
T Consensus        81 ~~~~~~~~---------~~~lv~e~~~g~~~~~~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~N  145 (187)
T cd05119          81 VPKPIDLN---------RHVLVMEFIGGDGIPAPRLKDVR-----L-LEDPEELYDQILELMRKLYREAGLVHGDLSEYN  145 (187)
T ss_pred             CCceEecC---------CCEEEEEEeCCCCccChhhhhhh-----h-cccHHHHHHHHHHHHHHHhhccCcCcCCCChhh
Confidence            22222211         1479999999721 0 1111110     0 156788999999999999982399999999999


Q ss_pred             eeeeCCCCcEEEEeeCCcccc
Q 017452          204 LLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+++ ++ .++|+|||.+...
T Consensus       146 ili~-~~-~~~liDfg~a~~~  164 (187)
T cd05119         146 ILVD-DG-KVYIIDVPQAVEI  164 (187)
T ss_pred             EEEE-CC-cEEEEECcccccc
Confidence            9999 65 8999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.67  E-value=1.1e-15  Score=133.56  Aligned_cols=134  Identities=15%  Similarity=0.234  Sum_probs=97.5

Q ss_pred             eEeec-cCCceEEEEEEECCCCcEEEEEEeecc-----------------hhhhHHHHHHHHHcCCCCe--eecceeEEe
Q 017452           76 ERIVG-QGSFGVVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNV--VSLKHCFFS  135 (371)
Q Consensus        76 ~~~lg-~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~e~~~l~~l~h~ni--v~~~~~~~~  135 (371)
                      ...|| .||.|+||.+..  .+..++||.+...                 .....+|++++..+.|+++  +..++....
T Consensus        36 ~~~lg~~~g~gtv~~v~~--~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~  113 (239)
T PRK01723         36 ARVVGSAKGRGTTWFVQT--PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVV  113 (239)
T ss_pred             CceeecCCCCccEEEEEe--CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeee
Confidence            34677 888999999876  4788999987431                 1234579999999998875  445444322


Q ss_pred             cCCCCceeEEEeeccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcE
Q 017452          136 TTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV  213 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~  213 (371)
                      .. ......++|||+++|  +|.+.+.     ...+++..    +.||+.+|.+||++ ||+|+||||.|||++.++ .+
T Consensus       114 ~~-~~~~~~~lV~e~l~G~~~L~~~l~-----~~~l~~~~----~~~i~~~l~~lH~~-GI~HrDlkp~NILv~~~~-~v  181 (239)
T PRK01723        114 RH-GLFYRADILIERIEGARDLVALLQ-----EAPLSEEQ----WQAIGQLIARFHDA-GVYHADLNAHNILLDPDG-KF  181 (239)
T ss_pred             ec-CcceeeeEEEEecCCCCCHHHHHh-----cCCCCHHH----HHHHHHHHHHHHHC-CCCCCCCCchhEEEcCCC-CE
Confidence            11 111123599999996  5665543     23455543    46899999999987 999999999999999877 89


Q ss_pred             EEEeeCCccc
Q 017452          214 KLCDFGSAKV  223 (371)
Q Consensus       214 kl~Dfg~a~~  223 (371)
                      +|+|||.+..
T Consensus       182 ~LIDfg~~~~  191 (239)
T PRK01723        182 WLIDFDRGEL  191 (239)
T ss_pred             EEEECCCccc
Confidence            9999998865

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.64  E-value=9.8e-16  Score=124.23  Aligned_cols=131  Identities=18%  Similarity=0.241  Sum_probs=101.8

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecch--hhhHHHHHHHHHcCC--CCeeecceeEEecCCCCceeEEEeecc
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      +.+.||.|.++.||++...  +..+++|......  ....+|...++.+.+  .++++++..+     ......+++|||
T Consensus         2 ~~~~i~~g~~~~v~~~~~~--~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~-----~~~~~~~~v~e~   74 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASG-----ESDGWSYLLMEW   74 (155)
T ss_pred             cceecccccccceEEEEec--CCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEc-----CCCCccEEEEEe
Confidence            4578999999999999973  4789999886554  357789999999976  4777776655     222457899999


Q ss_pred             ccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc--CCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS--IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       151 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~--~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +.|.....          ++......++.+++.+|..||..  .+++|+|++|.||++++.+ .++++|||.+..
T Consensus        75 ~~g~~~~~----------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~-~~~l~Df~~~~~  138 (155)
T cd05120          75 IEGETLDE----------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK-ILGIIDWEYAGY  138 (155)
T ss_pred             cCCeeccc----------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc-EEEEEecccccC
Confidence            98742211          14456677888999999999963  2699999999999999866 899999998864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.63  E-value=1.1e-15  Score=143.00  Aligned_cols=247  Identities=27%  Similarity=0.288  Sum_probs=187.8

Q ss_pred             CCcccceeeeEeecc--CCceEEEEEEE--CCCCcEEEEEEeec------chhhhHHHHHHHHHcC-CCCeeecceeEEe
Q 017452           67 PKQTISYMAERIVGQ--GSFGVVFQAKC--LETGETVAIKKVLQ------DKRYKNRELQTMRLLD-HPNVVSLKHCFFS  135 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~--G~~g~V~~~~~--~~~~~~vaiK~~~~------~~~~~~~e~~~l~~l~-h~niv~~~~~~~~  135 (371)
                      ......+.+...+|.  |.+|.||.+..  ..++..+|+|.-+.      ......+|+...+.++ |+|.++.+..+  
T Consensus       110 s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~--  187 (524)
T KOG0601|consen  110 SFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAW--  187 (524)
T ss_pred             chhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCccc--
Confidence            334456888899999  99999999998  88999999997422      2333456777777774 89999876666  


Q ss_pred             cCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHH----HHHHHHhcCCcEeeccCCCceeeeCCCC
Q 017452          136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~----~l~~LH~~~~ivH~dlkp~NIli~~~~~  211 (371)
                         .+....++-+|+++.++..+...   ....++...++..+.+...    ||.++|.. +|+|-|+||.||+...+..
T Consensus       188 ---e~~~~lfiqtE~~~~sl~~~~~~---~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~-~~~~~~~kp~~i~~~~~~~  260 (524)
T KOG0601|consen  188 ---EGSGILFIQTELCGESLQSYCHT---PCNFLPDNLLWNSLRDWLSRDVTALSHLHSN-NIVHDDLKPANIFTTSDWT  260 (524)
T ss_pred             ---ccCCcceeeeccccchhHHhhhc---ccccCCchhhhhHHhhhhhcccccccccCCC-cccccccchhheecccccc
Confidence               55666889999999877666553   3455888889999999999    99999987 9999999999999999844


Q ss_pred             cEEEEeeCCccccccCCCcc------cccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCC--CcHHHH
Q 017452          212 QVKLCDFGSAKVLVKGEPNI------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD--SGVDQL  283 (371)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~------~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~--~~~~~~  283 (371)
                      ..+++|||+...+.++....      ...+...|++||...+  -++...|+++||.++.+..++..+....  +....+
T Consensus       261 s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~  338 (524)
T KOG0601|consen  261 SCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL  338 (524)
T ss_pred             eeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc
Confidence            89999999988776554221      2256777999999843  3789999999999999999887665433  222211


Q ss_pred             HHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+.                              ....+....+.++...+.+|++.+|..|++++.++.+
T Consensus       339 r~~~------------------------------ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l  379 (524)
T KOG0601|consen  339 RQGY------------------------------IPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTAL  379 (524)
T ss_pred             cccc------------------------------CchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcc
Confidence            1100                              1111334567788889999999999999999998887

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.59  E-value=2.7e-15  Score=130.26  Aligned_cols=238  Identities=18%  Similarity=0.182  Sum_probs=161.5

Q ss_pred             EEEEEEECCCCcEEEEEEe--------ecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecccc-chHH
Q 017452           86 VVFQAKCLETGETVAIKKV--------LQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVH  156 (371)
Q Consensus        86 ~V~~~~~~~~~~~vaiK~~--------~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  156 (371)
                      .||++-++..|..|+--.+        +......+.-+.-|-.+.|.|||++..++......+.....++.||+. |++.
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~  160 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLK  160 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHH
Confidence            5777777777766653222        111111222345566778999999988775555445666788999998 7888


Q ss_pred             HHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC-----CCc
Q 017452          157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----EPN  230 (371)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~-----~~~  230 (371)
                      ..+....+....+......+|+.||+.||.|||.- --|+|+++....|++..++ -+|+..-.........     ...
T Consensus       161 ~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ng-LIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  161 QFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNG-LIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCc-eEEecccCccccchhhhhhhHhhh
Confidence            88888888888999999999999999999999962 2599999999999999887 6666543222111110     111


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccc
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL-FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      ....+-++|.+||.=. ....+.++|||++|+...+|..+..- -.+......-..+.+..                   
T Consensus       240 ~~~~~~~g~~a~~sg~-~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i-------------------  299 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGT-TTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVI-------------------  299 (458)
T ss_pred             hccccCCccccCCcCc-ccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhhe-------------------
Confidence            2234567899999743 23367789999999999999988743 33332222222222110                   


Q ss_pred             cCcccCCCCcccCCCCCC-hhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          310 FPQIKAHPWHKIFPKRMP-PEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s-~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                    -.++ ..-++++.+||+..|+.||++++++.|.-.+
T Consensus       300 --------------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllf  335 (458)
T KOG1266|consen  300 --------------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLF  335 (458)
T ss_pred             --------------eeccCccccCcCcccccCCCCCCcchhhhhcCceee
Confidence                          0112 2235689999999999999999999994333

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.53  E-value=2.8e-13  Score=128.38  Aligned_cols=180  Identities=23%  Similarity=0.287  Sum_probs=127.3

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh----hhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      |.+ ...+-++.+..-.|..+.++.+|.|..++....    ...+-++.|+.++||||+++++++     .....+|||+
T Consensus        15 Y~l-e~~~~~~~a~~~~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~-----e~~~~~ylvT   88 (690)
T KOG1243|consen   15 YDL-EETAFSSEALWPDGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTT-----EEEGTLYLVT   88 (690)
T ss_pred             ccc-ccccCCCcccccccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhh-----cccCceEEEe
Confidence            555 333333333322466677888998888754433    345678889999999999999988     4455689999


Q ss_pred             ccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      |.+..- ...+..       +....+...+.||+.||.|||..++++|++|+-+.|+++..| ..||++|..+.......
T Consensus        89 ErV~Pl-~~~lk~-------l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~G-eWkLggle~v~~~~~~~  159 (690)
T KOG1243|consen   89 ERVRPL-ETVLKE-------LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESG-EWKLGGLELVSKASGFN  159 (690)
T ss_pred             eccccH-HHHHHH-------hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCC-cEEEeeeEEEeccccCC
Confidence            998752 223332       225667778889999999999777999999999999999998 89999999875542222


Q ss_pred             C-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC
Q 017452          229 P-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG  270 (371)
Q Consensus       229 ~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg  270 (371)
                      . .....---.|..|+.....   .-..|.|.|||+.++++.|
T Consensus       160 ~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  160 APAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            1 1111112235666654221   1356999999999999999

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.42  E-value=1.2e-12  Score=124.15  Aligned_cols=137  Identities=22%  Similarity=0.305  Sum_probs=88.0

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecch-hh-------------------------------------------h
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RY-------------------------------------------K  111 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~-------------------------------------------~  111 (371)
                      .+.||+|++|+||+|+. .+|+.||||+..... ..                                           .
T Consensus       122 ~~plasaSigQVh~A~l-~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf  200 (437)
T TIGR01982       122 EKPLAAASIAQVHRARL-VDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDL  200 (437)
T ss_pred             CcceeeeehhheEEEEe-cCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCH
Confidence            35799999999999985 579999999874321 00                                           1


Q ss_pred             HHHHHHHHHc----CCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHH-HH
Q 017452          112 NRELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR-AL  185 (371)
Q Consensus       112 ~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~-~l  185 (371)
                      .+|...+.++    ++.+-+.+...+....    ...++||||++| ++.+.... .  .....   ...++.+++. .+
T Consensus       201 ~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~----~~~vLvmE~i~G~~L~~~~~~-~--~~~~~---~~~ia~~~~~~~l  270 (437)
T TIGR01982       201 RREAANASELGENFKNDPGVYVPEVYWDRT----SERVLTMEWIDGIPLSDIAAL-D--EAGLD---RKALAENLARSFL  270 (437)
T ss_pred             HHHHHHHHHHHHhcCCCCCEEeCCEehhhc----CCceEEEEeECCcccccHHHH-H--hcCCC---HHHHHHHHHHHHH
Confidence            1233333333    2333344444442211    124799999997 44443321 1  11122   2345555555 46


Q ss_pred             HHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       186 ~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ..+|.. |++|+|+||.||+++.++ +++++|||++....
T Consensus       271 ~ql~~~-g~~H~D~hPgNilv~~~g-~i~liDfG~~~~l~  308 (437)
T TIGR01982       271 NQVLRD-GFFHADLHPGNIFVLKDG-KIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHhC-CceeCCCCcccEEECCCC-cEEEEeCCCeeECC
Confidence            778876 999999999999998887 89999999987654

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.42  E-value=1.5e-12  Score=107.94  Aligned_cols=124  Identities=15%  Similarity=0.177  Sum_probs=89.2

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCee-ecceeEEecCCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      .+.|+.|.++.||++..  .+..|++|......   ...++|+.+++.+.+.+++ +++...     ...  .++|||++
T Consensus         3 ~~~l~~G~~~~vy~~~~--~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~-----~~~--~~lv~e~i   73 (170)
T cd05151           3 ISPLKGGMTNKNYRVEV--ANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD-----PET--GVLITEFI   73 (170)
T ss_pred             eeecCCcccCceEEEEE--CCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe-----CCC--CeEEEEec
Confidence            46789999999999986  47889999875543   3457899999988665544 333221     111  35899999


Q ss_pred             cchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCc-----EeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          152 PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV-----CHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       152 ~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~i-----vH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|......           ......++.+++++|..||.. ++     +|+|++|.||+++ ++ .++++|||.+.
T Consensus        74 ~G~~l~~~-----------~~~~~~~~~~l~~~l~~LH~~-~~~~~~~~HgD~~~~Nil~~-~~-~~~liDf~~a~  135 (170)
T cd05151          74 EGSELLTE-----------DFSDPENLEKIAKLLKKLHSS-PLPDLVPCHNDLLPGNFLLD-DG-RLWLIDWEYAG  135 (170)
T ss_pred             CCCccccc-----------cccCHHHHHHHHHHHHHHhCC-CCCCceeecCCCCcCcEEEE-CC-eEEEEeccccc
Confidence            98421110           011234567899999999975 74     9999999999999 44 79999999875

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.42  E-value=1.4e-11  Score=113.63  Aligned_cols=215  Identities=20%  Similarity=0.237  Sum_probs=158.3

Q ss_pred             CceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc--hHH
Q 017452           83 SFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVH  156 (371)
Q Consensus        83 ~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~  156 (371)
                      ...+.|++....+|..|++|++.-++    ...-.-+++++++.|+|+|++..+|.... -+...+++|++|.++  +|.
T Consensus       288 ~~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~t-F~D~SlvlvYDYyP~s~TL~  366 (655)
T KOG3741|consen  288 FSITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYT-FGDLSLVLVYDYYPSSPTLY  366 (655)
T ss_pred             ccceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhc-cCcceEEEEEecCCCCchHH
Confidence            34588999999999999999993221    12235689999999999999999887333 345668899999984  666


Q ss_pred             HHHHHhhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          157 RVVKHFNK-----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       157 ~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ++...-..           .+...++..+|.++.||..||.++|++ |+.-+-|.|.+|+++.+. +++|+..|......
T Consensus       367 d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss-GLAck~L~~~kIlv~G~~-RIriS~C~i~Dvl~  444 (655)
T KOG3741|consen  367 DLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS-GLACKTLDLKKILVTGKM-RIRISGCGIMDVLQ  444 (655)
T ss_pred             HHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc-CceeecccHhHeEeeCcc-eEEEecccceeeec
Confidence            65433211           123578899999999999999999988 999999999999999887 89999999876654


Q ss_pred             cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHH-HHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQ-LVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....             |.+.    -..+-|.=.||.+++.|.||..-- ......+. +..                  
T Consensus       445 ~d~~-------------~~le----~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~------------------  489 (655)
T KOG3741|consen  445 EDPT-------------EPLE----SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTR------------------  489 (655)
T ss_pred             CCCC-------------cchh----HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHH------------------
Confidence            3320             1121    123568999999999999996321 11111111 111                  


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        +...+|.+++++|.-+...++.+ -++.+++.+
T Consensus       490 ------------------I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  490 ------------------ITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             ------------------hhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence                              22347899999999999999987 788888877

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.41  E-value=2.4e-12  Score=107.67  Aligned_cols=132  Identities=17%  Similarity=0.218  Sum_probs=92.4

Q ss_pred             eEeeccCCceEEEEEEECC------CCcEEEEEEeecc--------------h----------------hhhHHHHHHHH
Q 017452           76 ERIVGQGSFGVVFQAKCLE------TGETVAIKKVLQD--------------K----------------RYKNRELQTMR  119 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~------~~~~vaiK~~~~~--------------~----------------~~~~~e~~~l~  119 (371)
                      ...||.|--+.||.|....      .+..+|||+++-.              .                ...++|+..|+
T Consensus         2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~   81 (197)
T cd05146           2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK   81 (197)
T ss_pred             CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            3468999999999998543      3578999977311              0                11126888888


Q ss_pred             HcCC--CCeeecceeEEecCCCCceeEEEeeccccch-HH-HHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH-HhcCCc
Q 017452          120 LLDH--PNVVSLKHCFFSTTDKDELYLNLVLEYVPET-VH-RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI-HRSIGV  194 (371)
Q Consensus       120 ~l~h--~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~i  194 (371)
                      ++..  -++.+.+++.     .    -+|||||++++ +. ..+.     ...++...+..+..+++.+|..| |+. |+
T Consensus        82 rl~~~Gv~vP~pi~~~-----~----~~lvME~Ig~~~~~~~~Lk-----d~~~~~~~~~~i~~~i~~~l~~l~H~~-gl  146 (197)
T cd05146          82 RMQKAGIPCPEVVVLK-----K----HVLVMSFIGDDQVPAPKLK-----DAKLNDEEMKNAYYQVLSMMKQLYKEC-NL  146 (197)
T ss_pred             HHHHcCCCCCeEEEec-----C----CEEEEEEcCCCCccchhhh-----ccccCHHHHHHHHHHHHHHHHHHHHhC-Ce
Confidence            8843  3444444321     1    36899999863 11 1111     23455566777889999999998 765 99


Q ss_pred             EeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       195 vH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      |||||++.||+++. + .+.|+|||.+...
T Consensus       147 VHGDLs~~NIL~~~-~-~v~iIDF~qav~~  174 (197)
T cd05146         147 VHADLSEYNMLWHD-G-KVWFIDVSQSVEP  174 (197)
T ss_pred             ecCCCCHHHEEEEC-C-cEEEEECCCceeC
Confidence            99999999999974 4 6999999988654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.40  E-value=1.6e-12  Score=124.77  Aligned_cols=141  Identities=21%  Similarity=0.280  Sum_probs=89.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh------------------------------------------
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------------------------------------------  109 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------------------------------------------  109 (371)
                      .|.. +.||+|++|+||+|+...+|+.||||+......                                          
T Consensus       121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~  199 (537)
T PRK04750        121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD  199 (537)
T ss_pred             hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence            4665 789999999999999887899999998854310                                          


Q ss_pred             --hhHHHHHHHHHc----CCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhcc---CCCCHHHHHHHHH
Q 017452          110 --YKNRELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLN---QRMPMIYVKLYAY  179 (371)
Q Consensus       110 --~~~~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~---~~~~~~~~~~i~~  179 (371)
                        ...+|...+.++    .+.+.+.+...+..-    ....++||||+.| .+.+. .......   ..+.+..+..++.
T Consensus       200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~----st~~VLvmE~i~G~~l~d~-~~l~~~g~d~~~la~~~v~~~~~  274 (537)
T PRK04750        200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDY----CSETVMVMERMYGIPVSDV-AALRAAGTDMKLLAERGVEVFFT  274 (537)
T ss_pred             hhCHHHHHHHHHHHHHHccCCCCeecceeeccc----CCCceEEEeeecCccHHhH-HHHHhcCCCHHHHHHHHHHHHHH
Confidence              001222222222    233444444444321    1224699999997 44332 2111111   1344555555666


Q ss_pred             HHHHHHHHHHhcCCcEeeccCCCceeeeCCC---CcEEEEeeCCcccccc
Q 017452          180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKVLVK  226 (371)
Q Consensus       180 qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~---~~~kl~Dfg~a~~~~~  226 (371)
                      |++.       . |++|+|+||.||+++.++   ++++++|||++.....
T Consensus       275 Qif~-------~-GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        275 QVFR-------D-GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             HHHh-------C-CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            6553       4 999999999999998765   3799999999876643

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.37  E-value=3e-13  Score=126.90  Aligned_cols=245  Identities=20%  Similarity=0.177  Sum_probs=170.8

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC-CCCcEEEEEEeecch------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL-ETGETVAIKKVLQDK------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~~------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      ...++|.++..||.|.|+.|+.+..+ .++..|++|...+..      .....|+-+...+ .|.+++.++..+..... 
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~-  340 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQ-  340 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccc-
Confidence            34567999999999999999988766 678889999775542      2223456665555 58888888777744332 


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                          .|+-.|||.+....+-.   .....+.+...+.+..|++.++.++|+. .++|+|+||+||++..++...++.|||
T Consensus       341 ----~~ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~-~~~~~d~~psni~i~~~~~~~~~~~~~  412 (524)
T KOG0601|consen  341 ----GYIPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSK-LFVHLDVKPSNILISNDGFFSKLGDFG  412 (524)
T ss_pred             ----ccCchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccch-hhhcccccccceeeccchhhhhccccc
Confidence                46889999764333322   2245677888889999999999999975 999999999999998875589999999


Q ss_pred             CccccccCCCccccccccccc-CcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVKGEPNISYICSRYYR-APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~-aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +.+.+.-  ........-.++ ..|++.....+..+.|++|||..+.+.++|...-........   +...         
T Consensus       413 ~~t~~~~--~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~---i~~~---------  478 (524)
T KOG0601|consen  413 CWTRLAF--SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLT---IRSG---------  478 (524)
T ss_pred             cccccce--ecccccccccccccchhhccccccccccccccccccccccccCcccCccccccee---eecc---------
Confidence            9864211  111222233344 366665666688899999999999999998743222211111   0000         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILF  355 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l  355 (371)
                                ..+          .....+.++..+...+...++..|+.+.++..|.
T Consensus       479 ----------~~p----------~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  479 ----------DTP----------NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ----------ccc----------CCCchHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                      000          1112346788899999999999999999987773

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.33  E-value=4.9e-13  Score=132.12  Aligned_cols=241  Identities=24%  Similarity=0.280  Sum_probs=169.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..+.+.+-+-+|.++.++.+.-..+|...+.|+.....       +...++-.++....+|.++.....+     ....-
T Consensus       804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~-----~~rsP  878 (1205)
T KOG0606|consen  804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSF-----PCRSP  878 (1205)
T ss_pred             ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCC-----CCCCC
Confidence            45777788999999999999877777666666543322       1112222222223445555543332     22233


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++++|+++ ++...++.    ....+.+.++.....+..++++||.. .+.|+|++|.|+++..++ ..++.|||...
T Consensus       879 ~~L~~~~~~~~~~~Skl~~----~~~~saepaRs~i~~~vqs~e~L~s~-~r~h~~~~p~~~l~~~~g-h~~l~~~~t~~  952 (1205)
T KOG0606|consen  879 LPLVGHYLNGGDLPSKLHN----SGCLSAEPARSPILERVQSLESLHSS-LRKHRDLKPDSLLIAYDG-HRPLTDFGTLS  952 (1205)
T ss_pred             cchhhHHhccCCchhhhhc----CCCcccccccchhHHHHhhhhccccc-hhhcccccccchhhcccC-CcccCcccccc
Confidence            6789999975 44444443    34577777888888999999999975 699999999999999888 79999998332


Q ss_pred             cccc------C--------------------------CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC
Q 017452          223 VLVK------G--------------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG  270 (371)
Q Consensus       223 ~~~~------~--------------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg  270 (371)
                      ....      .                          .......+|+.|.+||.+.+.. ....+|+|+.|+++++.++|
T Consensus       953 ~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g 1031 (1205)
T KOG0606|consen  953 KVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTG 1031 (1205)
T ss_pred             ccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcC
Confidence            2100      0                          0012345799999999997765 68899999999999999999


Q ss_pred             CCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH
Q 017452          271 KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV  349 (371)
Q Consensus       271 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~  349 (371)
                      .+||........+..+.+..                         .+|-. -+...++++++++..+|..+|.+|..+.
T Consensus      1032 ~pp~na~tpq~~f~ni~~~~-------------------------~~~p~-g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1032 IPPFNAETPQQIFENILNRD-------------------------IPWPE-GPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCCCcchhhhhhccccCC-------------------------CCCCC-CccccChhhhhhhhhhhccCchhccCcc
Confidence            99999887766665544321                         11211 3445789999999999999999999887

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.32  E-value=8.5e-11  Score=106.09  Aligned_cols=270  Identities=15%  Similarity=0.170  Sum_probs=167.8

Q ss_pred             eeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhh-HHHHHHHHHc-CCCCeeeccee---EEecCCCCceeEEEee
Q 017452           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLL-DHPNVVSLKHC---FFSTTDKDELYLNLVL  148 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~e~~~l~~l-~h~niv~~~~~---~~~~~~~~~~~~~lv~  148 (371)
                      ..++.||+|+.+.+|-.-.   -...+.|++....... .+-++.|... .||-+-.-+..   ...+. .....+.++|
T Consensus        14 ~~gr~LgqGgea~ly~l~e---~~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~-~~~~~iGflm   89 (637)
T COG4248          14 PPGRPLGQGGEADLYTLGE---VRDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGG-RRGKVIGFLM   89 (637)
T ss_pred             CCCccccCCccceeeecch---hhchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCC-CccceeEEec
Confidence            4567899999999996543   2335668876543322 2233444433 45533220000   01111 2222367888


Q ss_pred             ccccc--hHHHHHHH--hhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          149 EYVPE--TVHRVVKH--FNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       149 e~~~~--~l~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +.+.|  .+..++.-  .+.......+..+.+.++.|+.+.+.||.+ |.+-||++++|+|+..++ .|.|.|=+.-...
T Consensus        90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~-Gh~vGDVn~~~~lVsd~~-~V~LVdsDsfqi~  167 (637)
T COG4248          90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH-GHVVGDVNQNSFLVSDDS-KVVLVDSDSFQIN  167 (637)
T ss_pred             ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc-CCcccccCccceeeecCc-eEEEEcccceeec
Confidence            88875  22222211  122234567889999999999999999987 999999999999999887 8999987765555


Q ss_pred             ccCCCcccccccccccCccccc----CCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .++......+|.+.|.+||.-.    ..-..+...|.|.||+++|+++.| ++||.+-.....       -+.+.+..+.
T Consensus       168 ~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~-------ap~p~E~~Ia  240 (637)
T COG4248         168 ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD-------APNPLETDIA  240 (637)
T ss_pred             cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC-------CCCcchhhhh
Confidence            5666666778899999999753    112346789999999999999976 899975321100       0000010111


Q ss_pred             hcCCCc----cccccCcccCCCCcccCCCCCChhHHHHHHhccCc--CCCCCCCHHHHhhhhcCCCcc
Q 017452          300 CMNPNY----TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQY--SPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       300 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~--dP~~R~t~~~~l~~l~~~~~~  361 (371)
                      ....-+    .....+.-...+|     .-+++++..|..+|+..  ++.-|||++.++..+..+.++
T Consensus       241 ~g~f~ya~~~~~g~~p~P~~~P~-----~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~  303 (637)
T COG4248         241 HGRFAYASDQRRGLKPPPRSIPL-----SMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQ  303 (637)
T ss_pred             cceeeechhccCCCCCCCCCCCh-----hhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHh
Confidence            000000    0000111111112     34788999999999985  467999999998887666554

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.29  E-value=7.8e-11  Score=95.07  Aligned_cols=139  Identities=19%  Similarity=0.272  Sum_probs=96.9

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEee-c-----------chhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVL-Q-----------DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~-~-----------~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ....+-+|+-+.|+++.+  .|+.+.||.-. +           .+....+|...|.++.--.|..-.-+|....   . 
T Consensus        11 ~l~likQGAEArv~~~~~--~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~---~-   84 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSF--SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTY---G-   84 (229)
T ss_pred             cceeeeccceeeEeeecc--CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecC---C-
Confidence            456788999999999987  78888888431 1           1233446888887764322222111222211   1 


Q ss_pred             eEEEeeccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcE--EEEee
Q 017452          143 YLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDF  218 (371)
Q Consensus       143 ~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~--kl~Df  218 (371)
                       -.|+|||++|  ++.+.+....  ...........++.+|-+.+.-||.. +||||||..+||++.+++..+  .++||
T Consensus        85 -~~i~ME~~~g~~~vk~~i~~~~--~~~~~d~~~~~~~~~iG~~igklH~n-diiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   85 -GQIYMEFIDGASTVKDFILSTM--EDESEDEGLAELARRIGELIGKLHDN-DIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             -CeEEEEeccchhHHHHHHHHHc--cCcccchhHHHHHHHHHHHHHHhhhC-CeecccccccceEEecCCCcCceEEEee
Confidence             2589999998  6666655432  23333444478889999999999987 999999999999998887665  89999


Q ss_pred             CCccc
Q 017452          219 GSAKV  223 (371)
Q Consensus       219 g~a~~  223 (371)
                      |++..
T Consensus       161 gls~~  165 (229)
T KOG3087|consen  161 GLSSV  165 (229)
T ss_pred             cchhc
Confidence            99864

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.20  E-value=2.7e-10  Score=92.42  Aligned_cols=125  Identities=15%  Similarity=0.301  Sum_probs=84.0

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+++|+-+.+|.+.+  -|..+++|.=.+.            .....+|..++.++.--.|..-+-+++.+..     ..
T Consensus         3 ~i~~GAEa~i~~~~~--~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~-----~~   75 (204)
T COG3642           3 LIKQGAEAIIYLTDF--LGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDN-----GL   75 (204)
T ss_pred             hhhCCcceeEEeeec--cCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-----CE
Confidence            578899999999966  4556777743211            1223468888888753333222222222222     45


Q ss_pred             EeeccccchHHH-HHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          146 LVLEYVPETVHR-VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~~l~~-~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+|||++|.+.. .+...           ...++..+-.-+.-||.. ||+|+||+++||++..+  .+.++|||++..
T Consensus        76 I~me~I~G~~lkd~l~~~-----------~~~~~r~vG~~vg~lH~~-givHGDLTtsNiIl~~~--~i~~IDfGLg~~  140 (204)
T COG3642          76 IVMEYIEGELLKDALEEA-----------RPDLLREVGRLVGKLHKA-GIVHGDLTTSNIILSGG--RIYFIDFGLGEF  140 (204)
T ss_pred             EEEEEeCChhHHHHHHhc-----------chHHHHHHHHHHHHHHhc-CeecCCCccceEEEeCC--cEEEEECCcccc
Confidence            899999995444 44321           134556677778889987 99999999999999865  499999999864

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.15  E-value=2.3e-10  Score=95.48  Aligned_cols=121  Identities=23%  Similarity=0.312  Sum_probs=76.0

Q ss_pred             EEEEEEECCCCcEEEEEEeecc------------------------------hhhhHHHHHHHHHcCCC--CeeecceeE
Q 017452           86 VVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDHP--NVVSLKHCF  133 (371)
Q Consensus        86 ~V~~~~~~~~~~~vaiK~~~~~------------------------------~~~~~~e~~~l~~l~h~--niv~~~~~~  133 (371)
                      .||.|.. .+|..+|+|+....                              ....++|.+.|.++..-  ++.+.+.+.
T Consensus         1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            4899985 57789999987321                              11224699999999755  345554332


Q ss_pred             EecCCCCceeEEEeecccc--chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH-HHhcCCcEeeccCCCceeeeCCC
Q 017452          134 FSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY-IHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~-LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                           .    -+|||||++  |.....+..     ..++......++.+++..+.. +|. .||+||||.+.||+++.+ 
T Consensus        80 -----~----~~ivME~I~~~G~~~~~l~~-----~~~~~~~~~~~~~~il~~~~~~~~~-~givHGDLs~~NIlv~~~-  143 (188)
T PF01163_consen   80 -----R----NVIVMEYIGEDGVPLPRLKD-----VDLSPEEPKELLEEILEEIIKMLHK-AGIVHGDLSEYNILVDDG-  143 (188)
T ss_dssp             -----T----TEEEEE--EETTEEGGCHHH-----CGGGGSTHHHHHHHHHHHHHHHHHC-TTEEESS-STTSEEEETT-
T ss_pred             -----C----CEEEEEecCCCccchhhHHh-----ccccchhHHHHHHHHHHHHHHHHHh-cCceecCCChhhEEeecc-
Confidence                 1    269999999  632222222     122234466677788886666 466 499999999999999966 


Q ss_pred             CcEEEEeeCCcccc
Q 017452          211 HQVKLCDFGSAKVL  224 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~  224 (371)
                       .+.|+|||.+...
T Consensus       144 -~~~iIDf~qav~~  156 (188)
T PF01163_consen  144 -KVYIIDFGQAVDS  156 (188)
T ss_dssp             -CEEE--GTTEEET
T ss_pred             -eEEEEecCcceec
Confidence             6999999988654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.13  E-value=4.9e-11  Score=113.87  Aligned_cols=148  Identities=22%  Similarity=0.319  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc----------ccccccccccCcccccCCc
Q 017452          180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN----------ISYICSRYYRAPELIFGAT  249 (371)
Q Consensus       180 qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~----------~~~~~t~~y~aPE~~~~~~  249 (371)
                      +++.|+.|+|.+.++||++|.|++|.++..+ .+||+.|+.+.........          ....-...|.|||.+.. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~-~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-~  184 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANG-DWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-T  184 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCc-ceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-c
Confidence            3448999999988999999999999999988 8999999987654331110          01122556999999966 4


Q ss_pred             CCCCcchHHHHHHHHHHHH-hCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCCh
Q 017452          250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP  328 (371)
Q Consensus       250 ~~~~~~DiwslG~il~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  328 (371)
                      ..+.++|+||+|+++|.+. .|+.-+...........-....+..                         ...+...++.
T Consensus       185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~-------------------------~~~~s~~~p~  239 (700)
T KOG2137|consen  185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG-------------------------AFGYSNNLPS  239 (700)
T ss_pred             cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc-------------------------cccccccCcH
Confidence            4789999999999999988 5665555443322222111110000                         0003356899


Q ss_pred             hHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          329 EAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       329 ~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ++.+-+.+++..++..||++..++..
T Consensus       240 el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  240 ELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             HHHHHHHHHhcCCcccCcchhhhhcc
Confidence            99999999999999999987776554

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=2.6e-09  Score=94.50  Aligned_cols=133  Identities=11%  Similarity=0.120  Sum_probs=89.1

Q ss_pred             EEEEEEECCCCcEEEEEEeecch---------------hhhHHHHHHHHHcCCCCeeec--ceeEEecCCCCceeEEEee
Q 017452           86 VVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSL--KHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        86 ~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~--~~~~~~~~~~~~~~~~lv~  148 (371)
                      .|+++..  .|+.|.||......               ....+|...+.++..-+|...  +.+...........-++||
T Consensus        37 rvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVt  114 (268)
T PRK15123         37 RTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIIT  114 (268)
T ss_pred             eEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEE
Confidence            3555543  56678888653211               135688888887754343332  2333221212123357899


Q ss_pred             ccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC------CCcEEEEeeCC
Q 017452          149 EYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH------THQVKLCDFGS  220 (371)
Q Consensus       149 e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~------~~~~kl~Dfg~  220 (371)
                      |++++  +|.+++....  ....+......++.+++..+.-||.. ||+|+|++++|||++.+      ...+.|+||+.
T Consensus       115 e~l~~~~sL~~~~~~~~--~~~~~~~~~~~ll~~la~~i~~LH~~-Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r  191 (268)
T PRK15123        115 EDLAPTISLEDYCADWA--TNPPDPRLKRMLIKRVATMVRDMHAA-GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHR  191 (268)
T ss_pred             eeCCCCccHHHHHHhhc--ccCCCHHHHHHHHHHHHHHHHHHHHC-cCccCCCChhhEEEeccccCCCCCceEEEEECCc
Confidence            99997  5666664321  24456677888999999999999987 99999999999999852      34799999998


Q ss_pred             ccc
Q 017452          221 AKV  223 (371)
Q Consensus       221 a~~  223 (371)
                      +..
T Consensus       192 ~~~  194 (268)
T PRK15123        192 AQI  194 (268)
T ss_pred             ccc
Confidence            853

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.06  E-value=1.7e-09  Score=93.57  Aligned_cols=139  Identities=17%  Similarity=0.182  Sum_probs=90.3

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCC--eeecceeEEecCCCCceeEEEeec
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +.|+.|..+.||++... +|+.+++|.....     .....+|.++++.+.+.+  +.+++......  ......++|||
T Consensus         4 ~~l~~G~~n~~~~v~~~-~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~--~~~~~~~~v~e   80 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG-GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDP--SVLGTPFYVME   80 (223)
T ss_pred             eecCCCccceEEEEEec-CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCC--CccCCceEEEE
Confidence            56899999999999863 3688999987543     345678999999997643  44444433111  11123579999


Q ss_pred             cccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------
Q 017452          150 YVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR--------------------------------------  190 (371)
Q Consensus       150 ~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~--------------------------------------  190 (371)
                      |++|. +...+.     ...++......++.+++++|..||+                                      
T Consensus        81 ~i~G~~l~~~~~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  155 (223)
T cd05154          81 RVDGRVLRDRLL-----RPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPP  155 (223)
T ss_pred             EeCCEecCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccH
Confidence            99873 211110     0234444455555555555555552                                      


Q ss_pred             -----------------cCCcEeeccCCCceeeeCC-CCcEEEEeeCCccc
Q 017452          191 -----------------SIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (371)
Q Consensus       191 -----------------~~~ivH~dlkp~NIli~~~-~~~~kl~Dfg~a~~  223 (371)
                                       ...++|+|++|.||+++.+ +..+.|+||+.+..
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         156 AMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                             1257999999999999983 22689999998854

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.98  E-value=3.5e-09  Score=91.12  Aligned_cols=132  Identities=20%  Similarity=0.196  Sum_probs=92.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec--------------------------chhhhHHHHHHHHHcCCC-
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--------------------------DKRYKNRELQTMRLLDHP-  124 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--------------------------~~~~~~~e~~~l~~l~h~-  124 (371)
                      -+.++..||-|--+.||.|.+ ..|.++|||.=..                          .....++|+++|++|... 
T Consensus        92 ve~iG~~IGvGKEsdVY~~~~-~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G  170 (304)
T COG0478          92 VEAIGTKIGVGKESDVYVAID-PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEG  170 (304)
T ss_pred             HHhhccccccCccceEEEEEC-CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcC
Confidence            367889999999999999995 4789999994210                          123345799999998543 


Q ss_pred             -CeeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          125 -NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       125 -niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                       .+.+.++         ....++|||+++|-.+  ..      -++..+.+..++..|+.-+..+-.. ||||||+.+-|
T Consensus       171 ~~VP~P~~---------~nRHaVvMe~ieG~eL--~~------~r~~~en~~~il~~il~~~~~~~~~-GiVHGDlSefN  232 (304)
T COG0478         171 VKVPKPIA---------WNRHAVVMEYIEGVEL--YR------LRLDVENPDEILDKILEEVRKAYRR-GIVHGDLSEFN  232 (304)
T ss_pred             CCCCCccc---------cccceeeeehccccee--ec------ccCcccCHHHHHHHHHHHHHHHHHc-CccccCCchhe
Confidence             4555433         2235799999998421  11      1113334444555566655555544 99999999999


Q ss_pred             eeeeCCCCcEEEEeeCCccc
Q 017452          204 LLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~~  223 (371)
                      |+++.|| .+.++||-.+..
T Consensus       233 IlV~~dg-~~~vIDwPQ~v~  251 (304)
T COG0478         233 ILVTEDG-DIVVIDWPQAVP  251 (304)
T ss_pred             EEEecCC-CEEEEeCccccc
Confidence            9999998 799999987754

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.83  E-value=8.4e-08  Score=82.03  Aligned_cols=108  Identities=17%  Similarity=0.296  Sum_probs=76.8

Q ss_pred             hhHHHHHHHHHcCCCCe--eecceeEEecCCCCceeEEEeeccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHH
Q 017452          110 YKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL  185 (371)
Q Consensus       110 ~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l  185 (371)
                      ...+|...+..+..-.|  .+.+++....... ....++|+|++++  +|.+.+...    ...+......++.+++..+
T Consensus        57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~-~~~s~lite~l~~~~~L~~~~~~~----~~~~~~~~~~ll~~l~~~i  131 (206)
T PF06293_consen   57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGG-GYRSYLITEALPGAQDLRDLLQQW----EQLDPSQRRELLRALARLI  131 (206)
T ss_pred             HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCC-ceeEEEEEEeCCCcccHHHHHHhh----cccchhhHHHHHHHHHHHH
Confidence            45678887777743333  3333333332222 2445789999987  566666542    2256667888999999999


Q ss_pred             HHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCCccc
Q 017452          186 SYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  223 (371)
Q Consensus       186 ~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~a~~  223 (371)
                      .-||.. ||+|+|+++.|||++.++  ..+.++||+.+..
T Consensus       132 ~~lH~~-gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  132 AKLHDA-GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHC-cCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999987 999999999999998764  3699999998764

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>PRK09902 hypothetical protein; Provisional

Probab=98.82  E-value=1.7e-07  Score=78.90  Aligned_cols=138  Identities=12%  Similarity=0.072  Sum_probs=95.4

Q ss_pred             ccCCceEEEEEEECCCCcEEEEEEee----------cchhhhHHHHHHHHHcCCCC--eeecceeEEecCCCCceeEEEe
Q 017452           80 GQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        80 g~G~~g~V~~~~~~~~~~~vaiK~~~----------~~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      |.||-+.|+....  .|..+-+|.-.          -....+.+|+..|+.+..-+  +.++. ++-.......-.-+||
T Consensus        27 ~rgG~SgV~r~~~--~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVER--NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEe--CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            5678888888764  44467788653          12455678999998885433  33333 2211222334446789


Q ss_pred             eccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC-cEEEEeeCCccc
Q 017452          148 LEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (371)
Q Consensus       148 ~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~-~~kl~Dfg~a~~  223 (371)
                      +|-++|  +|.+.+...  .-.+.+......++.+++.++.-||+. |+.|+|+.+.||+++.++. .++++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~--~~~~~~~~~k~~il~~va~~ia~LH~~-Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQH--AVSPYSDEVRQAMLKAVALAFKKMHSV-NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcC--CcCCcchHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            998884  766665421  123456777788999999999999987 9999999999999986651 399999997754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.76  E-value=1.8e-07  Score=78.97  Aligned_cols=135  Identities=16%  Similarity=0.221  Sum_probs=85.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhH-------------HHHHHHHHcCC---CCeeecceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLDH---PNVVSLKHCFF  134 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~-------------~e~~~l~~l~h---~niv~~~~~~~  134 (371)
                      ++|.+.+.+-......|.+..-  +|+.+++|.........+             +++..+.++..   .....++.+..
T Consensus        31 ~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e  108 (229)
T PF06176_consen   31 NNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE  108 (229)
T ss_pred             CCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence            4688888888888777777754  788999997754432222             33443444422   22222222221


Q ss_pred             ecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcE
Q 017452          135 STTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV  213 (371)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~  213 (371)
                      -.........+++|||++|- +.+..        .+++.    +...+.+++.-||+. |++|||..|.|++++.++  +
T Consensus       109 kk~~~~~~~~~ll~EYIeG~~l~d~~--------~i~e~----~~~ki~~~ikqlH~~-G~~HGD~hpgNFlv~~~~--i  173 (229)
T PF06176_consen  109 KKIFRYTSSYVLLMEYIEGVELNDIE--------DIDED----LAEKIVEAIKQLHKH-GFYHGDPHPGNFLVSNNG--I  173 (229)
T ss_pred             eeeccceeEEEEEEEEecCeecccch--------hcCHH----HHHHHHHHHHHHHHc-CCccCCCCcCcEEEECCc--E
Confidence            11112233456899999983 22221        12222    334677889999986 999999999999999654  9


Q ss_pred             EEEeeCCcc
Q 017452          214 KLCDFGSAK  222 (371)
Q Consensus       214 kl~Dfg~a~  222 (371)
                      +++||+..+
T Consensus       174 ~iID~~~k~  182 (229)
T PF06176_consen  174 RIIDTQGKR  182 (229)
T ss_pred             EEEECcccc
Confidence            999998664

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.74  E-value=1.5e-07  Score=80.35  Aligned_cols=132  Identities=15%  Similarity=0.194  Sum_probs=89.6

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecch----------------------------hhhHHHHHHHHHcCCC--Cee
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------------------------RYKNRELQTMRLLDHP--NVV  127 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------------~~~~~e~~~l~~l~h~--niv  127 (371)
                      .|..|--+.||+|. ..++..+|+|++....                            ....+|+.-|+++...  .+.
T Consensus        55 ~istGKEA~Vy~a~-~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP  133 (268)
T COG1718          55 CISTGKEANVYLAE-TGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP  133 (268)
T ss_pred             eecCCcceEEEeec-cCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence            67778888999997 4678999999984321                            1112577777776432  233


Q ss_pred             ecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       128 ~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                      +-+.+.     .    -.+||||++.. ..  ..-.-....+....+..+..++++.+.-|-...++||+||..-|||+.
T Consensus       134 ~Pi~~~-----~----nVLvMEfIg~~-g~--pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         134 EPIAFR-----N----NVLVMEFIGDD-GL--PAPRLKDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH  201 (268)
T ss_pred             Cceeec-----C----CeEEEEeccCC-CC--CCCCcccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE
Confidence            333332     1    25899999853 00  000000223344467788889999999988746999999999999999


Q ss_pred             CCCCcEEEEeeCCcccc
Q 017452          208 PHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~  224 (371)
                       ++ .+.|+|||.|...
T Consensus       202 -~~-~p~iID~~QaV~~  216 (268)
T COG1718         202 -DG-EPYIIDVSQAVTI  216 (268)
T ss_pred             -CC-eEEEEECcccccc
Confidence             55 7999999988654

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.68  E-value=7.5e-08  Score=92.28  Aligned_cols=138  Identities=21%  Similarity=0.281  Sum_probs=82.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecchhh--------------------------------------------hH
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY--------------------------------------------KN  112 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~--------------------------------------------~~  112 (371)
                      .-|+.++-|+||+|+. .+|+.||||+....-..                                            ..
T Consensus       131 ~PiAsASIaQVH~A~L-~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVL-KSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEe-cCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            5689999999999995 45999999987432100                                            01


Q ss_pred             HHHHHHHHc----CCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 017452          113 RELQTMRLL----DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY  187 (371)
Q Consensus       113 ~e~~~l~~l----~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  187 (371)
                      +|...+.++    ....-+.+-..|++...+    -.++|||++| .+.+.... .  ...++...+...+.++.-  ..
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~----~VLtmE~i~Gi~i~d~~~l-~--~~g~d~k~ia~~~~~~f~--~q  280 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTR----RVLTMEWIDGIKISDIAAL-K--SAGIDRKELAELLVRAFL--RQ  280 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCC----cEEEEEeeCCEecccHHHH-H--hcCCCHHHHHHHHHHHHH--HH
Confidence            233333333    222233444444332221    4699999998 33333221 1  234443333222222111  11


Q ss_pred             HHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       188 LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      +=.. |++|.|..|.||+++.++ ++.+.|||+.....+
T Consensus       281 ~~~d-gffHaDpHpGNi~v~~~g-~i~~lDfGi~g~l~~  317 (517)
T COG0661         281 LLRD-GFFHADPHPGNILVRSDG-RIVLLDFGIVGRLDP  317 (517)
T ss_pred             HHhc-CccccCCCccceEEecCC-cEEEEcCcceecCCH
Confidence            1114 999999999999999998 899999999876543

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.47  E-value=1.1e-06  Score=89.09  Aligned_cols=202  Identities=17%  Similarity=0.236  Sum_probs=134.5

Q ss_pred             hhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Q 017452          110 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI  188 (371)
Q Consensus       110 ~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  188 (371)
                      ..+.|++.+..+.|+|++.++.+.+.....+ ..+.+..+++.+ ++..++.+    -...+...++.+..++..||.++
T Consensus       228 ~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~----v~~i~~~~~r~~~~~~~~GL~~~  302 (1351)
T KOG1035|consen  228 TTEIELESLSKIAHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQS----VGSIPLETLRILHQKLLEGLAYL  302 (1351)
T ss_pred             HHHHHHHHHHhhccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhh----ccccCHHHHHHHHHHHhhhHHHH
Confidence            3345778888999999999877665443322 112234456664 44444444    46788899999999999999999


Q ss_pred             HhcCCcEeeccCCC---ceeeeCCCCcEEEE--eeCCccccccCCCcccccccccccCcccccCCc-CCCCcchHHHHHH
Q 017452          189 HRSIGVCHRDIKPQ---NLLVNPHTHQVKLC--DFGSAKVLVKGEPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGC  262 (371)
Q Consensus       189 H~~~~ivH~dlkp~---NIli~~~~~~~kl~--Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~  262 (371)
                      |.. ...|.-|..+   +...+.++ .+.++  ||+.+....+.........+..+.++|...... ......|+|++|.
T Consensus       303 h~~-~l~~v~L~~s~~~~~~~~~e~-~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgl  380 (1351)
T KOG1035|consen  303 HSL-SLEHVVLSASSSKESTVDGEG-VVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGL  380 (1351)
T ss_pred             HHh-ccceeEEecccccccccCccc-eeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHH
Confidence            975 5555555444   33344454 56666  898888776665555556667788888774333 1233469999999


Q ss_pred             HHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCC
Q 017452          263 VVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP  342 (371)
Q Consensus       263 il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP  342 (371)
                      .+..+..|..+-......   ...                                   .+........+++.+|+..++
T Consensus       381 l~~~~~~~~~i~~~~~~~---~~~-----------------------------------l~~~~~~~~~d~~~~~~~~~~  422 (1351)
T KOG1035|consen  381 LLLQLSQGEDISEKSAVP---VSL-----------------------------------LDVLSTSELLDALPKCLDEDS  422 (1351)
T ss_pred             HHhhhhhcCcccccccch---hhh-----------------------------------hccccchhhhhhhhhhcchhh
Confidence            999999876432211110   000                                   111112278899999999999


Q ss_pred             CCCCCHHHHhhhhc
Q 017452          343 NLRCTAVSKRILFS  356 (371)
Q Consensus       343 ~~R~t~~~~l~~l~  356 (371)
                      ++|+.+.+++.|.+
T Consensus       423 ~~Rl~~~~ll~~~f  436 (1351)
T KOG1035|consen  423 EERLSALELLTHPF  436 (1351)
T ss_pred             hhccchhhhhhchh
Confidence            99999999999943

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.42  E-value=9.1e-08  Score=91.10  Aligned_cols=189  Identities=19%  Similarity=0.107  Sum_probs=133.0

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCC-eeecceeEEecCCCCceeEEEeecc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPN-VVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~n-iv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      -|.....+++|+.+++++.+...+...+ .+.+... ....-++++|.+++||| .+..++.     ...+.+..+.+++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n~P~~~v~~~~d-----~~~E~~~~i~~~i  315 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVNNPNPVVRYLED-----YDGEDYLWIPMRI  315 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHccCCCCccccccc-----CCcccccchhhhh
Confidence            3566677899999999999876665544 6655443 44455899999999999 3333332     3567778899999


Q ss_pred             ccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCc
Q 017452          151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN  230 (371)
Q Consensus       151 ~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~  230 (371)
                      +.++-..... .....-.+..-....+.+.-.+++++||+. --+|+|    ||+..++  ..+..||+....+......
T Consensus       316 ~s~~rs~~~~-~~~se~~~~~~~~~~~~r~et~~l~~l~~~-~~~~~d----~~l~s~~--~~~~~~~~v~~~L~~~~~~  387 (829)
T KOG0576|consen  316 CSTGRSSALE-MTVSEIALEQYQFAYPLRKETRPLAELHSS-YKVHRD----NILGSEE--EVKLLDFAVPPQLTRTMKP  387 (829)
T ss_pred             hcCCcccccc-CChhhHhhhhhhhhhhhhhhcccccccccc-cccCcc----ccccccc--ccccccccCCcccCccccc
Confidence            9854000000 001112233344556666777899999964 558888    8887763  5999999988777666556


Q ss_pred             ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       231 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                      ....+++.++|||+..... +....|.|++|+--.++.-|-+|-..
T Consensus       388 ~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~~~~~ap~~pPr~~  432 (829)
T KOG0576|consen  388 RTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVSAIQMAPGLPPRSS  432 (829)
T ss_pred             ccCCCCCCCCCchhhcccc-cccCCCccCCCcchhhcCCCCCCCCC
Confidence            6778899999999886655 78889999999887777777776543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.42  E-value=2.7e-06  Score=73.96  Aligned_cols=74  Identities=19%  Similarity=0.187  Sum_probs=49.4

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC--eeecceeEEecCCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      ++.|+.|..+.||++....  ..+++|.....  .....+|..+++.+....  +.+++....  ........+++|+++
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~--~~~~~~~~~~~~~~i   77 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDT--SDEFNGFPYLLMEYI   77 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEE--ETEETSEEEEEEEEE
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecc--cccccccceEEEEEe
Confidence            4678999999999998643  58999987554  355668888888885333  344443221  122233468899998


Q ss_pred             cc
Q 017452          152 PE  153 (371)
Q Consensus       152 ~~  153 (371)
                      +|
T Consensus        78 ~g   79 (239)
T PF01636_consen   78 PG   79 (239)
T ss_dssp             SS
T ss_pred             cc
Confidence            86

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.39  E-value=4.3e-06  Score=72.48  Aligned_cols=69  Identities=17%  Similarity=0.149  Sum_probs=45.5

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCe--eecceeEEecCCCCceeEEEeecccc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV--VSLKHCFFSTTDKDELYLNLVLEYVP  152 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~ni--v~~~~~~~~~~~~~~~~~~lv~e~~~  152 (371)
                      ..||+|..+.||+.    .|..+++|.....  .....+|.++++.+..-.+  .++++..     .......+||++++
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~-----~~~~~~glv~e~i~   77 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLV-----EDGGRLGLIYELIV   77 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEE-----ecCCeeeeeeeecC
Confidence            56899999999984    2556889987542  3456789999988854333  3333333     22222467999998


Q ss_pred             ch
Q 017452          153 ET  154 (371)
Q Consensus       153 ~~  154 (371)
                      |.
T Consensus        78 G~   79 (226)
T TIGR02172        78 GK   79 (226)
T ss_pred             Cc
Confidence            83

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=5.2e-06  Score=67.26  Aligned_cols=127  Identities=19%  Similarity=0.286  Sum_probs=84.8

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeee-cceeEEecCCCCceeEEEeec
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVS-LKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~-~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      -++.+.||+|.+|.||++.+  .|..+|+|+-..+  +..++.|.++|..++..++-. +|.+-   .      .++.||
T Consensus        24 ~~v~~~L~KG~~s~Vyl~~~--~~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg---~------~~i~me   92 (201)
T COG2112          24 LRVEKELAKGTTSVVYLGEW--RGGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYG---E------DFIRME   92 (201)
T ss_pred             hhhhhhhhcccccEEEEeec--cCceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEec---h------hhhhhh
Confidence            35667899999999999987  6779999977543  566788999999998666543 22211   1      246799


Q ss_pred             cccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccC-CCceeeeCCCCcEEEEeeCCccc
Q 017452          150 YVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIK-PQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       150 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlk-p~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+.| .|.+....       .+.+.    +..+++.---|-. +||-|+.|. |..+++.+++ .+.|+||..|+.
T Consensus        93 ~i~G~~L~~~~~~-------~~rk~----l~~vlE~a~~LD~-~GI~H~El~~~~k~vlv~~~-~~~iIDFd~At~  155 (201)
T COG2112          93 YIDGRPLGKLEIG-------GDRKH----LLRVLEKAYKLDR-LGIEHGELSRPWKNVLVNDR-DVYIIDFDSATF  155 (201)
T ss_pred             hhcCcchhhhhhc-------ccHHH----HHHHHHHHHHHHH-hccchhhhcCCceeEEecCC-cEEEEEccchhh
Confidence            9998 44443321       12222    2345555333443 599999885 5555555555 799999999873

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.26  E-value=7.7e-06  Score=78.45  Aligned_cols=138  Identities=19%  Similarity=0.272  Sum_probs=81.5

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecchhhh-----------------------------------------HHHH
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----------------------------------------NREL  115 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-----------------------------------------~~e~  115 (371)
                      +.||..+.|.||+|+.+ +|+.||||+-...-+..                                         .+|.
T Consensus       167 ~piaaASlaQVhrA~L~-~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLK-NGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEec-CCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            56899999999999955 59999999764321100                                         0222


Q ss_pred             HH----HHHcCCCC---eeecceeEEecCCCCceeEEEeeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHH
Q 017452          116 QT----MRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY  187 (371)
Q Consensus       116 ~~----l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  187 (371)
                      +-    .+.+.|-+   -|.+-.+|+.-..    .-.++||||+|- +.++ ....  ...++...+..-+.+...-.- 
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st----~RVLtME~~~G~~i~Dl-~~i~--~~gi~~~~i~~~l~~~~~~qI-  317 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLST----KRVLTMEYVDGIKINDL-DAID--KRGISPHDILNKLVEAYLEQI-  317 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcCc----ceEEEEEecCCccCCCH-HHHH--HcCCCHHHHHHHHHHHHHHHH-
Confidence            22    22234544   2334444433222    257999999972 2222 1111  244555544433333222222 


Q ss_pred             HHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCccccc
Q 017452          188 IHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       188 LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a~~~~  225 (371)
                      ++ . |++|+|-.|.||++.+   .+..+.+-|||+.....
T Consensus       318 f~-~-GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is  356 (538)
T KOG1235|consen  318 FK-T-GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS  356 (538)
T ss_pred             Hh-c-CCccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence            22 3 9999999999999984   24589999999987653

>PLN02876 acyl-CoA dehydrogenase

Probab=98.11  E-value=3.8e-05  Score=79.31  Aligned_cols=77  Identities=18%  Similarity=0.186  Sum_probs=49.7

Q ss_pred             eEeeccCCceEEEEEEECCCC--cEEEEEEeec-----chhhhHHHHHHHHHcC-CCCe--eecceeEEecCCCCceeEE
Q 017452           76 ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTMRLLD-HPNV--VSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~--~~vaiK~~~~-----~~~~~~~e~~~l~~l~-h~ni--v~~~~~~~~~~~~~~~~~~  145 (371)
                      .+.++.|.+..+|+......+  ..+++|+...     ......+|+.+++.+. |.++  .+++..+.  +.......|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~--d~~v~G~~f  120 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCT--DASVIGTAF  120 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEec--CCCcCCCce
Confidence            467899999999998764332  4678887643     2245678999999995 6664  44433321  111123357


Q ss_pred             Eeeccccch
Q 017452          146 LVLEYVPET  154 (371)
Q Consensus       146 lv~e~~~~~  154 (371)
                      +||||++|.
T Consensus       121 lVME~v~G~  129 (822)
T PLN02876        121 YIMEYLEGR  129 (822)
T ss_pred             EEEEecCCc
Confidence            899999874

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.06  E-value=0.00014  Score=60.97  Aligned_cols=126  Identities=25%  Similarity=0.348  Sum_probs=87.0

Q ss_pred             cceeeeEeeccCCc-eEEEEEEECCCCcEEEEEEeec-----c---------h-----------hhhHHHHHHHH---Hc
Q 017452           71 ISYMAERIVGQGSF-GVVFQAKCLETGETVAIKKVLQ-----D---------K-----------RYKNRELQTMR---LL  121 (371)
Q Consensus        71 ~~y~~~~~lg~G~~-g~V~~~~~~~~~~~vaiK~~~~-----~---------~-----------~~~~~e~~~l~---~l  121 (371)
                      .+++..+.||.|.. |.||++..  .|+.||+|++..     .         .           ..+..|.....   .+
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I--~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEI--DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEE--CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            57999999999999 99999987  788999998311     0         0           11224555444   44


Q ss_pred             CCCCe--eecceeEEecCC-------------CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHH
Q 017452          122 DHPNV--VSLKHCFFSTTD-------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS  186 (371)
Q Consensus       122 ~h~ni--v~~~~~~~~~~~-------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~  186 (371)
                      .+.++  |+++++.....+             .......||.||+...-            .+....    +.+|.+-+.
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~~~----~~~~~~dl~  178 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQIRD----IPQMLRDLK  178 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccchhH----HHHHHHHHH
Confidence            56666  888887755421             12233467888877531            122222    347888899


Q ss_pred             HHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       187 ~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+|.. ||+-+|+++.|..      .-+|+|||.+
T Consensus       179 ~~~k~-gI~~~Dv~~~ny~------~G~lvDfs~~  206 (207)
T PF13095_consen  179 ILHKL-GIVPRDVKPRNYR------GGKLVDFSSS  206 (207)
T ss_pred             HHHHC-CeeeccCcccccc------CCEEEecccC
Confidence            99975 9999999999986      3489999965

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=98.01  E-value=5e-05  Score=68.64  Aligned_cols=138  Identities=16%  Similarity=0.214  Sum_probs=96.1

Q ss_pred             eeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------------------------------hhhhHHHHHHHHHcCC
Q 017452           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------------------------KRYKNRELQTMRLLDH  123 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------------------------~~~~~~e~~~l~~l~h  123 (371)
                      .+..+|..|--+.||.|. ..+|..+|||+++-.                              .-..++|+.-|++|..
T Consensus       147 ~inGCiSTGKEANVYHat-~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~  225 (520)
T KOG2270|consen  147 EINGCISTGKEANVYHAT-EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNN  225 (520)
T ss_pred             ecccccccCccceeEeee-cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHh
Confidence            345567888899999998 678889999987421                              1223468888888865


Q ss_pred             CCeeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       124 ~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                      ..|..---+.+. .      ..|||++++..-   +....-....++...+..+-.|++.-+.-|-+.+++||.||.--|
T Consensus       226 aGIP~PePIlLk-~------hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN  295 (520)
T KOG2270|consen  226 AGIPCPEPILLK-N------HVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFN  295 (520)
T ss_pred             cCCCCCCceeee-c------ceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhh
Confidence            554332222211 1      258999998420   011111134567777888888999999998888899999999999


Q ss_pred             eeeeCCCCcEEEEeeCCcccc
Q 017452          204 LLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~~~  224 (371)
                      +|+.. | .+.|+|.+.+...
T Consensus       296 ~Lyhd-G-~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  296 LLYHD-G-KLYIIDVSQSVEH  314 (520)
T ss_pred             heEEC-C-EEEEEEccccccC
Confidence            99974 4 7999999987654

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.01  E-value=7.3e-05  Score=65.67  Aligned_cols=68  Identities=18%  Similarity=0.127  Sum_probs=41.4

Q ss_pred             eccCCc-eEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEEeeccccc
Q 017452           79 VGQGSF-GVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (371)
Q Consensus        79 lg~G~~-g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (371)
                      |-.|.. ..||++..  .+..+.+|+.... .....+|+++++.+. +--+.+++.+...     ....++||++++|
T Consensus         6 ~~~g~~~~~v~~~~~--~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~lv~e~i~G   76 (244)
T cd05150           6 VTEGQSGATVYRLDG--KNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSD-----DGRAWLLTSAVPG   76 (244)
T ss_pred             cCCCCCcCeEEEEcC--CCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEec-----CCccEEEEEeeCC
Confidence            344444 78999964  3467888876432 234567999988884 3223344443311     1235689999987

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.92  E-value=0.00022  Score=60.13  Aligned_cols=126  Identities=21%  Similarity=0.337  Sum_probs=82.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecch--------------------hhhHHHHHHHHHcC------CCCeeecc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------------------RYKNRELQTMRLLD------HPNVVSLK  130 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--------------------~~~~~e~~~l~~l~------h~niv~~~  130 (371)
                      ..||+|+.-.||.--   ......||+.....                    ....+|+.....+.      +.+|.+++
T Consensus         7 ~~i~~G~~R~cy~HP---~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQHP---DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEECC---CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            568999999998654   34557888875544                    34456777666665      77888888


Q ss_pred             eeEEecCCCCceeEEEeecccc---c----hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          131 HCFFSTTDKDELYLNLVLEYVP---E----TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~---~----~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                      +...     .+.-..+|+|.+.   |    +|.+++.     ...+++ .+..   .+-+-..+|-++ +|+.+|++|.|
T Consensus        84 G~ve-----T~~G~Glv~e~I~d~dG~~s~TL~~~l~-----~~~~~~-~~~~---~L~~f~~~l~~~-~Iv~~dl~~~N  148 (199)
T PF10707_consen   84 GFVE-----TNLGLGLVVELIRDADGNISPTLEDYLK-----EGGLTE-ELRQ---ALDEFKRYLLDH-HIVIRDLNPHN  148 (199)
T ss_pred             EEEe-----cCCceEEEEEEEECCCCCcCccHHHHHH-----cCCccH-HHHH---HHHHHHHHHHHc-CCeecCCCccc
Confidence            8763     2223567777654   3    5555553     355666 3333   334445566665 99999999999


Q ss_pred             eeeeCC--CC-cEEEEe-eCC
Q 017452          204 LLVNPH--TH-QVKLCD-FGS  220 (371)
Q Consensus       204 Ili~~~--~~-~~kl~D-fg~  220 (371)
                      |++...  +. .+.|+| ||.
T Consensus       149 Iv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  149 IVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             EEEEecCCCceEEEEEeCCCC
Confidence            999533  22 577888 443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.88  E-value=0.00025  Score=61.91  Aligned_cols=69  Identities=19%  Similarity=0.305  Sum_probs=43.8

Q ss_pred             eEeeccCCceEEEEEEECC-CCcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeEEEeecc
Q 017452           76 ERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .+.|..|-...+|++.... .+..|++|+.....   ...++|+.+++.+....+ ++++...     .+    .++|||
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~-----~~----~~l~e~   73 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATF-----QN----GLIYEF   73 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEe-----CC----cEEEEe
Confidence            4567888888999987432 35789999775432   223478888888854333 3333221     11    369999


Q ss_pred             ccc
Q 017452          151 VPE  153 (371)
Q Consensus       151 ~~~  153 (371)
                      ++|
T Consensus        74 i~G   76 (235)
T cd05157          74 IPG   76 (235)
T ss_pred             eCC
Confidence            876

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.87  E-value=9.9e-05  Score=65.39  Aligned_cols=132  Identities=18%  Similarity=0.253  Sum_probs=72.7

Q ss_pred             eccCCceEEEEEEECCCCcEEEEEEeecchh----hhHHHHHHHHHcCCCCee-ecceeEEecCCCCceeEEEeeccccc
Q 017452           79 VGQGSFGVVFQAKCLETGETVAIKKVLQDKR----YKNRELQTMRLLDHPNVV-SLKHCFFSTTDKDELYLNLVLEYVPE  153 (371)
Q Consensus        79 lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~----~~~~e~~~l~~l~h~niv-~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (371)
                      +..|-...+|+..  .++..+++|.......    ...+|..+++.+....++ +++...     .    -++||+|++|
T Consensus         4 ~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~-----~----~~~v~e~i~G   72 (256)
T TIGR02721         4 LSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN-----E----HWLLVEWLEG   72 (256)
T ss_pred             CCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe-----C----CEEEEEeccC
Confidence            4567777889886  3567888997643322    346789999988643332 222221     1    1478999886


Q ss_pred             hHHH------------HHHHhhhc------cCCCCH-HHHHHHHHHH---------HHHHHHHHh-------cCCcEeec
Q 017452          154 TVHR------------VVKHFNKL------NQRMPM-IYVKLYAYQI---------FRALSYIHR-------SIGVCHRD  198 (371)
Q Consensus       154 ~l~~------------~~~~~~~~------~~~~~~-~~~~~i~~qi---------~~~l~~LH~-------~~~ivH~d  198 (371)
                      ...+            +.....+.      ..+++. ..+..+..++         ...+..+-.       ...++|+|
T Consensus        73 ~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~D  152 (256)
T TIGR02721        73 EVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMD  152 (256)
T ss_pred             cccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCC
Confidence            2211            11111111      111111 1112221111         111222211       12589999


Q ss_pred             cCCCceeeeCCCCcEEEEeeCCccc
Q 017452          199 IKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       199 lkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +.|.||+++.++  +.|+||+.+..
T Consensus       153 l~~~Nil~~~~~--~~lIDwE~a~~  175 (256)
T TIGR02721       153 VHAYNLVVTPQG--LKLIDWEYASD  175 (256)
T ss_pred             CCcCcEEEeCCC--CEEEeccccCc
Confidence            999999999765  78999998864

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.84  E-value=0.00019  Score=62.72  Aligned_cols=30  Identities=37%  Similarity=0.476  Sum_probs=25.0

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|+|+.+.||+++.++ ..-|+||+.+..
T Consensus       165 ~l~HGD~~~~Nvlv~~~~-i~giIDw~~a~~  194 (235)
T cd05155         165 VWFHGDLAPGNLLVQDGR-LSAVIDFGCLGV  194 (235)
T ss_pred             eEEeCCCCCCcEEEECCC-EEEEEeCcccCc
Confidence            589999999999998654 557999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.73  E-value=4.4e-05  Score=67.89  Aligned_cols=130  Identities=16%  Similarity=0.168  Sum_probs=86.1

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEee----------cc----------------hhhhHHHHHHHHHcC-CC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----------QD----------------KRYKNRELQTMRLLD-HP  124 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~----------~~----------------~~~~~~e~~~l~~l~-h~  124 (371)
                      -|.++++||-|--+.||.+-+ ..|.+.++|.=.          ..                +-...+|+..|+.|. |.
T Consensus        93 v~svGnqIGVGKESDIY~v~d-~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVAD-EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEec-CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            478899999999999999985 568888888321          11                112236888888773 32


Q ss_pred             C-eeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCc
Q 017452          125 N-VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN  203 (371)
Q Consensus       125 n-iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~N  203 (371)
                      . +.+.++         ....++|||++.|--...+.      ...+   +..+...+..-+..|..+ |+||+|++-=|
T Consensus       172 fpVPkpiD---------~~RH~Vvmelv~g~Pl~~v~------~v~d---~~~ly~~lm~~Iv~la~~-GlIHgDFNEFN  232 (465)
T KOG2268|consen  172 FPVPKPID---------HNRHCVVMELVDGYPLRQVR------HVED---PPTLYDDLMGLIVRLANH-GLIHGDFNEFN  232 (465)
T ss_pred             CCCCCccc---------ccceeeHHHhhcccceeeee------ecCC---hHHHHHHHHHHHHHHHHc-Cceecccchhe
Confidence            2 222222         22357999999873222111      1122   223334555566667776 99999999999


Q ss_pred             eeeeCCCCcEEEEeeCCcc
Q 017452          204 LLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       204 Ili~~~~~~~kl~Dfg~a~  222 (371)
                      |+++.++ .++++||-...
T Consensus       233 imv~dd~-~i~vIDFPQmv  250 (465)
T KOG2268|consen  233 IMVKDDD-KIVVIDFPQMV  250 (465)
T ss_pred             eEEecCC-CEEEeechHhh
Confidence            9999877 89999997543

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.72  E-value=0.0011  Score=61.95  Aligned_cols=71  Identities=21%  Similarity=0.335  Sum_probs=46.3

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeec-----------chhhhHHHHHHHHHcC---CCCeeecceeEEecCCCCc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~  141 (371)
                      .+.||.|.+..||++.....++.++||.-..           .......|.+.|+.+.   ..++++++++.     .. 
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~D-----~~-  104 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHYD-----EE-  104 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEEC-----CC-
Confidence            3578999999999999754335899997421           1223456777787763   24566665542     21 


Q ss_pred             eeEEEeeccccc
Q 017452          142 LYLNLVLEYVPE  153 (371)
Q Consensus       142 ~~~~lv~e~~~~  153 (371)
                       ..++|||++++
T Consensus       105 -~~~lVME~L~~  115 (401)
T PRK09550        105 -LAVTVMEDLSD  115 (401)
T ss_pred             -CCEEEEecCCC
Confidence             14689999874

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.68  E-value=0.00013  Score=61.09  Aligned_cols=101  Identities=22%  Similarity=0.208  Sum_probs=75.4

Q ss_pred             HHHHHHHHHcCC-CCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH
Q 017452          112 NRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH  189 (371)
Q Consensus       112 ~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH  189 (371)
                      ..|.-+++.+++ ++++++++++     .    -+++.||.+. ++....... ..-...++....+|+.++++.+++|+
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~C-----G----~~~v~E~~~~~~~~~~~~~l-~~~~~~~w~~R~~iA~~lL~~l~~l~   76 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSC-----G----RFYVVEYVGAGSLYGIYRPL-SQFLQSPWEQRAKIALQLLELLEELD   76 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeEC-----C----CEEEEEeecCcccccccccc-ccccccCHHHHHHHHHHHHHHHHHHh
Confidence            358888999976 6899998887     2    2568999884 332210000 00134588899999999999999999


Q ss_pred             h---cCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          190 R---SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       190 ~---~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      .   . .+.-.|++|+|+-++.++ ++|++|.+.+...
T Consensus        77 ~~~~~-~~~lcDv~~~nfgv~~~~-~lk~iDld~v~~~  112 (188)
T PF12260_consen   77 HGPLG-FFYLCDVSPDNFGVNDDG-RLKLIDLDDVFVE  112 (188)
T ss_pred             cCCCC-cEEEeecchHHeEEeCCC-cEEEEechhcchh
Confidence            6   3 478889999999999887 8999999976543

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK10593 hypothetical protein; Provisional

Probab=97.62  E-value=0.0014  Score=59.41  Aligned_cols=76  Identities=8%  Similarity=0.041  Sum_probs=49.8

Q ss_pred             eeeEeeccCCceEEEEEEECCCCcEEEEEEeec--chhhhHHHHHHHHHcCCC---CeeecceeEEecCCCCceeEEEee
Q 017452           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHP---NVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~---niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .-.+.||+|..+.||+... .++ .+++|..+.  .......|.+.|+.+...   .+.++++.+...  ......++||
T Consensus        17 ~~~~~i~~G~~~~vy~~~~-~~~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~--~~~g~~~LVm   92 (297)
T PRK10593         17 SRVECISEQPYAALWALYD-SQG-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHE--QSPGPDVLLL   92 (297)
T ss_pred             heeeecCCccceeEEEEEc-CCC-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccC--CcCCCeEEEE
Confidence            3456799999999999864 233 467777544  235778999999988542   455555543221  1123357999


Q ss_pred             ccccc
Q 017452          149 EYVPE  153 (371)
Q Consensus       149 e~~~~  153 (371)
                      |+++|
T Consensus        93 E~i~G   97 (297)
T PRK10593         93 ERLRG   97 (297)
T ss_pred             eccCC
Confidence            99886

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.56  E-value=0.0011  Score=60.53  Aligned_cols=145  Identities=13%  Similarity=0.087  Sum_probs=76.6

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC--eeecceeEEec-CCCCceeEEEeecc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEY  150 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~  150 (371)
                      .+.++.|....+|++.. .+ ..+++|+....  ......|.+++..|....  +.+++...-.. ........+++++|
T Consensus        27 i~~~~~G~~n~~y~v~t-~~-~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTT-DV-GRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEe-CC-CcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            45567777788998863 33 46888987543  344556777777774322  23332211000 00112345789999


Q ss_pred             ccchH------------HHHHHHhhhccCCC--------C-HHH----HH----------HHHHHHHHHHHHHHh-----
Q 017452          151 VPETV------------HRVVKHFNKLNQRM--------P-MIY----VK----------LYAYQIFRALSYIHR-----  190 (371)
Q Consensus       151 ~~~~l------------~~~~~~~~~~~~~~--------~-~~~----~~----------~i~~qi~~~l~~LH~-----  190 (371)
                      ++|.-            ...+...-.....+        . ..+    ..          .....+...++++..     
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            87611            01111000000000        0 000    00          001123334555532     


Q ss_pred             -cCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          191 -SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       191 -~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                       ..+++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~-~~~vIDfd~~~~  217 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDS-VKGVIDFYFACT  217 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCc-eEEEeecccccC
Confidence             23899999999999999876 578999998743

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK05231 homoserine kinase; Provisional

Probab=97.47  E-value=0.0025  Score=58.34  Aligned_cols=30  Identities=30%  Similarity=0.304  Sum_probs=25.6

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||+|+.|.||+++.+. ..-|+||+.+..
T Consensus       188 ~liHgD~~~~Nil~~~~~-~~~iIDf~~~~~  217 (319)
T PRK05231        188 GVIHADLFRDNVLFEGDR-LSGFIDFYFACN  217 (319)
T ss_pred             ccCCCCCCCCcEEEECCc-eEEEEecccccC
Confidence            899999999999998654 458999998753

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.46  E-value=0.0014  Score=59.41  Aligned_cols=145  Identities=10%  Similarity=0.001  Sum_probs=77.3

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeec-chhhhHHHHHHHHHcCCCC--eeecceeEEec-CCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNRELQTMRLLDHPN--VVSLKHCFFST-TDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~-~~~~~~~~~lv~e~~  151 (371)
                      .+.+..|....+|+...  ++..+++|+... .......|+.++..+.+..  +.+++...-.. ........+++++++
T Consensus        19 i~~i~~G~~n~~y~v~~--~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTT--DSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEe--CCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            45677787788998863  445789998763 3345567888888875333  33332211000 001112356899998


Q ss_pred             cchHH------------HHH---HHhhh-ccCC----CCHHHHHH------------HHHHHHHHHHHHHh------cCC
Q 017452          152 PETVH------------RVV---KHFNK-LNQR----MPMIYVKL------------YAYQIFRALSYIHR------SIG  193 (371)
Q Consensus       152 ~~~l~------------~~~---~~~~~-~~~~----~~~~~~~~------------i~~qi~~~l~~LH~------~~~  193 (371)
                      +|...            ..+   +.... ....    ....+...            ....+..++.++..      ..+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            75211            111   11000 0000    00011000            11112233444432      137


Q ss_pred             cEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|+|+.|.||+++.++ .+.|+||+.+..
T Consensus       177 l~HgD~~~~Nil~~~~~-~~~iIDfe~a~~  205 (296)
T cd05153         177 VIHADLFRDNVLFDGDE-LSGVIDFYFACT  205 (296)
T ss_pred             CCccCcCcccEEEeCCc-eEEEeehhhhcC
Confidence            99999999999999765 568999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.30  E-value=0.0063  Score=55.26  Aligned_cols=30  Identities=30%  Similarity=0.542  Sum_probs=26.3

Q ss_pred             CCcEeeccCCCceeeeCC----CCcEEEEeeCCcc
Q 017452          192 IGVCHRDIKPQNLLVNPH----THQVKLCDFGSAK  222 (371)
Q Consensus       192 ~~ivH~dlkp~NIli~~~----~~~~kl~Dfg~a~  222 (371)
                      ..++|+|+.+.||+++.+    + .+.++||..|.
T Consensus       179 ~~lcH~Dl~~~Nil~~~~~~~~~-~i~lIDwEya~  212 (302)
T cd05156         179 VVFCHNDLQEGNILLLNPSSETK-KLVLIDFEYAS  212 (302)
T ss_pred             ceEEecCCCcCeEEecCCCCCCC-cEEEEeeCCCC
Confidence            368999999999999874    5 79999999885

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.24  E-value=0.00059  Score=64.44  Aligned_cols=164  Identities=19%  Similarity=0.224  Sum_probs=98.7

Q ss_pred             HHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 017452          113 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI  192 (371)
Q Consensus       113 ~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  192 (371)
                      --+.+++.+.|+|...+++.--    .......+|||+++.++.+.+....     +-..       ++.       .+ 
T Consensus        31 gr~~~lktl~~~~l~~yl~~~r----~~~~r~IVV~e~~~~Sled~~~~~~-----l~~~-------s~~-------~~-   86 (725)
T KOG1093|consen   31 GRFQYLKSLQHDNLCQYLDFSR----GKHERVIVVMEHYTMSLEDILKTGN-----LKDE-------SLL-------AH-   86 (725)
T ss_pred             hhhHHHHhhcCccceeeEeeec----CccceEEEEehhhccchHHHHHhcc-----cchh-------hhc-------cc-
Confidence            3577888899999998876542    2222367899999999888776421     1111       111       11 


Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCC
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP  272 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~  272 (371)
                      ++.|-     |        .++++| .++..               |  |-.      ..+++||||+|.++.++..|..
T Consensus        87 ~~~~~-----~--------~~~~td-~~~t~---------------~--~~~------~~pKsdVwsl~~i~~el~L~~~  129 (725)
T KOG1093|consen   87 GVLHL-----N--------IIYITD-HFLTK---------------Y--PSP------IGPKSDVWSLGFIILELYLGIS  129 (725)
T ss_pred             cccee-----h--------hhhccc-ccccc---------------C--CCC------CCcchhhhhHHHHHHHHHHhhH
Confidence            33332     1        234444 11100               0  111      1259999999999999999988


Q ss_pred             CCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          273 LFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       273 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                      .+......+....+.+....+.....-.+..                 .+.-.++..+.+++.+|+...|..||...++.
T Consensus       130 l~~~~~~s~~l~~i~k~~~~d~~~~~~a~e~-----------------~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~  192 (725)
T KOG1093|consen  130 LEAELTESEYLEILLKYYTDDQELLSTAMEH-----------------LIQLLADKKRLPLLKKCLWLEPIIRPLPMELS  192 (725)
T ss_pred             HHHHHHHHHHHHHHHHhccCchhHHHHHHHH-----------------HHHHhhhHhHHHHhccCCccccccccchhHHh
Confidence            7776666666555555433222211110000                 01122567788999999999999999888877


Q ss_pred             hh
Q 017452          353 IL  354 (371)
Q Consensus       353 ~~  354 (371)
                      ++
T Consensus       193 k~  194 (725)
T KOG1093|consen  193 KR  194 (725)
T ss_pred             cC
Confidence            76

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.23  E-value=0.0073  Score=55.52  Aligned_cols=29  Identities=24%  Similarity=0.304  Sum_probs=24.8

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|||+.+.||+++.++  ++++|+..+..
T Consensus       193 ~llHGDl~~gNi~~~~~~--~~~iD~e~~~~  221 (370)
T TIGR01767       193 TLLHGDLHSGSIFVSEHE--TKVIDPEFAFY  221 (370)
T ss_pred             eeeeccCCcccEEEcCCC--CEEEcCccccc
Confidence            689999999999998654  88999987754

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.10  E-value=0.0024  Score=57.12  Aligned_cols=31  Identities=29%  Similarity=0.531  Sum_probs=25.6

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|+|++|.||+++.++...-|+||+.+..
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            4899999999999997553456999998864

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.04  E-value=0.013  Score=53.28  Aligned_cols=29  Identities=31%  Similarity=0.600  Sum_probs=25.1

Q ss_pred             CCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       192 ~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+++|||+.+.||+++. + .+.|+||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~-~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-N-EVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-C-cEEEEECcccc
Confidence            37999999999999987 4 68999999764

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PLN02236 choline kinase

Probab=97.00  E-value=0.0072  Score=55.94  Aligned_cols=31  Identities=26%  Similarity=0.649  Sum_probs=26.6

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|+|+++.||+++.+...+.|+||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999986544799999998854

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.96  E-value=0.0022  Score=58.22  Aligned_cols=76  Identities=17%  Similarity=0.287  Sum_probs=62.4

Q ss_pred             CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .+..|.|++|++.++.+...        ..-..+++..++++.+..+.-+..+..+-|||+...||||+ +| +|.|+||
T Consensus       296 de~~y~yl~~kdhgt~is~i--------k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~G-nvtLIDf  365 (488)
T COG5072         296 DETLYLYLHFKDHGTPISII--------KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EG-NVTLIDF  365 (488)
T ss_pred             CCceEEEEEEecCCceeeee--------ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cC-ceEEEEe
Confidence            45678899999988764321        22356778889999999999998888899999999999999 77 8999999


Q ss_pred             CCcccc
Q 017452          219 GSAKVL  224 (371)
Q Consensus       219 g~a~~~  224 (371)
                      -+++..
T Consensus       366 klsRl~  371 (488)
T COG5072         366 KLSRLS  371 (488)
T ss_pred             eeeecc
Confidence            999854

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.89  E-value=0.012  Score=54.18  Aligned_cols=30  Identities=23%  Similarity=0.411  Sum_probs=26.0

Q ss_pred             cEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|+|+.+.||+++++++.++++||..|..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999986544899999998854

>PRK12396 5-methylribose kinase; Reviewed

Probab=96.85  E-value=0.017  Score=53.82  Aligned_cols=70  Identities=17%  Similarity=0.167  Sum_probs=44.2

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeec----------chhhhHHHHHHHHHcC--CC-CeeecceeEEecCCCCce
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----------DKRYKNRELQTMRLLD--HP-NVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----------~~~~~~~e~~~l~~l~--h~-niv~~~~~~~~~~~~~~~  142 (371)
                      .+.||.|.-..||++.+...++.++||.-..          +.....-|.+.|+...  .| ++++++.+-      ...
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~D------~e~  107 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLFD------SVM  107 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEEC------cHH
Confidence            5678999999999999743356799985421          1233345777777653  23 455554422      111


Q ss_pred             eEEEeecccc
Q 017452          143 YLNLVLEYVP  152 (371)
Q Consensus       143 ~~~lv~e~~~  152 (371)
                       ..+|||+++
T Consensus       108 -~~~vMEdL~  116 (409)
T PRK12396        108 -NCCVMEDLS  116 (409)
T ss_pred             -hhHHHHhCc
Confidence             357999885

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.83  E-value=0.019  Score=52.05  Aligned_cols=30  Identities=27%  Similarity=0.515  Sum_probs=27.3

Q ss_pred             cEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++|||+.+.|+++++++ -+-|+||+.+..-
T Consensus       200 lvHGD~~~gNlii~~~~-~~gVlDwe~~~lG  229 (321)
T COG3173         200 LVHGDYRPGNLIIDPGR-PTGVLDWELATLG  229 (321)
T ss_pred             eeeCCcccCCEEEeCCC-eeEEEeccccccC
Confidence            89999999999999988 5999999998753

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=96.75  E-value=0.022  Score=51.94  Aligned_cols=30  Identities=13%  Similarity=0.199  Sum_probs=27.0

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++|+|+.+.||+++.++ .+.++||..+..
T Consensus       197 ~lcHgD~~~~Nvl~~~~~-~~~iIDfd~~~~  226 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETR-GGYFINFEKASF  226 (309)
T ss_pred             eeeCCCCcHHhEEEcCCC-CEEEEEhhhccc
Confidence            799999999999999887 799999998754

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=96.71  E-value=0.00035  Score=73.58  Aligned_cols=156  Identities=14%  Similarity=0.007  Sum_probs=101.9

Q ss_pred             HHHHHHHcCCCCeeecceeEEecCCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 017452          114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI  192 (371)
Q Consensus       114 e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~  192 (371)
                      |...++...|+++...+.-.   ........+..++|+. |.+...+..-......+...-+.....+.+.+..-.|..-
T Consensus      1279 e~de~~~~~h~~~~~~p~rI---~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1279 ERDELREAKHYLTEVDPLRI---PPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhceeeecccccC---CCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcc
Confidence            34455567898887765433   2233333567888887 4555555443332333334434444444355566655432


Q ss_pred             C----cEeeccCCCceeeeCCCCcEEEEeeCCcccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHH
Q 017452          193 G----VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       193 ~----ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  267 (371)
                      +    -+|++||+-|.+|..+. .++++++|+.+...+ ........+++.|+.|+... ...++.++|+|..|+.+|..
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny-~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~r 1433 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNY-NVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLR 1433 (2724)
T ss_pred             cCCccchhhhhhhhccceecCC-cccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHH
Confidence            3    58999999999999888 899999999984322 22233456788899998774 34477789999999999998


Q ss_pred             HhCCCCC
Q 017452          268 MLGKPLF  274 (371)
Q Consensus       268 ltg~~pf  274 (371)
                      .-|..+|
T Consensus      1434 s~~n~~f 1440 (2724)
T KOG1826|consen 1434 SDGNAYF 1440 (2724)
T ss_pred             hcccHHH
Confidence            8776554

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.63  E-value=0.015  Score=52.15  Aligned_cols=72  Identities=14%  Similarity=0.143  Sum_probs=43.0

Q ss_pred             eeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceeEEecCCCCceeEEEeec
Q 017452           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +-.+.++.|....+|+..  .+++.+.||+-... ...+..|.+-|+.|.   --.+.++++......   .  -+++||
T Consensus        20 ~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~---~--~fLlle   92 (288)
T PF03881_consen   20 TSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD---D--AFLLLE   92 (288)
T ss_dssp             -EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS---C--CEEEEE
T ss_pred             eeeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC---C--ceEEEE
Confidence            345678889999999987  57788999977643 445678998888883   233555555442221   1  378999


Q ss_pred             ccc
Q 017452          150 YVP  152 (371)
Q Consensus       150 ~~~  152 (371)
                      |++
T Consensus        93 ~l~   95 (288)
T PF03881_consen   93 FLE   95 (288)
T ss_dssp             ---
T ss_pred             eec
Confidence            986

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.37  E-value=0.099  Score=49.11  Aligned_cols=70  Identities=19%  Similarity=0.242  Sum_probs=44.2

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeec-----------chhhhHHHHHHHHHcC---CCCeeecceeEEecCCCC
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  140 (371)
                      ..+.||.|....||+..+  .+..++||.-..           .......|.+.|+.+.   ..++.+++.+.     .+
T Consensus        36 ~~~eiggGn~N~VyrV~~--~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~d-----ed  108 (418)
T PLN02756         36 KIKEVGDGNLNFVYIVVS--SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFD-----RT  108 (418)
T ss_pred             eEEEcCCCceeeEEEEEc--CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEEC-----CC
Confidence            367789999999999986  345688996531           2223345666666653   23566665544     21


Q ss_pred             ceeEEEeeccccc
Q 017452          141 ELYLNLVLEYVPE  153 (371)
Q Consensus       141 ~~~~~lv~e~~~~  153 (371)
                      .  .+++||++++
T Consensus       109 ~--~vlvME~L~~  119 (418)
T PLN02756        109 M--ALIGMRYLEP  119 (418)
T ss_pred             C--CEEEEeecCC
Confidence            1  3578998865

>PTZ00384 choline kinase; Provisional

Probab=95.98  E-value=0.2  Score=46.98  Aligned_cols=30  Identities=27%  Similarity=0.370  Sum_probs=25.0

Q ss_pred             CCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       192 ~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ...+|.|+-+.||+.+.+  .+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~~--~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFNQ--GIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecCC--CEEEEEeccccC
Confidence            368999999999998654  599999998754

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.82  E-value=0.14  Score=46.84  Aligned_cols=29  Identities=31%  Similarity=0.564  Sum_probs=25.4

Q ss_pred             cEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +||+|+.|.||+++.+...+.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            99999999999999876338899999875

>PRK11768 serine/threonine protein kinase; Provisional

Probab=95.49  E-value=0.3  Score=44.88  Aligned_cols=28  Identities=25%  Similarity=0.363  Sum_probs=23.8

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||+|+.+.||+++ +  .+.|+||+.+..
T Consensus       197 ~liHgD~h~~NvL~~-d--~~~iIDFDd~~~  224 (325)
T PRK11768        197 LRLHGDCHPGNILWR-D--GPHFVDLDDARM  224 (325)
T ss_pred             cceecCCCchhcccc-C--CcEEEeCCCCCC
Confidence            789999999999995 3  478999998753

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=95.39  E-value=0.047  Score=50.66  Aligned_cols=62  Identities=31%  Similarity=0.291  Sum_probs=40.9

Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                      ..++-+|..| ++...+..     ..-+++..+.++.-.++||.-+----+++|.|+.|.||++..+.
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~-----~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~~  382 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKW-----KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFNK  382 (565)
T ss_pred             ceeeeeccccccHHhhhhc-----ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEecC
Confidence            3466677776 55555542     44456666677766677766544323899999999999985443

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.49  E-value=0.06  Score=47.88  Aligned_cols=51  Identities=25%  Similarity=0.408  Sum_probs=37.9

Q ss_pred             HHHHHHHHHHHHHHHHHHhc-CCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          172 IYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       172 ~~~~~i~~qi~~~l~~LH~~-~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ..+...+..+-.++.-.+.. +-++|+|+.|+|++.++.+ .++|+||..|..
T Consensus       132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~-~l~LIDWEyAg~  183 (269)
T COG0510         132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKG-GLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCC-cEEEEecccCCC
Confidence            33444555666666666632 2489999999999999866 799999998854

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.27  E-value=0.039  Score=47.20  Aligned_cols=30  Identities=43%  Similarity=0.734  Sum_probs=20.1

Q ss_pred             CcEeeccCCCceee-eCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli-~~~~~~~kl~Dfg~a~~  223 (371)
                      -++|+|+.|.||++ +.++ .++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~-~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDG-EVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSS-CEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCC-eEEEecHHHHhh
Confidence            58999999999999 5455 899999998854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.03  E-value=0.047  Score=45.45  Aligned_cols=29  Identities=24%  Similarity=0.324  Sum_probs=25.1

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      -.+|+|+.|.||+++.++  ++|+||+.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~--~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG--LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC--EEEEeCCcccC
Confidence            469999999999998655  89999998864

>PF07914 DUF1679: Protein of unknown function (DUF1679); InterPro: IPR012877 This region is found in a number of Caenorhabditis elegans and Caenorhabditis briggsae proteins, in one case (Q19034 from SWISSPROT) as a repeat

Probab=93.85  E-value=0.07  Score=50.53  Aligned_cols=30  Identities=17%  Similarity=0.306  Sum_probs=24.1

Q ss_pred             cEeeccCCCceeeeCCCC----cEEEEeeCCccc
Q 017452          194 VCHRDIKPQNLLVNPHTH----QVKLCDFGSAKV  223 (371)
Q Consensus       194 ivH~dlkp~NIli~~~~~----~~kl~Dfg~a~~  223 (371)
                      ++||||...|||.+.++.    -..|+||-.+..
T Consensus       270 L~HGDLw~~NiLw~k~~~g~~~l~AIIDwQ~vh~  303 (414)
T PF07914_consen  270 LVHGDLWSSNILWDKDSDGKLKLKAIIDWQCVHR  303 (414)
T ss_pred             eecCCccHHheeeecCCchhHHHHHHHHHHHhhc
Confidence            799999999999988653    456888876644

In many of the family members, this region is associated with the CHK region described by SMART as being found in zinc finger-C4 and HLH domain-containing kinases. In fact, one member of this family (Q9GUC1 from SWISSPROT) is annotated as being a member of the nuclear hormone receptor family, and contains regions typical of such proteins (IPR000536 from INTERPRO, IPR008946 from INTERPRO, and IPR001628 from INTERPRO).

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	371
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-124
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		1e-124
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-124
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		1e-124
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-124
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-123
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-122
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-122
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-122
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-122
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-122
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-122
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-121
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-121
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-121
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		1e-121
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-121
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-120
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-120
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-119
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-118
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-116
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		9e-86
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		1e-77
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-42
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-42
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		6e-42
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-42
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		9e-42
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		1e-41
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-41
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-41
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-41
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-41
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		3e-41
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-41
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		3e-41
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-41
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-41
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		3e-41
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-41
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-41
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		3e-41
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-41
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-41
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		3e-41
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-41
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		3e-41
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		3e-41
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		3e-41
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-41
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-41
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		4e-41
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		6e-41
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		7e-41
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		7e-41
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		8e-41
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-40
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-40
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-40
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-40
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-40
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-40
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-40
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		7e-40
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		1e-39
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-39
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		2e-39
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-39
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		2e-39
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-39
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		3e-39
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-39
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		4e-39
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		4e-39
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		4e-39
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		5e-39
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		5e-39
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-39
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-39
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-39
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-39
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-39
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-39
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-39
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-39
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-38
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-38
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		2e-38
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		3e-38
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		3e-38
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-38
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-38
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-38
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		6e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-38
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		6e-38
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		8e-38
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-38
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-37
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		9e-37
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-36
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-36
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-36
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-35
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		8e-35
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-34
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-34
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-34
2oza_B	366	Structure Of P38alpha Complex Length = 366		1e-34
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-34
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-34
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-34
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-34
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-34
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-34
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-34
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-34
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		2e-34
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-34
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-34
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-34
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-34
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-34
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-34
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-34
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-34
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-34
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-34
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		4e-34
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-34
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		4e-34
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-34
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		4e-34
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		4e-34
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-34
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-34
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-34
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-34
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-34
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-34
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-34
3hec_A	348	P38 In Complex With Imatinib Length = 348		4e-34
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-34
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-34
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-34
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-34
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-34
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-34
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-34
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-34
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-34
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		5e-34
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		6e-34
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		6e-34
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		7e-34
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-33
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-33
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		1e-33
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		2e-33
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-33
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-33
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-33
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		5e-33
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-33
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-33
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		7e-33
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		8e-33
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		8e-33
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		3e-32
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-32
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-32
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-31
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		2e-30
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-30
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		3e-30
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		3e-30
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		4e-30
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		5e-30
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		6e-30
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-30
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		9e-30
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-29
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-29
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-29
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		2e-29
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		2e-29
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		2e-29
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-29
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		2e-29
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		2e-29
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		2e-29
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		2e-29
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-29
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		2e-29
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-29
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-29
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-29
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-29
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		8e-29
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-28
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		2e-28
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-28
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-28
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-28
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-28
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		8e-28
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-28
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		1e-27
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		1e-27
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		2e-27
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-27
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		8e-27
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-26
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		2e-26
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-26
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		2e-26
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		3e-26
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		4e-26
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		4e-26
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		4e-26
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		4e-26
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		4e-26
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		5e-26
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		5e-26
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		5e-26
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		5e-26
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		5e-26
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		5e-26
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		5e-26
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		5e-26
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		5e-26
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		5e-26
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		5e-26
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		6e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		6e-26
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		6e-26
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		6e-26
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		6e-26
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		7e-26
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		8e-26
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		9e-26
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-25
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		1e-25
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		1e-25
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		1e-25
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		4e-25
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		4e-25
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-25
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-25
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-24
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-24
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-23
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-23
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-23
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		6e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-22
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-22
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		4e-22
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		5e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		6e-22
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		7e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-21
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-21
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-21
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-21
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-21
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-21
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-21
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-21
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-21
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-21
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-21
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-21
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-21
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-21
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-20
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		2e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		4e-20
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-20
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-20
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-20
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		8e-20
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-19
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-19
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-19
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-19
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-19
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-19
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-19
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		2e-19
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-19
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-19
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-19
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-19
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-19
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-19
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-19
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-19
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		3e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		3e-19
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		3e-19
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-19
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-19
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-19
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		3e-19
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-19
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		4e-19
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-19
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		4e-19
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		4e-19
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		4e-19
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		4e-19
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		4e-19
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		4e-19
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		4e-19
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		4e-19
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		4e-19
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		4e-19
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-19
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-19
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		5e-19
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		5e-19
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		5e-19
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		5e-19
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		6e-19
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		6e-19
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		7e-19
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		7e-19
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-19
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		9e-19
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		1e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		1e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		1e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		1e-18
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		2e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-18
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		3e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		4e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-18
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		5e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-18
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		6e-18
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		7e-18
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		8e-18
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		8e-18
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-18
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-18
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-18
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		9e-18
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-18
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		9e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		1e-17
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-17
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		2e-17
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-17
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-17
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-17
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-17
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-17
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-17
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-17
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-17
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		5e-17
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		5e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		5e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		5e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		5e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		5e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		5e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		6e-17
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		6e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		6e-17
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		6e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		6e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		7e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		7e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		8e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-17
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		9e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-16
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-16
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-16
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-16
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-16
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		1e-16
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		1e-16
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-16
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-16
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		2e-16
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-16
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-16
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-16
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		3e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		4e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-16
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		5e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		5e-16
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		6e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		6e-16
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		7e-16
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		7e-16
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		7e-16
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		8e-16
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-15
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-15
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		1e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-15
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-15
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-15
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-15
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-15
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-15
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-15
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		4e-15
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-15
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		4e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-15
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		5e-15
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		6e-15
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		6e-15
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-15
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-15
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		7e-15
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		7e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		8e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-15
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		8e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		8e-15
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		8e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		8e-15
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-15
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		8e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		8e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		9e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		9e-15
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		9e-15
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-15
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		1e-14
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-14
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-14
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		2e-14
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-14
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-14
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-14
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-14
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-14
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-14
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-14
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-14
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-14
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-14
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-14
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		2e-14
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-14
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-14
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-14
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-14
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-14
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		3e-14
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-14
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-14
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		3e-14
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		3e-14
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-14
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-14
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-14
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		5e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		5e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		6e-14
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		6e-14
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		6e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		7e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		7e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		8e-14
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		8e-14
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		9e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		9e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		1e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		1e-13
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-13
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-13
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		1e-13
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-13
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-13
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-13
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		2e-13
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-13
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		2e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		3e-13
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		3e-13
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		3e-13
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		3e-13
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		3e-13
3soa_A	444	Full-Length Human Camkii Length = 444		4e-13
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		4e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		4e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		5e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		5e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		5e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		5e-13
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-13
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		6e-13
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		1e-12
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-12
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		1e-12
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-12
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-12
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		2e-12
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-12
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-12
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-12
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		3e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		3e-12
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		3e-12
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-12
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		3e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-12
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-12
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		5e-12
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		5e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		5e-12
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		5e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		5e-12
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		7e-12
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-12
3kk9_A	282	Camkii Substrate Complex B Length = 282		8e-12
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		8e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-12
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		9e-12
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-11
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		1e-11
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-11
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-11
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-11
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-11
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-11
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-11
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-11
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-11
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-11
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-11
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-11
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-11
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-11
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-11
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-11
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-11
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-11
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-11
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-11
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-11
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		3e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		4e-11
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		4e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		4e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		4e-11
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-11
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		5e-11
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-11
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-11
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		6e-11
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-11
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-11
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		8e-11
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-10
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		1e-10
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-10
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		1e-10
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-10
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-10
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		2e-10
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-10
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-10
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		3e-10
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		3e-10
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		3e-10
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		3e-10
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		3e-10
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		3e-10
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-10
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		3e-10
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		3e-10
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		3e-10
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		3e-10
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		3e-10
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-10
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		3e-10
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-10
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		3e-10
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		3e-10
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-10
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		3e-10
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		3e-10
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		3e-10
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		3e-10
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		3e-10
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-10
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		3e-10
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-10
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-10
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		3e-10
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		3e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-10
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		4e-10
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		4e-10
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		4e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-10
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		5e-10
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		6e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		7e-10
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		7e-10
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		7e-10
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		8e-10
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		8e-10
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		9e-10
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		9e-10
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		9e-10
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-09
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		1e-09
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-09
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		1e-09
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		1e-09
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		1e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-09
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-09
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		1e-09
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		1e-09
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		1e-09
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-09
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-09
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-09
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		2e-09
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		2e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		2e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		2e-09
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-09
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-09
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-09
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		4e-09
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-09
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		4e-09
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-09
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		4e-09
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		4e-09
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		4e-09
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		5e-09
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-09
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		5e-09
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-09
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-09
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		5e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-09
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-09
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		7e-09
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		7e-09
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		7e-09
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-09
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		7e-09
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		8e-09
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		8e-09
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		9e-09
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		9e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-09
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-08
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-08
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-08
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		1e-08
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-08
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-08
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-08
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-08
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		1e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		1e-08
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-08
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-08
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-08
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-08
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-08
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-08
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-08
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-08
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-08
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-08
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-08
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-08
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		2e-08
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		3e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-08
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-08
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-08
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		4e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		4e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		4e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		4e-08
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		4e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		4e-08
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-08
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		4e-08
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-08
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		5e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		7e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		7e-08
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		8e-08
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		9e-08
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		1e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		1e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		1e-07
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-07
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-07
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-07
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-07
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-07
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		2e-07
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		2e-07
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		3e-07
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-07
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-07
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		6e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		6e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		6e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		7e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		8e-07
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		1e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-06
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-06
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-06
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-06
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-06
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-06
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-06
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-06
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-06
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-06
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-06
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-06
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-06
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-06
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		4e-06
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-06
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-06
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-06
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-06
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		5e-06
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-06
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		5e-06
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		5e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		7e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		9e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		1e-05
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		1e-05
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		2e-05
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-05
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		2e-05
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		2e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		2e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		2e-05
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		2e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		2e-05
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-05
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-05
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-05
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		4e-05
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-05
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		5e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		9e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		9e-05
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		1e-04
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		1e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-04
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-04
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		4e-04
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		4e-04
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-04
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		4e-04
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		5e-04
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		6e-04
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		6e-04
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		6e-04
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		7e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-04
2csn_A	297	Binary Complex Of Casein Kinase-1 With Cki7 Length		7e-04
1eh4_A	298	Binary Complex Of Casein Kinase-1 From S. Pombe Wit		7e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		8e-04
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		9e-04
2cmw_A	310	Structure Of Human Casein Kinase 1 Gamma-1 In Compl		9e-04

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  440 bits (1131), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 261/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 14  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 62
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 63  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 122
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 123 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 181
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 182 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 241
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 242 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 301
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 302 RTPPEAIALCSRLLEYTPTARLTPL 326

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  440 bits (1131), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 261/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 24  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 72
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 73  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 132
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 133 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 191
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 192 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 251
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 252 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 311
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 312 RTPPEAIALCSRLLEYTPTARLTPL 336

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  440 bits (1131), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 261/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 20  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 68
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPL 332

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  439 bits (1130), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 261/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 65  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 113
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 114 VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 173
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 174 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 232
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 233 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 292
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 293 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 352
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 353 RTPPEAIALCSRLLEYTPTARLTPL 377

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  439 bits (1130), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 210/325 (64%), Positives = 261/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 22  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 70
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 71  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 130
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 131 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 189
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 190 LLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVL 249
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 250 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 309
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 310 RTPPEAIALCSRLLEYTPTARLTPL 334

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  437 bits (1123), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 209/325 (64%), Positives = 260/325 (80%), Gaps = 13/325 (4%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFG 85
           P     MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFG
Sbjct: 20  PSAFGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFG 68
Query: 86  VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYL 144
           VV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YL
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYL 128
Query: 145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNL 204
           NLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNL
Sbjct: 129 NLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNL 187
Query: 205 LVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
           L++P T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVL 247
Query: 265 AELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK 324
           AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  
Sbjct: 248 AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRP 307
Query: 325 RMPPEAVDLVSRLLQYSPNLRCTAV 349
           R PPEA+ L SRLL+Y+P  R T +
Sbjct: 308 RTPPEAIALCSRLLEYTPTARLTPL 332

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  436 bits (1120), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 202/305 (66%), Positives = 255/305 (83%), Gaps = 4/305 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 10  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 67
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 68  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 127
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 128 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+SYICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 306
Query: 345 RCTAV 349
           R T +
Sbjct: 307 RLTPL 311

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  435 bits (1119), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 202/295 (68%), Positives = 251/295 (85%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 11  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 69
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 70  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 129
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 130 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 188
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 189 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 248
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 249 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 303

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  433 bits (1114), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 201/305 (65%), Positives = 254/305 (83%), Gaps = 4/305 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 9   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 66
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 67  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 126
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 127 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 305
Query: 345 RCTAV 349
           R T +
Sbjct: 306 RLTPL 310

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  433 bits (1114), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 208/322 (64%), Positives = 259/322 (80%), Gaps = 13/322 (4%)
Query: 29  MNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVF 88
              MK+  DK       DG+   T   +V T G    +P Q +SY   +++G GSFGVV+
Sbjct: 1   FGSMKVSRDK-------DGSKVTT---VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVY 49
Query: 89  QAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLV 147
           QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLV
Sbjct: 50  QAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 109
Query: 148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN 207
           L+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++
Sbjct: 110 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLD 168
Query: 208 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL 267
           P T  +KLCDFGSAK LV+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL
Sbjct: 169 PDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAEL 228
Query: 268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP 327
           +LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R P
Sbjct: 229 LLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTP 288
Query: 328 PEAVDLVSRLLQYSPNLRCTAV 349
           PEA+ L SRLL+Y+P  R T +
Sbjct: 289 PEAIALCSRLLEYTPTARLTPL 310

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  433 bits (1113), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 202/295 (68%), Positives = 251/295 (85%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  433 bits (1113), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 201/305 (65%), Positives = 254/305 (83%), Gaps = 4/305 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 5   DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 62
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 63  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 122
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 123 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 301
Query: 345 RCTAV 349
           R T +
Sbjct: 302 RLTPL 306

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  432 bits (1112), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/305 (65%), Positives = 254/305 (83%), Gaps = 4/305 (1%)
Query: 46  DGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL 105
           D +G++   ++ T   G+     Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVL
Sbjct: 16  DKDGSKVTTVVATP--GQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL 73
Query: 106 QDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNK 164
           QDKR+KNRELQ MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++
Sbjct: 74  QDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSR 133
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
             Q +P+IYVKLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK L
Sbjct: 134 AKQTLPVIYVKLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
           V+GEPN+S ICSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLV
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
           EIIKVLGTPTRE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTA 312
Query: 345 RCTAV 349
           R T +
Sbjct: 313 RLTPL 317

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  430 bits (1106), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/295 (68%), Positives = 250/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  430 bits (1106), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/295 (68%), Positives = 250/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  430 bits (1105), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/295 (68%), Positives = 250/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 7   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 65
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 66  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 125
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 126 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 184
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 185 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 244
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 245 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 299

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  430 bits (1105), Expect = e-121,   Method: Compositional matrix adjust.
 Identities = 201/295 (68%), Positives = 250/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 10  VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 68
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 69  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 128
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 129 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 187
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 188 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 247
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 248 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 302

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  427 bits (1099), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 200/295 (67%), Positives = 249/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  426 bits (1096), Expect = e-120,   Method: Compositional matrix adjust.
 Identities = 200/295 (67%), Positives = 249/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K D +YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  426 bits (1094), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 199/295 (67%), Positives = 248/295 (84%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  421 bits (1081), Expect = e-118,   Method: Compositional matrix adjust.
 Identities = 197/295 (66%), Positives = 246/295 (83%), Gaps = 3/295 (1%)
Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQ K +KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNREL 64
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+ +K DE+YLNLVL+YVP TV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYV 124
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+S I
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXI 183
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           RE+I+ MNPNYTEF FPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T +
Sbjct: 244 REQIREMNPNYTEFAFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPL 298

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  414 bits (1063), Expect = e-116,   Method: Compositional matrix adjust.
 Identities = 196/296 (66%), Positives = 244/296 (82%), Gaps = 4/296 (1%)
Query: 55  IIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE 114
           I V    G+ G+ ++ I+Y   +++G GSFGVVFQAK +E+ E VAIKKVLQDKR+KNRE
Sbjct: 25  IKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRE 82
Query: 115 LQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
           LQ MR++ HPNVV LK  F+S  DK DE++LNLVLEYVPETV+R  +H+ KL Q MPM+ 
Sbjct: 83  LQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLL 142
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +KLY YQ+ R+L+YIH SIG+CHRDIKPQNLL++P +  +KL DFGSAK+L+ GEPN+S 
Sbjct: 143 IKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSX 201
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           ICSRYYRAPELIFGAT YTT IDIWS GCV+AELM G+PLFPG+SG+DQLVEIIKVLGTP
Sbjct: 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTP 261
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+SRLL+Y+P+ R TA+
Sbjct: 262 SREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  313 bits (802), Expect = 9e-86,   Method: Compositional matrix adjust.
 Identities = 147/308 (47%), Positives = 210/308 (68%), Gaps = 34/308 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH N++ L   
Sbjct: 9   YSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDY 68
Query: 133 FFSTTDKD---------------------------------ELYLNLVLEYVPETVHRVV 159
           F++T D++                                   YLN+++EYVP+T+H+V+
Sbjct: 69  FYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVL 128
Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           K F +  + +PM  + +Y YQ+FRA+ +IH S+G+CHRDIKPQNLLVN   + +KLCDFG
Sbjct: 129 KSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDNTLKLCDFG 187
Query: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           SAK L+  EP+++ ICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LGKPLF G++ 
Sbjct: 188 SAKKLIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETS 247
Query: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQ 339
           +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI P+  P  A+DL+ ++L+
Sbjct: 248 IDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILR 307
Query: 340 YSPNLRCT 347
           Y P+LR  
Sbjct: 308 YEPDLRIN 315

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  286 bits (732), Expect = 1e-77,   Method: Compositional matrix adjust.
 Identities = 140/287 (48%), Positives = 197/287 (68%), Gaps = 9/287 (3%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR---LLDHP 124
           K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R++NRELQ M+   +L HP
Sbjct: 20  KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHP 79
Query: 125 NVVSLKHCFFSTTDKD--ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           N+V L+  F++  ++D  ++YLN+V+EYVP+T+HR  +++ +     P I +K++ +Q+ 
Sbjct: 80  NIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLI 139
Query: 183 RALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
           R++  +H  S+ VCHRDIKP N+LVN     +KLCDFGSAK L   EPN++YICSRYYRA
Sbjct: 140 RSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRA 199
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PELIFG   YTTA+DIWS GC+ AE+MLG+P+F GD+   QL EI++VLG P+RE ++ +
Sbjct: 200 PELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL 259
Query: 302 NPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYSPNLR 345
           NP++T+      K  PW  +F     +   EA DL+S LLQY P  R
Sbjct: 260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEER 306

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  168 bits (426), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 104/281 (37%), Positives = 161/281 (57%), Gaps = 25/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     E  L LV E++ + + +V+   NK   +   I  K+Y YQ+ R +++ H+  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQI--KIYLYQLLRGVAHCHQH- 138
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             F   +  PW  I P     E +DL+S +L + PN R +A
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISA 295

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  168 bits (425), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 168/300 (56%), Gaps = 28/300 (9%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------REL 115
           G  G P+   ++     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIY 173
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K F   +    +P+  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +K Y +Q+ + L++ H S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
              + + +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 291 GTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           GTP       +   P+Y    FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 285

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  168 bits (425), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 104/281 (37%), Positives = 161/281 (57%), Gaps = 25/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S     E  L LV E++ + + +V+   NK   +   I  K+Y YQ+ R +++ H+  
Sbjct: 88  IHS-----ERCLTLVFEFMEKDLKKVLDE-NKTGLQDSQI--KIYLYQLLRGVAHCHQH- 138
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLINSDG-ALKLADFGLARAF--GIPVRSYTHEVVTLWYRAPDVLMGSK 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP   E   +   P + +
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQ 255
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             F   +  PW  I P     E +DL+S +L + PN R +A
Sbjct: 256 RTFQVFEKKPWSSIIPG-FCQEGIDLLSNMLCFDPNKRISA 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 105/300 (35%), Positives = 168/300 (56%), Gaps = 28/300 (9%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------REL 115
           G  G P+   ++     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+
Sbjct: 1   GPLGSPEFMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREI 60
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIY 173
             ++ L+HPN+V L     +   +++LYL      V E +H+ +K F   +    +P+  
Sbjct: 61  SLLKELNHPNIVKLLDVIHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPL 111
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +K Y +Q+ + L++ H S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y
Sbjct: 112 IKSYLFQLLQGLAFCH-SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTY 167
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
              + + +YRAPE++ G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + L
Sbjct: 168 THEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTL 227
Query: 291 GTPTREEIKCMN--PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           GTP       +   P+Y    FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 228 GTPDEVVWPGVTSMPDYKP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 285

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  167 bits (423), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 107/300 (35%), Positives = 162/300 (54%), Gaps = 33/300 (11%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
            +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ 
Sbjct: 17  FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 76
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   ++     ++LV +++   +  ++K  N L   +   ++K Y     + L Y+
Sbjct: 77  LLDAFGHKSN-----ISLVFDFMETDLEVIIKD-NSL--VLTPSHIKAYMLMTLQGLEYL 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H+   + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+
Sbjct: 129 HQHW-ILHRDLKPNNLLLD-ENGVLKLADFGLAKSF--GSPNRAYXHQVVTRWYRAPELL 184
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK--CMNP 303
           FGA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT E+    C  P
Sbjct: 185 FGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLP 244
Query: 304 NYTEFK-FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS--KRILFSNCPS 360
           +Y  FK FP I   P H IF      + +DL+  L  ++P  R TA    K   FSN P 
Sbjct: 245 DYVTFKSFPGI---PLHHIF-SAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG 300

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 103/279 (36%), Positives = 160/279 (57%), Gaps = 23/279 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKH 131
           +VG+GS+G+V + +  +TG  VAIKK L+       K+   RE++ ++ L H N+V+L  
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLE 91
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHF-NKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  K   YL  V E+V  T+   ++ F N L+ ++    V+ Y +QI   + + H 
Sbjct: 92  V---CKKKKRWYL--VFEFVDHTILDDLELFPNGLDYQV----VQKYLFQIINGIGFCH- 141
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-GEPNISYICSRYYRAPELIFGAT 249
           S  + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  
Sbjct: 142 SHNIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDV 200
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 307
           +Y  A+D+W+ GC+V E+ +G+PLFPGDS +DQL  I+  LG   P  +E+   NP +  
Sbjct: 201 KYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAG 260
Query: 308 FKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            + P+IK   P  + +PK +    +DL  + L   P+ R
Sbjct: 261 VRLPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKR 298

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  166 bits (421), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 103/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + LS+ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 103/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E VH+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  166 bits (420), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 279

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 279

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 280

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 279

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 124
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 181
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 242 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 282

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 15  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 75  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 124
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 125 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 181
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 241
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 242 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 282

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  165 bits (418), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 280

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  165 bits (417), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 102/283 (36%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  164 bits (416), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 161/281 (57%), Gaps = 24/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E+V + + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 74  IHT---ENKLYL--VFEHVDQDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 125
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 243 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 72  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 121
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 122 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 178
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 238
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 239 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 279

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  164 bits (415), Expect = 7e-41,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  164 bits (415), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 280

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 167/288 (57%), Gaps = 22/288 (7%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVV 127
           Y   + +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H NV+
Sbjct: 45  YTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTLREIQILLRFRHENVI 104
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            ++    ++T +    + +V + +   +++++K     +Q++   ++  + YQI R L Y
Sbjct: 105 GIRDILRASTLEAMRDVYIVQDLMETDLYKLLK-----SQQLSNDHICYFLYQILRGLKY 159
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPE 243
           IH S  V HRD+KP NLL+N  T  +K+CDFG A++      +  +    + +R+YRAPE
Sbjct: 160 IH-SANVLHRDLKPSNLLINT-TCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPE 217
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+  
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 277
Query: 302 --NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
               NY +   P      W K+FPK    +A+DL+ R+L ++PN R T
Sbjct: 278 MKARNYLQ-SLPSKTKVAWAKLFPKS-DSKALDLLDRMLTFNPNKRIT 323

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 11  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 71  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 120
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 121 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 177
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 237
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 238 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 278

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  163 bits (413), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+ K+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 10  IGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +H+ +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 70  IHT---ENKLYL------VFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 119
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 120 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYTHEVVTLWYRAPEILLG 176
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 236
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 237 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 160/281 (56%), Gaps = 24/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 12  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 71
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 72  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 123
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 124 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 181 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 240
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 241 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 279

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  161 bits (408), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 160/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 13  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 72
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +   +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 73  IHT---ENKLYL------VFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 123 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 179
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 239
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 240 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 280

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 99/281 (35%), Positives = 160/281 (56%), Gaps = 24/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +   +++LYL  V E++   + + +         +P+I  K Y +Q+ + L++ H S 
Sbjct: 74  IHT---ENKLYL--VFEFLSMDLKKFMDASALTGIPLPLI--KSYLFQLLQGLAFCH-SH 125
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KP+NLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G  
Sbjct: 126 RVLHRDLKPENLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNYTE 307
            Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y  
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKP 242
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 243 -SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  161 bits (408), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 101/283 (35%), Positives = 160/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+V L   
Sbjct: 14  IGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDV 73
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQR--MPMIYVKLYAYQIFRALSYIHR 190
             +   +++LYL      V E +   +K F   +    +P+  +K Y +Q+ + L++ H 
Sbjct: 74  IHT---ENKLYL------VFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH- 123
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFG 247
           S  V HRD+KPQNLL+N     +KL DFG A+    G P  +Y   + + +YRAPE++ G
Sbjct: 124 SHRVLHRDLKPQNLLINTEG-AIKLADFGLARAF--GVPVRTYXHEVVTLWYRAPEILLG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN--PNY 305
              Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP       +   P+Y
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY 240
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 241 KP-SFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 281

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  160 bits (406), Expect = 7e-40,   Method: Compositional matrix adjust.
 Identities = 95/317 (29%), Positives = 168/317 (52%), Gaps = 57/317 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTM-RLLDHPNVVSLKH 131
           +G+G++G+V+++    TGE VA+KK+        D +   RE+  +  L  H N+V+L +
Sbjct: 17  LGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLN 76
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              +  D+D   + LV +Y+   +H V++        +  ++ +   YQ+ + + Y+H S
Sbjct: 77  VLRADNDRD---VYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLH-S 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK---------------------GEPN 230
            G+ HRD+KP N+L+N   H VK+ DFG ++  V                       +P 
Sbjct: 128 GGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPI 186
Query: 231 IS-YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++ Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E++ GKP+FPG S ++QL  II V
Sbjct: 187 LTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV 246
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAH-------------PWHKIFPKRMP-----PEAV 331
           +  P+ E+++ +   + +     +K                W  +  K  P      EA+
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEAL 306
Query: 332 DLVSRLLQYSPNLRCTA 348
           DL+ +LLQ++PN R +A
Sbjct: 307 DLLDKLLQFNPNKRISA 323

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  160 bits (405), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  160 bits (404), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 158/287 (55%), Gaps = 22/287 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K  
Sbjct: 62  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 121
Query: 133 FFSTTDKDEL-YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              T    E   + +VL+ +   +H+++      +Q + + +V+ + YQ+ R L Y+H S
Sbjct: 122 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH-S 176
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIF 246
             V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+ 
Sbjct: 177 AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 235
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              EYT AID+WS GC+  E++  + LFPG + V QL  I+ VLGTP+   I+ +     
Sbjct: 236 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 295
Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
                  P  +  PW  ++P     +A+ L+ R+L++ P+ R +A +
Sbjct: 296 RAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAA 341

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  159 bits (403), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 101/281 (35%), Positives = 158/281 (56%), Gaps = 25/281 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+GS+GVVF+ +  +TG+ VAIKK L+       K+   RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     + +  L+LV EY     H V+   ++  + +P   VK   +Q  +A+++ H+  
Sbjct: 71  F-----RRKRRLHLVFEYCD---HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH- 121
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
              HRD+KP+N+L+  H+  +KLCDFG A++L    P+  Y   + +R+YR+PEL+ G T
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTG--PSDYYDDEVATRWYRSPELLVGDT 178
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT--PTREEIKCMNPNYTE 307
           +Y   +D+W+ GCV AEL+ G PL+PG S VDQL  I K LG   P  +++   N  ++ 
Sbjct: 179 QYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG 238
Query: 308 FKFPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            K P  +   P    FP    P A+ L+   L   P  R T
Sbjct: 239 VKIPDPEDMEPLELKFPNISYP-ALGLLKGCLHMDPTERLT 278

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 95/287 (33%), Positives = 158/287 (55%), Gaps = 22/287 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK------VLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G++GVV  A+   TG+ VAIKK      V+ + +   REL+ ++   H N++++K  
Sbjct: 63  IGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI 122
Query: 133 FFSTTDKDEL-YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
              T    E   + +VL+ +   +H+++      +Q + + +V+ + YQ+ R L Y+H S
Sbjct: 123 LRPTVPYGEFKSVYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMH-S 177
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-----ISYICSRYYRAPELIF 246
             V HRD+KP NLLVN +  ++K+ DFG A+ L             Y+ +R+YRAPEL+ 
Sbjct: 178 AQVIHRDLKPSNLLVNENC-ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELML 236
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              EYT AID+WS GC+  E++  + LFPG + V QL  I+ VLGTP+   I+ +     
Sbjct: 237 SLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERV 296
Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
                  P  +  PW  ++P     +A+ L+ R+L++ P+ R +A +
Sbjct: 297 RAYIQSLPPRQPVPWETVYPG-ADRQALSLLGRMLRFEPSARISAAA 342

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 93/283 (32%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + LV   +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 111 RAPTIEQMKDVYLVTHLMGADLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 164
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 321

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  159 bits (401), Expect = 3e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 90/282 (31%), Positives = 160/282 (56%), Gaps = 26/282 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TSDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC---MNP 303
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C   +  
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                  P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 303

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 169/297 (56%), Gaps = 28/297 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +   + S           Y+ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITA 300

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 39  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 98
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 99  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 152
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 153 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 269 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 309

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  158 bits (400), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 51  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 111 RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 164
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 165 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 281 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 321

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 95/297 (31%), Positives = 170/297 (57%), Gaps = 28/297 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-----EPN------ISYIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +      EP       + ++ 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITA 300

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 303

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 33  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 92
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 93  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 146
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 147 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 263 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 303

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 149
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 266 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 306

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 37  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 97  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 150
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 151 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 267 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 307

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 28  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 88  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 141
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 142 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 258 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 298

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  158 bits (399), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  158 bits (399), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 142
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 299

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 161/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 29  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 89  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 142
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 143 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P +E++ C+     
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 259 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 299

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAI+K+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  156 bits (395), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 162/283 (57%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----CQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----N 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+     
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 265 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 160/280 (57%), Gaps = 22/280 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 35  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 95  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 148
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 249
           V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 149 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 207
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----NPNY 305
            YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 208 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 267
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 268 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 305

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 90/280 (32%), Positives = 160/280 (57%), Gaps = 22/280 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 36  IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 96  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 149
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY----ICSRYYRAPELIFGAT 249
           V HRD+KP NLL+N  T  +K+CDFG A+V      +  +    + +R+YRAPE++  + 
Sbjct: 150 VLHRDLKPSNLLLNT-TCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSK 208
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM----NPNY 305
            YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+      NY
Sbjct: 209 GYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNY 268
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 269 L-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 306

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/297 (31%), Positives = 168/297 (56%), Gaps = 28/297 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRY----KNRELQTMRLLDHPNV 126
            +  + ++G+G++GVV  A    TGE VAIKK+   DK        RE++ ++   H N+
Sbjct: 12  DFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENI 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +++ +     + ++   + ++ E +   +HRV+       Q +   +++ + YQ  RA+ 
Sbjct: 72  ITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLRAVK 126
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----------YIC 235
            +H S  V HRD+KP NLL+N +   +K+CDFG A+++ +   + S            + 
Sbjct: 127 VLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVA 184
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP-T 294
           +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GTP +
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 295 REEIKCM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +++C+ +P   E+    P   A P  K+FP R+ P+ +DL+ R+L + P  R TA
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFP-RVNPKGIDLLQRMLVFDPAKRITA 300

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  155 bits (392), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 92/283 (32%), Positives = 160/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+CDFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKICDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMN 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  155 bits (391), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/285 (33%), Positives = 158/285 (55%), Gaps = 34/285 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEIVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 158/285 (55%), Gaps = 34/285 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 105/287 (36%), Positives = 157/287 (54%), Gaps = 36/287 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S  DK    L LV E+  + +    K+F+  N  +    VK + +Q+ + L + H S 
Sbjct: 70  LHS--DKK---LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SR 120
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 309 KFPQIKAHPWH-------KIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           K P  K +P +        + PK +     DL+  LL+ +P  R +A
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISA 277

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  154 bits (390), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 95/285 (33%), Positives = 158/285 (55%), Gaps = 34/285 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             +        L LV E++ + + +++   +     +  +  K +  Q+   ++Y H   
Sbjct: 69  IHTKKR-----LVLVFEHLDQDLKKLL---DVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   + + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARAF--GIPVRKYTHEVVTLWYRAPDVLMGSK 176
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------EIKCMNP 303
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +      E+   +P
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP 236
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N+T +     +  PW   F K +    +DL+S++L+  PN R TA
Sbjct: 237 NFTVY-----EPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITA 275

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 94/287 (32%), Positives = 158/287 (55%), Gaps = 23/287 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           +Y+    +G+G++  V++ K   T   VA+K++  +          RE+  ++ L H N+
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANI 62
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V+L H    T    E  L LV EY+ + +    ++ +     + M  VKL+ +Q+ R L+
Sbjct: 63  VTL-HDIIHT----EKSLTLVFEYLDKDLK---QYLDDCGNIINMHNVKLFLFQLLRGLA 114
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +YR P+
Sbjct: 115 YCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARA--KSIPTKTYDNEVVTLWYRPPD 170
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E    +  
Sbjct: 171 ILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILS 230
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           N  +  + +P+ +A       P R+  +  DL+++LLQ+    R +A
Sbjct: 231 NEEFKTYNYPKYRAEALLSHAP-RLDSDGADLLTKLLQFEGRNRISA 276

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  154 bits (389), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 105/287 (36%), Positives = 156/287 (54%), Gaps = 36/287 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
             S  DK    L LV E+  + +    K+F+  N  +    VK + +Q+ + L + H S 
Sbjct: 70  LHS--DKK---LTLVFEFCDQDLK---KYFDSCNGDLDPEIVKSFLFQLLKGLGFCH-SR 120
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL DFG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLADFGLARAF--GIPVRCYSAEVVTLWYRPPDVLFGAK 177
Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            Y+T+ID+WSAGC+ AEL    +PLFPG+   DQL  I ++LGTPT E+   M       
Sbjct: 178 LYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT------ 231
Query: 309 KFPQIKAHPWH-------KIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           K P  K +P +        + PK +     DL+  LL+ +P  R +A
Sbjct: 232 KLPDYKPYPMYPATTSLVNVVPK-LNATGRDLLQNLLKCNPVQRISA 277

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  151 bits (381), Expect = 6e-37,   Method: Compositional matrix adjust.
 Identities = 91/283 (32%), Positives = 159/283 (56%), Gaps = 28/283 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G++G+V  A        VAIKK+   + + Y  R L+ +++L    H N++ +    
Sbjct: 31  IGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 90
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            + T +    + +V + +   +++++K      Q +   ++  + YQI R L YIH S  
Sbjct: 91  RAPTIEQMKDVYIVQDLMETDLYKLLK-----TQHLSNDHICYFLYQILRGLKYIH-SAN 144
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-------ISYICSRYYRAPELIF 246
           V HRD+KP NLL+N  T  +K+ DFG A+V    +P+         Y+ +R+YRAPE++ 
Sbjct: 145 VLHRDLKPSNLLLNT-TXDLKIXDFGLARV---ADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE----IKCMN 302
            +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E+    I    
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            NY     P     PW+++FP     +A+DL+ ++L ++P+ R
Sbjct: 261 RNYL-LSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKR 301

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  150 bits (380), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 97/285 (34%), Positives = 150/285 (52%), Gaps = 24/285 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL  V   +   ++ +VK     +Q +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----SQALSDEHVQFLVYQLLRGLKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IH-SAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                 P +       IF +   P A+DL+ R+L    + R +A 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAA 306

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 153/289 (52%), Gaps = 23/289 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 125
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 25  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 84
Query: 126 VVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+ L   F   +     Y   LV+ ++   + ++      +  +     ++   YQ+ + 
Sbjct: 85  VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGLKFSEEKIQYLVYQMLKG 138
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 243
           L YIH S GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 139 LKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 193
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +N 
Sbjct: 194 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 253
Query: 304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
              +      PQ     + ++FP R  P+A DL+ ++L+   + R TA 
Sbjct: 254 KAAKSYIQSLPQTPRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAA 301

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  149 bits (377), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 94/289 (32%), Positives = 152/289 (52%), Gaps = 23/289 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPN 125
           +Y++   VG G++G V  A    +GE VAIKK+    Q + +  R   EL  ++ + H N
Sbjct: 43  TYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHEN 102
Query: 126 VVSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+ L   F   +     Y   LV+ ++   + ++      +        ++   YQ+ + 
Sbjct: 103 VIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKI------MGMEFSEEKIQYLVYQMLKG 156
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPE 243
           L YIH S GV HRD+KP NL VN    ++K+ DFG A+     +  ++ Y+ +R+YRAPE
Sbjct: 157 LKYIH-SAGVVHRDLKPGNLAVNEDC-ELKILDFGLAR---HADAEMTGYVVTRWYRAPE 211
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ +N 
Sbjct: 212 VILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND 271
Query: 304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
              +      PQ     + ++FP R  P+A DL+ ++L+   + R TA 
Sbjct: 272 KAAKSYIQSLPQTPRKDFTQLFP-RASPQAADLLEKMLELDVDKRLTAA 319

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 97/285 (34%), Positives = 149/285 (52%), Gaps = 24/285 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 34  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 93
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL   L  +   ++ +VK      Q +   +V+   YQ+ R L Y
Sbjct: 94  DVFTPATSIEDFSEVYLVTTL--MGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN  + ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 147 IH-SAGIIHRDLKPSNVAVNEDS-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 202
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 203 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 262
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                 P +       IF +   P A+DL+ R+L    + R +A 
Sbjct: 263 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAA 306

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  147 bits (370), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/285 (34%), Positives = 148/285 (51%), Gaps = 24/285 (8%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLK 130
           R VG G++G V  A      + VA+KK+      L   R   REL+ ++ L H NV+ L 
Sbjct: 26  RPVGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVIGLL 85
Query: 131 HCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             F   T   D  E+YL  V   +   ++ +VK      Q +   +V+   YQ+ R L Y
Sbjct: 86  DVFTPATSIEDFSEVYL--VTTLMGADLNNIVK-----CQALSDEHVQFLVYQLLRGLKY 138
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           IH S G+ HRD+KP N+ VN    ++++ DFG A+     E    Y+ +R+YRAPE++  
Sbjct: 139 IH-SAGIIHRDLKPSNVAVNEDC-ELRILDFGLARQ--ADEEMTGYVATRWYRAPEIMLN 194
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS GC++AEL+ GK LFPG   +DQL  I++V+GTP+ E +  ++  +  
Sbjct: 195 WMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHAR 254
Query: 308 F---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                 P +       IF +   P A+DL+ R+L    + R +A 
Sbjct: 255 TYIQSLPPMPQKDLSSIF-RGANPLAIDLLGRMLVLDSDQRVSAA 298

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  144 bits (363), Expect = 8e-35,   Method: Compositional matrix adjust.
 Identities = 97/283 (34%), Positives = 151/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++  A  
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNAMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 151/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 306

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/281 (33%), Positives = 147/281 (52%), Gaps = 22/281 (7%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDH---PNVVSLKHC 132
           VG G++G V  A    TG  VAIKK+    Q + +  R  + +RLL H    NV+ L   
Sbjct: 33  VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 133 FFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F      D+     LV+ ++   + +++KH     +++    ++   YQ+ + L YIH +
Sbjct: 93  FTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIH-A 146
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+ HRD+KP NL VN    ++K+ DFG A+           + +R+YRAPE+I     Y
Sbjct: 147 AGIIHRDLKPGNLAVNEDC-ELKILDFGLARQ--ADSEMXGXVVTRWYRAPEVILNWMRY 203
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYTE 307
           T  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ +      NY +
Sbjct: 204 TQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMK 263
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              P+++   +  I      P AV+L+ ++L      R TA
Sbjct: 264 -GLPELEKKDFASIL-TNASPLAVNLLEKMLVLDAEQRVTA 302

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  143 bits (361), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 266 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 306

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 151/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDS-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 302

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 162 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 279 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 319

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 280 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 320

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 40  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 98
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 99  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 152
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 153 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 209
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 210 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 269
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 270 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 310

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----XQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 296

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 151/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK     +Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----SQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN  + ++K+ DFG  +     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDS-ELKILDFGLCRH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  142 bits (359), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 311

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 305

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 307

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 307

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TADEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 307

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 312

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 312

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  142 bits (358), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 42  VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 100
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 101 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 154
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 155 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 211
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 212 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 271
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 272 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 312

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  142 bits (357), Expect = 3e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 280 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 320

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 306

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 28  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 86
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 87  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 140
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 141 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 197
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 198 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 257
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 258 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 298

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 49  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 107
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 108 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 161
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 162 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 218
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 219 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 278
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 279 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 319

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 36  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 94
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 95  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 148
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 149 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 205
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 206 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 265
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 266 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 306

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 41  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 99
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 100 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 153
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 154 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 210
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 211 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 270
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 271 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 311

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 305

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 166 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGYVATRWYRAPEIMLNWMH 222
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 283 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 323

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 302

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVN-EDXELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 305

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 53  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 111
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 112 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 165
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 166 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 222
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 223 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 282
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 283 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 323

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 256 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 296

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 302

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  142 bits (357), Expect = 4e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 37  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 95
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 96  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 150 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 206
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 207 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 266
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 267 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 307

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 297

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 32  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 90
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 91  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 145 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 201
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 202 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 261
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 262 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 302

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 35  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 93
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 94  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 147
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 148 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 204
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 205 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 264
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 265 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 305

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 29  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 87
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 88  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 141
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 142 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 198
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 199 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 258
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 259 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 299

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 96/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 27  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 85
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 86  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 140 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 196
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 197 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 256
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 257 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 297

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  141 bits (356), Expect = 5e-34,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  141 bits (356), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 296

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  141 bits (355), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    ++ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMAGFVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  141 bits (355), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 94/282 (33%), Positives = 149/282 (52%), Gaps = 24/282 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  +  +++G  +A+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 59  VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 117
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F   T  +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 118 VFTPATSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 171
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 172 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 228
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   ++QL +I+++ GTP    I  M      NY 
Sbjct: 229 YNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHEARNYI 288
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               PQ+    +  +F     P AVDL+ ++L    + R TA
Sbjct: 289 N-SLPQMPKRNFADVFIG-ANPLAVDLLEKMLVLDTDKRITA 328

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 26  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 84
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK       ++   +V+   YQI R L YIH 
Sbjct: 85  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CAKLTDDHVQFLIYQILRGLKYIH- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +    Y+ +R+YRAPE++     
Sbjct: 139 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 195
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 255
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 256 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 296

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 150/283 (53%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D+G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDYGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 96/301 (31%), Positives = 159/301 (52%), Gaps = 38/301 (12%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVV- 127
           YM  + +G G  G+VF A   +  + VAIKK++    Q  ++  RE++ +R LDH N+V 
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVK 72
Query: 128 ----------SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
                      L     S T+ + +Y+  V EY+   +  V++    L +     + +L+
Sbjct: 73  VFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQGPLLEE-----HARLF 125
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---- 233
            YQ+ R L YIH S  V HRD+KP NL +N     +K+ DFG A+++   +P+ S+    
Sbjct: 126 MYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM---DPHYSHKGHL 181
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL---VEII 287
              + +++YR+P L+     YT AID+W+AGC+ AE++ GK LF G   ++Q+   +E I
Sbjct: 182 SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            V+    R+E+  + P Y      +    P  ++ P  +  EAVD + ++L +SP  R T
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTE-PHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLT 299
Query: 348 A 348
           A
Sbjct: 300 A 300

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 50  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 108
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 109 VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 163 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMXGXVATRWYRAPEIMLNWMH 219
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 220 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 279
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 280 Q-SLAQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 320

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  139 bits (350), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DF  A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFYLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  139 bits (349), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+  FG A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILGFGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ DFG A+     +     + +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDFGLARH--TDDEMTGXVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (348), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDAGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 5e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDGGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  138 bits (347), Expect = 6e-33,   Method: Compositional matrix adjust.
 Identities = 95/283 (33%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKK-------VLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           VG G++G V  A   +TG  VA+KK       ++  KR   REL+ ++ + H NV+ L  
Sbjct: 30  VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKR-TYRELRLLKHMKHENVIGLLD 88
Query: 132 CFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F      +E   + LV   +   ++ +VK      Q++   +V+   YQI R L YIH 
Sbjct: 89  VFTPARSLEEFNDVYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIH- 142
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S  + HRD+KP NL VN    ++K+ D G A+     +    Y+ +R+YRAPE++     
Sbjct: 143 SADIIHRDLKPSNLAVNEDC-ELKILDRGLARH--TDDEMTGYVATRWYRAPEIMLNWMH 199
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP----NYT 306
           Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++     NY 
Sbjct: 200 YNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYI 259
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
           +    Q+    +  +F     P AVDL+ ++L    + R TA 
Sbjct: 260 Q-SLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITAA 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  137 bits (346), Expect = 7e-33,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 152/284 (53%), Gaps = 21/284 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
              F    A P  K F   +     DL+ + L ++P  R +A S
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 152/284 (53%), Gaps = 21/284 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
              F    A P  K F   +     DL+ + L ++P  R +A S
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  137 bits (346), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 98/284 (34%), Positives = 152/284 (53%), Gaps = 21/284 (7%)
Query: 79  VGQGSFGVVFQAKCLETG-ETVAIKKVLQDKRYKNRELQTMR---------LLDHPNVVS 128
           +G+G++G VF+A+ L+ G   VA+K+V      +   L T+R           +HPNVV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
           L   C  S TD+ E  L LV E+V + +     + +K+ +  +P   +K   +Q+ R L 
Sbjct: 79  LFDVCTVSRTDR-ETKLTLVFEHVDQDL---TTYLDKVPEPGVPTETIKDMMFQLLRGLD 134
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAPE++ 
Sbjct: 135 FLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLL 192
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +    
Sbjct: 193 QSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RDVALP 250
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
              F    A P  K F   +     DL+ + L ++P  R +A S
Sbjct: 251 RQAFHSKSAQPIEK-FVTDIDELGKDLLLKCLTFNPAKRISAYS 293

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/289 (31%), Positives = 154/289 (53%), Gaps = 32/289 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHCF 133
           +G G++  V++     TG  VA+K+V  D          RE+  M+ L H N+V L    
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRALSYIHRS 191
            +     E  L LV E++   + + +      N  + + +  VK + +Q+ + L++ H +
Sbjct: 73  HT-----ENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGA 248
             + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP+++ G+
Sbjct: 128 -KILHRDLKPQNLLINKRG-QLKLGDFGLARAF--GIPVNTFSSEVVTLWYRAPDVLMGS 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y+T+IDIWS GC++AE++ GKPLFPG +  +QL  I  ++GTP     + + P+ T+ 
Sbjct: 184 RTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPN----ESLWPSVTKL 239
Query: 309 -KF-PQIKAHPWHKIFPKRMP-------PEAVDLVSRLLQYSPNLRCTA 348
            K+ P I+  P   +     P          +D +  LLQ +P++R +A
Sbjct: 240 PKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/296 (30%), Positives = 150/296 (50%), Gaps = 30/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---------RELQTMRL 120
           Y  +R +  GS+G V  A     G  VAIK+V     D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 121 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVK 175
           L+H   PN++ L+  F    +     L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            + Y I   L  +H + GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 296 EEIKCMNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           E++   +     +Y       + A  W  + P    P A+DL++++L+++P  R +
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIS 310

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  135 bits (340), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 90/296 (30%), Positives = 150/296 (50%), Gaps = 30/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKN---------RELQTMRL 120
           Y  +R +  GS+G V  A     G  VAIK+V     D R  N         R L+ +RL
Sbjct: 24  YTVQRFISSGSYGAVC-AGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82
Query: 121 LDH---PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVK 175
           L+H   PN++ L+  F    +     L LV E +   + +V+      +QR+ +   +++
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIH-----DQRIVISPQHIQ 137
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            + Y I   L  +H + GV HRD+ P N+L+    + + +CDF  A+          Y+ 
Sbjct: 138 YFMYHILLGLHVLHEA-GVVHRDLHPGNILL-ADNNDITICDFNLAREDTADANKTHYVT 195
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP  
Sbjct: 196 HRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI 255
Query: 296 EEIKCMNP----NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           E++   +     +Y       + A  W  + P    P A+DL++++L+++P  R +
Sbjct: 256 EDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIS 310

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 85/260 (32%), Positives = 137/260 (52%), Gaps = 38/260 (14%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                      L+L+ EY    +    K +   N  + M  +K + YQ+   +++ H S 
Sbjct: 102 IHHNH-----RLHLIFEYAENDL----KKYMDKNPDVSMRVIKSFLYQLINGVNFCH-SR 151
Query: 193 GVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
              HRD+KPQNLL++      T  +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF--GIPIRQFTHEIITLWYRPPEIL 209
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G+  Y+T++DIWS  C+ AE+++  PLFPGDS +DQL +I +VLG P            
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP------------ 257
Query: 306 TEFKFPQIKAHP-WHKIFPK 324
            +  +P + A P W + FPK
Sbjct: 258 DDTTWPGVTALPDWKQSFPK 277

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  129 bits (325), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  129 bits (324), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLXGI 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  129 bits (323), Expect = 3e-30,   Method: Compositional matrix adjust.
 Identities = 93/298 (31%), Positives = 156/298 (52%), Gaps = 35/298 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 304 -NYTEF--KFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E   K+P IK   + ++FP  + P           +A DL+S++L   P+ R +
Sbjct: 257 RNYVENRPKYPGIK---FEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 311

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  129 bits (323), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  128 bits (321), Expect = 5e-30,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 154/296 (52%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYLL-----YQMLVGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  128 bits (321), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDX-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  127 bits (320), Expect = 8e-30,   Method: Compositional matrix adjust.
 Identities = 90/296 (30%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A     G  VA+KK+    Q++ +  R   EL  ++ ++H N+
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNI 83
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V+ H    ++RM  +      YQ+   +
Sbjct: 84  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-HMELDHERMSYLL-----YQMLCGI 137
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 138 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ EL+ G  +F G   +DQ  ++I+ LGTP+ E +  + P  
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P      + ++FP  + P           +A DL+S++L   P+ R +
Sbjct: 255 RNYVENR-PAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRIS 309

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  127 bits (319), Expect = 9e-30,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 154/296 (52%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 177
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  127 bits (318), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/290 (29%), Positives = 145/290 (50%), Gaps = 25/290 (8%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMR-LLDHPNVVSL 129
            Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNIITL 97
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y H
Sbjct: 98  ADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 148
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 149 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 250 EYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKCMN 302
            Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ ++
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE-LD 266
Query: 303 PNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 267 PRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 250 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 304

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 123
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 124 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 177
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 178 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 295 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 349

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 257 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 311

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 258 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 312

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 251 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 305

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 93/296 (31%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 84
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F      +E   + LV+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 85  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 138
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 139 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
            NY E + P+     + K+FP  + P           +A DL+S++L   P  R +
Sbjct: 256 RNYVENR-PKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRIS 310

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 89/296 (30%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  126 bits (316), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLVGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 150/287 (52%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  125 bits (313), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 88/296 (29%), Positives = 153/296 (51%), Gaps = 31/296 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M++++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ-MELDHERMSYLL-----YQMLVGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDA-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS G ++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLLQYSPNLRCT 347
             Y E + P+   + + K+FP  + P           +A DL+S++L    + R +
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRIS 311

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  124 bits (312), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 26/284 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 125
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 126 VVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           VV L   C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRG 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L ++H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEV 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVS 240
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                FP     P   + P+ M      L+  +L ++P+ R +A
Sbjct: 241 LPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISA 283

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 26/284 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 125
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 126 VVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           VV L   C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRG 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L ++H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEV 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVS 240
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                FP     P   + P+ M      L+  +L ++P+ R +A
Sbjct: 241 LPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISA 283

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  124 bits (311), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 150/287 (52%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP+ E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 89/284 (31%), Positives = 144/284 (50%), Gaps = 26/284 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD---HPN 125
           +G G++G V++A+   +G  VA+K V    R  N          RE+  +R L+   HPN
Sbjct: 12  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGEEGLPISTVREVALLRRLEAFEHPN 67
Query: 126 VVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           VV L   C  S TD+ E+ + LV E+V + +   +         +P   +K    Q  R 
Sbjct: 68  VVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQFLRG 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L ++H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRAPE+
Sbjct: 125 LDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEV 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    + +
Sbjct: 183 LLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-RDVS 240
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                FP     P   + P+ M      L+  +L ++P+ R +A
Sbjct: 241 LPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISA 283

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 149/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 86
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 87  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 141 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 258 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 303

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 89/287 (31%), Positives = 144/287 (50%), Gaps = 29/287 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------------RELQTMRLLD--- 122
           +G G++G V++A+   +G  VA+K V    R  N             RE+  +R L+   
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSV----RVPNGGGGGGGLPISTVREVALLRRLEAFE 72
Query: 123 HPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           HPNVV L   C  S TD+ E+ + LV E+V + +   +         +P   +K    Q 
Sbjct: 73  HPNVVRLMDVCATSRTDR-EIKVTLVFEHVDQDLRTYLDKAPPPG--LPAETIKDLMRQF 129
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            R L ++H +  + HRD+KP+N+LV      VKL DFG A++          + + +YRA
Sbjct: 130 LRGLDFLHANC-IVHRDLKPENILVT-SGGTVKLADFGLARIYSYQMALTPVVVTLWYRA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++    
Sbjct: 188 PEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWP-R 245
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + +     FP     P   + P+ M      L+  +L ++P+ R +A
Sbjct: 246 DVSLPRGAFPPRGPRPVQSVVPE-MEESGAQLLLEMLTFNPHKRISA 291

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 88/287 (30%), Positives = 149/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 150/287 (52%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 28  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 87
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 88  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 141
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+        + ++ +RYYRAPE+I
Sbjct: 142 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 200 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 259 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 304

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  121 bits (303), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 103/346 (29%), Positives = 159/346 (45%), Gaps = 87/346 (25%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y+ + ++G+GS+G V+ A    T + VAIKKV      L D +   RE+  +  L    
Sbjct: 27  NYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 86
Query: 126 VVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L            DELY+  VLE     + ++ K    L +     ++K   Y +  
Sbjct: 87  IIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEE----HIKTILYNLLL 140
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNI----------- 231
             ++IH S G+ HRD+KP N L+N     VK+CDFG A+ +  + + NI           
Sbjct: 141 GENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLARTINSEKDTNIVNDLEENEEPG 198
Query: 232 -----------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL--MLGK------- 271
                      S++ +R+YRAPELI     YT +IDIWS GC+ AEL  ML         
Sbjct: 199 PHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN 258
Query: 272 --PLFPGD-----------------SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ 312
             PLFPG                  S  DQL  I  ++GTPT +++K +N        P+
Sbjct: 259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINK-------PE 311
Query: 313 IKAHPWHKIFPKRMP-----------PEAVDLVSRLLQYSPNLRCT 347
           +    + K+FP R P            + ++L+  +L+++PN R T
Sbjct: 312 VIK--YIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRIT 355

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  121 bits (303), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 146/260 (56%), Gaps = 20/260 (7%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHP 317
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  120 bits (302), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 146/260 (56%), Gaps = 20/260 (7%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+GSFG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +   + I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P++  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHP 317
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 149/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 31  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 90
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 91  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 144
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 145 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 262 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 307

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  120 bits (301), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 149/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 79
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 80  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 134 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 251 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 296

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/292 (29%), Positives = 145/292 (49%), Gaps = 29/292 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E VA+K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVAVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N+L++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  119 bits (299), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 148/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKML 302

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  117 bits (294), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 143/260 (55%), Gaps = 20/260 (7%)
Query: 67  PKQTISYMAE--RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDH- 123
           P   ++Y  E  +++G+G FG V +A   +  + VA+K V  +KR+  +  + +R+L+H 
Sbjct: 91  PHDHVAYRYEVLKVIGKGXFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHL 150
Query: 124 -----PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
                 N +++ H   + T ++  ++ +  E +   ++ ++K  NK  Q   +  V+ +A
Sbjct: 151 RKQDKDNTMNVIHMLENFTFRN--HICMTFELLSMNLYELIKK-NKF-QGFSLPLVRKFA 206
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-VKLCDFGSAKVLVKGEPNISYICSR 237
           + I + L  +H++  + H D+KP+N+L+       +K+ DFGS+    + +     I SR
Sbjct: 207 HSILQCLDALHKNR-IIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSR 263
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           +YRAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P +  
Sbjct: 264 FYRAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPXQ-- 320
Query: 298 IKCMNPNYTEFKFPQIKAHP 317
            K ++ +     F   K +P
Sbjct: 321 -KLLDASKRAKNFVSXKGYP 339

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 87/287 (30%), Positives = 148/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYLL-----YQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP    +K + P  
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
            NY E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RNYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 145/302 (48%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L+  
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLMGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/287 (29%), Positives = 148/287 (51%), Gaps = 31/287 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNR---ELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+    Q++ +  R   EL  M+ ++H N+
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 85
Query: 127 VSLKHCFFSTTDKDELY-LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L + F      +E   + +V+E +   + +V++     ++RM  +      YQ+   +
Sbjct: 86  IGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ-MELDHERMSYL-----LYQMLCGI 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V      +K+ DFG A+           + +RYYRAPE+I
Sbjct: 140 KHLH-SAGIIHRDLKPSNIVVKSDC-TLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVI 197
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP-- 303
            G   Y   +D+WS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 198 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 304 -NYTEFKFPQIKAHPWHKIFPKRMPP-----------EAVDLVSRLL 338
             Y E + P+   + + K+FP  + P           +A DL+S++L
Sbjct: 257 RTYVENR-PKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKML 302

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  116 bits (290), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 47  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 106
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 107 PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 157
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 158 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 216
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 217 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 270
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 271 AYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 330
Query: 349 VS 350
           + 
Sbjct: 331 LE 332

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 144/292 (49%), Gaps = 29/292 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLRQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 86
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 349 VS 350
           + 
Sbjct: 311 LE 312

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLXGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 103/353 (29%), Positives = 152/353 (43%), Gaps = 95/353 (26%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ------DKRYKNRELQTMRLLDHPNV 126
           Y    ++G GS+G V +A        VAIKK+L+      D +   RE+  +  L+H +V
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHV 114
Query: 127 VSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V +            DELY+  VLE       ++ +    L +    +++K   Y +   
Sbjct: 115 VKVLDIVIPKDVEKFDELYV--VLEIADSDFKKLFRTPVYLTE----LHIKTLLYNLLVG 168
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS------------ 232
           + Y+H S G+ HRD+KP N LVN     VK+CDFG A+ +   E   S            
Sbjct: 169 VKYVH-SAGILHRDLKPANCLVNQDC-SVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 233 ----------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAEL--MLGK--- 271
                           ++ +R+YRAPELI     YT AID+WS GC+ AEL  M+ +   
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVA 286
Query: 272 ------PLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCMNPNY 305
                 PLFPG S                      DQL  I  +LGTP+ E+I+ +    
Sbjct: 287 YHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKE- 345
Query: 306 TEFKFPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCT 347
                    A  + +IFPKR              +A+ L+ R+L ++PN R T
Sbjct: 346 --------DAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRIT 390

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 265 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 43  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 100
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 101 TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 151
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 152 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 210
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 211 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 270
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 271 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 320

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 28  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 87
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 88  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 138
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 139 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 197
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 198 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 251
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 252 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 311
Query: 349 VS 350
           + 
Sbjct: 312 LE 313

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 266 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 37  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 94
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 95  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 145
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 146 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 204
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 205 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 264
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 265 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 84/291 (28%), Positives = 142/291 (48%), Gaps = 27/291 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 36  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 94  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 144
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 145 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 203
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC-----M 301
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +        +
Sbjct: 204 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL 263
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           +P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 264 DPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 85/292 (29%), Positives = 144/292 (49%), Gaps = 29/292 (9%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVV 127
            Y   R +G+G +  VF+A  +   E V +K +   K+ K +     L+ +R    PN++
Sbjct: 38  DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLR--GGPNII 95
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           +L         +      LV E+V  T       F +L Q +    ++ Y Y+I +AL Y
Sbjct: 96  TLADIVKDPVSRTPA---LVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+  
Sbjct: 147 CH-SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVD 205
Query: 248 ATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP------TREEIKC 300
              Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT        +  I+ 
Sbjct: 206 YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE- 264
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           ++P + +    +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 265 LDPRFNDI-LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 315

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 27  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 86
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 87  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 138 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 196
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 197 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 250
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 251 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 310
Query: 349 VS 350
           + 
Sbjct: 311 LE 312

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  114 bits (286), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 89/302 (29%), Positives = 144/302 (47%), Gaps = 33/302 (10%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKNRELQTMRLLDH 123
           Q  +   Y   R VG+G +  VF+   +   E   + I K ++ K+ K        L   
Sbjct: 26  QWGEQDDYEVVRKVGRGKYSEVFEGINVNNNEKCIIKILKPVKKKKIKREIKILQNLCGG 85
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PN+V L        D+     +L+ EYV  T       F  L   +    ++ Y Y++ +
Sbjct: 86  PNIVKLLDI---VRDQHSKTPSLIFEYVNNT------DFKVLYPTLTDYDIRYYIYELLK 136
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           AL Y H S G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PE
Sbjct: 137 ALDYCH-SQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPE 195
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           L+    +Y  ++D+WS GC+ A ++  K P F G    DQLV+I KVLGT        +N
Sbjct: 196 LLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT------DGLN 249
Query: 303 PNYTEFKF---PQIKA-------HPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
               +++    PQ++A        PW K         + PEA+D + +LL+Y    R TA
Sbjct: 250 VYLNKYRIELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTA 309
Query: 349 VS 350
           + 
Sbjct: 310 LE 311

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 90/269 (33%), Positives = 133/269 (49%), Gaps = 40/269 (14%)
Query: 113 RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQ 167
           RE+  +R L HPNV+SL+  F S  D+    + L+ +Y    +  ++K       NK   
Sbjct: 67  REIALLRELKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPV 123
Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL 224
           ++P   VK   YQI   + Y+H +  V HRD+KP N+LV    P   +VK+ D G A++ 
Sbjct: 124 QLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 182
Query: 225 ---VKGEPNIS-YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF------ 274
              +K   ++   + + +YRAPEL+ GA  YT AIDIW+ GC+ AEL+  +P+F      
Sbjct: 183 NSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 242
Query: 275 ---PGDSGVDQLVEIIKVLGTPTR---EEIKCMNPNYTEFK-FPQ--------IKAHPWH 319
                    DQL  I  V+G P     E+IK M  + T  K F +        IK    H
Sbjct: 243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKH 302
Query: 320 KIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           K+ P     +A  L+ +LL   P  R T+
Sbjct: 303 KVKPDS---KAFHLLQKLLTMDPIKRITS 328

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  114 bits (285), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 24/216 (11%)
Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           LV EY+  T       F +L Q +    ++ Y Y++ +AL Y H S G+ HRD+KP N++
Sbjct: 112 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 164
Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVA 265
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC++A
Sbjct: 165 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 224
Query: 266 ELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 316
            ++  + P F G    DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 225 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 280
Query: 317 PWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
            W           + PEA+DL+ +LL+Y    R TA
Sbjct: 281 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTA 316

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  114 bits (285), Expect = 9e-26,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 111/216 (51%), Gaps = 24/216 (11%)
Query: 146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL 205
           LV EY+  T       F +L Q +    ++ Y Y++ +AL Y H S G+ HRD+KP N++
Sbjct: 117 LVFEYINNT------DFKQLYQILTDFDIRFYMYELLKALDYCH-SKGIMHRDVKPHNVM 169
Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVA 265
           ++    +++L D+G A+     +     + SRY++ PEL+     Y  ++D+WS GC++A
Sbjct: 170 IDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLA 229
Query: 266 ELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKC--------MNPNYTEFKFPQIKAH 316
            ++  + P F G    DQLV I KVLGT   EE+          ++P++ +    Q    
Sbjct: 230 SMIFRREPFFHGQDNYDQLVRIAKVLGT---EELYGYLKKYHIDLDPHFNDI-LGQHSRK 285
Query: 317 PWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
            W           + PEA+DL+ +LL+Y    R TA
Sbjct: 286 RWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTA 321

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 105/351 (29%), Positives = 156/351 (44%), Gaps = 94/351 (26%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPN 125
           +Y  + ++G+GS+G V+ A      + VAIKKV      L D +   RE+  +  L    
Sbjct: 29  NYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDY 88
Query: 126 VVSLKHCFFSTTDK---DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           ++ L H      D    DELY+  VLE     + ++ K    L ++    +VK   Y + 
Sbjct: 89  IIRL-HDLIIPEDLLKFDELYI--VLEIADSDLKKLFKTPIFLTEQ----HVKTILYNLL 141
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----------- 231
               +IH S G+ HRD+KP N L+N     VK+CDFG A+  +  + +I           
Sbjct: 142 LGEKFIHES-GIIHRDLKPANCLLNQDC-SVKICDFGLART-INSDKDIHIVNDLEEKEE 198
Query: 232 ----------------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGK--- 271
                           S++ +R+YRAPELI     YT +IDIWS GC+ AEL+ + K   
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHI 258
Query: 272 -------PLFPGD-----------------SGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
                  PLFPG                  S  DQL  I  V+GTP  E++KC+      
Sbjct: 259 NNPTNRFPLFPGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCIT----- 313
Query: 308 FKFPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCT 347
            K   IK   + K+FP R           +  E +DL+  +L+++   R T
Sbjct: 314 -KQEVIK---YIKLFPTRDGIDLSKKYSSISKEGIDLLESMLRFNAQKRIT 360

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 158
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 216
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 292 TP 293
            P
Sbjct: 276 IP 277

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 28  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 86
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 87  LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 139
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 140 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIY 197
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 198 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 256
Query: 292 TP 293
            P
Sbjct: 257 IP 258

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/242 (33%), Positives = 132/242 (54%), Gaps = 22/242 (9%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD 122
           +NG+ K    Y  + ++G+GSFG V +A      E VAIK +   K + N+    +RLL+
Sbjct: 47  KNGE-KWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLE 105
Query: 123 HPN---------VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
             N         +V LK  F         +L LV E +   ++ ++++ N   + + +  
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRN-----HLCLVFEMLSYNLYDLLRNTN--FRGVSLNL 158
Query: 174 VKLYAYQIFRALSYIHR-SIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            + +A Q+  AL ++    + + H D+KP+N LL NP    +K+ DFGS+  L  G+   
Sbjct: 159 TRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIY 216
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             I SR+YR+PE++ G   Y  AID+WS GC++ E+  G+PLF G + VDQ+ +I++VLG
Sbjct: 217 QXIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLG 275
Query: 292 TP 293
            P
Sbjct: 276 IP 277

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 83/285 (29%), Positives = 145/285 (50%), Gaps = 24/285 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 133 F---FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                S  ++ +  + LV ++     H +    + +  +  +  +K     +   L YIH
Sbjct: 86  CRTKASPYNRCKASIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIH 142
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAPEL 244
           R+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR PEL
Sbjct: 143 RN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPPEL 200
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           + G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++ N
Sbjct: 201 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD-N 259
Query: 305 YTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLR 345
           Y  ++  ++      K+  +       P A+DL+ +LL   P  R
Sbjct: 260 YELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQR 304

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  112 bits (279), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 28/290 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTA 348
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  +
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 307

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 28/290 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 26  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 85
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 86  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 141 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 258
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTA 348
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  +
Sbjct: 259 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 307

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  111 bits (278), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 145/290 (50%), Gaps = 28/290 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV+L   
Sbjct: 25  IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI 84
Query: 133 FFSTTD-----KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
             +        K  +YL  V ++     H +    + +  +  +  +K     +   L Y
Sbjct: 85  CRTKASPYNRCKGSIYL--VFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV---KGEPN--ISYICSRYYRAP 242
           IHR+  + HRD+K  N+L+      +KL DFG A+        +PN   + + + +YR P
Sbjct: 140 IHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 197
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           EL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E    ++
Sbjct: 198 ELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVD 257
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMP----PEAVDLVSRLLQYSPNLRCTA 348
            NY  ++  ++      K+  +       P A+DL+ +LL   P  R  +
Sbjct: 258 -NYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 148/321 (46%), Gaps = 42/321 (13%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 125 N--------VVSLKHCF-----FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           N         +   H       F+    + +++ +V E + E +  ++K +   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 226
           IYVK  + Q+   L Y+HR  G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------V 280
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 281 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FPKRMP 327
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 328 PEAVDLVSRLLQYSPNLRCTA 348
            E  D +S +LQ  P  R  A
Sbjct: 308 KEISDFLSPMLQLDPRKRADA 328

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 91/321 (28%), Positives = 148/321 (46%), Gaps = 42/321 (13%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G+P +   Y+  R +G G F  V+ AK +     VA+K V  DK Y       ++LL   
Sbjct: 13  GEPYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV 72
Query: 125 N--------VVSLKHCF-----FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           N         +   H       F+    + +++ +V E + E +  ++K +   ++ +P+
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPL 130
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-----PHTHQVKLCDFGSAKVLVK 226
           IYVK  + Q+   L Y+HR  G+ H DIKP+N+L+       +  Q+K+ D G+A     
Sbjct: 131 IYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWY 188
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------V 280
            E   + I +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       
Sbjct: 189 DEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD 247
Query: 281 DQLVEIIKVLG------------TPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FPKRMP 327
           D + +II++LG            T T    + +  N ++ KF  ++     K  F K   
Sbjct: 248 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEA 307
Query: 328 PEAVDLVSRLLQYSPNLRCTA 348
            E  D +S +LQ  P  R  A
Sbjct: 308 KEISDFLSPMLQLDPRKRADA 328

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 138/287 (48%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 51  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 110
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 111 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 160
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 161 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 219
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 220 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 264
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A
Sbjct: 265 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISA 299

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  106 bits (264), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 138/287 (48%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 52  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 111
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 112 IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 161
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 162 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 220
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 221 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 265
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A
Sbjct: 266 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISA 300

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 138/287 (48%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISA 276

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  104 bits (260), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 138/287 (48%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 34  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 93
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 94  IMKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 143
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 144 GITYMHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 202
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 203 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 247
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              YT F+ PQ     W     K++   A DL+ ++L Y P++R +A
Sbjct: 248 -GKYT-FELPQ-----W-----KKVSESAKDLIRKMLTYVPSMRISA 282

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGCLLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 201 VSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 249
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 250 -------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  102 bits (254), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 83/287 (28%), Positives = 134/287 (46%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-------KVLQDKRYKNRELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K       K   DK    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
           +  L   F     +D+ Y  LV E     V+   + F+++   +R   +       Q+  
Sbjct: 88  IXKLYEFF-----EDKGYFYLVGE-----VYTGGELFDEIISRKRFSEVDAARIIRQVLS 137
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y H++  + HRD+KP+NLL+   +    +++ DFG +      +     I + YY A
Sbjct: 138 GITYXHKN-KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIA 196
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  D L ++ K             
Sbjct: 197 PEVLHGT--YDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEK------------- 241
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              YT F+ PQ     W     K++   A DL+ + L Y P+ R +A
Sbjct: 242 -GKYT-FELPQ-----W-----KKVSESAKDLIRKXLTYVPSXRISA 276

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 143
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y
Sbjct: 144 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQY 201
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 202 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 250
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 251 -------EYDFPE-------KFFPK-----ARDLVEKLL 270

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 66/280 (23%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEI 298
            +PEL+   +   ++ D+W+ GC++ +L+ G P F  G+ G+    +IIK+         
Sbjct: 201 VSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKL--------- 249
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                   E+ FP+       K FPK     A DLV +LL
Sbjct: 250 --------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  101 bits (252), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 135/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 139
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     S++ +  Y
Sbjct: 140 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQY 197
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 198 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 246
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 247 -------EYDFPE-------KFFPK-----ARDLVEKLL 266

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  101 bits (252), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 85/279 (30%), Positives = 133/279 (47%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 43  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 102
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             CF    D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 103 YFCF---QDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 147
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 148 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 205
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 206 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 254
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 255 -------EYDFPE-------KFFPK-----ARDLVEKLL 274

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 135/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K     +++ +  Y
Sbjct: 141 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANAFVGTAQY 198
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 199 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 247
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 248 -------EYDFPE-------KFFPK-----ARDLVEKLL 267

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  101 bits (251), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 88/282 (31%), Positives = 138/282 (48%), Gaps = 70/282 (24%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 240 RAPELIFGATEYTT--AIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTRE 296
            +PEL+   TE +   + D+W+ GC++ +L+ G P F  G+ G+    +IIK+       
Sbjct: 201 VSPELL---TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGL-IFAKIIKL------- 249
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                     E+ FP+       K FPK     A DLV +LL
Sbjct: 250 ----------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 201 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 249
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 250 -------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 201 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 249
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 250 -------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  100 bits (249), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 68/281 (24%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 39  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 98
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 99  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 143
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 144 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 201
Query: 240 RAPELIFGATEYTT--AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            +PEL+   TE +   + D+W+ GC++ +L+ G P F   +      +IIK+        
Sbjct: 202 VSPELL---TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------- 250
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                    E+ FP+       K FPK     A DLV +LL
Sbjct: 251 ---------EYDFPE-------KFFPK-----ARDLVEKLL 270

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  100 bits (248), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 141 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 199 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 247
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 248 -------EYDFPE-------KFFPK-----ARDLVEKLL 267

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 141 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 199 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 247
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 248 -------EYDFPE-------KFFPK-----ARDLVEKLL 267

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 38  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 97
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 98  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 143 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 200
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 201 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 249
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 250 -------EYDFPE-------KFFPK-----ARDLVEKLL 269

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 20  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 79
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 80  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 124
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 125 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 182
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 183 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 231
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 232 -------EYDFPE-------KFFPK-----ARDLVEKLL 251

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 66/280 (23%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 128
           +I+G+GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 13  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 71
Query: 129 LKHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L   +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I
Sbjct: 72  L---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEI 116
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRY 238
             AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  
Sbjct: 117 VSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQ 174
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+         
Sbjct: 175 YVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 224
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                   E+ FP+       K FPK     A DLV +LL
Sbjct: 225 --------EYDFPE-------KFFPK-----ARDLVEKLL 244

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 66/280 (23%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 128
           +I+G+GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 15  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 73
Query: 129 LKHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L   +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I
Sbjct: 74  L---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEI 118
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRY 238
             AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  
Sbjct: 119 VSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQ 176
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+         
Sbjct: 177 YVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 226
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                   E+ FP+       K FPK     A DLV +LL
Sbjct: 227 --------EYDFPE-------KFFPK-----ARDLVEKLL 246

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 66/280 (23%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 128
           +I+G+GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 16  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 74
Query: 129 LKHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L   +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I
Sbjct: 75  L---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEI 119
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRY 238
             AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  
Sbjct: 120 VSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQ 177
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+         
Sbjct: 178 YVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 227
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                   E+ FP+       K FPK     A DLV +LL
Sbjct: 228 --------EYDFPE-------KFFPK-----ARDLVEKLL 247

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/280 (30%), Positives = 133/280 (47%), Gaps = 66/280 (23%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------YKNRELQTMRLLDHPNVVS 128
           +I+G+GSF  V  A+ L T    AIK +L+ +         Y  RE   M  LDHP  V 
Sbjct: 14  KILGEGSFSTVVLARELATSREYAIK-ILEKRHIIKENKVPYVTRERDVMSRLDHPFFVK 72
Query: 129 LKHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           L   +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I
Sbjct: 73  L---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEI 117
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRY 238
             AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  
Sbjct: 118 VSALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQ 175
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+         
Sbjct: 176 YVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL--------- 225
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                   E+ FP+       K FPK     A DLV +LL
Sbjct: 226 --------EYDFPE-------KFFPK-----ARDLVEKLL 245

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 84/279 (30%), Positives = 134/279 (48%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 35  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 94
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 95  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 139
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 140 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 197
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 198 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 246
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 247 -------EYDFPE-------KFFPK-----ARDLVEKLL 266

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 73/215 (33%), Positives = 109/215 (50%), Gaps = 17/215 (7%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHP 124
           ++  E+ +G+G F  V++A CL  G  VA+KKV    L D + +    +E+  ++ L+HP
Sbjct: 33  NFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 92
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           NV+     F    +     LN+VLE      + R++KHF K  + +P   V  Y  Q+  
Sbjct: 93  NVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCS 147
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAP 242
           AL ++H S  V HRDIKP N+ +   T  VKL D G  +    K     S + + YY +P
Sbjct: 148 ALEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSP 205
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD 277
           E I     Y    DIWS GC++ E+   +  F GD
Sbjct: 206 ERIH-ENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 98.6 bits (244), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 83/279 (29%), Positives = 133/279 (47%), Gaps = 64/279 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF     A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 96  ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 141 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 198
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            +PEL+   +   ++ D+W+ GC++ +L+ G P F   +      +IIK+          
Sbjct: 199 VSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL---------- 247
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                  E+ FP+       K FPK     A DLV +LL
Sbjct: 248 -------EYDFPE-------KFFPK-----ARDLVEKLL 267

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 133/281 (47%), Gaps = 68/281 (24%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++ +  Y  RE   M  LDHP  V L
Sbjct: 41  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 100
Query: 130 KHCFFSTTDKDELYLNL-------VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
              +F+  D ++LY  L       +L+Y+     R +  F++   R        Y  +I 
Sbjct: 101 ---YFTFQDDEKLYFGLSYAKNGELLKYI-----RKIGSFDETCTR-------FYTAEIV 145
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYY 239
            AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL    K      ++ +  Y
Sbjct: 146 SALEYLHGK-GIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANXFVGTAQY 203
Query: 240 RAPELIFGATEYTT--AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            +PEL+   TE +   + D+W+ GC++ +L+ G P F   +      +IIK+        
Sbjct: 204 VSPELL---TEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKL-------- 252
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                    E+ FP          FPK     A DLV +LL
Sbjct: 253 ---------EYDFPA-------AFFPK-----ARDLVEKLL 272

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 46/281 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             PQ     W  I       +A DL+ ++L + P+LR TA 
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITAT 272

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 46/281 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 133
           ++G+G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 88
Query: 134 FSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                 +  ++ + +E VP      + R      K N++     +  Y  QI   L Y+H
Sbjct: 89  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLKYLH 139
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-G 247
            +  + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 140 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  A DIWS GC + E+  GKP F                        +   P    
Sbjct: 199 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 235
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           FK    K HP     P+ M  EA   + +  +  P+ R  A
Sbjct: 236 FKVGMFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACA 273

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 95.5 bits (236), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 76/281 (27%), Positives = 124/281 (44%), Gaps = 46/281 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYK---NRELQTMRLLDHPNVVSLKHCF 133
           ++G+G++G+V+  + L     +AIK++ + D RY    + E+   + L H N+V     F
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSF 74
Query: 134 FSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                 +  ++ + +E VP      + R      K N++     +  Y  QI   L Y+H
Sbjct: 75  -----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT----IGFYTKQILEGLKYLH 125
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIF-G 247
            +  + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I  G
Sbjct: 126 DN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y  A DIWS GC + E+  GKP F                        +   P    
Sbjct: 185 PRGYGKAADIWSLGCTIIEMATGKPPF-----------------------YELGEPQAAM 221
Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           FK    K HP     P+ M  EA   + +  +  P+ R  A
Sbjct: 222 FKVGMFKVHPE---IPESMSAEAKAFILKCFEPDPDKRACA 259

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 46/281 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             PQ     W  I       +A DL+ ++L + P+LR TA 
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITAT 272

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 95.1 bits (235), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 78/281 (27%), Positives = 127/281 (45%), Gaps = 46/281 (16%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLK 130
           ++G+GSFG V + K   T +  A+K V+     KN       RE++ ++ LDHPN++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVK-VINKASAKNKDTSTILREVELLKKLDHPNIMKL- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             F    D    Y+   L    E    ++K   + ++      +K    Q+F  ++Y+H+
Sbjct: 87  --FEILEDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSGITYMHK 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
              + HRD+KP+N+L+        +K+ DFG +    +       I + YY APE++ G 
Sbjct: 140 H-NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGT 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WSAG ++  L+ G P F G +  D L               K +      F
Sbjct: 199 --YDEKCDVWSAGVILYILLSGTPPFYGKNEYDIL---------------KRVETGKYAF 241
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
             PQ     W  I       +A DL+ ++L + P+LR TA 
Sbjct: 242 DLPQ-----WRTI-----SDDAKDLIRKMLTFHPSLRITAT 272

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 94.7 bits (234), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 80/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+   +   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F  +T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDSTR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKKVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  D    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 61  GGRN-GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---- 113
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 2   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 60
Query: 114 -ELQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ--R 168
            E+Q M+ L+HPNVVS +           ++L L L +EY      R  K+ N+      
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 117
Query: 169 MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVK 226
           +    ++     I  AL Y+H +  + HRD+KP+N+++ P   ++  K+ D G AK L +
Sbjct: 118 LKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 176
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFP 275
           GE    ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 177 GELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 31  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 90
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 91  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 141
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 142 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 198
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 199 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 240
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 241 TFPDF------------VTEGARDLISRLLKHNPSQR 265

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 78/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 61  GGRN-GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR---- 113
           GGR+   P QT     M ER+ G G FG V +    +TGE VAIK+  Q+   KNR    
Sbjct: 3   GGRSPSLPTQTCGPWEMKERL-GTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWC 61
Query: 114 -ELQTMRLLDHPNVVSLKHC--FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ--R 168
            E+Q M+ L+HPNVVS +           ++L L L +EY      R  K+ N+      
Sbjct: 62  LEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL-LAMEYCEGGDLR--KYLNQFENCCG 118
Query: 169 MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV--KLCDFGSAKVLVK 226
           +    ++     I  AL Y+H +  + HRD+KP+N+++ P   ++  K+ D G AK L +
Sbjct: 119 LKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ 177
Query: 227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFP 275
           GE    ++ +  Y APEL+    +YT  +D WS G +  E + G +P  P
Sbjct: 178 GELCTEFVGTLQYLAPELL-EQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 151 H-SKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 207
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQR 274

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 13  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 72
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 73  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 123
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 124 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 180
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 181 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 222
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 223 TFPDF------------VTEGARDLISRLLKHNPSQR 247

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNPSQR 252

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 47/283 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 74
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 75  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 125
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 126 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 183
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 184 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 229
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           YT                PK + P A  L+ R+L  +P  R +
Sbjct: 230 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRIS 257

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 47/283 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 68
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 69  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 119
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 120 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 177
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 178 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 223
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           YT                PK + P A  L+ R+L  +P  R +
Sbjct: 224 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRIS 251

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 93.2 bits (230), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 47/283 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 73
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 74  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 125 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 183 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 228
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           YT                PK + P A  L+ R+L  +P  R +
Sbjct: 229 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRIS 256

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTELCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 182
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY+P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY+P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYMPGG--DMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 83/283 (29%), Positives = 132/283 (46%), Gaps = 47/283 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNR---ELQTMRLLDHP 124
           +Y   + +G+GSFG V  A    TG+ VA+K    KVL     + R   E+  +RLL HP
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHP 64
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +++ L     S   KDE+ +  V+EY    +   +   +K++++      + +  QI  A
Sbjct: 65  HIIKLYDVIKS---KDEIIM--VIEYAGNELFDYIVQRDKMSEQE----ARRFFQQIISA 115
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ H + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 116 VEYCHRH-KIVHRDLKPENLLLDEHLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 173
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G       +D+WS G V+  +ML + L   D  +  L + I              N  
Sbjct: 174 ISGKLYAGPEVDVWSCG-VILYVMLCRRLPFDDESIPVLFKNIS-------------NGV 219
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           YT                PK + P A  L+ R+L  +P  R +
Sbjct: 220 YT---------------LPKFLSPGAAGLIKRMLIVNPLNRIS 247

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRAALCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEXIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 X-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 182
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 183 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 224
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 225 TFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 127 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQR 250

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K +E    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGLAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPE 204
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 205 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 40  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 99
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 100 YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 150
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 151 H-SKRVIHRDIKPENLLLG-SAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 207
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 208 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 249
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 250 TFPDF------------VTEGARDLISRLLKHNPSQR 274

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 14  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 73
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 74  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 124
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 125 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPEMIEGR 181
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 182 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 223
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 224 TFPDF------------VTEGARDLISRLLKHNPSQR 248

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/229 (33%), Positives = 117/229 (51%), Gaps = 19/229 (8%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 19  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 78
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 79  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 133
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  
Sbjct: 134 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWTLCGTPE 189
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 190 YLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ L
Sbjct: 11  RPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 70
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 71  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 122 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 178
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 179 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 220
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 221 TFPDF------------VTEGARDLISRLLKHNPSQR 245

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 80/284 (28%), Positives = 132/284 (46%), Gaps = 64/284 (22%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 75  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-------SAKVLVKGEPNISYICSRYYRA 241
           H S  V HRDIKP+NLL+     ++K+ DFG       S +  + G  +        Y  
Sbjct: 126 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWSCHAPSSRRTTLSGTLD--------YLP 175
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   +   +D+WS G +  E ++GKP F  ++  +    I +V            
Sbjct: 176 PEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV------------ 222
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                EF FP              +   A DL+SRLL+++P+ R
Sbjct: 223 -----EFTFPDF------------VTEGARDLISRLLKHNPSQR 249

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYVP     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 91.7 bits (226), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLTKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 79/277 (28%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 91.7 bits (226), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 16  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 76  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 127 H-SKRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 183
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 184 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 225
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 226 TFPDF------------VTEGARDLISRLLKHNPSQR 250

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 78/277 (28%), Positives = 131/277 (47%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 17  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 76
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  +K +++    Y+     ++  ALSY 
Sbjct: 77  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSKFDEQRTATYIT----ELANALSYC 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ +FG + V        +   +  Y  PE+I G 
Sbjct: 128 H-SKRVIHRDIKPENLLLGS-AGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 184
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 185 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 226
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 227 TFPDF------------VTEGARDLISRLLKHNPSQR 251

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K +E    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGLAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFXEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 130/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P   V++ ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 54  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 113
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 114 RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 168
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 169 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 223
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 224 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           + ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFSEPHARFYA 140
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/233 (31%), Positives = 121/233 (51%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ------ 116
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++++      
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 117 -TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
             ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 123/233 (52%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEK 92
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           + ++ ++ P +V L++ F     KD   L +V+EYVP     +  H  ++  R    + +
Sbjct: 93  RILQAVNFPFLVKLEYSF-----KDNSNLYMVMEYVPGG--EMFSHLRRIG-RFSEPHAR 144
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C
Sbjct: 145 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLC 199
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 200 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/277 (27%), Positives = 129/277 (46%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 19  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 78
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P   V++ ++  +K +++    Y+     ++  ALSY 
Sbjct: 79  YGYFHDATR-----VYLILEYAPRGEVYKELQKLSKFDEQRTATYIT----ELANALSYC 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+     ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 130 H-SKRVIHRDIKPENLLLGS-AGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPEMIEGR 186
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++GKP F  ++  +    I +V                 EF
Sbjct: 187 M-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-----------------EF 228
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
            FP              +   A DL+SRLL+++P+ R
Sbjct: 229 TFPDF------------VTEGARDLISRLLKHNPSQR 253

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 75/230 (32%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EY P     +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 120/233 (51%), Gaps = 27/233 (11%)
Query: 67  PKQTISYMAE----RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--REL 115
           P Q  +++ +    R +G GSFG V   K  ETG   A+K     KV++ K+ ++   E 
Sbjct: 34  PAQNTAHLDQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           +  + ++ P +V L+   FS  D   LY  +VLEY P     +  H  ++  R    + +
Sbjct: 94  RIQQAVNFPFLVKLE---FSFKDNSNLY--MVLEYAPGG--EMFSHLRRIG-RFSEPHAR 145
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            YA QI     Y+H S+ + +RD+KP+NLL++   + +K+ DFG AK  VKG      +C
Sbjct: 146 FYAAQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IKVADFGFAK-RVKG--RTWXLC 200
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 201 GTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 77/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 26  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 85
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EYVP     +  H  ++  R    + + YA
Sbjct: 86  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYVPGG--EMFSHLRRIG-RFXEPHARFYA 140
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 141 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTP 195
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 196 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 243

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/263 (26%), Positives = 124/263 (47%), Gaps = 31/263 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 59  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 118
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 119 LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 173
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---FGAT 249
            V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I       
Sbjct: 174 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQK 232
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------------- 296
            Y+   DIWS G  + EL + +  FP DS      ++ +V+  P+ +             
Sbjct: 233 GYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVDF 290
Query: 297 EIKCMNPNYTEF-KFPQIKAHPW 318
             +C+  N  E   +P++  HP+
Sbjct: 291 TSQCLKKNSKERPTYPELMQHPF 313

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 115/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K  ETG   A+K + + K  K ++    L   
Sbjct: 34  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEK 93
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY+  V+EY P     +  H  ++  R    + + YA
Sbjct: 94  RILQAVNFPFLVKLEFSFKDNSNLYM--VMEYAPGG--EMFSHLRRIG-RFSEPHARFYA 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NL+++   + +K+ DFG AK  VKG      +C   
Sbjct: 149 AQIVLTFEYLH-SLDLIYRDLKPENLMIDQQGY-IKVTDFGFAK-RVKGR--TWXLCGTP 203
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 204 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 76/230 (33%), Positives = 116/230 (50%), Gaps = 21/230 (9%)
Query: 67  PKQTISYMA--ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTM 118
           P Q  +++   ERI  +G GSFG V   K +ETG   A+K + + K  K ++    L   
Sbjct: 33  PAQNTAHLDQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEK 92
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           R+L   N   L    FS  D   LY  +V+EYV      +  H  ++  R    + + YA
Sbjct: 93  RILQAVNFPFLVKLEFSFKDNSNLY--MVMEYVAGG--EMFSHLRRIG-RFSEPHARFYA 147
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR- 237
            QI     Y+H S+ + +RD+KP+NLL++   + +++ DFG AK  VKG      +C   
Sbjct: 148 AQIVLTFEYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG--RTWXLCGTP 202
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y APE+I  +  Y  A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 EYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 89.0 bits (219), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 60  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 119
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 120 RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 171
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 172 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 226
Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKP 251

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 65/205 (31%), Positives = 102/205 (49%), Gaps = 22/205 (10%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN +  
Sbjct: 21  REIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQY 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C+       E    LV+EY   +   +++   K  Q + +  V   A Q    L+Y+H
Sbjct: 81  RGCYLR-----EHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ---GLAYLH 132
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S  + HRD+K  N+L++     VKL DFGSA ++    P   ++ + Y+ APE+I    
Sbjct: 133 -SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMA---PANXFVGTPYWMAPEVILAMD 187
Query: 250 E--YTTAIDIWSAGCVVAELMLGKP 272
           E  Y   +D+WS G    EL   KP
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 127/264 (48%), Gaps = 33/264 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++      Q+++    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 248
            V HRD+KP N+L+N    QVK+CDFG +  LV     +I   C + Y APE I      
Sbjct: 130 SVIHRDVKPSNVLINA-LGQVKMCDFGISGYLVDDVAKDIDAGC-KPYMAPERINPELNQ 187
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------------ 296
             Y+   DIWS G  + EL + +  FP DS      ++ +V+  P+ +            
Sbjct: 188 KGYSVKSDIWSLGITMIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 245
Query: 297 -EIKCMNPNYTEF-KFPQIKAHPW 318
              +C+  N  E   +P++  HP+
Sbjct: 246 FTSQCLKKNSKERPTYPELMQHPF 269

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 52/285 (18%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   K   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVK-ILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + +D     + +V+EYV   E    + K     N R+     +    QI 
Sbjct: 77  HIIKLYQVISTPSD-----IFMVMEYVSGGELFDYICK-----NGRLDEKESRRLFQQIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             + Y HR + V HRD+KP+N+L++ H +  K+ DFG + ++  GE       S  Y AP
Sbjct: 127 SGVDYCHRHM-VVHRDLKPENVLLDAHMN-AKIADFGLSNMMSDGEFLRXSCGSPNYAAP 184
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+I G       +DIWS+G ++  L+ G   F  D               PT  +  C  
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-------------VPTLFKKICDG 231
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             YT                P+ + P  + L+  +LQ  P  R T
Sbjct: 232 IFYT----------------PQYLNPSVISLLKHMLQVDPMKRAT 260

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 88.2 bits (217), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 104/208 (50%), Gaps = 23/208 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + TD       +V+EYV   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            A+ Y HR + V HRD+KP+N+L++ H    K+ DFG + ++  GE   +   S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRTSCGSPNYAAP 179
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG 270
           E+I G       +DIWS G ++  L+ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 88.2 bits (217), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 50/279 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  ++ +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRTTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            FP              +   A DL+SRLL+++ + R T
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLT 254

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 56/294 (19%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 18  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 76
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 77  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 127
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 128 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 184
Query: 237 R-YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 185 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 234
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 235 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 274

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 56/294 (19%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 268

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 56/294 (19%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 268

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 42/283 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 11  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 70
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   TD   +YL + L    E   RVV H     +      +K     +  A++Y 
Sbjct: 71  LYETFEDNTD---IYLVMELCTGGELFERVV-HKRVFRESDAARIMK----DVLSAVAYC 122
Query: 189 HRSIGVCHRDIKPQN--LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H+ + V HRD+KP+N   L +     +KL DFG A     G+   + + + YY +P+++ 
Sbjct: 123 HK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    D WSAG ++  L+ G P F   +  + +++I +  GT              
Sbjct: 182 GL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-------------- 223
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
            F FP+     W  +      P+A  L+ RLL  SP  R T++
Sbjct: 224 -FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSL 257

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 87.8 bits (216), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 42/283 (14%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y  E  +G+GS+G V  A    T    A KK+    ++D     +E++ M+ LDHPN++ 
Sbjct: 28  YTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIR 87
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F   TD   +YL + L    E   RVV H     +      +K     +  A++Y 
Sbjct: 88  LYETFEDNTD---IYLVMELCTGGELFERVV-HKRVFRESDAARIMK----DVLSAVAYC 139
Query: 189 HRSIGVCHRDIKPQN--LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H+ + V HRD+KP+N   L +     +KL DFG A     G+   + + + YY +P+++ 
Sbjct: 140 HK-LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 198
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           G   Y    D WSAG ++  L+ G P F   +  + +++I +  GT              
Sbjct: 199 GL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIRE--GT-------------- 240
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
            F FP+     W  +      P+A  L+ RLL  SP  R T++
Sbjct: 241 -FTFPE---KDWLNV-----SPQAESLIRRLLTKSPKQRITSL 274

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/208 (30%), Positives = 103/208 (49%), Gaps = 23/208 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y+    +G G+FG V   +   TG  VA+K +L  ++ ++        RE+Q ++L  HP
Sbjct: 13  YVLGDTLGVGTFGKVKIGEHQLTGHKVAVK-ILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +++ L     + TD       +V+EYV   E    + KH      R+  +  +    QI 
Sbjct: 72  HIIKLYQVISTPTD-----FFMVMEYVSGGELFDYICKH-----GRVEEMEARRLFQQIL 121
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            A+ Y HR + V HRD+KP+N+L++ H    K+ DFG + ++  GE       S  Y AP
Sbjct: 122 SAVDYCHRHM-VVHRDLKPENVLLDAHM-NAKIADFGLSNMMSDGEFLRDSCGSPNYAAP 179
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLG 270
           E+I G       +DIWS G ++  L+ G
Sbjct: 180 EVISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 56/294 (19%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 70
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 71  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 121
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 122 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 178
Query: 237 R-YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 228
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 229 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 268

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 80/294 (27%), Positives = 139/294 (47%), Gaps = 56/294 (19%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAIK ++  +++                E++ ++
Sbjct: 11  YIMSKTLGSGACGEVKLAFERKTCKKVAIK-IISKRKFAIGSAREADPALNVETEIEILK 69
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 70  KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 120
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNI-SYICS 236
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L  GE ++   +C 
Sbjct: 121 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--GETSLMRTLCG 177
Query: 237 R-YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
              Y APE++   G   Y  A+D WS G ++   + G P F        L          
Sbjct: 178 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL---------- 227
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            +++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 228 -KDQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 267

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 82/306 (26%), Positives = 139/306 (45%), Gaps = 54/306 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVV 127
           ++ +R +G G+FG V   +   +G    IK + +D+          E++ ++ LDHPN++
Sbjct: 24  FIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNII 83
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +   F    D   +Y+ +      E + R+V    +  + +   YV     Q+  AL+Y
Sbjct: 84  KIFEVF---EDYHNMYIVMETCEGGELLERIVSAQAR-GKALSEGYVAELMKQMMNALAY 139
Query: 188 IHRSIGVCHRDIKPQNLL---VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
            H S  V H+D+KP+N+L    +PH+  +K+ DFG A++    E + +   +  Y APE+
Sbjct: 140 FH-SQHVVHKDLKPENILFQDTSPHS-PIKIIDFGLAELFKSDEHSTNAAGTALYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                + T   DIWSAG V+  L+ G   F G S    L E+        +++     PN
Sbjct: 198 F--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS----LEEV--------QQKATYKEPN 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVL 364
           Y       ++  P        + P+AVDL+ ++L   P  R +A              VL
Sbjct: 244 YA------VECRP--------LTPQAVDLLKQMLTKDPERRPSAAQ------------VL 277
Query: 365 HHFCFR 370
           HH  F+
Sbjct: 278 HHEWFK 283

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 77/279 (27%), Positives = 130/279 (46%), Gaps = 50/279 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN++ L
Sbjct: 18  RPLGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRL 77
Query: 130 KHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   T      + L+LEY P  TV+R ++  ++ +++    Y+     ++  ALSY 
Sbjct: 78  YGYFHDATR-----VYLILEYAPLGTVYRELQKLSRFDEQRTATYIT----ELANALSYC 128
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H S  V HRDIKP+NLL+  +  ++K+ DFG + V        +   +  Y  PE+I G 
Sbjct: 129 H-SKRVIHRDIKPENLLLGSNG-ELKIADFGWS-VHAPSSRRDTLCGTLDYLPPEMIEGR 185
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             +   +D+WS G +  E ++G P F   +  +    I +V                 EF
Sbjct: 186 M-HDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRISRV-----------------EF 227
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            FP              +   A DL+SRLL+++ + R T
Sbjct: 228 TFPDF------------VTEGARDLISRLLKHNASQRLT 254

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 119/229 (51%), Gaps = 30/229 (13%)
Query: 76  ERI--VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNV 126
           ERI  +G G+ GVV + +   +G  +A       IK  ++++    RELQ +   + P +
Sbjct: 19  ERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQII--RELQVLHECNSPYI 76
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V     F+S  +     +++ +E++   ++ +V+K      +R+P   +   +  + R L
Sbjct: 77  VGFYGAFYSDGE-----ISICMEHMDGGSLDQVLKE----AKRIPEEILGKVSIAVLRGL 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+     + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y APE +
Sbjct: 128 AYLREKHQIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMAPERL 185
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTP 293
            G T Y+   DIWS G  + EL +G+ P+ P D+      E+  + G P
Sbjct: 186 QG-THYSVQSDIWSMGLSLVELAVGRYPIPPPDAK-----ELEAIFGRP 228

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 90/341 (26%), Positives = 151/341 (44%), Gaps = 70/341 (20%)
Query: 30  NDMKIRDDKEME---ATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAE----RIVGQG 82
           + +K ++++EM+    +  D +G E   + +        +PK  ++ M E    +++G+G
Sbjct: 111 DGLKKQEEEEMDFRSGSPSDNSGAEEMEVSL-------AKPKHRVT-MNEFEYLKLLGKG 162
Query: 83  SFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +FG V   K   TG          E +  K  +     +NR LQ  R   HP + +LK+ 
Sbjct: 163 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALKYS 219
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL Y+H   
Sbjct: 220 F-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALDYLHSEK 271
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +    +Y
Sbjct: 272 NVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-VLEDNDY 329
Query: 252 TTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
             A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+           
Sbjct: 330 GRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----------- 370
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                      FP+ + PEA  L+S LL+  P  R    S+
Sbjct: 371 -----------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 400

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 55/287 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 73  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 124
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 125 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 182
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 183 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 229
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                            FP+ + PEA  L+S LL+  P  R    S+
Sbjct: 230 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 259

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 55/287 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 70
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 71  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 122
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 123 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 180
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 181 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 227
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                            FP+ + PEA  L+S LL+  P  R    S+
Sbjct: 228 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 257

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 55/287 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 15  KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 71
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 72  TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 123
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 124 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKXFCGTPEYLAPE-V 181
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 182 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 228
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                            FP+ + PEA  L+S LL+  P  R    S+
Sbjct: 229 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 258

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 76/285 (26%), Positives = 135/285 (47%), Gaps = 50/285 (17%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK-----KVLQDKRYKNRELQTMRLLDH----P 124
           +++G G++G VF  + +   +TG+  A+K      ++Q  +         ++L+H    P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +V+L + F     + E  L+L+L+Y+      +  H ++  +R     V++Y  +I  A
Sbjct: 120 FLVTLHYAF-----QTETKLHLILDYI--NGGELFTHLSQ-RERFTEHEVQIYVGEIVLA 171
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAP 242
           L ++H+ +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C    Y AP
Sbjct: 172 LEHLHK-LGIIYRDIKLENILLDSNGHVV-LTDFGLSKEFVADETERAYDFCGTIEYMAP 229
Query: 243 ELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           +++ G  + +  A+D WS G ++ EL+ G   F  D   +   EI       +R  +K  
Sbjct: 230 DIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI-------SRRILKSE 282
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
            P                  +P+ M   A DL+ RLL   P  R 
Sbjct: 283 PP------------------YPQEMSALAKDLIQRLLMKDPKKRL 309

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 85.9 bits (211), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/287 (27%), Positives = 127/287 (44%), Gaps = 55/287 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETG----------ETVAIKKVLQDKRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   K   TG          E +  K  +     +NR LQ  R   HP +
Sbjct: 154 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFL 210
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            +LK+ F  T D+    L  V+EY       +  H ++  +       + Y  +I  AL 
Sbjct: 211 TALKYSF-QTHDR----LCFVMEYA--NGGELFFHLSR-ERVFSEDRARFYGAEIVSALD 262
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELI 245
           Y+H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C    Y APE +
Sbjct: 263 YLHSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPE-V 320
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
               +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+     
Sbjct: 321 LEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--EKLFELILM------EEIR----- 367
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                            FP+ + PEA  L+S LL+  P  R    S+
Sbjct: 368 -----------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSE 397

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y  ++ +G+G+F  V  A+ + TG  VA+K +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLQKTIGKGNFAKVKLARHVLTGREVAVKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 123
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 124 VSAVQYCHQKY-IVHRDLKAENLLLDGDMN-IKIADFGFSNEFTVGNKLDTFCGSPPYAA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 52/292 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 195
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 196 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 246
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 237
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 247 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 238 YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            Y APE++   G   Y  A+D WS G ++   + G P F        L           +
Sbjct: 306 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 354
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           ++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 355 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 393

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 136/292 (46%), Gaps = 52/292 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------------NRELQTMR 119
           Y+  + +G G+ G V  A   +T + VAI+ ++  +++                E++ ++
Sbjct: 151 YIMSKTLGSGACGEVKLAFERKTCKKVAIR-IISKRKFAIGSAREADPALNVETEIEILK 209
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
            L+HP ++ +K+ F    D ++ Y+ L L    E   +VV      N+R+     KLY Y
Sbjct: 210 KLNHPCIIKIKNFF----DAEDYYIVLELMEGGELFDKVVG-----NKRLKEATCKLYFY 260
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSR 237
           Q+  A+ Y+H + G+ HRD+KP+N+L++       +K+ DFG +K+L +     +   + 
Sbjct: 261 QMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 238 YYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
            Y APE++   G   Y  A+D WS G ++   + G P F        L           +
Sbjct: 320 TYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSL-----------K 368
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           ++I     N+     P++    W ++  K     A+DLV +LL   P  R T
Sbjct: 369 DQITSGKYNF----IPEV----WAEVSEK-----ALDLVKKLLVVDPKARFT 407

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 108/210 (51%), Gaps = 20/210 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           Y+    +G+GSFG V  A   +T + VA+K + +    K+       RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L     + TD     + +V+EY   E    +V+      +RM     + +  QI  A
Sbjct: 71  IIKLYDVITTPTD-----IVMVIEYAGGELFDYIVE-----KKRMTEDEGRRFFQQIICA 120
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + Y HR   + HRD+KP+NLL++ + + VK+ DFG + ++  G    +   S  Y APE+
Sbjct: 121 IEYCHRH-KIVHRDLKPENLLLDDNLN-VKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           I G       +D+WS G V+  +++G+  F
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.5 bits (210), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/307 (25%), Positives = 130/307 (42%), Gaps = 59/307 (19%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------- 113
           R  + K   SY   R +G G++G V   K        AIK + + +  K R         
Sbjct: 28  RKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIE 87
Query: 114 --------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFN 163
                   E+  ++ LDHPN++ L   F     +D+ Y  LV E+    E   +++   +
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINR-H 141
Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSA 221
           K ++      +K    QI   + Y+H+   + HRDIKP+N+L+        +K+ DFG +
Sbjct: 142 KFDECDAANIMK----QILSGICYLHKH-NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               K       + + YY APE++    +Y    D+WS G ++  L+ G P F G +  D
Sbjct: 197 SFFSKDYKLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            + ++ K                Y +F       + W     K +  EA +L+  +L Y 
Sbjct: 255 IIKKVEK-------------GKYYFDF-------NDW-----KNISDEAKELIKLMLTYD 289
Query: 342 PNLRCTA 348
            N RCTA
Sbjct: 290 YNKRCTA 296

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 181
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG    +   +  Y APE+I  +  Y 
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKG-ATWTLCGTPEYLAPEIIL-SKGYN 237
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 238 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 81/295 (27%), Positives = 132/295 (44%), Gaps = 39/295 (13%)
Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKR 109
           H IVT    + G      +     I+G G FG V + +   TG  +A K +    ++DK 
Sbjct: 75  HRIVT---AKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKE 131
Query: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQ 167
               E+  M  LDH N++ L   F S  D     + LV+EYV   E   R++     L +
Sbjct: 132 EVKNEISVMNQLDHANLIQLYDAFESKND-----IVLVMEYVDGGELFDRIIDESYNLTE 186
Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVK 226
              ++++K    QI   + ++H+ + + H D+KP+N+L VN    Q+K+ DFG A+    
Sbjct: 187 LDTILFMK----QICEGIRHMHQ-MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241
Query: 227 GEPNISYICSRYYRAPELI-FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
            E       +  + APE++ +    + T  D+WS G +   L+ G   F GD+  + L  
Sbjct: 242 REKLKVNFGTPEFLAPEVVNYDFVSFPT--DMWSVGVIAYMLLSGLSPFLGDNDAETLNN 299
Query: 286 IIKVLGTPTREEIKCMNPNYTEF--------KFPQIKA-----HPW---HKIFPK 324
           I+        EE + ++    EF        K  +I A     HPW   HK+  +
Sbjct: 300 ILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHKLHSR 354

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 61/212 (28%), Positives = 111/212 (52%), Gaps = 23/212 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVD 281
           Y+   DIWS G  + E+ +G+ P+ P D+  D
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKED 211

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADEPI-QIYEKI 250

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFAEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 48  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 107
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 108 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 161
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 162 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 216
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 251

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLAGTPEYLAPEIIL-SKGYN 216
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 85.1 bits (209), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 76  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 133
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 134 AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 184
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 185 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 241
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 242 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 270

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L + F     + E  L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 90  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P++   Y+A  I +G+GS G+V  A    TG+ VA+KK+  D R + R      E+  
Sbjct: 41  GDPRE---YLANFIKIGEGSTGIVCIATEKHTGKQVAVKKM--DLRKQQRRELLFNEVVI 95
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV +   +      DEL++  V+E++       +    ++N+      +   
Sbjct: 96  MRDYHHDNVVDMYSSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IATV 146
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              + RALSY+H   GV HRDIK  ++L+     ++KL DFG    + K  P    +  +
Sbjct: 147 CLSVLRALSYLHNQ-GVIHRDIKSDSILLTSDG-RIKLSDFGFCAQVSKEVPKRKXLVGT 204
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE+I     Y T +DIWS G +V E++ G+P
Sbjct: 205 PYWMAPEVI-SRLPYGTEVDIWSLGIMVIEMIDGEP 239

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 68  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 127
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 128 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 181
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 182 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 236
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 237 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 271

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 31  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 90
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 91  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 140
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 141 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 198
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 199 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 247

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/249 (30%), Positives = 120/249 (48%), Gaps = 22/249 (8%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH 123
           QP++    + +  +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D 
Sbjct: 26  QPEEVFDVLEK--LGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDS 83
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           P+VV     +F  TD     L +V+EY    +V  +++  NK    +    +        
Sbjct: 84  PHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNKT---LTEDEIATILQSTL 135
Query: 183 RALSYIH--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRYY 239
           + L Y+H  R I   HRDIK  N+L+N   H  KL DFG A  L       +  I + ++
Sbjct: 136 KGLEYLHFMRKI---HRDIKAGNILLNTEGH-AKLADFGVAGQLTDXMAKRNXVIGTPFW 191
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I     Y    DIWS G    E+  GKP +  D    + + +I     PT  + +
Sbjct: 192 MAPEVI-QEIGYNCVADIWSLGITAIEMAEGKPPY-ADIHPMRAIFMIPTNPPPTFRKPE 249
Query: 300 CMNPNYTEF 308
             + N+T+F
Sbjct: 250 LWSDNFTDF 258

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 69/215 (32%), Positives = 107/215 (49%), Gaps = 15/215 (6%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            + +RD+KP+NLL++   + +++ DFG AK  VKG        +  Y APE+I  +  Y 
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR-TWXLXGTPEYLAPEIIL-SKGYN 216
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 34  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 93
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 94  EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 147
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 148 DLIYRDLKPENLLIDEQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 202
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 203 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 237

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 69/230 (30%), Positives = 116/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAI--KKVLQDKRYKNRELQTMRL-------LDHPNVV 127
           +++GQGSFG VF  K +   +   +   KVL+    K R+    ++       ++HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L H  F T  K    L L+L+++     R    F +L++ +      VK Y  ++  AL
Sbjct: 90  KL-HYAFQTEGK----LYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALAL 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     +T + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 198 V-NRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP 246

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 70/216 (32%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 42  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 102 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFXEPHARFYAAQIVLTFEYLH-SL 155
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 156 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 210
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 211 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 245

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 98
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 99  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 150 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 206
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 207 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 84.7 bits (208), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 84.3 bits (207), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 82/295 (27%), Positives = 136/295 (46%), Gaps = 54/295 (18%)
Query: 68  KQTISYMAERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMR 119
           K  +S M +R+  +G G++G V   +   T    AIK + +     +       E+  ++
Sbjct: 32  KGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLK 91
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVL----EYVPETVHRVVKHFNKLNQRMPMIYVK 175
           LLDHPN++ L + FF   DK   YL +      E   E +HR+     K N+    + +K
Sbjct: 92  LLDHPNIMKL-YDFFE--DKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIK 143
Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISY 233
               Q+   ++Y+H+   + HRD+KP+NLL+        +K+ DFG + V    +     
Sbjct: 144 ----QVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKER 198
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ  EI++     
Sbjct: 199 LGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EILR----- 247
Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                K     YT F  P+     W     K +   A DL+ ++LQ+    R +A
Sbjct: 248 -----KVEKGKYT-FDSPE-----W-----KNVSEGAKDLIKQMLQFDSQRRISA 286

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/209 (28%), Positives = 110/209 (52%), Gaps = 23/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 14  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 71
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 72  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 122
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 123 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 179
Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDS 278
           Y+   DIWS G  + E+ +G+ P+ P D+
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/217 (30%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 127/288 (44%), Gaps = 48/288 (16%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE   +   + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKTLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLR 284

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ ++  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYQMAAGYPPFFADQPI-QIYEKI 250

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 108/216 (50%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NL+++   + +++ DFG AK  VKG      +C    Y APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLIIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPEIII-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 111/217 (51%), Gaps = 22/217 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 33  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 90
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 91  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 141
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G T 
Sbjct: 142 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG-TH 198
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           Y+   DIWS G  + E+ +G+      SG   + E++
Sbjct: 199 YSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELL 235

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 48/288 (16%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 21  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 80
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 81  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 132
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 133 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 190
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 191 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 227
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR
Sbjct: 228 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLR 268

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 83/306 (27%), Positives = 130/306 (42%), Gaps = 53/306 (17%)
Query: 59  TIGGRNGQPKQTISYMAERI---------VGQGSFGVVFQAKCLETGETVAIK----KVL 105
           ++   NG+   +    AE I         +G G+F  V  A+   TG+  A+K    K L
Sbjct: 1   SMARENGESSSSWKKQAEDIKKIFEFKETLGTGAFSEVVLAEEKATGKLFAVKCIPKKAL 60
Query: 106 QDKRYK-NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFN 163
           + K      E+  +R + H N+V+L+  + S    + LYL + L    E   R+V K F 
Sbjct: 61  KGKESSIENEIAVLRKIKHENIVALEDIYESP---NHLYLVMQLVSGGELFDRIVEKGFY 117
Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK--LCDFGSA 221
                  +I       Q+  A+ Y+HR +G+ HRD+KP+NLL      + K  + DFG +
Sbjct: 118 TEKDASTLIR------QVLDAVYYLHR-MGIVHRDLKPENLLYYSQDEESKIMISDFGLS 170
Query: 222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           K+  KG+   +   +  Y APE +     Y+ A+D WS G +   L+ G P F  ++   
Sbjct: 171 KMEGKGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSK 229
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
              +I+K                  EF  P      W  I        A D +  L++  
Sbjct: 230 LFEQILKA---------------EYEFDSPY-----WDDI-----SDSAKDFIRNLMEKD 264
Query: 342 PNLRCT 347
           PN R T
Sbjct: 265 PNKRYT 270

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 48/288 (16%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKDLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLR 284

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 77/288 (26%), Positives = 126/288 (43%), Gaps = 48/288 (16%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTM 118
            P+    YM  R +G+G F   ++   ++T E  A K V +        K   + E+   
Sbjct: 37  DPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIH 96
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           + LD+P+VV   H FF    +D+ ++ +VLE       R +   +K  + +     + + 
Sbjct: 97  KSLDNPHVVGF-HGFF----EDDDFVYVVLEIC---RRRSLLELHKRRKAVTEPEARYFM 148
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSR 237
            Q  + + Y+H +  V HRD+K  NL +N     VK+ DFG A K+   GE       + 
Sbjct: 149 RQTIQGVQYLHNN-RVIHRDLKLGNLFLN-DDMDVKIGDFGLATKIEFDGERKKXLCGTP 206
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y APE +     ++  +DIWS GC++  L++GKP F                      E
Sbjct: 207 NYIAPE-VLCKKGHSFEVDIWSLGCILYTLLVGKPPF----------------------E 243
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             C+   Y      +IK + +    P+ + P A  L+ R+L   P LR
Sbjct: 244 TSCLKETYI-----RIKKNEYS--VPRHINPVASALIRRMLHADPTLR 284

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 69/227 (30%), Positives = 108/227 (47%), Gaps = 25/227 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------R 113
           G + QP    +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        R
Sbjct: 4   GSDEQP-HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFR 60
Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPM 171
           E++ M++L+HPN+V L         + E  L L++EY    E    +V H      RM  
Sbjct: 61  EVRIMKILNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKE 110
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
              +    QI  A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    
Sbjct: 111 KEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLD 168
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           ++  S  Y APEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 169 TFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 117/230 (50%), Gaps = 26/230 (11%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVV 127
           +++GQGSFG VF  + +   ++G   A+K +      ++D+     E   +  ++HP VV
Sbjct: 34  KVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVV 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
            L + F     + E  L L+L+++     R    F +L++ +      VK Y  ++   L
Sbjct: 94  KLHYAF-----QTEGKLYLILDFL-----RGGDLFTRLSKEVMFTEEDVKFYLAELALGL 143
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C    Y APE+
Sbjct: 144 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEV 201
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LGTP 293
           +     ++ + D WS G ++ E++ G   F G    + +  I+K  LG P
Sbjct: 202 V-NRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKLGMP 250

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C    Y AP +I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEYLAPAIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 67  PKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMR 119
           P    SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 146 PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 203
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              H NVV + + +      DEL++  V+E++       +    ++N+      +     
Sbjct: 204 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 254
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRY 238
            + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P     + + Y
Sbjct: 255 AVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 312
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           + APELI     Y   +DIWS G +V E++ G+P +
Sbjct: 313 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA++ +  DK   N        RE++ M++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRII--DKTQLNSSSLQKLFREVRIMKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV+EY    E    +V H      RM     +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAH-----GRMKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G     +  S  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDEFCGSPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 16  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 70
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 71  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 121
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 122 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 179
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APELI     Y   +DIWS G +V E++ G+P
Sbjct: 180 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEP 214

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 68/216 (31%), Positives = 109/216 (50%), Gaps = 22/216 (10%)
Query: 67  PKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMR 119
           P    SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  MR
Sbjct: 69  PGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVIMR 126
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              H NVV + + +      DEL++  V+E++       +    ++N+      +     
Sbjct: 127 DYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAVCL 177
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRY 238
            + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  + Y
Sbjct: 178 AVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY 235
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           + APELI     Y   +DIWS G +V E++ G+P +
Sbjct: 236 WMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 270

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 25/218 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 27  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 81
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 82  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 132
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 133 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 190
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            Y+ APELI     Y   +DIWS G +V E++ G+P +
Sbjct: 191 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 227

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 110/216 (50%), Gaps = 25/216 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 20  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 74
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 75  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 125
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 126 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 183
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APELI     Y   +DIWS G +V E++ G+P
Sbjct: 184 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEP 218

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/218 (31%), Positives = 111/218 (50%), Gaps = 25/218 (11%)
Query: 65  GQPKQTISYMAERI-VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQT 117
           G P+   SY+   I +G+GS G+V  A    +G+ VA+KK+  D R + R      E+  
Sbjct: 25  GDPR---SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKM--DLRKQQRRELLFNEVVI 79
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           MR   H NVV + + +      DEL++  V+E++       +    ++N+      +   
Sbjct: 80  MRDYQHENVVEMYNSYLVG---DELWV--VMEFLEGGALTDIVTHTRMNEEQ----IAAV 130
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              + +ALS +H + GV HRDIK  ++L+  H  +VKL DFG    + K  P    +  +
Sbjct: 131 CLAVLQALSVLH-AQGVIHRDIKSDSILLT-HDGRVKLSDFGFCAQVSKEVPRRKXLVGT 188
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            Y+ APELI     Y   +DIWS G +V E++ G+P +
Sbjct: 189 PYWMAPELI-SRLPYGPEVDIWSLGIMVIEMVDGEPPY 225

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 69/220 (31%), Positives = 114/220 (51%), Gaps = 21/220 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           R++G+GSFG V  A+  ETG+  A+K + +D   ++ +++ TM   R+L    +HP +  
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 88
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  C F T D+    L  V+E+V      ++ H  K ++R      + YA +I  AL ++
Sbjct: 89  L-FCCFQTPDR----LFFVMEFV--NGGDLMFHIQK-SRRFDEARARFYAAEIISALMFL 140
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H   G+ +RD+K  N+L++ H    KL DFG  K  +  G    ++  +  Y APE I  
Sbjct: 141 HDK-GIIYRDLKLDNVLLD-HEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPE-ILQ 197
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
              Y  A+D W+ G ++ E++ G   F  ++  D L E I
Sbjct: 198 EMLYGPAVDWWAMGVLLYEMLCGHAPFEAENE-DDLFEAI 236

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 33/264 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+  A+K++      Q+++    +L  + R +D P  V+    
Sbjct: 42  LGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCPFTVTFYGA 101
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + +  E    ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 102 LFREGD-----VWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 156
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELI---FGA 248
            V HRD+KP N+L+N    QVK CDFG +  LV     +I   C + Y APE I      
Sbjct: 157 SVIHRDVKPSNVLINA-LGQVKXCDFGISGYLVDDVAKDIDAGC-KPYXAPERINPELNQ 214
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE------------ 296
             Y+   DIWS G    EL + +  FP DS      ++ +V+  P+ +            
Sbjct: 215 KGYSVKSDIWSLGITXIELAILR--FPYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFVD 272
Query: 297 -EIKCMNPNYTEF-KFPQIKAHPW 318
              +C+  N  E   +P++  HP+
Sbjct: 273 FTSQCLKKNSKERPTYPELXQHPF 296

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 69/216 (31%), Positives = 107/216 (49%), Gaps = 17/216 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE----LQTMRLLDHPNVVSLKHC 132
           + +G GSFG V   K  E+G   A+K + + K  K ++    L   R+L   N   L   
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            FS  D   LY+  V+EYV      +  H  ++  R    + + YA QI     Y+H S+
Sbjct: 107 EFSFKDNSNLYM--VMEYVAGG--EMFSHLRRIG-RFSEPHARFYAAQIVLTFEYLH-SL 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
            + +RD+KP+NLL++   + +++ DFG AK  VKG      +C      APE+I  +  Y
Sbjct: 161 DLIYRDLKPENLLIDQQGY-IQVTDFGFAK-RVKGR--TWXLCGTPEALAPEIIL-SKGY 215
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             A+D W+ G ++ E+  G P F  D  + Q+ E I
Sbjct: 216 NKAVDWWALGVLIYEMAAGYPPFFADQPI-QIYEKI 250

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 88/324 (27%), Positives = 139/324 (42%), Gaps = 80/324 (24%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 122
           Y  +  +GQGS+GVV  A   +T    AIK + ++K          R K  E++ M+ L 
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKT-EVRLMKKLH 86
Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV------------------------------- 151
           HPN+  L   +     +DE Y+ LV+E                                 
Sbjct: 87  HPNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 152 -----PETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN 203
                 E ++  +  F +     QR  +I   +   QIF AL Y+H   G+CHRDIKP+N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMR--QIFSALHYLHNQ-GICHRDIKPEN 198
Query: 204 LLVNPH-THQVKLCDFGSAKVLVKGEPNISY-----ICSRYYRAPELIFGATE-YTTAID 256
            L + + + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 257 IWSAGCVVAELMLGKPLFPGDSGVDQLVEII-----------KVLGTPTREEI-KCMNPN 304
            WSAG ++  L++G   FPG +  D + +++            VL    R+ +   +N N
Sbjct: 259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRN 318
Query: 305 YTEFKFPQIKA--HPWHKIFPKRM 326
             E +F  ++A  HPW   F  ++
Sbjct: 319 VDE-RFDAMRALQHPWISQFSDKI 341

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 81.6 bits (200), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+H
Sbjct: 16  NYRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNH 73
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L L++EY    E    +V H      RM     +    QI
Sbjct: 74  PNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQI 123
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 124 VSAVQYCHQK-RIVHRDLKAENLLLDADMN-IKIADFGFSNEFTVGGKLDAFCGAPPYAA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 182 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 132/283 (46%), Gaps = 49/283 (17%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DH 123
            ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +H
Sbjct: 18  DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 77
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           P    L H F +   K+ L+   V+EY+      ++ H    + +  +     YA +I  
Sbjct: 78  P---FLTHMFCTFQTKENLF--FVMEYL--NGGDLMYHIQSCH-KFDLSRATFYAAEIIL 129
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAP 242
            L ++H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y AP
Sbjct: 130 GLQFLH-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNXFCGTPDYIAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G  +Y  ++D WS G ++ E+++G+  F G    +                I+  N
Sbjct: 188 EILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDN 234
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           P Y                 P+ +  EA DL+ +L    P  R
Sbjct: 235 PFY-----------------PRWLEKEAKDLLVKLFVREPEKR 260

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 133/300 (44%), Gaps = 51/300 (17%)
Query: 62  GRNGQPKQTISYMAERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ 113
           GR     Q +S   +R+  +G G++G V   K   TG   AIK + +             
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 114 -ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK--LNQRMP 170
            E+  ++ LDHPN++ L   F    DK   YL  V+E     V+R  + F++  L Q+  
Sbjct: 70  DEVAVLKQLDHPNIMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFS 119
Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 228
            +   +   Q+    +Y+H+   + HRD+KP+NLL+   +    +K+ DFG +     G 
Sbjct: 120 EVDAAVIMKQVLSGTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGG 178
Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
                + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ     +
Sbjct: 179 KMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----E 229
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +L    + +     P++T+                  +  EA  LV  +L Y P+ R +A
Sbjct: 230 ILKRVEKGKFSFDPPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISA 271

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 81.3 bits (199), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 72/301 (23%), Positives = 138/301 (45%), Gaps = 40/301 (13%)
Query: 57  VTTIGGRNGQPKQTISYMAERI-----VGQGSFGVVFQAKCLETGETVAIKKVLQ--DKR 109
           + + G     P+Q   + AE +     +G+G++G V +     +G+ +A+K++    D++
Sbjct: 3   IESSGKLKISPEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEK 62
Query: 110 YKNRELQ----TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH-FNK 164
            + + L      MR  D P +V      F   D       + +E +  +  +  K+ ++ 
Sbjct: 63  EQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD-----CWICMELMSTSFDKFYKYVYSV 117
Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
           L+  +P   +        +AL+++  ++ + HRDIKP N+L++  +  +KLCDFG +  L
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNIKLCDFGISGQL 176
Query: 225 VKGEPNISYICSRYYRAPELIFGATE---YTTAIDIWSAGCVVAELMLGKPLFP-GDSGV 280
           V           R Y APE I  +     Y    D+WS G  + EL  G+  +P  +S  
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 281 DQLVEIIKVLGTP---TREEIKCMNPNYTEF-------------KFPQIKAHPWHKIFPK 324
           DQL +++K  G P   +  E +  +P++  F             K+ ++  HP+  ++ +
Sbjct: 237 DQLTQVVK--GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294
Query: 325 R 325
           R
Sbjct: 295 R 295

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/217 (29%), Positives = 106/217 (48%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++ M++L+H
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIMKVLNH 65
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L    F   + ++  L LV+EY    E    +V H       M     +    QI
Sbjct: 66  PNIVKL----FEVIETEKT-LYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFRQI 115
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  S  Y A
Sbjct: 116 VSAVQYCHQKF-IVHRDLKAENLLLDADMN-IKIADFGFSNEFTFGNKLDTFCGSPPYAA 173
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 174 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 210

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/287 (26%), Positives = 132/287 (45%), Gaps = 46/287 (16%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDH 123
           ++T  +M   ++G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H
Sbjct: 8   RKTFIFM--EVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKH 65
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V+L+  + STT     YL + L    E   R+++      +   ++       Q+  
Sbjct: 66  ENIVTLEDIYESTT---HYYLVMQLVSGGELFDRILERGVYTEKDASLV-----IQQVLS 117
Query: 184 ALSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSR-YYR 240
           A+ Y+H + G+ HRD+KP+NLL + P  + ++ + DFG +K+   G   +S  C    Y 
Sbjct: 118 AVKYLHEN-GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG--IMSTACGTPGYV 174
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE +     Y+ A+D WS G +   L+ G P F  ++   +L E IK            
Sbjct: 175 APE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETE-SKLFEKIK------------ 220
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
               Y EF+ P          F   +   A D +  LL+  PN R T
Sbjct: 221 --EGYYEFESP----------FWDDISESAKDFICHLLEKDPNERYT 255

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 85/293 (29%), Positives = 138/293 (47%), Gaps = 46/293 (15%)
Query: 64  NGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMR 119
           +G  +  +S  +  E  +G+G+  +V++ K   T +  A+K  K   DK+    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103
Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L HPN++ LK  F + T+     ++LVLE V   E   R+V+     ++R     VK  
Sbjct: 104 RLSHPNIIKLKEIFETPTE-----ISLVLELVTGGELFDRIVEK-GYYSERDAADAVK-- 155
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQ-VKLCDFGSAKVLVKGEPNISYIC 235
             QI  A++Y+H + G+ HRD+KP+NLL   P     +K+ DFG +K+ V+ +  +  +C
Sbjct: 156 --QILEAVAYLHEN-GIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVC 211
Query: 236 SR-YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
               Y APE++ G   Y   +D+WS G +   L+ G   F  + G DQ +          
Sbjct: 212 GTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERG-DQFM---------F 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           R  + C      E+ F      PW       +   A DLV +L+   P  R T
Sbjct: 261 RRILNC------EYYF----ISPWW----DEVSLNAKDLVRKLIVLDPKKRLT 299

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 80.5 bits (197), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 116/241 (48%), Gaps = 39/241 (16%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F  
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               +      ++ +V E +  + +  +K    L  R+   +++  AYQI ++++++H S
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLH-S 136
Query: 192 IGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPN 230
             + H D+KP+N+L                     +NP    +K+ DFGSA      E +
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHH 191
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
            + + +R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++L
Sbjct: 192 STLVSTRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 291 G 291
           G
Sbjct: 251 G 251

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 120/278 (43%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 28  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 87  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 139
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 140 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 196
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 197 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 231
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 232 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 265

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/287 (26%), Positives = 127/287 (44%), Gaps = 49/287 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-------ELQTMRLLDHPN 125
           Y   + +G G++G V   K   TG   AIK + +              E+  ++ LDHPN
Sbjct: 6   YQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPN 65
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK--LNQRMPMIYVKLYAYQIFR 183
           ++ L   F    DK   YL  V+E     V+R  + F++  L Q+   +   +   Q+  
Sbjct: 66  IMKLYEFF---EDKRNYYL--VME-----VYRGGELFDEIILRQKFSEVDAAVIMKQVLS 115
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +Y+H+   + HRD+KP+NLL+   +    +K+ DFG +     G      + + YY A
Sbjct: 116 GTTYLHKH-NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIA 174
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++    +Y    D+WS G ++  L+ G P F G +  DQ     ++L    + +    
Sbjct: 175 PEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQT--DQ-----EILKRVEKGKFSFD 225
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            P++T+                  +  EA  LV  +L Y P+ R +A
Sbjct: 226 PPDWTQ------------------VSDEAKQLVKLMLTYEPSKRISA 254

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 104/201 (51%), Gaps = 22/201 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVA-------IKKVLQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G G+ GVVF+     +G  +A       IK  ++++    RELQ +   + P +V    
Sbjct: 17  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQII--RELQVLHECNSPYIVGFYG 74
Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            F+S  +     +++ +E++   ++ +V+K       R+P   +   +  + + L+Y+  
Sbjct: 75  AFYSDGE-----ISICMEHMDGGSLDQVLKKAG----RIPEQILGKVSIAVIKGLTYLRE 125
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP N+LVN    ++KLCDFG +  L+    N  ++ +R Y +PE + G T 
Sbjct: 126 KHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQLIDEMAN-EFVGTRSYMSPERLQG-TH 182
Query: 251 YTTAIDIWSAGCVVAELMLGK 271
           Y+   DIWS G  + E+ +G+
Sbjct: 183 YSVQSDIWSMGLSLVEMAVGR 203

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 119/278 (42%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K  + + M       R L H +VV   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 83  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 136 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 192
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 227
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 228 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 261

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 119/278 (42%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K  + + M       R L H +VV   
Sbjct: 24  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 83  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE   +   +  Y APE +    
Sbjct: 136 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE-VLSKK 192
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 193 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 227
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 228 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 261

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/209 (29%), Positives = 113/209 (54%), Gaps = 20/209 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-TM---RLL----DHPNVVS 128
           +++G+GSFG VF A+  +T +  AIK + +D    + +++ TM   R+L    +HP    
Sbjct: 24  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP---F 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L H F +   K+ L+   V+EY+      ++ H    + +  +     YA +I   L ++
Sbjct: 81  LTHMFCTFQTKENLF--FVMEYL--NGGDLMYHIQSCH-KFDLSRATFYAAEIILGLQFL 135
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C +  Y APE++ G
Sbjct: 136 H-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLG 193
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
             +Y  ++D WS G ++ E+++G+  F G
Sbjct: 194 -QKYNHSVDWWSFGVLLYEMLIGQSPFHG 221

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 79.7 bits (195), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/205 (28%), Positives = 106/205 (51%), Gaps = 28/205 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSL 129
           R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F     +D   + ++++Y+   E    + K     +QR P    K YA ++  AL Y
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRK-----SQRFPNPVAKFYAAEVCLALEY 121
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYRAPELI 245
           +H S  + +RD+KP+N+L++ + H +K+ DFG AK +    P+++Y +C +  Y APE++
Sbjct: 122 LH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYV----PDVTYXLCGTPDYIAPEVV 175
Query: 246 FGATEYTTAIDIWSAGCVVAELMLG 270
                Y  +ID WS G ++ E++ G
Sbjct: 176 -STKPYNKSIDWWSFGILIYEMLAG 199

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 79.3 bits (194), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/241 (26%), Positives = 115/241 (47%), Gaps = 39/241 (16%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V +  C++    G  VA+K V    RY       +++L+H N       F  
Sbjct: 22  LGEGAFGKVVE--CIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRC 79
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               +      ++ +V E +  + +  +K    L  R+   +++  AYQI ++++++H S
Sbjct: 80  VQMLEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLD--HIRKMAYQICKSVNFLH-S 136
Query: 192 IGVCHRDIKPQNLL---------------------VNPHTHQVKLCDFGSAKVLVKGEPN 230
             + H D+KP+N+L                     +NP    +K+ DFGSA      E +
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP---DIKVVDFGSATY--DDEHH 191
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
            + +  R+YRAPE+I  A  ++   D+WS GC++ E  LG  +FP     + L  + ++L
Sbjct: 192 STLVXXRHYRAPEVIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERIL 250
Query: 291 G 291
           G
Sbjct: 251 G 251

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 118/278 (42%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K  + + M       R L H +VV   
Sbjct: 48  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 106
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 107 HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 159
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 160 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 216
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 217 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 251
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 252 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 285

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 239
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 240 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 117/228 (51%), Gaps = 31/228 (13%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 125
           R++G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK----LYAYQI 181
           +V L + F  T  K    L L+LEY+        + F +L +    I+++     Y  +I
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGG-----ELFMQLEREG--IFMEDTACFYLAEI 130
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV-KGEPNISYICSRYYR 240
             AL ++H+  G+ +RD+KP+N+++N H   VKL DFG  K  +  G    ++  +  Y 
Sbjct: 131 SMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYM 188
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           APE++   + +  A+D WS G ++ +++ G P F G++    + +I+K
Sbjct: 189 APEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 70  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 129
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 130 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 178
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 179 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 234
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 235 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 286

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 78/278 (28%), Positives = 118/278 (42%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K  + + M       R L H +VV   
Sbjct: 46  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 104
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 105 HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 157
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 158 N-RVIHRDLKLGNLFLN-EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 214
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 215 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 249
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 250 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 283

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 43/238 (18%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   T +  A+K + +       D  +   E   M   + P
Sbjct: 75  DYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 134
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L + F     +D+ YL +V+EY+P  + V+ +       N  +P  + + Y  ++ 
Sbjct: 135 WVVQLFYAF-----QDDRYLYMVMEYMPGGDLVNLMS------NYDVPEKWARFYTAEVV 183
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK----------GEPNIS 232
            AL  IH S+G  HRD+KP N+L++   H +KL DFG+   + K          G P+  
Sbjct: 184 LALDAIH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPD-- 239
Query: 233 YICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                 Y +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 240 ------YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIM 291

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 79.0 bits (193), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 67/230 (29%), Positives = 114/230 (49%), Gaps = 27/230 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-------DKRYKNRELQTMRLLDHP 124
            Y   +++G+G+FG V   +   + +  A+K + +       D  +   E   M   + P
Sbjct: 76  DYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP 135
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            VV L  C F    +D+ YL +V+EY+P  + V+ +       N  +P  + K Y  ++ 
Sbjct: 136 WVVQL-FCAF----QDDKYLYMVMEYMPGGDLVNLMS------NYDVPEKWAKFYTAEVV 184
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS-AKVLVKGEPNI-SYICSRYYR 240
            AL  IH S+G+ HRD+KP N+L++ H H +KL DFG+  K+   G  +  + + +  Y 
Sbjct: 185 LALDAIH-SMGLIHRDVKPDNMLLDKHGH-LKLADFGTCMKMDETGMVHCDTAVGTPDYI 242
Query: 241 APELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           +PE++    G   Y    D WS G  + E+++G   F  DS V    +I+
Sbjct: 243 SPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIM 292

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 80/278 (28%), Positives = 119/278 (42%), Gaps = 48/278 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--NRELQTM-----RLLDHPNVVSLK 130
            +G+G F   F+    +T E  A K V +    K   RE  +M     R L H +VV   
Sbjct: 22  FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGF- 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H FF   D    ++ +VLE       R +   +K  + +     + Y  QI     Y+HR
Sbjct: 81  HGFFEDND----FVFVVLELC---RRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHR 133
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISYICSRYYRAPELIFGAT 249
           +  V HRD+K  NL +N    +VK+ DFG A KV   GE       +  Y APE +    
Sbjct: 134 N-RVIHRDLKLGNLFLNEDL-EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE-VLSKK 190
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            ++  +D+WS GC++  L++GKP F                      E  C+   Y    
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKETYL--- 225
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             +IK + +    PK + P A  L+ ++LQ  P  R T
Sbjct: 226 --RIKKNEYS--IPKHINPVAASLIQKMLQTDPTARPT 259

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 114/228 (50%), Gaps = 31/228 (13%)
Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIK--------KVLQDKRYKNRELQTMRLLDHPN 125
           R++G+G +G VFQ + +    TG+  A+K        +  +D  +   E   +  + HP 
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK----LYAYQI 181
           +V L + F  T  K    L L+LEY+        + F +L +    I+++     Y  +I
Sbjct: 83  IVDLIYAF-QTGGK----LYLILEYLSGG-----ELFMQLEREG--IFMEDTACFYLAEI 130
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YR 240
             AL ++H+  G+ +RD+KP+N+++N H   VKL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLHQK-GIIYRDLKPENIMLN-HQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYM 188
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           APE++   + +  A+D WS G ++ +++ G P F G++    + +I+K
Sbjct: 189 APEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILK 235

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 64/223 (28%), Positives = 113/223 (50%), Gaps = 28/223 (12%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR-------LLDHPNVVSLK 130
           ++G+GSF  V++A+ + TG  VAIK + +   YK   +Q ++        L HP+++ L 
Sbjct: 18  LLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELY 77
Query: 131 HCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + F     +D  Y+ LVLE      +   +   VK F++   R        + +QI   +
Sbjct: 78  NYF-----EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARH-------FMHQIITGM 125
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPEL 244
            Y+H S G+ HRD+   NLL+  +   +K+ DFG A  L +  E + +   +  Y +PE 
Sbjct: 126 LYLH-SHGILHRDLTLSNLLLTRNM-NIKIADFGLATQLKMPHEKHYTLCGTPNYISPE- 182
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           I   + +    D+WS GC+   L++G+P F  D+  + L +++
Sbjct: 183 IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV 225

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 26  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 86  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 138 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 195
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 196 E-DYGFSVDWWALGVLMFEMMAGRSPF 221

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    K L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV---LGTPTREEIKCM 301
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K      +P  ++I   
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 302 NPNY----------TEFKFPQIKAHPW 318
             ++            F   Q   HPW
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 78.2 bits (191), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 137/292 (46%), Gaps = 44/292 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           R +G+GSFG V   +  +T +  A+K     K ++    +N  +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALSY 187
              ++S  D++++++ + L    +  + + +  HF +         VKL+  ++  AL Y
Sbjct: 81  ---WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEET-------VKLFICELVMALDY 130
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +     + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQNQ-RIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188
Query: 248 --ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP--------TREE 297
                Y+ A+D WS G    EL+ G+  +   S      EI+    T         ++E 
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSS-KEIVHTFETTVVTYPSAWSQEM 247
Query: 298 I----KCMNPN----YTEF----KFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
           +    K + PN    +++      FP +    W  +F KR+ P  +    RL
Sbjct: 248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKGRL 299

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 74
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 75  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 126
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 127 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 184
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 185 E-DYGFSVDWWALGVLMFEMMAGRSPF 210

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 78.2 bits (191), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---QTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A+K V ++    + ++   QT + +     +HP +V 
Sbjct: 11  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 71  LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 122
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C    Y APE++ G
Sbjct: 123 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRG 180
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 181 E-DYGFSVDWWALGVLMFEMMAGRSPF 206

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 113/242 (46%), Gaps = 33/242 (13%)
Query: 48  NGTETGHIIVTTIGGRNGQPK-QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ 106
           +G +TG++   TIGG+  Q +   +  + E  +G G+ G V++ +  +TG  +A+K++  
Sbjct: 6   SGKQTGYL---TIGGQRYQAEINDLENLGE--MGSGTCGQVWKMRFRKTGHVIAVKQM-- 58
Query: 107 DKRYKNRELQTMRLLDHPNVVSLKHC---------FFSTTDKDELYLNLVLEYVPETVHR 157
            +R  N+E     L+D   V+    C         F + TD     + + +E +     +
Sbjct: 59  -RRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD-----VFIAMELMGTCAEK 112
Query: 158 VVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD 217
           + K   ++   +P   +      I +AL Y+    GV HRD+KP N+L++    Q+KLCD
Sbjct: 113 LKK---RMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLD-ERGQIKLCD 168
Query: 218 FGSAKVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPL 273
           FG +  LV  +          Y APE I        +Y    D+WS G  + EL  G+  
Sbjct: 169 FGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ-- 226
Query: 274 FP 275
           FP
Sbjct: 227 FP 228

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 73/277 (26%), Positives = 123/277 (44%), Gaps = 39/277 (14%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +   T E VA+K + +         RE+   R L HPN+V  K    +
Sbjct: 28  IGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILT 87
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +++EY    E   R+         R      + +  Q+   +SY H S+ 
Sbjct: 88  PT-----HLAIIMEYASGGELYERICN-----AGRFSEDEARFFFQQLLSGVSYCH-SMQ 136
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++    EY 
Sbjct: 137 ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL-RQEYD 195
Query: 253 TAI-DIWSAGCVVAELMLG-----KPLFPGD--SGVDQLVEIIKVLGTPTREEIKC---- 300
             I D+WS G  +  +++G      P  P D    + +++ +   +    R   +C    
Sbjct: 196 GKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255
Query: 301 -----MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVD 332
                 +P  T    P+IK H W   F K +P + ++
Sbjct: 256 SRIFVADPA-TRISIPEIKTHSW---FLKNLPADLMN 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 108/207 (52%), Gaps = 20/207 (9%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLL-----DHPNVVS 128
           R++G+GS+  V   +  +T    A   +KK L +       +QT + +     +HP +V 
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 117
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L  CF     + E  L  V+EYV      ++ H  +  +++P  + + Y+ +I  AL+Y+
Sbjct: 118 LHSCF-----QTESRLFFVIEYV--NGGDLMFHMQR-QRKLPEEHARFYSAEISLALNYL 169
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFG 247
           H   G+ +RD+K  N+L++   H +KL D+G  K  L  G+   ++  +  Y APE++ G
Sbjct: 170 HER-GIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRG 227
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLF 274
             +Y  ++D W+ G ++ E+M G+  F
Sbjct: 228 E-DYGFSVDWWALGVLMFEMMAGRSPF 253

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N+L++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANILISA-TNAVKVVDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS V
Sbjct: 174 XQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 24/209 (11%)
Query: 77  RIVGQGSFGVVFQAK--------CLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS 128
           +++G+GSFG V  A+         ++  +  AI K  ++K   +     ++ + HP +V 
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 103
Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L H  F T DK    L  VL+Y+   E  + + +    L  R      + YA +I  AL 
Sbjct: 104 L-HFSFQTADK----LYFVLDYINGGELFYHLQRERCFLEPR-----ARFYAAEIASALG 153
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           Y+H S+ + +RD+KP+N+L++   H V L DFG  K  ++     S  C +  Y APE +
Sbjct: 154 YLH-SLNIVYRDLKPENILLDSQGHIV-LTDFGLCKENIEHNSTTSTFCGTPEYLAPE-V 210
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLF 274
                Y   +D W  G V+ E++ G P F
Sbjct: 211 LHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 21/212 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G+GS G+V  A+   +G  VA+K  + D R + R      E+  MR   H NVV +   
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVK--MMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKS 110
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           +      +EL++  ++E++       +    +LN+      +      + +AL+Y+H + 
Sbjct: 111 YLVG---EELWV--LMEFLQGGALTDIVSQVRLNEEQ----IATVCEAVLQALAYLH-AQ 160
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGATEY 251
           GV HRDIK  ++L+     +VKL DFG    + K  P    +    Y+ APE+I   + Y
Sbjct: 161 GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVI-SRSLY 218
Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
            T +DIWS G +V E++ G+P +  DS V  +
Sbjct: 219 ATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 250

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.8 bits (190), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 16  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 73  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 122
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 123 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 180
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 181 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 228
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 229 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 252

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 34/216 (15%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVVSLKH 131
           R++ +G F  V++A+ + +G   A+K++L ++  KNR +        +L  HPN+V    
Sbjct: 34  RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQF-- 91
Query: 132 CFFSTTDKDELYLNLVLEYVPET---VHRVVKHFNKLNQRMPM---IYVKLYAYQIFRAL 185
           C  ++  K+E       E++  T     ++V+   K+  R P+     +K++ YQ  RA+
Sbjct: 92  CSAASIGKEESDTGQA-EFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF-YQTCRAV 149
Query: 186 SYIHRSI-GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
            ++HR    + HRD+K +NLL++ +   +KLCDFGSA   +   P+ S+   R       
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLS-NQGTIKLCDFGSATT-ISHYPDYSWSAQRRALVEEE 207
Query: 238 -------YYRAPELIFGATEYTTA--IDIWSAGCVV 264
                   YR PE+I   + +      DIW+ GC++
Sbjct: 208 ITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/198 (27%), Positives = 95/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 26  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 85
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 86  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 134
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE++       
Sbjct: 135 VCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 194
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 195 KVADVWSCGVTLYVMLVG 212

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 112/219 (51%), Gaps = 21/219 (9%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  A    T E  AIK + +D   ++ +++        + LLD P  ++  
Sbjct: 26  VLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQL 85
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSYIH 189
           H  F T D+    L  V+EYV      ++ H  ++ + + P      YA +I   L ++H
Sbjct: 86  HSCFQTVDR----LYFVMEYV--NGGDLMYHIQQVGKFKEPQ--AVFYAAEISIGLFFLH 137
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV-LVKGEPNISYICSRYYRAPELIFGA 248
           +  G+ +RD+K  N++++   H +K+ DFG  K  ++ G     +  +  Y APE+I   
Sbjct: 138 KR-GIIYRDLKLDNVMLDSEGH-IKIADFGMCKEHMMDGVTTREFCGTPDYIAPEII-AY 194
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             Y  ++D W+ G ++ E++ G+P F G+   D+L + I
Sbjct: 195 QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE-DELFQSI 232

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 77.8 bits (190), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 189 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 247
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 248 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 297
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 298 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 354
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 414
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 415 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 467

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/293 (25%), Positives = 133/293 (45%), Gaps = 50/293 (17%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL---------- 121
            +   RI+G+G FG V+  +  +TG+  A+ K L  KR K ++ +T+ L           
Sbjct: 190 DFSVHRIIGRGGFGEVYGCRKADTGKMYAM-KCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 122 -DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH--FNKLNQRMPMIYVKLYA 178
            D P +V + +  F T DK    L+L+     +  + + +H  F++ + R        YA
Sbjct: 249 GDCPFIVCMSYA-FHTPDKLSFILDLM--NGGDLHYHLSQHGVFSEADMR-------FYA 298
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L ++H    V +RD+KP N+L++ H H V++ D G A    K +P+ S + +  
Sbjct: 299 AEIILGLEHMHNRF-VVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHAS-VGTHG 355
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG---------------------D 277
           Y APE++     Y ++ D +S GC++ +L+ G   F                       D
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPD 415
Query: 278 SGVDQLVEIIK-VLGTPTREEIKCMNPNYTEFK-FPQIKAHPWHKIFPKRMPP 328
           S   +L  +++ +L       + C+     E K  P  ++  W  +F ++ PP
Sbjct: 416 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLDWQMVFLQKYPP 468

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKXFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 14  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 70
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 71  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 120
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 121 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 178
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 179 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 226
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 227 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 250

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 146/303 (48%), Gaps = 60/303 (19%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKL-YAYQIFRAL 185
            ++    TTD+   +L + LE     +  +V  K+ +  N ++   Y  +    QI   +
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISY 233
           +++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     
Sbjct: 147 AHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 234 IC-----SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
                  +  +RAPEL+  +T+   T +IDI+S GCV    +L K   P      +   I
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNI 264
Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           I+  G  + +E+KC++                     + +  EA DL+S+++ + P  R 
Sbjct: 265 IR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRP 302
Query: 347 TAV 349
           TA+
Sbjct: 303 TAM 305

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 78/283 (27%), Positives = 127/283 (44%), Gaps = 60/283 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNV 126
           +++G+G+FG V   +   TG   A+K + ++             ++R LQ  R   HP +
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR---HPFL 67
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +LK+ F  T D+    L  V+EY    E    + +      +R      + Y  +I  A
Sbjct: 68  TALKYAF-QTHDR----LCFVMEYANGGELFFHLSRERVFTEER-----ARFYGAEIVSA 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPE 243
           L Y+H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE
Sbjct: 118 LEYLH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPE 175
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            +    +Y  A+D W  G V+ E+M G+ P +  D   ++L E+I +      EEI+   
Sbjct: 176 -VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH--ERLFELILM------EEIR--- 223
Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              FP+ + PEA  L++ LL+  P  R
Sbjct: 224 -------------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 85/303 (28%), Positives = 146/303 (48%), Gaps = 60/303 (19%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 36  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKL-YAYQIFRAL 185
            ++    TTD+   +L + LE     +  +V  K+ +  N ++   Y  +    QI   +
Sbjct: 91  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 146
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISY 233
           +++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     
Sbjct: 147 AHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 205
Query: 234 IC-----SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
                  +  +RAPEL+  +T+   T +IDI+S GCV    +L K   P      +   I
Sbjct: 206 NLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSRESNI 264
Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           I+  G  + +E+KC++                     + +  EA DL+S+++ + P  R 
Sbjct: 265 IR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDPLKRP 302
Query: 347 TAV 349
           TA+
Sbjct: 303 TAM 305

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV---LGTPTREEIKCM 301
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K      +P  ++I   
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 302 NPNY----------TEFKFPQIKAHPW 318
             ++            F   Q   HPW
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/210 (27%), Positives = 107/210 (50%), Gaps = 29/210 (13%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++G+G FG   +    ETGE + +K+++    + +R   +E++ MR L+HPNV+     F
Sbjct: 17  VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK----F 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                KD+  LN + EY+     R +     ++ + P      +A  I   ++Y+H S+ 
Sbjct: 73  IGVLYKDK-RLNFITEYIKGGTLRGI--IKSMDSQYPWSQRVSFAKDIASGMAYLH-SMN 128
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV--KGEPN-------------ISYICSRY 238
           + HRD+   N LV  + + V + DFG A+++V  K +P               + + + Y
Sbjct: 129 IIHRDLNSHNCLVRENKNVV-VADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           + APE+I G + Y   +D++S G V+ E++
Sbjct: 188 WMAPEMINGRS-YDEKVDVFSFGIVLCEII 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDH 123
           +Y   + +G+G+F  V  A+ + TG+ VA+K +  DK   N        RE++  ++L+H
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKII--DKTQLNSSSLQKLFREVRIXKVLNH 72
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L         + E  L LV EY    E    +V H      R      +    QI
Sbjct: 73  PNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAH-----GRXKEKEARAKFRQI 122
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             A+ Y H+   + HRD+K +NLL++   + +K+ DFG +     G    ++  +  Y A
Sbjct: 123 VSAVQYCHQKF-IVHRDLKAENLLLDADXN-IKIADFGFSNEFTFGNKLDAFCGAPPYAA 180
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
           PEL  G       +D+WS G ++  L+ G   F G +
Sbjct: 181 PELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 130/286 (45%), Gaps = 51/286 (17%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLLD-HPNVVSL 129
           + ++ +G+GSF +    KC+      A    +  KR +    +E+  ++L + HPN+V L
Sbjct: 14  LKDKPLGEGSFSIC--RKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKL 71
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRAL 185
              F      D+L+  LV+E +   E   R+ K  HF++      M        ++  A+
Sbjct: 72  HEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIM-------RKLVSAV 119
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 242
           S++H  +GV HRD+KP+NLL        ++K+ DFG A++       +   C + +Y AP
Sbjct: 120 SHMH-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAP 178
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGV--DQLVEIIKVLGTPTREEIK 299
           EL+     Y  + D+WS G ++  ++ G+ P    D  +     VEI+K +         
Sbjct: 179 ELL-NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK------- 230
Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                  +F F   +   W     K +  EA DL+  LL   PN R
Sbjct: 231 ------GDFSF---EGEAW-----KNVSQEAKDLIQGLLTVDPNKR 262

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 83/278 (29%), Positives = 130/278 (46%), Gaps = 33/278 (11%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   VA+K + + +  K        RE++    L HPN++ L
Sbjct: 29  RPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRL 88
Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F+   D+  +YL  +LEY P  E    + K      QR   I  +L       AL Y
Sbjct: 89  YNYFY---DRRRIYL--ILEYAPRGELYKELQKSCTFDEQRTATIMEELAD-----ALMY 138
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
            H    V HRDIKP+NLL+     ++K+ DFG + V        +   +  Y  PE+I G
Sbjct: 139 CH-GKKVIHRDIKPENLLLG-LKGELKIADFGWS-VHAPSLRRKTMCGTLDYLPPEMIEG 195
Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-----LGTPTREE---IK 299
              +   +D+W  G +  EL++G P F   S  +    I+KV        PT  +    K
Sbjct: 196 RM-HNEKVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPASVPTGAQDLISK 254
Query: 300 CMNPNYTE-FKFPQIKAHPWHKIFPKR-MPPEAVDLVS 335
            +  N +E     Q+ AHPW +   +R +PP A+  V+
Sbjct: 255 LLRHNPSERLPLAQVSAHPWVRANSRRVLPPSALQSVA 292

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV---LGTPTREEIKCM 301
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K      +P  ++I   
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 302 NPNY----------TEFKFPQIKAHPW 318
             ++            F   Q   HPW
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 113/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 116/267 (43%), Gaps = 32/267 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYK-NRELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK    + L+ K      E+  +  + HPN+V
Sbjct: 20  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIV 79
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + S      LYL + L    E   R+V K F        +I+      Q+  A+ 
Sbjct: 80  ALDDIYESGG---HLYLIMQLVSGGELFDRIVEKGFYTERDASRLIF------QVLDAVK 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE 
Sbjct: 131 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV---LGTPTREEIKCM 301
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K      +P  ++I   
Sbjct: 189 VLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDS 248
Query: 302 NPNY----------TEFKFPQIKAHPW 318
             ++            F   Q   HPW
Sbjct: 249 AKDFIRHLMEKDPEKRFTCEQALQHPW 275

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/207 (30%), Positives = 107/207 (51%), Gaps = 26/207 (12%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVS 128
           R +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V 
Sbjct: 19  RQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVK 78
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            K   +S   ++   L L++E++P    R  ++  K  +R+  I +  Y  QI + + Y+
Sbjct: 79  YKGVCYSAGRRN---LKLIMEFLPYGSLR--EYLQKHKERIDHIKLLQYTSQICKGMEYL 133
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRA 241
             +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ A
Sbjct: 134 G-TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYA 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE +   ++++ A D+WS G V+ EL 
Sbjct: 189 PESL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 25  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 85  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 139 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 194
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 195 SL-TESKFSVASDVWSFGVVLYELF 218

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 109 GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 162
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 163 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 218
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 219 SL-TESKFSVASDVWSFGVVLYELF 242

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 21  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 80
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            + F    D+  +YL  +LE+ P   +++ ++   + +++    +++    ++  AL Y 
Sbjct: 81  YNYFH---DRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 132 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 188
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T +   +D+W AG +  E ++G P F   S  +    I+ V                 + 
Sbjct: 189 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 230
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           KFP              +   + DL+S+LL+Y P  R
Sbjct: 231 KFPPF------------LSDGSKDLISKLLRYHPPQR 255

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 112/231 (48%), Gaps = 25/231 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
               + I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 134
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 50/277 (18%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K + + +  K        RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79
Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
            + F    D+  +YL  +LE+ P   +++ ++   + +++    +++    ++  AL Y 
Sbjct: 80  YNYF---HDRKRIYL--MLEFAPRGELYKELQKHGRFDEQRSATFME----ELADALHYC 130
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
           H    V HRDIKP+NLL+  +  ++K+ DFG + V            +  Y  PE+I G 
Sbjct: 131 HER-KVIHRDIKPENLLMG-YKGELKIADFGWS-VHAPSLRRRXMCGTLDYLPPEMIEGK 187
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
           T +   +D+W AG +  E ++G P F   S  +    I+ V                 + 
Sbjct: 188 T-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV-----------------DL 229
Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           KFP              +   + DL+S+LL+Y P  R
Sbjct: 230 KFPPF------------LSDGSKDLISKLLRYHPPQR 254

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 78  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 132 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEFFKVKEPGESPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 188 SL-TESKFSVASDVWSFGVVLYELF 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 22  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 82  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 135
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 136 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 191
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 192 SL-TESKFSVASDVWSFGVVLYELF 215

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 23  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 83  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 136
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 137 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 192
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 193 SL-TESKFSVASDVWSFGVVLYELF 216

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 18  GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 77
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 78  -REAQNAAALNHPAIVAVYDTGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 135
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 136 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 190
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 191 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 242

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 24  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 84  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 137
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 138 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 193
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 194 SL-TESKFSVASDVWSFGVVLYELF 217

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 69/233 (29%), Positives = 114/233 (48%), Gaps = 25/233 (10%)
Query: 65  GQPKQTISYMAER-----IVGQGSFGVVFQAKCLETGETVAIKKVLQDK--------RYK 111
           G    T S++++R     I+G G    V  A+ L     VA+K +  D         R++
Sbjct: 1   GSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFR 60
Query: 112 NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
            RE Q    L+HP +V++     + T    L   +V+EYV     R + H          
Sbjct: 61  -REAQNAAALNHPAIVAVYATGEAETPAGPLPY-IVMEYVDGVTLRDIVHTEGPMTPKRA 118
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           I V   A Q   AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ +     ++
Sbjct: 119 IEVIADACQ---ALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIADSGNSV 173
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               + I +  Y +PE   G +    + D++S GCV+ E++ G+P F GDS V
Sbjct: 174 TQTAAVIGTAQYLSPEQARGDSVDARS-DVYSLGCVLYEVLTGEPPFTGDSPV 225

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 36  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 96  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 149
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 150 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 205
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 206 SL-TESKFSVASDVWSFGVVLYELF 229

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 16  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 76  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 129
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 130 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 185
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 186 SL-TESKFSVASDVWSFGVVLYELF 209

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 63/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 17  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 77  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 130
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 131 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 187 SL-TESKFSVASDVWSFGVVLYELF 210

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 75.9 bits (185), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 22/220 (10%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 13  RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 69
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHP +V L   ++         L +++E+ P      +    +L++ +    +++ 
Sbjct: 70  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 122
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL+++H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I +
Sbjct: 123 CRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGT 180
Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE++       T Y    DIWS G  + E+   +P
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 22/220 (10%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P +    + E  +G G+FG V++AK  ETG  +A  KV++ K  +       E++ 
Sbjct: 5   RDLDPNEVWEIVGE--LGDGAFGKVYKAKNKETG-ALAAAKVIETKSEEELEDYIVEIEI 61
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHP +V L   ++         L +++E+ P      +    +L++ +    +++ 
Sbjct: 62  LATCDHPYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVV 114
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q+  AL+++H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I +
Sbjct: 115 CRQMLEALNFLH-SKRIIHRDLKAGNVLMTLEG-DIRLADFGVSAKNLKTLQKRDSFIGT 172
Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE++       T Y    DIWS G  + E+   +P
Sbjct: 173 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 75.5 bits (184), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 121/270 (44%), Gaps = 50/270 (18%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC-LETG--ETVAIKKVLQDKR--YKNRELQTMRLL 121
           P+ +  +  E  +G+G+F  V+ A   L+ G  E +A+K ++          ELQ + + 
Sbjct: 17  PQLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVA 76
Query: 122 D-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
               NV+ +K+CF     +   ++ + + Y+        + F  +   +    V+ Y   
Sbjct: 77  GGQDNVMGVKYCF-----RKNDHVVIAMPYLEH------ESFLDILNSLSFQEVREYMLN 125
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK----------VLVKGEP- 229
           +F+AL  IH+  G+ HRD+KP N L N    +  L DFG A+            V+ E  
Sbjct: 126 LFKALKRIHQ-FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQ 184
Query: 230 ------NISYIC-SRY-----------YRAPELIFGATEYTTAIDIWSAGCVVAELMLGK 271
                 N   IC SR            +RAPE++      TTAID+WSAG +   L+ G+
Sbjct: 185 QERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR 244
Query: 272 -PLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            P +     +  L +I+ + G  +RE I+ 
Sbjct: 245 YPFYKASDDLTALAQIMTIRG--SRETIQA 272

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 130/283 (45%), Gaps = 50/283 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +   +  G+  A K +       +D +   RE +  RLL HPN+V L H 
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 88
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  A+ + H+
Sbjct: 89  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 139
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
            +GV HRD+KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 140 -MGVVHRDLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 196
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 197 RKDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 239
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
            + FP  +   W  +      PEA DL++++L  +P+ R TA 
Sbjct: 240 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAA 274

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 75.1 bits (183), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 50/291 (17%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 123
           T  Y     +G+G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L H   S      L  +LV   E   + V R  +++++ +    +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 237
             ++++ H + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  + 
Sbjct: 113 LESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y +PE +     Y   +D+W+ G ++  L++G P F  D    +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKA-------- 220
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     + FP  +   W  +      PEA DL++++L  +P  R TA
Sbjct: 221 --------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITA 255

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y  + ++G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 12  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFR 183
           S    F     KDEL+L + L     +V  ++KH     +    +     +     ++  
Sbjct: 72  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 127
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 237
            L Y+H++ G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 128 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 185
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
            + APE++     Y    DIWS G    EL  G
Sbjct: 186 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 218

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y  + ++G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+V
Sbjct: 17  YELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIV 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFR 183
           S    F     KDEL+L + L     +V  ++KH     +    +     +     ++  
Sbjct: 77  SYYTSFVV---KDELWLVMKL-LSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132
Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG------EPNISYICSR 237
            L Y+H++ G  HRD+K  N+L+      V++ DFG +  L  G      +   +++ + 
Sbjct: 133 GLEYLHKN-GQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
            + APE++     Y    DIWS G    EL  G
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATG 223

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L + +EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/198 (27%), Positives = 94/198 (47%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+C FG +K  V      S + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 73/249 (29%), Positives = 116/249 (46%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVMLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L + +EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID++S G +  E+     ++P  +G+++ V I+
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM-----IYPFSTGMER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 74.7 bits (182), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 79/291 (27%), Positives = 133/291 (45%), Gaps = 50/291 (17%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 123
           T  Y     +G+G+F VV +   + TG+  A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           PN+V L H   S      L  +LV   E   + V R  +++++ +    +        QI
Sbjct: 63  PNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 237
             ++++ H + G+ HRD+KP+NLL+   +    VKL DFG A + V+G+      +  + 
Sbjct: 113 LESVNHCHLN-GIVHRDLKPENLLLASKSKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y +PE +     Y   +D+W+ G ++  L++G P F  D    +L + IK         
Sbjct: 171 GYLSPE-VLRKDPYGKPVDMWACGVILYILLVGYPPF-WDEDQHRLYQQIKA-------- 220
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     + FP  +   W  +      PEA DL++++L  +P  R TA
Sbjct: 221 --------GAYDFPSPE---WDTV-----TPEAKDLINKMLTINPAKRITA 255

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSEMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 74.7 bits (182), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 45/277 (16%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 223
Query: 135 STTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               +D+  + ++ E++   E   +V    NK+++   + Y++    Q+ + L ++H + 
Sbjct: 224 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 274
Query: 193 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 250
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 275 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 334
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y T  D+WS G +   L+ G   F G++  + L              +K  + N  +  F
Sbjct: 335 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 380
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             I               +  D + +LL   PN R T
Sbjct: 381 SGISE-------------DGKDFIRKLLLADPNTRMT 404

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 145/307 (47%), Gaps = 64/307 (20%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKLYAY-QIFRAL 185
            ++    TTD+   +L + LE     +  +V  K+ +  N ++   Y  +    QI   +
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISY 233
           +++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+ +   
Sbjct: 129 AHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187
Query: 234 IC-----SRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
                  +  +RAPEL+  +    T      +IDI+S GCV    +L K   P      +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSR 246
Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
              II+  G  + +E+KC++                     + +  EA DL+S+++ + P
Sbjct: 247 ESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDP 284
Query: 343 NLRCTAV 349
             R TA+
Sbjct: 285 LKRPTAM 291

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 74.3 bits (181), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 16  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 73
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 74  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 123
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 124 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 181
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 182 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 239
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 240 EKLSAIFRDF 249

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 123/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 124
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HRDIK  N+L+      VKL DFG  A++  +       + + Y
Sbjct: 125 ECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSXMVGTPY 182
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 70/277 (25%), Positives = 122/277 (44%), Gaps = 45/277 (16%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+L   F 
Sbjct: 59  LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF- 117
Query: 135 STTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               +D+  + ++ E++   E   +V    NK+++   + Y++    Q+ + L ++H + 
Sbjct: 118 ----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QVCKGLCHMHEN- 168
Query: 193 GVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TE 250
              H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G    
Sbjct: 169 NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG 228
Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y T  D+WS G +   L+ G   F G++  + L              +K  + N  +  F
Sbjct: 229 YYT--DMWSVGVLSYILLSGLSPFGGENDDETL------------RNVKSCDWNMDDSAF 274
Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
             I               +  D + +LL   PN R T
Sbjct: 275 SGISE-------------DGKDFIRKLLLADPNTRMT 298

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 19  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +  K  +R+  I +  Y  QI + + Y+  
Sbjct: 79  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQKHKERIDHIKLLQYTSQICKGMEYLG- 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HR++  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 133 TKRYIHRNLATRNILVE-NENRVKIGDFGLTKVLPQDKEYYKVKEPGESPI---FWYAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 189 SL-TESKFSVASDVWSFGVVLYELF 212

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 76/286 (26%), Positives = 126/286 (44%), Gaps = 50/286 (17%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVA-----IKKVLQDKRYKNRELQTMRLLDHPNVV 127
           YM    +G+G FG+V   +C+ET          +K    D+    +E+  + +  H N++
Sbjct: 7   YMIAEDLGRGEFGIVH--RCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNIL 64
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L   F S  +     L ++ E++   +   R+     +LN+R  + YV    +Q+  AL
Sbjct: 65  HLHESFESMEE-----LVMIFEFISGLDIFERINTSAFELNEREIVSYV----HQVCEAL 115
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
            ++H S  + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE 
Sbjct: 116 QFLH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPE- 173
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +      +TA D+WS G +V  L+ G   F  ++   Q++E I             MN  
Sbjct: 174 VHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN-QQIIENI-------------MNAE 219
Query: 305 YT--EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           YT  E  F +I               EA+D V RLL      R TA
Sbjct: 220 YTFDEEAFKEI-------------SIEAMDFVDRLLVKERKSRMTA 252

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/226 (28%), Positives = 107/226 (47%), Gaps = 24/226 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y+  + +G+GSFG     K  E G    IK++       +++    RE+  +  + HPN+
Sbjct: 26  YVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNI 85
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY----VKLYAYQIF 182
           V  +  F    +   LY+  V++Y           F ++N +  +++    +  +  QI 
Sbjct: 86  VQYRESF---EENGSLYI--VMDYCEGG-----DLFKRINAQKGVLFQEDQILDWFVQIC 135
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRA 241
            AL ++H    + HRDIK QN+ +      V+L DFG A+VL    E   + I + YY +
Sbjct: 136 LALKHVHDR-KILHRDIKSQNIFLT-KDGTVQLGDFGIARVLNSTVELARACIGTPYYLS 193
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           PE I     Y    DIW+ GCV+ EL   K  F   S  + +++II
Sbjct: 194 PE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 84/307 (27%), Positives = 144/307 (46%), Gaps = 64/307 (20%)
Query: 74  MAERIVGQGSFG-VVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL----DHPNVVS 128
           ++E+I+G GS G VVFQ      G  VA+K++L D  + +  L  ++LL    DHPNV+ 
Sbjct: 18  VSEKILGYGSSGTVVFQGSF--QGRPVAVKRMLID--FCDIALMEIKLLTESDDHPNVI- 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKLYAY-QIFRAL 185
            ++    TTD+   +L + LE     +  +V  K+ +  N ++   Y  +    QI   +
Sbjct: 73  -RYYCSETTDR---FLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGV 128
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGEPNISY 233
           +++H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     
Sbjct: 129 AHLH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRX 187
Query: 234 IC-----SRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
                  +  +RAPEL+  +    T      +IDI+S GCV    +L K   P      +
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFY-YILSKGKHPFGDKYSR 246
Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
              II+  G  + +E+KC++                     + +  EA DL+S+++ + P
Sbjct: 247 ESNIIR--GIFSLDEMKCLH--------------------DRSLIAEATDLISQMIDHDP 284
Query: 343 NLRCTAV 349
             R TA+
Sbjct: 285 LKRPTAM 291

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/223 (27%), Positives = 112/223 (50%), Gaps = 32/223 (14%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKN--RELQTMRLLDHPNVV 127
           E I+G G FG V++A  +  G+ VA+K    D      +  +N  +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69
Query: 128 SLKHCFFSTTDKDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L+          E  L LV+E+     ++RV+       +R+P   +  +A QI R ++
Sbjct: 70  ALRGVCLK-----EPNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMN 119
Query: 187 YIHRS--IGVCHRDIKPQNLLV-------NPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
           Y+H    + + HRD+K  N+L+       +     +K+ DFG A+   +    +S   + 
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR-TTKMSAAGAY 178
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
            + APE+I  A+ ++   D+WS G ++ EL+ G+  F G  G+
Sbjct: 179 AWMAPEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/205 (30%), Positives = 104/205 (50%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TGE VA+KK+        R   RE++ ++ L H N+V  K
Sbjct: 21  LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +S   ++   L L++EY+P    R   +     +R+  I +  Y  QI + + Y+  
Sbjct: 81  GVCYSAGRRN---LKLIMEYLPYGSLR--DYLQAHAERIDHIKLLQYTSQICKGMEYLG- 134
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------EPNISYICSRYYRAPE 243
           +    HRD+  +N+LV  + ++VK+ DFG  KVL +        EP  S I   ++ APE
Sbjct: 135 TKRYIHRDLATRNILVE-NENRVKIGDFGLTKVLPQDKEXXKVKEPGESPI---FWYAPE 190
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +   ++++ A D+WS G V+ EL 
Sbjct: 191 SL-TESKFSVASDVWSFGVVLYELF 214

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  ++ E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYCH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           VCHRD+K +N L++     ++K+C FG +K  V        + +  Y APE++       
Sbjct: 136 VCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 124/250 (49%), Gaps = 22/250 (8%)
Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRL 120
           G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++ LQ +  K     E+  MR 
Sbjct: 17  GDPKK--KYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
             +PN+V+    +      DEL++  V+EY+   ++  VV         M    +     
Sbjct: 75  NKNPNIVNYLDSYLVG---DELWV--VMEYLAGGSLTDVVTE-----TCMDEGQIAAVCR 124
Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRY 238
           +  +AL ++H S  V HR+IK  N+L+      VKL DFG  A++  +     + + + Y
Sbjct: 125 ECLQALEFLH-SNQVIHRNIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 182
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE++     Y   +DIWS G +  E++ G+P +  ++ +  L  +I   GTP  +  
Sbjct: 183 WMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPELQNP 240
Query: 299 KCMNPNYTEF 308
           + ++  + +F
Sbjct: 241 EKLSAIFRDF 250

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 96/217 (44%), Gaps = 22/217 (10%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           Y+  + +G+G F  V   + L  G   A+K++L    QD+    RE    RL +HPN++ 
Sbjct: 31  YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILR 90
Query: 129 L-KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L  +C      K E +L L   +   T+   ++        +    +      I R L  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPF-FKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS---AKVLVKGEPNISYI-------CSR 237
           IH + G  HRD+KP N+L+      V L D GS   A + V+G      +       C+ 
Sbjct: 150 IH-AKGYAHRDLKPTNILLGDEGQPV-LMDLGSMNQACIHVEGSRQALTLQDWAAQRCTI 207
Query: 238 YYRAPELIFGATEYTTA---IDIWSAGCVVAELMLGK 271
            YRAPEL F    +       D+WS GCV+  +M G+
Sbjct: 208 SYRAPEL-FSVQSHCVIDERTDVWSLGCVLYAMMFGE 243

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 28/215 (13%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTT 137
           ++G G FG VF+AK    G+T  I++V  +     RE++ +  LDH N+V    C+    
Sbjct: 19  LIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLDHVNIVHYNGCW-DGF 77
Query: 138 DKDELYLNLVLE---YVPETVHRVVKHFNK-----------------LNQRMPMIYVKLY 177
           D D    +  LE   Y PE      +   K                 + +R      K+ 
Sbjct: 78  DYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVL 137
Query: 178 AYQIF----RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           A ++F    + + YIH S  + HRD+KP N+ +   T QVK+ DFG    L         
Sbjct: 138 ALELFEQITKGVDYIH-SKKLIHRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRTRS 195
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
             +  Y +PE I  + +Y   +D+++ G ++AEL+
Sbjct: 196 KGTLRYMSPEQI-SSQDYGKEVDLYALGLILAELL 229

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++     +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++     +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLD-ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 130/283 (45%), Gaps = 50/283 (17%)
Query: 79  VGQGSFGVVFQ-AKCLETGETVAI-----KKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G+G+F VV +  K L   E  A+     K   +D +   RE +  RLL HPN+V L H 
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRL-HD 77
Query: 133 FFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             S      L  +LV   E   + V R  +++++ +    +        QI  A+ + H+
Sbjct: 78  SISEEGHHYLIFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQILEAVLHCHQ 128
Query: 191 SIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSRYYRAPELIF 246
            +GV HR++KP+NLL+        VKL DFG A + V+GE      +  +  Y +PE + 
Sbjct: 129 -MGVVHRNLKPENLLLASKLKGAAVKLADFGLA-IEVEGEQQAWFGFAGTPGYLSPE-VL 185
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +D+W+ G ++  L++G P F  D    +L + IK                  
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPF-WDEDQHRLYQQIKA----------------G 228
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
            + FP  +   W  +      PEA DL++++L  +P+ R TA 
Sbjct: 229 AYDFPSPE---WDTV-----TPEAKDLINKMLTINPSKRITAA 263

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 11  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 67
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 68  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 119
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 120 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 177
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 178 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 216
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 253

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 128/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 179
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 180 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 218
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 125/281 (44%), Gaps = 48/281 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV    
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVK--- 68
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 69  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 121
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 122 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 179
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 180 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 218
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 219 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 100/203 (49%), Gaps = 17/203 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS-- 135
           ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C+    
Sbjct: 18  LIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFD 77
Query: 136 ----TTDKDELY-----LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
               T+ K+        L + +E+  + T+ + ++   +  +++  +       QI + +
Sbjct: 78  YDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQITKGV 135
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            YIH S  + +RD+KP N+ +   T QVK+ DFG    L           +  Y +PE I
Sbjct: 136 DYIH-SKKLINRDLKPSNIFL-VDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQI 193
Query: 246 FGATEYTTAIDIWSAGCVVAELM 268
             + +Y   +D+++ G ++AEL+
Sbjct: 194 -SSQDYGKEVDLYALGLILAELL 215

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/198 (26%), Positives = 92/198 (46%), Gaps = 17/198 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G+FGV    +  +  E VA+K + + ++      RE+   R L HPN+V  K    +
Sbjct: 27  IGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKREIINHRSLRHPNIVRFKEVILT 86
Query: 136 TTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
            T     +L +V+EY    E   R+         R      + +  Q+   +SY H ++ 
Sbjct: 87  PT-----HLAIVMEYASGGELFERICN-----AGRFSEDEARFFFQQLISGVSYAH-AMQ 135
Query: 194 VCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           V HRD+K +N L++     ++K+ DFG +K  V      S + +  Y APE++       
Sbjct: 136 VAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEVLLKKEYDG 195
Query: 253 TAIDIWSAGCVVAELMLG 270
              D+WS G  +  +++G
Sbjct: 196 KVADVWSCGVTLYVMLVG 213

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score = 71.6 bits (174), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 24/226 (10%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-------DHPNVVSL 129
           +++G+G+F  V   K  +TG+  A+K + +    K  E+   R         D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     +DE YL LV+EY       ++   +K  +R+P    + Y  +I  A+  +H
Sbjct: 127 HFAF-----QDENYLYLVMEYY--VGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGE-PNISYICSRYYRAPELIFG 247
           R +G  HRDIKP N+L++   H ++L DFGS  K+   G   ++  + +  Y +PE++  
Sbjct: 180 R-LGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQA 237
Query: 248 ATEYTTAI------DIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
                         D W+ G    E+  G+  F  DS  +   +I+
Sbjct: 238 VGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIV 283

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 130/291 (44%), Gaps = 50/291 (17%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDH 123
           T  Y     +G+G+F VV +   L TG   A K +       +D +   RE +  RLL H
Sbjct: 3   TDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKH 62
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            N+V L H   S      L  +LV   E   + V R  +++++ +    +        QI
Sbjct: 63  SNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI-------QQI 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--ISYICSR 237
             A+ + H+ +GV HRD+KP+NLL+        VKL DFG A + V+G+      +  + 
Sbjct: 113 LEAVLHCHQ-MGVVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGDQQAWFGFAGTP 170
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
            Y +PE +     Y   +DIW+ G ++  L++G P F  D    +L + IK         
Sbjct: 171 GYLSPE-VLRKEAYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKA-------- 220
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     + FP  +   W  +      PEA +L++++L  +P  R TA
Sbjct: 221 --------GAYDFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITA 255

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEIXINKMLNHENVVK-- 69
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 70  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 121
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 122 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 177
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 178 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 217
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 124/281 (44%), Gaps = 48/281 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-----NRELQTMRLLDHPNVVSLKH 131
           + +G+G++G V  A    T E VA+K V   +         +E+    +L+H NVV    
Sbjct: 13  QTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVK--- 69
Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+H
Sbjct: 70  -FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYLH 122
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELIF 246
             IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+ 
Sbjct: 123 -GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 180
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               +   +D+WS G V+  ++ G+   P D   D   E                   Y+
Sbjct: 181 RREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------YS 219
Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           ++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 220 DWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 255

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 79/299 (26%), Positives = 126/299 (42%), Gaps = 55/299 (18%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM----- 118
           N   K + +Y  +  +G+G+F VV +     TG   A K ++  K+   R+ Q +     
Sbjct: 22  NASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAK-IINTKKLSARDFQKLEREAR 80
Query: 119 --RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIY 173
             R L HPN+V L         ++E +  LV + V   E    +V + F         I 
Sbjct: 81  ICRKLQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ 135
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNI 231
                 QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E   
Sbjct: 136 ------QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWH 188
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
            +  +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L        
Sbjct: 189 GFAGTPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL-------- 238
Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA 348
                             + QIKA  +    P+   + PEA  L+  +L  +P  R TA
Sbjct: 239 ------------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 279

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 106/210 (50%), Gaps = 23/210 (10%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTM--RLLDHPNVVSLKHCF 133
           +VG G++G V++ + ++TG+  AIK   V  D+  + ++   M  +   H N+ +    F
Sbjct: 31  LVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 134 FSTTD---KDELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    D+L+  LV+E+    +V  ++K  N     +   ++     +I R LS++H
Sbjct: 91  IKKNPPGMDDQLW--LVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLSHLH 146
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISYICSRYYRAPELIF- 246
           +   V HRDIK QN+L+  +  +VKL DFG +  L +  G  N ++I + Y+ APE+I  
Sbjct: 147 QH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSAQLDRTVGRRN-TFIGTPYWMAPEVIAC 203
Query: 247 ----GATEYTTAIDIWSAGCVVAELMLGKP 272
                AT Y    D+WS G    E+  G P
Sbjct: 204 DENPDAT-YDFKSDLWSLGITAIEMAEGAP 232

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 76/291 (26%), Positives = 128/291 (43%), Gaps = 49/291 (16%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 128
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV--KHFNKLNQRMPMIYVKLYAYQIFRA 184
           LK  +      D  Y+ +V E +   E + +++  K F++      +       + I + 
Sbjct: 81  LKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-------FTITKT 128
Query: 185 LSYIHRSIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRY 238
           + Y+H   GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  
Sbjct: 129 VEYLHAQ-GVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLMTPCYTAN 185
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE +     Y  A DIWS G ++  ++ G   F  +   D   EI+  +G+      
Sbjct: 186 FVAPE-VLERQGYDAACDIWSLGVLLYTMLTGYTPF-ANGPDDTPEEILARIGSG----- 238
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                     KF  +    W+ +        A DLVS++L   P+ R TA 
Sbjct: 239 ----------KF-SLSGGYWNSV-----SDTAKDLVSKMLHVDPHQRLTAA 273

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 127/282 (45%), Gaps = 50/282 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G+ G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAAGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--EPNISYICSRY-YRAPELI 245
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      E  ++ +C    Y APEL+
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELL 178
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                +   +D+WS G V+  ++ G+   P D   D   E                   Y
Sbjct: 179 KRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE-------------------Y 217
Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           +++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 218 SDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/244 (27%), Positives = 115/244 (47%), Gaps = 41/244 (16%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE------LQTMRLLDHPN 125
           +++  R +G G+FG V   + ++  +  A+K V   K+Y          L+ ++  D  N
Sbjct: 36  AFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINN 95
Query: 126 VVSLK-HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
              +K H  F   D    ++ L+ E +  +++ ++   N     +  I  KLY  +I +A
Sbjct: 96  NNIVKYHGKFMYYD----HMCLIFEPLGPSLYEIITRNNYNGFHIEDI--KLYCIEILKA 149
Query: 185 LSYIHRSIGVCHRDIKPQNLLVN-PHTHQ-----------------------VKLCDFGS 220
           L+Y+ R + + H D+KP+N+L++ P+  +                       +KL DFG 
Sbjct: 150 LNYL-RKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGC 208
Query: 221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           A    K + + S I +R YRAPE+I     +  + D+WS GCV+AEL  G  LF     +
Sbjct: 209 ATF--KSDYHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHM 265
Query: 281 DQLV 284
           + L 
Sbjct: 266 EHLA 269

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSXQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 43/284 (15%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    D   +YL   L    E + ++++   K        +V    + I + + Y+H S
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFV---LHTIGKTVEYLH-S 139
Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y    DIWS G ++  ++ G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               KF  +    W+ +        A DLVS++L   P+ R TA
Sbjct: 244 ----KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTA 277

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/296 (27%), Positives = 132/296 (44%), Gaps = 60/296 (20%)
Query: 70  TISYMAERIVGQGSFGVV-----------FQAKCLETGETVAIKKVLQDKRYKNRELQTM 118
           T  Y     +G+G+F VV           + AK + T +  A     +D +   RE +  
Sbjct: 30  TDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSA-----RDHQKLEREARIC 84
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVL--EYVPETVHRVVKHFNKLNQRMPMIYVKL 176
           RLL HPN+V L H   S      L  +LV   E   + V R  +++++ +    +     
Sbjct: 85  RLLKHPNIVRL-HDSISEEGFHYLVFDLVTGGELFEDIVAR--EYYSEADASHCI----- 136
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPN--IS 232
             +QI  ++++IH+   + HRD+KP+NLL+        VKL DFG A + V+GE      
Sbjct: 137 --HQILESVNHIHQH-DIVHRDLKPENLLLASKCKGAAVKLADFGLA-IEVQGEQQAWFG 192
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           +  +  Y +PE +     Y   +DIW+ G ++  L++G P F  D    +L + IK    
Sbjct: 193 FAGTPGYLSPE-VLRKDPYGKPVDIWACGVILYILLVGYPPF-WDEDQHKLYQQIKA--- 247
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                          + FP  +   W  +      PEA +L++++L  +P  R TA
Sbjct: 248 -------------GAYDFPSPE---WDTV-----TPEAKNLINQMLTINPAKRITA 282

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 76/284 (26%), Positives = 125/284 (44%), Gaps = 43/284 (15%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y+ +  +G GS+    +     T    A+K + + KR  + E++ + R   HPN+++LK 
Sbjct: 29  YVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNIITLKD 88
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    D   +YL   L    E + ++++   K        +V    + I + + Y+H S
Sbjct: 89  VY---DDGKHVYLVTELMRGGELLDKILRQ--KFFSEREASFV---LHTIGKTVEYLH-S 139
Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
            GV HRD+KP N+L      NP    +++CDFG AK L      +   C +  + APE +
Sbjct: 140 QGVVHRDLKPSNILYVDESGNPEC--LRICDFGFAKQLRAENGLLMTPCYTANFVAPE-V 196
Query: 246 FGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y    DIWS G ++  ++ G  P   G S  D   EI+  +G+            
Sbjct: 197 LKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPS--DTPEEILTRIGSG----------- 243
Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               KF  +    W+ +        A DLVS++L   P+ R TA
Sbjct: 244 ----KF-TLSGGNWNTV-----SETAKDLVSKMLHVDPHQRLTA 277

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 34/216 (15%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 14  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 71
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-----YAYQIFRALSYI 188
            +        + LV+EY           +N L+   P+ Y        +  Q  + ++Y+
Sbjct: 72  LNP-------VCLVMEYAEGG-----SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 119
Query: 189 H--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H  +   + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F
Sbjct: 120 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 176
Query: 247 GATEYTTAIDIWSAGCVVAELM--------LGKPLF 274
             + Y+   D++S G ++ E++        +G P F
Sbjct: 177 EGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAF 212

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 80/301 (26%), Positives = 132/301 (43%), Gaps = 50/301 (16%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTM-RLLDHPNVVS 128
           +   ++G+G++  V  A  L+ G+  A+K + +   +      RE++T+ +   + N++ 
Sbjct: 16  LTSELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILE 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRAL 185
           L   F     +D+    LV E +      ++ H  K    N+R     V+     +  AL
Sbjct: 76  LIEFF-----EDDTRFYLVFEKLQGG--SILAHIQKQKHFNEREASRVVR----DVAAAL 124
Query: 186 SYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDF--GSAKVLVKG-----EPNISYIC- 235
            ++H + G+ HRD+KP+N+L         VK+CDF  GS   L         P ++  C 
Sbjct: 125 DFLH-TKGIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCG 183
Query: 236 SRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIK 288
           S  Y APE++      AT Y    D+WS G V+  ++ G P F G  G D      E+ +
Sbjct: 184 SAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCR 243
Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           V      E I+       +++FP      W  I       EA DL+S+LL      R +A
Sbjct: 244 VCQNKLFESIQ-----EGKYEFPD---KDWAHI-----SSEAKDLISKLLVRDAKQRLSA 290
Query: 349 V 349
Sbjct: 291 A 291

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 102/208 (49%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--ELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGAC 70
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-----YAYQIFRALSYI 188
            +        + LV+EY           +N L+   P+ Y        +  Q  + ++Y+
Sbjct: 71  LNP-------VCLVMEYAEGG-----SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYL 118
Query: 189 H--RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H  +   + HRD+KP NLL+      +K+CDFG+A  +     N     S  + APE +F
Sbjct: 119 HSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNK--GSAAWMAPE-VF 175
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLF 274
             + Y+   D++S G ++ E++  +  F
Sbjct: 176 EGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/303 (24%), Positives = 129/303 (42%), Gaps = 52/303 (17%)
Query: 19  TVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERI 78
           + GVD   E +    ++  K    +V D    + GH+ V  IG           ++ ER 
Sbjct: 8   SSGVDLGTENLYFQSMQSSKRSSRSVED---DKEGHL-VCRIG----------DWLQERY 53
Query: 79  -----VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLK 130
                +G+G+FG V   +CL+       VA+K +    +Y+      + +L        +
Sbjct: 54  EIVGNLGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKE 111
Query: 131 HCFFSTTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + F      D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL 
Sbjct: 112 NKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALR 169
Query: 187 YIHRSIGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGE 228
           ++H +  + H D+KP+N+L          N H            +++ DFGSA      E
Sbjct: 170 FLHEN-QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHE 226
Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
            + + + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K
Sbjct: 227 HHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEK 285
Query: 289 VLG 291
           +LG
Sbjct: 286 ILG 288

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 69.3 bits (168), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 74/284 (26%), Positives = 127/284 (44%), Gaps = 54/284 (19%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLK 130
           + +G+G++G V  A    T E VA+K ++  KR  +      +E+   ++L+H NVV   
Sbjct: 12  QTLGEGAYGEVQLAVNRVTEEAVAVK-IVDMKRAVDCPENIKKEICINKMLNHENVVK-- 68
Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F+    +  +   L LEY    E   R+          MP    + + +Q+   + Y+
Sbjct: 69  --FYGHRREGNIQY-LFLEYCSGGELFDRIEPDIG-----MPEPDAQRFFHQLMAGVVYL 120
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAPE 243
           H  IG+ HRDIKP+NLL++   + +K+ DFG A V      N   + ++      Y APE
Sbjct: 121 H-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYN--NRERLLNKMXGTLPYVAPE 176
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           L+     +   +D+WS G V+  ++ G+   P D   D   E                  
Sbjct: 177 LLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQE------------------ 216
Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            Y+++K  +   +PW KI         + L+ ++L  +P+ R T
Sbjct: 217 -YSDWKEKKTYLNPWKKI-----DSAPLALLHKILVENPSARIT 254

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +   S+I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDSFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE++   T     Y    D+WS G  + E+   +P
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/215 (29%), Positives = 106/215 (49%), Gaps = 28/215 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSLKH 131
           +G G    V+ A+       VAIK +    R K        RE+     L H N+VS+  
Sbjct: 19  LGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSM-- 76
Query: 132 CFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                 ++D+ Y  LV+EY+   T+   ++    L+    + +      QI   + + H 
Sbjct: 77  --IDVDEEDDCYY-LVMEYIEGPTLSEYIESHGPLSVDTAINFTN----QILDGIKHAH- 128
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPELIF 246
            + + HRDIKPQN+L++ +   +K+ DFG AK L   E +++     + +  Y +PE   
Sbjct: 129 DMRIVHRDIKPQNILIDSNK-TLKIFDFGIAKAL--SETSLTQTNHVLGTVQYFSPEQAK 185
Query: 247 G-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           G AT+  T  DI+S G V+ E+++G+P F G++ V
Sbjct: 186 GEATDECT--DIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 74/288 (25%), Positives = 125/288 (43%), Gaps = 43/288 (14%)
Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVS 128
           T  Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++
Sbjct: 21  TDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRDPTEEIEILLRYGQHPNIIT 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSY 187
           LK  +    D   +Y+   L    E + ++++  F    +   +++       I + + Y
Sbjct: 81  LKDVY---DDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFT------ITKTVEY 131
Query: 188 IHRSIGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           +H + GV HRD+KP N+L      NP +  +++CDFG AK L      +   C +  + A
Sbjct: 132 LH-AQGVVHRDLKPSNILYVDESGNPES--IRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y  A DIWS G ++   + G   F  +   D   EI+  +G+         
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTXLTGYTPF-ANGPDDTPEEILARIGSG-------- 238
Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                  KF  +    W+ +        A DLVS+ L   P+ R TA 
Sbjct: 239 -------KF-SLSGGYWNSV-----SDTAKDLVSKXLHVDPHQRLTAA 273

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 79  VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 36  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 93
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H +
Sbjct: 94  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN 151
Query: 192 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 233
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 152 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 208
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG
Sbjct: 209 VATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 265

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 22/220 (10%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +   S+I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRTIQRRDSFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE++   T     Y    D+WS G  + E+   +P
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 35  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 94
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 95  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 145
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 146 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 202
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 203 SKADIWSLGITAIELARGEP 222

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/238 (25%), Positives = 106/238 (44%), Gaps = 33/238 (13%)
Query: 79  VGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G+FG V   +CL+       VA+K +    +Y+      + +L        ++ F  
Sbjct: 27  LGEGTFGKV--VECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLC 84
Query: 136 TTDKDEL----YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
               D      ++ +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H +
Sbjct: 85  VLMSDWFNFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHEN 142
Query: 192 IGVCHRDIKPQNLLV---------NPHTH---------QVKLCDFGSAKVLVKGEPNISY 233
             + H D+KP+N+L          N H            +++ DFGSA      E + + 
Sbjct: 143 -QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATF--DHEHHTTI 199
Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           + +R+YR PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG
Sbjct: 200 VATRHYRPPEVIL-ELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILG 256

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 93/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 125
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +    +++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-KQSAYD 182
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/249 (28%), Positives = 112/249 (44%), Gaps = 44/249 (17%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-------MRLLDHPNVVSLK 130
           ++GQG+FG V +A+        AIKK+    R+   +L T       +  L+H  VV   
Sbjct: 13  VLGQGAFGQVVKARNALDSRYYAIKKI----RHTEEKLSTILSEVXLLASLNHQYVVRYY 68
Query: 131 HCFFS--------TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
             +          T  K +  L +  EY        + H   LNQ+    Y +L+  QI 
Sbjct: 69  AAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDE-YWRLFR-QIL 126
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEPNI---- 231
            ALSYIH S G+ HR++KP N+ ++  +  VK+ DFG AK       +L     N+    
Sbjct: 127 EALSYIH-SQGIIHRNLKPXNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               S I +  Y A E++ G   Y   ID +S G +  E      ++P  +G ++ V I+
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE-----XIYPFSTGXER-VNIL 238
Query: 288 KVLGTPTRE 296
           K L + + E
Sbjct: 239 KKLRSVSIE 247

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 89/340 (26%), Positives = 135/340 (39%), Gaps = 84/340 (24%)
Query: 26  PEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGR-NGQPKQTISYMAERIVGQGSF 84
           PE+  ++   DD E E    D N    G   +  IG   NG+      Y   R +G G F
Sbjct: 1   PEQEEEILGSDDDEQE----DPNDYCKGGYHLVKIGDLFNGR------YHVIRKLGWGHF 50
Query: 85  GVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHPN---VVSLKHCF 133
             V+ +  ++  + VA+K V   + Y    L  +RLL        + PN   VV L   F
Sbjct: 51  STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDF 110
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQIFRALSYIHRSI 192
              +  +  ++ +V E +    H ++K   K N Q +P+  VK    Q+ + L Y+H   
Sbjct: 111 -KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC 166
Query: 193 GVCHRDIKPQNLLV---------------------------------------------- 206
            + H DIKP+N+L+                                              
Sbjct: 167 RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLE 226
Query: 207 --NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV 264
             N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y T  DIWS  C+ 
Sbjct: 227 PKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMA 283
Query: 265 AELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEI 298
            EL  G  LF   SG       D +  II++LG   R+ I
Sbjct: 284 FELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 323

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 68.2 bits (165), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 215
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA 348
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA
Sbjct: 216 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 2   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 60
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 61  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 111
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 112 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 168
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 169 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 214
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA 348
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA
Sbjct: 215 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 255

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/295 (26%), Positives = 125/295 (42%), Gaps = 55/295 (18%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-------RL 120
           K + +Y  +  +G+G+F VV +     TG   A  K++  K+   R+ Q +       R 
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFA-AKIINTKKLSARDFQKLEREARICRK 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLY 177
           L HPN+V L         ++E +  LV + V   E    +V + F         I     
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQ---- 112
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  +++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  
Sbjct: 113 --QILESIAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG 169
Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           +  Y +PE +     Y+  +DIW+ G ++  L++G P F  D    +L            
Sbjct: 170 TPGYLSPE-VLKKDPYSKPVDIWACGVILYILLVGYPPF-WDEDQHRL------------ 215
Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPK--RMPPEAVDLVSRLLQYSPNLRCTA 348
                         + QIKA  +    P+   + PEA  L+  +L  +P  R TA
Sbjct: 216 --------------YAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITA 256

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 30  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 89
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 90  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 140
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 141 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 197
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 198 SKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 67.8 bits (164), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 92/200 (46%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG VF+     T + VAIK +       +     +E+  +   D P V      +
Sbjct: 15  IGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY 74
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T      L +++EY+       +     L++      ++    +I + L Y+H    
Sbjct: 75  LKDTK-----LWIIMEYLGGGSALDLLEPGPLDETQIATILR----EILKGLDYLHSEKK 125
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++ H  +VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 126 I-HRDIKAANVLLSEHG-EVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 182
Query: 253 TAIDIWSAGCVVAELMLGKP 272
           +  DIWS G    EL  G+P
Sbjct: 183 SKADIWSLGITAIELARGEP 202

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 67.8 bits (164), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 78/287 (27%), Positives = 116/287 (40%), Gaps = 71/287 (24%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 124
           Y   R +G G F  V+    ++    VA+K V   + Y    L  ++LL          P
Sbjct: 33  YHVIRKLGWGHFSTVWLCWDMQGKRFVAMKVVKSAQHYTETALDEIKLLKCVRESDPSDP 92
Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQ 180
           N   VV L   F   +  + +++ +V E +    H ++K   K N Q +P+  VK    Q
Sbjct: 93  NKDMVVQLIDDF-KISGMNGIHVCMVFEVLG---HHLLKWIIKSNYQGLPVRCVKSIIRQ 148
Query: 181 IFRALSYIHRSIGVCHRDIKPQN------------------------------------- 203
           + + L Y+H    + H DIKP+N                                     
Sbjct: 149 VLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMAAEATEWQKAGAPPPSGSAVSTAP 208
Query: 204 ---LLVNP------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
              LLVNP         +VK+ D G+A  + K       I +R YR+ E++ GA  Y+T 
Sbjct: 209 AADLLVNPLDPRNADKIRVKIADLGNACWVHKH--FTEDIQTRQYRSIEVLIGAG-YSTP 265
Query: 255 IDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTR 295
            DIWS  C+  EL  G  LF   SG       D +  II++LG+  R
Sbjct: 266 ADIWSTACMAFELATGDYLFEPHSGEDYSRDEDHIAHIIELLGSIPR 312

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 99/220 (45%), Gaps = 17/220 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L   E     ++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDG-KQNVKLGDFGLARILNHDEDFAKEFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            + YY +PE +     Y    DIWS GC++ EL    P F
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 76/279 (27%), Positives = 128/279 (45%), Gaps = 35/279 (12%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--------NRELQTMRLLDHP 124
           Y+   ++G+GS+G V +    ET    A+K + + K  +         +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           NV+ L    ++  +K ++Y+  V+EY    +  ++    +  +R P+     Y  Q+   
Sbjct: 67  NVIQLVDVLYNE-EKQKMYM--VMEYCVCGMQEMLDSVPE--KRFPVCQAHGYFCQLIDG 121
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---VKGEPNISYICSRYYRA 241
           L Y+H S G+ H+DIKP NLL+      +K+   G A+ L      +   +   S  ++ 
Sbjct: 122 LEYLH-SQGIVHKDIKPGNLLLT-TGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 242 PELIFGATEYTT-AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV--------LGT 292
           PE+  G   ++   +DIWSAG  +  +  G   F GD+ + +L E I           G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN-IYKLFENIGKGSYAIPGDCGP 238
Query: 293 PTREEIKCM---NPNYTEFKFPQIKAHPWHKIFPKRMPP 328
           P  + +K M    P    F   QI+ H W   F K+ PP
Sbjct: 239 PLSDLLKGMLEYEPA-KRFSIRQIRQHSW---FRKKHPP 273

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 27  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 86
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K      T+     + L++E++P    +  + K+ NK+N +  +     YA QI + +
Sbjct: 87  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL----KYAVQICKGM 139
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRA 241
            Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ A
Sbjct: 140 DYLG-SRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 197
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE +   +++  A D+WS G  + EL+
Sbjct: 198 PECLM-QSKFYIASDVWSFGVTLHELL 223

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 102/207 (49%), Gaps = 25/207 (12%)
Query: 77  RIVGQGSFGVV----FQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           R +G+G FG V    +  +   TGE VA+K +  +    +     +E++ +R L H N+V
Sbjct: 15  RDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIV 74
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K      T+     + L++E++P    +  + K+ NK+N +  + Y    A QI + +
Sbjct: 75  KYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY----AVQICKGM 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRA 241
            Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +   +    R    ++ A
Sbjct: 128 DYLG-SRQYVHRDLAARNVLVESE-HQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYA 185
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE +   +++  A D+WS G  + EL+
Sbjct: 186 PECLM-QSKFYIASDVWSFGVTLHELL 211

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 102/220 (46%), Gaps = 22/220 (10%)
Query: 63  RNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQT 117
           R+  P+     + E  +G G+FG V++A+  ET   +A  KV+  K  +       E+  
Sbjct: 31  RDLNPEDFWEIIGE--LGDGAFGKVYKAQNKETS-VLAAAKVIDTKSEEELEDYMVEIDI 87
Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           +   DHPN+V L   F+   +     L +++E+        V    +L + +    +++ 
Sbjct: 88  LASCDHPNIVKLLDAFYYENN-----LWILIEFCAGGAVDAV--MLELERPLTESQIQVV 140
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICS 236
             Q   AL+Y+H +  + HRD+K  N+L       +KL DFG SAK     +    +I +
Sbjct: 141 CKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNTRXIQRRDXFIGT 198
Query: 237 RYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKP 272
            Y+ APE++   T     Y    D+WS G  + E+   +P
Sbjct: 199 PYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +  K C     D+ E  L LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H S    HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLH-SQHYIHRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 185 FWYAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 23  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 79
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 80  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 130
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 131 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 188
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 189 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 224

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 78
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 79  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 130 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 187
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/348 (22%), Positives = 149/348 (42%), Gaps = 70/348 (20%)
Query: 34  IRDDKEMEATVV-------DGNGTETGHIIVTTIGGRNGQPKQTIS------YMAERIVG 80
           +RDD    A ++       D     T ++   ++G  +  P    +      Y  + ++G
Sbjct: 44  LRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIG 103
Query: 81  QGSFGVV-----------FQAKCLE-TGETVAIKKVLQDKRYKNRELQTMR-LLDHPNVV 127
           +G   VV           F  K +E T E ++ +++ + +    RE   +R +  HP+++
Sbjct: 104 RGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHII 163
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--VKLYAYQIFRAL 185
           +L   + S++     ++ LV + +     R  + F+ L +++ +     +     +  A+
Sbjct: 164 TLIDSYESSS-----FMFLVFDLM-----RKGELFDYLTEKVALSEKETRSIMRSLLEAV 213
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           S++H +  + HRD+KP+N+L++ +  Q++L DFG +  L  GE       +  Y APE++
Sbjct: 214 SFLHAN-NIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEIL 271
Query: 246 FGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
             + +     Y   +D+W+ G ++  L+ G P F     +  L  I              
Sbjct: 272 KCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMI-------------- 317
Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           M   Y +F  P+     W             DL+SRLLQ  P  R TA
Sbjct: 318 MEGQY-QFSSPE-----WDD-----RSSTVKDLISRLLQVDPEARLTA 354

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 30  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 86
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 87  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 137
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 138 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 195
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 196 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 231

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 98/220 (44%), Gaps = 35/220 (15%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTM-RLLDHPNVVSLKH 131
           +G GS+G VF+ +  E G   A+K+ +      +D+  K  E+ +  ++  HP  V L+ 
Sbjct: 65  LGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQ 124
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            +    +   LYL   L         + +H       +P   V  Y      AL+++H S
Sbjct: 125 AW---EEGGILYLQTEL-----CGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH-S 175
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFG--------SAKVLVKGEPNISYICSRYYRAPE 243
            G+ H D+KP N+ + P   + KL DFG         A  + +G+P         Y APE
Sbjct: 176 QGLVHLDVKPANIFLGPRG-RCKLGDFGLLVELGTAGAGEVQEGDPR--------YMAPE 226
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
           L+ G+  Y TA D++S G  + E+     L  G  G  QL
Sbjct: 227 LLQGS--YGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 28  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 84
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 85  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 135
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 136 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 193
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 194 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 229

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 29  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 85
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 86  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 136
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 137 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 194
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 195 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 230

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 80
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 81  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 132 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 74  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 130
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 131 ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 181
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 182 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 239
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 240 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 275

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 38  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 94
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 95  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 145
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 146 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 203
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 204 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 239

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 107/218 (49%), Gaps = 19/218 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 407
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++ H  ++  R    +   YA +I   L ++ +
Sbjct: 408 HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL-Q 459
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE+I    
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 517
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y  ++D W+ G ++ E++ G+  F G+   D+L + I
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 554

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 68  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 124
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 125 ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 175
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 176 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 233
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           ++G+GSFG V  ++   T E  A+K + +D   ++ +++        + L   P  ++  
Sbjct: 27  VLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL 86
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           H  F T D+    L  V+EYV      ++ H  ++  R    +   YA +I   L ++ +
Sbjct: 87  HSCFQTMDR----LYFVMEYV--NGGDLMYHIQQVG-RFKEPHAVFYAAEIAIGLFFL-Q 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-YYRAPELIFGAT 249
           S G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE+I    
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKXFCGTPDYIAPEII-AYQ 196
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            Y  ++D W+ G ++ E++ G+  F G+   D+L + I
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI 233

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 104/211 (49%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +  D   ++R     E+  +R L H ++
Sbjct: 20  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHI 78
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +  K C     D+ E  L LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 79  IKYKGC---CEDQGEKSLQLVMEYVPLGSLRDYLPRHSIGLAQLL------LFAQQICEG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR++  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 130 MAYLHAQHYI-HRNLAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 184
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 185 FWYAPECL-KEYKFYYASDVWSFGVTLYELL 214

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 102/216 (47%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 80
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 81  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE 
Sbjct: 132 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE- 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 225

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/207 (28%), Positives = 105/207 (50%), Gaps = 26/207 (12%)
Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVS 128
           IS+  + ++G G+ G +      +  + VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIVYRGMFDNRD-VAVKRILPECFSFADREVQLLRESDEHPNVIR 82
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVV--KHFNKLNQRMPMIYVKLYAYQIFRALS 186
                +  T+KD  +  + +E    T+   V  K F  L    P+  ++    Q    L+
Sbjct: 83  -----YFCTEKDRQFQYIAIELCAATLQEYVEQKDFAHLGLE-PITLLQ----QTTSGLA 132
Query: 187 YIHRSIGVCHRDIKPQNLLVN-PHTH---QVKLCDFGSAKVLVKGEPNISYIC----SRY 238
           ++H S+ + HRD+KP N+L++ P+ H   +  + DFG  K L  G  + S       +  
Sbjct: 133 HLH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEG 191
Query: 239 YRAPELIFGATEY--TTAIDIWSAGCV 263
           + APE++    +   T  +DI+SAGCV
Sbjct: 192 WIAPEMLSEDCKENPTYTVDIFSAGCV 218

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 26/216 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 22  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 78
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 79  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 129
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK             + YY APE 
Sbjct: 130 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE- 187
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           + G  +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 223

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 43/296 (14%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 118
           QP    ++   R++G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++   VVSL + + +   KD L L L L    +    +  H  +     P      YA
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHIY-HMGQAG--FPEARAVFYA 292
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L  +HR   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y APE++     YT + D W+ GC++ E++ G+  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP--NLRCTAVSKR 352
           + +           +K  P  + + +R  P+A  L S+LL   P   L C   S R
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAR 440

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKTFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            + YY +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 100/224 (44%), Gaps = 17/224 (7%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRL 120
           P +   Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R 
Sbjct: 2   PSRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 61
Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           L HPN+V     +    D+    L +V+EY     +  V+    K  Q +   +V     
Sbjct: 62  LKHPNIVRY---YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 180 QIFRALSYIHR-SIG---VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYI 234
           Q+  AL   HR S G   V HRD+KP N+ ++     VKL DFG A++L        +++
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK-QNVKLGDFGLARILNHDTSFAKAFV 177
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            + YY +PE +     Y    DIWS GC++ EL    P F   S
Sbjct: 178 GTPYYMSPEQM-NRMSYNEKSDIWSLGCLLYELCALMPPFTAFS 220

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 134/296 (45%), Gaps = 43/296 (14%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTM 118
           QP    ++   R++G+G FG V   +   TG+  A KK+ + +  K         E Q +
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
             ++   VVSL + + +   KD L L L L    +    +  H  +     P      YA
Sbjct: 239 EKVNSRFVVSLAYAYET---KDALCLVLTLMNGGDLKFHIY-HMGQAG--FPEARAVFYA 292
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
            +I   L  +HR   + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  
Sbjct: 293 AEICCGLEDLHRE-RIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVG 350
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           Y APE++     YT + D W+ GC++ E++ G+  F       Q  + IK      REE+
Sbjct: 351 YMAPEVV-KNERYTFSPDWWALGCLLYEMIAGQSPF------QQRKKKIK------REEV 397
Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP--NLRCTAVSKR 352
           + +           +K  P  + + +R  P+A  L S+LL   P   L C   S R
Sbjct: 398 ERL-----------VKEVP--EEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAR 440

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 72/310 (23%), Positives = 136/310 (43%), Gaps = 50/310 (16%)
Query: 79  VGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKNRELQTMRLLD-----HPNVVSLK 130
           +G+G+FG V Q  C++    G  VA+K +   ++YK      + +L+      P+  +L 
Sbjct: 41  LGEGTFGRVVQ--CVDHRRGGARVALKIIKNVEKYKEAARLEINVLEKINEKDPDNKNLC 98
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              F   D    ++ +  E +  +    +K  N L    P+  V+  A+Q+ +A+ ++H 
Sbjct: 99  VQMFDWFDY-HGHMCISFELLGLSTFDFLKDNNYLP--YPIHQVRHMAFQLCQAVKFLHD 155
Query: 191 SIGVCHRDIKPQNLLVNPHTHQ------------------VKLCDFGSAKVLVKGEPNIS 232
           +  + H D+KP+N+L     ++                  V++ DFGSA      E + +
Sbjct: 156 N-KLTHTDLKPENILFVNSDYELTYNLEKKRDERSVKSTAVRVVDFGSATF--DHEHHST 212
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG- 291
            + +R+YRAPE+I     ++   D+WS GC++ E  +G  LF      + L  + ++LG 
Sbjct: 213 IVSTRHYRAPEVILELG-WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGP 271
Query: 292 TPTREEIKC------------MNPNYTEFKFPQIKAHPWHKIFPKRMPP--EAVDLVSRL 337
            P+R   K              + N +  ++ +    P  +          +  DL+  +
Sbjct: 272 IPSRMIRKTRKQKYFYRGRLDWDENTSAGRYVRENCKPLRRYLTSEAEEHHQLFDLIESM 331
Query: 338 LQYSPNLRCT 347
           L+Y P  R T
Sbjct: 332 LEYEPAKRLT 341

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 18  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 78  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 131
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 132 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 188 SL-SDNIFSRQSDVWSFGVVLYELF 211

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 19  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 79  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 132
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 133 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 189 SL-SDNIFSRQSDVWSFGVVLYELF 212

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 15  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +     +   L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 75  GVSYGPGRPE---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 128
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 129 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDXXVVREPGQSPI---FWYAPE 184
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 185 SL-SDNIFSRQSDVWSFGVVLYELF 208

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 60/205 (29%), Positives = 96/205 (46%), Gaps = 26/205 (12%)
Query: 79  VGQGSFGVV----FQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLK 130
           +G+G+FG V    +      TG  VA+K++       +R   RE+Q ++ L    +V  +
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
              +    +    L LV+EY+P    R      +   R+    + LY+ QI + + Y+  
Sbjct: 91  GVSYGPGRQS---LRLVMEYLPSGCLR--DFLQRHRARLDASRLLLYSSQICKGMEYLG- 144
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAPE 243
           S    HRD+  +N+LV    H VK+ DFG AK+L       V  EP  S I   ++ APE
Sbjct: 145 SRRCVHRDLAARNILVESEAH-VKIADFGLAKLLPLDKDYYVVREPGQSPI---FWYAPE 200
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            +     ++   D+WS G V+ EL 
Sbjct: 201 SL-SDNIFSRQSDVWSFGVVLYELF 224

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 76/292 (26%), Positives = 117/292 (40%), Gaps = 73/292 (25%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL--------DHP 124
           Y   R +G G F  V+ +  ++  + VA+K V   + Y    L  +RLL        + P
Sbjct: 23  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 82
Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN-QRMPMIYVKLYAYQ 180
           N   VV L   F   +  +  ++ +V E +    H ++K   K N Q +P+  VK    Q
Sbjct: 83  NREMVVQLLDDF-KISGVNGTHICMVFEVLG---HHLLKWIIKSNYQGLPLPCVKKIIQQ 138
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---------------------------------- 206
           + + L Y+H    + H DIKP+N+L+                                  
Sbjct: 139 VLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP 198
Query: 207 --------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
                         N    +VK+ D G+A  + K       I +R YR+ E++ G+  Y 
Sbjct: 199 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-YN 255
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEI 298
           T  DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I
Sbjct: 256 TPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLI 307

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 119
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 120 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 174
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 175 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 233
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 234 DAKVDIWSSCCMMLHMLNG 252

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ R + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 204 YSFQVARGMEFLS-SRKCIHRDLAARNILLS-ENNVVKICDFGLARDIYKNPDYVRKGDT 261
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    Y+T  D+WS G ++ E+  LG   +PG       V++ +   +
Sbjct: 262 RLPLKWMAPESIFDKI-YSTKSDVWSYGVLLWEIFSLGGSPYPG-------VQMDEDFCS 313
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             RE ++   P Y+  +  QI    WH+   +R  P   +LV +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKER--PRFAELVEKL 356

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 65.1 bits (157), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           VG+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 135
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 190
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 191 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 249
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 250 DAKVDIWSSCCMMLHMLNG 268

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 15  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 73
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K C     D+ E  + LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 74  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 124
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 125 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 179
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 180 FWYAPECL-KECKFYYASDVWSFGVTLYELL 209

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 64.7 bits (156), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 103/211 (48%), Gaps = 35/211 (16%)
Query: 77  RIVGQGSFGVVFQAKCLE-----TGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNV 126
           R +G+G FG V    C +     TGE VA+K +      Q +    RE++ +R L H ++
Sbjct: 14  RDLGEGHFGKV-SLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHI 72
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHR--VVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K C     D+ E  + LV+EYVP    R  + +H   L Q +      L+A QI   
Sbjct: 73  VKYKGC---CEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLAQLL------LFAQQICEG 123
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------- 237
           ++Y+H    + HR +  +N+L++ +   VK+ DFG AK + +G     Y   R       
Sbjct: 124 MAYLHAQHYI-HRALAARNVLLD-NDRLVKIGDFGLAKAVPEGH---EYYRVREDGDSPV 178
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           ++ APE +    ++  A D+WS G  + EL+
Sbjct: 179 FWYAPECL-KECKFYYASDVWSFGVTLYELL 208

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 64.7 bits (156), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 107/222 (48%), Gaps = 16/222 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMR----LLDHPNVVSLKHC 132
           +++G+G+FG V   K     +  A+K + + +  K  E    R    +L + +   +   
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            ++  D + LYL  V++Y       ++   +K   R+P    + Y  ++  A+  +H+ +
Sbjct: 140 HYAFQDDNNLYL--VMDYY--VGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-L 194
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K++  G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           G   Y    D WS G  + E++ G+  F  +S V+   +I+ 
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMN 295

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 154
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ ++VK    L +   + Y+     Q    L Y+H S  + H 
Sbjct: 155 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLH-SRRILHG 209
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++       LCDFG A  L       S +   Y      + APE++ G +  
Sbjct: 210 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-C 268
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +D+WS+ C++  ++ G
Sbjct: 269 DAKVDVWSSCCMMLHMLNG 287

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 107/226 (47%), Gaps = 39/226 (17%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM 118
            G+  Q  S M+   +G G+FG V+ A   E  + V +K     KVL+D   ++ +L  +
Sbjct: 19  EGEYSQKYSTMSP--LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKV 76
Query: 119 RL-------LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN----- 166
            L       ++H N++ +   F     +++ +  LV+E          KH + L+     
Sbjct: 77  TLEIAILSRVEHANIIKVLDIF-----ENQGFFQLVME----------KHGSGLDLFAFI 121
Query: 167 QRMPMIYVKLYAY---QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223
            R P +   L +Y   Q+  A+ Y+ R   + HRDIK +N+++      +KL DFGSA  
Sbjct: 122 DRHPRLDEPLASYIFRQLVSAVGYL-RLKDIIHRDIKDENIVI-AEDFTIKLIDFGSAAY 179
Query: 224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML 269
           L +G+   ++  +  Y APE++ G       +++WS G  +  L+ 
Sbjct: 180 LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVF 225

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/214 (27%), Positives = 95/214 (44%), Gaps = 16/214 (7%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHC 132
           +  +++G G  G V Q     T E  A+K  LQD     RE++   R    P++V +   
Sbjct: 65  VTSQVLGLGINGKVLQIFNKRTQEKFALK-XLQDCPKARREVELHWRASQCPHIVRIVDV 123
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYI 188
           +      + LY       +        + F+++  R    + +  A +I +    A+ Y+
Sbjct: 124 Y------ENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYL 177
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           H SI + HRD+KP+NLL         +KL DFG AK         +   + YY APE + 
Sbjct: 178 H-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE-VL 235
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           G  +Y  + D WS G +   L+ G P F  + G+
Sbjct: 236 GPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGL 269

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 69/278 (24%), Positives = 115/278 (41%), Gaps = 47/278 (16%)
Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQ----DKRYKNRELQTMRLLDHPNVVSLKHC 132
           +G G+FGVV   +C+E  TG     K +      DK     E+  M  L HP +++L   
Sbjct: 59  LGSGAFGVVH--RCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDA 116
Query: 133 FFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
           F     +D+  + L+LE++   E   R+     K+++   + Y++    Q    L ++H 
Sbjct: 117 F-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLKHMHE 167
Query: 191 SIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
              + H DIKP+N++        VK+ DFG A  L   E       +  + APE++    
Sbjct: 168 H-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIV-DRE 225
Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
                 D+W+ G +   L+ G   F G+  ++ L            + +K  +  + E  
Sbjct: 226 PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL------------QNVKRCDWEFDEDA 273
Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
           F  +              PEA D +  LLQ  P  R T
Sbjct: 274 FSSVS-------------PEAKDFIKNLLQKEPRKRLT 298

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 89/200 (44%), Gaps = 18/200 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G+GSFG V++     T E VAIK +       +     +E+  +   D P +      +
Sbjct: 27  IGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYFGSY 86
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
             +T      L +++EY+       +     L +     Y+     +I + L Y+H    
Sbjct: 87  LKSTK-----LWIIMEYLGGGSALDLLKPGPLEE----TYIATILREILKGLDYLHSERK 137
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYT 252
           + HRDIK  N+L++     VKL DFG A  L   +     ++ + ++ APE+I   + Y 
Sbjct: 138 I-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVI-KQSAYD 194
Query: 253 TAIDIWSAGCVVAELMLGKP 272
              DIWS G    EL  G+P
Sbjct: 195 FKADIWSLGITAIELAKGEP 214

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 95/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + K  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKV-RLEVFRVEELVACAGLSSPRIVPLYGAV----- 133
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ +++K    L +   + Y+     Q    L Y+H +  + H 
Sbjct: 134 REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLG----QALEGLEYLH-TRRILHG 188
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++    +  LCDFG A  L       S +   Y      + APE++ G    
Sbjct: 189 DVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-C 247
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +DIWS+ C++  ++ G
Sbjct: 248 DAKVDIWSSCCMMLHMLNG 266

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 78/304 (25%), Positives = 124/304 (40%), Gaps = 59/304 (19%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-------- 113
           G +G   Q   Y  +  +G+GS+GVV  A   E   T    KVL  K+   +        
Sbjct: 4   GSSGDCVQLNQYTLKDEIGKGSYGVVKLAYN-ENDNTYYAMKVLSKKKLIRQAGFPRRPP 62
Query: 114 -----------------------ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEY 150
                                  E+  ++ LDHPNVV L        D +E +L +V E 
Sbjct: 63  PRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL---DDPNEDHLYMVFEL 119
Query: 151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT 210
           V +     V     L++       + Y   + + + Y+H    + HRDIKP NLLV    
Sbjct: 120 VNQGPVMEVPTLKPLSEDQ----ARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVGEDG 174
Query: 211 HQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAPELIFGATEYTT--AIDIWSAGCVVAEL 267
           H +K+ DFG +      +  +S  + +  + APE +    +  +  A+D+W+ G  +   
Sbjct: 175 H-IKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF 233
Query: 268 MLGKPLFPGDSGVDQLVEIIK--VLGTPTR----EEIKCM-------NPNYTEFKFPQIK 314
           + G+  F  D  +  L   IK   L  P +    E++K +       NP  +    P+IK
Sbjct: 234 VFGQCPF-MDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPE-SRIVVPEIK 291
Query: 315 AHPW 318
            HPW
Sbjct: 292 LHPW 295

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 80  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 137
Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +DE +L LV++Y       ++   +K   ++P    + Y  ++  A+  IH+ +
Sbjct: 138 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 194
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 195 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 253
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+
Sbjct: 254 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 294

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 108/221 (48%), Gaps = 16/221 (7%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFST 136
           +++G+G+FG V   K   T    A+K + + +  K  E    R  +  +V+    C + T
Sbjct: 96  KVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR--EERDVLVNGDCQWIT 153
Query: 137 T----DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +DE +L LV++Y       ++   +K   ++P    + Y  ++  A+  IH+ +
Sbjct: 154 ALHYAFQDENHLYLVMDYY--VGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQ-L 210
Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSA-KVLVKGEPNISY-ICSRYYRAPELI----F 246
              HRDIKP N+L++ + H ++L DFGS  K+   G    S  + +  Y +PE++     
Sbjct: 211 HYVHRDIKPDNVLLDVNGH-IRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMED 269
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
           G  +Y    D WS G  + E++ G+  F  +S V+   +I+
Sbjct: 270 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIM 310

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 125
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 126 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 183
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 18  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 77  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 127
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 128 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 186
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 187 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 231

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 125
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 126 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 183
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 35  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 93
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 94  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 144
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 145 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 202
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 203 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 255

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 137
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 138 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 195
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 196 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGKFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 138
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 139 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 196
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 197 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 124
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 125 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 182
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 183 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 137
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 138 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 195
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 196 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 16  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 74
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 75  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 125
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 126 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 183
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 236

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 15  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 73
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 74  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 124
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 125 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 182
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 183 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 235

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 137
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 138 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 195
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 196 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 138
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 139 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 196
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 197 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 138
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 139 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 196
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 197 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 28  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 86
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 87  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 137
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 138 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 195
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 196 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 248

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 29  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 87
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 88  PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 138
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 139 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 196
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 197 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 249

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 48  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 106
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 107 PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 157
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 158 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 215
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 216 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 268

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 68/226 (30%), Positives = 110/226 (48%), Gaps = 28/226 (12%)
Query: 65  GQPKQTIS---YMAERIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE---- 114
           G P+  I+    +  RI+G+G FG V++       GE   VA+K   +D    N+E    
Sbjct: 15  GSPQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMS 74
Query: 115 -LQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
               M+ LDHP++V L        +++  ++ + L    E  H + ++ N L     ++ 
Sbjct: 75  EAVIMKNLDHPHIVKL----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLT 126
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           + LY+ QI +A++Y+  SI   HRDI  +N+LV      VKL DFG ++  ++ E     
Sbjct: 127 LVLYSLQICKAMAYLE-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKA 183
Query: 234 ICSRY---YRAPELIFGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
             +R    + +PE I     +TTA D+W  A C+   L  GK P F
Sbjct: 184 SVTRLPIKWMSPESI-NFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/217 (26%), Positives = 102/217 (47%), Gaps = 26/217 (11%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGET---VAIKKV-----LQDKRYKNRELQTM 118
           P + +   ++R++G+G FGVV+  + ++  +     AIK +     +Q      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76
Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           R L+HPNV++L            + L       P   H  +  F +  QR P +   + +
Sbjct: 77  RGLNHPNVLALIGIMLPPEGLPHVLL-------PYMCHGDLLQFIRSPQRNPTVKDLISF 129
Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ R + Y+     V HRD+  +N +++  +  VK+ DFG A+ ++  E   S    R
Sbjct: 130 GLQVARGMEYLAEQKFV-HRDLAARNCMLD-ESFTVKVADFGLARDILDRE-YYSVQQHR 186
Query: 238 YYRAPELIFGATE------YTTAIDIWSAGCVVAELM 268
           + R P + + A E      +TT  D+WS G ++ EL+
Sbjct: 187 HARLP-VKWTALESLQTYRFTTKSDVWSFGVLLWELL 222

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 152
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 153 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 210
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 211 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 99/213 (46%), Gaps = 34/213 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G+F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L   + S        L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP+N+L+    ++  VKL DFG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL--GESGLVAGGRVGTP 197
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
           ++ APE++     Y   +D+W  G ++  L+ G
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSG 229

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 105/233 (45%), Gaps = 26/233 (11%)
Query: 62  GRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL 121
           G+  +P ++  Y    ++G G FG V+    +     VAIK V +D+     EL     +
Sbjct: 43  GKEKEPLES-QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 101
Query: 122 DHPNVVSLKHC------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM 169
               VV LK              +F   D       L+LE  PE V  +   F+ + +R 
Sbjct: 102 PM-EVVLLKKVSSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERG 152
Query: 170 PMI--YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
            +     + + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K 
Sbjct: 153 ALQEELARSFFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKD 210
Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 211 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 94/199 (47%), Gaps = 19/199 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD 138
           +G+GSFG V + +  +TG   A+KKV + + ++  EL     L  P +V L         
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKV-RLEVFRAEELMACAGLTSPRIVPLYGAV----- 135
Query: 139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
           ++  ++N+ +E +   ++ ++VK    L +   + Y+     Q    L Y+H S  + H 
Sbjct: 136 REGPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLG----QALEGLEYLH-SRRILHG 190
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELIFGATEY 251
           D+K  N+L++       LCDFG A  L         +   Y      + APE++ G +  
Sbjct: 191 DVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-C 249
Query: 252 TTAIDIWSAGCVVAELMLG 270
              +D+WS+ C++  ++ G
Sbjct: 250 DAKVDVWSSCCMMLHMLNG 268

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 13  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 72  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 122 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 180
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           E++          D+WS G +   L+ G   F G++  + L  I  V
Sbjct: 181 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 226

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 20  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNII 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 79  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 129 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           E++          D+WS G +   L+ G   F G++  + L  I  V
Sbjct: 188 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 233

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 97/202 (48%), Gaps = 27/202 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RS 191
            F         L++V EY+       + H +   +++        AY + + ++Y+H R+
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 245
             + HRD+K  NLLV+   + VK+CDFG +++         ++ S+       + APE++
Sbjct: 158 PPIVHRDLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----XFLXSKXAAGTPEWMAPEVL 211
Query: 246 FGATEYTTAIDIWSAGCVVAEL 267
                   + D++S G ++ EL
Sbjct: 212 RDEPSNEKS-DVYSFGVILWEL 232

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 57/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGVFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+LE V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILILELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 76/294 (25%), Positives = 130/294 (44%), Gaps = 53/294 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETVHRVVKHFNKLNQRMPM 171
                      P +V ++ C F        YL     E+VP     + K F  L      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKPEDLYKDFLTLE----- 148
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
            ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +
Sbjct: 149 -HLIXYSFQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDXV 205
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEII 287
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I 
Sbjct: 206 RKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKID 257
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 258 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 77  RIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 128
           RI+G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 18  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 77
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L        +++  ++ + L    E  H + ++ N L     ++ + LY+ QI +A++Y+
Sbjct: 78  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLTLVLYSLQICKAMAYL 129
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 245
             SI   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I
Sbjct: 130 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 186
Query: 246 FGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
                +TTA D+W  A C+   L  GK P F
Sbjct: 187 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 104/227 (45%), Gaps = 29/227 (12%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F +V + +   TG+  A  K ++ +R  +           RE+  +R + HPN++
Sbjct: 34  LGSGQFAIVRKCRQKGTGKEYA-AKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNII 92
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRAL 185
           +L   F + TD     + L+LE V        + F+ L ++  +   +   +  QI   +
Sbjct: 93  TLHDIFENKTD-----VVLILELVSGG-----ELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
            Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G    +   +  + AP
Sbjct: 143 HYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAP 201
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           E++          D+WS G +   L+ G   F G++  + L  I  V
Sbjct: 202 EIV-NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAV 247

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 97/215 (45%), Gaps = 11/215 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-----MRLLDHPNVV 127
           Y    ++G G FG V+    +     VAIK V +D+     EL       M ++    V 
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 69
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRAL 185
           S         D  E   + VL  + E +  V   F+ + +R  +     + + +Q+  A+
Sbjct: 70  SGFSGVIRLLDWFERPDSFVL--ILERMEPVQDLFDFITERGALQEELARSFFWQVLEAV 127
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y  PE I
Sbjct: 128 RHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEWI 185
Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +  +  +WS G ++ +++ G   F  D  +
Sbjct: 186 RYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 65/211 (30%), Positives = 104/211 (49%), Gaps = 25/211 (11%)
Query: 77  RIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQDKRYKNRE-----LQTMRLLDHPNVVS 128
           RI+G+G FG V++       GE   VA+K   +D    N+E        M+ LDHP++V 
Sbjct: 14  RILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVK 73
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L        +++  ++ + L    E  H + ++ N L     ++ + LY+ QI +A++Y+
Sbjct: 74  L----IGIIEEEPTWIIMELYPYGELGHYLERNKNSLK----VLTLVLYSLQICKAMAYL 125
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELI 245
             SI   HRDI  +N+LV      VKL DFG ++  ++ E       +R    + +PE I
Sbjct: 126 E-SINCVHRDIAVRNILV-ASPECVKLGDFGLSR-YIEDEDYYKASVTRLPIKWMSPESI 182
Query: 246 FGATEYTTAIDIWS-AGCVVAELMLGK-PLF 274
                +TTA D+W  A C+   L  GK P F
Sbjct: 183 -NFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 27/202 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR------ELQTMRLLDHPNVVSLKHC 132
           +G GSFG V +A+    G  VA+K +++   +  R      E+  M+ L HPN+V     
Sbjct: 45  IGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIV----- 97
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RS 191
            F         L++V EY+       + H +   +++        AY + + ++Y+H R+
Sbjct: 98  LFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY------YRAPELI 245
             + HR++K  NLLV+   + VK+CDFG +++        +++ S+       + APE++
Sbjct: 158 PPIVHRNLKSPNLLVD-KKYTVKVCDFGLSRLKAS-----TFLSSKSAAGTPEWMAPEVL 211
Query: 246 FGATEYTTAIDIWSAGCVVAEL 267
                   + D++S G ++ EL
Sbjct: 212 RDEPSNEKS-DVYSFGVILWEL 232

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 97/219 (44%), Gaps = 20/219 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      TT + ++   L++E+ P      V         +P     +    +   +++
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 188 IHRSIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + R  G+ HR+IKP N++  +      V KL DFG+A+ L   E  +S   +  Y  P++
Sbjct: 128 L-RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDM 186
Query: 245 IFGAT-------EYTTAIDIWSAGCVVAELMLGK-PLFP 275
              A        +Y   +D+WS G        G  P  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 61.6 bits (148), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 37  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      ++      L LV +Y+P    +  V +H   L    P + +  +  QI + +
Sbjct: 97  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALG---PQLLLN-WGVQIAKGM 146
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 147 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 204
Query: 243 ELI-FGATEYTTAIDIWSAGCVVAELM 268
           E I FG  +YT   D+WS G  V ELM
Sbjct: 205 ESIHFG--KYTHQSDVWSYGVTVWELM 229

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 37/219 (16%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLD---------- 122
           Y    ++G+G FG VF    L     VAIK +      +NR L    L D          
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVI-----PRNRVLGWSPLSDSVTCPLEVAL 87
Query: 123 ---------HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY 173
                    HP V+ L   F    +  E ++ LVLE  P     +   F+ + ++ P+  
Sbjct: 88  LWKVGAGGGHPGVIRLLDWF----ETQEGFM-LVLER-PLPAQDL---FDYITEKGPLGE 138
Query: 174 --VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
              + +  Q+  A+ + H S GV HRDIK +N+L++      KL DFGS   L+  EP  
Sbjct: 139 GPSRCFFGQVVAAIQHCH-SRGVVHRDIKDENILIDLRRGCAKLIDFGSG-ALLHDEPYT 196
Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
            +  +R Y  PE I     +     +WS G ++ +++ G
Sbjct: 197 DFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCG 235

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 61.2 bits (147), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 10  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 68
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 69  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 120
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 121 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 178
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 179 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 220

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 100/207 (48%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNR------ELQTMRLLDHPNVV 127
           +++G G FG V +   +  GE++ I    KV++DK  +         +  +  LDH ++V
Sbjct: 19  KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      ++      L LV +Y+P    +  V +H   L    P + +  +  QI + +
Sbjct: 79  RLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALG---PQLLLN-WGVQIAKGM 128
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
            Y+    G+ HR++  +N+L+   + QV++ DFG A +L   +  + Y  ++    + A 
Sbjct: 129 YYLEEH-GMVHRNLAARNVLLKSPS-QVQVADFGVADLLPPDDKQLLYSEAKTPIKWMAL 186
Query: 243 ELI-FGATEYTTAIDIWSAGCVVAELM 268
           E I FG  +YT   D+WS G  V ELM
Sbjct: 187 ESIHFG--KYTHQSDVWSYGVTVWELM 211

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 69
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 70  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 121
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 179
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 91/203 (44%), Gaps = 19/203 (9%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPNVVSLK 130
           ERI G+GSFG VF+     T + VAIK +       +     +E+  +   D   V    
Sbjct: 29  ERI-GKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYVTKYY 87
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
             +   +      L +++EY+       +      ++      +K    +I + L Y+H 
Sbjct: 88  GSYLKGSK-----LWIIMEYLGGGSALDLLRAGPFDEFQIATMLK----EILKGLDYLHS 138
Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-PNISYICSRYYRAPELIFGAT 249
              + HRDIK  N+L++     VKL DFG A  L   +    +++ + ++ APE+I   +
Sbjct: 139 EKKI-HRDIKAANVLLSEQG-DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI-QQS 195
Query: 250 EYTTAIDIWSAGCVVAELMLGKP 272
            Y +  DIWS G    EL  G+P
Sbjct: 196 AYDSKADIWSLGITAIELAKGEP 218

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++++++G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 13  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 72
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIH 189
            +        L +++E +        + F+++ +R    + +  A +I R    A+ ++H
Sbjct: 73  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 126
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
            S  + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 127 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 182
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           G  +Y  + D+WS G ++  L+ G P F  ++G
Sbjct: 183 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 215

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 65  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 116
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 117 WQVLEAVRHCH-NXGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 174
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 107/220 (48%), Gaps = 38/220 (17%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 129
           +G+G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 13  LGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 68
Query: 130 KHCFF--STTDK-----DELYLNLVLEYV-PETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
            + +   +TT+K      ++YL + ++    E +   +     + +R   + + ++  QI
Sbjct: 69  FNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF-LQI 127
Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY- 233
             A+ ++H S G+ HRD+KP N+        VK+ DFG    + + E       P  +Y 
Sbjct: 128 AEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 234 -----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
                + ++ Y +PE I G + Y+  +DI+S G ++ EL+
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL 224

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 69
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 70  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 121
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 179
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 11  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 69
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 70  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 121
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 122 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 179
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 221

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 33  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 91
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 92  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 143
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 144 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 201
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 202 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 243

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 101/213 (47%), Gaps = 17/213 (7%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           ++++++G G  G V +     TG+  A+K +    + +       +    P++V +   +
Sbjct: 32  LSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVY 91
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALSYIH 189
            +        L +++E +        + F+++ +R    + +  A +I R    A+ ++H
Sbjct: 92  ENMHHGKRCLL-IIMECMEGG-----ELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH 145
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
            S  + HRD+KP+NLL         +KL DFG AK   +    +   C + YY APE + 
Sbjct: 146 -SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VL 201
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           G  +Y  + D+WS G ++  L+ G P F  ++G
Sbjct: 202 GPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 73/287 (25%), Positives = 132/287 (45%), Gaps = 41/287 (14%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SLKHCFFSTTDKDELYLNLVLE---------YVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           +L         K    L +++E         Y+    +  V + +     + + ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYS 150
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 239 ---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCRRL 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 306

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 65  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 116
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 117 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 174
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 9   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 67
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 68  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 119
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 120 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 177
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 178 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 219

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 25/222 (11%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y    ++G G FG V+    +     VAIK V +D+     EL     +    VV LK  
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKV 64
Query: 133 ------------FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYA 178
                       +F   D       L+LE  PE V  +   F+ + +R  +     + + 
Sbjct: 65  SSGFSGVIRLLDWFERPDS----FVLILER-PEPVQDL---FDFITERGALQEELARSFF 116
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R 
Sbjct: 117 WQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRV 174
Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 175 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 216

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + HPN+++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALS 186
           L   + + TD     + L+LE V        + F+ L Q+  +   +  ++  QI   ++
Sbjct: 80  LHDVYENRTD-----VVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 456 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+  T  VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 507 LE-SKRFVHRDIAARNVLVSA-TDCVKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 561
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 562 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 102/206 (49%), Gaps = 19/206 (9%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCFFS 135
           +G G FG V++    +   TVA+K + +D        +E   M+ + HPN+V L      
Sbjct: 19  LGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQL---LGV 75
Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHRSIGV 194
            T +   Y  ++ E++  T   ++ +  + N++     V LY A QI  A+ Y+ +    
Sbjct: 76  CTREPPFY--IITEFM--TYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK-NF 130
Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEY 251
            HRD+  +N LV    H VK+ DFG ++ L+ G+   ++  +++   + APE +    ++
Sbjct: 131 IHRDLAARNCLVG-ENHLVKVADFGLSR-LMTGDTXTAHAGAKFPIKWTAPESL-AYNKF 187
Query: 252 TTAIDIWSAGCVVAELM-LGKPLFPG 276
           +   D+W+ G ++ E+   G   +PG
Sbjct: 188 SIKSDVWAFGVLLWEIATYGMSPYPG 213

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 72/131 (54%), Gaps = 10/131 (7%)
Query: 137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQR----MPMIYVKLYAYQIFRALSYIHRS 191
           T+ DE+Y+  + EY+  +++ +  ++F  L++     +P+  +K     +  + SYIH  
Sbjct: 113 TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNE 170
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
             +CHRD+KP N+L++ +  +VKL DFG ++ +V  +   S   +  +  PE     + Y
Sbjct: 171 KNICHRDVKPSNILMDKNG-RVKLSDFGESEYMVDKKIKGSR-GTYEFMPPEFFSNESSY 228
Query: 252 TTA-IDIWSAG 261
             A +DIWS G
Sbjct: 229 NGAKVDIWSLG 239

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 96/219 (43%), Gaps = 20/219 (9%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      TT + ++   L++E+ P      V         +P     +    +   +++
Sbjct: 71  KLFAIEEETTTRHKV---LIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNH 127
Query: 188 IHRSIGVCHRDIKPQNLL--VNPHTHQV-KLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           + R  G+ HR+IKP N++  +      V KL DFG+A+ L   E  +    +  Y  P++
Sbjct: 128 L-RENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDM 186
Query: 245 IFGAT-------EYTTAIDIWSAGCVVAELMLGK-PLFP 275
              A        +Y   +D+WS G        G  P  P
Sbjct: 187 YERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRP 225

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 68/137 (49%), Gaps = 24/137 (17%)
Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV---KLC 216
           +HFN+L          +    +  AL ++H   G+ HRD+KP+N+L   H +QV   K+C
Sbjct: 106 RHFNELE-------ASVVVQDVASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKIC 156
Query: 217 DFG-SAKVLVKGE------PNISYIC-SRYYRAPELIFGATE----YTTAIDIWSAGCVV 264
           DFG  + + + G+      P +   C S  Y APE++   +E    Y    D+WS G ++
Sbjct: 157 DFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVIL 216
Query: 265 AELMLGKPLFPGDSGVD 281
             L+ G P F G  G D
Sbjct: 217 YILLSGYPPFVGRCGSD 233

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 44  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 103
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            L     S T      + LV + +P     E VH   +H + +  ++ +     +  QI 
Sbjct: 104 RLLGVCLSPT------IQLVTQLMPHGCLLEYVH---EHKDNIGSQLLLN----WCVQIA 150
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---Y 239
           + + Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    +
Sbjct: 151 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 208
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML--GKP 272
            A E I    ++T   D+WS G  + ELM   GKP
Sbjct: 209 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 242

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 102/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHPNVV 127
           +G G F VV + +   TG   A  K ++ +R K+           RE+  ++ + HPNV+
Sbjct: 19  LGSGQFAVVKKCREKSTGLQYA-AKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 77
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   + + TD     + L+ E V    +   +     L +     ++K    QI   + 
Sbjct: 78  TLHEVYENKTD-----VILIGELVAGGELFDFLAEKESLTEEEATEFLK----QILNGVY 128
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G    +   +  + APE
Sbjct: 129 YLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE 187
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  +  V
Sbjct: 188 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAV 232

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 35/215 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQ------TMRLLDHPNVV 127
           +++G G+FG V++   +  GETV I    K+L +       ++       M  +DHP++V
Sbjct: 21  KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            L     S T      + LV + +P     E VH   +H + +  ++ +     +  QI 
Sbjct: 81  RLLGVCLSPT------IQLVTQLMPHGCLLEYVH---EHKDNIGSQLLLN----WCVQIA 127
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---Y 239
           + + Y+     + HRD+  +N+LV    H VK+ DFG A++L   E   +    +    +
Sbjct: 128 KGMMYLEER-RLVHRDLAARNVLVKSPNH-VKITDFGLARLLEGDEKEYNADGGKMPIKW 185
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELML--GKP 272
            A E I    ++T   D+WS G  + ELM   GKP
Sbjct: 186 MALECIH-YRKFTHQSDVWSYGVTIWELMTFGGKP 219

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 77/295 (26%), Positives = 132/295 (44%), Gaps = 54/295 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVP-ETVHRVVKHFNKLNQRMP 170
                      P +V ++ C F        YL     E+VP +T   + K F  L     
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKTPEDLYKDFLTLE---- 148
Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 230
             ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    
Sbjct: 149 --HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPDX 204
Query: 231 ISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEI 286
           +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I
Sbjct: 205 VRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKI 256
Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
            +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 257 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 109/226 (48%), Gaps = 37/226 (16%)
Query: 72  SYMAERIVGQGSFGVV-----------FQAKCLET--GETVAIKKVLQDKRYKNRELQTM 118
           +Y  + I+G+G   VV           +  K ++   G + + ++V + +    +E+  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 119 RLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           R +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 78  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 125
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE   S 
Sbjct: 126 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLRSV 183
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLF 274
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVP--ETVHRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  E    + K F  L    
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKEAPEDLYKDFLTLE--- 150
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 151 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 205
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 206 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 257
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 258 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 312

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 21  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 80
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 81  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 131
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 132 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 186
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 187 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 220

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 396 RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 455
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 456 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 506
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 507 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 561
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 562 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 595

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 139
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 140 ---HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 19  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 78
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 79  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 129
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 130 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 184
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 185 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 218

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  V    + K F  L    
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 139
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 140 ---HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 13  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 72
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 73  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 123
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 124 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 178
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 179 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 18  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 77
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 78  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 128
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 129 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 183
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 184 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 217

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 58.9 bits (141), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 181
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 182 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/215 (30%), Positives = 104/215 (48%), Gaps = 30/215 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 44  RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 103
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 104 L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKYSLDLASLILYAYQLSTALAY 154
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +   E +  Y  S+      + AP
Sbjct: 155 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYM---EDSTYYKASKGKLPIKWMAP 209
Query: 243 ELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
           E I     +T+A D+W  G C+   LM G   F G
Sbjct: 210 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 243

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIXKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 139
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 140 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 25  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 84
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 85  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 134
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 135 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 192
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 193 ESILHRI-YTHQSDVWSYGVTVWELM 217

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  V    + K F  L    
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 185
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 186 ---HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 240
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 241 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 292
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 347

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 84  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 133
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 134 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 191
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 192 ESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ER++G G FG V   +    G+    VAIK +      K R     E   M   DHPNVV
Sbjct: 48  ERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVV 107
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  +   +V+E++      +     K + +  +I +      I   + Y
Sbjct: 108 HLEGVV--TRGKPVM---IVIEFMENGA--LDAFLRKHDGQFTVIQLVGMLRGIAAGMRY 160
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+LVN +    K+ DFG ++V ++ +P   Y  +       + AP
Sbjct: 161 LA-DMGYVHRDLAARNILVNSNL-VCKVSDFGLSRV-IEDDPEAVYTTTGGKIPVRWTAP 217
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 218 EAI-QYRKFTSASDVWSYGIVMWEVM 242

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 83  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 132
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 133 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 191 ESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 58.2 bits (139), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 79/296 (26%), Positives = 132/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 128 SL---------------KHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
           +L               + C F        YL     E+VP  V    + K F  L    
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 139
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 140 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 194
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 195 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 246
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 247 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 301

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 97/206 (47%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 22  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 81
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+++ +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 82  RLLGICLTST------VQLIMQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 131
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 132 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 189
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 190 ESILHRI-YTHQSDVWSYGVTVWELM 214

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 131/296 (44%), Gaps = 55/296 (18%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLLDH-------- 123
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L H        
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 124 -----------PNVVSLKHCFFSTTDKDELYLNLVL-EYVPETV--HRVVKHFNKLNQRM 169
                      P +V ++ C F        YL     E+VP  V    + K F  L    
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLST---YLRSKRNEFVPYKVAPEDLYKDFLTLE--- 148
Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
              ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K   
Sbjct: 149 ---HLICYSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPD 203
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+
Sbjct: 204 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VK 255
Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           I +      +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 256 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 310

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 205 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 262
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 263 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 314
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 315 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 362

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 203 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 260
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 261 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 312
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 313 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 360

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 196 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 253
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 254 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 305
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 306 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 353

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 49/169 (28%), Positives = 82/169 (48%), Gaps = 17/169 (10%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K    +    +
Sbjct: 198 YSFQVAKGMEFLA-SRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDPDYVRKGDA 255
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGT 292
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +    
Sbjct: 256 RLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFCR 307
Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
             +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 308 RLKEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 355

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIK--KVLQDKRYKNRELQ---TMRLLDHPNVVS 128
           R +G+G FG V Q   +        VAIK  K       + + LQ   TMR  DHP++V 
Sbjct: 16  RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVK 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALSY 187
           L         ++ +++ + L  + E     ++ F ++ +  + +  + LYAYQ+  AL+Y
Sbjct: 76  L----IGVITENPVWIIMELCTLGE-----LRSFLQVRKFSLDLASLILYAYQLSTALAY 126
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--------VKGEPNISYICSRYY 239
           +  S    HRDI  +N+LV+ +   VKL DFG ++ +         KG+  I ++     
Sbjct: 127 LE-SKRFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTXXKASKGKLPIKWM----- 179
Query: 240 RAPELIFGATEYTTAIDIWSAG-CVVAELMLGKPLFPG 276
            APE I     +T+A D+W  G C+   LM G   F G
Sbjct: 180 -APESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQG 215

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+ + +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 81  RLLGICLTST------VQLITQLMPFGXLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 130
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 131 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 189 ESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 57.8 bits (138), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/175 (30%), Positives = 84/175 (48%), Gaps = 24/175 (13%)
Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           HP++V + +    T    +    +V+EYV     +  K      Q++P+     Y  +I 
Sbjct: 138 HPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEIL 192
Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-----VKGEPNISYICSR 237
            ALSY+H SIG+ + D+KP+N+++     Q+KL D G+   +     + G P        
Sbjct: 193 PALSYLH-SIGLVYNDLKPENIMLT--EEQLKLIDLGAVSRINSFGYLYGTPG------- 242
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
            ++APE++   T  T A DI++ G  +A L L  P   G   VD L E   VL T
Sbjct: 243 -FQAPEIV--RTGPTVATDIYTVGRTLAALTLDLPTRNGRY-VDGLPEDDPVLKT 293

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 28  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 87
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 88  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 136
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 137 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 194
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 195 LESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 72  SYMAERIVGQGSFGVV-----------FQAKCLET--GETVAIKKVLQDKRYKNRELQTM 118
           +Y  + I+G+G   VV           +  K ++   G + + ++V + +    +E+  +
Sbjct: 18  NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 77
Query: 119 RLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           R +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 78  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 125
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE     
Sbjct: 126 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREV 183
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLF 274
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/238 (26%), Positives = 109/238 (45%), Gaps = 40/238 (16%)
Query: 69  QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRLL----DH 123
           + +  + E ++G+G+   V     L T +  A+K +  Q    ++R  + + +L     H
Sbjct: 11  EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH 70
Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLE-----YVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
            NV+ L        ++D  YL  V E      +   +H+  +HFN+L          +  
Sbjct: 71  RNVLELI---EFFEEEDRFYL--VFEKMRGGSILSHIHKR-RHFNELE-------ASVVV 117
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQV---KLCDFG-SAKVLVKGE------ 228
             +  AL ++H   G+ HRD+KP+N+L   H +QV   K+CDF   + + + G+      
Sbjct: 118 QDVASALDFLHNK-GIAHRDLKPENILCE-HPNQVSPVKICDFDLGSGIKLNGDCSPIST 175
Query: 229 PNISYIC-SRYYRAPELIFGATE----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           P +   C S  Y APE++   +E    Y    D+WS G ++  L+ G P F G  G D
Sbjct: 176 PELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSD 233

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           +          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGRAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/226 (24%), Positives = 108/226 (47%), Gaps = 37/226 (16%)
Query: 72  SYMAERIVGQGSFGVV-----------FQAKCLET--GETVAIKKVLQDKRYKNRELQTM 118
           +Y  + I+G+G   VV           +  K ++   G + + ++V + +    +E+  +
Sbjct: 5   NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 64
Query: 119 RLLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
           R +  HPN++ LK  + + T     +  LV + + +      + F+ L +++ +   +  
Sbjct: 65  RKVSGHPNIIQLKDTYETNT-----FFFLVFDLMKKG-----ELFDYLTEKVTL--SEKE 112
Query: 178 AYQIFRAL----SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
             +I RAL      +H+ + + HRD+KP+N+L++   + +KL DFG +  L  GE     
Sbjct: 113 TRKIMRALLEVICALHK-LNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREV 170
Query: 234 ICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLF 274
             +  Y APE+I  +       Y   +D+WS G ++  L+ G P F
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALS 186
           L   + + TD     + L+LE V        + F+ L Q+  +   +  ++  QI   ++
Sbjct: 80  LHDVYENRTD-----VVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 72/287 (25%), Positives = 131/287 (45%), Gaps = 41/287 (14%)
Query: 79  VGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRY-KNRELQT-MRLL----DHPNVV 127
           +G+G+FG V +A         T  TVA+K + +   + ++R L + +++L     H NVV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 128 SLKHCFFSTTDKDELYLNLVLE---------YVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
           +L         K    L +++E         Y+    +  V + +     + + ++  Y+
Sbjct: 95  NL----LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYS 150
Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
           +Q+ + + ++  S    HRD+  +N+L++   + VK+ DFG A+ + K    +    +R 
Sbjct: 151 FQVAKGMEFL-ASRKXIHRDLAARNILLS-EKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 239 ---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + APE IF    YT   D+WS G ++ E+  LG   +PG       V+I +      
Sbjct: 209 PLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG-------VKIDEEFXRRL 260
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP--PEAVDLVSRLLQ 339
           +E  +   P+YT  +  Q     WH   P + P   E V+ +  LLQ
Sbjct: 261 KEGTRMRAPDYTTPEMYQTMLDCWHGE-PSQRPTFSELVEHLGNLLQ 306

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/294 (23%), Positives = 122/294 (41%), Gaps = 62/294 (21%)
Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 126
           +  + +G+G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91
Query: 127 VSLKHCFFSTTDKDELYLNLVLEY----------VPETVHRVVKHFNKLNQRMPMIYVKL 176
           ++L   + +T++     + L+LEY          +PE    V +     N  + +I    
Sbjct: 92  INLHEVYENTSE-----IILILEYAAGGEIFSLCLPELAEMVSE-----NDVIRLIK--- 138
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKVLVKGEPNISYI 234
              QI   + Y+H++  + H D+KPQN+L++       +K+ DFG ++ +         +
Sbjct: 139 ---QILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIM 194
Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            +  Y APE I      TTA D+W+ G +   L+     F G+   +  + I +V     
Sbjct: 195 GTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQV----- 248
Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  N +Y+E  F  +                A D +  LL  +P  R TA
Sbjct: 249 -------NVDYSEETFSSVSQL-------------ATDFIQSLLVKNPEKRPTA 282

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 34  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 93
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 94  HLEGVVTKCKP-----VMIITEYMEN--GSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 146
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 147 LS-DMSAVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 203
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 204 EAI-AYRKFTSASDVWSYGIVMWEVM 228

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/226 (25%), Positives = 102/226 (45%), Gaps = 27/226 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY--QIFRALS 186
           L   + + TD     + L+LE V        + F+ L Q+  +   +  ++  QI   ++
Sbjct: 80  LHDVYENRTD-----VVLILELVSGG-----ELFDFLAQKESLSEEEATSFIKQILDGVN 129
Query: 187 YIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE
Sbjct: 130 YLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           ++          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 189 IV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSV 233

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 107/221 (48%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 20  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 71
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L +  V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 72  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 126
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 127 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 185
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 186 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 226

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           ER++G G FG V   +    G+    VAIK +      K R     E   M   DHPN++
Sbjct: 27  ERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 86
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 87  HLEGVVTKSKP-----VMIVTEYMENG--SLDTFLKKNDGQFTVIQLVGMLRGISAGMKY 139
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 140 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTAP 196
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E++
Sbjct: 197 EAI-AFRKFTSASDVWSYGIVMWEVV 221

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           +          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 25/225 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYK--------NRELQTMRLLDHPNVVS 128
           +G G F +V + +   TG   A K  K  Q +  +         RE+  +R + H NV++
Sbjct: 20  LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   + + TD     + L+LE V    +   +     L++     ++K    QI   ++Y
Sbjct: 80  LHDVYENRTD-----VVLILELVSGGELFDFLAQKESLSEEEATSFIK----QILDGVNY 130
Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           +H +  + H D+KP+N+++   N     +KL DFG A  +  G    +   +  + APE+
Sbjct: 131 LH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEI 189
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV 289
           +          D+WS G +   L+ G   F GD+  + L  I  V
Sbjct: 190 V-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAV 233

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/233 (27%), Positives = 104/233 (44%), Gaps = 37/233 (15%)
Query: 59  TIGGRNGQ-PKQTI-------SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR- 109
            +G R+G+ P Q +        +   +++G G+FG V++   +  GE V I   +++ R 
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 110 ----YKNREL----QTMRLLDHPNVVSLKH-CFFSTTD--KDELYLNLVLEYVPETVHRV 158
                 N+E+      M  +D+P+V  L   C  ST       +    +L+YV E     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE----- 116
Query: 159 VKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
             H + +  +    Y+  +  QI + ++Y+     + HRD+  +N+LV    H VK+ DF
Sbjct: 117 --HKDNIGSQ----YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDF 168
Query: 219 GSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           G AK+L   E        +    + A E I     YT   D+WS G  V ELM
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 23  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 82
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 83  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 131
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 132 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 189
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 190 LESILHRI-YTHQSDVWSYGVTVWELM 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 27  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 86
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 87  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 135
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 136 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 193
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 194 LESILHRI-YTHQSDVWSYGVTVWELM 219

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 24  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 83
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 84  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 132
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 133 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 190
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 191 LESILHRI-YTHQSDVWSYGVTVWELM 216

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 96/206 (46%), Gaps = 27/206 (13%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 46  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 105
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L     ++T      + L+ + +P    +  V +H + +  +    Y+  +  QI + +
Sbjct: 106 RLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQ----YLLNWCVQIAKGM 155
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAP 242
           +Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A 
Sbjct: 156 NYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 213
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I     YT   D+WS G  V ELM
Sbjct: 214 ESILHRI-YTHQSDVWSYGVTVWELM 238

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 54/206 (26%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG A+VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLARVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 31  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 90
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 91  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 139
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 140 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 197
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 198 LESILHRI-YTHQSDVWSYGVTVWELM 223

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 148
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 149 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEA 206
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 207 LRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 39  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 95
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 96  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 148
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 149 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEA 206
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 207 LRG--EITPKSDIYSFGVVLLEIITGLP 232

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/205 (25%), Positives = 89/205 (43%), Gaps = 25/205 (12%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVS-------- 128
           +++G G+FG V++   +  GE V I   ++  R          +LD   V++        
Sbjct: 23  KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 129 --LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
             L  C  ST       + LV + +P     ++ H  +   R+    +  +  QI + +S
Sbjct: 83  RLLGICLTST-------VQLVTQLMPYGC--LLDHVRENRGRLGSQDLLNWCMQIAKGMS 133
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE 243
           Y+   + + HRD+  +N+LV    H VK+ DFG A++L   E        +    + A E
Sbjct: 134 YLE-DVRLVHRDLAARNVLVKSPNH-VKITDFGLARLLDIDETEYHADGGKVPIKWMALE 191
Query: 244 LIFGATEYTTAIDIWSAGCVVAELM 268
            I     +T   D+WS G  V ELM
Sbjct: 192 SIL-RRRFTHQSDVWSYGVTVWELM 215

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/208 (28%), Positives = 101/208 (48%), Gaps = 28/208 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLK 130
           +G+G FGVV++     T  TVA+KK+         + K+  ++E++ M    H N+V L 
Sbjct: 33  MGEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL- 89
Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY---VKLYAYQIFRALSY 187
              FS+   D   L LV  Y+P     ++   + L+   P+ +    K+ A      +++
Sbjct: 90  -LGFSSDGDD---LCLVYVYMPNG--SLLDRLSCLDGTPPLSWHMRCKI-AQGAANGINF 142
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE 
Sbjct: 143 LHENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEA 200
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKP 272
           + G  E T   DI+S G V+ E++ G P
Sbjct: 201 LRG--EITPKSDIYSFGVVLLEIITGLP 226

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 83
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L +  V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 84  LFMGYSTKPQLAI--VTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 138
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 13  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 72
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 73  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 125
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 126 LS-DMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 182
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 183 EAI-AYRKFTSASDVWSYGIVMWEVM 207

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 94/207 (45%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 75  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 123
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 124 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELM 207

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 55/206 (26%), Positives = 95/206 (46%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKV---LQDKRYKN--RELQTMRLLDHPNVV 127
           E+++G G FG V   +    G+    VAIK +     DK+ ++   E   M   DHPN++
Sbjct: 19  EKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNII 78
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+             + ++ EY+      +     K + R  +I +      I   + Y
Sbjct: 79  HLEGVVTKCKP-----VMIITEYMENG--SLDAFLRKNDGRFTVIQLVGMLRGIGSGMKY 131
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y          + AP
Sbjct: 132 LS-DMSYVHRDLAARNILVNSNL-VCKVSDFGMSRVL-EDDPEAAYTTRGGKIPIRWTAP 188
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 189 EAI-AYRKFTSASDVWSYGIVMWEVM 213

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   + + R       N+E+      M  +D+P+V 
Sbjct: 55  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDNPHVC 114
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 115 RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 163
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 164 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 221
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 222 LESILHRI-YTHQSDVWSYGVTVWELM 247

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGFVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++G G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 18  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 77
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI   
Sbjct: 78  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAEG 126
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 127 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 184
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 185 LESILHRI-YTHQSDVWSYGVTVWELM 210

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 56/104 (53%), Gaps = 2/104 (1%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           + +Q+  A+ + H + GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +
Sbjct: 162 FFWQVLEAVRHCH-NCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 219
Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
           R Y  PE I     +  +  +WS G ++ +++ G   F  D  +
Sbjct: 220 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI 263

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 106/232 (45%), Gaps = 35/232 (15%)
Query: 59  TIGGRNGQ-PKQTI-------SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR- 109
            +G R+G+ P Q +        +   +++  G+FG V++   +  GE V I   +++ R 
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 110 ----YKNREL----QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVV 159
                 N+E+      M  +D+P+V  L     ++T      + L+++ +P    +  V 
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST------VQLIMQLMPFGCLLDYVR 115
Query: 160 KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG 219
           +H + +  +    Y+  +  QI + ++Y+     + HRD+  +N+LV    H VK+ DFG
Sbjct: 116 EHKDNIGSQ----YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFG 169
Query: 220 SAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
            AK+L   E        +    + A E I     YT   D+WS G  V ELM
Sbjct: 170 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 38  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 97
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 98  RLEGVVTKSKP-----VMIVTEYMEN--GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 150
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 151 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 207
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 208 EAI-AYRKFTSASDVWSYGIVLWEVM 232

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           Y  +  + APEL+ G  EY  ++D ++ G  + E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 32  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 85
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             +ST  +    L +V ++   +   +  H +    +  M  +   A Q  R + Y+H +
Sbjct: 86  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHASETKFEMKKLIDIARQTARGMDYLH-A 138
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++   + VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 139 KSIIHRDLKSNNIFLH-EDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 197
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
            +  Y+   D+++ G V+ ELM G+  +   +  DQ++E++
Sbjct: 198 DSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMV 238

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           Y  +  + APEL+ G  EY  ++D ++ G  + E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +     R   H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIMNGGDIRY--HIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           Y  +  + APEL+ G  EY  ++D ++ G  + E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 81  RLEGVVTKSKP-----VMIVTEYMEN--GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 104/222 (46%), Gaps = 21/222 (9%)
Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNR--ELQ 116
             QP     ++  R++G+G FG VF  +   TG+  A KK+ + +      Y+    E +
Sbjct: 178 EAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKK 237
Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIY--- 173
            +  +    +VSL + F + TD     L LV+  +      +  H   +++  P      
Sbjct: 238 ILAKVHSRFIVSLAYAFETKTD-----LCLVMTIM--NGGDIRYHIYNVDEDNPGFQEPR 290
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-S 232
              Y  QI   L ++H+   + +RD+KP+N+L++   + V++ D G A  L  G+     
Sbjct: 291 AIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKG 348
Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
           Y  +  + APEL+ G  EY  ++D ++ G  + E++  +  F
Sbjct: 349 YAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG  +VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLGRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 94/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 48  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 107
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     +       + +V EY+      +     K + +  +I +      I   + Y
Sbjct: 108 RLEGVVTKSKP-----VMIVTEYMENG--SLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 160
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 161 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 217
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 218 EAI-AYRKFTSASDVWSYGIVLWEVM 242

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 20/193 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQ-------TMRLLDHPNVVSLK 130
           +G+GSF  V+  K L+T  TV +    LQD++    E Q        ++ L HPN+V   
Sbjct: 34  IGRGSFKTVY--KGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFY 91
Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             + ST  K +  + LV E     T+   +K F     ++    ++ +  QI + L ++H
Sbjct: 92  DSWESTV-KGKKCIVLVTELXTSGTLKTYLKRFKVXKIKV----LRSWCRQILKGLQFLH 146
Query: 190 -RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            R+  + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE     
Sbjct: 147 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEFXAPEXY--E 203
Query: 249 TEYTTAIDIWSAG 261
            +Y  ++D+++ G
Sbjct: 204 EKYDESVDVYAFG 216

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGAVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 77/290 (26%), Positives = 120/290 (41%), Gaps = 60/290 (20%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 33  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 92
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L   + S        L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 93  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 142
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + 
Sbjct: 143 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 199
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           ++ APE++     Y   +D+W  G ++  L+ G   F G    ++L E I       + +
Sbjct: 200 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGI------IKGK 250
Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            K MNP              W  I        A DLV R+L   P  R T
Sbjct: 251 YK-MNPRQ------------WSHI-----SESAKDLVRRMLMLDPAERIT 282

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 34/213 (15%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVS 128
           ++G+G F VV +    ETG+  A+K V   K   +         RE     +L HP++V 
Sbjct: 31  VIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVE 90
Query: 129 LKHCFFSTTDKDELYLNLVLEYV--PETVHRVVKHFNKLNQRMPMIYVKL----YAYQIF 182
           L   + S        L +V E++   +    +VK  +        +Y +     Y  QI 
Sbjct: 91  LLETYSSDG-----MLYMVFEFMDGADLCFEIVKRADA-----GFVYSEAVASHYMRQIL 140
Query: 183 RALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---SYICSR 237
            AL Y H +  + HRD+KP  +L+    ++  VKL  FG A  L  GE  +     + + 
Sbjct: 141 EALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL--GESGLVAGGRVGTP 197
Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLG 270
           ++ APE++     Y   +D+W  G ++  L+ G
Sbjct: 198 HFMAPEVV-KREPYGKPVDVWGCGVILFILLSG 229

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 103/233 (44%), Gaps = 37/233 (15%)
Query: 59  TIGGRNGQ-PKQTI-------SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR- 109
            +G R+G+ P Q +        +   +++  G+FG V++   +  GE V I   +++ R 
Sbjct: 2   AMGIRSGEAPNQALLRILKETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELRE 61
Query: 110 ----YKNREL----QTMRLLDHPNVVSLKH-CFFSTTD--KDELYLNLVLEYVPETVHRV 158
                 N+E+      M  +D+P+V  L   C  ST       +    +L+YV E     
Sbjct: 62  ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVRE----- 116
Query: 159 VKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF 218
             H + +  +    Y+  +  QI + ++Y+     + HRD+  +N+LV    H VK+ DF
Sbjct: 117 --HKDNIGSQ----YLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDF 168
Query: 219 GSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           G AK+L   E        +    + A E I     YT   D+WS G  V ELM
Sbjct: 169 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELM 220

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 29/207 (14%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNREL----QTMRLLDHPNVV 127
           +++  G+FG V++   +  GE V I   +++ R       N+E+      M  +D+P+V 
Sbjct: 21  KVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 128 SLKH-CFFSTTD--KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            L   C  ST       +    +L+YV E       H + +  +    Y+  +  QI + 
Sbjct: 81  RLLGICLTSTVQLITQLMPFGCLLDYVRE-------HKDNIGSQ----YLLNWCVQIAKG 129
Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRA 241
           ++Y+     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A
Sbjct: 130 MNYLEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
            E I     YT   D+WS G  V ELM
Sbjct: 188 LESILHRI-YTHQSDVWSYGVTVWELM 213

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 21  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 80
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 81  RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 133
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 134 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 190
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 191 EAI-AYRKFTSASDVWSYGIVLWEVM 215

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/206 (25%), Positives = 93/206 (45%), Gaps = 24/206 (11%)
Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L+     T  K  + +   +E        +     K + +  +I +      I   + Y
Sbjct: 110 RLEGVV--TKSKPVMIVTEXMEN-----GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY 162
Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRAP 242
           +   +G  HRD+  +N+L+N +    K+ DFG ++VL + +P  +Y          + +P
Sbjct: 163 LS-DMGYVHRDLAARNILINSNL-VCKVSDFGLSRVL-EDDPEAAYTTRGGKIPIRWTSP 219
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM 268
           E I    ++T+A D+WS G V+ E+M
Sbjct: 220 EAI-AYRKFTSASDVWSYGIVLWEVM 244

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 96/214 (44%), Gaps = 27/214 (12%)
Query: 71  ISYMA-ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 121
           +SY+  E ++G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 13  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 72
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQ 180
           +HPN++ L+     T     + L   +E      +  +  F +LN  +  +I +      
Sbjct: 73  EHPNIIRLEGVV--TNSMPVMILTEFME------NGALDSFLRLNDGQFTVIQLVGMLRG 124
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 237
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +Y  S    
Sbjct: 125 IASGMRYLA-EMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTYTSSLGGK 182
Query: 238 ---YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               + APE I    ++T+A D WS G V+ E+M
Sbjct: 183 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 215

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/206 (28%), Positives = 96/206 (46%), Gaps = 26/206 (12%)
Query: 80  GQGSFGVVFQAKCLETGETVAIKKVL--------QDKRYKNRELQTMRLLDHPNVVSLKH 131
           G+G FGVV++     T  TVA+KK+         + K+  ++E++      H N+V L  
Sbjct: 31  GEGGFGVVYKGYVNNT--TVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVEL-- 86
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIH 189
             FS+   D   L LV  Y P     ++   + L+   P+ +      A      ++++H
Sbjct: 87  LGFSSDGDD---LCLVYVYXPNG--SLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLH 141
Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
            +  + HRDIK  N+L++      K+ DFG A+   K    +     + +  Y APE + 
Sbjct: 142 ENHHI-HRDIKSANILLD-EAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALR 199
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKP 272
           G  E T   DI+S G V+ E++ G P
Sbjct: 200 G--EITPKSDIYSFGVVLLEIITGLP 223

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 107/244 (43%), Gaps = 43/244 (17%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNRE-----LQ 116
           P++ + +   +++G G+FG V  A      +T     VA+K + +      RE     L+
Sbjct: 43  PRENLEF--GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELK 100
Query: 117 TM-RLLDHPNVVSL--------------KHCFFSTT-----DKDELYLNLVLEYVPETVH 156
            M +L  H N+V+L              ++C +         K E +    +EY  +   
Sbjct: 101 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 160
Query: 157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC 216
              +  N L     + +    AYQ+ + + ++     V HRD+  +N+LV  H   VK+C
Sbjct: 161 EEEEDLNVLTFEDLLCF----AYQVAKGMEFLEFKSCV-HRDLAARNVLVT-HGKVVKIC 214
Query: 217 DFGSAKVLVKGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKP 272
           DFG A+ ++     +    +R    + APE +F    YT   D+WS G ++ E+  LG  
Sbjct: 215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVN 273
Query: 273 LFPG 276
            +PG
Sbjct: 274 PYPG 277

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 43  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 94
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 95  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 149
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 150 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 208
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 209 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 105/222 (47%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DFG+++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 18  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 69
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 70  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 124
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 125 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 183
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 184 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 57/219 (26%), Positives = 102/219 (46%), Gaps = 22/219 (10%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVVSLKHCF 133
           +G GSFG V++ K       V I KV+     Q + ++N E+  +R   H N++     F
Sbjct: 44  IGSGSFGTVYKGKW-HGDVAVKILKVVDPTPEQFQAFRN-EVAVLRKTRHVNIL----LF 97
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                KD L   +V ++   +   + KH +    +  M  +   A Q  + + Y+H +  
Sbjct: 98  MGYMTKDNL--AIVTQWCEGS--SLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH-AKN 152
Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK--GEPNISY-ICSRYYRAPELIF--GA 248
           + HRD+K  N+ ++     VK+ DFG A V  +  G   +     S  + APE+I     
Sbjct: 153 IIHRDMKSNNIFLHEGL-TVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDN 211
Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
             ++   D++S G V+ ELM G+  +   +  DQ++ ++
Sbjct: 212 NPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMV 250

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 66  QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL----QTMRLL 121
           +P+    +   R +G GSFG ++    ++T E VAIK  L++ + K+ +L    +  R+L
Sbjct: 2   EPRVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIK--LENVKTKHPQLLYESKIYRIL 59
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
                +     F    D + L ++L+   + +        FN  ++++ +  V + A Q+
Sbjct: 60  QGGTGIPNVRWFGVEGDYNVLVMDLLGPSLEDL-------FNFCSRKLSLKTVLMLADQM 112
Query: 182 FRALSYIHRSIGVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              + ++H S    HRDIKP N L  +    +QV + DFG AK
Sbjct: 113 INRVEFVH-SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 21  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 72
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 73  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 127
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 128 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 186
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 187 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 36  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 87
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 88  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 142
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 143 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 201
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 202 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 44  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 95
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 96  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 150
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 151 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 209
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 210 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 105/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N++    
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNIL---- 67
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   + K +L   +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 68  LFMGYSTKPQL--AIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--KVLVKGEPNISYIC-SRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A  K    G      +  S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/207 (26%), Positives = 97/207 (46%), Gaps = 26/207 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L+        +  L + +V EY+   ++   ++  +     M ++ +        R LS
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRA 241
                +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +Y  +       + A
Sbjct: 169 ----DLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWTA 222
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE I   T +++A D+WS G V+ E++
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/221 (25%), Positives = 106/221 (47%), Gaps = 26/221 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPNVVSLKH 131
           +G GSFG V++ K    G+ VA+K +        Q + +KN E+  +R   H N+  L  
Sbjct: 16  IGSGSFGTVYKGKW--HGD-VAVKMLNVTAPTPQQLQAFKN-EVGVLRKTRHVNI--LLF 69
Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
             +ST  +    L +V ++   +   +  H + +  +  MI +   A Q  + + Y+H +
Sbjct: 70  MGYSTAPQ----LAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH-A 122
Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF-- 246
             + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I   
Sbjct: 123 KSIIHRDLKSNNIFLHEDL-TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               Y+   D+++ G V+ ELM G+  +   +  DQ++ ++
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 166 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 223
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 224 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 278

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 104/222 (46%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DFG ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 51.6 bits (122), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 168 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 225
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 226 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 280

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARHIKNDSNYVVKGNA 230
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 173 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 230
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 231 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 285

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 60/120 (50%), Gaps = 15/120 (12%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK-------VLVKGEP 229
           ++YQ+ + ++++  S    HRD+  +N+L+  H    K+CDFG A+        +VKG  
Sbjct: 150 FSYQVAKGMAFL-ASKNCIHRDLAARNILLT-HGRITKICDFGLARDIKNDSNYVVKGNA 207
Query: 230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
            +       + APE IF    YT   D+WS G  + EL  LG   +PG     +  ++IK
Sbjct: 208 RLPV----KWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIK 262

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 54/208 (25%), Positives = 93/208 (44%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+++G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 38  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     +T      + ++ E++    +  +  F + N  +  +I +      I   + 
Sbjct: 98  HLEGVVTKSTP-----VMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 149
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 150 YLA-DMNYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 207
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 208 APEAI-QYRKFTSASDVWSYGIVMWEVM 234

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 95/216 (43%), Gaps = 47/216 (21%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT-MRLLDHPNVVSLKHCFFS 135
           +++G G  G V Q     T E  A+K +LQD     RE++   R    P++V +   +  
Sbjct: 24  QVLGLGINGKVLQIFNKRTQEKFALK-MLQDCPKARREVELHWRASQCPHIVRIVDVY-- 80
Query: 136 TTDKDELY-----LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR----ALS 186
               + LY     L +V+E +        + F+++  R    + +  A +I +    A+ 
Sbjct: 81  ----ENLYAGRKCLLIVMECLDGG-----ELFSRIQDRGDQAFTEREASEIMKSIGEAIQ 131
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H SI + HRD+KP+NLL         +KL DFG AK    GE                
Sbjct: 132 YLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE-TTGE---------------- 173
Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
                +Y  + D+WS G ++  L+ G P F  + G+
Sbjct: 174 -----KYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 204

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/214 (24%), Positives = 99/214 (46%), Gaps = 27/214 (12%)
Query: 71  ISYMA-ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLL 121
           +SY+  E ++G G FG V + +    G+    VAIK +      + R     E   M   
Sbjct: 15  VSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQF 74
Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQ 180
           +HPN++ L+    ++     + + ++ E++    +  +  F +LN  +  +I +      
Sbjct: 75  EHPNIIRLEGVVTNS-----MPVMILTEFME---NGALDSFLRLNDGQFTVIQLVGMLRG 126
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--- 237
           I   + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L +   + +   S    
Sbjct: 127 IASGMRYLA-EMSYVHRDLAARNILVNSNL-VCKVSDFGLSRFLEENSSDPTETSSLGGK 184
Query: 238 ---YYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               + APE I    ++T+A D WS G V+ E+M
Sbjct: 185 IPIRWTAPEAI-AFRKFTSASDAWSYGIVMWEVM 217

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 62/262 (23%), Positives = 118/262 (45%), Gaps = 32/262 (12%)
Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-RELQTMRLLDHPNVVSLKHCFFST 136
           ++G+G +G V++    E    V +      + + N + +  + L++H N+          
Sbjct: 20  LIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERV 79
Query: 137 TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI---- 192
           T    +   LV+EY P   +  +  +  L+    +   +L A+ + R L+Y+H  +    
Sbjct: 80  TADGRMEYLLVMEYYP---NGSLXKYLSLHTSDWVSSCRL-AHSVTRGLAYLHTELPRGD 135
Query: 193 ----GVCHRDIKPQNLLVNPHTHQVKLCDFG-----SAKVLVK-GEPN---ISYICSRYY 239
                + HRD+  +N+LV      V + DFG     +   LV+ GE +   IS + +  Y
Sbjct: 136 HYKPAISHRDLNSRNVLVKNDGTCV-ISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRY 194
Query: 240 RAPELIFGATEYTTA------IDIWSAGCVVAEL-MLGKPLFPGDSGVD-QLVEIIKVLG 291
            APE++ GA            +D+++ G +  E+ M    LFPG+S  + Q+    +V  
Sbjct: 195 MAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGN 254
Query: 292 TPTREEIKCMNPNYTEF-KFPQ 312
            PT E+++ +     +  KFP+
Sbjct: 255 HPTFEDMQVLVSREKQRPKFPE 276

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 50.4 bits (119), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 97/239 (40%), Gaps = 52/239 (21%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDKRYK-----NRELQ 116
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K + ++          RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102
Query: 117 TMRLLDHPNVVSL--------KHC----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNK 164
            M   D+PN+V L          C    + +  D +E   ++    V    H  +    +
Sbjct: 103 LMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRAR 162
Query: 165 LNQRMP----MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220
           ++   P           A Q+   ++Y+     V HRD+  +N LV      VK+ DFG 
Sbjct: 163 VSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFV-HRDLATRNCLVG-ENMVVKIADFGL 220
Query: 221 AKVLVKGEPNISYICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
           ++ +   +         YY+A            PE IF    YTT  D+W+ G V+ E+
Sbjct: 221 SRNIYSAD---------YYKADGNDAIPIRWMPPESIF-YNRYTTESDVWAYGVVLWEI 269

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 126/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ ++  E +  +   
Sbjct: 139 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMLDKEFDSVHNKT 196
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 197 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 252
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 253 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 292

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 45  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 103
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 104 KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 155
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 156 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 209
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 210 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 269
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 270 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 309

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    +   
Sbjct: 137 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEXXSVHNKT 194
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 195 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 250
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 251 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 290

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 19  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 77
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 78  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 129
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 130 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 187
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 188 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 243
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 244 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 283

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 27/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKNR-----ELQTMRLLDHPN 125
           ++++G G FG V++   L+T        VAIK +      K R     E   M    H N
Sbjct: 49  QKVIGAGEFGEVYKG-MLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           ++ L+             + ++ EY+      + K   + +    ++ +      I   +
Sbjct: 108 IIRLEGVISKYKP-----MMIITEYMENGA--LDKFLREKDGEFSVLQLVGMLRGIAAGM 160
Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYR 240
            Y+  ++   HRD+  +N+LVN +    K+ DFG ++VL + +P  +Y  S       + 
Sbjct: 161 KYLA-NMNYVHRDLAARNILVNSNL-VCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRWT 217
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 218 APEAI-SYRKFTSASDVWSFGIVMWEVM 244

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 138 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 196 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 251
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 24  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 82
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 83  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 134
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 135 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 192
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 193 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 248
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 249 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 288

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 46  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 104
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 105 KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 156
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 157 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 214
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 215 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 270
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 271 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 310

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 136 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 193
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 194 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 249
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 250 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 289

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 22  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 80
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 81  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 132
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 133 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 190
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 191 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 246
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 247 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 286

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 70/291 (24%), Positives = 122/291 (41%), Gaps = 46/291 (15%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 26  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 84
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 85  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 136
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E    Y   
Sbjct: 137 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE----YYSV 190
Query: 237 RYYRAPEL--------IFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEII 287
                 +L             ++TT  D+WS G ++ ELM  G P +P  +  D  V ++
Sbjct: 191 HNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL 250
Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                   +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 251 --------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 290

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 124/289 (42%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE------PN 230
           +  Q+ + + Y+  S    HRD+  +N +++     VK+ DFG A+ +   E        
Sbjct: 138 FGLQVAKGMKYL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEYYSVHNKT 195
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
            + +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 196 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 251
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 103/222 (46%), Gaps = 40/222 (18%)
Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKK-VLQDKRYK----------NRELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK  +L D   +           RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY-VKL-YAYQ 180
           N+V L     +          +V+E+VP  +  HR+      L++  P+ + VKL     
Sbjct: 84  NIVKLYGLMHNPP-------RMVMEFVPCGDLYHRL------LDKAHPIKWSVKLRLMLD 130
Query: 181 IFRALSYI-HRSIGVCHRDIKPQNLLVNPHTHQVKLC----DFGSAKVLVKGEPNISYIC 235
           I   + Y+ +++  + HRD++  N+ +        +C    DF  ++  V    ++S + 
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVH---SVSGLL 187
Query: 236 SRY-YRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLF 274
             + + APE I GA E  YT   D +S   ++  ++ G+  F
Sbjct: 188 GNFQWMAPETI-GAEEESYTEKADTYSFAMILYTILTGEGPF 228

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 32  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 90
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 91  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 142
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +   
Sbjct: 143 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKT 200
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 201 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 256
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 257 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 296

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 26/207 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
            L+        +  L + +V EY+   ++   ++  +     M ++ +        R LS
Sbjct: 114 RLE----GVVTRGRLAM-IVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS 168
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-----YYRA 241
                +G  HRD+  +N+LV+ +    K+ DFG ++VL + +P+ +   +       + A
Sbjct: 169 ----DLGYVHRDLAARNVLVDSNL-VCKVSDFGLSRVL-EDDPDAAXTTTGGKIPIRWTA 222
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELM 268
           PE I   T +++A D+WS G V+ E++
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 68/269 (25%), Positives = 126/269 (46%), Gaps = 37/269 (13%)
Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHP 124
           ++ I+ + E  +G G FGVV   K  +    VA+K + +    ++   +E QTM  L HP
Sbjct: 7   REEITLLKE--LGSGQFGVVKLGK-WKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHP 63
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKL--NQRMPMIYVKLYAYQ 180
            +V     F+    K E  + +V EY+     ++ +  H   L  +Q + M       Y 
Sbjct: 64  KLVK----FYGVCSK-EYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEM------CYD 112
Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-- 238
           +   ++++  S    HRD+  +N LV+     VK+ DFG  + ++  +  +S + +++  
Sbjct: 113 VCEGMAFL-ESHQFIHRDLAARNCLVDRDL-CVKVSDFGMTRYVLDDQ-YVSSVGTKFPV 169
Query: 239 -YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            + APE +F   +Y++  D+W+ G ++ E+  LGK   P D   +  V ++KV      +
Sbjct: 170 KWSAPE-VFHYFKYSSKSDVWAFGILMWEVFSLGK--MPYDLYTNSEV-VLKV-----SQ 220
Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKR 325
             +   P+       QI    WH++  KR
Sbjct: 221 GHRLYRPHLASDTIYQIMYSCWHELPEKR 249

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 48.9 bits (115), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 86  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 144
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 145 KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 196
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E     + +
Sbjct: 197 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDSVHN 252
Query: 237 RYYRAPELIFGATE------YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
           +      + + A E      +TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 253 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 310
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 311 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 350

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 28  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 86
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 87  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 138
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +   
Sbjct: 139 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKT 196
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 197 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 252
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 253 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 292

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +   
Sbjct: 138 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKT 195
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 196 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 251
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 69/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 27  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 85
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 86  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 137
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E     + +
Sbjct: 138 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKE--FDSVHN 193
Query: 237 RYYRAPELIFGATE------YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
           +      + + A E      +TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 194 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 251
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 252 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 291

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 48.5 bits (114), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 68/289 (23%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLET-GETV--AIKKV--LQDKRYKNRELQ---TM 118
           P   I +  E ++G+G FG V+    L+  G+ +  A+K +  + D    ++ L     M
Sbjct: 25  PSSLIVHFNE-VIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIM 83
Query: 119 RLLDHPNVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL- 176
           +   HPNV+SL   C  S            L  +P   H  +++F +     P +   + 
Sbjct: 84  KDFSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIG 135
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY--- 233
           +  Q+ + + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +  +   
Sbjct: 136 FGLQVAKGMKFL-ASKKFVHRDLAARNCMLD-EKFTVKVADFGLARDMYDKEFDSVHNKT 193
Query: 234 ---ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKV 289
              +  ++     L     ++TT  D+WS G ++ ELM  G P +P  +  D  V ++  
Sbjct: 194 GAKLPVKWMALESL--QTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLL-- 249
Query: 290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRL 337
                 +  + + P Y      ++    WH   PK  M P   +LVSR+
Sbjct: 250 ------QGRRLLQPEYCPDPLYEVMLKCWH---PKAEMRPSFSELVSRI 289

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMSLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 53/208 (25%), Positives = 92/208 (44%), Gaps = 26/208 (12%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+++G G FG V        G+    VAIK +      K R     E   M   DHPNV+
Sbjct: 12  EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L+     +T      + ++ E++    +  +  F + N  +  +I +      I   + 
Sbjct: 72  HLEGVVTKSTP-----VMIITEFME---NGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMK 123
Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------YYR 240
           Y+   +   HR +  +N+LVN +    K+ DFG ++ L     + +Y  +        + 
Sbjct: 124 YLA-DMNYVHRALAARNILVNSNL-VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWT 181
Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM 268
           APE I    ++T+A D+WS G V+ E+M
Sbjct: 182 APEAI-QYRKFTSASDVWSYGIVMWEVM 208

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 90  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 143
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 144 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 199
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 200 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 235

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 47.8 bits (112), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 20  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 80  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 133
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HRD+  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 134 LLHFAADVARGMDYLSQKQFI-HRDLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 189
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 190 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 225

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSXVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 54/229 (23%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +    P  +       +   +++  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLRRKRPPGLEYSYNPSHNPEEQLSS 165
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 166 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 223
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 224 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 271

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 97/229 (42%), Gaps = 40/229 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +          + VLE  P         F   N  +  
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTLST 163
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 96/222 (43%), Gaps = 35/222 (15%)
Query: 69  QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPN 125
           Q++      +  +G FG V++A+ L   E VA+K   +QDK+    E +   L  + H N
Sbjct: 22  QSMPLQLLEVKARGRFGCVWKAQLLN--EYVAVKIFPIQDKQSWQNEYEVYSLPGMKHEN 79
Query: 126 VVSLKHCFFSTTDKD-ELYLNLVLE---YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           ++         T  D +L+L         + + +   V  +N+L            A  +
Sbjct: 80  ILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANVVSWNELCH---------IAETM 130
Query: 182 FRALSYIHRSI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP--- 229
            R L+Y+H  I          + HRDIK +N+L+  +     + DFG A     G+    
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC-IADFGLALKFEAGKSAGD 189
Query: 230 NISYICSRYYRAPELIFGATEYTTA----IDIWSAGCVVAEL 267
               + +R Y APE++ GA  +       ID+++ G V+ EL
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 86  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 138 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 193
Query: 243 ELIFGATEYTTAIDIWSAGCVVAEL 267
           E +   T ++ A D W  G  + E+
Sbjct: 194 ESLKTRT-FSHASDTWMFGVTLWEM 217

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 70/152 (46%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    + +GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSI 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 71  KWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 124
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 105/235 (44%), Gaps = 43/235 (18%)
Query: 77  RIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNV 126
           + +G+G FG V +A         G T    K+L++       R    E   ++ ++HP+V
Sbjct: 29  KTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHV 88
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLN------------------- 166
           + L    +    +D   L L++EY    ++   ++   K+                    
Sbjct: 89  IKL----YGACSQDGPLL-LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPD 143
Query: 167 -QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
            + + M  +  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ + 
Sbjct: 144 ERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILV-AEGRKMKISDFGLSRDVY 201
Query: 226 KGEPNISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           + +  +     R    + A E +F    YTT  D+WS G ++ E++ LG   +PG
Sbjct: 202 EEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPG 255

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 80  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 132 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 233

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 125
           ++  + I+G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 31  NFXNKNILGRGGFGKVYKGR-LADGXLVAVKR-LKEERTQGGELQFQTEVEMISMAVHRN 88
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY--AYQIFR 183
           ++ L+    + T++  +Y  +    V   +        +   + P+ + K    A    R
Sbjct: 89  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 142
Query: 184 ALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 239
            L+Y+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGXIGH 201
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            APE +    + +   D++  G ++ EL+ G+  F
Sbjct: 202 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 235

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 183
Query: 243 ELIFGATEYTTAIDIWSAGCVVAEL 267
           E +   T ++ A D W  G  + E+
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEM 207

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 89/205 (43%), Gaps = 29/205 (14%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 20  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 79
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 80  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 131
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 132 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 187
Query: 243 ELIFGATEYTTAIDIWSAGCVVAEL 267
           E +   T ++ A D W  G  + E+
Sbjct: 188 ESLKTRT-FSHASDTWMFGVTLWEM 211

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 31/85 (36%), Positives = 44/85 (51%), Gaps = 4/85 (4%)
Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFG--SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
            HRD+KP+N+LV+       L DFG  SA    K     + + + YY APE  F  +  T
Sbjct: 156 THRDVKPENILVSADDF-AYLVDFGIASATTDEKLTQLGNTVGTLYYXAPER-FSESHAT 213
Query: 253 TAIDIWSAGCVVAELMLGKPLFPGD 277
              DI++  CV+ E + G P + GD
Sbjct: 214 YRADIYALTCVLYECLTGSPPYQGD 238

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/227 (25%), Positives = 99/227 (43%), Gaps = 30/227 (13%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------AP 242
             S    HRD+  +NLL+      VK+ DFG  + L + + +  Y+   + +      AP
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDH--YVMQEHRKVPFAWCAP 183
Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIK 288
           E +   T ++ A D W  G  + E+   G+  + G +G   L +I K
Sbjct: 184 ESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK 229

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 46.6 bits (109), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 57/229 (24%), Positives = 96/229 (41%), Gaps = 40/229 (17%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTMRLL-DHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +          + VLE  P         F   N     
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPA--------FAIANSTAST 163
Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
             +  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYI 221
Query: 232 SYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 222 VKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 269

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/215 (23%), Positives = 102/215 (47%), Gaps = 22/215 (10%)
Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQ------TMRLLDHPN 125
           ++  + I+G+G FG V++ + L  G  VA+K+ L+++R +  ELQ       + +  H N
Sbjct: 39  NFSNKNILGRGGFGKVYKGR-LADGTLVAVKR-LKEERXQGGELQFQTEVEMISMAVHRN 96
Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY--AYQIFR 183
           ++ L+    + T++  +Y  +    V   +        +   + P+ + K    A    R
Sbjct: 97  LLRLRGFCMTPTERLLVYPYMANGSVASCLR------ERPESQPPLDWPKRQRIALGSAR 150
Query: 184 ALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--Y 239
            L+Y+H      + HRD+K  N+L++     V + DFG AK++   + ++         +
Sbjct: 151 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAV-VGDFGLAKLMDYKDXHVXXAVRGTIGH 209
Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF 274
            APE +    + +   D++  G ++ EL+ G+  F
Sbjct: 210 IAPEYL-STGKSSEKTDVFGYGVMLLELITGQRAF 243

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 26  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 85
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 86  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 137
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 244
             S    HRD+  +NLL+      VK+ DFG  + L + + +      R     + APE 
Sbjct: 138 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 195
Query: 245 IFGATEYTTAIDIWSAGCVVAEL 267
           +   T ++ A D W  G  + E+
Sbjct: 196 LKTRT-FSHASDTWMFGVTLWEM 217

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 103/264 (39%), Gaps = 81/264 (30%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL---------QTMRLLDHPNVVSL 129
           +G+G FGVVF+AK        AIK++    R  NREL         + +  L+HP +V  
Sbjct: 14  MGRGGFGVVFEAKNKVDDCNYAIKRI----RLPNRELAREKVMREVKALAKLEHPGIVRY 69
Query: 130 KHCFFST------TDKDELYL-NLVLEY---------VPETVHRVVKHF---NKLNQRMP 170
            + +  T       + DE++L +   ++          P    R +  F   N + Q  P
Sbjct: 70  FNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQP 129
Query: 171 MIYVKLYAY-------------QIFRALSYIHRSIGVC--------------------HR 197
               K+Y Y              + R  S   R  GVC                    HR
Sbjct: 130 S-SPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHR 188
Query: 198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------PNISY------ICSRYYRAPEL 244
           D+KP N+        VK+ DFG    + + E       P  +Y      + ++ Y +PE 
Sbjct: 189 DLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQ 247
Query: 245 IFGATEYTTAIDIWSAGCVVAELM 268
           I G   Y+  +DI+S G ++ EL+
Sbjct: 248 IHG-NNYSHKVDIFSLGLILFELL 270

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 51/203 (25%), Positives = 87/203 (42%), Gaps = 25/203 (12%)
Query: 79  VGQGSFGVVFQAKC-LETGETVAIK------KVLQDKRYKN---RELQTMRLLDHPNVVS 128
           +G GSFGVV + +    +G+TV++        VL      +   RE+  M  LDH N++ 
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIR 75
Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L     +        + +V E  P  +  ++    K      +  +  YA Q+   + Y+
Sbjct: 76  LYGVVLTPP------MKMVTELAP--LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYL 127
Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPEL 244
             S    HRD+  +NLL+      VK+ DFG  + L + + +      R     + APE 
Sbjct: 128 E-SKRFIHRDLAARNLLLATRD-LVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPES 185
Query: 245 IFGATEYTTAIDIWSAGCVVAEL 267
           +   T ++ A D W  G  + E+
Sbjct: 186 LKTRT-FSHASDTWMFGVTLWEM 207

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    +  GE VAIK      ++    +++         V +   
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 71  RWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 124
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 100/218 (45%), Gaps = 37/218 (16%)
Query: 76  ERIVGQGSFGVVFQAKCLETG--ETVAIKKVLQ-----DKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++ +     D R    EL+ + +L  HPN++
Sbjct: 27  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 128 SL-KHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKH------FNKLNQRMPMIY 173
           +L   C      +   YL L +EY P           RV++        N     +    
Sbjct: 87  NLLGAC------EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQ 140
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK---VLVKGEPN 230
           +  +A  + R + Y+ +   + HR++  +N+LV    +  K+ DFG ++   V VK    
Sbjct: 141 LLHFAADVARGMDYLSQKQFI-HRNLAARNILVG-ENYVAKIADFGLSRGQEVYVK--KT 196
Query: 231 ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
           +  +  R+     L +    YTT  D+WS G ++ E++
Sbjct: 197 MGRLPVRWMAIESLNYSV--YTTNSDVWSYGVLLWEIV 232

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 69/152 (45%), Gaps = 8/152 (5%)
Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   R +G GSFG ++    +  GE VAIK      ++    +++         V +   
Sbjct: 9   YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 68
Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            +   + D  Y  +V+E +  ++  +   FN  +++  +  V L A Q+   + YIH S 
Sbjct: 69  RWCGAEGD--YNVMVMELLGPSLEDL---FNFCSRKFSLKTVLLLADQMISRIEYIH-SK 122
Query: 193 GVCHRDIKPQNLL--VNPHTHQVKLCDFGSAK 222
              HRD+KP N L  +    + V + DFG AK
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 154

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.1 bits (105), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 54/311 (17%)
Query: 78  IVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
           ++G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 16  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 75
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F +    +EL++             +  HF      + + Y+      + +AL YIH
Sbjct: 76  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 129
Query: 190 RSIGVCHRDIKPQNLLVNPHT--------HQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 130 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 188
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII-------------- 287
             L      Y    DI+S G    EL  G   F        L+E +              
Sbjct: 189 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 248
Query: 288 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 249 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVEQC 301
Query: 338 LQYSPNLRCTA 348
           LQ +P+ R +A
Sbjct: 302 LQRNPDARPSA 312

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 44.7 bits (104), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 62/311 (19%), Positives = 114/311 (36%), Gaps = 54/311 (17%)
Query: 78  IVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
           ++G+G      V  A+   TGE V ++++  +        +   EL   +L +HPN+V  
Sbjct: 32  VIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPY 91
Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F +    +EL++             +  HF      + + Y+      + +AL YIH
Sbjct: 92  RATFIA---DNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYI---LQGVLKALDYIH 145
Query: 190 RSIGVCHRDIKPQNLLVNPHT--------HQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
             +G  HR +K  ++L++             + +   G  + +V   P  S     +   
Sbjct: 146 H-MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSP 204
Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII-------------- 287
             L      Y    DI+S G    EL  G   F        L+E +              
Sbjct: 205 EVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIP 264
Query: 288 --KVLGTPTR--------EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             ++  +P+R        + +    P  +    P   +HP+H+ F     P     V + 
Sbjct: 265 AEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSP---SHPYHRTF----SPHFHHFVEQC 317
Query: 338 LQYSPNLRCTA 348
           LQ +P+ R +A
Sbjct: 318 LQRNPDARPSA 328

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 52  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 111
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +         +     +K + R P+
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLR-------RKAEADLDKEDGR-PL 157
Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++    
Sbjct: 158 ELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 215
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            I    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 216 YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 265

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 44.7 bits (104), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 57/231 (24%), Positives = 99/231 (42%), Gaps = 48/231 (20%)
Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVL----------QDKRYKNRELQTM-RLLDHPN 125
           + +G G+FG V +A     G+  A+ KV            +K     EL+ M  L  H N
Sbjct: 44  KTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHEN 103
Query: 126 VVSL--------------KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM 171
           +V+L              ++C +         LN +         +     +K + R P+
Sbjct: 104 IVNLLGACTHGGPVLVITEYCCYGDL------LNFLR-------RKAEADLDKEDGR-PL 149
Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++    
Sbjct: 150 ELRDLLHFSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSN 207
Query: 230 NISYICSRY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            I    +R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 208 YIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 257

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 31/104 (29%), Positives = 55/104 (52%), Gaps = 7/104 (6%)
Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           ++ Q+ + ++++  S    HRD+  +N+L+  + H  K+ DFG A+ ++     I    +
Sbjct: 163 FSSQVAQGMAFL-ASKNCIHRDVAARNVLLT-NGHVAKIGDFGLARDIMNDSNYIVKGNA 220
Query: 237 RY---YRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R    + APE IF    YT   D+WS G ++ E+  LG   +PG
Sbjct: 221 RLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPG 263

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 57  VTTIGGRNGQPKQTISYMAERIV-----GQGSFGVVFQAKCLETGETVAIK---KVLQDK 108
           +TT G  +G P      +A  IV     G+G FG V++ K    GE VA+K      +  
Sbjct: 23  MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS 80
Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE---LYLNLVLEYVPETVHRVVKHFNKL 165
            ++  E+    +L H N++     F +  +KD      L LV +Y     H     F+ L
Sbjct: 81  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDY-----HEHGSLFDYL 131
Query: 166 NQRMPMI--YVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLC 216
           N+    +   +KL A      L+++H  I        + HRD+K +N+LV  +     + 
Sbjct: 132 NRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 189
Query: 217 DFG------SAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVA 265
           D G      SA   +   PN   + ++ Y APE++  +      E     DI++ G V  
Sbjct: 190 DLGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 248
Query: 266 EL 267
           E+
Sbjct: 249 EI 250

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 43.9 bits (102), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 93/212 (43%), Gaps = 34/212 (16%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL---QDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           VG+G +G V++   L  GE+VA+K      +   ++  E+    LL H N++        
Sbjct: 16  VGKGRYGEVWRG--LWHGESVAVKIFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDM- 72
Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--- 192
           T+      L L+  Y     H  +  F +     P + ++L A      L+++H  I   
Sbjct: 73  TSRNSSTQLWLITHY---HEHGSLYDFLQRQTLEPHLALRL-AVSAACGLAHLHVEIFGT 128
Query: 193 ----GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-----NISYICSRYYRAPE 243
                + HRD K +N+LV  +  Q  + D G A +  +G       N   + ++ Y APE
Sbjct: 129 QGKPAIAHRDFKSRNVLVKSNL-QCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPE 187
Query: 244 LI--------FGATEYTTAIDIWSAGCVVAEL 267
           ++        F + ++T   DIW+ G V+ E+
Sbjct: 188 VLDEQIRTDCFESYKWT---DIWAFGLVLWEI 216

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 63/242 (26%), Positives = 103/242 (42%), Gaps = 45/242 (18%)
Query: 57  VTTIGGRNGQPKQTISYMAERIV-----GQGSFGVVFQAKCLETGETVAIK---KVLQDK 108
           +TT G  +G P      +A  IV     G+G FG V++ K    GE VA+K      +  
Sbjct: 10  MTTSGSGSGLPLLVQRTIARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERS 67
Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE---LYLNLVLEYVPETVHRVVKHFNKL 165
            ++  E+    +L H N++     F +  +KD      L LV +Y     H     F+ L
Sbjct: 68  WFREAEIYQTVMLRHENILG----FIAADNKDNGTWTQLWLVSDY-----HEHGSLFDYL 118
Query: 166 NQRMPMI--YVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLC 216
           N+    +   +KL A      L+++H  I        + HRD+K +N+LV  +     + 
Sbjct: 119 NRYTVTVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIA 176
Query: 217 DFG------SAKVLVKGEPNISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVA 265
           D G      SA   +   PN   + ++ Y APE++  +      E     DI++ G V  
Sbjct: 177 DLGLAVRHDSATDTIDIAPN-HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFW 235
Query: 266 EL 267
           E+
Sbjct: 236 EI 237

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 43.1 bits (100), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 93/226 (41%), Gaps = 51/226 (22%)
Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +R +G+G+FG VF A+C     T     VA+K +    L  ++   RE + +  L H ++
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 79
Query: 127 VSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIY 173
           V     +    D D L   +V EY+             P+ +  V     +    + +  
Sbjct: 80  VKF---YGVCGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++           
Sbjct: 135 MLHIASQIASGMVYL-ASQHFVHRDLATRNCLVGANL-LVKIGDFGMSR---------DV 183
Query: 234 ICSRYYRA------------PELIFGATEYTTAIDIWSAGCVVAEL 267
             + YYR             PE I    ++TT  D+WS G ++ E+
Sbjct: 184 YSTDYYRVGGHTMLPIRWMPPESIM-YRKFTTESDVWSFGVILWEI 228

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI 292

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI 292

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T K  +Y  +V+E V     +       L      + VK     +  A + +     
Sbjct: 179 GVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 194 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY---YRAPE-LIFG 247
            C  HRD+  +N LV    + +K+ DFG ++    G    S    +    + APE L +G
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYG 290
Query: 248 ATEYTTAIDIWSAGCVVAE-LMLGKPLFP 275
              Y++  D+WS G ++ E   LG   +P
Sbjct: 291 --RYSSESDVWSFGILLWETFSLGASPYP 317

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 42.4 bits (98), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 158 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 214
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 215 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 268
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 269 QIINQISKLHA-------IIDPNH-EIEFPDI 292

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 42.0 bits (97), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 186
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 240
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDI 264

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 111 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDTTSVVKD 167
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 168 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 221
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 222 QIINQISKLHA-------IIDPNH-EIEFPDI 245

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 89/214 (41%), Gaps = 29/214 (13%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL---DHPNVVSLKHCF 133
           +G+G+FG VF  +       VA+K   +      K + LQ  R+L    HPN+V L    
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL---I 178
Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T K  +Y  +V+E V     +       L      + VK     +  A + +     
Sbjct: 179 GVCTQKQPIY--IVMELV-----QGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231
Query: 194 VC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
            C  HRD+  +N LV    + +K+ DFG    + + E +  Y  S   R   + + A E 
Sbjct: 232 KCCIHRDLAARNCLVT-EKNVLKISDFG----MSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 251 -----YTTAIDIWSAGCVVAE-LMLGKPLFPGDS 278
                Y++  D+WS G ++ E   LG   +P  S
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 42.0 bits (97), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 114 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 170
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 171 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 224
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 225 QIINQISKLHA-------IIDPNH-EIEFPDI 248

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 64/152 (42%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   
Sbjct: 110 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV--DGMLKLIDFGIANQMQPDTTSVVKD 166
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 167 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 220
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 221 QIINQISKLHA-------IIDPNH-EIEFPDI 244

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 14  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 67
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 68  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 121
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 122 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 179
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 180 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 17  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 70
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 71  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 124
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 125 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 182
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 183 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2CSN|A Chain A, Binary Complex Of Casein Kinase-1 With Cki7 Length = 297

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH----P 124
           + Y   R +G+GSFGV+F+   L   + VAIK      D      E +T +LL      P
Sbjct: 9   VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 68
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           NV      +F    ++ L+  LV++ +  ++  ++   +   ++  +  V + A Q+   
Sbjct: 69  NVY-----YFG---QEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLAR 117
Query: 185 LSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
           +  IH    + +RDIKP N L+    + + + + + DFG  K
Sbjct: 118 VQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 158

>pdb|1EH4|A Chain A, Binary Complex Of Casein Kinase-1 From S. Pombe With An Atp Competitive Inhibitor, Ic261 Length = 298

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 22/162 (13%)
Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH----P 124
           + Y   R +G+GSFGV+F+   L   + VAIK      D      E +T +LL      P
Sbjct: 10  VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIP 69
Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           NV      +F    ++ L+  LV++ +  ++  ++   +   ++  +  V + A Q+   
Sbjct: 70  NVY-----YFG---QEGLHNVLVIDLLGPSLEDLL---DLCGRKFSVKTVAMAAKQMLAR 118
Query: 185 LSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
           +  IH    + +RDIKP N L+    + + + + + DFG  K
Sbjct: 119 VQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 41.6 bits (96), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 11  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 64
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 65  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 118
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 119 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 176
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 177 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIK---KVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFS 135
           +G+G FG V++ K    GE VA+K      +   ++  E+    +L H N++     F +
Sbjct: 12  IGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG----FIA 65
Query: 136 TTDKDE---LYLNLVLEYVPETVHRVVKHFNKLNQRMPMI--YVKLYAYQIFRALSYIHR 190
             +KD      L LV +Y     H     F+ LN+    +   +KL A      L+++H 
Sbjct: 66  ADNKDNGTWTQLWLVSDY-----HEHGSLFDYLNRYTVTVEGMIKL-ALSTASGLAHLHM 119
Query: 191 SI-------GVCHRDIKPQNLLVNPHTHQVKLCDFG------SAKVLVKGEPNISYICSR 237
            I        + HRD+K +N+LV  +     + D G      SA   +   PN   + ++
Sbjct: 120 EIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLGLAVRHDSATDTIDIAPN-HRVGTK 177
Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAEL 267
            Y APE++  +      E     DI++ G V  E+
Sbjct: 178 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 40/152 (26%), Positives = 63/152 (41%), Gaps = 30/152 (19%)
Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--- 231
           K Y   +  A+  IH+  G+ H D+KP N L+      +KL DFG A  +      +   
Sbjct: 130 KSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVDGM--LKLIDFGIANQMQPDXXXVVKD 186
Query: 232 SYICSRYYRAPELIFGATE----------YTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
           S + +  Y  PE I   +            +   D+WS GC++  +  GK  F       
Sbjct: 187 SQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF------Q 240
Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
           Q++  I  L          ++PN+ E +FP I
Sbjct: 241 QIINQISKLHA-------IIDPNH-EIEFPDI 264

>pdb|2CMW|A Chain A, Structure Of Human Casein Kinase 1 Gamma-1 In Complex With 2-(2-Hydroxyethylamino)-6-(3-Chloroanilino)-9- Isopropylpurine (Casp Target) Length = 310

Iteration: 1
 Score = 41.2 bits (95), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 42/156 (26%), Positives = 70/156 (44%), Gaps = 13/156 (8%)
Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--MRLLDHPNVVSLKHCFFST 136
           +G G+FG +   K L T E VAIK      R     L+    + L        +  +F  
Sbjct: 8   IGCGNFGELRLGKNLYTNEYVAIKLEPIKSRAPQLHLEYRFYKQLGSAGEGLPQVYYFGP 67
Query: 137 TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH 196
             K   Y  +VLE +  ++  +   F+  ++   +  V + A Q+   + Y+H S  + +
Sbjct: 68  XGK---YNAMVLELLGPSLEDL---FDLCDRTFTLKTVLMIAIQLLSRMEYVH-SKNLIY 120
Query: 197 RDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGE 228
           RD+KP+N L+    N   H + + DFG AK  +  E
Sbjct: 121 RDVKPENFLIGRQGNKKEHVIHIIDFGLAKEYIDPE 156

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	371
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	0.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	0.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	0.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	0.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	8e-94
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-93
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-92
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-90
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	9e-90
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-89
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	6e-89
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	6e-89
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	8e-89
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-88
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-88
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	4e-88
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-87
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-86
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-86
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-86
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-85
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-84
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-84
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	8e-84
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	5e-82
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-82
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	2e-81
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-81
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-81
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-81
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	7e-75
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-59
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-57
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-57
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-56
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-55
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	1e-54
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-54
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	1e-53
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-53
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-53
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	3e-53
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-53
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	4e-53
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	7e-53
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-52
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-52
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-52
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-51
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-50
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	3e-50
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-50
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	5e-50
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-50
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	7e-50
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-49
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	4e-49
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-49
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-48
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-48
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-48
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-47
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-47
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-47
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-47
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	4e-47
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	8e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-46
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-46
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-46
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-46
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	2e-46
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-46
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	4e-46
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	8e-46
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	9e-46
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-45
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	2e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-45
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-45
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-44
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	8e-44
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-44
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-43
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-43
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-43
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	3e-43
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-43
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-43
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-43
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-43
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-42
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-42
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	4e-42
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	6e-42
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-41
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-41
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-40
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-40
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	3e-40
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-40
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-40
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-40
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-39
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-39
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-39
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-39
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	7e-39
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-38
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-38
3an0_A	340	Dual specificity mitogen-activated protein kinase;	3e-38
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	4e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-38
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	5e-38
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-37
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	7e-37
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-36
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-36
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-36
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	7e-36
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-35
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-35
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-35
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	5e-35
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	6e-35
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-35
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	4e-34
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-34
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	5e-34
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	6e-34
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-33
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-33
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-33
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-33
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	1e-32
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-32
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-32
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	3e-32
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	4e-32
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	4e-32
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-32
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	8e-32
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-31
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	8e-31
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-30
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-30
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-30
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	3e-30
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	9e-30
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	2e-29
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-29
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-29
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-29
3ork_A	311	Serine/threonine protein kinase; structural genomi	4e-29
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	9e-29
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	2e-28
3q4u_A	301	Activin receptor type-1; structural genomics conso	4e-28
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	7e-28
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-27
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-27
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-27
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-26
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-25
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	7e-21
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-20
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-20
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-20
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-20
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-19
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-19
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-19
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	4e-19
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-19
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	4e-19
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	5e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-19
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	7e-19
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	7e-19
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	7e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	7e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	8e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-18
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-18
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-18
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	7e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	8e-18
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	8e-18
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-18
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-18
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	9e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	1e-17
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-17
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	3e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	4e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	5e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	7e-17
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	9e-17
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	2e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-16
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	2e-16
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-16
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-16
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	1e-15
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-15
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	9e-15
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	1e-14
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	2e-14
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-14
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	4e-12
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	4e-05

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  560 bits (1446), Expect = 0.0
 Identities = 207/337 (61%), Positives = 262/337 (77%), Gaps = 13/337 (3%)

Query: 13  RESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS 72
             S   +    + P     MK+  DK         +G++   ++ T   G+     Q +S
Sbjct: 7   TTSFAESCKPVQQPSAFGSMKVSRDK---------DGSKVTTVVATP--GQGPDRPQEVS 55

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           Y   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNRELQ MR LDH N+V L++ 
Sbjct: 56  YTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYF 115

Query: 133 FFSTTDK-DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           F+S+ +K DE+YLNLVL+YVPETV+RV +H+++  Q +P+IYVKLY YQ+FR+L+YIH S
Sbjct: 116 FYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIH-S 174

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
            G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYICSRYYRAPELIFGAT+Y
Sbjct: 175 FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 234

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           T++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPTRE+I+ MNPNYTEFKFP
Sbjct: 235 TSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFP 294

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           QIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T 
Sbjct: 295 QIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 331

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  553 bits (1426), Expect = 0.0
 Identities = 197/313 (62%), Positives = 248/313 (79%), Gaps = 4/313 (1%)

Query: 37  DKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG 96
           +  +    ++        I V    G+ G+ ++ I+Y   +++G GSFGVVFQAK +E+ 
Sbjct: 7   NAPLNGVKLNPLDDPNKVIKVLASDGKTGEQRE-IAYTNCKVIGNGSFGVVFQAKLVESD 65

Query: 97  ETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELYLNLVLEYVPETV 155
           E VAIKKVLQDKR+KNRELQ MR++ HPNVV LK  F+S  DK DE++LNLVLEYVPETV
Sbjct: 66  E-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV 124

Query: 156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
           +R  +H+ KL Q MPM+ +KLY YQ+ R+L+YIH SIG+CHRDIKPQNLL++P +  +KL
Sbjct: 125 YRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIH-SIGICHRDIKPQNLLLDPPSGVLKL 183

Query: 216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFP 275
            DFGSAK+L+ GEPN+SYICSRYYRAPELIFGAT YTT IDIWS GCV+AELM G+PLFP
Sbjct: 184 IDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFP 243

Query: 276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVS 335
           G+SG+DQLVEIIKVLGTP+RE+IK MNPNY E KFPQI+ HP+ K+F  R PP+A+DL+S
Sbjct: 244 GESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLIS 303

Query: 336 RLLQYSPNLRCTA 348
           RLL+Y+P+ R TA
Sbjct: 304 RLLEYTPSARLTA 316

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  534 bits (1378), Expect = 0.0
 Identities = 141/307 (45%), Positives = 199/307 (64%), Gaps = 11/307 (3%)

Query: 53  GHIIVTTIGGRNGQP--KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRY 110
           G ++         +   K+   +  ER+ GQG+FG V   K   TG +VAIKKV+QD R+
Sbjct: 3   GSMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRF 62

Query: 111 KNRELQTMRLL---DHPNVVSLKHCFFSTT--DKDELYLNLVLEYVPETVHRVVKHFNKL 165
           +NRELQ M+ L    HPN+V L+  F++    D+ ++YLN+V+EYVP+T+HR  +++ + 
Sbjct: 63  RNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRR 122

Query: 166 NQRMPMIYVKLYAYQIFRALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               P I +K++ +Q+ R++  +H  S+ VCHRDIKP N+LVN     +KLCDFGSAK L
Sbjct: 123 QVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKL 182

Query: 225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
              EPN++YICSRYYRAPELIFG   YTTA+DIWS GC+ AE+MLG+P+F GD+   QL 
Sbjct: 183 SPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLH 242

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYS 341
           EI++VLG P+RE ++ +NP++T+      K  PW  +F     +   EA DL+S LLQY 
Sbjct: 243 EIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYL 302

Query: 342 PNLRCTA 348
           P  R   
Sbjct: 303 PEERMKP 309

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  515 bits (1327), Expect = 0.0
 Identities = 149/317 (47%), Positives = 212/317 (66%), Gaps = 34/317 (10%)

Query: 65  GQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHP 124
           G    +  Y   + +G GSFG+V +   +E+G+  A+KKVLQD RYKNREL  M++LDH 
Sbjct: 1   GLETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHV 60

Query: 125 NVVSLKHCFFSTTDK---------------------------------DELYLNLVLEYV 151
           N++ L   F++T D+                                    YLN+++EYV
Sbjct: 61  NIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYV 120

Query: 152 PETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH 211
           P+T+H+V+K F +  + +PM  + +Y YQ+FRA+ +IH S+G+CHRDIKPQNLLVN   +
Sbjct: 121 PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIH-SLGICHRDIKPQNLLVNSKDN 179

Query: 212 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK 271
            +KLCDFGSAK L+  EP+++YICSR+YRAPEL+ GATEYT +ID+WS GCV  EL+LGK
Sbjct: 180 TLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

Query: 272 PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAV 331
           PLF G++ +DQLV II+++GTPT+E++  MNP+YTE +FP +KA  W KI P+  P  A+
Sbjct: 240 PLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAI 299

Query: 332 DLVSRLLQYSPNLRCTA 348
           DL+ ++L+Y P+LR   
Sbjct: 300 DLLEQILRYEPDLRINP 316

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  281 bits (722), Expect = 8e-94
 Identities = 97/280 (34%), Positives = 150/280 (53%), Gaps = 21/280 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+GS+GVVF+ +  +TG+ VAIKK L+ +          RE++ ++ L HPN+V+L   
Sbjct: 11  IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F     K  L+L  V EY   TV   +    +  + +P   VK   +Q  +A+++ H+  
Sbjct: 71  F---RRKRRLHL--VFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH- 121

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 251
              HRD+KP+N+L+  H+  +KLCDFG A++L    +     + +R+YR+PEL+ G T+Y
Sbjct: 122 NCIHRDVKPENILITKHS-VIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQY 180

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM--NPNYTEFK 309
              +D+W+ GCV AEL+ G PL+PG S VDQL  I K LG       +    N  ++  K
Sbjct: 181 GPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK 240

Query: 310 FPQIK-AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            P  +   P    FP  +   A+ L+   L   P  R T 
Sbjct: 241 IPDPEDMEPLELKFPN-ISYPALGLLKGCLHMDPTERLTC 279

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  281 bits (722), Expect = 2e-93
 Identities = 99/280 (35%), Positives = 151/280 (53%), Gaps = 21/280 (7%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+GS+G+V + +  +TG  VAIKK L+    K       RE++ ++ L H N+V+L   
Sbjct: 33  VGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV 92

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 K   YL  V E+V  T+   ++ F      +    V+ Y +QI   + + H   
Sbjct: 93  C---KKKKRWYL--VFEFVDHTILDDLELFP---NGLDYQVVQKYLFQIINGIGFCHSH- 143

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELIFGATEY 251
            + HRDIKP+N+LV+  +  VKLCDFG A+ L   GE     + +R+YRAPEL+ G  +Y
Sbjct: 144 NIIHRDIKPENILVS-QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKY 202

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--EIKCMNPNYTEFK 309
             A+D+W+ GC+V E+ +G+PLFPGDS +DQL  I+  LG       E+   NP +   +
Sbjct: 203 GKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVR 262

Query: 310 FPQIKAH-PWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            P+IK   P  + +PK +    +DL  + L   P+ R   
Sbjct: 263 LPEIKEREPLERRYPK-LSEVVIDLAKKCLHIDPDKRPFC 301

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  278 bits (714), Expect = 2e-92
 Identities = 89/299 (29%), Positives = 149/299 (49%), Gaps = 34/299 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQD----KR-YKNRELQTMRLLDHPNV 126
           YM  + +G G  G+VF A   +  + VAIKK+ L D    K     RE++ +R LDH N+
Sbjct: 13  YMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHAL--REIKIIRRLDHDNI 70

Query: 127 VSLKHCF-----------FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
           V +                S T+ + +Y+  V EY+   +  V++        +   + +
Sbjct: 71  VKVFEILGPSGSQLTDDVGSLTELNSVYI--VQEYMETDLANVLEQ-----GPLLEEHAR 123

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--- 232
           L+ YQ+ R L YIH S  V HRD+KP NL +N     +K+ DFG A+++     +     
Sbjct: 124 LFMYQLLRGLKYIH-SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLS 182

Query: 233 -YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             + +++YR+P L+     YT AID+W+AGC+ AE++ GK LF G   ++Q+  I++ + 
Sbjct: 183 EGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIP 242

Query: 292 TPTREEIKCMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               E+ + +      +          P  ++ P  +  EAVD + ++L +SP  R TA
Sbjct: 243 VVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPG-ISREAVDFLEQILTFSPMDRLTA 300

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  274 bits (704), Expect = 1e-90
 Identities = 102/300 (34%), Positives = 153/300 (51%), Gaps = 37/300 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 129
           +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++ L
Sbjct: 18  LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 77

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     K  + L  V +++      +       +  +   ++K Y     + L Y+H
Sbjct: 78  LDAF---GHKSNISL--VFDFME---TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLH 129

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
           +   + HRD+KP NLL++     +KL DFG AK    G PN +Y   + +R+YRAPEL+F
Sbjct: 130 QH-WILHRDLKPNNLLLD-ENGVLKLADFGLAKS--FGSPNRAYTHQVVTRWYRAPELLF 185

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI---KCMNP 303
           GA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT EE     C  P
Sbjct: 186 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPT-EEQWPDMCSLP 244

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL----FSNCP 359
           +Y    F      P H IF      + +DL+  L  ++P  R TA   + L    FSN P
Sbjct: 245 DYVT--FKSFPGIPLHHIFS-AAGDDLLDLIQGLFLFNPCARITA--TQALKMKYFSNRP 299

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  272 bits (697), Expect = 9e-90
 Identities = 92/292 (31%), Positives = 156/292 (53%), Gaps = 33/292 (11%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLD 122
           +Y+    +G+G++  V++ K   T   VA+K++    R ++         RE+  ++ L 
Sbjct: 3   TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEI----RLEHEEGAPCTAIREVSLLKDLK 58

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           H N+V+L         +  L L  V EY+      + ++ +     + M  VKL+ +Q+ 
Sbjct: 59  HANIVTLHDII---HTEKSLTL--VFEYLD---KDLKQYLDDCGNIINMHNVKLFLFQLL 110

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYY 239
           R L+Y HR   V HRD+KPQNLL+N    ++KL DFG A+   K  P  +Y   + + +Y
Sbjct: 111 RGLAYCHRQ-KVLHRDLKPQNLLIN-ERGELKLADFGLARA--KSIPTKTYDNEVVTLWY 166

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--- 296
           R P+++ G+T+Y+T ID+W  GC+  E+  G+PLFPG +  +QL  I ++LGTPT E   
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWP 226

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            I      +  + +P+ +A       P R+  +  DL+++LLQ+    R +A
Sbjct: 227 GILSN-EEFKTYNYPKYRAEALLSHAP-RLDSDGADLLTKLLQFEGRNRISA 276

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  270 bits (692), Expect = 3e-89
 Identities = 99/297 (33%), Positives = 163/297 (54%), Gaps = 33/297 (11%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           VG+G++GVV++AK    G  VA+K++  D   +       RE+  ++ L HPN+VSL   
Sbjct: 29  VGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV 87

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 +  L L  V E++      + K  ++    +    +K+Y YQ+ R +++ H+  
Sbjct: 88  I---HSERCLTL--VFEFME---KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQH- 138

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            + HRD+KPQNLL+N     +KL DFG A+    G P  SY   + + +YRAP+++ G+ 
Sbjct: 139 RILHRDLKPQNLLIN-SDGALKLADFGLARA--FGIPVRSYTHEVVTLWYRAPDVLMGSK 195

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 306
           +Y+T++DIWS GC+ AE++ GKPLFPG +  DQL +I  +LGTP      +++ + P + 
Sbjct: 196 KYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL-PLWK 254

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL----FSNCP 359
           +  F   +  PW  I P     E +DL+S +L + PN R +A  +  +    F +  
Sbjct: 255 QRTFQVFEKKPWSSIIP-GFCQEGIDLLSNMLCFDPNKRISA--RDAMNHPYFKDLD 308

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  270 bits (692), Expect = 6e-89
 Identities = 85/286 (29%), Positives = 150/286 (52%), Gaps = 30/286 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G V++A    T ETVAIK++  +   +       RE+  ++ L H N++ LK  
Sbjct: 42  LGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSV 101

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                    L+L  + EY    + + +      N  + M  +K + YQ+   +++ H   
Sbjct: 102 I---HHNHRLHL--IFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR- 151

Query: 193 GVCHRDIKPQNLLVNPHTH----QVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
              HRD+KPQNLL++         +K+ DFG A+    G P   +   I + +YR PE++
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA--FGIPIRQFTHEIITLWYRPPEIL 209

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMN 302
            G+  Y+T++DIWS  C+ AE+++  PLFPGDS +DQL +I +VLG P       +  + 
Sbjct: 210 LGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTAL- 268

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           P++ +  FP+ +     ++    +  E +DL++ +L+  P  R +A
Sbjct: 269 PDWKQS-FPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISA 313

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  270 bits (693), Expect = 8e-89
 Identities = 92/300 (30%), Positives = 163/300 (54%), Gaps = 36/300 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-----LQD-KR-YKNRELQTMRLLDHPN 125
           +  + ++G+G++GVV  A    TGE VAIKK+          R    RE++ ++   H N
Sbjct: 13  FQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTL--REIKILKHFKHEN 70

Query: 126 VVSLKHCFFSTTDKD--ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++++ +     + ++  E+Y+  + E +   +HRV+       Q +   +++ + YQ  R
Sbjct: 71  IITIFNIQRPDSFENFNEVYI--IQELMQTDLHRVIS-----TQMLSDDHIQYFIYQTLR 123

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 232
           A+  +H    V HRD+KP NLL+N     +K+CDFG A+++ +   + S           
Sbjct: 124 AVKVLH-GSNVIHRDLKPSNLLIN-SNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVE 181

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
           ++ +R+YRAPE++  + +Y+ A+D+WS GC++AEL L +P+FPG     QL+ I  ++GT
Sbjct: 182 FVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGT 241

Query: 293 PTREEI--KCMNPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           P  +       +P   E+    P   A P  K+FP+ + P+ +DL+ R+L + P  R TA
Sbjct: 242 PHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPKGIDLLQRMLVFDPAKRITA 300

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  269 bits (690), Expect = 1e-88
 Identities = 85/288 (29%), Positives = 141/288 (48%), Gaps = 23/288 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKNRELQTMR-LLDHPNVVSL 129
           Y   R +G+G +  VF+A  +   E V +K +  ++ K+ K RE++ +  L   PN+++L
Sbjct: 38  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIK-REIKILENLRGGPNIITL 96

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +       V E+V  T       F +L Q +    ++ Y Y+I +AL Y H
Sbjct: 97  ADIVKDPVSRTPAL---VFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH 147

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+    
Sbjct: 148 -SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 250 EYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEI--KCMNPNYT 306
            Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +   K       
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDP 266

Query: 307 EFK--FPQIKAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
            F     +     W +         + PEA+D + +LL+Y    R TA
Sbjct: 267 RFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 314

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  269 bits (691), Expect = 2e-88
 Identities = 86/299 (28%), Positives = 144/299 (48%), Gaps = 34/299 (11%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------------RELQT 117
           Y  +R +  GS+G V        G  VAIK+V                       RE++ 
Sbjct: 24  YTVQRFISSGSYGAVCAGVD-SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRL 82

Query: 118 MRLLDHPNVVSLKHCF--FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPM--IY 173
           +    HPN++ L+  F  F      +LYL  V E +   + +V+       QR+ +   +
Sbjct: 83  LNHFHHPNILGLRDIFVHFEEPAMHKLYL--VTELMRTDLAQVIHD-----QRIVISPQH 135

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           ++ + Y I   L  +H   GV HRD+ P N+L+    + + +CDF  A+          Y
Sbjct: 136 IQYFMYHILLGLHVLH-EAGVVHRDLHPGNILLA-DNNDITICDFNLAREDTADANKTHY 193

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  R+YRAPEL+     +T  +D+WSAGCV+AE+   K LF G +  +QL +I++V+GTP
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253

Query: 294 TREEIKCM-NP---NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             E++    +P   +Y       + A  W  + P    P A+DL++++L+++P  R + 
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPT-ADPVALDLIAKMLEFNPQRRIST 311

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  266 bits (683), Expect = 4e-88
 Identities = 95/282 (33%), Positives = 151/282 (53%), Gaps = 28/282 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDV 68

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 K  L L  V E++      + K  +     +  +  K +  Q+   ++Y H   
Sbjct: 69  I---HTKKRLVL--VFEHLD---QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR- 119

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++K+ DFG A+    G P   Y   I + +YRAP+++ G+ 
Sbjct: 120 RVLHRDLKPQNLLIN-REGELKIADFGLARA--FGIPVRKYTHEIVTLWYRAPDVLMGSK 176

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNYT 306
           +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +  + P Y 
Sbjct: 177 KYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTEL-PKY- 234

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +  F   +  PW       +    +DL+S++L+  PN R TA
Sbjct: 235 DPNFTVYEPLPWESFLK-GLDESGIDLLSKMLKLDPNQRITA 275

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  267 bits (686), Expect = 1e-87
 Identities = 90/292 (30%), Positives = 159/292 (54%), Gaps = 28/292 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQD----KR-YKNRELQTMRLLDHPN 125
           Y     +G+G++G+V  A        VAIKK+   +     +R    RE++ +    H N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTL--REIKILLRFRHEN 86

Query: 126 VVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ +       +     ++Y+  V + +   +++++K      Q +   ++  + YQI R
Sbjct: 87  IIGINDIIRAPTIEQMKDVYI--VQDLMETDLYKLLK-----TQHLSNDHICYFLYQILR 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYY 239
            L YIH S  V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+Y
Sbjct: 140 GLKYIH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 197

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ 
Sbjct: 198 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLN 257

Query: 300 CM-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           C+ N     +    P     PW+++FP     +A+DL+ ++L ++P+ R   
Sbjct: 258 CIINLKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEV 308

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  264 bits (678), Expect = 2e-86
 Identities = 95/291 (32%), Positives = 153/291 (52%), Gaps = 31/291 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 124
           Y++   VG G++G V  A    +GE VAIKK+    Q     KR Y  REL  ++ + H 
Sbjct: 26  YVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAY--RELLLLKHMQHE 83

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           NV+ L   F   +      + YL  V+ ++   + +++        +     ++   YQ+
Sbjct: 84  NVIGLLDVFTPASSLRNFYDFYL--VMPFMQTDLQKIMG------LKFSEEKIQYLVYQM 135

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYR 240
            + L YIH S GV HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YR
Sbjct: 136 LKGLKYIH-SAGVVHRDLKPGNLAVNEDCE-LKILDFGLARHA---DAEMTGYVVTRWYR 190

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE+I     Y   +DIWS GC++AE++ GK LF G   +DQL +I+KV G P  E ++ 
Sbjct: 191 APEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQK 250

Query: 301 M-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + +     +    PQ     + ++FP+   P+A DL+ ++L+   + R TA
Sbjct: 251 LNDKAAKSYIQSLPQTPRKDFTQLFPR-ASPQAADLLEKMLELDVDKRLTA 300

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  262 bits (672), Expect = 2e-86
 Identities = 97/283 (34%), Positives = 151/283 (53%), Gaps = 28/283 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKHC 132
           +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+V L   
Sbjct: 10  IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                   +L L  V E+       + K+F+  N  +    VK + +Q+ + L + H   
Sbjct: 70  L---HSDKKLTL--VFEFCD---QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR- 120

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIFGAT 249
            V HRD+KPQNLL+N    ++KL +FG A+    G P   Y   + + +YR P+++FGA 
Sbjct: 121 NVLHRDLKPQNLLIN-RNGELKLANFGLARA--FGIPVRCYSAEVVTLWYRPPDVLFGAK 177

Query: 250 EYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCMNPNY 305
            Y+T+ID+WSAGC+ AEL   G+PLFPG+   DQL  I ++LGTPT E    +  + P+Y
Sbjct: 178 LYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL-PDY 236

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +            + P ++     DL+  LL+ +P  R +A
Sbjct: 237 KPYPMYPAT-TSLVNVVP-KLNATGRDLLQNLLKCNPVQRISA 277

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  264 bits (678), Expect = 2e-86
 Identities = 92/289 (31%), Positives = 152/289 (52%), Gaps = 26/289 (8%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y   + VG G++G V  A    TG  VAIKK+          +   REL+ ++ + H NV
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 86

Query: 127 VSLKHCFF---STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           + L   F    +  D  + YL  V+ ++   + +++K     ++++    ++   YQ+ +
Sbjct: 87  IGLLDVFTPDETLDDFTDFYL--VMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLK 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYRAP 242
            L YIH + G+ HRD+KP NL VN     +K+ DFG A+     +  ++ Y+ +R+YRAP
Sbjct: 140 GLRYIH-AAGIIHRDLKPGNLAVNEDCE-LKILDFGLARQA---DSEMTGYVVTRWYRAP 194

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM- 301
           E+I     YT  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ + 
Sbjct: 195 EVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ 254

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +     +    P+++   +  I      P AV+L+ ++L      R TA
Sbjct: 255 SDEAKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTA 302

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  260 bits (666), Expect = 3e-85
 Identities = 85/291 (29%), Positives = 150/291 (51%), Gaps = 36/291 (12%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVVSL 129
           +G G++  V++     TG  VA+K+V    +  +         RE+  M+ L H N+V L
Sbjct: 13  LGNGTYATVYKGLNKTTGVYVALKEV----KLDSEEGTPSTAIREISLMKELKHENIVRL 68

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFRALSY 187
                    +++L L  V E++   + + +      N  + + +  VK + +Q+ + L++
Sbjct: 69  YDVI---HTENKLTL--VFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAF 123

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 244
            H +  + HRD+KPQNLL+N    Q+KL DFG A+    G P  ++   + + +YRAP++
Sbjct: 124 CHEN-KILHRDLKPQNLLIN-KRGQLKLGDFGLARA--FGIPVNTFSSEVVTLWYRAPDV 179

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE---EIKCM 301
           + G+  Y+T+IDIWS GC++AE++ GKPLFPG +  +QL  I  ++GTP       +  +
Sbjct: 180 LMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKL 239

Query: 302 NPNYTEFKFPQIKAHPWHKIFPK----RMPPEAVDLVSRLLQYSPNLRCTA 348
            P Y      Q       ++        +    +D +  LLQ +P++R +A
Sbjct: 240 -PKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSA 288

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  260 bits (666), Expect = 1e-84
 Identities = 96/291 (32%), Positives = 153/291 (52%), Gaps = 30/291 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y     VG G++G V  A   +TG  VA+KK+ +        KR Y  REL+ ++ + H 
Sbjct: 31  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTY--RELRLLKHMKHE 88

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           NV+ L   F      +   ++YL  V   +   ++ +VK      Q++   +V+   YQI
Sbjct: 89  NVIGLLDVFTPARSLEEFNDVYL--VTHLMGADLNNIVKC-----QKLTDDHVQFLIYQI 141

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-YICSRYYR 240
            R L YIH S  + HRD+KP NL VN    ++K+ DFG A+        ++ Y+ +R+YR
Sbjct: 142 LRGLKYIH-SADIIHRDLKPSNLAVN-EDCELKILDFGLARHT---ADEMTGYVATRWYR 196

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE++     Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K 
Sbjct: 197 APEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK 256

Query: 301 M-NPNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + + +   +     Q+    +  +F     P AVDL+ ++L    + R TA
Sbjct: 257 ISSESARNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 306

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  259 bits (664), Expect = 2e-84
 Identities = 83/293 (28%), Positives = 143/293 (48%), Gaps = 26/293 (8%)

Query: 76  ERI--VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           E++  +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NVV
Sbjct: 20  EKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVV 79

Query: 128 SLK---HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           +L        S  ++ +  + LV ++     H +    + +  +  +  +K     +   
Sbjct: 80  NLIEICRTKASPYNRCKGSIYLVFDFCE---HDLAGLLSNVLVKFTLSEIKRVMQMLLNG 136

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV--LVKGEPNISY---ICSRYY 239
           L YIHR+  + HRD+K  N+L+      +KL DFG A+   L K      Y   + + +Y
Sbjct: 137 LYYIHRN-KILHRDMKAANVLIT-RDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWY 194

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE--- 296
           R PEL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E   
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPK-RMPPEAVDLVSRLLQYSPNLRCTA 348
            +      Y + +  + +              P A+DL+ +LL   P  R  +
Sbjct: 255 NVDNY-ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 306

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  256 bits (656), Expect = 8e-84
 Identities = 83/288 (28%), Positives = 138/288 (47%), Gaps = 31/288 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RE---LQTMRLLDHPNV 126
           +G G++G V++A+   +G  VA+K V                 RE   L+ +   +HPNV
Sbjct: 17  IGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNV 76

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L     ++    E+ + LV E+V + +   +         +P   +K    Q  R L 
Sbjct: 77  VRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLD 134

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPE 243
           ++H +  + HRD+KP+N+LV      VKL DFG A++       ++    + + +YRAPE
Sbjct: 135 FLHAN-CIVHRDLKPENILVT-SGGTVKLADFGLARI--YSYQ-MALTPVVVTLWYRAPE 189

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++  +T Y T +D+WS GC+ AE+   KPLF G+S  DQL +I  ++G P  ++     P
Sbjct: 190 VLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDW----P 244

Query: 304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    FP     P   + P  M      L+  +L ++P+ R +A
Sbjct: 245 RDVSLPRGAFPPRGPRPVQSVVP-EMEESGAQLLLEMLTFNPHKRISA 291

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  253 bits (649), Expect = 5e-82
 Identities = 87/300 (29%), Positives = 148/300 (49%), Gaps = 37/300 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQD----KR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A        VAIKK+    Q+    KR Y  REL  M+ ++H 
Sbjct: 27  YQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 84

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N++ L + F      +   ++Y+  V+E +   + +V++        +    +    YQ+
Sbjct: 85  NIIGLLNVFTPQKSLEEFQDVYI--VMELMDANLCQVIQ------MELDHERMSYLLYQM 136

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 137 LCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 194

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   Y   +DIWS GC++ E++ G  LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 195 PEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKL 253

Query: 302 NPNYTEF--KFPQIKAHPWHKIFPKRMP-----------PEAVDLVSRLLQYSPNLRCTA 348
            P    +    P+   + + K+FP  +             +A DL+S++L    + R + 
Sbjct: 254 QPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISV 313

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  256 bits (656), Expect = 6e-82
 Identities = 90/300 (30%), Positives = 147/300 (49%), Gaps = 37/300 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y   + +G G+ G+V  A        VAIKK+ +        KR Y  REL  M+ ++H 
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAY--RELVLMKCVNHK 121

Query: 125 NVVSLKHCFFSTTDKD---ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N++SL + F      +   ++YL  V+E +   + +V++        +    +    YQ+
Sbjct: 122 NIISLLNVFTPQKTLEEFQDVYL--VMELMDANLCQVIQ------MELDHERMSYLLYQM 173

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              + ++H S G+ HRD+KP N++V      +K+ DFG A+          Y+ +RYYRA
Sbjct: 174 LCGIKHLH-SAGIIHRDLKPSNIVVK-SDCTLKILDFGLARTAGTSFMMTPYVVTRYYRA 231

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE+I G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K +
Sbjct: 232 PEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKL 290

Query: 302 NPNYTEF--KFPQIKAHPWHKIFP-----------KRMPPEAVDLVSRLLQYSPNLRCTA 348
            P    +    P+     + K+FP           K    +A DL+S++L   P  R + 
Sbjct: 291 QPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 350

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  250 bits (642), Expect = 2e-81
 Identities = 89/287 (31%), Positives = 141/287 (49%), Gaps = 31/287 (10%)

Query: 79  VGQGSFGVVFQAK-CLETGETVAIKKVLQDKRYKN-------RE---LQTMRLLDHPNVV 127
           +G+G++G VF+A+     G  VA+K+V      +        RE   L+ +   +HPNVV
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTG-EEGMPLSTIREVAVLRHLETFEHPNVV 77

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L      +    E  L LV E+V + +   +         +P   +K   +Q+ R L +
Sbjct: 78  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDF 135

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPEL 244
           +H    V HRD+KPQN+LV   + Q+KL DFG A++       ++    + + +YRAPE+
Sbjct: 136 LHSH-RVVHRDLKPQNILVT-SSGQIKLADFGLARI--YSFQ-MALTSVVVTLWYRAPEV 190

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +  ++ Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+     P 
Sbjct: 191 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDW----PR 245

Query: 305 YTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                   F    A P  K     +     DL+ + L ++P  R +A
Sbjct: 246 DVALPRQAFHSKSAQPIEKFVT-DIDELGKDLLLKCLTFNPAKRISA 291

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  255 bits (652), Expect = 2e-81
 Identities = 100/348 (28%), Positives = 150/348 (43%), Gaps = 83/348 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KR-YKNRELQTMRLLDHP 124
           Y    ++G GS+G V +A        VAIKK+L+        KR    RE+  +  L+H 
Sbjct: 55  YEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRIL--REIAILNRLNHD 112

Query: 125 NVVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           +VV +            DELY  +VLE       ++ +        +  +++K   Y + 
Sbjct: 113 HVVKVLDIVIPKDVEKFDELY--VVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLL 166

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 232
             + Y+H S G+ HRD+KP N LVN     VK+CDFG A+ +   E   S          
Sbjct: 167 VGVKYVH-SAGILHRDLKPANCLVNQDCS-VKVCDFGLARTVDYPENGNSQLPISPREDD 224

Query: 233 ------------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML----- 269
                             ++ +R+YRAPELI     YT AID+WS GC+ AEL+      
Sbjct: 225 MNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKEN 284

Query: 270 ------GKPLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCM-N 302
                   PLFPG S                      DQL  I  +LGTP+ E+I+ +  
Sbjct: 285 VAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEK 344

Query: 303 PNYTEF--KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +   +   FP+ +     + FP     +A+ L+ R+L ++PN R T 
Sbjct: 345 EDAKRYIRIFPKREGTDLAERFPA-SSADAIHLLKRMLVFNPNKRITI 391

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  253 bits (649), Expect = 3e-81
 Identities = 96/340 (28%), Positives = 151/340 (44%), Gaps = 75/340 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQD-KR-YKNRELQTMRLLDHP 124
           Y+ + ++G+GS+G V+ A    T + VAIKKV      L D KR    RE+  +  L   
Sbjct: 28  YIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL--REITILNRLKSD 85

Query: 125 NVVSLKHCFF--STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            ++ L            DELY+  VLE     + ++ K        +   ++K   Y + 
Sbjct: 86  YIIRLYDLIIPDDLLKFDELYI--VLEIADSDLKKLFKT----PIFLTEEHIKTILYNLL 139

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------- 232
              ++IH   G+ HRD+KP N L+N     VK+CDFG A+ +   +              
Sbjct: 140 LGENFIH-ESGIIHRDLKPANCLLNQDCS-VKVCDFGLARTINSEKDTNIVNDLEENEEP 197

Query: 233 -------------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG--------- 270
                        ++ +R+YRAPELI     YT +IDIWS GC+ AEL+           
Sbjct: 198 GPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPT 257

Query: 271 --KPLFPGDSG-----------------VDQLVEIIKVLGTPTREEIKCM-NPNYTEF-- 308
              PLFPG S                   DQL  I  ++GTPT +++K +  P   ++  
Sbjct: 258 NRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIK 317

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            FP  K     + +P  +  + ++L+  +L+++PN R T 
Sbjct: 318 LFPHRKPINLKQKYPS-ISDDGINLLESMLKFNPNKRITI 356

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  252 bits (645), Expect = 3e-81
 Identities = 97/325 (29%), Positives = 169/325 (52%), Gaps = 61/325 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL---QD----KR-YKNRELQTMRLL-DH 123
           Y   + +G+G++G+V+++    TGE VA+KK+    Q+    +R +  RE+  +  L  H
Sbjct: 11  YELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTF--REIMILTELSGH 68

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
            N+V+L +   +  D+D +YL  V +Y+   +H V++        +  ++ +   YQ+ +
Sbjct: 69  ENIVNLLNVLRADNDRD-VYL--VFDYMETDLHAVIR-----ANILEPVHKQYVVYQLIK 120

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----------- 232
            + Y+H S G+ HRD+KP N+L+N   H VK+ DFG ++  V      +           
Sbjct: 121 VIKYLH-SGGLLHRDMKPSNILLNAECH-VKVADFGLSRSFVNIRRVTNNIPLSINENTE 178

Query: 233 -----------YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
                      Y+ +R+YRAPE++ G+T+YT  ID+WS GC++ E++ GKP+FPG S ++
Sbjct: 179 NFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238

Query: 282 QLVEIIKVLGTPTREEIKCMN-----------------PNYTEFKFPQIKAHPWHKIFPK 324
           QL  II V+  P+ E+++ +                      +        +   KI PK
Sbjct: 239 QLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

Query: 325 R-MPPEAVDLVSRLLQYSPNLRCTA 348
                EA+DL+ +LLQ++PN R +A
Sbjct: 299 ADCNEEALDLLDKLLQFNPNKRISA 323

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  236 bits (604), Expect = 7e-75
 Identities = 88/306 (28%), Positives = 143/306 (46%), Gaps = 42/306 (13%)

Query: 79  VGQGSFGVVFQAKCLE--TGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 134
           VG+G++G V++AK  +    +  A+K++       +  RE+  +R L HPNV+SL+  F 
Sbjct: 29  VGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFL 88

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHF-----NKLNQRMPMIYVKLYAYQIFRALSYIH 189
           S  D+    + L+ +Y    +  ++K       NK   ++P   VK   YQI   + Y+H
Sbjct: 89  SHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145

Query: 190 RSIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVLVKGEPNISY------ICSRYYR 240
            +  V HRD+KP N+LV    P   +VK+ D G A++     P          + + +YR
Sbjct: 146 AN-WVLHRDLKPANILVMGEGPERGRVKIADMGFARLF--NSPLKPLADLDPVVVTFWYR 202

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS---------GVDQLVEIIKVLG 291
           APEL+ GA  YT AIDIW+ GC+ AEL+  +P+F               DQL  I  V+G
Sbjct: 203 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMG 262

Query: 292 TPTRE---------EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
            P  +         E   +  ++    +       + +    +   +A  L+ +LL   P
Sbjct: 263 FPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP 322

Query: 343 NLRCTA 348
             R T+
Sbjct: 323 IKRITS 328

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  196 bits (501), Expect = 3e-59
 Identities = 85/319 (26%), Positives = 148/319 (46%), Gaps = 57/319 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL------DH 123
           Y   +++G+GSFG V +A   +  + VA+K V  +KR+      E++ +  L      + 
Sbjct: 99  YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNT 158

Query: 124 PNVVSLKHCFFSTTDKDELYLN---LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
            NV+ +   F         + N   +  E +   ++ ++K      Q   +  V+ +A+ 
Sbjct: 159 MNVIHMLENF--------TFRNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHS 208

Query: 181 IFRALSYIHRSIGVCHRDIKPQN-LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           I + L  +H++  + H D+KP+N LL       +K+ DFGS+      +   +YI SR+Y
Sbjct: 209 ILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFY 265

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           RAPE+I GA  Y   ID+WS GC++AEL+ G PL PG+   DQL  +I++LG P+++ + 
Sbjct: 266 RAPEVILGA-RYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD 324

Query: 300 -----------CMNPNYTEFKFPQIKAHPWHKIFPKR----MPPEA-------------- 330
                         P Y         +   +    +R     PPE+              
Sbjct: 325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPL 384

Query: 331 -VDLVSRLLQYSPNLRCTA 348
            +D + + L++ P +R T 
Sbjct: 385 FLDFLKQCLEWDPAVRMTP 403

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  190 bits (485), Expect = 2e-57
 Identities = 81/313 (25%), Positives = 139/313 (44%), Gaps = 42/313 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLL-----DHP 124
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ +        
Sbjct: 21  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 80

Query: 125 NVVSLKHC-----FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
           + +   H       F+    + +++ +V E + E +  ++K +   ++ +P+IYVK  + 
Sbjct: 81  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 138

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSAKVLVKGEPNISYI 234
           Q+   L Y+HR  G+ H DIKP+N+L+           +K+ D G+A      E   + I
Sbjct: 139 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA--CWYDEHYTNSI 196

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIK 288
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       D + +II+
Sbjct: 197 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 255

Query: 289 VLGTPTREEI-------KCMNPNYTEFKFPQIKAHPWHKIFPKRMP------PEAVDLVS 335
           +LG      +          N         ++K  P   +  ++         E  D +S
Sbjct: 256 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 315

Query: 336 RLLQYSPNLRCTA 348
            +LQ  P  R  A
Sbjct: 316 PMLQLDPRKRADA 328

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  190 bits (485), Expect = 2e-57
 Identities = 92/355 (25%), Positives = 150/355 (42%), Gaps = 74/355 (20%)

Query: 46  DGNGTETGHIIVT---TIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK 102
           DG   +    IV        R         Y  + ++G+GSFG V +A      E VAIK
Sbjct: 35  DGYDDDNYDYIVKNGEKWMDR---------YEIDSLIGKGSFGQVVKAYDRVEQEWVAIK 85

Query: 103 KVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEY 150
            +   K + N    E++ + L+          +V LK  F         + N   LV E 
Sbjct: 86  IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFM--------FRNHLCLVFEM 137

Query: 151 VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-IGVCHRDIKPQN-LLVNP 208
           +   ++ ++++ N   + + +   + +A Q+  AL ++    + + H D+KP+N LL NP
Sbjct: 138 LSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNP 195

Query: 209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM 268
               +K+ DFGS+     G+    YI SR+YR+PE++ G   Y  AID+WS GC++ E+ 
Sbjct: 196 KRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMH 252

Query: 269 LGKPLFPGDSGVDQLVEIIKVLGTPTREEIK-----------CMNPNYTEFKFPQIKAH- 316
            G+PLF G + VDQ+ +I++VLG P    +              +  +   K    K   
Sbjct: 253 TGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREY 312

Query: 317 --PWHKIFP-----KRMPPEA----------------VDLVSRLLQYSPNLRCTA 348
             P  +        +   P                   DL+ R+L Y P  R   
Sbjct: 313 KPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQP 367

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  185 bits (472), Expect = 2e-56
 Identities = 67/284 (23%), Positives = 104/284 (36%), Gaps = 49/284 (17%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHP 124
           S+     +G GS+G VF+ +  E G   A+K+     +  + + R+L  +        HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             V L+  +    +   LY  L  E    ++    +H       +P   V  Y      A
Sbjct: 118 CCVRLEQAWE---EGGILY--LQTELCGPSLQ---QHCEAWGASLPEAQVWGYLRDTLLA 169

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           L+++H S G+ H D+KP N+ + P     KL DFG    L              Y APEL
Sbjct: 170 LAHLH-SQGLVHLDVKPANIFLGPRGR-CKLGDFGLLVELGTAGAGEVQEGDPRYMAPEL 227

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y TA D++S G  + E+     L  G  G  QL +                   
Sbjct: 228 L--QGSYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL---------------- 269

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                            F   +  E   ++  +L+  P LR TA
Sbjct: 270 --------------PPEFTAGLSSELRSVLVMMLEPDPKLRATA 299

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  182 bits (464), Expect = 5e-55
 Identities = 67/307 (21%), Positives = 109/307 (35%), Gaps = 56/307 (18%)

Query: 57  VTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKN 112
           +  I  ++        Y+  + +G+G F  V   + L  G   A+K++L    QD+    
Sbjct: 23  MVIIDNKH--------YLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQ 74

Query: 113 RELQTMRLLDHPNVVSLKHCFF-STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMP 170
           RE    RL +HPN++ L          K E +  L+L +    T+   ++        + 
Sbjct: 75  READMHRLFNHPNILRLVAYCLRERGAKHEAW--LLLPFFKRGTLWNEIERLKDKGNFLT 132

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG--- 227
              +      I R L  IH + G  HRD+KP N+L+     Q  L D GS          
Sbjct: 133 EDQILWLLLGICRGLEAIH-AKGYAHRDLKPTNILLG-DEGQPVLMDLGSMNQACIHVEG 190

Query: 228 -------EPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
                  +   +  C+  YRAPEL             D+WS GCV+  +M G+  +    
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250

Query: 279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
                V +  V                 +   PQ            R       L++ ++
Sbjct: 251 QKGDSVALA-VQN---------------QLSIPQ----------SPRHSSALWQLLNSMM 284

Query: 339 QYSPNLR 345
              P+ R
Sbjct: 285 TVDPHQR 291

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  182 bits (465), Expect = 1e-54
 Identities = 74/353 (20%), Positives = 141/353 (39%), Gaps = 78/353 (22%)

Query: 51  ETGHIIV---TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           E  H        +            ++  R +G G+FG V   + ++  +  A+K V   
Sbjct: 21  EIVHFSWKKGMLLNNA---------FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI 71

Query: 108 KRYKN---RELQTMRLL-----DHPNVVSLKHCFFSTTDKDELYLN---LVLEYVPETVH 156
           K+Y      E   ++ +     ++ N+V     F        +Y +   L+ E +  +++
Sbjct: 72  KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKF--------MYYDHMCLIFEPLGPSLY 123

Query: 157 RVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--------- 207
            ++   N       +  +KLY  +I +AL+Y+ + + + H D+KP+N+L++         
Sbjct: 124 EIITRNNY--NGFHIEDIKLYCIEILKALNYLRK-MSLTHTDLKPENILLDDPYFEKSLI 180

Query: 208 ---------------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
                            +  +KL DFG A    K + + S I +R YRAPE+I     + 
Sbjct: 181 TVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEVILNL-GWD 237

Query: 253 TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI---------KCMNP 303
            + D+WS GCV+AEL  G  LF     ++ L  +  ++    +  +         K +N 
Sbjct: 238 VSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNK 297

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEA--------VDLVSRLLQYSPNLRCTA 348
           +  +  +P+  +        K+  P           D +  +LQ  P LR + 
Sbjct: 298 DELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSP 350

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  180 bits (460), Expect = 1e-54
 Identities = 74/280 (26%), Positives = 126/280 (45%), Gaps = 42/280 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
            ++G+G++G+V+  + L     +AIK++  +D RY      E+   + L H N+V     
Sbjct: 28  VVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQ---- 83

Query: 133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
            +  +  +  ++ + +E VP  ++  +++  +  L      I    Y  QI   L Y+H 
Sbjct: 84  -YLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI--GFYTKQILEGLKYLHD 140

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIFGAT 249
           +  + HRDIK  N+L+N ++  +K+ DFG++K L    P   ++  +  Y APE+I    
Sbjct: 141 N-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGP 199

Query: 250 E-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y  A DIWS GC + E+  GKP F       +L E    +                 F
Sbjct: 200 RGYGKAADIWSLGCTIIEMATGKPPFY------ELGEPQAAM-----------------F 236

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           K    K HP     P+ M  EA   + +  +  P+ R  A
Sbjct: 237 KVGMFKVHP---EIPESMSAEAKAFILKCFEPDPDKRACA 273

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  179 bits (455), Expect = 1e-53
 Identities = 58/297 (19%), Positives = 107/297 (36%), Gaps = 60/297 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V      ++   +   E+  +  L   + 
Sbjct: 30  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 88

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 89  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 139

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 140 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196

Query: 242 PELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 252

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    ++PN+   +            FP     +  D++   L+  P  R + 
Sbjct: 253 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISI 287

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  179 bits (456), Expect = 1e-53
 Identities = 73/346 (21%), Positives = 133/346 (38%), Gaps = 72/346 (20%)

Query: 52  TGHIIVTT---IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQD 107
           + H+I  +   +  R         Y     +G+G+FG V +    + G   VA+K V   
Sbjct: 1   SMHLICQSGDVLSAR---------YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV 51

Query: 108 KRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKDELYLN---LVLEYVPETV 155
            RY      E+Q +  L           V +   F         +     +V E +  + 
Sbjct: 52  DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFE--------HHGHICIVFELLGLST 103

Query: 156 HRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-------- 207
           +  +K          + +++  AYQI ++++++H    + H D+KP+N+L          
Sbjct: 104 YDFIKENGF--LPFRLDHIRKMAYQICKSVNFLHS-NKLTHTDLKPENILFVQSDYTEAY 160

Query: 208 ----------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDI 257
                          +K+ DFGSA      E + + + +R+YRAPE+I     ++   D+
Sbjct: 161 NPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPEVILA-LGWSQPCDV 217

Query: 258 WSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI-KCMNPNY-TEFKFPQIKA 315
           WS GC++ E  LG  +FP     + L  + ++LG   +  I K     Y    +    + 
Sbjct: 218 WSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEH 277

Query: 316 HPWHKIFPKRMPP-------------EAVDLVSRLLQYSPNLRCTA 348
               +   +   P                DL+ ++L+Y P  R T 
Sbjct: 278 SSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITL 323

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  178 bits (454), Expect = 2e-53
 Identities = 58/295 (19%), Positives = 111/295 (37%), Gaps = 27/295 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      TT      L  ++E+ P       + +  N     +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 186 SYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           +++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 243 ELIFGAT-------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK--VLGTP 293
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +               +      P      + +      +++ +L+         
Sbjct: 245 SGAISGVQKAENGPIDWS--GDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  179 bits (455), Expect = 3e-53
 Identities = 76/364 (20%), Positives = 132/364 (36%), Gaps = 85/364 (23%)

Query: 34  IRDDKEMEATVVDGNGTETGHIIVT---TIGGRNGQPKQTISYMAERIVGQGSFGVVFQA 90
           + DDKE             GH++      +  R         Y     +G+G+FG V + 
Sbjct: 1   VEDDKE-------------GHLVCRIGDWLQER---------YEIVGNLGEGTFGKVVEC 38

Query: 91  KCLETG-ETVAIKKVLQDKRYKN---RELQTMRLL------DHPNVVSLKHCFFSTTDKD 140
                G   VA+K +    +Y+     E+  ++ +      +    V +   F       
Sbjct: 39  LDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWF------- 91

Query: 141 ELYLN---LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR 197
             +     +  E + +     +K  N   Q  P+ +V+  AYQ+  AL ++H    + H 
Sbjct: 92  -NFHGHMCIAFELLGKNTFEFLKENN--FQPYPLPHVRHMAYQLCHALRFLHE-NQLTHT 147

Query: 198 DIKPQNLLVN------------------PHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           D+KP+N+L                         +++ DFGSA      E + + + +R+Y
Sbjct: 148 DLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHY 205

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           R PE+I     +    D+WS GC++ E   G  LF      + LV + K+LG      I 
Sbjct: 206 RPPEVILE-LGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIH 264

Query: 300 CM---------NPNYTEFKFPQIKAHPWHKIFPKRMPPEA------VDLVSRLLQYSPNL 344
                         + E            K     M  ++       DL+ R+L++ P  
Sbjct: 265 RTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQ 324

Query: 345 RCTA 348
           R T 
Sbjct: 325 RITL 328

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  179 bits (456), Expect = 4e-53
 Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 60/297 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 58  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 117 KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 167

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 168 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224

Query: 242 PELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 280

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    ++PN+   +            FP     +  D++   L+  P  R + 
Sbjct: 281 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISI 315

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  176 bits (448), Expect = 4e-53
 Identities = 72/288 (25%), Positives = 113/288 (39%), Gaps = 45/288 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 8   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 67

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V          D+    L +V+EY     +  V+    K  Q +   +V     Q+  AL
Sbjct: 68  VRYYDRII---DRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 186 SYIHR----SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 240
              HR       V HRD+KP N+ ++     VKL DFG A++L            + YY 
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLD-GKQNVKLGDFGLARILNHDTSFAKTFVGTPYYM 183

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           +PE +     Y    DIWS GC++ EL    P F   S   +L   I+            
Sbjct: 184 SPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFTAFS-QKELAGKIR------------ 229

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 E KF +I         P R   E  ++++R+L      R + 
Sbjct: 230 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSV 262

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  177 bits (451), Expect = 7e-53
 Identities = 58/297 (19%), Positives = 106/297 (35%), Gaps = 60/297 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPN- 125
           Y   + +G G    VFQ    E  +  AIK V  ++           E+  +  L   + 
Sbjct: 11  YSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 69

Query: 126 -VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            ++ L           + Y+ +V+E     ++  +K      + +     K Y   +  A
Sbjct: 70  KIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKK----KSIDPWERKSYWKNMLEA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRA 241
           +  IH+  G+ H D+KP N L+      +KL DFG A  +     ++   S + +  Y  
Sbjct: 121 VHTIHQH-GIVHSDLKPANFLI--VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177

Query: 242 PELIFG----------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
           PE I             ++ +   D+WS GC++  +  GK  F         +  I    
Sbjct: 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---- 233

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    ++PN+   +            FP     +  D++   L+  P  R + 
Sbjct: 234 ---------IDPNH---EIE----------FPDIPEKDLQDVLKCCLKRDPKQRISI 268

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  179 bits (455), Expect = 1e-52
 Identities = 62/292 (21%), Positives = 118/292 (40%), Gaps = 51/292 (17%)

Query: 71  ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLD-HPNVVS 128
           IS+  + ++G G+ G +   + +     VA+K++L +   + +RE+Q +R  D HPNV+ 
Sbjct: 24  ISFCPKDVLGHGAEGTIV-YRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIR 82

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVH-RVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                     KD  +  + +E    T+   V +         P+  ++    Q    L++
Sbjct: 83  YFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQ----QTTSGLAH 133

Query: 188 IHRSIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKVLVKGEPNISY---IC-SRYY 239
           +H S+ + HRD+KP N+L++        +  + DFG  K L  G  + S    +  +  +
Sbjct: 134 LH-SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGW 192

Query: 240 RAPELIFGATE--YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            APE++    +   T  +DI+SAGCV   ++  G   F                G   + 
Sbjct: 193 IAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF----------------GKSLQR 236

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +   +               P            A +L+ +++   P  R +A
Sbjct: 237 QANILLGAC-SLDCLH----PEKHE-----DVIARELIEKMIAMDPQKRPSA 278

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  177 bits (451), Expect = 2e-52
 Identities = 58/295 (19%), Positives = 111/295 (37%), Gaps = 27/295 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           ++   I+GQG+   VF+ +  +TG+  AIK       L+    + RE + ++ L+H N+V
Sbjct: 11  WLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L      TT      L  ++E+ P       + +  N     +P     +    +   +
Sbjct: 71  KLFAIEEETT-TRHKVL--IMEFCPCGSLYTVLEEPSNA--YGLPESEFLIVLRDVVGGM 125

Query: 186 SYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           +++    G+ HR+IKP N++           KL DFG+A+ L   E  +S   +  Y  P
Sbjct: 126 NHLR-ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHP 184

Query: 243 ELIFGAT-------EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK--VLGTP 293
           ++   A        +Y   +D+WS G        G   F    G  +  E++   + G P
Sbjct: 185 DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKP 244

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           +               +      P      + +      +++ +L+         
Sbjct: 245 SGAISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCWGF 297

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  175 bits (446), Expect = 3e-52
 Identities = 64/307 (20%), Positives = 118/307 (38%), Gaps = 48/307 (15%)

Query: 51  ETGHIIVTTIGGRNGQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDK 108
             G ++   +   + + ++ +     +  VG+GSFG V + K  +TG   A+KKV L+  
Sbjct: 37  NEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV- 95

Query: 109 RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQ 167
            ++  EL     L  P +V L         ++  ++N+ +E +   ++ +++K    L +
Sbjct: 96  -FRVEELVACAGLSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPE 149

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG 227
                    Y  Q    L Y+H +  + H D+K  N+L++    +  LCDFG A  L   
Sbjct: 150 D----RALYYLGQALEGLEYLH-TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPD 204

Query: 228 EPNISYICSR------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               S +          + APE++ G       +DIWS+ C++  ++ G   +       
Sbjct: 205 GLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGP 263

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
             ++I      P   EI                        P    P     +   L+  
Sbjct: 264 LCLKIAS--EPPPIREI------------------------PPSCAPLTAQAIQEGLRKE 297

Query: 342 PNLRCTA 348
           P  R +A
Sbjct: 298 PVHRASA 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  172 bits (439), Expect = 2e-51
 Identities = 79/294 (26%), Positives = 122/294 (41%), Gaps = 60/294 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 125
           +  E+ +G+G F  V++A CL  G  VA+KKV        + +    +E+  ++ L+HPN
Sbjct: 34  FRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPN 93

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V+     F    + +EL   +VLE      + R++KHF K  + +P   V  Y  Q+  A
Sbjct: 94  VIKYYASFI---EDNELN--IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA 148

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL---------VKGEPNISYIC 235
           L ++H S  V HRDIKP N+ +   T  VKL D G  +           + G P      
Sbjct: 149 LEHMH-SRRVMHRDIKPANVFITA-TGVVKLGDLGLGRFFSSKTTAAHSLVGTP------ 200

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPT 294
             YY +PE I     Y    DIWS GC++ E+   +  F GD   +  L + I+      
Sbjct: 201 --YYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE------ 251

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       +  +P +               E   LV+  +   P  R   
Sbjct: 252 ------------QCDYPPLP--------SDHYSEELRQLVNMCINPDPEKRPDV 285

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  169 bits (430), Expect = 2e-50
 Identities = 60/289 (20%), Positives = 112/289 (38%), Gaps = 52/289 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHC 132
           +    ++G G FG VF+AK    G+T  IK+V  +     RE++ +  LDH N+V    C
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGC 72

Query: 133 F-----------FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           +            +++      L + +E+  + T+ + ++   +  +++  +       Q
Sbjct: 73  WDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIE--KRRGEKLDKVLALELFEQ 130

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           I + + YIH S  + +RD+KP N+ +   T QVK+ DFG    L           +  Y 
Sbjct: 131 ITKGVDYIH-SKKLINRDLKPSNIFLV-DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYM 188

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           +PE I    +Y   +D+++ G ++AEL+ +    F            ++           
Sbjct: 189 SPEQISS-QDYGKEVDLYALGLILAELLHVCDTAFETSK----FFTDLR----------- 232

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                I       +   L+ +LL   P  R   
Sbjct: 233 -------------------DGIISDIFDKKEKTLLQKLLSKKPEDRPNT 262

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  174 bits (444), Expect = 3e-50
 Identities = 68/286 (23%), Positives = 119/286 (41%), Gaps = 48/286 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y   + +G G++G V   +   T    AIK +               E+  ++LLDHPN+
Sbjct: 39  YQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNI 98

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L   F     +D+    LV+E     E    ++    K N+        +   Q+   
Sbjct: 99  MKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHR-MKFNEV----DAAVIIKQVLSG 148

Query: 185 LSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N LL +      +K+ DFG + V    +     + + YY AP
Sbjct: 149 VTYLH-KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++    +Y    D+WS G ++  L+ G P F G +  DQ  EI+         +++   
Sbjct: 208 EVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQT--DQ--EIL--------RKVEKGK 253

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +            W  +        A DL+ ++LQ+    R +A
Sbjct: 254 YTFDS--------PEWKNV-----SEGAKDLIKQMLQFDSQRRISA 286

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  169 bits (431), Expect = 3e-50
 Identities = 68/304 (22%), Positives = 110/304 (36%), Gaps = 61/304 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
           +    ++GQG+FG V +A+        AIKK+   +   +    E+  +  L+H  VV  
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRY 67

Query: 130 KHCFFSTTDKDEL--------YLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              +    +  +          L + +EY         +       N             
Sbjct: 68  YAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE----NLNQQRDEYWRLFR 123

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 237
           QI  ALSYIH S G+ HRD+KP N+ ++  +  VK+ DFG AK + +    +        
Sbjct: 124 QILEALSYIH-SQGIIHRDLKPMNIFID-ESRNVKIGDFGLAKNVHRSLDILKLDSQNLP 181

Query: 238 -------------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                         Y A E++ G   Y   ID++S G +  E++   P   G       V
Sbjct: 182 GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGME----RV 235

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
            I+K L +                +FP     P    F          ++  L+ + PN 
Sbjct: 236 NILKKLRSV-------------SIEFP-----PD---FDDNKMKVEKKIIRLLIDHDPNK 274

Query: 345 RCTA 348
           R  A
Sbjct: 275 RPGA 278

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  170 bits (433), Expect = 3e-50
 Identities = 72/304 (23%), Positives = 116/304 (38%), Gaps = 47/304 (15%)

Query: 54  HIIVTTIGGRNGQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQ 106
           H       G      Q++  Y+  + +G+GSFG     K  E G    IK++       +
Sbjct: 6   HHSSGVDLGTENLYFQSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSK 65

Query: 107 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKL 165
           ++    RE+  +  + HPN+V  +  F    +   LY  +V++Y     + + +      
Sbjct: 66  EREESRREVAVLANMKHPNIVQYRESFE---ENGSLY--IVMDYCEGGDLFKRINAQKG- 119

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
                   +  +  QI  AL ++H    + HRDIK QN+ +      V+L DFG A+VL 
Sbjct: 120 -VLFQEDQILDWFVQICLALKHVH-DRKILHRDIKSQNIFLTKD-GTVQLGDFGIARVLN 176

Query: 226 KGEPNISYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
                      + YY +PE+      Y    DIW+ GCV+ EL   K  F   S +  LV
Sbjct: 177 STVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGS-MKNLV 234

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
             I                      FP +               +   LVS+L + +P  
Sbjct: 235 LKII------------------SGSFPPV---------SLHYSYDLRSLVSQLFKRNPRD 267

Query: 345 RCTA 348
           R + 
Sbjct: 268 RPSV 271

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  173 bits (441), Expect = 5e-50
 Identities = 73/287 (25%), Positives = 130/287 (45%), Gaps = 49/287 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKN---RELQTMRLLDHPN 125
           Y  +R++G+GSFG V   K   TG+  A+K +    ++ K  K    RE+Q ++ LDHPN
Sbjct: 28  YKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPN 87

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L   F     +D+ Y  LV E     E    ++    + ++            Q+  
Sbjct: 88  IMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISR-KRFSEV----DAARIIRQVLS 137

Query: 184 ALSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
            ++Y+H    + HRD+KP+N LL +      +++ DFG +      +     I + YY A
Sbjct: 138 GITYMH-KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA 196

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G   Y    D+WS G ++  L+ G P F G +  +   +I+        ++++  
Sbjct: 197 PEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGAN--EY--DIL--------KKVEKG 242

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +            W K+        A DL+ ++L Y P++R +A
Sbjct: 243 KYTFEL--------PQWKKV-----SESAKDLIRKMLTYVPSMRISA 276

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  170 bits (432), Expect = 6e-50
 Identities = 37/326 (11%), Positives = 77/326 (23%), Gaps = 64/326 (19%)

Query: 63  RNGQPKQTIS--------YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK--- 111
                    S              +  G   VVF  + +E  E  A+K            
Sbjct: 46  PQNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSE 105

Query: 112 ----NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN---------------------L 146
               +        L   +    +         D + +                      L
Sbjct: 106 LERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLL 165

Query: 147 VLEYVPETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQN 203
           ++      +  +    + +        ++ + +   Q+ R  + +    G+ H    P N
Sbjct: 166 LMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVHGHFTPDN 224

Query: 204 LLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGC 262
           L + P    + L D  +   +  G    +      Y   E +      +T A++ W  G 
Sbjct: 225 LFIMPDGR-LMLGDVSALWKV--GTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGL 281

Query: 263 VVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIF 322
            +  +      F   +   +       L  P  +                          
Sbjct: 282 SIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTD--------------------SLAFGS 321

Query: 323 PKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +P     L+ R L +    R   
Sbjct: 322 CTPLPDFVKTLIGRFLNFDRRRRLLP 347

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  168 bits (427), Expect = 7e-50
 Identities = 59/286 (20%), Positives = 113/286 (39%), Gaps = 56/286 (19%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSLKH 131
            +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V    
Sbjct: 33  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH- 189
            + ST    +  + LV E +   T+   +K F      M +  ++ +  QI + L ++H 
Sbjct: 93  SWESTVKGKK-CIVLVTELMTSGTLKTYLKRFKV----MKIKVLRSWCRQILKGLQFLHT 147

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------VKGEPNISYICSRYYRAP 242
           R+  + HRD+K  N+ +   T  VK+ D G A +        V G P         + AP
Sbjct: 148 RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTP--------EFMAP 199

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+     +Y  ++D+++ G  + E+   +  +       Q+                   
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI------------------- 238

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                ++       P    F K   PE  +++   ++ + + R + 
Sbjct: 239 -----YRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSI 277

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  171 bits (435), Expect = 1e-49
 Identities = 74/305 (24%), Positives = 127/305 (41%), Gaps = 60/305 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMR-LLDHPNVVSLK 130
            ++E+I+G GS G V   +    G  VA+K++L D       E++ +    DHPNV+   
Sbjct: 17  VVSEKILGYGSSGTVV-FQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRY- 74

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVH-RVVKH--FNKLNQRMPMIYVKLYAYQIFRALSY 187
           +C  +      LY+   LE     +   V      ++  +            QI   +++
Sbjct: 75  YCSET--TDRFLYI--ALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAH 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTH------------QVKLCDFGSAKVLVKGE----PNI 231
           +H S+ + HRD+KPQN+LV+  +             ++ + DFG  K L  G+     N+
Sbjct: 131 LH-SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL 189

Query: 232 SYIC-SRYYRAPELIFGATE------YTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
           +    +  +RAPEL+  +         T +IDI+S GCV   ++  GK  F       + 
Sbjct: 190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY--SRE 247

Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
             II+                   F   ++K      +       EA DL+S+++ + P 
Sbjct: 248 SNIIR-----------------GIFSLDEMKCLHDRSL-----IAEATDLISQMIDHDPL 285

Query: 344 LRCTA 348
            R TA
Sbjct: 286 KRPTA 290

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  171 bits (436), Expect = 4e-49
 Identities = 76/297 (25%), Positives = 125/297 (42%), Gaps = 59/297 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------------REL 115
           Y   R +G G++G V   K        AIK + + +  K                   E+
Sbjct: 38  YFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEI 97

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY 173
             ++ LDHPN++ L   F     +D+ Y  LV E+    E   +++   +K ++      
Sbjct: 98  SLLKSLDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINR-HKFDEC----D 147

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNI 231
                 QI   + Y+H    + HRDIKP+N LL N ++   +K+ DFG +    K     
Sbjct: 148 AANIMKQILSGICYLH-KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLR 206

Query: 232 SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG 291
             + + YY APE++    +Y    D+WS G ++  L+ G P F G +  DQ  +II    
Sbjct: 207 DRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQN--DQ--DII---- 256

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               ++++     +          + W  I       EA +L+  +L Y  N RCTA
Sbjct: 257 ----KKVEKGKYYFDF--------NDWKNI-----SDEAKELIKLMLTYDYNKRCTA 296

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  171 bits (434), Expect = 5e-49
 Identities = 71/286 (24%), Positives = 125/286 (43%), Gaps = 48/286 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y    ++G+GSFG V + K   T +  A+K +       +D     RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L         +D     +V E     E    ++K   + ++            Q+F  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKR-KRFSEH----DAARIIKQVFSG 133

Query: 185 LSYIHRSIGVCHRDIKPQN-LLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N LL +      +K+ DFG +    +       I + YY AP
Sbjct: 134 ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G   Y    D+WSAG ++  L+ G P F G +  +   +I+        + ++   
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKN--EY--DIL--------KRVETGK 238

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +            W  I       +A DL+ ++L + P+LR TA
Sbjct: 239 YAFDL--------PQWRTI-----SDDAKDLIRKMLTFHPSLRITA 271

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  164 bits (418), Expect = 1e-48
 Identities = 76/287 (26%), Positives = 121/287 (42%), Gaps = 66/287 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  ++   +A+K     ++ +        RE++    L HPN++ L
Sbjct: 15  RPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRL 74

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D   +Y  L+LEY P       + K       +        Y  ++  ALSY
Sbjct: 75  YGYFH---DATRVY--LILEYAPLGTVYRELQKL-----SKFDEQRTATYITELANALSY 124

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 240
            H S  V HRDIKP+NLL+      +K+ DFG +            G  +        Y 
Sbjct: 125 CH-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSVHAPSSRRTDLCGTLD--------YL 174

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE+I G   +   +D+WS G +  E ++GKP F  ++  +    I +V           
Sbjct: 175 PPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV----------- 222

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                 EF FP      +       +   A DL+SRLL+++P+ R  
Sbjct: 223 ------EFTFP-----DF-------VTEGARDLISRLLKHNPSQRPM 251

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  164 bits (417), Expect = 2e-48
 Identities = 70/302 (23%), Positives = 131/302 (43%), Gaps = 68/302 (22%)

Query: 65  GQPKQTIS-YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQ 116
               + I  +    ++G+GSF  V++A+ + TG  VAIK + +   YK         E++
Sbjct: 4   TCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVK 63

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYV 174
               L HP+++ L + F    D + +Y  LVLE     E    +       ++       
Sbjct: 64  IHCQLKHPSILELYNYF---EDSNYVY--LVLEMCHNGEMNRYLKNRVKPFSENE----A 114

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE----- 228
           + + +QI   + Y+H S G+ HRD+   NLL+  +   +K+ DFG + ++ +  E     
Sbjct: 115 RHFMHQIITGMLYLH-SHGILHRDLTLSNLLLTRN-MNIKIADFGLATQLKMPHEKHYTL 172

Query: 229 ---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
              PN        Y +PE+    + +    D+WS GC+   L++G+P F  D+  + L +
Sbjct: 173 CGTPN--------YISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNK 223

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           ++                   +++ P      +       +  EA DL+ +LL+ +P  R
Sbjct: 224 VVLA-----------------DYEMP-----SF-------LSIEAKDLIHQLLRRNPADR 254

Query: 346 CT 347
            +
Sbjct: 255 LS 256

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  163 bits (415), Expect = 4e-48
 Identities = 77/299 (25%), Positives = 119/299 (39%), Gaps = 68/299 (22%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 119
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 11  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L H +VV     F    D D ++  +VLE       +    +      + +     + Y
Sbjct: 71  SLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKRR-----KALTEPEARYY 120

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE-------- 228
             QI     Y+HR+  V HRD+K  NL +N    +VK+ DFG + KV   GE        
Sbjct: 121 LRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGT 178

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           PN        Y APE++     ++  +D+WS GC++  L++GKP F   S + +    IK
Sbjct: 179 PN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFE-TSCLKETYLRIK 228

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                           Y+                PK + P A  L+ ++LQ  P  R T
Sbjct: 229 -------------KNEYS---------------IPKHINPVAASLIQKMLQTDPTARPT 259

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  163 bits (415), Expect = 2e-47
 Identities = 58/300 (19%), Positives = 113/300 (37%), Gaps = 47/300 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN----------------REL 115
           R + QG F  +   +  +  +  A+K      + + + +                   EL
Sbjct: 37  RTLNQGKFNKIILCE--KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNEL 94

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHF---NKLNQRMP 170
           Q +  + +   ++ +      T+ DE+Y+  + EY+     +      F         +P
Sbjct: 95  QIITDIKNEYCLTCEGII---TNYDEVYI--IYEYMENDSILKFDEYFFVLDKNYTCFIP 149

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN 230
           +  +K     +  + SYIH    +CHRD+KP N+L++ +   VKL DFG ++ +V  +  
Sbjct: 150 IQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGR-VKLSDFGESEYMVDKK-- 206

Query: 231 ISYIC-SRYYRAPELIFGATEY-TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           I     +  +  PE     + Y    +DIWS G  +  +      F     + +L   I+
Sbjct: 207 IKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIR 266

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  + I+   P      F     +         +  E +D +   L+ +P  R T+
Sbjct: 267 ------TKNIEY--PLDRN-HFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITS 317

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  161 bits (409), Expect = 2e-47
 Identities = 80/294 (27%), Positives = 126/294 (42%), Gaps = 48/294 (16%)

Query: 65  GQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM 118
           G  K  I+  Y  E  +G+GS+G V  A    T    A K      ++D     +E++ M
Sbjct: 1   GSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIM 60

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL 176
           + LDHPN++ L   F     +D   + LV+E     E   RVV       +      +K 
Sbjct: 61  KSLDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHK-RVFRESDAARIMK- 113

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYI 234
               +  A++Y H  + V HRD+KP+N L    +    +KL DFG A     G+   + +
Sbjct: 114 ---DVLSAVAYCH-KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKV 169

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            + YY +P+++ G   Y    D WSAG ++  L+ G P F   +  + +++I +      
Sbjct: 170 GTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREG----- 222

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                        F FP      W  +      P+A  L+ RLL  SP  R T+
Sbjct: 223 ------------TFTFP---EKDWLNV-----SPQAESLIRRLLTKSPKQRITS 256

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  162 bits (413), Expect = 2e-47
 Identities = 76/299 (25%), Positives = 117/299 (39%), Gaps = 68/299 (22%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN---RELQTMR 119
           P+    Y+  R +G+G F   F+    +T E  A K     +L     +     E+   R
Sbjct: 37  PRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L H +VV     F    D D ++  +VLE       +    +      + +     + Y
Sbjct: 97  SLAHQHVVGFHGFF---EDNDFVF--VVLELCRRRSLLELHKRR-----KALTEPEARYY 146

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGE-------- 228
             QI     Y+HR+  V HRD+K  NL +N    +VK+ DFG + KV   GE        
Sbjct: 147 LRQIVLGCQYLHRN-RVIHRDLKLGNLFLNED-LEVKIGDFGLATKVEYDGERKKVLCGT 204

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
           PN        Y APE++     ++  +D+WS GC++  L++GKP F        L E   
Sbjct: 205 PN--------YIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSC----LKETYL 251

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                     +     Y+                PK + P A  L+ ++LQ  P  R T
Sbjct: 252 ----------RIKKNEYS---------------IPKHINPVAASLIQKMLQTDPTARPT 285

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  161 bits (409), Expect = 3e-47
 Identities = 53/314 (16%), Positives = 95/314 (30%), Gaps = 90/314 (28%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLL----DHPN 125
           +     +G G FG VF+      G   AIK+    L     +   L+ +        H +
Sbjct: 13  FHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSH 72

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           VV     +    + D + +    EY    ++   +    ++        +K    Q+ R 
Sbjct: 73  VVRYFSAWA---EDDHMLI--QNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRG 127

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPH------------------THQVKLCDFGSAKVL-- 224
           L YIH S+ + H DIKP N+ ++                        K+ D G    +  
Sbjct: 128 LRYIH-SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISS 186

Query: 225 ---VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD 281
               +G+          + A E++     +    DI++    V      +PL        
Sbjct: 187 PQVEEGDS--------RFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---- 234

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPP-------EAVDLV 334
                                               WH+I   R+P        E  +L+
Sbjct: 235 ----------------------------------DQWHEIRQGRLPRIPQVLSQEFTELL 260

Query: 335 SRLLQYSPNLRCTA 348
             ++   P  R +A
Sbjct: 261 KVMIHPDPERRPSA 274

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  160 bits (408), Expect = 4e-47
 Identities = 73/287 (25%), Positives = 120/287 (41%), Gaps = 66/287 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK--NRELQTMRLLDHPNVVSL 129
           R +G+G FG V+ A+  +    +A+K     ++ ++       RE++    L HPN++ +
Sbjct: 20  RPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRM 79

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D+  +Y  L+LE+ P  E    + KH      R        +  ++  AL Y
Sbjct: 80  YNYFH---DRKRIY--LMLEFAPRGELYKELQKH-----GRFDEQRSATFMEELADALHY 129

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK-------GEPNISYICSRYYR 240
            H    V HRDIKP+NLL+      +K+ DFG +            G  +        Y 
Sbjct: 130 CH-ERKVIHRDIKPENLLMGYKGE-LKIADFGWSVHAPSLRRRTMCGTLD--------YL 179

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE+I G   +   +D+W AG +  E ++G P F   S  +    I+ V           
Sbjct: 180 PPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------- 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                 + KFP     P+       +   + DL+S+LL+Y P  R  
Sbjct: 228 ------DLKFP-----PF-------LSDGSKDLISKLLRYHPPQRLP 256

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  161 bits (409), Expect = 8e-47
 Identities = 71/284 (25%), Positives = 124/284 (43%), Gaps = 46/284 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVA---IKKVLQDKRYKNRELQTMRLLDHPNVVSL 129
           YM    +G+G FG+V +     + +T     +K    D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F      +EL   ++ E++   +   R+     +LN+R  + YV     Q+  AL +
Sbjct: 67  HESF---ESMEELV--MIFEFISGLDIFERINTSAFELNEREIVSYVH----QVCEALQF 117

Query: 188 IHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           +H S  + H DI+P+N++     +  +K+ +FG A+ L  G+     +  +  Y APE +
Sbjct: 118 LH-SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN-FRLLFTAPEYYAPE-V 174

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                 +TA D+WS G  +  ++L G   F  ++  +Q  +II        E I      
Sbjct: 175 HQHDVVSTATDMWSLG-TLVYVLLSGINPFLAET--NQ--QII--------ENIMNAEYT 221

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           + E  F +I               EA+D V RLL      R TA
Sbjct: 222 FDEEAFKEIS-------------IEAMDFVDRLLVKERKSRMTA 252

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  163 bits (414), Expect = 1e-46
 Identities = 76/295 (25%), Positives = 133/295 (45%), Gaps = 56/295 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------------RELQTMRL 120
           Y+  + +G G+ G V  A   +T + VAI+ + + K                 E++ ++ 
Sbjct: 137 YIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKK 196

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYA 178
           L+HP ++ +K+ F    D ++ Y  +VLE +   E   +VV +  +L +       KLY 
Sbjct: 197 LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGN-KRLKEAT----CKLYF 245

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC- 235
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 246 YQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 303

Query: 236 SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  Y APE++       Y  A+D WS G ++   + G P F        L + I   G  
Sbjct: 304 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 360

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                        ++ F       W ++       +A+DLV +LL   P  R T 
Sbjct: 361 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTT 394

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  162 bits (412), Expect = 1e-46
 Identities = 70/284 (24%), Positives = 113/284 (39%), Gaps = 45/284 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG     K        DK     E+  M  L HP +++
Sbjct: 53  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 112

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L   F    DK E+   L+LE++   E   R+     K+++   + Y++    Q    L 
Sbjct: 113 LHDAF---EDKYEMV--LILEFLSGGELFDRIAAEDYKMSEAEVINYMR----QACEGLK 163

Query: 187 YIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           ++H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE I
Sbjct: 164 HMH-EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPE-I 221

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                     D+W+ G V+  ++L G   F G+  ++ L  + +                
Sbjct: 222 VDREPVGFYTDMWAIG-VLGYVLLSGLSPFAGEDDLETLQNVKRC--------------- 265

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +++F       +  +      PEA D +  LLQ  P  R T 
Sbjct: 266 --DWEFD---EDAFSSV-----SPEAKDFIKNLLQKEPRKRLTV 299

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  159 bits (405), Expect = 1e-46
 Identities = 63/302 (20%), Positives = 112/302 (37%), Gaps = 60/302 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKNRELQTMRLLDHPNVV 127
           +   + +G+G FGVVF+AK        AIK++        +    RE++ +  L+HP +V
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 66

Query: 128 SLKHCFF-------STTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAY 179
              + +              ++YL + ++    E +   +       +            
Sbjct: 67  RYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG-RCTIEERERSVCLHIFL 125

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR-- 237
           QI  A+ ++H S G+ HRD+KP N+        VK+ DFG    + + E   + +     
Sbjct: 126 QIAEAVEFLH-SKGLMHRDLKPSNIFFT-MDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 238 -----------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
                       Y +PE I G   Y+  +DI+S G ++ EL+   P F       + +  
Sbjct: 184 YARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELL--YP-FSTQMERVRTLTD 239

Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           ++                    KFP +           +  P    +V  +L  SP  R 
Sbjct: 240 VR------------------NLKFPPL---------FTQKYPCEYVMVQDMLSPSPMERP 272

Query: 347 TA 348
            A
Sbjct: 273 EA 274

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  167 bits (424), Expect = 1e-46
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 21/300 (7%)

Query: 61  GGRNGQPKQTI--SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----R 113
           GGR+          +  +  +G G FG V +    +TGE VAIK+  Q+   KN      
Sbjct: 2   GGRSPSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCL 61

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEYVP--ETVHRVVKHFNKLNQRMP 170
           E+Q M+ L+HPNVVS +             L  L +EY    +    + +  N     + 
Sbjct: 62  EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFEN--CCGLK 119

Query: 171 MIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGE 228
              ++     I  AL Y+H +  + HRD+KP+N+++ P   +   K+ D G AK L +GE
Sbjct: 120 EGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK 288
               ++ +  Y APEL+    +YT  +D WS G +  E + G   F  +    Q    ++
Sbjct: 179 LCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVR 237

Query: 289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                + E I   +      KF  +   P H         +    +  +L +    R T 
Sbjct: 238 ---EKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAG--KLERWLQCMLMWHQRQRGTD 292

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  165 bits (420), Expect = 2e-46
 Identities = 75/349 (21%), Positives = 135/349 (38%), Gaps = 47/349 (13%)

Query: 8   PTSCVRESSGHTVGVDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQP 67
           PT+ V               +     +R    + +   +             +  ++   
Sbjct: 96  PTAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHV 155

Query: 68  KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDH 123
                Y     +G G+FGVV +     TG   A K V      DK    +E+QTM +L H
Sbjct: 156 LDH--YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           P +V+L   F    D +E+   ++ E++   E   +V    NK+++   + Y++    Q+
Sbjct: 214 PTLVNLHDAF---EDDNEMV--MIYEFMSGGELFEKVADEHNKMSEDEAVEYMR----QV 264

Query: 182 FRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
            + L ++H      H D+KP+N++     ++++KL DFG    L   +       +  + 
Sbjct: 265 CKGLCHMH-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFA 323

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           APE+  G        D+WS G V++ ++L G   F G++  +            T   +K
Sbjct: 324 APEVAEG-KPVGYYTDMWSVG-VLSYILLSGLSPFGGENDDE------------TLRNVK 369

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             + N  +  F  I               +  D + +LL   PN R T 
Sbjct: 370 SCDWNMDDSAFSGIS-------------EDGKDFIRKLLLADPNTRMTI 405

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  160 bits (406), Expect = 3e-46
 Identities = 82/329 (24%), Positives = 129/329 (39%), Gaps = 84/329 (25%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL---------QDKRYKNRELQTMRLLDH 123
           Y  +  +GQGS+GVV  A   +T    AIK +          +D      E++ M+ L H
Sbjct: 28  YHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHH 87

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL----- 176
           PN+  L   +     +DE Y+ LV+E       + ++    +    +  M  VK      
Sbjct: 88  PNIARLYEVY-----EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPC 142

Query: 177 ------------------------------YAYQIFRALSYIHRSIGVCHRDIKPQN-LL 205
                                            QIF AL Y+H + G+CHRDIKP+N L 
Sbjct: 143 PECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH-NQGICHRDIKPENFLF 201

Query: 206 VNPHTHQVKLCDFGSAKVLVKGEPNISYIC-----SRYYRAPELIFGATE-YTTAIDIWS 259
               + ++KL DFG +K   K      Y       + Y+ APE++    E Y    D WS
Sbjct: 202 STNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS 261

Query: 260 AGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWH 319
           AG ++  L++G   FPG +  D + +++                   +  F       ++
Sbjct: 262 AGVLLHLLLMGAVPFPGVNDADTISQVLN-----------------KKLCFE---NPNYN 301

Query: 320 KIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +      P A DL+S LL  + + R  A
Sbjct: 302 VL-----SPLARDLLSNLLNRNVDERFDA 325

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  158 bits (401), Expect = 4e-46
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 46/306 (15%)

Query: 54  HIIVTTIGGRNGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQ 106
           H    + G  N   + TI   ++ +R +G G+FG V   +   +G    IK     +   
Sbjct: 3   HHHHHSSGRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQV 62

Query: 107 DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNK 164
                  E++ ++ LDHPN++ +   F     +D   + +V+E     E + R+V    +
Sbjct: 63  PMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQAR 117

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK 222
             + +   YV     Q+  AL+Y H S  V H+D+KP+N+L    +    +K+ DFG A+
Sbjct: 118 -GKALSEGYVAELMKQMMNALAYFH-SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAE 175

Query: 223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ 282
           +    E + +   +  Y APE+     + T   DIWSAG V+  L+ G   F G S  + 
Sbjct: 176 LFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSP 342
             +                     E  +               + P+AVDL+ ++L   P
Sbjct: 234 QQKATYK-----------------EPNYAV---ECRP------LTPQAVDLLKQMLTKDP 267

Query: 343 NLRCTA 348
             R +A
Sbjct: 268 ERRPSA 273

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  157 bits (399), Expect = 8e-46
 Identities = 72/286 (25%), Positives = 124/286 (43%), Gaps = 48/286 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y    ++G+GSFG V + K   T +  A+K + +            RE++ ++ LDHPN+
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNI 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           + L         +D     +V E     E    ++K   + ++      +K    Q+F  
Sbjct: 84  MKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIK----QVFSG 133

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y+H    + HRD+KP+N+L+        +K+ DFG +    +       I + YY AP
Sbjct: 134 ITYMH-KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++ G   Y    D+WSAG ++  L+ G P F G +  D L  +                
Sbjct: 193 EVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET-------------- 236

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               ++ F       W  I       +A DL+ ++L + P+LR TA
Sbjct: 237 ---GKYAFD---LPQWRTI-----SDDAKDLIRKMLTFHPSLRITA 271

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  157 bits (400), Expect = 9e-46
 Identities = 68/285 (23%), Positives = 126/285 (44%), Gaps = 48/285 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----RELQTMRLLDHPNVVS 128
           ++   ++G G+F  VF  K   TG+  A+K + +   +++     E+  ++ + H N+V+
Sbjct: 11  FIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVT 70

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L+  +         Y  LV++ V   E   R+++      ++   + ++    Q+  A+ 
Sbjct: 71  LEDIY---ESTTHYY--LVMQLVSGGELFDRILER-GVYTEKDASLVIQ----QVLSAVK 120

Query: 187 YIHRSIGVCHRDIKPQNLLV-NPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           Y+H   G+ HRD+KP+NLL   P  + ++ + DFG +K+   G   +S  C +  Y APE
Sbjct: 121 YLH-ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI--MSTACGTPGYVAPE 177

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            +     Y+ A+D WS G +   L+ G P F  ++      +I +               
Sbjct: 178 -VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEG-------------- 222

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               ++F    +  W  I        A D +  LL+  PN R T 
Sbjct: 223 ---YYEFE---SPFWDDI-----SESAKDFICHLLEKDPNERYTC 256

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  159 bits (404), Expect = 1e-45
 Identities = 73/297 (24%), Positives = 126/297 (42%), Gaps = 45/297 (15%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNREL 115
           +  + G      +     I+G G FG V + +   TG  +A K    + ++DK     E+
Sbjct: 78  VTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEI 137

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY 173
             M  LDH N++ L   F     K+++   LV+EYV   E   R++     L +   +++
Sbjct: 138 SVMNQLDHANLIQLYDAF---ESKNDIV--LVMEYVDGGELFDRIIDESYNLTELDTILF 192

Query: 174 VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           +K    QI   + ++H  + + H D+KP+N+L VN    Q+K+ DFG A+     E    
Sbjct: 193 MK----QICEGIRHMH-QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV 247

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
              +  + APE +      +   D+WS G V+A ++L G   F GD+  + L  I+    
Sbjct: 248 NFGTPEFLAPE-VVNYDFVSFPTDMWSVG-VIAYMLLSGLSPFLGDNDAETLNNILAC-- 303

Query: 292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                           +         +  I       EA + +S+LL    + R +A
Sbjct: 304 ---------------RWDLE---DEEFQDI-----SEEAKEFISKLLIKEKSWRISA 337

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  157 bits (399), Expect = 2e-45
 Identities = 76/295 (25%), Positives = 132/295 (44%), Gaps = 56/295 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKN--------RELQTMRL 120
           Y+  + +G G+ G V  A   +T + VAIK    +       +          E++ ++ 
Sbjct: 12  YIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKK 71

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYA 178
           L+HP ++ +K+ F    D ++ Y  +VLE +   E   +VV +  +L +       KLY 
Sbjct: 72  LNHPCIIKIKNFF----DAEDYY--IVLELMEGGELFDKVVGN-KRLKEA----TCKLYF 120

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYIC- 235
           YQ+  A+ Y+H   G+ HRD+KP+N+L++       +K+ DFG +K+L +    +  +C 
Sbjct: 121 YQMLLAVQYLH-ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-MRTLCG 178

Query: 236 SRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           +  Y APE++       Y  A+D WS G ++   + G P F        L + I   G  
Sbjct: 179 TPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT-SG-- 235

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                        ++ F       W ++       +A+DLV +LL   P  R T 
Sbjct: 236 -------------KYNFI---PEVWAEV-----SEKALDLVKKLLVVDPKARFTT 269

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  155 bits (394), Expect = 4e-45
 Identities = 69/293 (23%), Positives = 114/293 (38%), Gaps = 56/293 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG+  A K          +    +    RE+  +R + 
Sbjct: 7   YEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR 66

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPN+++L   F    +K ++   L+LE V   E    + +    L +     ++K    Q
Sbjct: 67  HPNIITLHDIF---ENKTDVV--LILELVSGGELFDFLAEK-ESLTEDEATQFLK----Q 116

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   + Y+H S  + H D+KP+N+++   N    ++KL DFG A  +  G      I  +
Sbjct: 117 ILDGVHYLH-SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE-FKNIFGT 174

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F G++  + L  I  V      
Sbjct: 175 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGETKQETLTNISAV------ 226

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       + F       +           A D + RLL   P  R T 
Sbjct: 227 -----------NYDFD---EEYFSNT-----SELAKDFIRRLLVKDPKRRMTI 260

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  156 bits (396), Expect = 8e-45
 Identities = 65/302 (21%), Positives = 115/302 (38%), Gaps = 61/302 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR-LLDHPNVV 127
               R++ +G F  V++A+ + +G   A+K++L    +  R   +E+  M+ L  HPN+V
Sbjct: 30  LRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIV 89

Query: 128 SLKHCFF-----STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
                       S T + E    L+ E     +   +K   +    +    V    YQ  
Sbjct: 90  QFCSAASIGKEESDTGQAEFL--LLTELCKGQLVEFLKK-MESRGPLSCDTVLKIFYQTC 146

Query: 183 RALSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-------------E 228
           RA+ ++H +   + HRD+K +NLL++     +KLCDFGSA  +                E
Sbjct: 147 RAVQHMHRQKPPIIHRDLKVENLLLSNQ-GTIKLCDFGSATTISHYPDYSWSAQRRALVE 205

Query: 229 PNISYICSRYYRAPELI--FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI 286
             I+   +  YR PE+I  +         DIW+ GC++  L   +  F   +     + I
Sbjct: 206 EEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGA----KLRI 261

Query: 287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC 346
           +                   ++  P                     L+  +LQ +P  R 
Sbjct: 262 VNG-----------------KYSIPP----------HDTQYTVFHSLIRAMLQVNPEERL 294

Query: 347 TA 348
           + 
Sbjct: 295 SI 296

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  153 bits (390), Expect = 5e-44
 Identities = 68/293 (23%), Positives = 115/293 (39%), Gaps = 56/293 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F VV + +   TG   A K          +    +    RE+  ++ + 
Sbjct: 13  YDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ 72

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPNV++L   +    +K ++   L+LE V   E    + +    L +     ++K    Q
Sbjct: 73  HPNVITLHEVY---ENKTDVI--LILELVAGGELFDFLAEK-ESLTEEEATEFLK----Q 122

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   + Y+H S+ + H D+KP+N+++   N    ++K+ DFG A  +  G      I  +
Sbjct: 123 ILNGVYYLH-SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE-FKNIFGT 180

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  +  V      
Sbjct: 181 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANVSAV------ 232

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       ++F       +           A D + RLL   P  R T 
Sbjct: 233 -----------NYEFE---DEYFSNT-----SALAKDFIRRLLVKDPKKRMTI 266

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  153 bits (388), Expect = 8e-44
 Identities = 65/293 (22%), Positives = 112/293 (38%), Gaps = 56/293 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL 73

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           H NV++L   +    ++ ++   L+LE V   E    + +    L++     ++K    Q
Sbjct: 74  HHNVITLHDVY---ENRTDVV--LILELVSGGELFDFLAQK-ESLSEEEATSFIK----Q 123

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   ++Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G      I  +
Sbjct: 124 ILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  I  V      
Sbjct: 182 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANITSV------ 233

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       + F       +           A D + +LL      R T 
Sbjct: 234 -----------SYDFD---EEFFSHT-----SELAKDFIRKLLVKETRKRLTI 267

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  156 bits (396), Expect = 9e-44
 Identities = 69/287 (24%), Positives = 118/287 (41%), Gaps = 48/287 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G+F VV +   +  G+  A   +   K          RE +  RLL HPN+
Sbjct: 13  YQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNI 72

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L       +++   Y  L+ + V   E    +V      ++      ++    QI  A
Sbjct: 73  VRLHDSI---SEEGHHY--LIFDLVTGGELFEDIVAR-EYYSEADASHCIQ----QILEA 122

Query: 185 LSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           + + H  +GV HR++KP+NLL  +      VKL DFG A  +   +        +  Y +
Sbjct: 123 VLHCH-QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y   +D+W+ G ++  L++G P F  +       +I               
Sbjct: 182 PE-VLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA------------- 227

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 + FP   +  W  +      PEA DL++++L  +P+ R TA
Sbjct: 228 ----GAYDFP---SPEWDTV-----TPEAKDLINKMLTINPSKRITA 262

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  153 bits (389), Expect = 1e-43
 Identities = 79/294 (26%), Positives = 128/294 (43%), Gaps = 46/294 (15%)

Query: 64  NGQPKQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMR 119
           +G  +  +S  +  E  +G+G+  +V++ K   T +  A+K + +    K    E+  + 
Sbjct: 44  DGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLL 103

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
            L HPN++ LK  F       E+   LVLE V   E   R+V+     ++R     VK  
Sbjct: 104 RLSHPNIIKLKEIF---ETPTEIS--LVLELVTGGELFDRIVEK-GYYSERDAADAVK-- 155

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC 235
             QI  A++Y+H   G+ HRD+KP+NLL   P     +K+ DFG +K++      +  +C
Sbjct: 156 --QILEAVAYLH-ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL-MKTVC 211

Query: 236 -SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            +  Y APE I     Y   +D+WS G +   L+ G   F  + G   +   I       
Sbjct: 212 GTPGYCAPE-ILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL------ 264

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                C      E+ F    +  W ++        A DLV +L+   P  R T 
Sbjct: 265 ----NC------EYYFI---SPWWDEV-----SLNAKDLVRKLIVLDPKKRLTT 300

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  152 bits (387), Expect = 2e-43
 Identities = 71/287 (24%), Positives = 122/287 (42%), Gaps = 49/287 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
           Y  +  +G GS+ V  +     T    A+K + + KR    E++ + R   HPN+++LK 
Sbjct: 24  YEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKD 83

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +      D  Y+ +V E +   E + ++++   F++      +       + I + + Y
Sbjct: 84  VY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVL-------FTITKTVEY 131

Query: 188 IHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           +H + GV HRD+KP N+L    + +   +++CDFG AK L      +   C +  + APE
Sbjct: 132 LH-AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPE 190

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVL-GTPTREEIKCM 301
            +     Y  A DIWS G V+   ML G   F           + ++  G          
Sbjct: 191 -VLERQGYDAACDIWSLG-VLLYTMLTGYTPFANGPDDTPEEILARIGSG---------- 238

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                +F         W+ +        A DLVS++L   P+ R TA
Sbjct: 239 -----KFSLS---GGYWNSV-----SDTAKDLVSKMLHVDPHQRLTA 272

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  151 bits (383), Expect = 2e-43
 Identities = 71/287 (24%), Positives = 115/287 (40%), Gaps = 49/287 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y  +  +G+G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 8   YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 67

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L        ++   Y  LV + V   E    +V      ++      ++    QI  +
Sbjct: 68  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAR-EFYSEADASHCIQ----QILES 117

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
           ++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E        +  Y +
Sbjct: 118 IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA-WHGFAGTPGYLS 175

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE +     Y+  +DIW+ G ++  L++G P F  +       +I               
Sbjct: 176 PE-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------ 222

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 + +P   +  W  +      PEA  L+  +L  +P  R TA
Sbjct: 223 -----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITA 256

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  152 bits (387), Expect = 3e-43
 Identities = 73/294 (24%), Positives = 110/294 (37%), Gaps = 56/294 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDH 123
           Y    ++G+G F VV +    ETG+  A+K V   K   +         RE     +L H
Sbjct: 26  YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLY 177
           P++V L   +       +  L +V E++   +    +VK           +Y       Y
Sbjct: 86  PHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKR-----ADAGFVYSEAVASHY 135

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC 235
             QI  AL Y H    + HRD+KP   LL +   +  VKL  FG A  L +         
Sbjct: 136 MRQILEALRYCH-DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRV 194

Query: 236 -SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
            + ++ APE +     Y   +D+W  G ++  L+ G   F G    ++L E I       
Sbjct: 195 GTPHFMAPE-VVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK--ERLFEGII------ 245

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       ++K        W  I        A DLV R+L   P  R T 
Sbjct: 246 ----------KGKYKMN---PRQWSHI-----SESAKDLVRRMLMLDPAERITV 281

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  152 bits (385), Expect = 3e-43
 Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 40/277 (14%)

Query: 80  GQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTD 138
           G G  G V +     TG+  A+ K+L D     +E+    +    P++V +    +    
Sbjct: 38  GLGVNGKVLECFHRRTGQKCAL-KLLYDSPKARQEVDHHWQASGGPHIVCILD-VYENMH 95

Query: 139 KDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
             +  L +++E +   E   R+  +      +R     ++     I  A+ ++H S  + 
Sbjct: 96  HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMR----DIGTAIQFLH-SHNIA 150

Query: 196 HRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFGATEYT 252
           HRD+KP+NLL  +      +KL DFG AK   +    +   C + YY APE + G  +Y 
Sbjct: 151 HRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA--LQTPCYTPYYVAPE-VLGPEKYD 207

Query: 253 TAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
            + D+WS G V+  ++L G P F  ++G      + +         I+       ++ FP
Sbjct: 208 KSCDMWSLG-VIMYILLCGFPPFYSNTGQAISPGMKR--------RIRLG-----QYGFP 253

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 W ++       +A  L+  LL+  P  R T 
Sbjct: 254 ---NPEWSEV-----SEDAKQLIRLLLKTDPTERLTI 282

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  152 bits (387), Expect = 3e-43
 Identities = 71/286 (24%), Positives = 116/286 (40%), Gaps = 47/286 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y  +  +G+G+F VV +     TG   A K +   K          RE +  R L HPN+
Sbjct: 31  YDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNI 90

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V L        ++   Y  LV + V   E    +V      ++      ++    QI  +
Sbjct: 91  VRLHDSI---QEESFHY--LVFDLVTGGELFEDIVAR-EFYSEADASHCIQ----QILES 140

Query: 185 LSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           ++Y H S G+ HR++KP+NLL+        VKL DFG A  +   E    +  +  Y +P
Sbjct: 141 IAYCH-SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E +     Y+  +DIW+ G ++  L++G P F  +       +I                
Sbjct: 200 E-VLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAG------------- 245

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                + +P   +  W  +      PEA  L+  +L  +P  R TA
Sbjct: 246 ----AYDYP---SPEWDTV-----TPEAKSLIDSMLTVNPKKRITA 279

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  153 bits (388), Expect = 4e-43
 Identities = 72/286 (25%), Positives = 119/286 (41%), Gaps = 43/286 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
            +  +++G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 64  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRI-V 121

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFRAL 185
             +         L +V+E +   E        F+++  R    +           I  A+
Sbjct: 122 DVYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 174

Query: 186 SYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            Y+H SI + HRD+KP+NLL  +   +  +KL DFG AK         +   + YY APE
Sbjct: 175 QYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            + G  +Y  + D+WS G V+  ++L G P F  + G+     +           I+   
Sbjct: 234 -VLGPEKYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 280

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               +++FP      W ++       E   L+  LL+  P  R T 
Sbjct: 281 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTI 316

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  152 bits (386), Expect = 4e-43
 Identities = 65/293 (22%), Positives = 114/293 (38%), Gaps = 56/293 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK----------KVLQDKRYKNRELQTMRLLD 122
           Y     +G G F +V + +   TG   A K          +    +    RE+  +R + 
Sbjct: 14  YDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL 73

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           HPN+++L   +    ++ ++   L+LE V   E    + +    L++     ++K    Q
Sbjct: 74  HPNIITLHDVY---ENRTDVV--LILELVSGGELFDFLAQK-ESLSEEEATSFIK----Q 123

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
           I   ++Y+H +  + H D+KP+N+++   N     +KL DFG A  +  G      I  +
Sbjct: 124 ILDGVNYLH-TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE-FKNIFGT 181

Query: 237 RYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR 295
             + APE I          D+WS G V+  ++L G   F GD+  + L  I  V      
Sbjct: 182 PEFVAPE-IVNYEPLGLEADMWSIG-VITYILLSGASPFLGDTKQETLANITAV------ 233

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       + F       + +         A D + +LL      R T 
Sbjct: 234 -----------SYDFD---EEFFSQT-----SELAKDFIRKLLVKETRKRLTI 267

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  150 bits (380), Expect = 1e-42
 Identities = 69/284 (24%), Positives = 130/284 (45%), Gaps = 39/284 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTMRLLD-HPNVVSLK 130
            + ++ +G+GSF +  +    ++ +  A+K + +       +E+  ++L + HPN+V L 
Sbjct: 13  DLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLH 72

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
             F      D+L+  LV+E +   E   R+ K     ++      ++    ++  A+S++
Sbjct: 73  EVF-----HDQLHTFLVMELLNGGELFERIKKK-KHFSETEASYIMR----KLVSAVSHM 122

Query: 189 HRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           H  +GV HRD+KP+NLL  + + + ++K+ DFG A++       +   C + +Y APE +
Sbjct: 123 H-DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE-L 180

Query: 246 FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                Y  + D+WS G V+   ML G+  F            ++++     ++IK     
Sbjct: 181 LNQNGYDESCDLWSLG-VILYTMLSGQVPFQSHDRSLTCTSAVEIM-----KKIKKG--- 231

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +F F       W  +       EA DL+  LL   PN R   
Sbjct: 232 --DFSFE---GEAWKNV-----SQEAKDLIQGLLTVDPNKRLKM 265

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  148 bits (377), Expect = 2e-42
 Identities = 78/287 (27%), Positives = 118/287 (41%), Gaps = 66/287 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +I+G+GSF  V  A+ L T    AIK      ++++    Y  RE   M  LDHP  V L
Sbjct: 36  KILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKL 95

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D ++LY    L Y    E +     +  K          + Y  +I  AL Y
Sbjct: 96  YFTF---QDDEKLY--FGLSYAKNGELLK----YIRK-IGSFDETCTRFYTAEIVSALEY 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS---------YICSRY 238
           +H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL                 Y+    
Sbjct: 146 LH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSFVGTAQYV---- 199

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
             +PEL+        + D+W+ GC++ +L+ G P F                        
Sbjct: 200 --SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAG--------------------- 235

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
              N       F +I    +   FP++  P+A DLV +LL      R
Sbjct: 236 ---NEYLI---FQKIIKLEYD--FPEKFFPKARDLVEKLLVLDATKR 274

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  148 bits (377), Expect = 4e-42
 Identities = 65/289 (22%), Positives = 118/289 (40%), Gaps = 52/289 (17%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDH-PNV 126
           +  + +G+G F VV Q     TG+  A K + + +R ++       E+  + L    P V
Sbjct: 32  LTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRV 91

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVV-KHFNKLNQRMPMIYVKLYAYQIFR 183
           ++L   +    +  E+   L+LEY    E     + +    +++   +  +K    QI  
Sbjct: 92  INLHEVY---ENTSEII--LILEYAAGGEIFSLCLPELAEMVSENDVIRLIK----QILE 142

Query: 184 ALSYIHRSIGVCHRDIKPQN-LLVNPH-THQVKLCDFGSAKVLVKGEPNISYIC-SRYYR 240
            + Y+H    + H D+KPQN LL + +    +K+ DFG ++ +      +  I  +  Y 
Sbjct: 143 GVYYLH-QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE-LREIMGTPEYL 200

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           APE I      TTA D+W+ G ++A ++L     F G+   +  + I +V          
Sbjct: 201 APE-ILNYDPITTATDMWNIG-IIAYMLLTHTSPFVGEDNQETYLNISQV---------- 248

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     +       +  +        A D +  LL  +P  R TA
Sbjct: 249 -------NVDYS---EETFSSV-----SQLATDFIQSLLVKNPEKRPTA 282

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  147 bits (374), Expect = 6e-42
 Identities = 72/291 (24%), Positives = 118/291 (40%), Gaps = 56/291 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN---RELQTMRLLDHP 124
           Y+   ++G+GS+G V +    ET    A+K     K+ +    +    +E+Q +R L H 
Sbjct: 7   YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHK 66

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP----ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
           NV+ L    ++   +  +Y  +V+EY      E +  V +       R P+     Y  Q
Sbjct: 67  NVIQLVDVLYNEEKQK-MY--MVMEYCVCGMQEMLDSVPEK------RFPVCQAHGYFCQ 117

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SR 237
           +   L Y+H S G+ H+DIKP NLL+      +K+   G A+ L     +        S 
Sbjct: 118 LIDGLEYLH-SQGIVHKDIKPGNLLLTTG-GTLKISALGVAEALHPFAADDTCRTSQGSP 175

Query: 238 YYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            ++ PE+  G   ++   +DIWSAG  +  +  G   F GD+        I  L     E
Sbjct: 176 AFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN--------IYKL----FE 223

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
            I         +  P                P   DL+  +L+Y P  R +
Sbjct: 224 NIG-----KGSYAIP-----GD-------CGPPLSDLLKGMLEYEPAKRFS 257

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  148 bits (375), Expect = 2e-41
 Identities = 70/284 (24%), Positives = 115/284 (40%), Gaps = 46/284 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTMRLLDHPNVV 127
           Y   + +G G+FGV    +   T E VA+K       + +     RE+   R L HPN+V
Sbjct: 22  YDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQ--REIINHRSLRHPNIV 79

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             K    + T    L   +++EY    E   R+         R      + +  Q+   +
Sbjct: 80  RFKEVILTPTH---LA--IIMEYASGGELYERICNA-----GRFSEDEARFFFQQLLSGV 129

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           SY H S+ +CHRD+K +N L++     ++K+CDFG +K  V      S + +  Y APE+
Sbjct: 130 SYCH-SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 188

Query: 245 IFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +    EY     D+WS G  +  +++G   F                   T + I  +  
Sbjct: 189 LLR-QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE--------EPRDYRKTIQRILSV-- 237

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
              ++  P             R+ PE   L+SR+    P  R +
Sbjct: 238 ---KYSIPD----------DIRISPECCHLISRIFVADPATRIS 268

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  145 bits (368), Expect = 5e-41
 Identities = 67/298 (22%), Positives = 120/298 (40%), Gaps = 60/298 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK------------KVLQDKRYK-NRELQTMR 119
           Y  + I+G+G   VV +     T +  A+K            + +Q+ R    +E+  +R
Sbjct: 19  YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 78

Query: 120 LLD-HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKL 176
            +  HPN++ LK  +         +  LV + +   E    + +    L+++      + 
Sbjct: 79  KVSGHPNIIQLKDTY---ETNTFFF--LVFDLMKKGELFDYLTEK-VTLSEK----ETRK 128

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC- 235
               +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE  +  +C 
Sbjct: 129 IMRALLEVICALH-KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEK-LREVCG 185

Query: 236 SRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
           +  Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I+   
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSG- 244

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                            ++F    +  W             DLVSR L   P  R TA
Sbjct: 245 ----------------NYQFG---SPEWDDY-----SDTVKDLVSRFLVVQPQKRYTA 278

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  146 bits (369), Expect = 1e-40
 Identities = 65/290 (22%), Positives = 117/290 (40%), Gaps = 31/290 (10%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           +G G+ GVVF+     +G  +A K +   ++        RELQ +   + P +V     F
Sbjct: 41  LGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF 100

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +S  +     +++ +E++       +    K   R+P   +   +  + + L+Y+     
Sbjct: 101 YSDGE-----ISICMEHMDGGS---LDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK 152

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
           + HRD+KP N+LVN    ++KLCDFG +  L+    N S++ +R Y +PE + G   Y+ 
Sbjct: 153 IMHRDVKPSNILVN-SRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQGTH-YSV 209

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQI 313
             DIWS G  + E+ +G+   P     +  +     +     E                +
Sbjct: 210 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGM 269

Query: 314 KAHPWHKIF---------------PKRMPPEAVDLVSRLLQYSPNLRCTA 348
            + P   IF                     E  D V++ L  +P  R   
Sbjct: 270 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  143 bits (362), Expect = 2e-40
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 50/286 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
                          Y  L LEY    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 242
            Y+H  IG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 243 ELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           EL+    E+    +D+WS G V+  ++ G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                          PW K     +    + L+ ++L  +P+ R T
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARIT 255

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  143 bits (364), Expect = 3e-40
 Identities = 76/300 (25%), Positives = 125/300 (41%), Gaps = 54/300 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIK----KVLQDKRYKNRELQTM-RLLDHPNVVSLK 130
           E ++G+G+   V     L T +  A+K    +    +    RE++ + +   H NV+ L 
Sbjct: 18  EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVK--HFNKLNQRMPMIYVKLYAYQIFRALS 186
             F     ++E    LV E +     +  + K  HFN+L   + +         +  AL 
Sbjct: 78  EFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVV-------QDVASALD 125

Query: 187 YIHRSIGVCHRDIKPQNLL-VNP-HTHQVKLCDFGSAKVLVKGE-------PNISYIC-S 236
           ++H + G+ HRD+KP+N+L  +P     VK+CDF     +           P +   C S
Sbjct: 126 FLH-NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184

Query: 237 RYYRAPELI----FGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLG 291
             Y APE++      A+ Y    D+WS G V+  ++L G P F G  G D   +  +   
Sbjct: 185 AEYMAPEVVEAFSEEASIYDKRCDLWSLG-VILYILLSGYPPFVGRCGSDCGWDRGEACP 243

Query: 292 TPTR---EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  E I+       +++FP      W  I        A DL+S+LL      R +A
Sbjct: 244 ACQNMLFESIQEG-----KYEFP---DKDWAHI-----SCAAKDLISKLLVRDAKQRLSA 290

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  143 bits (363), Expect = 3e-40
 Identities = 69/286 (24%), Positives = 119/286 (41%), Gaps = 50/286 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 9   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 68

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
                          Y  L LEY    E   R+          MP    + + +Q+   +
Sbjct: 69  KFYGHRREGNI---QY--LFLEYCSGGELFDRIEPD-----IGMPEPDAQRFFHQLMAGV 118

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN--ISYIC-SRYYRAP 242
            Y+H  IG+ HRDIKP+NLL++     +K+ DFG A V         ++ +C +  Y AP
Sbjct: 119 VYLH-GIGITHRDIKPENLLLDER-DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176

Query: 243 ELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           EL+    E+    +D+WS G V+  ++ G+  +      DQ  +  +       ++    
Sbjct: 177 ELLKR-REFHAEPVDVWSCGIVLTAMLAGELPW------DQPSDSCQEYSDWKEKKTYLN 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                          PW K     +    + L+ ++L  +P+ R T
Sbjct: 230 ---------------PWKK-----IDSAPLALLHKILVENPSARIT 255

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  145 bits (366), Expect = 3e-40
 Identities = 53/345 (15%), Positives = 102/345 (29%), Gaps = 92/345 (26%)

Query: 56  IVTTIGGRNGQPKQTISYMAE--------RIVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           +V+T     GQP +  S + E         ++GQ       +A   ETGE+  +      
Sbjct: 50  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 109

Query: 108 KRYKN-------RELQTMRLL-------------------------DHPNVVSLKHCFFS 135
           +R  +        E+  +RLL                             ++ ++     
Sbjct: 110 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 169

Query: 136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
                  +L   ++   +T   V+   +  ++ +          Q+ R L+ +H   G+ 
Sbjct: 170 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLH-HYGLV 228

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI---------- 245
           H  ++P +++++     V L  F      V+    +    SR +  PEL           
Sbjct: 229 HTYLRPVDIVLDQRGG-VFLTGFEHL---VRDGARVVSSVSRGFEPPELEARRATISYHR 284

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
              T  T + D W+ G V+  +         D+ +                         
Sbjct: 285 DRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALG------------------------ 320

Query: 306 TEFKFPQIKAHPWHKIF--PKRMPPEAVDLVSRLLQYSPNLRCTA 348
                          IF   K +P     L+   L+Y    R   
Sbjct: 321 -----------GSEWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 354

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  142 bits (359), Expect = 9e-40
 Identities = 67/310 (21%), Positives = 116/310 (37%), Gaps = 73/310 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--------------- 112
           Y  +  +G+GS+GVV  A         A+K     K+++   +                 
Sbjct: 15  YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74

Query: 113 ----------RELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVK 160
                     +E+  ++ LDHPNVV L        ++D LY+  V E V     V  V  
Sbjct: 75  QPRGPIEQVYQEIAILKKLDHPNVVKL-VEVLDDPNEDHLYM--VFELVNQGP-VMEVPT 130

Query: 161 HFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS 220
                 + +     + Y   + + + Y+H    + HRDIKP NLLV      +K+ DFG 
Sbjct: 131 L-----KPLSEDQARFYFQDLIKGIEYLHYQ-KIIHRDIKPSNLLVG-EDGHIKIADFGV 183

Query: 221 AKVLVKGEPNISYIC-SRYYRAPELIFGAT-EYT-TAIDIWSAGCVVAELMLGKPLFPGD 277
           +      +  +S    +  + APE +      ++  A+D+W+ G  +   + G+  F  +
Sbjct: 184 SNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE 243

Query: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
             +  L   IK                    +FP     P        +  +  DL++R+
Sbjct: 244 R-IMCLHSKIK----------------SQALEFPD---QPD-------IAEDLKDLITRM 276

Query: 338 LQYSPNLRCT 347
           L  +P  R  
Sbjct: 277 LDKNPESRIV 286

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  142 bits (360), Expect = 1e-39
 Identities = 77/287 (26%), Positives = 121/287 (42%), Gaps = 57/287 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHP 124
           Y   + +G+G+F  V  A+ + TG  VAIK +  DK   N        RE++ M++L+HP
Sbjct: 17  YRLLKTIGKGNFAKVKLARHILTGREVAIKII--DKTQLNPTSLQKLFREVRIMKILNHP 74

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           N+V L     +        L L++EY    E    +V H      RM     +    QI 
Sbjct: 75  NIVKLFEVIETEKT-----LYLIMEYASGGEVFDYLVAH-----GRMKEKEARSKFRQIV 124

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            A+ Y H+   + HRD+K +NLL++     +K+ DFG +     G   +   C +  Y A
Sbjct: 125 SAVQYCHQ-KRIVHRDLKAENLLLD-ADMNIKIADFGFSNEFTVGGK-LDAFCGAPPYAA 181

Query: 242 PELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           PEL  G  +Y    +D+WS G ++  L+ G   F G + + +L E +             
Sbjct: 182 PELFQG-KKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-LKELRERVL------------ 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
               Y                 P  M  +  +L+ R L  +P  R T
Sbjct: 228 -RGKYR---------------IPFYMSTDCENLLKRFLVLNPIKRGT 258

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  143 bits (362), Expect = 1e-39
 Identities = 68/298 (22%), Positives = 129/298 (43%), Gaps = 61/298 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----------KVLQDKRYK-NRELQTMRL 120
           Y  + ++G+G   VV +     TG   A+K           + L++ R    RE   +R 
Sbjct: 96  YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155

Query: 121 L-DHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLY 177
           +  HP++++L   +        ++  LV + +   E    + +    L+++      +  
Sbjct: 156 VAGHPHIITLIDSY---ESSSFMF--LVFDLMRKGELFDYLTEK-VALSEK----ETRSI 205

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
              +  A+S++H +  + HRD+KP+N+L++ +  Q++L DFG +  L  GE  +  +C +
Sbjct: 206 MRSLLEAVSFLH-ANNIVHRDLKPENILLDDNM-QIRLSDFGFSCHLEPGEK-LRELCGT 262

Query: 237 RYYRAPELIFGATE-----YTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVL 290
             Y APE++  + +     Y   +D+W+ G V+   +L G P F     +  L  I++  
Sbjct: 263 PGYLAPEILKCSMDETHPGYGKEVDLWACG-VILFTLLAGSPPFWHRRQILMLRMIMEG- 320

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                           +++F    +  W             DL+SRLLQ  P  R TA
Sbjct: 321 ----------------QYQFS---SPEWDDR-----SSTVKDLISRLLQVDPEARLTA 354

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  142 bits (359), Expect = 3e-39
 Identities = 42/296 (14%), Positives = 99/296 (33%), Gaps = 38/296 (12%)

Query: 72  SYMAERIVGQGSFGVVFQAKC-----LETGETVAIK----KVLQDKRYKNRELQTMRLLD 122
                 ++G+G+F  V++A        +  +   +K        +     + ++ ++   
Sbjct: 66  LVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
               +           ++   L  V E       ++ +  + N   + MP   V  +A +
Sbjct: 126 QHMFMKFYSAHL---FQNGSVL--VGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMR 180

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ----------VKLCDFGSA---KVLVKG 227
           +   +  +H    + H DIKP N ++     +          + L D G +   K+  KG
Sbjct: 181 MLYMIEQVH-DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKG 239

Query: 228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEI 286
               +   +  ++  E++     +   ID +     V  ++ G  +   + G + +   +
Sbjct: 240 TIFTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPEGL 298

Query: 287 IKVL-GTPTREEI--KCMNPNYTEFKFPQIKA--HPWHKIFPKRMPPEAVDLVSRL 337
            + L       E     +N        P +        K+F +    +   L +RL
Sbjct: 299 FRRLPHLDMWNEFFHVMLNIP-DCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRL 353

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  142 bits (360), Expect = 3e-39
 Identities = 69/282 (24%), Positives = 127/282 (45%), Gaps = 53/282 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           R +G+GSFG V   +  +T +  A+K     K ++    R   +ELQ M+ L+HP +V+L
Sbjct: 21  RAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNL 80

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D+++++  +V++ +   +  +    H  + N       VKL+  ++  AL Y
Sbjct: 81  WYSF---QDEEDMF--MVVDLLLGGDLRY----HLQQ-NVHFKEETVKLFICELVMALDY 130

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF- 246
           +  +  + HRD+KP N+L++ H H V + DF  A +L +     +   ++ Y APE+   
Sbjct: 131 LQ-NQRIIHRDMKPDNILLDEHGH-VHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSS 188

Query: 247 -GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--VDQLVEIIKVLGTPTREEIKCMNP 303
                Y+ A+D WS G    EL+ G+  +   S     ++V   +         +     
Sbjct: 189 RKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFE------TTVVT---- 238

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                             +P     E V L+ +LL+ +P+ R
Sbjct: 239 ------------------YPSAWSQEMVSLLKKLLEPNPDQR 262

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  140 bits (356), Expect = 4e-39
 Identities = 59/292 (20%), Positives = 104/292 (35%), Gaps = 66/292 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 122
           Y    ++G G FG V+    +     VAIK     ++       N      E+  ++ + 
Sbjct: 45  YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 104

Query: 123 H--PNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLY 177
                V+ L   +F     D   L  +LE      +    + +        +     + +
Sbjct: 105 SGFSGVIRLLD-WFER--PDSFVL--ILERPEPVQDLFDFITER-----GALQEELARSF 154

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
            +Q+  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS  +L       +    +
Sbjct: 155 FWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT--VYTDFDGT 211

Query: 237 RYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
           R Y  PE I     Y   +  +WS G ++ +++ G   F  D                  
Sbjct: 212 RVYSPPEWIRY-HRYHGRSAAVWSLGILLYDMVCGDIPFEHDE----------------- 253

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                           +I        F +R+  E   L+   L   P+ R T
Sbjct: 254 ----------------EIIRGQVF--FRQRVSSECQHLIRWCLALRPSDRPT 287

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  139 bits (353), Expect = 4e-39
 Identities = 80/291 (27%), Positives = 127/291 (43%), Gaps = 37/291 (12%)

Query: 61  GGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------R 113
           G ++    +   Y+    +G G+FG V   +   TG  VA+K + + K           R
Sbjct: 1   GSKHDGRVKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKR 60

Query: 114 ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPM 171
           E+Q ++L  HP+++ L     + TD    ++  V+EYV   E    + KH      R+  
Sbjct: 61  EIQNLKLFRHPHIIKLYQVISTPTD---FFM--VMEYVSGGELFDYICKH-----GRVEE 110

Query: 172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI 231
           +  +    QI  A+ Y HR   V HRD+KP+N+L++ H    K+ DFG + ++  GE  +
Sbjct: 111 MEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-L 167

Query: 232 SYIC-SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV- 289
              C S  Y APE+I G       +DIWS G ++  L+ G   F  +  V  L + I+  
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH-VPTLFKKIRGG 226

Query: 290 -------LGTPTREEIKCM---NPNYTEFKFPQIKAHPWHKI-FPKRMPPE 329
                  L       +  M   +P         I+ H W K   P  + PE
Sbjct: 227 VFYIPEYLNRSVATLLMHMLQVDPL-KRATIKDIREHEWFKQDLPSYLFPE 276

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  142 bits (359), Expect = 7e-39
 Identities = 51/341 (14%), Positives = 98/341 (28%), Gaps = 85/341 (24%)

Query: 56  IVTTIGGRNGQPKQTISYMAER--------IVGQGSFGVVFQAKCLETGETVAIKKVLQD 107
           +V+T     GQP +  S + ER        ++GQ       +A   ETGE+  +      
Sbjct: 55  LVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFT 114

Query: 108 KRYKNRELQTMR-----------------------------LLDHPNVVSLKHCFFSTTD 138
           +R  +  ++ M+                             L+  P    +        D
Sbjct: 115 ERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERD 174

Query: 139 KDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVC 195
              L    +   +    +T   V+   +  ++ +          Q+ R L+ +H   G+ 
Sbjct: 175 MWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLV 233

Query: 196 HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----YRAPELIFGA--- 248
           H  ++P +++++     V L  F        G   +S I   +      A  ++      
Sbjct: 234 HTYLRPVDIVLDQRGG-VFLTGFEHLVRD--GASAVSPIGRGFAPPETTAERMLPFGQHH 290

Query: 249 -TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            T  T A D W+ G  +  +         D+ +                           
Sbjct: 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS------------------------ 326

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     W     K +P     L+   L+Y    R   
Sbjct: 327 ---------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLP 358

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  138 bits (349), Expect = 2e-38
 Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 41/279 (14%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQ-TMRLLDHPNVVSLKHC 132
           +G+G++GVV + + + +G+ +A+K++   +  +  K    +L  +MR +D P  V+    
Sbjct: 15  LGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
            F   D     + + +E +  ++ +  K      Q +P   +   A  I +AL ++H  +
Sbjct: 75  LFREGD-----VWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL 129

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG---AT 249
            V HRD+KP N+L+N    QVK+CDFG +  LV           + Y APE I       
Sbjct: 130 SVIHRDVKPSNVLIN-ALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQK 188

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y+   DIWS G  + EL + +  +       Q ++ + V                    
Sbjct: 189 GYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQV-VEEPS---------------- 231

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            PQ+ A  +          E VD  S+ L+ +   R T 
Sbjct: 232 -PQLPADKF--------SAEFVDFTSQCLKKNSKERPTY 261

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  138 bits (350), Expect = 2e-38
 Identities = 66/294 (22%), Positives = 107/294 (36%), Gaps = 68/294 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-----RELQTMRLLD 122
           Y    ++G+G FG VF    L     VAIK     +VL      +      E+  +  + 
Sbjct: 33  YRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVG 92

Query: 123 ----HPNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVK 175
               HP V+ L   +F T  ++   L  VLE      +    + +        +     +
Sbjct: 93  AGGGHPGVIRL-LDWFET--QEGFML--VLERPLPAQDLFDYITEK-----GPLGEGPSR 142

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC 235
            +  Q+  A+ + H   GV HRDIK +N+L++      KL DFGS  +L       +   
Sbjct: 143 CFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE--PYTDFD 199

Query: 236 -SRYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
            +R Y  PE I    +Y      +WS G ++ +++ G   F  D                
Sbjct: 200 GTRVYSPPEWISR-HQYHALPATVWSLGILLYDMVCGDIPFERDQ--------------- 243

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                             +I     H  FP  + P+   L+ R L   P+ R +
Sbjct: 244 ------------------EILEAELH--FPAHVSPDCCALIRRCLAPKPSSRPS 277

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  137 bits (347), Expect = 4e-38
 Identities = 66/286 (23%), Positives = 110/286 (38%), Gaps = 64/286 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKH 131
            +  +++G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +  
Sbjct: 20  KVTSQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVD 78

Query: 132 CFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIY----VKLYAYQIFRAL 185
             +         L +V+E +   E        F+++  R    +           I  A+
Sbjct: 79  -VYENLYAGRKCLLIVMECLDGGEL-------FSRIQDRGDQAFTEREASEIMKSIGEAI 130

Query: 186 SYIHRSIGVCHRDIKPQNLL-VNPHTH-QVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            Y+H SI + HRD+KP+NLL  +   +  +KL DFG AK                     
Sbjct: 131 QYLH-SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGE---------------- 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
                 +Y  + D+WS G V+  ++L G P F  + G+     +           I+   
Sbjct: 174 ------KYDKSCDMWSLG-VIMYILLCGYPPFYSNHGLAISPGMK--------TRIR--- 215

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               +++FP      W ++       E   L+  LL+  P  R T 
Sbjct: 216 --MGQYEFP---NPEWSEV-----SEEVKMLIRNLLKTEPTQRMTI 251

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  143 bits (363), Expect = 5e-38
 Identities = 68/282 (24%), Positives = 118/282 (41%), Gaps = 53/282 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRE-----------LQTMRLLDHPN 125
           RI+G+G FG V+  +  +TG+  A+K  L  KR K ++           L  +   D P 
Sbjct: 195 RIIGRGGFGEVYGCRKADTGKMYAMK-CLDKKRIKMKQGETLALNERIMLSLVSTGDCPF 253

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +V + + F      D+L    +L+ +   +  + + +H            ++ YA +I  
Sbjct: 254 IVCMSYAF---HTPDKLSF--ILDLMNGGDLHYHLSQH-----GVFSEADMRFYAAEIIL 303

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
            L ++H +  V +RD+KP N+L++ H H V++ D G A    K +P+ + + +  Y APE
Sbjct: 304 GLEHMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPH-ASVGTHGYMAPE 360

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y ++ D +S GC++ +L+ G   F      D             + EI     
Sbjct: 361 VLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD-------------KHEI----- 402

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                              P    PE   L+  LLQ   N R
Sbjct: 403 ------DRMTLTMA--VELPDSFSPELRSLLEGLLQRDVNRR 436

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  135 bits (343), Expect = 4e-37
 Identities = 72/284 (25%), Positives = 126/284 (44%), Gaps = 51/284 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 125
           Y+    +G+GSFG V  A   +T + VA+K      + +   +    RE+  ++LL HP+
Sbjct: 11  YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPH 70

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L     + TD   +   +V+EY   E    +V+      +RM     + +  QI  A
Sbjct: 71  IIKLYDVITTPTD---IV--MVIEYAGGELFDYIVEK-----KRMTEDEGRRFFQQIICA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           + Y HR   + HRD+KP+NLL++ +   VK+ DFG + ++  G   +   C S  Y APE
Sbjct: 121 IEYCHRH-KIVHRDLKPENLLLDDN-LNVKIADFGLSNIMTDGNF-LKTSCGSPNYAAPE 177

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I G       +D+WS G V+  +++G+  F  +  +  L + +                
Sbjct: 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEF-IPNLFKKVN--------------- 221

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
               +  P      +       + P A  L+ R++   P  R T
Sbjct: 222 -SCVYVMP-----DF-------LSPGAQSLIRRMIVADPMQRIT 252

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  136 bits (345), Expect = 7e-37
 Identities = 69/292 (23%), Positives = 112/292 (38%), Gaps = 65/292 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKK-----VLQDKR--YKNRELQTMRLLDHPNVVSL 129
           +++G+G+F  V   K  +TG+  A+K      +L+         E   +   D   +  L
Sbjct: 67  KVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQL 126

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              F    D++ LY  LV+EY    + +       +K  +R+P    + Y  +I  A+  
Sbjct: 127 HFAF---QDENYLY--LVMEYYVGGDLLT----LLSKFGERIPAEMARFYLAEIVMAIDS 177

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 239
           +H  +G  HRDIKP N+L++   H ++L DFGS   L       S        Y+     
Sbjct: 178 VH-RLGYVHRDIKPDNILLDRCGH-IRLADFGSCLKLRADGTVRSLVAVGTPDYL----- 230

Query: 240 RAPELI------FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
            +PE++       G   Y    D W+ G    E+  G+  F  DS   +    I      
Sbjct: 231 -SPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS-TAETYGKI------ 282

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                  ++        P            + +P EA D + RLL   P  R
Sbjct: 283 -------VHYK-EHLSLPL---------VDEGVPEEARDFIQRLLC-PPETR 316

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  138 bits (350), Expect = 1e-36
 Identities = 63/280 (22%), Positives = 114/280 (40%), Gaps = 46/280 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           R++G+G FG VF  +   TG+  A  K L  KR K R        E + +  +    +VS
Sbjct: 191 RVLGRGGFGEVFACQMKATGKLYAC-KKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVS 249

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           L + F +   K +L   LV+  +   +  +  + + ++ N          Y  QI   L 
Sbjct: 250 LAYAFET---KTDLC--LVMTIMNGGDIRYH-IYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELI 245
           ++H    + +RD+KP+N+L++   + V++ D G A  L  G+        +  + APEL+
Sbjct: 304 HLH-QRNIIYRDLKPENVLLDDDGN-VRISDLGLAVELKAGQTKTKGYAGTPGFMAPELL 361

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G  EY  ++D ++ G  + E++  +  F                     +E+       
Sbjct: 362 LG-EEYDFSVDYFALGVTLYEMIAARGPFRARG------------EKVENKEL------- 401

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                 ++        +P +  P + D    LLQ  P  R
Sbjct: 402 ----KQRVLEQAVT--YPDKFSPASKDFCEALLQKDPEKR 435

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  136 bits (343), Expect = 2e-36
 Identities = 65/278 (23%), Positives = 114/278 (41%), Gaps = 50/278 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +++G+G+FG V   K     +  A+K     ++L+         E   +   D   + +L
Sbjct: 80  KVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTL 139

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F    D + LY  LV++Y    + +       +K   R+P    + Y  ++  A+  
Sbjct: 140 HYAF---QDDNNLY--LVMDYYVGGDLLT----LLSKFEDRLPEEMARFYLAEMVIAIDS 190

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-ICSRY-YRAPELI 245
           +H  +   HRDIKP N+L++ + H ++L DFGS   L++     S        Y +PE++
Sbjct: 191 VH-QLHYVHRDIKPDNILMDMNGH-IRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEIL 248

Query: 246 ----FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
                G   Y    D WS G  + E++ G+  F  +S + +    I             M
Sbjct: 249 QAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES-LVETYGKI-------------M 294

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQ 339
           N     F+FP              +   A DL+ RL+ 
Sbjct: 295 NHK-ERFQFPT---------QVTDVSENAKDLIRRLIC 322

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  132 bits (334), Expect = 5e-36
 Identities = 64/280 (22%), Positives = 117/280 (41%), Gaps = 39/280 (13%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKHC 132
           +G+G++G V +     +G+ +A+K++   + +K  K    +L   MR  D P +V     
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKH-FNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
            F   D       + +E +  +  +  K+ ++ L+  +P   +        +AL+++  +
Sbjct: 90  LFREGD-----CWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE- 250
           + + HRDIKP N+L++  +  +KLCDFG +  LV           R Y APE I  +   
Sbjct: 145 LKIIHRDIKPSNILLD-RSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASR 203

Query: 251 --YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
             Y    D+WS G  + EL  G+  +P  + V   +  + V G P               
Sbjct: 204 QGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQV-VKGDP--------------- 247

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             PQ+          +   P  ++ V+  L    + R   
Sbjct: 248 --PQLSNSE-----EREFSPSFINFVNLCLTKDESKRPKY 280

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  132 bits (335), Expect = 7e-36
 Identities = 75/286 (26%), Positives = 120/286 (41%), Gaps = 69/286 (24%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           + +G GSFG V   K  E+G   A+K     KV++ K   +   E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--E--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +  F     KD   L +V+EYV   E  +  R +  F+           + YA QI    
Sbjct: 107 EFSF-----KDNSNLYMVMEYVAGGEMFSHLRRIGRFS--EPH-----ARFYAAQIVLTF 154

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYY 239
            Y+H S+ + +RD+KP+NLL++   + +++ DFG AK +        G P          
Sbjct: 155 EYLH-SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAKRVKGRTWTLCGTPE--------A 204

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE+I     Y  A+D W+ G ++ E+  G P F  D    Q+ E I         +++
Sbjct: 205 LAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQ-PIQIYEKI------VSGKVR 256

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                                 FP     +  DL+  LLQ     R
Sbjct: 257 ----------------------FPSHFSSDLKDLLRNLLQVDLTKR 280

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  131 bits (332), Expect = 1e-35
 Identities = 55/221 (24%), Positives = 100/221 (45%), Gaps = 20/221 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKN--RELQT-MRLLDHPNVVSLKHC 132
           +G G+ G V++ +  +TG  +A+K++      +  K    +L   ++  D P +V     
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
           F + TD     + + +E +     ++ K   ++   +P   +      I +AL Y+    
Sbjct: 93  FITNTD-----VFIAMELMGTCAEKLKK---RMQGPIPERILGKMTVAIVKALYYLKEKH 144

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI----FGA 248
           GV HRD+KP N+L++    Q+KLCDFG +  LV  +          Y APE I       
Sbjct: 145 GVIHRDVKPSNILLD-ERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIK 288
            +Y    D+WS G  + EL  G+  +       + L ++++
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  136 bits (343), Expect = 1e-35
 Identities = 74/280 (26%), Positives = 122/280 (43%), Gaps = 49/280 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR--------ELQTMRLLDHPNVVS 128
           R++G+G FG V   +   TG+  A  K L+ KR K R        E Q +  ++   VVS
Sbjct: 190 RVLGKGGFGEVCACQVRATGKMYAC-KKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVS 248

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRM-PMIYVKLYAYQIFRAL 185
           L + + +   KD L   LVL  +   +       H   + Q   P      YA +I   L
Sbjct: 249 LAYAYET---KDALC--LVLTLMNGGDLKF----HIYHMGQAGFPEARAVFYAAEICCGL 299

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
             +H    + +RD+KP+N+L++ H H +++ D G A  + +G+     + +  Y APE++
Sbjct: 300 EDLH-RERIVYRDLKPENILLDDHGH-IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                YT + D W+ GC++ E++ G+  F                    REE+       
Sbjct: 358 KN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRK------------KKIKREEV------- 397

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                  +K  P  + + +R  P+A  L S+LL   P  R
Sbjct: 398 ----ERLVKEVP--EEYSERFSPQARSLCSQLLCKDPAER 431

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  134 bits (339), Expect = 1e-35
 Identities = 77/285 (27%), Positives = 121/285 (42%), Gaps = 52/285 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPN 125
           Y+    +G G+FG V   K   TG  VA+K     K+          RE+Q ++L  HP+
Sbjct: 18  YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPH 77

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           ++ L     + +D   ++  +V+EYV   E    + K+      R+     +    QI  
Sbjct: 78  IIKLYQVISTPSD---IF--MVMEYVSGGELFDYICKN-----GRLDEKESRRLFQQILS 127

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAP 242
            + Y HR   V HRD+KP+N+L++ H    K+ DFG + ++  GE  +   C S  Y AP
Sbjct: 128 GVDYCHRH-MVVHRDLKPENVLLDAH-MNAKIADFGLSNMMSDGEF-LRTSCGSPNYAAP 184

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E+I G       +DIWS+G ++  L+ G   F  D  V  L + I               
Sbjct: 185 EVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH-VPTLFKKIC-------------- 229

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                F  P      +       + P  + L+  +LQ  P  R T
Sbjct: 230 --DGIFYTP-----QY-------LNPSVISLLKHMLQVDPMKRAT 260

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  130 bits (328), Expect = 5e-35
 Identities = 66/292 (22%), Positives = 113/292 (38%), Gaps = 66/292 (22%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN-------RELQTMRL 120
           Y     +G G+FG V+ A   E  + V +K     KVL+D   ++        E+  +  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85

Query: 121 LDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP---ETVHRVVKHFNKLNQRMPMIYVKLY 177
           ++H N++ +   F    ++      LV+E      +    + +H      R+        
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQ--LVMEKHGSGLDLFAFIDRH-----PRLDEPLASYI 135

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-S 236
             Q+  A+ Y+     + HRDIK +N+++      +KL DFGSA  L +G+      C +
Sbjct: 136 FRQLVSAVGYLRLK-DIIHRDIKDENIVIAED-FTIKLIDFGSAAYLERGKL-FYTFCGT 192

Query: 237 RYYRAPELIFGATEYT-TAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR 295
             Y APE++ G   Y    +++WS G  +  L+  +  F       +L E ++       
Sbjct: 193 IEYCAPEVLMG-NPYRGPELEMWSLGVTLYTLVFEENPF------CELEETVE------- 238

Query: 296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                          P              +  E + LVS LLQ  P  R T
Sbjct: 239 ----------AAIHPP-----YL-------VSKELMSLVSGLLQPVPERRTT 268

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  132 bits (333), Expect = 6e-35
 Identities = 83/338 (24%), Positives = 142/338 (42%), Gaps = 60/338 (17%)

Query: 22  VDKLPEEMNDMKIRDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTIS-YMAERIVG 80
              +    + +K +   EM+     G+ ++        +     + + T++ +   +++G
Sbjct: 100 TTAIQTVADGLKKQAAAEMDFR--SGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLG 157

Query: 81  QGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNVVSLK 130
           +G+FG V   K   TG   A+K      ++           NR LQ  R   HP + +LK
Sbjct: 158 KGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR---HPFLTALK 214

Query: 131 HCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           + F  T D+  L    V+EY    E    + +      +       + Y  +I  AL Y+
Sbjct: 215 YSF-QTHDR--LCF--VMEYANGGELFFHLSRE-----RVFSEDRARFYGAEIVSALDYL 264

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H    V +RD+K +NL+++   H +K+ DFG  K  +K    +   C +  Y APE++  
Sbjct: 265 HSEKNVVYRDLKLENLMLDKDGH-IKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED 323

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
             +Y  A+D W  G V+ E+M G+  F      ++L E+I        EEI+        
Sbjct: 324 -NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HEKLFELIL------MEEIR-------- 367

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                         FP+ + PEA  L+S LL+  P  R
Sbjct: 368 --------------FPRTLGPEAKSLLSGLLKKDPKQR 391

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  129 bits (327), Expect = 7e-35
 Identities = 70/286 (24%), Positives = 122/286 (42%), Gaps = 69/286 (24%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           R +G GSFG V   +    G   A+K      V++ K   + N E   + ++ HP ++ +
Sbjct: 12  RTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRM 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--E--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
              F     +D   + ++++Y+   E  ++ R  + F   N        K YA ++  AL
Sbjct: 72  WGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFP--NPV-----AKFYAAEVCLAL 119

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK------GEPNISYICSRYY 239
            Y+H S  + +RD+KP+N+L++ + H +K+ DFG AK +        G P+        Y
Sbjct: 120 EYLH-SKDIIYRDLKPENILLDKNGH-IKITDFGFAKYVPDVTYTLCGTPD--------Y 169

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
            APE++     Y  +ID WS G ++ E++ G   F   +   +  E I         E++
Sbjct: 170 IAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSN-TMKTYEKI------LNAELR 221

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                                 FP     +  DL+SRL+    + R
Sbjct: 222 ----------------------FPPFFNEDVKDLLSRLITRDLSQR 245

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  129 bits (325), Expect = 1e-34
 Identities = 64/347 (18%), Positives = 118/347 (34%), Gaps = 105/347 (30%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G FGVVF+AK        AIK++    R        RE++ +  L+HP +V
Sbjct: 8   FEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIV 67

Query: 128 SLKHCF----------------------------------------------------FS 135
              + +                                                      
Sbjct: 68  RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127

Query: 136 TTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
                ++YL + ++    E +   +     L  R   + + ++  QI  A+ ++H S G+
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIF-IQIAEAVEFLH-SKGL 185

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-------------VKGEPNISYICSRYYRA 241
            HRD+KP N+        VK+ DFG    +                  +   + ++ Y +
Sbjct: 186 MHRDLKPSNIFFTMD-DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMS 244

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE I G   Y+  +DI+S G ++ EL+     F       +++  ++             
Sbjct: 245 PEQIHG-NNYSHKVDIFSLGLILFELLYS---FSTQMERVRIITDVR------------- 287

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  KFP +           +  P+   +V  +L  SP  R  A
Sbjct: 288 -----NLKFPLL---------FTQKYPQEHMMVQDMLSPSPTERPEA 320

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  127 bits (320), Expect = 4e-34
 Identities = 67/275 (24%), Positives = 119/275 (43%), Gaps = 44/275 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
           E +VG+G+FGVV +AK     + VAIK++  +   K    EL+ +  ++HPN+V L    
Sbjct: 13  EEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGA- 69

Query: 134 FSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS- 191
               +     + LV+EY    +++ V+ H  +        +   +  Q  + ++Y+H   
Sbjct: 70  --CLNP----VCLVMEYAEGGSLYNVL-HGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122

Query: 192 -IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
              + HRD+KP NLL+      +K+CDFG+A          +   S  + APE+  G + 
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC--DIQTHMTNNKGSAAWMAPEVFEG-SN 179

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           Y+   D++S G ++ E++  +  F    G      I+  +   TR               
Sbjct: 180 YSEKCDVFSWGIILWEVITRRKPFDEIGGPAF--RIMWAVHNGTR--------------- 222

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           P +          K +P     L++R     P+ R
Sbjct: 223 PPL---------IKNLPKPIESLMTRCWSKDPSQR 248

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  127 bits (322), Expect = 5e-34
 Identities = 73/279 (26%), Positives = 122/279 (43%), Gaps = 52/279 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKN--RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   TG   A+K      ++      +   E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           K+  F T D+  L    V+EY    E    + +      +       + Y  +I  AL Y
Sbjct: 71  KYA-FQTHDR--LC--FVMEYANGGELFFHLSRE-----RVFTEERARFYGAEIVSALEY 120

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPELIF 246
           +H S  V +RDIK +NL+++   H +K+ DFG  K  +     +   C    Y APE++ 
Sbjct: 121 LH-SRDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLE 178

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
              +Y  A+D W  G V+ E+M G+  F      ++L E+I        EEI+       
Sbjct: 179 D-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD-HERLFELIL------MEEIR------- 223

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                          FP+ + PEA  L++ LL+  P  R
Sbjct: 224 ---------------FPRTLSPEAKSLLAGLLKKDPKQR 247

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  128 bits (324), Expect = 5e-34
 Identities = 55/311 (17%), Positives = 107/311 (34%), Gaps = 44/311 (14%)

Query: 73  YMAERIVGQG--SFGVVFQAKCLETGETVAIKKV----LQDKRYKN--RELQTMRLLDHP 124
           Y    ++G+G      V  A+   TGE V ++++      ++       EL   +L +HP
Sbjct: 27  YELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHP 86

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           N+V  +  F +    +EL+  +V  ++   +   ++         M  + +      + +
Sbjct: 87  NIVPYRATFIA---DNELW--VVTSFMAYGSAKDLICT--HFMDGMNELAIAYILQGVLK 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA--------KVLVKGEPNISYIC 235
           AL YIH   G  HR +K  ++L++    +V L    S         +  V  +     + 
Sbjct: 140 ALDYIHHM-GYVHRSVKASHILIS-VDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVK 197

Query: 236 SRYYRAPELIF-GATEYTTAIDIWSAGCVVAELMLGKP----------LF-------PGD 277
              + +PE++      Y    DI+S G    EL  G            L        P  
Sbjct: 198 VLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCL 257

Query: 278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRL 337
                +      +          ++ + T               + +   P     V + 
Sbjct: 258 LDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC 317

Query: 338 LQYSPNLRCTA 348
           LQ +P+ R +A
Sbjct: 318 LQRNPDARPSA 328

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  129 bits (325), Expect = 6e-34
 Identities = 71/282 (25%), Positives = 117/282 (41%), Gaps = 64/282 (22%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDK--RYKNRELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   T +  A+K     ++++     +   E   M   + P VV L
Sbjct: 75  KVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQL 134

Query: 130 KHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            + F     +D+ YL +V+EY+P  + V+      +     +P  + + Y  ++  AL  
Sbjct: 135 FYAF-----QDDRYLYMVMEYMPGGDLVN----LMSN--YDVPEKWARFYTAEVVLALDA 183

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--------YICSRYY 239
           IH S+G  HRD+KP N+L++   H +KL DFG+   + K              YI     
Sbjct: 184 IH-SMGFIHRDVKPDNMLLDKSGH-LKLADFGTCMKMNKEGMVRCDTAVGTPDYI----- 236

Query: 240 RAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            +PE++    G   Y    D WS G  + E+++G   F  DS    LV            
Sbjct: 237 -SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS----LVGTYS-------- 283

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLL 338
             K MN       FP              +  EA +L+   L
Sbjct: 284 --KIMNHK-NSLTFPD---DND-------ISKEAKNLICAFL 312

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  128 bits (322), Expect = 1e-33
 Identities = 76/354 (21%), Positives = 132/354 (37%), Gaps = 84/354 (23%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK---NRELQTMRLL-----DHP 124
           Y   R +G G F  V+ +  ++  + VA+K V   + Y      E++ ++ +     + P
Sbjct: 39  YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDP 98

Query: 125 N---VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           N   VV L   F  +      ++ +V E +   + + +   N   Q +P+  VK    Q+
Sbjct: 99  NREMVVQLLDDFKISGVNGT-HICMVFEVLGHHLLKWIIKSN--YQGLPLPCVKKIIQQV 155

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLV----------------------------------- 206
            + L Y+H    + H DIKP+N+L+                                   
Sbjct: 156 LQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPA 215

Query: 207 -------------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT 253
                        N    +VK+ D G+A  +   +     I +R YR+ E++ G+  Y T
Sbjct: 216 TAGNFLVNPLEPKNAEKLKVKIADLGNACWV--HKHFTEDIQTRQYRSLEVLIGS-GYNT 272

Query: 254 AIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIKVLGTPTREEI-------KC 300
             DIWS  C+  EL  G  LF   SG       D +  II++LG   R+ I       + 
Sbjct: 273 PADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEF 332

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMP------PEAVDLVSRLLQYSPNLRCTA 348
                      ++K     ++  ++            D +  +L+  P  R TA
Sbjct: 333 FTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATA 386

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  124 bits (315), Expect = 4e-33
 Identities = 73/285 (25%), Positives = 126/285 (44%), Gaps = 60/285 (21%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQ----DKRYKNRELQTM---RLL---DH 123
           R++G+G +G VFQ + +    TG+  A+K VL+     +  K+    T     +L    H
Sbjct: 23  RVLGKGGYGKVFQVRKVTGANTGKIFAMK-VLKKAMIVRNAKDTA-HTKAERNILEEVKH 80

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           P +V L + F  T  K  LYL  +LEY+   E   ++ +                Y  +I
Sbjct: 81  PFIVDLIYAF-QTGGK--LYL--ILEYLSGGELFMQLERE-----GIFMEDTACFYLAEI 130

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YR 240
             AL ++H   G+ +RD+KP+N+++N   H VKL DFG  K  +         C    Y 
Sbjct: 131 SMALGHLH-QKGIIYRDLKPENIMLNHQGH-VKLTDFGLCKESIHDGTVTHTFCGTIEYM 188

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           APE++   + +  A+D WS G ++ +++ G P F G++   + ++ I       + ++  
Sbjct: 189 APEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTGEN-RKKTIDKI------LKCKLN- 239

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                                 P  +  EA DL+ +LL+ +   R
Sbjct: 240 ---------------------LPPYLTQEARDLLKKLLKRNAASR 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  124 bits (315), Expect = 4e-33
 Identities = 71/281 (25%), Positives = 126/281 (44%), Gaps = 54/281 (19%)

Query: 77  RIVGQGSFGVVFQAK---CLETGETVAIKKVLQDKRYKNRELQTM---RLL---DHPNVV 127
           +++GQGSFG VF  K     +  +  A+K + +        ++T     +L   +HP +V
Sbjct: 30  KVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIV 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L + F  T  K  LYL  +L+++   +   R+ K             VK Y  ++  AL
Sbjct: 90  KLHYAF-QTEGK--LYL--ILDFLRGGDLFTRLSKE-----VMFTEEDVKFYLAELALAL 139

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPEL 244
            ++H S+G+ +RD+KP+N+L++   H +KL DFG +K  +  E      C +  Y APE+
Sbjct: 140 DHLH-SLGIIYRDLKPENILLDEEGH-IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEV 197

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     +T + D WS G ++ E++ G   F G     + + +I       + ++      
Sbjct: 198 VNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKD-RKETMTMI------LKAKLG----- 244

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                             P+ + PEA  L+  L + +P  R
Sbjct: 245 -----------------MPQFLSPEAQSLLRMLFKRNPANR 268

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  123 bits (312), Expect = 6e-33
 Identities = 61/215 (28%), Positives = 92/215 (42%), Gaps = 28/215 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLK 130
           E I G G+  VV  A C    E VAIK++  +K   +     +E+Q M    HPN+VS  
Sbjct: 21  EVI-GSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYY 79

Query: 131 HCFFSTTDKDELYLNLVLEY-----VPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
             F     KDEL+  LV++      V + +  +V      +  +    +     ++   L
Sbjct: 80  TSFV---VKDELW--LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSR------- 237
            Y+H   G  HRD+K  N+L+      V++ DFG SA +   G+   +    R       
Sbjct: 135 EYLH-KNGQIHRDVKAGNILLG-EDGSVQIADFGVSAFLATGGDITRNK--VRKTFVGTP 190

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
            + APE++     Y    DIWS G    EL  G  
Sbjct: 191 CWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA 225

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  124 bits (313), Expect = 1e-32
 Identities = 73/282 (25%), Positives = 123/282 (43%), Gaps = 57/282 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
           R++G+GSFG V  A+  ETG+  A+K      +LQD   +      R L   R  +HP +
Sbjct: 29  RVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR--NHPFL 86

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  L+   V+E+V   + +  + K      +R      + YA +I  A
Sbjct: 87  TQLFCC-FQTPDR--LF--FVMEFVNGGDLMFHIQKS-----RRFDEARARFYAAEIISA 136

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++H   G+ +RD+K  N+L++   H  KL DFG  K  +      +  C    Y APE
Sbjct: 137 LMFLH-DKGIIYRDLKLDNVLLDHEGH-CKLADFGMCKEGICNGVTTATFCGTPDYIAPE 194

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++     Y  A+D W+ G ++ E++ G   F  ++  D L E I        +E+     
Sbjct: 195 ILQE-MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN-EDDLFEAI------LNDEVV---- 242

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                             +P  +  +A  ++   +  +P +R
Sbjct: 243 ------------------YPTWLHEDATGILKSFMTKNPTMR 266

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  124 bits (314), Expect = 1e-32
 Identities = 71/281 (25%), Positives = 117/281 (41%), Gaps = 55/281 (19%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQ-DKRYKNRELQ-TM-------RLLDHPNVV 127
           +++G+GSFG V  A+        A+ KVLQ     K +E +  M       + + HP +V
Sbjct: 44  KVIGKGSFGKVLLARHKAEEVFYAV-KVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLV 102

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            L    F T DK  LY   VL+Y+   E  + + +      +       + YA +I  AL
Sbjct: 103 GLHFS-FQTADK--LY--FVLDYINGGELFYHLQRE-----RCFLEPRARFYAAEIASAL 152

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPEL 244
            Y+H S+ + +RD+KP+N+L++   H + L DFG  K  ++     S  C    Y APE+
Sbjct: 153 GYLH-SLNIVYRDLKPENILLDSQGH-IVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEV 210

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y   +D W  G V+ E++ G P F   +   ++ + I        + ++     
Sbjct: 211 LHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRN-TAEMYDNIL------NKPLQ----- 257

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                                +   A  L+  LLQ     R
Sbjct: 258 -----------------LKPNITNSARHLLEGLLQKDRTKR 281

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  123 bits (310), Expect = 3e-32
 Identities = 72/286 (25%), Positives = 131/286 (45%), Gaps = 54/286 (18%)

Query: 77  RIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDKRYKNREL--QTM---RLL----DHP 124
           +++G G++G VF  + +   +TG+  A+K + +    +  +    T    ++L      P
Sbjct: 60  KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V+L + F     + +L+L  +L+Y+   E    + +      +R     V++Y  +I 
Sbjct: 120 FLVTLHYAF---QTETKLHL--ILDYINGGELFTHLSQR-----ERFTEHEVQIYVGEIV 169

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY-IC-SRYYR 240
            AL ++H  +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y  C +  Y 
Sbjct: 170 LALEHLH-KLGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIEYM 227

Query: 241 APELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK 299
           AP+++ G    +  A+D WS G ++ EL+ G   F  D   +   EI + +    + E  
Sbjct: 228 APDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRI---LKSEPP 284

Query: 300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                                 +P+ M   A DL+ RLL   P  R
Sbjct: 285 ----------------------YPQEMSALAKDLIQRLLMKDPKKR 308

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  123 bits (310), Expect = 3e-32
 Identities = 71/284 (25%), Positives = 127/284 (44%), Gaps = 61/284 (21%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           +++G+GSFG VF A+  +T +  AIK      VL D   +     TM   R+L    +HP
Sbjct: 23  KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVEC----TMVEKRVLSLAWEHP 78

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +  +    F T +   L+   V+EY+   + ++ +         +  +     YA +I 
Sbjct: 79  FLTHMFCT-FQTKEN--LF--FVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEII 128

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRA 241
             L ++H S G+ +RD+K  N+L++   H +K+ DFG  K  + G+   +  C    Y A
Sbjct: 129 LGLQFLH-SKGIVYRDLKLDNILLDKDGH-IKIADFGMCKENMLGDAKTNTFCGTPDYIA 186

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D WS G ++ E+++G+  F G    ++L   I+       +     
Sbjct: 187 PEILLG-QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD-EEELFHSIR------MDNPF-- 236

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                               +P+ +  EA DL+ +L    P  R
Sbjct: 237 --------------------YPRWLEKEAKDLLVKLFVREPEKR 260

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  122 bits (309), Expect = 4e-32
 Identities = 70/282 (24%), Positives = 116/282 (41%), Gaps = 57/282 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
            ++G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 26  MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 83

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  LY   V+EYV   + ++ + +       R    +   YA +I   
Sbjct: 84  TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIG 133

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-YRAPE 243
           L ++  S G+ +RD+K  N++++   H +K+ DFG  K  +         C    Y APE
Sbjct: 134 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 191

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y  ++D W+ G ++ E++ G+  F G+   D+L + I          +     
Sbjct: 192 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNVA---- 239

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                             +PK M  EAV +   L+   P  R
Sbjct: 240 ------------------YPKSMSKEAVAICKGLMTKHPGKR 263

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  122 bits (308), Expect = 4e-32
 Identities = 65/284 (22%), Positives = 121/284 (42%), Gaps = 52/284 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           R++G+GS+  V   +  +T    A+K      V  D+              +     +HP
Sbjct: 15  RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDID----WVQTEKHVFEQASNHP 70

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V L  C F T  +  L+   V+EYV   + +  + +      +++P  + + Y+ +I 
Sbjct: 71  FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEIS 120

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            AL+Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 121 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 178

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D W+ G ++ E+M G+  F      D   +        T + +   
Sbjct: 179 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 227

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                   F  I         P+ +  +A  ++   L   P  R
Sbjct: 228 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 261

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  120 bits (304), Expect = 5e-32
 Identities = 54/288 (18%), Positives = 103/288 (35%), Gaps = 55/288 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----------RELQTMRLLDHP 124
           E+ +G+G FG+V + + ++    VAIK ++                  RE+  M  L+HP
Sbjct: 24  EKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHP 83

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           N+V L        +       +V+E+VP   ++  +         +           I  
Sbjct: 84  NIVKLYGL---MHNP----PRMVMEFVPCGDLYHRL---LDKAHPIKWSVKLRLMLDIAL 133

Query: 184 ALSYIH-RSIGVCHRDIKPQNLLVNPHTHQ----VKLCDFGSAKVLVKGEPNISYICSRY 238
            + Y+  ++  + HRD++  N+ +           K+ DFG ++           + +  
Sbjct: 134 GIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSGLLGNFQ 191

Query: 239 YRAPELIFGATE-YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           + APE I    E YT   D +S   ++  ++ G+  F   S   ++  I  +     R  
Sbjct: 192 WMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYG-KIKFINMIREEGLR-- 248

Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        P I         P+  PP   +++       P  R
Sbjct: 249 -------------PTI---------PEDCPPRLRNVIELCWSGDPKKR 274

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  125 bits (316), Expect = 8e-32
 Identities = 57/236 (24%), Positives = 99/236 (41%), Gaps = 46/236 (19%)

Query: 58  TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQD-------KR 109
             + G+         Y  +  +  G  G ++ A      G  V +K  L           
Sbjct: 76  DIVAGQ---------YEVKGCIAHGGLGWIYLALDRNVNGRPVVLK-GLVHSGDAEAQAM 125

Query: 110 YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN-LVLEYVP-ETVHRVVKHFNKLNQ 167
               E Q +  + HP++V +   F   TD+    +  +V+EYV  +++ R         Q
Sbjct: 126 AM-AERQFLAEVVHPSIVQI-FNFVEHTDRHGDPVGYIVMEYVGGQSLKRS------KGQ 177

Query: 168 RMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL--- 224
           ++P+     Y  +I  ALSY+H  IG+ + D+KP+N+++     Q+KL D G+   +   
Sbjct: 178 KLPVAEAIAYLLEILPALSYLHS-IGLVYNDLKPENIMLTEE--QLKLIDLGAVSRINSF 234

Query: 225 --VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
             + G P         ++APE++      T A DI++ G  +A L L  P   G  
Sbjct: 235 GYLYGTP--------GFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLPTRNGRY 280

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  121 bits (306), Expect = 2e-31
 Identities = 64/284 (22%), Positives = 121/284 (42%), Gaps = 52/284 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYKNRELQTM---RLL----DHP 124
           R++G+GS+  V   +  +T    A++      V  D+              +     +HP
Sbjct: 58  RVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDID----WVQTEKHVFEQASNHP 113

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            +V L  C F T  +  L+   V+EYV   + +  + +      +++P  + + Y+ +I 
Sbjct: 114 FLVGLHSC-FQTESR--LF--FVIEYVNGGDLMFHMQRQ-----RKLPEEHARFYSAEIS 163

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRA 241
            AL+Y+H   G+ +RD+K  N+L++   H +KL D+G  K  ++     S  C +  Y A
Sbjct: 164 LALNYLH-ERGIIYRDLKLDNVLLDSEGH-IKLTDYGMCKEGLRPGDTTSTFCGTPNYIA 221

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE++ G  +Y  ++D W+ G ++ E+M G+  F      D   +        T + +   
Sbjct: 222 PEILRG-EDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ-------NTEDYL--- 270

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                   F  I         P+ +  +A  ++   L   P  R
Sbjct: 271 --------FQVILEKQIR--IPRSLSVKAASVLKSFLNKDPKER 304

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  120 bits (302), Expect = 3e-31
 Identities = 60/209 (28%), Positives = 101/209 (48%), Gaps = 22/209 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 56  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +  + C+            LV+EY   +   +++   K    +  + +    +   + L
Sbjct: 116 TIQYRGCYLREHT-----AWLVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 167

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+H S  + HRD+K  N+L++     VKL DFGSA ++       S++ + Y+ APE+I
Sbjct: 168 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIMAPAN---SFVGTPYWMAPEVI 222

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKP 272
               E  Y   +D+WS G    EL   KP
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKP 251

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  118 bits (297), Expect = 8e-31
 Identities = 53/207 (25%), Positives = 96/207 (46%), Gaps = 20/207 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +     +G+GSFG VF+     T + VAIK +  ++         +E+  +   D P V 
Sbjct: 24  FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                +   T      L +++EY+   +   +++    L++      +     +I + L 
Sbjct: 84  KYYGSYLKDTK-----LWIIMEYLGGGSALDLLEP-GPLDET----QIATILREILKGLD 133

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 245
           Y+H S    HRDIK  N+L++    +VKL DFG + ++        +++ + ++ APE+I
Sbjct: 134 YLH-SEKKIHRDIKAANVLLS-EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVI 191

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKP 272
             +  Y +  DIWS G    EL  G+P
Sbjct: 192 KQS-AYDSKADIWSLGITAIELARGEP 217

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  117 bits (296), Expect = 1e-30
 Identities = 53/210 (25%), Positives = 103/210 (49%), Gaps = 19/210 (9%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           +  +G GSFG V +A+    G  VA+K +++   +        RE+  M+ L HPN+V  
Sbjct: 42  KEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLF 99

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
                + T    L   +V EY+   +++R++ H +   +++        AY + + ++Y+
Sbjct: 100 MG---AVTQPPNLS--IVTEYLSRGSLYRLL-HKSGAREQLDERRRLSMAYDVAKGMNYL 153

Query: 189 H-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYRAPELIF 246
           H R+  + HR++K  NLLV+   + VK+CDFG +++      +  S   +  + APE++ 
Sbjct: 154 HNRNPPIVHRNLKSPNLLVDKK-YTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLR 212

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
                    D++S G ++ EL   +  +  
Sbjct: 213 D-EPSNEKSDVYSFGVILWELATLQQPWGN 241

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  117 bits (295), Expect = 1e-30
 Identities = 62/215 (28%), Positives = 102/215 (47%), Gaps = 21/215 (9%)

Query: 64  NGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMR 119
            G PK+   Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR
Sbjct: 15  VGDPKKK--YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMR 72

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYA 178
              +PN+V+    +      DEL+  +V+EY+   ++  VV         M    +    
Sbjct: 73  ENKNPNIVNYLDSYLV---GDELW--VVMEYLAGGSLTDVVT-----ETCMDEGQIAAVC 122

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN-ISYICSR 237
            +  +AL ++H S  V HRDIK  N+L+      VKL DFG    +   +    + + + 
Sbjct: 123 RECLQALEFLH-SNQVIHRDIKSDNILLG-MDGSVKLTDFGFCAQITPEQSKRSTMVGTP 180

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           Y+ APE++     Y   +DIWS G +  E++ G+P
Sbjct: 181 YWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP 214

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  116 bits (292), Expect = 2e-30
 Identities = 57/221 (25%), Positives = 102/221 (46%), Gaps = 36/221 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--------RELQTMRLLDHPNVV 127
           E I+G G FG V++A  +  G+ VA+K    D             +E +   +L HPN++
Sbjct: 12  EEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNII 69

Query: 128 SLK-HCFFSTTDKDELYLNLVLEYVPE-TVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRA 184
           +L+  C      +  L   LV+E+     ++RV+       +  +        A QI R 
Sbjct: 70  ALRGVC----LKEPNLC--LVMEFARGGPLNRVLSGKRIPPDILVNW------AVQIARG 117

Query: 185 LSYIHRS--IGVCHRDIKPQNLLVN-------PHTHQVKLCDFGSAKVLVKGEPNISYIC 235
           ++Y+H    + + HRD+K  N+L+             +K+ DFG A+   +    +S   
Sbjct: 118 MNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAG 176

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
           +  + APE+I  +  ++   D+WS G ++ EL+ G+  F G
Sbjct: 177 AYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRG 216

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  116 bits (293), Expect = 3e-30
 Identities = 53/225 (23%), Positives = 98/225 (43%), Gaps = 39/225 (17%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKN--RELQTMRLLDHPNVVSLKH 131
             ++G+G FG   +    ETGE + +K++++  ++  +   +E++ MR L+HPNV+    
Sbjct: 15  GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKF-- 72

Query: 132 CFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
                     L    + EY+        +  +   +   +QR+        A  I   ++
Sbjct: 73  -IGVLYKDKRLN--FITEYIKGGTLRGIIKSMDSQYP-WSQRVSF------AKDIASGMA 122

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--------- 237
           Y+H S+ + HRD+   N LV      V + DFG A+++V  +     + S          
Sbjct: 123 YLH-SMNIIHRDLNSHNCLVR-ENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRY 180

Query: 238 ------YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
                 Y+ APE+I G   Y   +D++S G V+ E++      P 
Sbjct: 181 TVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPD 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  115 bits (290), Expect = 9e-30
 Identities = 59/200 (29%), Positives = 102/200 (51%), Gaps = 19/200 (9%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVSLKHCFF 134
           +G+GS G+V  A+   +G  VA+K +     Q +     E+  MR   H NVV +   + 
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYL 112

Query: 135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
                +EL+  +++E++    +  +V        R+    +      + +AL+Y+H + G
Sbjct: 113 V---GEELW--VLMEFLQGGALTDIVSQ-----VRLNEEQIATVCEAVLQALAYLH-AQG 161

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGATEYT 252
           V HRDIK  ++L+     +VKL DFG  A++        S + + Y+ APE+I   + Y 
Sbjct: 162 VIHRDIKSDSILLT-LDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYA 219

Query: 253 TAIDIWSAGCVVAELMLGKP 272
           T +DIWS G +V E++ G+P
Sbjct: 220 TEVDIWSLGIMVIEMVDGEP 239

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  119 bits (299), Expect = 1e-29
 Identities = 70/282 (24%), Positives = 117/282 (41%), Gaps = 57/282 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIK-----KVLQDKRYK-----NRELQTMRLLDHPNV 126
            ++G+GSFG V  ++   T E  A+K      V+QD   +      R L        P +
Sbjct: 347 MVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG--KPPFL 404

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
             L  C F T D+  LY   V+EYV   + ++ + +       R    +   YA +I   
Sbjct: 405 TQLHSC-FQTMDR--LY--FVMEYVNGGDLMYHIQQV-----GRFKEPHAVFYAAEIAIG 454

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++  S G+ +RD+K  N++++   H +K+ DFG  K  +         C +  Y APE
Sbjct: 455 LFFLQ-SKGIIYRDLKLDNVMLDSEGH-IKIADFGMCKENIWDGVTTKTFCGTPDYIAPE 512

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           +I     Y  ++D W+ G ++ E++ G+  F G+   D+L + I          +     
Sbjct: 513 IIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGED-EDELFQSI------MEHNVA---- 560

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                             +PK M  EAV +   L+   P  R
Sbjct: 561 ------------------YPKSMSKEAVAICKGLMTKHPGKR 584

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  114 bits (288), Expect = 2e-29
 Identities = 56/210 (26%), Positives = 101/210 (48%), Gaps = 20/210 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           +     +G G+FG V++AK  ETG   A K +     ++      E++ +   DHP +V 
Sbjct: 21  WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           L   ++         L +++E+ P   V  ++   ++    +    +++   Q+  AL++
Sbjct: 81  LLGAYYHDGK-----LWIMIEFCPGGAVDAIMLELDR---GLTEPQIQVVCRQMLEALNF 132

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIF 246
           +H S  + HRD+K  N+L+      ++L DFG SAK L   +   S+I + Y+ APE++ 
Sbjct: 133 LH-SKRIIHRDLKAGNVLMT-LEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVM 190

Query: 247 GAT----EYTTAIDIWSAGCVVAELMLGKP 272
             T     Y    DIWS G  + E+   +P
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  113 bits (286), Expect = 2e-29
 Identities = 57/282 (20%), Positives = 109/282 (38%), Gaps = 49/282 (17%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 29  GQRIGSGSFGTVYKGKWHGD---VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILL- 84

Query: 130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
              F   +   +L   +V ++    +++  +        +  M  +   A Q  R + Y+
Sbjct: 85  ---FMGYSTAPQLA--IVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYL 136

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELI 245
           H +  + HRD+K  N+ ++   + VK+ DFG A    +   +  +     S  + APE+I
Sbjct: 137 H-AKSIIHRDLKSNNIFLHED-NTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
                  Y+   D+++ G V+ ELM G+  +   +  DQ   II+++G  +         
Sbjct: 195 RMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSL-------- 243

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                        P         P     L++  L+   + R
Sbjct: 244 ------------SPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  114 bits (287), Expect = 2e-29
 Identities = 55/219 (25%), Positives = 93/219 (42%), Gaps = 28/219 (12%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYK---NRELQTMRLLDHP 124
           Y   R+VG+G  G V++A+       VA+K ++      D  ++    RE +T   L  P
Sbjct: 36  YRLRRLVGRGGMGDVYEAEDTVRERIVALK-LMSETLSSDPVFRTRMQREARTAGRLQEP 94

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           +VV +           +LY+   +  +    +  +++        +          QI  
Sbjct: 95  HVVPI---HDFGEIDGQLYV--DMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGS 145

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYY 239
           AL   H + G  HRD+KP+N+LV+       L DFG A      +  +    + + + YY
Sbjct: 146 ALDAAHAA-GATHRDVKPENILVSA-DDFAYLVDFGIASAT--TDEKLTQLGNTVGTLYY 201

Query: 240 RAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS 278
            APE    +   T   DI++  CV+ E + G P + GD 
Sbjct: 202 MAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQ 239

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  113 bits (286), Expect = 3e-29
 Identities = 61/204 (29%), Positives = 98/204 (48%), Gaps = 15/204 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLK 130
           +     +G+GS+G V++A   ETG+ VAIK+V  +   +   +E+  M+  D P+VV   
Sbjct: 31  FDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYY 90

Query: 131 HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
             +F  TD     L +V+EY    +V  +++  NK    +    +        + L Y+H
Sbjct: 91  GSYFKNTD-----LWIVMEYCGAGSVSDIIRLRNK---TLTEDEIATILQSTLKGLEYLH 142

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELIFGA 248
             +   HRDIK  N+L+N      KL DFG + ++        + I + ++ APE+I   
Sbjct: 143 -FMRKIHRDIKAGNILLN-TEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI 200

Query: 249 TEYTTAIDIWSAGCVVAELMLGKP 272
             Y    DIWS G    E+  GKP
Sbjct: 201 -GYNCVADIWSLGITAIEMAEGKP 223

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  113 bits (285), Expect = 3e-29
 Identities = 64/241 (26%), Positives = 106/241 (43%), Gaps = 39/241 (16%)

Query: 54  HIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------ 107
           H+I   I  R         Y     +G G    V+ A+       VAIK  +        
Sbjct: 3   HMIGKIINER---------YKIVDKLGGGGMSTVYLAEDTILNIKVAIK-AIFIPPREKE 52

Query: 108 ---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFN 163
              KR++ RE+     L H N+VS+        + D  YL  V+EY+   T+   ++   
Sbjct: 53  ETLKRFE-REVHNSSQLSHQNIVSM---IDVDEEDDCYYL--VMEYIEGPTLSEYIES-- 104

Query: 164 KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV 223
             +  + +     +  QI   + + H    + HRDIKPQN+L++     +K+ DFG AK 
Sbjct: 105 --HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDS-NKTLKIFDFGIAKA 160

Query: 224 LVKGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG 279
           L   E +++     + +  Y +PE   G        DI+S G V+ E+++G+P F G++ 
Sbjct: 161 L--SETSLTQTNHVLGTVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGETA 217

Query: 280 V 280
           V
Sbjct: 218 V 218

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  113 bits (285), Expect = 4e-29
 Identities = 63/239 (26%), Positives = 106/239 (44%), Gaps = 37/239 (15%)

Query: 58  TTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-----QDKRYKN 112
           + +  R         Y    I+G G    V  A+ L     VA+K VL     +D  +  
Sbjct: 8   SHLSDR---------YELGEILGFGGMSEVHLARDLRDHRDVAVK-VLRADLARDPSFYL 57

Query: 113 R---ELQTMRLLDHPNVVSLKHCFF---STTDKDELYLNLVLEYVP-ETVHRVVKHFNKL 165
           R   E Q    L+HP +V++    +              +V+EYV   T+  +V      
Sbjct: 58  RFRREAQNAAALNHPAIVAV----YDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT---- 109

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
              M             +AL++ H++ G+ HRD+KP N++++  T+ VK+ DFG A+ + 
Sbjct: 110 EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISA-TNAVKVMDFGIARAIA 167

Query: 226 KGEPNISY----ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV 280
               +++     I +  Y +PE   G +      D++S GCV+ E++ G+P F GDS V
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPEQARGDSV-DARSDVYSLGCVLYEVLTGEPPFTGDSPV 225

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  113 bits (284), Expect = 9e-29
 Identities = 57/211 (27%), Positives = 100/211 (47%), Gaps = 15/211 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMR-LLDHPNVVS 128
           +    +VG G++G V++ + ++TG+  AIK +     ++    +E+  ++    H N+ +
Sbjct: 26  FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIAT 85

Query: 129 LKHCFF-STTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
               F        +  L LV+E+    +V  ++K  N     +   ++     +I R LS
Sbjct: 86  YYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIK--NTKGNTLKEEWIAYICREILRGLS 143

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG-SAKVLVKGEPNISYICSRYYRAPELI 245
           ++H    V HRDIK QN+L+     +VKL DFG SA++        ++I + Y+ APE+I
Sbjct: 144 HLH-QHKVIHRDIKGQNVLLT-ENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI 201

Query: 246 ----FGATEYTTAIDIWSAGCVVAELMLGKP 272
                    Y    D+WS G    E+  G P
Sbjct: 202 ACDENPDATYDFKSDLWSLGITAIEMAEGAP 232

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  112 bits (281), Expect = 2e-28
 Identities = 43/216 (19%), Positives = 86/216 (39%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
            + +G+G +G V+  K    GE VA+K     ++    RE  +    L+ H N++  +  
Sbjct: 42  VKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAA 99

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFN-KLNQRMPMIYVKLYAYQIFRALSYIH 189
               T    +LYL  + +Y    +++  +K         + +      AY     L ++H
Sbjct: 100 DIKGTGSWTQLYL--ITDYHENGSLYDYLKSTTLDAKSMLKL------AYSSVSGLCHLH 151

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A   +     +    +     +
Sbjct: 152 TEIFSTQGKPAIAHRDLKSKNILVKKN-GTCCIADLGLAVKFISDTNEVDIPPNTRVGTK 210

Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAELM 268
            Y  PE++  +      +     D++S G ++ E+ 
Sbjct: 211 RYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVA 246

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  110 bits (278), Expect = 4e-28
 Identities = 45/216 (20%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
              VG+G +G V++      GE VA+K    +D++   RE  L    +L H N++  +  
Sbjct: 13  LECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIAS 70

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVV-KHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              S     +L+L  +  Y    +++  +          + +         I   L+++H
Sbjct: 71  DMTSRHSSTQLWL--ITHYHEMGSLYDYLQLTTLDTVSCLRI------VLSIASGLAHLH 122

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A +  +    +    +     +
Sbjct: 123 IEIFGTQGKPAIAHRDLKSKNILVKKNGQ-CCIADLGLAVMHSQSTNQLDVGNNPRVGTK 181

Query: 238 YYRAPELI-----FGATEYTTAIDIWSAGCVVAELM 268
            Y APE++         +    +DIW+ G V+ E+ 
Sbjct: 182 RYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  109 bits (274), Expect = 7e-28
 Identities = 27/215 (12%), Positives = 72/215 (33%), Gaps = 30/215 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSL 129
              + +   G +++ +    G  + +K +          R  N E   +R+  HPNV+ +
Sbjct: 15  LTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPV 72

Query: 130 KHCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
                        +  L+  ++P       +H         +Q +        A  + R 
Sbjct: 73  LGA---CQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF------ALDMARG 123

Query: 185 LSYIH-RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPE 243
           ++++H     +    +  ++++++      ++                  + +  + APE
Sbjct: 124 MAFLHTLEPLIPRHALNSRSVMIDED-MTARISMADVKFSFQSP----GRMYAPAWVAPE 178

Query: 244 LIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
            +          + D+WS   ++ EL+  +  F  
Sbjct: 179 ALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  108 bits (273), Expect = 2e-27
 Identities = 43/225 (19%), Positives = 87/225 (38%), Gaps = 41/225 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
             ++G+G FG V+  +       VAI+ +  ++  ++      RE+   R   H NVV  
Sbjct: 38  GELIGKGRFGQVYHGRWHGE---VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLF 94

Query: 130 K-HCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
              C         L +  +       T++ VV+        + +   +  A +I + + Y
Sbjct: 95  MGAC----MSPPHLAI--ITSLCKGRTLYSVVR---DAKIVLDVNKTRQIAQEIVKGMGY 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--------Y 239
           +H + G+ H+D+K +N+  +     V + DFG     + G         +         +
Sbjct: 146 LH-AKGILHKDLKSKNVFYDNGK--VVITDFGLFS--ISGVLQAGRREDKLRIQNGWLCH 200

Query: 240 RAPELIFGATE--------YTTAIDIWSAGCVVAELMLGKPLFPG 276
            APE+I   +         ++   D+++ G +  EL   +  F  
Sbjct: 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  107 bits (270), Expect = 1e-26
 Identities = 46/216 (21%), Positives = 87/216 (40%), Gaps = 34/216 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNVVS-LKH 131
           +  +G+G FG V++ K    GE VA+K    +++R   RE  +    +L H N++  +  
Sbjct: 47  QESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAA 104

Query: 132 CFFSTTDKDELYLNLVLEYVPE-TVHRVVK-HFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    +L+L  V +Y    ++   +  +   +   + +      A      L+++H
Sbjct: 105 DNKDNGTWTQLWL--VSDYHEHGSLFDYLNRYTVTVEGMIKL------ALSTASGLAHLH 156

Query: 190 RSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS-----R 237
             I        + HRD+K +N+LV  +     + D G A         I    +     +
Sbjct: 157 MEIVGTQGKPAIAHRDLKSKNILVKKNGT-CCIADLGLAVRHDSATDTIDIAPNHRVGTK 215

Query: 238 YYRAPELIFGAT-----EYTTAIDIWSAGCVVAELM 268
            Y APE++  +      E     DI++ G V  E+ 
Sbjct: 216 RYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  107 bits (268), Expect = 1e-26
 Identities = 55/255 (21%), Positives = 106/255 (41%), Gaps = 39/255 (15%)

Query: 70  TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVL-QDKRYKNRE--LQTMRLLDHPNV 126
           ++      +  +G FG V++A+     E VA+K    QDK+    E  + ++  + H N+
Sbjct: 23  SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENI 80

Query: 127 VS-LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVK-HFNKLNQRMPMIYVKLYAYQIFR 183
           +  +      T+   +L+L  +  +  + ++   +K +    N+   +      A  + R
Sbjct: 81  LQFIGAEKRGTSVDVDLWL--ITAFHEKGSLSDFLKANVVSWNELCHI------AETMAR 132

Query: 184 ALSYIHRSI---------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
            L+Y+H  I          + HRDIK +N+L+  +     + DFG A      E   S  
Sbjct: 133 GLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNN-LTACIADFGLALKF---EAGKSAG 188

Query: 235 CSRY------YRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV 284
            +        Y APE++ GA     +    ID+++ G V+ EL        G      L 
Sbjct: 189 DTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLP 248

Query: 285 EIIKVLGTPTREEIK 299
              ++   P+ E+++
Sbjct: 249 FEEEIGQHPSLEDMQ 263

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  103 bits (259), Expect = 2e-25
 Identities = 50/254 (19%), Positives = 96/254 (37%), Gaps = 39/254 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRELQTMRL--LDHPNVVSLKHC 132
             ++G+G +G V++         VA+K     +++    E    R+  ++H N+      
Sbjct: 18  LELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVG 75

Query: 133 FFSTTDKDELYLNLVLEYVPET--VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
               T    +   LV+EY P       +  H +       +      A+ + R L+Y+H 
Sbjct: 76  DERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL------AHSVTRGLAYLHT 129

Query: 191 SI--------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---------PNISY 233
            +         + HRD+  +N+LV        + DFG +  L               IS 
Sbjct: 130 ELPRGDHYKPAISHRDLNSRNVLVKNDGT-CVISDFGLSMRLTGNRLVRPGEEDNAAISE 188

Query: 234 ICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD--QLVE 285
           + +  Y APE++ GA            +D+++ G +  E+ +          V   Q+  
Sbjct: 189 VGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAF 248

Query: 286 IIKVLGTPTREEIK 299
             +V   PT E+++
Sbjct: 249 QTEVGNHPTFEDMQ 262

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 94.0 bits (234), Expect = 3e-22
 Identities = 33/267 (12%), Positives = 57/267 (21%), Gaps = 60/267 (22%)

Query: 35  RDDKEMEATVVDGNGTETGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLE 94
           R+     +   D      G        GR         Y      G       +QA    
Sbjct: 7   REPDRESSAPPDDVQLVPGA---RIANGR---------YRLLIFHGGVPPLQFWQALDTA 54

Query: 95  TGETVAIKKVL----QDKRYKNR---ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV 147
               VA+  V                    +  +D P V  +         +    +  V
Sbjct: 55  LDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARV---LDVVHTRAGGLV--V 109

Query: 148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV 206
            E++   ++  V       +     +        +  A    HR+ GV      P  + V
Sbjct: 110 AEWIRGGSLQEV------ADTSPSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRV 162

Query: 207 NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAE 266
           +     V L                                        DI   G  +  
Sbjct: 163 SI-DGDVVLAYPA-------------------TMPDA--------NPQDDIRGIGASLYA 194

Query: 267 LMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           L++ +   P       L    +     
Sbjct: 195 LLVNRWPLPEAGVRSGLAPAERDTAGQ 221

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 93.6 bits (233), Expect = 1e-21
 Identities = 61/233 (26%), Positives = 102/233 (43%), Gaps = 40/233 (17%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            R +G+G FG V           TGE VA+K +  D   ++     +E+  +R L H ++
Sbjct: 36  IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +  K C     D     L LV+EYVP      ++ +      + +  + L+A QI   ++
Sbjct: 96  IKYKGC---CEDAGAASLQLVMEYVP---LGSLRDYLP-RHSIGLAQLLLFAQQICEGMA 148

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+H +    HRD+  +N+L++ +   VK+ DFG AK + +G          YYR      
Sbjct: 149 YLH-AQHYIHRDLAARNVLLD-NDRLVKIGDFGLAKAVPEGH--------EYYRVREDGD 198

Query: 241 ------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEI 286
                 APE +     +  A D+WS G  + EL+          +   +L+ I
Sbjct: 199 SPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI 250

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 92.7 bits (231), Expect = 2e-21
 Identities = 57/238 (23%), Positives = 99/238 (41%), Gaps = 52/238 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
             L   C         +   L+ + +P      +  + + ++  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           ++Y+   R +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    A E ++     YT   D+WS G  V ELM  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHR--IYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 91.6 bits (228), Expect = 3e-21
 Identities = 57/216 (26%), Positives = 100/216 (46%), Gaps = 42/216 (19%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            + +G+G+FG V   +       TGE VA+KK LQ    ++     RE++ ++ L H N+
Sbjct: 15  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKK-LQHSTEEHLRDFEREIEILKSLQHDNI 73

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K             L L++EY+P       + KH  +++    +     Y  QI + 
Sbjct: 74  VKYKGV---CYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLL----QYTSQICKG 126

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  +    HRD+  +N+LV    ++VK+ DFG  KVL + +         +++    
Sbjct: 127 MEYLG-TKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDKE--------FFKVKEP 176

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM 268
                   APE +   ++++ A D+WS G V+ EL 
Sbjct: 177 GESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 211

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 90.9 bits (226), Expect = 7e-21
 Identities = 56/215 (26%), Positives = 105/215 (48%), Gaps = 40/215 (18%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIK--KVLQDKRYKN--RELQTMRLLDHPNVV 127
            + +G+G+FG V   +       TGE VA+K  +   ++  ++  RE++ ++ L H N+V
Sbjct: 46  LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 105

Query: 128 SLKHCFFSTTDKDE-LYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
             K      +     L   L++EY+P   +  ++ + + ++ R+  I +  Y  QI + +
Sbjct: 106 KYKGV--CYSAGRRNLK--LIMEYLP---YGSLRDYLQKHKERIDHIKLLQYTSQICKGM 158

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  +    HRD+  +N+LV    ++VK+ DFG  KVL + +         YY+     
Sbjct: 159 EYLG-TKRYIHRDLATRNILVENE-NRVKIGDFGLTKVLPQDK--------EYYKVKEPG 208

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM 268
                  APE +   ++++ A D+WS G V+ EL 
Sbjct: 209 ESPIFWYAPESLT-ESKFSVASDVWSFGVVLYELF 242

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 90.1 bits (224), Expect = 2e-20
 Identities = 50/232 (21%), Positives = 89/232 (38%), Gaps = 48/232 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
            R++G+G FG V +A+  +       VA+K +  D    +      RE   M+  DHP+V
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYA 178
             L      S          ++L ++            R+ ++   L  +  ++    + 
Sbjct: 88  AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT-LVR---FM 143

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             I   + Y+  S    HRD+  +N ++      V + DFG ++ +  G+         Y
Sbjct: 144 VDIACGMEYLS-SRNFIHRDLAARNCMLAED-MTVCVADFGLSRKIYSGD---------Y 192

Query: 239 YR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           YR            A E L      YT   D+W+ G  + E+M  G+  + G
Sbjct: 193 YRQGCASKLPVKWLALESLADN--LYTVHSDVWAFGVTMWEIMTRGQTPYAG 242

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 89.3 bits (222), Expect = 2e-20
 Identities = 59/216 (27%), Positives = 97/216 (44%), Gaps = 41/216 (18%)

Query: 76  ERIVGQGSFGVVFQAKCL----ETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            R +G+G FG V   +       TGE VA+K +  +    +     +E++ +R L H N+
Sbjct: 26  IRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENI 85

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           V  K      T+     + L++E++P       + K+ NK+N +  +     YA QI + 
Sbjct: 86  VKYKGI---CTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQL----KYAVQICKG 138

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  S    HRD+  +N+LV    HQVK+ DFG  K +   +         YY     
Sbjct: 139 MDYLG-SRQYVHRDLAARNVLVE-SEHQVKIGDFGLTKAIETDK--------EYYTVKDD 188

Query: 241 --------APELIFGATEYTTAIDIWSAGCVVAELM 268
                   APE +  +  +  A D+WS G  + EL+
Sbjct: 189 RDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELL 223

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 88.9 bits (221), Expect = 4e-20
 Identities = 57/215 (26%), Positives = 92/215 (42%), Gaps = 40/215 (18%)

Query: 76  ERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
              +G+G+FG V   +       TG  VA+K  LQ           RE+Q ++ L    +
Sbjct: 28  ISQLGKGNFGSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFI 86

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V  +        +  L   LV+EY+P      ++ F + ++ R+    + LY+ QI + +
Sbjct: 87  VKYRGV-SYGPGRQSLR--LVMEYLP---SGCLRDFLQRHRARLDASRLLLYSSQICKGM 140

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+  S    HRD+  +N+LV      VK+ DFG AK+L   +         YY      
Sbjct: 141 EYLG-SRRCVHRDLAARNILVE-SEAHVKIADFGLAKLLPLDK--------DYYVVREPG 190

Query: 241 -------APELIFGATEYTTAIDIWSAGCVVAELM 268
                  APE +     ++   D+WS G V+ EL 
Sbjct: 191 QSPIFWYAPESLS-DNIFSRQSDVWSFGVVLYELF 224

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 88.5 bits (220), Expect = 5e-20
 Identities = 56/252 (22%), Positives = 97/252 (38%), Gaps = 56/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            + +G G+FG V +A        +   TVA+K +     L ++     EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPM 171
           N+V+L       T        ++ EY                 +          +  + +
Sbjct: 88  NIVNLLGA---CTIGGPTL--VITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L  ++YQ+ + ++++  S    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHG-RITKICDFGLARDIKNDS- 199

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                    Y             APE IF    YT   D+WS G  + EL  LG   +PG
Sbjct: 200 --------NYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPG 250

Query: 277 DSGVDQLVEIIK 288
                +  ++IK
Sbjct: 251 MPVDSKFYKMIK 262

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 90.2 bits (224), Expect = 5e-20
 Identities = 53/224 (23%), Positives = 98/224 (43%), Gaps = 29/224 (12%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 225 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 284

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
               T +   Y  ++ E++    +  +  + +   R  +  V L   A QI  A+ Y+  
Sbjct: 285 ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 335

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
                HR++  +N LV    H VK+ DFG ++++        Y      +      APE 
Sbjct: 336 KKNFIHRNLAARNCLVG-ENHLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 390

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG--DSGVDQLVE 285
           +     ++   D+W+ G ++ E+   G   +PG   S V +L+E
Sbjct: 391 LAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE 433

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 87.0 bits (216), Expect = 1e-19
 Identities = 46/231 (19%), Positives = 85/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
            +I+G+G FG V +    +       VA+K +  D   +        E   M+   HPNV
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           + L       + +      ++L ++            R+      +  +  ++    +  
Sbjct: 99  IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQT-LLK---FMV 154

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
            I   + Y+  +    HRD+  +N ++      V + DFG +K +  G+         YY
Sbjct: 155 DIALGMEYLS-NRNFLHRDLAARNCMLRDD-MTVCVADFGLSKKIYSGD---------YY 203

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R            A E L      YT+  D+W+ G  + E+   G   +PG
Sbjct: 204 RQGRIAKMPVKWIAIESLADRV--YTSKSDVWAFGVTMWEIATRGMTPYPG 252

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 86.5 bits (215), Expect = 2e-19
 Identities = 48/232 (20%), Positives = 94/232 (40%), Gaps = 47/232 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKV---LQDKRYKN---RELQTMRLLDHPN 125
           + ++ +G G+FG V +           VA+K +     D   K+    E   M+ LD+P 
Sbjct: 20  LEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPY 79

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V +        + +     LV+E         +  + + N+ +    +    +Q+   +
Sbjct: 80  IVRM----IGICEAESWM--LVMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGM 130

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HRD+  +N+L+    H  K+ DFG +K L   E         YY+   
Sbjct: 131 KYLEESNFV---HRDLAARNVLLVTQ-HYAKISDFGLSKALRADEN--------YYKAQT 178

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                    APE + +   ++++  D+WS G ++ E    G+  + G  G +
Sbjct: 179 HGKWPVKWYAPECINYY--KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 228

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 86.6 bits (215), Expect = 3e-19
 Identities = 58/237 (24%), Positives = 98/237 (41%), Gaps = 50/237 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V
Sbjct: 20  IKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHV 79

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
             L   C         +   L+ + +P      +  + + ++  +   Y+  +  QI + 
Sbjct: 80  CRLLGICL-----TSTVQ--LITQLMP---FGCLLDYVREHKDNIGSQYLLNWCVQIAKG 129

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           ++Y+   R +   HRD+  +N+LV      VK+ DFG AK+L   E          Y   
Sbjct: 130 MNYLEDRRLV---HRDLAARNVLVK-TPQHVKITDFGLAKLLGAEEK--------EYHAE 177

Query: 241 ---------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    A E I     YT   D+WS G  V ELM  G   + G    +   ++E
Sbjct: 178 GGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 233

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 86.2 bits (214), Expect = 3e-19
 Identities = 59/249 (23%), Positives = 104/249 (41%), Gaps = 53/249 (21%)

Query: 77  RIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLD-HPN 125
           + +G+G+FG V +A         T  TVA+K +       + R    EL+ +  +  H N
Sbjct: 33  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 92

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMI 172
           VV+L      T     L   +++E+               E V   V   +     + + 
Sbjct: 93  VVNLLGA--CTKPGGPLM--VIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLE 148

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
           ++  Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K      
Sbjct: 149 HLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEK-NVVKICDFGLARDIYKDP---- 202

Query: 233 YICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG 279
                 Y             APE IF    YT   D+WS G ++ E+  LG   +PG   
Sbjct: 203 -----DYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256

Query: 280 VDQLVEIIK 288
            ++    +K
Sbjct: 257 DEEFCRRLK 265

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 86.9 bits (216), Expect = 4e-19
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 45/223 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 130
              +G+G+FG VF  +       VA+K   +      +     E + ++   HPN+V L 
Sbjct: 119 GEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRL- 177

Query: 131 H--CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALSY 187
              C    T K  +Y  +V+E V          F +       +   L         + Y
Sbjct: 178 IGVC----TQKQPIY--IVMELVQ---GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY 228

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------- 240
           +  S    HRD+  +N LV    + +K+ DFG ++    G          Y         
Sbjct: 229 LE-SKCCIHRDLAARNCLVTEK-NVLKISDFGMSREEADGV---------YAASGGLRQV 277

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                APE L +G   Y++  D+WS G ++ E   LG   +P 
Sbjct: 278 PVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPN 318

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 85.3 bits (212), Expect = 4e-19
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 26  LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 82

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHRS 191
               +K  LY  +V EY+       +  + +   R  +    L  ++  +  A+ Y+   
Sbjct: 83  -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 135

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 244
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 136 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 186

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                +++T  D+WS G ++ E+   G+  +P 
Sbjct: 187 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 217

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 59/224 (26%), Positives = 96/224 (42%), Gaps = 31/224 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 189 EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 244

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  +V EY+       +  F K      +   +L   A QI   ++Y+  
Sbjct: 245 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 297

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 298 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 352

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG--DSGVDQLVE 285
                 +T   D+WS G ++ EL   G+  +PG  +  V   VE
Sbjct: 353 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 395

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 87.0 bits (216), Expect = 4e-19
 Identities = 50/213 (23%), Positives = 85/213 (39%), Gaps = 33/213 (15%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCF 133
            + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L    
Sbjct: 198 LQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGV- 254

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHRS 191
               +K  LY  +V EY+       +  + +   R  +    L  ++  +  A+ Y+   
Sbjct: 255 -IVEEKGGLY--IVTEYMA---KGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE-G 307

Query: 192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE-L 244
               HRD+  +N+LV+   +  K+ DFG  K                 +      APE L
Sbjct: 308 NNFVHRDLAARNVLVSED-NVAKVSDFGLTKEA--------SSTQDTGKLPVKWTAPEAL 358

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                +++T  D+WS G ++ E+   G+  +P 
Sbjct: 359 REK--KFSTKSDVWSFGILLWEIYSFGRVPYPR 389

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 87.2 bits (216), Expect = 5e-19
 Identities = 58/224 (25%), Positives = 95/224 (42%), Gaps = 31/224 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 272 EVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQL--- 327

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  +V EY+       +  F K      +   +L   A QI   ++Y+  
Sbjct: 328 -YAVVSEEPIY--IVTEYMS---KGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE- 380

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APEL 244
            +   HRD++  N+LV  +    K+ DFG A+++   E    Y   +  +      APE 
Sbjct: 381 RMNYVHRDLRAANILVGEN-LVCKVADFGLARLIEDNE----YTARQGAKFPIKWTAPEA 435

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                 +T   D+WS G ++ EL   G+  +PG    +    VE
Sbjct: 436 ALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 478

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 85.5 bits (212), Expect = 6e-19
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 34/229 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
            +++G G FG V +   +  GE     V IK +      ++       +  +  LDH ++
Sbjct: 18  LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L            L   LV +Y+P      +    + ++  +    +  +  QI + +
Sbjct: 78  VRL----LGLCPGSSLQ--LVTQYLP---LGSLLDHVRQHRGALGPQLLLNWGVQIAKGM 128

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+    G+ HR++  +N+L+     QV++ DFG A +L   +     +     +     
Sbjct: 129 YYLE-EHGMVHRNLAARNVLLKSP-SQVQVADFGVADLLPPDD---KQLLYSEAKTPIKW 183

Query: 241 -APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
            A E I     YT   D+WS G  V ELM  G   + G    +   L+E
Sbjct: 184 MALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLE 231

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 85.1 bits (211), Expect = 7e-19
 Identities = 37/157 (23%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 129
           Y   R +G+GSFGV+F+   L   + VAIK   +         E +T +LL     + ++
Sbjct: 12  YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNV 71

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +       ++ L+  LV++ +  ++       +   ++  +  V + A Q+   +  IH
Sbjct: 72  YYF-----GQEGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMAAKQMLARVQSIH 123

Query: 190 RSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
               + +RDIKP N L+    + + + + + DFG  K
Sbjct: 124 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.4 bits (212), Expect = 7e-19
 Identities = 53/243 (21%), Positives = 98/243 (40%), Gaps = 50/243 (20%)

Query: 77  RIVGQGSFGVVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTMRLLDHPNV 126
           R +GQGSFG+V++       +      VAIK V     ++++     E   M+  +  +V
Sbjct: 31  RELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHV 90

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYAY 179
           V L       +        +++E +            R     N +     +  +   A 
Sbjct: 91  VRLLGV---VSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG 145

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYY 239
           +I   ++Y++ +    HRD+  +N +V      VK+ DFG  + + + +         YY
Sbjct: 146 EIADGMAYLN-ANKFVHRDLAARNCMVAED-FTVKIGDFGMTRDIYETD---------YY 194

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
           R            +PE L  G   +TT  D+WS G V+ E+  L +  + G S  +Q++ 
Sbjct: 195 RKGGKGLLPVRWMSPESLKDG--VFTTYSDVWSFGVVLWEIATLAEQPYQGLS-NEQVLR 251

Query: 286 IIK 288
            + 
Sbjct: 252 FVM 254

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 51/214 (23%), Positives = 95/214 (44%), Gaps = 29/214 (13%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 18  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 77

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
               T +   Y  ++ E++    +  +  + +   R  +  V L   A QI  A+ Y+  
Sbjct: 78  ---CTREPPFY--IITEFMT---YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLE- 128

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------APE- 243
                HRD+  +N LV  + H VK+ DFG ++++        Y      +      APE 
Sbjct: 129 KKNFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDT----YTAHAGAKFPIKWTAPES 183

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           L +   +++   D+W+ G ++ E+   G   +PG
Sbjct: 184 LAYN--KFSIKSDVWAFGVLLWEIATYGMSPYPG 215

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 84.6 bits (210), Expect = 7e-19
 Identities = 46/233 (19%), Positives = 80/233 (34%), Gaps = 46/233 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-------VAIKKVLQDKRYKN----RELQTMRLLDHP 124
              +GQG+F  +F+    E G+        V +K + +  R  +         M  L H 
Sbjct: 13  NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72

Query: 125 NVVSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIF 182
           ++V     C       DE    LV E+V       +  + K N+    I  KL  A Q+ 
Sbjct: 73  HLVLNYGVC----VCGDENI--LVQEFVK---FGSLDTYLKKNKNCINILWKLEVAKQLA 123

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-------VKLCDFGSAKVLVKGEPNISYIC 235
            A+ ++     + H ++  +N+L+     +       +KL D G +  ++  +       
Sbjct: 124 AAMHFL-EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD------- 175

Query: 236 SRYYR------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
               +       PE I        A D WS G  + E+   G           
Sbjct: 176 --ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQR 226

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 84.6 bits (210), Expect = 8e-19
 Identities = 54/226 (23%), Positives = 92/226 (40%), Gaps = 45/226 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 30  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRALS 186
           SL         +      +VL Y+    H  +++F +     P +   + +  Q+ + + 
Sbjct: 90  SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMK 142

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRD+  +N +++     VK+ DFG A+ +   E         YY       
Sbjct: 143 YLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKE---------YYSVHNKTG 191

Query: 241 --------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   A E L     ++TT  D+WS G ++ ELM  G P +P 
Sbjct: 192 AKLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 235

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 36/157 (22%), Positives = 67/157 (42%), Gaps = 16/157 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIK--KVLQDKRYKNRELQTMRLLDH-PNVVSL 129
           +   + +G G+FG +   K L T E VAIK   +       + E +  + L     +  +
Sbjct: 11  FRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQV 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +           Y  +VLE +  ++      F+  ++   +  V + A Q+   + Y+H
Sbjct: 71  YYF-----GPCGKYNAMVLELLGPSLE---DLFDLCDRTFSLKTVLMIAIQLISRMEYVH 122

Query: 190 RSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAK 222
            S  + +RD+KP+N L+    N     + + DF  AK
Sbjct: 123 -SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.5 bits (207), Expect = 2e-18
 Identities = 55/238 (23%), Positives = 95/238 (39%), Gaps = 49/238 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 13  IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 72

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L          + L   LV+E         +  F    +  +P+  V    +Q+   +
Sbjct: 73  VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 123

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HRD+  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 124 KYLEEKNFV---HRDLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 171

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                    APE + F   ++++  D+WS G  + E +  G+  +    G +    +E
Sbjct: 172 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 83.1 bits (206), Expect = 3e-18
 Identities = 58/235 (24%), Positives = 104/235 (44%), Gaps = 45/235 (19%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTM 118
           P + +   ++R++G+G FGVV+  + ++  +     AIK    + + +      RE   M
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLM 76

Query: 119 RLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-Y 177
           R L+HPNV++L          + L   ++L Y+    H  +  F +  QR P +   + +
Sbjct: 77  RGLNHPNVLALIGI---MLPPEGLPH-VLLPYMC---HGDLLQFIRSPQRNPTVKDLISF 129

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR 237
             Q+ R + Y+       HRD+  +N +++  +  VK+ DFG A+ ++  E         
Sbjct: 130 GLQVARGMEYLA-EQKFVHRDLAARNCMLD-ESFTVKVADFGLARDILDRE--------- 178

Query: 238 YYR--------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           YY               A E L      +TT  D+WS G ++ EL+  G P +  
Sbjct: 179 YYSVQQHRHARLPVKWTALESLQTYR--FTTKSDVWSFGVLLWELLTRGAPPYRH 231

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 82.0 bits (203), Expect = 6e-18
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 14/155 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDH-PNVVSL 129
           Y   R +G GSFG ++    +  GE VAIK      ++     E +  +++     + ++
Sbjct: 11  YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTI 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           + C       +  Y  +V+E +  ++      FN  +++  +  V L A Q+   + YIH
Sbjct: 71  RWC-----GAEGDYNVMVMELLGPSLE---DLFNFCSRKFSLKTVLLLADQMISRIEYIH 122

Query: 190 RSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK 222
            S    HRD+KP N L+      + V + DFG AK
Sbjct: 123 -SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAK 156

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 82.7 bits (205), Expect = 7e-18
 Identities = 57/257 (22%), Positives = 98/257 (38%), Gaps = 61/257 (23%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            +++G G+FG V  A             VA+K +       ++     EL+ M +L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPM 171
           N+V+L       T    +Y  L+ EY               +     +++ N+       
Sbjct: 110 NIVNLLGA---CTLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164

Query: 172 IYVKL-------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               L       +AYQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL-EFKSCVHRDLAARNVLVTHG-KVVKICDFGLARDI 222

Query: 225 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
           +             Y             APE +F    YT   D+WS G ++ E+  LG 
Sbjct: 223 MSDS---------NYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGV 272

Query: 272 PLFPGDSGVDQLVEIIK 288
             +PG        ++I+
Sbjct: 273 NPYPGIPVDANFYKLIQ 289

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 81.5 bits (202), Expect = 8e-18
 Identities = 49/219 (22%), Positives = 93/219 (42%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FGVV   K       VA+K + +    ++   +E QTM  L HP +V     
Sbjct: 13  LKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGV 71

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C    + +  +Y  +V EY+    +  + ++ + + +       L   Y +   ++++  
Sbjct: 72  C----SKEYPIY--IVTEYIS---NGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE- 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
           S    HRD+  +N LV+     VK+ DFG  + ++  +         Y            
Sbjct: 122 SHQFIHRDLAARNCLVDRD-LCVKVSDFGMTRYVLDDQ---------YVSSVGTKFPVKW 171

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            APE   +   +Y++  D+W+ G ++ E+  LGK  +  
Sbjct: 172 SAPEVFHYF--KYSSKSDVWAFGILMWEVFSLGKMPYDL 208

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 83.6 bits (207), Expect = 8e-18
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 43/230 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E+ +G G FG V+ A   +    VA+K +            E   M+ L H  +V L   
Sbjct: 193 EKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAV 251

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
                 K+ +Y  ++ E++       +  F K ++       KL  ++ QI   +++I  
Sbjct: 252 VT----KEPIY--IITEFMA---KGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIE- 301

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
                HRD++  N+LV+      K+ DFG A+V+   E         Y            
Sbjct: 302 QRNYIHRDLRAANILVSAS-LVCKIADFGLARVIEDNE---------YTAREGAKFPIKW 351

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
            APE + FG   +T   D+WS G ++ E++  G+  +PG S  +  + +E
Sbjct: 352 TAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALE 399

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 81.5 bits (202), Expect = 9e-18
 Identities = 52/219 (23%), Positives = 92/219 (42%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
              +G G FG V+          VA+K + Q     +    E   M+ L H  +V L   
Sbjct: 18  VERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL--- 73

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL--YAYQIFRALSYIHR 190
            ++   ++ +Y  ++ EY+    +  +  F K    + +   KL   A QI   +++I  
Sbjct: 74  -YAVVTQEPIY--IITEYME---NGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIE- 126

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
                HRD++  N+LV+      K+ DFG A+++   E         Y            
Sbjct: 127 ERNYIHRDLRAANILVSDT-LSCKIADFGLARLIEDNE---------YTAREGAKFPIKW 176

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            APE + +G   +T   D+WS G ++ E++  G+  +PG
Sbjct: 177 TAPEAINYG--TFTIKSDVWSFGILLTEIVTHGRIPYPG 213

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 83.5 bits (206), Expect = 9e-18
 Identities = 40/155 (25%), Positives = 73/155 (47%), Gaps = 14/155 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLL-DHPNVVSL 129
           +   R +G GSFG ++    ++T E VAIK      ++     E +  R+L     + ++
Sbjct: 9   FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNV 68

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +         +  Y  LV++ +  ++      FN  ++++ +  V + A Q+   + ++H
Sbjct: 69  RWF-----GVEGDYNVLVMDLLGPSLE---DLFNFCSRKLSLKTVLMLADQMINRVEFVH 120

Query: 190 RSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAK 222
            S    HRDIKP N L+      +QV + DFG AK
Sbjct: 121 -SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAK 154

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.5 bits (204), Expect = 9e-18
 Identities = 52/225 (23%), Positives = 91/225 (40%), Gaps = 43/225 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIK--KVLQDKRYKN---RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K    + D    +    E   M+   HPNV+
Sbjct: 94  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 153

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK---LYAYQIFRA 184
           SL         +      +VL Y+    H  +++F  +        VK    +  Q+ + 
Sbjct: 154 SLLGI--CLRSEGSPL--VVLPYMK---HGDLRNF--IRNETHNPTVKDLIGFGLQVAKG 204

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + ++  S    HRD+  +N +++     VK+ DFG A+ +   E +        +     
Sbjct: 205 MKFLA-SKKFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFD------SVHNKTGA 256

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                  A E L     ++TT  D+WS G ++ ELM  G P +P 
Sbjct: 257 KLPVKWMALESLQTQ--KFTTKSDVWSFGVLLWELMTRGAPPYPD 299

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 83.5 bits (206), Expect = 1e-17
 Identities = 53/232 (22%), Positives = 93/232 (40%), Gaps = 47/232 (20%)

Query: 74  MAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           +A+  +G G+FG V Q       +   VAIK + Q     +      E Q M  LD+P +
Sbjct: 339 IADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYI 398

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRAL 185
           V L          + L   LV+E         +  F    +  +P+  V    +Q+   +
Sbjct: 399 VRL----IGVCQAEALM--LVMEMAG---GGPLHKFLVGKREEIPVSNVAELLHQVSMGM 449

Query: 186 SYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            Y+     +   HR++  +N+L+  + H  K+ DFG +K L   +         YY    
Sbjct: 450 KYLEEKNFV---HRNLAARNVLLV-NRHYAKISDFGLSKALGADDS--------YYTARS 497

Query: 241 ---------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                    APE + F   ++++  D+WS G  + E +  G+  +    G +
Sbjct: 498 AGKWPLKWYAPECINFR--KFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 81.1 bits (201), Expect = 1e-17
 Identities = 60/228 (26%), Positives = 105/228 (46%), Gaps = 44/228 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            RI+G+G FG V++            VA+K   +D    N+     E   M+ LDHP++V
Sbjct: 17  NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L        +++  +  +++E  P   +  + H+ + N+  + ++ + LY+ QI +A++
Sbjct: 77  KL----IGIIEEEPTW--IIMELYP---YGELGHYLERNKNSLKVLTLVLYSLQICKAMA 127

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  SI   HRDI  +N+LV      VKL DFG ++ +   +         YY+      
Sbjct: 128 YLE-SINCVHRDIAVRNILVASP-ECVKLGDFGLSRYIEDED---------YYKASVTRL 176

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                +PE + F    +TTA D+W     + E++  GK  F      D
Sbjct: 177 PIKWMSPESINFRR--FTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 56/231 (24%), Positives = 93/231 (40%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           +++VG G FG V   +     +   +VAIK +      K R     E   M   DHPN++
Sbjct: 50  DKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNII 109

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK---LYAYQIFR 183
            L+       T    +   +V EY+    +  +  F  L +      V         I  
Sbjct: 110 RLEGVV----TKSKPVM--IVTEYME---NGSLDSF--LRKHDAQFTVIQLVGMLRGIAS 158

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR--- 240
            + Y+   +G  HRD+  +N+L+N +    K+ DFG  +VL              Y    
Sbjct: 159 GMKYLS-DMGYVHRDLAARNILINSN-LVCKVSDFGLGRVLEDDP-------EAAYTTRG 209

Query: 241 --------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                   +PE + +   ++T+A D+WS G V+ E+M  G+  +   S  D
Sbjct: 210 GKIPIRWTSPEAIAYR--KFTSASDVWSYGIVLWEVMSYGERPYWEMSNQD 258

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 80.7 bits (200), Expect = 1e-17
 Identities = 47/219 (21%), Positives = 87/219 (39%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FG+V     L   + VAIK + +    +     E + M  L HP +V L   
Sbjct: 13  VQEIGSGQFGLVHLGYWLNKDK-VAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGV 71

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C     ++  +   LV E++    H  +  + +  + +      L     +   ++Y+  
Sbjct: 72  C----LEQAPIC--LVTEFME---HGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYL-E 121

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
              V HRD+  +N LV  +   +K+ DFG  + ++  +         Y            
Sbjct: 122 EACVIHRDLAARNCLVGEN-QVIKVSDFGMTRFVLDDQ---------YTSSTGTKFPVKW 171

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
            +PE   F    Y++  D+WS G ++ E+   GK  +  
Sbjct: 172 ASPEVFSFS--RYSSKSDVWSFGVLMWEVFSEGKIPYEN 208

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 81.6 bits (202), Expect = 1e-17
 Identities = 52/230 (22%), Positives = 91/230 (39%), Gaps = 45/230 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
           E+I+G G  G V   +    G+    VAIK +      + R     E   M   DHPN++
Sbjct: 54  EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113

Query: 128 SLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRAL 185
            L+       T        +V EY+    +  +  F + +     I   +     +   +
Sbjct: 114 RLEGVV----TRGRLAM--IVTEYME---NGSLDTFLRTHDGQFTIMQLVGMLRGVGAGM 164

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR----- 240
            Y+   +G  HRD+  +N+LV+ +    K+ DFG ++VL                     
Sbjct: 165 RYLS-DLGYVHRDLAARNVLVDSN-LVCKVSDFGLSRVLEDDP--------DAAYTTTGG 214

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                  APE + F    +++A D+WS G V+ E++  G+  +   +  D
Sbjct: 215 KIPIRWTAPEAIAFR--TFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD 262

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 53/257 (20%), Positives = 100/257 (38%), Gaps = 62/257 (24%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            + +G+G FG V +A            TVA+K +       + R    E   ++ ++HP+
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPH 87

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-------------------ETVHRVVKHFNKLN 166
           V+ L       +    L   L++EY                      +            
Sbjct: 88  VIKLYGA---CSQDGPLL--LIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142

Query: 167 QRMPMIYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               +    L  +A+QI + + Y+   + + HRD+  +N+LV     ++K+ DFG ++ +
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLA-EMKLVHRDLAARNILVAEG-RKMKISDFGLSRDV 200

Query: 225 VKGEPNISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGK 271
            + +          Y             A E +F    YTT  D+WS G ++ E++ LG 
Sbjct: 201 YEED---------SYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGG 250

Query: 272 PLFPGDSGVDQLVEIIK 288
             +PG    ++L  ++K
Sbjct: 251 NPYPGIP-PERLFNLLK 266

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 81.5 bits (200), Expect = 2e-17
 Identities = 47/314 (14%), Positives = 87/314 (27%), Gaps = 69/314 (21%)

Query: 79  VGQGSFGVVFQAKCLETGETVAIKKV-LQDKRYKNRE--------------------LQT 117
           +G+G FG VFQ         VAIK + ++     N                      L  
Sbjct: 28  IGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG 85

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIY-- 173
                    + L            L L     Y     + +     F      + + +  
Sbjct: 86  EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEF 145

Query: 174 -----------------VKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC 216
                             K   +Q+  +L+    S+   HRD+   N+L+   +   KL 
Sbjct: 146 GGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSL-KKLH 204

Query: 217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG 276
              + K                     L     +YT +        V  ++ + + LF G
Sbjct: 205 YTLNGKSSTIPSCG-------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTG 251

Query: 277 DSGVDQLVEIIKVLGTPTREEIKCMNP-------NYTEFKFPQIKAHPWHKIFP--KRMP 327
           D   D   +I +++           +P       +Y   K  +          P  K++ 
Sbjct: 252 DG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIK 309

Query: 328 PEAVDLVSRLLQYS 341
            +  +    +L +S
Sbjct: 310 RKIQEFHRTMLNFS 323

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.4 bits (199), Expect = 2e-17
 Identities = 61/228 (26%), Positives = 99/228 (43%), Gaps = 44/228 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 20  GRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 79

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L         ++ ++  +++E         ++ F ++ +  + +  + LYAYQ+  AL+
Sbjct: 80  KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKYSLDLASLILYAYQLSTALA 130

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 131 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 179

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                APE + F    +T+A D+W  G  + E++  G   F G    D
Sbjct: 180 PIKWMAPESINFRR--FTSASDVWMFGVCMWEILMHGVKPFQGVKNND 225

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.4 bits (199), Expect = 3e-17
 Identities = 60/258 (23%), Positives = 105/258 (40%), Gaps = 57/258 (22%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQT 117
            ++ I     R +G+G+FG VF A+C           VA+K +    L  ++   RE + 
Sbjct: 13  KRRDIVLK--RELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAEL 70

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNK 164
           +  L H ++V          D D L   +V EY+             P+ +  V     +
Sbjct: 71  LTNLQHEHIVKFYGV---CGDGDPLI--MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               + +  +   A QI   + Y+  S    HRD+  +N LV  +   VK+ DFG ++ +
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLA-SQHFVHRDLATRNCLVGAN-LLVKIGDFGMSRDV 183

Query: 225 VKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LG 270
              +         YYR             PE +++   ++TT  D+WS G ++ E+   G
Sbjct: 184 YSTD---------YYRVGGHTMLPIRWMPPESIMYR--KFTTESDVWSFGVILWEIFTYG 232

Query: 271 KPLFPGDSGVDQLVEIIK 288
           K  +   S   +++E I 
Sbjct: 233 KQPWFQLS-NTEVIECIT 249

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 81.8 bits (202), Expect = 4e-17
 Identities = 62/234 (26%), Positives = 101/234 (43%), Gaps = 46/234 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVV 127
            R +G+G FG V Q   +        VAIK          R     E  TMR  DHP++V
Sbjct: 395 GRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIV 454

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRALS 186
            L         ++ ++  +++E         ++ F ++ +  + +  + LYAYQ+  AL+
Sbjct: 455 KL----IGVITENPVW--IIMELCT---LGELRSFLQVRKFSLDLASLILYAYQLSTALA 505

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR------ 240
           Y+  S    HRDI  +N+LV+ +   VKL DFG ++ +             YY+      
Sbjct: 506 YLE-SKRFVHRDIAARNVLVSSN-DCVKLGDFGLSRYMEDST---------YYKASKGKL 554

Query: 241 -----APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSG--VDQLVE 285
                APE + F    +T+A D+W  G  + E++  G   F G     V   +E
Sbjct: 555 PIKWMAPESINFR--RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIE 606

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 80.1 bits (198), Expect = 5e-17
 Identities = 49/230 (21%), Positives = 91/230 (39%), Gaps = 44/230 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKNR-----ELQTMRLLDHPNV 126
           ++++G G FG V++     +       VAIK +      K R     E   M    H N+
Sbjct: 49  QKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNI 108

Query: 127 VSLKH-CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL-YAYQIFRA 184
           + L+       +    +   ++ EY+    +  +  F +       +   +     I   
Sbjct: 109 IRLEGVI----SKYKPMM--IITEYME---NGALDKFLREKDGEFSVLQLVGMLRGIAAG 159

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---- 240
           + Y+  ++   HRD+  +N+LVN +    K+ DFG ++VL              Y     
Sbjct: 160 MKYLA-NMNYVHRDLAARNILVNSN-LVCKVSDFGLSRVLEDDP-------EATYTTSGG 210

Query: 241 -------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
                  APE + +    +T+A D+WS G V+ E+M  G+  +   S  +
Sbjct: 211 KIPIRWTAPEAISYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 258

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 80.0 bits (198), Expect = 5e-17
 Identities = 54/248 (21%), Positives = 94/248 (37%), Gaps = 52/248 (20%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE-----TVAIKKV-----LQDKRYKNRELQTM-RLLDHP 124
            + +G G+FG V +A     G+      VA+K +       +K     EL+ M  L  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP---------ETVHRVVKHFNKLNQRMPMIYVK 175
           N+V+L       T    +   ++ EY                +                 
Sbjct: 111 NIVNLLGA---CTHGGPVL--VITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165

Query: 176 L--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY 233
           L  ++ Q+ + ++++  S    HRD+  +N+L+    H  K+ DFG A+ ++        
Sbjct: 166 LLHFSSQVAQGMAFLA-SKNCIHRDVAARNVLLTNG-HVAKIGDFGLARDIMNDS----- 218

Query: 234 ICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
                Y             APE IF    YT   D+WS G ++ E+  LG   +PG    
Sbjct: 219 ----NYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVN 273

Query: 281 DQLVEIIK 288
            +  +++K
Sbjct: 274 SKFYKLVK 281

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 79.2 bits (196), Expect = 7e-17
 Identities = 56/239 (23%), Positives = 95/239 (39%), Gaps = 52/239 (21%)

Query: 76  ERIVGQGSFGVVFQAKC-LETGET--VAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
              +G GSFGVV + +    +G+T  VA+K +  D   +        RE+  M  LDH N
Sbjct: 23  LEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRN 82

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQ-RMPMIYVKLYAYQIFRA 184
           ++ L    +       +   +V E  P      +    + +Q    +  +  YA Q+   
Sbjct: 83  LIRL----YGVVLTPPMK--MVTELAP---LGSLLDRLRKHQGHFLLGTLSRYAVQVAEG 133

Query: 185 LSYI--HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR-- 240
           + Y+   R I   HRD+  +NLL+      VK+ DFG  + L + +         +Y   
Sbjct: 134 MGYLESKRFI---HRDLAARNLLLATR-DLVKIGDFGLMRALPQNDD--------HYVMQ 181

Query: 241 ----------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD--QLVE 285
                     APE L      ++ A D W  G  + E+   G+  + G +G      ++
Sbjct: 182 EHRKVPFAWCAPESLKTRT--FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKID 238

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 79.7 bits (197), Expect = 8e-17
 Identities = 59/252 (23%), Positives = 106/252 (42%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRM 169
           H N+++L       T    LY  +++EY              P  +           ++M
Sbjct: 146 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               +    YQ+ R + Y+  S    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 201 TFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 257

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 258 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 308

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 309 IP-VEELFKLLK 319

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 79.3 bits (196), Expect = 9e-17
 Identities = 54/248 (21%), Positives = 98/248 (39%), Gaps = 54/248 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE-----TVAIKKV----LQDKRYKNRELQTMRLLDHPNV 126
           +  +G+G+FG VF A+C           VA+K +       ++   RE + + +L H ++
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHI 105

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP----------ETVHRVVKHFNKLNQRMPMIYVKL 176
           V         T+   L   +V EY+                 +    +     P+   +L
Sbjct: 106 VRFFGV---CTEGRPLL--MVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160

Query: 177 --YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
              A Q+   + Y+   +   HRD+  +N LV      VK+ DFG ++ +   +      
Sbjct: 161 LAVASQVAAGMVYLA-GLHFVHRDLATRNCLVGQG-LVVKIGDFGMSRDIYSTD------ 212

Query: 235 CSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
              YYR             PE +++   ++TT  D+WS G V+ E+   GK  +   S  
Sbjct: 213 ---YYRVGGRTMLPIRWMPPESILYR--KFTTESDVWSFGVVLWEIFTYGKQPWYQLS-N 266

Query: 281 DQLVEIIK 288
            + ++ I 
Sbjct: 267 TEAIDCIT 274

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 79.0 bits (195), Expect = 2e-16
 Identities = 37/190 (19%), Positives = 61/190 (32%), Gaps = 33/190 (17%)

Query: 53  GHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQA-----KCLETGETVAIKKVLQD 107
           G II                +     +GQG FG ++ A     + + +     +K    D
Sbjct: 26  GEIITDMAAAA---------WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSD 76

Query: 108 KRYKNRELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEYVPE 153
                 EL+  +    P  +                           + Y  ++++    
Sbjct: 77  NGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRFGS 136

Query: 154 TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQ 212
            +    K +    +R     V   + +I   L YIH      H DIK  NLL+N  +  Q
Sbjct: 137 DLQ---KIYEANAKRFSRKTVLQLSLRILDILEYIH-EHEYVHGDIKASNLLLNYKNPDQ 192

Query: 213 VKLCDFGSAK 222
           V L D+G A 
Sbjct: 193 VYLVDYGLAY 202

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.5 bits (194), Expect = 2e-16
 Identities = 59/252 (23%), Positives = 107/252 (42%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G+FG V  A+ +       +   TVA+K +      +D      E++ M  +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRM 169
           H N+++L       T    LY  +++EY              P  +           ++M
Sbjct: 100 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               +    YQ+ R + Y+  S    HRD+  +N+LV  + + +K+ DFG A+ +   + 
Sbjct: 155 TFKDLVSCTYQLARGMEYLA-SQKCIHRDLAARNVLVTEN-NVMKIADFGLARDINNID- 211

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 212 --------YYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPG 262

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 263 IP-VEELFKLLK 273

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 78.2 bits (193), Expect = 2e-16
 Identities = 36/189 (19%), Positives = 65/189 (34%), Gaps = 32/189 (16%)

Query: 52  TGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK 111
            G ++    G +         ++  + +G G FG+++ A      E  A   V  + +  
Sbjct: 27  EGKVLDDMEGNQ---------WVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQEN 77

Query: 112 N---RELQTMRLLDHPNVVSLK--------------HCFFSTTDKDELYLNLVLEYVPET 154
                EL+  + +   + +                 +    T  K   Y  +V+E +   
Sbjct: 78  GPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERLGID 137

Query: 155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQV 213
           +    K   + N       V     ++   L YIH      H DIK  NLL+   +  QV
Sbjct: 138 LQ---KISGQ-NGTFKKSTVLQLGIRMLDVLEYIH-ENEYVHGDIKAANLLLGYKNPDQV 192

Query: 214 KLCDFGSAK 222
            L D+G + 
Sbjct: 193 YLADYGLSY 201

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 77.3 bits (191), Expect = 2e-16
 Identities = 50/219 (22%), Positives = 91/219 (41%), Gaps = 41/219 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKH- 131
            + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L   
Sbjct: 29  LKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGV 87

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY-AYQIFRALSYIHR 190
           C    T +  ++  ++ EY+    +  + ++ +  +        L     +  A+ Y+  
Sbjct: 88  C----TKQRPIF--IITEYMA---NGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYL-E 137

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR---------- 240
           S    HRD+  +N LVN     VK+ DFG ++ ++  E         Y            
Sbjct: 138 SKQFLHRDLAARNCLVNDQ-GVVKVSDFGLSRYVLDDE---------YTSSVGSKFPVRW 187

Query: 241 -APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
             PE L++   ++++  DIW+ G ++ E+  LGK  +  
Sbjct: 188 SPPEVLMYS--KFSSKSDIWAFGVLMWEIYSLGKMPYER 224

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 59/252 (23%), Positives = 103/252 (40%), Gaps = 57/252 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-------ETGETVAIKKV-----LQDKRYKNRELQTM-RLLD 122
            + +G+G+FG V  A+ +            VA+K +      +D      E++ M  +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVP-----------ETVHRVVKHFNKLNQRMPM 171
           H N+++L       T    LY  +++EY                     +    N    +
Sbjct: 134 HKNIINLLGA---CTQDGPLY--VIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 172 IYVKL--YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
               L   AYQ+ R + Y+  S    HRD+  +N+LV    + +K+ DFG A+ +   + 
Sbjct: 189 SSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTED-NVMKIADFGLARDIHHID- 245

Query: 230 NISYICSRYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
                   YY+            APE +F    YT   D+WS G ++ E+  LG   +PG
Sbjct: 246 --------YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPG 296

Query: 277 DSGVDQLVEIIK 288
              V++L +++K
Sbjct: 297 VP-VEELFKLLK 307

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 76.9 bits (190), Expect = 4e-16
 Identities = 54/250 (21%), Positives = 89/250 (35%), Gaps = 56/250 (22%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
              +G+  FG V++         E  + VAIK +        +     E      L HPN
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMI 172
           VV L       T    L   ++  Y              P +          +   +   
Sbjct: 74  VVCLLGV---VTKDQPLS--MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128

Query: 173 YVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS 232
                  QI   + Y+  S  V H+D+  +N+LV      VK+ D G  + +   +    
Sbjct: 129 DFVHLVAQIAAGMEYLS-SHHVVHKDLATRNVLVYDK-LNVKISDLGLFREVYAAD---- 182

Query: 233 YICSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDS 278
                YY+            APE +++G  +++   DIWS G V+ E+   G   + G S
Sbjct: 183 -----YYKLLGNSLLPIRWMAPEAIMYG--KFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235

Query: 279 GVDQLVEIIK 288
               +VE+I+
Sbjct: 236 -NQDVVEMIR 244

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 59/267 (22%), Positives = 102/267 (38%), Gaps = 66/267 (24%)

Query: 67  PKQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQ 116
           P+  I Y+  R +G+G+FG VFQA+       E    VA+K +        +    RE  
Sbjct: 45  PRNNIEYV--RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAA 102

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFN 163
            M   D+PN+V L            + L  + EY+             P TV  +     
Sbjct: 103 LMAEFDNPNIVKLLGV---CAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 157

Query: 164 KLNQRMPMIYVKL--------YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL 215
               R+                A Q+   ++Y+       HRD+  +N LV  +   VK+
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGEN-MVVKI 215

Query: 216 CDFGSAKVLVKGEPNISYICSRYYR------------APE-LIFGATEYTTAIDIWSAGC 262
            DFG ++ +   +         YY+             PE + +    YTT  D+W+ G 
Sbjct: 216 ADFGLSRNIYSAD---------YYKADGNDAIPIRWMPPESIFYN--RYTTESDVWAYGV 264

Query: 263 VVAELM-LGKPLFPGDSGVDQLVEIIK 288
           V+ E+   G   + G +  ++++  ++
Sbjct: 265 VLWEIFSYGLQPYYGMA-HEEVIYYVR 290

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 48/231 (20%), Positives = 84/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           +V        +      +  ++LE +      +  R  +        + M+ +   A  I
Sbjct: 136 IVRCIGV---SLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYY 239
                Y+       HRDI  +N L+         K+ DFG A+ + +           YY
Sbjct: 191 ACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAG---------YY 240

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R             PE  + G   +T+  D WS G ++ E+  LG   +P 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 289

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 47/231 (20%), Positives = 84/231 (36%), Gaps = 47/231 (20%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +G G+FG V++ +        +   VA+K +      QD+     E   +   +H N
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE----TVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
           +V        +      +  +++E +      +  R  +        + M+ +   A  I
Sbjct: 95  IVRCIGV---SLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYY 239
                Y+       HRDI  +N L+         K+ DFG A+ + +           YY
Sbjct: 150 ACGCQYLE-ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAS---------YY 199

Query: 240 R------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
           R             PE  + G   +T+  D WS G ++ E+  LG   +P 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEG--IFTSKTDTWSFGVLLWEIFSLGYMPYPS 248

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 73.4 bits (181), Expect = 9e-15
 Identities = 49/220 (22%), Positives = 93/220 (42%), Gaps = 47/220 (21%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT----MRLLDHPNVVSL-K 130
           + ++G G FG V++   L  G  VA+K+   +      E +T    +    HP++VSL  
Sbjct: 44  KFLIGHGVFGKVYKGV-LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIG 102

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKL--NQRMPMIYVKLYAYQIFR 183
            C     +++E+   L+ +Y+        ++        +   QR+  I          R
Sbjct: 103 FC----DERNEMI--LIYKYMENGNLKRHLYGSDLPTMSMSWEQRL-EI-----CIGAAR 150

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY----- 238
            L Y+H    + HRD+K  N+L++ +    K+ DFG +K   + +   +++ +       
Sbjct: 151 GLHYLHTR-AIIHRDVKSINILLDENFV-PKITDFGISKKGTELDQ--THLSTVVKGTLG 206

Query: 239 YRAPELIFGATEY------TTAIDIWSAGCVVAELMLGKP 272
           Y  P       EY      T   D++S G V+ E++  + 
Sbjct: 207 YIDP-------EYFIKGRLTEKSDVYSFGVVLFEVLCARS 239

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 53/236 (22%), Positives = 92/236 (38%), Gaps = 56/236 (23%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 128 SLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLNQRMPMIYV 174
           +L         +  LY  L +EY                         N     +    +
Sbjct: 90  NLLGA---CEHRGYLY--LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             +A  + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 145 LHFAADVARGMDYLS-QKQFIHRDLAARNILVGEN-YVAKIADFGLSRG----------- 191

Query: 235 CSRYYR------------APE-LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPG 276
               Y             A E L +    YTT  D+WS G ++ E++ LG   + G
Sbjct: 192 -QEVYVKKTMGRLPVRWMAIESLNYS--VYTTNSDVWSYGVLLWEIVSLGGTPYCG 244

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 33/191 (17%), Positives = 66/191 (34%), Gaps = 33/191 (17%)

Query: 52  TGHIIVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETG--------ETVAIKK 103
           TG ++    G +         +  +    + + G++++A    T         +  ++K 
Sbjct: 32  TGTVLTDKSGRQ---------WKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKL 82

Query: 104 VLQDKRYKNRELQTMRLLDHPNVVSLK-----------HCFFSTTDKDELYLNLVLEYVP 152
             +D R  N +    R      V   K            C      +D+    LVL  + 
Sbjct: 83  DAKDGRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRF-LVLPSLG 141

Query: 153 ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTH 211
            ++   +    K    +    V   A ++  AL ++H      H ++  +N+ V+P    
Sbjct: 142 RSLQSALDVSPK--HVLSERSVLQVACRLLDALEFLH-ENEYVHGNVTAENIFVDPEDQS 198

Query: 212 QVKLCDFGSAK 222
           QV L  +G A 
Sbjct: 199 QVTLAGYGFAF 209

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 71.8 bits (177), Expect = 3e-14
 Identities = 51/217 (23%), Positives = 100/217 (46%), Gaps = 40/217 (18%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNR-----ELQTMRLLDHPNVVSLK 130
           + I+G+G FG V++ + L  G  VA+K++ +++          E++ + +  H N++ L+
Sbjct: 35  KNILGRGGFGKVYKGR-LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93

Query: 131 HCFFSTTDKDELYLNLVLEYVP-----ETVHRVVKHFNKLN--QRMPMIYVKLYAYQIFR 183
                 T  + L   LV  Y+        +    +    L+  +R   I     A    R
Sbjct: 94  GF--CMTPTERL---LVYPYMANGSVASCLRERPESQPPLDWPKRQ-RI-----ALGSAR 142

Query: 184 ALSYIHRSIGVC--HRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY--- 238
            L+Y+H        HRD+K  N+L++    +  + DFG AK++   +   +++ +     
Sbjct: 143 GLAYLHDHCDPKIIHRDVKAANILLD-EEFEAVVGDFGLAKLM---DYKDTHVTTAVRGT 198

Query: 239 --YRAPE-LIFG-ATEYTTAIDIWSAGCVVAELMLGK 271
             + APE L  G ++E T   D++  G ++ EL+ G+
Sbjct: 199 IGHIAPEYLSTGKSSEKT---DVFGYGVMLLELITGQ 232

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 65.3 bits (160), Expect = 4e-12
 Identities = 58/221 (26%), Positives = 92/221 (41%), Gaps = 52/221 (23%)

Query: 78  IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK----NRELQT----MRLLDHPNVVSL 129
            +G+G FGVV++   +    TVA+KK+            ++       M    H N+V L
Sbjct: 38  KMGEGGFGVVYKG-YVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVEL 95

Query: 130 K-HCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPM-------IYVKLYAYQ 180
                   +D D+L L  V  Y+P  ++       + L+   P+       I     A  
Sbjct: 96  LGFS----SDGDDLCL--VYVYMPNGSLLD---RLSCLDGTPPLSWHMRCKI-----AQG 141

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
               ++++H +    HRDIK  N+L+           K+ DFG A+   K     + + S
Sbjct: 142 AANGINFLHEN-HHIHRDIKSANILLDEAFTA-----KISDFGLARASEKFA--QTVMTS 193

Query: 237 R----Y-YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKP 272
           R      Y APE + G  E T   DI+S G V+ E++ G P
Sbjct: 194 RIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLP 232

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 56.5 bits (136), Expect = 4e-09
 Identities = 34/125 (27%), Positives = 58/125 (46%), Gaps = 25/125 (20%)

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICS 236
           Y++Q+ + + ++  S    HRD+  +N+L++   + VK+CDFG A+ + K          
Sbjct: 198 YSFQVAKGMEFL-ASRKCIHRDLAARNILLS-EKNVVKICDFGLARDIYKDP-------- 247

Query: 237 RYYR------------APELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQL 283
             Y             APE IF    YT   D+WS G ++ E+  LG   +PG    ++ 
Sbjct: 248 -DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305

Query: 284 VEIIK 288
              +K
Sbjct: 306 CRRLK 310

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 49.9 bits (118), Expect = 1e-06
 Identities = 39/341 (11%), Positives = 90/341 (26%), Gaps = 113/341 (33%)

Query: 102 KKVLQDKRYK------NRELQTMRLLD-------------------------------HP 124
           K +L  +         +    T+RL                                   
Sbjct: 43  KSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQ 102

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRM----PMIYVKLY--- 177
              S+    +    +D LY N    +    V R ++ + KL Q +    P   V +    
Sbjct: 103 RQPSMMTRMYIEQ-RDRLY-NDNQVFAKYNVSR-LQPYLKLRQALLELRPAKNVLIDGVL 159

Query: 178 -------AYQIFRALSYIHR--------SIGVCHRD---IKPQNLLVNPHTHQVKLCDFG 219
                  A  +  +     +        ++  C+     ++    L+    +Q+   ++ 
Sbjct: 160 GSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLL----YQID-PNWT 214

Query: 220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAI----DIWSA--------GCVVAEL 267
           S         NI             +  +  Y   +    ++ +A         C +  L
Sbjct: 215 S---RSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKI--L 269

Query: 268 MLGKPLFPGDSGV-DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRM 326
           +  +        V D L        T T   +   +   T  +   +    +    P+ +
Sbjct: 270 LTTR-----FKQVTDFLSA-----ATTTHISLDHHSMTLTPDEVKSLLLK-YLDCRPQDL 318

Query: 327 PPEAVD-------LVSRLL-------QYSPNLRCTAVSKRI 353
           P E +        +++  +           ++ C  ++  I
Sbjct: 319 PREVLTTNPRRLSIIAESIRDGLATWDNWKHVNCDKLTTII 359

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.8 bits (105), Expect = 4e-05
 Identities = 42/342 (12%), Positives = 101/342 (29%), Gaps = 111/342 (32%)

Query: 75  AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVV---SLKH 131
           A+ ++  G  G         +G+T     V    + + +             +   +LK+
Sbjct: 150 AKNVLIDGVLG---------SGKTWVALDVCLSYKVQCK---------MDFKIFWLNLKN 191

Query: 132 CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS 191
           C     +  E     VLE + + ++++  ++   +     I +++++ Q    L  +   
Sbjct: 192 C-----NSPE----TVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQ--AELRRL--- 237

Query: 192 IGVCHRDIKPQNLLV-----NPHTHQVKLCDFGSAKVLV--KGEPNISYICSRYYRAPEL 244
             +  +      LLV     N         +    K+L+  + +    ++ +       L
Sbjct: 238 --LKSKP-YENCLLVLLNVQNAKA--WNAFNLSC-KILLTTRFKQVTDFLSAATTTHISL 291

Query: 245 IFGATEYTT--AIDIWS--AGCVVAEL-------------MLGKPL--FPG------DSG 279
              +   T      +      C   +L             ++ + +              
Sbjct: 292 DHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWDNWKHVN 351

Query: 280 VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMP-PEAV------- 331
            D+L  II+         +  + P      F ++       +FP     P  +       
Sbjct: 352 CDKLTTIIES-------SLNVLEPAEYRKMFDRL------SVFPPSAHIPTILLSLIWFD 398

Query: 332 -------DLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHH 366
                   +V++L +YS       V K+       S + +  
Sbjct: 399 VIKSDVMVVVNKLHKYS------LVEKQ----PKESTISIPS 430

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	371
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.9
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.85
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.75
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.36
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.12
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.03
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.69
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.55
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.3
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.28
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.27
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.18
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.15
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.85
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.84
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.65
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.52
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.52
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.44
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.33
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.32
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.3
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.2
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.18
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.93
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.27
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.08
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.15

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=2e-62  Score=434.80  Aligned_cols=245  Identities=29%  Similarity=0.445  Sum_probs=199.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||+||+|++..+|+.||||++.+.       ...+.+|+.+++.++|||||++++++     .+..
T Consensus        12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~   86 (275)
T 3hyh_A           12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVI-----KSKD   86 (275)
T ss_dssp             --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE-----EECC
Confidence            46899999999999999999999999999999998543       23467899999999999999999998     4445


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+|+||||++|+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        87 ~~~ivmEy~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDiKP~NILl~~~~-~vkl~DFGla~  160 (275)
T 3hyh_A           87 EIIMVIEYAGNELFDYIVQ----RDKMSEQEARRFFQQIISAVEYCHRH-KIVHRDLKPENLLLDEHL-NVKIADFGLSN  160 (275)
T ss_dssp             EEEEEEECCCEEHHHHHHH----SCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTC-CEEECCSSCC-
T ss_pred             EEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCChHHeEECCCC-CEEEeecCCCe
Confidence            6899999999998888765    57899999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .........+.+||+.|||||++.+..+++.++|||||||++|+|++|+.||.+.+....+..+.+..  +         
T Consensus       161 ~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~--~---------  229 (275)
T 3hyh_A          161 IMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGV--Y---------  229 (275)
T ss_dssp             --------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C---------
T ss_pred             ecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence            87666666678999999999999877766789999999999999999999998877666655554421  0         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        .+|..+|+++.+||.+||+.||++|||+.|+++|
T Consensus       230 ------------------~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          230 ------------------TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHC
T ss_pred             ------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence                              1456689999999999999999999999998877

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.8e-62  Score=438.25  Aligned_cols=254  Identities=31%  Similarity=0.494  Sum_probs=218.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+++|+.++|||||+++++|     .+..+
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~  106 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK  106 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            5799999999999999999999999999999999643       23467899999999999999999998     44556


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|||||||+| +|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus       107 ~yivmEy~~gG~L~~~i~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~IiHRDlKPeNILl~~~g-~vKl~DFGla~  180 (311)
T 4aw0_A          107 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  180 (311)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEEcCCC-CEEEEEcCCce
Confidence            8999999985 88887764    46899999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ......   ...+.+||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..  .      
T Consensus       181 ~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~--~------  251 (311)
T 4aw0_A          181 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLE--Y------  251 (311)
T ss_dssp             ECCTTTTCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC--C------
T ss_pred             ecCCCCCcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--C------
Confidence            764332   334678999999999997655 7999999999999999999999999888777777766521  0      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                                           .+|..+|+++.+||.+||++||.+|||+.|++.|-      -+..||||++
T Consensus       252 ---------------------~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~------~i~~Hp~F~~  296 (311)
T 4aw0_A          252 ---------------------DFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG------PLKAHPFFES  296 (311)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHH------HHHTSGGGTT
T ss_pred             ---------------------CCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCH------HHHCCCCcCC
Confidence                                 14567899999999999999999999999976552      2567888864

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2e-60  Score=433.87  Aligned_cols=245  Identities=29%  Similarity=0.405  Sum_probs=209.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..|++.++||+|+||+||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|..     ...+||
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  148 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  148 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3556789999999999999999999854     345899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      |||||+| +|.+++.     ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+...
T Consensus       149 vmEy~~gg~L~~~l~-----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla~~~~  221 (346)
T 4fih_A          149 VMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  221 (346)
T ss_dssp             EECCCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEECCCC-CEEEecCcCceecC
Confidence            9999985 7777665     35799999999999999999999987 999999999999999998 89999999998765


Q ss_pred             cC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .. ....+.+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+........          
T Consensus       222 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~~----------  290 (346)
T 4fih_A          222 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPRL----------  290 (346)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC----------
T ss_pred             CCCCcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC----------
Confidence            43 3345678999999999986554 89999999999999999999999998887777666654211000          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ..+..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       291 ----------------~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          291 ----------------KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             ----------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------------CccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                            0223579999999999999999999999998887

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=8.8e-61  Score=436.94  Aligned_cols=248  Identities=27%  Similarity=0.371  Sum_probs=206.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++++.||+|+||+||+|++..+|+.||||++...      ...+.+|+.+|+.++|||||++++++..     ..
T Consensus        22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~-----~~   96 (350)
T 4b9d_A           22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEE-----NG   96 (350)
T ss_dssp             CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TT
T ss_pred             cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEE-----CC
Confidence            346899999999999999999999999999999998643      2445689999999999999999999843     44


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+|||||||+ |+|.+.+...  ....+++..++.|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus        97 ~~yiVmEy~~gg~L~~~i~~~--~~~~~~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGla  172 (350)
T 4b9d_A           97 SLYIVMDYCEGGDLFKRINAQ--KGVLFQEDQILDWFVQICLALKHVHDR-KILHRDIKSQNIFLTKDG-TVQLGDFGIA  172 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCEETTCCGGGEEECTTC-CEEECSTTEE
T ss_pred             EEEEEEeCCCCCcHHHHHHHc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHHHEEECCCC-CEEEcccccc
Confidence            5899999998 5888887642  245679999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +...... .....+||+.|||||++.+.. |+.++|||||||++|+|++|+.||.+.+..+.+..+.+....        
T Consensus       173 ~~~~~~~~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~--------  243 (350)
T 4b9d_A          173 RVLNSTVELARACIGTPYYLSPEICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFP--------  243 (350)
T ss_dssp             SCCCHHHHHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCC--------
T ss_pred             eeecCCcccccccCCCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCC--------
Confidence            8764332 223567999999999997654 899999999999999999999999998887777776653110        


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          .++..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       244 --------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          244 --------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                0345689999999999999999999999999988

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.2e-60  Score=434.21  Aligned_cols=263  Identities=23%  Similarity=0.329  Sum_probs=218.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEeec
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      ...|++.++||+|+||.||+|+++.+|+.||||++..+. ...+|+.+++.++|||||++++++..     ..++|||||
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~HpnIV~l~~~~~~-----~~~~~ivmE  130 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLSSPRIVPLYGAVRE-----GPWVNIFME  130 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCCCTTBCCEEEEEEE-----TTEEEEEEC
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEEEEEe
Confidence            356999999999999999999999999999999997543 34579999999999999999999843     445899999


Q ss_pred             ccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          150 YVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       150 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      ||+ |+|.+++..    .+.+++..++.|+.||+.||+|||++ |||||||||+|||++.++..+||+|||+|+......
T Consensus       131 y~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~  205 (336)
T 4g3f_A          131 LLEGGSLGQLIKQ----MGCLPEDRALYYLGQALEGLEYLHTR-RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG  205 (336)
T ss_dssp             CCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred             ccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence            998 588888765    46799999999999999999999987 999999999999999887569999999998764432


Q ss_pred             C------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          229 P------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       229 ~------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .      ....+||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...  .++        
T Consensus       206 ~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~--~~~--------  274 (336)
T 4g3f_A          206 LGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE--PPP--------  274 (336)
T ss_dssp             --------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS--CCG--------
T ss_pred             cccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC--CCC--------
Confidence            1      12357999999999997655 899999999999999999999999887766666655542  110        


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC-Ccchhhcccccc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC-PSLLVLHHFCFR  370 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~-~~~~~~~~~~~~  370 (371)
                                      ...++..+|+++.+||.+||+.||.+|||+.|+++|+... ....-+.|||+.
T Consensus       275 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~  327 (336)
T 4g3f_A          275 ----------------IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKG  327 (336)
T ss_dssp             ----------------GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSS
T ss_pred             ----------------chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcC
Confidence                            0114567899999999999999999999999999997665 333457899975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.5e-59  Score=418.43  Aligned_cols=245  Identities=21%  Similarity=0.315  Sum_probs=201.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++.+.||+|+||+||+|.+..++..||+|++...      ...+.+|+++++.++|||||+++++|.... ....++||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~-~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeecc-CCCcEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999886543 34566899


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeC-CCCcEEEEeeCCcc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNP-HTHQVKLCDFGSAK  222 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~-~~~~~kl~Dfg~a~  222 (371)
                      |||||+ |+|.+++..    ...+++..++.|+.||+.||+|||++ |  ||||||||+|||++. ++ .+||+|||+|+
T Consensus       107 vmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g-~vKl~DFGla~  180 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGLAT  180 (290)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTS-CEEECCTTGGG
T ss_pred             EEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCC-CEEEEeCcCCE
Confidence            999998 588887764    46899999999999999999999986 7  999999999999985 55 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... .....+.+||+.|||||++.+  .++.++|||||||++|+|+||+.||.+......+...+... ..+.       
T Consensus       181 ~~~-~~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~-~~~~-------  249 (290)
T 3fpq_A          181 LKR-ASFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSG-VKPA-------  249 (290)
T ss_dssp             GCC-TTSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTT-CCCG-------
T ss_pred             eCC-CCccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcC-CCCC-------
Confidence            643 334456789999999999854  38999999999999999999999998766555444333211 0100       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                                        .++...++++.+||.+||+.||.+|||+.++++
T Consensus       250 ------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          250 ------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                              123457899999999999999999999999544

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-59  Score=435.96  Aligned_cols=277  Identities=34%  Similarity=0.629  Sum_probs=228.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      ++|++++.||+|+||+||+|+++.+|+.||||++...      .....+|+.+|+.++|||||++++++..... .+...
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~  133 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS  133 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence            5799999999999999999999999999999999643      2334579999999999999999998754321 23456


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|||||||+|+|.+.+..    .+.+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|+.
T Consensus       134 ~~ivmE~~~g~L~~~i~~----~~~l~~~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NIl~~~~~-~~Ki~DFGla~~  207 (398)
T 4b99_A          134 VYVVLDLMESDLHQIIHS----SQPLTLEHVRYFLYQLLRGLKYMHSA-QVIHRDLKPSNLLVNENC-ELKIGDFGMARG  207 (398)
T ss_dssp             EEEEEECCSEEHHHHHTS----SSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCcCCCcCccccccCCCC-CEEEeecceeee
Confidence            899999999998877754    57899999999999999999999987 999999999999999988 899999999986


Q ss_pred             cccC-----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          224 LVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       224 ~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ....     ....+.+||+.|||||++.+..+++.++||||+||++|+|++|++||.+.+..+.+..+....+.++...+
T Consensus       208 ~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~  287 (398)
T 4b99_A          208 LCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVI  287 (398)
T ss_dssp             C-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGT
T ss_pred             cccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHh
Confidence            5332     23346789999999999988777899999999999999999999999999999999999999999987765


Q ss_pred             hhcCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .........   ..++.....+|...++ .+|+++.+||.+||.+||.+||||.|+|+|
T Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          288 QAVGAERVRAYIQSLPPRQPVPWETVYP-GADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             C-----CHHHHHHSSCCCCCCCHHHHST-TCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhhcCCCcCCCCHHHhCC-CCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            433211111   1223333334444333 479999999999999999999999999988

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=4.2e-59  Score=435.37  Aligned_cols=245  Identities=29%  Similarity=0.404  Sum_probs=210.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..|++.+.||+|+||.||+|+++.+|+.||||++...    ...+.+|+.+|+.++|||||+++++|..     ...+||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~-----~~~~~i  225 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-----GDELWV  225 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE-----CCEEEE
Confidence            4699999999999999999999999999999998532    3456799999999999999999999954     345899


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      |||||+| +|.+++.     ...+++..++.|+.||+.||+|||++ |||||||||+||||+.++ .+||+|||+|+...
T Consensus       226 VmEy~~gG~L~~~i~-----~~~l~e~~~~~~~~qil~aL~ylH~~-~IiHRDiKp~NILl~~~g-~vKl~DFGla~~~~  298 (423)
T 4fie_A          226 VMEFLEGGALTDIVT-----HTRMNEEQIAAVCLAVLQALSVLHAQ-GVIHRDIKSDSILLTHDG-RVKLSDFGFCAQVS  298 (423)
T ss_dssp             EEECCTTEEHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSTTTEEECTTC-CEEECCCTTCEECC
T ss_pred             EEeCCCCCcHHHHHh-----ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEecCccceECC
Confidence            9999995 7777665     35799999999999999999999987 999999999999999998 89999999998765


Q ss_pred             cC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      .. ......+||+.|||||++.+.. |+.++|||||||++|||++|+.||.+.+..+.+..+.......           
T Consensus       299 ~~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~-----------  366 (423)
T 4fie_A          299 KEVPRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPR-----------  366 (423)
T ss_dssp             SSCCCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-----------
T ss_pred             CCCccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC-----------
Confidence            43 3445678999999999996554 8999999999999999999999999888777766665421100           


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ...+..+|+++.+||.+||+.||.+|||+.|+|+|
T Consensus       367 ---------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          367 ---------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             ---------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                           00234689999999999999999999999998888

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=3.1e-59  Score=419.88  Aligned_cols=243  Identities=27%  Similarity=0.417  Sum_probs=201.4

Q ss_pred             cceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||+||+|++.   .+++.||||++.+.      .....+|+.+++.++|||||++++++..     .
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~   98 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQT-----E   98 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEE-----T
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEE-----C
Confidence            57999999999999999999874   46789999998543      2345679999999999999999999843     4


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+|||||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        99 ~~~~ivmEy~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~ylH~~-~IiHRDlKp~NILl~~~g-~vKl~DFGl  172 (304)
T 3ubd_A           99 GKLYLILDFLRGGDLFTRLSK----EVMFTEEDVKFYLAELALALDHLHSL-GIIYRDLKPENILLDEEG-HIKLTDFGL  172 (304)
T ss_dssp             TEEEEEECCCTTCEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTS-CEEEESSEE
T ss_pred             CEEEEEEEcCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHeEEcCCC-CEEeccccc
Confidence            45899999998 487777764    46899999999999999999999987 999999999999999998 899999999


Q ss_pred             ccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      |+..... ....+.+||+.|||||++.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+.+..  +      
T Consensus       173 a~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~--~------  243 (304)
T 3ubd_A          173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAK--L------  243 (304)
T ss_dssp             EEC-----CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C------
T ss_pred             ceeccCCCccccccccCcccCCHHHhccCC-CCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCC--C------
Confidence            9865433 3445678999999999997655 8999999999999999999999999888877777665521  0      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                           .+|..+|+++.+||.+||+.||++|||+     +|+++|
T Consensus       244 ---------------------~~p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          244 ---------------------GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             ---------------------CCCTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             ---------------------CCCCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence                                 1456689999999999999999999994     786666

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=3.9e-56  Score=411.48  Aligned_cols=274  Identities=26%  Similarity=0.420  Sum_probs=207.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecch--hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQDK--RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~~--~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...++|++.+.||+|+||+||+|+++   .+++.||+|++....  ....+|+++|+.+ +|||||+++++|.     ..
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~-----~~   92 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFR-----KN   92 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEE-----ET
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEE-----EC
Confidence            34567999999999999999999875   467899999886543  3456899999998 6999999999984     34


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .++|+||||++| +|.+.+       +.+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||+|||+
T Consensus        93 ~~~~lvmE~~~g~~L~~~~-------~~l~~~~~~~~~~qll~al~ylH~~-gIiHRDiKPeNiLl~~~~~~~kl~DFGl  164 (361)
T 4f9c_A           93 DHVVIAMPYLEHESFLDIL-------NSLSFQEVREYMLNLFKALKRIHQF-GIVHRDVKPSNFLYNRRLKKYALVDFGL  164 (361)
T ss_dssp             TEEEEEEECCCCCCHHHHH-------TTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred             CEEEEEEeCCCcccHHHHH-------cCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCcCCHHHeEEeCCCCeEEECcCCC
Confidence            458999999984 666654       3589999999999999999999987 9999999999999998755899999999


Q ss_pred             ccccccCC-----------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC
Q 017452          221 AKVLVKGE-----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK  271 (371)
Q Consensus       221 a~~~~~~~-----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  271 (371)
                      |+...+..                             ...+.+||+.|+|||++.+...++.++||||+||++|+|++|+
T Consensus       165 a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~  244 (361)
T 4f9c_A          165 AQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGR  244 (361)
T ss_dssp             CEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTC
T ss_pred             CcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCC
Confidence            97543321                             1224579999999999987777899999999999999999999


Q ss_pred             CCCC-CCCcHHHHHHHHHHhCCCCHhHHhhcCCC-------cc--------------ccccCc----ccCCCCcccCCCC
Q 017452          272 PLFP-GDSGVDQLVEIIKVLGTPTREEIKCMNPN-------YT--------------EFKFPQ----IKAHPWHKIFPKR  325 (371)
Q Consensus       272 ~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~--------------~~~~~~----~~~~~~~~~~~~~  325 (371)
                      .||. +.+..+.+..+.+..|.+....+......       ..              ....+.    .............
T Consensus       245 ~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~  324 (361)
T 4f9c_A          245 YPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNE  324 (361)
T ss_dssp             SSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTT
T ss_pred             CCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhcccccccccccccccccccccccccc
Confidence            9985 45667778888888776544332211000       00              000000    0000111112356


Q ss_pred             CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          326 MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       326 ~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +|+++.+||.+||++||.+|+||.|+|+|
T Consensus       325 is~~a~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          325 VPDEAYDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            89999999999999999999999995433

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9.5e-57  Score=404.47  Aligned_cols=253  Identities=24%  Similarity=0.340  Sum_probs=208.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|.+.+.||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++++|||||++++++.     +
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~   86 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCV-----E   86 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEe-----e
Confidence            357999999999999999999875     36789999998643    244668999999999999999999984     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhh---------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFN---------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~---------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                      ...++||||||+ |+|.+++....         .....+++..+..++.||+.||+|||++ +||||||||+|||++.++
T Consensus        87 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDlKp~NILl~~~~  165 (299)
T 4asz_A           87 GDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ-HFVHRDLATRNCLVGENL  165 (299)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccCHhhEEECCCC
Confidence            344889999998 68888887532         2235799999999999999999999987 999999999999999988


Q ss_pred             CcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017452          211 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  286 (371)
                       .+||+|||+|+.......   .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+..+
T Consensus       166 -~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i  243 (299)
T 4asz_A          166 -LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRK-FTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECI  243 (299)
T ss_dssp             -CEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH
T ss_pred             -cEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence             899999999986543322   22346899999999997655 8999999999999999998 89999988877766665


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .+....                            ..|..+|+++.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       244 ~~~~~~----------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~  287 (299)
T 4asz_A          244 TQGRVL----------------------------QRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNL  287 (299)
T ss_dssp             HHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HcCCCC----------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            542110                            14567899999999999999999999999999888765

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3e-56  Score=406.53  Aligned_cols=254  Identities=22%  Similarity=0.318  Sum_probs=204.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|.+.++||+|+||+||+|++.     .++..||||++...    ...+.+|+++|++++|||||++++++.     .
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~-----~  114 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCT-----E  114 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----S
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            347999999999999999999865     36889999999643    244668999999999999999999983     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhh-----------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNK-----------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~-----------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      ...++||||||+ |+|.+++.....           ...++++..+..|+.||+.||+|||++ +||||||||+|||++.
T Consensus       115 ~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLKp~NILl~~  193 (329)
T 4aoj_A          115 GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL-HFVHRDLATRNCLVGQ  193 (329)
T ss_dssp             SSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEET
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecccccHhhEEECC
Confidence            444889999999 588888765321           235699999999999999999999987 9999999999999999


Q ss_pred             CCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHH
Q 017452          209 HTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLV  284 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~  284 (371)
                      ++ .+||+|||+|+.......   .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+.+.
T Consensus       194 ~~-~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~-~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~  271 (329)
T 4aoj_A          194 GL-VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRK-FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAID  271 (329)
T ss_dssp             TT-EEEECCCC----------------CCCCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHH
T ss_pred             CC-cEEEcccccceeccCCCcceecCcccccccccChhhhcCCC-CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence            88 999999999987543322   23467899999999997655 8999999999999999998 899999888777666


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      .+.+... +                           ..|..+++++.+|+.+||+.||.+|||+.+++++|+.+.
T Consensus       272 ~i~~g~~-~---------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~  318 (329)
T 4aoj_A          272 CITQGRE-L---------------------------ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALA  318 (329)
T ss_dssp             HHHHTCC-C---------------------------CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHcCCC-C---------------------------CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHh
Confidence            6554211 0                           145678999999999999999999999999999988763

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=3.2e-55  Score=415.47  Aligned_cols=287  Identities=69%  Similarity=1.186  Sum_probs=261.3

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCceeEE
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLN  145 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~  145 (371)
                      .....+|++.+.||+|+||.||+|.+..+|+.||||++..+.....+|+++++.++||||++++++++.... .+..+++
T Consensus        50 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           50 RPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             CCEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             CcccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence            334567999999999999999999999999999999998777777789999999999999999998876543 4567788


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+++++...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||+++...
T Consensus       130 lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            9999999998888877766678899999999999999999999986 999999999999999776579999999998876


Q ss_pred             cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      .........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+.++++.++.+..+.+..+++.+
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            66666677899999999999776668999999999999999999999999999999999999999999999999999999


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+.++.+...+|...++..+++++.+||.+||.+||.+|||+.++++|
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence            9999999999999999999999999999999999999999999999998

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=7.1e-56  Score=400.45  Aligned_cols=255  Identities=22%  Similarity=0.272  Sum_probs=209.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...+++.+.||+|+||+||+|...     .+++.||||++...     ...+.+|+.++++++|||||++++++..    
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----  100 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTK----  100 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEE----
Confidence            346899999999999999999863     46789999998543     3456789999999999999999999843    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhh------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                       ...++||||||+ |+|.+++....            .....+++..+..|+.||+.||+|||++ +||||||||+|||+
T Consensus       101 -~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHRDLK~~NILl  178 (308)
T 4gt4_A          101 -DQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH-HVVHKDLATRNVLV  178 (308)
T ss_dssp             -SSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEE
T ss_pred             -CCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCccccceEE
Confidence             334789999998 58888886432            1235689999999999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQ  282 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  282 (371)
                      +.++ .+||+|||+|+......   ......||+.|||||++.+.. ++.++|||||||++|||+| |..||.+.+..+.
T Consensus       179 ~~~~-~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~  256 (308)
T 4gt4_A          179 YDKL-NVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGK-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDV  256 (308)
T ss_dssp             CGGG-CEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHH
T ss_pred             CCCC-CEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCC-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9988 89999999998654322   233467899999999997655 8999999999999999998 8999998877666


Q ss_pred             HHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      +..+.+....+                            .|..+++++.+|+.+||+.||.+|||+.+++++|+...+
T Consensus       257 ~~~i~~~~~~~----------------------------~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~~n  306 (308)
T 4gt4_A          257 VEMIRNRQVLP----------------------------CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAWGN  306 (308)
T ss_dssp             HHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCC
T ss_pred             HHHHHcCCCCC----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhccC
Confidence            55554321100                            456789999999999999999999999999999987643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-56  Score=398.32  Aligned_cols=254  Identities=22%  Similarity=0.259  Sum_probs=202.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..++++.++||+|+||+||+|++.   ..||||+++..      ...+.+|+.++++++|||||++++++..    +  .
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~----~--~  105 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH---GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK----D--N  105 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS---SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS----S--S
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC---CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC----C--e
Confidence            457899999999999999999853   35999988532      2445689999999999999999987621    1  2


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ++||||||+ |+|.+.+..   ....+++..+..|+.||+.||+|||++ +||||||||+|||++.++ .+||+|||+|+
T Consensus       106 ~~iVmEy~~gGsL~~~l~~---~~~~l~~~~~~~i~~qia~gL~yLH~~-~IiHRDlKp~NILl~~~~-~~Ki~DFGla~  180 (307)
T 3omv_A          106 LAIVTQWCEGSSLYKHLHV---QETKFQMFQLIDIARQTAQGMDYLHAK-NIIHRDMKSNNIFLHEGL-TVKIGDFGLAT  180 (307)
T ss_dssp             CEEEEECCSSCBHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCSSSEEEETTE-EEEECCCSSCB
T ss_pred             EEEEEEcCCCCCHHHHHhh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCccCHHHEEECCCC-cEEEeeccCce
Confidence            689999999 588777753   246799999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCC---CcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+....+..++.....++   
T Consensus       181 ~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p---  257 (307)
T 3omv_A          181 VKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASP---  257 (307)
T ss_dssp             C------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCC---
T ss_pred             ecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCC---
Confidence            754322   23456899999999998643  2478999999999999999999999988777666555544211110   


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                    .      ....+..+++++.+|+.+||+.||.+|||+.+++++|+.+++
T Consensus       258 --------------~------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~  300 (307)
T 3omv_A          258 --------------D------LSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQH  300 (307)
T ss_dssp             --------------C------STTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHT
T ss_pred             --------------C------cccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhc
Confidence                          0      011445689999999999999999999999999999876643

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8.2e-55  Score=408.21  Aligned_cols=284  Identities=52%  Similarity=0.996  Sum_probs=256.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC-----------
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-----------  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-----------  138 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++..+.....+|+.+++.++||||+++++++.....           
T Consensus         6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~   85 (383)
T 3eb0_A            6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDD   85 (383)
T ss_dssp             CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------
T ss_pred             cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccc
Confidence            457999999999999999999999999999999998887777899999999999999999999866443           


Q ss_pred             ----------------------CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEe
Q 017452          139 ----------------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCH  196 (371)
Q Consensus       139 ----------------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH  196 (371)
                                            .+..++++||||++++|.+.+.........+++..++.++.||+.||.|||++ ||+|
T Consensus        86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-gi~H  164 (383)
T 3eb0_A           86 HNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL-GICH  164 (383)
T ss_dssp             ------------------------CCEEEEEECCCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEEC
T ss_pred             cccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC-cCcc
Confidence                                  34566889999999999988887777778999999999999999999999986 9999


Q ss_pred             eccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       197 ~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                      |||||+|||++.+.+.+||+|||+++............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+
T Consensus       165 ~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  244 (383)
T 3eb0_A          165 RDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSG  244 (383)
T ss_dssp             SCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             CccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCC
Confidence            99999999998544489999999998876666666778899999999987766689999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+..+.+..+++..+.++.+.+..+++.+....++......|...++..+++++.+||.+||++||.+|||+.++++|
T Consensus       245 ~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          245 ETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             SSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            999999999999999999999999999999999999999999999999999999999999999999999999998888

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.2e-55  Score=397.77  Aligned_cols=250  Identities=23%  Similarity=0.374  Sum_probs=187.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC-------
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-------  138 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-------  138 (371)
                      .+|++.+.||+|+||+||+|+++.+|+.||||++...     ...+.+|+.+|+.++|||||+++++|...+.       
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~   84 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS   84 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred             hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence            4699999999999999999999999999999998543     2345689999999999999999999876543       


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      ....++|+|||||+| +|.+.+..... ....++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~al~ylH~~-~IiHRDlKp~NILl~~~~-~vKl~D  161 (299)
T 4g31_A           85 SPKVYLYIQMQLCRKENLKDWMNGRCT-IEERERSVCLHIFLQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGD  161 (299)
T ss_dssp             --CEEEEEEEECCCSCCHHHHHHTCCS-GGGSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC
T ss_pred             CCCcEEEEEEecCCCCcHHHHHHhcCC-CChhHHHHHHHHHHHHHHHHHHHHHC-cCccccCcHHHeEECCCC-cEEEcc
Confidence            234568999999984 77777764221 22345677899999999999999987 999999999999999988 899999


Q ss_pred             eCCccccccCCC-------------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017452          218 FGSAKVLVKGEP-------------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (371)
Q Consensus       218 fg~a~~~~~~~~-------------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (371)
                      ||+|+.......             ....+||+.|||||++.+.. ++.++|||||||++|||++   ||....  +...
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-CCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            999987644321             22457999999999997654 8999999999999999996   775432  2222


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+........+..+                         ...++.+.+||.+||+.||.+|||+.++++|
T Consensus       236 ~~~~~~~~~~p~~~-------------------------~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVRNLKFPPLF-------------------------TQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHTTCCCHHH-------------------------HHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCCCCC-------------------------cccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            22222111111100                         1246778999999999999999999998887

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.9e-54  Score=404.15  Aligned_cols=283  Identities=67%  Similarity=1.163  Sum_probs=257.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCceeEEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLV  147 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv  147 (371)
                      ...+|++.+.||+|+||.||+|.+..++. +|+|++........+|+.+++.++||||+++++++..... .+..++++|
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv  116 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLV  116 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEE
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEE
Confidence            34579999999999999999999877665 8999888777777889999999999999999999877654 556778899


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee-CCCCcEEEEeeCCcccccc
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~-~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++ .++ .+||+|||+++....
T Consensus       117 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~-~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI-GICHRDIKPQNLLLDPPSG-VLKLIDFGSAKILIA  194 (394)
T ss_dssp             EECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTT-EEEECCCTTCEECCT
T ss_pred             eeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEcCCCC-cEEEeeCCCcccccC
Confidence            99999988888777767678999999999999999999999987 999999999999999 455 899999999988766


Q ss_pred             CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          227 GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       227 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      ........||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+..+.+...++++.
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            66666788999999999997766689999999999999999999999999999999999999999999999999888888


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ...++.+...+|...++..+++++.+||.+||++||.+|||+.++++|
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence            888999888889888999999999999999999999999999999998

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.5e-54  Score=422.23  Aligned_cols=250  Identities=25%  Similarity=0.369  Sum_probs=203.3

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHH---HHHHHHcCCCCeeecceeEEec
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRE---LQTMRLLDHPNVVSLKHCFFST  136 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e---~~~l~~l~h~niv~~~~~~~~~  136 (371)
                      +...++|++.+.||+|+||.||+|+++.+|+.||||++.+..       ....+|   +.+++.++|||||+++++|   
T Consensus       185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f---  261 (689)
T 3v5w_A          185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF---  261 (689)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE---
T ss_pred             CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEE---
Confidence            445678999999999999999999999999999999986431       122233   4556667899999999998   


Q ss_pred             CCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          137 TDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                        .+...+|||||||+| +|..++..    .+.+++..++.|+.||+.||+|||++ |||||||||+||||+.+| .+||
T Consensus       262 --~~~~~lylVmEy~~GGdL~~~l~~----~~~l~E~~a~~y~~qIl~aL~yLH~~-gIiHRDLKPeNILld~~G-~vKL  333 (689)
T 3v5w_A          262 --HTPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRI  333 (689)
T ss_dssp             --ECSSEEEEEECCCCSCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTS-CEEE
T ss_pred             --EECCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCchHHeEEeCCC-CEEe
Confidence              445568999999995 77777764    47899999999999999999999987 999999999999999998 8999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +|||+|+..... ...+.+||+.|||||++.....|+.++|+|||||++|+|++|.+||.+.+..+...........+  
T Consensus       334 ~DFGlA~~~~~~-~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~--  410 (689)
T 3v5w_A          334 SDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA--  410 (689)
T ss_dssp             CCCTTCEECSSC-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC--
T ss_pred             cccceeeecCCC-CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCC--
Confidence            999999876543 34567899999999999765568999999999999999999999997644322221111111000  


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                              -.+|..+|+++.+||.+||+.||.+|++     +.++++|
T Consensus       411 ------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          411 ------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             ------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             ------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence                                    1156678999999999999999999998     7897666

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-54  Score=398.92  Aligned_cols=255  Identities=23%  Similarity=0.334  Sum_probs=208.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCC-----CcEEEEEEeecc-----hhhhHHHHHHHHHcCC-CCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQD-----KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~  138 (371)
                      ..+|++++.||+|+||.||+|.+..+     ++.||||.+...     ...+.+|+++|++++| ||||++++++...  
T Consensus        63 ~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~--  140 (353)
T 4ase_A           63 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  140 (353)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             HHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEec--
Confidence            35799999999999999999997654     367999998643     2345689999999976 8999999987432  


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCcee
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIl  205 (371)
                        ...++||||||+ |+|.+++.....            ....+++..+..++.||+.||+|||++ +||||||||+|||
T Consensus       141 --~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~-~iiHRDLK~~NIL  217 (353)
T 4ase_A          141 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  217 (353)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC-CeecCccCcccee
Confidence              233789999999 688888875432            134589999999999999999999987 9999999999999


Q ss_pred             eeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017452          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (371)
Q Consensus       206 i~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (371)
                      ++.++ .+||+|||+|+.......   .....||+.|||||++.+.. ++.++|||||||++|||+| |+.||.+.+..+
T Consensus       218 l~~~~-~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~  295 (353)
T 4ase_A          218 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  295 (353)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             eCCCC-CEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCC-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHH
Confidence            99988 899999999987644332   23456899999999997655 8999999999999999998 999998876555


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .+...+.....+                           ..|..+++++.+|+.+||+.||.+|||+.++++||..+
T Consensus       296 ~~~~~i~~g~~~---------------------------~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~l  345 (353)
T 4ase_A          296 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  345 (353)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC---------------------------CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHH
Confidence            554444321111                           14566899999999999999999999999999998775

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3.7e-54  Score=421.06  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=213.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++.+.||+|+||.||+|.++.+|+.||+|++...    .....+|+.+|+.++|||||+++++|     .+...+|
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~-----~~~~~~~  230 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAF-----EDDNEMV  230 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEE-----ECSSEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECCEEE
Confidence            46899999999999999999999999999999998653    34456899999999999999999998     4455689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-CCcEEEEeeCCccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-~~~~kl~Dfg~a~~  223 (371)
                      ||||||+| +|.+.+.   .....+++..++.++.||+.||+|||++ ||+||||||+|||++.+ .+.+||+|||+|+.
T Consensus       231 iv~E~~~gg~L~~~i~---~~~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~  306 (573)
T 3uto_A          231 MIYEFMSGGELFEKVA---DEHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  306 (573)
T ss_dssp             EEEECCCCCBHHHHHT---CTTSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCSSCEE
T ss_pred             EEEeecCCCcHHHHHH---HhCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeccCChhhccccCCCCCCEEEeeccceeE
Confidence            99999985 6666553   2246799999999999999999999987 99999999999999864 23899999999998


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..........+||+.|||||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+..       
T Consensus       307 ~~~~~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------  378 (573)
T 3uto_A          307 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------  378 (573)
T ss_dssp             CCTTSEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSG-------
T ss_pred             ccCCCceeeeEECccccCHHHhCCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcc-------
Confidence            87666666788999999999997655 7999999999999999999999999988877777765532221111       


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        .+..+|+++.+||.+||+.||.+|||+.|+|+|
T Consensus       379 ------------------~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          379 ------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             ------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                              224589999999999999999999999998887

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=6.8e-51  Score=367.63  Aligned_cols=274  Identities=33%  Similarity=0.528  Sum_probs=220.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .+|++.+.||+|+||+||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   76 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHS-----DKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEe-----CCEE
Confidence            47999999999999999999999999999999986432      345579999999999999999998843     3458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+++++...+..   ....+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        77 ~lv~e~~~~~l~~~~~~---~~~~l~~~~~~~~~~ql~~~l~~lH~~-~ivH~dikp~Nil~~~~~-~~kl~Dfg~~~~~  151 (292)
T 3o0g_A           77 TLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCCHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEeecccceec
Confidence            89999999987776654   246799999999999999999999987 999999999999999988 8999999999876


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCC-CCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPL-FPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..| |.+.+..+.+..+.+..+.+..+.+....
T Consensus       152 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  231 (292)
T 3o0g_A          152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             CCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhc
Confidence            433 2334567899999999997766689999999999999999988776 56667777788888888888877665433


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ........+..............++.++.+||.+||+.||.+|||+.++++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            2111111121111111222345689999999999999999999999995544

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.8e-52  Score=378.77  Aligned_cols=263  Identities=20%  Similarity=0.231  Sum_probs=192.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-hh--HHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-YK--NRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~--~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|.+.+.||+|+||+||+|++  +|+.||||++..... ..  +.|+..+..++|||||++++++.... .....++||
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~-~~~~~~~lV   79 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecC-CCceEEEEE
Confidence            3699999999999999999987  689999999865432 22  34555566789999999999886543 233457899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-------CCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-------IGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ||||+ |+|.+.+..     ..+++..+..++.|++.||+|||++       .+||||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~gsL~~~l~~-----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~-~~Ki~DFG  153 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             ecCCCCCcHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC-CEEEEeCC
Confidence            99998 588887763     5789999999999999999999963       2899999999999999998 89999999


Q ss_pred             CccccccCCCc-----ccccccccccCcccccCCc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH--------
Q 017452          220 SAKVLVKGEPN-----ISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD--------  281 (371)
Q Consensus       220 ~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--------  281 (371)
                      +|+........     ....||+.|||||++.+..     .++.++|||||||++|||+||..||......+        
T Consensus       154 la~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~  233 (303)
T 3hmm_A          154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP  233 (303)
T ss_dssp             TCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSC
T ss_pred             CCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccc
Confidence            99876544322     2357999999999986542     25678999999999999999987764332110        


Q ss_pred             ---HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          282 ---QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       282 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                         ....+.+.....          .    ..+.++. .+   .....+..+.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       234 ~~~~~~~~~~~~~~~----------~----~rp~~p~-~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l  295 (303)
T 3hmm_A          234 SDPSVEEMRKVVCEQ----------K----LRPNIPN-RW---QSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQL  295 (303)
T ss_dssp             SSCCHHHHHHHHTTS----------C----CCCCCCG-GG---GSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHH
T ss_pred             ccchHHHHHHHHhcc----------c----CCCCCCc-cc---cchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHH
Confidence               011111110000          0    0000000 00   0011235788999999999999999999999999876


Q ss_pred             Cc
Q 017452          359 PS  360 (371)
Q Consensus       359 ~~  360 (371)
                      ..
T Consensus       296 ~~  297 (303)
T 3hmm_A          296 SQ  297 (303)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.1e-50  Score=369.63  Aligned_cols=274  Identities=34%  Similarity=0.618  Sum_probs=220.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+. +|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus        19 l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~   92 (311)
T 3niz_A           19 LMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI-----HSER   92 (311)
T ss_dssp             SSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCSS
T ss_pred             hHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEE-----ccCC
Confidence            4468999999999999999999985 58999999985431      3456899999999999999999988     4445


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++||||+++++.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        93 ~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~  167 (311)
T 3niz_A           93 CLTLVFEFMEKDLKKVLDE---NKTGLQDSQIKIYLYQLLRGVAHCHQH-RILHRDLKPQNLLINSDG-ALKLADFGLAR  167 (311)
T ss_dssp             CEEEEEECCSEEHHHHHHT---CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCCHHHHHHh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCchHhEEECCCC-CEEEccCcCce
Confidence            6899999999988777653   245699999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          223 VLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       223 ~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ..... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+....+...
T Consensus       168 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  247 (311)
T 3niz_A          168 AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQV  247 (311)
T ss_dssp             ETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGG
T ss_pred             ecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhh
Confidence            76433 22344578999999999977666899999999999999999999999998888899999999888877665433


Q ss_pred             CCCc--cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNY--TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..-.  ....+......+|.. +...+++++.+||.+||++||.+|||+.++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          248 QELPLWKQRTFQVFEKKPWSS-IIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             TTSHHHHSCCCCCCCCCCHHH-HSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hccchhhhcccccccCCcHHH-hCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            2110  011112222223322 234578999999999999999999999996655

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=7.3e-51  Score=389.77  Aligned_cols=276  Identities=30%  Similarity=0.532  Sum_probs=219.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            45799999999999999999999999999999998643      2344589999999999999999998854332 2335


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+|+||||+++++...+.      ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       141 ~~~lv~E~~~~~l~~~~~------~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDlkp~NIll~~~~-~~kl~DFG~a~  212 (464)
T 3ttj_A          141 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  212 (464)
T ss_dssp             EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCCC-
T ss_pred             eEEEEEeCCCCCHHHHHh------hcCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChHhEEEeCCC-CEEEEEEEeee
Confidence            678999999998766553      4589999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+.+|.+..+.+....
T Consensus       213 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~  291 (464)
T 3ttj_A          213 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQ  291 (464)
T ss_dssp             ----CCCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSC
T ss_pred             ecCCCcccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcc
Confidence            876665566788999999999997654 8999999999999999999999999999999999999999999888776543


Q ss_pred             CCccccc--cCcccCCCCcccCCCC-----------CChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFK--FPQIKAHPWHKIFPKR-----------MPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~--~~~~~~~~~~~~~~~~-----------~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....+.  .+......+...++..           .++++.+||.+||++||.+|||+.|+|+|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          292 PTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            2211110  0111111111112221           15679999999999999999999998888

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.6e-50  Score=370.78  Aligned_cols=247  Identities=28%  Similarity=0.406  Sum_probs=212.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++     ...
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~-----~~~   86 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVI-----ETE   86 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            44568999999999999999999999999999999986532      2345899999999999999999988     334


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++||||++ ++|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        87 ~~~~lv~e~~~~~~L~~~l~~----~~~l~~~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~  160 (328)
T 3fe3_A           87 KTLYLIMEYASGGEVFDYLVA----HGRMKEKEARSKFRQIVSAVQYCHQK-RIVHRDLKAENLLLDADM-NIKIADFGF  160 (328)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTC
T ss_pred             CEEEEEEECCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCCHHHEEEcCCC-CEEEeeccC
Confidence            55899999997 577777654    46799999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.+..+....+.....         
T Consensus       161 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~---------  231 (328)
T 3fe3_A          161 SNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKY---------  231 (328)
T ss_dssp             CGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC---------
T ss_pred             ceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC---------
Confidence            98776666666778999999999998776556899999999999999999999998876666555544210         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          .+|..+++++.+||.+||..||.+|||+.++++|
T Consensus       232 --------------------~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          232 --------------------RIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             --------------------CCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                                1345689999999999999999999999999988

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.9e-50  Score=375.40  Aligned_cols=283  Identities=47%  Similarity=0.860  Sum_probs=234.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh---hhHHHHHHHHHcCCCCeeecceeEEecCC--CCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVSLKHCFFSTTD--KDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++..+..   ...+++..++.++||||+++++++.....  ....++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~  101 (360)
T 3e3p_A           22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYL  101 (360)
T ss_dssp             HTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeE
Confidence            4579999999999999999999999999999999865533   33456667788899999999999876543  445668


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH--hcCCcEeeccCCCceeeeC-CCCcEEEEeeCCc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--RSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSA  221 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~ivH~dlkp~NIli~~-~~~~~kl~Dfg~a  221 (371)
                      ++||||+++++...+.........+++..++.++.||+.||.|||  ++ ||+||||||+|||++. ++ .+||+|||++
T Consensus       102 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~-~ivH~Dlkp~NIll~~~~~-~~kl~Dfg~a  179 (360)
T 3e3p_A          102 NVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV-NVCHRDIKPHNVLVNEADG-TLKLCDFGSA  179 (360)
T ss_dssp             EEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT-CCBCSCCCGGGEEEETTTT-EEEECCCTTC
T ss_pred             EEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC-CeecCcCCHHHEEEeCCCC-cEEEeeCCCc
Confidence            899999999888877766666788999999999999999999999  86 9999999999999997 55 9999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .............||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+.+..+.++.+.+...
T Consensus       180 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3e3p_A          180 KKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKL  259 (360)
T ss_dssp             BCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHH
T ss_pred             eecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhc
Confidence            88766666667788999999999977666899999999999999999999999999999999999999999999998888


Q ss_pred             CCCccccccCcccCCCCcccCCC---CCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPK---RMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~---~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+......+......+|...++.   ..++++.+||.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          260 NPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             CTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             ccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            77776666666666666655544   367899999999999999999999998877

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=2.8e-50  Score=366.36  Aligned_cols=278  Identities=30%  Similarity=0.512  Sum_probs=226.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------hhhHHHHHHHHHcC---CCCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLD---HPNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~---h~niv~~~~~~~~~~  137 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....         ....+|+.+++.++   ||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            458999999999999999999999999999999986322         34557887777664   999999999987766


Q ss_pred             CCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      .......++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|
T Consensus        88 ~~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVDQDLRTYLDKAP--PPGLPAETIKDLMRQFLRGLDFLHAN-CIVHRDLKPENILVTSGG-TVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCCCBHHHHHHTCC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCTTTEEECTTS-CEEECS
T ss_pred             CCCceeEEEEehhhhcCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCC-CEEEee
Confidence            55566789999999999888876522  23499999999999999999999987 999999999999999888 899999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...
T Consensus       164 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  242 (308)
T 3g33_A          164 FGLARIYSYQMALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD  242 (308)
T ss_dssp             CSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSC-CCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             CccccccCCCcccCCccccccccCchHHcCCC-CCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            99998776666666778899999999997655 89999999999999999999999999999999999999988887766


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      |...... ....++.....++.. ....+++++.+||.+||++||.+|||+.++++|
T Consensus       243 ~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          243 WPRDVSL-PRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             SCSSCSS-CGGGSCCCCCCCHHH-HSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccchhhc-cccccCCCCCCcHHH-hCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            5432111 111111111111111 234589999999999999999999999996655

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.4e-50  Score=362.37  Aligned_cols=272  Identities=33%  Similarity=0.608  Sum_probs=215.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||+|+||.||+|.+ .+|+.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~   75 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEcc-----CCeE
Confidence            4799999999999999999998 678999999985432      345689999999999999999998843     3458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        76 ~lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  150 (288)
T 1ob3_A           76 VLVFEHLDQDLKKLLDVC---EGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (288)
T ss_dssp             EEEEECCSEEHHHHHHTS---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             EEEEEecCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEeECcccccc
Confidence            899999999888777642   46799999999999999999999987 999999999999999888 8999999998765


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (288)
T 1ob3_A          151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (288)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             CccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhc
Confidence            432 2233457899999999997666689999999999999999999999999888888888888888876655532211


Q ss_pred             Cc-cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NY-TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .. ....+......+|.. +...+++++.+||.+||+.||.+|||+.++++|
T Consensus       231 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          231 LPKYDPNFTVYEPLPWES-FLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             STTCCTTCCCCCCCCGGG-TCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccCccHHH-HhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            00 000111112222322 345689999999999999999999999995443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=9e-50  Score=364.55  Aligned_cols=277  Identities=30%  Similarity=0.515  Sum_probs=210.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++....     ....+|+.+++.++||||+++++++     ......+
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~~~   79 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI-----HTENKLT   79 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE-----CCTTEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE-----EECCeEE
Confidence            47999999999999999999999999999999986432     3456899999999999999999988     4455689


Q ss_pred             EeeccccchHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          146 LVLEYVPETVHRVVKHFNK--LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +||||++++|.+.+.....  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus        80 lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~~~~  157 (317)
T 2pmi_A           80 LVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN-KILHRDLKPQNLLINKRG-QLKLGDFGLARA  157 (317)
T ss_dssp             EEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCSSCEE
T ss_pred             EEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCChHHeEEcCCC-CEEECcCcccee
Confidence            9999999998888876432  224689999999999999999999987 999999999999999988 899999999987


Q ss_pred             cccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .... .......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...+....
T Consensus       158 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          158 FGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             cCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            5432 233456789999999999765568999999999999999999999999999888899999988888766554321


Q ss_pred             CCccc-cccCcccCCCC----cccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTE-FKFPQIKAHPW----HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~-~~~~~~~~~~~----~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..... ..........+    ....+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence            10000 00000000111    112334688999999999999999999999997766

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=4.7e-50  Score=384.59  Aligned_cols=278  Identities=33%  Similarity=0.543  Sum_probs=211.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+|+.++||||+++++++..........
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             CTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            46899999999999999999999999999999998543      234568999999999999999999886554444566


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|+||||++++|..++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       132 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~iiHrDlKp~NILl~~~~-~~kl~DFGla~~  205 (458)
T 3rp9_A          132 LYVVLEIADSDFKKLFRT----PVYLTELHIKTLLYNLLVGVKYVHSA-GILHRDLKPANCLVNQDC-SVKVCDFGLART  205 (458)
T ss_dssp             EEEEECCCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTC-CEEECCCTTCBC
T ss_pred             EEEEEeccccchhhhccc----CCCCCHHHHHHHHHHHHHHHHHHHhC-CcCCCCCChhhEEECCCC-CEeecccccchh
Confidence            899999999998887764    56799999999999999999999987 999999999999999988 899999999987


Q ss_pred             cccCC----------------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh------
Q 017452          224 LVKGE----------------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML------  269 (371)
Q Consensus       224 ~~~~~----------------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt------  269 (371)
                      .....                            .....+||+.|+|||++.....++.++|||||||++|||++      
T Consensus       206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~  285 (458)
T 3rp9_A          206 VDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENV  285 (458)
T ss_dssp             TTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTC
T ss_pred             ccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccc
Confidence            54221                            12345779999999987666668999999999999999999      


Q ss_pred             -----CCCCCCCCC--------------------cHHHHHHHHHHhCCCCHhHHhhcCCCcccc---ccCcccCCCCccc
Q 017452          270 -----GKPLFPGDS--------------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKI  321 (371)
Q Consensus       270 -----g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  321 (371)
                           |+++|.+.+                    ..+.+..+...+|.++.+.+..........   .++......+...
T Consensus       286 ~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  365 (458)
T 3rp9_A          286 AYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER  365 (458)
T ss_dssp             SSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGG
T ss_pred             cccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHH
Confidence                 677776654                    256778888899999988776443211110   1111122222222


Q ss_pred             CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          322 FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       322 ~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      + ..+++++.+||.+||..||.+|||+.|+|+|
T Consensus       366 ~-~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          366 F-PASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             S-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             C-CCCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            2 3469999999999999999999999999988

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.4e-50  Score=377.56  Aligned_cols=275  Identities=32%  Similarity=0.628  Sum_probs=214.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.+. ||||+++++++...   +..
T Consensus         8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~---~~~   84 (388)
T 3oz6_A            8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRAD---NDR   84 (388)
T ss_dssp             HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECT---TSS
T ss_pred             cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecC---CCC
Confidence            35799999999999999999999999999999988532      233457999999997 99999999988542   334


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+|+||||++++|...+..     ..+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus        85 ~~~lv~e~~~~~L~~~~~~-----~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~  157 (388)
T 3oz6_A           85 DVYLVFDYMETDLHAVIRA-----NILEPVHKQYVVYQLIKVIKYLHSG-GLLHRDMKPSNILLNAEC-HVKVADFGLSR  157 (388)
T ss_dssp             CEEEEEECCSEEHHHHHHH-----TCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEecccCcCHHHHHHc-----CCCCHHHHHHHHHHHHHHHHHHHhC-CEEeCCCCHHHeEEcCCC-CEEecCCcccc
Confidence            5789999999998887763     5789999999999999999999987 999999999999999988 89999999997


Q ss_pred             ccccC----------------------CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 017452          223 VLVKG----------------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (371)
Q Consensus       223 ~~~~~----------------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (371)
                      .....                      .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  237 (388)
T 3oz6_A          158 SFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM  237 (388)
T ss_dssp             ESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            65321                      11234578999999999977666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHhHHhhcCCCccccccCc------ccCCCCccc------------CCCCCChhHHHHHHhccCcCC
Q 017452          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQ------IKAHPWHKI------------FPKRMPPEAVDLVSRLLQYSP  342 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~~------------~~~~~s~~l~~li~~~l~~dP  342 (371)
                      +.+..+....+.|..+.+......+.......      .....+...            .+..+++++.+||.+||+.||
T Consensus       238 ~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP  317 (388)
T 3oz6_A          238 NQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNP  317 (388)
T ss_dssp             HHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCc
Confidence            99999999999998887754432221110000      000011111            123678999999999999999


Q ss_pred             CCCCCHHHHhhh
Q 017452          343 NLRCTAVSKRIL  354 (371)
Q Consensus       343 ~~R~t~~~~l~~  354 (371)
                      .+|||+.++++|
T Consensus       318 ~~R~t~~e~l~H  329 (388)
T 3oz6_A          318 NKRISANDALKH  329 (388)
T ss_dssp             GGSCCHHHHTTS
T ss_pred             ccCCCHHHHhCC
Confidence            999999999988

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.1e-49  Score=369.67  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=211.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++....          ..+.+|+.+++.++||||+++++++     
T Consensus        10 ~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----   84 (361)
T 2yab_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVY-----   84 (361)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             hhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEE-----
Confidence            4457999999999999999999999999999999986532          3457899999999999999999988     


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---cEE
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---~~k  214 (371)
                      .....+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 ~~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~~~vk  159 (361)
T 2yab_A           85 ENRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (361)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHHTT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             EeCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEeCCCCCccCEE
Confidence            34455899999996 577776643    56799999999999999999999987 9999999999999987653   699


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+
T Consensus       160 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~  238 (361)
T 2yab_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFD  238 (361)
T ss_dssp             ECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EEecCCceEcCCCCccccCCCCccEECchHHcCCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC
Confidence            99999998876665566778999999999986544 89999999999999999999999998877776666654322222


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..                         ++..+++++.+||.+||..||.+|||+.++++|
T Consensus       239 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          239 EE-------------------------FFSQTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ch-------------------------hccCCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            22                         224578999999999999999999999998877

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=1e-50  Score=372.93  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=208.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~-----~   80 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVIT-----T   80 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEE-----e
Confidence            3456899999999999999999999999999999998543       234678999999999999999999884     3


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ....++||||++|+|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        81 ~~~~~lv~E~~~g~l~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~DFG~  154 (336)
T 3h4j_B           81 PTDIVMVIEYAGGELFDYIVE----KKRMTEDEGRRFFQQIICAIEYCHRH-KIVHRDLKPENLLLDDNL-NVKIADFGL  154 (336)
T ss_dssp             SSEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-TCCCCCCSTTTEEECTTC-CEEECCSSC
T ss_pred             CCEEEEEEECCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCchhhEEEcCCC-CEEEEEecc
Confidence            445889999999988887765    46799999999999999999999997 999999999999999888 899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.......                 
T Consensus       155 s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~-----------------  217 (336)
T 3h4j_B          155 SNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLF-----------------  217 (336)
T ss_dssp             TBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCB-----------------
T ss_pred             ceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHH-----------------
Confidence            987766665667789999999999977665578999999999999999999999764321110                 


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                ..+...  ...++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       218 ----------~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  259 (336)
T 3h4j_B          218 ----------KKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRD  259 (336)
T ss_dssp             ----------CCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTC
T ss_pred             ----------HHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                      001110  112466789999999999999999999999999888

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=5.8e-50  Score=367.70  Aligned_cols=277  Identities=30%  Similarity=0.542  Sum_probs=215.8

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..     .
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~  105 (329)
T 3gbz_A           31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHH-----N  105 (329)
T ss_dssp             -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEE-----T
T ss_pred             cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEec-----C
Confidence            34568999999999999999999999999999999985432      234589999999999999999998843     3


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC----CcEEEEe
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCD  217 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~----~~~kl~D  217 (371)
                      ...++||||++++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ..+||+|
T Consensus       106 ~~~~lv~e~~~~~L~~~~~~----~~~~~~~~~~~i~~ql~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~~~kl~D  180 (329)
T 3gbz_A          106 HRLHLIFEYAENDLKKYMDK----NPDVSMRVIKSFLYQLINGVNFCHSR-RCLHRDLKPQNLLLSVSDASETPVLKIGD  180 (329)
T ss_dssp             TEEEEEEECCSEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEC-----CCEEEECC
T ss_pred             CEEEEEEecCCCCHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEECCCCCHHHEEEecCCCCccceEEECc
Confidence            45889999999998888765    46799999999999999999999987 999999999999995333    2599999


Q ss_pred             eCCccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          218 FGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       218 fg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ||++...... .......+|+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.++..
T Consensus       181 fg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~  260 (329)
T 3gbz_A          181 FGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDT  260 (329)
T ss_dssp             TTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchh
Confidence            9999765432 223445779999999999776668999999999999999999999999999999999999988888766


Q ss_pred             HHhhcCCCc-cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNY-TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+....... -...++......+...++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          261 TWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             TSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence            553221000 0011122222222222334478999999999999999999999996544

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-49  Score=366.77  Aligned_cols=274  Identities=33%  Similarity=0.584  Sum_probs=221.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~  104 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD  104 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCce
Confidence            4799999999999999999999999999999998542      2344589999999999999999998854322 12234


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|+||||++++|..++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~a~~  177 (367)
T 1cm8_A          105 FYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLARQ  177 (367)
T ss_dssp             CEEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCHHHEEEcCCC-CEEEEeeecccc
Confidence            689999998888887763     5789999999999999999999987 999999999999999988 899999999987


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+.....
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  234567899999999997756689999999999999999999999999999999999999999999887764432


Q ss_pred             Cccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....   ..++......|.. +...+++.+.+||.+||..||.+|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHHHhCCCCCCCCHHH-HCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence            2111   0122233333433 334689999999999999999999999999998

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=6.6e-49  Score=361.14  Aligned_cols=244  Identities=26%  Similarity=0.403  Sum_probs=207.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|..+++.++||||+++++++     ....
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~-----~~~~   78 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEE-----EeCC
Confidence            45799999999999999999999999999999998653       23456799999999999999999988     3445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        79 ~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG~a  152 (337)
T 1o6l_A           79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCCHHHEEECCCC-CEEEeeccch
Confidence            58999999985 77666654    46799999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +... ........+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+....          
T Consensus       153 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  221 (337)
T 1o6l_A          153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE----------  221 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             hhcccCCCcccccccChhhCChhhhcCCC-CCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCC----------
Confidence            8643 233445678999999999996654 7999999999999999999999998877666555554310          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                         ..++..+++++.+||.+||+.||.+||     ++.++++|
T Consensus       222 -------------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          222 -------------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcC
Confidence                               014566899999999999999999999     99998888

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.9e-50  Score=366.40  Aligned_cols=273  Identities=32%  Similarity=0.602  Sum_probs=217.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-----hhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-----YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-----~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++.....     ...+|+.+++.++||||+++++++..     ....+
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~~   76 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHT-----EKSLT   76 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEEC-----SSCEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEee-----CCEEE
Confidence            479999999999999999999999999999999854321     33469999999999999999998843     34478


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||++++|...+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        77 lv~e~~~~~l~~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~~  151 (324)
T 3mtl_A           77 LVFEYLDKDLKQYLDDC---GNIINMHNVKLFLFQLLRGLAYCHRQ-KVLHRDLKPQNLLINERG-ELKLADFGLARAKS  151 (324)
T ss_dssp             EEEECCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCCGGGEEECTTC-CEEECSSSEEECC-
T ss_pred             EEecccccCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCcCHHHEEECCCC-CEEEccCccccccc
Confidence            99999999888877643   45689999999999999999999987 999999999999999988 89999999987654


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....|......
T Consensus       152 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  231 (324)
T 3mtl_A          152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN  231 (324)
T ss_dssp             -----------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGC
T ss_pred             CCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcc
Confidence            322 2334577999999999977666899999999999999999999999999999999999999998887766533221


Q ss_pred             c--cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 Y--TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~--~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  ..+.++......+.. ....+++++.+||.+||+.||.+|||+.|+++|
T Consensus       232 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          232 EEFKTYNYPKYRAEALLS-HAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HHHHHTCCCCCCCCCHHH-HCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhcccccccccchhhhh-hcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence            1  111111111111111 234588999999999999999999999998877

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=3.5e-49  Score=375.52  Aligned_cols=278  Identities=32%  Similarity=0.522  Sum_probs=219.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..........
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~  104 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE  104 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence            46899999999999999999999999999999998643      234568999999999999999999885543333356


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|+||||++++|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~~lv~e~~~~~L~~~~~~----~~~l~~~~~~~i~~qil~aL~~LH~~-givHrDlkp~NILl~~~~-~~kL~DFGla~~  178 (432)
T 3n9x_A          105 LYIVLEIADSDLKKLFKT----PIFLTEEHIKTILYNLLLGENFIHES-GIIHRDLKPANCLLNQDC-SVKVCDFGLART  178 (432)
T ss_dssp             EEEEEECCSEEHHHHHHS----SCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCcCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCCCCCHHHeEECCCC-CEEEccCCCccc
Confidence            899999999998887764    46799999999999999999999987 999999999999999988 899999999987


Q ss_pred             cccCC-----------------------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC----------
Q 017452          224 LVKGE-----------------------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG----------  270 (371)
Q Consensus       224 ~~~~~-----------------------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg----------  270 (371)
                      .....                       ......||+.|+|||++.....++.++|||||||++|+|++|          
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            64332                       124567899999999976666689999999999999999984          


Q ss_pred             -CCCCCCCC-----------------cHHHHHHHHHHhCCCCHhHHhhcCCCcccc---ccCcccCCCCcccCCCCCChh
Q 017452          271 -KPLFPGDS-----------------GVDQLVEIIKVLGTPTREEIKCMNPNYTEF---KFPQIKAHPWHKIFPKRMPPE  329 (371)
Q Consensus       271 -~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~  329 (371)
                       .++|.+.+                 ..+.+..+...+|.++.+.+.........-   .++.....++...+ ..++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~  337 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD  337 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHS-TTSCHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHC-CCCCHH
Confidence             44454433                 256788889999999988776433211100   11111111122212 348999


Q ss_pred             HHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          330 AVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       330 l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+||.+||+.||.+|||+.++|+|
T Consensus       338 ~~dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          338 GINLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcC
Confidence            9999999999999999999999988

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.2e-49  Score=368.28  Aligned_cols=245  Identities=26%  Similarity=0.453  Sum_probs=203.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++.+.       .....+|..+++.+ +||||+++++++     ..
T Consensus        21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~~   95 (353)
T 3txo_A           21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCF-----QT   95 (353)
T ss_dssp             --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEE-----EC
T ss_pred             chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEE-----Ee
Confidence            346899999999999999999999999999999998653       23345788899988 799999999988     34


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||+.| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        96 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NILl~~~g-~ikL~DFG  169 (353)
T 3txo_A           96 PDRLFFVMEFVNGGDLMFHIQK----SRRFDEARARFYAAEIISALMFLHDK-GIIYRDLKLDNVLLDHEG-HCKLADFG  169 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCCHHHEEECCCC-CEEEcccc
Confidence            4558999999985 77766654    46799999999999999999999987 999999999999999988 89999999


Q ss_pred             Ccccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+....        
T Consensus       170 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  240 (353)
T 3txo_A          170 MCKEGICNGVTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDE--------  240 (353)
T ss_dssp             TCBCSCC---------CCGGGCCHHHHHHHH-CTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             ceeecccCCccccccCCCcCeEChhhcCCCC-cCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCC--------
Confidence            9986432 33345678999999999986544 8999999999999999999999999888777776665521        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                                           ..++..+++++.+||.+||+.||.+||++      .++++|
T Consensus       241 ---------------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          241 ---------------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhC
Confidence                                 01455689999999999999999999998      887777

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=6.1e-49  Score=365.87  Aligned_cols=277  Identities=30%  Similarity=0.593  Sum_probs=228.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....     ....+|+.+++.++||||+++++++...........
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  105 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV  105 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence            357999999999999999999999999999999986432     345689999999999999999998865544444568


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||++++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus       106 ~iv~e~~~~~L~~~l~~-----~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          106 YIVQDLMETDLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVA  178 (364)
T ss_dssp             EEEEECCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEcccCcCHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCChHhEEECCCC-CEEEEeCcceEec
Confidence            89999999998887763     5799999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          225 VKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       225 ~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .....    .....||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.+..+.+..
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            43322    23457899999999987666689999999999999999999999999999999999999999998887654


Q ss_pred             cCCCccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .......   ...+.....+|.. +...+++++.+||.+||++||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHH-HCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHHHHHHhcCCccCCCHHH-hCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            3211100   1111222222322 224578999999999999999999999999888

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-49  Score=362.35  Aligned_cols=249  Identities=25%  Similarity=0.371  Sum_probs=211.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|.+...   .....+|+.+++.++||||+++++++..     ...+++
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~~~~l   78 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELVM   78 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEec-----CCEEEE
Confidence            45799999999999999999999999999999998643   2345689999999999999999998843     345889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC--CCCcEEEEeeCCccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP--HTHQVKLCDFGSAKV  223 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~--~~~~~kl~Dfg~a~~  223 (371)
                      ||||++| +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.  ++ .+||+|||++..
T Consensus        79 v~e~~~g~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-givH~Dlkp~NIl~~~~~~~-~~kl~Dfg~a~~  153 (321)
T 1tki_A           79 IFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQ  153 (321)
T ss_dssp             EECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCC-CEEECCCTTCEE
T ss_pred             EEEeCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEccCCCC-CEEEEECCCCeE
Confidence            9999985 77666542   235799999999999999999999987 9999999999999986  44 899999999988


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......+...+     
T Consensus       154 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~-----  227 (321)
T 1tki_A          154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF-----  227 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH-----
T ss_pred             CCCCCccccccCChhhcCcHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh-----
Confidence            76665556678899999999996654 789999999999999999999999988877777776664333322221     


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ..++.++.+||.+||..||.+|||+.++++|
T Consensus       228 --------------------~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~h  258 (321)
T 1tki_A          228 --------------------KEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             --------------------TTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             --------------------ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                                3478999999999999999999999999988

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-49  Score=364.82  Aligned_cols=274  Identities=32%  Similarity=0.583  Sum_probs=220.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...         .....+|+.+++.++||||+++++++     ..
T Consensus         9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~   83 (346)
T 1ua2_A            9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GH   83 (346)
T ss_dssp             ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CC
T ss_pred             hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEE-----ee
Confidence            45799999999999999999999999999999998532         13456899999999999999999988     33


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ....++||||++++|...+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~  158 (346)
T 1ua2_A           84 KSNISLVFDFMETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGL  158 (346)
T ss_dssp             TTCCEEEEECCSEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGG
T ss_pred             CCceEEEEEcCCCCHHHHHHh---cCcCCCHHHHHHHHHHHHHHHHHHHHC-CEECCCCCHHHEEEcCCC-CEEEEeccc
Confidence            445789999999987776643   245789999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      +...... .......+|+.|+|||++.+...++.++|||||||++|+|++|.+||.+.+..+.+..+....+.+..+.|.
T Consensus       159 a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~  238 (346)
T 1ua2_A          159 AKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWP  238 (346)
T ss_dssp             GSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSS
T ss_pred             ceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhh
Confidence            9876433 233456789999999999766668899999999999999999999999999999999999998888877665


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..........+......++.. +...++.++.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  292 (346)
T 1ua2_A          239 DMCSLPDYVTFKSFPGIPLHH-IFSAAGDDLLDLIQGLFLFNPCARITATQALKM  292 (346)
T ss_dssp             STTSSTTCCCCCCCCCCCHHH-HCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             hhccCcccccccccCCCChHH-hhccCCHHHHHHHHHHhccChhhCCCHHHHhcC
Confidence            443222222222222222221 224578999999999999999999999999888

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.3e-48  Score=371.07  Aligned_cols=274  Identities=29%  Similarity=0.506  Sum_probs=223.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHc------CCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLL------DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l------~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+      +|+||+++++.+..     
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  170 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTF-----  170 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEE-----
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeeccc-----
Confidence            457999999999999999999999999999999997653   3445688888877      57799999998843     


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC-cEEEEeeC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~-~~kl~Dfg  219 (371)
                      ...+++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++. .+||+|||
T Consensus       171 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          171 RNHICMTFELLSMNLYELIKKNK--FQGFSLPLVRKFAHSILQCLDALHKN-RIIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TTEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHH-TEECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CCeEEEEEeccCCCHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEccCCCcceEEeecc
Confidence            34588999999999888887532  34599999999999999999999997 9999999999999998872 29999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++....  .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+....+.++...+.
T Consensus       248 ~a~~~~--~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~  324 (429)
T 3kvw_A          248 SSCYEH--QRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD  324 (429)
T ss_dssp             TCEETT--CCCCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHH
T ss_pred             cceecC--CcccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHH
Confidence            997643  2334568899999999997655 8999999999999999999999999999999999999999999887665


Q ss_pred             hcCCCccccc------------------------------cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH
Q 017452          300 CMNPNYTEFK------------------------------FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV  349 (371)
Q Consensus       300 ~~~~~~~~~~------------------------------~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~  349 (371)
                      ........+.                              ........|...++...++.+.+||.+||++||.+|||+.
T Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~  404 (429)
T 3kvw_A          325 ASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPG  404 (429)
T ss_dssp             TBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             hhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHH
Confidence            3221100000                              0011223344555666789999999999999999999999


Q ss_pred             HHhhh
Q 017452          350 SKRIL  354 (371)
Q Consensus       350 ~~l~~  354 (371)
                      |+|+|
T Consensus       405 e~L~H  409 (429)
T 3kvw_A          405 QALRH  409 (429)
T ss_dssp             HHHTS
T ss_pred             HHhCC
Confidence            97766

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.3e-48  Score=365.76  Aligned_cols=247  Identities=25%  Similarity=0.443  Sum_probs=202.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|..+++++ +||||+++++++     .
T Consensus        49 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~-----~  123 (396)
T 4dc2_A           49 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q  123 (396)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEE-----E
T ss_pred             CChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEE-----E
Confidence            34568999999999999999999999999999999986532       3356788888877 899999999988     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ....+++||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus       124 ~~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DF  197 (396)
T 4dc2_A          124 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  197 (396)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCC
T ss_pred             ECCEEEEEEEcCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEECCCC-CEEEeec
Confidence            44568999999985 77666654    46799999999999999999999987 999999999999999998 8999999


Q ss_pred             CCcccc-ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH--------HHHHHHHHH
Q 017452          219 GSAKVL-VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV--------DQLVEIIKV  289 (371)
Q Consensus       219 g~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~--------~~~~~~~~~  289 (371)
                      |+++.. .........+||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||......        +.+.+.+..
T Consensus       198 Gla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~  276 (396)
T 4dc2_A          198 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  276 (396)
T ss_dssp             TTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHH
T ss_pred             ceeeecccCCCccccccCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhc
Confidence            999863 3344455678999999999997654 799999999999999999999999643221        112111111


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                      .                            ...+|..+++++.+||.+||+.||.+||++      .++++|
T Consensus       277 ~----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          277 K----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             C----------------------------CCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             c----------------------------ccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            0                            001566789999999999999999999995      787777

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.3e-48  Score=358.23  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=209.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.    
T Consensus         9 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----   84 (326)
T 2y0a_A            9 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE----   84 (326)
T ss_dssp             HHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             cccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE----
Confidence            346799999999999999999999999999999998643          234678999999999999999999883    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---cEE
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---~~k  214 (371)
                       .....++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.   .+|
T Consensus        85 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~k  158 (326)
T 2y0a_A           85 -NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIK  158 (326)
T ss_dssp             -CSSEEEEEEECCCSCBHHHHHTT----SSCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCSSSSSCCEE
T ss_pred             -eCCEEEEEEEcCCCCCHHHHHHh----cCCcCHHHHHHHHHHHHHHHHHHHHC-CeEcCCCCHHHEEEecCCCCCCCEE
Confidence             3445889999997 577776643    56799999999999999999999987 9999999999999987652   699


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+|||++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+....+.+..+.......+
T Consensus       159 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  237 (326)
T 2y0a_A          159 IIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFE  237 (326)
T ss_dssp             ECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC
T ss_pred             EEECCCCeECCCCCccccccCCcCcCCceeecCCC-CCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC
Confidence            99999998876555555678999999999986544 89999999999999999999999988877666666554322221


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..                         ....++..+.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          238 DE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HH-------------------------HHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             cc-------------------------ccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11                         123478999999999999999999999998887

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=9.6e-49  Score=354.44  Aligned_cols=246  Identities=26%  Similarity=0.394  Sum_probs=206.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++...     ...+
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-----~~~~   93 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-----DELW   93 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-----TEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-----CEEE
Confidence            45799999999999999999999999999999998543    34456899999999999999999988543     3478


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. ++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        94 lv~e~~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~  166 (297)
T 3fxz_A           94 VVMEYLAGGSLTDVVTE-----TCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQI  166 (297)
T ss_dssp             EEEECCTTCBHHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEECCCCCCHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEECCCC-CEEEeeCCCceec
Confidence            9999996 577777653     5699999999999999999999987 999999999999999888 8999999998776


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+.......+.......          
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~----------  235 (297)
T 3fxz_A          167 TPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPE----------  235 (297)
T ss_dssp             CSTTCCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCC----------
T ss_pred             CCcccccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC----------
Confidence            4433 234567899999999997655 7999999999999999999999998877766655554431110          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       236 ----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          236 ----------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             ----------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                            00234578999999999999999999999998888

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=353.75  Aligned_cols=274  Identities=34%  Similarity=0.594  Sum_probs=212.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     ....
T Consensus         3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~~~~   77 (311)
T 4agu_A            3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRR-----KRRL   77 (311)
T ss_dssp             CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeec-----CCeE
Confidence            57999999999999999999999999999999885432      334579999999999999999998843     3447


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+++++...+.   .....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        78 ~lv~e~~~~~~l~~~~---~~~~~~~~~~~~~i~~~l~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  152 (311)
T 4agu_A           78 HLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQAVNFCHKH-NCIHRDVKPENILITKHS-VIKLCDFGFARLL  152 (311)
T ss_dssp             EEEEECCSEEHHHHHH---HTSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEEeCCCchHHHHH---hhhcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCChhhEEEcCCC-CEEEeeCCCchhc
Confidence            8999999975443332   2256799999999999999999999987 999999999999999888 8999999999876


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+|+.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+....+.+..+............
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (311)
T 4agu_A          153 TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFST  232 (311)
T ss_dssp             C------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHT
T ss_pred             cCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccc
Confidence            4322 234567899999999997766689999999999999999999999999998888888888888776654432211


Q ss_pred             C--ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 N--YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~--~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .  +.....+..............++.++.+||.+||+.||.+|||+.++++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          233 NQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             ccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence            1  11111111111000011123588999999999999999999999998877

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.8e-48  Score=363.54  Aligned_cols=248  Identities=27%  Similarity=0.429  Sum_probs=205.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++.+..       ....+|+.+++.++||||+++++++.     .
T Consensus        12 v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~-----~   86 (384)
T 4fr4_A           12 VNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQ-----D   86 (384)
T ss_dssp             CCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----e
Confidence            34568999999999999999999999999999999986432       34567999999999999999999883     4


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+++||||+.| +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  160 (384)
T 4fr4_A           87 EEDMFMVVDLLLGGDLRYHLQQ----NVHFKEETVKLFICELVMALDYLQNQ-RIIHRDMKPDNILLDEHG-HVHITDFN  160 (384)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCcHHHeEECCCC-CEEEeccc
Confidence            4458999999975 77666653    56799999999999999999999987 999999999999999988 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH--HHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD--QLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~  295 (371)
                      ++.............||+.|+|||++...  ..++.++|||||||++|+|++|..||.......  .+.......     
T Consensus       161 ~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~-----  235 (384)
T 4fr4_A          161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETT-----  235 (384)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhc-----
Confidence            99887666666778899999999998642  347889999999999999999999997543322  222211110     


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-HHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-AVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-~~~~l~~  354 (371)
                                             ...++..+++++.+||.+||+.||.+||+ +.++++|
T Consensus       236 -----------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          236 -----------------------VVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             -----------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             -----------------------ccCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcC
Confidence                                   00145668999999999999999999999 8887766

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=9.9e-49  Score=363.83  Aligned_cols=249  Identities=27%  Similarity=0.399  Sum_probs=208.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     .....
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~~  102 (362)
T 2bdw_A           28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEESF  102 (362)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             ccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            457999999999999999999999999999999986432      3456899999999999999999988     34455


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCC
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~  220 (371)
                      .++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+||+|||+
T Consensus       103 ~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~  177 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFGL  177 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEeecCc
Confidence            8899999985 77666543    46789999999999999999999987 999999999999998653  2599999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.......+..    
T Consensus       178 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----  252 (362)
T 2bdw_A          178 AIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP----  252 (362)
T ss_dssp             CBCCTTCCSCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT----
T ss_pred             ceEecCCcccccCCCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcc----
Confidence            98776555555678999999999996544 8999999999999999999999998887766666655432111111    


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       253 ---------------------~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          253 ---------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             ---------------------GGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ---------------------cccCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                 112478999999999999999999999998888

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=2.7e-48  Score=359.79  Aligned_cols=281  Identities=27%  Similarity=0.466  Sum_probs=219.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC---C
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD---K  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~  139 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++.....   .
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             BGGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             cccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            4568999999999999999999999999999999885432      244689999999999999999998865432   1


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ....+++||||+++++...+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        95 ~~~~~~lv~e~~~~~l~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg  169 (351)
T 3mi9_A           95 CKGSIYLVFDFCEHDLAGLLSNV---LVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFG  169 (351)
T ss_dssp             --CEEEEEEECCSEEHHHHHHCT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCT
T ss_pred             CCceEEEEEeccCCCHHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCHHHEEEcCCC-CEEEccch
Confidence            24567899999999887776532   45799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccC-----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          220 SAKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       220 ~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ++......     .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+....+..+....+.++
T Consensus       170 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~  249 (351)
T 3mi9_A          170 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSIT  249 (351)
T ss_dssp             TCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             hcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99765422     2223467899999999997766689999999999999999999999999998888899988888877


Q ss_pred             HhHHhhcCCCcc--ccccCcccCCCCcccC-CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYT--EFKFPQIKAHPWHKIF-PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~-~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.+........  ...............+ ....++++.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          250 PEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            665543211100  0000000000000000 00136789999999999999999999998777

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-48  Score=360.55  Aligned_cols=253  Identities=26%  Similarity=0.343  Sum_probs=206.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...         .....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----   97 (351)
T 3c0i_A           22 FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSS----   97 (351)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             cccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEe----
Confidence            345799999999999999999999999999999998532         3446789999999999999999998843    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEE
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLC  216 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~  216 (371)
                       ...+++||||++ ++|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+||+
T Consensus        98 -~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivHrDlkp~NIl~~~~~~~~~vkl~  175 (351)
T 3c0i_A           98 -DGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN-NIIHRDVKPHCVLLASKENSAPVKLG  175 (351)
T ss_dssp             -TTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECSSSTTCCEEEC
T ss_pred             -CCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChHHeEEecCCCCCcEEEe
Confidence             345889999998 577777766554456799999999999999999999987 999999999999998655  249999


Q ss_pred             eeCCccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          217 DFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       217 Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |||++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.. ......+.........
T Consensus       176 Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~  253 (351)
T 3c0i_A          176 GFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREP-YGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNP  253 (351)
T ss_dssp             CCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCH
T ss_pred             cCcceeEecCCCeeecCCcCCcCccCHHHHcCCC-CCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCc
Confidence            9999987654332 33567899999999996654 7999999999999999999999998743 3333333332111111


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..                         ...++.++.+||.+||..||.+|||+.++++|
T Consensus       254 ~~-------------------------~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          254 RQ-------------------------WSHISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             HH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cc-------------------------cccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            11                         13478999999999999999999999998887

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-48  Score=353.46  Aligned_cols=242  Identities=25%  Similarity=0.447  Sum_probs=207.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|..+++.++||||+++++++     .+..
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~-----~~~~   79 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQ   79 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSS
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEE-----EeCC
Confidence            45799999999999999999999999999999998643       23445799999999999999999988     3445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        80 ~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~Dfg~a  153 (318)
T 1fot_A           80 QIFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFA  153 (318)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSC
T ss_pred             EEEEEEeCCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChheEEEcCCC-CEEEeecCcc
Confidence            68999999985 87777764    56799999999999999999999986 999999999999999888 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      +....  .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+.......+....           
T Consensus       154 ~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-----------  219 (318)
T 1fot_A          154 KYVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE-----------  219 (318)
T ss_dssp             EECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC-----------
T ss_pred             eecCC--ccccccCCccccCHhHhcCCC-CCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-----------
Confidence            86533  334568899999999986554 7999999999999999999999998887766666655420           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                        ..++..+++++.++|.+||..||.+||     ++.++++|
T Consensus       220 ------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          220 ------------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcC
Confidence                              014556899999999999999999999     89998777

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=3.4e-48  Score=360.55  Aligned_cols=277  Identities=29%  Similarity=0.555  Sum_probs=218.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------------hhhHHHHHHHHHcCCCCeeecceeEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------------RYKNRELQTMRLLDHPNVVSLKHCFFS  135 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------~~~~~e~~~l~~l~h~niv~~~~~~~~  135 (371)
                      ++|++.+.||+|+||.||+|.+.. |..||||++....               ....+|+.+++.++||||+++++++..
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  100 (362)
T 3pg1_A           22 SPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVH  100 (362)
T ss_dssp             CSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEE
T ss_pred             cceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEe
Confidence            579999999999999999999754 9999999885321               345689999999999999999999877


Q ss_pred             cCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      ........+++||||++++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||
T Consensus       101 ~~~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl  175 (362)
T 3pg1_A          101 FEEPAMHKLYLVTELMRTDLAQVIHD---QRIVISPQHIQYFMYHILLGLHVLHEA-GVVHRDLHPGNILLADNN-DITI  175 (362)
T ss_dssp             CCTTTCCEEEEEEECCSEEHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEE
T ss_pred             ccCCCcceEEEEEccCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-cCEecCCChHHEEEcCCC-CEEE
Confidence            66566677899999999988887763   245799999999999999999999987 999999999999999888 8999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +|||++.............+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+....+.+..+....+.+..
T Consensus       176 ~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~  255 (362)
T 3pg1_A          176 CDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKI  255 (362)
T ss_dssp             CCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCH
T ss_pred             EecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCh
Confidence            99999986655555556788999999999876566899999999999999999999999999999999999999998887


Q ss_pred             hHHhhcCCCc-cc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNY-TE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+....... ..   ..........|.. ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          256 EDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             HHHHHTSCHHHHHHTTTCCCCCCCCCHHH-HSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHhhhccchhhhHHHHhhcccCChhhHHh-hCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            6554222110 00   0111112222222 234578999999999999999999999998887

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.5e-48  Score=359.76  Aligned_cols=245  Identities=25%  Similarity=0.468  Sum_probs=205.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|.+.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|..+++.+ +||||+++++++     ..
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~-----~~   89 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QT   89 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----EC
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEE-----Ee
Confidence            345799999999999999999999999999999998653       23345688888876 999999999988     34


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~vkL~DFG  163 (345)
T 1xjd_A           90 KENLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFG  163 (345)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCChhhEEECCCC-CEEEeECh
Confidence            4558999999974 77777664    46799999999999999999999987 999999999999999988 89999999


Q ss_pred             Ccccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++.... .......+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....        
T Consensus       164 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  234 (345)
T 1xjd_A          164 MCKENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN--------  234 (345)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             hhhhcccCCCcccCCCCCcccCChhhhcCCC-CCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9986432 23345678999999999997654 7999999999999999999999999877766665554310        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH-HHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV-SKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~-~~l~~  354 (371)
                                           ..++..+++++.+||.+||..||.+||++. ++++|
T Consensus       235 ---------------------~~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          235 ---------------------PFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             ---------------------CCCCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcC
Confidence                                 014556899999999999999999999997 76665

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-48  Score=364.08  Aligned_cols=274  Identities=33%  Similarity=0.570  Sum_probs=208.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... .....
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~  108 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND  108 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCe
Confidence            4799999999999999999999999999999998543      2344589999999999999999998854311 11244


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|||+++++|.+++..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++.
T Consensus       109 ~~lv~e~~~~~L~~~~~~-----~~l~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kL~DFG~a~~  181 (367)
T 2fst_X          109 VYLVTHLMGADLNNIVKC-----QKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  181 (367)
T ss_dssp             CEEEEECCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECC------
T ss_pred             EEEEecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHhhEEECCCC-CEEEeecccccc
Confidence            689999999888777653     6799999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.++.+.+.....
T Consensus       182 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~  259 (367)
T 2fst_X          182 TAD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  259 (367)
T ss_dssp             -----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCC
T ss_pred             ccc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            533  234567899999999997756689999999999999999999999999999999999999999998887764432


Q ss_pred             Cccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....   ..++......|...+ ..+++.+.+||.+||..||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          260 ESARNYIQSLTQMPKMNFANVF-IGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHT-TTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHHhccCCCCCCCHHHHC-CCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence            1111   011222222333322 3578999999999999999999999999998

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.6e-48  Score=368.48  Aligned_cols=250  Identities=26%  Similarity=0.359  Sum_probs=207.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~-----~~~~   83 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSI-----SEEG   83 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEE-----ECSS
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEE-----EECC
Confidence            3467999999999999999999999999999999986432      3456899999999999999999988     4455


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC--CCcEEEEeeC
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~--~~~~kl~Dfg  219 (371)
                      ..++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+  +..+||+|||
T Consensus        84 ~~~lv~E~~~gg~L~~~i~~----~~~~~e~~~~~i~~qil~aL~~lH~~-givHrDlKp~NIll~~~~~~~~vkL~DFG  158 (444)
T 3soa_A           84 HHYLIFDLVTGGELFEDIVA----REYYSEADASHCIQQILEAVLHCHQM-GVVHRNLKPENLLLASKLKGAAVKLADFG  158 (444)
T ss_dssp             EEEEEECCCBCCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSSTTEEESBSSTTCCEEECCCS
T ss_pred             EEEEEEEeCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEeccCCCCcEEEccCc
Confidence            68899999985 77776654    56799999999999999999999987 99999999999999842  2379999999


Q ss_pred             CccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ++........ .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+....+.......+..  
T Consensus       159 ~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~--  235 (444)
T 3soa_A          159 LAIEVEGEQQAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSP--  235 (444)
T ss_dssp             SCBCCCTTCCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTT--
T ss_pred             eeEEecCCCceeecccCCcccCCHHHhcCCC-CCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCcc--
Confidence            9977654332 34568999999999996544 7999999999999999999999999888777766665532211111  


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       236 -----------------------~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          236 -----------------------EWDTVTPEAKDLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             -----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             -----------------------ccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                                   123579999999999999999999999998887

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=9.4e-48  Score=354.82  Aligned_cols=247  Identities=25%  Similarity=0.448  Sum_probs=201.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++.+..       ....+|..+++.+ +||||+++++++     .
T Consensus         6 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~   80 (345)
T 3a8x_A            6 LGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCF-----Q   80 (345)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEE-----E
T ss_pred             CchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEE-----E
Confidence            44568999999999999999999999999999999996542       2345788999887 899999999988     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ....+++||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus        81 ~~~~~~lv~e~~~gg~L~~~l~~----~~~l~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DF  154 (345)
T 3a8x_A           81 TESRLFFVIEYVNGGDLMFHMQR----QRKLPEEHARFYSAEISLALNYLHER-GIIYRDLKLDNVLLDSEG-HIKLTDY  154 (345)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCG
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEEec
Confidence            44568999999975 77776654    46799999999999999999999987 999999999999999988 8999999


Q ss_pred             CCccccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc--------HHHHHHHHHH
Q 017452          219 GSAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG--------VDQLVEIIKV  289 (371)
Q Consensus       219 g~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~--------~~~~~~~~~~  289 (371)
                      |+++... ........+||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.....        ...+.+.+..
T Consensus       155 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~  233 (345)
T 3a8x_A          155 GMCKEGLRPGDTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE  233 (345)
T ss_dssp             GGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHH
T ss_pred             cccccccCCCCcccccCCCccccCccccCCCC-CChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHc
Confidence            9998643 233445678999999999997654 79999999999999999999999965321        1111111111


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH------HHHhhh
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA------VSKRIL  354 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~------~~~l~~  354 (371)
                      .                            ...++..++.++.+||.+||+.||.+||++      .++++|
T Consensus       234 ~----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          234 K----------------------------QIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             C----------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             C----------------------------CCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            0                            001456789999999999999999999995      787777

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.3e-48  Score=364.56  Aligned_cols=276  Identities=29%  Similarity=0.529  Sum_probs=209.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++..... ....
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            35799999999999999999999999999999998643      2334579999999999999999998854321 2234


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++||||++++|.+.+.      ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus       104 ~~~lv~e~~~~~l~~~~~------~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~NIl~~~~~-~~kl~Dfg~a~  175 (371)
T 2xrw_A          104 DVYIVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLAR  175 (371)
T ss_dssp             EEEEEEECCSEEHHHHHH------SCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCCCC--
T ss_pred             ceEEEEEcCCCCHHHHHh------hccCHHHHHHHHHHHHHHHHHHHHC-CeecccCCHHHEEEcCCC-CEEEEEeeccc
Confidence            678999999998877664      4589999999999999999999987 999999999999999888 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+..+.
T Consensus       176 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  254 (371)
T 2xrw_A          176 TAGTSFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQ  254 (371)
T ss_dssp             --------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSC
T ss_pred             ccccccccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            765554455678899999999997654 8999999999999999999999999999888889998888888877665432


Q ss_pred             CCcccc--ccCcccCCCCcccC-----CC------CCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEF--KFPQIKAHPWHKIF-----PK------RMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~--~~~~~~~~~~~~~~-----~~------~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +....+  ..+......+...+     +.      ..+.++.+||.+||+.||.+|||+.++++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  319 (371)
T 2xrw_A          255 PTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  319 (371)
T ss_dssp             HHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             hHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCC
Confidence            111110  00000001111111     11      125689999999999999999999999998

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=2.3e-48  Score=365.95  Aligned_cols=248  Identities=27%  Similarity=0.427  Sum_probs=207.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|..+++.++||||+++++++     .+..
T Consensus        68 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~  142 (410)
T 3v8s_A           68 AEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAF-----QDDR  142 (410)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             ccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EECC
Confidence            45799999999999999999999999999999998642       23456899999999999999999988     4455


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++|+||||++ |+|.+++.     ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       143 ~~~lV~E~~~gg~L~~~l~-----~~~~~e~~~~~~~~qi~~aL~~LH~~-givHrDLKp~NILl~~~g-~ikL~DFG~a  215 (410)
T 3v8s_A          143 YLYMVMEYMPGGDLVNLMS-----NYDVPEKWARFYTAEVVLALDAIHSM-GFIHRDVKPDNMLLDKSG-HLKLADFGTC  215 (410)
T ss_dssp             EEEEEECCCTTEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEeCCCCCcHHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCCHHHeeECCCC-CEEEecccee
Confidence            6899999996 57777665     35699999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCCC--cccccccccccCcccccCCc---CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFGAT---EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~---~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +.......  ....+||+.|+|||++.+..   .++.++|||||||++|+|++|+.||.+.+..+....+.......   
T Consensus       216 ~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~---  292 (410)
T 3v8s_A          216 MKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSL---  292 (410)
T ss_dssp             EECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHC---
T ss_pred             EeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccc---
Confidence            87644332  23568999999999996543   26789999999999999999999999888777777766532100   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~  354 (371)
                                  .++          ....+|+++.+||.+||+.+|.+  |+++.++++|
T Consensus       293 ------------~~p----------~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          293 ------------TFP----------DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             ------------CCC----------TTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             ------------cCC----------CcccccHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence                        011          11358999999999999999988  9999998888

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=2.9e-48  Score=356.72  Aligned_cols=278  Identities=33%  Similarity=0.581  Sum_probs=218.1

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      -...++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++..     
T Consensus        21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----   95 (331)
T 4aaa_A           21 FQSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKK-----   95 (331)
T ss_dssp             CBCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----
T ss_pred             hhhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeec-----
Confidence            345678999999999999999999999999999999885432      234579999999999999999998843     


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ....++||||+++++...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        96 ~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  170 (331)
T 4aaa_A           96 KKRWYLVFEFVDHTILDDLEL---FPNGLDYQVVQKYLFQIINGIGFCHSH-NIIHRDIKPENILVSQSG-VVKLCDFGF  170 (331)
T ss_dssp             TTEEEEEEECCSEEHHHHHHH---STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CCEEEEEEecCCcchHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHHHC-CEEccCcChheEEEcCCC-cEEEEeCCC
Confidence            345789999999865554432   246799999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      +...... .......+|+.|+|||.+.+...++.++|||||||++|+|++|+.||......+.+..+....+........
T Consensus       171 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  250 (331)
T 4aaa_A          171 ARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQE  250 (331)
T ss_dssp             C------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHH
T ss_pred             ceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhh
Confidence            9765432 223456789999999999776568999999999999999999999999999888888888888877665443


Q ss_pred             hc--CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CM--NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..  .+.+....++..............+++.+.+||.+||+.||.+|||+.++++|
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          251 LFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             HHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             HhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            21  12222223333322222222234689999999999999999999999997666

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.9e-48  Score=361.81  Aligned_cols=253  Identities=25%  Similarity=0.411  Sum_probs=193.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...   .....+|+.+++.++||||+++++++.     .....+
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~~~~   92 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVIL-----TPTHLA   92 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEe-----eCCEEE
Confidence            346899999999999999999999999999999998654   345668999999999999999999984     344588


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC-cEEEEeeCCccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~-~~kl~Dfg~a~~  223 (371)
                      +||||+. ++|.+.+..    .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++. .+||+|||+++.
T Consensus        93 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~ql~~~L~~LH~~-~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~  167 (361)
T 3uc3_A           93 IIMEYASGGELYERICN----AGRFSEDEARFFFQQLLSGVSYCHSM-QICHRDLKLENTLLDGSPAPRLKICDFGYSKS  167 (361)
T ss_dssp             EEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCSCCCCGGGEEECSSSSCCEEECCCCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEcCCCCceEEEeecCcccc
Confidence            9999997 477777654    46799999999999999999999987 9999999999999987652 499999999986


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|+|||++.+....+.++|||||||++|+|++|+.||.+.........+........         
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~---------  238 (361)
T 3uc3_A          168 SVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVK---------  238 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTC---------
T ss_pred             ccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCC---------
Confidence            54444555678999999999997766445559999999999999999999987554333333322211000         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                          ..++          ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       239 ----~~~~----------~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          239 ----YSIP----------DDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             ----CCCC----------TTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             ----CCCC----------CcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence                0000          122578999999999999999999999999998

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.2e-48  Score=356.60  Aligned_cols=243  Identities=28%  Similarity=0.426  Sum_probs=208.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.+..       ....+|+.+++.++||||+++++++     .+.
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  113 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDN  113 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECS
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EcC
Confidence            4568999999999999999999999999999999986432       3455799999999999999999988     344


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++||||++ ++|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~g-~~kL~DFg~  187 (350)
T 1rdq_E          114 SNLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGF  187 (350)
T ss_dssp             SEEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTT
T ss_pred             CEEEEEEcCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCccceEEECCCC-CEEEccccc
Confidence            56899999997 577777764    36799999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ++....  .....+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....          
T Consensus       188 a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~----------  254 (350)
T 1rdq_E          188 AKRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGK----------  254 (350)
T ss_dssp             CEECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ceeccC--CcccccCCccccCHHHhcCCC-CCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCC----------
Confidence            987543  234568999999999997654 7999999999999999999999999887766666655420          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                         ..++..+++++.+||.+||+.||.+||+     +.++++|
T Consensus       255 -------------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          255 -------------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhC
Confidence                               0145668999999999999999999998     9998887

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4.2e-47  Score=347.99  Aligned_cols=281  Identities=33%  Similarity=0.531  Sum_probs=226.7

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEEC-CCCcEEEEEEeecc------hhhhHHHHHHHHHc---CCCCeeecceeEEec
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCL-ETGETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFST  136 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~  136 (371)
                      ....++|++.+.||+|+||.||+|.+. .+|+.||+|++...      .....+|+.+++.+   +||||+++++++...
T Consensus         7 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~   86 (326)
T 1blx_A            7 CRADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVS   86 (326)
T ss_dssp             CCGGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEE
T ss_pred             cCchhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeec
Confidence            344568999999999999999999985 67899999988542      23455788877776   899999999988654


Q ss_pred             CCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          137 TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                      ........++||||++++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        87 ~~~~~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-gi~H~dlkp~Nili~~~~-~~kl~  162 (326)
T 1blx_A           87 RTDRETKLTLVFEHVDQDLTTYLDKVP--EPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLA  162 (326)
T ss_dssp             ECSSEEEEEEEEECCSCBHHHHHHHSC--TTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEEC
T ss_pred             ccCCCceEEEEEecCCCCHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCHHHeEEcCCC-CEEEe
Confidence            444667789999999999888876532  34589999999999999999999987 999999999999999888 89999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |||++.............+|+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+.+..+.+..+....+.+...
T Consensus       163 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          163 DFGLARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             SCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             cCcccccccCCCCccccccccceeCHHHHhcCC-CCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            999998765444445567899999999996654 8999999999999999999999999999888889999888888776


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .|........ ..+......+ ...+...++..+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          242 DWPRDVALPR-QAFHSKSAQP-IEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GSCTTCSSCG-GGSCCCCCCC-GGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccccch-hhhcccCcch-hhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            6543221111 1111111111 122456689999999999999999999999998887

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=1.6e-47  Score=355.69  Aligned_cols=271  Identities=24%  Similarity=0.417  Sum_probs=214.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcC-----CCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLD-----HPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~-----h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++...   .....+|+.+++.+.     ||||+++++++...     
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-----  108 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-----  108 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-----
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-----
Confidence            35799999999999999999999999999999998643   234457899999986     99999999988543     


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC-------------
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-------------  208 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~-------------  208 (371)
                      ...++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.             
T Consensus       109 ~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          109 DHMCLIFEPLGPSLYEIITRNN--YNGFHIEDIKLYCIEILKALNYLRKM-SLTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             TEEEEEECCCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             CeeEEEEcCCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCcccEEEccccccccccchhcc
Confidence            3588999999889988887532  34699999999999999999999987 9999999999999974             


Q ss_pred             ------------CCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC
Q 017452          209 ------------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG  276 (371)
Q Consensus       209 ------------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~  276 (371)
                                  ++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~-~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKST-GIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCC-CEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCC-CEEEEeccCceecCC--CCcCccCcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        44 899999999986433  234567899999999997655 89999999999999999999999999


Q ss_pred             CCcHHHHHHHHHHhCCCCHhHHhhcCCCccc-cccCcccCCCCcc----------------cCCCCCChhHHHHHHhccC
Q 017452          277 DSGVDQLVEIIKVLGTPTREEIKCMNPNYTE-FKFPQIKAHPWHK----------------IFPKRMPPEAVDLVSRLLQ  339 (371)
Q Consensus       277 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----------------~~~~~~s~~l~~li~~~l~  339 (371)
                      .+..+.+..+....+..+...+......... +.........|..                .++...++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            9888888888888888777655432211110 0000000001100                0111234778899999999


Q ss_pred             cCCCCCCCHHHHh
Q 017452          340 YSPNLRCTAVSKR  352 (371)
Q Consensus       340 ~dP~~R~t~~~~l  352 (371)
                      .||.+|||+.++|
T Consensus       342 ~dP~~Rpta~elL  354 (360)
T 3llt_A          342 IDPTLRPSPAELL  354 (360)
T ss_dssp             SSGGGSCCHHHHT
T ss_pred             CChhhCCCHHHHh
Confidence            9999999999944

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-48  Score=360.32  Aligned_cols=273  Identities=33%  Similarity=0.587  Sum_probs=218.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC-Ccee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  143 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  121 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  121 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCccccee
Confidence            4799999999999999999999999999999998653      23445799999999999999999988543321 1122


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++||||+.++|...+      ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       122 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kL~Dfg~a~~  193 (371)
T 4exu_A          122 FYLVMPFMQTDLQKIM------GMEFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  193 (371)
T ss_dssp             CEEEEECCCEEHHHHT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECSTTCC--
T ss_pred             EEEEEccccccHHHHh------hcCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCcCHHHeEECCCC-CEEEEecCcccc
Confidence            4899999999876654      35599999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+|+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++.+.+.....
T Consensus       194 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  271 (371)
T 4exu_A          194 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  271 (371)
T ss_dssp             --------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSC
T ss_pred             ccc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhh
Confidence            533  234567899999999997756689999999999999999999999999999999999999999988876654432


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   ..+......+.. ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          272 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             HHHHHHHHHSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhccCCCcchhHHH-hccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence            21111   111111111111 234579999999999999999999999998888

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.4e-48  Score=346.59  Aligned_cols=249  Identities=27%  Similarity=0.409  Sum_probs=199.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..++|++.+.||+|+||.||+|.+..++..+|+|++....     ....+|+++++.++||||+++++++     .....
T Consensus        20 i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~~~   94 (285)
T 3is5_A           20 IDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF-----EDYHN   94 (285)
T ss_dssp             HHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe-----ecCCe
Confidence            4468999999999999999999999999999999986543     4567899999999999999999988     34455


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeC
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFG  219 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg  219 (371)
                      .++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||
T Consensus        95 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dikp~NIl~~~~~~~~-~~kl~Dfg  172 (285)
T 3is5_A           95 MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ-HVVHKDLKPENILFQDTSPHS-PIKIIDFG  172 (285)
T ss_dssp             EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEESSSSTTC-CEEECCCC
T ss_pred             EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC-CEEECCCCHHHEEEecCCCCC-CEEEEeee
Confidence            8899999985 88888876655568899999999999999999999987 9999999999999953   34 79999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.............+|+.|+|||.+.+  .++.++||||||+++|+|++|+.||.+....+....+.......      
T Consensus       173 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  244 (285)
T 3is5_A          173 LAELFKSDEHSTNAAGTALYMAPEVFKR--DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNY------  244 (285)
T ss_dssp             CCCC----------CTTGGGCCHHHHTT--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC------
T ss_pred             cceecCCcccCcCcccccCcCChHHhcc--CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCccc------
Confidence            9987665555566788999999999843  47899999999999999999999998876555443332210000      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                                          ......+++++.+||.+||+.||.+|||+.+++
T Consensus       245 --------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  277 (285)
T 3is5_A          245 --------------------AVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL  277 (285)
T ss_dssp             --------------------CC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHH
T ss_pred             --------------------ccccCcCCHHHHHHHHHHccCChhhCcCHHHHh
Confidence                                001234789999999999999999999999944

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.3e-48  Score=352.11  Aligned_cols=252  Identities=25%  Similarity=0.381  Sum_probs=198.8

Q ss_pred             CCCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------------------------hhhHHHH
Q 017452           66 QPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------------------------RYKNREL  115 (371)
Q Consensus        66 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------------------------~~~~~e~  115 (371)
                      .....++|++.+.||+|+||.||+|.+..+|+.||||++....                              ....+|+
T Consensus         8 ~~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~   87 (298)
T 2zv2_A            8 DCVQLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEI   87 (298)
T ss_dssp             --CEETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHH
T ss_pred             CceeecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHH
Confidence            3345578999999999999999999999999999999985432                              3456899


Q ss_pred             HHHHHcCCCCeeecceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCc
Q 017452          116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV  194 (371)
Q Consensus       116 ~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~i  194 (371)
                      .+++.++||||+++++++..   ......++||||+++ +|.+..     ....+++..++.++.||+.||.|||++ ||
T Consensus        88 ~~l~~l~h~~iv~~~~~~~~---~~~~~~~lv~e~~~~~~l~~~~-----~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i  158 (298)
T 2zv2_A           88 AILKKLDHPNVVKLVEVLDD---PNEDHLYMVFELVNQGPVMEVP-----TLKPLSEDQARFYFQDLIKGIEYLHYQ-KI  158 (298)
T ss_dssp             HHHHTCCCTTBCCEEEEEEC---SSSSEEEEEEECCTTCBSCCSS-----CSSCCCHHHHHHHHHHHHHHHHHHHHT-TE
T ss_pred             HHHHhCCCCCCCeEEEEEEc---CCCCEEEEEEecCCCCcHHHHh-----hcCCCCHHHHHHHHHHHHHHHHHHHHC-Ce
Confidence            99999999999999998753   224567899999985 443321     246799999999999999999999987 99


Q ss_pred             EeeccCCCceeeeCCCCcEEEEeeCCccccccCCC-cccccccccccCcccccCCcC--CCCcchHHHHHHHHHHHHhCC
Q 017452          195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGK  271 (371)
Q Consensus       195 vH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~  271 (371)
                      +||||||+|||++.++ .+||+|||++........ .....||+.|+|||.+.+...  ++.++|||||||++|+|++|.
T Consensus       159 vH~Dlkp~Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~  237 (298)
T 2zv2_A          159 IHRDIKPSNLLVGEDG-HIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ  237 (298)
T ss_dssp             ECCCCCGGGEEECTTS-CEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSS
T ss_pred             eccCCCHHHEEECCCC-CEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCC
Confidence            9999999999999888 899999999987644322 234678999999999865442  367899999999999999999


Q ss_pred             CCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHH
Q 017452          272 PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK  351 (371)
Q Consensus       272 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~  351 (371)
                      .||...........+.....                 .++          ....+++++.+||.+||+.||.+|||+.++
T Consensus       238 ~pf~~~~~~~~~~~~~~~~~-----------------~~~----------~~~~~~~~l~~li~~~l~~dp~~R~s~~e~  290 (298)
T 2zv2_A          238 CPFMDERIMCLHSKIKSQAL-----------------EFP----------DQPDIAEDLKDLITRMLDKNPESRIVVPEI  290 (298)
T ss_dssp             CSSCCSSHHHHHHHHHHCCC-----------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHH
T ss_pred             CCCCCccHHHHHHHHhcccC-----------------CCC----------CccccCHHHHHHHHHHhhcChhhCCCHHHH
Confidence            99987765544443332100                 000          123578999999999999999999999995


Q ss_pred             hhh
Q 017452          352 RIL  354 (371)
Q Consensus       352 l~~  354 (371)
                      ++|
T Consensus       291 l~h  293 (298)
T 2zv2_A          291 KLH  293 (298)
T ss_dssp             TTC
T ss_pred             hcC
Confidence            544

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=2e-47  Score=343.33  Aligned_cols=250  Identities=26%  Similarity=0.394  Sum_probs=208.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....      ....+|+.+++.++||||+++++++     ....
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~~   78 (284)
T 3kk8_A            4 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSI-----QEES   78 (284)
T ss_dssp             TTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECSS
T ss_pred             hhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEE-----EcCC
Confidence            3468999999999999999999999999999999986532      3455799999999999999999988     3445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeC
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg  219 (371)
                      ..++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||
T Consensus        79 ~~~~v~e~~~~~~l~~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~~~~~~kl~Dfg  153 (284)
T 3kk8_A           79 FHYLVFDLVTGGELFEDIVA----REFYSEADASHCIQQILESIAYCHSN-GIVHRNLKPENLLLASKAKGAAVKLADFG  153 (284)
T ss_dssp             EEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSTTCCEEECCCT
T ss_pred             EEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcCcCCCCHHHEEEecCCCCCcEEEeece
Confidence            57899999985 66666654    46799999999999999999999987 999999999999998655  249999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.............||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.......+..   
T Consensus       154 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~---  229 (284)
T 3kk8_A          154 LAIEVNDSEAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSP---  229 (284)
T ss_dssp             TCEECCSSCBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT---
T ss_pred             eeEEcccCccccCCCCCcCCcCchhhcCCC-CCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCch---
Confidence            998776655555678899999999996654 7999999999999999999999998877766666555432111110   


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       230 ----------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          230 ----------------------EWDTVTPEAKSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             ----------------------TTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             ----------------------hhcccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                                  123578999999999999999999999998887

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=5.7e-48  Score=357.00  Aligned_cols=245  Identities=25%  Similarity=0.410  Sum_probs=206.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|++.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|..++..+ .||||+++++++     ..
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~-----~~   92 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT   92 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEE-----EC
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEE-----Ec
Confidence            3467999999999999999999999999999999986532       3345688888877 799999999988     34


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        93 ~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~vkL~DFG  166 (353)
T 2i0e_A           93 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  166 (353)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CEEeccCCHHHEEEcCCC-cEEEEeCC
Confidence            4568999999985 77777664    46799999999999999999999987 999999999999999988 89999999


Q ss_pred             Cccccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++... ........+||+.|+|||++.+.. ++.++|+|||||++|+|++|+.||.+.+..+....+....        
T Consensus       167 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~--------  237 (353)
T 2i0e_A          167 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  237 (353)
T ss_dssp             TCBCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             cccccccCCcccccccCCccccChhhhcCCC-cCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 233445678999999999996554 7999999999999999999999999887766666665420        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                           ..++..+++++.+||.+||..||.+||+     +.++++|
T Consensus       238 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          238 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             ---------------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence                                 0145668999999999999999999994     6898777

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.3e-48  Score=370.39  Aligned_cols=247  Identities=29%  Similarity=0.434  Sum_probs=211.4

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|.+++.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++.     .
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~-----~   87 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVIS-----T   87 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----E
Confidence            3456899999999999999999999999999999998643       234568999999999999999999883     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        88 ~~~~~lv~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDLkp~NIll~~~~-~vkL~DFG  161 (476)
T 2y94_A           88 PSDIFMVMEYVSGGELFDYICK----NGRLDEKESRRLFQQILSGVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFG  161 (476)
T ss_dssp             SSEEEEEEECCSSEEHHHHTTS----SSSCCHHHHHHHHHHHHHHHHHHHTT-TEECSCCSGGGEEECTTC-CEEECCCS
T ss_pred             CCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcccccHHHEEEecCC-CeEEEecc
Confidence            445889999996 577666542    56799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.....+......+||+.|+|||++.+....+.++|||||||++|+|++|..||.+.+.......+.....        
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~--------  233 (476)
T 2y94_A          162 LSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIF--------  233 (476)
T ss_dssp             SCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCC--------
T ss_pred             chhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCc--------
Confidence            998876665556778999999999997766567899999999999999999999998777666555543210        


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ..+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       234 ---------------------~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          234 ---------------------YTPQYLNPSVISLLKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             ---------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---------------------CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHhC
Confidence                                 1345589999999999999999999999999998

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3.4e-48  Score=357.39  Aligned_cols=250  Identities=26%  Similarity=0.382  Sum_probs=204.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.+......+|++++.++ +||||+++++++     .+...+|+|
T Consensus        20 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~-----~~~~~~~lv   94 (342)
T 2qr7_A           20 FTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVY-----DDGKYVYVV   94 (342)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEE
T ss_pred             ccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEE-----EcCCEEEEE
Confidence            34679999999999999999999999999999999988777778899999888 799999999988     445568999


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC---CcEEEEeeCCccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---HQVKLCDFGSAKV  223 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~---~~~kl~Dfg~a~~  223 (371)
                      |||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||+..+.   ..+||+|||++..
T Consensus        95 ~E~~~gg~L~~~i~~----~~~~~~~~~~~~~~qi~~al~~lH~~-givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~  169 (342)
T 2qr7_A           95 TELMKGGELLDKILR----QKFFSEREASAVLFTITKTVEYLHAQ-GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQ  169 (342)
T ss_dssp             ECCCCSCBHHHHHHT----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEE
T ss_pred             EeCCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeccCCHHHEEEecCCCCcCeEEEEECCCccc
Confidence            999975 77776653    46799999999999999999999987 999999999999985432   2499999999987


Q ss_pred             cccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC--c-HHHHHHHHHHhCCCCHhHHh
Q 017452          224 LVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS--G-VDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       224 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~--~-~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .... .......||+.|+|||++.+.. ++.++|||||||++|+|++|..||....  . .+.+..+....  .      
T Consensus       170 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~--~------  240 (342)
T 2qr7_A          170 LRAENGLLMTPCYTANFVAPEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGK--F------  240 (342)
T ss_dssp             CBCTTCCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCC--C------
T ss_pred             CcCCCCceeccCCCccccCHHHhcCCC-CCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCC--c------
Confidence            6443 2334567899999999986543 7889999999999999999999997632  2 22223322210  0      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               .        .....+..+++++.+||.+||..||.+|||+.++++|
T Consensus       241 ---------~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~h  278 (342)
T 2qr7_A          241 ---------S--------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRH  278 (342)
T ss_dssp             ---------C--------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ---------c--------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                     0        0111335689999999999999999999999999988

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=6.6e-48  Score=360.77  Aligned_cols=251  Identities=25%  Similarity=0.343  Sum_probs=208.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++.     .....
T Consensus        49 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~~~  123 (387)
T 1kob_A           49 VYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE-----DKYEM  123 (387)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE-----CSSEE
T ss_pred             cccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE-----eCCEE
Confidence            346799999999999999999999999999999998653    334668999999999999999999883     34558


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-CCcEEEEeeCCcc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAK  222 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-~~~~kl~Dfg~a~  222 (371)
                      ++||||+.| +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.+ ...+||+|||++.
T Consensus       124 ~lv~E~~~gg~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDlkp~NIll~~~~~~~vkL~DFG~a~  199 (387)
T 1kob_A          124 VLILEFLSGGELFDRIAA---EDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLAT  199 (387)
T ss_dssp             EEEEECCCCCBHHHHTTC---TTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhC-CeeecccchHHeEEecCCCCceEEEecccce
Confidence            999999985 66655542   235799999999999999999999987 99999999999999753 2379999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.......         
T Consensus       200 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~---------  269 (387)
T 1kob_A          200 KLNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEF---------  269 (387)
T ss_dssp             ECCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCC---------
T ss_pred             ecCCCcceeeeccCCCccCchhccCCC-CCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---------
Confidence            876555555668999999999996544 7899999999999999999999999887766666554421111         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       270 ----------------~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          270 ----------------DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             ----------------CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                            011234579999999999999999999999999988

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=2.6e-48  Score=362.34  Aligned_cols=247  Identities=26%  Similarity=0.351  Sum_probs=200.2

Q ss_pred             ceee--eEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           72 SYMA--ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        72 ~y~~--~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .|.+  .+.||+|+||.||+|.+..+|+.||+|++...    ...+.+|+.+++.++||||+++++++.     .....+
T Consensus        88 ~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-----~~~~~~  162 (373)
T 2x4f_A           88 FYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFE-----SKNDIV  162 (373)
T ss_dssp             TEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             ceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEE-----ECCEEE
Confidence            3555  67899999999999999999999999998653    345668999999999999999999883     344588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee--CCCCcEEEEeeCCcc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--PHTHQVKLCDFGSAK  222 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~--~~~~~~kl~Dfg~a~  222 (371)
                      +||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||+.  .++ .+||+|||++.
T Consensus       163 lv~E~~~~~~L~~~l~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~-~~kl~DFG~a~  237 (373)
T 2x4f_A          163 LVMEYVDGGELFDRIID---ESYNLTELDTILFMKQICEGIRHMHQM-YILHLDLKPENILCVNRDAK-QIKIIDFGLAR  237 (373)
T ss_dssp             EEEECCTTCEEHHHHHH---TGGGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEETTTT-EEEECCCSSCE
T ss_pred             EEEeCCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccccCCHHHEEEecCCCC-cEEEEeCCCce
Confidence            99999985 66666653   235689999999999999999999987 999999999999994  344 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ............||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..      
T Consensus       238 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~------  310 (373)
T 2x4f_A          238 RYKPREKLKVNFGTPEFLAPEVVNYD-FVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDE------  310 (373)
T ss_dssp             ECCTTCBCCCCCSSCTTCCHHHHTTC-BCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSG------
T ss_pred             ecCCccccccccCCCcEeChhhccCC-CCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChh------
Confidence            87665555567799999999998654 47899999999999999999999999888777777666532211111      


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       311 -------------------~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          311 -------------------EFQDISEEAKEFISKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             -------------------GGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------------------hhccCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                               123478999999999999999999999998877

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1e-47  Score=346.11  Aligned_cols=253  Identities=25%  Similarity=0.360  Sum_probs=192.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh------hhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++.....      ...++...++.++||||+++++++..     ..
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~-----~~   79 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFR-----EG   79 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEC-----SS
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeec-----cC
Confidence            34689999999999999999999999999999999864321      12234445677899999999998853     33


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++||||++++|.+.+.........+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++.
T Consensus        80 ~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~  158 (290)
T 3fme_A           80 DVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALG-QVKMCDFGISG  158 (290)
T ss_dssp             SEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTC-CEEBCCC----
T ss_pred             CEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCC-CEEEeecCCcc
Confidence            47899999999998888776666788999999999999999999999755999999999999999888 89999999998


Q ss_pred             ccccCCCcccccccccccCcccc---cCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHhHH
Q 017452          223 VLVKGEPNISYICSRYYRAPELI---FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~---~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~~~  298 (371)
                      ............||+.|+|||.+   .....++.++||||||+++|+|++|..||..... ...+....... .      
T Consensus       159 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~------  231 (290)
T 3fme_A          159 YLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEP-S------  231 (290)
T ss_dssp             -----------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSC-C------
T ss_pred             cccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccC-C------
Confidence            76655555556789999999997   2344578899999999999999999999986443 33333332210 0      


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       232 --------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          232 --------------------PQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             --------------------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             --------------------CCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence                                001224578999999999999999999999997776

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.8e-47  Score=349.91  Aligned_cols=250  Identities=24%  Similarity=0.337  Sum_probs=209.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.    
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----   85 (321)
T 2a2a_A           10 VEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYE----   85 (321)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE----
T ss_pred             hhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEe----
Confidence            345799999999999999999999999999999998643          234678999999999999999999883    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---cEE
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVK  214 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---~~k  214 (371)
                       .....++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+|
T Consensus        86 -~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivH~dikp~NIl~~~~~~~~~~~k  159 (321)
T 2a2a_A           86 -NRTDVVLILELVSGGELFDFLAQ----KESLSEEEATSFIKQILDGVNYLHTK-KIAHFDLKPENIMLLDKNIPIPHIK  159 (321)
T ss_dssp             -CSSEEEEEECCCCSCBHHHHHHT----CSCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCTTSSSCCEE
T ss_pred             -cCCEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCChHHEEEecCCCCcCCEE
Confidence             3455889999997 588777753    46789999999999999999999987 9999999999999987763   699


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+|||++.............||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+....+.+..+.......+
T Consensus       160 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  238 (321)
T 2a2a_A          160 LIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFD  238 (321)
T ss_dssp             ECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC
T ss_pred             EccCccceecCccccccccCCCCCccCcccccCCC-CCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC
Confidence            99999998776655556677899999999986544 79999999999999999999999988777666655544221111


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..                         ++..++..+.+||.+||..||.+|||+.++++|
T Consensus       239 ~~-------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          239 EE-------------------------FFSHTSELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             HH-------------------------HHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             hh-------------------------hhcccCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            11                         224578999999999999999999999998887

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6.3e-48  Score=364.12  Aligned_cols=279  Identities=29%  Similarity=0.486  Sum_probs=204.8

Q ss_pred             cceee-eEeeccCCceEEEEEEEC--CCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMA-ERIVGQGSFGVVFQAKCL--ETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~-~~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      +.|.+ +++||+|+||.||+|.+.  .+++.||||++...  .....+|+.+++.++||||+++++++...   ....++
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~---~~~~~~   96 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSH---ADRKVW   96 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEET---TTTEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecC---CCCeEE
Confidence            45777 568999999999999965  57899999998654  34567899999999999999999988652   344578


Q ss_pred             EeeccccchHHHHHHHhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee----eCCCCcEEEE
Q 017452          146 LVLEYVPETVHRVVKHFNKL-----NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLC  216 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli----~~~~~~~kl~  216 (371)
                      +||||+.++|.+.+......     ...+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||+
T Consensus        97 lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kl~  174 (405)
T 3rgf_A           97 LLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN-WVLHRDLKPANILVMGEGPERG-RVKIA  174 (405)
T ss_dssp             EEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECCSSTTTT-CEEEC
T ss_pred             EEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeCCCcCHHHeEEecCCCCCC-cEEEE
Confidence            99999999988887654322     22599999999999999999999987 99999999999999    4455 89999


Q ss_pred             eeCCccccccC----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---------HHHH
Q 017452          217 DFGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---------VDQL  283 (371)
Q Consensus       217 Dfg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---------~~~~  283 (371)
                      |||+++.....    .......||+.|+|||++.+...++.++|||||||++|+|++|..||.+...         .+.+
T Consensus       175 Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l  254 (405)
T 3rgf_A          175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQL  254 (405)
T ss_dssp             CTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHH
T ss_pred             ECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHH
Confidence            99999876432    2233467899999999997766689999999999999999999999976554         4778


Q ss_pred             HHHHHHhCCCCHhHHhhcCCCcccc---------ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          284 VEIIKVLGTPTREEIKCMNPNYTEF---------KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+...++.++...|..........         .+.......+........+..+.+||.+||++||.+|||+.++|+|
T Consensus       255 ~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~h  334 (405)
T 3rgf_A          255 DRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  334 (405)
T ss_dssp             HHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            8888999988877665332110000         0000000001111223347899999999999999999999998888

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.2e-47  Score=363.80  Aligned_cols=251  Identities=24%  Similarity=0.389  Sum_probs=208.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||.||+|++..+++.||+|++.+.       .....+|..++..++||||+++++++     .+..
T Consensus        73 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  147 (437)
T 4aw2_A           73 REDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAF-----QDDN  147 (437)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-----eeCC
Confidence            35799999999999999999999999999999998642       23367899999999999999999988     3445


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||+. |+|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       148 ~~~lV~Ey~~gg~L~~~l~~---~~~~l~e~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILl~~~g-~vkL~DFGla  222 (437)
T 4aw2_A          148 NLYLVMDYYVGGDLLTLLSK---FEDRLPEEMARFYLAEMVIAIDSVHQL-HYVHRDIKPDNILMDMNG-HIRLADFGSC  222 (437)
T ss_dssp             EEEEEECCCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEecCCCCcHHHHHHH---ccCCCCHHHHHHHHHHHHHHHHHHHhC-CeEecccCHHHeeEcCCC-CEEEcchhhh
Confidence            5899999996 577777653   246799999999999999999999986 999999999999999988 8999999999


Q ss_pred             cccccCCC--cccccccccccCccccc----CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +.......  ....+||+.|+|||++.    +...++.++|||||||++|+|++|+.||.+.+..+....+......   
T Consensus       223 ~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~---  299 (437)
T 4aw2_A          223 LKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKER---  299 (437)
T ss_dssp             EECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH---
T ss_pred             hhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhcccc---
Confidence            76644332  23467999999999986    2344799999999999999999999999988877777776543111   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCC--CCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL--RCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~--R~t~~~~l~~  354 (371)
                                  +.++.         ....+|+++.+||++||..+|.+  |+++.++++|
T Consensus       300 ------------~~~p~---------~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          300 ------------FQFPT---------QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             ------------CCCCS---------SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             ------------ccCCc---------ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence                        01111         12348999999999999988888  9999998887

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=8.7e-48  Score=352.21  Aligned_cols=249  Identities=25%  Similarity=0.323  Sum_probs=201.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++     .....
T Consensus         5 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~-----~~~~~   79 (323)
T 3tki_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR-----REGNI   79 (323)
T ss_dssp             TTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE-----ECSSE
T ss_pred             HhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE-----ecCCe
Confidence            346899999999999999999999999999999998543     24567899999999999999999988     34455


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||+++ +|.+.+.    ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++.
T Consensus        80 ~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~aL~~LH~~-givH~Dlkp~NIll~~~~-~~kl~Dfg~a~  153 (323)
T 3tki_A           80 QYLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLAT  153 (323)
T ss_dssp             EEEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHC-CccccccchHHEEEeCCC-CEEEEEeeccc
Confidence            7899999985 6555443    256799999999999999999999987 999999999999999888 89999999997


Q ss_pred             ccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ......   ......||+.|+|||++.+....+.++|||||||++|+|++|..||...................      
T Consensus       154 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~------  227 (323)
T 3tki_A          154 VFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY------  227 (323)
T ss_dssp             ECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT------
T ss_pred             eeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc------
Confidence            653322   22356789999999999776655789999999999999999999997765432222211110000      


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     ..     ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       228 ---------------~~-----~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          228 ---------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             ---------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------------CC-----ccccCCHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence                           00     113478999999999999999999999998887

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=5.1e-47  Score=348.11  Aligned_cols=273  Identities=29%  Similarity=0.495  Sum_probs=211.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++... .....+|+.+++.++ ||||+++++++..   ......++||
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~---~~~~~~~lv~  112 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVF  112 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCCEEEEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeecc---CCCCceEEEE
Confidence            4799999999999999999999999999999998643 456678999999997 9999999998753   2244578999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|...+       ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++..+||+|||++......
T Consensus       113 e~~~~~~l~~~~-------~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~  184 (330)
T 3nsz_A          113 EHVNNTDFKQLY-------QTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  184 (330)
T ss_dssp             ECCCCCCHHHHG-------GGCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred             eccCchhHHHHH-------HhCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCC
Confidence            99986 444433       3489999999999999999999987 99999999999999977768999999999877666


Q ss_pred             CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCC-CCcHHHHHHHHHHhCCCCHhHHh-hcCCCc
Q 017452          228 EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTREEIK-CMNPNY  305 (371)
Q Consensus       228 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  305 (371)
                      .......+++.|+|||.+.+...++.++|||||||++|+|++|..||.. ....+.+..+....+.+....+. ......
T Consensus       185 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  264 (330)
T 3nsz_A          185 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIEL  264 (330)
T ss_dssp             CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCC
T ss_pred             CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhcccc
Confidence            5566678899999999997756689999999999999999999999954 44555566666655543322211 100000


Q ss_pred             cc---cccCcccCCCCcccC----CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TE---FKFPQIKAHPWHKIF----PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~---~~~~~~~~~~~~~~~----~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..   -.........|....    +..+++++.+||.+||++||.+|||+.++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          265 DPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00   001111122232222    23379999999999999999999999995544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=3.5e-47  Score=348.86  Aligned_cols=245  Identities=27%  Similarity=0.434  Sum_probs=199.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      ...+|++.+.||+|+||.||+|++.   .+|+.||+|++.+.        .....+|+.+++.++||||+++++++..  
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--   92 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQT--   92 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEEC--
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEc--
Confidence            3468999999999999999999985   68999999998643        2334579999999999999999998843  


Q ss_pred             CCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          138 DKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                         ...+++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus        93 ---~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~ivH~Dlkp~Nill~~~~-~~kl~  163 (327)
T 3a62_A           93 ---GGKLYLILEYLSGGELFMQLER----EGIFMEDTACFYLAEISMALGHLHQK-GIIYRDLKPENIMLNHQG-HVKLT  163 (327)
T ss_dssp             ---SSCEEEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCTTTEEECTTS-CEEEC
T ss_pred             ---CCEEEEEEeCCCCCcHHHHHHh----CCCCCHHHHHHHHHHHHHHHHHHHhC-CEEcccCCHHHeEECCCC-cEEEE
Confidence               345889999998 577777654    46789999999999999999999987 999999999999999888 89999


Q ss_pred             eeCCccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          217 DFGSAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       217 Dfg~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |||+++..... .......||+.|+|||++.+.. ++.++||||||+++|+|++|..||.+.+....+..+.+...    
T Consensus       164 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~----  238 (327)
T 3a62_A          164 DFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKL----  238 (327)
T ss_dssp             CCSCC----------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC----
T ss_pred             eCCcccccccCCccccccCCCcCccCHhhCcCCC-CCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC----
Confidence            99998764322 2334567899999999996654 79999999999999999999999998877666666554210    


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                               .++..++.++.+||.+||+.||.+||     ++.++++|
T Consensus       239 -------------------------~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          239 -------------------------NLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             -------------------------CCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             -------------------------CCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence                                     14456899999999999999999999     88998888

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.2e-47  Score=340.87  Aligned_cols=247  Identities=29%  Similarity=0.439  Sum_probs=209.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...    .....+|+++++.++||||+++++++     ......+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   82 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETF-----EDNTDIY   82 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCeEE
Confidence            45799999999999999999999999999999998643    34567899999999999999999988     3445588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee---eCCCCcEEEEeeCCc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli---~~~~~~~kl~Dfg~a  221 (371)
                      +||||+++ +|.+.+..    ...+++..++.++.|++.||.|||++ ||+||||||+||++   +.++ .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~~l~Dfg~~  156 (277)
T 3f3z_A           83 LVMELCTGGELFERVVH----KRVFRESDAARIMKDVLSAVAYCHKL-NVAHRDLKPENFLFLTDSPDS-PLKLIDFGLA  156 (277)
T ss_dssp             EEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeccCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCCHHHEEEecCCCCC-cEEEEecccc
Confidence            99999975 77676654    46799999999999999999999987 99999999999999   5555 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .............+|+.|+|||.+.+.  ++.++||||||+++|+|++|..||......+....+.......+...+   
T Consensus       157 ~~~~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---  231 (277)
T 3f3z_A          157 ARFKPGKMMRTKVGTPYYVSPQVLEGL--YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW---  231 (277)
T ss_dssp             EECCTTSCBCCCCSCTTTCCHHHHTTC--BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH---
T ss_pred             eeccCccchhccCCCCCccChHHhccc--CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh---
Confidence            877666556667899999999998543  799999999999999999999999988877766666554332222211   


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            ..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       232 ----------------------~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          232 ----------------------LNVSPQAESLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             ----------------------TTSCHHHHHHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             ----------------------hcCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                  2478999999999999999999999997776

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=353.19  Aligned_cols=250  Identities=26%  Similarity=0.375  Sum_probs=190.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+|+.+++.++||||+++++++.     .....+
T Consensus        50 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----~~~~~~  124 (349)
T 2w4o_A           50 ALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFE-----TPTEIS  124 (349)
T ss_dssp             CGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             cccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEe-----cCCeEE
Confidence            3446799999999999999999999999999999998654  344568999999999999999999883     344588


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a  221 (371)
                      +||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||++
T Consensus       125 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIll~~~~~~~-~~kl~Dfg~a  198 (349)
T 2w4o_A          125 LVLELVTGGELFDRIVE----KGYYSERDAADAVKQILEAVAYLHEN-GIVHRDLKPENLLYATPAPDA-PLKIADFGLS  198 (349)
T ss_dssp             EEECCCCSCBHHHHHTT----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESSSSTTC-CEEECCCC--
T ss_pred             EEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEecCCCcccEEEecCCCCC-CEEEccCccc
Confidence            9999998 477666643    46789999999999999999999987 9999999999999975   55 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHHHHhCCCCHhHHhh
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~  300 (371)
                      .............||+.|+|||++.+.. ++.++|||||||++|+|++|..||......... ..+.......       
T Consensus       199 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~-------  270 (349)
T 2w4o_A          199 KIVEHQVLMKTVCGTPGYCAPEILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYF-------  270 (349)
T ss_dssp             --------------CGGGSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCC-------
T ss_pred             cccCcccccccccCCCCccCHHHhcCCC-CCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCcc-------
Confidence            8765544445677899999999997654 899999999999999999999999876655433 3332210000       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        .......++.++.+||.+||+.||.+|||+.++++|
T Consensus       271 ------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          271 ------------------ISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             ------------------CTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ------------------CCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                              001234578999999999999999999999998888

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.2e-47  Score=359.56  Aligned_cols=250  Identities=28%  Similarity=0.451  Sum_probs=206.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+|++.+.||+|+||.||+|++..+|+.||+|++.+.       .....+|..++..++||||+++++++     .+..
T Consensus        60 ~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~-----~~~~  134 (412)
T 2vd5_A           60 RDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAF-----QDEN  134 (412)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEE-----ECSS
T ss_pred             hhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEE-----eeCC
Confidence            45799999999999999999999999999999998642       23456899999999999999999988     4455


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++|+||||++ |+|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       135 ~~~lVmE~~~gg~L~~~l~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~-giiHrDLKp~NILld~~g-~vkL~DFGla  209 (412)
T 2vd5_A          135 YLYLVMEYYVGGDLLTLLSKF---GERIPAEMARFYLAEIVMAIDSVHRL-GYVHRDIKPDNILLDRCG-HIRLADFGSC  209 (412)
T ss_dssp             EEEEEECCCCSCBHHHHHHHH---SSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             EEEEEEcCCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccCHHHeeecCCC-CEEEeechhh
Confidence            6899999996 5887777642   35799999999999999999999986 999999999999999988 8999999999


Q ss_pred             cccccCCC--cccccccccccCcccccC------CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      +.......  ....+||+.|+|||++..      ...++.++|+|||||++|+|++|+.||.+.+..+....+...... 
T Consensus       210 ~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~-  288 (412)
T 2vd5_A          210 LKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEH-  288 (412)
T ss_dssp             EECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHH-
T ss_pred             eeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-
Confidence            87644332  234679999999999862      234799999999999999999999999988877777666542100 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCC---CCHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR---CTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R---~t~~~~l~~  354 (371)
                                    ..++.         ++..+|+++.+||.+||. +|.+|   +++.++++|
T Consensus       289 --------------~~~p~---------~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          289 --------------LSLPL---------VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --------------CCCC-------------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             --------------cCCCc---------cccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence                          00110         234689999999999999 99998   599998888

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=5.3e-47  Score=351.21  Aligned_cols=277  Identities=31%  Similarity=0.583  Sum_probs=217.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|+.+++.++||||+++++++...........
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   89 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV   89 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence            457999999999999999999999999999999985432     234579999999999999999987754333334568


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      ++||||+.++|.+.+..     ..+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++...
T Consensus        90 ~lv~e~~~~~L~~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~-~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           90 YIIQELMQTDLHRVIST-----QMLSDDHIQYFIYQTLRAVKVLHGS-NVIHRDLKPSNLLINSNC-DLKVCDFGLARII  162 (353)
T ss_dssp             EEEECCCSEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             EEEEeccCccHHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeEEcCCC-cEEEEeccccccc
Confidence            89999999998887763     5799999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCCC-----------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          225 VKGEP-----------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       225 ~~~~~-----------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      .....           .....||+.|+|||++.+...++.++|||||||++|+|++|..||.+.+..+.+..+....+.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            43211           1234679999999998665668999999999999999999999999998888888888887776


Q ss_pred             CHhHHhhcCCCcc--c--cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          294 TREEIKCMNPNYT--E--FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~--~--~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .............  .  ..++......+.. ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHH-HSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhh-hcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence            5322111000000  0  0011111111111 224589999999999999999999999998888

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=2.2e-47  Score=355.53  Aligned_cols=246  Identities=24%  Similarity=0.393  Sum_probs=200.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-------hhHHHHHH-HHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-------YKNRELQT-MRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-------~~~~e~~~-l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||.||+|++..+++.||+|++.+...       ...+|..+ ++.++||||+++++++     .
T Consensus        35 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~-----~  109 (373)
T 2r5t_A           35 AKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSF-----Q  109 (373)
T ss_dssp             CCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEE-----E
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEE-----E
Confidence            345689999999999999999999999999999999865431       22234444 4567999999999988     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ....+|+||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+||
T Consensus       110 ~~~~~~lv~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-givHrDlkp~NIll~~~g-~ikL~DF  183 (373)
T 2r5t_A          110 TADKLYFVLDYINGGELFYHLQR----ERCFLEPRARFYAAEIASALGYLHSL-NIVYRDLKPENILLDSQG-HIVLTDF  183 (373)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC
T ss_pred             eCCEEEEEEeCCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEECCCC-CEEEeeC
Confidence            44568999999985 77776654    46789999999999999999999987 999999999999999988 8999999


Q ss_pred             CCcccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          219 GSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       219 g~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      |+++.... .......+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+.+..+....+....       
T Consensus       184 G~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-------  255 (373)
T 2r5t_A          184 GLCKENIEHNSTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-------  255 (373)
T ss_dssp             CBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-------
T ss_pred             ccccccccCCCccccccCCccccCHHHhCCCC-CCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-------
Confidence            99986432 33445678999999999996654 8999999999999999999999999887776666665420       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH----HHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA----VSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~----~~~l~~  354 (371)
                                            ..++..++.++.+||.+||+.||.+||++    .++++|
T Consensus       256 ----------------------~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h  294 (373)
T 2r5t_A          256 ----------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSH  294 (373)
T ss_dssp             ----------------------CCCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTS
T ss_pred             ----------------------cCCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCC
Confidence                                  01445689999999999999999999997    466666

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=5.7e-48  Score=352.87  Aligned_cols=274  Identities=20%  Similarity=0.295  Sum_probs=209.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~~~   84 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecC---CCceE
Confidence            35799999999999999999999999999999998643     24456899999999999999999987542   33457


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee----eCCCCcEEEEeeC
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  219 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli----~~~~~~~kl~Dfg  219 (371)
                      ++||||++ ++|.+.+..... ...+++..++.++.||+.||.|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSN-AYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGG-TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEECTTSCE-EEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEEeccCCCCc-eEEEccCC
Confidence            89999997 588777765322 33499999999999999999999987 99999999999998    5555 79999999


Q ss_pred             CccccccCCCcccccccccccCcccccC-------CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHH
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFG-------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG----VDQLVEIIK  288 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~~~  288 (371)
                      ++.............||+.|+|||++..       ...++.++|||||||++|+|++|..||.....    .+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  241 (319)
T 4euu_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (319)
T ss_dssp             TCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHH
T ss_pred             CceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhc
Confidence            9988766666666789999999999852       34578999999999999999999999965433    333333333


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCccc------CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI------FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      .   .+...+....       ........|...      ++..++..+.+||.+||+.||.+|||+.|+++|..+-.
T Consensus       242 ~---~p~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          242 G---KPSGAISGVQ-------KAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             H---CCTTCCEEEE-------CSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             C---CCcccchhhh-------cccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            2   2211111000       000000112111      22345678999999999999999999999999976543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.4e-47  Score=347.54  Aligned_cols=241  Identities=27%  Similarity=0.388  Sum_probs=190.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh------hhHHHHHHHHHc-CCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR------YKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~------~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|++.++||+|+||+||+|.+..+|+.||||++.....      ....|+..+..+ +||||+++++++..     ...
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~-----~~~  131 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEE-----GGI  131 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEe-----CCE
Confidence            679999999999999999999999999999998854321      122344444444 89999999998843     445


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +++||||++++|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       132 ~~lv~e~~~~~L~~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~DFG~a~~  206 (311)
T 3p1a_A          132 LYLQTELCGPSLQQHCEAW---GASLPEAQVWGYLRDTLLALAHLHSQ-GLVHLDVKPANIFLGPRG-RCKLGDFGLLVE  206 (311)
T ss_dssp             EEEEEECCCCBHHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECGGG-CEEECCCTTCEE
T ss_pred             EEEEEeccCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEecCCCCHHHEEECCCC-CEEEccceeeee
Confidence            8899999999888877653   46799999999999999999999987 999999999999999888 899999999987


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|+|||++.+  .++.++|||||||++|+|++|..|+.....   ...+..  +..+         
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~---~~~~~~--~~~~---------  270 (311)
T 3p1a_A          207 LGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEG---WQQLRQ--GYLP---------  270 (311)
T ss_dssp             CC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHH---HHHHTT--TCCC---------
T ss_pred             cccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccH---HHHHhc--cCCC---------
Confidence            765555556678999999999865  479999999999999999999776654322   111111  0011         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                                      ..++..+++++.+||.+||+.||.+|||+.++++
T Consensus       271 ----------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          271 ----------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ----------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ----------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                            1123457899999999999999999999999443

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.2e-47  Score=367.51  Aligned_cols=250  Identities=27%  Similarity=0.431  Sum_probs=207.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ....+|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++     ...
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~   93 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEIL-----EDS   93 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEE-----ECS
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEE-----EcC
Confidence            3456899999999999999999999999999999998532      34566899999999999999999988     345


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEee
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDF  218 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Df  218 (371)
                      ..+++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+||
T Consensus        94 ~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~Df  168 (486)
T 3mwu_A           94 SSFYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDF  168 (486)
T ss_dssp             SEEEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEESSSSTTCCEEECSC
T ss_pred             CEEEEEEEcCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeccCchHHEEEecCCCCCCEEEEEC
Confidence            568999999985 77666654    46799999999999999999999987 999999999999996432  27999999


Q ss_pred             CCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       219 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      |++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.......+..  
T Consensus       169 g~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~--  244 (486)
T 3mwu_A          169 GLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP--  244 (486)
T ss_dssp             SCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSG--
T ss_pred             CcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCc--
Confidence            99987766555566789999999999865  37899999999999999999999999888777766665532111111  


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             .+..+|+++.+||.+||+.||.+|||+.++++|
T Consensus       245 -----------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          245 -----------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             -----------------------GGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             -----------------------ccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                                   113478999999999999999999999999988

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=4.4e-47  Score=356.50  Aligned_cols=278  Identities=20%  Similarity=0.298  Sum_probs=203.4

Q ss_pred             CcccceeeeEeeccC--CceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQG--SFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G--~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...++|++.+.||+|  +||.||+|.+..+|+.||||++....      ....+|+.+++.++||||+++++++..    
T Consensus        22 ~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~----   97 (389)
T 3gni_B           22 PEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIA----   97 (389)
T ss_dssp             CCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE----
T ss_pred             CCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEE----
Confidence            345689999999999  99999999999999999999996442      345579999999999999999999854    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                       ...+++||||+. ++|.+++...  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        98 -~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~df  172 (389)
T 3gni_B           98 -DNELWVVTSFMAYGSAKDLICTH--FMDGMNELAIAYILQGVLKALDYIHHM-GYVHRSVKASHILISVDG-KVYLSGL  172 (389)
T ss_dssp             -TTEEEEEEECCTTCBHHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCG
T ss_pred             -CCEEEEEEEccCCCCHHHHHhhh--cccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEcCCC-CEEEccc
Confidence             334899999998 5777777642  236699999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCC--------CcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017452          219 GSAKVLVKGE--------PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       219 g~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  289 (371)
                      |.+.......        ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||.+.+..+.+..+...
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9876543221        12234788999999999763 45799999999999999999999999887766655444332


Q ss_pred             hCCCC-------HhHHh-hcC-----CCccccccC----cccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          290 LGTPT-------REEIK-CMN-----PNYTEFKFP----QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       290 ~~~~~-------~~~~~-~~~-----~~~~~~~~~----~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                      .....       .+.+. ...     .........    ..........++..+++++.+||.+||+.||.+|||+.+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            11000       00000 000     000000000    00000011113456899999999999999999999999998


Q ss_pred             hh
Q 017452          353 IL  354 (371)
Q Consensus       353 ~~  354 (371)
                      +|
T Consensus       333 ~h  334 (389)
T 3gni_B          333 NH  334 (389)
T ss_dssp             TS
T ss_pred             cC
Confidence            88

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=7e-47  Score=355.65  Aligned_cols=284  Identities=27%  Similarity=0.400  Sum_probs=219.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcC--------CCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD--------HPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~--------h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||+|++..+++.||||++....   ....+|+.+++.+.        |+||+++++++.... 
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~-  114 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG-  114 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE-
T ss_pred             CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC-
Confidence            368999999999999999999999999999999997543   44567999999885        788999999885432 


Q ss_pred             CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--------
Q 017452          139 KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--------  210 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--------  210 (371)
                      ....++++||||+++++.+.+...  ....+++..++.++.||+.||.|||++.||+||||||+|||++.++        
T Consensus       115 ~~~~~~~lv~e~~~~~l~~~~~~~--~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          115 VNGTHICMVFEVLGHHLLKWIIKS--NYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             TTEEEEEEEECCCCCBHHHHHHHT--TTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCceEEEEEeccCccHHHHHHhc--ccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence            245678999999999888777642  2357999999999999999999999744999999999999998664        


Q ss_pred             ----------------------------------------CcEEEEeeCCccccccCCCcccccccccccCcccccCCcC
Q 017452          211 ----------------------------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE  250 (371)
Q Consensus       211 ----------------------------------------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  250 (371)
                                                              ..+||+|||++......  .....||+.|+|||++.+.. 
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-  269 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSG-  269 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSC-
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCC-
Confidence                                                    26999999999876432  34567899999999997655 


Q ss_pred             CCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHHHHHHHhCCCCHhHHhhcCCCccccc----cCccc-CCCCc
Q 017452          251 YTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIK-AHPWH  319 (371)
Q Consensus       251 ~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~~  319 (371)
                      ++.++|||||||++|+|++|+.||...+      ....+..+....+.++...+.........+.    ...+. ..+|.
T Consensus       270 ~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  349 (397)
T 1wak_A          270 YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWG  349 (397)
T ss_dssp             CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCC
T ss_pred             CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcc
Confidence            8999999999999999999999997655      3456777888888887766543221111110    00000 00110


Q ss_pred             --------ccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          320 --------KIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       320 --------~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                              ...+...+..+.+||.+||+.||.+|||+.+            ++.||||++
T Consensus       350 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e------------~l~hp~~~~  397 (397)
T 1wak_A          350 LFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAE------------CLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHH------------HHTSGGGGC
T ss_pred             hhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHH------------HhhCccccC
Confidence                    0012234567899999999999999999999            566777764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.6e-47  Score=371.62  Aligned_cols=249  Identities=26%  Similarity=0.416  Sum_probs=207.0

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++.+.       .....+|+.+++.++||||+++++++     ..
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  255 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY-----ET  255 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEE-----ee
Confidence            4456899999999999999999999999999999998543       23356799999999999999999888     33


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||++ |+|...+...  ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       256 ~~~l~lVmEy~~gg~L~~~l~~~--~~~~l~e~~~~~i~~qIl~aL~yLH~~-gIvHrDLKPeNILld~~g-~vKL~DFG  331 (576)
T 2acx_A          256 KDALCLVLTLMNGGDLKFHIYHM--GQAGFPEARAVFYAAEICCGLEDLHRE-RIVYRDLKPENILLDDHG-HIRISDLG  331 (576)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHSS--SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CEeccCCchheEEEeCCC-CeEEEecc
Confidence            456899999997 5777666532  134599999999999999999999987 999999999999999988 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCCCHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~~~~  296 (371)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||.....   ...+...+...      
T Consensus       332 la~~~~~~~~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~------  404 (576)
T 2acx_A          332 LAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEV------  404 (576)
T ss_dssp             TCEECCTTCCEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC------
T ss_pred             cceecccCccccccCCCccccCHHHHcCCC-CCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcc------
Confidence            998876655556678999999999997654 79999999999999999999999987543   22222222210      


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                            ...++..+|+++.+||.+||+.||.+||     ++.++++|
T Consensus       405 ----------------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          405 ----------------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             ----------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             ----------------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence                                  0114566899999999999999999999     89998888

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.8e-47  Score=346.70  Aligned_cols=254  Identities=22%  Similarity=0.328  Sum_probs=198.9

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ....+|++.+.||+|+||.||+|.+  +|..||+|++....      ....+|+.++++++||||+++++++     ...
T Consensus        34 i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----~~~  106 (309)
T 3p86_A           34 IPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-----TQP  106 (309)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CST
T ss_pred             CChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----EEC
Confidence            3356899999999999999999987  68899999985432      2345799999999999999999988     333


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEee
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ...++||||+.+ +|.+.+.... ....+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .+||+||
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~-~~~ivH~Dikp~NIll~~~~-~~kL~Df  183 (309)
T 3p86_A          107 PNLSIVTEYLSRGSLYRLLHKSG-AREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKY-TVKVCDF  183 (309)
T ss_dssp             TCCEEEEECCTTCBHHHHHHSTT-HHHHSCHHHHHHHHHHHHHHHHHHHTS-SSCCCCTTCCGGGEEECTTC-CEEECCC
T ss_pred             CceEEEEecCCCCcHHHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHcC-CCCEECCCCChhhEEEeCCC-cEEECCC
Confidence            447899999985 8877776421 123489999999999999999999987 9  99999999999999888 8999999


Q ss_pred             CCccccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          219 GSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       219 g~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      |+++...... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.....      
T Consensus       184 g~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~------  256 (309)
T 3p86_A          184 GLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK------  256 (309)
T ss_dssp             C-----------------CCTTSCHHHHTTCC-CCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC------
T ss_pred             CCCccccccccccccCCCCccccChhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC------
Confidence            9997644332 233567899999999997654 79999999999999999999999988776655544432111      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                           ...++..+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       257 ---------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~  297 (309)
T 3p86_A          257 ---------------------RLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLI  297 (309)
T ss_dssp             ---------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                 01145678999999999999999999999999999987653

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=5.8e-47  Score=350.05  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=205.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||||++....       ..+.+|+.+++.++||||+++++++..     ...
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-----~~~  128 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHT  128 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEE-----CCe
Confidence            46999999999999999999999999999999986431       345689999999999999999998854     334


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++||||+.|++.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+|||++.++ .+||+|||++..
T Consensus       129 ~~lv~e~~~g~l~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~  203 (348)
T 1u5q_A          129 AWLVMEYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASI  203 (348)
T ss_dssp             EEEEEECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBS
T ss_pred             EEEEEecCCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHEEECCCC-CEEEeeccCcee
Confidence            7899999999888777542   46799999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          224 LVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...   .....||+.|+|||++.+  ...++.++|||||||++|+|++|+.||...+....+..+..... +        
T Consensus       204 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~-~--------  271 (348)
T 1u5q_A          204 MAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNES-P--------  271 (348)
T ss_dssp             SSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-C--------
T ss_pred             cCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCC-C--------
Confidence            533   234678999999999853  34478899999999999999999999988776665555443210 0        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ...+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       272 ------------------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          272 ------------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                              01234578999999999999999999999999988

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=9.1e-47  Score=365.82  Aligned_cols=248  Identities=28%  Similarity=0.456  Sum_probs=208.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----------------hhhhHHHHHHHHHcCCCCeeeccee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----------------KRYKNRELQTMRLLDHPNVVSLKHC  132 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------------~~~~~~e~~~l~~l~h~niv~~~~~  132 (371)
                      ..+|++++.||+|+||.||+|.+..++..||+|++...                 .....+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            45799999999999999999999999999999998643                 2345679999999999999999999


Q ss_pred             EEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC
Q 017452          133 FFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH  211 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~  211 (371)
                      +     .....+++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.
T Consensus       115 ~-----~~~~~~~lv~e~~~gg~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~  184 (504)
T 3q5i_A          115 F-----EDKKYFYLVTEFYEGGELFEQIIN----RHKFDECDAANIMKQILSGICYLHKH-NIVHRDIKPENILLENKNS  184 (504)
T ss_dssp             E-----ECSSEEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESSTTC
T ss_pred             E-----EcCCEEEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEeCCCcHHHEEEecCCC
Confidence            8     445568999999985 77776654    46799999999999999999999987 9999999999999987653


Q ss_pred             --cEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017452          212 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       212 --~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  289 (371)
                        .+||+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+...
T Consensus       185 ~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~  262 (504)
T 3q5i_A          185 LLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKG  262 (504)
T ss_dssp             CSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC
T ss_pred             CccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhcc--CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC
Confidence              699999999988766655667789999999999853  3799999999999999999999999988877777766653


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....+...                         +..+|+++.+||.+||++||.+|||+.++++|
T Consensus       263 ~~~~~~~~-------------------------~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h  302 (504)
T 3q5i_A          263 KYYFDFND-------------------------WKNISDEAKELIKLMLTYDYNKRCTAEEALNS  302 (504)
T ss_dssp             CCCCCHHH-------------------------HTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCCCCccc-------------------------cCCCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            22222221                         13479999999999999999999999999888

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-47  Score=365.40  Aligned_cols=245  Identities=27%  Similarity=0.399  Sum_probs=200.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~-----~  220 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQT-----H  220 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEE-----T
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEee-----C
Confidence            4568999999999999999999999999999999986431       233468888889999999999998843     3


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ..+++||||+++ +|...+..    ...+++..++.++.||+.||+|||+ + ||+||||||+|||++.++ .+||+|||
T Consensus       221 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~~-giiHrDlkp~NIll~~~~-~~kl~DFG  294 (446)
T 4ejn_A          221 DRLCFVMEYANGGELFFHLSR----ERVFSEDRARFYGAEIVSALDYLHSEK-NVVYRDLKLENLMLDKDG-HIKITDFG  294 (446)
T ss_dssp             TEEEEEECCCSSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHHT-CCCCCCCCGGGEEECSSS-CEEECCCC
T ss_pred             CEEEEEEeeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHhhcC-CEEECCCCHHHEEECCCC-CEEEccCC
Confidence            448899999985 77666654    4679999999999999999999997 6 999999999999999988 89999999


Q ss_pred             Ccccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++.... ........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||...+.......+....        
T Consensus       295 ~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~--------  365 (446)
T 4ejn_A          295 LCKEGIKDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE--------  365 (446)
T ss_dssp             CCCTTCC-----CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--------
T ss_pred             CceeccCCCcccccccCCccccCHhhcCCCC-CCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC--------
Confidence            9976432 23344578999999999997654 8999999999999999999999998877766655554310        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                           ..++..+++++.+||.+||+.||.+||     |+.++++|
T Consensus       366 ---------------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          366 ---------------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhC
Confidence                                 014566899999999999999999999     99998888

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-47  Score=368.28  Aligned_cols=250  Identities=23%  Similarity=0.383  Sum_probs=205.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ....+|.+.+.||+|+||.||+|++..+|+.||+|++.+..       ....+|..+++.++||||+++++++     ..
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~-----~~  256 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAF-----ET  256 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ee
Confidence            34568999999999999999999999999999999986432       3345799999999999999999988     33


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||++ |+|...+.........+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       257 ~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~-gIvHrDLKP~NILl~~~g-~vkL~DFG  334 (543)
T 3c4z_A          257 KTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR-NIIYRDLKPENVLLDDDG-NVRISDLG  334 (543)
T ss_dssp             SSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCT
T ss_pred             CCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc-CCcccCCChHHEEEeCCC-CEEEeecc
Confidence            455899999998 477777665443356799999999999999999999987 999999999999999988 89999999


Q ss_pred             CccccccCCCc-ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc----HHHHHHHHHHhCCCC
Q 017452          220 SAKVLVKGEPN-ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG----VDQLVEIIKVLGTPT  294 (371)
Q Consensus       220 ~a~~~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~----~~~~~~~~~~~~~~~  294 (371)
                      +++........ ...+||+.|+|||++.+.. ++.++|+|||||++|+|++|..||.+...    .+....+...     
T Consensus       335 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~-----  408 (543)
T 3c4z_A          335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQ-----  408 (543)
T ss_dssp             TCEECCTTCCCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHC-----
T ss_pred             eeeeccCCCcccccccCCccccChhhhcCCC-CChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhc-----
Confidence            99876544433 3458999999999997654 89999999999999999999999987542    2222222210     


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                              ...++..+++++.+||.+||+.||.+||+     +.++++|
T Consensus       409 ------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          409 ------------------------AVTYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             ------------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             ------------------------ccCCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence                                    00145678999999999999999999996     4787766

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1e-46  Score=340.73  Aligned_cols=256  Identities=24%  Similarity=0.347  Sum_probs=204.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++     ....
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~-----~~~~   84 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVD-----EEDD   84 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEE-----ECSS
T ss_pred             hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEee-----eeCC
Confidence            45799999999999999999999999999999988432       13456799999999999999999987     4445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||++| +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        85 ~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  158 (294)
T 4eqm_A           85 CYYLVMEYIEGPTLSEYIES----HGPLSVDTAINFTNQILDGIKHAHDM-RIVHRDIKPQNILIDSNK-TLKIFDFGIA  158 (294)
T ss_dssp             EEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCSSS
T ss_pred             eEEEEEeCCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-CEEEEeCCCc
Confidence            58899999985 88777764    46799999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ........  .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+...........  ..+.    
T Consensus       159 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~--~~~~----  231 (294)
T 4eqm_A          159 KALSETSLTQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD--SVPN----  231 (294)
T ss_dssp             TTC-------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS--CCCC----
T ss_pred             cccccccccccCccccCccccCHhHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc--cCCC----
Confidence            87543322  23456899999999997655 789999999999999999999999887765554333321  1100    


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-CHHHHhhhhcCCCcc
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TAVSKRILFSNCPSL  361 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-t~~~~l~~l~~~~~~  361 (371)
                                        .....+..+++.+.++|.+||+.||.+|| ++.++++.|+.+...
T Consensus       232 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          232 ------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             ------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence                              00113456899999999999999999999 788888888876543

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.6e-47  Score=351.18  Aligned_cols=273  Identities=33%  Similarity=0.589  Sum_probs=217.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC-Ccee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK-DELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~-~~~~  143 (371)
                      .+|.+.+.||+|+||.||+|.+..+|+.||||++...      .....+|+.+++.++||||+++++++...... ....
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~  103 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD  103 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence            4799999999999999999999999999999998543      23445799999999999999999988443211 1123


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++||||+.++|.+.+      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus       104 ~~lv~e~~~~~l~~~~------~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~~  175 (353)
T 3coi_A          104 FYLVMPFMQTDLQKIM------GLKFSEEKIQYLVYQMLKGLKYIHSA-GVVHRDLKPGNLAVNEDC-ELKILDFGLARH  175 (353)
T ss_dssp             CEEEEECCSEEGGGTT------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECTTC-CEEECSTTCTTC
T ss_pred             EEEEeccccCCHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEeECCCC-cEEEeecccccC
Confidence            5899999998765544      24699999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  ......+|+.|+|||.+.+...++.++||||||+++|+|++|..||.+.+..+.+..+.+..+.++.+.+.....
T Consensus       176 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  253 (353)
T 3coi_A          176 ADA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLND  253 (353)
T ss_dssp             ----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSC
T ss_pred             CCC--CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhh
Confidence            532  233467899999999987756689999999999999999999999999998888999999999888777654432


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   ..+......+.. ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          254 KAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             HHHHHHHHTSCBCSSCCTTT-TCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHhCcCCCCccHHH-hcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence            21110   111111112221 334689999999999999999999999998888

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.9e-46  Score=349.09  Aligned_cols=248  Identities=25%  Similarity=0.390  Sum_probs=206.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHc-CCCCeeecceeEEecC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (371)
                      ++|.+.+.||+|+||.||+|.+..+|+.||||++....            ....+|+.+++.+ +||||+++++++.   
T Consensus        94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  170 (365)
T 2y7j_A           94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE---  170 (365)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE---
T ss_pred             hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe---
Confidence            57999999999999999999999999999999885432            2345799999999 7999999999873   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                        .....++||||+.| +|.+.+..    ...+++..++.++.||+.||.|||+. ||+|+||||+||+++.++ .++|+
T Consensus       171 --~~~~~~lv~e~~~g~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-gi~H~Dlkp~NIl~~~~~-~ikl~  242 (365)
T 2y7j_A          171 --SSSFMFLVFDLMRKGELFDYLTE----KVALSEKETRSIMRSLLEAVSFLHAN-NIVHRDLKPENILLDDNM-QIRLS  242 (365)
T ss_dssp             --BSSEEEEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEEC
T ss_pred             --eCCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEECCCC-CEEEE
Confidence              34558899999986 77777654    46799999999999999999999987 999999999999999888 89999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccC-----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      |||++.............||+.|+|||++.+     ...++.++|||||||++|+|++|..||...+....+..+.....
T Consensus       243 DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  322 (365)
T 2y7j_A          243 DFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQY  322 (365)
T ss_dssp             CCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC
T ss_pred             ecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCC
Confidence            9999987766655666789999999999853     22478899999999999999999999988776666555544322


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ......                         +..++..+.+||.+||+.||.+|||+.++++|
T Consensus       323 ~~~~~~-------------------------~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          323 QFSSPE-------------------------WDDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             CCCHHH-------------------------HSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCCcc-------------------------cccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            222111                         13468899999999999999999999995443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.4e-47  Score=346.06  Aligned_cols=277  Identities=29%  Similarity=0.493  Sum_probs=212.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecC---------
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTT---------  137 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~---------  137 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.++||||+++++++....         
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~   90 (320)
T 2i6l_A           11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS   90 (320)
T ss_dssp             TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred             CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence            57999999999999999999999999999999886432    34568999999999999999998763221         


Q ss_pred             CCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          138 DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      .......++||||++++|.+.+.     ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++..+||+|
T Consensus        91 ~~~~~~~~lv~e~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           91 LTELNSVYIVQEYMETDLANVLE-----QGPLLEEHARLFMYQLLRGLKYIHSA-NVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             CCSCSEEEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccCceeEEeeccCCCHHHHhh-----cCCccHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEEcCCCCeEEEcc
Confidence            12345678999999998887764     46799999999999999999999987 9999999999999986555899999


Q ss_pred             eCCccccccC----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          218 FGSAKVLVKG----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       218 fg~a~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      ||++......    .......+|+.|+|||.+.+...++.++||||||+++|+|++|+.||.+.+..+.+..+....+..
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999865432    122345678999999998765668999999999999999999999999988888888888877666


Q ss_pred             CHhHHhhcCCCccccccCcc--cCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQI--KAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ..+.................  ...++ ..+...++.++.+||.+||+.||.+|||+.++++|
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPL-TQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCH-HHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             chhhhhhhhhcCcccccccccCCCCCh-hHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            65554332211111000000  00111 11234689999999999999999999999998777

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.3e-47  Score=368.47  Aligned_cols=249  Identities=30%  Similarity=0.484  Sum_probs=210.0

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++...       .....+|+.+++.++||||+++++++     ..
T Consensus        23 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   97 (484)
T 3nyv_A           23 IFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFF-----ED   97 (484)
T ss_dssp             CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEE-----EC
T ss_pred             cccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEE-----Ee
Confidence            3446899999999999999999999999999999998532       34466899999999999999999988     44


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee---CCCCcEEEE
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN---PHTHQVKLC  216 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~---~~~~~~kl~  216 (371)
                      ..+.++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++   .++ .+||+
T Consensus        98 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~-~~kl~  171 (484)
T 3nyv_A           98 KGYFYLVGEVYTGGELFDEIIS----RKRFSEVDAARIIRQVLSGITYMHKN-KIVHRDLKPENLLLESKSKDA-NIRII  171 (484)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHT----CSCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEEC
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeCCCCHHHEEEecCCCCC-cEEEE
Confidence            5568999999974 77666653    56799999999999999999999987 999999999999994   444 89999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+..
T Consensus       172 Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  249 (484)
T 3nyv_A          172 DFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELP  249 (484)
T ss_dssp             CTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG
T ss_pred             eeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence            9999987766665666789999999999865  37999999999999999999999999888777776665532111111


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                               .+..+|+++.+||.+||++||.+|||+.++++|
T Consensus       250 -------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  282 (484)
T 3nyv_A          250 -------------------------QWKKVSESAKDLIRKMLTYVPSMRISARDALDH  282 (484)
T ss_dssp             -------------------------GGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -------------------------ccccCCHHHHHHHHHHCCCChhHCcCHHHHhhC
Confidence                                     113478999999999999999999999998888

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.4e-47  Score=365.56  Aligned_cols=248  Identities=26%  Similarity=0.426  Sum_probs=205.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..+|++++.||+|+||.||+|.+..++..||+|++...      .....+|+.+++.++||||+++++++     .....
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~~~~  110 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFF-----EDKRN  110 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEE-----EeCCE
Confidence            35799999999999999999999999999999998643      34456899999999999999999998     34455


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCC
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~  220 (371)
                      .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++..+  ..+||+|||+
T Consensus       111 ~~lv~e~~~~g~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~  185 (494)
T 3lij_A          111 YYLVMECYKGGELFDEIIH----RMKFNEVDAAVIIKQVLSGVTYLHKH-NIVHRDLKPENLLLESKEKDALIKIVDFGL  185 (494)
T ss_dssp             EEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEecCCCCcHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCChhhEEEeCCCCCCcEEEEECCC
Confidence            8899999985 77666654    46799999999999999999999987 999999999999997643  2599999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+....+.+..+.......+..    
T Consensus       186 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~----  259 (494)
T 3lij_A          186 SAVFENQKKMKERLGTAYYIAPEVLRK--KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSP----  259 (494)
T ss_dssp             CEECBTTBCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSG----
T ss_pred             CeECCCCccccccCCCcCeeCHHHHcc--cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCch----
Confidence            988766555566789999999999853  47999999999999999999999999888777766665532221111    


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....+|+.+.+||.+||+.||.+|||+.++++|
T Consensus       260 ---------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          260 ---------------------EWKNVSEGAKDLIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTC
T ss_pred             ---------------------hcccCCHHHHHHHHHHCCCChhhCccHHHHhcC
Confidence                                 123579999999999999999999999998888

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.3e-47  Score=352.71  Aligned_cols=239  Identities=24%  Similarity=0.366  Sum_probs=202.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++    
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~----   98 (335)
T 3dls_A           23 SQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIF----   98 (335)
T ss_dssp             HHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEE----
T ss_pred             ccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEE----
Confidence            457999999999999999999999999999999986532            2445799999999999999999988    


Q ss_pred             CCCceeEEEeecccc-c-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          138 DKDELYLNLVLEYVP-E-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~-~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                       ......++||||+. | +|...+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||
T Consensus        99 -~~~~~~~lv~e~~~~g~~l~~~~~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL  171 (335)
T 3dls_A           99 -ENQGFFQLVMEKHGSGLDLFAFIDR----HPRLDEPLASYIFRQLVSAVGYLRLK-DIIHRDIKDENIVIAEDF-TIKL  171 (335)
T ss_dssp             -ECSSEEEEEEECCTTSCBHHHHHHT----CCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEE
T ss_pred             -eeCCEEEEEEEeCCCCccHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEEeccCHHHEEEcCCC-cEEE
Confidence             44456889999986 4 67666653    56799999999999999999999987 999999999999999887 8999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +|||++.............||+.|+|||++.+....+.++||||||+++|+|++|..||.......      .       
T Consensus       172 ~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~------~-------  238 (335)
T 3dls_A          172 IDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEETV------E-------  238 (335)
T ss_dssp             CCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGGT------T-------
T ss_pred             eecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHHH------h-------
Confidence            999999887666666677899999999999776655889999999999999999999996522100      0       


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            .....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       239 ----------------------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          239 ----------------------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             ----------------------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             ----------------------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                  0001344579999999999999999999999999888

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=9.9e-47  Score=337.40  Aligned_cols=246  Identities=28%  Similarity=0.426  Sum_probs=198.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++.     ..
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~   83 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVIS-----TP   83 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEe-----cC
Confidence            4468999999999999999999999999999999985432       34568999999999999999999883     34


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .++|+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~~l~dfg~  157 (276)
T 2h6d_A           84 TDFFMVMEYVSGGELFDYICK----HGRVEEMEARRLFQQILSAVDYCHRH-MVVHRDLKPENVLLDAHM-NAKIADFGL  157 (276)
T ss_dssp             SEEEEEEECCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-CSSCCCCCGGGEEECTTS-CEEECCCCG
T ss_pred             CeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChhhEEECCCC-CEEEeeccc
Confidence            45789999997 488777764    35789999999999999999999997 999999999999999888 899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............+++.|+|||.+.+....+.++|+||||+++|+|++|..||...........+....          
T Consensus       158 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------  227 (276)
T 2h6d_A          158 SNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV----------  227 (276)
T ss_dssp             GGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC----------
T ss_pred             ccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCc----------
Confidence            9876555444566789999999999766545789999999999999999999998776555444443210          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ..++..++..+.++|.+||+.||.+|||+.++++|
T Consensus       228 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          228 -------------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             -------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             -------------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                               01345578999999999999999999999999888

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.3e-46  Score=350.68  Aligned_cols=256  Identities=21%  Similarity=0.314  Sum_probs=207.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-------CCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ..++|++++.||+|+||.||+|.+.       .++..||+|++...     .....+|+.+++.+ +||||+++++++  
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~--  156 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC--  156 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEE--
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE--
Confidence            4568999999999999999999874       34567999998653     23456899999999 899999999988  


Q ss_pred             cCCCCceeEEEeeccccc-hHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                         .....+++||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus       157 ---~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~  232 (370)
T 2psq_A          157 ---TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAAR  232 (370)
T ss_dssp             ---CSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGG
T ss_pred             ---ccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-Ceeccccchh
Confidence               334447899999985 88888775321            124589999999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+..
T Consensus       233 NIll~~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          233 NVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             GEEECTTC-CEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hEEECCCC-CEEEccccCCcccCcccceecccCCCcccceECHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            99999888 899999999986543322   23345678899999997654 8999999999999999999 999998876


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+....+....                            ....+..++.++.++|.+||+.||.+|||+.+++++|+.+
T Consensus       311 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~i  362 (370)
T 2psq_A          311 VEELFKLLKEGH----------------------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  362 (370)
T ss_dssp             GGGHHHHHHTTC----------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCC----------------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence            655544433210                            0013456889999999999999999999999999998876


Q ss_pred             Cc
Q 017452          359 PS  360 (371)
Q Consensus       359 ~~  360 (371)
                      ..
T Consensus       363 l~  364 (370)
T 2psq_A          363 LT  364 (370)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.1e-47  Score=346.88  Aligned_cols=248  Identities=27%  Similarity=0.426  Sum_probs=180.1

Q ss_pred             cceeee---EeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAE---RIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~---~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|.+.   +.||+|+||.||+|.+..+|+.||||++... .....+|+.+++.+. ||||+++++++     .+....+
T Consensus         8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~-----~~~~~~~   82 (325)
T 3kn6_A            8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVF-----HDQLHTF   82 (325)
T ss_dssp             HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECSSEEE
T ss_pred             hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEE-----EcCCEEE
Confidence            457665   7899999999999999999999999999654 355678999999997 99999999998     3445588


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC--cEEEEeeCCcc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAK  222 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~--~~kl~Dfg~a~  222 (371)
                      +||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++.  .+||+|||++.
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~  157 (325)
T 3kn6_A           83 LVMELLNGGELFERIKK----KKHFSETEASYIMRKLVSAVSHMHDV-GVVHRDLKPENLLFTDENDNLEIKIIDFGFAR  157 (325)
T ss_dssp             EEECCCCSCBHHHHHHH----CSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEC----CEEEECCCTTCE
T ss_pred             EEEEccCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecCCCHHHEEEecCCCcccEEEeccccce
Confidence            99999985 77777764    56799999999999999999999987 9999999999999976542  69999999998


Q ss_pred             ccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-------HHHHHHHHHhCCCC
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-------DQLVEIIKVLGTPT  294 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~  294 (371)
                      ...... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||...+..       +.+..+.......+
T Consensus       158 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~  236 (325)
T 3kn6_A          158 LKPPDNQPLKTPCFTLHYAAPELLNQNG-YDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFE  236 (325)
T ss_dssp             ECCC----------------------CC-CCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCC
T ss_pred             ecCCCCCcccccCCCcCccCHHHhcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCC
Confidence            654332 234567799999999986554 899999999999999999999999765432       11222111100000


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+                         .+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       237 ~~-------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          237 GE-------------------------AWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             SH-------------------------HHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cc-------------------------cccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence            00                         113478999999999999999999999997776

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.4e-46  Score=352.28  Aligned_cols=255  Identities=25%  Similarity=0.333  Sum_probs=195.0

Q ss_pred             Ccccceeee-EeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHH-HHcCCCCeeecceeEEecCCCCceeEE
Q 017452           68 KQTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        68 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...++|.+. +.||+|+||+||+|.+..+|+.||||++.. .....+|+.++ +..+||||+++++++.... .+..++|
T Consensus        58 ~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~-~~~~~~~  135 (400)
T 1nxk_A           58 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL  135 (400)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             cccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecc-cCCcEEE
Confidence            344578877 789999999999999999999999999864 34567788887 4558999999999875422 3356689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a  221 (371)
                      +||||+.| +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.   ++ .+||+|||++
T Consensus       136 lv~E~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~Nill~~~~~~~-~~kl~DFG~a  211 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA  211 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC-----CCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEEeCCCCcHHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCcCcceEEEecCCCCc-cEEEEecccc
Confidence            99999984 887777642  234699999999999999999999987 9999999999999987   45 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH----HHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD----QLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~  297 (371)
                      +...........+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.....    ....+...  .     
T Consensus       212 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~--~-----  283 (400)
T 1nxk_A          212 KETTSHNSLTTPCYTPYYVAPEVLGPE-KYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG--Q-----  283 (400)
T ss_dssp             EECC-----------CTTCCGGGSCCC-CSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHT--C-----
T ss_pred             cccCCCCccccCCCCCCccCHhhcCCC-CCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcC--c-----
Confidence            876555555567889999999998654 48999999999999999999999997654322    11222211  0     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                +.++.        .....++.++.+||.+||+.||.+|||+.++++|
T Consensus       284 ----------~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          284 ----------YEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             ----------CCCCT--------TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             ----------ccCCC--------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                      00000        0124579999999999999999999999999998

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.2e-46  Score=335.83  Aligned_cols=245  Identities=30%  Similarity=0.447  Sum_probs=203.0

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..++..||+|++...       .....+|+.+++.++||||+++++++.     .
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   80 (279)
T 3fdn_A            6 WALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----D   80 (279)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEE-----C
T ss_pred             eecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEe-----c
Confidence            3457899999999999999999999999999999998543       234567999999999999999999883     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ....++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~----~~~~~~~~~~~~~~qi~~~l~~LH~~-~i~H~dlkp~Nili~~~~-~~~l~Dfg  154 (279)
T 3fdn_A           81 ATRVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFG  154 (279)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TCEECCCCGGGEEECTTS-CEEECSCC
T ss_pred             CCEEEEEEecCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecccCChHhEEEcCCC-CEEEEecc
Confidence            445889999998 477776654    36789999999999999999999986 999999999999999888 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++...... ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||......+....+....         
T Consensus       155 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---------  223 (279)
T 3fdn_A          155 WSVHAPSS-RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE---------  223 (279)
T ss_dssp             EESCC---------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ccccCCcc-cccccCCCCCccCHhHhccCC-CCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC---------
Confidence            88654332 234567899999999986544 7899999999999999999999998877666555544321         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ..++..++..+.+||.+||+.||.+|||+.++++|
T Consensus       224 --------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 --------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             --------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                01445678999999999999999999999998887

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.1e-46  Score=336.50  Aligned_cols=251  Identities=24%  Similarity=0.339  Sum_probs=207.1

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------------hhhHHHHHHHHHcC-CCCeeecceeE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCF  133 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~  133 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||||++....             ....+|+.+++++. ||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            34568999999999999999999999999999999985431             33457899999995 99999999988


Q ss_pred             EecCCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          134 FSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       134 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                           ......++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .
T Consensus        94 -----~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~  162 (298)
T 1phk_A           94 -----ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-N  162 (298)
T ss_dssp             -----ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-C
T ss_pred             -----ccCCeEEEEEeccCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCcceEEEcCCC-c
Confidence                 34456889999998 588777764    46799999999999999999999987 999999999999999888 8


Q ss_pred             EEEEeeCCccccccCCCcccccccccccCccccc-----CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF-----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII  287 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~  287 (371)
                      +||+|||++.............+++.|+|||++.     ....++.++||||||+++|+|++|..||...+.......+.
T Consensus       163 ~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~  242 (298)
T 1phk_A          163 IKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM  242 (298)
T ss_dssp             EEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             EEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHh
Confidence            9999999998776655556677899999999985     23447889999999999999999999998877666555554


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ......+..                         ....++..+.+||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          243 SGNYQFGSP-------------------------EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             HTCCCCCTT-------------------------TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             cCCcccCcc-------------------------cccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            421111100                         112478999999999999999999999997665

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3.3e-46  Score=335.23  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=202.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...          ...+.+|+.+++.++||||+++++++.     .
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~   79 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFE-----N   79 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheec-----C
Confidence            5799999999999999999999999999999998643          244678999999999999999999884     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---cEEEE
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVKLC  216 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---~~kl~  216 (371)
                      ....++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.   .+||+
T Consensus        80 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~~~~kl~  154 (283)
T 3bhy_A           80 KTDVVLILELVSGGELFDFLAE----KESLTEDEATQFLKQILDGVHYLHSK-RIAHFDLKPENIMLLDKNVPNPRIKLI  154 (283)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSSSSCCEEEC
T ss_pred             CCeEEEEEeecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChHHEEEecCCCCCCceEEE
Confidence            445789999997 588777754    46799999999999999999999987 9999999999999986652   69999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |||++.............+++.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+.......+..
T Consensus       155 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~  233 (283)
T 3bhy_A          155 DFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEE  233 (283)
T ss_dssp             CCTTCEECC--------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHH
T ss_pred             ecccceeccCCCcccccCCCcCccCcceecCCC-CCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcch
Confidence            999998765555555667899999999986544 7999999999999999999999998877666555544321111111


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                               ....++..+.+||.+||..||.+|||+.++++|
T Consensus       234 -------------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          234 -------------------------YFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             -------------------------HHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             -------------------------hcccCCHHHHHHHHHHccCCHhHCcCHHHHHhC
Confidence                                     123578999999999999999999999998877

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.7e-47  Score=358.74  Aligned_cols=249  Identities=29%  Similarity=0.431  Sum_probs=191.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|++....            ....+|+.+++.++||||+++++++.   
T Consensus       134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~---  210 (419)
T 3i6u_A          134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD---  210 (419)
T ss_dssp             HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE---
T ss_pred             hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe---
Confidence            467999999999999999999999999999999986432            23568999999999999999999862   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVK  214 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~k  214 (371)
                        .. ..++||||+.+ +|.+.+.    ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..+|
T Consensus       211 --~~-~~~lv~e~~~~g~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~NIll~~~~~~~~~k  282 (419)
T 3i6u_A          211 --AE-DYYIVLELMEGGELFDKVV----GNKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  282 (419)
T ss_dssp             --SS-EEEEEEECCTTCBGGGGTS----SSCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSSSCCEE
T ss_pred             --cC-ceEEEEEcCCCCcHHHHHh----ccCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCCCcceEE
Confidence              12 25799999985 5544333    256799999999999999999999987 999999999999997544  2599


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH-hC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV-LG  291 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~-~~  291 (371)
                      |+|||+++............||+.|+|||++.+  ...++.++|||||||++|+|++|..||........+...... ..
T Consensus       283 l~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~  362 (419)
T 3i6u_A          283 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  362 (419)
T ss_dssp             ECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCC
T ss_pred             EeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCC
Confidence            999999988765555556789999999999853  344678999999999999999999999775543333322221 11


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....+                         .+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       363 ~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          363 NFIPE-------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             CCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCch-------------------------hhcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            11111                         123478999999999999999999999997665

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.4e-46  Score=343.52  Aligned_cols=251  Identities=24%  Similarity=0.344  Sum_probs=193.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC------
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD------  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~------  138 (371)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...     .....+|+.+++.++||||+++++++.....      
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            45799999999999999999999999999999998632     2445689999999999999999998865432      


Q ss_pred             ----------------------------------------------CCceeEEEeeccccc-hHHHHHHHhhhccCCCCH
Q 017452          139 ----------------------------------------------KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPM  171 (371)
Q Consensus       139 ----------------------------------------------~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  171 (371)
                                                                    ....+.++||||+.+ +|.+.+.... .....++
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~  163 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRC-SLEDREH  163 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCC-SGGGSCH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhccc-Cccchhh
Confidence                                                          223458899999986 7777766432 2344567


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC-------------Cccccccccc
Q 017452          172 IYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE-------------PNISYICSRY  238 (371)
Q Consensus       172 ~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~-------------~~~~~~~t~~  238 (371)
                      ..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++.......             ......||+.
T Consensus       164 ~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          164 GVCLHIFIQIAEAVEFLHSK-GLMHRDLKPSNIFFTMDD-VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHHhC-CeeecCCCcccEEEeCCC-CEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            77899999999999999987 999999999999999888 89999999998765432             2234568999


Q ss_pred             ccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCC
Q 017452          239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPW  318 (371)
Q Consensus       239 y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (371)
                      |+|||.+.+.. ++.++||||||+++|+|++|..|+..     ....+..........                      
T Consensus       242 y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~----------------------  293 (332)
T 3qd2_B          242 YMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPL----------------------  293 (332)
T ss_dssp             GSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCH----------------------
T ss_pred             ccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCc----------------------
Confidence            99999997654 79999999999999999998765421     111111111111000                      


Q ss_pred             cccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          319 HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       319 ~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                         .....++++.+||.+||+.||.+|||+.++++|
T Consensus       294 ---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~  326 (332)
T 3qd2_B          294 ---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIEN  326 (332)
T ss_dssp             ---HHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHS
T ss_pred             ---ccccCChhHHHHHHHHccCCCCcCCCHHHHhhc
Confidence               011246788999999999999999999995443

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=7.4e-47  Score=349.13  Aligned_cols=254  Identities=30%  Similarity=0.453  Sum_probs=201.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...         .....+|+.+++.++||||+++++++     ..
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~-----~~   99 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVY-----ED   99 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEE-----EC
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhh-----cc
Confidence            35799999999999999999999999999999998543         23456799999999999999999988     34


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhh------------------------------------ccCCCCHHHHHHHHHHHHH
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNK------------------------------------LNQRMPMIYVKLYAYQIFR  183 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~------------------------------------~~~~~~~~~~~~i~~qi~~  183 (371)
                      ....++||||++ ++|.+.+.....                                    ....+++..++.++.||+.
T Consensus       100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~  179 (345)
T 3hko_A          100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS  179 (345)
T ss_dssp             SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred             CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence            456899999997 577666532110                                    0123467889999999999


Q ss_pred             HHHHHHhcCCcEeeccCCCceeeeCCCC-cEEEEeeCCccccccCC-----CcccccccccccCcccccCC-cCCCCcch
Q 017452          184 ALSYIHRSIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKVLVKGE-----PNISYICSRYYRAPELIFGA-TEYTTAID  256 (371)
Q Consensus       184 ~l~~LH~~~~ivH~dlkp~NIli~~~~~-~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~-~~~~~~~D  256 (371)
                      ||+|||++ ||+||||||+||+++.++. .+||+|||++.......     ......||+.|+|||++.+. ..++.++|
T Consensus       180 ~l~~LH~~-~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~D  258 (345)
T 3hko_A          180 ALHYLHNQ-GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD  258 (345)
T ss_dssp             HHHHHHHT-TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHH
T ss_pred             HHHHHHHC-CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHH
Confidence            99999987 9999999999999986542 79999999998653321     12356789999999998642 45789999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHh
Q 017452          257 IWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSR  336 (371)
Q Consensus       257 iwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~  336 (371)
                      |||||+++|+|++|+.||.+.+..+....+.......+..                         ....+++++.+||.+
T Consensus       259 iwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~  313 (345)
T 3hko_A          259 AWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP-------------------------NYNVLSPLARDLLSN  313 (345)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSG-------------------------GGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCc-------------------------ccccCCHHHHHHHHH
Confidence            9999999999999999999888777766665532111110                         112368999999999


Q ss_pred             ccCcCCCCCCCHHHHhhh
Q 017452          337 LLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       337 ~l~~dP~~R~t~~~~l~~  354 (371)
                      ||+.||.+|||+.++++|
T Consensus       314 ~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          314 LLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HSCSCTTTSCCHHHHHHS
T ss_pred             HcCCChhHCCCHHHHhcC
Confidence            999999999999998887

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.1e-45  Score=333.16  Aligned_cols=247  Identities=22%  Similarity=0.313  Sum_probs=200.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ..|++.+.||+|+||.||+|.+..++..||+|++....      ....+|+.+++.++||||+++++++.... .+..++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecccc-CCCceE
Confidence            36999999999999999999999999999999986432      33567999999999999999999876543 345668


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeee-CCCCcEEEEeeCC
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVN-PHTHQVKLCDFGS  220 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~-~~~~~~kl~Dfg~  220 (371)
                      ++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ |  |+||||||+||+++ .++ .+||+|||+
T Consensus       105 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~~-~~kl~Dfg~  178 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTG-SVKIGDLGL  178 (290)
T ss_dssp             EEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTS-CEEECCTTG
T ss_pred             EEEEEecCCCCHHHHHHH----ccCCCHHHHHHHHHHHHHHHHHHHcC-CCCEEECCCCHHHEEEECCCC-CEEEeeCCC
Confidence            999999975 88877764    46789999999999999999999986 8  99999999999998 455 899999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +...... ......||+.|+|||.+.+  .++.++||||||+++|+|++|..||................. .       
T Consensus       179 ~~~~~~~-~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~-~-------  247 (290)
T 1t4h_A          179 ATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGV-K-------  247 (290)
T ss_dssp             GGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTC-C-------
T ss_pred             ccccccc-ccccccCCcCcCCHHHHhc--cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccC-C-------
Confidence            9754332 3345678999999998853  379999999999999999999999987665554433322100 0       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                                        ...++...++++.+||.+||+.||.+|||+.++++
T Consensus       248 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          248 ------------------PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------------------CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------------ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                              00123456789999999999999999999999443

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=5.2e-46  Score=340.15  Aligned_cols=245  Identities=28%  Similarity=0.422  Sum_probs=202.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..|...+.||+|+||.||+|.+..+|+.||||++...    .....+|+.+++.++||||+++++++...     ...++
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-----~~~~l  119 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVG-----EELWV  119 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEET-----TEEEE
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-----CEEEE
Confidence            3588889999999999999999999999999998643    23456899999999999999999988543     34789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+++.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       120 v~e~~~~~~L~~~l~-----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Dfg~~~~~~  192 (321)
T 2c30_A          120 LMEFLQGGALTDIVS-----QVRLNEEQIATVCEAVLQALAYLHAQ-GVIHRDIKSDSILLTLDG-RVKLSDFGFCAQIS  192 (321)
T ss_dssp             EECCCCSCBHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEecCCCCCHHHHHH-----hcCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEECCCC-cEEEeeeeeeeecc
Confidence            9999985 6666554     35799999999999999999999987 999999999999999888 89999999987654


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+.+..+..... +..         
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~-~~~---------  261 (321)
T 2c30_A          193 KDVPKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPP-PKL---------  261 (321)
T ss_dssp             SSSCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCC---------
T ss_pred             cCccccccccCCccccCHhhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCC-CCc---------
Confidence            432 234567899999999996544 78999999999999999999999988776665554433210 000         


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ..+..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       262 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          262 ----------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             ----------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ----------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                            0123478899999999999999999999999888

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-46  Score=343.08  Aligned_cols=245  Identities=29%  Similarity=0.419  Sum_probs=206.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+|.+.+.||+|+||.||++.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     ..
T Consensus        39 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~-----~~  113 (335)
T 2owb_A           39 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----DN  113 (335)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CS
T ss_pred             cCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----cC
Confidence            345799999999999999999999999999999998643       234567999999999999999999883     34


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+. ++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       114 ~~~~lv~e~~~~~~L~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~  187 (335)
T 2owb_A          114 DFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFGL  187 (335)
T ss_dssp             SEEEEEECCCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCCHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCEecCCCchhEEEcCCC-CEEEeeccC
Confidence            56899999998 477766654    46799999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      +...... .......||+.|+|||++.+.. ++.++||||||+++|+|++|+.||......+....+....         
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~---------  257 (335)
T 2owb_A          188 ATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE---------  257 (335)
T ss_dssp             CEECCSTTCCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC---------
T ss_pred             ceecccCcccccccCCCccccCHHHhccCC-CCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCC---------
Confidence            9876432 2334567899999999997654 7899999999999999999999998877655554443310         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                          ..++..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       258 --------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          258 --------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             --------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                01345678999999999999999999999998888

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2.4e-46  Score=373.34  Aligned_cols=245  Identities=25%  Similarity=0.410  Sum_probs=207.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|++.+.||+|+||.||+|.+..+++.||||++.+.       ......|..++..+ .||+|+++++++     ..
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~-----~~  413 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCF-----QT  413 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEEC-----BC
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEE-----Ee
Confidence            446899999999999999999999999999999998653       23345678888877 799999998888     44


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+|+||||++| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       414 ~~~~~lV~E~~~gg~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-gIiHrDLKp~NILl~~~g-~ikL~DFG  487 (674)
T 3pfq_A          414 MDRLYFVMEYVNGGDLMYHIQQ----VGRFKEPHAVFYAAEIAIGLFFLQSK-GIIYRDLKLDNVMLDSEG-HIKIADFG  487 (674)
T ss_dssp             SSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-SEECCCCCSTTEEECSSS-CEEECCCT
T ss_pred             CCEEEEEEeCcCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeEeccCChhhEEEcCCC-cEEEeecc
Confidence            5568999999985 77777664    46799999999999999999999987 999999999999999998 89999999


Q ss_pred             Cccccc-cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLV-KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +++... .........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+.+..+....        
T Consensus       488 la~~~~~~~~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~--------  558 (674)
T 3pfq_A          488 MCKENIWDGVTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHN--------  558 (674)
T ss_dssp             TCEECCCTTCCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSC--------
T ss_pred             eeeccccCCcccccccCCCcccCHhhhcCCC-CCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCC--------
Confidence            998643 333445678999999999996554 7999999999999999999999999887777666664310        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCH-----HHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA-----VSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~-----~~~l~~  354 (371)
                                           ..++..+++++.+||.+||+.||.+||++     .++++|
T Consensus       559 ---------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          559 ---------------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             ---------------------CCCCccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcC
Confidence                                 11556789999999999999999999997     887777

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=1.2e-46  Score=342.91  Aligned_cols=253  Identities=26%  Similarity=0.373  Sum_probs=201.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....       ....+|+.+++.++||||+++++++.... ...
T Consensus        10 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~   88 (311)
T 3ork_A           10 LSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   88 (311)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEE-TTE
T ss_pred             ecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccC-CCC
Confidence            3467999999999999999999999999999999986532       23457888899999999999999876544 233


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~lv~e~~~g~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~  162 (311)
T 3ork_A           89 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  162 (311)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEETTS-CEEECCCSC
T ss_pred             cccEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCCcCCCCHHHEEEcCCC-CEEEeeccC
Confidence            45689999997 588777764    46799999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +........    .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.+....+....+......++..
T Consensus       163 a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~  241 (311)
T 3ork_A          163 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA  241 (311)
T ss_dssp             C------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHH
T ss_pred             cccccccccccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCccc
Confidence            976543322    22356899999999997654 7999999999999999999999998877766655554422111111


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                               ....++.++.+||.+||+.||.+||++.+++.+
T Consensus       242 -------------------------~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~  274 (311)
T 3ork_A          242 -------------------------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRA  274 (311)
T ss_dssp             -------------------------HSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             -------------------------ccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHH
Confidence                                     224579999999999999999999998888877

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=341.29  Aligned_cols=255  Identities=24%  Similarity=0.415  Sum_probs=204.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...    ...+.+|+++++.++||||+++++++..     ....+
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-----~~~~~   83 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYK-----DKRLN   83 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEec-----CCeeE
Confidence            45799999999999999999999999999999988542    3445689999999999999999999854     34478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  158 (310)
T 3s95_A           84 FITEYIKGGTLRGIIKSM---DSQYPWSQRVSFAKDIASGMAYLHSM-NIIHRDLNSHNCLVRENK-NVVVADFGLARLM  158 (310)
T ss_dssp             EEEECCTTCBHHHHHHHC---CTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCcCeEEECCCC-CEEEeecccceec
Confidence            99999985 877777642   46799999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCCCc---------------ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017452          225 VKGEPN---------------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       225 ~~~~~~---------------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  289 (371)
                      ......               ....||+.|+|||++.+.. ++.++||||||+++|+|++|..||..........     
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~-----  232 (310)
T 3s95_A          159 VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDF-----  232 (310)
T ss_dssp             C--------------------CCCCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTS-----
T ss_pred             ccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHH-----
Confidence            433221               1457899999999996644 8999999999999999999999986533211000     


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                           ............+..+++.+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       233 ---------------------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~  283 (310)
T 3s95_A          233 ---------------------GLNVRGFLDRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMH  283 (310)
T ss_dssp             ---------------------SBCHHHHHHHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------------hhhhhccccccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence                                 000000001113566889999999999999999999999999998877554

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=6.8e-46  Score=333.48  Aligned_cols=245  Identities=27%  Similarity=0.441  Sum_probs=205.8

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..++..||+|++...       .....+|+++++.++||||+++++++.     .
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~   85 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFH-----D   85 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEE-----c
Confidence            3456899999999999999999999999999999998543       234568999999999999999999883     3


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ....++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg  159 (284)
T 2vgo_A           86 RKRIYLMLEFAPRGELYKELQK----HGRFDEQRSATFMEELADALHYCHER-KVIHRDIKPENLLMGYKG-ELKIADFG  159 (284)
T ss_dssp             SSEEEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEEeCCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCHHHEEEcCCC-CEEEeccc
Confidence            4458899999974 88777764    35789999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++...... ......|++.|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+....+...          
T Consensus       160 ~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~----------  227 (284)
T 2vgo_A          160 WSVHAPSL-RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV----------  227 (284)
T ss_dssp             TCEECSSS-CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT----------
T ss_pred             ccccCccc-ccccccCCCCcCCHHHhccCC-CCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhcc----------
Confidence            98765332 233567899999999986654 789999999999999999999999887765554444321          


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ...++..++.++.++|.+||+.||.+|||+.++++|
T Consensus       228 -------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          228 -------------------DLKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             -------------------CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTC
T ss_pred             -------------------ccCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhC
Confidence                               001445689999999999999999999999998887

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=5.2e-46  Score=335.92  Aligned_cols=246  Identities=28%  Similarity=0.421  Sum_probs=205.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|.+.+.||+|+||.||+|.+..+++.||+|++...       .....+|+.+++.++||||+++++++.     .
T Consensus        12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~   86 (294)
T 2rku_A           12 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFE-----D   86 (294)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-----C
T ss_pred             CcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeec-----c
Confidence            3446899999999999999999999999999999998643       234457999999999999999999883     3


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ....++||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        87 ~~~~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg  160 (294)
T 2rku_A           87 NDFVFVVLELCRRRSLLELHKR----RKALTEPEARYYLRQIVLGCQYLHRN-RVIHRDLKLGNLFLNEDL-EVKIGDFG  160 (294)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCT
T ss_pred             CCEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEcCCC-CEEEEecc
Confidence            455889999998 477666554    46799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          220 SAKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       220 ~a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ++...... .......+|+.|+|||.+.+.. ++.++|+||||+++|+|++|..||......+....+....        
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~--------  231 (294)
T 2rku_A          161 LATKVEYDGERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNE--------  231 (294)
T ss_dssp             TCEECCSTTCCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC--------
T ss_pred             CceecccCccccccccCCCCcCCcchhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhcc--------
Confidence            99875432 2334467899999999986544 7899999999999999999999998876655444332210        


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ..++..+++.+.++|.+||+.||.+|||+.++++|
T Consensus       232 ---------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  266 (294)
T 2rku_A          232 ---------------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLND  266 (294)
T ss_dssp             ---------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             ---------------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence                                 01345678999999999999999999999999888

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.8e-46  Score=336.12  Aligned_cols=246  Identities=28%  Similarity=0.465  Sum_probs=181.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++....       ....+|+.+++.++||||+++++++     ...
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   83 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYF-----EDS   83 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEE-----ECS
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEE-----ccC
Confidence            3457999999999999999999999999999999986432       3456899999999999999999988     334


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        84 ~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~  158 (278)
T 3cok_A           84 NYVYLVLEMCHNGEMNRYLKN---RVKPFSENEARHFMHQIITGMLYLHSH-GILHRDLTLSNLLLTRNM-NIKIADFGL  158 (278)
T ss_dssp             SEEEEEEECCTTEEHHHHHHT---CSSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSSCCGGGEEECTTC-CEEECCCTT
T ss_pred             CeEEEEEecCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHEEEcCCC-CEEEEeecc
Confidence            568899999974 77766653   236789999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          221 AKVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       221 a~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      +...... .......+|+.|+|||.+.+.. ++.++|+||||+++|+|++|+.||......+....+.            
T Consensus       159 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~------------  225 (278)
T 3cok_A          159 ATQLKMPHEKHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVV------------  225 (278)
T ss_dssp             CEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CC------------
T ss_pred             eeeccCCCCcceeccCCCCcCCcchhcCCC-CCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHh------------
Confidence            9865432 2233467899999999986544 7899999999999999999999997655433221110            


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                .     .  ....+..++.++.+||.+||+.||.+|||+.++++|
T Consensus       226 ----------~-----~--~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          226 ----------L-----A--DYEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             ----------S-----S--CCCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ----------h-----c--ccCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcC
Confidence                      0     0  011345689999999999999999999999997776

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.9e-46  Score=343.68  Aligned_cols=253  Identities=21%  Similarity=0.291  Sum_probs=205.4

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...++|++.+.||+|+||.||+|.+..++.   .||||++...     ...+.+|+.+++.++||||+++++++     .
T Consensus        46 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  120 (325)
T 3kul_A           46 IEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV-----T  120 (325)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C
T ss_pred             cChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            345689999999999999999999986554   4999998653     23456799999999999999999988     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .....++||||+++ +|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Df  195 (325)
T 3kul_A          121 RGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGMRYLSDL-GYVHRDLAARNVLVDSNL-VCKVSDF  195 (325)
T ss_dssp             GGGCCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCC
T ss_pred             eCCccEEEeeCCCCCcHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEECCCC-CEEECCC
Confidence            44457899999975 87777653   245799999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          219 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       219 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      |++.........    ....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+...... 
T Consensus       196 g~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~-  273 (325)
T 3kul_A          196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRL-  273 (325)
T ss_dssp             SSCEECC----CCEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-
T ss_pred             CcccccccCccceeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCC-
Confidence            999876443221    2234577899999996554 7899999999999999998 99999887776665554432110 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                                 ..+..+++.+.+||.+||..||.+|||+.++++.|+.+.
T Consensus       274 ---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~  312 (325)
T 3kul_A          274 ---------------------------PAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI  312 (325)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                       134568999999999999999999999999999987753

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4e-46  Score=349.68  Aligned_cols=244  Identities=23%  Similarity=0.329  Sum_probs=194.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcC--CCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||.||+|.+.. ++.||||++....      ....+|+.+++.++  ||||+++++++.     ...
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~-----~~~  129 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  129 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CSS
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEe-----cCC
Confidence            469999999999999999999754 8999999986432      34568999999997  599999999874     334


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ++++|||+.+++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||+++
T Consensus       130 ~~~lv~E~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~lH~~-~ivHrDlkp~NIll~-~~-~~kl~DFG~a~  202 (390)
T 2zmd_A          130 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIAN  202 (390)
T ss_dssp             EEEEEEECCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCCGGGEEES-SS-CEEECCCSSSC
T ss_pred             EEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCHHHEEEE-CC-eEEEEecCccc
Confidence            5899999888888888765    45789999999999999999999987 999999999999996 45 79999999998


Q ss_pred             ccccCCC---cccccccccccCcccccCC----------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHH
Q 017452          223 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIK  288 (371)
Q Consensus       223 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~  288 (371)
                      .......   .....||+.|+|||++.+.          ..++.++|||||||++|+|++|+.||...... ..+..+..
T Consensus       203 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~  282 (390)
T 2zmd_A          203 QMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  282 (390)
T ss_dssp             CC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHC
T ss_pred             cccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhC
Confidence            7643322   2356789999999998641          24788999999999999999999999765432 22222221


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                         ..                        ....++...+.++.+||.+||..||.+|||+.++++|
T Consensus       283 ---~~------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          283 ---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             ---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---cc------------------------ccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence               00                        0011344568899999999999999999999999988

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=9.1e-46  Score=346.68  Aligned_cols=272  Identities=31%  Similarity=0.534  Sum_probs=211.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcC-CC-----CeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-HP-----NVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-h~-----niv~~~~~~~~~~~~~  140 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.++ |+     +|+++++++..     
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~-----  127 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMF-----  127 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEE-----
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeecc-----
Confidence            468999999999999999999999999999999997543   33456888888875 55     48888887744     


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCCceeeeC--CCCcEEEEe
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQNLLVNP--HTHQVKLCD  217 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~NIli~~--~~~~~kl~D  217 (371)
                      ....++||||++++|.+.+....  ...+++..++.++.||+.||.|||. ..||+||||||+|||++.  ++ .+||+|
T Consensus       128 ~~~~~lv~e~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~-~~kL~D  204 (382)
T 2vx3_A          128 RNHLCLVFEMLSYNLYDLLRNTN--FRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRS-AIKIVD  204 (382)
T ss_dssp             TTEEEEEEECCCCBHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSC-CEEECC
T ss_pred             CCceEEEEecCCCCHHHHHhhcC--cCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCC-cEEEEe
Confidence            34588999999999988887532  3568999999999999999999994 249999999999999954  44 799999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ||++.....  ......+|+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+....+.++...
T Consensus       205 FG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~  281 (382)
T 2vx3_A          205 FGSSCQLGQ--RIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHI  281 (382)
T ss_dssp             CTTCEETTC--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHH
T ss_pred             ccCceeccc--ccccccCCccccChHHHcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHH
Confidence            999987633  334567899999999997654 89999999999999999999999999999999999999988888766


Q ss_pred             HhhcCCCccccccCcccCCCCcc--------------------cCCC-----------------CCChhHHHHHHhccCc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHK--------------------IFPK-----------------RMPPEAVDLVSRLLQY  340 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~--------------------~~~~-----------------~~s~~l~~li~~~l~~  340 (371)
                      +..... ...+ +..+....|..                    .+..                 ..++++.+||.+||++
T Consensus       282 ~~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  359 (382)
T 2vx3_A          282 LDQAPK-ARKF-FEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDY  359 (382)
T ss_dssp             HTTCTT-HHHH-EEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCS
T ss_pred             HHhhHH-HHHH-HHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCC
Confidence            542211 0000 00001111100                    0000                 0013789999999999


Q ss_pred             CCCCCCCHHHHhhh
Q 017452          341 SPNLRCTAVSKRIL  354 (371)
Q Consensus       341 dP~~R~t~~~~l~~  354 (371)
                      ||.+|||+.++|+|
T Consensus       360 dP~~Rpta~e~L~h  373 (382)
T 2vx3_A          360 DPKTRIQPYYALQH  373 (382)
T ss_dssp             CTTTSCCHHHHTTS
T ss_pred             ChhhCCCHHHHhcC
Confidence            99999999995544

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.4e-46  Score=335.37  Aligned_cols=253  Identities=19%  Similarity=0.299  Sum_probs=207.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.++++++||||+++++++     ......+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   81 (269)
T 4hcu_A            8 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC-----LEQAPIC   81 (269)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             ChhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEE-----ecCCceE
Confidence            3457999999999999999999976 5778999998653   34567899999999999999999988     3344478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+.+..   ....+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        82 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  156 (269)
T 4hcu_A           82 LVFEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFV  156 (269)
T ss_dssp             EEEECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECGGG-CEEECCTTGGGGB
T ss_pred             EEEEeCCCCcHHHHHHh---cCcccCHHHHHHHHHHHHHHHHHHHhC-CeecCCcchheEEEcCCC-CEEeccccccccc
Confidence            99999985 77776653   245689999999999999999999987 999999999999999887 8999999999765


Q ss_pred             ccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....  ......+++.|+|||.+.+.. ++.++|+||||+++|+|++ |..||......+....+....           
T Consensus       157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~-----------  224 (269)
T 4hcu_A          157 LDDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF-----------  224 (269)
T ss_dssp             CCHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-----------
T ss_pred             cccccccccCcccccccCCHHHhcCCC-CCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCc-----------
Confidence            3321  222345677899999986544 7999999999999999999 999998877666555543321           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                       ....+..+++++.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       225 -----------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~~  267 (269)
T 4hcu_A          225 -----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAES  267 (269)
T ss_dssp             -----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             -----------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHHc
Confidence                             0113455789999999999999999999999999999876543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=4.6e-46  Score=333.60  Aligned_cols=258  Identities=26%  Similarity=0.352  Sum_probs=211.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...++|++.+.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.++||||+++++++...   ..
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~---~~   79 (279)
T 2w5a_A            3 SRAEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDR---TN   79 (279)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEG---GG
T ss_pred             CchhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecC---CC
Confidence            3456899999999999999999999999999999998643      23456799999999999999999987543   23


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cEeeccCCCceeeeCCCCcEEE
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-----VCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      ...++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ |     |+||||||+||+++.++ .+||
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~~~~~~ivH~dl~p~NIl~~~~~-~~kl  157 (279)
T 2w5a_A           80 TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKL  157 (279)
T ss_dssp             TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH-C------CCCCCSGGGEEECSSS-CEEE
T ss_pred             ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc-cCCCCeeEEeccchhhEEEcCCC-CEEE
Confidence            457899999974 88888877655556799999999999999999999987 8     99999999999999888 8999


Q ss_pred             EeeCCccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          216 CDFGSAKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      +|||++........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+..+....+.....   
T Consensus       158 ~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~---  233 (279)
T 2w5a_A          158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---  233 (279)
T ss_dssp             CCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCC---
T ss_pred             ecCchheeeccccccccccCCCccccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccc---
Confidence            99999876543322 22456899999999997654 78999999999999999999999988776555444433210   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                               ..++..++.++.++|.+||+.||.+|||+.++++|+....
T Consensus       234 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~  273 (279)
T 2w5a_A          234 -------------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENPLILE  273 (279)
T ss_dssp             -------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCG
T ss_pred             -------------------------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhh
Confidence                                     0134568999999999999999999999999999876543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6.2e-46  Score=337.08  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=204.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++.     .....+
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~   82 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE-----STTHYY   82 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE-----CSSEEE
T ss_pred             hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc-----cCCEEE
Confidence            35799999999999999999999999999999998653    234568999999999999999999883     344588


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee---eCCCCcEEEEeeCCc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli---~~~~~~~kl~Dfg~a  221 (371)
                      +||||++ ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||++   +.++ .++|+|||++
T Consensus        83 lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dikp~NIl~~~~~~~~-~~kl~Dfg~~  156 (304)
T 2jam_A           83 LVMQLVSGGELFDRILE----RGVYTEKDASLVIQQVLSAVKYLHEN-GIVHRDLKPENLLYLTPEENS-KIMITDFGLS  156 (304)
T ss_dssp             EEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCSCCGGGCEESSSSTTC-CEEBCSCSTT
T ss_pred             EEEEcCCCccHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCCHHHEEEecCCCCC-CEEEccCCcc
Confidence            9999997 477777654    45789999999999999999999987 99999999999999   5555 8999999998


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...... ......||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+.......        
T Consensus       157 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~--------  226 (304)
T 2jam_A          157 KMEQNG-IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEF--------  226 (304)
T ss_dssp             CCCCCB-TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCC--------
T ss_pred             eecCCC-ccccccCCCCccChHHhccCC-CCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            764332 233456899999999986544 7899999999999999999999998877666655554421110        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       ...++..+++++.+||.+||..||.+|||+.++++|
T Consensus       227 -----------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h  262 (304)
T 2jam_A          227 -----------------ESPFWDDISESAKDFICHLLEKDPNERYTCEKALSH  262 (304)
T ss_dssp             -----------------CTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             -----------------CccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                             111335689999999999999999999999999988

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-46  Score=344.18  Aligned_cols=253  Identities=19%  Similarity=0.223  Sum_probs=205.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...  .....+|+.+++.+ +||||+++++++..     ..+.++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~-----~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC-----GKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEE-----TTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEec-----CCccEE
Confidence            35799999999999999999999999999999998643  34567899999999 99999999998744     345789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc-----EEEEeeCCc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-----VKLCDFGSA  221 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~-----~kl~Dfg~a  221 (371)
                      ||||++++|.+++...   ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .     +||+|||++
T Consensus        83 v~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~iiHrDlkp~Nill~~~~-~~~~~~~kl~DFg~a  157 (330)
T 2izr_A           83 VLELLGPSLEDLFDLC---DRTFSLKTVLMIAIQLISRMEYVHSK-NLIYRDVKPENFLIGRPG-NKTQQVIHIIDFALA  157 (330)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGG-GTCTTSEEECCCTTC
T ss_pred             EEEeCCCCHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCCHHHeeeccCC-CCCCceEEEEEcccc
Confidence            9999988888888753   46899999999999999999999987 999999999999998776 5     999999999


Q ss_pred             cccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHh
Q 017452          222 KVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVL  290 (371)
Q Consensus       222 ~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~~~~~  290 (371)
                      ........        .....||+.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+..+   .+..+....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~  236 (330)
T 2izr_A          158 KEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTK  236 (330)
T ss_dssp             EESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHH
T ss_pred             eeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhh
Confidence            87544322        23567899999999997654 7999999999999999999999998754332   233332221


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ...+.+.                        ....++ ++.+++..||+.||.+||++.++++.|..+
T Consensus       237 ~~~~~~~------------------------~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~  279 (330)
T 2izr_A          237 RATPIEV------------------------LCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDL  279 (330)
T ss_dssp             HHSCHHH------------------------HTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             ccCCHHH------------------------HhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHH
Confidence            1111111                        112234 999999999999999999999999987754

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.9e-46  Score=339.16  Aligned_cols=249  Identities=27%  Similarity=0.405  Sum_probs=204.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...        .....+|+.+++.++||||+++++++..   ...
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---~~~   80 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYN---EEK   80 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEC---C--
T ss_pred             ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEc---CCC
Confidence            46799999999999999999999999999999998643        2445689999999999999999998753   233


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ...++||||+.+++.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        81 ~~~~lv~e~~~~~l~~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~-~i~H~dlkp~NIl~~~~~-~~kl~dfg~~  156 (305)
T 2wtk_C           81 QKMYMVMEYCVCGMQEMLDSVP--EKRFPVCQAHGYFCQLIDGLEYLHSQ-GIVHKDIKPGNLLLTTGG-TLKISALGVA  156 (305)
T ss_dssp             -CEEEEEECCSEEHHHHHHHST--TCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTC
T ss_pred             CeEEEEehhccCCHHHHHHhCc--ccccCHHHHHHHHHHHHHHHHHHHHC-CeeecCCCcccEEEcCCC-cEEeeccccc
Confidence            4578999999988877776532  46799999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCC---CcccccccccccCcccccCCc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGE---PNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......   ......||+.|+|||++.+.. ..+.++||||||+++|+|++|..||.+.+..+....+.+..       
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~-------  229 (305)
T 2wtk_C          157 EALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGS-------  229 (305)
T ss_dssp             EECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCC-------
T ss_pred             cccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCC-------
Confidence            7654322   223456899999999986533 24679999999999999999999998876655554443310       


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                            ..++..+++.+.+||.+||..||.+|||+.++++|
T Consensus       230 ----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          230 ----------------------YAIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             ----------------------CCCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ----------------------CCCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                                  01345688999999999999999999999999988

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.4e-46  Score=335.72  Aligned_cols=257  Identities=20%  Similarity=0.239  Sum_probs=208.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...  .....+|+.+++.+ .|+|++++++++.     .....++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecC-----CCceeEE
Confidence            35799999999999999999999999999999988543  35567899999999 7999999998873     3345789


Q ss_pred             eeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC----cEEEEeeCCcc
Q 017452          147 VLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH----QVKLCDFGSAK  222 (371)
Q Consensus       147 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~----~~kl~Dfg~a~  222 (371)
                      ||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.    .+||+|||++.
T Consensus        84 v~e~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEecCCCHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            9999988998888653   35699999999999999999999987 9999999999999987651    39999999998


Q ss_pred             ccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhC
Q 017452          223 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLG  291 (371)
Q Consensus       223 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~  291 (371)
                      .......        .....||+.|+|||++.+.. ++.++||||||+++|+|++|+.||.....   ...+..+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  238 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ  238 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCC-CChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhcc
Confidence            7654322        23456899999999986654 79999999999999999999999987432   333333333221


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      .++...                        +...+++++.+++.+||+.||.+|||+.++++.|..+..
T Consensus       239 ~~~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~  283 (298)
T 1csn_A          239 STPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLE  283 (298)
T ss_dssp             HSCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHH
T ss_pred             CccHHH------------------------HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHH
Confidence            121111                        223578999999999999999999999999999887643

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=7.8e-46  Score=342.16  Aligned_cols=245  Identities=24%  Similarity=0.336  Sum_probs=194.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCC--CCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~  141 (371)
                      ..+|++.+.||+|+||.||+|.+ .+++.||||++....      ....+|+.+++.++|  +||+++++++.     ..
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~   81 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLN-EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TD   81 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEEC-TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEE-----CS
T ss_pred             cCEEEEEEEEecCCCeEEEEEEe-CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEe-----eC
Confidence            34799999999999999999987 568999999986432      345679999999987  99999999883     44


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .++++|||+.+++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++ ++ .+||+|||++
T Consensus        82 ~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~al~~lH~~-~iiHrDikp~NIll~-~~-~~kl~DFG~a  154 (343)
T 3dbq_A           82 QYIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIV-DG-MLKLIDFGIA  154 (343)
T ss_dssp             SEEEEEECCCSEEHHHHHHH----SCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEE-TT-EEEECCCSSS
T ss_pred             CEEEEEEeCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCcceEEEE-CC-cEEEeecccc
Confidence            56899999888998888875    56799999999999999999999987 999999999999997 45 7999999999


Q ss_pred             cccccCCC---cccccccccccCcccccC----------CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHH
Q 017452          222 KVLVKGEP---NISYICSRYYRAPELIFG----------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEII  287 (371)
Q Consensus       222 ~~~~~~~~---~~~~~~t~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~  287 (371)
                      ........   .....||+.|+|||++.+          ...++.++|||||||++|+|++|+.||...... ..+..+.
T Consensus       155 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  234 (343)
T 3dbq_A          155 NQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAII  234 (343)
T ss_dssp             CCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHH
T ss_pred             cccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHh
Confidence            87644322   235678999999999853          244788999999999999999999999764432 2222211


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .   .                        .....++...+.++.+||.+||+.||.+|||+.++++|
T Consensus       235 ~---~------------------------~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          235 D---P------------------------NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             C---T------------------------TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             c---C------------------------CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            1   0                        01111455568899999999999999999999999988

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-46  Score=342.64  Aligned_cols=250  Identities=24%  Similarity=0.344  Sum_probs=200.8

Q ss_pred             ccceeee-EeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCc
Q 017452           70 TISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|.+. +.||+|+||.||+|.+..+|+.||+|++...      .....+|+.+++.+. ||||+++++++     ...
T Consensus        27 ~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~-----~~~  101 (327)
T 3lm5_A           27 NNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVY-----ENT  101 (327)
T ss_dssp             HHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEE-----ECS
T ss_pred             hhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEE-----EeC
Confidence            3568887 8999999999999999999999999998643      245568999999995 69999999988     344


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEe
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCD  217 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~D  217 (371)
                      ...++||||+.+ +|.+.+..  .....+++..++.++.||+.||+|||++ ||+||||||+||+++.   ++ .+||+|
T Consensus       102 ~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~i~~ql~~~L~~LH~~-givH~Dikp~NIl~~~~~~~~-~~kL~D  177 (327)
T 3lm5_A          102 SEIILILEYAAGGEIFSLCLP--ELAEMVSENDVIRLIKQILEGVYYLHQN-NIVHLDLKPQNILLSSIYPLG-DIKIVD  177 (327)
T ss_dssp             SEEEEEEECCTTEEGGGGGSS--CC-CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEESCBTTBC-CEEECC
T ss_pred             CeEEEEEEecCCCcHHHHHHH--hcccCCCHHHHHHHHHHHHHHHHHHHHC-CeecCcCChHHEEEecCCCCC-cEEEee
Confidence            558899999986 55554422  2246799999999999999999999987 9999999999999987   45 899999


Q ss_pred             eCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          218 FGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       218 fg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ||++.............||+.|+|||++.+.. ++.++||||||+++|+|++|+.||...+..+....+.......+.  
T Consensus       178 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~--  254 (327)
T 3lm5_A          178 FGMSRKIGHACELREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSE--  254 (327)
T ss_dssp             GGGCEEC---------CCCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT--
T ss_pred             CccccccCCccccccccCCcCccCCeeecCCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCc--
Confidence            99998776555555678999999999996554 899999999999999999999999988877766665553222111  


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       255 -----------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          255 -----------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             -----------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             -----------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCC
Confidence                                   1234578999999999999999999999998887

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-46  Score=339.20  Aligned_cols=251  Identities=25%  Similarity=0.346  Sum_probs=193.8

Q ss_pred             cccceeee-EeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++. +.||+|+||.||+|.+..+++.||||++...    .....+|+.+++++ +||||+++++++..     ..
T Consensus        10 ~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~-----~~   84 (316)
T 2ac3_A           10 FEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEE-----ED   84 (316)
T ss_dssp             TTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TT
T ss_pred             cceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEee-----CC
Confidence            34579985 7899999999999999999999999998653    34456899999885 79999999998844     34


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC--cEEEEeeC
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~--~~kl~Dfg  219 (371)
                      ..++||||+. ++|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++.  .+||+|||
T Consensus        85 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg  159 (316)
T 2ac3_A           85 RFYLVFEKMRGGSILSHIHK----RRHFNELEASVVVQDVASALDFLHNK-GIAHRDLKPENILCEHPNQVSPVKICDFD  159 (316)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEESCSSSSCSEEECCTT
T ss_pred             EEEEEEEcCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CceeCCCCHHHEEEccCCCcCceEEEEcc
Confidence            5889999998 588777765    46789999999999999999999987 9999999999999987662  39999999


Q ss_pred             CccccccCC--------CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH------
Q 017452          220 SAKVLVKGE--------PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD------  281 (371)
Q Consensus       220 ~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~------  281 (371)
                      ++.......        ......||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+....+      
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~  239 (316)
T 2ac3_A          160 LGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRG  239 (316)
T ss_dssp             CCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC---
T ss_pred             CccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccccccccccc
Confidence            987643211        1223458999999999853    1236889999999999999999999997754311      


Q ss_pred             ---------HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          282 ---------QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       282 ---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                               ....+.......+..                         ....++.++.+||.+||+.||.+|||+.+++
T Consensus       240 ~~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l  294 (316)
T 2ac3_A          240 EACPACQNMLFESIQEGKYEFPDK-------------------------DWAHISCAAKDLISKLLVRDAKQRLSAAQVL  294 (316)
T ss_dssp             -CCHHHHHHHHHHHHHCCCCCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             ccchhHHHHHHHHHhccCcccCch-------------------------hcccCCHHHHHHHHHHhhCChhhCCCHHHHh
Confidence                     112222111001100                         1134789999999999999999999999988


Q ss_pred             hh
Q 017452          353 IL  354 (371)
Q Consensus       353 ~~  354 (371)
                      +|
T Consensus       295 ~h  296 (316)
T 2ac3_A          295 QH  296 (316)
T ss_dssp             HS
T ss_pred             cC
Confidence            87

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=5.7e-46  Score=334.07  Aligned_cols=247  Identities=20%  Similarity=0.250  Sum_probs=199.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+..+..+ +||||+++++++..     
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~-----   82 (289)
T 1x8b_A            8 RYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAE-----   82 (289)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEE-----
T ss_pred             cccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeec-----
Confidence            3456899999999999999999999999999999998643      23345688888888 99999999998843     


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC---------
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT---------  210 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~---------  210 (371)
                      ....++||||+++ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++         
T Consensus        83 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~~~~~~~~~~  161 (289)
T 1x8b_A           83 DDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM-SLVHMDIKPSNIFISRTSIPNAASEEG  161 (289)
T ss_dssp             TTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC------------
T ss_pred             CCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC-CEeecCCCHHHEEEcCCCCCccccccc
Confidence            3357899999975 99988887655567899999999999999999999987 999999999999998432         


Q ss_pred             ---------CcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH
Q 017452          211 ---------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD  281 (371)
Q Consensus       211 ---------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~  281 (371)
                               ..+||+|||.+......   ....||+.|+|||.+.+...++.++||||||+++|+|++|.+|+.....  
T Consensus       162 ~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~--  236 (289)
T 1x8b_A          162 DEDDWASNKVMFKIGDLGHVTRISSP---QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--  236 (289)
T ss_dssp             --------CCCEEECCCTTCEETTCS---CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHH--
T ss_pred             ccccccCCceEEEEcccccccccCCc---cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhH--
Confidence                     26999999999876432   2346899999999997665567899999999999999999987754422  


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                       ...+...                   .         ...++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       237 -~~~~~~~-------------------~---------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          237 -WHEIRQG-------------------R---------LPRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             -HHHHHTT-------------------C---------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             -HHHHHcC-------------------C---------CCCCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence             2222110                   0         011455689999999999999999999999996554

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-45  Score=332.44  Aligned_cols=252  Identities=21%  Similarity=0.316  Sum_probs=202.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----------hhhHHHHHHHHHcCCCCeeecceeEEec
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----------RYKNRELQTMRLLDHPNVVSLKHCFFST  136 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----------~~~~~e~~~l~~l~h~niv~~~~~~~~~  136 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.||+|++....           ....+|+.+++.++||||+++++++   
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~---   92 (287)
T 4f0f_A           16 LADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM---   92 (287)
T ss_dssp             CCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEE---
T ss_pred             hhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheee---
Confidence            34468999999999999999999999999999999985321           4456899999999999999999987   


Q ss_pred             CCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCC--
Q 017452          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTH--  211 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~--  211 (371)
                        ....  ++||||+. ++|.+.+..   ....+++..++.++.|++.||.|||++ |  |+||||||+||+++.++.  
T Consensus        93 --~~~~--~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~~l~~~l~~lH~~-~~~ivH~dikp~Nil~~~~~~~~  164 (287)
T 4f0f_A           93 --HNPP--RMVMEFVPCGDLYHRLLD---KAHPIKWSVKLRLMLDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENA  164 (287)
T ss_dssp             --TTTT--EEEEECCTTCBHHHHHHC---TTSCCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCSCCSGGGEEESCCCTTC
T ss_pred             --cCCC--eEEEEecCCCCHHHHHhc---ccCCccHHHHHHHHHHHHHHHHHHHhC-CCCeecCCCCcceEEEeccCCCC
Confidence              2232  58999998 577666543   246799999999999999999999987 9  999999999999987662  


Q ss_pred             --cEEEEeeCCccccccCCCcccccccccccCcccccC-CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHH-HHHH
Q 017452          212 --QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG-ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL-VEII  287 (371)
Q Consensus       212 --~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~-~~~~  287 (371)
                        .+||+|||++.....  ......||+.|+|||++.. ...++.++||||||+++|+|++|+.||......... ....
T Consensus       165 ~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~  242 (287)
T 4f0f_A          165 PVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI  242 (287)
T ss_dssp             SCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHH
T ss_pred             ceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHH
Confidence              299999999975432  3345678999999999843 233688999999999999999999999775543331 1111


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ...+                          +...++..+++++.++|.+||+.||.+|||+.++++.|+.+
T Consensus       243 ~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          243 REEG--------------------------LRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             HHSC--------------------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             hccC--------------------------CCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            1111                          11124567899999999999999999999999999998764

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.8e-46  Score=336.89  Aligned_cols=255  Identities=23%  Similarity=0.346  Sum_probs=211.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC----------
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD----------  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~----------  138 (371)
                      ...+|++.+.||+|+||.||+|.+..+|+.||+|++........+|+++++.++||||+++++++.....          
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~   88 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSS   88 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------
T ss_pred             hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccccccc
Confidence            3457999999999999999999999999999999998877888999999999999999999998743211          


Q ss_pred             -CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          139 -KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       139 -~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                       .....+++||||+++ +|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus        89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~  164 (284)
T 2a19_B           89 RSKTKCLFIQMEFCDKGTLEQWIEKRR--GEKLDKVLALELFEQITKGVDYIHSK-KLINRDLKPSNIFLVDTK-QVKIG  164 (284)
T ss_dssp             CCEEEEEEEEECCCCSCBHHHHHHHGG--GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEEC
T ss_pred             ccCcceEEEEEeccCCCCHHHHHhhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCCHHHEEEcCCC-CEEEC
Confidence             224557899999996 8888876532  46799999999999999999999987 999999999999999888 89999


Q ss_pred             eeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          217 DFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       217 Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++|..||....  .....+..        
T Consensus       165 Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~~--------  233 (284)
T 2a19_B          165 DFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLRD--------  233 (284)
T ss_dssp             CCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSC-CCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHHT--------
T ss_pred             cchhheeccccccccccCCcccccChhhhccCC-CcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhhc--------
Confidence            999998776655555677899999999997654 7999999999999999999998874211  11111100        


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                             ..++..++..+.++|.+||+.||.+|||+.+++++|..+...
T Consensus       234 -----------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~  275 (284)
T 2a19_B          234 -----------------------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS  275 (284)
T ss_dssp             -----------------------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred             -----------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence                                   013445789999999999999999999999999998776544

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=7.3e-46  Score=330.41  Aligned_cols=253  Identities=19%  Similarity=0.260  Sum_probs=207.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..++|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++     ......+
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~~   79 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVC-----SKEYPIY   79 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCceE
Confidence            3468999999999999999999865 5678999998654   34467899999999999999999988     4444578


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++...
T Consensus        80 lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~~  154 (268)
T 3sxs_A           80 IVTEYISNGCLLNYLRSH---GKGLEPSQLLEMCYDVCEGMAFLESH-QFIHRDLAARNCLVDRDL-CVKVSDFGMTRYV  154 (268)
T ss_dssp             EEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEEESSCSGGGEEECTTC-CEEECCTTCEEEC
T ss_pred             EEEEccCCCcHHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCcCcceEEECCCC-CEEEccCccceec
Confidence            9999997 4677777643   35699999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ......  ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+.....          
T Consensus       155 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~----------  223 (268)
T 3sxs_A          155 LDDQYVSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHR----------  223 (268)
T ss_dssp             CTTCEEECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC----------
T ss_pred             chhhhhcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCC----------
Confidence            443221  2344567899999986544 7899999999999999998 9999988776665554433110          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                        ...+...++.+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       224 ------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          224 ------------------LYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ------------------CCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence                              013445789999999999999999999999999999987653

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-46  Score=348.53  Aligned_cols=257  Identities=19%  Similarity=0.242  Sum_probs=206.1

Q ss_pred             cccceeeeEeeccCCceEEEEEE-----ECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ...+|++.+.||+|+||.||+|.     +..++..||||++...     .....+|+.+++.++||||+++++++.    
T Consensus        69 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~----  144 (367)
T 3l9p_A           69 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----  144 (367)
T ss_dssp             CGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             CHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEe----
Confidence            34689999999999999999999     4457789999998542     234567999999999999999999883    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--Cc
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK---LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQ  212 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~  212 (371)
                       .....++||||+. |+|.+++.....   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..
T Consensus       145 -~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~~~  222 (367)
T 3l9p_A          145 -QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  222 (367)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             -cCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEEecCCCCce
Confidence             3344689999996 588888876432   124589999999999999999999987 999999999999998544  25


Q ss_pred             EEEEeeCCccccccC---CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKG---EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      +||+|||+++.....   .......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||......+....+..
T Consensus       223 ~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~  301 (367)
T 3l9p_A          223 AKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  301 (367)
T ss_dssp             EEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECCCccccccccccccccCCCcCCcccEECHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999754322   2233456789999999986554 8999999999999999998 9999988776665554433


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ....                            ..+..++..+.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       302 ~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~  345 (367)
T 3l9p_A          302 GGRM----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  345 (367)
T ss_dssp             TCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCC----------------------------CCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhh
Confidence            2100                            1345678999999999999999999999999999887643

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-45  Score=344.13  Aligned_cols=282  Identities=29%  Similarity=0.485  Sum_probs=215.2

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcC-----------CCCeeeccee
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHC  132 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~  132 (371)
                      +...++|++.+.||+|+||.||+|.+..+++.||||++....   ....+|+.+++.+.           |+||++++++
T Consensus        15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~   94 (373)
T 1q8y_A           15 PYKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   94 (373)
T ss_dssp             EETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             cccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHH
Confidence            344568999999999999999999999999999999997542   44567888888876           8999999998


Q ss_pred             EEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--
Q 017452          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--  210 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--  210 (371)
                      +.... ....++++||||++++|.+.+....  ...+++..++.++.||+.||.|||++.||+||||||+|||++.++  
T Consensus        95 ~~~~~-~~~~~~~lv~e~~~~~L~~~~~~~~--~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~  171 (373)
T 1q8y_A           95 FNHKG-PNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP  171 (373)
T ss_dssp             EEEEE-TTEEEEEEEECCCCEEHHHHHHHTT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred             hhccC-CCCceEEEEEecCCCCHHHHHHHhh--ccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCC
Confidence            86543 3345689999999889988887533  456999999999999999999999744999999999999995322  


Q ss_pred             ---CcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHH
Q 017452          211 ---HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS------GVD  281 (371)
Q Consensus       211 ---~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~  281 (371)
                         ..+||+|||++......  .....+|+.|+|||++.+.. ++.++|||||||++|+|++|..||...+      ...
T Consensus       172 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~  248 (373)
T 1q8y_A          172 ENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDD  248 (373)
T ss_dssp             TTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHH
T ss_pred             cCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHH
Confidence               27999999999876432  33457899999999997655 7999999999999999999999997654      455


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccc----cCccc-CCCC--------cccCCCCCChhHHHHHHhccCcCCCCCCCH
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQIK-AHPW--------HKIFPKRMPPEAVDLVSRLLQYSPNLRCTA  348 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~-~~~~--------~~~~~~~~s~~l~~li~~~l~~dP~~R~t~  348 (371)
                      .+..+....+.++...+.........+.    ...+. ...|        ...++..++.++.+||.+||+.||.+|||+
T Consensus       249 ~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  328 (373)
T 1q8y_A          249 HIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADA  328 (373)
T ss_dssp             HHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCH
T ss_pred             HHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCH
Confidence            6777888888887765532211000000    00000 0000        001233456789999999999999999999


Q ss_pred             HHHhhh
Q 017452          349 VSKRIL  354 (371)
Q Consensus       349 ~~~l~~  354 (371)
                      .++++|
T Consensus       329 ~ell~h  334 (373)
T 1q8y_A          329 GGLVNH  334 (373)
T ss_dssp             HHHHTC
T ss_pred             HHHhhC
Confidence            998888

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.2e-46  Score=340.95  Aligned_cols=249  Identities=29%  Similarity=0.444  Sum_probs=198.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||||++....            ....+|+.+++.++||||+++++++..  
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~--   86 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA--   86 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEES--
T ss_pred             hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcC--
Confidence            357999999999999999999999999999999985431            235689999999999999999988732  


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC--cEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVK  214 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~--~~k  214 (371)
                         .. .++||||+.+ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+|
T Consensus        87 ---~~-~~lv~e~~~~~~L~~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~~~k  157 (322)
T 2ycf_A           87 ---ED-YYIVLELMEGGELFDKVVG----NKRLKEATCKLYFYQMLLAVQYLHEN-GIIHRDLKPENVLLSSQEEDCLIK  157 (322)
T ss_dssp             ---SS-EEEEEECCTTEETHHHHST----TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSSSCCEE
T ss_pred             ---Cc-eEEEEecCCCCcHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHHHEEEecCCCCCeEE
Confidence               11 6899999975 76665543    56799999999999999999999987 9999999999999987652  499


Q ss_pred             EEeeCCccccccCCCcccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh-C
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL-G  291 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~-~  291 (371)
                      |+|||++.............||+.|+|||++.  +...++.++|||||||++|+|++|..||........+....... .
T Consensus       158 l~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  237 (322)
T 2ycf_A          158 ITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKY  237 (322)
T ss_dssp             ECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCC
T ss_pred             EccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCcc
Confidence            99999998764443334567899999999974  34457899999999999999999999997755433332222211 1


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....                         .+..++..+.+||.+||+.||.+|||+.++++|
T Consensus       238 ~~~~~-------------------------~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          238 NFIPE-------------------------VWAEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             CCCHH-------------------------HHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccCch-------------------------hhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            11111                         123478999999999999999999999997766

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5e-46  Score=345.45  Aligned_cols=256  Identities=23%  Similarity=0.318  Sum_probs=206.2

Q ss_pred             ccceeeeEeeccCCceEEEEEE-----ECCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||+|.     +..+++.||||++....     ....+|+++++.+ .||||+++++++...  
T Consensus        21 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~--   98 (359)
T 3vhe_A           21 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--   98 (359)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST--
T ss_pred             ccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC--
Confidence            4579999999999999999998     55677999999986532     3456899999999 789999999987432  


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhc----------------------------------------------------
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKL----------------------------------------------------  165 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------------------------------------------------  165 (371)
                        ....++||||+.+ +|.+++......                                                    
T Consensus        99 --~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           99 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             --CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence              2336899999985 888887653211                                                    


Q ss_pred             ----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC---ccc
Q 017452          166 ----------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NIS  232 (371)
Q Consensus       166 ----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~  232 (371)
                                ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||++........   ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Dfg~a~~~~~~~~~~~~~~  254 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILLSEKN-VVKICDFGLARDIYKDPDYVRKGD  254 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCGGGSCTTSCTTCEEC--
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC-CcccCCCChhhEEEcCCC-cEEEEeccceeeecccccchhccc
Confidence                      12289999999999999999999987 999999999999999888 899999999986543322   234


Q ss_pred             ccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccC
Q 017452          233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP  311 (371)
Q Consensus       233 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (371)
                      ..+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+....+.+..........                  
T Consensus       255 ~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~------------------  315 (359)
T 3vhe_A          255 ARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM------------------  315 (359)
T ss_dssp             CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC------------------
T ss_pred             cCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC------------------
Confidence            56788999999986544 7999999999999999998 999998876555554444321111                  


Q ss_pred             cccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       312 ~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                               ..+..+++++.+++.+||+.||.+|||+.++++||+.+.
T Consensus       316 ---------~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~  354 (359)
T 3vhe_A          316 ---------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  354 (359)
T ss_dssp             ---------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHH
Confidence                     134568899999999999999999999999999998653

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=5e-46  Score=347.14  Aligned_cols=257  Identities=13%  Similarity=0.116  Sum_probs=183.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHc--CCCCeeecceeEE-------
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLL--DHPNVVSLKHCFF-------  134 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l--~h~niv~~~~~~~-------  134 (371)
                      ..|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.+  +||||++++..++       
T Consensus        62 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~  141 (371)
T 3q60_A           62 RKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVA  141 (371)
T ss_dssp             EEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEE
T ss_pred             eeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhee
Confidence            45999999999999999999999999999999997632       2334675555555  6999888654332       


Q ss_pred             ecCC------------CCceeEEEeeccccchHHHHHHHhhhccCCCCHHHH------HHHHHHHHHHHHHHHhcCCcEe
Q 017452          135 STTD------------KDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV------KLYAYQIFRALSYIHRSIGVCH  196 (371)
Q Consensus       135 ~~~~------------~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~------~~i~~qi~~~l~~LH~~~~ivH  196 (371)
                      ....            .....+++||||++++|.+++....   ..+++...      ..++.||+.||+|||++ ||+|
T Consensus       142 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~---~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~-~ivH  217 (371)
T 3q60_A          142 VQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLD---FVYVFRGDEGILALHILTAQLIRLAANLQSK-GLVH  217 (371)
T ss_dssp             ETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHH---HSCCCCHHHHHHHHHHHHHHHHHHHHHHHHT-TEEE
T ss_pred             cCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhc---cccchhhhhhhhhHHHHHHHHHHHHHHHHHC-CCcc
Confidence            1111            0114579999999999999988653   23444445      67779999999999987 9999


Q ss_pred             eccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCC
Q 017452          197 RDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFP  275 (371)
Q Consensus       197 ~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~  275 (371)
                      |||||+|||++.++ .+||+|||+++....  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|+.||.
T Consensus       218 rDikp~NIll~~~~-~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~  294 (371)
T 3q60_A          218 GHFTPDNLFIMPDG-RLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFG  294 (371)
T ss_dssp             TTCSGGGEEECTTS-CEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTT
T ss_pred             CcCCHHHEEECCCC-CEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCC
Confidence            99999999999988 899999999986532  22255677999999999651 347999999999999999999999997


Q ss_pred             CCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          276 GDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .......                    ..+............+....+..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       295 ~~~~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          295 LVTPGIK--------------------GSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             BCCTTCT--------------------TCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CcCcccc--------------------cchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            6532110                    0011111111111111111234689999999999999999999999996655

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.4e-46  Score=339.80  Aligned_cols=258  Identities=21%  Similarity=0.297  Sum_probs=193.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .++|++.+.||+|+||.||+|.+..++.   .||+|++...      .....+|+.+++.++||||+++++++......+
T Consensus        22 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  101 (323)
T 3qup_A           22 EQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKG  101 (323)
T ss_dssp             ---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC----
T ss_pred             hhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccccc
Confidence            4579999999999999999999877765   8999988543      244568999999999999999999886543321


Q ss_pred             -ceeEEEeeccccc-hHHHHHHHhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          141 -ELYLNLVLEYVPE-TVHRVVKHFNK--LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       141 -~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                       ....++||||+.+ +|.+.+.....  ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+
T Consensus       102 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~ivH~Dikp~NIli~~~~-~~kl~  179 (323)
T 3qup_A          102 RLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR-NFIHRDLAARNCMLAEDM-TVCVA  179 (323)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEEC
T ss_pred             CCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC-CcccCCCCcceEEEcCCC-CEEEe
Confidence             1234899999985 88777765332  122689999999999999999999987 999999999999999887 89999


Q ss_pred             eeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 017452          217 DFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       217 Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |||++........   .....+++.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+.+..+....+..... 
T Consensus       180 Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~-  257 (323)
T 3qup_A          180 DFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR-  257 (323)
T ss_dssp             CCCC-----------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC-
T ss_pred             eccccccccccccccccccccCcccccCchhhcCCC-CCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC-
Confidence            9999987544322   22345577899999986554 7999999999999999999 9999988777666555443210 


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                 ...+..+++++.+|+.+||+.||.+|||+.++++.|+.+
T Consensus       258 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~  296 (323)
T 3qup_A          258 ---------------------------LKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENI  296 (323)
T ss_dssp             ---------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence                                       013456889999999999999999999999999998874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-45  Score=344.15  Aligned_cols=257  Identities=21%  Similarity=0.303  Sum_probs=208.4

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECC-------CCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (371)
                      ...++|++.+.||+|+||.||+|.+..       .+..||+|++....     ....+|+++++.+ +||||+++++++.
T Consensus        66 i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           66 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            345689999999999999999999753       33579999986532     3456899999999 9999999999883


Q ss_pred             ecCCCCceeEEEeeccccc-hHHHHHHHhhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCC
Q 017452          135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNKL------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (371)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp  201 (371)
                           .....++||||+.+ +|.+.+......            ...+++..++.++.||+.||.|||++ ||+||||||
T Consensus       146 -----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  219 (382)
T 3tt0_A          146 -----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAA  219 (382)
T ss_dssp             -----SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCG
T ss_pred             -----cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC-CEecCCCCc
Confidence                 34447899999975 888888764321            24599999999999999999999987 999999999


Q ss_pred             CceeeeCCCCcEEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 017452          202 QNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (371)
Q Consensus       202 ~NIli~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (371)
                      +|||++.++ .+||+|||+++......   ......+|+.|+|||++.+.. ++.++|||||||++|+|++ |..||.+.
T Consensus       220 ~NIll~~~~-~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          220 RNVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             GGEEECTTC-CEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-cEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCC-CCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999888 89999999998664432   223455688899999997654 8999999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ...+....+....                            ....+..+++++.+||.+||+.||.+|||+.+++++|+.
T Consensus       298 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~  349 (382)
T 3tt0_A          298 PVEELFKLLKEGH----------------------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  349 (382)
T ss_dssp             CHHHHHHHHHTTC----------------------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHHcCC----------------------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHH
Confidence            7655544433211                            001345689999999999999999999999999999877


Q ss_pred             CCc
Q 017452          358 CPS  360 (371)
Q Consensus       358 ~~~  360 (371)
                      +..
T Consensus       350 ~~~  352 (382)
T 3tt0_A          350 IVA  352 (382)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=6.1e-46  Score=342.66  Aligned_cols=257  Identities=23%  Similarity=0.296  Sum_probs=208.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ..++|++.+.||+|+||.||+|.+.     .+++.||+|++...     ...+.+|+.+++.++||||+++++++.    
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~----  120 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA----  120 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc----
Confidence            3468999999999999999999986     45589999998653     234568999999999999999999883    


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhc--------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKL--------------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~--------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (371)
                       .....++||||+.+ +|.+++......                    ...+++..++.++.||+.||.|||++ ||+||
T Consensus       121 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-~ivH~  198 (343)
T 1luf_A          121 -VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHR  198 (343)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCS
T ss_pred             -cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence             34447899999985 888888753211                    26789999999999999999999987 99999


Q ss_pred             ccCCCceeeeCCCCcEEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCC
Q 017452          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPL  273 (371)
Q Consensus       198 dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  273 (371)
                      ||||+||+++.++ .+||+|||++.......   ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       199 Dlkp~NIl~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  276 (343)
T 1luf_A          199 DLATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQP  276 (343)
T ss_dssp             CCSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             CCCcceEEECCCC-eEEEeecCCCcccccCccccccCCCcccceecChhhhccCC-cCcccccHHHHHHHHHHHhcCCCc
Confidence            9999999999888 89999999997653321   223456788999999986554 8999999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       274 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                      |.+....+....+.....                            ..++..++.++.++|.+||+.||.+|||+.++++
T Consensus       277 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          277 YYGMAHEEVIYYVRDGNI----------------------------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             TTTSCHHHHHHHHHTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCChHHHHHHHhCCCc----------------------------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            988776555444432100                            0134568999999999999999999999999999


Q ss_pred             hhcCCCcc
Q 017452          354 LFSNCPSL  361 (371)
Q Consensus       354 ~l~~~~~~  361 (371)
                      +|+.+...
T Consensus       329 ~L~~~~~~  336 (343)
T 1luf_A          329 ILQRMCER  336 (343)
T ss_dssp             HHHHTTC-
T ss_pred             HHHHHHhh
Confidence            99887543

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7e-46  Score=331.79  Aligned_cols=247  Identities=25%  Similarity=0.339  Sum_probs=199.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++....     ....+|+.+++.++||||+++++++..     ....
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~   80 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   80 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEc-----CCEE
Confidence            357999999999999999999999999999999986432     445689999999999999999998843     3457


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+.+.    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||.+..
T Consensus        81 ~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~  154 (276)
T 2yex_A           81 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  154 (276)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEEecCCCcHHHHHh----hccCCCHHHHHHHHHHHHHHHHHHHhC-CeeccCCChHHEEEccCC-CEEEeeCCCccc
Confidence            899999985 6655443    246799999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCHhHHh
Q 017452          224 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ-LVEIIKVLGTPTREEIK  299 (371)
Q Consensus       224 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~  299 (371)
                      .....   ......|++.|+|||.+.+....+.++||||||+++|+|++|..||........ ...+...   ..     
T Consensus       155 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~-----  226 (276)
T 2yex_A          155 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KT-----  226 (276)
T ss_dssp             CEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTT---CT-----
T ss_pred             cCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhc---cc-----
Confidence            53322   233457899999999997665457789999999999999999999987654322 2222110   00     


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                               ..     .     ....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       227 ---------~~-----~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          227 ---------YL-----N-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             ---------TS-----T-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             ---------cc-----C-----chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcC
Confidence                     00     0     113478999999999999999999999997665

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.6e-45  Score=328.71  Aligned_cols=247  Identities=26%  Similarity=0.427  Sum_probs=192.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..+|++.+.||+|+||.||+|.+  +|..||+|++...        .....+|+++++.++||||+++++++     ...
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-----~~~   78 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFW--IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-----LKE   78 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEE--TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEE-----CCC
T ss_pred             hhheeeeeeeccCCCeEEEEEEE--cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEE-----ecC
Confidence            35799999999999999999997  5889999988543        23456799999999999999999988     344


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC---cEeeccCCCceeeeCC-------C
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG---VCHRDIKPQNLLVNPH-------T  210 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~---ivH~dlkp~NIli~~~-------~  210 (371)
                      ...++||||++ ++|.+.+.     ...+++..++.++.|++.||.|||++ |   |+||||||+||+++.+       .
T Consensus        79 ~~~~lv~e~~~~~~L~~~~~-----~~~~~~~~~~~i~~~l~~~l~~lH~~-~~~~i~H~dikp~Nil~~~~~~~~~~~~  152 (271)
T 3dtc_A           79 PNLCLVMEFARGGPLNRVLS-----GKRIPPDILVNWAVQIARGMNYLHDE-AIVPIIHRDLKSSNILILQKVENGDLSN  152 (271)
T ss_dssp             --CEEEEECCTTEEHHHHHT-----SSCCCHHHHHHHHHHHHHHHHHHHHS-SSSCCCCSCCSGGGEEESSCCSSSCCSS
T ss_pred             CceEEEEEcCCCCCHHHHhh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceeecCCchHHEEEecccccccccC
Confidence            45789999997 46665553     56899999999999999999999987 8   9999999999999862       2


Q ss_pred             CcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017452          211 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  290 (371)
                      ..+||+|||++....... .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.+.+.......+....
T Consensus       153 ~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~  230 (271)
T 3dtc_A          153 KILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNK  230 (271)
T ss_dssp             CCEEECCCCC--------------CCGGGSCHHHHHHCC-CSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSC
T ss_pred             cceEEccCCccccccccc-ccCCCCccceeCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCC
Confidence            379999999997654332 23567899999999986544 7999999999999999999999998876655444332210


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                 +....+..+++.+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       231 ---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          231 ---------------------------LALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             ---------------------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             ---------------------------CCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence                                       01114456899999999999999999999999999999764

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.8e-47  Score=357.63  Aligned_cols=247  Identities=16%  Similarity=0.197  Sum_probs=188.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHH---HHHHcCCCCeeecceeEE-----
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQ---TMRLLDHPNVVSLKHCFF-----  134 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~---~l~~l~h~niv~~~~~~~-----  134 (371)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.   +++.++||||+++++.+.     
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~  151 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL  151 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred             CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence            45799999999999999999999899999999998632       244567884   455558999999984332     


Q ss_pred             --ecC---------CCCce---eEEEeeccccchHHHHHHHhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 017452          135 --STT---------DKDEL---YLNLVLEYVPETVHRVVKHFNKLN---QRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (371)
Q Consensus       135 --~~~---------~~~~~---~~~lv~e~~~~~l~~~~~~~~~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (371)
                        ...         +....   ..++||||++|+|.+++.......   ..+++..++.++.||+.||+|||++ ||+||
T Consensus       152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHr  230 (377)
T 3byv_A          152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHT  230 (377)
T ss_dssp             EECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT-TEECS
T ss_pred             hhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC-CeecC
Confidence              111         11111   368999999999999887643211   1234588888999999999999987 99999


Q ss_pred             ccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCC----------cCCCCcchHHHHHHHHHHH
Q 017452          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA----------TEYTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       198 dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~l  267 (371)
                      ||||+|||++.++ .+||+|||+++...  .......| +.|+|||++.+.          ..++.++|||||||++|+|
T Consensus       231 Dikp~NIll~~~~-~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          231 YLRPVDIVLDQRG-GVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             CCCGGGEEECTTC-CEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCHHHEEEcCCC-CEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999888 89999999998642  23344566 999999999765          2489999999999999999


Q ss_pred             HhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC
Q 017452          268 MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT  347 (371)
Q Consensus       268 ltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t  347 (371)
                      ++|+.||...+.......+.                                 ..+..+++++.+||.+||+.||.+|||
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~~li~~~L~~dp~~Rpt  353 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIF---------------------------------RSCKNIPQPVRALLEGFLRYPKEDRLL  353 (377)
T ss_dssp             HHSSCCC------CCSGGGG---------------------------------SSCCCCCHHHHHHHHHHTCSSGGGCCC
T ss_pred             HHCCCCCcccccccchhhhh---------------------------------hhccCCCHHHHHHHHHHcCCCchhCCC
Confidence            99999996544221110000                                 012468999999999999999999999


Q ss_pred             HHHHhhh
Q 017452          348 AVSKRIL  354 (371)
Q Consensus       348 ~~~~l~~  354 (371)
                      +.++++|
T Consensus       354 ~~e~l~h  360 (377)
T 3byv_A          354 PLQAMET  360 (377)
T ss_dssp             HHHHHTS
T ss_pred             HHHHhhC
Confidence            9997776

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.5e-45  Score=343.09  Aligned_cols=263  Identities=17%  Similarity=0.153  Sum_probs=202.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC-----CcEEEEEEeecchhhhHHHHHH---------------HHHcCCCCeeecc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET-----GETVAIKKVLQDKRYKNRELQT---------------MRLLDHPNVVSLK  130 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~-----~~~vaiK~~~~~~~~~~~e~~~---------------l~~l~h~niv~~~  130 (371)
                      ++|++.+.||+|+||.||+|.+..+     ++.||||++........+|+++               ++.++||||++++
T Consensus        35 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~  114 (364)
T 3op5_A           35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYW  114 (364)
T ss_dssp             CEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEE
T ss_pred             CeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEE
Confidence            4799999999999999999998764     5889999987665444444444               4455799999999


Q ss_pred             eeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee--C
Q 017452          131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN--P  208 (371)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~--~  208 (371)
                      +++.... .+..+.++||||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++  .
T Consensus       115 ~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~-~iiHrDlkp~Nill~~~~  189 (364)
T 3op5_A          115 GSGLHDK-NGKSYRFMIMDRFGSDLQKIYEAN---AKRFSRKTVLQLSLRILDILEYIHEH-EYVHGDIKASNLLLNYKN  189 (364)
T ss_dssp             EEEEEEE-TTEEEEEEEEECEEEEHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEESSC
T ss_pred             eeeeecc-CCcceEEEEEeCCCCCHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeEEecCCHHHEEEecCC
Confidence            9886643 345678999999988888887642   46799999999999999999999987 999999999999998  6


Q ss_pred             CCCcEEEEeeCCccccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 017452          209 HTHQVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (371)
                      ++ .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....
T Consensus       190 ~~-~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          190 PD-QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             TT-CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CC-eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence            66 899999999976543221        12345899999999997655 899999999999999999999999864333


Q ss_pred             HHHHHHHH-HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          281 DQLVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       281 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ........ ............                .|   ....++.++.+++..||+.||.+||++.++++.|..+.
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~----------------~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~  328 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDK----------------CF---PAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGL  328 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHH----------------HS---CTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhhhHHHHHHH----------------hc---ccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHH
Confidence            32222222 111111111100                00   12457899999999999999999999999999987653

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.7e-46  Score=343.71  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=199.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc--------hhhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ....+|++.+.||+|+||.||+|++.   .+|+.||||++...        .....+|+.+++.+ .||||+++++++..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  130 (355)
T 1vzo_A           51 VGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT  130 (355)
T ss_dssp             CCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE
T ss_pred             ccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEee
Confidence            34568999999999999999999984   58999999988532        23455799999999 69999999988843


Q ss_pred             cCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEE
Q 017452          136 TTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~k  214 (371)
                           ....++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+|
T Consensus       131 -----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~k  199 (355)
T 1vzo_A          131 -----ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVV  199 (355)
T ss_dssp             -----TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEE
T ss_pred             -----CceEEEEeecCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEECCCC-cEE
Confidence                 3347899999985 88777764    35799999999999999999999987 999999999999999888 899


Q ss_pred             EEeeCCccccccCC--CcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          215 LCDFGSAKVLVKGE--PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       215 l~Dfg~a~~~~~~~--~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      |+|||+++......  ......||+.|+|||++.+. ..++.++|||||||++|+|++|+.||...........+.....
T Consensus       200 l~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~  279 (355)
T 1vzo_A          200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRIL  279 (355)
T ss_dssp             ESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHH
T ss_pred             EeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHh
Confidence            99999997653222  22345789999999999753 3468899999999999999999999975443222222222110


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                      ..                         ...++..++..+.+||.+||..||.+||     |+.++++|
T Consensus       280 ~~-------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          280 KS-------------------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HC-------------------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             cc-------------------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            00                         0014556899999999999999999999     99999988

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.3e-45  Score=336.76  Aligned_cols=273  Identities=24%  Similarity=0.418  Sum_probs=212.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEE-CCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCC------eeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKC-LETGETVAIKKVLQDK---RYKNRELQTMRLLDHPN------VVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.+ ..+++.||+|++....   ....+|+.+++.++|++      ++++++++..    
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~----   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH----   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE----
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc----
Confidence            35799999999999999999998 5688999999986543   44567899999887654      8898888733    


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC-----------
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-----------  208 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~-----------  208 (371)
                       ....++||||++++|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.           
T Consensus        89 -~~~~~lv~e~~~~~l~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           89 -HGHICIVFELLGLSTYDFIKENG--FLPFRLDHIRKMAYQICKSVNFLHSN-KLTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHTT--TCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESCCCEEEEEC---
T ss_pred             -CCcEEEEEcCCCCCHHHHHHhcC--CCCCcHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEEEeccccccccCCcc
Confidence             34589999999989888876522  34689999999999999999999987 9999999999999986           


Q ss_pred             --------CCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 017452          209 --------HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (371)
Q Consensus       209 --------~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (371)
                              ++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..
T Consensus       165 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINP-DIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCC-CEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCC-CceEeeCcccccCcc--ccccccCCccccChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    34 799999999976433  234567899999999997654 899999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHhHHhhcCCCccc----cccCcc---------cCCCCcc--cCCCCCChhHHHHHHhccCcCCCCC
Q 017452          281 DQLVEIIKVLGTPTREEIKCMNPNYTE----FKFPQI---------KAHPWHK--IFPKRMPPEAVDLVSRLLQYSPNLR  345 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~---------~~~~~~~--~~~~~~s~~l~~li~~~l~~dP~~R  345 (371)
                      +....+.+..+..+...+.........    ......         ...++..  ..+...++++.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            888888888888877665533211000    000000         0000000  0122345789999999999999999


Q ss_pred             CCHHHHhhh
Q 017452          346 CTAVSKRIL  354 (371)
Q Consensus       346 ~t~~~~l~~  354 (371)
                      ||+.++++|
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999996665

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=333.11  Aligned_cols=255  Identities=24%  Similarity=0.364  Sum_probs=201.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC-Ccee
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK-DELY  143 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~-~~~~  143 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...   .....+|+.+++.+ +||||+++++++...... ....
T Consensus        22 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~  101 (326)
T 2x7f_A           22 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ  101 (326)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccce
Confidence            456799999999999999999999999999999998543   35567899999999 799999999988664321 2456


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||+++ +|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       102 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~-~~kl~Dfg~~~  177 (326)
T 2x7f_A          102 LWLVMEFCGAGSVTDLIKNTK--GNTLKEEWIAYICREILRGLSHLHQH-KVIHRDIKGQNVLLTENA-EVKLVDFGVSA  177 (326)
T ss_dssp             EEEEEECCTTEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCCTTTC
T ss_pred             EEEEEEcCCCCcHHHHHHhcc--cCCCCHHHHHHHHHHHHHHHHHHHHC-CccccCCcHHHEEEcCCC-CEEEeeCcCce
Confidence            7899999985 8888776532  35789999999999999999999987 999999999999999888 89999999987


Q ss_pred             ccccCC-CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ...... ......|++.|+|||++..    ...++.++|||||||++|+|++|..||...........+.....      
T Consensus       178 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~------  251 (326)
T 2x7f_A          178 QLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA------  251 (326)
T ss_dssp             -------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC------
T ss_pred             ecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc------
Confidence            654322 2334578999999999852    33478899999999999999999999987776555444332100      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....+..++..+.+||.+||..||.+|||+.++++|
T Consensus       252 ---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          252 ---------------------PRLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             ---------------------CCCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             ---------------------ccCCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                                 001234578999999999999999999999998887

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.3e-45  Score=339.41  Aligned_cols=255  Identities=24%  Similarity=0.363  Sum_probs=189.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----hhhHHHHHHHHHcC-CCCeeecceeEEecCC---CCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----RYKNRELQTMRLLD-HPNVVSLKHCFFSTTD---KDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~---~~~~  142 (371)
                      .+|++.+.||+|+||.||+|.+..+|+.||+|++....    ....+|+.+++.+. ||||+++++++.....   ....
T Consensus        28 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~  107 (337)
T 3ll6_A           28 LRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQA  107 (337)
T ss_dssp             EEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSE
T ss_pred             ceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCc
Confidence            47999999999999999999999999999999885432    34567899999996 9999999998864432   4456


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      .++++|||++|+|.+.+..... ...+++..++.++.||+.||.|||++ |  |+||||||+|||++.++ .+||+|||+
T Consensus       108 ~~~lv~e~~~g~L~~~l~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~ivH~Dikp~NIl~~~~~-~~kl~Dfg~  184 (337)
T 3ll6_A          108 EFLLLTELCKGQLVEFLKKMES-RGPLSCDTVLKIFYQTCRAVQHMHRQ-KPPIIHRDLKVENLLLSNQG-TIKLCDFGS  184 (337)
T ss_dssp             EEEEEEECCSEEHHHHHHHHHT-TCSCCHHHHHHHHHHHHHHHHHHHTS-SSCCBCCCCCGGGCEECTTS-CEEBCCCTT
T ss_pred             eEEEEEEecCCCHHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCEEEccCCcccEEECCCC-CEEEecCcc
Confidence            6889999999999888875433 45799999999999999999999986 8  99999999999999888 899999999


Q ss_pred             ccccccCCCc-------------ccccccccccCccccc--CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Q 017452          221 AKVLVKGEPN-------------ISYICSRYYRAPELIF--GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE  285 (371)
Q Consensus       221 a~~~~~~~~~-------------~~~~~t~~y~aPE~~~--~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~  285 (371)
                      +.........             ....+|+.|+|||++.  ....++.++||||||+++|+|++|..||...........
T Consensus       185 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~  264 (337)
T 3ll6_A          185 ATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG  264 (337)
T ss_dssp             CBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----------
T ss_pred             ceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC
Confidence            9876433221             1445899999999983  233478899999999999999999999975433221110


Q ss_pred             HHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                         .                            +....+...+..+.+||.+||+.||.+|||+.+++++|..+.
T Consensus       265 ---~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~  307 (337)
T 3ll6_A          265 ---K----------------------------YSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIA  307 (337)
T ss_dssp             --------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---c----------------------------ccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence               0                            000123446788999999999999999999999999987653

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=9.2e-46  Score=337.20  Aligned_cols=254  Identities=22%  Similarity=0.332  Sum_probs=205.9

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ...+|++.+.||+|+||.||+|.+.     .++..||+|++....     ....+|+.+++.++||||+++++++     
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~-----   95 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC-----   95 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE-----
Confidence            3468999999999999999999873     456899999986532     3456799999999999999999988     


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh--------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK--------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~--------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (371)
                      ......++||||+. ++|.+.+.....                    ....+++..++.++.||+.||.|||++ ||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~  174 (314)
T 2ivs_A           96 SQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM-KLVHR  174 (314)
T ss_dssp             CSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT-TEECC
T ss_pred             ecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC-CCccc
Confidence            33444789999998 688888876432                    123589999999999999999999987 99999


Q ss_pred             ccCCCceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCC
Q 017452          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPL  273 (371)
Q Consensus       198 dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  273 (371)
                      ||||+||+++.++ .+||+|||++........   .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       175 dikp~NIli~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  252 (314)
T 2ivs_A          175 DLAARNILVAEGR-KMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNP  252 (314)
T ss_dssp             CCSGGGEEEETTT-EEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCS
T ss_pred             ccchheEEEcCCC-CEEEccccccccccccccceeccCCCCcccccChhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999887 899999999976543322   22345678899999986544 7899999999999999999 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       274 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                      |.+.........+....                            ....+..+++++.++|.+||+.||.+|||+.++++
T Consensus       253 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~  304 (314)
T 2ivs_A          253 YPGIPPERLFNLLKTGH----------------------------RMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISK  304 (314)
T ss_dssp             STTCCGGGHHHHHHTTC----------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCCHHHHHHHhhcCC----------------------------cCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            98877655444332210                            00134568999999999999999999999999999


Q ss_pred             hhcCC
Q 017452          354 LFSNC  358 (371)
Q Consensus       354 ~l~~~  358 (371)
                      +|+.+
T Consensus       305 ~l~~~  309 (314)
T 2ivs_A          305 DLEKM  309 (314)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            98765

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=5.8e-47  Score=356.36  Aligned_cols=278  Identities=21%  Similarity=0.292  Sum_probs=210.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+++++.++||||+++++++...   .....
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---~~~~~   84 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEET---TTRHK   84 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECT---TTCCE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccC---CCCee
Confidence            35799999999999999999999999999999998643     24456899999999999999999887542   23357


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee----eCCCCcEEEEeeC
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV----NPHTHQVKLCDFG  219 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli----~~~~~~~kl~Dfg  219 (371)
                      ++||||+. ++|.+.+.... ....+++..++.++.||+.||+|||++ ||+||||||+|||+    +.++ .+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~~~-~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPS-NAYGLPESEFLIVLRDVVGGMNHLREN-GIVHRNIKPGNIMRVIGEDGQS-VYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGG-GTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEEEECTTSCE-EEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHHC-CEEECCcCHHHEEEeecCCCce-eEEEecCC
Confidence            89999997 57777765432 233499999999999999999999987 99999999999998    5555 79999999


Q ss_pred             CccccccCCCcccccccccccCcccccCC-------cCCCCcchHHHHHHHHHHHHhCCCCCCCCC----cHHHHHHHHH
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGA-------TEYTTAIDIWSAGCVVAELMLGKPLFPGDS----GVDQLVEIIK  288 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~lltg~~pf~~~~----~~~~~~~~~~  288 (371)
                      +++............||+.|+|||++.+.       ..++.++|||||||++|+|++|+.||....    ..+.+..+..
T Consensus       162 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~  241 (396)
T 4eut_A          162 AARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIIT  241 (396)
T ss_dssp             GCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHH
T ss_pred             CceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhc
Confidence            99877655555567799999999998531       336789999999999999999999996432    2333333333


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCccc------CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcch
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI------FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLL  362 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~  362 (371)
                         ..+...+.....       .......|...      ++..++..+.++|.+||+.||++|||+.++++++..+....
T Consensus       242 ---~~p~~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~~  311 (396)
T 4eut_A          242 ---GKPSGAISGVQK-------AENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHRM  311 (396)
T ss_dssp             ---SCCTTCCEEEEC-------STTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTCE
T ss_pred             ---CCCcccchhhee-------ccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhce
Confidence               222221111100       00000112211      22335568899999999999999999999999988776554


Q ss_pred             h
Q 017452          363 V  363 (371)
Q Consensus       363 ~  363 (371)
                      +
T Consensus       312 ~  312 (396)
T 4eut_A          312 V  312 (396)
T ss_dssp             E
T ss_pred             E
Confidence            4

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=2.8e-45  Score=330.00  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=204.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...      .....+|+.+++.++||||+++++++.     ....
T Consensus        21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~   95 (287)
T 2wei_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILE-----DSSS   95 (287)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSSE
T ss_pred             hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEe-----CCCe
Confidence            45899999999999999999999999999999998543      234568999999999999999999883     3445


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCC
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~  220 (371)
                      .++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus        96 ~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~  170 (287)
T 2wei_A           96 FYIVGELYTGGELFDEIIK----RKRFSEHDAARIIKQVFSGITYMHKH-NIVHRDLKPENILLESKEKDCDIKIIDFGL  170 (287)
T ss_dssp             EEEEECCCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCCEEECSTTG
T ss_pred             EEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCChhhEEEecCCCcccEEEeccCc
Confidence            789999997 477666654    35789999999999999999999987 999999999999997643  2699999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............+++.|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+....+.......+..    
T Consensus       171 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----  244 (287)
T 2wei_A          171 STCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLP----  244 (287)
T ss_dssp             GGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSG----
T ss_pred             ceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCch----
Confidence            987655555555678999999999864  37899999999999999999999998877666555544321110000    


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                           ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       245 ---------------------~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          245 ---------------------QWRTISDDAKDLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             ---------------------GGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             ---------------------hhhhcCHHHHHHHHHHcccChhhCcCHHHHhcC
Confidence                                 113478999999999999999999999997776

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=4.5e-46  Score=348.03  Aligned_cols=253  Identities=20%  Similarity=0.269  Sum_probs=205.9

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ....+|.+.+.||+|+||.||+|.+..+++.||||++...     ...+.+|+.+++.++||||+++++++.     ...
T Consensus       111 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~-----~~~  185 (377)
T 3cbl_A          111 LNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCT-----QKQ  185 (377)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC-----SSS
T ss_pred             EchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe-----cCC
Confidence            3446899999999999999999999999999999998643     234568999999999999999999883     334


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||++ |+|.+.+...   ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       186 ~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nil~~~~~-~~kl~DfG~s  260 (377)
T 3cbl_A          186 PIYIVMELVQGGDFLTFLRTE---GARLRVKTLLQMVGDAAAGMEYLESK-CCIHRDLAARNCLVTEKN-VLKISDFGMS  260 (377)
T ss_dssp             SCEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCGGGC
T ss_pred             CcEEEEEcCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CcCCcccCHHHEEEcCCC-cEEECcCCCc
Confidence            4789999997 5877777642   35689999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          222 KVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       222 ~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      +........   ....+++.|+|||.+.... ++.++|||||||++|||++ |..||......+....+.... ..    
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~-~~----  334 (377)
T 3cbl_A          261 REEADGVYAASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGG-RL----  334 (377)
T ss_dssp             EECTTSEEECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTC-CC----
T ss_pred             eecCCCceeecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-CC----
Confidence            764332111   1223467899999986544 7899999999999999998 999998876655443332210 00    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                             ..+..+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       335 -----------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~  373 (377)
T 3cbl_A          335 -----------------------PCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIR  373 (377)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHH
Confidence                                   034568899999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=6.2e-46  Score=335.58  Aligned_cols=270  Identities=23%  Similarity=0.373  Sum_probs=200.2

Q ss_pred             cccceeeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ...+|++.+.||+|+||.||+|+    +..+++.||+|++....    ..+.+|+.+++.++||||+++++++....   
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG---   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH---
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC---
Confidence            34689999999999999999998    56789999999986543    34568999999999999999999875422   


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+++||||++ ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Dfg  159 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDFG  159 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHC---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhc---ccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHhhEEEcCCC-eEEEccCc
Confidence            233689999996 5888877643   34589999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ++........    .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||......     .....+....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~~l~~g~~~~~~~~~~-----~~~~~~~~~~  233 (295)
T 3ugc_A          160 LTKVLPQDKEFFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPAE-----FMRMIGNDKQ  233 (295)
T ss_dssp             SCC-------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTTCTTCSHHHH-----HHHHHCTTCC
T ss_pred             ccccccCCcceeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHHHHHHhcccccCCChHH-----HHhhhcCccc
Confidence            9987644322    22344677899999986554 799999999999999999999998643211     1111111110


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ......       ..............+..+++++.+|+.+||+.||.+|||+.++++.|+.+.
T Consensus       234 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~  290 (295)
T 3ugc_A          234 GQMIVF-------HLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIR  290 (295)
T ss_dssp             THHHHH-------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cchhHH-------HHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHH
Confidence            000000       000000000011135568999999999999999999999999999988754

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.9e-45  Score=329.63  Aligned_cols=257  Identities=22%  Similarity=0.254  Sum_probs=206.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++...  .....+|+.+++.++|++++..+..+..    .....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~----~~~~~~lv   83 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGA----EGDYNVMV   83 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEE----ETTEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccC----CCCceEEE
Confidence            45799999999999999999999999999999988543  3456789999999999888777665543    23347899


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee---CCCCcEEEEeeCCcccc
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN---PHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~---~~~~~~kl~Dfg~a~~~  224 (371)
                      |||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++   .++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~ivH~dlkp~NIl~~~~~~~~-~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEecCCCHHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhC-CeeeCCCCHHHeEEecCCCCC-eEEEeeCCCcccc
Confidence            999988988887642   45799999999999999999999987 999999999999994   555 8999999999876


Q ss_pred             ccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc---HHHHHHHHHHhCCC
Q 017452          225 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG---VDQLVEIIKVLGTP  293 (371)
Q Consensus       225 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~---~~~~~~~~~~~~~~  293 (371)
                      .....        .....||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||.....   ...+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cccccccccccccccccccccccCChhhhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCC
Confidence            54332        23567899999999997655 79999999999999999999999976432   23333333321111


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      +...                        .+..+++++.+++.+||+.||.+|||+.++++.|..+..
T Consensus       238 ~~~~------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  280 (296)
T 3uzp_A          238 PIEV------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             chHH------------------------HHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHH
Confidence            1111                        234578999999999999999999999999999887643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=5.8e-45  Score=330.46  Aligned_cols=243  Identities=26%  Similarity=0.392  Sum_probs=203.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..|++.+.||+|+||.||+|.+..+++.||+|++...     .....+|+.+++.++||||+++++++..     ....+
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   96 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLK-----DTKLW   96 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEec-----CCeEE
Confidence            4699999999999999999999999999999998543     2456789999999999999999998854     33478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|.+++.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        97 lv~e~~~~~~L~~~~~-----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~Dfg~~~~~  169 (303)
T 3a7i_A           97 IIMEYLGGGSALDLLE-----PGPLDETQIATILREILKGLDYLHSE-KKIHRDIKAANVLLSEHG-EVKLADFGVAGQL  169 (303)
T ss_dssp             EEEECCTTEEHHHHHT-----TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEeCCCCcHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCChheEEECCCC-CEEEeecccceec
Confidence            99999985 7766654     46799999999999999999999987 999999999999999888 8999999999775


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......|++.|+|||.+.+.. ++.++||||||+++|+|++|..||...........+...  .+          
T Consensus       170 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~--~~----------  236 (303)
T 3a7i_A          170 TDTQIKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKN--NP----------  236 (303)
T ss_dssp             BTTBCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS--CC----------
T ss_pred             CccccccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcC--CC----------
Confidence            4432 233457899999999996554 789999999999999999999999877665544433221  00          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ..++..++..+.+||.+||+.||.+|||+.++++|
T Consensus       237 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          237 ----------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----------------CCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----------------CCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                            01345688999999999999999999999998888

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=2.6e-45  Score=330.37  Aligned_cols=250  Identities=18%  Similarity=0.202  Sum_probs=200.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC-------cEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG-------ETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ..+|++.+.||+|+||.||+|.+..++       ..||+|++....    ....+|+.+++.++||||+++++++..   
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~---   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVC---   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECC---
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe---
Confidence            458999999999999999999988777       469999985432    445679999999999999999998843   


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc-----
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ-----  212 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~-----  212 (371)
                        ....++||||+. ++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .     
T Consensus        84 --~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~-~~~~~~  156 (289)
T 4fvq_A           84 --GDENILVQEFVKFGSLDTYLKKN---KNCINILWKLEVAKQLAAAMHFLEEN-TLIHGNVCAKNILLIREE-DRKTGN  156 (289)
T ss_dssp             --TTCCEEEEECCTTCBHHHHHHHT---GGGCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEEECC-BGGGTB
T ss_pred             --CCCCEEEEECCCCCCHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeECCCcCcceEEEecCC-cccccc
Confidence              334689999998 5888877642   34489999999999999999999987 999999999999998877 4     


Q ss_pred             ---EEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017452          213 ---VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       213 ---~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  289 (371)
                         +||+|||++.....   .....+|+.|+|||.+.+...++.++||||||+++|+|++|..|+...............
T Consensus       157 ~~~~kl~Dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~  233 (289)
T 4fvq_A          157 PPFIKLSDPGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED  233 (289)
T ss_dssp             CCEEEECCCCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT
T ss_pred             cceeeeccCcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc
Confidence               99999999865422   234567889999999977566899999999999999999965444333333333222221


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                      .                             ..++...++++.+|+.+||+.||.+|||+.+++++|+.+...
T Consensus       234 ~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          234 R-----------------------------HQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             T-----------------------------CCCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             c-----------------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence            0                             013445688999999999999999999999999999998765

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=8.6e-45  Score=336.22  Aligned_cols=273  Identities=24%  Similarity=0.410  Sum_probs=211.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC-cEEEEEEeecc---hhhhHHHHHHHHHcCCCC------eeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG-ETVAIKKVLQD---KRYKNRELQTMRLLDHPN------VVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~-~~vaiK~~~~~---~~~~~~e~~~l~~l~h~n------iv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|.+..++ ..||+|++...   .....+|+.+++.+.|++      ++.+++++..    
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~----   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF----   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE----
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee----
Confidence            357999999999999999999998777 68999998653   344567899999987655      7777777633    


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee-------------
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV-------------  206 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli-------------  206 (371)
                       ....++||||+++++.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+|||+             
T Consensus        94 -~~~~~lv~e~~~~~l~~~l~~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~-~ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 -HGHMCIAFELLGKNTFEFLKEN--NFQPYPLPHVRHMAYQLCHALRFLHEN-QLTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             -TTEEEEEEECCCCBHHHHHHHT--TTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             -CCeEEEEEeccCCChHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCCHHHEEEecccccccccccc
Confidence             3458899999998888777652  235799999999999999999999987 99999999999999             


Q ss_pred             ------eCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH
Q 017452          207 ------NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV  280 (371)
Q Consensus       207 ------~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  280 (371)
                            +.++ .+||+|||++.....  ......||+.|+|||++.+.. ++.++|||||||++|+|++|..||...+..
T Consensus       170 ~~~~~~~~~~-~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNT-SIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCC-CEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCC-cEEEeecCccccccc--cccCCcCCCcccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  4455 899999999976433  234567899999999997654 899999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHhHHhhcCCCccccc----cCcc---------cCCCCccc--CCCCCChhHHHHHHhccCcCCCCC
Q 017452          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFK----FPQI---------KAHPWHKI--FPKRMPPEAVDLVSRLLQYSPNLR  345 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~---------~~~~~~~~--~~~~~s~~l~~li~~~l~~dP~~R  345 (371)
                      +.+..+.+..+..+...+...........    .+..         ...++...  .....+.++.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            88888888888887766543221110000    0000         00000000  111234689999999999999999


Q ss_pred             CCHHHHhhh
Q 017452          346 CTAVSKRIL  354 (371)
Q Consensus       346 ~t~~~~l~~  354 (371)
                      ||+.++++|
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999997776

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=3.2e-46  Score=341.75  Aligned_cols=274  Identities=19%  Similarity=0.225  Sum_probs=202.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.+.||+|+||.||+|.+  .++.||||++....   ...++|+.+++.++||||+++++++..... ....+++
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~-~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQL--LNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTS-VDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECS-SSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEE--CCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCC-CCceEEE
Confidence            35799999999999999999987  47999999986543   233457888999999999999998865442 2455789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC----------CcEeeccCCCceeeeCCCCcEEE
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI----------GVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      ||||+.+ +|.+++..     ..+++..++.++.||+.||.|||+ .          ||+||||||+|||++.++ .+||
T Consensus       100 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~al~~LH~-~~~~l~~~~~~~ivH~Dlkp~Nill~~~~-~~kL  172 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-----NVVSWNELCHIAETMARGLAYLHE-DIPGLKDGHKPAISHRDIKSKNVLLKNNL-TACI  172 (322)
T ss_dssp             EEECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHTC-CEEEETTEEECEEECSCCSGGGEEECTTC-CEEE
T ss_pred             EEecCCCCCHHHHHHh-----cCCCHHHHHHHHHHHHHHHHHHHh-hccccccccCCCEEeCCCChHhEEECCCC-eEEE
Confidence            9999985 88888763     569999999999999999999996 5          999999999999999888 8999


Q ss_pred             EeeCCccccccCCC---cccccccccccCcccccCC----cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Q 017452          216 CDFGSAKVLVKGEP---NISYICSRYYRAPELIFGA----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~----~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~  288 (371)
                      +|||+++.......   .....||+.|+|||++.+.    ..++.++|||||||++|+|++|+.||.+............
T Consensus       173 ~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~  252 (322)
T 3soc_A          173 ADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEE  252 (322)
T ss_dssp             CCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHH
T ss_pred             ccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhh
Confidence            99999977544322   2345789999999998653    2345688999999999999999999976543222111111


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCccc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ....+....+......       ......+... .....+.++.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       253 ~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~  318 (322)
T 3soc_A          253 IGQHPSLEDMQEVVVH-------KKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQR  318 (322)
T ss_dssp             HCSSCCHHHHHHHHTT-------SCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hccCCchhhhhhhhhc-------ccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            1222222222110000       0000000000 011234569999999999999999999999999887644

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=6.3e-46  Score=345.03  Aligned_cols=273  Identities=24%  Similarity=0.388  Sum_probs=201.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+..++..||+|++...     .....+|+.+++.++||||+++++++..     ....
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~-----~~~~  106 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYS-----DGEI  106 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEE-----TTEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEE-----CCEE
Confidence            45799999999999999999999999999999998654     2345689999999999999999998854     3347


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+.+..    ...+++..++.++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++..
T Consensus       107 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~  181 (360)
T 3eqc_A          107 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  181 (360)
T ss_dssp             EEEECCCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEECCCCCCHHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCC-CEEEEECCCCcc
Confidence            899999985 88887765    457999999999999999999999733899999999999999988 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh-HHhhcC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE-EIKCMN  302 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  302 (371)
                      .... ......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...+..+....+.......... ......
T Consensus       182 ~~~~-~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (360)
T 3eqc_A          182 LIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  259 (360)
T ss_dssp             HHHH-C----CCCCTTCCHHHHTTC-CCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC----------------
T ss_pred             cccc-cccCCCCCCCeECHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCccc
Confidence            5332 22345789999999999665 48999999999999999999999998766544332221111000000 000000


Q ss_pred             --CCccccc------------cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 --PNYTEFK------------FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 --~~~~~~~------------~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        .....+.            ...+............++.++.+||.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  325 (360)
T 3eqc_A          260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  325 (360)
T ss_dssp             --------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             CCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhC
Confidence              0000000            000000111111234578999999999999999999999998777

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.7e-45  Score=329.30  Aligned_cols=251  Identities=20%  Similarity=0.262  Sum_probs=203.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ....+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+++++.++||||+++++++     ......
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   94 (283)
T 3gen_A           21 IDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC-----TKQRPI   94 (283)
T ss_dssp             CCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEE-----CSSSSE
T ss_pred             CCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEE-----ecCCCe
Confidence            34568999999999999999999875 6778999998653   34567899999999999999999988     344457


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        95 ~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~~~~  169 (283)
T 3gen_A           95 FIITEYMANGCLLNYLREM---RHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRY  169 (283)
T ss_dssp             EEEECCCTTCBHHHHHHCG---GGCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTS-CEEECSTTGGGG
T ss_pred             EEEEeccCCCcHHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHC-CccCCCCccceEEEcCCC-CEEEcccccccc
Confidence            89999997 5777776532   35699999999999999999999987 999999999999999888 899999999976


Q ss_pred             cccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          224 LVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       224 ~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .....  ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+.....         
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~---------  239 (283)
T 3gen_A          170 VLDDEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLR---------  239 (283)
T ss_dssp             BCCHHHHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCC---------
T ss_pred             ccccccccccCCccCcccCCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccC---------
Confidence            53321  122345578899999987554 7999999999999999998 9999988777665555443211         


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                         ...+...++.+.++|.+||+.||.+|||+.+++++|..+
T Consensus       240 -------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~  278 (283)
T 3gen_A          240 -------------------LYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  278 (283)
T ss_dssp             -------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -------------------CCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHH
Confidence                               113455789999999999999999999999999998764

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-45  Score=338.60  Aligned_cols=263  Identities=21%  Similarity=0.309  Sum_probs=182.3

Q ss_pred             CCCCcccceeeeE-eeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           65 GQPKQTISYMAER-IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        65 ~~~~~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ......++|.+.+ .||+|+||.||+|.+..+|+.||||++........+....++.++||||+++++++.... ....+
T Consensus        22 ~~~~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~  100 (336)
T 3fhr_A           22 KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKARQEVDHHWQASGGPHIVCILDVYENMH-HGKRC  100 (336)
T ss_dssp             BCSCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEE
T ss_pred             CCccccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHHHHHHHHHHHHhcCCCChHHHHHHHhhcc-CCCce
Confidence            3344567899965 699999999999999999999999999776555555555677889999999999885533 33566


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCC
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~  220 (371)
                      +++||||+.+ +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++  ..+||+|||+
T Consensus       101 ~~lv~e~~~gg~L~~~l~~~--~~~~l~~~~~~~i~~ql~~~l~~LH~~-~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~  177 (336)
T 3fhr_A          101 LLIIMECMEGGELFSRIQER--GDQAFTEREAAEIMRDIGTAIQFLHSH-NIAHRDVKPENLLYTSKEKDAVLKLTDFGF  177 (336)
T ss_dssp             EEEEEECCTTEEHHHHHHTC---CCCCBHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEeccCCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeecCCCCHHHEEEEecCCCceEEEecccc
Confidence            8899999985 888777642  235799999999999999999999987 999999999999997643  2599999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +...... ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||...................       
T Consensus       178 ~~~~~~~-~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------  248 (336)
T 3fhr_A          178 AKETTQN-ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG-------  248 (336)
T ss_dssp             CEEC-----------------------CH-HHHHHHHHHHHHHHHHHHHSSCCC--------------------------
T ss_pred             ceecccc-ccccCCCCcCccChhhhCCCC-CCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc-------
Confidence            9765432 233567799999999985544 7889999999999999999999997655433211111110000       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                            ...+        .......+++++.+||.+||+.||.+|||+.++++|
T Consensus       249 ------~~~~--------~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  288 (336)
T 3fhr_A          249 ------QYGF--------PNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNH  288 (336)
T ss_dssp             --------CC--------CTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------cccc--------CchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence                  0000        000124579999999999999999999999999988

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=2.1e-45  Score=330.82  Aligned_cols=254  Identities=21%  Similarity=0.321  Sum_probs=210.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ....+|++.+.||+|+||.||+|.+..++..||+|++..+.   ....+|+.+++.++||||+++++++     ......
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-----~~~~~~   84 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-----TREPPF   84 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEE-----CSSSSE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----ccCCCE
Confidence            34568999999999999999999999999999999986543   4456899999999999999999988     344457


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+. ++|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .++|+|||++..
T Consensus        85 ~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~~l~Dfg~~~~  160 (288)
T 3kfa_A           85 YIITEFMTYGNLLDYLREC--NRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRL  160 (288)
T ss_dssp             EEEEECCTTEEHHHHHHHC--CTTTSCHHHHHHHHHHHHHHHHHHHHH-TCCCSCCSGGGEEECGGG-CEEECCCCGGGT
T ss_pred             EEEEEcCCCCcHHHHHHhc--ccCCccHhHHHHHHHHHHHHHHHHHHC-CccCCCCCcceEEEcCCC-CEEEccCcccee
Confidence            89999998 6888877642  245689999999999999999999997 999999999999999887 899999999987


Q ss_pred             cccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          224 LVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       224 ~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ......  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+.......+....          
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~----------  229 (288)
T 3kfa_A          161 MTGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY----------  229 (288)
T ss_dssp             SCSSSSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC----------
T ss_pred             ccCCccccccCCccccCcCChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccC----------
Confidence            643332  12345578899999986554 7899999999999999999 999998877655544433211          


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                        ....+..+++.+.+|+.+||..||.+|||+.++++.|+.+.
T Consensus       230 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~  270 (288)
T 3kfa_A          230 ------------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  270 (288)
T ss_dssp             ------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ------------------CCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHH
Confidence                              11134568999999999999999999999999999987653

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.8e-45  Score=332.28  Aligned_cols=256  Identities=23%  Similarity=0.317  Sum_probs=207.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (371)
                      ..++|++.+.||+|+||.||+|.+     ..+++.||+|++...     .....+|+.+++.+ +||||+++++++.   
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~---   97 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---   97 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe---
Confidence            346899999999999999999985     457789999998643     24456899999999 9999999999883   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhh--------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNK--------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~--------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                        .....++||||+++ +|.+.+.....              ....+++..++.++.||+.||.|||++ ||+||||||+
T Consensus        98 --~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~  174 (313)
T 1t46_A           98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (313)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             --cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCccc
Confidence              33447899999975 88888775431              123589999999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      ||+++.++ .+||+|||++.........   ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+..
T Consensus       175 Nil~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             eEEEcCCC-CEEEccccccccccccccceeccCCCCcceeeChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            99999887 8999999999876544321   2345678899999986544 8999999999999999998 999998876


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..............                           ...+..++.++.++|.+||+.||.+|||+.+++++|+++
T Consensus       253 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  305 (313)
T 1t46_A          253 VDSKFYKMIKEGFR---------------------------MLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (313)
T ss_dssp             SSHHHHHHHHHTCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             chhHHHHHhccCCC---------------------------CCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHH
Confidence            65555444432111                           113455789999999999999999999999999998765


Q ss_pred             C
Q 017452          359 P  359 (371)
Q Consensus       359 ~  359 (371)
                      .
T Consensus       306 ~  306 (313)
T 1t46_A          306 I  306 (313)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=8.5e-45  Score=330.97  Aligned_cols=247  Identities=29%  Similarity=0.401  Sum_probs=199.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .+|.+.+.||+|+||.||+|.+..+|+.||+|.+...  .....+|+.+++.++||||+++++++..     ....++||
T Consensus        29 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~lv~  103 (314)
T 3com_A           29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFK-----NTDLWIVM  103 (314)
T ss_dssp             -CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             hhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe-----CCEEEEEe
Confidence            4799999999999999999999999999999998654  3456789999999999999999998854     33478999


Q ss_pred             ccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||+++ +|.+++..   ....+++..++.++.||+.||.|||++ ||+|+||||+||+++.++ .+||+|||++......
T Consensus       104 e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~dfg~~~~~~~~  178 (314)
T 3com_A          104 EYCGAGSVSDIIRL---RNKTLTEDEIATILQSTLKGLEYLHFM-RKIHRDIKAGNILLNTEG-HAKLADFGVAGQLTDT  178 (314)
T ss_dssp             ECCTTEEHHHHHHH---HTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECBTT
T ss_pred             ecCCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CCcCCCcCHHHEEECCCC-CEEEeecccchhhhhh
Confidence            99985 77777653   256799999999999999999999987 999999999999999888 8999999999765443


Q ss_pred             C-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCcc
Q 017452          228 E-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT  306 (371)
Q Consensus       228 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  306 (371)
                      . ......+++.|+|||.+.+.. ++.++||||||+++|+|++|..||...+.......+.... .+             
T Consensus       179 ~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~-------------  243 (314)
T 3com_A          179 MAKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNP-PP-------------  243 (314)
T ss_dssp             BSCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CC-------------
T ss_pred             ccccCccCCCCCccChhhcCCCC-CCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCC-Cc-------------
Confidence            2 233457899999999986554 7899999999999999999999998776555443332210 00             


Q ss_pred             ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                  ....+..++..+.+||.+||..||.+|||+.++++|
T Consensus       244 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          244 ------------TFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             ------------CCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence                        000233468999999999999999999999998887

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=6e-45  Score=328.94  Aligned_cols=257  Identities=22%  Similarity=0.254  Sum_probs=204.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .++|++.+.||+|+||.||+|.+..+++.||+|++...  .....+|+.+++.++|++++..+..+...    ..+.++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~----~~~~~lv   83 (296)
T 4hgt_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMV   83 (296)
T ss_dssp             ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEE----TTEEEEE
T ss_pred             CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCC----CCceEEE
Confidence            45799999999999999999999999999999986443  45567899999999999888877666432    3347899


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee---eCCCCcEEEEeeCCcccc
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli---~~~~~~~kl~Dfg~a~~~  224 (371)
                      |||++++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+|||+   +.++ .+||+|||++...
T Consensus        84 ~e~~~~~L~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivH~Dlkp~NIl~~~~~~~~-~~kL~Dfg~a~~~  158 (296)
T 4hgt_A           84 MELLGPSLEDLFNFC---SRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGN-LVYIIDFGLAKKY  158 (296)
T ss_dssp             EECCCCBHHHHHHHT---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECCGGGTT-CEEECCCTTCEEC
T ss_pred             EEccCCCHHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CeecCCCCHHHeeeeccCCCC-eEEEecCccceec
Confidence            999988988887642   45799999999999999999999987 99999999999999   6666 8999999999876


Q ss_pred             ccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH---HHHHHHHHHhCCC
Q 017452          225 VKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV---DQLVEIIKVLGTP  293 (371)
Q Consensus       225 ~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~---~~~~~~~~~~~~~  293 (371)
                      .....        .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+....   ..+..+.......
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~  237 (296)
T 4hgt_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMST  237 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHS
T ss_pred             cCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccc
Confidence            44322        23457899999999997654 899999999999999999999999764432   2233332221111


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      +...                        ....+++++.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       238 ~~~~------------------------~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~  280 (296)
T 4hgt_A          238 PIEV------------------------LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  280 (296)
T ss_dssp             CHHH------------------------HTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHH
T ss_pred             hhhh------------------------hhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHH
Confidence            1111                        224578999999999999999999999999999887643

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=3.2e-45  Score=334.26  Aligned_cols=261  Identities=23%  Similarity=0.341  Sum_probs=205.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|++...    .....+|+.+++.++||||+++++++.... ......++
T Consensus        29 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~~~~~l  107 (317)
T 2buj_A           29 KHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRER-GAKHEAWL  107 (317)
T ss_dssp             EEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEE-TTEEEEEE
T ss_pred             eEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEecc-CCCceeEE
Confidence            4799999999999999999999999999999988543    344568999999999999999999886433 24556789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus       108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivH~dlkp~NIl~~~~~-~~kl~dfg~~~~~~  185 (317)
T 2buj_A          108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK-GYAHRDLKPTNILLGDEG-QPVLMDLGSMNQAC  185 (317)
T ss_dssp             EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCSSCEESC
T ss_pred             EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEcCCC-CEEEEecCcchhcc
Confidence            9999986 88888887665667899999999999999999999987 999999999999999888 89999999887542


Q ss_pred             cCCC----------cccccccccccCcccccCCc--CCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCC
Q 017452          226 KGEP----------NISYICSRYYRAPELIFGAT--EYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGT  292 (371)
Q Consensus       226 ~~~~----------~~~~~~t~~y~aPE~~~~~~--~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~  292 (371)
                      ....          .....||+.|+|||.+.+..  .++.++||||||+++|+|++|+.||...... .........   
T Consensus       186 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~---  262 (317)
T 2buj_A          186 IHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN---  262 (317)
T ss_dssp             EEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC---
T ss_pred             cccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc---
Confidence            2111          11345699999999986443  2588999999999999999999999431100 001111110   


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                    ....+          .+..++.++.++|.+||+.||.+|||+.+++++|..+...
T Consensus       263 --------------~~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          263 --------------QLSIP----------QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             --------------C--CC----------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             --------------cCCCC----------ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence                          00000          1245789999999999999999999999999999887543

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=337.40  Aligned_cols=258  Identities=21%  Similarity=0.284  Sum_probs=205.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (371)
                      ...+|.+.+.||+|+||.||+|.+     ..++..||+|++...     .....+|+.+++.+ +||||+++++++.   
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~---  119 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT---  119 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            346899999999999999999997     346678999998643     24456899999999 8999999999883   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhc-------------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEee
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL-------------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHR  197 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~-------------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~  197 (371)
                        .....++||||+++ +|.+.+......                   ...+++..++.++.||+.||.|||++ ||+||
T Consensus       120 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivH~  196 (344)
T 1rjb_A          120 --LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHR  196 (344)
T ss_dssp             --SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEET
T ss_pred             --eCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CcccC
Confidence              33447899999974 888887653211                   13479999999999999999999987 99999


Q ss_pred             ccCCCceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCC
Q 017452          198 DIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPL  273 (371)
Q Consensus       198 dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~p  273 (371)
                      ||||+||+++.++ .+||+|||++.........   ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..|
T Consensus       197 Dikp~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p  274 (344)
T 1rjb_A          197 DLAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNP  274 (344)
T ss_dssp             TCSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCS
T ss_pred             CCChhhEEEcCCC-cEEeCCCccCcccccCccceeccCccCccCccCHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCC
Confidence            9999999999888 8999999999866443322   2345688899999986554 7999999999999999998 9999


Q ss_pred             CCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          274 FPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       274 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                      |.+......+..+.....                           ....+..+++++.+||.+||+.||.+|||+.++++
T Consensus       275 ~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  327 (344)
T 1rjb_A          275 YPGIPVDANFYKLIQNGF---------------------------KMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTS  327 (344)
T ss_dssp             STTCCCSHHHHHHHHTTC---------------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccCCcHHHHHHHHhcCC---------------------------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            988765555444443210                           00134557899999999999999999999999999


Q ss_pred             hhcCCCcc
Q 017452          354 LFSNCPSL  361 (371)
Q Consensus       354 ~l~~~~~~  361 (371)
                      +|..+...
T Consensus       328 ~l~~~~~~  335 (344)
T 1rjb_A          328 FLGCQLAD  335 (344)
T ss_dssp             HHHHHC--
T ss_pred             HHHHHHHH
Confidence            98876443

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.1e-45  Score=336.73  Aligned_cols=251  Identities=23%  Similarity=0.306  Sum_probs=200.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcE----EEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGET----VAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...+|++.+.||+|+||.||+|.+..++..    ||+|.+...     .....+|+.+++.++||||+++++++.     
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----   85 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----   85 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-----
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----
Confidence            345799999999999999999999888876    677766432     234557999999999999999999762     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                       ....++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        86 -~~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  159 (325)
T 3kex_A           86 -GSSLQLVTQYLPLGSLLDHVRQ---HRGALGPQLLLNWGVQIAKGMYYLEEH-GMVHRNLAARNVLLKSPS-QVQVADF  159 (325)
T ss_dssp             -BSSEEEEEECCTTCBSHHHHHS---SGGGSCTTHHHHHHHHHHHHHHHHHHT-TCCCSCCSSTTEEESSSS-CEEECSC
T ss_pred             -CCccEEEEEeCCCCCHHHHHHH---ccccCCHHHHHHHHHHHHHHHHHHHhC-CCCCCccchheEEECCCC-eEEECCC
Confidence             122679999998 577766653   235789999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          219 GSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       219 g~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+++.......   .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+....    
T Consensus       160 g~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~----  234 (325)
T 3kex_A          160 GVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGE----  234 (325)
T ss_dssp             SGGGGSCCCTTCCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTC----
T ss_pred             CcccccCcccccccccCCCCcccccChHHhccCC-CChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCC----
Confidence            99987644332   23455678899999996554 8999999999999999999 999998876555444433210    


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                              ....+..++.++.+++.+||..||.+|||+.+++++|..+.
T Consensus       235 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~  275 (325)
T 3kex_A          235 ------------------------RLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMA  275 (325)
T ss_dssp             ------------------------BCCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHT
T ss_pred             ------------------------CCCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                    00134457889999999999999999999999999987764

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.6e-45  Score=337.82  Aligned_cols=254  Identities=22%  Similarity=0.306  Sum_probs=205.1

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEE--EEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETV--AIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v--aiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~  140 (371)
                      ..++|++.+.||+|+||.||+|.+..++..+  |+|.+...     .....+|+++++.+ +||||+++++++..     
T Consensus        23 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~-----   97 (327)
T 1fvr_A           23 DWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH-----   97 (327)
T ss_dssp             CGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEE-----
T ss_pred             cHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeee-----
Confidence            3478999999999999999999998888865  99988542     34456899999999 89999999998843     


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhh------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFN------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                      ....++||||+++ +|.+.+....            .....+++..++.++.||+.||.|||++ ||+||||||+||+++
T Consensus        98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~  176 (327)
T 1fvr_A           98 RGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVG  176 (327)
T ss_dssp             TTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEC
T ss_pred             CCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCccceEEEc
Confidence            3458899999974 8888876532            2235799999999999999999999987 999999999999999


Q ss_pred             CCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017452          208 PHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (371)
Q Consensus       208 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  286 (371)
                      .++ .+||+|||++.............+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       177 ~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~  254 (327)
T 1fvr_A          177 ENY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL  254 (327)
T ss_dssp             GGG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHG
T ss_pred             CCC-eEEEcccCcCccccccccccCCCCCccccChhhhcccc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHh
Confidence            887 89999999997554433344456688999999986544 7899999999999999998 99999887655544333


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ....                            ....+..+++++.+||.+||..||.+|||+.+++++|..+
T Consensus       255 ~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~  298 (327)
T 1fvr_A          255 PQGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM  298 (327)
T ss_dssp             GGTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             hcCC----------------------------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            2110                            0113456789999999999999999999999999998765

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4e-45  Score=331.02  Aligned_cols=259  Identities=21%  Similarity=0.308  Sum_probs=198.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-hhhHHHHHHHHH--cCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..++|++.+.||+|+||.||+|.+  +|+.||||++.... ....+|.+++..  ++||||+++++++.... .....++
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~-~~~~~~~   82 (301)
T 3q4u_A            6 VARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSR-HSSTQLW   82 (301)
T ss_dssp             CGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeecccc-CCCceeE
Confidence            456899999999999999999987  78999999986543 334567777776  79999999999876543 3455678


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--------RSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                      +||||+.+ +|.+.+.     ...+++..++.++.||+.||.|||        ++ ||+||||||+|||++.++ .+||+
T Consensus        83 lv~e~~~~g~L~~~l~-----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~Nill~~~~-~~kl~  155 (301)
T 3q4u_A           83 LITHYHEMGSLYDYLQ-----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP-AIAHRDLKSKNILVKKNG-QCCIA  155 (301)
T ss_dssp             EEECCCTTCBHHHHHT-----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC-EEECSCCCGGGEEECTTS-CEEEC
T ss_pred             EehhhccCCCHHHHHh-----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC-CeecCCCChHhEEEcCCC-CEEEe
Confidence            99999985 8877774     467999999999999999999999        76 999999999999999888 89999


Q ss_pred             eeCCccccccCCCc-----ccccccccccCcccccCCcC-----CCCcchHHHHHHHHHHHHhC----------CCCCCC
Q 017452          217 DFGSAKVLVKGEPN-----ISYICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLG----------KPLFPG  276 (371)
Q Consensus       217 Dfg~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~  276 (371)
                      |||++.........     ....||+.|+|||++.+...     ++.++|||||||++|+|++|          ..||..
T Consensus       156 Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~  235 (301)
T 3q4u_A          156 DLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD  235 (301)
T ss_dssp             CCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTT
T ss_pred             eCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccc
Confidence            99999765443322     23478999999999966532     34689999999999999999          888855


Q ss_pred             CCc----HHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          277 DSG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       277 ~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                      ...    ...+..........                 +..    ....++...++++.+|+.+||+.||.+|||+.+++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~-----------------~~~----~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~  294 (301)
T 3q4u_A          236 VVPNDPSFEDMRKVVCVDQQR-----------------PNI----PNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIK  294 (301)
T ss_dssp             TSCSSCCHHHHHHHHTTSCCC-----------------CCC----CGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHH
T ss_pred             cCCCCcchhhhhHHHhccCCC-----------------CCC----ChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHH
Confidence            322    12222221110000                 000    00001233567899999999999999999999999


Q ss_pred             hhhcCC
Q 017452          353 ILFSNC  358 (371)
Q Consensus       353 ~~l~~~  358 (371)
                      +.|+.+
T Consensus       295 ~~L~~i  300 (301)
T 3q4u_A          295 KTLTKI  300 (301)
T ss_dssp             HHHHHH
T ss_pred             HHHhcc
Confidence            998754

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.7e-45  Score=335.09  Aligned_cols=263  Identities=15%  Similarity=0.154  Sum_probs=198.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECC---CCcEEEEEEeecchhh---------------hHHHHHHHHHcCCCCeeeccee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRY---------------KNRELQTMRLLDHPNVVSLKHC  132 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~~~~---------------~~~e~~~l~~l~h~niv~~~~~  132 (371)
                      ++|++.+.||+|+||.||+|.+..   ++..+|+|++......               ..+|+..++.++||||++++++
T Consensus        37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~  116 (345)
T 2v62_A           37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS  116 (345)
T ss_dssp             CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred             ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence            579999999999999999999987   7889999998654322               2346667777899999999998


Q ss_pred             EEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC-C
Q 017452          133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT-H  211 (371)
Q Consensus       133 ~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~-~  211 (371)
                      +.... .+..+.++||||++++|.+++..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .
T Consensus       117 ~~~~~-~~~~~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          117 GLTEF-KGRSYRFMVMERLGIDLQKISGQ----NGTFKKSTVLQLGIRMLDVLEYIHEN-EYVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEES-SSCEEEEEEEECEEEEHHHHCBG----GGBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEESSSTT
T ss_pred             ccccc-CCCcEEEEEEeccCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCcCHHHEEEccCCCC
Confidence            86643 33567899999997788776653    34899999999999999999999987 999999999999998654 2


Q ss_pred             cEEEEeeCCccccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCC-CcHHH
Q 017452          212 QVKLCDFGSAKVLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD-SGVDQ  282 (371)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~-~~~~~  282 (371)
                      .+||+|||+++.......        .....||+.|+|||++.+.. ++.++|||||||++|+|++|+.||... .....
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~  269 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVA  269 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHHHHHHHHHHhCCCCccccccccHH
Confidence            799999999976533211        13457899999999997654 799999999999999999999999553 23232


Q ss_pred             HHHHHH-HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          283 LVEIIK-VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       283 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ...... .....+.......                    -...++.++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~--------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  328 (345)
T 2v62_A          270 VQTAKTNLLDELPQSVLKWA--------------------PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHGI  328 (345)
T ss_dssp             HHHHHHHHHHTTTHHHHHHS--------------------CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTCC
T ss_pred             HHHHHHhhcccccHHHHhhc--------------------cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccCC
Confidence            222222 2222221111110                    112578999999999999999999999999999988653

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=6.1e-45  Score=331.85  Aligned_cols=260  Identities=19%  Similarity=0.267  Sum_probs=199.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECC---CCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...+|.+.+.||+|+||.||+|.+..   ++..||+|++...      .....+|+.+++.++||||+++++++......
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~  111 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ  111 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC----
T ss_pred             CHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecccc
Confidence            34579999999999999999998765   5568999998643      13356799999999999999999998765544


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhh--hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFN--KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                      .....++||||+.+ +|.+.+....  .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+
T Consensus       112 ~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kl~  189 (313)
T 3brb_A          112 GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR-NFLHRDLAARNCMLRDDM-TVCVA  189 (313)
T ss_dssp             ---CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT-TCCCCCCSGGGEEECTTS-CEEEC
T ss_pred             CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEEe
Confidence            44457899999985 7777775432  2346799999999999999999999987 999999999999999888 89999


Q ss_pred             eeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCC
Q 017452          217 DFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       217 Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |||++.......   ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+..... 
T Consensus       190 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~-  267 (313)
T 3brb_A          190 DFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRV-YTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHR-  267 (313)
T ss_dssp             SCSCC----------------CCGGGSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-
T ss_pred             ecCcceecccccccCcccccCCCccccCchhhcCCC-ccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCC-
Confidence            999997654332   122345678899999996644 7999999999999999999 8999988776665554433110 


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                                 ...+..+++++.++|.+||..||.+|||+.+++++|..+.
T Consensus       268 ---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~  307 (313)
T 3brb_A          268 ---------------------------LKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLL  307 (313)
T ss_dssp             ---------------------------CCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ---------------------------CCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence                                       0134568899999999999999999999999999988753

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=3.7e-45  Score=328.18  Aligned_cols=253  Identities=26%  Similarity=0.352  Sum_probs=195.5

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ....++|++.+.||+|+||.||+|.+..+   +..||+|++...     .....+|+.+++.++||||+++++++.    
T Consensus        11 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~----   86 (281)
T 1mp8_A           11 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT----   86 (281)
T ss_dssp             BCCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC----
T ss_pred             EEehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEc----
Confidence            34456899999999999999999998654   457999987542     234567999999999999999998862    


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                       + ...++||||+.+ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        87 -~-~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  159 (281)
T 1mp8_A           87 -E-NPVWIIMELCTLGELRSFLQVR---KYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGD  159 (281)
T ss_dssp             -S-SSCEEEEECCTTEEHHHHHHHT---TTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC
T ss_pred             -c-CccEEEEecCCCCCHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhC-CeecccccHHHEEECCCC-CEEECc
Confidence             1 225799999985 777777542   34689999999999999999999987 999999999999999887 899999


Q ss_pred             eCCccccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          218 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       218 fg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ||++........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+.....   
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~---  235 (281)
T 1mp8_A          160 FGLSRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGER---  235 (281)
T ss_dssp             -------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC---
T ss_pred             cccccccCcccccccccCCCcccccChhhcccCC-CCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCC---
Confidence            999987644322  22345578899999986544 7899999999999999996 9999988776665554433110   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                               ..++..+++++.+++.+||+.||.+|||+.+++++|..+.
T Consensus       236 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~  275 (281)
T 1mp8_A          236 -------------------------LPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  275 (281)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence                                     0134568999999999999999999999999999988753

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.3e-45  Score=334.19  Aligned_cols=256  Identities=21%  Similarity=0.298  Sum_probs=207.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (371)
                      ...+|++.+.||+|+||.||+|.+..++.     .||+|.+...     .....+|+.+++.+ +||||+++++++.   
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~---  120 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACT---  120 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe---
Confidence            34679999999999999999999877664     7999998653     23456899999999 8999999999883   


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhc----------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL----------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~----------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                        .....++||||+++ +|.+.+......          ...+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus       121 --~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 --HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK-NCIHRDVAARNVLL  197 (333)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGCEE
T ss_pred             --cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC-CcccCCcccceEEE
Confidence              33447899999975 888888754321          35689999999999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQ  282 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~  282 (371)
                      +.++ .+||+|||++.........   ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+......
T Consensus       198 ~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~  275 (333)
T 2i1m_A          198 TNGH-VAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK  275 (333)
T ss_dssp             EGGG-EEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHH
T ss_pred             CCCC-eEEECccccccccccccceeecCCCCCCccccCHHHhccCC-CChHHHHHHHHHHHHHHHcCCCCCCcccchhHH
Confidence            9887 8999999999865443321   2345678899999986544 7899999999999999998 9999988766555


Q ss_pred             HHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      ...+......+                           ..+...++.+.++|.+||+.||.+|||+.+++++|+.+.
T Consensus       276 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~  325 (333)
T 2i1m_A          276 FYKLVKDGYQM---------------------------AQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQA  325 (333)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHH
Confidence            55544421110                           134457899999999999999999999999999987653

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.7e-45  Score=333.31  Aligned_cols=261  Identities=20%  Similarity=0.238  Sum_probs=209.7

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTT  137 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~  137 (371)
                      ...++|++.+.||+|+||.||+|.+.     .+++.||+|++....     ....+|+.+++.++||||+++++++    
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~----   97 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVV----   97 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEE----
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEE----
Confidence            34468999999999999999999876     457889999986432     2355799999999999999999988    


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKL------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                       ......++||||+.+ +|.+.+......      ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++
T Consensus        98 -~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~NIli~~~~  175 (322)
T 1p4o_A           98 -SQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF  175 (322)
T ss_dssp             -CSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC
T ss_pred             -ccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC-CCccCCCccceEEEcCCC
Confidence             333447899999984 888887754321      24678999999999999999999987 999999999999999888


Q ss_pred             CcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHH
Q 017452          211 HQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEI  286 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~  286 (371)
                       .+||+|||++........   .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+
T Consensus       176 -~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  253 (322)
T 1p4o_A          176 -TVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFV  253 (322)
T ss_dssp             -CEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHH
T ss_pred             -eEEECcCccccccccccccccccCCCCCCCccChhhhccCC-CCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHH
Confidence             899999999976543321   12345688899999986544 7899999999999999999 89999887665554443


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhh
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVL  364 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~  364 (371)
                      .....                            ...+..++..+.++|.+||+.||.+|||+.+++++|+.+....+.
T Consensus       254 ~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~~~~  303 (322)
T 1p4o_A          254 MEGGL----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR  303 (322)
T ss_dssp             HTTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHH
T ss_pred             HcCCc----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhccCCc
Confidence            32100                            003456889999999999999999999999999999887655443

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=7.3e-45  Score=329.53  Aligned_cols=249  Identities=25%  Similarity=0.399  Sum_probs=198.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.||+|++...    .....+|+.+++.++||||+++++++..     ....+
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-----~~~~~   92 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYH-----DGKLW   92 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEEC-----C-CEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeee-----CCeEE
Confidence            45799999999999999999999999999999988543    2445679999999999999999998843     33478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+++ +|...+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        93 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~Dfg~~~~~  167 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLE---LDRGLTEPQIQVVCRQMLEALNFLHSK-RIIHRDLKAGNVLMTLEG-DIRLADFGVSAKN  167 (302)
T ss_dssp             EEEECCTTEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTS-CEEECCCHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHh---hccCCCHHHHHHHHHHHHHHHHHHhcC-CcccCCCCHHHEEECCCC-CEEEEECCCCccc
Confidence            99999985 66665543   246799999999999999999999987 999999999999999888 8999999987543


Q ss_pred             ccC-CCcccccccccccCccccc----CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          225 VKG-EPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ... .......||+.|+|||.+.    ....++.++||||||+++|+|++|..||...+.......+......       
T Consensus       168 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  240 (302)
T 2j7t_A          168 LKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPP-------  240 (302)
T ss_dssp             HHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-------
T ss_pred             cccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCc-------
Confidence            211 1223456899999999984    3345789999999999999999999999887766655554432100       


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         ....+..++..+.++|.+||+.||.+|||+.++++|
T Consensus       241 -------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          241 -------------------TLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             -------------------CCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             -------------------ccCCccccCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                               001234578899999999999999999999997776

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1e-44  Score=333.45  Aligned_cols=257  Identities=21%  Similarity=0.310  Sum_probs=205.3

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC-------CCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL-------ETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFF  134 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~-------~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~  134 (371)
                      ...++|++.+.||+|+||.||+|.+.       .++..||+|++....     ....+|+.+++.+ +||||+++++++ 
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~-  110 (334)
T 2pvf_A           32 FPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGAC-  110 (334)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-
T ss_pred             CCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEE-
Confidence            34468999999999999999999975       467789999986532     3456799999999 899999999988 


Q ss_pred             ecCCCCceeEEEeeccccc-hHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCC
Q 017452          135 STTDKDELYLNLVLEYVPE-TVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKP  201 (371)
Q Consensus       135 ~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp  201 (371)
                          ......++||||+.+ +|.+++.....            ....+++..++.++.||+.||.|||++ ||+||||||
T Consensus       111 ----~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp  185 (334)
T 2pvf_A          111 ----TQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ-KCIHRDLAA  185 (334)
T ss_dssp             ----CSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSG
T ss_pred             ----ccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCcc
Confidence                334457899999985 88888765321            123589999999999999999999987 999999999


Q ss_pred             CceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q 017452          202 QNLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGD  277 (371)
Q Consensus       202 ~NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~  277 (371)
                      +||+++.++ .+||+|||++........   .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.
T Consensus       186 ~NIll~~~~-~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          186 RNVLVTENN-VMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRV-YTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             GGEEECTTC-CEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ceEEEcCCC-CEEEccccccccccccccccccCCCCcccceeChHHhcCCC-cChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            999999888 899999999986544322   22345678899999986544 7899999999999999999 99999887


Q ss_pred             CcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          278 SGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ...+....+.....                            ...+..++.++.++|.+||+.||.+|||+.+++++|+.
T Consensus       264 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~  315 (334)
T 2pvf_A          264 PVEELFKLLKEGHR----------------------------MDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDR  315 (334)
T ss_dssp             CHHHHHHHHHHTCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             CHHHHHHHHhcCCC----------------------------CCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            66555444433210                            01345688999999999999999999999999999887


Q ss_pred             CCc
Q 017452          358 CPS  360 (371)
Q Consensus       358 ~~~  360 (371)
                      +..
T Consensus       316 l~~  318 (334)
T 2pvf_A          316 ILT  318 (334)
T ss_dssp             HHH
T ss_pred             HHh
Confidence            643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.2e-44  Score=329.53  Aligned_cols=258  Identities=29%  Similarity=0.440  Sum_probs=196.9

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||+|++...       .....+|+.+++.++||||+++++++..     .
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-----~  104 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIE-----D  104 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEc-----C
Confidence            345799999999999999999999999999999998642       2345679999999999999999998854     3


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+.+ +|.+++.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dl~p~NIl~~~~~-~~kl~Dfg~  182 (310)
T 2wqm_A          105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR-RVMHRDIKPANVFITATG-VVKLGDLGL  182 (310)
T ss_dssp             TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCC--
T ss_pred             CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCcHHHEEEcCCC-CEEEEeccc
Confidence            347899999986 88888877666677899999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCCC-cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHHHhCCCCHhHH
Q 017452          221 AKVLVKGEP-NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGV-DQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       221 a~~~~~~~~-~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~  298 (371)
                      +........ .....+++.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.... ..+........       
T Consensus       183 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-------  254 (310)
T 2wqm_A          183 GRFFSSKTTAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD-------  254 (310)
T ss_dssp             ----------------CCSSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTC-------
T ss_pred             eeeecCCCccccccCCCeeEeChHHhCCCC-CCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhccc-------
Confidence            876543322 23456899999999986544 789999999999999999999999764321 12211111100       


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                 +        .......++.++.++|.+||+.||.+|||+.+++++|..+..
T Consensus       255 -----------~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~  297 (310)
T 2wqm_A          255 -----------Y--------PPLPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA  297 (310)
T ss_dssp             -----------S--------CCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -----------C--------CCCcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHH
Confidence                       0        001224578999999999999999999999999999887744

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-45  Score=334.60  Aligned_cols=260  Identities=25%  Similarity=0.373  Sum_probs=188.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++...     .....+|+.+++.++||||+++++++...     ..
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-----~~   87 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-----DE   87 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-----SC
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-----CC
Confidence            345799999999999999999999889999999988543     23445788889999999999999988443     34


Q ss_pred             EEEeecccc-chHHHHHHHhhh----ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNK----LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .++||||++ ++|.+++.....    ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        88 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~-~~kl~df  165 (303)
T 2vwi_A           88 LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN-GQIHRDVKAGNILLGEDG-SVQIADF  165 (303)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEECTTC-CEEECCC
T ss_pred             cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCCCCChhhEEEcCCC-CEEEEec
Confidence            789999997 588887765432    235689999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCC------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Q 017452          219 GSAKVLVKGE------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT  292 (371)
Q Consensus       219 g~a~~~~~~~------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~  292 (371)
                      |++.......      ......||+.|+|||.+.+...++.++||||||+++|+|++|..||................  
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--  243 (303)
T 2vwi_A          166 GVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQND--  243 (303)
T ss_dssp             HHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSS--
T ss_pred             cchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccC--
Confidence            9987654321      12345689999999998654457999999999999999999999998876655443332211  


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ++.                 .............++.++.++|.+||+.||.+|||+.++++|
T Consensus       244 ~~~-----------------~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          244 PPS-----------------LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             CCC-----------------TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCc-----------------cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            000                 000000111345678999999999999999999999998877

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.3e-44  Score=329.08  Aligned_cols=254  Identities=24%  Similarity=0.296  Sum_probs=197.1

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....       ....+|+.+++.++||||+++++++..     .
T Consensus        32 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  106 (309)
T 2h34_A           32 QFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEI-----D  106 (309)
T ss_dssp             --CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----T
T ss_pred             EeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEee-----C
Confidence            3467999999999999999999999999999999986432       345679999999999999999998844     3


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+++ +|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       107 ~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~NIl~~~~~-~~kl~Dfg~  180 (309)
T 2h34_A          107 GQLYVDMRLINGVDLAAMLRR----QGPLAPPRAVAIVRQIGSALDAAHAA-GATHRDVKPENILVSADD-FAYLVDFGI  180 (309)
T ss_dssp             TEEEEEEECCCCEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSCCC
T ss_pred             CeEEEEEEecCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-cCCcCCCChHHEEEcCCC-CEEEecCcc
Confidence            457899999985 88877764    36799999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          221 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       221 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      +.......  ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.. .+....... .+     
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~-~~~~~~~~~-~~-----  252 (309)
T 2h34_A          181 ASATTDEKLTQLGNTVGTLYYMAPERFSES-HATYRADIYALTCVLYECLTGSPPYQGDQLS-VMGAHINQA-IP-----  252 (309)
T ss_dssp             ----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHH-HHHHHHHSC-CC-----
T ss_pred             CccccccccccccccCCCcCccCHHHHcCC-CCCchHhHHHHHHHHHHHHHCCCCCCCchHH-HHHHHhccC-CC-----
Confidence            87654332  22345689999999998654 4789999999999999999999999875543 222222210 00     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-CHHHHhhhhcCCCc
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TAVSKRILFSNCPS  360 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-t~~~~l~~l~~~~~  360 (371)
                                         .....+..++.++.++|.+||+.||.+|| ++.++++.|+....
T Consensus       253 -------------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~  296 (309)
T 2h34_A          253 -------------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALA  296 (309)
T ss_dssp             -------------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC
T ss_pred             -------------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHH
Confidence                               01113456899999999999999999999 99999999876644

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.4e-44  Score=345.45  Aligned_cols=253  Identities=21%  Similarity=0.296  Sum_probs=205.9

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ....+|++.+.||+|+||.||+|.+  .|+.||||++...  ...+.+|+.+++.++||||+++++++...    ...++
T Consensus       190 i~~~~~~~~~~lG~G~fg~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~----~~~~~  263 (450)
T 1k9a_A          190 LNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLY  263 (450)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECT----TSCEE
T ss_pred             cChHHeEEEeeecCcCCeeEEEEEe--cCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcC----CCceE
Confidence            3456899999999999999999987  4789999999654  34567899999999999999999987542    22478


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+.+ +|.+.+....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       264 iv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  339 (450)
T 1k9a_A          264 IVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEA  339 (450)
T ss_dssp             EEEECCTTCBHHHHHHHHC--TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEEecCCCcHHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEECCCC-CEEEeeCCCcccc
Confidence            99999984 8888876532  33479999999999999999999987 999999999999999888 8999999999854


Q ss_pred             ccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  .....+++.|+|||++.+.. ++.++||||||+++|+|++ |..||......+....+.+...            
T Consensus       340 ~~~--~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~------------  404 (450)
T 1k9a_A          340 SST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK------------  404 (450)
T ss_dssp             C--------CCCTTTSCHHHHHSSC-CCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC------------
T ss_pred             ccc--ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------------
Confidence            322  22335688899999997654 8999999999999999998 9999988766555544433110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                      ...+..+++++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       405 ----------------~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          405 ----------------MDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             ----------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence                            014566899999999999999999999999999998876543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.7e-45  Score=323.57  Aligned_cols=252  Identities=14%  Similarity=0.202  Sum_probs=204.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ...+|++.+.||+|+||.||+|.+  ++..||+|++...      .....+|+.+++.++||||+++++++...   ...
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~--~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---~~~   82 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRW--QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSP---PAP   82 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTT---TSS
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEE--CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccC---CCC
Confidence            456899999999999999999998  4889999998643      23456789999999999999999987432   224


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ..++||||+++ +|.+.+...  ....+++..++.++.||+.||.|||++ |  |+||||||+||+++.++ .++|+|||
T Consensus        83 ~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~~~i~H~dikp~Nil~~~~~-~~~l~~~~  158 (271)
T 3kmu_A           83 HPTLITHWMPYGSLYNVLHEG--TNFVVDQSQAVKFALDMARGMAFLHTL-EPLIPRHALNSRSVMIDEDM-TARISMAD  158 (271)
T ss_dssp             SCEEEEECCTTCBHHHHHHSC--SSCCCCHHHHHHHHHHHHHHHHHHTTS-SSCCTTCCCSGGGEEECTTS-CEEEEGGG
T ss_pred             CeEeeecccCCCcHHHHHhhc--ccCCCCHHHHHHHHHHHHHHHHHHhcC-CCceecCCCccceEEEcCCc-ceeEEecc
Confidence            57899999985 888887642  123589999999999999999999986 8  99999999999999887 89999998


Q ss_pred             CccccccCCCcccccccccccCcccccCCcC--CCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ++...    ......+|+.|+|||.+.+...  ++.++||||||+++|+|++|+.||...+..+....+.....      
T Consensus       159 ~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~------  228 (271)
T 3kmu_A          159 VKFSF----QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGL------  228 (271)
T ss_dssp             SCCTT----SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCC------
T ss_pred             ceeee----cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCC------
Confidence            87543    2234577999999999976442  23379999999999999999999988776665554433211      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                           ...++..+++++.+++.+||+.||.+|||+.++++.|+.+..
T Consensus       229 ---------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          229 ---------------------RPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             ---------------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             ---------------------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence                                 111456689999999999999999999999999999887643

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.2e-45  Score=334.08  Aligned_cols=240  Identities=25%  Similarity=0.378  Sum_probs=198.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHcC--CCCeeecceeEEec
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFST  136 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~  136 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||||++....          ....+|+.+++.+.  |+||+++++++.  
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~--  118 (320)
T 3a99_A           41 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE--  118 (320)
T ss_dssp             CTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE--
T ss_pred             ccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe--
Confidence            3457999999999999999999999999999999986532          34457999999996  599999999883  


Q ss_pred             CCCCceeEEEeecccc--chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEE
Q 017452          137 TDKDELYLNLVLEYVP--ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVK  214 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~--~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~k  214 (371)
                         .....++|||++.  ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+.+.+|
T Consensus       119 ---~~~~~~lv~e~~~~~~~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dlkp~NIll~~~~~~~k  190 (320)
T 3a99_A          119 ---RPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELK  190 (320)
T ss_dssp             ---CSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEE
T ss_pred             ---cCCcEEEEEEcCCCCccHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CcEeCCCCHHHEEEeCCCCCEE
Confidence               3445789999987  688877765    46789999999999999999999987 9999999999999994434899


Q ss_pred             EEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          215 LCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       215 l~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+|||++...... ......||+.|+|||.+.+....+.++||||||+++|+|++|+.||....      .+...     
T Consensus       191 L~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~-----  258 (320)
T 3a99_A          191 LIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG-----  258 (320)
T ss_dssp             ECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC-----
T ss_pred             EeeCccccccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhcc-----
Confidence            9999999876433 23356789999999998766655788999999999999999999996532      11110     


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                              ...++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       259 ------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          259 ------------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             ------------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ------------------------cccccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                    001345689999999999999999999999998877

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=5.8e-45  Score=334.11  Aligned_cols=250  Identities=24%  Similarity=0.346  Sum_probs=196.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEE----EEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETV----AIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...+|++.+.||+|+||.||+|.+..+++.+    |+|.+...     ...+.+|+.+++.++||||+++++++...   
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS---   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS---
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC---
Confidence            3457999999999999999999998887654    77766422     34566899999999999999999988531   


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                        . .++|++|+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus        90 --~-~~~v~e~~~~g~L~~~l~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivH~Dikp~NIll~~~~-~~kl~Df  161 (327)
T 3poz_A           90 --T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDF  161 (327)
T ss_dssp             --S-EEEEEECCTTCBHHHHHHHS---TTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCT
T ss_pred             --C-eEEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CeeCCCCChheEEECCCC-CEEEccC
Confidence              1 467888877 5777766542   46799999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          219 GSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       219 g~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |+++........   ....+|+.|+|||.+.+.. ++.++|||||||++|+|++ |..||.+....+....+......  
T Consensus       162 g~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~--  238 (327)
T 3poz_A          162 GLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL--  238 (327)
T ss_dssp             THHHHHTTTCC-------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC--
T ss_pred             cceeEccCCcccccccCCCccccccChHHhccCC-CCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCC--
Confidence            999876443322   2344577899999997654 7999999999999999999 99999887665544333221100  


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                ..+..++.++.+++.+||+.||.+|||+.+++++|..+
T Consensus       239 --------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~  276 (327)
T 3poz_A          239 --------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  276 (327)
T ss_dssp             --------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHH
T ss_pred             --------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHH
Confidence                                      03445789999999999999999999999999998765

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.7e-44  Score=323.79  Aligned_cols=253  Identities=26%  Similarity=0.326  Sum_probs=202.2

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECC---CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~---~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ....++|++.+.||+|+||.||+|.+..   ++..||+|.+...     .....+|+.+++.++||||+++++++.    
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~----   83 (281)
T 3cc6_A            8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE----   83 (281)
T ss_dssp             SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC----
T ss_pred             eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc----
Confidence            3445689999999999999999998653   3456999998653     344567999999999999999999862    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                       .. ..++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        84 -~~-~~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~kl~D  156 (281)
T 3cc6_A           84 -EE-PTWIIMELYPYGELGHYLERN---KNSLKVLTLVLYSLQICKAMAYLESI-NCVHRDIAVRNILVASPE-CVKLGD  156 (281)
T ss_dssp             -SS-SCEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEEETT-EEEECC
T ss_pred             -CC-CCEEEEecCCCCCHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHHHHC-CcccCCCccceEEECCCC-cEEeCc
Confidence             12 2478999998 5777777542   45689999999999999999999987 999999999999999888 899999


Q ss_pred             eCCccccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          218 FGSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       218 fg~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ||++........  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+......  
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~--  233 (281)
T 3cc6_A          157 FGLSRYIEDEDYYKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRL--  233 (281)
T ss_dssp             CCGGGCC---------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCC--
T ss_pred             cCCCcccccccccccccCCCCcceeCchhhccCC-CCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCC--
Confidence            999986543322  22345678899999986544 7899999999999999998 99999877666655444332110  


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                                ..+..+++.+.+++.+||..||.+|||+.+++++|+.+.
T Consensus       234 --------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~  272 (281)
T 3cc6_A          234 --------------------------PKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVY  272 (281)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHH
Confidence                                      034457899999999999999999999999999988764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.6e-44  Score=331.09  Aligned_cols=257  Identities=23%  Similarity=0.323  Sum_probs=180.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHH-HHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQ-TMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~-~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....     ....+|.. +++.++||||+++++++..     ..
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~-----~~   94 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFR-----EG   94 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEEC-----SS
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEe-----CC
Confidence            3467999999999999999999999999999999986532     12223444 5667799999999998843     34


Q ss_pred             eEEEeeccccchHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+.++|.+++..... ....+++..++.++.|++.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        95 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~-~~kl~Dfg~~  173 (327)
T 3aln_A           95 DCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSG-NIKLCDFGIS  173 (327)
T ss_dssp             EEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTT-EEEECCCSSS
T ss_pred             ceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCC-CEEEccCCCc
Confidence            5789999999988887765432 3568999999999999999999999744999999999999999888 8999999999


Q ss_pred             cccccCCCcccccccccccCccccc---CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIF---GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~---~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      .............||+.|+|||.+.   ....++.++||||||+++|+|++|..||........  .+...         
T Consensus       174 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~--~~~~~---------  242 (327)
T 3aln_A          174 GQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFD--QLTQV---------  242 (327)
T ss_dssp             CC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC---------CCC---------
T ss_pred             eecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHH--HHHHH---------
Confidence            8765554444557899999999983   233478999999999999999999999976432110  00000         


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                             .....     ..+.......+++.+.+||.+||+.||.+|||+.++++|
T Consensus       243 -------~~~~~-----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  286 (327)
T 3aln_A          243 -------VKGDP-----PQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKH  286 (327)
T ss_dssp             -------CCSCC-----CCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             -------hcCCC-----CCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhC
Confidence                   00000     011111234589999999999999999999999998887

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.1e-44  Score=332.22  Aligned_cols=271  Identities=23%  Similarity=0.281  Sum_probs=206.0

Q ss_pred             CCcccceeeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      -....+|++.+.||+|+||.||+|.    +..+++.||+|++....    ....+|+.+++.++||||+++++++..   
T Consensus        19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~---   95 (327)
T 3lxl_A           19 IFEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG---   95 (327)
T ss_dssp             BCCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEC---
T ss_pred             hhchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEec---
Confidence            3445689999999999999999998    56789999999986542    335689999999999999999988754   


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      .+....++||||++ ++|.+++...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~al~~lH~~-~ivH~Dikp~NIl~~~~~-~~kl~D  170 (327)
T 3lxl_A           96 PGRQSLRLVMEYLPSGCLRDFLQRH---RARLDASRLLLYSSQICKGMEYLGSR-RCVHRDLAARNILVESEA-HVKIAD  170 (327)
T ss_dssp             SSSCEEEEEEECCTTCBHHHHHHHH---GGGCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECC
T ss_pred             CCCceEEEEEeecCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCChhhEEECCCC-CEEEcc
Confidence            34456789999996 5888777643   34689999999999999999999987 999999999999999888 899999


Q ss_pred             eCCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          218 FGSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       218 fg~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      ||++........    .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||.........  ........
T Consensus       171 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~--~~~~~~~~  247 (327)
T 3lxl_A          171 FGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLR--MMGCERDV  247 (327)
T ss_dssp             GGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH--HCC----C
T ss_pred             cccceecccCCccceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHHHHHHhCCCCCccccchhhh--hccccccc
Confidence            999987644332    22345788899999986554 788999999999999999999998653321110  00000000


Q ss_pred             C-HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          294 T-REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       294 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      + ......            ..........+..+++++.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       248 ~~~~~~~~------------~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~  303 (327)
T 3lxl_A          248 PALSRLLE------------LLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWS  303 (327)
T ss_dssp             CHHHHHHH------------HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC--
T ss_pred             ccHHHHHH------------HhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence            0 000000            000000111345689999999999999999999999999999987744

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.2e-44  Score=326.82  Aligned_cols=252  Identities=23%  Similarity=0.331  Sum_probs=183.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ....+|++.+.||+|+||.||+|.+..+|+.||||++....      ....++..+++.++||||+++++++..     .
T Consensus        22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~-----~   96 (318)
T 2dyl_A           22 AEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFIT-----N   96 (318)
T ss_dssp             CCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEEC-----S
T ss_pred             hhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEec-----C
Confidence            34568999999999999999999999999999999986532      112234456777899999999998843     3


Q ss_pred             eeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          142 LYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       142 ~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ...++||||+++.+..+...   ....+++..++.++.||+.||.|||++.||+||||||+||+++.++ .+||+|||++
T Consensus        97 ~~~~lv~e~~~~~~~~l~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~-~~kl~dfg~~  172 (318)
T 2dyl_A           97 TDVFIAMELMGTCAEKLKKR---MQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERG-QIKLCDFGIS  172 (318)
T ss_dssp             SEEEEEECCCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             CcEEEEEeccCCcHHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCC-CEEEEECCCc
Confidence            45889999997665555443   2467999999999999999999999733999999999999999888 8999999999


Q ss_pred             cccccCCCcccccccccccCccccc----CCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-HHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIF----GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-VDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~----~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~-~~~~~~~~~~~~~~~~~  296 (371)
                      .............+++.|+|||.+.    ....++.++||||||+++|+|++|+.||..... .+.+..+....  ++  
T Consensus       173 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--~~--  248 (318)
T 2dyl_A          173 GRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEE--PP--  248 (318)
T ss_dssp             --------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSC--CC--
T ss_pred             hhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccC--CC--
Confidence            8765555555667899999999985    234478899999999999999999999987443 33333333310  00  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                  .++          ....+++++.+||.+||+.||.+|||+.++++|
T Consensus       249 ------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          249 ------------LLP----------GHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             ------------CCC----------SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             ------------CCC----------ccCCCCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence                        000          113478999999999999999999999998887

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=9.6e-45  Score=350.40  Aligned_cols=254  Identities=21%  Similarity=0.324  Sum_probs=209.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+..++..||||++...   ...+.+|+.+++.++||||+++++++.     ....++
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-----~~~~~~  292 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFY  292 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEe-----cCCcEE
Confidence            346799999999999999999999988999999998654   345668999999999999999999883     334478


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. |+|.+++....  ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       293 lv~E~~~~g~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  368 (495)
T 1opk_A          293 IITEFMTYGNLLDYLRECN--RQEVSAVVLLYMATQISSAMEYLEKK-NFIHRNLAARNCLVGENH-LVKVADFGLSRLM  368 (495)
T ss_dssp             EEEECCTTCBHHHHHHHSC--TTTSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECGGG-CEEECCTTCEECC
T ss_pred             EEEEccCCCCHHHHHHhcC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCChhhEEECCCC-cEEEeecccceec
Confidence            9999998 68888876532  35689999999999999999999987 999999999999999887 8999999999875


Q ss_pred             ccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....  .....+++.|+|||++.... ++.++|||||||++|+|++ |..||.+.+..+....+....           
T Consensus       369 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~-----------  436 (495)
T 1opk_A          369 TGDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY-----------  436 (495)
T ss_dssp             TTCCEECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC-----------
T ss_pred             cCCceeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            43221  12334567899999986554 7899999999999999999 999998877655544433210           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                       ....+..+++.+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       437 -----------------~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          437 -----------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -----------------CCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                             011355689999999999999999999999999999988743

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.6e-45  Score=334.56  Aligned_cols=267  Identities=19%  Similarity=0.267  Sum_probs=202.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||.||+|.+ .+|+.||+|++....     ....+|+.+++.++||||+++++++.     .....
T Consensus        29 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-----~~~~~  102 (326)
T 3uim_A           29 SDNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCM-----TPTER  102 (326)
T ss_dssp             TTSSCSTTEEECCSSSEEEEECC-SSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEEC-----CSSCC
T ss_pred             hhccccceeEecCCCcEEEEEEe-cCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEe-----cCCce
Confidence            45799999999999999999984 578999999986432     24578999999999999999999884     33446


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--CcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--GVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++.  ||+||||||+|||++.++ .+||+|||++
T Consensus       103 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~-~~kl~Dfg~~  181 (326)
T 3uim_A          103 LLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF-EAVVGDFGLA  181 (326)
T ss_dssp             EEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTC-CEEECCCSSC
T ss_pred             EEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCC-CEEeccCccc
Confidence            899999985 888888765544566999999999999999999999732  999999999999999887 8999999999


Q ss_pred             cccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCC----CcHHHHHHHHHHhCCCCH
Q 017452          222 KVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGD----SGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       222 ~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~----~~~~~~~~~~~~~~~~~~  295 (371)
                      ........  .....||+.|+|||.+.+.. ++.++||||||+++|+|++|..||...    ............      
T Consensus       182 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~------  254 (326)
T 3uim_A          182 KLMDYKDTHVTTAVRGTIGHIAPEYLSTGK-SSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKG------  254 (326)
T ss_dssp             EECCSSSSCEECCCCSCGGGCCHHHHHHSE-ECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTT------
T ss_pred             cccCcccccccccccCCcCccCHHHhccCC-CCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHH------
Confidence            87643322  23345899999999986555 799999999999999999999999521    111111111110      


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                              ..................++...+..+.+++.+||+.||.+|||+.+++++|+..
T Consensus       255 --------~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          255 --------LLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             --------TTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             --------HhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence                    0001111111111111222333457899999999999999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=2.8e-44  Score=324.45  Aligned_cols=249  Identities=25%  Similarity=0.422  Sum_probs=195.6

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      |.....||+|+||.||+|.+..+++.||+|.+...    .....+|+.+++.++||||+++++++..     ....++||
T Consensus        24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~~~~~lv~   98 (295)
T 2clq_A           24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE-----NGFIKIFM   98 (295)
T ss_dssp             TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEEEEEE
T ss_pred             CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe-----CCcEEEEE
Confidence            44455899999999999999999999999998653    2445689999999999999999998843     34578999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++ ++|.+++... .....+++..++.++.||+.||.|||++ ||+||||||+||+++.+.+.+||+|||++......
T Consensus        99 e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A           99 EQVPGGSLSALLRSK-WGPLKDNEQTIGFYTKQILEGLKYLHDN-QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             ECCSEEEHHHHHHHT-TCCCTTCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             EeCCCCCHHHHHHhh-ccCCCccHHHHHHHHHHHHHHHHHHHhC-CEEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            9996 5777777642 2234567899999999999999999987 99999999999999983348999999999765432


Q ss_pred             C-CcccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCc
Q 017452          228 E-PNISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY  305 (371)
Q Consensus       228 ~-~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (371)
                      . ......|++.|+|||++.+. ..++.++||||||+++|+|++|+.||.................              
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~--------------  242 (295)
T 2clq_A          177 NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFK--------------  242 (295)
T ss_dssp             ----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHC--------------
T ss_pred             CCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcccc--------------
Confidence            2 23345789999999998643 2368899999999999999999999976544332221111111              


Q ss_pred             cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       306 ~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                  ....++..+++++.+||.+||+.||.+|||+.++++|
T Consensus       243 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          243 ------------VHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             ------------ccccccccCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence                        0111456689999999999999999999999998777

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=7.9e-46  Score=339.00  Aligned_cols=267  Identities=19%  Similarity=0.238  Sum_probs=202.0

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ...++|++.+.||+|+||.||+|.+ .+|+.||+|++...    .....+|+.+++.++||||+++++++     .....
T Consensus        36 ~~~~~y~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~~~~~  109 (321)
T 2qkw_B           36 EATNNFDHKFLIGHGVFGKVYKGVL-RDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFC-----DERNE  109 (321)
T ss_dssp             CCCCCCSCCCCSCBCSSSEEEEEEC-TTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEEC-----CCTTC
T ss_pred             HHHhccCccceeecCCCeeEEEEEE-CCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEE-----cCCCe
Confidence            3456799999999999999999995 47899999988543    24456899999999999999999987     33444


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||+.+ +|.+.+.........+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~ivH~dlkp~Nil~~~~~-~~kl~Dfg~~~  187 (321)
T 2qkw_B          110 MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR-AIIHRDVKSINILLDENF-VPKITDFGISK  187 (321)
T ss_dssp             CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCSTTEEECTTC-CEEECCCTTCE
T ss_pred             EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC-CeecCCCCHHHEEECCCC-CEEEeeccccc
Confidence            7899999985 76665543222234689999999999999999999987 999999999999999888 89999999997


Q ss_pred             ccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH--HH-HHHhCCCCHh
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV--EI-IKVLGTPTRE  296 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~--~~-~~~~~~~~~~  296 (371)
                      ......   ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||......+...  .. .....     
T Consensus       188 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-----  261 (321)
T 2qkw_B          188 KGTELDQTHLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN-----  261 (321)
T ss_dssp             ECSSSSCCCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHT-----
T ss_pred             ccccccccccccccCCCccccCHHHhcCCC-CCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccc-----
Confidence            643221   223456899999999986554 7999999999999999999999997654322110  00 00000     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                ...+...........++...+..+.+++.+||+.||.+|||+.+++++|+.+
T Consensus       262 ----------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~  313 (321)
T 2qkw_B          262 ----------NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYA  313 (321)
T ss_dssp             ----------TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ----------cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHH
Confidence                      0011111111111122334567899999999999999999999999998765

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.6e-44  Score=325.50  Aligned_cols=254  Identities=21%  Similarity=0.269  Sum_probs=192.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..++|++.+.||+|+||.||+|.+.   ..||+|++...      ...+.+|+.+++.++||||++++++.     . ..
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~-~~   92 (289)
T 3og7_A           22 PDGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-----T-AP   92 (289)
T ss_dssp             CTTSCEEEEEEEECSSEEEEEEESS---SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-----C-SS
T ss_pred             CccceeeeeEecCCCCeEEEEEEEc---CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-----c-CC
Confidence            3458999999999999999999853   35999988543      23456899999999999999998854     1 12


Q ss_pred             eEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..++||||+. ++|.+.+.   .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++
T Consensus        93 ~~~lv~e~~~~~~L~~~l~---~~~~~~~~~~~~~i~~qi~~~L~~lH~~-~i~H~Dlkp~Nil~~~~~-~~kl~Dfg~~  167 (289)
T 3og7_A           93 QLAIVTQWCEGSSLYHHLH---ASETKFEMKKLIDIARQTARGMDYLHAK-SIIHRDLKSNNIFLHEDN-TVKIGDFGLA  167 (289)
T ss_dssp             SCEEEEECCCEEEHHHHHT---TC---CCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTT-EEEECCCC--
T ss_pred             ccEEEEEecCCCcHHHHHh---hccCCCCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEEECCCC-CEEEccceec
Confidence            2679999998 46666553   2346799999999999999999999987 999999999999999988 8999999998


Q ss_pred             cccccC---CCcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKG---EPNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~---~~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ......   .......||+.|+|||.+..  ...++.++||||||+++|+|++|+.||......+.+..........+. 
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-  246 (289)
T 3og7_A          168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPD-  246 (289)
T ss_dssp             ----------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCC-
T ss_pred             cccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcc-
Confidence            765321   22234568999999999852  334688999999999999999999999887776666555543211110 


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                            .......+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       247 ----------------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          247 ----------------------LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             ----------------------TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ----------------------hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence                                  00133467899999999999999999999999999988764

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=6.9e-45  Score=323.74  Aligned_cols=251  Identities=19%  Similarity=0.301  Sum_probs=205.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.+.||+|+||.||+|.+. ++..||+|++...   .....+|+.+++.++||||+++++++.     .....++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-----~~~~~~l   80 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCL-----EQAPICL   80 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEc-----cCCCeEE
Confidence            457999999999999999999975 6788999999654   345678999999999999999999883     3344789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++ ++|.+.+...   ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++....
T Consensus        81 v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dl~p~Nili~~~~-~~kl~dfg~~~~~~  155 (267)
T 3t9t_A           81 VTEFMEHGCLSDYLRTQ---RGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVL  155 (267)
T ss_dssp             EECCCTTCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCCGGGEEECGGG-CEEECCTTGGGGBC
T ss_pred             EEeCCCCCcHHHHHhhC---cccCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEECCCC-CEEEcccccccccc
Confidence            999997 4787777542   35689999999999999999999987 999999999999999887 89999999987653


Q ss_pred             cCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ...  ......+++.|+|||++.+.. ++.++|+||||+++|+|++ |..||...+..+....+....            
T Consensus       156 ~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~------------  222 (267)
T 3t9t_A          156 DDQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGF------------  222 (267)
T ss_dssp             CHHHHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC------------
T ss_pred             cccccccccccccccccChhhhcCCC-ccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCC------------
Confidence            221  122345677899999986544 7899999999999999999 899998877665554443311            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                      ....+..++..+.+++.+||+.||.+|||+.+++++|..+..
T Consensus       223 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          223 ----------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             ----------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence                            011344578999999999999999999999999999987644

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=4.6e-45  Score=337.53  Aligned_cols=265  Identities=20%  Similarity=0.292  Sum_probs=200.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------------------hhhHHHHHHHHHcCCCCeee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------------------RYKNRELQTMRLLDHPNVVS  128 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------------------~~~~~e~~~l~~l~h~niv~  128 (371)
                      .++|++.+.||+|+||.||+|.+  +|+.||+|++....                     ....+|+.+++.++||||++
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~  107 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLT  107 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCC
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcce
Confidence            45799999999999999999998  89999999985432                     55678999999999999999


Q ss_pred             cceeEEecCCCCceeEEEeeccccc-hHHHHHHH----hhhccCCCCHHHHHHHHHHHHHHHHHHHh-cCCcEeeccCCC
Q 017452          129 LKHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKH----FNKLNQRMPMIYVKLYAYQIFRALSYIHR-SIGVCHRDIKPQ  202 (371)
Q Consensus       129 ~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~ivH~dlkp~  202 (371)
                      +++++..     ....++||||+++ +|.+.+..    .......+++..++.++.||+.||.|||+ + ||+||||||+
T Consensus       108 ~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~i~H~dl~p~  181 (348)
T 2pml_X          108 CEGIITN-----YDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-NICHRDVKPS  181 (348)
T ss_dssp             CSEEEES-----SSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-CEECCCCCGG
T ss_pred             EEEEEee-----CCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-CEeecCCChH
Confidence            9998843     3458899999986 66554211    01114679999999999999999999998 6 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCC-cchHHHHHHHHHHHHhCCCCCCCCCc-H
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTT-AIDIWSAGCVVAELMLGKPLFPGDSG-V  280 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~-~~DiwslG~il~~lltg~~pf~~~~~-~  280 (371)
                      ||+++.++ .+||+|||++...... ......+++.|+|||.+.+...++. ++||||||+++|+|++|..||..... .
T Consensus       182 Nil~~~~~-~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  259 (348)
T 2pml_X          182 NILMDKNG-RVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLV  259 (348)
T ss_dssp             GEEECTTS-CEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSH
T ss_pred             hEEEcCCC-cEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHH
Confidence            99999888 8999999999875433 3345678999999999976534555 99999999999999999999988766 4


Q ss_pred             HHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +....+.......+..        ...+ ...... .-.......++.++.+||.+||+.||.+|||+.++++|
T Consensus       260 ~~~~~i~~~~~~~~~~--------~~~~-~~~~~~-~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          260 ELFNNIRTKNIEYPLD--------RNHF-LYPLTN-KKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             HHHHHHTSCCCCCCCS--------SSSS-TTTTCC---------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHhccCcCCccc--------hhhh-hccccc-cccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            4333332211000000        0000 000000 00011235689999999999999999999999998777

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=2.6e-44  Score=325.61  Aligned_cols=253  Identities=25%  Similarity=0.347  Sum_probs=193.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCC--------
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTD--------  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--------  138 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||+|++....   ....+|+.+++.++||||+++++++.....        
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~   84 (303)
T 1zy4_A            5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAV   84 (303)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC-----
T ss_pred             cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhccc
Confidence            357999999999999999999999999999999986543   345679999999999999999998765321        


Q ss_pred             CCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEe
Q 017452          139 KDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       139 ~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      ......++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|
T Consensus        85 ~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dlkp~Nil~~~~~-~~kl~d  159 (303)
T 1zy4_A           85 KKKSTLFIQMEYCENGTLYDLIHSE---NLNQQRDEYWRLFRQILEALSYIHSQ-GIIHRDLKPMNIFIDESR-NVKIGD  159 (303)
T ss_dssp             -CEEEEEEEEECCCSCBHHHHHHHS---CGGGCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECC
T ss_pred             ccCCceEEEEecCCCCCHHHhhhcc---ccccchHHHHHHHHHHHHHHHHHHhC-CeecccCCHHhEEEcCCC-CEEEee
Confidence            235678999999974 888877642   35678899999999999999999987 999999999999999888 899999


Q ss_pred             eCCccccccC---------------CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH
Q 017452          218 FGSAKVLVKG---------------EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ  282 (371)
Q Consensus       218 fg~a~~~~~~---------------~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~  282 (371)
                      ||++......               .......|++.|+|||++.+...++.++||||||+++|+|++   ||........
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            9998765321               122345689999999999765568999999999999999998   5543222211


Q ss_pred             HHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .........                        ..+...++...+..+.++|.+||+.||.+|||+.++++|
T Consensus       237 ~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          237 ILKKLRSVS------------------------IEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHSTT------------------------CCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhccccc------------------------cccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            111111000                        001111445577889999999999999999999998776

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=2.7e-44  Score=324.21  Aligned_cols=250  Identities=23%  Similarity=0.281  Sum_probs=201.8

Q ss_pred             ccceeeeE-eeccCCceEEEEEEE--CCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAER-IVGQGSFGVVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|.+.+ .||+|+||.||+|.+  ..+++.||+|++...      .....+|+.+++.++||||+++++++ ..    
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~----   89 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA----   89 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES----
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC----
Confidence            35799998 999999999999954  567789999998643      24456899999999999999999987 21    


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                       ...++||||+. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        90 -~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg  162 (291)
T 1xbb_A           90 -ESWMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFG  162 (291)
T ss_dssp             -SSEEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCT
T ss_pred             -CCcEEEEEeCCCCCHHHHHHh----CcCCCHHHHHHHHHHHHHHHHHHHhC-CeEcCCCCcceEEEeCCC-cEEEccCC
Confidence             12679999998 578777764    46799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          220 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       220 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      ++.........    ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+....  . 
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~--~-  238 (291)
T 1xbb_A          163 LSKALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R-  238 (291)
T ss_dssp             TCEECCTTCSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C-
T ss_pred             cceeeccCCCcccccccCCCCceeeChHHhccCC-CChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCC--C-
Confidence            99876443321    2234568899999986544 7889999999999999999 999998877655444332210  0 


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                               ..++..+++.+.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       239 -------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~  279 (291)
T 1xbb_A          239 -------------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  279 (291)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             -------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence                                     01345689999999999999999999999999999887643

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=326.81  Aligned_cols=251  Identities=25%  Similarity=0.368  Sum_probs=193.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ..+|++.+.||+|+||.||+|.+  .++.||+|++...  .....+|+.+++.++||||+++++++.     +.  .++|
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-----~~--~~lv   77 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKW--RAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL-----NP--VCLV   77 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT-----TT--TEEE
T ss_pred             HhHeeeeeEeecCCCceEEEEEE--CCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc-----CC--cEEE
Confidence            35799999999999999999987  5789999998654  344568999999999999999988762     22  5799


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR---SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |||+++ +|.+.+.... ....+++..+..++.||+.||.|||+   + ||+||||||+||+++.++..+||+|||++..
T Consensus        78 ~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~-~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~  155 (307)
T 2eva_A           78 MEYAEGGSLYNVLHGAE-PLPYYTAAHAMSWCLQCSQGVAYLHSMQPK-ALIHRDLKPPNLLLVAGGTVLKICDFGTACD  155 (307)
T ss_dssp             EECCTTCBHHHHHHCSS-SEECCCHHHHHHHHHHHHHHHHHHHTCSSS-CCCCCCCSGGGEEEETTTTEEEECCCCC---
T ss_pred             EEcCCCCCHHHHHhccC-CCCccCHHHHHHHHHHHHHHHHHHHhCCCC-CeecCCCChhHEEEeCCCCEEEEcccccccc
Confidence            999975 8877776421 12357889999999999999999998   5 9999999999999998874589999999976


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ....  .....||+.|+|||++.+. .++.++||||||+++|+|++|+.||................+..          
T Consensus       156 ~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~----------  222 (307)
T 2eva_A          156 IQTH--MTNNKGSAAWMAPEVFEGS-NYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR----------  222 (307)
T ss_dssp             -----------CCTTSSCHHHHTCC-CCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC----------
T ss_pred             cccc--cccCCCCCceEChhhhCCC-CCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC----------
Confidence            5322  2345689999999999654 48999999999999999999999997644322111111110100          


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                      ...+..++..+.+++.+||+.||.+|||+.+++++|..+..
T Consensus       223 ----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~  263 (307)
T 2eva_A          223 ----------------PPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMR  263 (307)
T ss_dssp             ----------------CCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGG
T ss_pred             ----------------CCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHH
Confidence                            01334678999999999999999999999999999876543

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.1e-45  Score=339.67  Aligned_cols=252  Identities=23%  Similarity=0.310  Sum_probs=193.6

Q ss_pred             CcccceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|.+.+.||+|+||.||+|.+.   .++..||||++...     ...+.+|+.+++.++||||+++++++.     
T Consensus        42 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~-----  116 (373)
T 2qol_A           42 LDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT-----  116 (373)
T ss_dssp             CCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-----
T ss_pred             cCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            34468999999999999999999876   46778999998643     234568999999999999999999883     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .....++||||++ ++|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       117 ~~~~~~lv~e~~~~~sL~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dlkp~NIll~~~~-~~kl~Df  191 (373)
T 2qol_A          117 KSKPVMIVTEYMENGSLDSFLRK---HDAQFTVIQLVGMLRGIASGMKYLSDM-GYVHRDLAARNILINSNL-VCKVSDF  191 (373)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             eCCceEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeCCCCCcceEEEcCCC-CEEECcC
Confidence            3445789999996 588877753   245799999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          219 GSAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       219 g~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      |+++........    ....+++.|+|||.+.+.. ++.++||||||+++|+|++ |+.||...+..+....+...... 
T Consensus       192 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~-  269 (373)
T 2qol_A          192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRL-  269 (373)
T ss_dssp             ----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEEC-
T ss_pred             ccccccccCCccceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC-
Confidence            999876433211    1223467899999986544 8999999999999999997 99999887765554444321110 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                 ..+..++..+.+++.+||+.||.+||++.++++.|+.+
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~  307 (373)
T 2qol_A          270 ---------------------------PPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKL  307 (373)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHH
Confidence                                       02345789999999999999999999999999998765

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.5e-44  Score=325.98  Aligned_cols=265  Identities=22%  Similarity=0.325  Sum_probs=200.7

Q ss_pred             cceeeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||.||+|.    +..+++.||+|++...     .....+|+.+++.++||||+++++++...   +.
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~   97 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTED---GG   97 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC------
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecC---CC
Confidence            469999999999999999998    5678999999998643     24567899999999999999999988542   22


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++||||+++ +|.+.+...   ...+++..++.++.||+.||+|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        98 ~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  172 (302)
T 4e5w_A           98 NGIKLIMEFLPSGSLKEYLPKN---KNKINLKQQLKYAVQICKGMDYLGSR-QYVHRDLAARNVLVESEH-QVKIGDFGL  172 (302)
T ss_dssp             CCEEEEEECCTTCBHHHHHHHH---TTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTT
T ss_pred             ceEEEEEEeCCCCcHHHHHHhc---cccCCHHHHHHHHHHHHHHHHHhhcC-CcccCCCchheEEEcCCC-CEEECcccc
Confidence            447899999975 888777542   46799999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +........    .....+|..|+|||.+.+.. ++.++||||||+++|+|++|..|+....     .......+.....
T Consensus       173 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~-----~~~~~~~~~~~~~  246 (302)
T 4e5w_A          173 TKAIETDKEYYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTLHELLTYCDSDSSPM-----ALFLKMIGPTHGQ  246 (302)
T ss_dssp             CEECCTTCCEEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHH-----HHHHHHHCSCCGG
T ss_pred             cccccCCCcceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHHHHHHHccCCCcchh-----hHHhhccCCcccc
Confidence            987654432    22455788899999986554 7889999999999999999998864321     1111111111100


Q ss_pred             HH-hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EI-KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .. ....         ...........+..+++++.+||.+||+.||.+|||+.++++.|+.+
T Consensus       247 ~~~~~~~---------~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  300 (302)
T 4e5w_A          247 MTVTRLV---------NTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEAL  300 (302)
T ss_dssp             GHHHHHH---------HHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             cCHHHHH---------HHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHH
Confidence            00 0000         00000001114556899999999999999999999999999998764

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.5e-44  Score=329.51  Aligned_cols=256  Identities=23%  Similarity=0.326  Sum_probs=204.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEE-----CCCCcEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~-----~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      .++|++.+.||+|+||.||+|.+     ..+++.||+|++....     ....+|+.+++.+ +||||+++++++...  
T Consensus        26 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--  103 (316)
T 2xir_A           26 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP--  103 (316)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCT--
T ss_pred             hhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecC--
Confidence            45799999999999999999985     4577899999986532     3456799999999 689999999987432  


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhc------------cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCcee
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL------------NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~------------~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIl  205 (371)
                        ...+++||||+. ++|.+.+......            ...+++..++.++.||+.||.|||++ ||+||||||+||+
T Consensus       104 --~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-~i~H~dikp~Nil  180 (316)
T 2xir_A          104 --GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNIL  180 (316)
T ss_dssp             --TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEE
T ss_pred             --CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-CcccccCccceEE
Confidence              234689999998 4888877653221            12388999999999999999999987 9999999999999


Q ss_pred             eeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017452          206 VNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (371)
Q Consensus       206 i~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (371)
                      ++.++ .+||+|||++........   .....+|+.|+|||++.+.. ++.++||||||+++|+|++ |..||.+.....
T Consensus       181 ~~~~~-~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          181 LSEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             ECGGG-CEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             ECCCC-CEEECCCccccccccCccceeccCCCcceeecCchhhcccc-ccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99887 899999999986543322   12345688999999986544 7899999999999999998 999998766554


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      .+..........                           ..+..+++.+.++|.+||+.||.+|||+.++++||..+.
T Consensus       259 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          259 EFCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             HHHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHhccCccC---------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence            444333321110                           134557899999999999999999999999999988754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=8.8e-45  Score=325.20  Aligned_cols=254  Identities=20%  Similarity=0.308  Sum_probs=199.8

Q ss_pred             CCcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           67 PKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        67 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .....+|++.+.||+|+||.||+|.+  +|+.||+|++...  .....+|+.+++.++||||+++++++..    .....
T Consensus        17 ~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~~~~   90 (278)
T 1byg_A           17 ALNMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE----EKGGL   90 (278)
T ss_dssp             BCCGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECC----C--CC
T ss_pred             cCChhhceEEeEEecCCCceEEEEEE--cCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEc----CCCce
Confidence            34456899999999999999999987  5889999998654  3445689999999999999999997643    22347


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++||||+++ +|.+.+....  ...+++..++.++.|++.||.|||++ ||+||||||+||+++.++ .+||+|||++..
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dlkp~Nil~~~~~-~~~l~Dfg~~~~  166 (278)
T 1byg_A           91 YIVTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKE  166 (278)
T ss_dssp             EEEECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC---
T ss_pred             EEEEecCCCCCHHHHHHhcc--cccCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCcceEEEeCCC-cEEEeecccccc
Confidence            899999985 8888876532  23488999999999999999999987 999999999999999888 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+...             
T Consensus       167 ~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~-------------  230 (278)
T 1byg_A          167 ASST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKG-------------  230 (278)
T ss_dssp             -----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTT-------------
T ss_pred             cccc--ccCCCccccccCHHHhCCCC-CCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcC-------------
Confidence            5332  22345688899999986544 7899999999999999998 99999877655544333221             


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                     +....+..+++.+.++|.+||+.||.+|||+.++++.|+.+...
T Consensus       231 ---------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          231 ---------------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence                           00113456899999999999999999999999999998876543

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-44  Score=331.60  Aligned_cols=250  Identities=24%  Similarity=0.345  Sum_probs=195.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEE----EEEEeec-----chhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETV----AIKKVLQ-----DKRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~v----aiK~~~~-----~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|++.+.||+|+||.||+|.+..+++.+    |+|.+..     ......+|+.+++.++||||+++++++...    
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----   89 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS----   89 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS----
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC----
Confidence            457999999999999999999998888765    5665532     234566899999999999999999988532    


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                       . .+++++|+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        90 -~-~~~v~~~~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kL~DfG  162 (327)
T 3lzb_A           90 -T-VQLITQLMPFGCLLDYVREH---KDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFG  162 (327)
T ss_dssp             -S-EEEEECCCSSCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCTT
T ss_pred             -C-ceEEEEecCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHhhC-CCcCCCCCHHHEEEcCCC-CEEEccCc
Confidence             1 567888877 5777766542   46799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          220 SAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       220 ~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ++.........   ....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+......   
T Consensus       163 ~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~---  238 (327)
T 3lzb_A          163 LAKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERL---  238 (327)
T ss_dssp             C----------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---
T ss_pred             ceeEccCccccccccCCCccccccCHHHHcCCC-CChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99876433222   2344577899999997554 7999999999999999999 99999887766554443321100   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                               ..+..++.++.++|.+||+.||.+|||+.++++.|..+.
T Consensus       239 -------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  277 (327)
T 3lzb_A          239 -------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMA  277 (327)
T ss_dssp             -------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                                     034457899999999999999999999999999988764

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.9e-44  Score=328.76  Aligned_cols=251  Identities=21%  Similarity=0.292  Sum_probs=197.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCC----cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||+|++...     .....+|+.+++.++||||+++++++     .
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-----~  116 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-----S  116 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-----C
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----e
Confidence            3457999999999999999999976553    45999998643     23355799999999999999999988     3


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      .....++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       117 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~Dikp~NIl~~~~~-~~kl~Df  191 (333)
T 1mqb_A          117 KYKPMMIITEYMENGALDKFLRE---KDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDF  191 (333)
T ss_dssp             SSSSEEEEEECCTTEEHHHHHHH---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC
T ss_pred             cCCCcEEEEeCCCCCcHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChheEEECCCC-cEEECCC
Confidence            44457899999985 87777653   246799999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       219 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      |++........    .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+...... 
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-  269 (333)
T 1mqb_A          192 GLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL-  269 (333)
T ss_dssp             CC-----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC-
T ss_pred             CcchhhccccccccccCCCCccccccCchhcccCC-CCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC-
Confidence            99987543321    12234577899999986554 7899999999999999998 99999887765554444321100 


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                 ..+..++..+.+++.+||+.||.+||++.+++++|+.+
T Consensus       270 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~  307 (333)
T 1mqb_A          270 ---------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  307 (333)
T ss_dssp             ---------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHH
Confidence                                       02345789999999999999999999999999998765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=6.8e-45  Score=337.06  Aligned_cols=262  Identities=13%  Similarity=0.109  Sum_probs=202.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECC--------CCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeec-------------
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE--------TGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSL-------------  129 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~-------------  129 (371)
                      ++|++.+.||+|+||.||+|.+..        .++.||+|++... ....+|+.+++.++||||+++             
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~  120 (352)
T 2jii_A           42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIP  120 (352)
T ss_dssp             CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCC
T ss_pred             CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhcccchhhhhhhhccCCccCcc
Confidence            479999999999999999999987        4889999998754 567889999999999999984             


Q ss_pred             --ceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee
Q 017452          130 --KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN  207 (371)
Q Consensus       130 --~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~  207 (371)
                        ++++..    ...+.++||||++++|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++
T Consensus       121 ~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivH~Dikp~NIl~~  193 (352)
T 2jii_A          121 TCMGFGVH----QDKYRFLVLPSLGRSLQSALDVSP--KHVLSERSVLQVACRLLDALEFLHEN-EYVHGNVTAENIFVD  193 (352)
T ss_dssp             CCCEEEEE----TTTEEEEEEECCCEEHHHHHHHSG--GGCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCCGGGEEEE
T ss_pred             chhhcccc----CCcEEEEEecCCCcCHHHHHHhCC--cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEEc
Confidence              333322    234578999999889998887532  36799999999999999999999987 999999999999999


Q ss_pred             CCC-CcEEEEeeCCccccccCC--------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q 017452          208 PHT-HQVKLCDFGSAKVLVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS  278 (371)
Q Consensus       208 ~~~-~~~kl~Dfg~a~~~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  278 (371)
                      .++ ..+||+|||+++......        ......||+.|+|||.+.+.. ++.++||||||+++|+|++|+.||....
T Consensus       194 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          194 PEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             TTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             CCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCC-CCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            765 279999999997654322        113347899999999986654 8999999999999999999999998754


Q ss_pred             -cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          279 -GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       279 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                       ....+.............                ...   .......+++++.+||.+||+.||.+|||+.++++.|..
T Consensus       273 ~~~~~~~~~~~~~~~~~~~----------------~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~  333 (352)
T 2jii_A          273 PNTEDIMKQKQKFVDKPGP----------------FVG---PCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEA  333 (352)
T ss_dssp             TCHHHHHHHHHHHHHSCCC----------------EEC---TTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHH
T ss_pred             cCHHHHHHHHHhccCChhh----------------hhh---hccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHH
Confidence             333333333221111000                000   000113478999999999999999999999999999877


Q ss_pred             CCc
Q 017452          358 CPS  360 (371)
Q Consensus       358 ~~~  360 (371)
                      +..
T Consensus       334 ~~~  336 (352)
T 2jii_A          334 LLQ  336 (352)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.5e-44  Score=321.56  Aligned_cols=252  Identities=24%  Similarity=0.300  Sum_probs=203.5

Q ss_pred             ccceeeeE-eeccCCceEEEEEEEC--CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAER-IVGQGSFGVVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|.+.+ .||+|+||.||+|.+.  .++..||+|++...     .....+|+.+++.++||||+++++++ ...    
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~----   82 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAE----   82 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESS----
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCC----
Confidence            35677776 9999999999999864  46788999998653     23456899999999999999999987 211    


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                       ..++||||+.+ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        83 -~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~  156 (287)
T 1u59_A           83 -ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGL  156 (287)
T ss_dssp             -SEEEEEECCTTEEHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTT
T ss_pred             -CcEEEEEeCCCCCHHHHHHh---CCccCCHHHHHHHHHHHHHHHHHHHHC-CEeeCCCchheEEEcCCC-CEEECcccc
Confidence             26899999985 77766642   245699999999999999999999987 999999999999999887 899999999


Q ss_pred             ccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +........    .....+|+.|+|||.+.+.. ++.++||||||+++|+|++ |+.||......+....+.....    
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~----  231 (287)
T 1u59_A          157 SKALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR----  231 (287)
T ss_dssp             CEECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC----
T ss_pred             eeeeccCcceeeccccccccccccCHHHhccCC-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCc----
Confidence            987643322    12334578899999986544 7899999999999999998 9999988776665544432100    


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                              ..++..+++++.++|.+||..||.+||++.+++++|..+...
T Consensus       232 ------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  273 (287)
T 1u59_A          232 ------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS  273 (287)
T ss_dssp             ------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                                    014456899999999999999999999999999998876544

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=3.5e-44  Score=343.18  Aligned_cols=252  Identities=23%  Similarity=0.357  Sum_probs=206.3

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|+.+++.++||||+++++++.      ....+
T Consensus       186 ~~~~~~~~~~lG~G~fg~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~------~~~~~  258 (454)
T 1qcf_A          186 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT------KEPIY  258 (454)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC------SSSCE
T ss_pred             chHHeEEEEEcccCCceEEEEEEEC-CccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe------CCccE
Confidence            4467999999999999999999975 4678999998653   345668999999999999999998762      12368


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. |+|.+.+....  ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       259 lv~e~~~~g~L~~~l~~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DFG~a~~~  334 (454)
T 1qcf_A          259 IITEFMAKGSLLDFLKSDE--GSKQPLPKLIDFSAQIAEGMAFIEQR-NYIHRDLRAANILVSASL-VCKIADFGLARVI  334 (454)
T ss_dssp             EEECCCTTCBHHHHHHSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSSCSGGGEEECTTC-CEEECSTTGGGGB
T ss_pred             EEEeecCCCcHHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCCHHHEEECCCC-cEEEeeCCCceEc
Confidence            9999997 58888876432  24688999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....  ......+++.|+|||++.... ++.++|||||||++|+|++ |+.||.+.+..+....+......+        
T Consensus       335 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~--------  405 (454)
T 1qcf_A          335 EDNEYTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP--------  405 (454)
T ss_dssp             CCHHHHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCC--------
T ss_pred             CCCceeccCCCcccccccCHHHhccCC-CCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC--------
Confidence            3321  112334577899999996544 8999999999999999999 999999877766665554421111        


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                          .+..+++++.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       406 --------------------~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~  444 (454)
T 1qcf_A          406 --------------------RPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYT  444 (454)
T ss_dssp             --------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSS
T ss_pred             --------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHh
Confidence                                345689999999999999999999999999999988754

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.3e-44  Score=345.15  Aligned_cols=257  Identities=21%  Similarity=0.257  Sum_probs=204.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...++|++.+.||+|+||.||+|.+..+++.||||++...  .....+|+++++.+.|++.+..+..+..    ...+.+
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~----~~~~~~   79 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGV----EGDYNV   79 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEE----ETTEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEe----eCCEEE
Confidence            3456899999999999999999999999999999987543  3456789999999988665555444432    233478


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee---eCCCCcEEEEeeCCcc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAK  222 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli---~~~~~~~kl~Dfg~a~  222 (371)
                      +||||++++|.+++...   ...+++..++.|+.||+.||.|||++ ||+||||||+||||   +.++ .+||+|||+++
T Consensus        80 lvme~~g~sL~~ll~~~---~~~l~~~~~~~i~~qi~~aL~yLH~~-gIvHrDIKP~NILl~~~~~~~-~vkL~DFGla~  154 (483)
T 3sv0_A           80 LVMDLLGPSLEDLFNFC---SRKLSLKTVLMLADQMINRVEFVHSK-SFLHRDIKPDNFLMGLGRRAN-QVYIIDFGLAK  154 (483)
T ss_dssp             EEEECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECCGGGTT-CEEECCCTTCE
T ss_pred             EEEECCCCCHHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHC-CEeecccCcceEEEecCCCCC-eEEEEeCCcce
Confidence            99999988998888643   46799999999999999999999987 99999999999999   4555 89999999998


Q ss_pred             ccccCCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH---HHHHHHHHhC
Q 017452          223 VLVKGEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD---QLVEIIKVLG  291 (371)
Q Consensus       223 ~~~~~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~---~~~~~~~~~~  291 (371)
                      .......        .....||+.|+|||.+.+.. ++.++|||||||++|+|++|+.||.+.....   .+..+.....
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~  233 (483)
T 3sv0_A          155 KYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV  233 (483)
T ss_dssp             ECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHH
T ss_pred             eccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccc
Confidence            7654332        12567899999999997654 8999999999999999999999998755432   2333322211


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ....+.                        +...++.++.+||.+||+.||.+||++.++++.|+.+
T Consensus       234 ~~~~~~------------------------l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l  276 (483)
T 3sv0_A          234 ATSIEA------------------------LCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDL  276 (483)
T ss_dssp             HSCHHH------------------------HHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHH
T ss_pred             cccHHH------------------------HhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            111111                        2245789999999999999999999999999998766

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=3e-44  Score=329.33  Aligned_cols=257  Identities=19%  Similarity=0.239  Sum_probs=200.5

Q ss_pred             cccceeeeEeeccCCceEEEEEE-----ECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAK-----CLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~-----~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~  138 (371)
                      ...+|++.+.||+|+||.||+|.     +..++..||+|++...     .....+|+.+++.++||||+++++++.    
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~----  103 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL----  103 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEc----
Confidence            44689999999999999999999     5567889999998532     234567999999999999999999883    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--Cc
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNKL---NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQ  212 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~  212 (371)
                       .....++||||++ ++|.+++......   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++  ..
T Consensus       104 -~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~-~i~H~dlkp~NIli~~~~~~~~  181 (327)
T 2yfx_A          104 -QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN-HFIHRDIAARNCLLTCPGPGRV  181 (327)
T ss_dssp             -SSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESCSSTTCC
T ss_pred             -CCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC-CeecCcCCHhHEEEecCCCcce
Confidence             3344689999995 6888888764321   14589999999999999999999987 999999999999998433  26


Q ss_pred             EEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~  288 (371)
                      +||+|||++.......   ......+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||......+....+..
T Consensus       182 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~  260 (327)
T 2yfx_A          182 AKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGI-FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS  260 (327)
T ss_dssp             EEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHT
T ss_pred             EEECccccccccccccccccCCCcCCCcceeCHhHhcCCC-CCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhc
Confidence            9999999987543322   223456788999999986544 7899999999999999998 9999988766554444332


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ...                            ...+..++..+.++|.+||+.||.+|||+.+++++|..+..
T Consensus       261 ~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~  304 (327)
T 2yfx_A          261 GGR----------------------------MDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQ  304 (327)
T ss_dssp             TCC----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCC----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhc
Confidence            100                            01345688999999999999999999999999999887643

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=6.3e-44  Score=322.79  Aligned_cols=254  Identities=21%  Similarity=0.304  Sum_probs=199.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..+|++.+.||+|+||.||+|.+..++   ..+|+|.+...     .....+|+.+++.++||||+++++++..    ..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~----~~   99 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR----SE   99 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC----SS
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEc----CC
Confidence            346999999999999999999975433   46899988542     2345679999999999999999997643    23


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+++ +|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus       100 ~~~~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~ql~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~  174 (298)
T 3f66_A          100 GSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKYLASK-KFVHRDLAARNCMLDEKF-TVKVADFGL  174 (298)
T ss_dssp             SCCEEEEECCTTCBHHHHHHC---TTCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSCGG
T ss_pred             CceEEEEeCCCCCCHHHHHHh---cccCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEECCCC-CEEECcccc
Confidence            346799999986 88777753   246689999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccCC-----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          221 AKVLVKGE-----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       221 a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      +.......     ......+|+.|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+.....   
T Consensus       175 a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~---  250 (298)
T 3f66_A          175 ARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRR---  250 (298)
T ss_dssp             GCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCC---
T ss_pred             cccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCC---
Confidence            97653322     223445678899999986544 7899999999999999999 5677776665555444433110   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                               ...+..++..+.+++.+||+.||.+|||+.++++.|..+...
T Consensus       251 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  292 (298)
T 3f66_A          251 -------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  292 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             -------------------------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                                     113455789999999999999999999999999998876443

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1e-43  Score=321.33  Aligned_cols=255  Identities=21%  Similarity=0.303  Sum_probs=200.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...|.+.+.||+|+||.||+|.+..++.   .||+|++....     ....+|+.+++.++||||+++++++....    
T Consensus        20 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~----   95 (298)
T 3pls_A           20 RVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE----   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSS----
T ss_pred             ceEEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCC----
Confidence            3468899999999999999999765544   79999886432     34457999999999999999999884322    


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||+
T Consensus        96 ~~~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~-~i~H~dikp~Nili~~~~-~~kl~Dfg~  170 (298)
T 3pls_A           96 GLPHVLLPYMCHGDLLQFIRS---PQRNPTVKDLISFGLQVARGMEYLAEQ-KFVHRDLAARNCMLDESF-TVKVADFGL  170 (298)
T ss_dssp             SCCEEEECCCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECCTTS
T ss_pred             CCcEEEEecccCCCHHHHHhc---cccCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCcceEEEcCCC-cEEeCcCCC
Confidence            22478999986 577776653   246789999999999999999999987 999999999999999888 899999999


Q ss_pred             ccccccC-----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCC
Q 017452          221 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       221 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      +......     .......+++.|+|||.+.+.. ++.++||||||+++|+|++|. +||...+..+....+.....   
T Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---  246 (298)
T 3pls_A          171 ARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRR---  246 (298)
T ss_dssp             SCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCC---
T ss_pred             cccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCC---
Confidence            9754322     2223456688999999996544 789999999999999999955 55555554444333322110   


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcch
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLL  362 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~  362 (371)
                                               ...+..+++.+.+++.+||+.||.+|||+.++++.|+.+....
T Consensus       247 -------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l  289 (298)
T 3pls_A          247 -------------------------LPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSAL  289 (298)
T ss_dssp             -------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred             -------------------------CCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHH
Confidence                                     0134557899999999999999999999999999988875543

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.6e-44  Score=326.70  Aligned_cols=263  Identities=23%  Similarity=0.293  Sum_probs=200.8

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .|..++.||+|+||.||+|.+  ++..||+|++...        .....+|+.+++.++||||+++++++.     ....
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~~~~  104 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSS-----DGDD  104 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSS
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEe-----cCCc
Confidence            466779999999999999986  6889999988542        234568999999999999999999883     3344


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||++ ++|.+.+... .....+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++.
T Consensus       105 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~i~~~i~~~l~~lH~~-~i~H~dlkp~Nili~~~~-~~kl~Dfg~~~  181 (307)
T 2nru_A          105 LCLVYVYMPNGSLLDRLSCL-DGTPPLSWHMRCKIAQGAANGINFLHEN-HHIHRDIKSANILLDEAF-TAKISDFGLAR  181 (307)
T ss_dssp             CEEEEECCTTCBHHHHHHTG-GGCCCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecCCCcHHHHHHhc-cCCCCCCHHHHHHHHHHHHHHHHHHhcC-CeecCCCCHHHEEEcCCC-cEEEeeccccc
Confidence            789999996 5877777643 2345799999999999999999999987 999999999999999887 89999999987


Q ss_pred             ccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      .......   .....||+.|+|||.+.+  .++.++||||||+++|+|++|..||........+..+.............
T Consensus       182 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (307)
T 2nru_A          182 ASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIED  259 (307)
T ss_dssp             ECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHH
T ss_pred             ccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhh
Confidence            6543322   223568999999999854  36899999999999999999999998765544333333222111100000


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ...        +.     . ...+...+..+.+++.+||+.||.+|||+.+++++|+.+..
T Consensus       260 ~~~--------~~-----~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~~  306 (307)
T 2nru_A          260 YID--------KK-----M-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMTA  306 (307)
T ss_dssp             HSC--------SS-----C-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC-
T ss_pred             hcc--------cc-----c-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhc
Confidence            000        00     0 00122345789999999999999999999999999987653

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.5e-43  Score=321.17  Aligned_cols=244  Identities=23%  Similarity=0.316  Sum_probs=191.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcC--CCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLD--HPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~--h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||.||+|.+. +++.||+|++...      .....+|+.+++.++  |+||+++++++.     ...
T Consensus        28 ~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~-----~~~  101 (313)
T 3cek_A           28 RIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI-----TDQ  101 (313)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE-----CSS
T ss_pred             ceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee-----cCC
Confidence            47999999999999999999974 5899999998543      234567999999997  599999999873     344


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +.++|||+.+++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++. + .+||+|||++.
T Consensus       102 ~~~lv~e~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dlkp~NIl~~~-~-~~kL~Dfg~~~  174 (313)
T 3cek_A          102 YIYMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQH-GIVHSDLKPANFLIVD-G-MLKLIDFGIAN  174 (313)
T ss_dssp             EEEEEECCCSEEHHHHHHH----CSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEEET-T-EEEECCCSSSC
T ss_pred             EEEEEEecCCCcHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CceecCCCcccEEEEC-C-eEEEeeccccc
Confidence            5889999888898888875    46789999999999999999999987 9999999999999974 4 89999999998


Q ss_pred             ccccCCC---cccccccccccCcccccCC----------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHH
Q 017452          223 VLVKGEP---NISYICSRYYRAPELIFGA----------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIK  288 (371)
Q Consensus       223 ~~~~~~~---~~~~~~t~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~  288 (371)
                      .......   .....|++.|+|||.+.+.          ..++.++||||||+++|+|++|..||....... .+..+..
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~  254 (313)
T 3cek_A          175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID  254 (313)
T ss_dssp             C--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHC
T ss_pred             cccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHh
Confidence            7543322   2245689999999998641          347889999999999999999999997654332 2222111


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                         ..                        ....++...+.++.++|.+||+.||.+|||+.++++|
T Consensus       255 ---~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  293 (313)
T 3cek_A          255 ---PN------------------------HEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  293 (313)
T ss_dssp             ---TT------------------------SCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ---cc------------------------cccCCcccchHHHHHHHHHHccCCcccCcCHHHHhcC
Confidence               00                        0111345568899999999999999999999998887

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=6.9e-44  Score=340.87  Aligned_cols=252  Identities=24%  Similarity=0.319  Sum_probs=201.4

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+++.++||||+++++++..      ...+
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~------~~~~  254 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  254 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC------CceE
Confidence            34679999999999999999999864 467999998653   3456789999999999999999987732      2368


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. |+|.+.+...  ....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       255 iv~e~~~~gsL~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~-~ivHrDlkp~Nill~~~~-~~kl~DfG~a~~~  330 (452)
T 1fmk_A          255 IVTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  330 (452)
T ss_dssp             EEECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC--
T ss_pred             EEehhhcCCCHHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCChhhEEECCCC-CEEECCCccceec
Confidence            9999998 4888877542  235689999999999999999999987 999999999999999887 8999999999875


Q ss_pred             ccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....  .....+++.|+|||.+.... ++.++||||||+++|+|++ |+.||.+....+....+......         
T Consensus       331 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---------  400 (452)
T 1fmk_A          331 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---------  400 (452)
T ss_dssp             ------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---------
T ss_pred             CCCceecccCCcccccccCHhHHhcCC-CCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---------
Confidence            43321  12344578899999986554 8999999999999999999 99999887766655544332110         


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                         ..+..+++.+.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       401 -------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~  440 (452)
T 1fmk_A          401 -------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  440 (452)
T ss_dssp             -------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             -------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhc
Confidence                               1345689999999999999999999999999999888743

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.3e-43  Score=317.63  Aligned_cols=250  Identities=22%  Similarity=0.314  Sum_probs=202.6

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+. ++..||+|.+...   .....+|+++++.++||||+++++++.     . ...+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-----~-~~~~   83 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-----Q-EPIY   83 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----S-SSCE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-----C-CCcE
Confidence            3467999999999999999999964 5678999998653   345668999999999999999998763     1 1267


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. ++|.+.+....  ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||++...
T Consensus        84 ~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dikp~Nil~~~~~-~~kl~Dfg~~~~~  159 (279)
T 1qpc_A           84 IITEYMENGSLVDFLKTPS--GIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLI  159 (279)
T ss_dssp             EEEECCTTCBHHHHTTSHH--HHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEEC
T ss_pred             EEEecCCCCCHHHHHhcCC--CCCCCHHHHHHHHHHHHHHHHHHHHC-CeeccCCCHhhEEEcCCC-CEEECCCcccccc
Confidence            9999997 58777765321  23689999999999999999999987 999999999999999887 8999999999876


Q ss_pred             ccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      .....  .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||.+....+....+....           
T Consensus       160 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-----------  227 (279)
T 1qpc_A          160 EDNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY-----------  227 (279)
T ss_dssp             SSSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC-----------
T ss_pred             cCcccccccCCCCccCccChhhhccCC-CCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhccc-----------
Confidence            44322  12345577899999986544 7889999999999999999 999998877665544443210           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                       ....+..++.++.+++.+||+.||.+|||+.++++.|+.+
T Consensus       228 -----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~  267 (279)
T 1qpc_A          228 -----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDF  267 (279)
T ss_dssp             -----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHH
Confidence                             0113456889999999999999999999999999988765

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=7.5e-44  Score=338.86  Aligned_cols=253  Identities=27%  Similarity=0.364  Sum_probs=185.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-hhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ..|.+.+.||+|+||+||.+. ..+|+.||||++..+. ....+|+.+++.+ +||||+++++++     .....+++||
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~-----~~~~~~~lv~   88 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSE-----TTDRFLYIAL   88 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEE-----ECSSEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEE-----ecCCeEEEEE
Confidence            457888999999999998754 5689999999986543 3456899999876 899999998887     3445689999


Q ss_pred             ccccchHHHHHHHhhhccCC---CCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC------------CcE
Q 017452          149 EYVPETVHRVVKHFNKLNQR---MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT------------HQV  213 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~------------~~~  213 (371)
                      ||++|+|.+++.........   .++..++.++.||+.||+|||++ ||+||||||+|||++.++            ..+
T Consensus        89 E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~  167 (434)
T 2rio_A           89 ELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL-KIIHRDLKPQNILVSTSSRFTADQQTGAENLRI  167 (434)
T ss_dssp             CCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEE
T ss_pred             ecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC-CccccCCChHhEEEecCcccccccccCCCceEE
Confidence            99999999888753221111   13334678999999999999987 999999999999997532            379


Q ss_pred             EEEeeCCccccccCCC-----cccccccccccCcccccC------CcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHH
Q 017452          214 KLCDFGSAKVLVKGEP-----NISYICSRYYRAPELIFG------ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVD  281 (371)
Q Consensus       214 kl~Dfg~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~------~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~  281 (371)
                      ||+|||++........     .....||+.|+|||++.+      ...++.++|||||||++|+|++ |..||.......
T Consensus       168 kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  247 (434)
T 2rio_A          168 LISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE  247 (434)
T ss_dssp             EECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH
T ss_pred             EEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH
Confidence            9999999987654322     224578999999999865      2447899999999999999998 999997654433


Q ss_pred             HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       282 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        ..+......                 .+..     ....+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       248 --~~i~~~~~~-----------------~~~~-----~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          248 --SNIIRGIFS-----------------LDEM-----KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             --HHHHHTCCC-----------------CCCC-----TTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --HHHhcCCCC-----------------cccc-----cccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence              222221100                 0000     000112356889999999999999999999997766

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-44  Score=326.65  Aligned_cols=239  Identities=27%  Similarity=0.412  Sum_probs=192.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHc----CCCCeeecceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLL----DHPNVVSLKHCFF  134 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l----~h~niv~~~~~~~  134 (371)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....          ....+|+.+++.+    +|+||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            3457999999999999999999999999999999985432          2344799999998    8999999999873


Q ss_pred             ecCCCCceeEEEeecc-cc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeee-CCCC
Q 017452          135 STTDKDELYLNLVLEY-VP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVN-PHTH  211 (371)
Q Consensus       135 ~~~~~~~~~~~lv~e~-~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~-~~~~  211 (371)
                           .....++|||+ +. ++|.+.+..    ...+++..++.++.||+.||.|||++ ||+||||||+||+++ .++ 
T Consensus       109 -----~~~~~~~v~e~~~~~~~L~~~l~~----~~~~~~~~~~~~~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~-  177 (312)
T 2iwi_A          109 -----TQEGFMLVLERPLPAQDLFDYITE----KGPLGEGPSRCFFGQVVAAIQHCHSR-GVVHRDIKDENILIDLRRG-  177 (312)
T ss_dssp             ---------CEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHH-TEECCCCSGGGEEEETTTT-
T ss_pred             -----cCCeEEEEEEecCCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecCCChhhEEEeCCCC-
Confidence                 33446889998 44 688877765    45799999999999999999999997 999999999999999 555 


Q ss_pred             cEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC
Q 017452          212 QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG  291 (371)
Q Consensus       212 ~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~  291 (371)
                      .+||+|||++...... ......|++.|+|||.+.+....+.++||||||+++|+|++|+.||....      .+...  
T Consensus       178 ~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~--  248 (312)
T 2iwi_A          178 CAKLIDFGSGALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEA--  248 (312)
T ss_dssp             EEEECCCSSCEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHT--
T ss_pred             eEEEEEcchhhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhh--
Confidence            8999999999876443 33456789999999998765544568999999999999999999996531      11110  


Q ss_pred             CCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          292 TPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                                 ...++..++..+.+||.+||+.||.+|||+.++++|
T Consensus       249 ---------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          249 ---------------------------ELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             ---------------------------CCCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             ---------------------------ccCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                                       001445689999999999999999999999998887

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=3.6e-44  Score=340.36  Aligned_cols=247  Identities=23%  Similarity=0.336  Sum_probs=184.5

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCceeEEEeec
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDELYLNLVLE  149 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~~~~lv~e  149 (371)
                      +|.+.+.||+|+||+|+. ....+|+.||||++... .....+|+.+++.+ +||||+++++++.     +..+.++|||
T Consensus        25 ~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~-----~~~~~~lv~E   98 (432)
T 3p23_A           25 SFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK-----DRQFQYIAIE   98 (432)
T ss_dssp             EEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEE-----ETTEEEEEEE
T ss_pred             EEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEe-----cCCEEEEEEE
Confidence            699999999999998653 33568899999998654 34567899999999 7999999998873     3445799999


Q ss_pred             cccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC----CcEEEEeeCCccccc
Q 017452          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT----HQVKLCDFGSAKVLV  225 (371)
Q Consensus       150 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~----~~~kl~Dfg~a~~~~  225 (371)
                      |++|+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++    ..+||+|||+++...
T Consensus        99 ~~~g~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~  174 (432)
T 3p23_A           99 LCAATLQEYVEQK---DFAHLGLEPITLLQQTTSGLAHLHSL-NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLA  174 (432)
T ss_dssp             CCSEEHHHHHHSS---SCCCCSSCHHHHHHHHHHHHHHHHHT-TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-
T ss_pred             CCCCCHHHHHHhc---CCCccchhHHHHHHHHHHHHHHHHHC-cCEeCCCCHHHEEEecCCCCCceeEEEecccceeecc
Confidence            9999988887642   23455556788999999999999987 999999999999995322    258899999998765


Q ss_pred             cCC----CcccccccccccCcccccC--CcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          226 KGE----PNISYICSRYYRAPELIFG--ATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       226 ~~~----~~~~~~~t~~y~aPE~~~~--~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      ...    ......||+.|+|||++.+  ...++.++|||||||++|+|++ |..||.......... +   .+.....  
T Consensus       175 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~-~---~~~~~~~--  248 (432)
T 3p23_A          175 VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANI-L---LGACSLD--  248 (432)
T ss_dssp             -----------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHH-H---TTCCCCT--
T ss_pred             CCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHH-H---hccCCcc--
Confidence            432    2334678999999999864  2346789999999999999999 899996554332211 1   1110000  


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   .     +  ..+...+..+.+||.+||+.||.+|||+.++++|
T Consensus       249 -------------~-----~--~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          249 -------------C-----L--HPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             -------------T-----S--CTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             -------------c-----c--CccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence                         0     0  0112235668999999999999999999997766

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-44  Score=333.88  Aligned_cols=255  Identities=21%  Similarity=0.298  Sum_probs=193.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      ....|.+.+.||+|+||.||+|.+..++   ..||+|.+...     ...+.+|+.+++.++||||+++++++...    
T Consensus        87 ~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~----  162 (373)
T 3c1x_A           87 SSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----  162 (373)
T ss_dssp             TTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCC----
T ss_pred             hhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC----
Confidence            3456999999999999999999875432   46899988542     23456799999999999999999976432    


Q ss_pred             ceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ....++||||+.+ +|.+++..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||
T Consensus       163 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~-~~kL~DFG  237 (373)
T 3c1x_A          163 EGSPLVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFG  237 (373)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC-
T ss_pred             CCCeEEEEECCCCCCHHHHHhh---cccCCCHHHHHHHHHHHHHHHHHHHHC-CEecCccchheEEECCCC-CEEEeecc
Confidence            2346799999985 88777753   245688999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       220 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      +++.......     .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |.+||...+..+....+....  .
T Consensus       238 ~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~--~  314 (373)
T 3c1x_A          238 LARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR--R  314 (373)
T ss_dssp             --------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTC--C
T ss_pred             ccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCC--C
Confidence            9976533221     22345678899999986544 7999999999999999999 678887766555444333210  0


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                                ...+..++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       315 --------------------------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~  356 (373)
T 3c1x_A          315 --------------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  356 (373)
T ss_dssp             --------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             --------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHh
Confidence                                      013456889999999999999999999999999998876444

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=7.5e-44  Score=325.48  Aligned_cols=268  Identities=24%  Similarity=0.341  Sum_probs=200.0

Q ss_pred             ccce-eeeEeeccCCceEEEEEEE----CCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISY-MAERIVGQGSFGVVFQAKC----LETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y-~~~~~lg~G~~g~V~~~~~----~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++| ++++.||+|+||.||++..    ..+++.||||++...     .....+|+++++.++||||+++++++...   
T Consensus        29 ~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  105 (318)
T 3lxp_A           29 HKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA---  105 (318)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET---
T ss_pred             cHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC---
Confidence            3455 9999999999999988754    457899999999654     23456899999999999999999988552   


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      +...+++||||+++ +|.+.+.     ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~i~~~l~~~l~~LH~~-~ivH~Dikp~Nil~~~~~-~~kl~Df  178 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLP-----RHSIGLAQLLLFAQQICEGMAYLHAQ-HYIHRDLAARNVLLDNDR-LVKIGDF  178 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGG-----GSCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEECCG
T ss_pred             CCceEEEEEecccCCcHHHHHh-----hCCCCHHHHHHHHHHHHHHHHHHHhC-CccCCCCchheEEEcCCC-CEEECCc
Confidence            23457899999985 7777664     34599999999999999999999987 999999999999999887 8999999


Q ss_pred             CCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       219 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |++........    .....+|+.|+|||.+.+.. ++.++||||||+++|+|++|..||........     ...+...
T Consensus       179 g~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~-----~~~~~~~  252 (318)
T 3lxp_A          179 GLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTLYELLTHCDSSQSPPTKFL-----ELIGIAQ  252 (318)
T ss_dssp             GGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHH-----HHHCSCC
T ss_pred             cccccccccccccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHHHHHHhCCCcccccchhhh-----hhhcccc
Confidence            99987654432    22345688899999996554 78899999999999999999999965322110     0000000


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                      ...-.        ...............+..++.++.+||.+||+.||.+|||+.++++.|+.+...
T Consensus       253 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~  311 (318)
T 3lxp_A          253 GQMTV--------LRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEK  311 (318)
T ss_dssp             HHHHH--------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchhH--------HHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHh
Confidence            00000        000000000001113456899999999999999999999999999998876443

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.4e-43  Score=325.91  Aligned_cols=278  Identities=19%  Similarity=0.285  Sum_probs=196.2

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-hhhHHHHHH--HHHcCCCCeeecceeEEecCCCCceeE
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQT--MRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~--l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ...++|++.+.||+|+||.||+|.+  +++.||||++.... .....|.++  +..++||||+++++.+......+...+
T Consensus        10 ~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           10 LDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred             cChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceE
Confidence            3456899999999999999999976  78999999986543 222334444  445899999999987766555666778


Q ss_pred             EEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC--------CcEeeccCCCceeeeCCCCcEEE
Q 017452          145 NLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI--------GVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       145 ~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                      ++||||++ |+|.+++..     ...++..++.++.||+.||.|||++.        ||+||||||+|||++.++ .+||
T Consensus        88 ~lv~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kL  161 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDG-TCVI  161 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTS-CEEE
T ss_pred             EEEEecCCCCcHHHHHhh-----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCC-cEEE
Confidence            89999996 588887753     45689999999999999999999632        999999999999999888 8999


Q ss_pred             EeeCCccccccCC---------CcccccccccccCcccccCC------cCCCCcchHHHHHHHHHHHHhCCCCCCCCCc-
Q 017452          216 CDFGSAKVLVKGE---------PNISYICSRYYRAPELIFGA------TEYTTAIDIWSAGCVVAELMLGKPLFPGDSG-  279 (371)
Q Consensus       216 ~Dfg~a~~~~~~~---------~~~~~~~t~~y~aPE~~~~~------~~~~~~~DiwslG~il~~lltg~~pf~~~~~-  279 (371)
                      +|||++.......         ......||+.|+|||++.+.      ..++.++|||||||++|+|++|..||..... 
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999997654321         12245689999999998652      2356789999999999999999766543322 


Q ss_pred             HHHHHHHHH-HhCCCCHhHHhhcCC-CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          280 VDQLVEIIK-VLGTPTREEIKCMNP-NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       280 ~~~~~~~~~-~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      ......+.. ....+....+..... ......++.    .|.  ....+++++.+||.+||+.||++|||+.++++.|+.
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~--~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~  315 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE----AWK--ENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAE  315 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT----TCC--CCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHH
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc----ccc--cccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHH
Confidence            111111111 111122221111000 000000000    000  011244579999999999999999999999999877


Q ss_pred             CC
Q 017452          358 CP  359 (371)
Q Consensus       358 ~~  359 (371)
                      +.
T Consensus       316 ll  317 (336)
T 3g2f_A          316 LM  317 (336)
T ss_dssp             HH
T ss_pred             HH
Confidence            54

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=344.09  Aligned_cols=252  Identities=24%  Similarity=0.325  Sum_probs=205.2

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...+|++.+.||+|+||.||+|.+.. +..||||++...   ...+.+|+.+++.++|+||+++++++..      ..++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~------~~~~  337 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE------EPIY  337 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS------SSCE
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee------ccce
Confidence            34679999999999999999999864 467999998653   3456789999999999999999987732      2368


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||+. |+|.+++....  ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+++..
T Consensus       338 lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~qi~~~L~~LH~~-~ivHrDlkp~NIll~~~~-~~kl~DFG~a~~~  413 (535)
T 2h8h_A          338 IVTEYMSKGSLLDFLKGET--GKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLI  413 (535)
T ss_dssp             EEECCCTTEEHHHHHSHHH--HTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCTTSTTTC
T ss_pred             EeeehhcCCcHHHHHhhcC--CCCCCHHHHHHHHHHHHHHHHHHHhC-CeeCCCCCHhhEEEcCCC-cEEEcccccceec
Confidence            9999998 48888775422  35689999999999999999999987 999999999999999887 8999999999765


Q ss_pred             ccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          225 VKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       225 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....  ......++..|+|||++.... ++.++|||||||++|+|++ |+.||.+....+.+..+.....          
T Consensus       414 ~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~----------  482 (535)
T 2h8h_A          414 EDNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR----------  482 (535)
T ss_dssp             CCHHHHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCC----------
T ss_pred             CCCceecccCCcCcccccCHHHhccCC-CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC----------
Confidence            3221  112334577899999986544 8999999999999999999 9999988776665554433110          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                        ...+..++.++.+||.+||+.||.+|||+.++++.|+.+..
T Consensus       483 ------------------~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~  523 (535)
T 2h8h_A          483 ------------------MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT  523 (535)
T ss_dssp             ------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSC
T ss_pred             ------------------CCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhh
Confidence                              01345689999999999999999999999999999988744

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.3e-43  Score=319.45  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=194.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC-CCc--EEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE-TGE--TVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~--~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ..+|++.+.||+|+||.||+|.+.. ++.  .||+|++...       .....+|+.+++.++||||+++++++..    
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~----   92 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT----   92 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS----
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcc----
Confidence            3579999999999999999998643 333  6899987542       2345689999999999999999998743    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                       .. .++||||+. ++|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus        93 -~~-~~~v~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~-~i~H~dikp~Nili~~~~-~~kl~Df  165 (291)
T 1u46_A           93 -PP-MKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDF  165 (291)
T ss_dssp             -SS-CEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             -CC-ceeeEecccCCCHHHHHHhc---cCCcCHHHHHHHHHHHHHHHHHHHhC-CcccCCCchheEEEcCCC-CEEEccc
Confidence             12 579999998 5777777643   35689999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       219 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      |++........    .....+++.|+|||.+.+.. ++.++||||||+++|+|++ |..||...+..+....+......+
T Consensus       166 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~  244 (291)
T 1u46_A          166 GLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL  244 (291)
T ss_dssp             TTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC
T ss_pred             cccccccccccchhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCC
Confidence            99987644332    12345677899999986544 7889999999999999999 999998877665554443211000


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                                 ..+..++.++.++|.+||..||.+|||+.+++++|..+...
T Consensus       245 ---------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  285 (291)
T 1u46_A          245 ---------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQPT  285 (291)
T ss_dssp             ---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC--
T ss_pred             ---------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCcc
Confidence                                       02346889999999999999999999999999998876554

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-43  Score=324.60  Aligned_cols=260  Identities=20%  Similarity=0.298  Sum_probs=192.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-hhhHHHHHHHHHc--CCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLL--DHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l--~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .++|++.+.||+|+||.||+|.+  +|+.||||++.... ....+|.+++..+  +||||+++++++.... ......++
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~l  112 (337)
T 3mdy_A           36 AKQIQMVKQIGKGRYGEVWMGKW--RGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGT-GSWTQLYL  112 (337)
T ss_dssp             HHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESC-GGGCEEEE
T ss_pred             ccceEEEeEeecCCCeEEEEEEE--CCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCC-CCCCceEE
Confidence            35799999999999999999987  48999999986543 3334555665544  8999999999876543 22356789


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC-------CcEeeccCCCceeeeCCCCcEEEEee
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI-------GVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-------~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ||||+.+ +|.+.+..     ..+++..++.++.|++.||.|||++.       ||+||||||+|||++.++ .+||+||
T Consensus       113 v~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~-~~kl~Df  186 (337)
T 3mdy_A          113 ITDYHENGSLYDYLKS-----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNG-TCCIADL  186 (337)
T ss_dssp             EECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTS-CEEECCC
T ss_pred             EEeccCCCcHHHHhhc-----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCC-CEEEEeC
Confidence            9999985 88888753     57999999999999999999999631       999999999999999888 8999999


Q ss_pred             CCccccccCCCc-----ccccccccccCcccccCCcCCCC------cchHHHHHHHHHHHHhC----------CCCCCCC
Q 017452          219 GSAKVLVKGEPN-----ISYICSRYYRAPELIFGATEYTT------AIDIWSAGCVVAELMLG----------KPLFPGD  277 (371)
Q Consensus       219 g~a~~~~~~~~~-----~~~~~t~~y~aPE~~~~~~~~~~------~~DiwslG~il~~lltg----------~~pf~~~  277 (371)
                      |++.........     ....||+.|+|||++.+.. ...      ++|||||||++|+|++|          ..||...
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            999765433221     2457899999999996554 334      38999999999999999          6666543


Q ss_pred             Cc----HHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          278 SG----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       278 ~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                      ..    ..............         +     .++       ....+..+++++.+|+.+||+.||.+|||+.++++
T Consensus       266 ~~~~~~~~~~~~~~~~~~~~---------~-----~~~-------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          266 VPSDPSYEDMREIVCIKKLR---------P-----SFP-------NRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             SCSSCCHHHHHHHHTTSCCC---------C-----CCC-------GGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCCCCchhhhHHHHhhhccC---------c-----ccc-------ccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence            21    11121111100000         0     000       00011235677999999999999999999999999


Q ss_pred             hhcCCCc
Q 017452          354 LFSNCPS  360 (371)
Q Consensus       354 ~l~~~~~  360 (371)
                      +|+.+..
T Consensus       325 ~L~~l~~  331 (337)
T 3mdy_A          325 TLAKMSE  331 (337)
T ss_dssp             HHHHHHH
T ss_pred             HHHHHHh
Confidence            9987644

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=322.57  Aligned_cols=272  Identities=24%  Similarity=0.380  Sum_probs=202.5

Q ss_pred             CcccceeeeEeeccCCceEEEEEE----ECCCCcEEEEEEeecch----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAK----CLETGETVAIKKVLQDK----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~----~~~~~~~vaiK~~~~~~----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||.||+|.    +..+|+.||+|++....    ....+|+.+++.++||||+++++++...   
T Consensus        38 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---  114 (326)
T 2w1i_A           38 FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSA---  114 (326)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----
T ss_pred             cCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEec---
Confidence            344679999999999999999998    46689999999986532    3456899999999999999999887432   


Q ss_pred             CceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      +....++||||+++ +|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+||
T Consensus       115 ~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~-~ivH~dikp~NIli~~~~-~~kL~Df  189 (326)
T 2w1i_A          115 GRRNLKLIMEYLPYGSLRDYLQKH---KERIDHIKLLQYTSQICKGMEYLGTK-RYIHRDLATRNILVENEN-RVKIGDF  189 (326)
T ss_dssp             ---CCEEEECCCTTCBHHHHHHHS---TTSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCC
T ss_pred             CCCceEEEEECCCCCCHHHHHHhc---ccCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEEcCCC-cEEEecC
Confidence            22346899999975 888877642   35689999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          219 GSAKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       219 g~a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      |++........    .....++..|+|||.+.+.. ++.++||||||+++|+|++|..||.....     ...+..+...
T Consensus       190 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~el~tg~~~~~~~~~-----~~~~~~~~~~  263 (326)
T 2w1i_A          190 GLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVLYELFTYIEKSKSPPA-----EFMRMIGNDK  263 (326)
T ss_dssp             TTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHHTTCGGGSHHH-----HHHHHHCTTC
T ss_pred             cchhhccccccccccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHHHHHHhcCCCCCCCHH-----HHHHhhcccc
Confidence            99987644332    12345677899999986554 78899999999999999999998864211     1111111111


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ......       ..+............+..++.++.++|.+||+.||.+|||+.++++.|+.+..
T Consensus       264 ~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~  322 (326)
T 2w1i_A          264 QGQMIV-------FHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRD  322 (326)
T ss_dssp             CTHHHH-------HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             chhhhH-------HHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence            000000       00000000000001345689999999999999999999999999999887644

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=5e-43  Score=347.13  Aligned_cols=246  Identities=23%  Similarity=0.303  Sum_probs=197.2

Q ss_pred             eee-eEeeccCCceEEEEEEE--CCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           73 YMA-ERIVGQGSFGVVFQAKC--LETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        73 y~~-~~~lg~G~~g~V~~~~~--~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      +.+ .+.||+|+||.||+|.+  ..+++.||||++...      ...+.+|+.+++.++|||||++++++..     . .
T Consensus       370 ~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-----~-~  443 (635)
T 4fl3_A          370 LTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----E-S  443 (635)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-S
T ss_pred             ccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-----C-C
Confidence            444 34899999999999954  456789999998653      2446689999999999999999997721     1 2


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .++||||+. |+|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++
T Consensus       444 ~~lv~E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~~L~yLH~~-~iiHrDLkp~NILl~~~~-~~kL~DFGla~  517 (635)
T 4fl3_A          444 WMLVMEMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSK  517 (635)
T ss_dssp             EEEEEECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCTTHHH
T ss_pred             EEEEEEccCCCCHHHHHhh----CCCCCHHHHHHHHHHHHHHHHHHHHC-CEeCCCCChHhEEEeCCC-CEEEEEcCCcc
Confidence            679999998 577777753    56799999999999999999999987 999999999999999888 89999999998


Q ss_pred             ccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      .......    .....+|+.|+|||++.+.. ++.++|||||||++|+|++ |+.||.+.+..+....+.....      
T Consensus       518 ~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~------  590 (635)
T 4fl3_A          518 ALRADENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER------  590 (635)
T ss_dssp             HTTC-------------CGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC------
T ss_pred             ccccCccccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC------
Confidence            7643322    22334578899999996544 8999999999999999998 9999988877665555443210      


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                            ...+..+++++.+||.+||+.||.+|||+.++++.|+++.
T Consensus       591 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~  630 (635)
T 4fl3_A          591 ----------------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  630 (635)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             ----------------------CCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                                  0145568999999999999999999999999999987653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=323.18  Aligned_cols=247  Identities=15%  Similarity=0.175  Sum_probs=192.0

Q ss_pred             ccceeeeEeeccCCceEEEEE-----EECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceeEEecCCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQA-----KCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~-----~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~  140 (371)
                      ..+|.+.+.||+|+||.||+|     .+..+++.||+|++... .....+|+.+++.+.   |+||+++++++...    
T Consensus        64 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~----  139 (365)
T 3e7e_A           64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ----  139 (365)
T ss_dssp             SSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS----
T ss_pred             CEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC----
Confidence            357999999999999999999     46778999999998654 345567888888886   89999999988443    


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC----------
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNK-LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP----------  208 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~----------  208 (371)
                       ...++||||++ |+|.+++..... ....+++..++.++.||+.||+|||++ ||+||||||+|||++.          
T Consensus       140 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~-~ivHrDiKp~NIll~~~~~~~~~~~~  217 (365)
T 3e7e_A          140 -NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC-EIIHGDIKPDNFILGNGFLEQDDEDD  217 (365)
T ss_dssp             -SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCSGGGEEECGGGTCC-----
T ss_pred             -CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC-CeecCCCCHHHEEecccccCcccccc
Confidence             33789999998 688888876543 256799999999999999999999986 9999999999999987          


Q ss_pred             -CCCcEEEEeeCCccccc---cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Q 017452          209 -HTHQVKLCDFGSAKVLV---KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV  284 (371)
Q Consensus       209 -~~~~~kl~Dfg~a~~~~---~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~  284 (371)
                       ++ .+||+|||+|+...   .........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.......   
T Consensus       218 ~~~-~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~---  292 (365)
T 3e7e_A          218 LSA-GLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE---  292 (365)
T ss_dssp             -CT-TEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE---
T ss_pred             ccC-CEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc---
Confidence             66 89999999997543   222334567899999999997655 8999999999999999999999995432210   


Q ss_pred             HHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-CHHHHhhhhcC
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TAVSKRILFSN  357 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-t~~~~l~~l~~  357 (371)
                                             ........       ....++.+.+++..||..+|.+|+ ++.++.+.|+.
T Consensus       293 -----------------------~~~~~~~~-------~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~  336 (365)
T 3e7e_A          293 -----------------------CKPEGLFR-------RLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKK  336 (365)
T ss_dssp             -----------------------EEECSCCT-------TCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHH
T ss_pred             -----------------------eeechhcc-------ccCcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHH
Confidence                                   00000000       012367889999999999999995 55555555544

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=9.7e-43  Score=344.16  Aligned_cols=248  Identities=24%  Similarity=0.302  Sum_probs=198.1

Q ss_pred             cceeeeE-eeccCCceEEEEEEEC--CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAER-IVGQGSFGVVFQAKCL--ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~-~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++.+.+ .||+|+||.||+|.+.  .++..||||++...     ...+.+|+.+++.++||||+++++++..      .
T Consensus       335 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~------~  408 (613)
T 2ozo_A          335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA------E  408 (613)
T ss_dssp             TSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES------S
T ss_pred             cceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc------C
Confidence            3456666 8999999999999875  35667999998653     3456789999999999999999998732      1


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||+.+ +|.+.+..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus       409 ~~~lv~E~~~~g~L~~~l~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~iiHrDlkp~NILl~~~~-~vkL~DFGla  483 (613)
T 2ozo_A          409 ALMLVMEMAGGGPLHKFLVG---KREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRNLAARNVLLVNRH-YAKISDFGLS  483 (613)
T ss_dssp             SEEEEEECCTTCBHHHHHTT---CTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCCSTT
T ss_pred             CeEEEEEeCCCCcHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHHHC-CEEcCcCCHHHEEEcCCC-cEEEeeccCc
Confidence            27899999985 67666542   245799999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +........    ....+++.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.+...     
T Consensus       484 ~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~-----  557 (613)
T 2ozo_A          484 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  557 (613)
T ss_dssp             TTCC--------------CCTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCC-----
T ss_pred             ccccCCCceeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            876433221    1233467899999996544 8999999999999999998 9999998887766555543210     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                             ..++..+++++.+||.+||+.||.+||++.++++.|+.+
T Consensus       558 -----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~  596 (613)
T 2ozo_A          558 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  596 (613)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence                                   014556899999999999999999999999999987764

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=9.2e-43  Score=321.23  Aligned_cols=259  Identities=20%  Similarity=0.263  Sum_probs=198.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHH--cCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRL--LDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~--l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||.||+|.+  +|+.||||++... .....+|.++++.  ++||||+++++++.... ......++|
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~-~~~~~~~lv  118 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV  118 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC-SSCCCEEEE
T ss_pred             ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC-CccceeEEE
Confidence            5799999999999999999987  6899999998654 3445678888887  78999999999875433 122357899


Q ss_pred             eccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH--------hcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          148 LEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH--------RSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       148 ~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      |||+.+ +|.+.+..     ..+++..++.++.||+.||.|||        ++ ||+||||||+|||++.++ .+||+||
T Consensus       119 ~e~~~~g~L~~~l~~-----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~-~ivH~Dlkp~NIll~~~~-~~kL~Df  191 (342)
T 1b6c_B          119 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKP-AIAHRDLKSKNILVKKNG-TCCIADL  191 (342)
T ss_dssp             ECCCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC-EEECSCCSGGGEEECTTS-CEEECCC
T ss_pred             EeecCCCcHHHHHhc-----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccC-CeeeCCCCHHHEEECCCC-CEEEEEC
Confidence            999986 88888753     57899999999999999999999        76 999999999999999888 8999999


Q ss_pred             CCccccccCCC-----cccccccccccCcccccCCcC-----CCCcchHHHHHHHHHHHHhC----------CCCCCCCC
Q 017452          219 GSAKVLVKGEP-----NISYICSRYYRAPELIFGATE-----YTTAIDIWSAGCVVAELMLG----------KPLFPGDS  278 (371)
Q Consensus       219 g~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~lltg----------~~pf~~~~  278 (371)
                      |++........     .....||+.|+|||.+.+...     ++.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            99977654432     234578999999999865432     23689999999999999999          77886543


Q ss_pred             c----HHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          279 G----VDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       279 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .    ...+..........         +.     ++    ..|   .....+..+.+|+.+||+.||.+|||+.+++++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~---------~~-----~~----~~~---~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLR---------PN-----IP----NRW---QSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCC---------CC-----CC----GGG---GTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cCcccHHHHHHHHHHHHhC---------CC-----Cc----ccc---cchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            2    12222211100000         00     00    000   012244679999999999999999999999999


Q ss_pred             hcCCCc
Q 017452          355 FSNCPS  360 (371)
Q Consensus       355 l~~~~~  360 (371)
                      |..+..
T Consensus       331 L~~i~~  336 (342)
T 1b6c_B          331 LSQLSQ  336 (342)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            987643

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.9e-43  Score=318.60  Aligned_cols=253  Identities=19%  Similarity=0.247  Sum_probs=197.1

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...++|++.+.||+|+||.||+|.+..   .+|+|++...      ...+.+|+.+++.++||||+++++++..     .
T Consensus        30 i~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-----~  101 (319)
T 2y4i_B           30 IPFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMS-----P  101 (319)
T ss_dssp             SCCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEEC-----S
T ss_pred             CCHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEec-----C
Confidence            345689999999999999999999743   4999988542      2345679999999999999999998843     3


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+. ++|.+.+..   ....+++..++.++.||+.||.|||++ ||+||||||+||+++ ++ .+||+|||+
T Consensus       102 ~~~~iv~e~~~~~~L~~~l~~---~~~~~~~~~~~~i~~qi~~al~~lH~~-~i~H~dlkp~NIl~~-~~-~~~l~Dfg~  175 (319)
T 2y4i_B          102 PHLAIITSLCKGRTLYSVVRD---AKIVLDVNKTRQIAQEIVKGMGYLHAK-GILHKDLKSKNVFYD-NG-KVVITDFGL  175 (319)
T ss_dssp             SCEEEECBCCCSEEHHHHTTS---SCCCCCSHHHHHHHHHHHHHHHHHHHT-TCCCCCCCSTTEEEC----CCEECCCSC
T ss_pred             CceEEEeecccCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCChhhEEEe-CC-CEEEeecCC
Confidence            34789999998 577666542   234689999999999999999999987 999999999999998 45 799999999


Q ss_pred             cccccc------CCCcccccccccccCcccccC--------CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Q 017452          221 AKVLVK------GEPNISYICSRYYRAPELIFG--------ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEI  286 (371)
Q Consensus       221 a~~~~~------~~~~~~~~~t~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~  286 (371)
                      +.....      ........|++.|+|||.+..        ...++.++||||||+++|+|++|..||...........+
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~  255 (319)
T 2y4i_B          176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQM  255 (319)
T ss_dssp             CC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence            765421      122234568999999999864        234688999999999999999999999887665554443


Q ss_pred             HHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          287 IKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                      ..... +                          ...+..++.++.+++.+||..||.+|||+.++++.|+.+...
T Consensus       256 ~~~~~-~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          256 GTGMK-P--------------------------NLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             HTTCC-C--------------------------CCCCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             ccCCC-C--------------------------CCCcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            32100 0                          001235788999999999999999999999999999988654

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=2.3e-43  Score=333.41  Aligned_cols=246  Identities=18%  Similarity=0.190  Sum_probs=186.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCC-CCeeecc---------eeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDH-PNVVSLK---------HCF  133 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h-~niv~~~---------~~~  133 (371)
                      ..|++.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+.| +|...+.         +..
T Consensus        78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~  157 (413)
T 3dzo_A           78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLV  157 (413)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEE
T ss_pred             eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhc
Confidence            4599999999999999999999999999999988632       2345688888888876 3221111         111


Q ss_pred             ------------EecCCCCceeEEEeeccccchHHHHHHHhh---hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeec
Q 017452          134 ------------FSTTDKDELYLNLVLEYVPETVHRVVKHFN---KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD  198 (371)
Q Consensus       134 ------------~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~d  198 (371)
                                  ...........+++|+++.++|.+++....   .....+++..+..++.||+.||+|||++ ||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~iiHrD  236 (413)
T 3dzo_A          158 KDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY-GLVHTY  236 (413)
T ss_dssp             ECCC---------------CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT-TEECSC
T ss_pred             ccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCC
Confidence                        000001123367889999998888886442   2245578888999999999999999987 999999


Q ss_pred             cCCCceeeeCCCCcEEEEeeCCccccccCCCcccccccccccCccccc---------CCcCCCCcchHHHHHHHHHHHHh
Q 017452          199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF---------GATEYTTAIDIWSAGCVVAELML  269 (371)
Q Consensus       199 lkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~llt  269 (371)
                      |||+|||++.++ .+||+|||+++.....  .....| +.|+|||++.         ....++.++|||||||++|+|++
T Consensus       237 iKp~NILl~~~~-~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ellt  312 (413)
T 3dzo_A          237 LRPVDIVLDQRG-GVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWC  312 (413)
T ss_dssp             CCGGGEEECTTC-CEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHH
T ss_pred             cccceEEEecCC-eEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHH
Confidence            999999999998 7999999998765433  344566 9999999983         33347889999999999999999


Q ss_pred             CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH
Q 017452          270 GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV  349 (371)
Q Consensus       270 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~  349 (371)
                      |+.||...+.......+                       +.          ....+++++.+||.+||+.||.+|||+.
T Consensus       313 g~~Pf~~~~~~~~~~~~-----------------------~~----------~~~~~~~~~~~li~~~l~~dP~~Rpt~~  359 (413)
T 3dzo_A          313 ADLPNTDDAALGGSEWI-----------------------FR----------SCKNIPQPVRALLEGFLRYPKEDRLLPL  359 (413)
T ss_dssp             SSCCCCTTGGGSCSGGG-----------------------GS----------SCCCCCHHHHHHHHHHTCSSGGGSCCHH
T ss_pred             CCCCCCCcchhhhHHHH-----------------------Hh----------hcccCCHHHHHHHHHHccCChhhCcCHH
Confidence            99999765432111000                       00          1235789999999999999999999999


Q ss_pred             HHhhh
Q 017452          350 SKRIL  354 (371)
Q Consensus       350 ~~l~~  354 (371)
                      ++++|
T Consensus       360 ~~l~~  364 (413)
T 3dzo_A          360 QAMET  364 (413)
T ss_dssp             HHTTS
T ss_pred             HHHhC
Confidence            98887

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=4.6e-42  Score=341.44  Aligned_cols=252  Identities=26%  Similarity=0.355  Sum_probs=203.1

Q ss_pred             CcccceeeeEeeccCCceEEEEEEECCC---CcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           68 KQTISYMAERIVGQGSFGVVFQAKCLET---GETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        68 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~---~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      ....+|++.+.||+|+||.||+|.+..+   +..||+|.+....     ..+.+|+.+++.++||||+++++++.     
T Consensus       387 i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-----  461 (656)
T 2j0j_A          387 IQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-----  461 (656)
T ss_dssp             CCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-----
T ss_pred             cccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-----
Confidence            4456899999999999999999998643   4679999875432     44567999999999999999998762     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      + ...++||||+. |+|.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+||
T Consensus       462 ~-~~~~lv~E~~~~g~L~~~l~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~-givHrDikp~NILl~~~~-~vkL~DF  535 (656)
T 2j0j_A          462 E-NPVWIIMELCTLGELRSFLQVR---KFSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDF  535 (656)
T ss_dssp             S-SSCEEEEECCTTCBHHHHHHHT---TTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECCC
T ss_pred             c-CceEEEEEcCCCCcHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhC-CccccccchHhEEEeCCC-CEEEEec
Confidence            1 12679999998 5887777532   34689999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          219 GSAKVLVKGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       219 g~a~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      |+++.......  .....+++.|+|||++.+. .++.++||||||+++|+|++ |..||.+....+.+..+......   
T Consensus       536 G~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---  611 (656)
T 2j0j_A          536 GLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---  611 (656)
T ss_dssp             CCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCC---
T ss_pred             CCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCC---
Confidence            99987643322  2234557889999998654 48999999999999999997 99999988776666555442110   


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                               .++..+++.+.+||.+||..||.+|||+.++++.|..+.
T Consensus       612 -------------------------~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il  650 (656)
T 2j0j_A          612 -------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  650 (656)
T ss_dssp             -------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -------------------------CCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence                                     034568999999999999999999999999999988753

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.7e-43  Score=343.81  Aligned_cols=277  Identities=25%  Similarity=0.337  Sum_probs=198.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+..+|+.||||++...     .....+|+.+++.++||||+++++++..... .....
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~   92 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDL   92 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSS
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCe
Confidence            36799999999999999999999999999999988643     2345679999999999999999887632111 12455


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC--cEEEEeeCC
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGS  220 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~--~~kl~Dfg~  220 (371)
                      .++||||++ ++|.+++.... ....+++..++.++.||+.||.|||++ ||+||||||+||+++.++.  .+||+|||+
T Consensus        93 ~~LVmEy~~ggsL~~~L~~~~-~~~~lse~~i~~I~~QLl~aL~yLHs~-gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           93 PLLAMEYCEGGDLRKYLNQFE-NCCGLKEGPIRTLLSDISSALRYLHEN-RIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             CCCEEECCSSCBHHHHHHSSS-CTTCCCSSHHHHHHHHHHHHHHHHHHT-TBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             EEEEEEeCCCCCHHHHHHhcc-cCCCCCHHHHHHHHHHHHHHHHHHHHC-CCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            689999996 58877776422 233689999999999999999999987 9999999999999987652  489999999


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.............||+.|+|||.+.+.. ++.++||||||+++|+|++|..||.+.........   ............
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~---~i~~~~~~~~~~  246 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHG---KVREKSNEHIVV  246 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSC-CSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSST---TCC------CCS
T ss_pred             ccccccccccccccCCcccCChHHhccCC-CCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhh---hhhcccchhhhh
Confidence            98876666666678999999999986544 89999999999999999999999977543321110   000000000000


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .........+.  ...++...+...+++.+.+||.+||.+||.+|||+.++++|
T Consensus       247 ~~~l~g~~~~~--~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~h  298 (676)
T 3qa8_A          247 YDDLTGAVKFS--SVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNV  298 (676)
T ss_dssp             CCCCSSSCCCC--SSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCC
T ss_pred             hhhhccccccc--cccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcC
Confidence            00000001111  01111122334467889999999999999999999996655

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.3e-41  Score=307.83  Aligned_cols=238  Identities=24%  Similarity=0.311  Sum_probs=182.4

Q ss_pred             Ccccceeee-EeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHH-HHcCCCCeeecceeEEecCCCCceeEE
Q 017452           68 KQTISYMAE-RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        68 ~~~~~y~~~-~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ...++|.+. +.||+|+||.||+|.+..+++.||+|++.. .....+|+.++ +.++||||+++++++.... ....+++
T Consensus        14 ~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~-~~~~~~~   91 (299)
T 3m2w_A           14 AIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLL   91 (299)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEE
T ss_pred             ccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhc-CCCceEE
Confidence            345678887 789999999999999999999999999865 44567788887 6669999999999875432 2356689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a  221 (371)
                      +||||+++ +|.+.+...  ....+++..++.++.||+.||.|||++ ||+||||||+||+++.   ++ .+||+|||++
T Consensus        92 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~-~i~H~dlkp~Nil~~~~~~~~-~~kl~Dfg~a  167 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDR--GDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNA-ILKLTDFGFA  167 (299)
T ss_dssp             EEECCCCSCBHHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESSSSTTC-CEEECCCTTC
T ss_pred             EEEeecCCCcHHHHHHhc--cCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCCCCHHHEEEecCCCCC-cEEEeccccc
Confidence            99999985 888877752  234799999999999999999999987 9999999999999987   45 8999999998


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ....                      ...++.++|||||||++|+|++|..||...........+..             
T Consensus       168 ~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~-------------  212 (299)
T 3m2w_A          168 KETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT-------------  212 (299)
T ss_dssp             EECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCC-------------
T ss_pred             cccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHH-------------
Confidence            6431                      12367899999999999999999999976543221100000             


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                           .+....   ..+.......+++++.+||.+||+.||.+|||+.++++|
T Consensus       213 -----~~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~h  257 (299)
T 3m2w_A          213 -----RIRMGQ---YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  257 (299)
T ss_dssp             -----SSCTTC---CSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             -----HHhhcc---ccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcC
Confidence                 000000   000000114579999999999999999999999999888

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.4e-41  Score=304.06  Aligned_cols=227  Identities=15%  Similarity=0.070  Sum_probs=178.7

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....       ....+|+.+++.++||||+++++++..     .
T Consensus        29 ~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~-----~  103 (286)
T 3uqc_A           29 ANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHT-----R  103 (286)
T ss_dssp             TTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEE-----T
T ss_pred             ecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEE-----C
Confidence            4468999999999999999999999999999999986542       345679999999999999999998844     3


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...|+||||++| +|.+++.      .......+..++.||+.||+|||++ ||+||||||+|||++.++ .+||++++ 
T Consensus       104 ~~~~lv~e~~~g~~L~~~l~------~~~~~~~~~~i~~ql~~aL~~lH~~-givH~Dikp~NIll~~~g-~~kl~~~~-  174 (286)
T 3uqc_A          104 AGGLVVAEWIRGGSLQEVAD------TSPSPVGAIRAMQSLAAAADAAHRA-GVALSIDHPSRVRVSIDG-DVVLAYPA-  174 (286)
T ss_dssp             TEEEEEEECCCEEEHHHHHT------TCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCSGGGEEEETTS-CEEECSCC-
T ss_pred             CcEEEEEEecCCCCHHHHHh------cCCChHHHHHHHHHHHHHHHHHHHC-CCccCCCCcccEEEcCCC-CEEEEecc-
Confidence            447899999984 7777663      2245667888999999999999987 999999999999999888 89987443 


Q ss_pred             ccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          221 AKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       221 a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                                        |++|        ++.++|||||||++|+|++|+.||.+.+..+.+...              
T Consensus       175 ------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~--------------  214 (286)
T 3uqc_A          175 ------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA--------------  214 (286)
T ss_dssp             ------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEEC--------------
T ss_pred             ------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHH--------------
Confidence                              3332        688999999999999999999999875542211000              


Q ss_pred             cCCCccccccCcccC-CCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          301 MNPNYTEFKFPQIKA-HPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                               ...... ......+...+++++.+||.+||+.||.+| |+.++++.|..+.
T Consensus       215 ---------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~  264 (286)
T 3uqc_A          215 ---------ERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQAT  264 (286)
T ss_dssp             ---------CBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHH
T ss_pred             ---------HHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHh
Confidence                     000000 000011335689999999999999999999 9999999987653

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=3.7e-42  Score=316.64  Aligned_cols=242  Identities=17%  Similarity=0.136  Sum_probs=176.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------------hhhHHHHHHHHHcC---------CCCeee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------------RYKNRELQTMRLLD---------HPNVVS  128 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------------~~~~~e~~~l~~l~---------h~niv~  128 (371)
                      .++|++.+.||+|+||.||+|++  +|+.||||++....            ....+|+.+++.++         ||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            35799999999999999999998  78999999986542            45678999999886         666666


Q ss_pred             cceeEEecC-------------------------CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHH
Q 017452          129 LKHCFFSTT-------------------------DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIF  182 (371)
Q Consensus       129 ~~~~~~~~~-------------------------~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~  182 (371)
                      +.+.+....                         ..+...+++||||+.+ ++.+.+.     ...+++..++.++.||+
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~-----~~~~~~~~~~~i~~qi~  171 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMR-----TKLSSLATAKSILHQLT  171 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGT-----TTCCCHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHH-----hcCCCHHHHHHHHHHHH
Confidence            555432210                         0124568999999975 3444332     36789999999999999


Q ss_pred             HHHHHHH-hcCCcEeeccCCCceeeeCCC-------------------CcEEEEeeCCccccccCCCcccccccccccCc
Q 017452          183 RALSYIH-RSIGVCHRDIKPQNLLVNPHT-------------------HQVKLCDFGSAKVLVKGEPNISYICSRYYRAP  242 (371)
Q Consensus       183 ~~l~~LH-~~~~ivH~dlkp~NIli~~~~-------------------~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aP  242 (371)
                      .||+||| ++ ||+||||||+|||++.++                   ..+||+|||+|+.....    ...||+.|+||
T Consensus       172 ~aL~~lH~~~-~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aP  246 (336)
T 2vuw_A          172 ASLAVAEASL-RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDE  246 (336)
T ss_dssp             HHHHHHHHHH-CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCS
T ss_pred             HHHHHHHHhC-CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccCh
Confidence            9999999 87 999999999999998764                   27999999999876432    45789999999


Q ss_pred             ccccCCcCCCCcchHHHHHHH-HHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcc
Q 017452          243 ELIFGATEYTTAIDIWSAGCV-VAELMLGKPLFPGDSGVD-QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHK  320 (371)
Q Consensus       243 E~~~~~~~~~~~~DiwslG~i-l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  320 (371)
                      |++.+..  +.++||||||++ .+++++|..||....... ....+.......                  ..    ...
T Consensus       247 E~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------~~----~~~  302 (336)
T 2vuw_A          247 DLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFK------------------TK----CNT  302 (336)
T ss_dssp             GGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCS------------------SC----CCS
T ss_pred             hhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccC------------------cc----cch
Confidence            9997544  789999998777 777889999984321101 111111110000                  00    000


Q ss_pred             cCCCCCChhHHHHHHhccCcCCCCCCCHHHHh
Q 017452          321 IFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKR  352 (371)
Q Consensus       321 ~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l  352 (371)
                      ..+..+++++.+||.+||++|     |+.++|
T Consensus       303 ~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          303 PAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             HHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            011236889999999999987     999954

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-40  Score=332.69  Aligned_cols=239  Identities=23%  Similarity=0.338  Sum_probs=189.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC-CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE-TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|.+.. +|+.||||++...     .....+|+.+++.++||||+++++++......+...
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~  158 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPV  158 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCce
Confidence            3689999999999999999999976 7899999988543     133457999999999999999999987766555556


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .|+||||++| +|.+.+      ...+++..++.++.||+.||.|||++ ||+||||||+|||++.+  .+||+|||+++
T Consensus       159 ~~lv~E~~~g~~L~~~~------~~~l~~~~~~~~~~qi~~aL~~lH~~-giiHrDlkp~NIll~~~--~~kl~DFG~a~  229 (681)
T 2pzi_A          159 GYIVMEYVGGQSLKRSK------GQKLPVAEAIAYLLEILPALSYLHSI-GLVYNDLKPENIMLTEE--QLKLIDLGAVS  229 (681)
T ss_dssp             EEEEEECCCCEECC----------CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSS--CEEECCCTTCE
T ss_pred             eEEEEEeCCCCcHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHHC-CCeecccChHHeEEeCC--cEEEEecccch
Confidence            7999999985 554433      23799999999999999999999987 99999999999999874  79999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .....   ....||+.|+|||++.+.  ++.++|||||||++|+|++|..||.+.....          .+..       
T Consensus       230 ~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~----------~~~~-------  287 (681)
T 2pzi_A          230 RINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVDG----------LPED-------  287 (681)
T ss_dssp             ETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECSS----------CCTT-------
T ss_pred             hcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCccccccc----------cccc-------
Confidence            76433   456789999999998653  4889999999999999999998886421100          0000       


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh-hcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL-FSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~-l~~  357 (371)
                                   .     .....++.+.+||.+||+.||.+||++.+.+.+ |..
T Consensus       288 -------------~-----~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          288 -------------D-----PVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             -------------C-----HHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             -------------c-----cccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHH
Confidence                         0     001136789999999999999999976666655 443

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=5.6e-32  Score=264.35  Aligned_cols=178  Identities=17%  Similarity=0.097  Sum_probs=124.0

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeecc--------------hhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCce
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQD--------------KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------------~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ..+.|++|.+..++....|+.|++|.+.++              ...+.+|+++|+++ .|+||+++++++     .+..
T Consensus       241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~-----ed~~  315 (569)
T 4azs_A          241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHG-----ENAQ  315 (569)
T ss_dssp             C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEE-----ECSS
T ss_pred             ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEE-----EECC
Confidence            456777887777777778999999998543              13456799999999 699999999988     5566


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ..||||||++| +|.+.+..    .+++++.   .|+.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       316 ~~yLVMEyv~G~~L~d~i~~----~~~l~~~---~I~~QIl~AL~ylH~~-GIIHRDIKPeNILL~~dg-~vKL~DFGlA  386 (569)
T 4azs_A          316 SGWLVMEKLPGRLLSDMLAA----GEEIDRE---KILGSLLRSLAALEKQ-GFWHDDVRPWNVMVDARQ-HARLIDFGSI  386 (569)
T ss_dssp             EEEEEEECCCSEEHHHHHHT----TCCCCHH---HHHHHHHHHHHHHHHT-TCEESCCCGGGEEECTTS-CEEECCCTTE
T ss_pred             EEEEEEecCCCCcHHHHHHh----CCCCCHH---HHHHHHHHHHHHHHHC-CceeccCchHhEEECCCC-CEEEeecccC
Confidence            68999999996 77777764    4566654   4789999999999987 999999999999999988 8999999999


Q ss_pred             cccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC
Q 017452          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK  271 (371)
Q Consensus       222 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~  271 (371)
                      +..... ....+.+||+.|||||++.+.  +..++|+||+|++++++.++.
T Consensus       387 r~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          387 VTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             eeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            876443 334567899999999999653  577899999999988776553

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.2e-27  Score=230.61  Aligned_cols=178  Identities=16%  Similarity=0.250  Sum_probs=132.1

Q ss_pred             eeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           74 MAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        74 ~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ...+.||+|+||.||+|.  ..+..+++|+....            ...+.+|++++++++||||+++..+.....   .
T Consensus       339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~---~  413 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLD---N  413 (540)
T ss_dssp             ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETT---T
T ss_pred             CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCC---c
Confidence            446689999999999994  36788999976332            122468999999999999996544443322   2


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                        .++||||++ ++|.+.+..            +..++.||+.||.|||++ ||+||||||+|||++.   .+||+|||+
T Consensus       414 --~~lVmE~~~ggsL~~~l~~------------~~~i~~qi~~aL~~LH~~-gIiHrDiKp~NILl~~---~~kL~DFGl  475 (540)
T 3en9_A          414 --KRIMMSYINGKLAKDVIED------------NLDIAYKIGEIVGKLHKN-DVIHNDLTTSNFIFDK---DLYIIDFGL  475 (540)
T ss_dssp             --TEEEEECCCSEEHHHHSTT------------CTHHHHHHHHHHHHHHHT-TEECTTCCTTSEEESS---SEEECCCTT
T ss_pred             --cEEEEECCCCCCHHHHHHH------------HHHHHHHHHHHHHHHHHC-cCccCCCCHHHEEECC---eEEEEECcc
Confidence              479999998 677766542            568899999999999987 9999999999999997   799999999


Q ss_pred             ccccccCCC--------cccccccccccCcccccCC-cCCCCcchHHHHHHHHHHHHhCCCCC
Q 017452          221 AKVLVKGEP--------NISYICSRYYRAPELIFGA-TEYTTAIDIWSAGCVVAELMLGKPLF  274 (371)
Q Consensus       221 a~~~~~~~~--------~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~~lltg~~pf  274 (371)
                      ++.......        .....||+.|||||++... ..|+..+|+|+..+-..+-+.++.+|
T Consensus       476 a~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          476 GKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             CEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             CEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            987644321        1256789999999998541 22677789999999888888777665

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.90  E-value=4.9e-24  Score=190.44  Aligned_cols=139  Identities=16%  Similarity=0.183  Sum_probs=109.7

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----------------------hhhhHHHHHHHHHcCCCCeeec
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------------------KRYKNRELQTMRLLDHPNVVSL  129 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------------------~~~~~~e~~~l~~l~h~niv~~  129 (371)
                      .|.+++.||+|+||.||+|.+ .+|+.||+|++...                      .....+|+.+++.++  | +++
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v  166 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAV  166 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSS
T ss_pred             EEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCc
Confidence            356669999999999999998 88999999998532                      223568999999998  5 677


Q ss_pred             ceeEEecCCCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          130 KHCFFSTTDKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       130 ~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      ++++..      ...++||||++| +|.+ +          .......++.||+.||.|||++ ||+||||||+|||++ 
T Consensus       167 ~~~~~~------~~~~lvmE~~~g~~L~~-l----------~~~~~~~i~~qi~~~l~~lH~~-giiHrDlkp~NILl~-  227 (282)
T 1zar_A          167 PKVYAW------EGNAVLMELIDAKELYR-V----------RVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVS-  227 (282)
T ss_dssp             CCEEEE------ETTEEEEECCCCEEGGG-C----------CCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEE-
T ss_pred             CeEEec------cceEEEEEecCCCcHHH-c----------chhhHHHHHHHHHHHHHHHHHC-CCEeCCCCHHHEEEE-
Confidence            665422      225899999986 5544 2          1123557899999999999986 999999999999999 


Q ss_pred             CCCcEEEEeeCCccccccCCCcccccccccccCccccc
Q 017452          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF  246 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~  246 (371)
                      ++ .+||+|||+|+.            +..++|||.+.
T Consensus       228 ~~-~vkl~DFG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          228 EE-GIWIIDFPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             TT-EEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred             CC-cEEEEECCCCeE------------CCCCCHHHHHH
Confidence            76 899999999863            33468888773

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.85  E-value=2.2e-21  Score=171.20  Aligned_cols=135  Identities=16%  Similarity=0.234  Sum_probs=103.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcE--EEEEEeecch----------------------------hhhHHHHHHHHHc
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQDK----------------------------RYKNRELQTMRLL  121 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~~~----------------------------~~~~~e~~~l~~l  121 (371)
                      -|.+.+.||+|+||.||+|.+..+|+.  ||||++....                            ....+|+.+++.+
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            388999999999999999998788999  9999864321                            1456799999999


Q ss_pred             CCCCeeecceeEEecCCCCceeEEEeeccccc------hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHH-hcCCc
Q 017452          122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPE------TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH-RSIGV  194 (371)
Q Consensus       122 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~------~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~i  194 (371)
                      .|+++... ..+.. .     ..++||||+++      .|.+...       ..++..+..++.||+.||.||| +. ||
T Consensus       128 ~~~~i~~p-~~~~~-~-----~~~lVmE~~g~~g~~~~~L~~~~~-------~~~~~~~~~i~~qi~~~l~~lH~~~-gi  192 (258)
T 1zth_A          128 KEAGVSVP-QPYTY-M-----KNVLLMEFIGEDELPAPTLVELGR-------ELKELDVEGIFNDVVENVKRLYQEA-EL  192 (258)
T ss_dssp             HHTTCCCC-CEEEE-E-----TTEEEEECCEETTEECCBHHHHGG-------GGGGSCHHHHHHHHHHHHHHHHHTS-CE
T ss_pred             HhCCCCCC-eEEEc-C-----CCEEEEEecCCCCCccccHHHHhh-------ccChHHHHHHHHHHHHHHHHHHHHC-CE
Confidence            88765222 11111 1     24799999953      4443321       1234567889999999999999 76 99


Q ss_pred             EeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       195 vH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +||||||+|||++.   .++|+|||+|...
T Consensus       193 vHrDlkp~NILl~~---~~~liDFG~a~~~  219 (258)
T 1zth_A          193 VHADLSEYNIMYID---KVYFIDMGQAVTL  219 (258)
T ss_dssp             ECSSCSTTSEEESS---SEEECCCTTCEET
T ss_pred             EeCCCCHHHEEEcC---cEEEEECcccccC
Confidence            99999999999987   6999999999653

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.75  E-value=2.5e-18  Score=157.81  Aligned_cols=135  Identities=14%  Similarity=0.152  Sum_probs=92.4

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh--------------------------hhHHHHHHHHHcCCCC
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR--------------------------YKNRELQTMRLLDHPN  125 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--------------------------~~~~e~~~l~~l~h~n  125 (371)
                      -|+++..||.|++|.||+|.+ .+|+.||||+++....                          ...+|...|.++.+.+
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d-~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~g  174 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVAD-EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEG  174 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEEC-TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTT
T ss_pred             EEEecCEeeeCCceEEEEEEC-CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcC
Confidence            399999999999999999996 5799999998742210                          0123455555553333


Q ss_pred             eeecceeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCcee
Q 017452          126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLL  205 (371)
Q Consensus       126 iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIl  205 (371)
                      +.. ...+.. . .    .+|||||++|....         .......+..++.||+.+|.+||+. |||||||||.|||
T Consensus       175 v~v-p~p~~~-~-~----~~LVME~i~G~~L~---------~l~~~~~~~~l~~qll~~l~~lH~~-gIVHrDLKp~NIL  237 (397)
T 4gyi_A          175 FPV-PEPIAQ-S-R----HTIVMSLVDALPMR---------QVSSVPDPASLYADLIALILRLAKH-GLIHGDFNEFNIL  237 (397)
T ss_dssp             CSC-CCEEEE-E-T----TEEEEECCSCEEGG---------GCCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEE
T ss_pred             CCC-Ceeeec-c-C----ceEEEEecCCccHh---------hhcccHHHHHHHHHHHHHHHHHHHC-CCcCCCCCHHHEE
Confidence            211 111111 1 1    26999999974211         1112233567889999999999986 9999999999999


Q ss_pred             eeCCCC---------cEEEEeeCCcccc
Q 017452          206 VNPHTH---------QVKLCDFGSAKVL  224 (371)
Q Consensus       206 i~~~~~---------~~kl~Dfg~a~~~  224 (371)
                      ++.++.         .+.|+||+.+...
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEET
T ss_pred             EeCCCCcccccccccceEEEEeCCcccC
Confidence            987652         3899999987654

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.36  E-value=3.7e-12  Score=112.09  Aligned_cols=134  Identities=15%  Similarity=0.096  Sum_probs=99.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeec----chhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQ----DKRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .|++...++.|+.+.||++..  .+..+++|+...    ......+|+.+++.+. +..+.++++....     ....|+
T Consensus        15 ~~~~~~~~~g~s~~~v~~~~~--~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~-----~~~~~l   87 (263)
T 3tm0_A           15 KYRCVKDTEGMSPAKVYKLVG--ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERH-----DGWSNL   87 (263)
T ss_dssp             TSEEEECCSCCSSSEEEEEEC--SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEE
T ss_pred             cceeEeeccCCCCCeEEEEEC--CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEec-----CCceEE
Confidence            588999999999999999974  468899998863    3446788999999985 5566777766532     344689


Q ss_pred             eeccccch-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------
Q 017452          147 VLEYVPET-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS----------------------------------  191 (371)
Q Consensus       147 v~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------------------------------  191 (371)
                      |||+++|. +...+         .+......++.+++.+|..||+.                                  
T Consensus        88 v~e~i~G~~l~~~~---------~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  158 (263)
T 3tm0_A           88 LMSEADGVLCSEEY---------EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW  158 (263)
T ss_dssp             EEECCSSEEHHHHC---------CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGG
T ss_pred             EEEecCCeehhhcc---------CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccc
Confidence            99999984 33221         01122346778999999999970                                  


Q ss_pred             ------------------------CCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          192 ------------------------IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       192 ------------------------~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                                              ..++|||++|.||+++.++ .+.|+||+.+.
T Consensus       159 ~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~lIDwe~a~  212 (263)
T 3tm0_A          159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGK-VSGFIDLGRSG  212 (263)
T ss_dssp             STTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTE-EEEECCCTTCE
T ss_pred             cccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCc-EEEEEEchhcc
Confidence                                    2589999999999998643 56799999874

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.18  E-value=8.7e-11  Score=102.91  Aligned_cols=133  Identities=16%  Similarity=0.062  Sum_probs=88.9

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcCCCC--eeecceeEEecCCCCceeEEEee
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      .|.+....+.|..+.||++. ..+|..+++|+.... .....+|+.+++.+.+.+  +.+++....     .....++||
T Consensus        21 ~~~~~~~~~gg~~~~v~~~~-~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~-----~~~~~~~v~   94 (264)
T 1nd4_A           21 GYDWAQQTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLL   94 (264)
T ss_dssp             TCEEEECSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEE
T ss_pred             CCceEecccCCCCceEEEEe-cCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEecc-----CCCCCEEEE
Confidence            46665544566679999996 456788999987543 245678999999986544  344655542     223368999


Q ss_pred             ccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------
Q 017452          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI------------------------------------  192 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------  192 (371)
                      ||++|.... .       ....   ...++.+++..|..||...                                    
T Consensus        95 e~i~G~~l~-~-------~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (264)
T 1nd4_A           95 GEVPGQDLL-S-------SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQ  163 (264)
T ss_dssp             ECCSSEETT-T-------SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGT
T ss_pred             EecCCcccC-c-------CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhcc
Confidence            999974212 0       0111   1245566677777777420                                    


Q ss_pred             ---------------------CcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          193 ---------------------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       193 ---------------------~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                                           .++|+|++|.||+++.++ .+.|+||+.+.
T Consensus       164 ~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~-~~~liD~~~a~  213 (264)
T 1nd4_A          164 GLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGR-FSGFIDCGRLG  213 (264)
T ss_dssp             TCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTE-EEEECCCTTCE
T ss_pred             CccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCc-EEEEEcchhcc
Confidence                                 299999999999998654 56799999875

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.12  E-value=2e-10  Score=105.76  Aligned_cols=140  Identities=15%  Similarity=0.157  Sum_probs=98.7

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEee--cc-----hhhhHHHHHHHHHcCC--CCeeecceeEEecCCCCceeEE
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVL--QD-----KRYKNRELQTMRLLDH--PNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~--~~-----~~~~~~e~~~l~~l~h--~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+.|+.|.++.||++..  .+..+++|+..  ..     .....+|..+++.+..  ..+++++..+...  ......+
T Consensus        42 ~~~~l~~G~sn~~y~v~~--~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~--~~~g~~~  117 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVT--PGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDE--SVIGRAF  117 (359)
T ss_dssp             EEEECCC-CCSCEEEEEC--SSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCT--TTTSSCE
T ss_pred             eEEEcCCcccceEEEEEE--CCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCC--CccCCeE
Confidence            457789999999999975  34678899775  22     3466789999999974  3456665544221  1113457


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-----------------------------------  190 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-----------------------------------  190 (371)
                      +||||++|....     ......++......++.+++.+|..||.                                   
T Consensus       118 ~vme~v~G~~l~-----~~~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (359)
T 3dxp_A          118 YIMEFVSGRVLW-----DQSLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE  192 (359)
T ss_dssp             EEEECCCCBCCC-----CTTCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred             EEEEecCCeecC-----CCccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence            899999984210     0112346777888889999999999996                                   


Q ss_pred             ----------------------cCCcEeeccCCCceeeeCCCC-cEEEEeeCCccc
Q 017452          191 ----------------------SIGVCHRDIKPQNLLVNPHTH-QVKLCDFGSAKV  223 (371)
Q Consensus       191 ----------------------~~~ivH~dlkp~NIli~~~~~-~~kl~Dfg~a~~  223 (371)
                                            ...++|||++|.||+++.++. .+.|+||+.+..
T Consensus       193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                  136999999999999997753 368999998865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.03  E-value=1.6e-10  Score=103.90  Aligned_cols=184  Identities=14%  Similarity=0.177  Sum_probs=110.2

Q ss_pred             EeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecC-CCCceeEEEeeccccc
Q 017452           77 RIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTT-DKDELYLNLVLEYVPE  153 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~-~~~~~~~~lv~e~~~~  153 (371)
                      +.++.|....||++.     ..+++|+....  .....+|..+++.+.+..-+.+...+.... .......|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            458999999999863     46899976543  345678999998884322122222222211 1222334789999997


Q ss_pred             h-HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-----------------------------------------
Q 017452          154 T-VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-----------------------------------------  191 (371)
Q Consensus       154 ~-l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-----------------------------------------  191 (371)
                      . +.....      ..++......++.|++..|..||+.                                         
T Consensus       101 ~~l~~~~~------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  174 (304)
T 3sg8_A          101 VPLTPLLL------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD  174 (304)
T ss_dssp             EECCHHHH------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred             eECCcccc------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence            3 221111      2355666666777777777777740                                         


Q ss_pred             ----------------CCcEeeccCCCceeeeCC-CCcEEEEeeCCccccccCCCcccccccccc---cCccccc-----
Q 017452          192 ----------------IGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYY---RAPELIF-----  246 (371)
Q Consensus       192 ----------------~~ivH~dlkp~NIli~~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y---~aPE~~~-----  246 (371)
                                      ..++|+|++|.||+++.+ +..+.|+||+.+.......   .......+   ..|+...     
T Consensus       175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~---Dl~~~~~~~~~~~~~~~~~~l~~  251 (304)
T 3sg8_A          175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDN---DFISLMEDDEEYGMEFVSKILNH  251 (304)
T ss_dssp             HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTH---HHHTTCCTTTSCCHHHHHHHHHH
T ss_pred             HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHH---HHHHHHhhccccCHHHHHHHHHH
Confidence                            147999999999999974 4368899999886532211   00000000   1222110     


Q ss_pred             -CCc-------CCCCcchHHHHHHHHHHHHhCCCCC
Q 017452          247 -GAT-------EYTTAIDIWSAGCVVAELMLGKPLF  274 (371)
Q Consensus       247 -~~~-------~~~~~~DiwslG~il~~lltg~~pf  274 (371)
                       +..       ......++|++|.++|.+.+|..+|
T Consensus       252 Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          252 YKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence             000       0112358999999999999998765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.55  E-value=7e-07  Score=80.09  Aligned_cols=69  Identities=12%  Similarity=-0.036  Sum_probs=45.5

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCC---eeecceeEEecCCCCceeEEEeecc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPN---VVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~n---iv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      .+.++.|....||+.     |..+++|+-...  .....+|..+|+.+.+..   +.+++....    ......++||++
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~----~~~g~~~~v~e~   94 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGK----RSDGNPFVGYRK   94 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEE----CTTSCEEEEEEC
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecc----cCCCceEEEEec
Confidence            345788888899988     567899975432  245678999999997532   233333221    122335699999


Q ss_pred             ccc
Q 017452          151 VPE  153 (371)
Q Consensus       151 ~~~  153 (371)
                      ++|
T Consensus        95 i~G   97 (306)
T 3tdw_A           95 VQG   97 (306)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            997

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=2.2e-06  Score=75.17  Aligned_cols=131  Identities=15%  Similarity=0.138  Sum_probs=82.1

Q ss_pred             eccCCce-EEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcCC-CCeeecceeEEecCCCCceeEEEeeccccc-h
Q 017452           79 VGQGSFG-VVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPE-T  154 (371)
Q Consensus        79 lg~G~~g-~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~  154 (371)
                      +..|..| .||+......+..+++|+-... .....+|...|+.+.. --+.+++.....     ....++||++++| .
T Consensus        32 ~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~-----~~~~~lvme~l~G~~  106 (272)
T 4gkh_A           32 DNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRT-----PDDAWLLTTAIPGKT  106 (272)
T ss_dssp             EECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEE-----TTEEEEEEECCCSEE
T ss_pred             ccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEE-----CCeEEEEEEeeCCcc
Confidence            3445444 7999887777788999987543 2345679999988852 123444444322     2336799999987 3


Q ss_pred             HHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 017452          155 VHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRS-------------------------------------------  191 (371)
Q Consensus       155 l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~-------------------------------------------  191 (371)
                      +.+....        .......+..++...|..||..                                           
T Consensus       107 ~~~~~~~--------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (272)
T 4gkh_A          107 AFQVLEE--------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQ  178 (272)
T ss_dssp             HHHHHHH--------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHH
T ss_pred             ccccccC--------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHH
Confidence            3332221        0111223444555555555531                                           


Q ss_pred             --------C------CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          192 --------I------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       192 --------~------~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                              .      .++|+|+.+.||+++.++ .+-|+||+.+..
T Consensus       179 ~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~-~~~viDwe~a~~  223 (272)
T 4gkh_A          179 VWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGK-LIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCCCCEEEECSCCCTTSEEEETTE-EEEECCCTTCEE
T ss_pred             HHHHHHhcccccCCcEEEcCCCCCCeEEEECCe-EEEEEECccccc
Confidence                    0      179999999999999765 667999998853

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.28  E-value=3.6e-06  Score=76.36  Aligned_cols=30  Identities=23%  Similarity=0.461  Sum_probs=26.6

Q ss_pred             CCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       192 ~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      ..++|||+++.||+++.++ .+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~-~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENE-QIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGG-CEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCC-cEEEEehhhcc
Confidence            4899999999999998666 79999999874

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.18  E-value=1.2e-05  Score=74.65  Aligned_cols=72  Identities=17%  Similarity=0.179  Sum_probs=44.6

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----------hhhhHHHHHHHHHcCC--CC-eeecceeEEecCCCC
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----------KRYKNRELQTMRLLDH--PN-VVSLKHCFFSTTDKD  140 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----------~~~~~~e~~~l~~l~h--~n-iv~~~~~~~~~~~~~  140 (371)
                      ..+.+|.|..+.||++....++..+++|.....           ......|.++++.+..  +. +.+++.+  .   ..
T Consensus        34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d---~~  108 (397)
T 2olc_A           34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TE  108 (397)
T ss_dssp             EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TT
T ss_pred             EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--c---CC
Confidence            346789999999999976556788999975321           1233678888888742  33 3344322  1   11


Q ss_pred             ceeEEEeeccccc
Q 017452          141 ELYLNLVLEYVPE  153 (371)
Q Consensus       141 ~~~~~lv~e~~~~  153 (371)
                      .  .++|||+++|
T Consensus       109 ~--~~lvmE~l~g  119 (397)
T 2olc_A          109 M--AVTVMEDLSH  119 (397)
T ss_dssp             T--TEEEECCCTT
T ss_pred             c--cEEEEEeCCC
Confidence            1  3689999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.15  E-value=9.8e-06  Score=74.10  Aligned_cols=78  Identities=10%  Similarity=0.075  Sum_probs=48.9

Q ss_pred             eeeEee-ccCCceEEEEEEEC--C----CCcEEEEEEeecch-------hhhHHHHHHHHHcCC---CCeeecceeEEec
Q 017452           74 MAERIV-GQGSFGVVFQAKCL--E----TGETVAIKKVLQDK-------RYKNRELQTMRLLDH---PNVVSLKHCFFST  136 (371)
Q Consensus        74 ~~~~~l-g~G~~g~V~~~~~~--~----~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h---~niv~~~~~~~~~  136 (371)
                      ...+.| +.|....+|++...  .    ++..+++|+.....       ....+|+.+++.+..   -.+.+++..... 
T Consensus        23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~-  101 (357)
T 3ats_A           23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETT-  101 (357)
T ss_dssp             EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECS-
T ss_pred             EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccC-
Confidence            345677 88888999988642  1    26689999765432       456789999888742   234555544311 


Q ss_pred             CCCCceeEEEeeccccc
Q 017452          137 TDKDELYLNLVLEYVPE  153 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~~  153 (371)
                       .......++|||+++|
T Consensus       102 -~~~~g~~~~v~e~l~G  117 (357)
T 3ats_A          102 -GDVLGTPFFLMDYVEG  117 (357)
T ss_dssp             -STTTSSCEEEEECCCC
T ss_pred             -CCccCCceEEEEecCC
Confidence             1111234689999986

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.85  E-value=0.00021  Score=63.07  Aligned_cols=74  Identities=15%  Similarity=0.119  Sum_probs=49.6

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      +..-++.+|.|..+.||++. ..+|+.|++|+....    ...+.+|...|+.|....-+.+-..+....      -++|
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~-l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~~------~~lv   88 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVE-LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWDD------RTLA   88 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEE-ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEET------TEEE
T ss_pred             CeEEEEecCCCCCeEEEEEE-ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEeccC------ceEE
Confidence            35667889999999999998 467899999986433    234678999999885322122222222211      2578


Q ss_pred             ecccc
Q 017452          148 LEYVP  152 (371)
Q Consensus       148 ~e~~~  152 (371)
                      ||++.
T Consensus        89 ~e~l~   93 (288)
T 3f7w_A           89 MEWVD   93 (288)
T ss_dssp             EECCC
T ss_pred             EEeec
Confidence            99876

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.84  E-value=0.00023  Score=59.28  Aligned_cols=98  Identities=16%  Similarity=0.108  Sum_probs=63.1

Q ss_pred             hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCcccc
Q 017452          154 TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY  233 (371)
Q Consensus       154 ~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~  233 (371)
                      +|.+++..+   +.+++++++|.++.|.+.+|.-+-.+..-..+=+.|..|++..+| .|.+.+ ..+.           
T Consensus        34 SL~eIL~~~---~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG-~V~f~~-~~s~-----------   97 (229)
T 2yle_A           34 SLEEILRLY---NQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDG-AVTLAP-AADD-----------   97 (229)
T ss_dssp             EHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTS-CEEECC-C--------------
T ss_pred             cHHHHHHHc---CCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCC-ceeccc-cccc-----------
Confidence            777888765   689999999999999999988762110112333456889999888 666553 1110           


Q ss_pred             cccccccCcccccCCcCCCCcchHHHHHHHHHHHHh
Q 017452          234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML  269 (371)
Q Consensus       234 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt  269 (371)
                      .....+.|||...  ...+.+.=|||||+++|..+-
T Consensus        98 ~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ---------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence            1122366888763  234678889999999999884

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.65  E-value=0.00021  Score=63.58  Aligned_cols=65  Identities=15%  Similarity=0.093  Sum_probs=40.9

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeEEEeeccc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEYV  151 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~~  151 (371)
                      .+.|+.|....+|++      ..+++|+.....   ....+|..+++.+....+ .+++...     .+.  -+++++|+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~-----~~~--~~~v~e~i   89 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD-----PAT--GVMVTRYI   89 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC-----TTT--CCEEEECC
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE-----CCC--CEEEEeec
Confidence            678889999999998      468999875432   223578888887743233 3443322     211  24789999


Q ss_pred             -cc
Q 017452          152 -PE  153 (371)
Q Consensus       152 -~~  153 (371)
                       +|
T Consensus        90 ~~g   92 (301)
T 3dxq_A           90 AGA   92 (301)
T ss_dssp             TTC
T ss_pred             CCC
Confidence             54

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.52  E-value=0.0009  Score=62.65  Aligned_cols=70  Identities=17%  Similarity=0.233  Sum_probs=46.5

Q ss_pred             eeEeeccCCceEEEEEEECC-------CCcEEEEEEeec-ch-hhhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeE
Q 017452           75 AERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQ-DK-RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~-~~-~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~  144 (371)
                      -.+.|+.|....||++....       ++..+++|+... .. ....+|..+++.+...++ .++++.+     .+    
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-----~~----  147 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----  147 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-----CC----
Confidence            35678888889999998542       257899998844 22 445578888888853334 4454443     21    


Q ss_pred             EEeeccccc
Q 017452          145 NLVLEYVPE  153 (371)
Q Consensus       145 ~lv~e~~~~  153 (371)
                      .+|++|++|
T Consensus       148 g~v~e~l~G  156 (429)
T 1nw1_A          148 GRLEEYIPS  156 (429)
T ss_dssp             EEEECCCCE
T ss_pred             CEEEEEeCC
Confidence            268888875

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.52  E-value=0.00034  Score=65.35  Aligned_cols=77  Identities=12%  Similarity=-0.046  Sum_probs=44.1

Q ss_pred             CCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCCcccccc--cccccCcccccCCcC--CCCcchHHHHHHHHHHH
Q 017452          192 IGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATE--YTTAIDIWSAGCVVAEL  267 (371)
Q Consensus       192 ~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~--t~~y~aPE~~~~~~~--~~~~~DiwslG~il~~l  267 (371)
                      ..++|||++|.|||++.++  +.|+||+.+..............  ...|++|+.......  .....++..+...+|+.
T Consensus       232 ~~liHGDl~~~Nil~~~~~--~~lID~e~a~~G~p~~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (420)
T 2pyw_A          232 QALIHGDLHTGSVMVTQDS--TQVIDPEFSFYGPMGFDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTWNL  309 (420)
T ss_dssp             CEEECSCCSGGGEEECSSC--EEECCCTTCEEECHHHHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHHHH
T ss_pred             CeEEecCCCCCcEEEeCCC--CEEEeCcccccCchHHHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHHHH
Confidence            3899999999999998764  99999998865322111111111  233556554421110  11123444666677766


Q ss_pred             HhC
Q 017452          268 MLG  270 (371)
Q Consensus       268 ltg  270 (371)
                      +.+
T Consensus       310 y~~  312 (420)
T 2pyw_A          310 FNK  312 (420)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            653

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.45  E-value=0.0016  Score=61.38  Aligned_cols=70  Identities=14%  Similarity=0.210  Sum_probs=45.2

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecchh---hhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeEEEeecc
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      -.+.|+.|-...+|++.....+..+++|+......   ...+|..+++.+...++ .++++.+     ..    .+||+|
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-----~~----G~v~e~  182 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-----TN----GRIEEF  182 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-----TT----EEEEEC
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-----CC----eEEEEe
Confidence            34678889899999998644457899998744322   22589999999975555 3454443     11    248888


Q ss_pred             ccc
Q 017452          151 VPE  153 (371)
Q Consensus       151 ~~~  153 (371)
                      ++|
T Consensus       183 I~G  185 (458)
T 2qg7_A          183 MDG  185 (458)
T ss_dssp             CCS
T ss_pred             eCC
Confidence            875

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.44  E-value=0.00066  Score=60.81  Aligned_cols=143  Identities=12%  Similarity=0.059  Sum_probs=75.0

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeec--chhhhHHHHHHHHHcCCCC--eeecceeEEecCCC----CceeEEE
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQ--DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTDK----DELYLNL  146 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~--~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~----~~~~~~l  146 (371)
                      -.+.|+.|....+|++... + ..+++|+...  .......|..+++.+....  +.+++...   ...    .....++
T Consensus        26 ~~~~i~~G~~n~~~~v~~~-~-g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~---~g~~~~~~~g~~~~  100 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT-K-DPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRK---DGELLGELSGRPAA  100 (322)
T ss_dssp             EEEEECC---EEEEEEEES-S-CCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBT---TCCSCEEETTEEEE
T ss_pred             EeeccCCCcccceEEEEeC-C-ccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCC---CCCEEEEECCEEEE
Confidence            3456788888999998752 3 3688998865  3455667888888774222  23332210   000    0123578


Q ss_pred             eeccccchH------------HHH---HHHhh-hccCC----CCHH-HHH---H-----------HHHHHHHHHHHHHh-
Q 017452          147 VLEYVPETV------------HRV---VKHFN-KLNQR----MPMI-YVK---L-----------YAYQIFRALSYIHR-  190 (371)
Q Consensus       147 v~e~~~~~l------------~~~---~~~~~-~~~~~----~~~~-~~~---~-----------i~~qi~~~l~~LH~-  190 (371)
                      ++++++|..            ...   ++... .....    .... +..   .           +...+...++.+.. 
T Consensus       101 l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~  180 (322)
T 2ppq_A          101 LISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAH  180 (322)
T ss_dssp             EEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhh
Confidence            999987521            011   11110 00000    0100 000   0           00113344455542 


Q ss_pred             -----cCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          191 -----SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       191 -----~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                           ..+++|+|+++.||+++.++ .+.|+||+.+..
T Consensus       181 ~~~~~~~~liHgDl~~~Nil~~~~~-~~~lIDf~~a~~  217 (322)
T 2ppq_A          181 WPKDLPAGVIHADLFQDNVFFLGDE-LSGLIDFYFACN  217 (322)
T ss_dssp             CCCSSCEEEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             CcccCCcccCCCCCCccCEEEeCCc-eEEEecchhccC
Confidence                 12699999999999998764 457999998753

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.33  E-value=0.00098  Score=60.05  Aligned_cols=31  Identities=42%  Similarity=0.560  Sum_probs=26.4

Q ss_pred             CcEeeccCCCceeeeCC---CCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~---~~~~kl~Dfg~a~~  223 (371)
                      .++|||+.+.||+++.+   ...+.|+||+.+..
T Consensus       184 ~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          184 VFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             EEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             eeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            79999999999999874   12799999998865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.32  E-value=0.0012  Score=59.04  Aligned_cols=72  Identities=17%  Similarity=0.065  Sum_probs=50.4

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC---CCCeeecceeEEecCCCCceeEEEeecc
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD---HPNVVSLKHCFFSTTDKDELYLNLVLEY  150 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~---h~niv~~~~~~~~~~~~~~~~~~lv~e~  150 (371)
                      -.+.|+.|....+|+...  ++..+++|+.... .....+|...|+.+.   ...+++++....     .....++|||+
T Consensus        40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~-----~~g~~~lvme~  112 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGN-----SQGHSFLLLEA  112 (312)
T ss_dssp             EEEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEE-----CSSEEEEEEEC
T ss_pred             eeEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEee-----cCCceEEEEEe
Confidence            356789999999999974  5678899987543 344678988888874   234555555432     12346899999


Q ss_pred             ccc
Q 017452          151 VPE  153 (371)
Q Consensus       151 ~~~  153 (371)
                      ++|
T Consensus       113 l~G  115 (312)
T 3jr1_A          113 LNK  115 (312)
T ss_dssp             CCC
T ss_pred             ccC
Confidence            985

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.30  E-value=0.0012  Score=60.57  Aligned_cols=138  Identities=16%  Similarity=0.254  Sum_probs=76.1

Q ss_pred             EeeccCCceEEEEEEECC-------CCcEEEEEEeec---chhhhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeEE
Q 017452           77 RIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQ---DKRYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~---~~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~  145 (371)
                      +.|..|-...+|++....       ++..|++|+...   ......+|..+++.+...++ .++++.+     .+    .
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~-----~~----g  126 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVF-----PE----G  126 (379)
T ss_dssp             EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEE-----TT----E
T ss_pred             EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEc-----CC----c
Confidence            456667777888887532       357899998633   23344579988888743223 4444443     22    2


Q ss_pred             Eeeccccch------------HHHHHHHhhh---c----cCCCC--HHHHHHHHHHHHH-------------------HH
Q 017452          146 LVLEYVPET------------VHRVVKHFNK---L----NQRMP--MIYVKLYAYQIFR-------------------AL  185 (371)
Q Consensus       146 lv~e~~~~~------------l~~~~~~~~~---~----~~~~~--~~~~~~i~~qi~~-------------------~l  185 (371)
                      +||||++|.            ...+.....+   .    .+...  ...+..|..++..                   .+
T Consensus       127 ~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~  206 (379)
T 3feg_A          127 RLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEM  206 (379)
T ss_dssp             EEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHH
T ss_pred             cEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHH
Confidence            789998751            1111111111   1    11111  3455556554422                   22


Q ss_pred             HHHHh-------cCCcEeeccCCCceeeeCC---CCcEEEEeeCCccc
Q 017452          186 SYIHR-------SIGVCHRDIKPQNLLVNPH---THQVKLCDFGSAKV  223 (371)
Q Consensus       186 ~~LH~-------~~~ivH~dlkp~NIli~~~---~~~~kl~Dfg~a~~  223 (371)
                      ..|.+       ...++|+|+.+.||+++.+   ...+.|+||..+..
T Consensus       207 ~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          207 GNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            33321       1259999999999999876   23799999998864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.20  E-value=0.0011  Score=60.81  Aligned_cols=69  Identities=12%  Similarity=0.109  Sum_probs=40.0

Q ss_pred             eEeeccCCceEEEEEEECC--------CCcEEEEEEeecchh---hhHHHHHHHHHcCCCCe-eecceeEEecCCCCcee
Q 017452           76 ERIVGQGSFGVVFQAKCLE--------TGETVAIKKVLQDKR---YKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELY  143 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~--------~~~~vaiK~~~~~~~---~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  143 (371)
                      ...++.|....+|++....        .+..+++|+......   ....|..+++.+...++ .++++.+     .    
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~-----~----  108 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF-----N----  108 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec-----C----
Confidence            4567778888899987542        136889998754322   23678888888753333 3444332     1    


Q ss_pred             EEEeeccccc
Q 017452          144 LNLVLEYVPE  153 (371)
Q Consensus       144 ~~lv~e~~~~  153 (371)
                      -++||+|++|
T Consensus       109 ~~~v~e~i~G  118 (369)
T 3c5i_A          109 GGRIEEWLYG  118 (369)
T ss_dssp             TEEEEECCCS
T ss_pred             CcEEEEEecC
Confidence            1468888875

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.18  E-value=0.0024  Score=57.27  Aligned_cols=72  Identities=14%  Similarity=-0.009  Sum_probs=42.9

Q ss_pred             eeccCCceEEEEEEECCCCcEEEEEEeec---chhhhHHHHHHHHHcCCCC--eeecceeEEecCC--CCceeEEEeecc
Q 017452           78 IVGQGSFGVVFQAKCLETGETVAIKKVLQ---DKRYKNRELQTMRLLDHPN--VVSLKHCFFSTTD--KDELYLNLVLEY  150 (371)
Q Consensus        78 ~lg~G~~g~V~~~~~~~~~~~vaiK~~~~---~~~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~--~~~~~~~lv~e~  150 (371)
                      .++ |....||++.. .+|+.+++|....   .......|..+++.+....  +++++..  ....  ......+++|++
T Consensus        33 ~l~-g~~n~~y~v~~-~~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~~~~~g~~~~l~~~  108 (328)
T 1zyl_A           33 PLN-SYENRVYQFQD-EDRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTLLNHQGFYFAVFPS  108 (328)
T ss_dssp             EEC-CSSSEEEEECC-TTCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSCEEETTEEEEEEEC
T ss_pred             eec-CcccceEEEEc-CCCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEEEEECCEEEEEEEe
Confidence            455 77788998763 4567899998863   2345567888888774222  3333332  1100  012345678999


Q ss_pred             ccc
Q 017452          151 VPE  153 (371)
Q Consensus       151 ~~~  153 (371)
                      ++|
T Consensus       109 i~G  111 (328)
T 1zyl_A          109 VGG  111 (328)
T ss_dssp             CCC
T ss_pred             cCC
Confidence            875

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.93  E-value=0.0012  Score=59.85  Aligned_cols=30  Identities=27%  Similarity=0.550  Sum_probs=26.5

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++|+|+.+.||+++.++ .+.|+||+.+..
T Consensus       207 ~~~HgD~~~~N~l~~~~~-~~~~iD~e~~~~  236 (339)
T 3i1a_A          207 VLCHSDIHAGNVLVGNEE-SIYIIDWDEPML  236 (339)
T ss_dssp             EEECSCCCGGGEEECGGG-CEEECCCSSCEE
T ss_pred             eeEeCCCCcCCEEEeCCC-eEEEEECCCCee
Confidence            699999999999998766 799999988764

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.27  E-value=0.029  Score=52.19  Aligned_cols=70  Identities=13%  Similarity=0.148  Sum_probs=44.5

Q ss_pred             eeEeeccCCceEEEEEEECCC-------CcEEEEEEeecch---hhhHHHHHHHHHcCCCCe-eecceeEEecCCCCcee
Q 017452           75 AERIVGQGSFGVVFQAKCLET-------GETVAIKKVLQDK---RYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELY  143 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~-------~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~  143 (371)
                      -.+.+..|-...+|++.....       +..|++|+.....   -...+|..+++.+...++ .++++.+     .    
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~-----~----  144 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADF-----P----  144 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEE-----T----
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEc-----C----
Confidence            345677788889999986421       5789999875432   223578888888853333 3444322     1    


Q ss_pred             EEEeeccccc
Q 017452          144 LNLVLEYVPE  153 (371)
Q Consensus       144 ~~lv~e~~~~  153 (371)
                      -+.||+|++|
T Consensus       145 ~~~I~efI~G  154 (424)
T 3mes_A          145 EGRIEEFIDG  154 (424)
T ss_dssp             TEEEEECCCS
T ss_pred             CCEEEEEeCC
Confidence            1468898875

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.15  E-value=0.19  Score=46.27  Aligned_cols=31  Identities=26%  Similarity=0.460  Sum_probs=25.1

Q ss_pred             CcEeeccCCCceeeeC-----CCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNP-----HTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~-----~~~~~kl~Dfg~a~~  223 (371)
                      .++|+|+.+.|||+.+     +...+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            3689999999999942     334799999998865

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	371
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	1e-103
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	5e-66
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-64
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-64
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	5e-62
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	6e-61
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-60
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-60
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-59
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-58
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	3e-58
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-58
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-58
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	1e-57
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	6e-57
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-57
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	1e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-56
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-55
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	6e-54
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	8e-54
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-52
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-52
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-52
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	1e-50
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	1e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-49
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	7e-49
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	8e-49
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-48
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	1e-47
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-47
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-46
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-44
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	2e-43
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-43
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-41
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	4e-41
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-39
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-39
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-39
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-39
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	4e-39
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	9e-39
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-38
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-38
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	3e-38
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	9e-38
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-36
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-36
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	3e-36
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-36
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-35
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	4e-35
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-35
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-34
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	8e-33
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-31
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-29
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-19

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  307 bits (786), Expect = e-103
 Identities = 202/294 (68%), Positives = 249/294 (84%), Gaps = 3/294 (1%)

Query: 56  IVTTIGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNREL 115
           +V T G    +P Q +SY   +++G GSFGVV+QAK  ++GE VAIKKVLQDKR+KNREL
Sbjct: 6   VVATPGQGPDRP-QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNREL 64

Query: 116 QTMRLLDHPNVVSLKHCFFST-TDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYV 174
           Q MR LDH N+V L++ F+S+   KDE+YLNLVL+YVPETV+RV +H+++  Q +P+IYV
Sbjct: 65  QIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV 124

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
           KLY YQ+FR+L+YIH S G+CHRDIKPQNLL++P T  +KLCDFGSAK LV+GEPN+SYI
Sbjct: 125 KLYMYQLFRSLAYIH-SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 183

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
           CSRYYRAPELIFGAT+YT++ID+WSAGCV+AEL+LG+P+FPGDSGVDQLVEIIKVLGTPT
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT 243

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
           RE+I+ MNPNYTEFKFPQIKAHPW K+F  R PPEA+ L SRLL+Y+P  R T 
Sbjct: 244 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTP 297

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  209 bits (534), Expect = 5e-66
 Identities = 70/296 (23%), Positives = 121/296 (40%), Gaps = 31/296 (10%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +     +G G+ GVVF+     +G  +A K +  + +        RELQ +   + P +V
Sbjct: 8   FEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIV 67

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                F       E+ +   +E++       +    K   R+P   +   +  + + L+Y
Sbjct: 68  GFYGAF---YSDGEISI--CMEHMD---GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTY 119

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           +     + HRD+KP N+LVN     +KLCDFG +  L+    N S++ +R Y +PE + G
Sbjct: 120 LREKHKIMHRDVKPSNILVNSRGE-IKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERLQG 177

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPG-DSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
            T Y+   DIWS G  + E+ +G+   P  D+   +L+   +V G       +   P   
Sbjct: 178 -THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP 236

Query: 307 EFKF--------------PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +                I   P  K+       E  D V++ L  +P  R   
Sbjct: 237 LSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 292

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  205 bits (523), Expect = 1e-64
 Identities = 90/282 (31%), Positives = 141/282 (50%), Gaps = 21/282 (7%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---------RELQTMRLLDHPNVV 127
             +G+G F  V++A+   T + VAIKK+    R +          RE++ ++ L HPN++
Sbjct: 4   DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L   F     K  + L  V +++   +          +  +   ++K Y     + L Y
Sbjct: 64  GLLDAF---GHKSNISL--VFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEY 115

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIF 246
           +H+   + HRD+KP NLL++ +   +KL DFG AK         ++   +R+YRAPEL+F
Sbjct: 116 LHQHW-ILHRDLKPNNLLLDEN-GVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLF 173

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
           GA  Y   +D+W+ GC++AEL+L  P  PGDS +DQL  I + LGTPT E+   M     
Sbjct: 174 GARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD 233

Query: 307 EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              F      P H IF      + +DL+  L  ++P  R TA
Sbjct: 234 YVTFKSFPGIPLHHIFSA-AGDDLLDLIQGLFLFNPCARITA 274

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  206 bits (524), Expect = 3e-64
 Identities = 90/288 (31%), Positives = 156/288 (54%), Gaps = 20/288 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV--LQDKRYKN---RELQTMRLLDHPNVV 127
           Y     +G+G++G+V  A        VAIKK+   + + Y     RE++ +    H N++
Sbjct: 10  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 69

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +     + T +    + LV   +   +++++K      Q +   ++  + YQI R L Y
Sbjct: 70  GINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKY 124

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRAPE 243
           IH S  V HRD+KP NLL+N  T  +K+CDFG A+V      +      Y+ +R+YRAPE
Sbjct: 125 IH-SANVLHRDLKPSNLLLN-TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM-- 301
           ++  +  YT +IDIWS GC++AE++  +P+FPG   +DQL  I+ +LG+P++E++ C+  
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 302 -NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     P     PW+++FP     +A+DL+ ++L ++P+ R   
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRIEV 289

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  199 bits (507), Expect = 5e-62
 Identities = 87/287 (30%), Positives = 141/287 (49%), Gaps = 21/287 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-NRELQTM-RLLDHPNVVSLK 130
           Y   R +G+G +  VF+A  +   E V +K +   K+ K  RE++ +  L   PN+++L 
Sbjct: 37  YQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLA 96

Query: 131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR 190
                  D       LV E+V  T       F +L Q +    ++ Y Y+I +AL Y H 
Sbjct: 97  DIV---KDPVSRTPALVFEHVNNT------DFKQLYQTLTDYDIRFYMYEILKALDYCH- 146

Query: 191 SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATE 250
           S+G+ HRD+KP N++++    +++L D+G A+    G+     + SRY++ PEL+     
Sbjct: 147 SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQM 206

Query: 251 YTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           Y  ++D+WS GC++A ++  K P F G    DQLV I KVLGT    +         + +
Sbjct: 207 YDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPR 266

Query: 310 FPQI----KAHPWHKIFPKR----MPPEAVDLVSRLLQYSPNLRCTA 348
           F  I        W +         + PEA+D + +LL+Y    R TA
Sbjct: 267 FNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTA 313

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 6e-61
 Identities = 78/293 (26%), Positives = 139/293 (47%), Gaps = 22/293 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +GQG+FG VF+A+  +TG+ VA+KKVL +   +       RE++ ++LL H NV
Sbjct: 12  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENV 71

Query: 127 VSLKHCFFSTT---DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           V+L     +     ++ +  + LV ++    +       + +  +  +  +K     +  
Sbjct: 72  VNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAG---LLSNVLVKFTLSEIKRVMQMLLN 128

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-----SYICSRY 238
            L YIH    + HRD+K  N+L+      +KL DFG A+     + +      + + + +
Sbjct: 129 GLYYIH-RNKILHRDMKAANVLITRDGV-LKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           YR PEL+ G  +Y   ID+W AGC++AE+    P+  G++   QL  I ++ G+ T E  
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW 246

Query: 299 KCMNPNYTEFKFPQIKAHP---WHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             ++      K   +K        ++      P A+DL+ +LL   P  R  +
Sbjct: 247 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDS 299

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  196 bits (498), Expect = 3e-60
 Identities = 63/281 (22%), Positives = 109/281 (38%), Gaps = 39/281 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL----QDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG   A K V+     DK    +E+QTM +L HP +V+
Sbjct: 28  YDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVN 87

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F    D +E+ +  + E++      + +     + +M       Y  Q+ + L ++
Sbjct: 88  LHDAF---EDDNEMVM--IYEFMSG--GELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 140

Query: 189 HRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           H      H D+KP+N++     ++++KL DFG    L   +       +  + APE+  G
Sbjct: 141 H-ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEG 199

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
                   D+WS G +   L+ G   F G++  + L  +                     
Sbjct: 200 -KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSA---------- 248

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                             +  +  D + +LL   PN R T 
Sbjct: 249 ---------------FSGISEDGKDFIRKLLLADPNTRMTI 274

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 5e-60
 Identities = 95/284 (33%), Positives = 153/284 (53%), Gaps = 18/284 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           +     +G+G++GVV++A+   TGE VA+KK+  D   +       RE+  ++ L+HPN+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           E  L LV E++ + + + +         +P+  +K Y +Q+ + L+
Sbjct: 64  VKLLDVI-----HTENKLYLVFEFLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLA 116

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H S  V HRD+KPQNLL+N     +KL DFG A+   V        + + +YRAPE++
Sbjct: 117 FCH-SHRVLHRDLKPQNLLINTE-GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEIL 174

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK-CMNPN 304
            G   Y+TA+DIWS GC+ AE++  + LFPGDS +DQL  I + LGTP         +  
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMP 234

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +  FP+     + K+ P  +  +   L+S++L Y PN R +A
Sbjct: 235 DYKPSFPKWARQDFSKVVPP-LDEDGRSLLSQMLHYDPNKRISA 277

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 8e-59
 Identities = 93/286 (32%), Positives = 148/286 (51%), Gaps = 20/286 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y   + VG G++G V  A    TG  VAIKK+ +  + +       REL+ ++ + H NV
Sbjct: 20  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENV 79

Query: 127 VSLKHCFFS-TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           + L   F    T  D     LV+ ++   + +++KH     +++    ++   YQ+ + L
Sbjct: 80  IGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-----EKLGEDRIQFLVYQMLKGL 134

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            YIH + G+ HRD+KP NL VN      K+ DFG A+          Y+ +R+YRAPE+I
Sbjct: 135 RYIH-AAGIIHRDLKPGNLAVNEDCEL-KILDFGLARQA--DSEMTGYVVTRWYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                YT  +DIWS GC++AE++ GK LF G   +DQL EI+KV GTP  E ++ +  + 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 306 TEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
            +      P+++   +  I      P AV+L+ ++L      R TA
Sbjct: 251 AKNYMKGLPELEKKDFASILTN-ASPLAVNLLEKMLVLDAEQRVTA 295

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-58
 Identities = 71/288 (24%), Positives = 116/288 (40%), Gaps = 45/288 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVL------QDKRYKNRELQTMRLLDHPNV 126
           Y     +G GS+G   + +    G+ +  K++        +K+    E+  +R L HPN+
Sbjct: 6   YEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNI 65

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           V         T+     L +V+EY     +  V+    K  Q +   +V     Q+  AL
Sbjct: 66  VRYYDRIIDRTNT---TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 186 SYIHR----SIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI-SYICSRYYR 240
              HR       V HRD+KP N+ ++   + VKL DFG A++L        +++ + YY 
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQN-VKLGDFGLARILNHDTSFAKAFVGTPYYM 181

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
           +PE +     Y    DIWS GC++ EL    P F   S  +   +I              
Sbjct: 182 SPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIR------------- 227

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 E KF +I         P R   E  ++++R+L      R + 
Sbjct: 228 ------EGKFRRI---------PYRYSDELNEIITRMLNLKDYHRPSV 260

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 3e-58
 Identities = 93/286 (32%), Positives = 145/286 (50%), Gaps = 17/286 (5%)

Query: 73  YMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQDKRYKN------RELQTMRLL---D 122
           Y     +G+G++G VF+A+ L+  G  VA+K+V      +       RE+  +R L   +
Sbjct: 9   YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 68

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           HPNVV L      +    E  L LV E+V + +   +    +    +P   +K   +Q+ 
Sbjct: 69  HPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPE--PGVPTETIKDMMFQLL 126

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
           R L ++H S  V HRD+KPQN+LV   + Q+KL DFG A++        S + + +YRAP
Sbjct: 127 RGLDFLH-SHRVVHRDLKPQNILVT-SSGQIKLADFGLARIYSFQMALTSVVVTLWYRAP 184

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++   + Y T +D+WS GC+ AE+   KPLF G S VDQL +I+ V+G P  E+    +
Sbjct: 185 EVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP-RD 242

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  F    A P  K     +     DL+ + L ++P  R +A
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTD-IDELGKDLLLKCLTFNPAKRISA 287

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (482), Expect = 5e-58
 Identities = 66/277 (23%), Positives = 115/277 (41%), Gaps = 31/277 (11%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTM-RLLDHPNVVSLKHCFF 134
            +++G G  G V Q     T E  A+ K+LQD     RE++   R    P++V +   + 
Sbjct: 17  SQVLGLGINGKVLQIFNKRTQEKFAL-KMLQDCPKARREVELHWRASQCPHIVRIVDVYE 75

Query: 135 STTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
           +     +  L +V+E +    +   ++  ++ +Q             I  A+ Y+H SI 
Sbjct: 76  NLYAGRK-CLLIVMECLDGGELFSRIQ--DRGDQAFTEREASEIMKSIGEAIQYLH-SIN 131

Query: 194 VCHRDIKPQNLLVNPHTHQ--VKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEY 251
           + HRD+KP+NLL         +KL DFG AK         +   + YY APE++    +Y
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKY 190

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
             + D+WS G ++  L+ G P F  + G+     +   +                +++FP
Sbjct: 191 DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMG-------------QYEFP 237

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +           +  E   L+  LL+  P  R T 
Sbjct: 238 NPE--------WSEVSEEVKMLIRNLLKTEPTQRMTI 266

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (481), Expect = 8e-58
 Identities = 89/285 (31%), Positives = 141/285 (49%), Gaps = 18/285 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV------LQDKRYKNRELQTMRLLDHPNV 126
           Y     VG G++G V  A   +TG  VA+KK+      +   +   REL+ ++ + H NV
Sbjct: 20  YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 79

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L   F      +E     ++ ++       +       Q++   +V+   YQI R L 
Sbjct: 80  IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLK 135

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIF 246
           YIH S  + HRD+KP NL VN      K+ DFG A+     +    Y+ +R+YRAPE++ 
Sbjct: 136 YIH-SADIIHRDLKPSNLAVNEDCEL-KILDFGLARHT--DDEMTGYVATRWYRAPEIML 191

Query: 247 GATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYT 306
               Y   +DIWS GC++AEL+ G+ LFPG   +DQL  I++++GTP  E +K ++    
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 307 EF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                   Q+    +  +F     P AVDL+ ++L    + R TA
Sbjct: 252 RNYIQSLTQMPKMNFANVFIG-ANPLAVDLLEKMLVLDSDKRITA 295

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  189 bits (480), Expect = 1e-57
 Identities = 66/281 (23%), Positives = 104/281 (37%), Gaps = 39/281 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +G G+FGVV +     TG     K +      DK     E+  M  L HP +++
Sbjct: 31  YDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLIN 90

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F    DK E+ L  +LE++      +       + +M    V  Y  Q    L ++
Sbjct: 91  LHDAF---EDKYEMVL--ILEFLSG--GELFDRIAAEDYKMSEAEVINYMRQACEGLKHM 143

Query: 189 HRSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFG 247
           H    + H DIKP+N++        VK+ DFG A  L   E       +  + APE++  
Sbjct: 144 HEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR 202

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
                   D+W+ G +   L+ G   F G+  ++ L  + +       +           
Sbjct: 203 -EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDED----------- 250

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                             + PEA D +  LLQ  P  R T 
Sbjct: 251 --------------AFSSVSPEAKDFIKNLLQKEPRKRLTV 277

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  187 bits (474), Expect = 2e-57
 Identities = 89/284 (31%), Positives = 148/284 (52%), Gaps = 20/284 (7%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G++GVV++A+    GET A+KK+  +K  +       RE+  ++ L H N+
Sbjct: 4   YHGLEKIGEGTYGVVYKAQ-NNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNI 62

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           +  L LV E++ + + +     +     +  +  K +  Q+   ++
Sbjct: 63  VKLYDVIH-----TKKRLVLVFEHLDQDLKK---LLDVCEGGLESVTAKSFLLQLLNGIA 114

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           Y H    V HRD+KPQNLL+N    ++K+ DFG A+   +        I + +YRAP+++
Sbjct: 115 YCH-DRRVLHRDLKPQNLLIN-REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN- 304
            G+ +Y+T IDIWS GC+ AE++ G PLFPG S  DQL+ I ++LGTP  +    +    
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELP 232

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             +  F   +  PW       +    +DL+S++L+  PN R TA
Sbjct: 233 KYDPNFTVYEPLPWESFLKG-LDESGIDLLSKMLKLDPNQRITA 275

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (474), Expect = 2e-57
 Identities = 61/285 (21%), Positives = 115/285 (40%), Gaps = 44/285 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           +     +G G+FG V++A+  ET    A K +     ++      E+  +   DHPN+V 
Sbjct: 14  WEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 73

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
           L   F     ++ L++  ++E+             +L + +    +++   Q   AL+Y+
Sbjct: 74  LLDAF---YYENNLWI--LIEFCAGGAVD--AVMLELERPLTESQIQVVCKQTLDALNYL 126

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG-EPNISYICSRYYRAPELIFG 247
           H +  + HRD+K  N+L       +KL DFG +    +  +   S+I + Y+ APE++  
Sbjct: 127 HDN-KIIHRDLKAGNILFTLDGD-IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMC 184

Query: 248 AT----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
            T     Y    D+WS G  + E+   +P     + +  L++I                 
Sbjct: 185 ETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKI----------------- 227

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     K+ P     P R      D + + L+ + + R T 
Sbjct: 228 ---------AKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTT 263

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 6e-57
 Identities = 56/280 (20%), Positives = 116/280 (41%), Gaps = 40/280 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
           +  +G+GSF  V++    ET   VA  ++   K  K+       E + ++ L HPN+V  
Sbjct: 14  DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
            +  + +T K +  + LV E +       +K + K  + M +  ++ +  QI + L ++H
Sbjct: 74  -YDSWESTVKGKKCIVLVTELMT---SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLH 129

Query: 190 -RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            R+  + HRD+K  N+ +   T  VK+ D G A  L +     + I +  + APE+    
Sbjct: 130 TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFMAPEMYEE- 187

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
            +Y  ++D+++ G  + E+   +  +       Q+                         
Sbjct: 188 -KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR---------------------- 224

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
               + +      F K   PE  +++   ++ + + R + 
Sbjct: 225 ----VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSI 260

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 7e-57
 Identities = 78/284 (27%), Positives = 129/284 (45%), Gaps = 50/284 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G+G FG V+ A+  ++   +A+K + + +  K        RE++    L HPN
Sbjct: 8   FEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPN 67

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++ L   F    D   +YL  +LEY P  TV+R ++  +K +++        Y  ++  A
Sbjct: 68  ILRLYGYF---HDATRVYL--ILEYAPLGTVYRELQKLSKFDEQR----TATYITELANA 118

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           LSY H S  V HRDIKP+NLL+      +K+ DFG +          +   +  Y  PE+
Sbjct: 119 LSYCH-SKRVIHRDIKPENLLLGSAGE-LKIADFGWSV-HAPSSRRTTLCGTLDYLPPEM 175

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           I G   +   +D+WS G +  E ++GKP F  ++  +    I +V  T            
Sbjct: 176 IEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFT------------ 222

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                            FP  +   A DL+SRLL+++P+ R   
Sbjct: 223 -----------------FPDFVTEGARDLISRLLKHNPSQRPML 249

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-56
 Identities = 92/284 (32%), Positives = 143/284 (50%), Gaps = 18/284 (6%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y     +G+G++G VF+AK  ET E VA+K+V  D   +       RE+  ++ L H N+
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNI 63

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           V L           +  L LV E+  + + +     N     +    VK + +Q+ + L 
Sbjct: 64  VRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNG---DLDPEIVKSFLFQLLKGLG 115

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL-VKGEPNISYICSRYYRAPELI 245
           + H    V HRD+KPQNLL+N +    KL +FG A+   +      + + + +YR P+++
Sbjct: 116 FCHSR-NVLHRDLKPQNLLINRNGEL-KLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           FGA  Y+T+ID+WSAGC+ AEL     PLFPG+   DQL  I ++LGTPT E+   M   
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                +P   A         ++     DL+  LL+ +P  R +A
Sbjct: 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISA 277

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  184 bits (469), Expect = 2e-56
 Identities = 69/285 (24%), Positives = 119/285 (41%), Gaps = 49/285 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           +   R +G GSFG V+ A+ +   E VAIKK+    +  N       +E++ ++ L HPN
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
            +  + C+     +   +  LV+EY   +   +++   K    +  + +    +   + L
Sbjct: 77  TIQYRGCY---LREHTAW--LVMEYCLGSASDLLEVHKK---PLQEVEIAAVTHGALQGL 128

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
           +Y+H S  + HRD+K  N+L++     VKL DFGSA ++    P  S++ + Y+ APE+I
Sbjct: 129 AYLH-SHNMIHRDVKAGNILLS-EPGLVKLGDFGSASIM---APANSFVGTPYWMAPEVI 183

Query: 246 FGATE--YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
               E  Y   +D+WS G    EL   KP     + +  L  I +               
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ--------------- 228

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       +    +          + V   LQ  P  R T+
Sbjct: 229 ------------NESPALQSGHWSEYFRNFVDSCLQKIPQDRPTS 261

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (464), Expect = 3e-56
 Identities = 64/284 (22%), Positives = 110/284 (38%), Gaps = 44/284 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +   + +G+G++G V  A    T E VA+K V   +         +E+   ++L+H NVV
Sbjct: 7   WDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVV 66

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                             L LEY             + +  MP    + + +Q+   + Y
Sbjct: 67  KFYGHRREGN-----IQYLFLEYCSGGELF---DRIEPDIGMPEPDAQRFFHQLMAGVVY 118

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPEL 244
           +H  IG+ HRDIKP+NLL++   + +K+ DFG A V               +  Y APEL
Sbjct: 119 LH-GIGITHRDIKPENLLLDERDN-LKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     +   +D+WS G V+  ++ G+  +   S   Q     K   T            
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNP-------- 228

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                              K++    + L+ ++L  +P+ R T 
Sbjct: 229 ------------------WKKIDSAPLALLHKILVENPSARITI 254

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 3e-55
 Identities = 64/280 (22%), Positives = 113/280 (40%), Gaps = 38/280 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV---LQDKRYKNRELQTMRLLDHPNVVSL 129
           YM    +G+G FG+V +     + +T   K V     D+    +E+  + +  H N++ L
Sbjct: 7   YMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHL 66

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
              F     +    L ++ E++      + +  N     +    +  Y +Q+  AL ++H
Sbjct: 67  HESF-----ESMEELVMIFEFISGL--DIFERINTSAFELNEREIVSYVHQVCEALQFLH 119

Query: 190 RSIGVCHRDIKPQNLLV-NPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGA 248
            S  + H DI+P+N++     +  +K+ +FG A+ L  G+       +  Y APE+    
Sbjct: 120 -SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH- 177

Query: 249 TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEF 308
              +TA D+WS G +V  L+ G   F  ++    +  I+    T   E            
Sbjct: 178 DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA----------- 226

Query: 309 KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                          K +  EA+D V RLL      R TA
Sbjct: 227 --------------FKEISIEAMDFVDRLLVKERKSRMTA 252

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (451), Expect = 6e-54
 Identities = 69/281 (24%), Positives = 117/281 (41%), Gaps = 43/281 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV----LQDKRYKNRELQTMRLLDHPNVVS 128
           Y     +GQG+ G V+ A  + TG+ VAI+++       K     E+  MR   +PN+V+
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81

Query: 129 LKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYI 188
               +      DEL++  V+EY+       V         M    +     +  +AL ++
Sbjct: 82  YLDSY---LVGDELWV--VMEYLAGGSLTDVVT----ETCMDEGQIAAVCRECLQALEFL 132

Query: 189 HRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPELIFG 247
           H +  V HRDIK  N+L+      VKL DFG    +   +   S +  + Y+ APE++  
Sbjct: 133 HSN-QVIHRDIKSDNILLGMDGS-VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR 190

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              Y   +DIWS G +  E++ G+P +  ++ +  L  I    GTP  +           
Sbjct: 191 -KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIAT-NGTPELQ----------- 237

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                          P+++     D ++R L      R +A
Sbjct: 238 --------------NPEKLSAIFRDFLNRCLDMDVEKRGSA 264

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 8e-54
 Identities = 79/295 (26%), Positives = 125/295 (42%), Gaps = 52/295 (17%)

Query: 66  QPKQTI--SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYK-------NRELQ 116
           QP++     +   +I+G+GSF  V  A+ L T    AIK + +    K        RE  
Sbjct: 1   QPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERD 60

Query: 117 TMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKL 176
            M  LDHP  V L   F    D ++LY    L Y     +  +  + +          + 
Sbjct: 61  VMSRLDHPFFVKLYFTF---QDDEKLY--FGLSYAK---NGELLKYIRKIGSFDETCTRF 112

Query: 177 YAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SY 233
           Y  +I  AL Y+H   G+ HRD+KP+N+L+N   H +++ DFG+AKVL          S+
Sbjct: 113 YTAEIVSALEYLH-GKGIIHRDLKPENILLNEDMH-IQITDFGTAKVLSPESKQARANSF 170

Query: 234 ICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           + +  Y +PEL+        + D+W+ GC++ +L+ G P F   +      +IIK+    
Sbjct: 171 VGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYD- 228

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                       FP++  P+A DLV +LL      R   
Sbjct: 229 ----------------------------FPEKFFPKARDLVEKLLVLDATKRLGC 255

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  174 bits (442), Expect = 2e-52
 Identities = 62/284 (21%), Positives = 111/284 (39%), Gaps = 44/284 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           Y    ++G G+F  V  A+   T + VAIK + +            E+  +  + HPN+V
Sbjct: 11  YDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIV 70

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           +L   +        LYL  +++ V    +   +       +R          +Q+  A+ 
Sbjct: 71  ALDDIY---ESGGHLYL--IMQLVSGGELFDRIVEKGFYTERD----ASRLIFQVLDAVK 121

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTH--QVKLCDFGSAKVLVKGEPNISYICSRYYRAPEL 244
           Y+H  +G+ HRD+KP+NLL        ++ + DFG +K+   G    +   +  Y APE+
Sbjct: 122 YLH-DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEV 180

Query: 245 IFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
           +     Y+ A+D WS G +   L+ G P F  ++      +I+K                
Sbjct: 181 LAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSP-------- 231

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                            +   +   A D +  L++  P  R T 
Sbjct: 232 -----------------YWDDISDSAKDFIRHLMEKDPEKRFTC 258

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 6e-52
 Identities = 87/296 (29%), Positives = 145/296 (48%), Gaps = 29/296 (9%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNV 126
           Y   + +G G+ G+V  A        VAIKK+ +  + +       REL  M+ ++H N+
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNI 78

Query: 127 VSLKHCFFS-TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +SL + F    T ++   + LV+E +   + +V++        +    +    YQ+   +
Sbjct: 79  ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM------ELDHERMSYLLYQMLCGI 132

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            ++H S G+ HRD+KP N++V       K+ DFG A+          Y+ +RYYRAPE+I
Sbjct: 133 KHLH-SAGIIHRDLKPSNIVVKSDCTL-KILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
            G   Y   +DIWS GC++ E++  K LFPG   +DQ  ++I+ LGTP  E +K + P  
Sbjct: 191 LG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 306 TEF--KFPQIKAHPWHKIFP-----------KRMPPEAVDLVSRLLQYSPNLRCTA 348
             +    P+     + K+FP           K    +A DL+S++L   P  R + 
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISV 305

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  172 bits (436), Expect = 6e-52
 Identities = 65/295 (22%), Positives = 114/295 (38%), Gaps = 54/295 (18%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------------LQDKRYKNRELQTMR 119
           Y  + I+G+G   VV +     T +  A+K +              + +    +E+  +R
Sbjct: 5   YEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILR 64

Query: 120 LL-DHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYA 178
            +  HPN++ LK  +     +   +  LV + +       +  +      +     +   
Sbjct: 65  KVSGHPNIIQLKDTY-----ETNTFFFLVFDLMK---KGELFDYLTEKVTLSEKETRKIM 116

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY 238
             +   +  +H  + + HRD+KP+N+L++   + +KL DFG +  L  GE       +  
Sbjct: 117 RALLEVICALH-KLNIVHRDLKPENILLDDDMN-IKLTDFGFSCQLDPGEKLREVCGTPS 174

Query: 239 YRAPELIFGATE-----YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP 293
           Y APE+I  +       Y   +D+WS G ++  L+ G P F     +  L  I       
Sbjct: 175 YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMI------- 227

Query: 294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  M+ NY +F  P+                   DLVSR L   P  R TA
Sbjct: 228 -------MSGNY-QFGSPE----------WDDYSDTVKDLVSRFLVVQPQKRYTA 264

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  171 bits (433), Expect = 1e-50
 Identities = 84/313 (26%), Positives = 141/313 (45%), Gaps = 42/313 (13%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
           Y+  R +G G F  V+ AK +     VA+K V  DK Y      E++ ++ ++  +    
Sbjct: 15  YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74

Query: 130 KH----------CFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAY 179
                         F+    + +++ +V E + E +  ++K +   ++ +P+IYVK  + 
Sbjct: 75  DSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYE--HRGIPLIYVKQISK 132

Query: 180 QIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH-----QVKLCDFGSAKVLVKGEPNISYI 234
           Q+   L Y+HR  G+ H DIKP+N+L+          Q+K+ D G+A      E   + I
Sbjct: 133 QLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSI 190

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSG------VDQLVEIIK 288
            +R YR+PE++ GA  +    DIWS  C++ EL+ G  LF  D G       D + +II+
Sbjct: 191 QTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 289 VLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHKI------FPKRMPPEAVDLVS 335
           +LG      ++      T F          ++K  P   +      F K    E  D +S
Sbjct: 250 LLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLS 309

Query: 336 RLLQYSPNLRCTA 348
            +LQ  P  R  A
Sbjct: 310 PMLQLDPRKRADA 322

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  168 bits (427), Expect = 1e-49
 Identities = 63/289 (21%), Positives = 115/289 (39%), Gaps = 47/289 (16%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD 122
           +   RI+G+G FG V+  +  +TG+  A+K + + +            +   L  +   D
Sbjct: 6   FSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD 65

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
            P +V + + F      D+L    +L+ +       + +    +       ++ YA +I 
Sbjct: 66  CPFIVCMSYAF---HTPDKLSF--ILDLMN---GGDLHYHLSQHGVFSEADMRFYAAEII 117

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAP 242
             L ++H +  V +RD+KP N+L++ H H V++ D G A    K +P+ S   +  Y AP
Sbjct: 118 LGLEHMH-NRFVVYRDLKPANILLDEHGH-VRISDLGLACDFSKKKPHASV-GTHGYMAP 174

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
           E++     Y ++ D +S GC++ +L+ G   F      D+       L            
Sbjct: 175 EVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE------- 227

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK 351
                               P    PE   L+  LLQ   N R   + +
Sbjct: 228 -------------------LPDSFSPELRSLLEGLLQRDVNRRLGCLGR 257

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 2e-49
 Identities = 65/285 (22%), Positives = 124/285 (43%), Gaps = 49/285 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQT--------MRLLDHP 124
           ++  +++G+GSFG VF A+  +T +  AIK + +D    + +++             +HP
Sbjct: 4   FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHP 63

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
            +  +   F     + +  L  V+EY+       + +  +   +  +     YA +I   
Sbjct: 64  FLTHMFCTF-----QTKENLFFVMEYLN---GGDLMYHIQSCHKFDLSRATFYAAEIILG 115

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC-SRYYRAPE 243
           L ++H S G+ +RD+K  N+L++   H  K+ DFG  K  + G+   +  C +  Y APE
Sbjct: 116 LQFLH-SKGIVYRDLKLDNILLDKDGHI-KIADFGMCKENMLGDAKTNTFCGTPDYIAPE 173

Query: 244 LIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           ++ G  +Y  ++D WS G ++ E+++G+  F G    +                I+  NP
Sbjct: 174 ILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF------------HSIRMDNP 220

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                             +P+ +  EA DL+ +L    P  R   
Sbjct: 221 F-----------------YPRWLEKEAKDLLVKLFVREPEKRLGV 248

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 7e-49
 Identities = 62/296 (20%), Positives = 112/296 (37%), Gaps = 50/296 (16%)

Query: 68  KQTIS--YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------REL 115
           ++ +   Y     +G G F VV + +   TG   A K + + +   +          RE+
Sbjct: 5   QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREV 64

Query: 116 QTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVK 175
             ++ + HPNV++L   +    +K ++ L  +LE V       +  F    + +      
Sbjct: 65  SILKEIQHPNVITLHEVY---ENKTDVIL--ILELVA---GGELFDFLAEKESLTEEEAT 116

Query: 176 LYAYQIFRALSYIHRSIGVCHRDIKPQNLLV---NPHTHQVKLCDFGSAKVLVKGEPNIS 232
            +  QI   + Y+H    + H D+KP+N+++   N    ++K+ DFG A  +  G    +
Sbjct: 117 EFLKQILNGVYYLHSLQ-IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN 175

Query: 233 YICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGT 292
              +  + APE++          D+WS G +   L+ G   F GD+  + L  +  V   
Sbjct: 176 IFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYE 234

Query: 293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              E                         +       A D + RLL   P  R T 
Sbjct: 235 FEDE-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTI 265

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  164 bits (415), Expect = 8e-49
 Identities = 62/289 (21%), Positives = 109/289 (37%), Gaps = 43/289 (14%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPN 125
           Y    I+G G    V  A+ L     VA+K +  D            RE Q    L+HP 
Sbjct: 9   YELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 68

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           +V++ +              +V+EYV       ++        M             +AL
Sbjct: 69  IVAV-YDTGEAETPAGPLPYIVMEYVD---GVTLRDIVHTEGPMTPKRAIEVIADACQAL 124

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI----SYICSRYYRA 241
           ++ H   G+ HRD+KP N++++   + VK+ DFG A+ +     ++    + I +  Y +
Sbjct: 125 NFSH-QNGIIHRDVKPANIMISAT-NAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 242 PELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           PE   G        D++S GCV+ E++ G+P F GDS V    + ++    P        
Sbjct: 183 PEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----- 236

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVS 350
                                 + +  +   +V + L  +P  R    +
Sbjct: 237 --------------------RHEGLSADLDAVVLKALAKNPENRYQTAA 265

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  163 bits (413), Expect = 4e-48
 Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 49/284 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKV-------LQDKRYKNRELQTMRLLDHPN 125
           +   R +G GSFG V   +    G   A+K +       L+   + N E   + ++ HP 
Sbjct: 6   FQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPF 65

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRAL 185
           ++ +   F     +D   + ++++Y+       +    + +QR P    K YA ++  AL
Sbjct: 66  IIRMWGTF-----QDAQQIFMIMDYIE---GGELFSLLRKSQRFPNPVAKFYAAEVCLAL 117

Query: 186 SYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELI 245
            Y+H    + +RD+KP+N+L++ + H +K+ DFG AK +   +   +   +  Y APE++
Sbjct: 118 EYLHSK-DIIYRDLKPENILLDKNGH-IKITDFGFAKYV--PDVTYTLCGTPDYIAPEVV 173

Query: 246 FGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNY 305
                Y  +ID WS G ++ E++ G   F   + +    +I+                  
Sbjct: 174 ST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN----------------- 215

Query: 306 TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV 349
                           FP     +  DL+SRL+    + R   +
Sbjct: 216 ------------AELRFPPFFNEDVKDLLSRLITRDLSQRLGNL 247

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 1e-47
 Identities = 63/288 (21%), Positives = 107/288 (37%), Gaps = 56/288 (19%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN----------RELQTMRLLD 122
           Y    ++G G FG V+    +     VAIK V +D+               E+  ++ + 
Sbjct: 6   YQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVS 65

Query: 123 --HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
                V+ L   F      D   L  +LE       + +  F      +     + + +Q
Sbjct: 66  SGFSGVIRLLDWFE---RPDSFVL--ILERPEP--VQDLFDFITERGALQEELARSFFWQ 118

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYR 240
           +  A+ + H   GV HRDIK +N+L++ +  ++KL DFGS   L+K      +  +R Y 
Sbjct: 119 VLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKLIDFGSGA-LLKDTVYTDFDGTRVYS 176

Query: 241 APELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC 300
            PE I     +  +  +WS G ++ +++ G   F  D       EII+            
Sbjct: 177 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR------------ 218

Query: 301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                F +R+  E   L+   L   P+ R T 
Sbjct: 219 -----------------GQVFFRQRVSSECQHLIRWCLALRPSDRPTF 249

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-47
 Identities = 55/284 (19%), Positives = 105/284 (36%), Gaps = 47/284 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVVSL 129
            + +G GSFG V++ K       VA+K +               E+  +R   H N++  
Sbjct: 13  GQRIGSGSFGTVYKGK---WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLF 69

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                         L +V ++   +   +  H + +  +  MI +   A Q  + + Y+H
Sbjct: 70  MGYS------TAPQLAIVTQWCEGS--SLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH 121

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISY---ICSRYYRAPELIF 246
               + HRD+K  N+ ++     VK+ DFG A V  +   +  +     S  + APE+I 
Sbjct: 122 AK-SIIHRDLKSNNIFLHEDLT-VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIR 179

Query: 247 G--ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN 304
                 Y+   D+++ G V+ ELM G+  +   +  DQ++ ++                 
Sbjct: 180 MQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVG---------------- 223

Query: 305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                  +    P         P     L++  L+   + R   
Sbjct: 224 -------RGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLF 260

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  157 bits (397), Expect = 6e-46
 Identities = 61/311 (19%), Positives = 107/311 (34%), Gaps = 51/311 (16%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 117
           +G R         Y   R +G GSFG ++    +  GE VAIK      ++     E + 
Sbjct: 5   VGNR---------YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKI 55

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
            +++     +       +  D    Y  +V+E +  ++      FN  +++  +  V L 
Sbjct: 56  YKMMQGGVGIPTIRWCGAEGD----YNVMVMELLGPSLED---LFNFCSRKFSLKTVLLL 108

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLV--NPHTHQVKLCDFGSAKVLVKGEPNI---- 231
           A Q+   + YIH S    HRD+KP N L+      + V + DFG AK       +     
Sbjct: 109 ADQMISRIEYIH-SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPY 167

Query: 232 ----SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEII 287
               +   +  Y +     G  E +   D+ S G V+    LG   + G     +  +  
Sbjct: 168 RENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY- 225

Query: 288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT 347
                                +  + K     ++  K  P E    ++       + +  
Sbjct: 226 --------------------ERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD 265

Query: 348 AVSKRILFSNC 358
               R LF N 
Sbjct: 266 YSYLRQLFRNL 276

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 5e-44
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 46/279 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           +++G+G+FG V   +   TG   A+K + ++             E + ++   HP + +L
Sbjct: 11  KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTAL 70

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           K+ F      D L        +       +       +       + Y  +I  AL Y+H
Sbjct: 71  KYAF---QTHDRLCF-----VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLH 122

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
               V +RDIK +NL+++   H +K+ DFG  K  +     +   C         +    
Sbjct: 123 S-RDVVYRDIKLENLMLDKDGH-IKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +Y  A+D W  G V+ E+M G+  F           I+        EEI+          
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-------EEIR---------- 223

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       FP+ + PEA  L++ LL+  P  R   
Sbjct: 224 ------------FPRTLSPEAKSLLAGLLKKDPKQRLGG 250

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-43
 Identities = 48/274 (17%), Positives = 97/274 (35%), Gaps = 41/274 (14%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQTMRLLDHPNVVSLKHCFF 134
           + +G+G FG V        G  VA+K +  D   +    E   M  L H N+V L     
Sbjct: 13  QTIGKGEFGDVMLGD--YRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIV 70

Query: 135 STTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGV 194
               +++  L +V EY+ +         ++    +    +  ++  +  A+ Y+  +   
Sbjct: 71  ----EEKGGLYIVTEYMAKGSLVDY-LRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN-NF 124

Query: 195 CHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTA 254
            HRD+  +N+LV+      K+ DFG  K         +      + APE +    +++T 
Sbjct: 125 VHRDLAARNVLVSEDNV-AKVSDFGLTKEA--SSTQDTGKLPVKWTAPEALRE-KKFSTK 180

Query: 255 IDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIK 314
            D+WS G ++ E+     +      +  +V  ++                          
Sbjct: 181 SDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE-------------------------- 214

Query: 315 AHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
              +    P   PP   +++         +R + 
Sbjct: 215 -KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSF 247

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  149 bits (377), Expect = 3e-43
 Identities = 53/313 (16%), Positives = 102/313 (32%), Gaps = 53/313 (16%)

Query: 60  IGGRNGQPKQTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN--RELQT 117
           +G           Y   R +G+GSFGV+F+   L   + VAIK   +         E +T
Sbjct: 3   VGVH---------YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRT 53

Query: 118 MRLLDHPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLY 177
            +LL     +   + F      + L+  LV++ +  ++       +   ++  +  V + 
Sbjct: 54  YKLLAGCTGIPNVYYFGQ----EGLHNVLVIDLLGPSLE---DLLDLCGRKFSVKTVAMA 106

Query: 178 AYQIFRALSYIHRSIGVCHRDIKPQNLLVN----PHTHQVKLCDFGSAKVLVKGEPNI-- 231
           A Q+   +  IH    + +RDIKP N L+      + + + + DFG  K           
Sbjct: 107 AKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHI 165

Query: 232 ------SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVE 285
                 +   +  Y +     G  E +   D+ + G V    + G   + G        +
Sbjct: 166 PYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK 224

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
             ++                      + K     +      P E    +      + +  
Sbjct: 225 YERIG---------------------EKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

Query: 346 CTAVSKRILFSNC 358
                 + LFS  
Sbjct: 264 PDYDYLQGLFSKV 276

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-41
 Identities = 51/281 (18%), Positives = 97/281 (34%), Gaps = 43/281 (15%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSL 129
                 +G G FG V+          VA+K + Q     +    E   M+ L H  +V L
Sbjct: 15  LKLVERLGAGQFGEVWMGY-YNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRL 73

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
                    ++ +Y+  + EY+                ++ +  +   A QI   +++I 
Sbjct: 74  YAVV----TQEPIYI--ITEYMENGSLVDFLKTPS-GIKLTINKLLDMAAQIAEGMAFIE 126

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFG 247
                 HRD++  N+LV+      K+ DFG A+++   E            + APE I  
Sbjct: 127 -ERNYIHRDLRAANILVSDTLSC-KIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY 184

Query: 248 ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
              +T   D+WS G ++ E++    +        ++++ ++                   
Sbjct: 185 G-TFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE------------------- 224

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                     +  + P   P E   L+    +  P  R T 
Sbjct: 225 --------RGYRMVRPDNCPEELYQLMRLCWKERPEDRPTF 257

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  145 bits (367), Expect = 4e-41
 Identities = 62/276 (22%), Positives = 107/276 (38%), Gaps = 49/276 (17%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN-------RELQTMRLLDHPNVVSL 129
           + +G GSFG V   K  E+G   A+K + + K  K         E + ++ ++ P +V L
Sbjct: 47  KTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL 106

Query: 130 KHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIH 189
           +  F   ++   +   +    +   + R          R    + + YA QI     Y+H
Sbjct: 107 EFSFKDNSNLYMVMEYVAGGEMFSHLRR--------IGRFSEPHARFYAAQIVLTFEYLH 158

Query: 190 RSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGAT 249
            S+ + +RD+KP+NLL++   + +++ DFG AK         +   +    APE+I    
Sbjct: 159 -SLDLIYRDLKPENLLIDQQGY-IQVTDFGFAK--RVKGRTWTLCGTPEALAPEIILS-K 213

Query: 250 EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
            Y  A+D W+ G ++ E+  G P F  D  +    +I                       
Sbjct: 214 GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKI----------------------- 250

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
                       FP     +  DL+  LLQ     R
Sbjct: 251 ------VSGKVRFPSHFSSDLKDLLRNLLQVDLTKR 280

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  140 bits (353), Expect = 1e-39
 Identities = 52/278 (18%), Positives = 109/278 (39%), Gaps = 41/278 (14%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           +  +G G +G V++    +   TVA+K + +D        +E   M+ + HPN+V L   
Sbjct: 22  KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGV 81

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
               T +   Y+    E++               Q +  + +   A QI  A+ Y+ +  
Sbjct: 82  C---TREPPFYIIT--EFMTYGNLLDYLRECN-RQEVSAVVLLYMATQISSAMEYLEKK- 134

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR--YYRAPELIFGATE 250
              HRD+  +N LV  + H VK+ DFG ++++                + APE +    +
Sbjct: 135 NFIHRDLAARNCLVGEN-HLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NK 192

Query: 251 YTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           ++   D+W+ G ++ E+            + Q+ E+++                  +++ 
Sbjct: 193 FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-----------------KDYRM 235

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       P+  P +  +L+    Q++P+ R + 
Sbjct: 236 E----------RPEGCPEKVYELMRACWQWNPSDRPSF 263

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 2e-39
 Identities = 62/308 (20%), Positives = 110/308 (35%), Gaps = 70/308 (22%)

Query: 76  ERIVGQGSFGVVFQAKCLETGET-----VAIKKVLQDKRYKN-----RELQTM-RLLDHP 124
            +++G G+FG V  A      +T     VA+K + +            EL+ M +L  H 
Sbjct: 42  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 101

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP--------------------ETVHRVVKHFNK 164
           N+V+L       T    +Y  L+ EY                      E  ++      +
Sbjct: 102 NIVNLLGAC---TLSGPIY--LIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 165 LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL 224
               +    +  +AYQ+ + + ++       HRD+  +N+LV      VK+CDFG A+ +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLE-FKSCVHRDLAARNVLVTHGKV-VKICDFGLARDI 214

Query: 225 VKGEPNISYICSR---YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGV 280
           +     +    +R    + APE +F    YT   D+WS G ++ E+  LG   +PG    
Sbjct: 215 MSDSNYVVRGNARLPVKWMAPESLFE-GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273

Query: 281 DQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQY 340
               ++I+                   FK             P     E   ++     +
Sbjct: 274 ANFYKLIQ-----------------NGFKMD----------QPFYATEEIYIIMQSCWAF 306

Query: 341 SPNLRCTA 348
               R + 
Sbjct: 307 DSRKRPSF 314

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  140 bits (353), Expect = 3e-39
 Identities = 68/291 (23%), Positives = 122/291 (41%), Gaps = 50/291 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCL---ETGETVAIKKV--------LQDKRYKNRELQTMRLL 121
           +   +++G G++G VF  + +   +TG+  A+K +         +   +   E Q +  +
Sbjct: 26  FELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI 85

Query: 122 DH-PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQ 180
              P +V+L + F     + +L+L L      E    + +       R     V++Y  +
Sbjct: 86  RQSPFLVTLHYAF---QTETKLHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGE 137

Query: 181 IFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC---SR 237
           I  AL ++H+ +G+ +RDIK +N+L++ + H V L DFG +K  V  E   +Y       
Sbjct: 138 IVLALEHLHK-LGIIYRDIKLENILLDSNGH-VVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE 297
           Y     +  G + +  A+D WS G ++ EL+ G   F  D   +   EI +         
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR--------- 246

Query: 298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                    + + P          +P+ M   A DL+ RLL   P  R   
Sbjct: 247 ------RILKSEPP----------YPQEMSALAKDLIQRLLMKDPKKRLGC 281

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 4e-39
 Identities = 53/298 (17%), Positives = 108/298 (36%), Gaps = 37/298 (12%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR---YKNRELQTMRLLDHPNVVS 128
           + + +  +G+G FG V++ K    GE VA+K     +    ++  E+    +L H N++ 
Sbjct: 4   TIVLQESIGKGRFGEVWRGK--WRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILG 61

Query: 129 LKHCFFSTTDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
                 +  +     L LV +Y    ++   +         + +  +   A      L++
Sbjct: 62  F-IAADNKDNGTWTQLWLVSDYHEHGSLFDYLN-----RYTVTVEGMIKLALSTASGLAH 115

Query: 188 IHRSI-------GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS-----YIC 235
           +H  I        + HRD+K +N+LV        + D G A         I       + 
Sbjct: 116 LHMEIVGTQGKPAIAHRDLKSKNILVK-KNGTCCIADLGLAVRHDSATDTIDIAPNHRVG 174

Query: 236 SRYYRAPELIFGA-----TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL 290
           ++ Y APE++  +      E     DI++ G V  E+     +        QL     V 
Sbjct: 175 TKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED-YQLPYYDLVP 233

Query: 291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
             P+ EE++ +          +++ +  ++            ++      +   R TA
Sbjct: 234 SDPSVEEMRKV------VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTA 285

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 4e-39
 Identities = 46/277 (16%), Positives = 96/277 (34%), Gaps = 43/277 (15%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 133
           + +G G FG+V         + VAIK + +    +     E + M  L HP +V L    
Sbjct: 11  QEIGSGQFGLVHLGY-WLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVC 69

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
               ++  +   LV E++         +            +      +   ++Y+  +  
Sbjct: 70  ---LEQAPIC--LVFEFMEHGCLS--DYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA-C 121

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAPELIFGATEY 251
           V HRD+  +N LV  +   +K+ DFG  + ++  +   S        + +PE+    + Y
Sbjct: 122 VIHRDLAARNCLVGENQV-IKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSF-SRY 179

Query: 252 TTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFP 311
           ++  D+WS G ++ E+     +   +    ++VE I                        
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS----------------------- 216

Query: 312 QIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 +    P+        +++   +  P  R   
Sbjct: 217 ----TGFRLYKPRLASTHVYQIMNHCWKERPEDRPAF 249

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (347), Expect = 9e-39
 Identities = 62/279 (22%), Positives = 104/279 (37%), Gaps = 45/279 (16%)

Query: 76  ERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHC 132
           E  +GQG FG V+      T   VAIK +           +E Q M+ L H  +V L   
Sbjct: 22  EVKLGQGCFGEVWMGTWNGTTR-VAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAV 80

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                 ++ +Y+  V EY+ +          +  + + +  +   A QI   ++Y+ R  
Sbjct: 81  V----SEEPIYI--VTEYMSKGSLLDFLK-GETGKYLRLPQLVDMAAQIASGMAYVERM- 132

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI--SYICSRYYRAPELIFGATE 250
              HRD++  N+LV  +    K+ DFG A+++   E            + APE       
Sbjct: 133 NYVHRDLRAANILVGENLV-CKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GR 190

Query: 251 YTTAIDIWSAGCVVAEL-MLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK 309
           +T   D+WS G ++ EL   G+  +PG    + L ++ +    P                
Sbjct: 191 FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP---------------- 234

Query: 310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                        P   P    DL+ +  +  P  R T 
Sbjct: 235 ------------CPPECPESLHDLMCQCWRKEPEERPTF 261

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 1e-38
 Identities = 52/278 (18%), Positives = 100/278 (35%), Gaps = 45/278 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKN---RELQTMRLLDHPNVVSLKHCF 133
           + +G G FGVV   K       VAIK + +    ++    E + M  L H  +V L    
Sbjct: 10  KELGTGQFGVVKYGK-WRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVC 68

Query: 134 FSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG 193
              T +  ++  ++ EY+         +  ++  R     +      +  A+ Y+     
Sbjct: 69  ---TKQRPIF--IITEYMANGCLL--NYLREMRHRFQTQQLLEMCKDVCEAMEYLESK-Q 120

Query: 194 VCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS--YICSRYYRAPELIFGATEY 251
             HRD+  +N LVN     VK+ DFG ++ ++  E   S        +  PE++   +++
Sbjct: 121 FLHRDLAARNCLVNDQGV-VKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMY-SKF 178

Query: 252 TTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKF 310
           ++  DIW+ G ++ E+  LGK  +   +  +    I + L                    
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY----------------- 221

Query: 311 PQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                       P     +   ++        + R T 
Sbjct: 222 -----------RPHLASEKVYTIMYSCWHEKADERPTF 248

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  137 bits (345), Expect = 1e-38
 Identities = 57/286 (19%), Positives = 104/286 (36%), Gaps = 51/286 (17%)

Query: 77  RIVGQGSFGVVFQAKCLET---GETVAIKKVLQDKRYKN-------RELQTMRLLDHPNV 126
             +G GSFGVV + +         +VA+K +  D   +        RE+  M  LDH N+
Sbjct: 14  EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNL 73

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALS 186
           + L     +        + +V E  P     ++    K      +  +  YA Q+   + 
Sbjct: 74  IRLYGVVLTP------PMKMVTELAPL--GSLLDRLRKHQGHFLLGTLSRYAVQVAEGMG 125

Query: 187 YIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNI---SYICSRYYRAPE 243
           Y+  S    HRD+  +NLL+      VK+ DFG  + L + + +     +    +     
Sbjct: 126 YLE-SKRFIHRDLAARNLLLA-TRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAP 183

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
                  ++ A D W  G  + E+   G+  + G +G   L +I K              
Sbjct: 184 ESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDK-------------- 229

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                 + P+          P+  P +  +++ +   + P  R T 
Sbjct: 230 ---EGERLPR----------PEDCPQDIYNVMVQCWAHKPEDRPTF 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  136 bits (344), Expect = 3e-38
 Identities = 62/292 (21%), Positives = 106/292 (36%), Gaps = 53/292 (18%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGET---VAIKKVL-----QDKRYKNRELQTMRLLDH 123
               E+++G G FG V        G+    VAIK +      + +R    E   M   DH
Sbjct: 27  CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDH 86

Query: 124 PNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFR 183
           PNV+ L+      T    +   ++ E++           N  + +  +I +      I  
Sbjct: 87  PNVIHLEGVV---TKSTPVM--IITEFMENGSLDSFLRQN--DGQFTVIQLVGMLRGIAA 139

Query: 184 ALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR------ 237
            + Y+   +   HRD+  +N+LVN +    K+ DFG ++ L     + +Y  +       
Sbjct: 140 GMKYLAD-MNYVHRDLAARNILVNSNLV-CKVSDFGLSRFLEDDTSDPTYTSALGGKIPI 197

Query: 238 YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTRE 296
            + APE I    ++T+A D+WS G V+ E+M  G+  +   +  D +  I +    P   
Sbjct: 198 RWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP--- 253

Query: 297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                     P   P     L+    Q   N R   
Sbjct: 254 -------------------------PPMDCPSALHQLMLDCWQKDRNHRPKF 280

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (342), Expect = 9e-38
 Identities = 62/285 (21%), Positives = 108/285 (37%), Gaps = 52/285 (18%)

Query: 77  RIVGQGSFGVVFQAKCLETGET----VAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
           +++G G+FG V++   +  GE     VAIK++ +    K       E   M  +D+P+V 
Sbjct: 15  KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            L     ++T      + L+ + +P     ++ +  +    +   Y+  +  QI + ++Y
Sbjct: 75  RLLGICLTST------VQLITQLMPF--GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR---YYRAPEL 244
           +     + HRD+  +N+LV    H VK+ DFG AK+L   E        +    + A E 
Sbjct: 127 LEDR-RLVHRDLAARNVLVKTPQH-VKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 245 IFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP 303
           I     YT   D+WS G  V ELM  G   + G        EI  +L    R        
Sbjct: 185 ILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP----ASEISSILEKGERLPQ----- 234

Query: 304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                              P     +   ++ +      + R   
Sbjct: 235 -------------------PPICTIDVYMIMVKCWMIDADSRPKF 260

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (332), Expect = 1e-36
 Identities = 55/286 (19%), Positives = 102/286 (35%), Gaps = 53/286 (18%)

Query: 76  ERIVGQGSFGVVFQAKC--LETGETVAIKKVLQDKRYKN------RELQTMRLLDHPNVV 127
           ++ +G G+FG V +      +  +TVA+K +  +            E   M+ LD+P +V
Sbjct: 12  DKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIV 71

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
            +        + +   L  V+E         +  + + N+ +    +    +Q+   + Y
Sbjct: 72  RMIGIC----EAESWML--VMEMAE---LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKY 122

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNIS----YICSRYYRAPE 243
           +  S    HRD+  +N+L+    H  K+ DFG +K L   E              + APE
Sbjct: 123 LEES-NFVHRDLAARNVLLVTQ-HYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPE 180

Query: 244 LIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN 302
            I    ++++  D+WS G ++ E    G+  + G  G +    + K              
Sbjct: 181 CINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG--------- 230

Query: 303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                               P   P E  DL++    Y    R   
Sbjct: 231 -------------------CPAGCPREMYDLMNLCWTYDVENRPGF 257

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  132 bits (334), Expect = 1e-36
 Identities = 52/287 (18%), Positives = 104/287 (36%), Gaps = 51/287 (17%)

Query: 76  ERIVGQGSFGVVFQAKCLE---TGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNVV 127
             ++G+G FG V+    L+        A+K + +            E   M+   HPNV+
Sbjct: 32  NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVL 91

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSY 187
           SL         + E    +VL Y+     R             +  +  +  Q+ + + +
Sbjct: 92  SLLGICL----RSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLIGFGLQVAKGMKF 145

Query: 188 IHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRY-----YRAP 242
           +       HRD+  +N +++     VK+ DFG A+ +   E +  +  +       + A 
Sbjct: 146 LASK-KFVHRDLAARNCMLDEK-FTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMAL 203

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           E +    ++TT  D+WS G ++ ELM  G P +P  +  D  V +++             
Sbjct: 204 ESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ------------- 249

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                              + P+  P    +++ +       +R + 
Sbjct: 250 ---------------GRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSF 281

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 3e-36
 Identities = 61/303 (20%), Positives = 107/303 (35%), Gaps = 65/303 (21%)

Query: 76  ERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQDKRYKN-----RELQTM-RLLDHP 124
            + +G G+FG V +A        +   TVA+K +              EL+ +  L +H 
Sbjct: 28  GKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHM 87

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVP---------------ETVHRVVKHFNKLNQRM 169
           N+V+L       T      +  + EY                                 +
Sbjct: 88  NIVNLLGAC---TIGGPTLV--ITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 170 PMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP 229
            +  +  ++YQ+ + ++++  S    HRD+  +N+L+       K+CDFG A+ +     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLA-SKNCIHRDLAARNILLTHGRIT-KICDFGLARDIKNDSN 200

Query: 230 NISYICSR---YYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVE 285
            +    +R    + APE IF    YT   D+WS G  + EL  LG   +PG     +  +
Sbjct: 201 YVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYK 259

Query: 286 IIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLR 345
           +IK                             +  + P+  P E  D++       P  R
Sbjct: 260 MIK---------------------------EGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292

Query: 346 CTA 348
            T 
Sbjct: 293 PTF 295

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  130 bits (329), Expect = 4e-36
 Identities = 60/281 (21%), Positives = 98/281 (34%), Gaps = 51/281 (18%)

Query: 80  GQGSFGVVFQAKCLETGE--TVAIKKVLQDKRYKN-----RELQTMRLLDHPNVVSLKHC 132
           G G+FG V Q       +   VAIK + Q     +     RE Q M  LD+P +V L   
Sbjct: 18  GCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGV 77

Query: 133 FFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSI 192
                      L LV+E          K      + +P+  V    +Q+   + Y+    
Sbjct: 78  C------QAEALMLVMEMAGGGPLH--KFLVGKREEIPVSNVAELLHQVSMGMKYLEEK- 128

Query: 193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSR----YYRAPELIFGA 248
              HRD+  +N+L+    +  K+ DFG +K L   +   +   +      + APE I   
Sbjct: 129 NFVHRDLAARNVLLVNRHY-AKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF- 186

Query: 249 TEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTE 307
            ++++  D+WS G  + E +  G+  +    G + +  I +                   
Sbjct: 187 RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME-------------- 232

Query: 308 FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                          P   PPE   L+S    Y    R   
Sbjct: 233 --------------CPPECPPELYALMSDCWIYKWEDRPDF 259

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (323), Expect = 2e-35
 Identities = 67/287 (23%), Positives = 104/287 (36%), Gaps = 50/287 (17%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGET---VAIKKVLQDKRYKN-----RELQTMRLLDHP 124
               R +G+G FG V Q   +        VAIK               +E  TMR  DHP
Sbjct: 9   IELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHP 68

Query: 125 NVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRA 184
           ++V L           E  + +++E       R           + +  + LYAYQ+  A
Sbjct: 69  HIVKLIGVI------TENPVWIIMELCTLGELR--SFLQVRKYSLDLASLILYAYQLSTA 120

Query: 185 LSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--SRYYRAP 242
           L+Y+       HRDI  +N+LV+ +   VKL DFG ++ +       +        + AP
Sbjct: 121 LAYLESK-RFVHRDIAARNVLVSSNDC-VKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 243 ELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM 301
           E I     +T+A D+W  G  + E+++ G   F G    D +  I      P        
Sbjct: 179 ESINF-RRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP-------- 229

Query: 302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                P   PP    L+++   Y P+ R   
Sbjct: 230 --------------------MPPNCPPTLYSLMTKCWAYDPSRRPRF 256

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  128 bits (322), Expect = 4e-35
 Identities = 58/307 (18%), Positives = 103/307 (33%), Gaps = 71/307 (23%)

Query: 77  RIVGQGSFGVVFQAKC-----LETGETVAIKKVLQDKRYKN-----RELQTMRLLDHPNV 126
           R +G+G+FG VFQA+       E    VA+K + ++          RE   M   D+PN+
Sbjct: 19  RDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNI 78

Query: 127 VSLKHCFFSTTDKDELYLNLVLEYVP---------------------ETVHRVVKHFNKL 165
           V              + L  + EY+                        +    +  +  
Sbjct: 79  V---KLLGVCAVGKPMCL--LFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPG 133

Query: 166 NQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV 225
              +        A Q+   ++Y+       HRD+  +N LV  +   VK+ DFG ++ + 
Sbjct: 134 PPPLSCAEQLCIARQVAAGMAYLS-ERKFVHRDLATRNCLVGENMV-VKIADFGLSRNIY 191

Query: 226 KGEPNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVD 281
             +      +      +  PE IF    YTT  D+W+ G V+ E+   G   + G +  +
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEE 250

Query: 282 QLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYS 341
            +  +               + N                  P+  P E  +L+       
Sbjct: 251 VIYYV--------------RDGNILA--------------CPENCPLELYNLMRLCWSKL 282

Query: 342 PNLRCTA 348
           P  R + 
Sbjct: 283 PADRPSF 289

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 8e-35
 Identities = 52/290 (17%), Positives = 96/290 (33%), Gaps = 50/290 (17%)

Query: 72  SYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQDKRYKN-----RELQTMRLLD 122
               ++++G G FG V++     +       VAIK +      K       E   M    
Sbjct: 8   CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS 67

Query: 123 HPNVVSLKHCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIF 182
           H N++ L+             + ++ EY+        K   + +    ++ +      I 
Sbjct: 68  HHNIIRLEGVIS-----KYKPMMIITEYMENGALD--KFLREKDGEFSVLQLVGMLRGIA 120

Query: 183 RALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC----SRY 238
             + Y+       HRD+  +N+LVN +    K+ DFG ++VL                  
Sbjct: 121 AGMKYLANM-NYVHRDLAARNILVNSNLV-CKVSDFGLSRVLEDDPEATYTTSGGKIPIR 178

Query: 239 YRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI 298
           + APE I    ++T+A D+WS G V+ E+M        +    ++++ I           
Sbjct: 179 WTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAIN---------- 227

Query: 299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                              +    P   P     L+ +  Q     R   
Sbjct: 228 -----------------DGFRLPTPMDCPSAIYQLMMQCWQQERARRPKF 260

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (319), Expect = 1e-34
 Identities = 57/294 (19%), Positives = 104/294 (35%), Gaps = 56/294 (19%)

Query: 76  ERIVGQGSFGVVFQAKCLETGE--TVAIKKV-----LQDKRYKNRELQTM-RLLDHPNVV 127
           + ++G+G+FG V +A+  + G     AIK++       D R    EL+ + +L  HPN++
Sbjct: 15  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 74

Query: 128 SLKHCFFSTTDKDELYLNLVLEYVP-------------ETVHRVVKHFNKLNQRMPMIYV 174
           +L             YL L +EY P                       N     +    +
Sbjct: 75  NLLGACEHRG-----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 175 KLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYI 234
             +A  + R + Y+       HRD+  +N+LV  + +  K+ DFG ++            
Sbjct: 130 LHFAADVARGMDYLS-QKQFIHRDLAARNILVGEN-YVAKIADFGLSRGQEVYVKKTMGR 187

Query: 235 CSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPT 294
               + A E +   + YTT  D+WS G ++ E++             +L E +       
Sbjct: 188 LPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP------ 240

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                        ++             P     E  DL+ +  +  P  R + 
Sbjct: 241 -----------QGYRLE----------KPLNCDDEVYDLMRQCWREKPYERPSF 273

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 8e-33
 Identities = 58/305 (19%), Positives = 109/305 (35%), Gaps = 64/305 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKCLETGE-------TVAIKKVLQDKRYKN-----RELQTM-R 119
            +  + +G+G+FG V  A+ +   +        VA+K +  D   K+      E++ M  
Sbjct: 15  LVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM 74

Query: 120 LLDHPNVVSLKHCFFSTTDKDELYLNLVLEYV-------------PETVHRVVKHFNKLN 166
           +  H N+++L       T    LY+  ++EY              P  +       +   
Sbjct: 75  IGKHKNIINLLGAC---TQDGPLYV--IVEYASKGNLREYLQARRPPGLEYSYNPSHNPE 129

Query: 167 QRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK 226
           +++    +   AYQ+ R + Y+  S    HRD+  +N+LV       K+ DFG A+ +  
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLA-SKKCIHRDLAARNVLVTEDNVM-KIADFGLARDIHH 187

Query: 227 GEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQL 283
            +      +      + APE +F    YT   D+WS G ++ E+            V++L
Sbjct: 188 IDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL 246

Query: 284 VEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPN 343
            +++K                                  P     E   ++       P+
Sbjct: 247 FKLLK---------------------------EGHRMDKPSNCTNELYMMMRDCWHAVPS 279

Query: 344 LRCTA 348
            R T 
Sbjct: 280 QRPTF 284

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 2e-31
 Identities = 58/304 (19%), Positives = 107/304 (35%), Gaps = 62/304 (20%)

Query: 73  YMAERIVGQGSFGVVFQAKC-----LETGETVAIKKVLQD------KRYKNRELQTMRLL 121
               + +G+G+FG V +A         T  TVA+K + +       +   +     + + 
Sbjct: 15  LKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 74

Query: 122 DHPNVVSLKHCFFSTTDKDELYLNLVLEYVP-------------ETVHRVVKHFNKLNQR 168
            H NVV+L              L +++E+               E V   V   +     
Sbjct: 75  HHLNVVNLLGACTKPGG----PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 169 MPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE 228
           + + ++  Y++Q+ + + ++  S    HRD+  +N+L++     VK+CDFG A+ + K  
Sbjct: 131 LTLEHLICYSFQVAKGMEFLA-SRKCIHRDLAARNILLSEKNV-VKICDFGLARDIYKDP 188

Query: 229 PNI---SYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLV 284
             +          + APE IF    YT   D+WS G ++ E+       +PG    ++  
Sbjct: 189 DYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFC 247

Query: 285 EIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNL 344
             +K                                  P    PE    +       P+ 
Sbjct: 248 RRLK---------------------------EGTRMRAPDYTTPEMYQTMLDCWHGEPSQ 280

Query: 345 RCTA 348
           R T 
Sbjct: 281 RPTF 284

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-29
 Identities = 55/294 (18%), Positives = 105/294 (35%), Gaps = 57/294 (19%)

Query: 76  ERIVGQGSFGVVFQAKC-----LETGETVAIKKV-----LQDKRYKNRELQTMRLLDHPN 125
            R +GQGSFG+V++         E    VAIK V     ++++     E   M+  +  +
Sbjct: 25  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 84

Query: 126 VVSLKHCFFSTTDKDELYLNLVLEYVPE-------TVHRVVKHFNKLNQRMPMIYVKLYA 178
           VV         +        +++E +            R     N +     +  +   A
Sbjct: 85  VV---RLLGVVSQGQPTL--VIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139

Query: 179 YQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYIC--- 235
            +I   ++Y++ +    HRD+  +N +V      VK+ DFG  + + + +          
Sbjct: 140 GEIADGMAYLNAN-KFVHRDLAARNCMVAEDFT-VKIGDFGMTRDIYETDYYRKGGKGLL 197

Query: 236 SRYYRAPELIFGATEYTTAIDIWSAGCVVAELM-LGKPLFPGDSGVDQLVEIIKVLGTPT 294
              + +PE +     +TT  D+WS G V+ E+  L +  + G S    L  +++      
Sbjct: 198 PVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME------ 250

Query: 295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTA 348
                                       P   P    +L+    QY+P +R + 
Sbjct: 251 ----------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSF 282

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 82.1 bits (202), Expect = 4e-19
 Identities = 30/205 (14%), Positives = 58/205 (28%), Gaps = 34/205 (16%)

Query: 77  RIVGQGSFGVVFQAKCLETGETVAIKKV--------------LQDKRYKNRELQTMRLLD 122
           +++G+G    VF     E      +K                     + +         +
Sbjct: 6   KLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 123 HPNVVSLKHCFFSTT-DKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQI 181
              +  L+          +   +  ++E              K   R+ +         I
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAV--LMEL----------IDAKELYRVRVENPDEVLDMI 112

Query: 182 FRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPNISYICSRYYRA 241
              ++  +    + H D+   N+LV      + + DF  +  +  GE     I  R  R 
Sbjct: 113 LEEVAKFYHRG-IVHGDLSQYNVLV--SEEGIWIIDFPQSVEV--GEEGWREILERDVRN 167

Query: 242 PELIFGATEYTTAIDIWSAGCVVAE 266
               F    Y T  DI SA   + +
Sbjct: 168 IITYFS-RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	371
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.92
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.37
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.1
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.99
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.13
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.05
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.88

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-59  Score=433.40  Aligned_cols=283  Identities=69%  Similarity=1.201  Sum_probs=256.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCceeEEEeec
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELYLNLVLE  149 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~~~lv~e  149 (371)
                      .+|+..++||+|+||+||+|++..+|+.||||++..+.....+|+++|++++||||++++++|..... .+..++++|||
T Consensus        20 ~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~E   99 (350)
T d1q5ka_          20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLD   99 (350)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEE
T ss_pred             CCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEe
Confidence            36999999999999999999999999999999998887777899999999999999999999876543 45677899999


Q ss_pred             cccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCCC
Q 017452          150 YVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGEP  229 (371)
Q Consensus       150 ~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~  229 (371)
                      ||++++...+.........+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||++........
T Consensus       100 y~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~-~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         100 YVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF-GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             CCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             ccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc-CCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            999988777777666678899999999999999999999986 9999999999999998876899999999988776666


Q ss_pred             cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccc
Q 017452          230 NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFK  309 (371)
Q Consensus       230 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  309 (371)
                      .....||+.|+|||.+.+...++.++|||||||++|||++|+.||...+..+.+..+.+..|.+..+.+......+....
T Consensus       179 ~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~  258 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK  258 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCC
T ss_pred             cccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhcc
Confidence            67788999999999988777789999999999999999999999999999999999999999999999998888888888


Q ss_pred             cCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          310 FPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       310 ~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ++.....+|.......+++++.+||.+||++||.+||||.|+|+|
T Consensus       259 ~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         259 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             CCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            888888888888888899999999999999999999999999888

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-59  Score=408.89  Aligned_cols=243  Identities=30%  Similarity=0.455  Sum_probs=207.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||+|++.+.       .....+|+.+++.++|||||++++++.     +..
T Consensus         5 l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~-----~~~   79 (263)
T d2j4za1           5 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH-----DAT   79 (263)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEE-----CSS
T ss_pred             hhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEE-----ECC
Confidence            45799999999999999999999999999999998542       234568999999999999999999983     445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++|||||++ +|.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        80 ~~~ivmEy~~~g~L~~~l~~----~~~l~e~~~~~i~~qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~~kl~DFG~a  153 (263)
T d2j4za1          80 RVYLILEYAPLGTVYRELQK----LSKFDEQRTATYITELANALSYCHSK-RVIHRDIKPENLLLGSAG-ELKIADFGWS  153 (263)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEECCCCSC
T ss_pred             EEEEEEeecCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHC-CeeeeeeccccceecCCC-CEeeccccee
Confidence            58999999984 77777764    46799999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      +..... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..           
T Consensus       154 ~~~~~~-~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~-----------  220 (263)
T d2j4za1         154 VHAPSS-RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE-----------  220 (263)
T ss_dssp             SCCCCC-CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTC-----------
T ss_pred             eecCCC-cccccCCCCcccCHHHHcCCC-CCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-----------
Confidence            866443 344678999999999997654 7999999999999999999999998877666655544310           


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ..+|..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       221 ------------------~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         221 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             ------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHcC
Confidence                              01456689999999999999999999999996554

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-58  Score=411.61  Aligned_cols=245  Identities=27%  Similarity=0.406  Sum_probs=207.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      .+|++.+.||+|+||+||+|++..+|+.||||++...    .....+|+++++.++|||||++++++..     ..++|+
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~i   94 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV-----GDELWV   94 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE-----CCEEEE
Confidence            3799999999999999999999999999999998643    3446789999999999999999999854     345889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      |||||+| +|.+++.     ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        95 vmEy~~gg~L~~~~~-----~~~l~~~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~vkl~DFG~a~~~~  167 (293)
T d1yhwa1          95 VMEYLAGGSLTDVVT-----ETCMDEGQIAAVCRECLQALEFLHSN-QVIHRDIKSDNILLGMDG-SVKLTDFGFCAQIT  167 (293)
T ss_dssp             EEECCTTCBHHHHHH-----HSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEecCCCcHHHHhh-----ccCCCHHHHHHHHHHHHHHHHHHHHC-CCcccCCcHHHeEECCCC-cEeeccchhheeec
Confidence            9999985 6665543     35799999999999999999999987 999999999999999888 89999999998765


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+..... +.          
T Consensus       168 ~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~----------  235 (293)
T d1yhwa1         168 PEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PE----------  235 (293)
T ss_dssp             STTCCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS-CC----------
T ss_pred             cccccccccccCCCccChhhhcCCC-CCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC-CC----------
Confidence            433 345667999999999997654 79999999999999999999999988887776666554311 10          


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                     -..+..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       236 ---------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         236 ---------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             ---------------CSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTC
T ss_pred             ---------------CCCcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                           01234589999999999999999999999998877

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-59  Score=411.90  Aligned_cols=248  Identities=25%  Similarity=0.317  Sum_probs=202.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...     ...+.+|++++++++|||||++++++..     ...+
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~-----~~~~   78 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRRE-----GNIQ   78 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----Ccee
Confidence            46799999999999999999999999999999998543     2346789999999999999999999854     3458


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||||++| +|.+.+.    ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+.
T Consensus        79 ~ivmEy~~gg~L~~~l~----~~~~l~e~~~~~i~~qi~~al~ylH~~-~IiHrDiKp~NILl~~~~-~~KL~DFG~a~~  152 (271)
T d1nvra_          79 YLFLEYCSGGELFDRIE----PDIGMPEPDAQRFFHQLMAGVVYLHGI-GITHRDIKPENLLLDERD-NLKISDFGLATV  152 (271)
T ss_dssp             EEEEECCTTEEGGGGSB----TTTBCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECTTC-CEEECCCTTCEE
T ss_pred             EEEEeccCCCcHHHHHh----cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCccCcccHHHEEECCCC-CEEEccchhhee
Confidence            899999985 6665543    256899999999999999999999987 999999999999999888 899999999987


Q ss_pred             cccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          224 LVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       224 ~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      .....   .....+||+.|||||++.+...++.++|||||||++|+|++|+.||...................       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~-------  225 (271)
T d1nvra_         153 FRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY-------  225 (271)
T ss_dssp             CEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-------
T ss_pred             eccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCC-------
Confidence            64332   23456899999999999877656788999999999999999999997765433332222211000       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                    ..     .+..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       226 --------------~~-----~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         226 --------------LN-----PWKKIDSAPLALLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             --------------ST-----TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTC
T ss_pred             --------------CC-----ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence                          00     123478999999999999999999999995543

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-58  Score=412.74  Aligned_cols=254  Identities=31%  Similarity=0.496  Sum_probs=212.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      ++|++++.||+|+||+||+|++..+|+.||||++.+.       .....+|++++++++||||+++++++     .+...
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~-----~~~~~   82 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTF-----QDDEK   82 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEE-----ECSSE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEE-----EECCE
Confidence            5799999999999999999999999999999998642       23456899999999999999999988     34456


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|+||||++| +|.+++..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        83 ~~ivmEy~~gg~L~~~~~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~NIll~~~~-~vkl~DFG~a~  156 (288)
T d1uu3a_          83 LYFGLSYAKNGELLKYIRK----IGSFDETCTRFYTAEIVSALEYLHGK-GIIHRDLKPENILLNEDM-HIQITDFGTAK  156 (288)
T ss_dssp             EEEEECCCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCE
T ss_pred             EEEEEEccCCCCHHHhhhc----cCCCCHHHHHHHHHHHHHHHHhhccc-cEEcCcCCccccccCCCc-eEEecccccce
Confidence            8999999985 77776654    57899999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ......   ......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..         
T Consensus       157 ~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~---------  226 (288)
T d1uu3a_         157 VLSPESKQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLE---------  226 (288)
T ss_dssp             ECC----------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTC---------
T ss_pred             ecccCCcccccccccCCccccCceeeccCC-CCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCC---------
Confidence            764332   233567999999999997655 7999999999999999999999999887766666554310         


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                                          -.+|..+|+++.+||.+||+.||.+|||++|+++|.      .+..||||++
T Consensus       227 --------------------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~------~i~~Hpff~~  272 (288)
T d1uu3a_         227 --------------------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYG------PLKAHPFFES  272 (288)
T ss_dssp             --------------------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHH------HHHTSGGGTT
T ss_pred             --------------------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCH------HHHcCCccCC
Confidence                                014567899999999999999999999999986652      2456788763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-58  Score=404.81  Aligned_cols=251  Identities=26%  Similarity=0.367  Sum_probs=201.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||+||+|+++.+|+.||+|++....      ..+.+|++++++++|||||++++++..   .....
T Consensus         3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~---~~~~~   79 (269)
T d2java1           3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIID---RTNTT   79 (269)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC-------C
T ss_pred             chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEe---CCCCE
Confidence            357999999999999999999999999999999985432      335679999999999999999998853   22344


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC-----cEeeccCCCceeeeCCCCcEEEEe
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG-----VCHRDIKPQNLLVNPHTHQVKLCD  217 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-----ivH~dlkp~NIli~~~~~~~kl~D  217 (371)
                      +|+|||||+ |+|.+++.........+++..++.++.||+.||+|||++ |     |+||||||+|||++.++ .+||+|
T Consensus        80 ~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~-~~~~~~IiHrDiKp~NIll~~~~-~vkl~D  157 (269)
T d2java1          80 LYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR-SDGGHTVLHRDLKPANVFLDGKQ-NVKLGD  157 (269)
T ss_dssp             EEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHH-CC---------CCGGGEEECTTS-CEEECC
T ss_pred             EEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHh-cCCCCCEEeCcCchhhcCcCCCC-cEEEee
Confidence            789999998 588888877666678899999999999999999999986 5     99999999999999988 899999


Q ss_pred             eCCccccccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          218 FGSAKVLVKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       218 fg~a~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      ||+|+...... ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+....+.....     
T Consensus       158 FG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~-----  231 (269)
T d2java1         158 FGLARILNHDTSFAKAFVGTPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF-----  231 (269)
T ss_dssp             HHHHHHC-----------CCCSCCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCC-----
T ss_pred             ccceeecccCCCccccCCCCcccCCHHHHcCCC-CChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            99998765433 234578899999999996554 89999999999999999999999988777666555544210     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             ..++..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       232 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         232 -----------------------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             -----------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------------------CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence                                   01456689999999999999999999999997665

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-57  Score=399.86  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=204.4

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      |++.++||+|+||+||+|.+..+++.||+|++...      ...+.+|++++++++|||||++++++.... .....+++
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~-~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTV-KGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEES-SSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeecc-ccCCEEEE
Confidence            47888999999999999999999999999998543      234568999999999999999999886543 34566889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCC--cEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIG--VCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~--ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ||||+++ +|.+.+..    ...+++..++.++.||+.||+|||++ +  |+||||||+|||++.+.+.+||+|||+|+.
T Consensus        90 vmE~~~~g~L~~~l~~----~~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~  164 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKR----FKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL  164 (270)
T ss_dssp             EEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred             EEeCCCCCcHHHHHhc----cccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCccee
Confidence            9999985 77777754    46799999999999999999999986 7  999999999999975333899999999976


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ... .......||+.|+|||++.+  .++.++|||||||++|+|++|+.||........+...+.. +..+.        
T Consensus       165 ~~~-~~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~-~~~~~--------  232 (270)
T d1t4ha_         165 KRA-SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTS-GVKPA--------  232 (270)
T ss_dssp             CCT-TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTT-TCCCG--------
T ss_pred             ccC-CccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHc-CCCCc--------
Confidence            432 33446789999999999854  3899999999999999999999999876655544333221 11110        


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhcccccc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFR  370 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~  370 (371)
                                       .++...++++.+||.+||++||.+|||+.|            ++.|||||
T Consensus       233 -----------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~e------------ll~Hp~fk  270 (270)
T d1t4ha_         233 -----------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKD------------LLNHAFFQ  270 (270)
T ss_dssp             -----------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHH------------HHTSGGGC
T ss_pred             -----------------ccCccCCHHHHHHHHHHccCCHhHCcCHHH------------HhCCcccC
Confidence                             133457899999999999999999999999            56667775

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=7.5e-58  Score=412.14  Aligned_cols=247  Identities=24%  Similarity=0.385  Sum_probs=194.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ++|++.+.||+|+||+||+|+++.+|+.||||++...     .....+|+.+++.++|||||++++++     .+..++|
T Consensus         9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~-----~~~~~~~   83 (307)
T d1a06a_           9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY-----ESGGHLY   83 (307)
T ss_dssp             GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE-----ECSSEEE
T ss_pred             cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            4699999999999999999999999999999998643     23345799999999999999999988     4455689


Q ss_pred             Eeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC---CCCcEEEEeeCCc
Q 017452          146 LVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP---HTHQVKLCDFGSA  221 (371)
Q Consensus       146 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~---~~~~~kl~Dfg~a  221 (371)
                      +|||||+ |+|.+.+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||+..   ++ .+||+|||+|
T Consensus        84 lvmE~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~al~ylH~~-~iiHrDiKp~Nil~~~~~~~~-~vkl~DFG~a  157 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVE----KGFYTERDASRLIFQVLDAVKYLHDL-GIVHRDLKPENLLYYSLDEDS-KIMISDFGLS  157 (307)
T ss_dssp             EEECCCCSCBHHHHHHT----CSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEESSSSTTC-CEEECCC---
T ss_pred             EEEeccCCCcHHHhhhc----ccCCCHHHHHHHHHHHHHHHHhhhhc-eeeeEEecccceeecccCCCc-eEEEecccee
Confidence            9999998 588877754    57899999999999999999999987 9999999999999953   44 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      +...........+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+....+....+.+.....+       
T Consensus       158 ~~~~~~~~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------  229 (307)
T d1a06a_         158 KMEDPGSVLSTACGTPGYVAPEVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFD-------  229 (307)
T ss_dssp             ---------------CTTSCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCC-------
T ss_pred             EEccCCCeeeeeeeCccccCcHHHcCCC-CCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCC-------
Confidence            8876666666788999999999997654 89999999999999999999999998877666666554211111       


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ...+..+|+++.+||.+||++||.+|||+.|+++|
T Consensus       230 ------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         230 ------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             ------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             ------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                              11335689999999999999999999999998887

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-57  Score=409.11  Aligned_cols=269  Identities=33%  Similarity=0.593  Sum_probs=220.5

Q ss_pred             eeEeeccCCceEEEEEEECCCCcEEEEEEeecch---------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           75 AERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        75 ~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..+.||+|+||+||+|++..+|+.||||++....         ....+|+.+++.++|||||++++++     ....++|
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~-----~~~~~~~   76 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAF-----GHKSNIS   76 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEE-----CCTTCCE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeee-----ccCCcee
Confidence            4578999999999999999999999999985431         3456899999999999999999998     4444588


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +||||+.+++...+.   .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        77 ivmE~~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~-~iiHrDiKp~NIli~~~~-~~KL~DFG~a~~~~  151 (299)
T d1ua2a_          77 LVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQH-WILHRDLKPNNLLLDENG-VLKLADFGLAKSFG  151 (299)
T ss_dssp             EEEECCSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCCGGGSTTT
T ss_pred             ehhhhhcchHHhhhh---hcccCCCHHHHHHHHHHHHHHHHHhhcc-ceecccCCcceEEecCCC-ccccccCccccccC
Confidence            999999987554443   3357799999999999999999999987 999999999999999888 89999999998764


Q ss_pred             cCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ... .....+||+.|+|||++.....++.++|||||||++|+|++|..||.+.+..+.+..+.+..+.+..+.+......
T Consensus       152 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~  231 (299)
T d1ua2a_         152 SPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL  231 (299)
T ss_dssp             SCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSS
T ss_pred             CCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhcc
Confidence            433 3345678999999999977666899999999999999999999999999999999999999999888766544333


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....+......++... ...+++++.+||.+||+.||++||||.|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~-~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         232 PDYVTFKSFPGIPLHHI-FSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             TTCCCCCCCCCCCHHHH-CTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             chhhhhccCCCCChHHh-cccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence            22233333322233222 23578999999999999999999999998777

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-57  Score=404.68  Aligned_cols=249  Identities=24%  Similarity=0.362  Sum_probs=213.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----------hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.          ...+.+|+.+|+.++|||||++++++     .
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~   83 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVY-----E   83 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEE-----E
T ss_pred             ccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEE-----E
Confidence            45799999999999999999999999999999998542          23457899999999999999999998     4


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC---cEEE
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH---QVKL  215 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~---~~kl  215 (371)
                      +...+|+|||||+ |+|.+++..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++.   .+||
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~----~~~l~~~~~~~~~~qi~~al~yLH~~-~ivHrDiKp~Nill~~~~~~~~~vkl  158 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAE----KESLTEEEATEFLKQILNGVYYLHSL-QIAHFDLKPENIMLLDRNVPKPRIKI  158 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSSSSCCEEE
T ss_pred             ECCEEEEEEEcCCCccccchhcc----ccccchhHHHHHHHHHHHHHHhhhhc-ceeecccccceEEEecCCCcccceEe
Confidence            4556899999998 588777764    46899999999999999999999987 9999999999999987653   5999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +|||+|.............||+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+.+..+.+.....+.
T Consensus       159 ~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~  237 (293)
T d1jksa_         159 IDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYE-PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED  237 (293)
T ss_dssp             CCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCH
T ss_pred             cchhhhhhcCCCccccccCCCCcccCHHHHcCC-CCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCc
Confidence            999999887766666778899999999999664 4799999999999999999999999988877776666543222221


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .                         .+..+|+++.+||.+||+.||.+|||+.++++|
T Consensus       238 ~-------------------------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         238 E-------------------------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             H-------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             h-------------------------hcCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1                         234579999999999999999999999998877

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=403.42  Aligned_cols=248  Identities=25%  Similarity=0.360  Sum_probs=207.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      +.|++.+.||+|+||.||+|++..+|+.||+|++...    .....+|+++++.++|||||++++++..     ...+++
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~-----~~~~~l   86 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY-----ENNLWI   86 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE-----TTEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee-----CCeEEE
Confidence            4699999999999999999999999999999998543    3456789999999999999999999854     344889


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      |||||++ +|..++...   .+.+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        87 vmEy~~~g~L~~~~~~~---~~~l~e~~~~~i~~qi~~gL~ylH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFG~a~~~~  161 (288)
T d2jfla1          87 LIEFCAGGAVDAVMLEL---ERPLTESQIQVVCKQTLDALNYLHDN-KIIHRDLKAGNILFTLDG-DIKLADFGVSAKNT  161 (288)
T ss_dssp             EEECCTTEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTCEECH
T ss_pred             EEecCCCCcHHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHC-CEEEeecChhheeECCCC-CEEEEechhhhccC
Confidence            9999985 666655432   46799999999999999999999987 999999999999999988 89999999997653


Q ss_pred             cCC-CcccccccccccCcccccC----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          226 KGE-PNISYICSRYYRAPELIFG----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       226 ~~~-~~~~~~~t~~y~aPE~~~~----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      ... ......||+.|+|||++..    ...++.++|||||||++|+|++|+.||.+.+..+.+..+.+.....       
T Consensus       162 ~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-------  234 (288)
T d2jfla1         162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-------  234 (288)
T ss_dssp             HHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-------
T ss_pred             CCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-------
Confidence            321 2235678999999999842    3347899999999999999999999999888877776665521100       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         -..+..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       235 -------------------~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         235 -------------------LAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             -------------------CSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             -------------------CCccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                               00234579999999999999999999999998877

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-56  Score=402.13  Aligned_cols=278  Identities=33%  Similarity=0.537  Sum_probs=227.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCC-CcEEEEEEeecc------hhhhHHHHHHHHHc---CCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLET-GETVAIKKVLQD------KRYKNRELQTMRLL---DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~-~~~vaiK~~~~~------~~~~~~e~~~l~~l---~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++++.||+|+||+||+|++..+ ++.||||++...      .....+|+.+++.+   +||||+++++++......
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~   85 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD   85 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred             cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence            46899999999999999999999765 677999998542      23445788887766   799999999998776666


Q ss_pred             CceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          140 DELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       140 ~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      ...+++++|||+++++......  .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||
T Consensus        86 ~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~-~ivHrDiKp~NILi~~~~-~~kl~dfg  161 (305)
T d1blxa_          86 RETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSH-RVVHRDLKPQNILVTSSG-QIKLADFG  161 (305)
T ss_dssp             SEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECSCC
T ss_pred             cCceEEEEEEeccCCchhhhhh--ccCCCCCHHHHHHHHHHHHHHHHHHHhC-CEEecCCCccEEEEcCCC-Ceeecchh
Confidence            6788999999999876555443  3356799999999999999999999987 999999999999999888 89999999


Q ss_pred             CccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHh
Q 017452          220 SAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIK  299 (371)
Q Consensus       220 ~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  299 (371)
                      ++.............||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.
T Consensus       162 ~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~-y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (305)
T d1blxa_         162 LARIYSFQMALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  240 (305)
T ss_dssp             SCCCCCGGGGGCCCCCCCTTCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSC
T ss_pred             hhhhhcccccCCCcccChhhcCcchhcCCC-CChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccc
Confidence            998766655666788999999999997655 8999999999999999999999999999999999999999988877665


Q ss_pred             hcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          300 CMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....... ..+......++ ..+...+++.+.+||.+||++||.+||||.|+|+|
T Consensus       241 ~~~~~~~-~~~~~~~~~~~-~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         241 RDVALPR-QAFHSKSAQPI-EKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             TTCSSCG-GGSCCCCCCCG-GGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccchh-hhhccccccch-hhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            3221111 11111111121 22456789999999999999999999999996655

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.6e-57  Score=414.15  Aligned_cols=250  Identities=25%  Similarity=0.353  Sum_probs=211.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++.+.||+|+||.||+|++..+|+.||||++...    ...+.+|+.+|+.++|||||+++++|     .+...+|
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~-----~~~~~~~  102 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAF-----EDKYEMV  102 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEE-----ECSSEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEE-----EECCEEE
Confidence            45799999999999999999999999999999998654    23456899999999999999999998     4455689


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC-CCCcEEEEeeCCccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP-HTHQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~-~~~~~kl~Dfg~a~~  223 (371)
                      +|||||+| +|.+.+.   ....++++..++.++.||+.||+|||++ ||+||||||+|||++. +.+.+||+|||+|..
T Consensus       103 ivmE~~~gg~L~~~~~---~~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~  178 (352)
T d1koba_         103 LILEFLSGGELFDRIA---AEDYKMSEAEVINYMRQACEGLKHMHEH-SIVHLDIKPENIMCETKKASSVKIIDFGLATK  178 (352)
T ss_dssp             EEEECCCCCBHHHHTT---CTTCCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTCCCEEECCCTTCEE
T ss_pred             EEEEcCCCChHHHHHH---hcCCCCCHHHHHHHHHHHHHHHHHHHHC-CeeecccccccccccccCCCeEEEeeccccee
Confidence            99999995 6554433   3345799999999999999999999986 9999999999999973 223899999999998


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+....++         
T Consensus       179 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  248 (352)
T d1koba_         179 LNPDEIVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFD---------  248 (352)
T ss_dssp             CCTTSCEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCC---------
T ss_pred             cCCCCceeeccCcccccCHHHHcCCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---------
Confidence            87766666788999999999997654 89999999999999999999999998888777777665322111         


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                      ...+..+|+++.+||.+||++||.+|||+.|+|+|
T Consensus       249 ----------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         249 ----------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             ----------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             ----------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                            11335689999999999999999999999998887

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-56  Score=404.04  Aligned_cols=274  Identities=34%  Similarity=0.604  Sum_probs=222.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||+|+||+||+|.+..+|+.||||++...      .....+|++++++++|||||++++++..     ...+
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~-----~~~~   76 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHT-----ENKL   76 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccccc-----ccce
Confidence            4799999999999999999999999999999998543      3445689999999999999999999954     3458


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+||||+.+++...+...  ....+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||.|+..
T Consensus        77 ~iv~e~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~-~IiHrDiKpeNIl~~~~~-~~kl~DFG~a~~~  152 (298)
T d1gz8a_          77 YLVFEFLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSH-RVLHRDLKPQNLLINTEG-AIKLADFGLARAF  152 (298)
T ss_dssp             EEEEECCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECSTTHHHHH
T ss_pred             eEEEeecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcC-CEEccccCchheeecccC-cceeccCCcceec
Confidence            999999998876665442  356799999999999999999999987 999999999999999888 8999999999876


Q ss_pred             ccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ... .......||+.|+|||.+.....++.++|+|||||++|+|++|+.||.+.+..+.+..+.+..+.+....+.....
T Consensus       153 ~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  232 (298)
T d1gz8a_         153 GVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTS  232 (298)
T ss_dssp             CCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             cCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccc
Confidence            443 3344568899999999987777778999999999999999999999999998888999998888877665442211


Q ss_pred             Ccc-ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYT-EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ... ...++......+.. ....+|+++.+||.+||.+||++|||+.|+++|
T Consensus       233 ~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         233 MPDYKPSFPKWARQDFSK-VVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             STTCCTTSCCCCCCCHHH-HSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchhh-hccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            000 00111111111111 123578999999999999999999999998877

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=9.1e-57  Score=411.84  Aligned_cols=250  Identities=24%  Similarity=0.355  Sum_probs=212.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .++|++++.||+|+||.||+|++..+|+.||||++...    ...+.+|+.+|+.++|||||++++++..     ...+|
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~-----~~~~~   99 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFED-----DNEMV   99 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEE-----TTEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEE-----CCEEE
Confidence            45799999999999999999999999999999998653    2345689999999999999999999843     34589


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC-CCcEEEEeeCCccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH-THQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~-~~~~kl~Dfg~a~~  223 (371)
                      +|||||+| +|.+.+..   ....+++..++.++.||+.||+|||++ |||||||||+|||++.+ .+.+||+|||+|+.
T Consensus       100 ivmE~~~gg~L~~~l~~---~~~~l~e~~~~~i~~qi~~aL~ylH~~-~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~  175 (350)
T d1koaa2         100 MIYEFMSGGELFEKVAD---EHNKMSEDEAVEYMRQVCKGLCHMHEN-NYVHLDLKPENIMFTTKRSNELKLIDFGLTAH  175 (350)
T ss_dssp             EEECCCCSCBHHHHHTC---TTSCBCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHh---hcCCCCHHHHHHHHHHHHHHHHHHHhc-CCeeeeechhHeeeccCCCCeEEEeecchhee
Confidence            99999985 77666532   246799999999999999999999987 99999999999999643 23899999999998


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|||||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.......+..       
T Consensus       176 ~~~~~~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-------  247 (350)
T d1koaa2         176 LDPKQSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDS-------  247 (350)
T ss_dssp             CCTTSCEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCG-------
T ss_pred             cccccccceecCcccccCHHHHcCCC-CChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc-------
Confidence            77666666788999999999997655 7899999999999999999999999888777777776542222111       


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                        ....+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       248 ------------------~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         248 ------------------AFSGISEDGKDFIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             ------------------GGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred             ------------------cccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                              123479999999999999999999999999888

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-57  Score=411.26  Aligned_cols=273  Identities=25%  Similarity=0.398  Sum_probs=202.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .++|++.+.||+|+||+||+|++..+|+.||+|++...     .....+|+.+|+.++|||||+++++|.     +...+
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~-----~~~~~   79 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY-----SDGEI   79 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEE-----CSSEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEE-----ECCEE
Confidence            46899999999999999999999999999999998643     234568999999999999999999984     34458


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||||+.| +|.+++..    .+.+++..++.++.||+.||.|||++.||+||||||+|||++.++ .+||+|||+|+.
T Consensus        80 ~iVmEy~~gg~L~~~l~~----~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~-~vkl~DFGla~~  154 (322)
T d1s9ja_          80 SICMEHMDGGSLDQVLKK----AGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRG-EIKLCDFGVSGQ  154 (322)
T ss_dssp             EEEEECCTTEEHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTC-CEEECCCCCCHH
T ss_pred             EEEEEcCCCCcHHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCC-CEEEeeCCCccc
Confidence            999999995 78777764    467999999999999999999999633899999999999999988 899999999987


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHH-HHHHHhCCCCHhHHhhcC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLV-EIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  302 (371)
                      ..+. ...+.+||+.|+|||++.+.. ++.++||||+||++|||++|+.||.+.+..+... ......+...........
T Consensus       155 ~~~~-~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (322)
T d1s9ja_         155 LIDS-MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT  232 (322)
T ss_dssp             HHHH-TC---CCSSCCCCHHHHHCSC-CCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC-----------------
T ss_pred             cCCC-ccccccCCccccCchHHcCCC-CCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCccccc
Confidence            6443 234578999999999998765 8999999999999999999999998765443221 111111111110000000


Q ss_pred             -------------CCcccc-ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 -------------PNYTEF-KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 -------------~~~~~~-~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                   +..... ....+............+|.++.+||.+||.+||.+|||+.|+|+|
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         233 PGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             -------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                         000000 0000001111111223468999999999999999999999997776

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.7e-56  Score=403.42  Aligned_cols=243  Identities=27%  Similarity=0.420  Sum_probs=204.3

Q ss_pred             ceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           72 SYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        72 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      .|++.+.||+|+||+||+|++..+|+.||||++....       ..+.+|+.+++.++|||||++++++..     ...+
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~   90 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLR-----EHTA   90 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE-----TTEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEE-----CCEE
Confidence            5999999999999999999999999999999986432       235679999999999999999999854     3448


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      |+|||||.+++...+..   ....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|...
T Consensus        91 ~iv~E~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHrDiKp~NILl~~~~-~~Kl~DFG~a~~~  165 (309)
T d1u5ra_          91 WLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSH-NMIHRDVKAGNILLSEPG-LVKLGDFGSASIM  165 (309)
T ss_dssp             EEEEECCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCSGGGEEEETTT-EEEECCCTTCBSS
T ss_pred             EEEEEecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhC-CEeccCCCcceEEECCCC-CEEEeeccccccc
Confidence            99999999765444332   257899999999999999999999987 999999999999999888 8999999999865


Q ss_pred             ccCCCcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGEPNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ..   .....||+.|||||++.+.  ..++.++|||||||++|+|++|..||.+.+..+.+..+......          
T Consensus       166 ~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~----------  232 (309)
T d1u5ra_         166 AP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESP----------  232 (309)
T ss_dssp             SS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC----------
T ss_pred             CC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCC----------
Confidence            33   3456899999999998642  34788999999999999999999999888777666655542110          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                       ...+..+|+++.+||.+||+.||.+|||+.++++|
T Consensus       233 -----------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         233 -----------------ALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             -----------------CCSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhC
Confidence                             01234579999999999999999999999999887

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-56  Score=404.64  Aligned_cols=244  Identities=26%  Similarity=0.401  Sum_probs=210.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++++.||+|+||.||+|++..+|+.||||++.+.       .....+|+.+|+.++||||+++++++     .+..
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~-----~~~~   78 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF-----QTHD   78 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEE-----ECSS
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeee-----cccc
Confidence            35799999999999999999999999999999998643       23456899999999999999999998     4455


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      ++|+|||||+| +|...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        79 ~~~iv~ey~~gg~L~~~~~~----~~~~~e~~~~~~~~qil~al~ylH~~-~iiHRDlKP~NILl~~~g-~vkl~DFG~a  152 (337)
T d1o6la_          79 RLCFVMEYANGGELFFHLSR----ERVFTEERARFYGAEIVSALEYLHSR-DVVYRDIKLENLMLDKDG-HIKITDFGLC  152 (337)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccceeccCCCchhhhhhc----ccCCcHHHHHHHHHHHhhhhhhhhhc-CccccccCHHHeEecCCC-CEEEeecccc
Confidence            68999999995 66666554    57899999999999999999999987 999999999999999998 8999999999


Q ss_pred             ccccc-CCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLVK-GEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +.... .......+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+....+....  +       
T Consensus       153 ~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~--~-------  222 (337)
T d1o6la_         153 KEGISDGATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE--I-------  222 (337)
T ss_dssp             BCSCCTTCCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC--C-------
T ss_pred             cccccCCcccccceeCHHHhhhhhccCCC-CChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCC--C-------
Confidence            87543 34445678999999999997665 7999999999999999999999999888766665554420  0       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                          .+|..+|+++.+||.+||++||.+|++     +.++++|
T Consensus       223 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         223 --------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             --------------------CCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcC
Confidence                                156678999999999999999999994     8998888

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-55  Score=390.94  Aligned_cols=247  Identities=24%  Similarity=0.348  Sum_probs=209.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------------hhhHHHHHHHHHcC-CCCeeecceeEEec
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------------RYKNRELQTMRLLD-HPNVVSLKHCFFST  136 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------------~~~~~e~~~l~~l~-h~niv~~~~~~~~~  136 (371)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..             ....+|+.++++++ ||||+++++++   
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~---   79 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY---   79 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE---
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeec---
Confidence            57999999999999999999999999999999985431             23457999999997 99999999998   


Q ss_pred             CCCCceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          137 TDKDELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       137 ~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                        .+..++||||||++ |+|.+++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||
T Consensus        80 --~~~~~~~ivmE~~~~g~L~~~l~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~ivHrDlkp~Nill~~~~-~~kl  151 (277)
T d1phka_          80 --ETNTFFFLVFDLMKKGELFDYLTE----KVTLSEKETRKIMRALLEVICALHKL-NIVHRDLKPENILLDDDM-NIKL  151 (277)
T ss_dssp             --ECSSEEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTC-CEEE
T ss_pred             --ccCcceEEEEEcCCCchHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHc-CCcccccccceEEEcCCC-CeEE
Confidence              44556899999998 488888764    56899999999999999999999987 999999999999999888 8999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccC-----CcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFG-----ATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVL  290 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~  290 (371)
                      +|||+++....+.......||+.|+|||.+.+     ...++.++||||+||++|+|++|+.||.+.+..+....+.+..
T Consensus       152 ~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~  231 (277)
T d1phka_         152 TDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN  231 (277)
T ss_dssp             CCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTC
T ss_pred             ccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCC
Confidence            99999998776666667889999999999852     3346889999999999999999999999888777666665531


Q ss_pred             CCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhh
Q 017452          291 GTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRI  353 (371)
Q Consensus       291 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~  353 (371)
                      ...+.                         .....+|+++.+||.+||++||.+|||+.|+++
T Consensus       232 ~~~~~-------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         232 YQFGS-------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             CCCCT-------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             CCCCC-------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            11110                         012358999999999999999999999999543

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.4e-55  Score=398.80  Aligned_cols=241  Identities=25%  Similarity=0.451  Sum_probs=206.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .+|++++.||+|+||+||+|+++.+|+.||||++.+.       .....+|+.+++.++|||||++++++     .+...
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~-----~~~~~   78 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-----QDAQQ   78 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEE-----ECSSE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeE-----eeCCe
Confidence            5799999999999999999999999999999998643       23456899999999999999999998     44556


Q ss_pred             EEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +|+||||+.| ++...+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        79 ~~ivmE~~~gg~l~~~~~~----~~~~~~~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NILl~~~g-~vkL~DFG~a~  152 (316)
T d1fota_          79 IFMIMDYIEGGELFSLLRK----SQRFPNPVAKFYAAEVCLALEYLHSK-DIIYRDLKPENILLDKNG-HIKITDFGFAK  152 (316)
T ss_dssp             EEEEECCCCSCBHHHHHHH----TSSCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECTTS-CEEECCCSSCE
T ss_pred             eeeEeeecCCccccccccc----cccccccHHHHHHHHHHHhhhhhccC-cEEccccCchheeEcCCC-CEEEecCccce
Confidence            8999999996 54444443    67789999999999999999999987 999999999999999988 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....  .....+||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+.+..            
T Consensus       153 ~~~~--~~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~------------  217 (316)
T d1fota_         153 YVPD--VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAE------------  217 (316)
T ss_dssp             ECSS--CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCC------------
T ss_pred             Eecc--ccccccCcccccCHHHHcCCC-CCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCC------------
Confidence            7643  334578999999999996654 7899999999999999999999999888777766665421            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                       ..++..+|+++.++|.+||..||.+|+     |++++++|
T Consensus       218 -----------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         218 -----------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             -----------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -----------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcC
Confidence                             014566899999999999999999996     89998777

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.3e-55  Score=404.84  Aligned_cols=247  Identities=25%  Similarity=0.374  Sum_probs=201.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHH---HHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRE---LQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e---~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||.||+|++..+|+.||||++.+..       ....+|   +.+++.++|||||++++++     .
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~-----~   77 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAF-----H   77 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEE-----E
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEE-----E
Confidence            357999999999999999999999999999999985431       122234   5556667899999999988     3


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDF  218 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Df  218 (371)
                      ....+|+||||++ |+|.+++..    ...+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+||
T Consensus        78 ~~~~~~ivmE~~~gg~L~~~l~~----~~~~~e~~~~~~~~qi~~aL~ylH~~-~iiHrDlKP~NILl~~~g-~iKl~DF  151 (364)
T d1omwa3          78 TPDKLSFILDLMNGGDLHYHLSQ----HGVFSEADMRFYAAEIILGLEHMHNR-FVVYRDLKPANILLDEHG-HVRISDL  151 (364)
T ss_dssp             CSSEEEEEECCCCSCBHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECSSS-CEEECCC
T ss_pred             ECCEEEEEEEecCCCcHHHHHHh----cccccHHHHHHHHHHHHHHHHHHHHC-CccceeeccceeEEcCCC-cEEEeee
Confidence            4455899999998 577777764    56789999999999999999999987 999999999999999888 8999999


Q ss_pred             CCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHH
Q 017452          219 GSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEI  298 (371)
Q Consensus       219 g~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  298 (371)
                      |+|+..... ......||+.|+|||++.....++.++|||||||++|+|+||+.||.+.+..+.......... .     
T Consensus       152 Gla~~~~~~-~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~-----  224 (364)
T d1omwa3         152 GLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-M-----  224 (364)
T ss_dssp             TTCEECSSS-CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS-C-----
T ss_pred             ceeeecCCC-cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-C-----
Confidence            999876543 334568999999999997666689999999999999999999999987654433222211111 0     


Q ss_pred             hhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCC-----HHHHhhh
Q 017452          299 KCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCT-----AVSKRIL  354 (371)
Q Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t-----~~~~l~~  354 (371)
                                          ...++..+|+++.+||.+||+.||.+|||     |+++++|
T Consensus       225 --------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         225 --------------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             --------------------CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             --------------------CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence                                01145678999999999999999999999     7998777

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-55  Score=401.03  Aligned_cols=242  Identities=27%  Similarity=0.415  Sum_probs=207.3

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.       .....+|+.+|+.++|||||++++++     ....
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~-----~~~~  114 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSF-----KDNS  114 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSS
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccc-----cccc
Confidence            46899999999999999999999999999999998643       23356899999999999999999988     4445


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||+.| ++...+..    .+.+++..++.++.||+.||.|||++ |||||||||+|||++.++ .+||+|||+|
T Consensus       115 ~~~~v~e~~~~g~l~~~l~~----~~~l~e~~~~~i~~qi~~aL~yLH~~-~iiHRDIKP~NILl~~~g-~ikL~DFG~a  188 (350)
T d1rdqe_         115 NLYMVMEYVAGGEMFSHLRR----IGRFSEPHARFYAAQIVLTFEYLHSL-DLIYRDLKPENLLIDQQG-YIQVTDFGFA  188 (350)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTS-CEEECCCTTC
T ss_pred             ccccccccccccchhhhHhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CEecCcCCHHHcccCCCC-CEEeeeceee
Confidence            58899999985 66666554    46799999999999999999999986 999999999999999988 8999999999


Q ss_pred             cccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          222 KVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       222 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      +....  ......||+.|||||++.+.. ++.++|||||||++|+|+||+.||.+.+....+..+.....          
T Consensus       189 ~~~~~--~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~----------  255 (350)
T d1rdqe_         189 KRVKG--RTWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKV----------  255 (350)
T ss_dssp             EECSS--CBCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCC----------
T ss_pred             eeccc--ccccccCccccCCHHHHcCCC-CCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCC----------
Confidence            87643  234578999999999997654 79999999999999999999999998877766666654210          


Q ss_pred             CCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          302 NPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                                         .++..+|+++.+||.+||..||.+|+     |+.++++|
T Consensus       256 -------------------~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         256 -------------------RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             -------------------CCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             -------------------CCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcC
Confidence                               14556899999999999999999995     99998887

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=4e-55  Score=391.90  Aligned_cols=276  Identities=34%  Similarity=0.617  Sum_probs=221.5

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++.+.||+|+||+||+|++. +|+.||||++...      ...+.+|+.+|+.++||||+++++++..     ....
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~-----~~~~   75 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT-----KKRL   75 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEEC-----SSCE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeeccc-----CCce
Confidence            58999999999999999999985 7899999998543      2345689999999999999999999844     3448


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +++|+|+.+++...+..   ..+.+++..++.++.||+.||+|||+. |||||||||+|||++.++ .+||+|||.+...
T Consensus        76 ~i~~e~~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~-~IvHrDiKp~NIll~~~~-~~kl~DfG~a~~~  150 (286)
T d1ob3a_          76 VLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDR-RVLHRDLKPQNLLINREG-ELKIADFGLARAF  150 (286)
T ss_dssp             EEEEECCSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTS-CEEECCTTHHHHH
T ss_pred             eEEEEeehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccC-cEEecCCCCceeeEcCCC-CEEecccccceec
Confidence            89999999876665543   357899999999999999999999986 999999999999999988 8999999999876


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .... ......+++.|+|||.+.+...++.++|||||||++|+|++|+.||.+.+..+.+.++.+..+.+....+.....
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  230 (286)
T d1ob3a_         151 GIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE  230 (286)
T ss_dssp             CC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             ccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhh
Confidence            4332 234557899999999998777789999999999999999999999999888888999999888887766543221


Q ss_pred             Ccc-ccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhcccccc
Q 017452          304 NYT-EFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFR  370 (371)
Q Consensus       304 ~~~-~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~  370 (371)
                      ... ...+......++ ..+...+++++.+||.+||++||++|||+.|+            +.|||||
T Consensus       231 ~~~~~~~~~~~~~~~~-~~~~~~~s~~~~dli~~~L~~dP~~R~s~~el------------l~Hp~f~  285 (286)
T d1ob3a_         231 LPKYDPNFTVYEPLPW-ESFLKGLDESGIDLLSKMLKLDPNQRITAKQA------------LEHAYFK  285 (286)
T ss_dssp             STTCCTTCCCCCCCCG-GGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH------------HTSGGGG
T ss_pred             hhhcccccccccCcch-hhhcccCCHHHHHHHHHHccCChhHCcCHHHH------------hcCcccC
Confidence            111 111111122222 22456689999999999999999999999995            5667776

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-55  Score=398.34  Aligned_cols=251  Identities=25%  Similarity=0.355  Sum_probs=213.5

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..++|++++.||+|+||+||+|.+..+|+.||||++....   ....+|+++|+.++|||||+++++|..     ...+|
T Consensus         3 ~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~-----~~~~~   77 (321)
T d1tkia_           3 LYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFES-----MEELV   77 (321)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEE-----TTEEE
T ss_pred             CccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEE-----CCEEE
Confidence            3468999999999999999999999999999999996543   345689999999999999999999843     44589


Q ss_pred             Eeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC-CcEEEEeeCCccc
Q 017452          146 LVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT-HQVKLCDFGSAKV  223 (371)
Q Consensus       146 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~-~~~kl~Dfg~a~~  223 (371)
                      +|||||+| +|.+.+..   ....+++..++.|+.||+.||+|||++ ||+||||||+|||++.++ ..+||+|||++..
T Consensus        78 lvmE~~~gg~L~~~i~~---~~~~l~e~~~~~i~~qi~~al~yLH~~-~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~  153 (321)
T d1tkia_          78 MIFEFISGLDIFERINT---SAFELNEREIVSYVHQVCEALQFLHSH-NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQ  153 (321)
T ss_dssp             EEECCCCCCBHHHHHTS---SSCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEESSSSCCCEEECCCTTCEE
T ss_pred             EEEecCCCCcHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHc-CCCcccccccceeecCCCceEEEEcccchhhc
Confidence            99999995 77666642   234799999999999999999999987 999999999999997543 3799999999988


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........+|+.|+|||.+.+.. ++.++|||||||++|+|++|..||.+.+..+.+..+.+.....+...      
T Consensus       154 ~~~~~~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~------  226 (321)
T d1tkia_         154 LKPGDNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEA------  226 (321)
T ss_dssp             CCTTCEEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHH------
T ss_pred             cccCCcccccccccccccchhccCCC-CCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhh------
Confidence            76666566778899999999986654 79999999999999999999999999888887777776433333222      


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                         +..+|+++.+||.+||..||.+|||+.|+++|
T Consensus       227 -------------------~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         227 -------------------FKEISIEAMDFVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             -------------------HTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             -------------------ccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                               23479999999999999999999999999988

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-54  Score=396.38  Aligned_cols=275  Identities=33%  Similarity=0.576  Sum_probs=223.1

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCce
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDEL  142 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~  142 (371)
                      ..+|++++.||+|+||+||+|.+..+|+.||||++...      .....+|+.+|+.++|||||+++++|..... ....
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            45899999999999999999999999999999998643      2345589999999999999999999855432 2344


Q ss_pred             eEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          143 YLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       143 ~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      .+|+||||++.++.....     ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+
T Consensus        97 ~~~lv~e~~~~~l~~~~~-----~~~l~~~~~~~~~~qi~~aL~~LH~~-~IiHrDiKp~NIL~~~~~-~~kl~Dfg~a~  169 (346)
T d1cm8a_          97 DFYLVMPFMGTDLGKLMK-----HEKLGEDRIQFLVYQMLKGLRYIHAA-GIIHRDLKPGNLAVNEDC-ELKILDFGLAR  169 (346)
T ss_dssp             CCEEEEECCSEEHHHHHH-----HCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCE
T ss_pred             eEEEEEecccccHHHHHH-----hccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCcchhhccccc-cccccccccee
Confidence            578999999887777665     36799999999999999999999987 999999999999999998 89999999998


Q ss_pred             ccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          223 VLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       223 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....  ......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+....+..+....+.++.+.+....
T Consensus       170 ~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         170 QADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             ECCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             ccCC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            7643  34567889999999999877778999999999999999999999999999999999999999998887665433


Q ss_pred             CCccc---cccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTE---FKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~---~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   ..++......|.. ....+++++.+||.+||..||.+|||+.|+|+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~-~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGG-TCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhhhhhhccCCcccccchHH-hccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            21111   1222333333333 335689999999999999999999999999888

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-55  Score=390.11  Aligned_cols=239  Identities=25%  Similarity=0.385  Sum_probs=199.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------hhhHHHHHHHHHcC--CCCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------RYKNRELQTMRLLD--HPNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------~~~~~e~~~l~~l~--h~niv~~~~~~~~~~  137 (371)
                      .++|++++.||+|+||+||+|++..+|+.||||++.+..          ....+|+.++++++  |||||++++++    
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~----   78 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWF----   78 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEE----
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEE----
Confidence            357999999999999999999999999999999986431          22458999999996  89999999988    


Q ss_pred             CCCceeEEEeeccccc--hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEE
Q 017452          138 DKDELYLNLVLEYVPE--TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKL  215 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~--~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl  215 (371)
                       ......++||||+.+  ++.+.+..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.+.+.+||
T Consensus        79 -~~~~~~~lv~e~~~~~~~l~~~~~~----~~~l~e~~~~~~~~qi~~al~~lH~~-~iiHrDiKp~NIll~~~~~~vkl  152 (273)
T d1xwsa_          79 -ERPDSFVLILERPEPVQDLFDFITE----RGALQEELARSFFWQVLEAVRHCHNC-GVLHRDIKDENILIDLNRGELKL  152 (273)
T ss_dssp             -ECSSEEEEEEECCSSEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEETTTTEEEE
T ss_pred             -eeCCeEEEEEEeccCcchHHHHHhc----cCCCCHHHHHHHHHHHHHHHHHHHHC-CCccccCcccceEEecCCCeEEE
Confidence             344458899999974  55555543    56899999999999999999999987 99999999999999976558999


Q ss_pred             EeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          216 CDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       216 ~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +|||+|+..... ......||+.|+|||++.+...++.++|||||||++|+|++|+.||...+      .+.+.      
T Consensus       153 ~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~------  219 (273)
T d1xwsa_         153 IDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRG------  219 (273)
T ss_dssp             CCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHC------
T ss_pred             Cccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhc------
Confidence            999999865433 34467899999999999776656788999999999999999999997532      12110      


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                                             ...++..+|+++.+||.+||+.||++|||++|+++|
T Consensus       220 -----------------------~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         220 -----------------------QVFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             -----------------------CCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             -----------------------ccCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence                                   001456789999999999999999999999997766

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9e-55  Score=388.67  Aligned_cols=253  Identities=20%  Similarity=0.284  Sum_probs=208.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.+.||+|+||+||+|.+..+|+.||||++..+   .+.+.+|+.+++.++|||||++++++.     ....+++
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~-----~~~~~~i   90 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT-----REPPFYI   90 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSSSCEE
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEe-----eCCeeEE
Confidence            45799999999999999999999999999999998654   345678999999999999999999884     3344789


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++ |+|...+..  .....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|+...
T Consensus        91 v~E~~~~g~l~~~l~~--~~~~~~~~~~~~~i~~qi~~gL~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFG~a~~~~  166 (287)
T d1opja_          91 ITEFMTYGNLLDYLRE--CNRQEVSAVVLLYMATQISSAMEYLEKK-NFIHRDLAARNCLVGENH-LVKVADFGLSRLMT  166 (287)
T ss_dssp             EEECCTTCBHHHHHHH--SCTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCCTTTCC
T ss_pred             EeecccCcchHHHhhh--ccccchHHHHHHHHHHHHHHHHHHHHHC-CcccCccccCeEEECCCC-cEEEccccceeecC
Confidence            999998 577777654  2246789999999999999999999987 999999999999999988 89999999998764


Q ss_pred             cCCCc--ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          226 KGEPN--ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       226 ~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      .....  ....|++.|+|||++.+.. ++.++|||||||++|||++|..||........+.+++....            
T Consensus       167 ~~~~~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~------------  233 (287)
T d1opja_         167 GDTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY------------  233 (287)
T ss_dssp             SSSSEEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCCceeeccccccccccChHHHcCCC-CCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC------------
Confidence            43322  2345788999999987655 89999999999999999997776655555444444433110            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                     ...++..+++++.+||.+||+.||.+|||+.++++.|+.+.
T Consensus       234 ---------------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         234 ---------------RMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             ---------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             ---------------CCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                           11145678999999999999999999999999999988764

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=391.71  Aligned_cols=243  Identities=26%  Similarity=0.486  Sum_probs=204.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHH-HHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTM-RLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l-~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      ++|++++.||+|+||+||+|.+..+|+.||||++.++.       ....+|..++ +.++|||||++++++     .+..
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~-----~~~~   76 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF-----QTKE   76 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEE-----ECSS
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEE-----ccCC
Confidence            47999999999999999999999999999999996431       2234566655 468999999999998     4455


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+|+||||+++ +|..++..    ...+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||++
T Consensus        77 ~~yivmEy~~~g~L~~~i~~----~~~~~e~~~~~~~~qi~~al~ylH~~-~iiHrDikp~NiL~~~~~-~~kl~DFG~a  150 (320)
T d1xjda_          77 NLFFVMEYLNGGDLMYHIQS----CHKFDLSRATFYAAEIILGLQFLHSK-GIVYRDLKLDNILLDKDG-HIKIADFGMC  150 (320)
T ss_dssp             EEEEEEECCTTCBHHHHHHH----HSSCCHHHHHHHHHHHHHHHHHHHHT-TCBCCCCCGGGEEECTTS-CEEECCCTTC
T ss_pred             ceeEEEeecCCCcHHHHhhc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CeeeccCcccceeecCCC-ceeccccchh
Confidence            68999999985 77777654    56799999999999999999999987 999999999999999888 8999999999


Q ss_pred             cccccC-CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhh
Q 017452          222 KVLVKG-EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKC  300 (371)
Q Consensus       222 ~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (371)
                      +..... .......||+.|+|||++.+.. ++.++|||||||++|+|++|+.||.+.+..+.+..+...  .+       
T Consensus       151 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~--~~-------  220 (320)
T d1xjda_         151 KENMLGDAKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMD--NP-------  220 (320)
T ss_dssp             BCCCCTTCCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC--CC-------
T ss_pred             hhcccccccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcC--CC-------
Confidence            865433 3334568899999999997655 799999999999999999999999988777666655431  11       


Q ss_pred             cCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHH-HHhhh
Q 017452          301 MNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAV-SKRIL  354 (371)
Q Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~-~~l~~  354 (371)
                                          .+|..+|+++.+||.+||+.||.+|||+. ++++|
T Consensus       221 --------------------~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         221 --------------------FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             --------------------CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             --------------------CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhC
Confidence                                14567899999999999999999999995 77666

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=3.9e-54  Score=383.50  Aligned_cols=257  Identities=26%  Similarity=0.377  Sum_probs=205.0

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-------hhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-------RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..++|++.+.||+|+||.||+|++..+|+.||||++....       ..+.+|+.+++.++||||+++++++.... ...
T Consensus         5 l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~-~~~   83 (277)
T d1o6ya_           5 LSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET-PAG   83 (277)
T ss_dssp             ETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEC-SSS
T ss_pred             ccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeecc-CCC
Confidence            3467999999999999999999999999999999986431       23568999999999999999999886644 344


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+|+||||++| +|...+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .++|+|||.
T Consensus        84 ~~~~lvmE~~~g~~L~~~~~~----~~~l~~~~~~~i~~qi~~al~~lH~~-~iiHrDiKP~NIll~~~~-~~~l~d~~~  157 (277)
T d1o6ya_          84 PLPYIVMEYVDGVTLRDIVHT----EGPMTPKRAIEVIADACQALNFSHQN-GIIHRDVKPANIMISATN-AVKVMDFGI  157 (277)
T ss_dssp             EEEEEEEECCCEEEHHHHHHH----HCSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTS-CEEECCCTT
T ss_pred             ceEEEEEECCCCCEehhhhcc----cCCCCHHHHHHHHHHHHHHHHHHHhC-CccCccccCcccccCccc-cceeehhhh
Confidence            567899999995 66655543    56899999999999999999999987 999999999999999888 899999998


Q ss_pred             ccccccCC----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +.......    ......||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+..+.+..+.+....++  
T Consensus       158 ~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~--  234 (277)
T d1o6ya_         158 ARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPP--  234 (277)
T ss_dssp             CEECC----------------TTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCG--
T ss_pred             hhhhccccccccccccccCcccccCHHHHcCCC-CCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCC--
Confidence            87543322    234567899999999996654 89999999999999999999999998877776666554211111  


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-CHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-TAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-t~~~~l~~l~~~  358 (371)
                                             ......+|+++.+||.+||++||.+|| |+++++..|.++
T Consensus       235 -----------------------~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~  274 (277)
T d1o6ya_         235 -----------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRV  274 (277)
T ss_dssp             -----------------------GGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----------------------chhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHH
Confidence                                   113456899999999999999999999 788887777653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=393.78  Aligned_cols=259  Identities=24%  Similarity=0.320  Sum_probs=204.6

Q ss_pred             cccceeeeE-eeccCCceEEEEEEECCCCcEEEEEEeecchhhhHHHHHHHHH-cCCCCeeecceeEEecCCCCceeEEE
Q 017452           69 QTISYMAER-IVGQGSFGVVFQAKCLETGETVAIKKVLQDKRYKNRELQTMRL-LDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        69 ~~~~y~~~~-~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~e~~~l~~-l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..++|.+.. .||+|+||+||+|++..+|+.||||++.. .....+|++++.+ .+|||||+++++|.... ....++|+
T Consensus         9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~-~~~~~~~i   86 (335)
T d2ozaa1           9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLY-AGRKCLLI   86 (335)
T ss_dssp             GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEE-TTEEEEEE
T ss_pred             cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecc-cCCCEEEE
Confidence            356798875 59999999999999999999999999864 4556789998655 58999999999885432 34567899


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC--CcEEEEeeCCccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT--HQVKLCDFGSAKV  223 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~--~~~kl~Dfg~a~~  223 (371)
                      |||||+ |+|.+.+..  .....+++..++.|+.||+.||+|||++ ||+||||||+|||++.++  ..+||+|||+|+.
T Consensus        87 vmEy~~gg~L~~~i~~--~~~~~l~e~~~~~i~~qi~~al~ylH~~-~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~  163 (335)
T d2ozaa1          87 VMECLDGGELFSRIQD--RGDQAFTEREASEIMKSIGEAIQYLHSI-NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKE  163 (335)
T ss_dssp             EEECCCSEEHHHHHHS--CSCCCEEHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEESCSSTTCCEEECCCTTCEE
T ss_pred             EEECCCCCcHHHHHHh--cCCCCcCHHHHHHHHHHHHHHHHHHHHc-CCccccccccccccccccccccccccccceeee
Confidence            999998 588887763  2245799999999999999999999987 999999999999997532  3699999999998


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........||+.|+|||++.+.. ++.++|||||||++|+|+||+.||.+.+.......+......           
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~-y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~-----------  231 (335)
T d2ozaa1         164 TTSHNSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM-----------  231 (335)
T ss_dssp             CCCCCCCCCCSCCCSSCCCCCCCGGG-GSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCS-----------
T ss_pred             ccCCCccccccCCcccCCcHHHcCCC-CCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc-----------
Confidence            77766667788999999999986544 899999999999999999999999876554433333221100           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                        ..+.++.        .....+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       232 --~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         232 --GQYEFPN--------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             --CSSSCCT--------THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             --CCCCCCC--------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence              0000100        0112478999999999999999999999999888

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=381.43  Aligned_cols=250  Identities=18%  Similarity=0.288  Sum_probs=195.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|++++++++|||||++++++..     ....++|
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~~~~~lv   78 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE-----QAPICLV   78 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----SSSCEEE
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceecc-----CCceEEE
Confidence            36999999999999999999975 5678999998653   3556789999999999999999999843     3347899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||++ |+|.+++..   ....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+++....
T Consensus        79 ~E~~~~g~L~~~l~~---~~~~~~~~~~~~i~~qia~gl~~lH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla~~~~~  153 (263)
T d1sm2a_          79 FEFMEHGCLSDYLRT---QRGLFAAETLLGMCLDVCEGMAYLEEA-CVIHRDLAARNCLVGENQ-VIKVSDFGMTRFVLD  153 (263)
T ss_dssp             EECCTTCBHHHHHHT---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TCCCTTCSGGGEEECGGG-CEEECSCC-------
T ss_pred             EEecCCCcHHHHhhc---cccCCCHHHHHHHHHHHHHHHHhhhcc-ceeecccchhheeecCCC-CeEecccchheeccC
Confidence            99998 577766553   246789999999999999999999987 999999999999999988 899999999987644


Q ss_pred             CCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  .....||+.|+|||++.+.. ++.++|||||||++|||+|+ .+||...+..+.+..+.....            
T Consensus       154 ~~~~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~------------  220 (263)
T d1sm2a_         154 DQYTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFR------------  220 (263)
T ss_dssp             -----------CTTSCCHHHHTTCC-CCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCC------------
T ss_pred             CCceeecceecCcccCChHHhcCCC-CCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCC------------
Confidence            332  22456799999999997655 89999999999999999995 566666555555554443211            


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                      ...|..+++++.+|+.+||+.||.+|||+++++++|+++.+
T Consensus       221 ----------------~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         221 ----------------LYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             ----------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ----------------CCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                            01345678999999999999999999999999999987643

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-54  Score=381.73  Aligned_cols=254  Identities=21%  Similarity=0.255  Sum_probs=201.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCcee
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELY  143 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~  143 (371)
                      .++|++.+.||+|+||.||+|+..   ..||||++...      ...+.+|+.++++++|||||+++++...      ..
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~------~~   77 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA------PQ   77 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS------SS
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec------cE
Confidence            457999999999999999999753   36999998532      2445689999999999999999886521      22


Q ss_pred             EEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcc
Q 017452          144 LNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAK  222 (371)
Q Consensus       144 ~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~  222 (371)
                      +++|||||+ |+|.+.+..   ....+++..+..++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+|+
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~-~ivHrDlKp~NiLl~~~~-~~Kl~DFGla~  152 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHI---IETKFEMIKLIDIARQTAQGMDYLHAK-SIIHRDLKSNNIFLHEDL-TVKIGDFGLAT  152 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHT---SCCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEETTS-SEEECCCCCSC
T ss_pred             EEEEEecCCCCCHHHHHhh---ccCCCCHHHHHHHHHHHHHHHHHHhcC-CEeccccCHHHEEEcCCC-CEEEcccccee
Confidence            689999998 587777653   246799999999999999999999987 999999999999999988 89999999997


Q ss_pred             ccccCC---CcccccccccccCcccccCC--cCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          223 VLVKGE---PNISYICSRYYRAPELIFGA--TEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       223 ~~~~~~---~~~~~~~t~~y~aPE~~~~~--~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      ......   ......||+.|||||++.+.  ..++.++|||||||++|||+||+.||.+.+....+.........++.  
T Consensus       153 ~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~--  230 (276)
T d1uwha_         153 VKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPD--  230 (276)
T ss_dssp             C------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCC--
T ss_pred             eccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCc--
Confidence            764322   22346789999999998643  23788999999999999999999999987776666555543211110  


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                                           ....+..+++++.+|+.+||+.||.+|||+.+++++|+.+..
T Consensus       231 ---------------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~  272 (276)
T d1uwha_         231 ---------------------LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLAR  272 (276)
T ss_dssp             ---------------------GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---------------------chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                                 011445689999999999999999999999999999887643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-53  Score=388.42  Aligned_cols=280  Identities=28%  Similarity=0.460  Sum_probs=214.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC---CC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD---KD  140 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~---~~  140 (371)
                      .++|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+|+.++||||+++++.+.....   ..
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            57899999999999999999999999999999988533      2335689999999999999999998755332   22


Q ss_pred             ceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          141 ELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       141 ~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...+++||||+.+++.....   .....+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~-~ivHrDlKp~NILl~~~~-~~kl~dfg~  163 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRN-KILHRDMKAANVLITRDG-VLKLADFGL  163 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTS-CEEECCCTT
T ss_pred             CceEEEEEeccCCCccchhh---hcccccccHHHHHHHHHHHHHHHHhccC-CEEecCcCchheeecCCC-cEEeeecce
Confidence            34578999999987655433   3356899999999999999999999987 999999999999999998 899999999


Q ss_pred             ccccccC-----CCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKG-----EPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      +......     .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+.++.
T Consensus       164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~  243 (318)
T d3blha1         164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  243 (318)
T ss_dssp             CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             eeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCCh
Confidence            9765322     22234578999999999987767899999999999999999999999998888888889898888776


Q ss_pred             hHHhhcCCCccccccCcccCCC--Cccc-CCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHP--WHKI-FPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~--~~~~-~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      +.+...................  .... .....++++.+||.+||++||++||||.|+|+|
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            6543322111111111110000  0000 001246788999999999999999999996655

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-53  Score=389.86  Aligned_cols=276  Identities=31%  Similarity=0.599  Sum_probs=221.9

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      .+|++++.||+|+||+||+|.+..+|+.||||++.+..     ....+|+++|+.++||||+++++++.........+++
T Consensus         8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~   87 (345)
T d1pmea_           8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY   87 (345)
T ss_dssp             TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred             CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence            47999999999999999999999999999999986432     2345799999999999999999998665555556678


Q ss_pred             EeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          146 LVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       146 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      +++++++|+|.+++..     ..+++..++.++.||+.||+|||++ |||||||||+|||++.++ .+||+|||+++...
T Consensus        88 l~~~~~~g~L~~~l~~-----~~l~~~~i~~i~~qil~al~yLH~~-~iiHRDIKp~NILl~~~~-~~kl~DfG~a~~~~  160 (345)
T d1pmea_          88 LVTHLMGADLYKLLKT-----QHLSNDHICYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNTTC-DLKICDFGLARVAD  160 (345)
T ss_dssp             EEEECCCEEHHHHHHH-----CCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCCGGGEEECTTC-CEEECCCTTCEECC
T ss_pred             EEEeecCCchhhhhhc-----CCCCHHHHHHHHHHHHHHHHHHHHC-CCcCCCCCcceEEECCCC-CEEEcccCceeecc
Confidence            8888888899888763     5799999999999999999999987 999999999999999888 89999999997654


Q ss_pred             cCC----CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhc
Q 017452          226 KGE----PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCM  301 (371)
Q Consensus       226 ~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  301 (371)
                      ...    ......||+.|+|||++.....++.++||||+||++|+|++|+.||.+.+..+...........+........
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (345)
T d1pmea_         161 PDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCI  240 (345)
T ss_dssp             GGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTC
T ss_pred             CCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhh
Confidence            332    2345678999999999877666899999999999999999999999998888888888887777776544321


Q ss_pred             CCCc---cccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          302 NPNY---TEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       302 ~~~~---~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....   .....+.....+|...+ ..+|+++.+||.+||++||.+|||+.++|+|
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         241 INLKARNYLLSLPHKNKVPWNRLF-PNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             CCHHHHHHHHTSCCCCCCCHHHHC-TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhhhcccccCCccCCCCHHHhC-CCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            1100   01122222333333333 3578999999999999999999999999988

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=2.2e-53  Score=387.94  Aligned_cols=279  Identities=29%  Similarity=0.504  Sum_probs=218.3

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc-hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD-KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ++|++++.||+|+||+||+|++..+|+.||||++... .....+|+.+|+.+. ||||++++++|..   ....++++||
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~---~~~~~~~~v~  111 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKD---PVSRTPALVF  111 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEEC---TTTCSEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEe---cCCCceeEEE
Confidence            4799999999999999999999999999999998654 455678999999995 9999999998754   2334578999


Q ss_pred             ccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccCC
Q 017452          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKGE  228 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~~  228 (371)
                      ||+.++.+.      ...+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++..+||+|||+|+......
T Consensus       112 e~~~~~~L~------~~~~~l~e~~i~~i~~qil~aL~~LH~~-gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~  184 (328)
T d3bqca1         112 EHVNNTDFK------QLYQTLTDYDIRFYMYEILKALDYCHSM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ  184 (328)
T ss_dssp             ECCCSCBGG------GTTTSCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC
T ss_pred             eecCCCcHH------HHhcCCCHHHHHHHHHHHHHHHHHHhhc-ccccccccccceEEcCCCCeeeecccccceeccCCC
Confidence            999964221      2246799999999999999999999987 999999999999999877679999999998877666


Q ss_pred             CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC-cHHHHHHHHHHhCCCCHhHHhhcCCCccc
Q 017452          229 PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS-GVDQLVEIIKVLGTPTREEIKCMNPNYTE  307 (371)
Q Consensus       229 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (371)
                      ......+|+.|+|||.+.+...++.++||||+||++|+|++|+.||.... ..+....+...++.+....+.........
T Consensus       185 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  264 (328)
T d3bqca1         185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELD  264 (328)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCC
T ss_pred             cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccC
Confidence            66778899999999999877778999999999999999999999997654 44455666666665544333221111111


Q ss_pred             cc----cCcccCCCCcccC----CCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhccccccC
Q 017452          308 FK----FPQIKAHPWHKIF----PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLHHFCFRS  371 (371)
Q Consensus       308 ~~----~~~~~~~~~~~~~----~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~~~~~~~  371 (371)
                      ..    ........|....    ...+++++.+||++||.+||.+|||++|+            +.||||++
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~------------L~Hp~F~~  324 (328)
T d3bqca1         265 PRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA------------MEHPYFYT  324 (328)
T ss_dssp             GGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHH------------HTSGGGTT
T ss_pred             cccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHH------------hcCcccCC
Confidence            11    1111112222222    23478999999999999999999999995            55777764

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.2e-54  Score=386.57  Aligned_cols=249  Identities=24%  Similarity=0.323  Sum_probs=193.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc---EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE---TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~---~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|++.+.||+|+||+||+|.+..+|+   .||||.+...     ...+.+|+.+|++++|||||++++++..     ..
T Consensus        26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~-----~~  100 (299)
T d1jpaa_          26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK-----ST  100 (299)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-----SS
T ss_pred             hhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee-----CC
Confidence            479999999999999999999887664   5889987542     2345689999999999999999998833     33


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++|||||++ +|.+++..   ....+++..+..++.||+.||.|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus       101 ~~~iv~Ey~~~g~L~~~~~~---~~~~l~~~~~~~i~~qia~gl~yLH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGla  175 (299)
T d1jpaa_         101 PVMIITEFMENGSLDSFLRQ---NDGQFTVIQLVGMLRGIAAGMKYLADM-NYVHRDLAARNILVNSNL-VCKVSDFGLS  175 (299)
T ss_dssp             SCEEEEECCTTEEHHHHHHT---TTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCC---
T ss_pred             EEEEEEEecCCCcceeeecc---ccCCCCHHHHHHHHHHHHHHHHHHhhC-CCccCccccceEEECCCC-cEEECCcccc
Confidence            47899999995 66665543   245799999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCCCc------ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          222 KVLVKGEPN------ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       222 ~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      +........      ....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+....+.+..+.+....+ 
T Consensus       176 ~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~-  253 (299)
T d1jpaa_         176 RFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP-  253 (299)
T ss_dssp             --------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-
T ss_pred             eEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            876443221      1245688999999987654 8999999999999999998 899998887766555544321100 


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                                 .+..++.++.+|+.+||+.||.+|||+.+++++|+.+
T Consensus       254 ---------------------------~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~  290 (299)
T d1jpaa_         254 ---------------------------PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM  290 (299)
T ss_dssp             ---------------------------CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             ---------------------------CCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                       3456899999999999999999999999999998764

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=375.09  Aligned_cols=248  Identities=20%  Similarity=0.262  Sum_probs=206.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|++.+.||+|+||+||+|+++ ++..||||++...   ...+.+|++++++++||||+++++++.     ....+++|
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~-----~~~~~~iv   77 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCT-----KQRPIFII   77 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEC-----CSSSEEEE
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEe-----eCCceEEE
Confidence            46999999999999999999974 7789999998653   455678999999999999999999883     33448899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccccc
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVK  226 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~  226 (371)
                      |||+. |++...+..   ....+++..++.++.||++||+|||++ ||+||||||+|||++.++ .+||+|||+++....
T Consensus        78 ~Ey~~~g~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~~LH~~-~iiH~dlk~~Nill~~~~-~~kl~DfG~a~~~~~  152 (258)
T d1k2pa_          78 TEYMANGCLLNYLRE---MRHRFQTQQLLEMCKDVCEAMEYLESK-QFLHRDLAARNCLVNDQG-VVKVSDFGLSRYVLD  152 (258)
T ss_dssp             EECCTTEEHHHHHHS---GGGCCCHHHHHHHHHHHHHHHHHHHHT-TBCCSCCSGGGEEECTTC-CEEECCCSSCCBCSS
T ss_pred             EEccCCCcHHHhhhc---cccCCcHHHHHHHHHHHHHHHHHHhhc-CcccccccceeEEEcCCC-cEEECcchhheeccC
Confidence            99998 566655443   246789999999999999999999987 999999999999999888 899999999986544


Q ss_pred             CCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          227 GEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       227 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...  .....+|+.|+|||.+.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+....           
T Consensus       153 ~~~~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~-----------  220 (258)
T d1k2pa_         153 DEYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRL-----------  220 (258)
T ss_dssp             SSCCCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCC-----------
T ss_pred             CCceeecccCCCCCcCCcHHhcCCC-CCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCC-----------
Confidence            332  23456899999999997655 8999999999999999998 89999988877666555432110           


Q ss_pred             CccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          304 NYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       304 ~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                       ..|..+++++.+||.+||+.||++|||+.++++||.++
T Consensus       221 -----------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di  258 (258)
T d1k2pa_         221 -----------------YRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV  258 (258)
T ss_dssp             -----------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred             -----------------CCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhCC
Confidence                             14456889999999999999999999999999998654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=386.82  Aligned_cols=252  Identities=21%  Similarity=0.308  Sum_probs=205.2

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCc-----EEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGE-----TVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTD  138 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~-----~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~  138 (371)
                      ..+|++++.||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.+++++ +|||||++++++.    
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~----  111 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACT----  111 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEC----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe----
Confidence            3579999999999999999999876543     6999988532     23456799999988 8999999999983    


Q ss_pred             CCceeEEEeecccc-chHHHHHHHhhh-------------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeec
Q 017452          139 KDELYLNLVLEYVP-ETVHRVVKHFNK-------------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD  198 (371)
Q Consensus       139 ~~~~~~~lv~e~~~-~~l~~~~~~~~~-------------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~d  198 (371)
                       ....+++|||||+ |+|.+++.....                   ....+++..++.++.||+.||+|||++ ||||||
T Consensus       112 -~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~-~IiHRD  189 (325)
T d1rjba_         112 -LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK-SCVHRD  189 (325)
T ss_dssp             -SSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT-TEEETT
T ss_pred             -eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecc
Confidence             3444789999998 588888764321                   124589999999999999999999987 999999


Q ss_pred             cCCCceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCC
Q 017452          199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLF  274 (371)
Q Consensus       199 lkp~NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf  274 (371)
                      |||+|||++.++ .+||+|||+|+........   ....||+.|||||++.+.. ++.++|||||||++|||+| |..||
T Consensus       190 lKp~Nill~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf  267 (325)
T d1rjba_         190 LAARNVLVTHGK-VVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPY  267 (325)
T ss_dssp             CSGGGEEEETTT-EEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CchhccccccCC-eEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCC
Confidence            999999999988 9999999999876554432   2456799999999987654 8999999999999999997 89999


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.+..+.+.+++.....+                           ..|..+|+++.+||.+||+.||.+|||+.|+++|
T Consensus       268 ~~~~~~~~~~~~~~~~~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         268 PGIPVDANFYKLIQNGFKM---------------------------DQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             TTCCCSHHHHHHHHTTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCC---------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            8877666666555421111                           1456689999999999999999999999999999


Q ss_pred             hc
Q 017452          355 FS  356 (371)
Q Consensus       355 l~  356 (371)
                      |.
T Consensus       321 L~  322 (325)
T d1rjba_         321 LG  322 (325)
T ss_dssp             HH
T ss_pred             Hh
Confidence            84

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=376.75  Aligned_cols=274  Identities=32%  Similarity=0.517  Sum_probs=218.4

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      ++|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||+++++++     .+....
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~-----~~~~~~   76 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-----HSDKKL   76 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE-----ECSSEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc-----ccccce
Confidence            4799999999999999999999999999999998543      23446899999999999999999988     444457


Q ss_pred             EEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCcccc
Q 017452          145 NLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVL  224 (371)
Q Consensus       145 ~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~  224 (371)
                      +++++++.++....+.   ...+.+++..++.++.|++.||+|||++ ||+||||||+|||++.++ .+||+|||.++..
T Consensus        77 ~iv~~~~~~~~l~~~~---~~~~~~~~~~~~~~~~q~~~aL~~lH~~-~IvHrDiKP~NIli~~~~-~~kl~DFG~a~~~  151 (292)
T d1unla_          77 TLVFEFCDQDLKKYFD---SCNGDLDPEIVKSFLFQLLKGLGFCHSR-NVLHRDLKPQNLLINRNG-ELKLANFGLARAF  151 (292)
T ss_dssp             EEEEECCSEEHHHHHH---HTTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEECTTC-CEEECCCTTCEEC
T ss_pred             eEEeeecccccccccc---ccccccchhHHHHHHHHHHHHHHHhhcC-CEeeecccCcccccccCC-ceeeeecchhhcc
Confidence            8999999975444433   2367889999999999999999999987 999999999999999888 8999999999876


Q ss_pred             ccCC-CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          225 VKGE-PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       225 ~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      .... ......+++.|+|||.+.....++.++|||||||++|+|++|+.|| .+.+..+.+..+....+.+....+....
T Consensus       152 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (292)
T d1unla_         152 GIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMT  231 (292)
T ss_dssp             CSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGG
T ss_pred             cCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhh
Confidence            5433 3334566888999999877776799999999999999999999885 5556666777788888887766554332


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ........+..............+++.+.+||.+||++||.+||||+|+|+|
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         232 KLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             GSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            2222222222222222233456789999999999999999999999996555

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-53  Score=373.53  Aligned_cols=248  Identities=23%  Similarity=0.308  Sum_probs=199.4

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++.+.||+|+||.||+|.+. ++..||||++...   ...+.+|++++++++|||||++++++..     . .+++
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-----~-~~~i   84 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-----E-PIYI   84 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-----S-SCEE
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-----C-CeEE
Confidence            357999999999999999999974 6788999998653   3446789999999999999999987621     1 2579


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+++ +|.+.+...  ....+++..+..++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+|+...
T Consensus        85 v~Ey~~~g~L~~~~~~~--~~~~l~~~~~~~i~~qi~~gl~~lH~~-~ivHrDiKp~NIll~~~~-~~Kl~DFGla~~~~  160 (272)
T d1qpca_          85 ITEYMENGSLVDFLKTP--SGIKLTINKLLDMAAQIAEGMAFIEER-NYIHRDLRAANILVSDTL-SCKIADFGLARLIE  160 (272)
T ss_dssp             EEECCTTCBHHHHTTSH--HHHTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECTTS-CEEECCCTTCEECS
T ss_pred             EEEeCCCCcHHHHHhhc--CCCCCCHHHHHHHHHHHHHHHHHHHhC-CcccCccchhheeeeccc-ceeeccccceEEcc
Confidence            9999984 666654432  234689999999999999999999987 999999999999999988 89999999998765


Q ss_pred             cCCC--cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGEP--NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ....  .....||+.|+|||++.+.. ++.++|||||||++|||+||. +||...+..+.+..+....            
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~------------  227 (272)
T d1qpca_         161 DNEYTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGY------------  227 (272)
T ss_dssp             SSCEECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC------------
T ss_pred             CCccccccccCCcccccChHHHhCCC-CCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcC------------
Confidence            4332  23456789999999997654 799999999999999999965 5555555544444443211            


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                      ....+..+++++.+|+.+||+.||.+|||+.++++.|+.
T Consensus       228 ----------------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~  266 (272)
T d1qpca_         228 ----------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLED  266 (272)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ----------------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhh
Confidence                            011455689999999999999999999999999987654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-52  Score=386.08  Aligned_cols=275  Identities=30%  Similarity=0.514  Sum_probs=211.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      .+|++++.||+|+||+||+|++..+|+.||||++...      .....+|+.+++.++||||++++++|..... ....+
T Consensus        17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            4799999999999999999999999999999999643      2345689999999999999999999854332 24567


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      +|+||||+.+++...+      ...+++..++.++.||+.||.|||++ ||+||||||+|||++.++ .++++|||+++.
T Consensus        97 ~~iv~Ey~~~~l~~~~------~~~~~~~~i~~~~~qil~gl~~LH~~-giiHrDlKP~Nil~~~~~-~~kl~df~~~~~  168 (355)
T d2b1pa1          97 VYLVMELMDANLCQVI------QMELDHERMSYLLYQMLCGIKHLHSA-GIIHRDLKPSNIVVKSDC-TLKILDFGLART  168 (355)
T ss_dssp             EEEEEECCSEEHHHHH------TSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC---
T ss_pred             eEEEEeccchHHHHhh------hcCCCHHHHHHHHHHHHHHHHHhhhc-ccccccCCcccccccccc-ceeeechhhhhc
Confidence            8999999999876654      36789999999999999999999987 999999999999999988 899999999988


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ...........+|+.|+|||++.+. .+++++||||+||++|+|++|+.||.+.+.......+....+.+..+.+.....
T Consensus       169 ~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  247 (355)
T d2b1pa1         169 AGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_dssp             ------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCH
T ss_pred             cccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhh
Confidence            7776666777899999999999765 489999999999999999999999999998888999999988888877654332


Q ss_pred             CccccccC--cccCCCCcccC-----------CCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEFKFP--QIKAHPWHKIF-----------PKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~~~~--~~~~~~~~~~~-----------~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      ....+...  ......+...+           ....|+++.+||++||..||++||||+|+|+|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence            21111000  00011111111           11246789999999999999999999998777

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-52  Score=373.08  Aligned_cols=248  Identities=25%  Similarity=0.322  Sum_probs=201.8

Q ss_pred             cceeeeEe-eccCCceEEEEEEECC--CCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCce
Q 017452           71 ISYMAERI-VGQGSFGVVFQAKCLE--TGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDEL  142 (371)
Q Consensus        71 ~~y~~~~~-lg~G~~g~V~~~~~~~--~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~  142 (371)
                      .+|.+.+. ||+|+||.||+|.++.  ++..||||++...     ...+.+|+++|++++|||||++++++..     . 
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-----~-   81 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-----E-   81 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-----S-
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-----C-
Confidence            46888885 9999999999998754  4557999998543     2345689999999999999999998732     1 


Q ss_pred             eEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCc
Q 017452          143 YLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSA  221 (371)
Q Consensus       143 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a  221 (371)
                      .+++||||+++ +|.+++.   .....+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+|
T Consensus        82 ~~~lvmE~~~~g~L~~~l~---~~~~~l~~~~~~~i~~qi~~gL~ylH~~-~iiHrDlKp~Nill~~~~-~~Kl~DFGla  156 (285)
T d1u59a_          82 ALMLVMEMAGGGPLHKFLV---GKREEIPVSNVAELLHQVSMGMKYLEEK-NFVHRDLAARNVLLVNRH-YAKISDFGLS  156 (285)
T ss_dssp             SEEEEEECCTTEEHHHHHT---TCTTTSCHHHHHHHHHHHHHHHHHHHHT-TEECCCCSGGGEEEEETT-EEEECCCTTC
T ss_pred             eEEEEEEeCCCCcHHHHhh---ccccCCCHHHHHHHHHHHHHHHHHHHhC-CeecCcCchhheeeccCC-ceeeccchhh
Confidence            26899999995 7766553   2246799999999999999999999987 999999999999999988 8999999999


Q ss_pred             cccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          222 KVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       222 ~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      +.......    .....||+.|+|||++.+.. ++.++|||||||++|||+| |+.||.+.+..+....+.+...     
T Consensus       157 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~-----  230 (285)
T d1u59a_         157 KALGADDSYYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKR-----  230 (285)
T ss_dssp             EECTTCSCEECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCC-----
T ss_pred             hcccccccccccccccccCccccChHHHhCCC-CCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC-----
Confidence            87644322    22446789999999996654 8999999999999999998 9999998877666555443210     


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                             ..+|..+|+++.+||.+||+.||++|||+.++++.|+.+
T Consensus       231 -----------------------~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         231 -----------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             -----------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             -----------------------CCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence                                   014567899999999999999999999999998876644

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-52  Score=370.34  Aligned_cols=240  Identities=24%  Similarity=0.312  Sum_probs=193.9

Q ss_pred             EeeccCCceEEEEEEEC--CCCcEEEEEEeecc------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           77 RIVGQGSFGVVFQAKCL--ETGETVAIKKVLQD------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        77 ~~lg~G~~g~V~~~~~~--~~~~~vaiK~~~~~------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ++||+|+||.||+|.+.  .+++.||||++...      ...+.+|++++++++|||||++++++..     .. .++||
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-----~~-~~lvm   86 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-----ES-WMLVM   86 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-----SS-EEEEE
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-----CC-EEEEE
Confidence            46999999999999864  45678999998542      2345689999999999999999998731     11 57999


Q ss_pred             cccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccccC
Q 017452          149 EYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLVKG  227 (371)
Q Consensus       149 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~~~  227 (371)
                      ||++ |+|.+++..    ...+++..+..++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+++.....
T Consensus        87 E~~~~g~L~~~l~~----~~~l~~~~~~~i~~qi~~gl~ylH~~-~iiHrDlKp~Nill~~~~-~~kl~DFGla~~~~~~  160 (277)
T d1xbba_          87 EMAELGPLNKYLQQ----NRHVKDKNIIELVHQVSMGMKYLEES-NFVHRDLAARNVLLVTQH-YAKISDFGLSKALRAD  160 (277)
T ss_dssp             ECCTTEEHHHHHHH----CTTCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEEEETT-EEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHhh----ccCCCHHHHHHHHHHHHHHHhhHHhC-CcccCCCcchhhcccccC-cccccchhhhhhcccc
Confidence            9998 577776654    56799999999999999999999987 999999999999999988 8999999999876443


Q ss_pred             CCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          228 EPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       228 ~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ...    ....||+.|+|||++.+.. ++.++|||||||++|||++ |+.||.+.+..+....+.+..  .         
T Consensus       161 ~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~--~---------  228 (277)
T d1xbba_         161 ENYYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGE--R---------  228 (277)
T ss_dssp             CSEEEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTC--C---------
T ss_pred             ccccccccccCCCceecCchhhcCCC-CCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCC--C---------
Confidence            322    2346789999999997654 7899999999999999997 899999877665544443311  0         


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                       -.+|..+|+++.+||.+||+.||.+|||+.++++.|+.
T Consensus       229 -----------------~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~  266 (277)
T d1xbba_         229 -----------------MGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRN  266 (277)
T ss_dssp             -----------------CCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHH
T ss_pred             -----------------CCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhC
Confidence                             01456689999999999999999999999999776543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-52  Score=371.40  Aligned_cols=249  Identities=20%  Similarity=0.261  Sum_probs=191.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCC----cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETG----ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~----~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..|++.+.||+|+||.||+|.++.++    ..||||++...     ...+.+|+.++++++|||||++++++.     ..
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~-----~~   81 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS-----KY   81 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-----SS
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe-----cC
Confidence            36999999999999999999987654    47999998543     234568999999999999999999884     33


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ...++||||+.+ ++.+.+.   .....+++..+..++.||+.||+|||++ +|+||||||+|||++.++ .+||+|||+
T Consensus        82 ~~~~~v~e~~~~~~l~~~~~---~~~~~~~~~~~~~i~~~i~~gl~~lH~~-~iiHrDlKp~NILl~~~~-~~Kl~DFGl  156 (283)
T d1mqba_          82 KPMMIITEYMENGALDKFLR---EKDGEFSVLQLVGMLRGIAAGMKYLANM-NYVHRDLAARNILVNSNL-VCKVSDFGL  156 (283)
T ss_dssp             SSEEEEEECCTTEEHHHHHH---HTTTCSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEECTTC-CEEECCCCC
T ss_pred             CceEEEEEecccCcchhhhh---cccccccHHHHHHHHHHHHHhhhhcccc-ccccCccccceEEECCCC-eEEEcccch
Confidence            447899999986 4444433   2356799999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCCC----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCH
Q 017452          221 AKVLVKGEP----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTR  295 (371)
Q Consensus       221 a~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~  295 (371)
                      ++.......    .....||+.|+|||++.+.. ++.++|||||||++|||++|..|+ ...+..+.+..+.... .+  
T Consensus       157 a~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~-~~--  232 (283)
T d1mqba_         157 SRVLEDDPEATYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGF-RL--  232 (283)
T ss_dssp             -----------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTC-CC--
T ss_pred             hhcccCCCccceEeccCCCCccccCHHHHccCC-CCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccC-CC--
Confidence            987644322    22346789999999987654 899999999999999999966555 4444433333332211 00  


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                               ..+..++.++.+||.+||+.||.+|||+.++++.|+.+
T Consensus       233 -------------------------~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l  270 (283)
T d1mqba_         233 -------------------------PTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKL  270 (283)
T ss_dssp             -------------------------CCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHH
T ss_pred             -------------------------CCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHH
Confidence                                     13456889999999999999999999999999988765

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=369.97  Aligned_cols=252  Identities=21%  Similarity=0.301  Sum_probs=201.8

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ...+|++.+.||+|+||.||+|.+  +|..||||++..+  .+.+.+|++++++++||||+++++++...    ...+++
T Consensus         5 ~~~~~~~~~~lG~G~fg~Vy~~~~--~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~~l   78 (262)
T d1byga_           5 NMKELKLLQTIGKGEFGDVMLGDY--RGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEE----KGGLYI   78 (262)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEE--TTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC------CCEE
T ss_pred             CHHHeEEeEEEecCCCeEEEEEEE--CCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEec----CCcEEE
Confidence            345799999999999999999997  5789999999654  35567899999999999999999987432    223689


Q ss_pred             eecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||++ |+|.+++....  ...+++..++.++.||+.||.|||++ +|+||||||+|||++.++ .+||+|||+++...
T Consensus        79 v~ey~~~g~L~~~l~~~~--~~~l~~~~~~~i~~~i~~al~ylH~~-~ivH~dlkp~Nil~~~~~-~~kl~dfg~s~~~~  154 (262)
T d1byga_          79 VTEYMAKGSLVDYLRSRG--RSVLGGDCLLKFSLDVCEAMEYLEGN-NFVHRDLAARNVLVSEDN-VAKVSDFGLTKEAS  154 (262)
T ss_dssp             EECCCTTEEHHHHHHHHH--HHHCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTS-CEEECCCCC-----
T ss_pred             EEeccCCCCHHHHHHhcC--CCCCCHHHHHHHHHHHHhhccccccC-ceeccccchHhheecCCC-CEeecccccceecC
Confidence            999998 57888776432  34689999999999999999999987 999999999999999998 89999999998653


Q ss_pred             cCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCCC
Q 017452          226 KGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNPN  304 (371)
Q Consensus       226 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  304 (371)
                      ..  .....+++.|+|||.+.+.. ++.++|||||||++|||+| |++||...+..+....+.+..              
T Consensus       155 ~~--~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~--------------  217 (262)
T d1byga_         155 ST--QDTGKLPVKWTAPEALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGY--------------  217 (262)
T ss_dssp             ---------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTC--------------
T ss_pred             CC--CccccccccCCChHHHhCCC-CChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCC--------------
Confidence            32  33456788999999997654 8999999999999999998 788888776666555543210              


Q ss_pred             ccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          305 YTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       305 ~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                    ...++..+++++.+||.+||..||.+|||+.+++++|+.++.+
T Consensus       218 --------------~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         218 --------------KMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             --------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------CCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence                          1114567899999999999999999999999999999887654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-52  Score=371.27  Aligned_cols=250  Identities=26%  Similarity=0.357  Sum_probs=194.5

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      ..+|++++.||+|+||.||+|.+..++   ..||||.+...     ...+.+|+.++++++|||||++++++..      
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~------   79 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE------   79 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS------
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec------
Confidence            357999999999999999999986543   56889987532     2345689999999999999999998721      


Q ss_pred             eeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      ..+++||||+.+ ++..++..   ....+++..++.++.||+.||.|||++ +|+||||||+||+++.++ .+||+|||+
T Consensus        80 ~~~~iv~E~~~~g~l~~~~~~---~~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDlKp~NIll~~~~-~~Kl~DfG~  154 (273)
T d1mp8a_          80 NPVWIIMELCTLGELRSFLQV---RKYSLDLASLILYAYQLSTALAYLESK-RFVHRDIAARNVLVSSND-CVKLGDFGL  154 (273)
T ss_dssp             SSCEEEEECCTTEEHHHHHHH---TTTTSCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEEEETT-EEEECC---
T ss_pred             CeEEEEEEeccCCcHHhhhhc---cCCCCCHHHHHHHHHHHHHHhhhhccc-CeeccccchhheeecCCC-cEEEccchh
Confidence            236899999985 55554432   356799999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHhH
Q 017452          221 AKVLVKGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTREE  297 (371)
Q Consensus       221 a~~~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
                      |+......  ......||+.|+|||++.+.. ++.++|||||||++|||++ |.+||.+.+..+....+.+....     
T Consensus       155 a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~-----  228 (273)
T d1mp8a_         155 SRYMEDSTYYKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL-----  228 (273)
T ss_dssp             ----------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC-----
T ss_pred             heeccCCcceeccceecCcccchhhHhccCC-CCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-----
Confidence            98754332  223456789999999996554 8999999999999999997 89999888877766655432100     


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                                             .++..+|+++.+||.+||+.||.+|||+.+++++|..+.
T Consensus       229 -----------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~  267 (273)
T d1mp8a_         229 -----------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL  267 (273)
T ss_dssp             -----------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             -----------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence                                   145678999999999999999999999999999988653

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-52  Score=381.73  Aligned_cols=274  Identities=33%  Similarity=0.551  Sum_probs=218.0

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch------hhhHHHHHHHHHcCCCCeeecceeEEecCC-CCcee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK------RYKNRELQTMRLLDHPNVVSLKHCFFSTTD-KDELY  143 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~------~~~~~e~~~l~~l~h~niv~~~~~~~~~~~-~~~~~  143 (371)
                      ++|++.+.||+|+||+||+|++..+|+.||||++.+..      ....+|+.+|+.++|||||++++++..... .+..+
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~   97 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFND   97 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCce
Confidence            47999999999999999999999999999999986432      234689999999999999999998865433 23344


Q ss_pred             EEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          144 LNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       144 ~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      .++++++.+|+|.+++.     .+++++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+|++|||.+..
T Consensus        98 ~~i~~~~~gg~L~~~~~-----~~~l~e~~~~~i~~qil~aL~~LH~~-giiHrDiKp~NILi~~~~-~~kl~dfg~a~~  170 (348)
T d2gfsa1          98 VYLVTHLMGADLNNIVK-----CQKLTDDHVQFLIYQILRGLKYIHSA-DIIHRDLKPSNLAVNEDC-ELKILDFGLARH  170 (348)
T ss_dssp             CEEEEECCSEEHHHHHT-----TCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTC-CEEECCC----C
T ss_pred             EEEEEeecCCchhhhcc-----cccccHHHHHHHHHHHHHHHHHHHhC-CCcccccCCccccccccc-cccccccchhcc
Confidence            55666666678887764     46799999999999999999999987 999999999999999998 899999999876


Q ss_pred             cccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCCHhHHhhcCC
Q 017452          224 LVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTPTREEIKCMNP  303 (371)
Q Consensus       224 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  303 (371)
                      ..  .......||+.|+|||++.+...++.++|||||||++|+|++|+.||.+.+.......+.+..+.++.+.......
T Consensus       171 ~~--~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         171 TD--DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             CT--GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             cC--cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            43  2334567899999999987777789999999999999999999999999999999999999888887765543221


Q ss_pred             Ccccc---ccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          304 NYTEF---KFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       304 ~~~~~---~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .....   .........+... ...+++++.+||.+||+.||.+||||.|+|+|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~-~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANV-FIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHH-STTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhcccCCCcchhhh-cCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence            11110   1112222222221 24579999999999999999999999999888

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-52  Score=374.90  Aligned_cols=248  Identities=24%  Similarity=0.343  Sum_probs=197.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCc----EEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCc
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGE----TVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~----~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~  141 (371)
                      .+|++.+.||+|+||+||+|.+..+|+    .||+|.+...     .+.+.+|++++++++|||||++++++...     
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-----   83 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-----   83 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-----
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-----
Confidence            469999999999999999999988876    5788877432     34567899999999999999999988432     


Q ss_pred             eeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGS  220 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~  220 (371)
                      . .+++++|+. ++|.+.+..   ....+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+|||+
T Consensus        84 ~-~~~v~e~~~~~~l~~~~~~---~~~~~~~~~~~~i~~qi~~gl~yLH~~-~iiHrDlKp~NIll~~~~-~~kl~DFGl  157 (317)
T d1xkka_          84 T-VQLITQLMPFGCLLDYVRE---HKDNIGSQYLLNWCVQIAKGMNYLEDR-RLVHRDLAARNVLVKTPQ-HVKITDFGL  157 (317)
T ss_dssp             S-EEEEEECCTTCBHHHHHHH---TSSSCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEEEETT-EEEECCCSH
T ss_pred             C-eeEEEEeccCCcccccccc---cccCCCHHHHHHHHHHHHHHHHHHHHc-CcccCcchhhcceeCCCC-CeEeecccc
Confidence            2 345666665 676665543   357899999999999999999999987 999999999999999988 899999999


Q ss_pred             ccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCCHh
Q 017452          221 AKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPTRE  296 (371)
Q Consensus       221 a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  296 (371)
                      |+........   ....||+.|+|||++.+.. ++.++|||||||++|||+| |..||.+.+..+....+.+... +   
T Consensus       158 a~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~-~---  232 (317)
T d1xkka_         158 AKLLGAEEKEYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGER-L---  232 (317)
T ss_dssp             HHHTTTTCC--------CCTTTSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCC-C---
T ss_pred             ceecccccccccccccccCccccChHHHhcCC-CChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCC-C---
Confidence            9876443322   2345799999999997654 8999999999999999998 7899988776665544443211 1   


Q ss_pred             HHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          297 EIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                                              ..+..+++++.+|+.+||+.||.+|||+.++++||..+
T Consensus       233 ------------------------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~  270 (317)
T d1xkka_         233 ------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKM  270 (317)
T ss_dssp             ------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             ------------------------CCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHH
Confidence                                    03456899999999999999999999999999998765

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=363.89  Aligned_cols=252  Identities=25%  Similarity=0.321  Sum_probs=196.0

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEE
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNL  146 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~l  146 (371)
                      ..+|++++.||+|+||.||+|++..+ ..||||++...   ...+.+|+.++++++|||||++++++.     +.. +++
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-----~~~-~~l   88 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-----EEP-IYI   88 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-----SSS-CEE
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-----cCC-eEE
Confidence            46899999999999999999998654 67999998644   355678999999999999999999762     122 579


Q ss_pred             eeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccccc
Q 017452          147 VLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKVLV  225 (371)
Q Consensus       147 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~~~  225 (371)
                      ||||+.+ ++...+...  ....+++..++.++.||+.||+|||++ ||+||||||+||||+.++ .+||+|||+++...
T Consensus        89 v~Ey~~~g~l~~~~~~~--~~~~l~~~~~~~i~~~i~~gl~~LH~~-~ivH~DlKp~NIll~~~~-~~kl~DfGla~~~~  164 (285)
T d1fmka3          89 VTEYMSKGSLLDFLKGE--TGKYLRLPQLVDMAAQIASGMAYVERM-NYVHRDLRAANILVGENL-VCKVADFGLARLIE  164 (285)
T ss_dssp             EECCCTTCBHHHHHSHH--HHTTCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECGGG-CEEECCCCTTC---
T ss_pred             EEEecCCCchhhhhhhc--ccccchHHHHHHHHHHHHHHHHHHhhh-heecccccceEEEECCCC-cEEEcccchhhhcc
Confidence            9999995 555555432  245799999999999999999999987 999999999999999888 89999999998764


Q ss_pred             cCC--CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCC-CCCCcHHHHHHHHHHhCCCCHhHHhhcC
Q 017452          226 KGE--PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLF-PGDSGVDQLVEIIKVLGTPTREEIKCMN  302 (371)
Q Consensus       226 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (371)
                      ...  ......||+.|+|||.+.... ++.++|||||||++|||++|..|+ ......+.+..+.+....          
T Consensus       165 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~----------  233 (285)
T d1fmka3         165 DNEYTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM----------  233 (285)
T ss_dssp             -----------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC----------
T ss_pred             CCCceeeccccccccccChHHHhCCC-CCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC----------
Confidence            332  223456899999999997554 799999999999999999976555 444444444443321110          


Q ss_pred             CCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          303 PNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       303 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                        ..+..+++++.+||.+||+.||++|||+.++++.|......
T Consensus       234 ------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         234 ------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             ------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             ------------------CCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence                              14456899999999999999999999999999887765433

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=368.71  Aligned_cols=254  Identities=23%  Similarity=0.326  Sum_probs=194.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~  139 (371)
                      .+|++++.||+|+||.||+|.+..     +++.||||++...     .....+|..++.++ .|+||+.+++++...   
T Consensus        13 ~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~---   89 (299)
T d1ywna1          13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP---   89 (299)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST---
T ss_pred             HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccC---
Confidence            579999999999999999999754     4578999998643     22334566677666 688999988876432   


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceee
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLV  206 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli  206 (371)
                       ...+++|||||+ |+|.+++.....            ....+++..++.++.||+.||+|||++ ||+||||||+|||+
T Consensus        90 -~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~-~ivHrDlKp~NILl  167 (299)
T d1ywna1          90 -GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-KCIHRDLAARNILL  167 (299)
T ss_dssp             -TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCCGGGEEE
T ss_pred             -CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC-CCcCCcCCccceeE
Confidence             334689999998 688888765432            134589999999999999999999987 99999999999999


Q ss_pred             eCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhC-CCCCCCCCcHHH
Q 017452          207 NPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLG-KPLFPGDSGVDQ  282 (371)
Q Consensus       207 ~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg-~~pf~~~~~~~~  282 (371)
                      +.++ .+||+|||+|+.......   .....||+.|+|||++.+.. ++.++|||||||++|||++| ..||.+....+.
T Consensus       168 ~~~~-~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~  245 (299)
T d1ywna1         168 SEKN-VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE  245 (299)
T ss_dssp             CGGG-CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHH
T ss_pred             CCCC-cEEEccCcchhhccccccccccCceeeCccccchhHhhcCC-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9888 899999999986543322   23457899999999997654 89999999999999999986 568877666555


Q ss_pred             HHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          283 LVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       283 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      +.........+                           ..+..+++++.+||.+||+.||.+|||+.++++||+.+
T Consensus       246 ~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~i  294 (299)
T d1ywna1         246 FCRRLKEGTRM---------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL  294 (299)
T ss_dssp             HHHHHHHTCCC---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHhcCCCC---------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHH
Confidence            55544431111                           14556899999999999999999999999999999875

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.2e-51  Score=368.67  Aligned_cols=254  Identities=23%  Similarity=0.291  Sum_probs=205.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++.+.||+|+||+||+|++.     .+++.||||++...     ...+.+|+++++.++||||+++++++..    
T Consensus        12 ~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~----   87 (301)
T d1lufa_          12 RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV----   87 (301)
T ss_dssp             GGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS----
T ss_pred             HHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeecc----
Confidence            457999999999999999999875     35678999998643     2446789999999999999999998843    


Q ss_pred             CceeEEEeecccc-chHHHHHHHhh--------------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeec
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFN--------------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRD  198 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~--------------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~d  198 (371)
                       ....+++|||+. |+|.+.+....                    .....+++..+..++.||+.||+|||++ +|||||
T Consensus        88 -~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-~ivHrD  165 (301)
T d1lufa_          88 -GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-KFVHRD  165 (301)
T ss_dssp             -SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSC
T ss_pred             -CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-CeEeeE
Confidence             334789999998 58888775421                    1233588999999999999999999987 999999


Q ss_pred             cCCCceeeeCCCCcEEEEeeCCccccccCC---CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCC
Q 017452          199 IKPQNLLVNPHTHQVKLCDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLF  274 (371)
Q Consensus       199 lkp~NIli~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf  274 (371)
                      |||+|||++.++ .+||+|||+|+......   ......+++.|+|||.+.+.. ++.++|||||||++|||++|. +||
T Consensus       166 lKp~NILld~~~-~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~  243 (301)
T d1lufa_         166 LATRNCLVGENM-VVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPY  243 (301)
T ss_dssp             CSGGGEEECGGG-CEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             EcccceEECCCC-cEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCC-CChhhhhccchhhHHHHHccCCCCC
Confidence            999999999988 89999999998654332   223456789999999997654 899999999999999999985 678


Q ss_pred             CCCCcHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhh
Q 017452          275 PGDSGVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRIL  354 (371)
Q Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~  354 (371)
                      .+.+..+.+..+.+... +                           ..+..+++++.+||.+||+.||.+|||+.++++.
T Consensus       244 ~~~~~~e~~~~v~~~~~-~---------------------------~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~  295 (301)
T d1lufa_         244 YGMAHEEVIYYVRDGNI-L---------------------------ACPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  295 (301)
T ss_dssp             TTSCHHHHHHHHHTTCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHcCCC-C---------------------------CCCccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            87777666555443210 0                           1456789999999999999999999999999999


Q ss_pred             hcCCC
Q 017452          355 FSNCP  359 (371)
Q Consensus       355 l~~~~  359 (371)
                      |+++.
T Consensus       296 L~~i~  300 (301)
T d1lufa_         296 LQRMC  300 (301)
T ss_dssp             HHHTT
T ss_pred             HHHhc
Confidence            98764

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=363.06  Aligned_cols=248  Identities=25%  Similarity=0.338  Sum_probs=193.8

Q ss_pred             cceeeeEeeccCCceEEEEEEECCC-C--cEEEEEEeecc-------hhhhHHHHHHHHHcCCCCeeecceeEEecCCCC
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLET-G--ETVAIKKVLQD-------KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKD  140 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~-~--~~vaiK~~~~~-------~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~  140 (371)
                      .+|++.+.||+|+||.||+|+...+ +  ..||||++.+.       ...+.+|+.+++.++||||+++++++..     
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-----   82 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-----   82 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-----
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-----
Confidence            4799999999999999999986533 3  46899987542       2345689999999999999999998832     


Q ss_pred             ceeEEEeecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          141 ELYLNLVLEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       141 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      . .+++||||++ |++.+.+...   ...+++..++.++.||+.||.|||++ ||+||||||+||+++.++ .+||+|||
T Consensus        83 ~-~~~lv~e~~~~~~l~~~~~~~---~~~l~~~~~~~~~~qi~~gl~ylH~~-~iiHrDikp~NIll~~~~-~vkl~DfG  156 (273)
T d1u46a_          83 P-PMKMVTELAPLGSLLDRLRKH---QGHFLLGTLSRYAVQVAEGMGYLESK-RFIHRDLAARNLLLATRD-LVKIGDFG  156 (273)
T ss_dssp             S-SCEEEEECCTTCBHHHHHHHH---GGGSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEEEETT-EEEECCCT
T ss_pred             c-chheeeeeecCcchhhhhhcc---cCCCCHHHHHHHHHHHHHHHHHhhhC-CEeeeeecHHHhcccccc-ceeeccch
Confidence            1 2579999998 4666555432   45799999999999999999999987 999999999999999988 89999999


Q ss_pred             CccccccCCCc----ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCCcHHHHHHHHHHhCCCC
Q 017452          220 SAKVLVKGEPN----ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDSGVDQLVEIIKVLGTPT  294 (371)
Q Consensus       220 ~a~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  294 (371)
                      +++........    ....++..|+|||.+.+.. ++.++|||||||++|||+| |..||.+.+..+.+..+.+....+ 
T Consensus       157 l~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~-  234 (273)
T d1u46a_         157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL-  234 (273)
T ss_dssp             TCEECCC-CCEEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC-
T ss_pred             hhhhcccCCCcceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC-
Confidence            99876444332    2345678899999997654 7999999999999999998 899999888777666554321000 


Q ss_pred             HhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          295 REEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                                                ..+..+|+++.+||.+||..||.+|||+.++++.|..
T Consensus       235 --------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~  271 (273)
T d1u46a_         235 --------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLE  271 (273)
T ss_dssp             --------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             --------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHh
Confidence                                      1345689999999999999999999999999988764

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-51  Score=369.58  Aligned_cols=254  Identities=22%  Similarity=0.298  Sum_probs=205.8

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcE--EEEEEeec-----chhhhHHHHHHHHHc-CCCCeeecceeEEecCCCCc
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGET--VAIKKVLQ-----DKRYKNRELQTMRLL-DHPNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~--vaiK~~~~-----~~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~~~~~  141 (371)
                      .++|++.+.||+|+||.||+|.++.+|..  ||||++..     ..+.+.+|+++|+++ +|||||++++++...     
T Consensus         9 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-----   83 (309)
T d1fvra_           9 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-----   83 (309)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-----
T ss_pred             HHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-----
Confidence            46899999999999999999999888875  67777643     234567899999998 799999999998543     


Q ss_pred             eeEEEeecccc-chHHHHHHHh------------hhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeC
Q 017452          142 LYLNLVLEYVP-ETVHRVVKHF------------NKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNP  208 (371)
Q Consensus       142 ~~~~lv~e~~~-~~l~~~~~~~------------~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~  208 (371)
                      ..+++||||++ |+|.+++...            ......+++..+..++.||+.||.|||++ +|+||||||+|||++.
T Consensus        84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~-~iiHrDlkp~NIL~~~  162 (309)
T d1fvra_          84 GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK-QFIHRDLAARNILVGE  162 (309)
T ss_dssp             TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT-TEECSCCSGGGEEECG
T ss_pred             CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC-CccccccccceEEEcC
Confidence            34889999999 5888877542            12346799999999999999999999987 9999999999999999


Q ss_pred             CCCcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHH
Q 017452          209 HTHQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEII  287 (371)
Q Consensus       209 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~  287 (371)
                      ++ .+||+|||+++............||..|+|||.+.+.. ++.++|||||||++|||++|. +||.+.+..+.+..+.
T Consensus       163 ~~-~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~  240 (309)
T d1fvra_         163 NY-VAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLP  240 (309)
T ss_dssp             GG-CEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGG
T ss_pred             CC-ceEEccccccccccccccccceecCCcccchHHhccCC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence            88 89999999998766555555667899999999997655 799999999999999999975 5777766555544433


Q ss_pred             HHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCC
Q 017452          288 KVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCP  359 (371)
Q Consensus       288 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~  359 (371)
                      +..                            .-..+..+++++.+||.+||+.||++|||+.+++++|+++.
T Consensus       241 ~~~----------------------------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~  284 (309)
T d1fvra_         241 QGY----------------------------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  284 (309)
T ss_dssp             GTC----------------------------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             hcC----------------------------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHH
Confidence            210                            01144568999999999999999999999999999987763

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-51  Score=368.71  Aligned_cols=249  Identities=28%  Similarity=0.456  Sum_probs=201.6

Q ss_pred             ccceeeeEeeccCCceEEEEEEEC---CCCcEEEEEEeecc--------hhhhHHHHHHHHHcCC-CCeeecceeEEecC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCL---ETGETVAIKKVLQD--------KRYKNRELQTMRLLDH-PNVVSLKHCFFSTT  137 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~---~~~~~vaiK~~~~~--------~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~  137 (371)
                      ..+|++++.||+|+||+||+|++.   .+|+.||||++.+.        .....+|++++++++| |||+++++++..  
T Consensus        23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~--  100 (322)
T d1vzoa_          23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQT--  100 (322)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEE--
T ss_pred             hhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeecc--
Confidence            367999999999999999999874   47899999988532        2345689999999987 799999988843  


Q ss_pred             CCCceeEEEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEE
Q 017452          138 DKDELYLNLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLC  216 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~  216 (371)
                         ...++++|||+.+ +|...+..    .+.+++..++.++.||+.||+|||++ ||+||||||+|||++.++ .+||+
T Consensus       101 ---~~~~~~v~e~~~~~~L~~~i~~----~~~~~e~~~~~~~~Qi~~al~~lH~~-~ivHrDiKp~Nill~~~~-~vkL~  171 (322)
T d1vzoa_         101 ---ETKLHLILDYINGGELFTHLSQ----RERFTEHEVQIYVGEIVLALEHLHKL-GIIYRDIKLENILLDSNG-HVVLT  171 (322)
T ss_dssp             ---TTEEEEEECCCCSCBHHHHHHH----HSCCCHHHHHHHHHHHHHHHHHHHHT-TCCCCCCCGGGEEECTTS-CEEES
T ss_pred             ---CCceeeeeecccccHHHHHHHh----cccccHHHHHHHHHHHHHHHHHhhcC-CEEeccCCccceeecCCC-CEEEe
Confidence               3458899999994 77766654    46788999999999999999999986 999999999999999988 89999


Q ss_pred             eeCCccccccC--CCcccccccccccCcccccCCc-CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Q 017452          217 DFGSAKVLVKG--EPNISYICSRYYRAPELIFGAT-EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLGTP  293 (371)
Q Consensus       217 Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~-~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~~~  293 (371)
                      |||+++.....  .......|++.|+|||.+.+.. .++.++|||||||+||+|++|+.||.+.+..+....+.+.....
T Consensus       172 DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~  251 (322)
T d1vzoa_         172 DFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKS  251 (322)
T ss_dssp             CSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHC
T ss_pred             eccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccC
Confidence            99999765332  2234567899999999996543 46889999999999999999999998776555555544432111


Q ss_pred             CHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCC-----CHHHHhhh
Q 017452          294 TREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRC-----TAVSKRIL  354 (371)
Q Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~-----t~~~~l~~  354 (371)
                      .                         ..++..+|+++.+||.+||.+||.+||     |++|+++|
T Consensus       252 ~-------------------------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         252 E-------------------------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             C-------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             C-------------------------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            0                         014556899999999999999999999     58998777

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-50  Score=363.12  Aligned_cols=255  Identities=21%  Similarity=0.302  Sum_probs=200.1

Q ss_pred             cccceeeeEeeccCCceEEEEEEECCCC-------cEEEEEEeecch-----hhhHHHHHHHHHc-CCCCeeecceeEEe
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCLETG-------ETVAIKKVLQDK-----RYKNRELQTMRLL-DHPNVVSLKHCFFS  135 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~-------~~vaiK~~~~~~-----~~~~~e~~~l~~l-~h~niv~~~~~~~~  135 (371)
                      ..++|++++.||+|+||.||+|++..++       ..||||++..+.     ....+|...+.++ +|||||++++++. 
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~-   89 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACT-   89 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccc-
Confidence            3468999999999999999999876544       479999986542     3344677788777 8999999999983 


Q ss_pred             cCCCCceeEEEeecccc-chHHHHHHHhhh------------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          136 TTDKDELYLNLVLEYVP-ETVHRVVKHFNK------------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~------------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                          +...+++||||+. |+|.+++.....            ....+++..++.++.||+.||+|||++ +||||||||+
T Consensus        90 ----~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~-~ivHrDiKp~  164 (299)
T d1fgka_          90 ----QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK-KCIHRDLAAR  164 (299)
T ss_dssp             ----SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             ----cCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC-CEEeeeeccc
Confidence                3445789999998 577777754321            235689999999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      |||++.++ .+||+|||+++.......   .....+|+.|+|||.+.+.. ++.++|||||||++|||++ |.+||.+.+
T Consensus       165 NiLl~~~~-~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~  242 (299)
T d1fgka_         165 NVLVTEDN-VMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP  242 (299)
T ss_dssp             GEEECTTC-CEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ceeecCCC-CeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC-CCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence            99999998 899999999987654432   23467899999999997654 8999999999999999998 788888776


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+....+... ..+                           ..+..+++++.+||.+||+.||++|||+.|+++.|+.+
T Consensus       243 ~~~~~~~i~~~-~~~---------------------------~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i  294 (299)
T d1fgka_         243 VEELFKLLKEG-HRM---------------------------DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI  294 (299)
T ss_dssp             HHHHHHHHHTT-CCC---------------------------CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHcC-CCC---------------------------CCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHH
Confidence            65544433221 101                           14566899999999999999999999999999998765


Q ss_pred             C
Q 017452          359 P  359 (371)
Q Consensus       359 ~  359 (371)
                      -
T Consensus       295 ~  295 (299)
T d1fgka_         295 V  295 (299)
T ss_dssp             H
T ss_pred             h
Confidence            3

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-50  Score=361.19  Aligned_cols=260  Identities=20%  Similarity=0.226  Sum_probs=209.7

Q ss_pred             ccceeeeEeeccCCceEEEEEEECC-----CCcEEEEEEeecch-----hhhHHHHHHHHHcCCCCeeecceeEEecCCC
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLE-----TGETVAIKKVLQDK-----RYKNRELQTMRLLDHPNVVSLKHCFFSTTDK  139 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~-----~~~~vaiK~~~~~~-----~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~  139 (371)
                      .++|++++.||+|+||.||+|.+..     ++..||||++....     ..+.+|+.++++++||||+++++++.     
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~-----   93 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS-----   93 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC-----
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe-----
Confidence            3589999999999999999998752     35789999986432     23468999999999999999999883     


Q ss_pred             CceeEEEeecccc-chHHHHHHHhhh------ccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCc
Q 017452          140 DELYLNLVLEYVP-ETVHRVVKHFNK------LNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQ  212 (371)
Q Consensus       140 ~~~~~~lv~e~~~-~~l~~~~~~~~~------~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~  212 (371)
                      .....++||||+. |+|.+++.....      ....+++..+..++.|++.||.|||++ +|+||||||+|||++.++ .
T Consensus        94 ~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~-~ivHrDlk~~NiLld~~~-~  171 (308)
T d1p4oa_          94 QGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN-KFVHRDLAARNCMVAEDF-T  171 (308)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT-TCBCSCCSGGGEEECTTC-C
T ss_pred             cCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC-CeeeceEcCCceeecCCc-e
Confidence            3334789999998 577777654321      224578899999999999999999987 999999999999999888 8


Q ss_pred             EEEEeeCCccccccCCC---cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCC-CCCCCCCcHHHHHHHHH
Q 017452          213 VKLCDFGSAKVLVKGEP---NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGK-PLFPGDSGVDQLVEIIK  288 (371)
Q Consensus       213 ~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~-~pf~~~~~~~~~~~~~~  288 (371)
                      +||+|||+|+.......   .....+|+.|+|||.+.+.. ++.++||||||+++|||+||. .||.+.+..+.+..+.+
T Consensus       172 ~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~-~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~  250 (308)
T d1p4oa_         172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME  250 (308)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHT
T ss_pred             EEEeecccceeccCCcceeeccceecccccCCHHHHccCC-CCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999987644332   23346799999999997654 789999999999999999984 78887776666655543


Q ss_pred             HhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcchhhc
Q 017452          289 VLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSLLVLH  365 (371)
Q Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~~~~~  365 (371)
                      ... +                           ..+..+++.+.++|.+||+.||.+|||+.+++++|++..+..+..
T Consensus       251 ~~~-~---------------------------~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         251 GGL-L---------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFRE  299 (308)
T ss_dssp             TCC-C---------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCTTHHH
T ss_pred             CCC-C---------------------------CCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCCCcC
Confidence            210 0                           034568899999999999999999999999999998876655443

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1e-49  Score=358.90  Aligned_cols=254  Identities=22%  Similarity=0.270  Sum_probs=198.1

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeEEEee
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLVL  148 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~  148 (371)
                      ++|++++.||+|+||.||+|++..+|+.||||++...  .....+|+++++.++|+|++..+..+...    ....++||
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~----~~~~~ivm   82 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE----GDYNVMVM   82 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEE----TTEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEec----CCEEEEEE
Confidence            4799999999999999999999999999999987543  45667899999999988776665544332    33478999


Q ss_pred             ccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC--CCcEEEEeeCCcccccc
Q 017452          149 EYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH--THQVKLCDFGSAKVLVK  226 (371)
Q Consensus       149 e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~--~~~~kl~Dfg~a~~~~~  226 (371)
                      ||+++++...+..   ....+++..+..++.|++.||+|||++ ||+||||||+|||++..  ...++|+|||+|+....
T Consensus        83 e~~~~~l~~~~~~---~~~~~~~~~~~~~~~qi~~~l~~lH~~-~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELLGPSLEDLFNF---CSRKFSLKTVLLLADQMISRIEYIHSK-NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECCCCBHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHT-TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEcCCchhhhhhh---ccCCCcHHHHHHHHHHHHHHHHHHHHC-CeeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            9999987766553   356899999999999999999999987 99999999999998542  23799999999987654


Q ss_pred             CCC--------cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhC---CCCH
Q 017452          227 GEP--------NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKVLG---TPTR  295 (371)
Q Consensus       227 ~~~--------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~~~---~~~~  295 (371)
                      ...        .....||+.|+|||.+.+.. ++.++|||||||++|||++|+.||...........+.+...   ..+.
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~  237 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  237 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCCh
Confidence            322        23457899999999997655 89999999999999999999999987665544333322110   0111


Q ss_pred             hHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcC
Q 017452          296 EEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSN  357 (371)
Q Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~  357 (371)
                      .                        .....+|+++.+|+.+||+.||.+||++.++.+.|++
T Consensus       238 ~------------------------~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  275 (299)
T d1ckia_         238 E------------------------VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRN  275 (299)
T ss_dssp             H------------------------HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHH
T ss_pred             h------------------------HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHH
Confidence            1                        0234689999999999999999999999887766554

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-49  Score=358.00  Aligned_cols=255  Identities=23%  Similarity=0.325  Sum_probs=205.9

Q ss_pred             cccceeeeEeeccCCceEEEEEEEC-----CCCcEEEEEEeecc-----hhhhHHHHHHHHHc-CCCCeeecceeEEecC
Q 017452           69 QTISYMAERIVGQGSFGVVFQAKCL-----ETGETVAIKKVLQD-----KRYKNRELQTMRLL-DHPNVVSLKHCFFSTT  137 (371)
Q Consensus        69 ~~~~y~~~~~lg~G~~g~V~~~~~~-----~~~~~vaiK~~~~~-----~~~~~~e~~~l~~l-~h~niv~~~~~~~~~~  137 (371)
                      ..++|++++.||+|+||.||+|++.     .+++.||||++...     ...+.+|+.+++.+ +|||||++++++.   
T Consensus        21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~---   97 (311)
T d1t46a_          21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACT---   97 (311)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC---
T ss_pred             CHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEe---
Confidence            3468999999999999999999863     46688999998653     23355799999998 6999999999983   


Q ss_pred             CCCceeEEEeecccc-chHHHHHHHhh--------------hccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCC
Q 017452          138 DKDELYLNLVLEYVP-ETVHRVVKHFN--------------KLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQ  202 (371)
Q Consensus       138 ~~~~~~~~lv~e~~~-~~l~~~~~~~~--------------~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~  202 (371)
                        .....++|||||+ |+|.+.+....              .....+++..+..++.||+.||+|||++ +|+||||||+
T Consensus        98 --~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~-~ivHrDLKp~  174 (311)
T d1t46a_          98 --IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK-NCIHRDLAAR  174 (311)
T ss_dssp             --SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGG
T ss_pred             --eCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC-Ceeecccccc
Confidence              3344789999998 57777776432              1234689999999999999999999987 9999999999


Q ss_pred             ceeeeCCCCcEEEEeeCCccccccCCCc---ccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q 017452          203 NLLVNPHTHQVKLCDFGSAKVLVKGEPN---ISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELML-GKPLFPGDS  278 (371)
Q Consensus       203 NIli~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~llt-g~~pf~~~~  278 (371)
                      ||+++.++ .+||+|||.++........   ....||+.|+|||.+.+.. ++.++|||||||++|||+| |.+||...+
T Consensus       175 NIl~~~~~-~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~  252 (311)
T d1t46a_         175 NILLTHGR-ITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (311)
T ss_dssp             GEEEETTT-EEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             cccccccC-cccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC-CCCcccccchHHHHHHHHhCCCCCCCCCC
Confidence            99999988 8999999999876543322   2357799999999997544 8999999999999999998 667777766


Q ss_pred             cHHHHHHHHHHhCCCCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          279 GVDQLVEIIKVLGTPTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      ..+.+.++++....+                           ..+..+++++.+||.+||+.||.+|||+.++++.|+..
T Consensus       253 ~~~~~~~~i~~~~~~---------------------------~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~  305 (311)
T d1t46a_         253 VDSKFYKMIKEGFRM---------------------------LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQ  305 (311)
T ss_dssp             SSHHHHHHHHHTCCC---------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCC---------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHh
Confidence            666666665532111                           13456789999999999999999999999999988753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-49  Score=354.72  Aligned_cols=251  Identities=20%  Similarity=0.250  Sum_probs=194.5

Q ss_pred             eeeeEeeccCCceEEEEEEECCCC---cEEEEEEeecc-----hhhhHHHHHHHHHcCCCCeeecceeEEecCCCCceeE
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETG---ETVAIKKVLQD-----KRYKNRELQTMRLLDHPNVVSLKHCFFSTTDKDELYL  144 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~---~~vaiK~~~~~-----~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~  144 (371)
                      +...++||+|+||+||+|.+..++   ..||||++...     ...+.+|++++++++||||+++++++...    ....
T Consensus        29 ~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~----~~~~  104 (311)
T d1r0pa_          29 VHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS----EGSP  104 (311)
T ss_dssp             EEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEET----TTEE
T ss_pred             eccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEec----CCce
Confidence            344688999999999999986543   36899988532     24467899999999999999999987543    2347


Q ss_pred             EEeeccccc-hHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          145 NLVLEYVPE-TVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       145 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      ++|||||++ +|.+++..   ....+++..+..++.|++.||.|||+. +|+||||||+|||++.++ .+||+|||+++.
T Consensus       105 ~lv~E~~~~g~l~~~~~~---~~~~~~~~~~~~i~~qia~gL~~lH~~-~iiHrDLK~~NILl~~~~-~~kL~DFG~~~~  179 (311)
T d1r0pa_         105 LVVLPYMKHGDLRNFIRN---ETHNPTVKDLIGFGLQVAKGMKFLASK-KFVHRDLAARNCMLDEKF-TVKVADFGLARD  179 (311)
T ss_dssp             EEEEECCTTCBHHHHHHC---TTCCCBHHHHHHHHHHHHHHHHHHHHT-TCCCSCCSGGGEEECTTC-CEEECSSGGGCC
T ss_pred             EEEEEEeecCchhhhhcc---ccccchHHHHHHHHHHHHHhhhhhccc-CcccCCccHHhEeECCCC-CEEEecccchhh
Confidence            899999995 55555442   245677888999999999999999986 999999999999999887 899999999987


Q ss_pred             cccCCC-----cccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHH-HHHHHHHHhCCCCHhH
Q 017452          224 LVKGEP-----NISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVD-QLVEIIKVLGTPTREE  297 (371)
Q Consensus       224 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~  297 (371)
                      ......     .....||+.|+|||.+.+.. ++.++||||||+++|||++|..||....... ....+.+.  ..    
T Consensus       180 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g--~~----  252 (311)
T d1r0pa_         180 MYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG--RR----  252 (311)
T ss_dssp             TTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTT--CC----
T ss_pred             ccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--CC----
Confidence            644322     22346789999999987654 8999999999999999999887776543322 22222211  00    


Q ss_pred             HhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCcc
Q 017452          298 IKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPSL  361 (371)
Q Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~~  361 (371)
                                            ...|..+++++.+||.+||+.||++|||+.|++++|+.+...
T Consensus       253 ----------------------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~  294 (311)
T d1r0pa_         253 ----------------------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST  294 (311)
T ss_dssp             ----------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             ----------------------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHh
Confidence                                  013456889999999999999999999999999998876543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.1e-48  Score=350.48  Aligned_cols=254  Identities=20%  Similarity=0.247  Sum_probs=203.2

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc--hhhhHHHHHHHHHcCC-CCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD--KRYKNRELQTMRLLDH-PNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h-~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      ++|++++.||+|+||+||+|++..+|+.||||++...  .....+|+++++.++| +|++.+++++.     .....++|
T Consensus         5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~-----~~~~~~~v   79 (293)
T d1csna_           5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQ-----EGLHNVLV   79 (293)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEE-----ETTEEEEE
T ss_pred             CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEee-----cCCccEEE
Confidence            5799999999999999999999999999999987543  4556789999999976 89999888773     34457899


Q ss_pred             eccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCC----CCcEEEEeeCCccc
Q 017452          148 LEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPH----THQVKLCDFGSAKV  223 (371)
Q Consensus       148 ~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~----~~~~kl~Dfg~a~~  223 (371)
                      |||++++|.+.+...   ...++...+..++.|++.||+|||++ ||+||||||+|||++.+    .+.+||+|||+|+.
T Consensus        80 me~~~~~l~~~~~~~---~~~~~~~~~~~i~~q~~~~l~~lH~~-giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~  155 (293)
T d1csna_          80 IDLLGPSLEDLLDLC---GRKFSVKTVAMAAKQMLARVQSIHEK-SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF  155 (293)
T ss_dssp             EECCCCBHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHTT-TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred             EEecCCCHHHHHHhh---ccchhhHHHHHHHHHHHHHHHHHHHC-CceeccCCccceeecCcccccCCceEEcccceeEE
Confidence            999999988876542   45799999999999999999999987 99999999999999642    23799999999987


Q ss_pred             cccCC--------CcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHH---HHHHHHHhCC
Q 017452          224 LVKGE--------PNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQ---LVEIIKVLGT  292 (371)
Q Consensus       224 ~~~~~--------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~---~~~~~~~~~~  292 (371)
                      .....        ......||+.|||||++.+.. ++.++|||||||++|+|++|..||.+......   ...+......
T Consensus       156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             cccCccccceeecccCceEEchhhcCHHHhcCCC-CChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            64322        223457999999999997654 89999999999999999999999976544332   2222222111


Q ss_pred             CCHhHHhhcCCCccccccCcccCCCCcccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCC
Q 017452          293 PTREEIKCMNPNYTEFKFPQIKAHPWHKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNC  358 (371)
Q Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~  358 (371)
                      .+...                        +...+|+++.+++..|+..+|.+||+.+.+.+.|.++
T Consensus       235 ~~~~~------------------------l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~  276 (293)
T d1csna_         235 TPLRE------------------------LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKV  276 (293)
T ss_dssp             SCHHH------------------------HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHH
T ss_pred             CChHH------------------------hcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHH
Confidence            11111                        2345789999999999999999999998887776654

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-49  Score=354.85  Aligned_cols=273  Identities=19%  Similarity=0.193  Sum_probs=192.7

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecchh-hhHH--HHHHHHHcCCCCeeecceeEEecCCCCceeEEEe
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDKR-YKNR--ELQTMRLLDHPNVVSLKHCFFSTTDKDELYLNLV  147 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~--e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv  147 (371)
                      .+|.+.+.||+|+||.||+|++  +|+.||||++..... ...+  |+..+..++|||||++++++.... .....+++|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~-~~~~~~~lv   79 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDN-GTWTQLWLV   79 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC-SSSEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCC-CcceEEEEE
Confidence            3699999999999999999986  789999999865432 2223  444556789999999999887654 344568899


Q ss_pred             ecccc-chHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHh-------cCCcEeeccCCCceeeeCCCCcEEEEeeC
Q 017452          148 LEYVP-ETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHR-------SIGVCHRDIKPQNLLVNPHTHQVKLCDFG  219 (371)
Q Consensus       148 ~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~-------~~~ivH~dlkp~NIli~~~~~~~kl~Dfg  219 (371)
                      |||++ |+|.+.+..     ..+++..+..++.|++.||+|||.       ..||+||||||+|||++.++ .+||+|||
T Consensus        80 ~Ey~~~g~L~~~l~~-----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~-~~Kl~DFG  153 (303)
T d1vjya_          80 SDYHEHGSLFDYLNR-----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG-TCCIADLG  153 (303)
T ss_dssp             EECCTTCBHHHHHHH-----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTS-CEEECCCT
T ss_pred             EecccCCCHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCC-CeEEEecC
Confidence            99998 588888763     468999999999999999999995       23999999999999999988 89999999


Q ss_pred             CccccccCCC-----cccccccccccCcccccCCc-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHH
Q 017452          220 SAKVLVKGEP-----NISYICSRYYRAPELIFGAT-----EYTTAIDIWSAGCVVAELMLGKPLFPGDSGVDQLVEIIKV  289 (371)
Q Consensus       220 ~a~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~~~~  289 (371)
                      +++.......     .....||+.|+|||.+.+..     .++.++|||||||++|||+||..||............. .
T Consensus       154 l~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~-~  232 (303)
T d1vjya_         154 LAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL-V  232 (303)
T ss_dssp             TCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT-S
T ss_pred             ccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhc-c
Confidence            9987654332     23467899999999986532     14668999999999999999998874422111000000 0


Q ss_pred             hCCCCHhHHhhcCCCccccccCcccCCCC-cccCCCCCChhHHHHHHhccCcCCCCCCCHHHHhhhhcCCCc
Q 017452          290 LGTPTREEIKCMNPNYTEFKFPQIKAHPW-HKIFPKRMPPEAVDLVSRLLQYSPNLRCTAVSKRILFSNCPS  360 (371)
Q Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~l~~l~~~~~  360 (371)
                      ...+....+...      ...... .... ...........+.+|+.+||+.||.+|||+.|++++|+.+..
T Consensus       233 ~~~~~~~~~~~~------~~~~~~-~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~  297 (303)
T d1vjya_         233 PSDPSVEEMRKV------VCEQKL-RPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ  297 (303)
T ss_dssp             CSSCCHHHHHHH------HTTSCC-CCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             cccchHHHHHHH------Hhcccc-CCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHH
Confidence            000000000000      000000 0000 000011123468999999999999999999999999987643

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.6e-46  Score=345.66  Aligned_cols=279  Identities=29%  Similarity=0.472  Sum_probs=203.9

Q ss_pred             ccceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch---hhhHHHHHHHHHcC-----------CCCeeecceeEEe
Q 017452           70 TISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK---RYKNRELQTMRLLD-----------HPNVVSLKHCFFS  135 (371)
Q Consensus        70 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~e~~~l~~l~-----------h~niv~~~~~~~~  135 (371)
                      .++|++++.||+|+||+||+|++..+|+.||||++.++.   ....+|+.+++.++           |+||+++++++..
T Consensus        12 ~~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~   91 (362)
T d1q8ya_          12 DARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH   91 (362)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeee
Confidence            357999999999999999999999999999999997653   34467888888775           5789999888754


Q ss_pred             cCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCCC----
Q 017452          136 TTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHTH----  211 (371)
Q Consensus       136 ~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~~----  211 (371)
                      .. ......++.+++..++......  ......+++..++.++.||+.||+|||+..||+||||||+|||++.++.    
T Consensus        92 ~~-~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~  168 (362)
T d1q8ya_          92 KG-PNGVHVVMVFEVLGENLLALIK--KYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL  168 (362)
T ss_dssp             EE-TTEEEEEEEECCCCEEHHHHHH--HTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTE
T ss_pred             cc-ccceeeeeeecccccccccccc--cccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCccccc
Confidence            33 2223333344444444333332  3446788999999999999999999997449999999999999986652    


Q ss_pred             -cEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHHHHHHhCCCCCCCCC------cHHHHH
Q 017452          212 -QVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVVAELMLGKPLFPGDS------GVDQLV  284 (371)
Q Consensus       212 -~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~------~~~~~~  284 (371)
                       .++++|||.+.....  ......||+.|+|||++.... ++.++|+||+||++++|++|+.||....      ..+.+.
T Consensus       169 ~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~  245 (362)
T d1q8ya_         169 IQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIA  245 (362)
T ss_dssp             EEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHH
T ss_pred             ceeeEeeccccccccc--ccccccccccccChhhccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHH
Confidence             499999999876533  334577999999999997655 7999999999999999999999996543      235567


Q ss_pred             HHHHHhCCCCHhHHhhcCCCcccc-------ccCcccCCCCcc------cCCCCCChhHHHHHHhccCcCCCCCCCHHHH
Q 017452          285 EIIKVLGTPTREEIKCMNPNYTEF-------KFPQIKAHPWHK------IFPKRMPPEAVDLVSRLLQYSPNLRCTAVSK  351 (371)
Q Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~------~~~~~~s~~l~~li~~~l~~dP~~R~t~~~~  351 (371)
                      .....+|.++.+.+.........+       ........++..      .++...++++.+||.+||++||.+||||+|+
T Consensus       246 ~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~  325 (362)
T d1q8ya_         246 QIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGL  325 (362)
T ss_dssp             HHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHH
T ss_pred             HHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHH
Confidence            777888888777654322111111       111111111111      1223456789999999999999999999998


Q ss_pred             hhh
Q 017452          352 RIL  354 (371)
Q Consensus       352 l~~  354 (371)
                      |+|
T Consensus       326 L~H  328 (362)
T d1q8ya_         326 VNH  328 (362)
T ss_dssp             HTC
T ss_pred             hcC
Confidence            877

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.92  E-value=5e-26  Score=189.72  Aligned_cols=166  Identities=16%  Similarity=0.121  Sum_probs=116.7

Q ss_pred             eeeeEeeccCCceEEEEEEECCCCcEEEEEEeecch----------------------hhhHHHHHHHHHcCCCCeeecc
Q 017452           73 YMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQDK----------------------RYKNRELQTMRLLDHPNVVSLK  130 (371)
Q Consensus        73 y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----------------------~~~~~e~~~l~~l~h~niv~~~  130 (371)
                      |.++++||+|+||+||+|.+ .+|+.||||++....                      ....+|...+.++.|.+++..+
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~-~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~   80 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVY   80 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEE
T ss_pred             chhCCEeeeCcceEEEEEEC-CCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEE
Confidence            57899999999999999997 478999999864210                      1123577888899999988876


Q ss_pred             eeEEecCCCCceeEEEeeccccchHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcEeeccCCCceeeeCCC
Q 017452          131 HCFFSTTDKDELYLNLVLEYVPETVHRVVKHFNKLNQRMPMIYVKLYAYQIFRALSYIHRSIGVCHRDIKPQNLLVNPHT  210 (371)
Q Consensus       131 ~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~ivH~dlkp~NIli~~~~  210 (371)
                      +..     .    .+++|||+++..          ...++...+..++.|++.+|.|||++ ||+||||||+|||++++ 
T Consensus        81 ~~~-----~----~~lvme~~~~~~----------~~~l~~~~~~~i~~ql~~~l~~lH~~-giiHrDiKP~NILv~~~-  139 (191)
T d1zara2          81 AWE-----G----NAVLMELIDAKE----------LYRVRVENPDEVLDMILEEVAKFYHR-GIVHGDLSQYNVLVSEE-  139 (191)
T ss_dssp             EEE-----T----TEEEEECCCCEE----------GGGCCCSCHHHHHHHHHHHHHHHHHT-TEECSCCSTTSEEEETT-
T ss_pred             Eec-----C----CEEEEEeecccc----------ccchhhHHHHHHHHHHHHHHHHHhhC-CEEEccCChhheeeeCC-
Confidence            543     2    268999999741          12345566778999999999999987 99999999999999965 


Q ss_pred             CcEEEEeeCCccccccCCCcccccccccccCcccccCCcCCCCcchHHHHHHHH
Q 017452          211 HQVKLCDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTAIDIWSAGCVV  264 (371)
Q Consensus       211 ~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  264 (371)
                       .++|+|||+|..........-....... -.+.+ . ..++.++|+||+.--+
T Consensus       140 -~~~liDFG~a~~~~~~~~~~~l~rd~~~-~~~~f-~-r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         140 -GIWIIDFPQSVEVGEEGWREILERDVRN-IITYF-S-RTYRTEKDINSAIDRI  189 (191)
T ss_dssp             -EEEECCCTTCEETTSTTHHHHHHHHHHH-HHHHH-H-HHHCCCCCHHHHHHHH
T ss_pred             -CEEEEECCCcccCCCCCcHHHHHHHHHH-HHHHH-c-CCCCCcccHHHHHHHH
Confidence             4999999999765322211000000000 00111 1 2368899999976433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.37  E-value=7.3e-07  Score=75.78  Aligned_cols=77  Identities=17%  Similarity=0.110  Sum_probs=49.6

Q ss_pred             cceeeeEeeccCCceEEEEEEECCCCcEEEEEEeecc----hhhhHHHHHHHHHcC-CCCeeecceeEEecCCCCceeEE
Q 017452           71 ISYMAERIVGQGSFGVVFQAKCLETGETVAIKKVLQD----KRYKNRELQTMRLLD-HPNVVSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        71 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~~  145 (371)
                      ..|++.+..+.++.+.||+..  .++..+++|+....    .....+|...++.+. +--+.+++...     ......+
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~-----~~~~~~~   86 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFE-----RHDGWSN   86 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEE-----EETTEEE
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEE-----ecCCceE
Confidence            357777776656667999886  36667888987543    234578898888774 22234444433     1223467


Q ss_pred             Eeeccccch
Q 017452          146 LVLEYVPET  154 (371)
Q Consensus       146 lv~e~~~~~  154 (371)
                      +||++++|.
T Consensus        87 lv~~~l~G~   95 (263)
T d1j7la_          87 LLMSEADGV   95 (263)
T ss_dssp             EEEECCSSE
T ss_pred             EEEEecccc
Confidence            899999873

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.10  E-value=1e-05  Score=68.06  Aligned_cols=69  Identities=16%  Similarity=0.109  Sum_probs=43.3

Q ss_pred             eccCC-ceEEEEEEECCCCcEEEEEEeecch-hhhHHHHHHHHHcCCCC--eeecceeEEecCCCCceeEEEeeccccc
Q 017452           79 VGQGS-FGVVFQAKCLETGETVAIKKVLQDK-RYKNRELQTMRLLDHPN--VVSLKHCFFSTTDKDELYLNLVLEYVPE  153 (371)
Q Consensus        79 lg~G~-~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~e~~~l~~l~h~n--iv~~~~~~~~~~~~~~~~~~lv~e~~~~  153 (371)
                      +..|. .+.||+.. ...+..+++|...... ....+|...++.+....  +.+++.+..     +....++||++++|
T Consensus        18 ~~~G~s~~~v~r~~-~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~-----~~~~~~~v~~~i~G   90 (255)
T d1nd4a_          18 QTIGCSDAAVFRLS-AQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVT-----EAGRDWLLLGEVPG   90 (255)
T ss_dssp             CSCTTSSCEEEEEE-CTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEE-----CSSCEEEEEECCSS
T ss_pred             cCCcccCCeEEEEE-eCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecc-----cccceEEEEEeeec
Confidence            34444 46889887 4566778899775443 34678999888875433  334444331     22346789999975

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.99  E-value=2.2e-05  Score=70.56  Aligned_cols=71  Identities=17%  Similarity=0.157  Sum_probs=42.7

Q ss_pred             eEeeccCCceEEEEEEECCCCcEEEEEEeec-----------chhhhHHHHHHHHHcC-C--CCeeecceeEEecCCCCc
Q 017452           76 ERIVGQGSFGVVFQAKCLETGETVAIKKVLQ-----------DKRYKNRELQTMRLLD-H--PNVVSLKHCFFSTTDKDE  141 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----------~~~~~~~e~~~l~~l~-h--~niv~~~~~~~~~~~~~~  141 (371)
                      .+.||.|....||++.+..+++.+++|.-..           .......|.+.|+.+. +  ..+++++.+  .   .+.
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d---~~~  105 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--D---TEM  105 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--E---TTT
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--c---CCC
Confidence            4568999999999998777788899996421           1122456888887763 2  234444332  2   112


Q ss_pred             eeEEEeeccccc
Q 017452          142 LYLNLVLEYVPE  153 (371)
Q Consensus       142 ~~~~lv~e~~~~  153 (371)
                        .++|||++++
T Consensus       106 --~~lvmE~L~~  115 (392)
T d2pula1         106 --AVTVMEDLSH  115 (392)
T ss_dssp             --TEEEECCCTT
T ss_pred             --CEEEEeccCC
Confidence              3579999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.13  E-value=0.0015  Score=58.23  Aligned_cols=69  Identities=17%  Similarity=0.228  Sum_probs=44.0

Q ss_pred             eEeeccCCceEEEEEEECC-------CCcEEEEEEeecc--hhhhHHHHHHHHHcCCCCe-eecceeEEecCCCCceeEE
Q 017452           76 ERIVGQGSFGVVFQAKCLE-------TGETVAIKKVLQD--KRYKNRELQTMRLLDHPNV-VSLKHCFFSTTDKDELYLN  145 (371)
Q Consensus        76 ~~~lg~G~~g~V~~~~~~~-------~~~~vaiK~~~~~--~~~~~~e~~~l~~l~h~ni-v~~~~~~~~~~~~~~~~~~  145 (371)
                      ++.|+.|-.-.+|++....       ....|++++.-..  .....+|..+++.+.-.++ .++++++     .+    .
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~-----~~----g  117 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-----SG----G  117 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-----TT----E
T ss_pred             EEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc-----CC----c
Confidence            3567888888999987542       3456888876532  2334578888888753344 4555554     21    4


Q ss_pred             Eeeccccc
Q 017452          146 LVLEYVPE  153 (371)
Q Consensus       146 lv~e~~~~  153 (371)
                      +|++|++|
T Consensus       118 ~I~efi~g  125 (395)
T d1nw1a_         118 RLEEYIPS  125 (395)
T ss_dssp             EEECCCCE
T ss_pred             eEEEEecc
Confidence            68888875

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.05  E-value=0.00095  Score=57.85  Aligned_cols=38  Identities=18%  Similarity=-0.017  Sum_probs=28.2

Q ss_pred             ceEEEEEEECCCCcEEEEEEeecc---hhhhHHHHHHHHHcC
Q 017452           84 FGVVFQAKCLETGETVAIKKVLQD---KRYKNRELQTMRLLD  122 (371)
Q Consensus        84 ~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~e~~~l~~l~  122 (371)
                      --.||++. ..+|..|++|+....   ...+..|...+..|.
T Consensus        35 EN~vy~v~-~~dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~   75 (325)
T d1zyla1          35 ENRVYQFQ-DEDRRRFVVKFYRPERWTADQILEEHQFALQLV   75 (325)
T ss_dssp             SSEEEEEC-CTTCCCEEEEEECTTTSCHHHHHHHHHHHHHHH
T ss_pred             cceeEEEE-cCCCCEEEEEEeCCCCCCHHHHHHHHHHHHHHH
Confidence            35799997 467899999988653   345667888887774

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.88  E-value=0.0024  Score=54.77  Aligned_cols=30  Identities=30%  Similarity=0.269  Sum_probs=26.3

Q ss_pred             CcEeeccCCCceeeeCCCCcEEEEeeCCccc
Q 017452          193 GVCHRDIKPQNLLVNPHTHQVKLCDFGSAKV  223 (371)
Q Consensus       193 ~ivH~dlkp~NIli~~~~~~~kl~Dfg~a~~  223 (371)
                      |+||+|+.++||+++.+. ..-|+||+.+..
T Consensus       184 giIHgDl~~dNvl~~~~~-v~gvIDF~~~~~  213 (316)
T d2ppqa1         184 GVIHADLFQDNVFFLGDE-LSGLIDFYFACN  213 (316)
T ss_dssp             EEECSCCCGGGEEEETTE-EEEECCCTTCEE
T ss_pred             ccccCCcchhhhhccccc-ceeEeccccccc
Confidence            799999999999999776 568999998753